PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, Y; Cui, P; Li, YH; Feng, GH; Tong, M; Guo, L; Li, TD; Liu, L; Li, W; Zhou, Q				Zhang, Ying; Cui, Peng; Li, Yuhuan; Feng, Guihai; Tong, Man; Guo, Lu; Li, Tianda; Liu, Lei; Li, Wei; Zhou, Qi			Mitochondrially produced ATP affects stem cell pluripotency via ActI6a-mediated histone acetylation	FASEB JOURNAL			English	Article						mitochondria; oxidative phosphorylation; developmental ability; epigenetics; regenerative medicine	CHROMATIN REMODELING COMPLEX; GLYCOLYTIC METABOLISM; NEURAL DEVELOPMENT; SELF-RENEWAL; IPS CELLS; DIFFERENTIATION; SUBUNIT; ACTIVATION; ENZYMES; SWITCH	ATP is mainly generated by glycolysis in pluripotent stem cells (PSCs) and is consumed to maintain cell viability. Differences in mitochondrial activity among induced (i) PSCs with different degrees of pluripotency are poorly understood. In this study, by comparing gene expression and mitochondrial activity among iPSCs with different degrees of pluripotency, we found that mitochondrial complex I gene expression, complex I activity, and cellular ATP levels were much higher in fully pluripotent stem cell lines than in partially pluripotent stem cell lines. Actin-like protein 6a (Actl6a), a component of ATP-dependent chromatin remodeling and histone acetylation complexes, was more highly expressed in fully pluripotent stem cell lines. ATP promoted Actl6a expression and histone acetylation. Actl6a knockdown reduced the pluripotency of embryonic stem cells (ESCs), and this reduction could not be rescued by the addition of ATP. Furthermore, inhibiting ATP formation by treatment with rotenone reduced the pluripotency of ESCs. These data suggest that the abundance of mitochondrially produced ATP affects stem cell pluripotency via Actl6a-mediated histone acetylation.	[Zhang, Ying; Cui, Peng; Li, Yuhuan; Feng, Guihai; Guo, Lu; Li, Tianda; Liu, Lei; Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Tong, Man] Chinese Acad Sci, Inst Genet & Dev Biol, Collaborat Ctr Genet & Dev, Key Lab Genet Network Biol, Beijing, Peoples R China; [Cui, Peng; Li, Yuhuan] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhouqi@ioz.ac.cn	Feng, Guihai/A-5105-2019	Feng, Guihai/0000-0002-8726-1734	National Basic Research Program of China [2014CB964903]; National Natural Science Foundation of China [31621004, 31471395]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 31621004 and 31471395 to Q.Z.), and the National Basic Research Program of China (Grant 2014CB964903). The authors declare no conflicts of interest.	Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; HEINEMAN FW, 1990, ANNU REV PHYSIOL, V52, P523; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee JH, 2003, MOL CELLS, V16, P78; Lee K, 2007, MOL BIOL CELL, V18, P4013, DOI 10.1091/mbc.E07-05-0437; Lee K, 2011, BIOCHEM BIOPH RES CO, V412, P328, DOI 10.1016/j.bbrc.2011.07.098; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Lu WS, 2015, STEM CELLS, V33, P1782, DOI 10.1002/stem.2000; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mu XP, 2015, CELL REPROGRAM, V17, P259, DOI 10.1089/cell.2014.0102; Novershtern N, 2011, NAT CELL BIOL, V13, P886, DOI 10.1038/ncb2311; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Sawan C, 2013, STEM CELLS, V31, P979, DOI 10.1002/stem.1341; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150454; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	43	16	16	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1891	1902		10.1096/fj.201700626RR	http://dx.doi.org/10.1096/fj.201700626RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29222327				2022-12-26	WOS:000429051400013
J	Araujo, SA; Soares, AMD; Silva, CR; Almeida, EB; Rocha, CAUQ; Ferreira, ATD; Perales, J; Costa, LM				Araujo, Sandra Alves; dos Santos Soares, Alexandra Martins; Silva, Carolina Rocha; Almeida Junior, Eduardo Bezerra; Rocha, Claudia Quintino; da Silva Ferreira, Andre Teixeira; Perales, Jonas; Costa-Junior, Livio M.			In vitro anthelmintic effects of Spigelia anthelmia protein fractions against Haemonchus contortus	PLOS ONE			English	Article							TANNIFEROUS PLANT-EXTRACTS; GASTROINTESTINAL NEMATODES; PARASITIC NEMATODES; NEMATOPHAGOUS FUNGI; RESISTANCE; LECTINS; SHEEP; EXSHEATHMENT; HELMINTHS; LIVESTOCK	Gastrointestinal nematodes are a significant concern for animal health and well-being, and anthelmintic treatment is mainly performed through the use of chemical products. However, bioactive compounds produced by plants have shown promise for development as novel anthelmintics. The aim of this study is to assess the anthelmintic activity of protein fractions from Spigelia anthelmia on the gastrointestinal nematode Haemonchus contortus. Plant parts were separated into leaves, stems and roots, washed with distilled water, freeze-dried and ground into a fine powder. Protein extraction was performed with sodium phosphate buffer (75 mM, pH 7.0). The extract was fractionated using ammonium sulfate (0 +/- 90%) and extensively dialyzed. The resulting fractions were named LPF (leaf protein fraction), SPF (stem protein fraction) and RPF (root protein fraction), and the protein contents and activities of the fractions were analyzed. H. contortus egg hatching (EHA), larval exsheathment inhibition (LEIA) and larval migration inhibition (LMIA) assays were performed. Proteomic analysis was conducted, and high-performance liquid chromatography (HPLC) chromatographic profiles of the fractions were established to identify proteins and possible secondary metabolites. S. anthelmia fractions inhibited H. contortus egg hatching, with LPF having the most potent effects (EC50 0.17 mg mL(-1)). During LEIA, SPF presented greater efficiency than the other fractions (EC50 0.25 mg mL(-1)). According to LMIA, the fractions from roots, stems and leaves also reduced the number of larvae, with EC50 values of 0.11, 0.14 and 0.21 mg mL(-1), respectively. Protein analysis indicated the presence of plant defense proteins in the S. anthelmia fractions, including protease, protease inhibitor, chitinase and others. Conversely, secondary metabolites were absent in the S. anthemia fractions. These results suggest that S. anthelmia proteins are promising for the control of the gastrointestinal nematode H. contortus.	[Araujo, Sandra Alves; dos Santos Soares, Alexandra Martins] Univ Fed Maranhao, Ctr Exact Sci & Technol, Lab Plant Biochem, Chem Engn Course, Sao Luis, MA, Brazil; [Silva, Carolina Rocha; Costa-Junior, Livio M.] Univ Fed Maranhao, Dept Pathol, Ctr Biol & Hlth Sci, Lab Parasite Control, Sao Luis, MA, Brazil; [Almeida Junior, Eduardo Bezerra] Univ Fed Maranhao, Dept Biol, Ctr Biol & Hlth Sci, Lab Bot Studies, Sao Luis, MA, Brazil; [Rocha, Claudia Quintino] Univ Fed Maranhao, Dept Chem, Ctr Exact Sci & Technol, Lab Adv Studies Phytomed, Sao Luis, MA, Brazil; [da Silva Ferreira, Andre Teixeira; Perales, Jonas] Fundacao Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Fundacao Oswaldo Cruz	Soares, AMD (corresponding author), Univ Fed Maranhao, Ctr Exact Sci & Technol, Lab Plant Biochem, Chem Engn Course, Sao Luis, MA, Brazil.; Costa, LM (corresponding author), Univ Fed Maranhao, Dept Pathol, Ctr Biol & Hlth Sci, Lab Parasite Control, Sao Luis, MA, Brazil.	alexandra.ufma@gmail.com; livio.martins@ufma.br	Costa-Junior, Livio M/H-7530-2012; da Rocha, Claudia Quintino/U-8013-2019; Rocha, Cláudia Quintino da/C-2320-2013	Costa-Junior, Livio M/0000-0002-1475-049X; da Rocha, Claudia Quintino/0000-0002-3578-1869; Rocha, Cláudia Quintino da/0000-0002-3578-1869; Alves de Araujo, Sandra/0000-0001-6398-9686; Rocha e Silva, Carolina/0000-0001-8667-1064	CNPq (The Brazilian National Council for Scientific and Technological Development); CAPES (the Brazilian Federal Agency for support and evaluation of graduate education); CNPq (The Brazilian National Council for Scientific and Technological Development) [447877/2014-3]; FAPEMA (Maranhao State Research Foundation) [PRONEM-01773/14]	CNPq (The Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (the Brazilian Federal Agency for support and evaluation of graduate education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (The Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMA (Maranhao State Research Foundation)	The work was supported by the following: CNPq (The Brazilian National Council for Scientific and Technological Development), grant number 447877/2014-3; and FAPEMA (Maranhao State Research Foundation), grant number PRONEM-01773/14.; The authors wish to thank the CNPq (The Brazilian National Council for Scientific and Technological Development) for awarding a fellowship to L.M. Costa-Junior and J. Perales, and CAPES (the Brazilian Federal Agency for support and evaluation of graduate education) for their scholarships to C.R. Silva and S.A. Araujo. We also thank Technology Platform Network from FIOCRUZ, Brazil for facilities support.	ABE M, 1992, EUR J BIOCHEM, V209, P933, DOI 10.1111/j.1432-1033.1992.tb17365.x; Ademola IO, 2007, PARASITOL RES, V101, P63, DOI 10.1007/s00436-006-0444-0; Assis LM, 2003, VET PARASITOL, V117, P43, DOI 10.1016/j.vetpar.2003.07.021; Bahuaud D, 2006, PARASITOLOGY, V132, P545, DOI 10.1017/S0031182005009509; Benchabane M, 2010, BIOCHIMIE, V92, P1657, DOI 10.1016/j.biochi.2010.06.006; de Oliveira LMB, 2011, REV BRAS PARASITOL V, V20, P155, DOI 10.1590/S1984-29612011000200011; Boller T, 1992, MOL PLANT PATHOL, P23; Boss EA, 2004, CHEM ENG PROCESS, V43, P1475, DOI 10.1016/j.cep.2004.01.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga FR, 2014, RES VET SCI, V97, P527, DOI 10.1016/j.rvsc.2014.09.005; COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; Soares AMD, 2015, REV BRAS PARASITOL V, V24, P396, DOI 10.1590/S1984-29612015072; Elandalousi RB, 2013, VET PARASITOL, V197, P374, DOI 10.1016/j.vetpar.2013.05.016; FETTERER RH, 1993, VET PARASITOL, V46, P103, DOI 10.1016/0304-4017(93)90051-N; Filipenko E., 2013, RUSSIAN J GENETICS A, V3, P474, DOI 10.1134/S2079059713060026; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Graphpad Software Inc., 2007, PRISM DAT AN SOFTW V; He MZ, 2015, ECOL EVOL, V5, P1494, DOI 10.1002/ece3.1441; Heim C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1032-x; Irum S, 2015, VET PARASITOL, V212, P451, DOI 10.1016/j.vetpar.2015.06.028; Jackson F, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P25, DOI 10.1007/978-90-481-3297-3_3; Liang LM, 2010, FASEB J, V24, P1391, DOI 10.1096/fj.09-136408; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Makkar HPS, 2003, SMALL RUMINANT RES, V49, P241, DOI 10.1016/S0921-4488(03)00142-1; MANSFIELD LS, 1992, COMP BIOCHEM PHYS B, V103, P681, DOI 10.1016/0305-0491(92)90390-D; MARBANMENDOZA N, 1987, J NEMATOL, V19, P331; Marie-Magdeleine C, 2010, RES VET SCI, V89, P88, DOI 10.1016/j.rvsc.2010.01.002; Martinez-Ortiz-de-Montellano C, 2013, EXP PARASITOL, V133, P281, DOI 10.1016/j.exppara.2012.11.024; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Nurit Kiriaki, 2005, Acta Bot. Bras., V19, P407, DOI 10.1590/S0102-33062005000200024; Rios-de Alvarez L, 2012, VET PARASITOL, V186, P390, DOI 10.1016/j.vetpar.2011.11.004; Rocha RO, 2015, J AGR FOOD CHEM, V63, P5335, DOI 10.1021/acs.jafc.5b01109; Roditakis E, 2005, PEST MANAG SCI, V61, P577, DOI 10.1002/ps.1029; ROGERS W. P., 1966, Biology of parasites. Emphasis on veterinary parasites., P33; ROGERS WP, 1965, COMP BIOCHEM PHYSIOL, V14, P311, DOI 10.1016/0010-406X(65)90207-0; ROGERS WP, 1977, INT J PARASITOL, V7, P61, DOI 10.1016/0020-7519(77)90026-1; Rogers WP, 1962, NATURE PARASITISM; Rose Hannah, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P209, DOI 10.1016/j.ijppaw.2014.01.001; Salgado JA, 2016, REV BRAS PARASITOL V, V25, P3, DOI 10.1590/S1984-29612016008; Sandoval-Castro CA, 2012, ANIM FEED SCI TECH, V176, P192, DOI 10.1016/j.anifeedsci.2012.07.023; Scopes R. K, 1994, PROTEIN PURIFICATION, V3rd, DOI 10.1007/978-1-4757-2333-5; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Shih MC, 2011, INT J MOL SCI, V12, P6077, DOI 10.3390/ijms12096077; Simpraga M, 2015, BERL MUNCH TIERARZTL, V128, P257, DOI 10.2376/0005-9366-128-257; Wang JW, 2013, FEMS MICROBIOL LETT, V344, P53, DOI 10.1111/1574-6968.12154; XAVIERFILHO J, 1989, J AGR FOOD CHEM, V37, P1139, DOI 10.1021/jf00088a071	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189803	10.1371/journal.pone.0189803	http://dx.doi.org/10.1371/journal.pone.0189803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244856	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700067
J	Einarsdottir, E; Grauers, A; Wang, JW; Jiao, H; Escher, SA; Danielsson, A; Simony, A; Andersen, M; Christensen, SB; Akesson, K; Kou, I; Khanshour, AM; Ohlin, A; Wise, C; Ikegawa, S; Kere, J; Gerdhem, P				Einarsdottir, Elisabet; Grauers, Anna; Wang, Jingwen; Jiao, Hong; Escher, Stefan A.; Danielsson, Aina; Simony, Ane; Andersen, Mikkel; Christensen, Steen Bach; Akesson, Kristina; Kou, Ikuyo; Khanshour, Anas M.; Ohlin, Acke; Wise, Carol; Ikegawa, Shiro; Kere, Juha; Gerdhem, Paul			CELSR2 is a candidate susceptibility gene in idiopathic scoliosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; FUNCTIONAL SNP; VARIANTS; CADHERINS; DISEASE; GPR126; PLINK; GWAS; LBX1	A Swedish pedigree with an autosomal dominant inheritance of idiopathic scoliosis was initially studied by genetic linkage analysis, prioritising genomic regions for further analysis. This revealed a locus on chromosome 1 with a putative risk haplotype shared by all affected individuals. Two affected individuals were subsequently exome-sequenced, identifying a rare, non-synonymous variant in the CELSR2 gene. This variant is rs141489111, a c. G6859A change in exon 21 (NM_001408), leading to a predicted p. V2287I (NP_001399.1) change. This variant was found in all affected members of the pedigree, but showed reduced penetrance. Analysis of tagging variants in CELSR1-3 in a set of 1739 Swedish-Danish scoliosis cases and 1812 controls revealed significant association (p = 0.0001) to rs2281894, a common synonymous variant in CELSR2. This association was not replicated in case-control cohorts from Japan and the US. No association was found to variants in CELSR1 or CELSR3. Our findings suggest a rare variant in CELSR2 as causative for idiopathic scoliosis in a family with dominant segregation and further highlight common variation in CELSR2 in general susceptibility to idiopathic scoliosis in the Swedish-Danish population. Both variants are located in the highly conserved GAIN protein domain, which is necessary for the auto-proteolysis of CELSR2, suggesting its functional importance.	[Einarsdottir, Elisabet; Kere, Juha] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Einarsdottir, Elisabet; Kere, Juha] Univ Helsinki, Mol Neurol Res Program, Helsinki, Finland; [Einarsdottir, Elisabet; Wang, Jingwen; Jiao, Hong; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Grauers, Anna] Sundsvall & Harnosand Cty Hosp, Dept Orthopaed, Sundsvall, Sweden; [Grauers, Anna; Gerdhem, Paul] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Escher, Stefan A.] Lund Univ, Genet & Mol Epidemiol Unit, Diabet Ctr, Dept Clin Sci, Malmo, Sweden; [Danielsson, Aina] Gothenburg Univ, Sahlgren Acad, Inst Clin Sci, Dept Orthopaed, Gothenburg, Sweden; [Danielsson, Aina] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden; [Simony, Ane; Andersen, Mikkel; Christensen, Steen Bach] Middelfart Hosp, Sect Spine Surg & Res, Middelfart, Denmark; [Akesson, Kristina] Lund Univ, Dept Clin Sci Malmo, Clin & Mol Osteoporosis Res Unit, Malmo, Sweden; [Akesson, Kristina] Skane Univ Hosp, Dept Orthoped, Malmo, Sweden; [Kou, Ikuyo; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Integrat Med Sci, Tokyo, Japan; [Khanshour, Anas M.; Wise, Carol] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Ohlin, Acke] Skane Univ Hosp, Dept Orthopaed, Malmo, Sweden; [Wise, Carol] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Wise, Carol] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Wise, Carol] Univ Texas Southwestern Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX USA; [Kere, Juha] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London, England; [Gerdhem, Paul] Karolinska Univ Hosp, Dept Orthopaed, Huddinge, Sweden	University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Lund University; University of Gothenburg; Sahlgrenska University Hospital; Lund University; Lund University; Skane University Hospital; RIKEN; Texas Scottish Rite Hospital for Children; Lund University; Skane University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Karolinska Institutet; Karolinska University Hospital	Einarsdottir, E (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.; Einarsdottir, E (corresponding author), Univ Helsinki, Mol Neurol Res Program, Helsinki, Finland.; Einarsdottir, E (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	elisabet.einarsdottir@ki.se	Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Ikegawa, Shiro/N-6895-2015	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Ikegawa, Shiro/0000-0003-0316-2147; Andersen, Malene Rask/0000-0001-7333-2653; Andersen, Mikkel Osterheden/0000-0001-8478-8218; Einarsdottir, Elisabet/0000-0003-3101-2285; Wang, Jingwen/0000-0001-9688-8793; Gerdhem, Paul/0000-0001-8061-7163	Swedish Research Council [K-2013-52X-22198-01-3]; Stockholm County Council; Karolinska Institutet; Department of Research and Development of Vasternorrland County Council; Karolinska Institutet research funds; Research and Development Council of Region Skke; Swedish Society of Spinal Surgeons; Visare Norr fund from the Northern County Councils Regional Federation; Scoliosis Research Society; Alfred Osterlund Foundation; Emil Andersson Foundation; Royal Society Wolfson Research Excellence Award; NIH [P01 HD084387]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD084387] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Department of Research and Development of Vasternorrland County Council; Karolinska Institutet research funds; Research and Development Council of Region Skke; Swedish Society of Spinal Surgeons; Visare Norr fund from the Northern County Councils Regional Federation; Scoliosis Research Society; Alfred Osterlund Foundation; Emil Andersson Foundation; Royal Society Wolfson Research Excellence Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was financially supported by funds from the Swedish Research Council (number K-2013-52X-22198-01-3), the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, the Department of Research and Development of Vasternorrland County Council, the Karolinska Institutet research funds, the Research and Development Council of Region Skke, the Swedish Society of Spinal Surgeons, the Visare Norr fund from the Northern County Councils Regional Federation, the Scoliosis Research Society, the Alfred Osterlund Foundation and the Emil Andersson Foundation. JK is a recipient of The Royal Society Wolfson Research Excellence Award. Genotyping and analysis of the US cohort was supported by the NIH P01 HD084387 to CW.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Baschal EE, 2015, G3-GENES GENOM GENET, V5, P167, DOI 10.1534/g3.114.015669; Boutin C, 2012, CURR TOP DEV BIOL, V101, P161, DOI 10.1016/B978-0-12-394592-1.00010-7; Buchan JG, 2014, DEV DYNAM, V243, P1646, DOI 10.1002/dvdy.24208; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cobb J., 1948, TECHNIQUE STUDY SCOL; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; dbGaP, DAT GEN PHEN; Edery P, 2011, EUR J HUM GENET, V19, P865, DOI 10.1038/ejhg.2011.31; Feng J, 2012, NEUROSCI BULL, V28, P309, DOI 10.1007/s12264-012-1232-8; Gao Xiaochong, 2014, Spine Deform, V2, P324, DOI 10.1016/j.jspd.2014.04.014; Grauers A, 2015, SPINE J, V15, P2239, DOI 10.1016/j.spinee.2015.05.013; Grauers A, 2012, EUR SPINE J, V21, P1069, DOI 10.1007/s00586-011-2074-1; Haller G, 2016, HUM MOL GENET, V25, P202, DOI 10.1093/hmg/ddv463; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Luk KDK, 2010, SPINE, V35, P1607, DOI 10.1097/BRS.0b013e3181c7cb8c; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Mitchell BD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00095; Miyake A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072802; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogura Y, 2015, AM J HUM GENET, V97, P337, DOI 10.1016/j.ajhg.2015.06.012; Patten SA, 2015, J CLIN INVEST, V125, P1124, DOI 10.1172/JCI77262; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu YB, 2014, P NATL ACAD SCI USA, V111, pE2996, DOI 10.1073/pnas.1402105111; Ravenscroft G, 2015, AM J HUM GENET, V96, P955, DOI 10.1016/j.ajhg.2015.04.014; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7452; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Tissir F, 2013, NAT REV NEUROSCI, V14, P525, DOI 10.1038/nrn3525; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Vilboux T, 2017, AM J MED GENETICS A; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WILLNER S, 1982, ACTA ORTHOP SCAND, V53, P233, DOI 10.3109/17453678208992208; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	47	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189591	10.1371/journal.pone.0189591	http://dx.doi.org/10.1371/journal.pone.0189591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240829	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600052
J	Brown, A; Hossein, I; Perez, LJ; Nzirorera, C; Tozer, K; D'Souza, K; Trivedi, PC; Aguiar, C; Yip, AM; Shea, J; Brunt, KR; Legare, JF; Hassan, A; Pulinilkunnil, T; Kienesberger, PC				Brown, Amy; Hossein, Intekhab; Perez, Lester J.; Nzirorera, Carine; Tozer, Kathleen; D'Souza, Kenneth; Trivedi, Purvi C.; Aguiar, Christie; Yip, Alexandra M.; Shea, Jennifer; Brunt, Keith R.; Legare, Jean-Francois; Hassan, Ansar; Pulinilkunnil, Thomas; Kienesberger, Petra C.			Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans	PLOS ONE			English	Article							INSULIN-RESISTANCE; AUTOTAXIN; CELLS; EXPRESSION; PROMOTES; DIFFERENTIATION; TRANSCRIPTION; INFLAMMATION; INVOLVEMENT; INJURY	Background Lysophosphatidic acid (LPA) receptor signaling has been implicated in cardiovascular and obesity-related metabolic disease. However, the distribution and regulation of LPA receptors in the myocardium and adipose tissue remain unclear. Objectives This study aimed to characterize the mRNA expression of LPA receptors (LPA1-6) in the murine and human myocardium and adipose tissue, and its regulation in response to obesity. Methods LPA receptor mRNA levels were determined by qPCR in i) heart ventricles, isolated cardiomyocytes, and perigonadal adipose tissue from chow or high fat-high sucrose (HFHS)-fed male C57BL/6 mice, ii) 3T3-L1 adipocytes and HL-1 cardiomyocytes under conditions mimicking gluco/lipotoxicity, and iii) human atrial and subcutaneous adipose tissue from nonobese, pre-obese, and obese cardiac surgery patients. Results LPA1-6 were expressed in myocardium and white adipose tissue from mice and humans, except for LPA3, which was undetectable in murine adipocytes and human adipose tissue. Obesity was associated with increased LPA4, LPA5 and/or LPA6 levels in mice ventricles and cardiomyocytes, HL-1 cells exposed to high palmitate, and human atrial tissue. LPA4 and LPA5 mRNA levels in human atrial tissue correlated with measures of obesity. LPA5 mRNA levels were increased in HFHS-fed mice and insulin resistant adipocytes, yet were reduced in adipose tissue from obese patients. LPA4, LPA5, and LPA6 mRNA levels in human adipose tissue were negatively associated with measures of obesity and cardiac surgery outcomes. This study suggests that obesity leads to marked changes in LPA receptor expression in the murine and human heart and white adipose tissue that may alter LPA receptor signaling during obesity.	[Brown, Amy; Hossein, Intekhab; Perez, Lester J.; Nzirorera, Carine; Tozer, Kathleen; D'Souza, Kenneth; Trivedi, Purvi C.; Pulinilkunnil, Thomas; Kienesberger, Petra C.] Dalhousie Univ, Dalhousie Med New Brunswick, Fac Med, Dept Biochem & Mol Biol, St John, NB, Canada; [Aguiar, Christie; Yip, Alexandra M.; Legare, Jean-Francois; Hassan, Ansar] St Johns Hosp, Cardiovasc Res New Brunswick, St John, NB, Canada; [Shea, Jennifer] St Johns Hosp, Dept Pathol, St John, NB, Canada; [Brunt, Keith R.] Dalhousie Univ, Dalhousie Med New Brunswick, Fac Med, Dept Pharmacol, St John, NB, Canada; [Legare, Jean-Francois; Hassan, Ansar] New Brunswick Heart Ctr, Dept Cardiac Surg, St John, NB, Canada	Dalhousie University; Dalhousie University	Kienesberger, PC (corresponding author), Dalhousie Univ, Dalhousie Med New Brunswick, Fac Med, Dept Biochem & Mol Biol, St John, NB, Canada.	pkienesb@dal.ca	Pulinilkunnil, Thomas/H-4387-2019; Pulinilkunnil, Thomas C/L-5511-2016; Yip, Alexandra/AAJ-1470-2020; Perez, Lester J./A-1339-2016; Brunt, Keith R./J-1052-2019	Pulinilkunnil, Thomas/0000-0003-1228-893X; Pulinilkunnil, Thomas C/0000-0003-1228-893X; Yip, Alexandra/0000-0002-0528-4677; Perez, Lester J./0000-0002-5717-5181; Brunt, Keith R./0000-0002-5728-8135; Shea, Jennifer/0000-0002-6586-2061; Kienesberger, Petra/0000-0001-9643-8338	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04454]; Banting Research Foundation; New Brunswick Health Research Foundation; New Brunswick Innovation Foundation; Chesley Research Fund; NSERC; Canadian Diabetes Association; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banting Research Foundation; New Brunswick Health Research Foundation; New Brunswick Innovation Foundation; Chesley Research Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Diabetes Association; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant (RGPIN-2014-04454), and grants from the Banting Research Foundation (http://bantingresearchfoundation.ca), the New Brunswick Health Research Foundation (https://www.nbhrf.com), the New Brunswick Innovation Foundation (http://nbif.ca/en/about_nbif/), and Chesley Research Fund to P.C.K.; T.P. would like to acknowledge NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp), the Canadian Diabetes Association, New Brunswick Health Research Foundation (https://www.nbhrf.com), New Brunswick Innovation Foundation (http://nbif.ca/en/about_nbif/), and Canada Foundation for Innovation (https://www.innovation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JJ, 2016, BIOCHEM J, V473, P3769, DOI 10.1042/BCJ20160385; Bot M, 2013, J LIPID RES, V54, P1265, DOI 10.1194/jlr.M032862; Bouchareb R, 2015, CIRCULATION, V132, P677, DOI 10.1161/CIRCULATIONAHA.115.016757; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Cai L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00356; Chandra M, 2018, REDOX BIOL, V14, P261, DOI 10.1016/j.redox.2017.09.015; Chen HB, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00153; Chen X, 2003, SCAND J CLIN LAB INV, V63, P497, DOI 10.1080/00365510310003265; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; D'Souza K, 2016, BIOCH BIOPHYS ACTA; D'Souza K, 2017, ENDOCRINOLOGY; Dohi T, 2013, ATHEROSCLEROSIS, V229, P192, DOI 10.1016/j.atherosclerosis.2013.03.038; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Enooku K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161825; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Evseenko D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063718; Farina AR, 2012, FEBS LETT, V586, P3681, DOI 10.1016/j.febslet.2012.08.026; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Katsifa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143083; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kim EK, 2008, EXP MOL MED, V40, P445, DOI 10.3858/emm.2008.40.4.445; Kostic I, 2015, SCI REP-UK, V5, DOI 10.1038/srep16406; Li SH, 2013, EUR HEART J, V34, P1157, DOI 10.1093/eurheartj/ehs072; Li S, 2012, FEBS LETT, V586, P792, DOI 10.1016/j.febslet.2012.01.044; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nsaibia MJ, 2017, CARDIOVASC RES, V113, P1351, DOI 10.1093/cvr/cvx089; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Perez LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03730-9; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pulinilkunnil T, 2005, AM J PHYSIOL-HEART C, V288, pH2802, DOI 10.1152/ajpheart.01162.2004; Pulinilkunnil T, 2014, INT J OBESITY, V38, P205, DOI 10.1038/ijo.2013.103; Rachakonda VP, 2015, OBESITY, V23, P965, DOI 10.1002/oby.20960; Rancoule C, 2013, DIABETOLOGIA, V56, P1394, DOI 10.1007/s00125-013-2891-3; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Reeves VL, 2015, OBESITY, V23, P2371, DOI 10.1002/oby.21232; Riaz A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020215; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Smyth SS, 2014, ARTERIOSCL THROM VAS, V34, P479, DOI 10.1161/ATVBAHA.113.302737; Song JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136629; Stoddard NC, 2015, BIOMOL THER, V23, P1, DOI 10.4062/biomolther.2014.109; Sun K, 2015, CLIN EXP MED, V15, P371, DOI 10.1007/s10238-014-0306-5; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Trivedi PC, 2016, BBA-MOL CELL BIOL L, V1861, P1893, DOI 10.1016/j.bbalip.2016.09.004; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	50	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189402	10.1371/journal.pone.0189402	http://dx.doi.org/10.1371/journal.pone.0189402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236751	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100065
J	Dehling, JM				Dehling, J. Maximilian			How lizards fly: A novel type of wing in animals	PLOS ONE			English	Article							DRACO; PERFORMANCE; AGAMIDAE; LOCOMOTION; MORPHOLOGY	Flying lizards of the genus Draco are renowned for their gliding ability, using an aerofoil formed by winglike patagial membranes and supported by elongated thoracic ribs. It remains unknown, however, how these lizards manoeuvre during flight. Here, I present the results of a study on the aerial behaviour of Dussumier's Flying Lizard (Draco dussumieri) and show that Draco attaches the forelimbs to the leading edge of the patagium while airborne, forming a hitherto unknown type of composite wing. The attachment of the forelimbs to the patagium suggests that that aerofoil is controlled through movements of the forelimbs. One major advantage for the lizards is that the forelimbs retain their complete range of movement and functionality for climbing and running when not used as a part of the wing. These findings not only shed a new light on the flight of Draco but also have implications for the interpretation of gliding performance in fossil species.	[Dehling, J. Maximilian] Univ Koblenz Landau, Zool Grp, Dept Biol, IfIN, Koblenz, Germany	University of Koblenz & Landau	Dehling, JM (corresponding author), Univ Koblenz Landau, Zool Grp, Dept Biol, IfIN, Koblenz, Germany.	dehling@uni-koblenz.de						Colbert E. H., 1970, Bull. Am. Mus. nat. Hist., V143, P85; COLBERT EDWIN H., 1967, AMER MUS NOVITATES, V2283, P1; COLBERT EDWIN H., 1966, AMER MUS NOVITATES, V2246, P1; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; Fraser NC, 2007, J VERTEBR PALEONTOL, V27, P261, DOI 10.1671/0272-4634(2007)27[261:ANGTDA]2.0.CO;2; Frey E, 1997, SCIENCE, V275, P1450, DOI 10.1126/science.275.5305.1450; Gunther A.C.L.G., 1872, P SCI M ZOOLOGICAL S, V1872, P586; HAIRSTON NELSON G., 1957, COPEIA, V1957, P262, DOI 10.2307/1439149; John K. O., 1967, Journal of the Bombay Natural History Society, V64, P112; John K.O., 1970, BRIT J HERPETOL, V4, P161; Lee C, 2015, WINGS DRAGONS; Li PP, 2007, P NATL ACAD SCI USA, V104, P5507, DOI 10.1073/pnas.0609552104; Lingham-Soliar T, 2015, VERTEBRATE INTEGUMEN, V2; Maindron MM, 1890, POP SCI MONTHLY, V36, P808; Manthey U., 2008, AGAMID LIZARDS SO AS; Marsden W., 1784, HIST SUMATRA CONTAIN, V2nd; McGuire JA, 2005, AM NAT, V166, P93, DOI 10.1086/430725; McGuire JA, 2003, AM NAT, V161, P337, DOI 10.1086/346085; McGuire JA, 2011, INTEGR COMP BIOL, V51, P983, DOI 10.1093/icb/icr090; MORI A, 1993, RAFFLES B ZOOL, V41, P83; Norberg UML, 1990, VERTEBRATE FLIGHT; Ratnovsky A, 2008, RESP PHYSIOL NEUROBI, V163, P82, DOI 10.1016/j.resp.2008.04.019; Robinson P. L., 1962, Proceedings of the Geological Society London, VNo. 1601, P137; Russell AP, 2001, J ZOOL, V253, P457, DOI 10.1017/S0952836901000425; Seba A., 1734, LOCUPLETISSIMI RERUM, V33; Socha JJ, 2015, CAN J ZOOL, V93, P901, DOI 10.1139/cjz-2014-0013; Stein K, 2008, PALAEONTOLOGY, V51, P967, DOI 10.1111/j.1475-4983.2008.00783.x; Vanhooydonck B, 2009, J EXP BIOL, V212, P2475, DOI 10.1242/jeb.031856; Yanoviak SP, 2005, NATURE, V433, P624, DOI 10.1038/nature03254; Young BA, 2002, J HERPETOL, V36, P412	31	3	3	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189573	10.1371/journal.pone.0189573	http://dx.doi.org/10.1371/journal.pone.0189573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236777	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100081
J	Perino, MG; Yamanaka, S; Riordon, DR; Tarasova, Y; Boheler, KR				Perino, Maria Grazia; Yamanaka, Satoshi; Riordon, Daniel R.; Tarasova, Yelena; Boheler, Kenneth R.			Ascorbic acid promotes cardiomyogenesis through SMAD1 signaling in differentiating mouse embryonic stem cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; VITAMIN-C PHARMACOKINETICS; ENHANCES DIFFERENTIATION; COLLAGEN BIOSYNTHESIS; CARDIAC MYOCYTES; CARDIOMYOCYTES; EXPRESSION; PROLIFERATION; ACTIVATION; MECHANISMS	Numerous groups have documented that Ascorbic Acid (AA) promotes cardiomyocyte differentiation from both mouse and human ESCs and iPSCs. AA is now considered indispensable for the routine production of hPSC-cardiomyocytes (CMs) using defined media; however, the mechanisms involved with the inductive process are poorly understood. Using a genetically modified mouse embryonic stem cell (mESC) line containing a dsRED transgene driven by the cardiac-restricted portion of the ncx1 promoter, we show that AA promoted differentiation of mESCs to CMs in a dose-and time-dependent manner. Treatment of mPSCs with AA did not modulate total SMAD content; however, the phosphorylated/ active forms of SMAD2 and SMAD1/5/8 were significantly elevated. Co-administration of the SMAD2/3 activator Activin A with AA had no significant effect, but the addition of the nodal co-receptor TDGF1 (Cripto) antagonized AA's cardiomyogenic-promoting ability. AA could also reverse some of the inhibitory effects on cardiomyogenesis of ALK/SMAD2 inhibition by SB431542, a TGF beta pathway inhibitor. Treatment with BMP2 and AA strongly amplified the positive cardiomyogenic effects of SMAD1/5/8 in a dose-dependent manner. AA could not, however, rescue dorsomorphin-mediated inhibition of ALK/SMAD1 activity. Using an inducible model system, we found that SMAD1, but not SMAD2, was essential for AA to promote the formation of TNNT2(+)-CMs. These data firmly demonstrate that BMP receptoractivated SMADs, preferential to TGF beta-receptor-activated SMADs, are necessary to promote AA stimulated cardiomyogenesis. AA-enhanced cardiomyogenesis thus relies on the ability of AA to modulate the ratio of SMAD signaling among the TGF beta-superfamily receptor signaling pathways.	[Perino, Maria Grazia; Yamanaka, Satoshi; Riordon, Daniel R.; Tarasova, Yelena] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA; [Boheler, Kenneth R.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, Sch Biomed Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Boheler, Kenneth R.] Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Hong Kong; Johns Hopkins University; Johns Hopkins Medicine	Perino, MG (corresponding author), NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.	mariagrazia.perino@nih.gov			NIH/NIA/Research Intramural Program (IRP); National Institutes of Health (NIH)/National Institute on Aging (NIA)/Research Intramural Program (IRP), Baltimore, MD (USA)	NIH/NIA/Research Intramural Program (IRP); National Institutes of Health (NIH)/National Institute on Aging (NIA)/Research Intramural Program (IRP), Baltimore, MD (USA)	This project was funded by the NIH/NIA/Research Intramural Program (IRP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the National Institutes of Health (NIH)/National Institute on Aging (NIA)/Research Intramural Program (IRP), Baltimore, MD (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino Hiromi, 2003, Angiogenesis, V6, P259, DOI 10.1023/B:AGEN.0000029390.09354.f8; Barth AS, 2008, MOL THER, V16, P957, DOI 10.1038/mt.2008.30; Behrens Ann N, 2012, J Clin Exp Cardiolog, VSuppl 11, P1; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004409; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Boheler KR, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.002; Boheler KR, 2003, METHOD ENZYMOL, V365, P228; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Crescini E, 2013, BBA-MOL CELL RES, V1833, P140, DOI 10.1016/j.bbamcr.2012.06.024; Davidson JM, 1997, J BIOL CHEM, V272, P345, DOI 10.1074/jbc.272.1.345; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Gao Y, 2013, BIOCHIMIE, V95, P2107, DOI 10.1016/j.biochi.2013.08.001; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; HAO JJ, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0002904; Heckelen A, 2004, ACTA OPHTHALMOL SCAN, V82, P564, DOI 10.1111/j.1600-0420.2004.00317.x; Ivanov VO, 1997, J MOL CELL CARDIOL, V29, P3293, DOI 10.1006/jmcc.1997.0555; Kim YY, 2013, AGE, V35, P1545, DOI 10.1007/s11357-012-9457-z; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Koban MU, 2001, MECH DEVELOP, V109, P267, DOI 10.1016/S0925-4773(01)00548-2; Kropp EM, 2015, STEM CELL TRANSL MED, V4, P483, DOI 10.5966/sctm.2014-0163; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; LEUSHNER JRA, 1986, BIOCHIM BIOPHYS ACTA, V883, P284, DOI 10.1016/0304-4165(86)90320-X; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Naidu KA, 2003, DIGEST DIS SCI, V48, P230, DOI 10.1023/A:1021779624971; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; PHILLIPS CL, 1992, ARCH BIOCHEM BIOPHYS, V295, P397, DOI 10.1016/0003-9861(92)90533-3; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Qiao H, 2009, J VASC RES, V46, P15, DOI 10.1159/000135661; Sakabe Masahide, 2005, Congenital Anomalies, V45, P107, DOI 10.1111/j.1741-4520.2005.00079.x; Samuel LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007650; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Shenje LT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4416; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Wobus A M, 2002, Methods Mol Biol, V185, P127; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x; Wu HB, 2014, STEM CELLS, V32, P166, DOI 10.1002/stem.1523; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zafonte BT, 2007, BLOOD, V109, P516, DOI 10.1182/blood-2006-02-004564; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188569	10.1371/journal.pone.0188569	http://dx.doi.org/10.1371/journal.pone.0188569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232368	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200005
J	Saheera, S; Nair, RR				Saheera, Sherin; Nair, Renuka R.			Accelerated decline in cardiac stem cell efficiency in Spontaneously hypertensive rat compared to normotensive Wistar rat	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; OXIDATIVE STRESS; MYOCARDIAL REGENERATION; PRESSURE-OVERLOAD; TELOMERASE; MODEL; AGE; ASSOCIATION; MULTIPOTENT	Cardiac hypertrophy is recognized as an independent risk factor for cardiac failure. Efficient management of hypertensive heart disease requires identification of factors that can possibly mediate the transition from hypertrophy to failure. Resident cardiac stem cells have a prominent role in the maintenance of cardiac tissue homeostasis. Decline in the proportion of healthy cardiac stem cells (CSCs) can affect tissue regeneration. In pathological conditions, apart from natural aging, an adverse microenvironment can lead to decrease in efficiency of CSCs. A systematic analysis of cardiac stem cell characteristics in pathological conditions has not been reported so far. Therefore, this study was designed with the objective of examining the age associated variation in stem cell attributes of Spontaneously hypertensive rat (SHR) in comparison with normotensive Wistar rat. Spontaneously hypertensive rat was used as the experimental model since the cardiac remodeling resembles the clinical course of hypertensive heart disease. CSCs were isolated from atrial explants. Stem cell attributes were assessed in 1-week, 6, 12 and 18-month-old male SHR, in comparison with age matched Wistar rats. In 1-week-old pups, stem cell attributes of SHR and Wistar were comparable. Migration potential, proliferative capacity, TERT expression, telomerase activity and the proportion of c-kit(+) cells decreased with age, both in SHR and Wistar. DNA damage and the proportion of senescent CSCs increased with age both in SHR and Wistar rats. Age associated increase was observed in the oxidative stress of stem cells, possibly mediated by the enhanced oxidative stress in the microenvironment. The changes were more pronounced in SHR, and as early as six months of age, there was significant decrease in efficiency of CSCs of SHR compared to Wistar. The density of healthy CSCs determined as a fraction of the differentiated cells was remarkably low in 18-month-old SHR. Age associated decrease in functionally efficient CSCs was therefore accelerated in SHR. Considering the vital role of CSCs in the maintenance of a healthy myocardium, decrease in functionally efficient CSCs can be a precipitating factor in pathological cardiac remodeling. Elevated ROS levels in CSCs of SHR lends scope for speculation that decrease in efficiency of CSCs is mediated by oxidative stress; and that modulation of the microenvironment by therapeutic interventions can restore a healthy stem cell population and facilitate maintenance of cardiac homeostasis and prevent cardiac decompensation.	[Saheera, Sherin; Nair, Renuka R.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Thiruvananthapuram, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Nair, RR (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Thiruvananthapuram, Kerala, India.	renukanairr52@gmail.com	Saheera, Sherin/AAL-4028-2020	Saheera, Sherin/0000-0002-1336-5872	Board of Research in Nuclear Sciences, Department of Atomic Energy, Government of India; Department of Science and Technology, Government of India	Board of Research in Nuclear Sciences, Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by the Board of Research in Nuclear Sciences, Department of Atomic Energy, Government of India; Department of Science and Technology, Government of India.	Abbate A, 2006, INT J CARDIOL, V111, P371, DOI 10.1016/j.ijcard.2005.07.061; Adiga IK, 2007, INT J CARDIOL, V115, P246, DOI 10.1016/j.ijcard.2006.01.049; ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; Baker M, 2007, NAT REP STEM CELLS; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; BING OHL, 1995, J MOL CELL CARDIOL, V27, P383, DOI 10.1016/S0022-2828(08)80035-1; Burova E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/474931; Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; Csanyi G, 2014, INT J MOL SCI, V15, P6002, DOI 10.3390/ijms15046002; Date M, 2002, J AM COLL CARDIOL, V39, P907, DOI 10.1016/S0735-1097(01)01826-5; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; ENGELMANN GL, 1987, CIRC RES, V60, P487, DOI 10.1161/01.RES.60.4.487; Flores I, 2010, FEBS LETT, V584, P3826, DOI 10.1016/j.febslet.2010.07.042; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; Hermeto LC, 2015, GENET MOL RES, V14, P339, DOI 10.4238/2015.January.23.7; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Hornsby PJ, 2007, EXP GERONTOL, V42, P575, DOI 10.1016/j.exger.2007.03.007; Hsiao LC, 2014, STEM CELLS DEV, V23, P1027, DOI 10.1089/scd.2013.0388; Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b; Kuster GM, 2005, CIRCULATION, V111, P420, DOI 10.1161/01.CIR.0000153800.09920.40; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Leri A, 2014, STEM CELL RES, V13, P631, DOI 10.1016/j.scr.2014.09.001; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Nakamura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22781; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Pons-Llado G, 2000, J AM COLL CARDIOL, V36, P2198, DOI 10.1016/S0735-1097(00)00983-9; Puceat M, 2005, ANTIOXID REDOX SIGN, V7, P1435, DOI 10.1089/ars.2005.7.1435; Purushothaman S, 2011, MOL CELL BIOCHEM, V351, P59, DOI 10.1007/s11010-011-0711-y; Romano Antonino D, 2010, J Nephrol, V23 Suppl 15, pS29; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; SEN S, 1974, CIRC RES, V35, P775, DOI 10.1161/01.RES.35.5.775; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Su GH, 2014, J CLIN HYPERTENS, V16, P192, DOI 10.1111/jch.12282; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	49	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189129	10.1371/journal.pone.0189129	http://dx.doi.org/10.1371/journal.pone.0189129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232369	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200021
J	Marinho, CD; Maioli, MCP; do Amaral, JLM; Lopes, AJ; de Melo, PL				Marinho, Cirlene de Lima; Paixao Maioli, Maria Christina; Machado do Amaral, Jorge Luis; Lopes, Agnaldo Jose; de Melo, Pedro Lopes			Respiratory resistance and reactance in adults with sickle cell anemia: Correlation with functional exercise capacity and diagnostic use	PLOS ONE			English	Article							ACUTE CHEST SYNDROME; MACHINE LEARNING ALGORITHMS; FORCED OSCILLATION MEASUREMENTS; OBSTRUCTIVE PULMONARY-DISEASE; 6-MINUTE WALK TEST; AIRWAY-OBSTRUCTION; LUNG-FUNCTION; YOUNG-ADULTS; BLOOD-FLOW; ASTHMA	Background The improvement in sickle cell anemia (SCA) care resulted in the emergence of a large population of adults living with this disease. The mechanisms of lung injury in this new population are largely unknown. The forced oscillation technique (FOT) represents the current state-of-the-art in the assessment of lung function. The present work uses the FOT to improve our knowledge about the respiratory abnormalities in SCA, evaluates the associations of FOT with the functional exercise capacity and investigates the early detection of respiratory abnormalities. Methodology/Principal findings Spirometric classification of restrictive abnormalities resulted in three categories: controls (n = 23), patients with a normal exam (n = 21) and presenting pulmonary restriction (n = 24). FOT analysis showed that, besides restrictive changes (reduced compliance; p< 0.001), there is also an increase in respiratory resistance (p< 0.001) and ventilation heterogeneity (p< 0.01). FOT parameters are associated with functional exercise capacity (R = -0.38), pulmonary diffusion (R = 0.66), respiratory muscle performance (R = 0.41), pulmonary volumes (R = 0.56) and airway obstruction (R = 0.54). The diagnostic accuracy was evaluated by investigating the area under the receiver operating characteristic curve (AUC). A combination of FOT and machine learning (ML) classifiers showed adequate diagnostic accuracy in the detection of early respiratory abnormalities (AUC = 0.82). Conclusions In this study, the use of FOT showed that adults with SCA develop a mixed pattern of respiratory disease. Changes in FOT parameters are associated with functional exercise capacity decline, abnormal pulmonary mechanics and diffusion. FOT associated with ML methods accurately diagnosed early respiratory abnormalities. This suggested the potential utility of the FOT and ML clinical decision support systems in the identification of respiratory abnormalities in patients with SCA.	[Marinho, Cirlene de Lima; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil; [Marinho, Cirlene de Lima; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil; [Marinho, Cirlene de Lima; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, BioVasc Res Lab, Inst Biol, Rio De Janeiro, Brazil; [Paixao Maioli, Maria Christina] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Hematol, Rio De Janeiro, Brazil; [Machado do Amaral, Jorge Luis] Univ Estado Rio De Janeiro, Dept Elect & Telecommun Engn, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose] Univ Estado Rio De Janeiro, Pulm Funct Testing Lab, Sch Med Sci, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose] Augusto Motta Univ Ctr, Rehabil Sci Postgrad Program, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Juiz de Fora; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Centro Universitario Augusto Motta (UNISUAM)	de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, BioVasc Res Lab, Inst Biol, Rio De Janeiro, Brazil.	plopes@uerj.br	Melo, Pedro/E-8440-2011; Lopes, Agnaldo José/AAB-5944-2019; Amaral, Jorge/U-2498-2017	Melo, Pedro/0000-0002-2081-6619; Lopes, Agnaldo José/0000-0001-8598-4878; Amaral, Jorge/0000-0001-6580-5668	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundagao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundagao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	The present study was funded by the Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq) and the Rio de Janeiro Research Foundation (Fundagao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ) to Pedro Lopes de Melo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy T, 2010, CLIN HEMORHEOL MICRO, V44, P155, DOI 10.3233/CH-2010-1270; Amaral JLM, 2017, COMPUT METH PROG BIO, V144, P113, DOI 10.1016/j.cmpb.2017.03.023; Amaral JLM, 2015, COMPUT METH PROG BIO, V118, P186, DOI 10.1016/j.cmpb.2014.11.002; Amaral JLM, 2013, COMPUT METH PROG BIO, V112, P441, DOI 10.1016/j.cmpb.2013.08.004; Amaral JLM, 2012, COMPUT METH PROG BIO, V105, P183, DOI 10.1016/j.cmpb.2011.09.009; An P, 2011, J ALLERGY CLIN IMMUN, V127, P1440, DOI 10.1016/j.jaci.2010.12.1114; [Anonymous], 2011, INT J BIOL MED RES, V2, P723; Arteta M, 2014, J PEDIAT HEMATOL ONC, V36, P185, DOI 10.1097/MPH.0000000000000011; Bates JHT, 2011, COMPR PHYSIOL, V1, P1233, DOI 10.1002/cphy.c100058; Bodas P, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-237; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brashier B, 2015, BREATHE, V11, P57, DOI 10.1183/20734735.020514; Britto RR, 2013, BRAZ J PHYS THER, V17, P556, DOI 10.1590/S1413-35552012005000122; Callahan LA, 2002, AM J RESP CRIT CARE, V165, P1309, DOI 10.1164/rccm.2002036; Cavalcanti JV, 2006, RESP MED, V100, P2207, DOI 10.1016/j.rmed.2006.03.009; Cohen RT, 2011, AM J HEMATOL, V86, P756, DOI 10.1002/ajh.22098; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; Cook J, 2013, INT J TUBERC LUNG D, V17, P1235, DOI 10.5588/ijtld.12.0965; Crabtree EA, 2011, PEDIATRICS, V127, pE480, DOI 10.1542/peds.2010-3099; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dassios T, 2013, PEDIATR PULM, V48, P865, DOI 10.1002/ppul.22709; de Melo PL, 2000, REV SCI INSTRUM, V71, P2867, DOI 10.1063/1.1150705; de Sa PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161981; de Sa PM, 2013, CLINICS, V68, P644, DOI 10.6061/clinics/2013(05)11; Delclaux C, 2005, CHEST, V128, P3336, DOI 10.1378/chest.128.5.3336; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Desai PC, 2013, EXPERT OPIN PHARMACO, V14, P991, DOI 10.1517/14656566.2013.783570; Faria ACD, 2012, CLINICS, V67, P987, DOI 10.6061/clinics/2012(09)01; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Duda R. O., 2001, PATTERN CLASSIFICATI, Vxx; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Faria ACD, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-22; Faria ACD, 2009, RESPIRATION, V78, P93, DOI 10.1159/000213756; Forsting M, 2017, J NUCL MED, V58, P357, DOI 10.2967/jnumed.117.190397; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Goedhart DM, 2005, PHYSIOL MEAS, V26, P1115, DOI 10.1088/0967-3334/26/6/020; Golpe R, 1999, SLEEP, V22, P932; Gonzalez G, 2017, AM J RESP CRITICAL C; Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016; Greenough A, 2014, THORAX, V69, P1051, DOI 10.1136/thoraxjnl-2014-205886; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Howard J, 2015, BRIT J HAEMATOL, V169, P492, DOI 10.1111/bjh.13348; Hussain SNA, 1996, J APPL PHYSIOL, V81, P1455, DOI 10.1152/jappl.1996.81.4.1455; Hyatt RE., 1997, INTERPRETATION PULMO; Intzes S, 2013, PEDIATR HEMAT ONCOL, V30, P726, DOI 10.3109/08880018.2012.756961; Kaimakamis E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150163; Klings ES, 2006, AM J RESP CRIT CARE, V173, P1264, DOI 10.1164/rccm.200601-125OC; Knight-Madden J, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2013.10.005; Knight-Madden JM, 2013, LUNG, V191, P95, DOI 10.1007/s00408-012-9435-3; Knight-Madden JM, 2005, THORAX, V60, P206, DOI 10.1136/thx.2004.029165; Ko FWS, 2008, INT J TUBERC LUNG D, V12, P713; LaPrad AS, 2008, RESP PHYSIOL NEUROBI, V163, P64, DOI 10.1016/j.resp.2008.04.015; Liem RI, 2009, AM J HEMATOL, V84, P645, DOI 10.1002/ajh.21507; Lima AN, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0007-7; LOCKHAT D, 1985, J APPL PHYSIOL, V59, P1164, DOI 10.1152/jappl.1985.59.4.1164; Lungu A, 2016, PULM CIRC, V6, P181, DOI 10.1086/686020; Lunt A, 2014, THORAX, V69, P746, DOI 10.1136/thoraxjnl-2013-204809; MacLeod D, 2001, MED BIOL ENG COMPUT, V39, P505, DOI 10.1007/BF02345140; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miranda IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061657; NAGELS J, 1980, J APPL PHYSIOL, V49, P408, DOI 10.1152/jappl.1980.49.3.408; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Ohara DG, 2014, BRAZ J PHYS THER, V18, P79, DOI 10.1590/S1413-35552012005000139; Ong BA, 2013, BRIT J HAEMATOL, V163, P112, DOI 10.1111/bjh.12481; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Palaniappan R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-223; Pereira CAC, 1992, J PNEUMOL, V18, P10; PESLIN R, 1986, B EUR PHYSIOPATH RES, V22, P621; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; Poole DC, 1997, MED SCI SPORT EXER, V29, P738, DOI 10.1097/00005768-199706000-00003; Ruby A., 2011, HEMOGLOBIN, P1; Santoli F, 1998, EUR RESPIR J, V12, P1124, DOI 10.1183/09031936.98.12051124; SBPT, 2009, J PNEUMOL S3, V38; Souza RB., 2002, J PNEUMOL, V28, P155; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tageja N, 2010, CASE REP MED, V2010, DOI DOI 10.1155/2010/659031; Teague WG, 2014, J ASTHMA, V51, P677, DOI 10.3109/02770903.2014.914535; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; VALERIANOMARCET J, 1991, ANN INTERN MED, V115, P99, DOI 10.7326/0003-4819-115-2-99; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Veezhinathan M, 2007, J MED SYST, V31, P461, DOI 10.1007/s10916-007-9085-9; Vicari P, 2004, SOUTH MED J, V97, P894, DOI 10.1097/01.SMJ.0000125172.95454.B7; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wedderburn CJ, 2014, PEDIATR PULM, V49, P724, DOI 10.1002/ppul.22952	86	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187833	10.1371/journal.pone.0187833	http://dx.doi.org/10.1371/journal.pone.0187833			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220407	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900007
J	Khan, SM; Bain, RES; Lunze, K; Unalan, T; Beshanski-Pedersen, B; Slaymaker, T; Johnston, R; Hancioglu, A				Khan, Shane M.; Bain, Robert E. S.; Lunze, Karsten; Unalan, Turgay; Beshanski-Pedersen, Bo; Slaymaker, Tom; Johnston, Richard; Hancioglu, Attila			Optimizing household survey methods to monitor the Sustainable Development Goals targets 6.1 and 6.2 on drinking water, sanitation and hygiene: A mixed-methods field-test in Belize	PLOS ONE			English	Article							CONTAMINATION; MANAGEMENT; COUNTRIES; QUALITY	Background The Sustainable Development Goals (SDGs) require household survey programmes such as the UNICEF-supported Multiple Indicator Cluster Surveys (MICS) to enhance data collection to cover new indicators. This study aims to evaluated methods for assessing water quality, water availability, emptying of sanitation facilities, menstrual hygiene management and the acceptability of water quality testing in households which are key to monitoring SDG targets 6.1 and 6.2 on drinking Water, Sanitation and Hygiene (WASH) and emerging issues. Methods As part of a MICS field test, we interviewed 429 households and 267 women age 15-49 in Stann Creek, Belize in a split-sample experiment. In a concurrent qualitative component, we conducted focus groups with interviewers and cognitive interviews with respondents during and immediately following questionnaire administration in the field to explore their question comprehension and response processes. Findings About 88% of respondents agreed to water quality testing but also desired test results, given the potential implications for their own health. Escherichia coli was present in 36% of drinking water collected at the source, and in 47% of samples consumed in the household. Both questions on water availability necessitated probing by interviewers. About one quarter of households reported emptying of pit latrines and septic tanks, though one-quarter could not provide an answer to the question. Asking questions on menstrual hygiene was acceptable to respondents, but required some clarification and probing. Conclusions In the context of Belize, this study confirmed the feasibility of collecting information on the availability and quality of drinking water, emptying of sanitation facilities and menstrual hygiene in a multi-purpose household survey, indicating specific areas to improve question formulation and field protocols. Improvements have been incorporated into the latest round of MICS surveys which will be a major source of national data for monitoring of SDG targets for drinking water, sanitation and hygiene and emerging issues for WASH sector programming.	[Khan, Shane M.; Bain, Robert E. S.; Unalan, Turgay; Beshanski-Pedersen, Bo; Slaymaker, Tom; Hancioglu, Attila] UNICEF, Div Data Res & Policy, New York, NY 10038 USA; [Lunze, Karsten] Boston Univ, Sch Med, Boston, MA 02118 USA; [Johnston, Richard] World Hlth Org, Dept Publ Hlth Environm & Social Determinants Hlt, Geneva, Switzerland	UNICEF; Boston University; World Health Organization	Khan, SM (corresponding author), UNICEF, Div Data Res & Policy, New York, NY 10038 USA.	smkhan@unicef.org	Lunze, Karsten/AAL-7240-2021	Lunze, Karsten/0000-0001-8495-0350	Netherlands Ministry of Foreign Affairs Directorate General for International Cooperation (DGIS)	Netherlands Ministry of Foreign Affairs Directorate General for International Cooperation (DGIS)	Funding for this study was provided to WHO/UNICEF JMP by the Netherlands Ministry of Foreign Affairs Directorate General for International Cooperation (DGIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KT, 2014, WATER-SUI, V6, P1453, DOI 10.3390/w6051453; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Baum R, 2013, ENVIRON SCI TECHNOL, V47, P1994, DOI 10.1021/es304284f; Blackett I, TARGETING URBAN POOR; Burt Z., 2016, GENDER EQUALITY SANI; Grant M, 2013, COMP EDUC REV, V57, P260, DOI 10.1086/669121; International Bank for Reconstruction and Development/ The World Bank, 2014, TARG URB POOR IMPR S; JMP, 2015, JMP GREEN PAP GLOB M; Kumpel E, 2016, ENVIRON SCI TECHNOL, V50, P542, DOI 10.1021/acs.est.5b03973; Loughnan LC, 2015, MEASUREMENT HANDWASH; Medical Research Council, 2014, FRAM FEEDB HLTH REL; Ongena Y. P., 2006, J OFF STAT, V22, P419; Peal A, 2014, J WATER SANIT HYG DE, V4, P563, DOI 10.2166/washdev.2014.026; Presser S, 2004, PUBLIC OPIN QUART, V68, P109, DOI 10.1093/poq/nfh008; Ram P, 2013, PRACTICAL GUIDANCE M; Reygadas F, 2015, WATER RES, V85, P74, DOI 10.1016/j.watres.2015.08.013; Sommer M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001962; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; UNICEF, 2015, MON SIT CHILDR WOM 2; UNICEF, 2015, PROGR SAN DRINK WAT; UNICEF and World Health Organization, SAF MAN DRINK WAT SE; UNICEF and World Health Organization, 2013, 2 M WHO UNICEF JMP T; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; WHO, 2017, PROGR DRINK WAT SAN; WHO & UNICEF, 2016, COR QUEST IND MON WA; Winkler I, 2014, BRINGING DIRTY BLOOD; World Health Organization (WHO), 2017, WHO GUID DRINK WAT Q; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	31	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189089	10.1371/journal.pone.0189089	http://dx.doi.org/10.1371/journal.pone.0189089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216244	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800069
J	McCafferty, CL; Sergeev, YV				McCafferty, Caitlyn L.; Sergeev, Yuri V.			Global computational mutagenesis provides a critical stability framework in protein structures	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; SEQUENCE ALIGNMENT; TRANSITION-STATE; MACULAR DEGENERATION; PREDICTION; CONSERVATION; EVOLUTIONARY; DISCOVERY; NETWORK; DISEASE	A protein's amino acid sequence dictates the folds and final structure the macromolecule will form. We propose that by identifying critical residues in a protein's atomic structure, we can select a critical stability framework within the protein structure essential to proper protein folding. We use global computational mutagenesis based on the unfolding mutation screen to test the effect of every possible missense mutation on the protein structure to identify the residues that cannot tolerate a substitution without causing protein misfolding. This method was tested using molecular dynamics to simulate the stability effects of mutating critical residues in proteins involved in inherited disease, such as myoglobin, p53, and the 15 th sushi domain of complement factor H. In addition we prove that when the critical residues are in place, other residues may be changed within the structure without a stability loss. We validate that critical residues are conserved using myoglobin to show that critical residues are the same for crystal structures of 6 different species and comparing conservation indices to critical residues in 9 eye disease-related proteins. Our studies demonstrate that by using a selection of critical elements in a protein structure we can identify a critical protein stability framework. The frame of critical residues can be used in genetic engineering to improve small molecule binding for drug studies, identify loss-of-function disease-causing missense mutations in genetics studies, and aide in identifying templates for homology modeling.	[McCafferty, Caitlyn L.; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sergeev, YV (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	sergeevy@nei.nih.gov			NIH Intramural program at the National Eye Institute [ZIA EY000476-07]; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	NIH Intramural program at the National Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grant ZIA EY000476-07 to Y.V.S. from the NIH Intramural program at the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Bross P, 1999, PROTEIN MISFOLDING D; Chatzou M., 2015, BRIEF BIOINFORM; Consortium U, 2014, NUCLEIC ACIDS RES; Cusack MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000421; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dolinska MB, 2017, BIOL CHEM; EISENHABER F, 1995, CRIT REV BIOCHEM MOL, V30, P1, DOI 10.3109/10409239509085139; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gromiha MM, 2010, METHODS MOL BIOL, V609, P97, DOI 10.1007/978-1-60327-241-4_6; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Johansson F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-388; Krieger E., 2013, YASARA YET ANOTHER S, V993; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Liu XS, 2008, AMINO ACIDS, V34, P643, DOI 10.1007/s00726-007-0017-2; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCafferty CL, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.112; McCafferty CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37298; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; Nishi K, 2009, J PHARM SCI-US, V98, P4316, DOI 10.1002/jps.21697; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; RICHARDS JE, 1995, OPHTHALMOLOGY, V102, P669, DOI 10.1016/S0161-6420(95)30972-4; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sergeev Y. V., 2013, HUM MOL GENET; Shatsky M, 2006, PROTEINS, V62, P209, DOI 10.1002/prot.20665; Simpson GL, 2009, CURR OPIN DRUG DISC, V12, P585; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; Zernant J, 2017, J MED GENET, V54, P404, DOI 10.1136/jmedgenet-2017-104540; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	48	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189064	10.1371/journal.pone.0189064	http://dx.doi.org/10.1371/journal.pone.0189064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216252	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800062
J	Sekizuka, T; Ogasawara, Y; Ohkusa, T; Kuroda, M				Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Ohkusa, Toshifumi; Kuroda, Makoto			Characterization of Fusobacterium varium Fv113-g1 isolated from a patient with ulcerative colitis based on complete genome sequence and transcriptome analysis	PLOS ONE			English	Article							LEMIERRES SYNDROME; MICROBIAL GENOMES; NUCLEATUM; ADHESIN; FADA; CARCINOGENESIS; NECROPHORUM; TECHNOLOGY; SEPTICEMIA; FLAVODOXIN	Fusobacterium spp. present in the oral and gut flora is carcinogenic and is associated with the risk of pancreatic and colorectal cancers. Fusobacterium spp. is also implicated in a broad spectrum of human pathologies, including Crohn's disease and ulcerative colitis (UC). Here we report the complete genome sequence of Fusobacterium varium Fv113-g1 (genome size, 3.96 Mb) isolated from a patient with UC. Comparative genome analyses totally suggested that Fv113-g1 is basically assigned as F. varium, in particular, it could be reclassified as notable F. varium subsp. similar to F. ulcerans because of partial shared orthologs. Compared with the genome sequences of F. varium ATCC 27725 (genome size, 3.30 Mb) and other strains of Fusobacterium spp., Fv113-g1 possesses many accessary pan-genome sequences with noteworthy multiple virulence factors, including 44 autotransporters (type V secretion system, T5SS) and 13 Fusobacterium adhesion (FadA) paralogs involved in potential mucosal inflammation. Indeed, transcriptome analysis demonstrated that Fv113-g1-specific accessary genes, such as multiple T5SS and fadA paralogs, showed notably increased expression with D-MEM cultivation than with brain heart infusion broth. This implied that growth condition may enhance the expression of such potential virulence factors, leading to remarkable survival against other gut microorganisms and to the pathogenicity to human intestinal epithelium.	[Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan; [Ohkusa, Toshifumi] Juntendo Univ, Grad Sch Med, Dept Microbiota Res, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Juntendo University	Kuroda, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan.	makokuro@niid.go.jp	大草, 敏史/HGD-2376-2022	Sekizuka, Tsuyoshi/0000-0002-1302-5472; Kuroda, Makoto/0000-0002-0487-4405	Ministry of Health, Labor, and Welfare, Japan [H25-Nanchi-Ippan-031]; Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [16fk0108119j0001, 17fk0108219j0002]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by the grant-in-aid from the Ministry of Health, Labor, and Welfare, Japan (H25-Nanchi-Ippan-031), and the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (grant numbers: 16fk0108119j0001 and 17fk0108219j0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-264; Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; Candoni A, 2003, CLIN MICROBIOL INFEC, V9, P1112, DOI 10.1046/j.1469-0691.2003.00717.x; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Gholizadeh P, 2017, BIOMED PHARMACOTHER, V89, P918, DOI 10.1016/j.biopha.2017.02.102; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Hasegawa N, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00886-16; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Holm K, 2016, ANAEROBE, V42, P89, DOI 10.1016/j.anaerobe.2016.09.006; Huggan PJ, 2008, J INFECTION, V57, P283, DOI 10.1016/j.jinf.2008.07.016; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Johannesen KM, 2016, INFECT DRUG RESIST, V9, P221, DOI 10.2147/IDR.S95050; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Margalit M, 2004, J GASTROEN HEPATOL, V19, P1338, DOI 10.1111/j.1440-1746.2004.03368.x; McGuire AM, 2014, MBIO, V5, DOI 10.1128/mBio.01864-14; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moyano AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004163; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rodriguez-Cardenas A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161020; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; SHANNON GW, 1983, J FAM PRACTICE, V16, P159; VOGEL LC, 1980, AM J DIS CHILD, V134, P356, DOI 10.1001/archpedi.1980.04490010014005; Wang Y, 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1016/J.MSEA.2015.01.021; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200; YAKUNIN AF, 1993, J BACTERIOL, V175, P6775, DOI 10.1128/jb.175.21.6775-6780.1993; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	36	10	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189319	10.1371/journal.pone.0189319	http://dx.doi.org/10.1371/journal.pone.0189319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216329	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800116
J	de Taeye, SW; de la Pena, AT; Vecchione, A; Scutigliani, E; Sliepen, K; Burger, JA; van der Woude, P; Schorcht, A; Schermer, EE; van Gils, MJ; LaBranche, CC; Montefiori, DC; Wilson, IA; Moore, JP; Ward, AB; Sanders, RW				de Taeye, Steven W.; de la Pena, Alba Torrents; Vecchione, Andrea; Scutigliani, Enzo; Sliepen, Kwinten; Burger, Judith A.; van der Woude, Patricia; Schorcht, Anna; Schermer, Edith E.; van Gils, Marit J.; LaBranche, Celia C.; Montefiori, David C.; Wilson, Ian A.; Moore, John P.; Ward, Andrew B.; Sanders, Rogier W.			Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); vaccine development; HIV envelope glycoprotein trimer; protein design; glycoprotein structure; structure-function; V3 domain	BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; AFFINITY MATURATION; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; IMMUNOGEN DESIGN; GLYCOPROTEIN; ENV; IMMUNIZATION; TARGET	To provide protective immunity against circulating primary HIV-1 strains, a vaccine most likely has to induce broadly neutralizing antibodies to the HIV-1 envelope glycoprotein (Env) spike. Recombinant Env trimers such as the prototype BG505 SOSIP.664 that closely mimic the native Env spike can induce autologous neutralizing antibodies (NAbs) against relatively resistant (tier 2) primary viruses. Ideally, Env immunogens should present broadly neutralizing antibody epitopes but limit the presentation of immunodominant non-NAb epitopes that might induce off-target and potentially interfering responses. The V3 loop in gp120 is such a non-NAb epitope that can effectively elicit non-NAbs when animals are immunized with SOSIP.664 trimers. V3 immunogenicity can be diminished, but not abolished, by reducing the conformational flexibility of trimers via targeted sequence changes, including an A316W substitution in V3, that create the SOSIP.v4.1 and SOSIP.v5.2 variants. Here, we further modified these trimer designs by introducing leucine residues at V3 positions 306 and 308 to create hydrophobic interactions with the tryptophan residue at position 316 and with other topologically proximal sites in the V1V2 domain. Together, these modifications further stabilized the resulting SOSIP.v5.2 S306L/R308L trimers in the prefusion state in which V3 is sequestered. When we tested these trimers as immunogens in rabbits, the induction of V3 non-NAbs was significantly reduced compared with the SOSIP.v5.2 trimers and even more so compared with the SOSIP.664 prototype, without affecting the autologous NAb response. Hence, these additional trimer sequence modifications may be beneficial for immunization strategies that seek to minimize off-target non-NAb responses.	[de Taeye, Steven W.; de la Pena, Alba Torrents; Vecchione, Andrea; Scutigliani, Enzo; Sliepen, Kwinten; Burger, Judith A.; van der Woude, Patricia; Schorcht, Anna; Schermer, Edith E.; van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, IAVI Neutralizing Antibody Ctr, Scripps CHAVI ID, La Jolla, CA 92037 USA; [Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [de Taeye, Steven W.] Sanquin Res, Dept Immunohematol Expt & Immunopathol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Duke University; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.; Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	r.w.sanders@amc.uva.nl	Ward, Andrew B/F-9203-2014; van Gils, Marit J./H-4791-2019; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; van Gils, Marit J./0000-0003-3422-8161; Ward, Andrew/0000-0001-7153-3769; Schorcht, Anna/0000-0003-1548-790X; Scutigliani, Enzo/0000-0003-2504-2058	National Institutes of Health HIVRAD Grant [P01 AI110657]; NIAID [HHSN27201100016C]; Bill AMP; Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery [OPP1132237, OPP1084519, OPP1115782]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110657] Funding Source: NIH RePORTER	National Institutes of Health HIVRAD Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill AMP; Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health HIVRAD Grant P01 AI110657 and NIAID Contract HHSN27201100016C and by the Bill & Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery Grants OPP1132237, OPP1084519, and OPP1115782. S. W. d. T., A. T. d. l. P., I. A. W., J. P. M., A. B. W., and R. W. S. are listed as inventors on patents and patent applications concerning stabilized native-like HIV-1 Env trimers. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Berro R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000548; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2017, IMMUNOL REV, V275, P145, DOI [10.1111/imr.12509, 10.]; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Chaudhury S, 2014, J IMMUNOL, V193, P2073, DOI 10.4049/jimmunol.1401054; Cheng C, 2016, J VIROL, V90, P2740, DOI 10.1128/JVI.02380-15; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garrity RR, 1997, J IMMUNOL, V159, P279; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HALL BF, 1991, IMMUNOPARASITOL TOD, pA22; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; He LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12041; Ingale J, 2016, CELL REP, V15, P1986, DOI 10.1016/j.celrep.2016.04.078; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Leaman DP, 2015, J VIROL, V89, P6725, DOI 10.1128/JVI.03738-14; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MARRACK P, 1994, CELL, V76, P323, DOI 10.1016/0092-8674(94)90339-5; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2017, IMMUNOL REV, V275, P217, DOI 10.1111/imr.12501; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Novotny LA, 2003, J IMMUNOL, V171, P1978, DOI 10.4049/jimmunol.171.4.1978; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pantophlet R, 2008, VIROLOGY, V381, P251, DOI 10.1016/j.virol.2008.08.032; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Peet NM, 1998, VIROLOGY, V251, P59, DOI 10.1006/viro.1998.9392; Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe RP, 2017, J VIROL, V91, DOI 10.1128/JVI.00677-17; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schiffner T, 2016, J VIROL, V90, P813, DOI 10.1128/JVI.01942-15; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sliepen K, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0210-4; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stanfield Robyn L., 2005, Human Antibodies, V14, P73; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Stieh DJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0207-z; Sullivan JT, 2017, J VIROL, V91, DOI 10.1128/JVI.00862-17; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; van Gils MJ, 2014, TRENDS MICROBIOL, V22, P550, DOI 10.1016/j.tim.2014.08.006; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2016, J VIROL, V90, P636, DOI 10.1128/JVI.01645-15	93	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1688	1701		10.1074/jbc.RA117.000709	http://dx.doi.org/10.1074/jbc.RA117.000709			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222332	hybrid, Green Published			2022-12-26	WOS:000424201700020
J	Coetzee, J; Hunt, G; Jaffer, M; Otwombe, K; Scott, L; Bongwe, A; Ledwaba, J; Molema, S; Jewkes, R; Gray, GE				Coetzee, Jenny; Hunt, Gillian; Jaffer, Maya; Otwombe, Kennedy; Scott, Lesley; Bongwe, Asiashu; Ledwaba, Johanna; Molema, Sephonono; Jewkes, Rachel; Gray, Glenda E.			HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIDDEN POPULATIONS	Background HIV drug resistance (HIVDR) poses a threat to future antiretroviral therapy success. Monitoring HIVDR patterns is of particular importance in populations such as sex workers (SWs), where documented HIV prevalence is between 34-89%, and in countries with limited therapeutic options. Currently in South Africa, there is a dearth in evidence and no ongoing surveillance of HIVDR amongst sex work populations. This study aims to describe the prevalence of HIVDR amongst a sample of female sex workers (FSWs) from Soweto, South Africa. Methodology A cross-sectional, respondent driven sampling (RDS) recruitment methodology was used to enrol FSWs based in Soweto. Participants were tested for HIV and undertook a survey that included HIV knowledge and treatment status. Whole blood specimens were collected from HIV positive FSWs to measure for CD4 counts, viral load (VL) and perform HIVDR genotyping. Frequencies were determined for categorical variables and medians and interquartile ranges (IQR) for the continuous. Results Of the 508 enrolled participants, 55% (n = 280) were HIV positive and of median age 32 (IQR: 20-51) years. Among the HIV positive, 51.8% (132/269) were defined as virologically suppressed (VL < 400 copies/ml). Of the 119 individuals with unsuppressed viral loads who were successfully genotyped for resistance testing 37.8% (45/119) had detectable drug resistance. In this group, HIVDR mutations were found amongst 73.7% (14/19) of individuals on treatment, 27.4% (26/95) of individuals who were treatment naive, and 100% (5/5) of defaulters. One phylogenetic cluster was found amongst treatment naive FSWs. The K103N mutation was detected most commonly in 68.9% (31/45) individuals with HIVDR mutations, with 20/26 (76.9%) of treatment naive FSW with detectable resistance having this mutation. The M184V mutation was found in both FSWs on treatment (12/14, 85.7%) and those defaulting (1/5, 20.0%). Discussion More than one third (45/119) of the genotyped sample had HIVDR, with resistance to the NNRTI class being the most common. Almost half of HIV positive FSWs had unsuppressed viral loads, increasing the likelihood for onward transmission of HIV. Disturbingly, more than 1: 4 treatment naive women with unsuppressed viral loads had HIVDR suggesting that possible sexual transmission of drug resistance is occurring in this high-risk population. Given the high burden of HIVDR in a population with a high background prevalence of HIV, it is imperative that routine monitoring of HIVDR be implemented. Understanding transmission dynamics of HIVDR in FSW and its impact on treatment success should be urgently elucidated.	[Coetzee, Jenny; Jaffer, Maya; Otwombe, Kennedy; Molema, Sephonono; Gray, Glenda E.] Univ Witwatersrand, PHRU, Fac Hlth Sci, Johannesburg, South Africa; [Coetzee, Jenny] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Hunt, Gillian; Bongwe, Asiashu; Ledwaba, Johanna] NICD, Johannesburg, South Africa; [Scott, Lesley] Univ Witwatersrand, Sch Pathol, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa; [Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gray, Glenda E.] South African Med Res Council, Off President, Cape Town, South Africa	University of Witwatersrand; University of Witwatersrand; National Institute for Communicable Diseases (NICD); University of Witwatersrand; South African Medical Research Council; South African Medical Research Council	Coetzee, J (corresponding author), Univ Witwatersrand, PHRU, Fac Hlth Sci, Johannesburg, South Africa.; Coetzee, J (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	coetzeej@phru.co.za		Ledwaba, Johanna/0000-0003-4727-1601; Jewkes, Rachel/0000-0002-4330-6267; Coetzee, Jenny/0000-0002-6145-6816; Scott, Lesley/0000-0001-6573-9525	Medical Research Council of South Africa; Albert Wessels' Trust; Global Fund; Networking HIV/AIDS Community of South Africa (NACOSA); SoMCHAT	Medical Research Council of South Africa(South African Medical Research Council); Albert Wessels' Trust; Global Fund; Networking HIV/AIDS Community of South Africa (NACOSA); SoMCHAT	The study was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided for the purpose of a PhD by the National Department of Health/Public Health Enhancement Fund. In addition, funding was received through The Albert Wessels Trust. The Global Fund and Networking HIV/AIDS Community of South Africa (NACOSA) provided support to the project. CLS (Clinical Laboratory Services) provided support for laboratory testing. Funding was also received from SoMCHAT for publication and conference attendance.	Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Coetzee J, LANCET; Coetzee J, PLOSONE; Decker MR, 1989, AM J REPROD IMMUNOLO, V69; Dunkle K, 2006, PERPETRATION PARTNER, V20; Dunkle KL, 2007, SOCIAL SCI MED, V65; Gould C., 2008, SELLING SEX CAPE TOW; Gous N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168244; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Lane T, 2015, KPN3 DATA ANAL LONG; Lessells RJ, 2013, AIDS REV, V15, P221; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Manasa Justen, 2016, AIDS RES HUMAN RETRO, V32; Meeme CK, 2009, MOL CHARACTERIZATION; National Insititute of Communicable Diseases, 2016, COMMUNICABLE DIS COM, V15; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Pando MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-58; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Salimo AT, 2015, J VIROL METHODS, V223, P30, DOI 10.1016/j.jviromet.2015.07.005; Sampathkumar R., 2014, RETROVIROLOGY, V11, P133; SANAC, 2016, S AFR NAT SEX WORK H; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stata Corp, 2013, STATA STAT SOFTW REL; Steegen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166305; UCSF Anova Health Institute WRHI, 2013, FIN REP INT BIOL BEH; WHO, 2016, GLOB REP EARL WARN I; World Health Organisation, 2013, MOD 4 INTR RESP DRIV; World Health Organization, 2004, RAP HIV TESTS GUID U; World Health Organization (WHO), 2012, HIV DRUG RES REP	35	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188606	10.1371/journal.pone.0188606	http://dx.doi.org/10.1371/journal.pone.0188606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244809	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700007
J	Cao, M; Wang, DM; Mao, YX; Kong, FN; Bi, GQ; Xing, QK; Weng, Z				Cao, Min; Wang, Dongmei; Mao, Yunxiang; Kong, Fanna; Bi, Guiqi; Xing, Qikun; Weng, Zhen			Integrating transcriptomics and metabolomics to characterize the regulation of EPA biosynthesis in response to cold stress in seaweed Bangia fuscopurpurea	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TEMPERATURE-DEPENDENT EXPRESSION; PHAEODACTYLUM-TRICORNUTUM; LIPID-COMPOSITION; DESATURASE GENE; MARINE DIATOM; LIFE-HISTORY; MICROALGAE; SYNECHOCYSTIS; CULTURE	Bangia fuscopurpurea is a traditional mariculture crop having high nutritional value, eicosapntemacnioc acid (EPA) production, and protein content. As an intertidal species, it can tolerate drastic changes in abiotic factors such as temperature, hydration, and light radiation; however, genomic information on the evolutionary aspect and mechanism of EPA enrichment in B. fuscopurpurea and the role of EPA in cold tolerance in this species remain elusive. We conducted transcriptome profile analysis in B. fuscopurpurea to investigate the biological functions of genes associated with resistance to various environment factors. We identified 41,935 unigenes that were assembled and applied to public databases to define their functional annotation (NR, GO, KEGG, KOG, and SwissProt). We further identified genes that encoded key enzymes in EPA biosynthesis; five paralogous genes encoding delta5 desaturase were detected in B. fuscopurpurea. Fatty acid profiling and gene expression analysis of B. fuscopurpurea grown under cold stress were simultaneously performed. The EPA content was increased by 29.8% in the samples grown at 4 degrees C, while the total amount of fatty acids remained unchanged. Moreover, all the EPA biosynthesis-related desaturase and elongase genes were upregulated under cold stress. Thus, we hypothesized that diverse EPA biosynthesis pathways and significant increase in gene copy numbers of fatty acid desaturases, together with the concomitant elevation in the transcriptional level of genes associated with fatty acid metabolism, lead to EPA accumulation and subsequently affect membrane fluidity, contributing to cold stress resistance in B. fuscopurpurea. Our findings not only provide a fundamental genetic background for further research in B. fuscopurpurea, but also have important implications for screening and genetic engineering of algae and plants for EPA production.	[Cao, Min; Wang, Dongmei; Mao, Yunxiang; Kong, Fanna; Bi, Guiqi; Xing, Qikun] Minist Educ, Key Lab Marine Genet & Breeding OUC, Qingdao, Peoples R China; [Cao, Min; Wang, Dongmei; Mao, Yunxiang; Kong, Fanna; Bi, Guiqi; Xing, Qikun] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Mao, Yunxiang; Weng, Zhen] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Mao, YX (corresponding author), Minist Educ, Key Lab Marine Genet & Breeding OUC, Qingdao, Peoples R China.; Mao, YX (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.; Mao, YX (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	yxmao@ouc.edu.cn			National Natural Science Foundation of China [31372517, 31401116, 31672641]; National High Technology Research and Development Program of China [2012M10A406, 2012AA10A411, 2012AA10A401]; Independent Innovation Foundation of Shandong Province [2013CXC80202]; Qingdao National Laboratory for Marine Science and Technology [2015ASKJ020*]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Independent Innovation Foundation of Shandong Province; Qingdao National Laboratory for Marine Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 31372517, No.31401116, No.31672641), National High Technology Research and Development Program of China (Grant No. 2012M10A406, No.2012AA10A411, and No. 2012AA10A401), Independent Innovation Foundation of Shandong Province (Grant No. 2013CXC80202), The scientific and Technological Innovation Project Finacially Supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ020*). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; ARAO T, 1994, PHYTOCHEMISTRY, V35, P1177, DOI 10.1016/S0031-9422(00)94817-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRENNER R R, 1981, Progress in Lipid Research, V20, P41, DOI 10.1016/0163-7827(81)90012-6; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; COHEN Z, 1988, J PHYCOL, V24, P328, DOI 10.1111/j.1529-8817.1988.tb04474.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; GRIMA EM, 1995, PROCESS BIOCHEM, V30, P711, DOI 10.1016/0032-9592(94)00047-L; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ji M.H., 2004, SEAWEED CHEM, P518; Jiang HM, 2004, J PHYCOL, V40, P651, DOI 10.1111/j.1529-8817.2004.03112.x; Karsten U, 1999, NEW PHYTOL, V143, P561, DOI 10.1046/j.1469-8137.1999.00477.x; Kawamoto J, 2009, J BACTERIOL, V191, P632, DOI 10.1128/JB.00881-08; Knutzon DS, 1999, PNAS, V89, P2624; Kodama H, 2000, PLANT SCI, V155, P153, DOI 10.1016/S0168-9452(00)00210-7; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Li M, 2011, BIOTECHNOL LETT, V33, P1823, DOI 10.1007/s10529-011-0626-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOS D, 1993, FEBS LETT, V318, P57, DOI 10.1016/0014-5793(93)81327-V; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Mikkilineni V, 2003, THEOR APPL GENET, V106, P1326, DOI 10.1007/s00122-003-1190-7; Otles S, 2001, J AOAC INT, V84, P1708; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Renaud SM, 1995, J APPL PHYCOL, V7, P595, DOI 10.1007/BF00003948; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RICHARDSON N, 1968, NATURE, V218, P496, DOI 10.1038/218496a0; Saito T, 1999, EUR J BIOCHEM, V265, P809, DOI 10.1046/j.1432-1327.1999.00789.x; SETO A, 1984, J AM OIL CHEM SOC, V61, P892, DOI 10.1007/BF02542159; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Usov A I, 1978, BIOORGANICHESKAIA KH; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Wang WJ, 2008, AQUACULTURE, V278, P101, DOI 10.1016/j.aquaculture.2008.01.008; Weintraub HS, 2014, POSTGRAD MED, V126, DOI 10.3810/pgm.2014.11.2828; West JA, 1999, HYDROBIOLOGIA, V399, P101; Xia J, 2009, J FISHERIES CHINA, V1	44	17	18	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0186986	10.1371/journal.pone.0186986	http://dx.doi.org/10.1371/journal.pone.0186986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240755	gold, Green Submitted, Green Published			2022-12-26	WOS:000417905600002
J	Choi, H; Geden, M; Feng, J				Choi, HeeSun; Geden, Michael; Feng, Jing			More visual mind wandering occurrence during visual task performance: Modality of the concurrent task affects how the mind wanders	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; WORKING-MEMORY; IMAGERY; PERCEPTION; RESOURCES; ATTENTION; REFLECT; SCENE; BACK	Mind wandering has been considered as a mental process that is either independent from the concurrent task or regulated like a secondary task. These accounts predict that the form of mind wandering (i.e., images or words) should be either unaffected by or different from the modality form (i.e., visual or auditory) of the concurrent task. Findings from this study challenge these accounts. We measured the rate and the form of mind wandering in three task conditions: fixation, visual 2-back, and auditory 2-back. Contrary to the general expectation, we found that mind wandering was more likely in the same form as the task. This result can be interpreted in light of recent findings on overlapping brain activations during internally-and externally-oriented processes. Our result highlights the importance to consider the unique interplay between the internal and external mental processes and to measure mind wandering as a multifaceted rather than a unitary construct.	[Choi, HeeSun; Geden, Michael; Feng, Jing] North Carolina State Univ, Dept Psychol, Raleigh, NC 27695 USA; [Choi, HeeSun] NIOSH, Morgantown, WV USA	University of North Carolina; North Carolina State University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Feng, J (corresponding author), North Carolina State Univ, Dept Psychol, Raleigh, NC 27695 USA.	jing_feng@ncsu.edu		Feng, Jing/0000-0002-0899-1641				Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; ANTROBUS JS, 1970, T NEW YORK ACAD SCI, V32, P242, DOI 10.1111/j.2164-0947.1970.tb02056.x; Axelrod V, 2015, P NATL ACAD SCI USA, V112, P3314, DOI 10.1073/pnas.1421435112; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Brandt SA, 1997, J COGNITIVE NEUROSCI, V9, P27, DOI 10.1162/jocn.1997.9.1.27; Cichy RM, 2012, CEREB CORTEX, V22, P372, DOI 10.1093/cercor/bhr106; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Domhoff GW, 2015, CONSCIOUS COGN, V33, P342, DOI 10.1016/j.concog.2015.01.019; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Fox KCR, 2015, P NATL ACAD SCI USA, V112, pE2414, DOI 10.1073/pnas.1504686112; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Jackson JD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00742; Jonassen D.H., 2012, HDB INDIVIDUAL DIFFE; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Karapanagiotidis T, 2017, NEUROIMAGE, V147, P272, DOI 10.1016/j.neuroimage.2016.12.031; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kirchner W. K., 1958, J EXP PSYCHOL, P1; Kirschner A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00139; Konishi M, 2017, COGNITION, V168, P16, DOI 10.1016/j.cognition.2017.06.006; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; McVay JC, 2013, ACTA PSYCHOL, V142, P136, DOI 10.1016/j.actpsy.2012.11.006; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; Medea B., 2016, EXP BRAIN RES; Seli P, 2016, PSYCHOL SCI, V27, P685, DOI 10.1177/0956797616634068; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2007, PSYCHON B REV, V14, P230, DOI 10.3758/BF03194057; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00441; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Wang H.-T., 2017, PSYCHOL SCI; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189667	10.1371/journal.pone.0189667	http://dx.doi.org/10.1371/journal.pone.0189667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240817	gold, Green Published, Green Submitted			2022-12-26	WOS:000417905600062
J	Jaen-Luchoro, D; Aliaga-Lozano, F; Gomila, RM; Gomila, M; Salva-Serra, F; Lalucat, J; Bennasar-Figueras, A				Jaen-Luchoro, Daniel; Aliaga-Lozano, Francisco; Gomila, Rosa Maria; Gomila, Margarita; Salva-Serra, Francisco; Lalucat, Jorge; Bennasar-Figueras, Antoni			First insights into a type II toxin-antitoxin system from the clinical isolate Mycobacterium sp MHSD3, similar to epsilon/zeta systems	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PROTEIN-STRUCTURE; STRUCTURAL MECHANISMS; CHELONAE INFECTION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BACTERIA; STRESS; ALGORITHMS	A putative type II toxin-antitoxin (TA) system was found in the clinical isolate Mycobacterium sp. MHSD3, a strain closely related to Mycobacterium chelonae. Further analyses of the protein sequences of the two genes revealed the presence of domains related to a TA system. BLAST analyses indicated the presence of closely related proteins in the genomes of other recently published M. chelonae strains. The functionality of both elements of the TA system was demonstrated when expressed in Escherichia coli cells, and the predicted structure of the toxin is very similar to those of well-known zeta-toxins, leading to the definition of a type II TA system similar to epsilon/zeta TA systems in strains that are closely related to M. chelonae.	[Jaen-Luchoro, Daniel; Aliaga-Lozano, Francisco; Gomila, Margarita; Salva-Serra, Francisco; Lalucat, Jorge; Bennasar-Figueras, Antoni] Univ Illes Balears, Dept Biol, Microbiol, Palma De Mallorca, Spain; [Jaen-Luchoro, Daniel; Salva-Serra, Francisco] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Jaen-Luchoro, Daniel; Salva-Serra, Francisco] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden; [Aliaga-Lozano, Francisco] Clin Rotger, Lab Biol Mol, Palma De Mallorca, Spain; [Gomila, Rosa Maria] Univ Illes Balears, Serv Cient Tecn, Palma De Mallorca, Spain; [Lalucat, Jorge] CSIC UIB, Inst Mediterrani Estudis Avancats, IMEDEA, Esporles, Spain; [Bennasar-Figueras, Antoni] Univ Illes Balears, Inst Univ Invest Ciencias Salud IUNICS UIB, Area Enfermedades Infecciosas, Palma De Mallorca, Spain	Universitat de les Illes Balears; University of Gothenburg; University of Gothenburg; Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Universitat de les Illes Balears	Jaen-Luchoro, D (corresponding author), Univ Illes Balears, Dept Biol, Microbiol, Palma De Mallorca, Spain.; Jaen-Luchoro, D (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden.; Jaen-Luchoro, D (corresponding author), Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden.	daniel.jaen@uib.es	Salvà-Serra, Francisco/N-7441-2019; Gomila, Rosa/K-9992-2014; Bennasar Figueras, Toni/I-4469-2015; Jaén-Luchoro, Daniel/AAB-5102-2021; Gomila, Margarita/H-3314-2015	Salvà-Serra, Francisco/0000-0003-0173-560X; Gomila, Rosa/0000-0002-0827-8504; Bennasar Figueras, Toni/0000-0002-2221-3248; Gomila, Margarita/0000-0001-8725-190X; Jaen-Luchoro, Daniel/0000-0002-5988-6227	Spanish MINECO [CGL2012-39604]; FEDER; Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes Balears; European Social Fund; European Commission [602860]; Swedish Vastra Gotaland Regional Fund [ALFGBG-437221]; Ministerio de Economia, lndustria y Competividad	Spanish MINECO(Spanish Government); FEDER(European Commission); Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes Balears; European Social Fund(European Social Fund (ESF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Vastra Gotaland Regional Fund; Ministerio de Economia, lndustria y Competividad	This work was supported by the Spanish MINECO through projects CGL2012-39604 (with FEDER co-funding). M.G. was supported by a postdoctoral contract from the Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes Balears and the European Social Fund. F.S-S. was supported by the European Commission: Tailored-Treatment, project 602860, and by the Swedish Vastra Gotaland Regional Fund, project ALFGBG-437221. RMG was supported by a PTA contract from the Ministerio de Economia, lndustria y Competividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Spanish MINECO through projects CGL2012-39604 (with FEDER co-funding). M.G. was supported by a postdoctoral contract from the Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes Balears and the European Social Fund. F.S-S. was supported by the European Commission: Tailored-Treatment, project 602860, and by the Swedish Vastra Gotaland Regional Fund, project ALFGBG-437221. RMG was supported by a PTA contract from the Ministerio de Economia, Industria y Competividad.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CEGLOWSKI P, 1993, GENE, V136, P1, DOI 10.1016/0378-1119(93)90441-5; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Eid AJ, 2007, CLIN INFECT DIS, V45, P687, DOI 10.1086/520982; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Frampton R, 2012, J BIOL CHEM, V287, P5340, DOI 10.1074/jbc.M111.286856; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gomila M, 2007, APPL ENVIRON MICROB, V73, P3787, DOI 10.1128/AEM.02934-06; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han Q, 2015, STRUCTURE, V23, P1900, DOI 10.1016/j.str.2015.06.030; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Li ZW, 2014, NUCLEIC ACIDS RES, V42, pW240, DOI 10.1093/nar/gku394; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sala A, 2013, CELL STRESS CHAPERON, V18, P129, DOI 10.1007/s12192-012-0396-5; Sberro H, 2013, MOL CELL, V50, P136, DOI 10.1016/j.molcel.2013.02.002; Schuebel F, 2016, J BIOL CHEM, V291, P22868, DOI 10.1074/jbc.M116.751297; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sergeant A, 2013, CLIN EXP DERMATOL, V38, P140, DOI 10.1111/j.1365-2230.2012.04421.x; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song Y, 2012, NEPHROL DIAL TRANSPL, V27, P1639, DOI 10.1093/ndt/gfr504; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tabone M, 2014, TOXINS, V6, P2787, DOI 10.3390/toxins6092787; Tabone M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086615; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, pD599, DOI 10.1093/nar/gku1062; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALLACE RJ, 1992, J INFECT DIS, V166, P405, DOI 10.1093/infdis/166.2.405; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	55	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189459	10.1371/journal.pone.0189459	http://dx.doi.org/10.1371/journal.pone.0189459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236773	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100070
J	Morton, A; Routledge, R; Hrushowy, S; Kibenge, M; Kibenge, F				Morton, Alexandra; Routledge, Richard; Hrushowy, Stacey; Kibenge, Molly; Kibenge, Frederick			The effect of exposure to farmed salmon on piscine orthoreovirus infection and fitness in wild Pacific salmon in British Columbia, Canada	PLOS ONE			English	Article							ATLANTIC SALMON; SOCKEYE-SALMON; ONCORHYNCHUS-NERKA; PREDICT MIGRATION; REOVIRUS PRV; SALAR L.; AQUACULTURE; FISH; SURVIVAL; DISEASE	The disease Heart and Skeletal Muscle Inflammation (HSMI) is causing substantial economic losses to the Norwegian salmon farming industry where the causative agent, piscine orthoreovirus (PRV), is reportedly spreading from farmed to wild Atlantic salmon (Salmo salar) with as yet undetermined impacts. To assess if PRV infection is epidemiologically linked between wild and farmed salmon in the eastern Pacific, wild Pacific salmon (Oncorhynchus sp.) from regions designated as high or low exposure to salmon farms and farmed Atlantic salmon reared in British Columbia (BC) were tested for PRV. The proportion of PRV infection in wild fish was related to exposure to salmon farms (p = 0.0097). PRV was detected in: 95% of farmed Atlantic salmon, 37-45% of wild salmon from regions highly exposed to salmon farms and 5% of wild salmon from the regions furthest from salmon farms. The proportion of PRV infection was also significantly lower (p = 0.0008) where wild salmon had been challenged by an arduous return migration into high-elevation spawning habitat. Inter-annual PRV infection declined in both wild and farmed salmon from 2012-2013 (p <= 0.002). These results suggest that PRV transfer is occurring from farmed Atlantic salmon to wild Pacific salmon, that infection in farmed salmon may be influencing infection rates in wild salmon, and that this may pose a risk of reduced fitness in wild salmon impacting their survival and reproduction.	[Morton, Alexandra] Raincoast Res Soc, Sointula, BC, Canada; [Routledge, Richard] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC, Canada; [Hrushowy, Stacey] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Kibenge, Molly; Kibenge, Frederick] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Charlottetown, PE, Canada	Simon Fraser University; Simon Fraser University; University of Prince Edward Island	Morton, A (corresponding author), Raincoast Res Soc, Sointula, BC, Canada.	AlexandraMorton5@gmail.com			NSERC; Eden Conservation Trust; Jaymac Foundation; Tides Foundation; Vancouver Foundation; Vancity Credit Union	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Eden Conservation Trust; Jaymac Foundation; Tides Foundation; Vancouver Foundation; Vancity Credit Union	This work was supported by NSERC Discovery Grant, T and K Allard, E Borak, D and V Bradshaw, Y Chouinard, J Corbett, Eden Conservation Trust, S Haney, The Jaymac Foundation, Patagonia, R North, B. Wheeler, The Tides Foundation, The Vancouver Foundation, Vancity Credit Union and many smaller donors.	Attoui H., 2011, VIRUS TAXONOMY, P541; Bergh O, 2007, DIS AQUAT ORGAN, V75, P159, DOI 10.3354/dao075159; Bjorgen H, 2015, VET RES, V46, DOI 10.1186/s13567-015-0244-6; Bradford MJ, 2011, DFO CAN SCI ADVIS SE, V123, P44; Cartagena J, 2016, DETECTION VIRUS RELA; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Fisheries and Oceans Canada, 1999, ESC OW LAK SOCK SALM; Fisheries and Oceans Canada (DFO), 2012, PUBL REP AQ SALM EGG; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; Foreman MGG, 2012, ATMOS OCEAN, V50, P301, DOI 10.1080/07055900.2012.686900; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Garver KA, 2016, J FISH DIS, V39, P117, DOI 10.1111/jfd.12329; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godfrey H, 1954, J FISH RES BOARD CAN, V101; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; GROOT C, 1987, FISH B-NOAA, V85, P455; Haatveit HM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030049; Hansen LP, 2006, ICES J MAR SCI, V63, P1159, DOI 10.1016/j.icesjms.2006.05.003; Hauge H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180293; Hauge H, 2016, VET RES, V47, DOI 10.1186/s13567-016-0343-z; Jeffries KM, 2014, MOL ECOL, V23, P5803, DOI 10.1111/mec.12980; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kitano T, 1997, GENES GENET SYST, V72, P25, DOI 10.1266/ggs.72.25; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Lapointe M. F., 2003, P 2003 GEORG BAS PUG; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Martins GC, 2013, 2013 26TH SYMPOSIUM ON INTEGRATED CIRCUITS AND SYSTEMS DESIGN (SBCCI 2013); Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; McKay SJ, 1996, CAN J FISH AQUAT SCI, V53, P1165, DOI 10.1139/cjfas-53-5-1165; Mennerat A, 2010, EVOL BIOL, V37, P59, DOI 10.1007/s11692-010-9089-0; Miller KM, 2017, CONS PHYSL, V5; Miller KM, 2014, EVOL APPL, V7, P812, DOI 10.1111/eva.12164; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Murray AG, 2009, PREV VET MED, V88, P167, DOI 10.1016/j.prevetmed.2008.09.006; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Polinski MP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3196-y; Saksida SM, 2012, J FISH DIS, V35, P137, DOI 10.1111/j.1365-2761.2011.01330.x; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; Sibley SD, 2016, J GEN VIROL, V97, P2482, DOI 10.1099/jgv.0.000568; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Taksdal T, 2007, J FISH DIS, V30, P545, DOI 10.1111/j.1365-2761.2007.00845.x; Taranger GL, 2015, ICES J MAR SCI, V72, P997, DOI 10.1093/icesjms/fsu132; TUKEY JW, 1980, AM STAT, V34, P23, DOI 10.2307/2682991; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Wessel O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183781; Wiik-Nielsen CR, 2012, DIS AQUAT ORGAN, V97, P255, DOI 10.3354/dao02425; Withler RE, 2005, ANIM GENET, V36, P43, DOI 10.1111/j.1365-2052.2004.01220.x	54	19	19	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188793	10.1371/journal.pone.0188793	http://dx.doi.org/10.1371/journal.pone.0188793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236731	gold, Green Submitted, Green Published			2022-12-26	WOS:000417884100032
J	Zhang, ZQ; Zhou, X; Tian, L; Ma, LN; Luo, SS; Zhang, JF; Li, XJ; Tian, CJ				Zhang, Zhenqing; Zhou, Xue; Tian, Lei; Ma, Lina; Luo, Shasha; Zhang, Jianfeng; Li, Xiujun; Tian, Chunjie			Fungal communities in ancient peatlands developed from different periods in the Sanjiang Plain, China	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; CARBON ACCUMULATION; ENZYME-ACTIVITIES; CLIMATE; BACTERIAL; DECOMPOSITION; SENSITIVITY; GRADIENT; DYNAMICS; AGE	Peatlands in the Sanjiang Plain could be more vulnerable to global warming because they are located at the southernmost boundary of northern peatlands. Unlike bacteria, fungi are often overlooked, even though they play important roles in substance circulation in the peatland ecosystems. Accordingly, it is imperative that we deepen our understanding of fungal community structure and diversity in the peatlands. In this study, high-throughput Illumina sequencing was used to study the fungal communities in three fens in the Sanjiang Plain, located at the southern edge of northern peatlands. Peat soil was collected from the three fens which developed during different periods. A total of 463,198 fungal ITS sequences were obtained, and these sequences were classified into at least six phyla, 21 classes, more than 60 orders and over 200 genera. The fungal community structures were distinct in the three sites and were dominated by Ascomycota and Basidiomycota. However, there were no significant differences between these three fens in any alpha-diversity index (p > 0.05). Soil age and the carbon (C) accumulation rate, as well as total carbon (TC), total nitrogen (TN), C/N ratio, and bulk density were found to be closely related to the abundance of several dominant fungal taxa. We captured a rich fungal community and confirmed that the dominant taxa were those which were frequently detected in other northern peatlands. Soil age and the C accumulation rate were found to play important roles in shaping the fungal community structure.	[Zhang, Zhenqing; Zhou, Xue; Tian, Lei; Ma, Lina; Luo, Shasha; Zhang, Jianfeng; Li, Xiujun; Tian, Chunjie] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Changchun, Jilin, Peoples R China; [Zhang, Zhenqing] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China; [Tian, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tian, CJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Changchun, Jilin, Peoples R China.	tiancj@iga.ac.cn	tian, lei/HGU-7245-2022; li, xiu/GXV-1745-2022; ZHOU, XUE/F-6129-2013	Tian, Chunjie/0000-0003-1792-6005	Science Foundation of Chinese Academy of Sciences [XDB15030103]; National Basic Foundation [2016YFC0501202]; Key Laboratory Foundation of Mollisols Agroecology [2016ZKHT-05]; CAS [Y6H2043001]; National Natural Science Foundation of China [41671094, 41571255, 31370144]; Natural Science Foundation of Jilin Province [20140101017JC]	Science Foundation of Chinese Academy of Sciences; National Basic Foundation(National Basic Research Program of China); Key Laboratory Foundation of Mollisols Agroecology; CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was financially supported by the Science Foundation of Chinese Academy of Sciences (XDB15030103), the National Basic Foundation (2016YFC0501202), Key Laboratory Foundation of Mollisols Agroecology (2016ZKHT-05), the Key Technology Research and Development Program of CAS during the "13th Five-Year Plan" (Y6H2043001), the National Natural Science Foundation of China (41671094, 41571255, 31370144), and the Natural Science Foundation of Jilin Province (20140101017JC).; This work was financially supported by the Science Foundation of Chinese Academy of Sciences (XDB15030103), the National Basic Foundation (2016YFC0501202), Key Laboratory Foundation of Mollisols Agroecology (2016ZKHT-05), the Key Technology Research and Development Program of CAS during the "13th Five-Year Plan" (Y6H2043001), the National Natural Science Foundation of China (41671094, 41571255, 31370144), and the Natural Science Foundation of Jilin Province (20140101017JC).	Andersen R, 2013, SOIL BIOL BIOCHEM, V57, P979, DOI 10.1016/j.soilbio.2012.10.003; [Anonymous], 1974, J SEDIMENT RES, V44, P242; Artz RRE, 2007, MICROB ECOL, V54, P508, DOI 10.1007/s00248-007-9220-7; Banerjee S, 2016, SOIL BIOL BIOCHEM, V97, P188, DOI 10.1016/j.soilbio.2016.03.017; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bragazza L, 2013, NAT CLIM CHANGE, V3, P273, DOI [10.1038/nclimate1781, 10.1038/NCLIMATE1781]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Christensen JH, 2007, CLIMATIC CHANGE, V81, P1, DOI 10.1007/s10584-006-9211-6; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Boer W, 1999, BIOL FERT SOILS, V29, P170, DOI 10.1007/s003740050541; Deng J, 2015, MOL ECOL, V24, P222, DOI 10.1111/mec.13015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliott DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124726; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; Gilbert D, 2006, MICROBIAL DIVERSITY, P287; Hui N, 2017, ENVIRON MICROBIOL, V19, P1281, DOI 10.1111/1462-2920.13660; Jiao S, 2016, SOIL BIOL BIOCHEM, V98, P64, DOI 10.1016/j.soilbio.2016.04.005; Jones MC, 2010, P NATL ACAD SCI USA, V107, P7347, DOI 10.1073/pnas.0911387107; Kalucka I, 2013, SYLWAN, V157, P817; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kocourkova J, 2009, BRYOLOGIST, V112, P363, DOI 10.1639/0007-2745-112.2.363; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; KRUSKAL WH, 1987, CC/SOC BEHAV SCI, P20; Kuehn KA, 2000, LIMNOL OCEANOGR, V45, P862, DOI 10.4319/lo.2000.45.4.0862; Kyaschenko J, 2017, ISME J, V11, P863, DOI 10.1038/ismej.2016.184; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Li CH, 2002, CAN J SOIL SCI, V82, P147, DOI 10.4141/S01-026; Lin X, 2012, APPL ENVIRON MICROB, V78, P7023, DOI 10.1128/AEM.01750-12; Lin XJ, 2012, ENVIRON MICROBIOL, V14, P414, DOI 10.1111/j.1462-2920.2011.02659.x; Liu JJ, 2015, SOIL BIOL BIOCHEM, V83, P29, DOI 10.1016/j.soilbio.2015.01.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MA XH, 1993, ECOL ENG, V2, P291, DOI 10.1016/0925-8574(93)90020-G; Mackay JE, 2016, SCI TOTAL ENVIRON, V566, P960, DOI 10.1016/j.scitotenv.2016.05.045; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Myers B, 2012, WETL ECOL MANAG, V20, P77, DOI 10.1007/s11273-011-9242-2; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Oksanen J., 2010, VEGAN PACKAGE VEGAN; Peltoniemi K, 2012, SOIL BIOL BIOCHEM, V51, P20, DOI 10.1016/j.soilbio.2012.04.013; Philben M, 2015, GLOBAL BIOGEOCHEM CY, V29, P729, DOI 10.1002/2014GB004989; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Simon M, 2015, ISME J, V9, P1941, DOI [10.1038/ISMEJ.2015.6, 10.1038/ismej.2015.6]; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sun H, 2016, APPL ENVIRON MICROB, V82, P2632, DOI 10.1128/AEM.03858-15; Sun S, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00966-17, 10.1128/aem.00966-17]; Thormann MN, 2006, CAN J SOIL SCI, V86, P281, DOI 10.4141/S05-082; Utstol-Klein S, 2015, NEW PHYTOL, V206, P1238, DOI 10.1111/nph.13311; Vitt DH, 2000, CAN J EARTH SCI, V37, P683, DOI 10.1139/e99-097; Weiss M, 12 TREMELLOMYCETES R, P331; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xing W, 2016, HOLOCENE, V26, P70, DOI 10.1177/0959683615596824; Xing W, 2015, QUATERNARY SCI REV, V115, P78, DOI 10.1016/j.quascirev.2015.03.005; YOUNGJU K, 2008, J MICROBIOL BIOTECHN, V18, P759; Yu ZC, 2009, GEOPHYS MONOGR SER, V184, P55, DOI 10.1029/2008GM000822; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/annotation/e34adc2a-f73a-4055-8519-fa2deb2e852f; Zhang HJ, 2015, BIOL FERT SOILS, V51, P137, DOI 10.1007/s00374-014-0957-0; Zhang ZJ, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/123521; Zheng HD, 2015, MYCOTAXON, V130, P1017, DOI 10.5248/130.1017; Zhuang WY, 2000, MYCOL RES, V104, P507, DOI 10.1017/S0953756299001902	63	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0187575	10.1371/journal.pone.0187575	http://dx.doi.org/10.1371/journal.pone.0187575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236715	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100004
J	Lebso, M; Anato, A; Loha, E				Lebso, Meaza; Anato, Anchamo; Loha, Eskindir			Prevalence of anemia and associated factors among pregnant women in Southern Ethiopia: A community based cross-sectional study	PLOS ONE			English	Article							ATTENDING ANTENATAL CARE; RISK-FACTORS; AREA; MALARIA; TOWN	Background Anemia is defined as a condition in which there is less than the normal hemoglobin (Hb) level in the body. During pregnancy; iron deficiency is associated with multiple adverse outcomes for both mother and infant. Most of the studies conducted in Ethiopia on anemia during pregnancy were conducted at institution level and associated factors are not well studied and documented. Independent factors like, food security status, dietary diversity and intestinal parasites infection were considered by only a few of them. Hence, the aim of this study was to determine the prevalence of anemia and associated factors among pregnant women in Lemo District, Southern Ethiopia. Methods Community based cross-sectional study was conducted from May-June 2015. Multistage sampling was used to include 507 study participants. Anaemia was diagnosed using Hemo-Cue HB 301 and haemoglobin concentration < 11 g/dl was classified as anaemic. Stool examinations were also done. Structured questionnaire was used as a tool to collect socio-demographic characteristics, individual dietary diversity and level of household food security data. Multivariate logistic regression model was employed to determine the effect of explanatory variables like level of education, level of household food security, dietary diversity, trimester of pregnancy, family planning before pregnancy, deworming, gravidity, iron intake in current pregnancy and soil transmitted helminthes on dependent variable anemia. Results The prevalence of anemia was 23.2% (95% CI: 19.5%-26.9%). Factors associated with anemia were: low socio-economic status (AOR = 2.03, 95% CI: 1.11-3.69),trimester second (AOR = 3.09, 95% CI: 1.41-6.79) and third (AOR = 3.68, 95% CI: 1.67-8.08), gravidity three to five (AOR = 1.78, 95% CI: 1.03-3.07) and six and above (AOR = 2.59, 95% CI: 1.37-4.92), not supplemented with iron (AOR = 1.72, 95% CI: 1.02-2.91), low dietary diversity score (AOR = 3.18, 95% CI: 1.37-7.37) and hookworm infection (AOR = 2.69, 95% CI: 1.34-5.39). Conclusion Anemia has moderate public health significance in the area. Community-based interventions should be enhanced considering the identified associated factors.	[Lebso, Meaza] Yirgalem Hosp, Dept Lab Med, Yirgalem, Ethiopia; [Anato, Anchamo] Hawassa Univ, Coll Agr, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia; [Loha, Eskindir] Hawassa Univ, Sch Publ & Environm Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia	Hawassa University; Hawassa University	Anato, A (corresponding author), Hawassa Univ, Coll Agr, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia.	anchamonanato@gmail.com	Shumbullo, Eskindir Loha/ABB-6422-2021; loha, eskindir/AAN-4925-2020	Shumbullo, Eskindir Loha/0000-0003-0003-2734; 	NORAD	NORAD(CGIAR)	The financial support was obtained from NORAD project and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriha Abrehet, 2014, BMC Res Notes, V7, P888, DOI 10.1186/1756-0500-7-888; Addis K, 2014, PREVALENCE ANEMIA AS; Alem M., 2013, J INTERDISCIP HISTOP, V1, P137, DOI [10.5455/jihp.20130122042052, DOI 10.5455/JIHP.20130122042052]; [Anonymous], 2008, WORLDW PREV AN 1993; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bekele A, 2016, PREVALENCE ANEMIA IT; Bisoi S, 2011, J FAMI WELFA, V57; Breymann C, 2013, EXPERT REV OBSTET GY, V8, P587, DOI DOI 10.1586/17474108.2013.842683; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; Clerk CA, 2009, TROP MED INT HEALTH, V14, P688, DOI 10.1111/j.1365-3156.2009.02280.x; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Freire WB, 2003, ANEMIA PREVENTION CO; Gebremedhin S, 2011, ETHIOP J HEALTH DEV, V25, P22; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Hailu A, 2014, J HEMATOL THROMB DIS, V2; HALLBERG L, 1991, AM J CLIN NUTR, V54, P1047, DOI 10.1093/ajcn/54.6.1047; Hallberg Leif, 1996, P165; Horque M, 2009, SA FAM PRACT, V51, P68; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Ivoke N, 2013, INT J MED MED SCI, V46, P1354; Karaoglu L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-329; Kedir H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078601; Kennedy G, 2011, GUIDELINE MEASURING; Kozuma S., 2009, JMAJ - Japan Medical Association Journal, V52, P214; Lone F W, 2004, East Mediterr Health J, V10, P801; Makhoul Z, 2012, SE ASIAN J TROP MED, V43, P735; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; Obse N, 2013, ETHIOP J HEALTH SCI, V23, P165; Ouedraogo S, 2012, AM J TROP MED HYG, V87, P418, DOI 10.4269/ajtmh.2012.11-0706; Passerini L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001608; Rizwan N, 2013, INRT J MEDI SCIE, V3, P328; Saaka M, 2015, INT J MED RES HEALTH, V4, P749, DOI 10.5958/2319-5886.2015.00146.0; Stoltzfus RJ, 1997, NUTR REV, V55, P223, DOI 10.1111/j.1753-4887.1997.tb01609.x; Tefera, 2014, IMMUNOLOGY INFECT DI, V2, P33; University of Texas, 2006, PRINC COMP AN ADD TO; Villanova PA, 1994, NATL COMMITTEE CLIN; Vivek RG., 2012, Determinants in Pregnant Women, V5, P216; Wen LM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-13; World Health Organization, 2001, IR DEF AN ASS PREV C; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS	42	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188783	10.1371/journal.pone.0188783	http://dx.doi.org/10.1371/journal.pone.0188783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228009	gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600014
J	Ha, AS; Ng, JYY				Ha, Amy S.; Ng, Johan Y. Y.			Rope skipping increases bone mineral density at calcanei of pubertal girls in Hong Kong: A quasi-experimental investigation	PLOS ONE			English	Article							WEIGHT-BEARING EXERCISE; ADOLESCENT GIRLS; CHILDREN; MASS; FITNESS; HEALTH	Bone mineral accrual during puberty is important, especially in girls, because it is related to reduced risks of osteoporosis in adulthood. Previous research has shown that jumping or plyometric exercises may be effective in increasing bone mineral density in adolescents. Rope skipping is a form of activity that involves jumping, thus regular skipping may also increase bone mineral density in pubertal girls. To this end, we conducted a quasi-experimental to examine the effects of rope skipping on girls' bone mineral density and cardiovascular fitness. 176 Hong Kong girls (age = 12.23 +/- 1.80 years at baseline) were recruited to take part in the study. Bone density at their forearms and calcanei were measured twice over two academic years (mean time between visits was 10.3 months). Using multilevel modeling analyses and adjusting for participants' height and physical activity, we found that girls who participated in weekly rope skipping activities, compared to those who did not, had higher levels of bone density at the calcanei (B = 0.023, p < .01). However, no differences were found for bone density at forearms or participants' cardiovascular fitness. The rates of change of these variables across time were also not significantly different. Results suggest that regular rope skipping may increase girls' bone density at the lower extremities, irrespective of the amount of self-report physical activity. However, further research is required to examine the potential dose-response relation between skipping behaviors and the measured outcomes.	[Ha, Amy S.; Ng, Johan Y. Y.] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ha, AS (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China.	sauchingha@cuhk.edu.hk	Ng, Johan/AAP-2441-2020	Ng, Johan/0000-0003-0783-879X	Direct Grant for Research, The Chinese University of Hong Kong	Direct Grant for Research, The Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded by the Direct Grant for Research, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TE, 2005, ORGAN RES METHODS, V8, P274, DOI 10.1177/1094428105278021; Behringer M, 2014, J BONE MINER RES, V29, P467, DOI 10.1002/jbmr.2036; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Boot AM, 1997, J CLIN ENDOCR METAB, V82, P57, DOI 10.1210/jc.82.1.57; Cadogan J, 1998, J BONE MINER RES, V13, P1602, DOI 10.1359/jbmr.1998.13.10.1602; Chan NPT, 2010, MATERN CHILD HLTH J, V14, P466, DOI 10.1007/s10995-009-0481-2; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Crabtree NJ, 2014, J CLIN DENSITOM, V17, P225, DOI 10.1016/j.jocd.2014.01.003; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Gammon C, 2017, J SPORT SCI, V35, P29, DOI 10.1080/02640414.2016.1154594; Gunter K, 2008, BONE, V42, P710, DOI 10.1016/j.bone.2008.01.002; Gutin B, 2002, AM J CLIN NUTR, V75, P818, DOI 10.1093/ajcn/75.5.818; Hind K, 2007, BONE, V40, P14, DOI 10.1016/j.bone.2006.07.006; Ishikawa S, 2013, SPORTS MED, V43, P875, DOI 10.1007/s40279-013-0060-y; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; MacKelvie KJ, 2001, J PEDIATR-US, V139, P501, DOI 10.1067/mpd.2001.118190; McKay HA, 1998, J PEDIATR-US, V133, P682, DOI 10.1016/S0022-3476(98)70112-X; Meredith M. D., 2013, FITNESSGRAM ACTIVITY, V4th; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Pang B, 2010, EUR PHYS EDUC REV, V16, P223, DOI 10.1177/1356336X10382971; Ridley K, 2008, MED SCI SPORT EXER, V40, P1439, DOI 10.1249/MSS.0b013e31817279ef; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Weeks BK, 2008, J BONE MINER RES, V23, P1002, DOI 10.1359/JBMR.080226; Wren TAL, 2014, J PEDIATR-US, V164, P1280, DOI 10.1016/j.jpeds.2013.12.040; Xu JC, 2016, SPORTS MED, V46, P1165, DOI 10.1007/s40279-016-0494-0	30	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189085	10.1371/journal.pone.0189085	http://dx.doi.org/10.1371/journal.pone.0189085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220384	Green Submitted, gold, Green Published			2022-12-26	WOS:000417469900031
J	Luo, G; Jacob, L; Bonvalet, M; Ambati, A; Plazzi, G; Pizza, F; Leib, R; Adams, CM; Partinen, M; Mignot, EJM				Luo, Guo; Jacob, Louis; Bonvalet, Melodie; Ambati, Aditya; Plazzi, Giuseppe; Pizza, Fabio; Leib, Ryan; Adams, Christopher M.; Partinen, Markku; Mignot, Emmanuel Jean-Marie			Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy	PLOS ONE			English	Article							INFLUENZA; VACCINATION; PEPTIDE; POPULATION; RESPONSES; CHILDREN; MUTATION; CELLS; CLIP	Background A recent publication suggested molecular mimicry of a nucleoprotein (NP) sequence from A/Puerto Rico/8/1934 (PR8) strain, the backbone used in the construction of the reassortant strain X-179A that was used in Pandemrix (R) vaccine, and reported on anti-hypocretin (HCRT) receptor 2 (anti-HCRTR2) autoantibodies in narcolepsy, mostly in post Pandemrix (R) narcolepsy cases (17 of 20 sera). In this study, we re-examined this hypothesis through mass spectrometry (MS) characterization of Pandemrix (R), and two other pandemic H1N1 (pH1N1)-2009 vaccines, Arepanrix (R) and Focetria (R), and analyzed anti-HCRTR2 autoantibodies in narcolepsy patients and controls using three independent strategies. Methods MS characterization of Pandemrix (R) (2 batches), Arepanrix (R) (4 batches) and Focetriar (1 batch) was conducted with mapping of NP 116I or 116M spectrogram. Two sets of narcolepsy cases and controls were used: 40 post Pandemrix (R) narcolepsy(PP-N) cases and 18 age-matched post Pandemrix (R) controls (PP-C), and 48 recent(<= 6 months) early onset narcolepsy (EO-N) cases and 70 age-matched other controls (O-C). Anti-HCRTR2 autoantibodies were detected using three strategies: (1) Human embryonic kidney (HEK) 293T cells with transient expression of HCRTR2 were stained with human sera and then analyzed by flow cytometer; (2) In vitro translation of [(35) S]-radiolabelled HCRTR2 was incubated with human sera and immune complexes of autoantibody and [(35) S]-radiolabelled HCRTR2 were quantified using a radioligand-binding assay; (3) Optical density (OD) at 450 nm (OD450) of human serum immunoglobulin G (IgG) binding to HCRTR2 stably expressed in Chinese hamster ovary (CHO)-K1 cell line was measured using an in-cell enzyme-linked immunosorbent assay (ELISA). Results NP 116M mutations were predominantly present in all batches of Pandemrix (R), Arepanrix (R) and Focetria (R). The wild- type NP109-123 (ILYDKEEIRRIWRQA), a mimic to HCRTR234-45 (YDDEEFLRYLWR), was not found to bind to DQ0602. Three or four subjects were found positive for anti-HCRTR2 autoantibodies using two strategies or the third one, respectively. None of the post Pandemrix (R) narcolepsy cases (0 of 40 sera) was found positive with all three strategies. Conclusion Anti-HCRTR2 autoantibody is not a significant biological feature of narcolepsy or of post Pandemrix (R) autoimmune responses.	[Luo, Guo; Jacob, Louis; Bonvalet, Melodie; Ambati, Aditya; Mignot, Emmanuel Jean-Marie] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Plazzi, Giuseppe; Pizza, Fabio] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Plazzi, Giuseppe; Pizza, Fabio] Inst Neurol Sci, Bologna, Italy; [Leib, Ryan; Adams, Christopher M.] Stanford Univ Mass Spectrometry, Palo Alto, CA USA; [Partinen, Markku] Helsinki Sleep Clin, Helsinki, Finland	Stanford University; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	Mignot, EJM (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Plazzi, Giuseppe/AAB-9627-2020; Jacob, Louis/AAL-3956-2020; Ambati, Aditya/K-4095-2019; Pizza, Fabio/AAC-1794-2020	Jacob, Louis/0000-0003-1071-1239; Ambati, Aditya/0000-0001-8462-3552; Partinen, Markku/0000-0002-8182-9368				Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ahmed SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2354; Amatoury M, 2013, JOVE-J VIS EXP, DOI 10.3791/50935; [Anonymous], 2014, R LANG ENV STAT COMP; Aran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012875; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Chaturvedi P, 2000, INT IMMUNOL, V12, P757, DOI 10.1093/intimm/12.6.757; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Deloumeau A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013320; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dye TJ, 2016, PAEDIAT RESP REV; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Feltelius N, 2015, J INTERN MED, V278, P335, DOI 10.1111/joim.12391; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Gadroen K, 2016, VACCINE, V34, P4892, DOI 10.1016/j.vaccine.2016.08.062; Giannoccaro MP, 2016, SLEEP; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2012, ANN NEUROLOGY; Han F, 2014, SLEEP, V37, P1601, DOI 10.5665/sleep.4066; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; Jacob L, 2015, BRAIN BEHAV IMMUN, V47, P44, DOI 10.1016/j.bbi.2014.11.004; KAO FT, 1969, SCIENCE, V164, P313, DOI 10.1126/science.164.3877.312; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; Koepsell TD, 2010, J SLEEP RES, V19, P80, DOI 10.1111/j.1365-2869.2009.00756.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Melen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068402; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Montplaisir J, 2014, PLOS ONE IN PRESS; Nicolson C, 2012, VACCINE, V30, P745, DOI 10.1016/j.vaccine.2011.11.081; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Flanagan D, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.17.20789; O'Flanagan D, 2009, INVESTIGATION ASS ON; Oberle D, 2015, SLEEP, V38, P1619, DOI 10.5665/sleep.5060; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; SMA, 2011, REG BAS COMP COH STU; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Tanaka S, 2006, SLEEP, V29, P633, DOI 10.1093/sleep/29.5.633; Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361; Van Elssen CHMJ, 2011, J IMMUNOL METHODS, V365, P87, DOI 10.1016/j.jim.2010.12.006; Vassalli A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2353; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Winstone AM, 2014, DEV MED CHILD NEUROL, V56, P1117, DOI 10.1111/dmcn.12522; Wu HJ, 2014, SLEEP MED, V15, P607, DOI 10.1016/j.sleep.2013.12.012; Yin LS, 2015, J IMMUNOL, V195, P706, DOI 10.4049/jimmunol.1403190; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	63	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187305	10.1371/journal.pone.0187305	http://dx.doi.org/10.1371/journal.pone.0187305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220370	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900004
J	Chang, VW; Langa, KM; Weir, D; Iwashyna, TJ				Chang, Virginia W.; Langa, Kenneth M.; Weir, David; Iwashyna, Theodore J.			The obesity paradox and incident cardiovascular disease: A population-based study	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC HEART-FAILURE; REVERSE CAUSATION; CORONARY EVENTS; SELECTION BIAS; MORTALITY; IMPACT; OUTCOMES; WEIGHT; RISK	Background Prior work suggests that obesity may confer a survival advantage among persons with cardiovascular disease (CVD). This obesity "paradox" is frequently studied in the context of prevalent disease, a stage in the disease process when confounding from illness-related weight loss and selective survival are especially problematic. Our objective was to examine the association of obesity with mortality among persons with incident CVD, where biases are potentially reduced, and to compare these findings with those based on prevalent disease. Methods We used data from the Health and Retirement Study, an ongoing, nationally representative longitudinal survey of U.S. adults age 50 years and older initiated in 1992 and linked to Medicare claims. Cox proportional hazard models were used to estimate the association between weight status and mortality among persons with specific CVD diagnoses. CVD diagnoses were established by self-reported survey data as well as Medicare claims. Prevalent disease models used concurrent weight status, and incident disease models used prediagnosis weight status. Results We examined myocardial infarction, congestive heart failure, stroke, and ischemic heart disease. A strong and significant obesity paradox was consistently observed in prevalent disease models (hazard of death 18-36% lower for obese class I relative to normal weight), replicating prior findings. However, in incident disease models of the same conditions in the same dataset, there was no evidence of this survival benefit. Findings from models using survey-vs. claims-based diagnoses were largely consistent. Conclusion We observed an obesity paradox in prevalent CVD, replicating prior findings in a population-based sample with longer-term follow-up. In incident CVD, however, we did not find evidence of a survival advantage for obesity. Our findings do not offer support for reevaluating clinical and public health guidelines in pursuit of a potential obesity paradox.	[Chang, Virginia W.] NYU, Dept Social & Behav Sci, Coll Global Publ Hlth, New York, NY 10003 USA; [Chang, Virginia W.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Weir, David] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	New York University; New York University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, VW (corresponding author), NYU, Dept Social & Behav Sci, Coll Global Publ Hlth, New York, NY 10003 USA.; Chang, VW (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA.	vc43@nyu.edu		Langa, Kenneth/0000-0002-2798-1836	American Diabetes Association [7-12-CT-12]; National Institute on Aging [U01AG009740]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Clinical Translational Research Award from the American Diabetes Association 7-12-CT-12, www.diabetes.org/ (VVVC), and the National Institute on Aging U01AG009740, https://www.nia.nih.gov/ (KML, DW). The funding organizations had no role in the study design, data analysis, decision to publish, or the preparation of the manuscript. The Health and Retirement Study data collection is supported by the National Institute on Aging.	Arena R, 2009, AM J CARDIOL, V104, P1116, DOI 10.1016/j.amjcard.2009.05.059; Banack HR, 2015, ANN EPIDEMIOL, V25, P342, DOI 10.1016/j.annepidem.2015.02.008; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Bozkurt B, 2005, AM HEART J, V150, P1233, DOI 10.1016/j.ahj.2005.02.004; Buccaneer Computer Systems and Services, CHRON COND DAT WAR U; Cicoira M, 2007, EUR J HEART FAIL, V9, P397, DOI 10.1016/j.ejheart.2006.10.016; Clark AL, 2012, AM J CARDIOL, V110, P77, DOI 10.1016/j.amjcard.2012.02.050; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Davos CH, 2003, J CARD FAIL, V9, P29, DOI 10.1054/jcaf.2003.4; Doehner W, 2015, EUR HEART J; Epstein AJ, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-42; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Galal W, 2007, AM J CARDIOL, V99, P1485, DOI 10.1016/j.amjcard.2007.01.018; Glymour MM, 2014, EPIDEMIOLOGY, V25, P4, DOI 10.1097/EDE.0000000000000013; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Hu FB, 2008, OBESITY EPIDEMIOLOGY, P216; Iakobishvili Zaza, 2006, Acute Card Care, V8, P95, DOI 10.1080/17482940600768673; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Kenchaiah S, 2007, CIRCULATION, V116, P627, DOI 10.1161/CIRCULATIONAHA.106.679779; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lopez-Jimenez F, 2004, CHEST, V125, P1205, DOI 10.1378/chest.125.4.1205; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mehta NK, 2011, OXFORD HDB SOCIAL SC, P502; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Rea TD, 2001, AM J CARDIOL, V88, P467, DOI 10.1016/S0002-9149(01)01720-9; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stokes A, 2015, OBESITY, V23, P2485, DOI 10.1002/oby.21239; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization, 2000, HLTH ORG TECHN SUPP	40	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188636	10.1371/journal.pone.0188636	http://dx.doi.org/10.1371/journal.pone.0188636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216243	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800033
J	Cohen, AA; Isaksson, C; Salguero-Gomez, R				Cohen, Alan A.; Isaksson, Caroline; Salguero-Gomez, Roberto			Co-existence of multiple trade-off currencies shapes evolutionary outcomes	PLOS ONE			English	Article							FAST-SLOW CONTINUUM; MAMMALIAN LIFE-HISTORY; OXIDATIVE STRESS; IMMUNE-RESPONSES; SENESCENCE; NUTRITION; PATTERNS; ECOLOGY; TRAITS	Evolutionary studies often assume that energy is the primary resource (i. e. "currency") at the heart of the survival-reproduction trade-off, despite recent evidence to the contrary. The evolutionary consequences of having a single trade-off currency versus multiple competing currencies are unknown. Using simulations, we modeled the evolution of either a single physiological currency between reproduction and survival, or of multiple such currencies. For a wide array of model specifications varying functional forms and strengths of the trade-offs, we show that the presence of multiple currencies (e.g. nutrients, time) generally results in the evolution of higher lifetime reproductive success through partial circumvention of such trade-offs. Evolution of the underlying physiology is also more highly contingent with multiple currencies. These results challenge the paradigm of a single survival-reproduction trade-off as central to life history evolution, suggesting greater roles for physiological constraints and contingency, and implying potential selection for evolution of multiple trade-off currencies.	[Cohen, Alan A.] Univ Sherbrooke, Dept Family Med, PRIMUS Res Grp, Sherbrooke, PQ, Canada; [Isaksson, Caroline] Lund Univ, Dept Biol, Evolutionary Ecol unit, Lund, Sweden; [Salguero-Gomez, Roberto] Univ Sheffield, Dept Anim & Plant Sci, Alfred Denny Bldg, Sheffield, S Yorkshire, England; [Salguero-Gomez, Roberto] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, St Lucia, Qld, Australia	University of Sherbrooke; Lund University; University of Sheffield; University of Queensland	Cohen, AA (corresponding author), Univ Sherbrooke, Dept Family Med, PRIMUS Res Grp, Sherbrooke, PQ, Canada.	Alan.Cohen@USherbrooke.ca	Salguero-Gomez, Rob/AAB-8488-2022	Salguero-Gomez, Roberto/0000-0002-6085-4433; Cohen, Alan/0000-0003-4113-3988	Canadian Institutes of Health Research; National Science and Engineering Research Council Discovery Grant [402079-2011]; Swedish Research Council [C0361301]; European Union [322217]; Australian Research Council [140100505]; NERC [R/142195-11-1]; Natural Environment Research Council [NE/M018458/1, NE/M018458/2] Funding Source: researchfish; NERC [NE/M018458/1, NE/M018458/2] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council Discovery Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Australian Research Council(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AAC is a member of the Fonds de recherche du Quebec-sante (FRQ-S; http://www.frqs.gouv.qc.ca/)-supported Centre de recherche sur le vieillissement and Centre de recherche du CHUS, and a funded New Investigator with the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). This project was supported by National Science and Engineering Research Council Discovery Grant # 402079-2011. CI is a member of Evolutionary Ecology unit in Lund, and was supported by the Swedish Research Council (https://www.vr.se/; #C0361301) and European Union (http://ec.europa.eu/research/mariecurieactions/; FP7-CIG # 322217). RSG is a Natural Environment Research Council (NERC; http://www.nerc.ac.uk/) research fellow and was supported by a Discovery Early Career Researcher Award # 140100505 of the Australian Research Council (http://www.arc.gov.au/) and NERC R/142195-11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Cohen AA, 2008, AM NAT, V172, P178, DOI 10.1086/589456; Cohen AA, 2016, BIOGERONTOLOGY, V17, P205, DOI 10.1007/s10522-015-9584-x; Cohen AA, 2009, OIKOS, V118, P1854, DOI 10.1111/j.1600-0706.2009.17785.x; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Fenton A, 2008, PARASITOLOGY, V135, P841, DOI 10.1017/S0031182008000310; Gaillard J.-M., 2016, ENCY EVOLUTIONARY BI, P312, DOI DOI 10.1016/B978-0-12-800049-6.00085-8; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Isaksson C, 2011, BIOSCIENCE, V61, P194, DOI 10.1525/bio.2011.61.3.5; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kramer BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137969; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lambers H., 2008, PLANT PHYSL ECOLOGY; Lee WS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2370; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P815, DOI 10.1098/rspb.2005.3376; Metcalf CJE, 2016, AM NAT, V187, pIII, DOI 10.1086/685487; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Roff DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P11; Roff Derek A., 1992; Salguero-Gomez R, 2016, P NATL ACAD SCI USA, V113, P230, DOI 10.1073/pnas.1506215112; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Snell-Rood E, 2015, EVOL APPL, V8, P635, DOI 10.1111/eva.12272; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; SPITZE K, 1991, EVOLUTION, V45, P1081, DOI 10.1111/j.1558-5646.1991.tb04376.x; Stearns S.C., 1992, pi; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Watson H, 2015, EXP GERONTOL, V71, P80, DOI 10.1016/j.exger.2015.08.009; Whitson A.R., 1912, SOILS SOIL FERTILITY; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0	46	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189124	10.1371/journal.pone.0189124	http://dx.doi.org/10.1371/journal.pone.0189124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216275	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800076
J	Park, J; Masaki, T; Mezaki, Y; Yokoyama, H; Nakamura, M; Maehashi, H; Fujimi, TJ; Gouraud, SS; Nagatsuma, K; Nakagomi, M; Kimura, N; Matsuura, T				Park, Jonghyuk; Masaki, Takahiro; Mezaki, Yoshihiro; Yokoyama, Hiroshi; Nakamura, Mariko; Maehashi, Haruka; Fujimi, Takahiko J.; Gouraud, Sabine S.; Nagatsuma, Keisuke; Nakagomi, Madoka; Kimura, Naofumi; Matsuura, Tomokazu			Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TRAUMATIC BRAIN-INJURY; AQUAPORIN-4 EXPRESSION; ALZHEIMERS-DISEASE; HEPATOCELLULAR-CARCINOMA; PORTACAVAL ANASTOMOSIS; CULTURED ASTROCYTES; EDEMA; AMMONIA; ALPHA-1-ANTICHYMOTRYPSIN	Background and aims We developed a bio-artificial liver (BAL) using a radial-flow bioreactor and rescued mini-pig models with lethal acute liver failure (ALF). The point of the rescue is the recovery from hepatic encephalopathy (HE). HE on ALF has sometimes resulted in brain death following brain edema with astrocyte swelling. Several factors, including ammonia and glutamine, have been reported to induce astrocyte swelling and injury. However, many clinicians believe that there are any other factors involved in the development of HE. Therefore, the aim of this study was to identify novel HE-inducible factors, particularly those inducing astrocyte dysfunction. Methods Mini-pig plasma samples were collected at three time points: before the administration of toxins (a-amanitin and LPS), when HE occurred after the administration of toxins, and after treatment with extracorporeal circulation (EC) by the BAL. To identify the causative factors of HE, each plasma sample was subjected to a comparative proteome analysis with two-dimensional gel electrophoresis and mass spectrometry. To assess the direct effects of candidate factors on the astrocyte function and injury, in vitro experiments with human astrocytes were performed. Results Using a proteome analysis, we identified alpha-1 antichymotrypsin (ACT), which was increased in plasma samples from mini-pigs with HE and decreased in those after treatment with EC by BAL. In in vitro experiments with human astrocytes, ACT showed growth-inhibitory and cytotoxic effects on astrocytes. In addition, the expression of water channel protein aquaporin-4, which is induced in injured astrocytes, was increased following ACT treatment. Interestingly, these effects of ACT were additively enhanced by adding argininevasopressin (AVP) and were canceled by adding an AVP receptor antagonist. Conclusions These results suggest that ACT is involved in astrocyte injury and dysfunction in concert with AVP during the development of acute HE.	[Park, Jonghyuk; Masaki, Takahiro; Mezaki, Yoshihiro; Yokoyama, Hiroshi; Nakamura, Mariko; Maehashi, Haruka; Nagatsuma, Keisuke; Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan; [Fujimi, Takahiko J.] Bunkyo Univ, Fac Hlth & Nutr, Chigasaki, Kanagawa, Japan; [Gouraud, Sabine S.] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo, Japan; [Nakagomi, Madoka] Hatano Res Inst, Food & Drug Safety Ctr, Kanagawa, Japan; [Kimura, Naofumi] Jikei Univ, Sch Med, Dept Pharmacol, Minato Ku, Tokyo, Japan	Jikei University; Ochanomizu University; Jikei University	Matsuura, T (corresponding author), Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan.	matsuurat@jikei.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Mezaki, Yoshihiro/0000-0003-4914-0541; Fujimi, Takahiko/0000-0003-1768-9695; Yokoyama, Hiroshi/0000-0003-4559-030X	Jikei University Research Fund for Graduate Students; Otsuka Toshimi Scholarship Foundation; Atsumi International Foundation; Japan Agency for Medical Research and Development [17fk0310112h0001]	Jikei University Research Fund for Graduate Students; Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical); Atsumi International Foundation; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Jikei University Research Fund for Graduate Students and Otsuka Toshimi Scholarship Foundation and Atsumi International Foundation, and the Research on the Innovative Development and the Practical Application of New Drugs for Hepatitis B (principal investigator: Soichi Kojima;17fk0310112h0001) provided by Japan Agency for Medical Research and Development.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Asai H, 2013, CELL MOL NEUROBIOL, V33, P393, DOI 10.1007/s10571-013-9905-z; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Braghin E, 2009, NEUROSCI LETT, V467, P40, DOI 10.1016/j.neulet.2009.09.057; Chung CH, 2003, J HEPATOL, V39, P193, DOI 10.1016/S0168-8278(03)00185-5; Ciecko-Michalska I, 2012, GASTROENT RES PRACT, V2012; Cordoba J, 1998, J HEPATOL, V29, P589, DOI 10.1016/S0168-8278(98)80154-2; Decaux G, 2008, LANCET, V371, P1624, DOI 10.1016/S0140-6736(08)60695-9; Ding T, 2011, INT J ONCOL, V38, P1521, DOI 10.3892/ijo.2011.983; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Ianni Manuela, 2010, Immun Ageing, V7 Suppl 1, pS6, DOI 10.1186/1742-4933-7-S1-S6; Iwasa M, 2015, HEPATOL RES, V45, P1155, DOI 10.1111/hepr.12495; Jia SW, 2016, J STROKE CEREBROVASC, V25, P1289, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.002; Kanai H, 2007, ARTIF ORGANS, V31, P148, DOI 10.1111/j.1525-1594.2007.00354.x; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Mihara T, 1999, BRAIN RES BULL, V49, P343, DOI 10.1016/S0361-9230(99)00064-7; Montana V, 2014, CURR NEUROPHARMACOL, V12, P324, DOI 10.2174/1570159X12666140903094700; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rabinstein AA, 2010, CURR TREAT OPTION NE, V12, P129, DOI 10.1007/s11940-010-0062-0; Rao KVR, 2007, METAB BRAIN DIS, V22, P265, DOI 10.1007/s11011-007-9063-4; Rao KVR, 2014, NEUROBIOL DIS, V63, P222, DOI 10.1016/j.nbd.2013.11.018; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rao KVR, 2010, J NEUROPATH EXP NEUR, V69, P869, DOI 10.1097/NEN.0b013e3181ebe581; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Ritchie A, 2004, MOL BRAIN RES, V131, P88, DOI 10.1016/j.molbrainres.2004.08.012; Tan XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-274; Thumburu KK, 2014, J NEUROCHEM, V128, P617, DOI 10.1111/jnc.12511; Wendon J, 2008, NEUROCRIT CARE, V9, P97, DOI 10.1007/s12028-008-9123-6; Wijdicks EFM, 2016, NEW ENGL J MED, V375, P1660, DOI 10.1056/NEJMra1600561; Yang MH, 2007, ANAL BIOANAL CHEM, V388, P637, DOI 10.1007/s00216-007-1263-6; Yang W, 2012, MOL CELL NEUROSCI, V49, P406, DOI 10.1016/j.mcn.2012.02.002; Yi MH, 2013, CELL MOL NEUROBIOL, V33, P223, DOI 10.1007/s10571-012-9889-0; Yin C, 2017, RES VET SCI, V111, P140, DOI 10.1016/j.rvsc.2017.02.016; Zhang B, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-30; Zhang R, 2014, BRAIN RES, V1583, P23, DOI 10.1016/j.brainres.2014.08.016	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189346	10.1371/journal.pone.0189346	http://dx.doi.org/10.1371/journal.pone.0189346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216295	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800120
J	Townsend, PD; Dixon, CH; Slootweg, EJ; Sukarta, OCA; Yang, AWH; Hughes, TR; Sharples, GJ; Palsson, LO; Takken, FLW; Goverse, A; Cann, MJ				Townsend, Philip D.; Dixon, Christopher H.; Slootweg, Erik J.; Sukarta, Octavina C. A.; Yang, Ally W. H.; Hughes, Timothy R.; Sharples, Gary J.; Palsson, Lars-Olof; Takken, Frank L. W.; Goverse, Aska; Cann, Martin J.			The intracellular immune receptor Rx1 regulates the DNA-binding activity of a Golden2-like transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SEQUENCE SPECIFICITY; N-MEDIATED RESISTANCE; TOBACCO MOSAIC-VIRUS; CELL-DEATH; PLANT TRANSFORMATION; NUCLEAR ACCUMULATION; FACTORS COORDINATE; DEFENSE RESPONSES; INNATE IMMUNITY; RNA-POLYMERASE	Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable the immune system to recognize and respond to pathogen attack. An early consequence of immune activation is transcriptional reprogramming, and some NLRs have been shown to act in the nucleus and interact with transcription factors. The Rx1 NLR protein of potato is further able to bind and distort double-stranded DNA. However, Rx1 host targets that support a role for Rx1 in transcriptional reprogramming at DNA are unknown. Here, we report a functional interaction between Rx1 and NbGlk1, a Golden2-like transcription factor. Rx1 binds to NbGlk1 in vitro and in planta. NbGlk1 binds to known Golden2-like consensus DNA sequences. Rx1 reduces the binding affinity of NbGlk1 for DNA in vitro. NbGlk1 activates cellular responses to potato virus X, whereas Rx1 associates with NbGlk1 and prevents its assembly on DNA in planta unless activated by PVX. This study provides new mechanistic insight into how an NLR can coordinate an immune signaling response at DNA following pathogen perceptions.	[Townsend, Philip D.; Dixon, Christopher H.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Dept Biosci, South Rd, Durham DH1 3LE, England; [Townsend, Philip D.; Dixon, Christopher H.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, South Rd, Durham DH1 3LE, England; [Palsson, Lars-Olof] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England; [Slootweg, Erik J.; Sukarta, Octavina C. A.; Goverse, Aska] Wageningen Univ, Dept Plant Sci, Nematol Lab, NL-6708 PB Wageningen, Netherlands; [Yang, Ally W. H.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	Durham University; Durham University; Durham University; Wageningen University & Research; University of Toronto; University of Amsterdam	Cann, MJ (corresponding author), Univ Durham, Dept Biosci, South Rd, Durham DH1 3LE, England.	rn.j.cann@durham.ac.uk	Sharples, Gary/B-8638-2016; Townsend, Phiip/J-3761-2018; Pålsson, Lars-Olof A/F-3877-2012; Takken, Frank/C-8051-2012	Sharples, Gary/0000-0003-2495-0062; Townsend, Phiip/0000-0001-9235-3492; Pålsson, Lars-Olof A/0000-0003-3592-8506; Takken, Frank/0000-0003-2655-3108; Slootweg, Erik J./0000-0001-9935-7728	Biotechnology and Biological Sciences Research Council [BB/M007405/1]; Dutch Technology Foundation STW and Earth and Life Sciences ALW; ALW-VICI [865.14.003]; CIHR [FDN-148403]; Biotechnology and Biological Sciences Research Council [1220464] Funding Source: researchfish; BBSRC [BB/M007405/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dutch Technology Foundation STW and Earth and Life Sciences ALW; ALW-VICI; CIHR(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/M007405/1 (to M.J.C., G.J.S., and L.O.P.), the Dutch Technology Foundation STW and Earth and Life Sciences ALW (to E.J.S., O.C.A.S., and A.G.), and ALW-VICI Project No. 865.14.003 (to F.L.W.T.) (Netherlands Organization for Scientific Research), and FDN-148403 from CIHR (to T.R.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bendahmane A, 1995, PLANT J, V8, P933, DOI 10.1046/j.1365-313X.1995.8060933.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chang C, 2013, PLANT CELL, V25, P1158, DOI 10.1105/tpc.113.109942; Chen M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01509; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fenyk S, 2016, J BIOL CHEM, V291, P1137, DOI 10.1074/jbc.M115.698589; Fenyk S, 2015, J BIOL CHEM, V290, P24945, DOI 10.1074/jbc.M115.672121; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Finzi L, 2010, J BIOL CHEM, V285, P18973, DOI 10.1074/jbc.R109.062612; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; FRIED MG, 1984, J MOL BIOL, V172, P241, DOI 10.1016/S0022-2836(84)80025-X; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garner CM, 2016, SEMIN CELL DEV BIOL, V56, P150, DOI 10.1016/j.semcdb.2016.05.002; Han XY, 2016, BIOCHEM BIOPH RES CO, V477, P626, DOI 10.1016/j.bbrc.2016.06.110; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim H, 2012, NUCLEIC ACIDS RES, V40, P371, DOI 10.1093/nar/gkr736; Kolomeisky AB, 2011, PHYS CHEM CHEM PHYS, V13, P2088, DOI 10.1039/c0cp01966f; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Murmu J, 2014, MOL PLANT PATHOL, V15, P174, DOI 10.1111/mpp.12077; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Peart JR, 2002, PLANT J, V29, P569, DOI 10.1046/j.1365-313X.2002.029005569.x; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Roberts M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003465; Rossini L, 2001, PLANT CELL, V13, P1231, DOI 10.1105/tpc.13.5.1231; Savitch LV, 2007, BIOCHEM BIOPH RES CO, V359, P234, DOI 10.1016/j.bbrc.2007.05.084; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tang GQ, 2011, J BIOL CHEM, V286, P38805, DOI 10.1074/jbc.M111.261966; Townsend PD, 2015, J BIOL CHEM, V290, P22225, DOI 10.1074/jbc.M115.669267; Tranier S, 2000, J BIOL CHEM, V275, P28075; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	58	29	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3218	3233		10.1074/jbc.RA117.000485	http://dx.doi.org/10.1074/jbc.RA117.000485			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29217772	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000426562800015
J	Huang, TT; Zhou, YH; Zhang, JL; Wong, CC; Li, WL; Kwan, JSH; Yang, R; Chan, AKY; Dong, YJ; Wu, F; Zhang, B; Cheung, AHK; Wu, WKK; Chen, ASL; Yu, J; Wong, N; Kang, W; To, KF				Huang, Tingting; Zhou, Yuhang; Zhang, Jinglin; Wong, Chi Chun; Li, Weilin; Kwan, Johnny S. H.; Yang, Rui; Chan, Aden K. Y.; Dong, Yujuan; Wu, Feng; Zhang, Bin; Cheung, Alvin H. K.; Wu, William K. K.; Chen, Alfred S. L.; Yu, Jun; Wong, Nathalie; Kang, Wei; To, Ka Fai			SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis	ONCOGENE			English	Article							RHO-GTPASES; BREAST-CANCER; PATHWAY; CARCINOGENESIS; MIGRATION; PROTEINS; PROMOTES; GROWTH; SLIT; ROBO	Slit-Robo GTPase-activating protein 1 (SRGAP1) functions as a GAP for Rho-family GTPases and downstream of Slit-Robo signaling. We aim to investigate the biological function of SRGAP1 and reveal its regulation by deregulated microRNAs (miRNAs) in gastric cancer (GC). mRNA and protein expression of SRGAP1 were examined by quantitative reverse transcription PCR (qRT-PCR) and western blot. The biological role of SRGAP1 was demonstrated through siRNA-mediated knockdown experiments. The regulation of SRGAP1 by miR-340 and miR-124 was confirmed by western blot, dual luciferase activity assays and rescue experiments. SRGAP1 is overexpressed in 9 out of 12 (75.0%) GC cell lines. In primary GC samples from TCGA cohort, SRGAP1 shows gene amplification in 5/258 (1.9%) of cases and its mRNA expression demonstrates a positive correlation with copy number gain. Knockdown of SRGAP1 in GC cells suppressed cell proliferation, reduced colony formation, and significantly inhibited cell invasion and migration. Luciferase reporter assays revealed that SRGAP1 knockdown significantly inhibited Wnt/beta-catenin pathway. In addition, SRGAP1 was found to be a direct target of two tumor-suppressive miRNAs, miR-340 and miR-124. Concordantly, these two miRNAs were downregulated in primary gastric tumors and these decreasing levels w5ere associated with poor outcomes. Expression of miR-340 and SRGAP1 displayed a reverse relationship in primary samples and re-expressed SRGAP1, rescued the anti-cancer effects of miR-340. Taken together, these data strongly suggest that, apart from gene amplification and mutation, the activation of SRGAP1 in GC is partly due to the downregulation of tumor-suppressive miRNAs, miR-340 and miR-124. Thus SRGAP1 is overexpressed in gastric carcinogenesis and plays an oncogenic role through activating Wnt/beta-catenin pathway.	[Huang, Tingting; Zhou, Yuhang; Zhang, Jinglin; Kwan, Johnny S. H.; Yang, Rui; Chan, Aden K. Y.; Wu, Feng; Cheung, Alvin H. K.; Wong, Nathalie; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Oncol South China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Huang, Tingting; Zhou, Yuhang; Zhang, Jinglin; Wong, Chi Chun; Li, Weilin; Dong, Yujuan; Wu, William K. K.; Yu, Jun; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Partner State Key Lab Digest Dis, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Huang, Tingting; Zhou, Yuhang; Zhang, Jinglin; Wong, Nathalie; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, Tingting; Chen, Alfred S. L.; Yu, Jun; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Zhang, Bin] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Wu, William K. K.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Chen, Alfred S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Nanjing University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Oncol South China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.; Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Partner State Key Lab Digest Dis, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.; Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.; Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	weikang@cuhk.edu.hk; kfto@cuhk.edu.hk	Wong, Chi Chun/C-4636-2016; Li, Weilin/ABG-9032-2021; KANG, Wei/C-5451-2016; Dong, Yujuan/AAS-3467-2021; Wu, William K.K./A-3277-2009; Cheng, Alfred SL/C-3327-2014; wu, william/HII-5817-2022; Chan, Aden, Ka-yin/I-2535-2015; Jun, Yu/D-8569-2015	KANG, Wei/0000-0002-4651-677X; Wu, William K.K./0000-0002-5662-5240; Cheng, Alfred SL/0000-0003-2345-6951; Cheung, Alvin Ho-Kwan/0000-0002-3913-8117; Chan, Aden, Ka-yin/0000-0001-9176-963X; Jun, Yu/0000-0001-5008-2153	General Research Fund (RGC) from The Research Grants Council of Hong Kong [CUHK14114414, CUHK14110016]	General Research Fund (RGC) from The Research Grants Council of Hong Kong	We acknowledge the TCGA Research Network (http://cancergcnome.nih.gov/), The UCSC Cancer Genomics Browser (https://genome-cancer.uese.edu/), and NCI Center for Cancer Genomics Office (http://gdc.nci.nih.gov/) for providing the gastric cancer data set and analysis. This study is supported by General Research Fund (RGC Reference No. CUHK14114414 and CUHK14110016) from The Research Grants Council of Hong Kong. We also acknowledge the technical support from Core Utilities of Cancer Genomics and Pathobiology of Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen KX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5682; Chia NY, 2015, GUT, V64, P707, DOI 10.1136/gutjnl-2013-306596; Coutinho-Budd J, 2012, J CELL SCI, V125, P3390, DOI 10.1242/jcs.098962; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fernandez S, 2015, ONCOGENE, V34, P3240, DOI 10.1038/onc.2014.267; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; He HL, 2013, J CLIN ENDOCR METAB, V98, pE973, DOI 10.1210/jc.2012-3823; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang TT, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0493-7; Huang TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1984-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kang W, 2016, WORLD J GASTROENTERO, V22, P1279, DOI 10.3748/wjg.v22.i3.1279; Kang W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0323-3; Kang W, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0281-3; Kang W, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-80; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Li WT, 2014, TUMOR BIOL, V35, P10897, DOI 10.1007/s13277-014-2402-2; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Liu S., 2015, COMPUT MATH METHODS, V2015, P1, DOI DOI 10.1155/2015/913726); Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Neukomm LJ, 2011, NAT CELL BIOL, V13, P79, DOI 10.1038/ncb2138; Peng XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-186; Qian ZL, 2014, GENE CHROMOSOME CANC, V53, P883, DOI 10.1002/gcc.22196; Shi L, 2014, ASIAN PAC J CANCER P, V15, P10439, DOI 10.7314/APJCP.2014.15.23.10439; Shi ZM, 2014, NEURO-ONCOLOGY, V16, P1341, DOI 10.1093/neuonc/nou084; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Strong AMP, 2014, ARCH BIOCHEM BIOPHYS, V563, P118, DOI 10.1016/j.abb.2014.07.012; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Yamashita D, 2015, CANCER RES, V75, P1123, DOI 10.1158/0008-5472.CAN-14-0938; Yamazaki D, 2013, MOL BIOL CELL, V24, P3393, DOI 10.1091/mbc.E13-04-0178; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zehentmayr F, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0198-1; Zhang QQ, 2015, ONCOTARGET, V6, P3123, DOI 10.18632/oncotarget.3060; Zhang T, 2014, ACTA BIOCH BIOPH SIN, V46, P1072, DOI 10.1093/abbs/gmu105; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17; Zhou X, 2013, BIOCHEM BIOPH RES CO, V437, P653, DOI 10.1016/j.bbrc.2013.07.033; Zhou Y, 2017, ONCOGENE, V36, P6518, DOI 10.1038/onc.2017.257; Zhou YH, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0647-2	49	31	33	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1159	1174		10.1038/s41388-017-0029-7	http://dx.doi.org/10.1038/s41388-017-0029-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29234151	hybrid, Green Published			2022-12-26	WOS:000426505400003
J	Sharma, P; Kranz, DM				Sharma, Preeti; Kranz, David M.			Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; major histocompatibility complex (MHC); protein engineering; protein-protein interaction; T-cell receptor (TCR); deep sequencing; single-codon libraries; yeast display	YEAST SURFACE-DISPLAY; PEPTIDE-MHC COMPLEXES; DIRECTED EVOLUTION; IN-VITRO; PHAGE DISPLAY; STAPHYLOCOCCAL-ENTEROTOXIN; THERMAL-STABILITY; RIBOSOME DISPLAY; PROTEIN FUNCTION; ALLOSTERIC SITE	Most affinity-maturation campaigns for antibodies and T-cell receptors (TCRs) operate on the residues at the binding site, located within the loops known as complementarity-determining regions (CDRs). Accordingly, mutations in contact residues, or so-called second shell residues, that increase affinity are typically identified by directed evolution involving combinatorial libraries. To determine the impact of residues located at a distance from the binding site, here we used single-codon libraries of both CDR and non-CDR residues to generate a deep mutational scan of a human TCR against the cancer antigen MART-1HLA-A2. Non-CDR residues included those at the interface of the TCR variable domains (V and V) and surface-exposed framework residues. Mutational analyses showed that both V/V interface and CDR residues were important in maintaining binding to MART-1HLA-A2, probably due to either structural requirements for proper V/V association or direct contact with the ligand. More surprisingly, many V/V interface substitutions yielded improved binding to MART-1HLA-A2. To further explore this finding, we constructed interface libraries and selected them for improved stability or affinity. Among the variants identified, one conservative substitution (F45Y) was most prevalent. Further analysis of F45Y showed that it enhanced thermostability and increased affinity by 60-fold. Thus, introducing a single hydroxyl group at the V/V interface, at a significant distance from the TCRpeptideMHC-binding site, remarkably affected ligand binding. The variant retained a high degree of specificity for MART-1HLA-A2, indicating that our approach provides a general strategy for engineering improvements in either soluble or cell-based TCRs for therapeutic purposes.	[Sharma, Preeti; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@illinois.edu	Sharma, Preeti/P-1044-2019	Sharma, Preeti/0000-0002-8210-9004	National Institutes of Health [CA178844, CA187592]; NATIONAL CANCER INSTITUTE [R21CA187592, R01CA178844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA178844 and CA187592 (to D. M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggen DH, 2011, PROTEIN ENG DES SEL, V24, P361, DOI 10.1093/protein/gzq113; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bonsor DA, 2011, BIOCHEMISTRY-US, V50, P2394, DOI 10.1021/bi102019c; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bowerman NA, 2009, J BIOL CHEM, V284, P32551, DOI 10.1074/jbc.M109.040501; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Carter P, 1995, J Hematother, V4, P463, DOI 10.1089/scd.1.1995.4.463; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Eisen HN, 2001, ANNU REV IMMUNOL, V19, P1, DOI 10.1146/annurev.immunol.19.1.1; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Haliloglu T, 2015, CURR OPIN STRUC BIOL, V35, P17, DOI 10.1016/j.sbi.2015.07.007; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Harris DT, 2016, J BIOL CHEM, V291, P24566, DOI 10.1074/jbc.M116.748681; Harris DT, 2016, STRUCTURE, V24, P1142, DOI 10.1016/j.str.2016.04.011; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; Hellman LM, 2016, J IMMUNOL METHODS, V432, P95, DOI 10.1016/j.jim.2016.02.016; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jones LL, 2008, BIOCHEMISTRY-US, V47, P12398, DOI 10.1021/bi801349g; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kieke MC, 1997, PROTEIN ENG, V10, P1303, DOI 10.1093/protein/10.11.1303; Kieke MC, 2001, J MOL BIOL, V307, P1305, DOI 10.1006/jmbi.2001.4560; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Posnett D. N., 1996, IMMUNOLOGIST, V4, P5; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Richman SA, 2009, MOL IMMUNOL, V46, P902, DOI 10.1016/j.molimm.2008.09.021; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Sadowsky JD, 2011, P NATL ACAD SCI USA, V108, P6056, DOI 10.1073/pnas.1102376108; Schmitt TM, 2015, CLIN CANCER RES, V21, P5191, DOI 10.1158/1078-0432.CCR-15-0860; Sharma P, 2013, PROTEIN ENG DES SEL, V26, P781, DOI 10.1093/protein/gzt054; Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith SN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6223; Smith SN, 2013, J MOL BIOL, V425, P4496, DOI 10.1016/j.jmb.2013.08.007; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Stone JD, 2011, J IMMUNOL, V187, P6281, DOI 10.4049/jimmunol.1101734; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Traxlmayr MW, 2017, METHODS MOL BIOL, V1575, P45, DOI 10.1007/978-1-4939-6857-2_4; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Wang N., CLIN VACCINE IMMUNOL, V17, P1781; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Yang XB, 2015, P NATL ACAD SCI USA, V112, P8166, DOI 10.1073/pnas.1510127112	76	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1820	1834		10.1074/jbc.M117.814152	http://dx.doi.org/10.1074/jbc.M117.814152			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29229779	Green Published, hybrid			2022-12-26	WOS:000424201700031
J	Bernard, K; Logsdon, NJ; Benavides, GA; Sanders, Y; Zhang, JH; Darley-Usmar, VM; Thannickal, VJ				Bernard, Karen; Logsdon, Naomi J.; Benavides, Gloria A.; Sanders, Yan; Zhang, Jianhua; Darley-Usmar, Victor M.; Thannickal, Victor J.			Glutaminolysis is required for transforming growth factor-beta 1-induced myofibroblast differentiation and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; myofibroblast; glutamine; transforming growth factor beta (TGF-B); differentiation	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TGF-BETA; PROTEIN-KINASE; TISSUE-REPAIR; CELLS; METABOLISM; STABILIZATION; PROLIFERATION; HIF1-ALPHA; EXPRESSION	Myofibroblasts participate in physiological wound healing and pathological fibrosis. Myofibroblast differentiation is characterized by the expression of -smooth muscle actin and extracellular matrix proteins and is dependent on metabolic reprogramming. In this study, we explored the role of glutaminolysis and metabolites of TCA in supporting myofibroblast differentiation. Glutaminolysis converts Gln into -ketoglutarate (-KG), a critical intermediate in the TCA cycle. Increases in the steady-state concentrations of TCA cycle metabolites including -KG, succinate, fumarate, malate, and citrate were observed in TGF-1-differentiated myofibroblasts. The concentration of glutamate was also increased in TGF-1-differentiated myofibroblasts compared with controls, whereas glutamine levels were decreased, suggesting enhanced glutaminolysis. This was associated with TGF-1-induced expression of the glutaminase (GLS) isoform, GLS1, which converts Gln into glutamate, at both the mRNA and protein levels. The stimulation of GLS1 expression by TGF-1 was dependent on both SMAD3 and p38 mitogen-activated protein kinase activation. Depletion of extracellular Gln prevented TGF-1-induced myofibroblast differentiation. The removal of extracellular Gln postmyofibroblast differentiation decreased the expression of the profibrotic markers fibronectin and hypoxia-inducible factor-1 and reversed TGF-1-induced metabolic reprogramming. Silencing of GLS1 expression, in the presence of Gln, abrogated TGF-1-induced expression of profibrotic markers. Treatment of GLS1-deficient myofibroblasts with exogenous glutamate or -KG restored TGF-1-induced expression of profibrotic markers in GLS1-deficient myofibroblasts. Together, these data demonstrate that glutaminolysis is a critical component of myofibroblast metabolic reprogramming that regulates myofibroblast differentiation.	[Bernard, Karen; Logsdon, Naomi J.; Sanders, Yan; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol & Med, Birmingham, AL 35294 USA; [Thannickal, Victor J.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Bernard, K (corresponding author), Div Pulm Allergy & Crit Care Med, 901 19th St S,BMRII 464, Birmingham, AL 35294 USA.	karenbernard@uabmc.edu	Sanders, Yan/AAJ-3413-2020	Darley-Usmar, Victor/0000-0001-8921-7086	National Institutes of Health [P01 HL114470, R01 AG046210, P30 DK079337]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210, P30AG050886] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. Roger Davis (University of Massachusetts) and Dr. A. Brent Carter (University of Alabama at Birmingham) for providing us with the p38 MAPK mutant used in this study. We thank Dr. Stephen Barnes and Taylor F. Berryhill (Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham). The University of Alabama at Birmingham O'Brien Acute Kidney Injury Center for the operation of the Targeted Metabolomics and Proteomics Laboratory, the University of Alabama at Birmingham Lung Health Center, and the University of Alabama at Birmingham Center for Free Radical Biology are supported by National Institutes of Health Grants P01 HL114470, R01 AG046210, and P30 DK079337.	Altman BJ, 2016, NAT REV CANCER, V16, P749, DOI 10.1038/nrc.2016.114; Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; BALDWIN JE, 1981, NATURE, V291, P381, DOI 10.1038/291381a0; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Burr SP, 2016, CELL METAB, V24, P740, DOI 10.1016/j.cmet.2016.09.015; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Glick GD, 2014, J PHARMACOL EXP THER, V351, P298, DOI 10.1124/jpet.114.218099; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kappler M, 2017, CLIN ORAL INVEST, V21, P211, DOI 10.1007/s00784-016-1780-9; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1951; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Phan SH, 2003, AM J RESP CELL MOL, V29, pS87; Portais JC, 1996, BIOCHIMIE, V78, P155, DOI 10.1016/0300-9084(96)89500-9; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; SHAPIRO RA, 1991, J BIOL CHEM, V266, P18792; Shi JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09020-8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smith MR, 2016, REDOX BIOL, V8, P136, DOI 10.1016/j.redox.2016.01.002; Stegen S, 2016, CELL METAB, V23, P265, DOI 10.1016/j.cmet.2016.01.002; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Yu DC, 2015, ONCOTARGET, V6, P7619, DOI 10.18632/oncotarget.3196; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	52	79	84	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1218	1228		10.1074/jbc.RA117.000444	http://dx.doi.org/10.1074/jbc.RA117.000444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29222329	hybrid, Green Published			2022-12-26	WOS:000423515000010
J	Jin, D; Lee, H				Jin, Daeyong; Lee, Hyunju			FGMD: A novel approach for functional gene module detection in cancer	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; BREAST-CANCER; EXPRESSION DATA; PROGRESSION; IDENTIFICATION; COEXPRESSION; CYTOKINES; EXPANDER; DATABASE	With the increasing availability of multi-dimensional biological datasets for the same samples (i.e., gene expression, microRNAs, copy numbers, mutations, methylations), it has now become possible to systematically understand the regulatory mechanisms operating in a cancer cell. For this task, it is important to discover a set of co-expressed genes with functions, representing a so-called functional gene module, because co-expressed genes tend to be co-regulated by the same regulators, including transcription factors, microRNAs, and copy number aberrations. Several algorithms have been used to identify such gene modules, including hierarchical clustering and non-negative matrix factorization. Although these algorithms have been applied to many microarray datasets, only a few systematic analyses of these algorithms have been performed for RNA-sequencing (RNA-Seq) data to date. Although gene expression levels determined based on microarray and RNA-Seq datasets tend to be highly correlated, the expression levels of some genes differ depending on the platforms used for analysis, which may result in the construction of different gene modules for the same samples. Here, we compare several module detection algorithms applied to both microarray and RNA-seq datasets. We further propose a new functional gene module detection algorithm (FGMD), which is based on a hierarchical clustering algorithm that was modified to reflect actual biological observations, including the fact that a single gene may be involved in multiple biological pathways. Application of existing algorithms and the new FGMD algorithm to breast cancer and ovarian cancer datasets from The Cancer Genome Atlas showed that the FGMD algorithm had the best performance for most of the functional pathway enrichment tests and in the transcription factor enrichment test. We expect that the FGMD algorithm will contribute to improving the identification of functional gene modules related to cancer.	[Jin, Daeyong] Korea Environm Inst, Sejong, South Korea; [Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, Gwangju, South Korea	Korea Environment Institute (KEI); Gwangju Institute of Science & Technology (GIST)	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, Gwangju, South Korea.	hyunjulee@gist.ac.kr		Lee, Hyunju/0000-0003-2389-7183	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2016R1A2B2013855]; Basic Science Research Program through the NRF - Ministry of Education [NRF-2013R1A1A2058053]; Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program [2014001300001]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP); Basic Science Research Program through the NRF - Ministry of Education; Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program	This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2016R1A2B2013855) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2058053), and by the Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program (2014001300001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2016R1A2B2013855), by the Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2013R1A1A2058053), and by the Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program (2014001300001).	Abubaker K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-317; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Charbonneau B, 2013, CANC RES; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Cui YY, 2016, TUMOR BIOL, V37, P5375, DOI 10.1007/s13277-015-4363-5; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Farazi TA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r9; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Huret JL, 2000, NUCLEIC ACIDS RES, V28, P349, DOI 10.1093/nar/28.1.349; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Jin D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004042; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kim PM, 2003, GENOME RES, V13, P1706, DOI 10.1101/gr.903503; Klinke DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003409; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liu XF, 2014, MOL CANCER THER, V13, P82, DOI 10.1158/1535-7163.MCT-13-0726; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Muccioli M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00341; Nash MA, 1999, ENDOCR-RELAT CANCER, V6, P93, DOI 10.1677/erc.0.0060093; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Sarvaiya PJ, 2013, ONCOTARGET, V4, P2171, DOI 10.18632/oncotarget.1426; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van Dam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-535; van der Graaf U, 2017, BRIEF BIOINFORM; Wang T, 2016, CANC IMMUNOLOGY RES; Wei SY, 2015, ONCOL LETT, V10, P2427, DOI 10.3892/ol.2015.3610; Xiao G, 2015, ONCOTARGET, V6, P14165, DOI 10.18632/oncotarget.3690; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188900	10.1371/journal.pone.0188900	http://dx.doi.org/10.1371/journal.pone.0188900			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244808	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700011
J	Zanotti, G; Vallese, F; Ferrari, A; Menozzi, I; Saldano, TE; Berto, P; Fernandez-Alberti, S; Berni, R				Zanotti, Giuseppe; Vallese, Francesca; Ferrari, Alberto; Menozzi, Ilaria; Saldano, Tadeo E.; Berto, Paola; Fernandez-Alberti, Sebastian; Berni, Rodolfo			Structural and dynamics evidence for scaffold asymmetric flexibility of the human transthyretin tetramer	PLOS ONE			English	Article							ANGSTROM RESOLUTION; SINGLE-PARAMETER; PROTEINS; BINDING; MOTIONS; STABILIZATION; FLUCTUATIONS; THYROXINE; COMPLEX; POTENT	The molecular symmetry of multimeric proteins is generally determined by using X-ray diffraction techniques, so that the basic question as to whether this symmetry is perfectly preserved for the same protein in solution remains open. In this work, human transthyretin (TTR), a homotetrameric plasma transport protein with two binding sites for the thyroid hormone thyroxine (T4), is considered as a case study. Based on the crystal structure of the TTR tetramer, a hypothetical D2 symmetry is inferred for the protein in solution, whose functional behavior reveals the presence of two markedly different K-d values for the two T4 binding sites. The latter property has been ascribed to an as yet uncharacterized negative binding cooperativity. A triple mutant form of human TTR (F87M/L110M/S117E TTR), which is monomeric in solution, crystallizes as a tetrameric protein and its structure has been determined. The exam of this and several other crystal forms of human TTR suggests that the TTR scaffold possesses a significant structural flexibility. In addition, TTR tetramer dynamics simulated using normal modes analysis exposes asymmetric vibrational patterns on both dimers and thermal fluctuations reveal small differences in size and flexibility for ligand cavities at each dimer-dimer interface. Such small structural differences between monomers can lead to significant functional differences on the TTR tetramer dynamics, a feature that may explain the functional heterogeneity of the T4 binding sites, which is partially overshadowed by the crystal state.	[Zanotti, Giuseppe; Vallese, Francesca; Berto, Paola] Univ Padua, Dept Biomed Sci, Padua, Italy; [Ferrari, Alberto; Menozzi, Ilaria; Berni, Rodolfo] Univ Parma, Dept Chem Sci Life Sci & Environm Sustainabil, Parma, Italy; [Saldano, Tadeo E.; Fernandez-Alberti, Sebastian] Univ Nacl Quilmes, CONICET, Bernal, Argentina	University of Padua; University of Parma; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Zanotti, G (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	giuseppe.zanotti@unipd.it		Berni, Rodolfo/0000-0002-1839-0479; Saldano, Tadeo Enrique/0000-0003-0017-4660; Menozzi, Ilaria/0000-0001-9726-6769; Zanotti, Giuseppe/0000-0002-0945-6501	Universities of Padua and Parma, Italy; MIUR (Ministero Istruzione Universita` Ricerca, Italy) PRIN (Progetti di Rilevante Interesse Nazionale) Project [2012A7LMS3_002]	Universities of Padua and Parma, Italy; MIUR (Ministero Istruzione Universita` Ricerca, Italy) PRIN (Progetti di Rilevante Interesse Nazionale) Project(Ministry of Education, Universities and Research (MIUR))	This work received financial support from: Universities of Padua and Parma, Italy; MIUR (Ministero Istruzione Universita` Ricerca, Italy) PRIN (Progetti di Rilevante Interesse Nazionale) Project 2012A7LMS3_002.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bahar I, 1999, BIOCHEMISTRY-US, V38, P3478, DOI 10.1021/bi982697v; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Cianci M, 2015, ACTA CRYSTALLOGR D, V71, P1582, DOI 10.1107/S1399004715010585; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Florio P, 2015, J BIOL CHEM, V290, P29769, DOI 10.1074/jbc.M115.690172; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Jeong JI, 2006, J MOL GRAPH MODEL, V24, P296, DOI 10.1016/j.jmgm.2005.09.006; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; Polsinelli I, 2016, J STRUCT BIOL, V194, P8, DOI 10.1016/j.jsb.2016.01.007; RStudio Team, 2016, RSTUDIO INT DEV R; Saldano TE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004775; Sant'Anna R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10787; Saraiva M, 1998, CRYSTAL STRUCTURE AM, V273, P748; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tomar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043522; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; Wojtczak A, 2001, ACTA CRYSTALLOGR D, V57, P957, DOI 10.1107/S0907444901006047; Zanotti G, 2013, FEBS LETT, V587, P2325, DOI 10.1016/j.febslet.2013.06.016	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0187716	10.1371/journal.pone.0187716	http://dx.doi.org/10.1371/journal.pone.0187716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240759	Green Submitted, gold, Green Published			2022-12-26	WOS:000417905600005
J	Embers, ME; Hasenkampf, NR; Jacobs, MB; Tardo, AC; Doyle-Meyers, LA; Philipp, MT; Hodzic, E				Embers, Monica E.; Hasenkampf, Nicole R.; Jacobs, Mary B.; Tardo, Amanda C.; Doyle-Meyers, Lara A.; Philipp, Mario T.; Hodzic, Emir			Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding	PLOS ONE			English	Article							LYME-DISEASE; ANTIBIOTIC-TREATMENT; RHESUS-MONKEY; INFECTION; NEUROBORRELIOSIS; MODEL; ARTHRITIS; EPIDEMIOLOGY; RESPONSES; OUTCOMES	The efficacy and accepted regimen of antibiotic treatment for Lyme disease has been a point of significant contention among physicians and patients. While experimental studies in animals have offered evidence of post-treatment persistence of Borrelia burgdorferi, variations in methodology, detection methods and limitations of the models have led to some uncertainty with respect to translation of these results to human infection. With all stages of clinical Lyme disease having previously been described in nonhuman primates, this animal model was selected in order to most closely mimic human infection and response to treatment. Rhesus macaques were inoculated with B. burgdorferi by tick bite and a portion were treated with recommended doses of doxycycline for 28 days at four months post-inoculation. Signs of infection, clinical pathology, and antibody responses to a set of five antigens were monitored throughout the similar to 1.2 year study. Persistence of B. burgdorferi was evaluated using xenodiagnosis, bioassays in mice, multiple methods of molecular detection, immunostaining with polyclonal and monoclonal antibodies and an in vivo culture system. Our results demonstrate host-dependent signs of infection and variation in antibody responses. In addition, we observed evidence of persistent, intact, metabolically-active B. burgdorferi after antibiotic treatment of disseminated infection and showed that persistence may not be reflected by maintenance of specific antibody production by the host.	[Embers, Monica E.; Hasenkampf, Nicole R.; Jacobs, Mary B.; Tardo, Amanda C.; Philipp, Mario T.] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70118 USA; [Doyle-Meyers, Lara A.] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Vet Med, Covington, LA USA; [Hodzic, Emir] Univ Calif Davis, Sch Med, Ctr Comparat Med, Davis, CA 95616 USA; [Hodzic, Emir] Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA	Tulane University; Tulane University; University of California System; University of California Davis; University of California System; University of California Davis	Embers, ME (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70118 USA.	members@tulane.edu		Embers, Monica/0000-0003-4051-7592	CoBRE grant from the NIH [2P20-RR020159-08]; Bay Area Lyme Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	CoBRE grant from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bay Area Lyme Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided though a CoBRE grant (2P20-RR020159-08) for The Louisiana Center of Biomedical Research Excellence from the NIH and through a grant from the Bay Area Lyme Foundation (http://www.bayarealyme.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; ASCH ES, 1994, J RHEUMATOL, V21, P454; Aucott JN, 2015, INFECT DIS CLIN N AM, V29, P309, DOI 10.1016/j.idc.2015.02.012; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Barbour A, 2012, J CLIN INVEST, V122, P2344, DOI 10.1172/JCI63975; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1995, LAB INVEST, V72, P127; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Bockenstedt LK, 2002, J INFECT DIS, V186, P1430, DOI 10.1086/345284; Brown JP, 1999, INFECT IMMUN, V67, P5142, DOI 10.1128/IAI.67.10.5142-5150.1999; Cadavid D, 2004, LAB INVEST, V84, P1439, DOI 10.1038/labinvest.3700177; Chandra A, 2011, CLIN VACCINE IMMUNOL, V18, P767, DOI 10.1128/CVI.00002-11; Chen YN, 2009, XENOTRANSPLANTATION, V16, P496, DOI 10.1111/j.1399-3089.2009.00554.x; COLEMAN JL, 1992, INFECT IMMUN, V60, P3098, DOI 10.1128/IAI.60.8.3098-3104.1992; Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237; Embers ME, 2016, CLIN VACCINE IMMUNOL, V23, P294, DOI 10.1128/CVI.00685-15; Embers ME, 2013, JOVE-J VIS EXP, DOI 10.3791/50617; Embers ME, 2013, J MED PRIMATOL, V42, P57, DOI 10.1111/jmp.12031; Embers ME, 2012, CLIN VACCINE IMMUNOL, V19, P1218, DOI 10.1128/CVI.00228-12; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Hodzic E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086907; Horowitz HW, 1996, HEPATOLOGY, V23, P1412, DOI 10.1002/hep.510230617; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Lohr B, 2015, TICKS TICK-BORNE DIS, V6, P56, DOI 10.1016/j.ttbdis.2014.09.004; Marques A, 2014, CLIN INFECT DIS, V58, P937, DOI 10.1093/cid/cit939; Mbow ML, 1999, INFECT IMMUN, V67, P5470, DOI 10.1128/IAI.67.10.5470-5472.1999; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Miller JC, 2008, EXP MOL PATHOL, V85, P20, DOI 10.1016/j.yexmp.2008.03.004; MONTGOMERY RR, 1993, J IMMUNOL, V150, P909; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; PACHNER AR, 1995, ANN NEUROL, V38, P667, DOI 10.1002/ana.410380417; PACHNER AR, 1995, NEUROLOGY, V45, P165, DOI 10.1212/WNL.45.1.165; Pachner AR, 1998, J CLIN MICROBIOL, V36, P3243, DOI 10.1128/JCM.36.11.3243-3247.1998; PHILIPP MT, 1993, INFECT IMMUN, V61, P3047, DOI 10.1128/IAI.61.7.3047-3059.1993; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Ramesh G, 2008, AM J PATHOL, V173, P1415, DOI 10.2353/ajpath.2008.080483; Roberts ED, 1998, J INFECT DIS, V178, P722, DOI 10.1086/515357; ROBERTS ED, 1995, LAB INVEST, V72, P146; Rosa PA, 2005, NAT REV MICROBIOL, V3, P129, DOI 10.1038/nrmicro1086; SHADICK NA, 1994, ANN INTERN MED, V121, P560, DOI 10.7326/0003-4819-121-8-199410150-00002; Soloski MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093243; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Stinco Giuseppe, 2014, ScientificWorldJournal, V2014, P414505, DOI 10.1155/2014/414505; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; Strle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064110; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; Tilly K, 2013, MOL MICROBIOL, V89, P216, DOI 10.1111/mmi.12271; van den Wijngaard CC, 2017, EUR J PUBLIC HEALTH, V27, P538, DOI 10.1093/eurpub/ckw269; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2	58	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189071	10.1371/journal.pone.0189071	http://dx.doi.org/10.1371/journal.pone.0189071			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236732	Green Submitted, gold, Green Published			2022-12-26	WOS:000417884100039
J	Rimpeekool, W; Yiengprugsawan, V; Kirk, M; Banwell, C; Seubsman, SA; Sleigh, A				Rimpeekool, Wimalin; Yiengprugsawan, Vasoontara; Kirk, Martyn; Banwell, Cathy; Seubsman, Sam-ang; Sleigh, Adrian			Nutrition label experience, obesity, high blood pressure, and high blood lipids in a cohort of 42,750 Thai adults	PLOS ONE			English	Article							PROCESSED FOODS; CONSUMPTION; ALCOHOL; HEALTH; URBANIZATION; PROFILE; IMPACT	Introduction Nutrition labels have been promoted for nearly two decades in Thailand to educate people about healthy eating and to combat nutrient-related non-communicable diseases (NCDs). But little is known about how nutrition labels are experienced and whether they are linked with better health. Our objective was to investigate the associations between nutrition label experience, obesity and nutrient-related NCDs in Thai consumers. Methods A cross-sectional study was undertaken with a nationwide cohort of 42,750 distance learning Thai adult students enrolled in an Open University in 2013. We measured exposure as nutrition label experience (read, understand, use). Health outcomes were high blood pressure, high blood lipids, and high Body Mass Index (overweight at risk and obesity). Multivariate logistic regression was used to determine the association between nutrition label experience and health outcome adjusting for sociodemographic attributes, physical activity, smoking, and alcohol intake. Results Frequent nutrition label use varied by cohort attributes and health outcomes and was least for those with low physical activity and high blood pressure. Being male, older, an urban resident or with low physical activity was associated with increasing high blood pressure and high blood lipids. Compared to those who read, understand and use nutrition labels, participants who did not (read, understand, and use), were more likely to report high blood pressure (Adjusted Odds Ratio 1.33; 1.17-1.51), high blood lipids (AOR 1.26; 1.14-1.39), and obesity (AOR 1.23; 1.13-1.33), but were not more likely to be overweight at risk (AOR 1.06; 0.97-1.16). Conclusions We found cross-sectional associations between low nutrition label experience and increased likelihood of high blood pressure, high blood lipids, and obesity among Thai adults. Nutrition label education should be promoted as part of a public health approach to appropriate food choices and better lifestyles to reduce obesity and nutrient-related NCDs.	[Rimpeekool, Wimalin; Kirk, Martyn; Banwell, Cathy; Seubsman, Sam-ang; Sleigh, Adrian] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Rimpeekool, Wimalin; Seubsman, Sam-ang] Sukhothai Thammathirat Open Univ, Sch Human Ecol, Nonthaburi, Thailand; [Yiengprugsawan, Vasoontara] Australian Natl Univ, Res Sch Populat Hlth, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia; [Yiengprugsawan, Vasoontara] Australian Res Council, Ctr Res Populat Ageing Res CEPAR, Canberra, ACT, Australia	Australian National University; Sukhothai Thammathirat Open University; Australian National University	Rimpeekool, W (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.; Rimpeekool, W (corresponding author), Sukhothai Thammathirat Open Univ, Sch Human Ecol, Nonthaburi, Thailand.	wimalin.rim@stou.ac.th; sam-ang.seu@stou.ac.th; adrian.sleigh@anu.edu.au	Yiengprugsawan, Vas Sbirakos/G-3176-2011; sleigh, adrian/J-4540-2019; rimpeekool, wimalin/K-3764-2016	Yiengprugsawan, Vas Sbirakos/0000-0001-9101-4704; sleigh, adrian/0000-0001-8443-7864; Kirk, Martyn/0000-0001-5432-5984; Banwell, Cathy/0000-0001-6808-1052; rimpeekool, wimalin/0000-0001-7654-1493	Wellcome Trust UK [GR071587MA]; Australian National Health and Medical Research Council (NHMRC) [268055]; International Collaborative Research Grants Scheme; NHMRC [585426]	Wellcome Trust UK(Wellcome Trust); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); International Collaborative Research Grants Scheme; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) and the Australian National Health and Medical Research Council (NHMRC, grant No.268055). It was also supported by a global health grant from the NHMRC (585426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Azman N, 2014, PROCD SOC BEHV, V130, P490, DOI 10.1016/j.sbspro.2014.04.057; Baker P, 2014, OBES REV, V15, P564, DOI 10.1111/obr.12174; Banks E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-762; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Drichoutis A.C., 2006, ACAD MARK SCI REV, V2006, P1; Ekezie J, 2011, N AM J MED SCI, V3, P242, DOI 10.4297/najms.2011.3242; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Goryakin Y, 2014, ECON HUM BIOL, V14, P109, DOI 10.1016/j.ehb.2013.11.003; Graham DJ, 2012, J ACAD NUTR DIET, V112, P414, DOI 10.1016/j.jada.2011.08.047; GUTHRIE JF, 1995, J NUTR EDUC, V27, P163, DOI 10.1016/S0022-3182(12)80422-5; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Kreuter MW, 1997, AM J PREV MED, V13, P277, DOI 10.1016/S0749-3797(18)30175-2; Lim Lynette Ly, 2009, Popul Health Metr, V7, P15, DOI 10.1186/1478-7954-7-15; Ministry of Public Health, 2015, IN PAT CAUS GROUPS H; Ministry of Public Health, HLTH SIM THAIL 2013; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Nwankwo T, 2013, NCHS DATA BRIEF, V133, P1; Ollberding NJ, 2010, J AM DIET ASSOC, V110, P1233, DOI 10.1016/j.jada.2010.05.007; Post RE, 2010, J AM DIET ASSOC, V110, P628, DOI 10.1016/j.jada.2009.12.015; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Rimpeekool W, BRIT FOOD J IN PRESS; Rimpeekool Wimalin, 2015, Glob J Health Sci, V8, P21, DOI 10.5539/gjhs.v8n1p21; Seubsman SA, 2012, ASEAN J OPEN DISTANC, V4, P58; Seubsman Sam-Ang, 2011, BMC Res Notes, V4, P166, DOI 10.1186/1756-0500-4-166; Shirani Shahin, 2011, Acta Biomed, V82, P223; Sleigh AC, 2008, INT J EPIDEMIOL, V37, P266, DOI 10.1093/ije/dym161; Sukprasert B, 2013, THESIS; Thawornchaisit Prasutr, 2013, Glob J Health Sci, V6, P1, DOI 10.5539/gjhs.v6n2p1; Thinkhamrop K, 2011, KKU J PUBLIC HLTH RE, V4, P73; Wakabayashi M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2662-9; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Yiengprugsuwan V, U EPIDOMIOL IN PRESS	35	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189574	10.1371/journal.pone.0189574	http://dx.doi.org/10.1371/journal.pone.0189574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236783	gold, Green Submitted, Green Published			2022-12-26	WOS:000417884100082
J	Setamou, M; Alabi, OJ; Simpson, CR; Jifon, JL				Setamou, Mamoudou; Alabi, Olufemi J.; Simpson, Catherine R.; Jifon, John L.			Contrasting amino acid profiles among permissive and non-permissive hosts of Candidatus Liberibacter asiaticus, putative causal agent of Huanglongbing	PLOS ONE			English	Article							ASIAN CITRUS; ABIOTIC STRESS; METABOLOMIC DIFFERENTIATION; CATHARANTHUS-ROSEUS; MURRAYA-PANICULATA; DIAPHORINA-CITRI; GREENING DISEASE; SWEET ORANGE; PROLINE; VECTOR	Huanglongbing is a devastating disease of citrus. In this study, a comprehensive profile of phloem sap amino acids (AA) in four permissive host plants of Candidatus Liberibacter asiaticus (CLas) and three non-permissive Rutaceae plants was conducted to gain a better understanding of host factors that may promote or suppress the bacterium. The AA profiles of Diaphorina citri nymphs and adults were similarly analyzed. A total of 38 unique AAs were detected in phloem sap of the various plants and D. citri samples, with phloem sap of young shoots containing more AAs and at higher concentrations than their mature counterparts. All AAs detected in phloem sap of non-permissive plants were also present in CLas -permissive hosts plus additional AAs in the latter class of plants. However, the relative composition of 18 commonly shared AAs varied between CLas -permissive hosts and non-permissive plants. Multivariate analysis with a partial least square discriminant methodology revealed a total of 12 AAs as major factors affecting CLas host status, of which seven were positively related to CLas tolerance/ resistance and five positively associated with CLas susceptibility. Most of the AAs positively associated with CLas susceptibility were predominantly of the glutamate family, notably stressed-induced AAs such as arginine, GABA and proline. In contrast, AAs positively correlated with CLas tolerance/ resistance were mainly of the serine family. Further analysis revealed that whereas the relative proportions of AAs positively associated with CLas susceptibility did not vary with host developmental stages, those associated with CLas tolerance/ resistance increased with flush shoot maturity. Significantly, the proline-to-glycine ratio was determined to be an important discriminating factor for CLas permissivity with higher values characteristic of CLas -permissive hosts. This ratio could be exploited as a biomarker in HLB-resistance breeding programs.	[Setamou, Mamoudou; Simpson, Catherine R.] Texas A&M Univ, Kingsville Citrus Ctr, Weslaco, TX 78599 USA; [Alabi, Olufemi J.] Texas A&M AgriLife Res & Extens Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Jifon, John L.] Texas A&M AgriLife Res & Extens Ctr, Dept Hort Sci, Weslaco, TX USA	Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Setamou, M (corresponding author), Texas A&M Univ, Kingsville Citrus Ctr, Weslaco, TX 78599 USA.	Mamoudou.setamou@tamuk.edu	Alabi, Olufemi J./ABD-9930-2020	Alabi, Olufemi J./0000-0002-2471-7052; Simpson, Catherine/0000-0002-8164-4275; Jifon, John/0000-0003-0618-6056; Setamou, Mamoudou/0000-0002-4777-4826	Texas Citrus Producers Board [TCPB-2013-571213]	Texas Citrus Producers Board	The work was supported by a research grant (TCPB-2013-571213) to Mamoudou Setamou from the Texas Citrus Producers Board. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2016, PLANT PHYSIOL BIOCH, V107, P33, DOI 10.1016/j.plaphy.2016.05.030; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; [Anonymous], 2015, J CITRUS PATHOL; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bertaccini A, 2009, PHYTOPATHOL MEDITERR, V48, P355; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Choi YH, 2004, PLANT PHYSIOL, V135, P2398, DOI 10.1104/pp.104.041012; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; Damsteegt VD, 2010, PLANT DIS, V94, P528, DOI 10.1094/PDIS-94-5-0528; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Fagard M, 2014, J EXP BOT, V65, P5643, DOI 10.1093/jxb/eru323; Fisher TW, 2014, PATHOGENS, V3, P875, DOI 10.3390/pathogens3040875; GARNIER M, 1983, PHYTOPATHOLOGY, V73, P1358, DOI 10.1094/Phyto-73-1358; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Giri J, 2011, PLANT SIGNAL BEHAV, V6, P1746, DOI 10.4161/psb.6.11.17801; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2016, J ECON ENTOMOL, V109, P558, DOI 10.1093/jee/tow009; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Halsey CR, 2017, MBIO, V8, DOI 10.1128/mBio.01434-16; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Hijaz F, 2016, ENTOMOL EXP APPL, V158, P34, DOI 10.1111/eea.12377; Hijaz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101830; HISHINUMA F, 1969, AGR BIOL CHEM TOKYO, V33, P1577, DOI 10.1080/00021369.1969.10859511; Hodges AW, 2015, EC IMPACTS CITRUS GR, P7; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Kendall MM, 2012, MBIO, V3, DOI 10.1128/mBio.00050-12; Killiny N., 2016, PLANT SIGNAL BEHAV, V11; Killiny N, 2017, PHYSIOL ENTOMOL, V42, P134, DOI 10.1111/phen.12183; Killiny N, 2016, PLANT PHYSIOL BIOCH, V109, P28, DOI 10.1016/j.plaphy.2016.09.002; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; Kube M, 2012, SCI WORLD J, DOI 10.1100/2012/185942; Lee JA, 2015, P NATL ACAD SCI USA, V112, P7605, DOI 10.1073/pnas.1508253112; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Liu HZ, 2008, GENE, V420, P57, DOI 10.1016/j.gene.2008.05.006; Minami M, 2004, ANTIMICROB AGENTS CH, V48, P3782, DOI 10.1128/AAC.48.10.3782-3788.2004; Miuigan GW, 1988, J CLASSIF, V204, P181; Mourier PAJ, 2015, J PHARMACEUT BIOMED, V115, P431, DOI 10.1016/j.jpba.2015.07.038; Nakajima K, 2008, BIOMED RES-TOKYO, V29, P9, DOI 10.2220/biomedres.29.9; Pennington JE, 2003, J INSECT PHYSIOL, V49, P115, DOI 10.1016/S0022-1910(02)00267-6; Ramadugu C, 2016, PLANT DIS; Roecker R, 2012, BIOL TRACE ELEM RES, V147, P172, DOI 10.1007/s12011-011-9276-6; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schwan WF, 2004, MICROBIOL-SGM, V150, P1055, DOI 10.1099/mic.0.26710-0; Setamou M, 2016, J APPL ENTOMOL, V140, P645, DOI 10.1111/jen.12300; Setamou M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168997; Setamou M, 2016, J ECON ENTOMOL, V109, P1973, DOI 10.1093/jee/tow171; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tonon T, 2000, J APPL MICROBIOL, V89, P526, DOI 10.1046/j.1365-2672.2000.01142.x; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Verslues PE, 2011, CURR OPIN PLANT BIOL, V14, P240, DOI 10.1016/j.pbi.2011.04.006; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Walter AJ, 2012, PLANT DIS, V96, P827, DOI 10.1094/PDIS-08-11-0668; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Zhang L, 2015, J BACTERIOL, V197, P431, DOI 10.1128/JB.02282-14	67	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0187921	10.1371/journal.pone.0187921	http://dx.doi.org/10.1371/journal.pone.0187921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236706	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100008
J	Strier, KB; Possamai, CB; Tabacow, FP; Pissinatti, A; Lanna, AM; de Melo, FR; Moreira, L; Talebi, M; Breves, P; Mendes, SL; Jerusalinsky, L				Strier, Karen B.; Possamai, Carla B.; Tabacow, Fernanda P.; Pissinatti, Alcides; Lanna, Andre M.; de Melo, Fabiano Rodrigues; Moreira, Leandro; Talebi, Mauricio; Breves, Paula; Mendes, Sergio L.; Jerusalinsky, Leandro			Demographic monitoring of wild muriqui populations: Criteria for defining priority areas and monitoring intensity	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST	Demographic data are essential to assessments of the status of endangered species. However, establishing an integrated monitoring program to obtain useful data on contemporary and future population trends requires both the identification of priority areas and populations and realistic evaluations of the kinds of data that can be obtained under different monitoring regimes. We analyzed all known populations of a critically endangered primate, the muriqui (genus: Brachyteles) using population size, genetic uniqueness, geographic importance (including potential importance in corridor programs) and implementability scores to define monitoring priorities. Our analyses revealed nine priority populations for the northern muriqui (B. hypoxanthus) and nine for the southern muriqui (B. arachnoides). In addition, we employed knowledge of muriqui developmental and life history characteristics to define the minimum monitoring intensity needed to evaluate demographic trends along a continuum ranging from simple descriptive changes in population size to predictions of population changes derived from individual based life histories. Our study, stimulated by the Brazilian government's National Action Plan for the Conservation of Muriquis, is fundamental to meeting the conservation goals for this genus, and also provides a model for defining priorities and methods for the implementation of integrated demographic monitoring programs for other endangered and critically endangered species of primates.	[Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Strier, Karen B.; Mendes, Sergio L.] Univ Fed Espirito Santo, Dept Ciencias Biol, Vitoria, ES, Brazil; [Strier, Karen B.] Preserve Muriqui, Caratinga, MG, Brazil; [Possamai, Carla B.; Tabacow, Fernanda P.; de Melo, Fabiano Rodrigues; Moreira, Leandro] Muriqui Inst Biodiversidade, Caratinga, MG, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio De Janeiro CPRJ INEA, Guapimirim, RJ, Brazil; [Lanna, Andre M.] Univ Fed Rio de Janeiro, Programa Posgrad Ecol, Rio De Janeiro, Brazil; [de Melo, Fabiano Rodrigues] Univ Fed Goias, Inst BioCiencias, Jatai, Go, Brazil; [Talebi, Mauricio] Univ Fed Sao Paulo, Lab Primatol & Conservacao Especies, Dept Ciencias Ambientais, Campus Diadema, Diadema Sao Paulo, Brazil; [Talebi, Mauricio] Programa Posgrad Anal Ambiental Integrada, Diadema Sao Paulo, Brazil; [Talebi, Mauricio] Inst Promuriqui, Sao Miguel Arcanjo, SP, Brazil; [Breves, Paula] Ecoatlantica, Rio De Janeiro, RJ, Brazil; [Mendes, Sergio L.] Inst Pesquisas Mate Atlantica IPEMA, Vitoria, ES, Brazil; [Jerusalinsky, Leandro] Inst Chico Mendes Conservacao Biodiversidade ICMB, Ctr Nacl Pesquisa & Conservacao Primatas Brasilei, Joao Pessoa, Paraiba, Brazil	University of Wisconsin System; University of Wisconsin Madison; Universidade Federal do Espirito Santo; Universidade Federal do Rio de Janeiro; Universidade Federal de Goias; Universidade Federal de Sao Paulo (UNIFESP)	Strier, KB (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.; Strier, KB (corresponding author), Univ Fed Espirito Santo, Dept Ciencias Biol, Vitoria, ES, Brazil.; Strier, KB (corresponding author), Preserve Muriqui, Caratinga, MG, Brazil.	kbstrier@wisc.edu	de Melo, Fabiano Rodrigues/AAN-5290-2020; Jerusalinsky, Leandro/AAN-2442-2021; Strier, Karen B./AAJ-3482-2020	de Melo, Fabiano Rodrigues/0000-0001-9958-2036; Jerusalinsky, Leandro/0000-0003-0744-1987; Strier, Karen/0000-0003-2520-9110; Possamai, Carla/0000-0002-3346-1351	Rede de Ensino Doctum, Caratinga, Minas Gerais, Brasil; Conservation International.	Rede de Ensino Doctum, Caratinga, Minas Gerais, Brasil; Conservation International.	The concepts and data presented in this paper were developed during the 2013 meeting of the Working Group of the National Action Plan for the Conservation of Muriquis (Plano de Agao Nacional para a Conservagao dos Muriquis, PAN Muriquis), promoted by the Institute Chico Mendes de Biodiversidade (ICMBio), with additional support from the Rede de Ensino Doctum, Caratinga, Minas Gerais, Brasil and Conservation International.	Aximoff I., 2015, OECOLOGIA AUSTRALIS, V18, P1, DOI [10.4257/oeco.2014.1801.01, DOI 10.4257/OECO.2014.1801.01]; Breves P, 2013, 2 C LAT 15 C BRAS PR; Campos FA, 2017, GLOBAL CHANGE BIOL, V23, P4907, DOI 10.1111/gcb.13754; Chaves PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020722; Cunha AA, 2009, ORYX, V43, P254, DOI 10.1017/S003060530700230X; Dias LG, 2005, PROGRAMA LIVRO REMOS, P42; Dias LG, 2006, CONSERVACAO MANEJO M; Ingberman B, PLOS ONE, V11; IUCN Standards and Petition Subcommittee, 2016, GUID US IUCN RED LIS; Jerusalinsky L., 2011, PLANO ACAO NACL CONS; Kinzey WG., 1982, BIOL DIVERSIFICATION, P455; Magnus T, 2011, THESIS; Melo F.R., 2005, NEOTROPICAL PRIMATES, V13, P26, DOI [10.1896/1413-4705.13.1.26, DOI 10.1896/1413-4705.13.1.26]; Melo FR, 2016, 26 C INT PRIM SOC 39, V1, P400; Melo FR, 2017, BRACHYTELES HYPOXANT; Melo FR, 2014, 25 C INT PRIM SOC 20, V1, P69; Mendes Sergio L., 2005, Neotropical Primates, V13, P31; Mendes Sergio L., 2005, Neotropical Primates, V13, P7; Strier KB, 2006, AM J PHYS ANTHROPOL, V130, P227, DOI 10.1002/ajpa.20366; Strier KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044407; Strier Karen B., 2012, P125; Strier KB, 2011, P NATL ACAD SCI USA, V108, P18915, DOI 10.1073/pnas.1116737108; Strier KB, 2010, AM J PRIMATOL, V72, P772, DOI 10.1002/ajp.20830; Tabacow FP, 2013, 2 C LAT 15 C BRAS PR; Tabacow FP, ICMBIO IN PRESS; Talebi M, 2017, SO MURIQUI BRACHYTEL; Talebi Mauricio, 2005, Neotropical Primates, V13, P53; Talebi MG, 2010, INT J PRIMATOL, V31, P571, DOI 10.1007/s10764-010-9414-6; Talebi MG, 2013, HDB MAMMALS WORLD, V3, P18; Talebi MG, 2017, ICMBIO UNPUB	30	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188922	10.1371/journal.pone.0188922	http://dx.doi.org/10.1371/journal.pone.0188922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236726	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100034
J	Wang, CC; Sulli, M; Fu, DQ				Wang, Cui-Cui; Sulli, Maria; Fu, Da-Qi			The role of phytochromes in regulating biosynthesis of sterol glycoalkaloid in eggplant leaves	PLOS ONE			English	Article							SOLANUM-TUBEROSUM L.; TOMATO FRUIT; ETHYLENE PRODUCTION; POTATO-TUBERS; LIGHT; SIDE; ACCUMULATION; SOLANACEAE; CULTIVARS; EXPOSURE	Glycoalkaloids are toxic compounds that are synthesized by many Solanum species. Glycoalkaloid biosynthesis is influenced by plant genetic and environmental conditions. Although many studies have shown that light is an important factor affecting glycoalkaloid biosynthesis, the specific mechanism is currently unknown. Chlorophyll and carotenoid biosynthesis depend on light signal transduction and share some intermediate metabolites with the glycoalkaloid biosynthetic pathway. Here, we used virus-induced gene silencing to silence genes encoding phytoene desaturase (PDS) and magnesium chelatase (CHLI and CHLH) to reduce chlorophyll and carotenoid levels in eggplant leaves. Quantification of carotenoid and chlorophyll levels is analyzed by LC/PDA/APCI/MS and semipolar metabolite profiling by LC/HESI/MS. Notably, the resulting lines showed decreases in glycoalkaloid production. We further found that the expression of some genes involved in the production of glycoalkaloids and other metabolites were suppressed in these silenced lines. Our results indicate that photosynthetic pigment accumulation affects steroidal glycoalkaloid biosynthesis in eggplant leaves. This finding lays the foundation for reducing the levels of endogenous antinutritional compounds in crops.	[Wang, Cui-Cui; Fu, Da-Qi] China Agr Univ, Coll Food Sci & Nutr Engn, Fruit Biol Lab, Beijing, Peoples R China; [Sulli, Maria] Italian Natl Agcy New Technol Energy & Sustainabl, Rome, Italy	China Agricultural University; Italian National Agency New Technical Energy & Sustainable Economics Development	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Fruit Biol Lab, Beijing, Peoples R China.	daqifu@126.com		Sulli, Maria/0000-0002-6875-2546				Cardenas PD, 2015, PHYTOCHEMISTRY, V113, P24, DOI 10.1016/j.phytochem.2014.12.010; Cardenas PD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10654; DALE MFB, 1993, ANN APPL BIOL, V123, P411, DOI 10.1111/j.1744-7348.1993.tb04103.x; DE MJ, 1988, J AGR SCI, V111, P57, DOI 10.1017/S0021859600082812; Edwards EJ, 1998, J SCI FOOD AGR, V76, P327, DOI [10.1002/(SICI)1097-0010(199803)76:3<327::AID-JSFA934>3.3.CO;2-7, 10.1002/(SICI)1097-0010(199803)76:3&lt;327::AID-JSFA934&gt;3.0.CO;2-G]; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; FRIEDMAN M, 1992, J AGR FOOD CHEM, V40, P419, DOI 10.1021/jf00015a011; Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Grunenfelder LA, 2006, J AGR FOOD CHEM, V54, P5847, DOI 10.1021/jf0607359; HEFTMANN E, 1983, PHYTOCHEMISTRY, V22, P1843, DOI 10.1016/0031-9422(83)80001-6; HERNER RC, 1973, PLANT PHYSIOL, V52, P38, DOI 10.1104/pp.52.1.38; Iijima Y, 2013, PHYTOCHEMISTRY, V95, P145, DOI 10.1016/j.phytochem.2013.07.016; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Itkin M, 2011, PLANT CELL, V23, P4507, DOI 10.1105/tpc.111.088732; Katz YS, 2006, PLANT MOL BIOL, V61, P255, DOI 10.1007/s11103-006-0009-8; Kozukue N, 2008, J AGR FOOD CHEM, V56, P11920, DOI 10.1021/jf802631t; Liu HP, 2012, J INTEGR PLANT BIOL, V54, P422, DOI 10.1111/j.1744-7909.2012.01102.x; Liu MC, 2014, NEW PHYTOL, V203, P206, DOI 10.1111/nph.12771; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mccue KF, 2007, PHYTOCHEMISTRY, V68, P327, DOI 10.1016/j.phytochem.2006.10.025; Mccue KF, 2006, PHYTOCHEMISTRY, V67, P1590, DOI 10.1016/j.phytochem.2005.09.037; McCue KF, 2005, PLANT SCI, V168, P267, DOI 10.1016/j.plantsci.2004.08.006; Nair PM, 1981, J SCI IND RES; Percival GC, 1999, PLANT SCI, V145, P99, DOI 10.1016/S0168-9452(99)00081-3; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; RAMASWAMY NK, 1976, EUR J BIOCHEM, V67, P275, DOI 10.1111/j.1432-1033.1976.tb10659.x; RODDICK JG, 1989, PHYTOCHEMISTRY, V28, P2631, DOI 10.1016/S0031-9422(00)98055-5; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Rodriguez-Amaya D.B., 2001, GUIDE CAROTENOID ANA; Sawai S, 2014, PLANT CELL, V26, P3763, DOI 10.1105/tpc.114.130096; Shakya R, 2008, J AGR FOOD CHEM, V56, P6949, DOI 10.1021/jf8006618; Spoladore D. S., 1983, Bragantia, V42, P221, DOI 10.1590/S0006-87051983000100020; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Zrust J, 2001, LIGHT INDUCED ALPHA	35	5	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189481	10.1371/journal.pone.0189481	http://dx.doi.org/10.1371/journal.pone.0189481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236780	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100073
J	Xiao, Y; Zhou, LX; Lei, XT; Cao, HX; Wang, Y; Dou, YJ; Tang, WQ; Xia, W				Xiao, Yong; Zhou, Lixia; Lei, Xintao; Cao, Hongxing; Wang, Yong; Dou, Yajing; Tang, Wenqi; Xia, Wei			Genome-wide identification of WRKY genes and their expression profiles under different abiotic stresses in Elaeis guineensis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DROUGHT TOLERANCE; ABSCISIC-ACID; DNA-BINDING; FAMILY; RICE; RESISTANCE; PATHOGEN; OVEREXPRESSION; SUPERFAMILY	African oil palm (Elaeis guineensis) is an important oil crop grown in tropical region and sensitive to low temperature along with high tolerance to salt and drought stresses. Since the WRKY transcription factor family plays central roles in the regulation of plant stress tolerance, 95 genes belonging to the WRKY family were identified and characterized in oil palm genome. Gene structure analysis showed that EgWRKY genes have considerable variation in intron number (0 to 12) and gene length (477bp to 89,167 bp). Duplicated genes identification indicated 32 EgWRKY genes originated from segmental duplication and two from tandem duplication. Based on transcriptome data, most EgWRKY genes showed tissue-specific expression patterns and their expression could be induced under cold stress. Furthermore, six EgWRKY genes with more than two-folded increased expression level under cold stress were validated by RT-qPCR, which has higher expression level in cold, drought and high salinity treatment. The identification and characterization of WRKY gene family showed that EgWRKY were associated with a wide range of abiotic stress responses in Elaeis guineensis and some EgWRKY members with high expression levels could be selected for further research in analyzing their functions in the stress response in African oil palm.	[Xiao, Yong; Zhou, Lixia; Lei, Xintao; Cao, Hongxing; Wang, Yong] Chinese Acad Trop Agr Sci, Coconuts Res Inst, Wenchang, Peoples R China; [Dou, Yajing; Tang, Wenqi; Xia, Wei] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Hainan University	Xiao, Y (corresponding author), Chinese Acad Trop Agr Sci, Coconuts Res Inst, Wenchang, Peoples R China.; Xia, W (corresponding author), Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China.	xiaoyong1980@catas.cn; saizjxiawei@hainu.edu.cn	Wang, Yong/GPW-9194-2022; Zhou, Li/GSE-4531-2022		Scientific and Technological Cooperation Projects of Hainan province [SQ2015GJXM0076]; fundamental Scientific Research Funds for Chinese Academy of Tropical Agriculture Sciences [1630152016006]	Scientific and Technological Cooperation Projects of Hainan province; fundamental Scientific Research Funds for Chinese Academy of Tropical Agriculture Sciences	This work was supported by the Scientific and Technological Cooperation Projects of Hainan province (No. SQ2015GJXM0076) and the fundamental Scientific Research Funds for Chinese Academy of Tropical Agriculture Sciences (1630152016006).	Bencke-Malato M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0236-0; Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fan XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126148; Gallou A, 2012, FUNCT INTEGR GENOMIC, V12, P183, DOI 10.1007/s10142-011-0241-4; Hu YR, 2012, PLANT SCI, V185, P288, DOI 10.1016/j.plantsci.2011.12.003; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HL, 2014, GENOMICS, V104, P14, DOI 10.1016/j.ygeno.2014.04.004; Li SJ, 2009, PLANT CELL REP, V28, P683, DOI 10.1007/s00299-008-0666-y; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Marchive C, 2007, J EXP BOT, V58, P1999, DOI 10.1093/jxb/erm062; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukhtar MS, 2008, PLANT J, V56, P935, DOI 10.1111/j.1365-313X.2008.03651.x; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Rabara RC, 2013, BIOCHEM BIOPH RES CO, V431, P409, DOI 10.1016/j.bbrc.2012.12.156; Raineri J, 2015, PLANT MOL BIOL, V88, P401, DOI 10.1007/s11103-015-0329-7; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Scarpeci TE, 2013, PLANT MOL BIOL, V83, P265, DOI 10.1007/s11103-013-0090-8; Shen HS, 2012, PLANT MOL BIOL, V80, P241, DOI 10.1007/s11103-012-9941-y; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1373-z; Wang NA, 2013, PLANT MOL BIOL REP, V31, P852, DOI 10.1007/s11105-013-0556-5; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YN, 2013, MOL PLANT PATHOL, V14, P131, DOI 10.1111/j.1364-3703.2012.00836.x; Wei KF, 2012, DNA RES, V19, P153, DOI 10.1093/dnares/dsr048; Wei YX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00025; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Xia W, 2014, J BIOTECHNOL, V184, P63, DOI 10.1016/j.jbiotec.2014.05.008; Xiao Y, 2012, PLANT OMICS, V5, P584; Xie Y, 2014, DEVELOPMENT, V141, P4772, DOI 10.1242/dev.117689; Xie Z, 2006, PLANT J, V46, P231, DOI 10.1111/j.1365-313X.2006.02694.x; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zou CS, 2010, J EXP BOT, V61, P3901, DOI 10.1093/jxb/erq204	44	34	36	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189224	10.1371/journal.pone.0189224	http://dx.doi.org/10.1371/journal.pone.0189224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228032	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600039
J	Wider, D; Picard, D				Wider, Diana; Picard, Didier			Secreted dual reporter assay with Gaussia luciferase and the red fluorescent protein mCherry	PLOS ONE			English	Article							FIREFLY LUCIFERASE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; BIOLUMINESCENT REPORTER; MAMMALIAN-CELLS; IN-VIVO; ACTIVATION; DNA; PATHWAY; CULTURE	The availability of a wide range of reporter proteins, which can easily be quantitated, has had a major impact on many fields of biomedical research. In some experiments with tissue culture cells, it is necessary to control for differences in transfection efficiency and in other expression parameters. This requirement has been very conveniently met with the popular dual luciferase assay. Its disadvantages are the requirement for cell lysis, the inability to analyze the same cells repeatedly, and the cost, at least in its most commonly used commercial format. Here we describe a novel dual reporter assay with the naturally secreted luciferase from Gaussia princeps as the main reporter protein and a secreted version of the red fluorescent protein mCherry as internal standard. After first measuring mCherry fluorescence in the medium, an enzyme buffer with coelenterazine as substrate is added to the same sample to trigger a glow-type luminescence of the luciferase. The simple and cheap assay can easily be adapted to a variety of experimental situations. As a case in point, we have developed a panel of Gaussia luciferase reporter genes for transcriptional activation assays with estrogen and glucocorticoid response elements, and with response elements for fusion proteins with the Gal4 DNA binding domain for use in mammalian cells. Our secreted dual reporter assay should be an attractive alternative to the currently available commercial kits.	[Wider, Diana; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland	University of Geneva	Picard, D (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland.	didier.picard@unige.ch	Wider, Diana/AAZ-9256-2020	Wider, Diana/0000-0002-7573-395X	Swiss National Science Foundation; Medic Foundation; Canton de Geneve	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medic Foundation; Canton de Geneve	This work was supported by the Swiss National Science Foundation, the Medic Foundation and the Canton de Geneve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Pierre-Andre Briand for generating the plasmid for Ga14.VP16 and to Abhinav Joshi for the HEK 293T variant. We thank Dr. Jay Yang for providing the MMP9-mCherry plasmid. This work was supported by the Swiss National Science Foundation, the Medic Foundation, and the Canton de Geneve.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; DEWET JR, 1986, METHOD ENZYMOL, V133, P3; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Duellman T, 2015, TRAFFIC, V16, P1108, DOI 10.1111/tra.12312; Duellman T, 2015, ANAL BIOCHEM, V473, P34, DOI 10.1016/j.ab.2014.12.010; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Kumita JR, 2000, BIOCHEM BIOPH RES CO, V267, P394, DOI 10.1006/bbrc.1999.1950; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; PICARD D, 1999, NUCL RECEPTORS PRACT; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherf BA., 1996, PROMEGA NOTES, V57, P2; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Wood Keith V., 1995, Current Opinion in Biotechnology, V6, P50, DOI 10.1016/0958-1669(95)80009-3; WOOD KV, 1998, PROMEGA NOTES, V65, P14; Wu C, 2007, BIOTECHNIQUES, V42, P290, DOI 10.2144/000112428	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189403	10.1371/journal.pone.0189403	http://dx.doi.org/10.1371/journal.pone.0189403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220385	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900056
J	Fiocchetti, M; Cipolletti, M; Marino, M				Fiocchetti, Marco; Cipolletti, Manuela; Marino, Maria			Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; OXIDATIVE STRESS; BREAST-CANCER; NEURODEGENERATIVE DISORDERS; HYDROGEN-PEROXIDE; CORTICAL-NEURONS; UP-REGULATION; IN-VITRO; AUTOPHAGY; APOPTOSIS	Environmental factors or adverse growth conditions that may reduce cell function or viability are considered stress. The cell ability to sense and respond to environmental stresses determine its function and survival destiny. We recently defined Neuroglobin (NGB), a heme-protein, as a compensatory protein in the 17 beta-Estradiol (E2) anti-apoptotic activity and as a sensor of oxidative stress in both neurons and breast cancer cells. Here, the possibility that NGB levels could represent a pivotal regulator of integrated response of cancer cells to stress has been evaluated. Data obtained in neuroblastoma and in breast cancer cell lines evidence that nutrient deprivation significantly up-regulated NGB levels at different time points. However, the analysis of autophagy activation led to exclude any possible role of stress-or E2-induced NGB in the upstream regulation of general autophagy. However, the over-expression of Flag-NGB in ERa stable transfected HEK-293 cells completely affects nutrient deprivation-induced decrease in cell number. In addition, reported results indicate that modulation of the anti-apoptotic Bcl-2 level may play a key role in the protective NGB function against energetic stress. Overall, these data define a role of NGB as compensatory protein in the cell machinery activated in response to stress and as general stress adaptation marker of cancer cells susceptible to oxidative stress, oxygen and, as demonstrated here for the first time, even to nutrient willingness. Despite the lacking of any direct NGB role on autophagic flux activated by energetic stress, NGB upregulation appears functional in delaying stress-related cell death allowing an appropriate cell response and adaptation to the changing extracellular conditions.	[Fiocchetti, Marco; Cipolletti, Manuela; Marino, Maria] Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi, Rome, Italy	Italfarmaco; Roma Tre University	Fiocchetti, M; Marino, M (corresponding author), Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi, Rome, Italy.	marco.fiocchetti@uniroma3.it; maria.marino@uniroma3.it	Fiocchetti, Marco/G-1486-2013; Marino, Maria/AAB-6357-2022	Fiocchetti, Marco/0000-0002-4888-0567; Cipolletti, Manuela/0000-0002-0987-2927	Associazione Italiana Ricerca sul Cancro (AIRC, IG) [15221]	Associazione Italiana Ricerca sul Cancro (AIRC, IG)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC, IG#15221) to Maria Marino (www.airc.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from Associazione Italiana Ricerca sul Cancro (AIRC, IG#15221) to M.M.	Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Ascenzi P, 2016, MOL ASPECTS MED, V52, P1, DOI 10.1016/j.mam.2016.10.004; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Brittain T, 2010, INT J MOL SCI, V11, P2306, DOI 10.3390/ijms11062306; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI DOI 10.2174/1876390101103010042; Chircop M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00304; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Deng S Y, 2017, Zhonghua Yi Xue Za Zhi, V97, P1505, DOI 10.3760/cma.j.issn.0376-2491.2017.19.016; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Emara M, 2009, MOL ONCOL, V3, P45, DOI 10.1016/j.molonc.2008.11.002; Fan DH, 2015, J CLIN ENDOCR METAB, V100, pE561, DOI 10.1210/jc.2014-3257; Fiocchetti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.418; Fiocchetti M, 2017, J CELL PHYS IN PRESS; Fiocchetti M, 2016, IUBMB LIFE, V68, P645, DOI 10.1002/iub.1522; Fiocchetti M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154959; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Jain K, 2013, AM J CANCER RES, V3, P251; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Li LT, 2017, CELL PHYSIOL BIOCHEM, V41, P2027, DOI 10.1159/000475433; Lin Y, 2015, NEUROL RES, V37, P531, DOI 10.1179/1743132814Y.0000000420; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mei J, 2015, HUM REPROD, V30, P1677, DOI 10.1093/humrep/dev100; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Pesiri V, 2015, CELL SIGNAL, V27, P2380, DOI 10.1016/j.cellsig.2015.08.021; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Shanle EK, 2015, AM J TRANSL RES, V7, P1246; Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Totta P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23727; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Watanabe S, 2012, J BIOL CHEM, V287, P30128, DOI 10.1074/jbc.M112.373381; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yang YH, 2013, APOPTOSIS, V18, P1363, DOI 10.1007/s10495-013-0867-x; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zhou GY, 2013, NEUROL SCI, V34, P1771, DOI 10.1007/s10072-013-1333-9	60	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189179	10.1371/journal.pone.0189179	http://dx.doi.org/10.1371/journal.pone.0189179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216269	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800087
J	Tsang, PWK; Fong, WP; Samaranayake, LP				Tsang, Paul Wai-Kei; Fong, Wing-Ping; Samaranayake, Lakshman Perera			Candida albicans orf19.3727 encodes phytase activity and is essential for human tissue damage	PLOS ONE			English	Article							INVASIVE CANDIDIASIS; GENE; EXPRESSION; INFECTION; DISEASE	Candida albicans is a clinically important human fungal pathogen. We previously identified the presence of cell-associated phytase activity in C. albicans. Here, we reveal for the first time, that orf19.3727 contributes to phytase activity in C. albicans and ultimately to its virulence potency. Compared with its wild type counterpart, disruption of C. albicans orf19.3727 led to decreased phytase activity, reduced ability to form hyphae, attenuated in vitro adhesion, and reduced ability to penetrate human epithelium, which are the major virulence attributes of this yeast. Thus, orf19.3727 of C. albicans plays a key role in fungal pathogenesis. Further, our data uncover a putative novel strategy for anti-Candidal drug design through inhibition of phytase activity of this common pathogen.	[Tsang, Paul Wai-Kei] Technol & Higher Educ Inst Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Fong, Wing-Ping] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Samaranayake, Lakshman Perera] Univ Sharjah, Coll Dent Med, University City, U Arab Emirates	Chinese University of Hong Kong; University of Sharjah	Tsang, PWK (corresponding author), Technol & Higher Educ Inst Hong Kong, Hong Kong, Hong Kong, Peoples R China.	paulwktsang@vtc.edu.hk		TSANG, Paul Wai-Kei/0000-0001-9163-4217	Health and Medical Research Fund; Food and Health Bureau of the Government of the HKSAR [11100992]; University Grants Council [UGC/FDS25/M04/15, UGC/FDS25/M02/16]	Health and Medical Research Fund; Food and Health Bureau of the Government of the HKSAR; University Grants Council	This work was supported by Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR (Project No. 11100992 to PWKT), and partially supported by Faculty Development Scheme of the University Grants Council (UGC/FDS25/M04/15 and UGC/FDS25/M02/16 to PWKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR (Project No. 11100992 to PWKT), and partially supported by Faculty Development Scheme of the University Grants Council (UGC/FDS25/M04/15 and UGC/FDS25/M02/16 to PWKT). We thank Mr. N.F. Li, Mr. K.Y. Chau, Mr. Y.Y. Chui, and Mr. A.Wong for their excellent technical assistance. We thank Dr. J. Chao-Chu for manuscript editing.	Antinori S, 2016, EUR J INTERN MED, V34, P21, DOI 10.1016/j.ejim.2016.06.029; Bizzarri M, 2016, EXPERT OPIN DRUG MET, V12, P1181, DOI 10.1080/17425255.2016.1206887; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Eggimann P, 2015, J HOSP INFECT, V89, P302, DOI 10.1016/j.jhin.2014.11.006; Haros M, 2005, FEMS MICROBIOL LETT, V247, P231, DOI 10.1016/j.femsle.2005.05.008; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Lazado CC, 2010, FISH PHYSIOL BIOCHEM, V36, P883, DOI 10.1007/s10695-009-9364-0; Lim CSY, 2012, EUR J CLIN MICROBIOL, V31, P21, DOI 10.1007/s10096-011-1273-3; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nakamura Y, 2000, BIOSCI BIOTECH BIOCH, V64, P841, DOI 10.1271/bbb.64.841; Quan CS, 2001, J BIOSCI BIOENG, V92, P154, DOI 10.1016/S1389-1723(01)80217-6; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Samaranayake YH, 2005, J MED MICROBIOL, V54, P583, DOI 10.1099/jmm.0.45762-0; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Shao N, 2008, J MICROBIOL BIOTECHN, V18, P1221; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Tsang PWK, 2011, MYCOPATHOLOGIA, V172, P473, DOI 10.1007/s11046-011-9453-3; Tsang PWK, 2010, YEAST, V27, P53, DOI 10.1002/yea.1732; Walther A, 2008, NAT PROTOC, V3, P1414, DOI 10.1038/nprot.2008.137	24	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189219	10.1371/journal.pone.0189219	http://dx.doi.org/10.1371/journal.pone.0189219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216308	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800097
J	Yamashita, J; Ohmoto, M; Yamaguchi, T; Matsumoto, I; Hirota, J				Yamashita, Junpei; Ohmoto, Makoto; Yamaguchi, Tatsuya; Matsumoto, Ichiro; Hirota, Junji			Skn-1a/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice	PLOS ONE			English	Article							SOLITARY CHEMORECEPTOR CELLS; TASTE RECEPTOR-CELLS; TUFT CELLS; CATION CHANNEL; NASAL CAVITY; TRPM5; ACETYLCHOLINE; EPITHELIUM; IMMUNITY; GUT	Transient receptor potential channel M5 (Trpm5)-expressing cells, such as sweet, umami, and bitter taste cells in the oropharyngeal epithelium, solitary chemosensory cells in the nasal respiratory epithelium, and tuft cells in the small intestine, that express taste-related genes function as chemosensory cells. Previous studies demonstrated that Skn-1a/Pou2f3, a POU homeodomain transcription factor is expressed in these Trpm5-expressing chemosensory cells, and is necessary for their generation. Trpm5-expressing cells have recently been found in trachea, auditory tube, urethra, thymus, pancreatic duct, stomach, and large intestine. They are considered to be involved in protective responses to potential hazardous compounds as Skn-1a-dependent bitter taste cells, respiratory solitary chemosensory cells, and intestinal tuft cells are. In this study, we examined the expression and function of Skn1a/Pou2f3 in Trpm5-expressing cells in trachea, auditory tube, urethra, thymus, pancreatic duct, stomach, and large intestine. Skn-1a/Pou2f3 is expressed in a majority of Trpm5-expressing cells in all tissues examined. In Skn-1a/Pou2f3-deficient mice, the expression of Trpm5 as well as marker genes for Trpm5-expressing cells were absent in all tested tissues. Immunohistochemical analyses demonstrated that two types of microvillous cells exist in trachea, urethra, and thymus, Trpm5-positive and Trpm5-negative cells. In Skn-1a/Pou2f3-deficient mice, a considerable proportion of Trpm5-negative and villin-positive microvillous cells remained present in these tissues. Thus, we propose that Skn-1a/Pou2f3 is the master regulator for the generation of the Trpm5-expressing microvillous cells in multiple tissues.	[Yamashita, Junpei; Yamaguchi, Tatsuya; Hirota, Junji] Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Yokohama, Kanagawa, Japan; [Ohmoto, Makoto; Matsumoto, Ichiro] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Hirota, Junji] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Monell Chemical Senses Center; Tokyo Institute of Technology	Hirota, J (corresponding author), Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Yokohama, Kanagawa, Japan.; Hirota, J (corresponding author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa, Japan.	jhirota@bio.titech.ac.jp	Hirota, Junji/O-9315-2019; Hirota, Junji/G-1357-2019	Hirota, Junji/0000-0002-5741-0655; Hirota, Junji/0000-0002-5741-0655	MEXT KAKENHI [JP20570208, JP16K07366]; JSPS KAKENHI; Yamazaki Spice Promotion Foundation [131]; NIH [R01DC015491];  [JP15J05301]; Grants-in-Aid for Scientific Research [16K07366, 15J05301] Funding Source: KAKEN; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015491] Funding Source: NIH RePORTER	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamazaki Spice Promotion Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grant support from MEXT KAKENHI (Grant Number JP20570208 and JP16K07366 to J.H.), JSPS KAKENHI, Grant-in-Aid for JSPS Fellows (JP15J05301 to J.Y.), the Yamazaki Spice Promotion Foundation (131 to J.H.), an NIH grant (R01DC015491 to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crowder EA, 2007, J PHYSIOL-LONDON, V582, P1047, DOI 10.1113/jphysiol.2007.134577; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; DelGiorno KE, 2014, GASTROENTEROLOGY, V146, P233, DOI 10.1053/j.gastro.2013.08.053; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Krasteva G, 2012, HISTOCHEM CELL BIOL, V137, P483, DOI 10.1007/s00418-012-0911-x; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Lemons K, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0135-17.2017; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Ogura T, 2011, J NEUROPHYSIOL, V106, P1274, DOI 10.1152/jn.00186.2011; Ogura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011924; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2013, BIOSCI BIOTECH BIOCH, V77, P2154, DOI 10.1271/bbb.130454; Panneck AR, 2014, CELL TISSUE RES, V358, P737, DOI 10.1007/s00441-014-2002-x; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Saqui-Salces M, 2011, HISTOCHEM CELL BIOL, V136, P191, DOI 10.1007/s00418-011-0831-1; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schutz B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00087; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Tomonari H, 2012, CHEM SENSES, V37, P241, DOI 10.1093/chemse/bjr098; Ushiama S, 2016, EBIOMEDICINE, V8, P60, DOI 10.1016/j.ebiom.2016.04.031; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Yamaguchi T, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-13	33	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189340	10.1371/journal.pone.0189340	http://dx.doi.org/10.1371/journal.pone.0189340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216297	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800119
J	Yannarelli, G; Pacienza, N; Montanari, S; Santa-Cruz, D; Viswanathan, S; Keating, A				Yannarelli, Gustavo; Pacienza, Natalia; Montanari, Sonia; Santa-Cruz, Diego; Viswanathan, Sowmya; Keating, Armand			OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EMBRYONIC STEM-CELLS; BONE-MARROW; CARDIAC-FUNCTION; FUNCTIONAL CARDIOMYOCYTES; DIFFERENTIATION CAPACITY; INDUCED PLURIPOTENCY; DIRECT CONVERSION; EMERGING CONCEPTS; PROGENITOR CELLS	Mesenchymal stem/stromal cells (MSCs) are in numerous cell therapy clinical trials, including for injured myocardium. Acquisition of cardiomyocyte characteristics by MSCs may improve cardiac regeneration but the mechanisms regulating this process are unclear. Here, we investigated whether the pluripotency transcription factor OCT4 is involved in the activation of cardiac lineage genetic programs in MSCs. We employed our established co-culture model of MSCs with rat embryonic cardiomyocytes showing co-expression of cardiac markers on MSCs independent of cell fusion. Bone marrow-derived MSCs were isolated from transgenic mice expressing GFP under the control of the cardiac-specific amyosin heavy chain promoter. After 5 days of co-culture, MSCs expressed cardiac specific genes, including Nkx2.5, atrial natriuretic factor and a-cardiac actin. The frequency of GFP+cells was 7.6 +/- 1.9%, however, these cells retained the stromal cell phenotype, indicating, as expected, only partial differentiation. Global OCT4 expression increased 2.6 +/- 0.7-fold in co-cultured MSCs and of interest, 87-5% vs 79-4% of MSCs expressed OCT4 by flow cytometry in controls and after co-culture, respectively. Consistent with the latter observation, the GFP+ cells did not express nuclear OCT4 and showed a significant increase in OCT4 promoter methylation compared with undifferentiated MSCs (92% vs 45%), inferring that OCT4 is regulated by an epigenetic mechanism. We further showed that siRNA silencing of OCT4 in MSCs resulted in a reduced frequency of GFP+ cells in co-culture to less than 1%. Our data infer that OCT4 expression may have a direct effect on partial cardiomyocyte reprogramming of MSCs and suggest a new mechanism(s) associated with MSC multipotency and a requirement for crosstalk with the cardiac microenvironment.	[Yannarelli, Gustavo; Montanari, Sonia; Viswanathan, Sowmya; Keating, Armand] Univ Hlth Network, Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada; [Yannarelli, Gustavo; Pacienza, Natalia; Santa-Cruz, Diego] Univ Favaloro, CONICET, Inst Med Traslac Trasplante & Bioingn IMeTTyB, Lab Regulac Gen & Celulas Madre, Buenos Aires, DF, Argentina	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Yannarelli, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada.; Yannarelli, G (corresponding author), Univ Favaloro, CONICET, Inst Med Traslac Trasplante & Bioingn IMeTTyB, Lab Regulac Gen & Celulas Madre, Buenos Aires, DF, Argentina.	gyannarelli@favaloro.edu.ar	Viswanathan, Sowmya/GRO-4533-2022; Viswanathan, Sowmya/N-1983-2019; Yannarelli, Gustavo/J-6055-2019	Viswanathan, Sowmya/0000-0002-4552-0179; Yannarelli, Gustavo/0000-0003-1450-5483; Keating, Armand/0000-0002-7676-6059; Santa-Cruz, Diego/0000-0001-7419-6120; Pacienza, Natalia/0000-0002-6124-5269	Orsino Translational Research Laboratory of Princess Margaret Hospital; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation of University Health Network; University of Toronto; Agencia Nacional de Promocion Cientffica y Tecnologica (ANPCyT) of Argentina [PICT-2014-1198]	Orsino Translational Research Laboratory of Princess Margaret Hospital; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation of University Health Network; University of Toronto(University of Toronto); Agencia Nacional de Promocion Cientffica y Tecnologica (ANPCyT) of Argentina(ANPCyT)	This work was supported by the Orsino Translational Research Laboratory of Princess Margaret Hospital, by the Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation of University Health Network and the University of Toronto held by AK, and by Grant PICT-2014-1198 from the Agencia Nacional de Promocion Cientffica y Tecnologica (ANPCyT) of Argentina held by GY.	Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Altun G, 2010, J CELL BIOCHEM, V109, P1, DOI 10.1002/jcb.22374; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gallo MP, 2007, J CELL BIOCHEM, V100, P86, DOI 10.1002/jcb.21012; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hao Q, 2015, CELL REPROGRAM, V17, P347, DOI 10.1089/cell.2015.0025; Hermann A, 2010, CYTOTHERAPY, V12, P17, DOI 10.3109/14653240903313941; Hodgkinson CP, 2016, CIRC RES, V118, P95, DOI 10.1161/CIRCRESAHA.115.305373; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li Q, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt213; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Liu Y, 2011, STEM CELLS, V29, P2077, DOI 10.1002/stem.764; Liu Y, 2010, CELL BIOL INT, V34, P1075, DOI 10.1042/CBI20100516; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maniatis T, 1989, MOL CLONING LAB MANU, V2; Merrell AJ, 2016, NAT REV MOL CELL BIO, V17, P413, DOI 10.1038/nrm.2016.24; Nagura S, 2013, CELL REPROGRAM, V15, P471, DOI 10.1089/cell.2013.0002; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Prockop DJ, 2016, MATRIX BIOL, V51, P7, DOI 10.1016/j.matbio.2016.01.010; Radzisheuskaya A, 2014, TRENDS CELL BIOL, V24, P275, DOI 10.1016/j.tcb.2013.11.010; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Rui YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11056; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; SHIMAZAKI T, 1993, EMBO J, V12, P4489, DOI 10.1002/j.1460-2075.1993.tb06138.x; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0341-0; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Ullah M, 2014, INT J BIOCHEM CELL B, V46, P124, DOI 10.1016/j.biocel.2013.11.010; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Yannarelli G, 2014, STEM CELL REV REP, V10, P304, DOI 10.1007/s12015-013-9483-y; Yannarelli G, 2013, CELL TRANSPLANT, V22, P1651, DOI 10.3727/096368912X657675; Yannarelli G, 2013, STEM CELLS, V31, P215, DOI 10.1002/stem.1262; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	58	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189131	10.1371/journal.pone.0189131	http://dx.doi.org/10.1371/journal.pone.0189131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216265	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800080
J	Yin, N; Fang, L; Shi, XH; Huang, HQ; Zhang, L				Yin, Ning; Fang, Lei; Shi, Xiaohua; Huang, Hongqiang; Zhang, Li			A comprehensive scoring system in correlation with perioperative airway management for neonatal Pierre Robin Sequence	PLOS ONE			English	Article							LARYNGEAL MASK AIRWAY; TRACHEAL INTUBATION	Purpose To evaluate a comprehensive scoring system which combines clinical manifestations of Pierre Robin Sequence (PRS) including severity of breathing difficulties, body weight and preoperative Cormack-Lehane grade, for its correlation with perioperative PRS airway management decision. Design Forty PRS children were retrospectively recruited after surgery. Specialists examined all subjects and scored for clinical manifestations (1' - 4'), weight gain (1' - 4'), dyspnea scores (1' - 4'), and Cormack- Lehane grade (1' - 4'). The correlation of the integrated scores and the necessity of endotracheal intubation or laryngeal mask application were analyzed. In addition, the score correlation with postoperative dyspnea and/or low pulse oxygen saturation (SPO2) levels after extubation was determined. Findings In our study every individual patient had a score from 0' to 16', while the higher in the numbers represented higher risk of breathing difficulty. All patients with comprehensive scores < 10 points underwent endotracheal intubation successfully. Patients scoring 10-12 points had an intubation success rate of 47%, whereas all patients scored > 13 points required a laryngeal mask assisted airway management and were considered to have difficult airways. Dyspnea after extubation and postoperative low SPO2 occurred among patients who scored over 10 points. Conclusion In PRS patients, preoperative weight gaining status and severity of dyspnea in combination with Cormack-Lehane classification provide a scoring system that could help to optimize airway management decisions such as endotracheal intubation or laryngeal mask airway placement and has the potential to predict postoperative dyspnea or low SPO2 levels.	[Yin, Ning] Nanjing Med Univ, Sir Run Run Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Yin, Ning; Fang, Lei] Southeast Univ, Zhongda Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Yin, Ning; Fang, Lei] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Shi, Xiaohua; Huang, Hongqiang; Zhang, Li] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Southeast University - China; Nanjing Medical University	Yin, N (corresponding author), Nanjing Med Univ, Sir Run Run Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.; Yin, N (corresponding author), Southeast Univ, Zhongda Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.; Yin, N (corresponding author), Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	yinning882000@126.com						BARAKA A, 1995, ANESTHESIOLOGY, V83, P645; CAOUETTELABERGE L, 1994, PLAST RECONSTR SURG, V93, P934, DOI 10.1097/00006534-199404001-00006; Cladis F, 2014, ANESTH ANALG, V119, P400, DOI 10.1213/ANE.0000000000000301; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Dinwiddie Robert, 2004, Paediatr Respir Rev, V5, P17, DOI 10.1016/j.prrv.2003.10.001; Gandini D, 2003, PAEDIATR ANAESTH, V13, P181, DOI 10.1046/j.1460-9592.2003.01019_4.x; Gangopadhyay Noopur, 2012, Semin Plast Surg, V26, P76, DOI 10.1055/s-0032-1320065; HANSEN TG, 1995, ACTA ANAESTH SCAND, V39, P129, DOI 10.1111/j.1399-6576.1995.tb05604.x; Hong Paul, 2015, Ear Nose Throat J, V94, pE25; Mackay DR, 2011, J CRANIOFAC SURG, V22, P415, DOI 10.1097/SCS.0b013e3182074799; MARKAKIS DA, 1992, ANESTH ANALG, V75, P823; Marston AP, 2012, LARYNGOSCOPE, V122, P1401, DOI 10.1002/lary.23260; Ryan G, 2016, SEMIN FETAL NEONAT M, V21, P230, DOI 10.1016/j.siny.2016.03.002; Smith MC, 2006, INT J PEDIATR OTORHI, V70, P319, DOI 10.1016/j.ijporl.2005.07.003; St-Hilaire H, 2000, OTOLARYNG CLIN N AM, V33, P1241, DOI 10.1016/S0030-6665(05)70279-6; Xiong X, 2007, MATERN CHILD HLTH J, V11, P57, DOI 10.1007/s10995-006-0140-9	16	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189052	10.1371/journal.pone.0189052	http://dx.doi.org/10.1371/journal.pone.0189052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216230	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800061
J	Val-Laillet, D; Guerin, S; Coquery, N; Nogret, I; Formal, M; Rome, V; Le Normand, L; Meurice, P; Randuineau, G; Guilloteau, P; Malbert, CH; Parnet, P; Lalles, JP; Segain, JP				Val-Laillet, David; Guerin, Sylvie; Coquery, Nicolas; Nogret, Isabelle; Formal, Michele; Rome, Veronique; Le Normand, Laurence; Meurice, Paul; Randuineau, Gwenaelle; Guilloteau, Paul; Malbert, Charles-Henri; Parnet, Patricia; Lalles, Jean-Paul; Segain, Jean-Pierre			Oral sodium butyrate impacts brain metabolism and hippocampal neurogenesis, with limited effects on gut anatomy and function in pigs	FASEB JOURNAL			English	Article						pancreas; cognition; hippocampus	REGULATES MEMORY FORMATION; VENTRAL HIPPOCAMPUS; MILK REPLACER; WEANED PIGS; FEED-INTAKE; RAT-BRAIN; DIET; PIGLETS; GLUCOSE; MODEL	Butyrate can improve gut functions, whereas histone deacetylase inhibitors might alleviate neurocognitive alterations. Our aim was to assess whether oral butyrate could modulate brain metabolism and plasticity and if this would relate to gut function. Sixteen pigs were subjected to sodium butyrate (SB) supplementation via beverage water or water only [control (C)]. All pigs had blood sampled after 2 and 3 wk of treatment, and were subjected to a brain positron emission tomography after 3 wk. Animals were euthanized after 4 wk to sample pancreas, intestine, and brain for gut physiology and anatomy measurements, as well as hippocampal histology, Ki67, and doublecortin (DCX) immunohistochemistry. SB compared with C treatment triggered basal brain glucose metabolism changes in the nucleus accumbens and hippocampus (P = 0.003), increased hippocampal granular cell layer volume (P = 0.006), and neurogenesis (Ki67: P = 0.026; DCX: P = 0.029). After 2 wk of treatment, plasma levels of glucose, insulin, lactate, glucagon-like peptide 1, and peptide tyrosine tyrosine remained unchanged. After 3 wk, plasma levels of lactate were lower in SB compared with C animals (P = 0.028), with no difference for glucose and insulin. Butyrate intake impacted very little gut anatomy and function. These results demonstrate that oral SB impacted brain functions with little effects on the gut.	[Val-Laillet, David; Guerin, Sylvie; Coquery, Nicolas; Nogret, Isabelle; Formal, Michele; Rome, Veronique; Le Normand, Laurence; Meurice, Paul; Randuineau, Gwenaelle; Guilloteau, Paul; Lalles, Jean-Paul] UBL, Univ Rennes, INSERM, Nutr Metab & Canc NuMeCan,INRA, Rennes, France; [Val-Laillet, David; Parnet, Patricia; Lalles, Jean-Paul; Segain, Jean-Pierre] Ctr Rech Nutr Humaine Ouest CRNH Ouest, Nantes, France; [Malbert, Charles-Henri] INRA, Unite Serv Ani Scans 1395, St Gilles, France; [Parnet, Patricia; Segain, Jean-Pierre] Univ Nantes, INRA, Unite Mixte Rech UMR 1280, Physiol Adaptat Nutr PhAN, Nantes, France; [Parnet, Patricia; Segain, Jean-Pierre] Ctr Hosp Univ CHU Hotel Dieu, Inst Malad Appareil Digestif, Nantes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; INRAE; INRAE; Nantes Universite; Nantes Universite; CHU de Nantes	Val-Laillet, D (corresponding author), INRA, 1341 NuMeCan, F-35590 St Gilles, France.	david.val-laillet@inra.fr	Parnet, Patricia/GOH-1209-2022; coquery, nicolas/N-9206-2019; Parnet, Patricia/AAW-5064-2021; coquery, nicolas/GQP-5662-2022; VAL-LAILLET, David/AAH-6454-2021	coquery, nicolas/0000-0002-4687-5924; coquery, nicolas/0000-0002-4687-5924; Lalles, Jean-Paul/0000-0003-2732-5350; Malbert, Charles-Henri/0000-0002-0665-4545	Region Pays de la Loire	Region Pays de la Loire(Region Pays de la Loire)	The authors gratefully acknowledge the efforts and cooperation of the technical staff, and especially Alain Chauvin and Francis Legouevec (INRA, Unite Experimentale Porcs de Rennes, France) for participating in this study and taking care of the animals. This study was part of a research project (EPIMEMO, Impact of butyrate on the consolidation of memory processes), funded by Region Pays de la Loire and coordinated by J.-P.S. and P.P. The authors declare no conflicts of interest.	Arnal ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118092; Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Boubaker J, 2012, J NEUROENDOCRINOL, V24, P1096, DOI 10.1111/j.1365-2826.2012.02326.x; Bourassa MW, 2016, NEUROSCI LETT, V625, P56, DOI 10.1016/j.neulet.2016.02.009; Canfora EE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02546-x; Castanon N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00229; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Clouard C, 2014, J ANIM SCI, V92, P2133, DOI 10.2527/jas.2013-6809; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Clouard C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00861; Clouard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037968; Courchesne-Loyer A, 2017, J CEREBR BLOOD F MET, V37, P2485, DOI 10.1177/0271678X16669366; Dienel GA, 2001, J NEUROSCI RES, V66, P812, DOI 10.1002/jnr.10063; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gagliano H, 2014, NEUROPHARMACOLOGY, V79, P75, DOI 10.1016/j.neuropharm.2013.10.031; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; GJEDDE A, 1975, AM J PHYSIOL, V229, P1165, DOI 10.1152/ajplegacy.1975.229.5.1165; Gorka P, 2009, J PHYSIOL PHARMACOL, V60, P47; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; GUILLOTEAU P, 1981, REPROD NUTR DEV, V21, P885, DOI 10.1051/rnd:19810702; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Guilloteau P, 2009, J DAIRY SCI, V92, P1038, DOI 10.3168/jds.2008-1213; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Han A, 2014, NEUROPHARMACOLOGY, V81, P292, DOI 10.1016/j.neuropharm.2014.02.017; Khan S, 2016, CHEM-BIOL INTERACT, V254, P124, DOI 10.1016/j.cbi.2016.06.007; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; Lalles JP, 2006, BRIT J NUTR, V95, P488, DOI 10.1079/BJN20051673; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Mairesse J, 2015, PSYCHONEUROENDOCRINO, V62, P36, DOI 10.1016/j.psyneuen.2015.07.005; Manzanilla EG, 2006, J ANIM SCI, V84, P2743, DOI 10.2527/jas.2005-509; Marion J, 2003, J NUTR, V133, P362, DOI 10.1093/jn/133.2.362; Mazzoni M, 2008, J NUTR, V138, P1426, DOI 10.1093/jn/138.8.1426; Moretti M, 2011, BEHAV PHARMACOL, V22, P766, DOI 10.1097/FBP.0b013e32834d0f1b; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Paille V., 2014, J DEV ORIG HLTH DIS, V6, pS39; Partanen KH, 1999, NUTR RES REV, V12, P117, DOI 10.1079/095442299108728884; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; REDIES C, 1989, AM J PHYSIOL, V256, pE805, DOI 10.1152/ajpendo.1989.256.6.E805; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Sharma S, 2015, BEHAV BRAIN RES, V291, P306, DOI 10.1016/j.bbr.2015.05.052; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Valvassori SS, 2014, CURR NEUROVASC RES, V11, P359, DOI 10.2174/1567202611666140829162158; Vanhoutvin SALW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006759; Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516; Zabielski R, 1998, BRIT J NUTR, V79, P287, DOI 10.1079/BJN19980046; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542; Zhang YF, 2015, J NEUROCHEM, V132, P301, DOI 10.1111/jnc.12965; Zhang YF, 2013, J CEREBR BLOOD F MET, V33, P1307, DOI 10.1038/jcbfm.2013.87	60	39	39	3	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2160	2171		10.1096/fj.201700547RR	http://dx.doi.org/10.1096/fj.201700547RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242276	Green Submitted			2022-12-26	WOS:000429051400035
J	Derler, I; Butorac, C; Krizova, A; Stadlbauer, M; Muik, M; Fahrner, M; Frischauf, I; Romanin, C				Derler, Isabella; Butorac, Carmen; Krizova, Adela; Stadlbauer, Michael; Muik, Martin; Fahrner, Marc; Frischauf, Irene; Romanin, Christoph			Authentic CRAC channel activity requires STIM1 and the conserved portion of the Orai N terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); electrophysiology; signal transduction; stromal interaction molecule 1 (STIM1); calcium-dependent inactivation; sodium permeation	INTERACTION MOLECULE-1 STIM1; ACTIVATED CALCIUM CURRENT; STORE-OPERATED CHANNELS; CA2+ CHANNELS; TRANSMEMBRANE SEGMENT; ION SELECTIVITY; I-CRAC; INACTIVATION; MUTATIONS; PERMEATION	Calcium (Ca2+) is an essential second messenger required for diverse signaling processes in immune cells. Ca2+ release-activated Ca2+ (CRAC) channels represent one main Ca2+ entry pathway into the cell. They are fully reconstituted via two proteins, the stromal interaction molecule 1 (STIM1), a Ca2+ sensor in the endoplasmic reticulum, and the Ca2+ ion channel Orai in the plasma membrane. After Ca2+ store depletion, STIM1 and Orai couple to each other, allowing Ca2+ influx. CRAC-/STIM1-mediated Orai channel currents display characteristic hallmarks such as high Ca2+ selectivity, an increase in current density when switching from a Ca2+-containing solution to a divalent-free Na+ one, and fast Ca2+-dependent inactivation. Here, we discovered several constitutively active Orai1 and Orai3 mutants, containing substitutions in the TM3 and/or TM4 regions, all of which displayed a loss of the typical CRAC channel hallmarks. Restoring authentic CRAC channel activity required both the presence of STIM1 and the conserved Orai N-terminal portion. Similarly, these structural requisites were found in store-operated Orai channels. Key molecular determinants within the Orai N terminus that together with STIM1 maintained the typical CRAC channel hallmarks were distinct from those that controlled store-dependent Orai activation. In conclusion, the conserved portion of the Orai N terminus is essential for STIM1, as it fine-tunes the open Orai channel gating, thereby establishing authentic CRAC channel activity.	[Derler, Isabella; Butorac, Carmen; Krizova, Adela; Stadlbauer, Michael; Muik, Martin; Fahrner, Marc; Frischauf, Irene; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria	Johannes Kepler University Linz	Derler, I; Romanin, C (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	Isabella.derler@jku.at; christoph.romanin@jku.at	Hoeglinger, Carmen/AAF-9364-2021; Fahrner, Marc/AAI-7927-2021; Romanin, Christoph/D-5399-2009; Derler, Isabella/B-7871-2019; Frischauf, Irene/AAG-2007-2019	Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Frischauf, Irene/0000-0003-0661-2932; Fahrner, Marc/0000-0002-2689-0158; Hoglinger, Carmen/0000-0002-2754-592X; Tiffner, Adela/0000-0002-7529-4504	Austrian Science Fund (FWF) [P25210, P27641, P28123, P28498, P26067, P27263, W1250]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Science Fund (FWF) projects P25210 and P27641 (to I. D.), P28123 (to M. F.), P28498 (to M. M.), and P26067, P27263, and W1250 (to C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Bergsmann J, 2011, J BIOL CHEM, V286, P31565, DOI 10.1074/jbc.M111.227546; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bohm J, 2017, HUM MUTAT, V38, P426, DOI 10.1002/humu.23172; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Dynes JL, 2016, P NATL ACAD SCI USA, V113, P440, DOI 10.1073/pnas.1523410113; Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477; Fahrner M, 2018, J BIOL CHEM, V293, P1271, DOI 10.1074/jbc.M117.812693; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2013, CURR TOP MEMBR, V71, P237, DOI 10.1016/B978-0-12-407870-3.00010-X; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Mullins FM, 2016, J GEN PHYSIOL, V147, P153, DOI 10.1085/jgp.201511438; Mullins FM, 2016, J GEN PHYSIOL, V147, P137, DOI 10.1085/jgp.201511437; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; Palty R, 2016, J BIOL CHEM, V291, P334, DOI 10.1074/jbc.M115.685289; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3033, DOI 10.1113/jphysiol.2008.156885; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Srikanth S, 2011, J BIOL CHEM, V286, P35318, DOI 10.1074/jbc.M111.265884; Su ZC, 2004, BIOPHYS J, V86, P805, DOI 10.1016/S0006-3495(04)74156-9; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yamashita M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14512; Yen M, 2016, BIOPHYS J, V111, P1897, DOI 10.1016/j.bpj.2016.09.020; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13725; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	64	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1259	1270		10.1074/jbc.M117.812206	http://dx.doi.org/10.1074/jbc.M117.812206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29237734	hybrid, Green Published			2022-12-26	WOS:000423515000013
J	Blache, Y; Begon, M; Michaud, B; Desmoulins, L; Allard, P; Dal Maso, F				Blache, Yoann; Begon, Mickael; Michaud, Benjamin; Desmoulins, Landry; Allard, Paul; Dal Maso, Fabien			Muscle function in glenohumeral joint stability during lifting task	PLOS ONE			English	Article							ROTATOR CUFF TEARS; ELECTROMYOGRAPHIC ANALYSIS; MUSCULOSKELETAL MODEL; SHOULDER MUSCLES; UPPER EXTREMITY; BIOMECHANICAL MODEL; ACTIVATION; PARAMETERS; FORCE; STABILIZATION	Ensuring glenohumeral stability during repetitive lifting tasks is a key factor to reduce the risk of shoulder injuries. Nevertheless, the literature reveals some lack concerning the assessment of the muscles that ensure glenohumeral stability during specific lifting tasks. Therefore, the purpose of this study was to assess the stabilization function of shoulder muscles during a lifting task. Kinematics and muscle electromyograms (n = 9) were recorded from 13 healthy adults during a bi-manual lifting task performed from the hip to the shoulder level. A generic upper-limb OpenSim model was implemented to simulate glenohumeral stability and instability by performing static optimizations with and without glenohumeral stability constraints. This procedure enabled to compute the level of shoulder muscle activity and forces in the two conditions. Without the stability constraint, the simulated movement was unstable during 74%+/- 16% of the time. The force of the supraspinatus was significantly increased of 107% (p<0.002) when the glenohumeral stability constraint was implemented. The increased supraspinatus force led to greater compressive force (p<0.001) and smaller shear force (p<0.001), which contributed to improved glenohumeral stability. It was concluded that the supraspinatus may be the main contributor to glenohumeral stability during lifting task.	[Blache, Yoann] Univ Lyon 1, Lab Interuniv Biol Motricite, Lyon, France; [Begon, Mickael; Michaud, Benjamin; Desmoulins, Landry; Allard, Paul; Dal Maso, Fabien] Univ Montreal, Dept Kinesiol, Lab Simulat & Modelisat Mouvement, Montreal, PQ, Canada	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montreal	Blache, Y (corresponding author), Univ Lyon 1, Lab Interuniv Biol Motricite, Lyon, France.	yoann.blache@univ-lyon1.fr	Allard, Paul/ABA-3257-2021; Begon, Mickaël/AAH-9887-2019	Begon, Mickaël/0000-0002-4107-9160				Alpert SW, 2000, J SHOULDER ELB SURG, V9, P47, DOI 10.1016/S1058-2746(00)90009-0; Belaise C, 2017, MULTIBODY SYSTEM DYN; Blache Y, 2015, ERGONOMICS, V58, P748, DOI 10.1080/00140139.2014.980336; Blache Y, 2015, J ELECTROMYOGR KINES, V25, P355, DOI 10.1016/j.jelekin.2014.11.004; Blache Y, IEEE T BIOM IN PRESS; Blache Y, 2017, SPORT BIOMECH, V16, P127, DOI 10.1080/14763141.2016.1216585; Blana D, 2008, J BIOMECH, V41, P1714, DOI 10.1016/j.jbiomech.2008.03.001; Blasier RB, 1997, J BONE JOINT SURG AM, V79A, P433, DOI 10.2106/00004623-199703000-00018; Chadwick EK, 2009, IEEE T BIO-MED ENG, V56, P941, DOI 10.1109/TBME.2008.2005946; Dal Maso F, 2016, ARCH PHYS MED REHAB, V97, P1542, DOI 10.1016/j.apmr.2015.12.024; De Luca CJ, 2010, J BIOMECH, V43, P1573, DOI 10.1016/j.jbiomech.2010.01.027; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dickerson Clark R., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P389, DOI 10.1080/10255840701592727; ENGIN AE, 1986, J BIOMECH ENG-T ASME, V108, P222, DOI 10.1115/1.3138606; Escamilla RF, 2009, SPORTS MED, V39, P663, DOI 10.2165/00007256-200939080-00004; Halder AM, 2001, J BONE JOINT SURG AM, V83A, P1062, DOI 10.2106/00004623-200107000-00013; Hawkes DH, 2012, J ORTHOP RES, V30, P53, DOI 10.1002/jor.21482; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hess SA, 2000, MANUAL THER, V5, P63, DOI 10.1054/math.2000.0241; Heuberer P, 2015, ARCH ORTHOP TRAUM SU, V135, P549, DOI 10.1007/s00402-015-2180-3; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Huang L, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/305434; Jackson M, 2012, J BIOMECH, V45, P2180, DOI 10.1016/j.jbiomech.2012.05.042; Kelly BT, 2002, AM J SPORT MED, V30, P837, DOI 10.1177/03635465020300061401; KRONBERG M, 1990, CLIN ORTHOP RELAT R, P76; Labriola JE, 2005, J SHOULDER ELB SURG, V14, p32S, DOI 10.1016/j.jse.2004.09.014; LIPPITT S, 1993, CLIN ORTHOP RELAT R, P20; Ludewig PM, 2009, J BONE JOINT SURG AM, V91A, P378, DOI 10.2106/JBJS.G.01483; Merletti R., 1999, J ELECTROMYOGR KINES, V9, P3; Meskers CGM, 2004, CLIN BIOMECH, V19, P913, DOI 10.1016/j.clinbiomech.2004.05.012; Michaud B, 2016, DIG HUM MOD C MONTR, P26; Moriguchi CS, 2012, WORK, V41, P2492, DOI 10.3233/WOR-2012-0487-2492; Nielsen PK, 1998, APPL ERGON, V29, P445, DOI 10.1016/S0003-6870(98)00005-2; Nikooyan AA, 2010, J BIOMECH, V43, P3007, DOI 10.1016/j.jbiomech.2010.06.015; Nikooyan AA, 2011, MED BIOL ENG COMPUT, V49, P1425, DOI 10.1007/s11517-011-0839-7; Noguchi M, 2013, J ELECTROMYOGR KINES, V23, P1356, DOI 10.1016/j.jelekin.2013.08.007; Pagnani M J, 1994, J Shoulder Elbow Surg, V3, P173, DOI 10.1016/S1058-2746(09)80098-0; Sangwan S, 2015, DISABIL REHABIL, V37, P1033, DOI 10.3109/09638288.2014.949357; Soslowsky LJ, 1997, J SHOULDER ELB SURG, V6, P371, DOI 10.1016/S1058-2746(97)90005-7; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Steele Travis, 2013, International Journal of Human Factors Modelling and Simulation, V4, P1; Steenbrink F, 2006, MANUAL THER, V11, P231, DOI 10.1016/j.math.2006.07.004; Steenbrink F, 2009, J BIOMECH, V42, P1740, DOI 10.1016/j.jbiomech.2009.04.011; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; VANDERHELM FCT, 1994, J BIOMECH, V27, P551, DOI 10.1016/0021-9290(94)90065-5; Veeger HEJ, 2007, J BIOMECH, V40, P2119, DOI 10.1016/j.jbiomech.2006.10.016; Veeger HEJ, 1997, J BIOMECH, V30, P647, DOI 10.1016/S0021-9290(97)00011-0; Ward SR, 2006, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000194680.94882.d3; Wattanaprakornkul D, 2011, J SCI MED SPORT, V14, P376, DOI 10.1016/j.jsams.2011.01.001; Wieber PB, 2002, INT WORKSH HUM HUM F; Wilk KE, 1997, J ORTHOP SPORT PHYS, V25, P364, DOI 10.2519/jospt.1997.25.6.364; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yoon J, 2012, APPL ERGON, V43, P1044, DOI 10.1016/j.apergo.2012.03.004	54	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189406	10.1371/journal.pone.0189406	http://dx.doi.org/10.1371/journal.pone.0189406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244838	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700032
J	Funato, T; Sato, Y; Fujiki, S; Sato, Y; Aoi, S; Tsuchiya, K; Yanagihara, D				Funato, Tetsuro; Sato, Yota; Fujiki, Soichiro; Sato, Yamato; Aoi, Shinya; Tsuchiya, Kazuo; Yanagihara, Dai			Postural control during quiet bipedal standing in rats	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; SPINAL-CORD-INJURY; INVERTED PENDULUM; BODY SWAY; BONNET MACAQUES; LIGHT TOUCH; OPEN-LOOP; BALANCE; LOCOMOTION; MODEL	The control of bipedal posture in humans is subject to non- ideal conditions such as delayed sensation and heartbeat noise. However, the controller achieves a high level of functionality by utilizing body dynamics dexterously. In order to elucidate the neural mechanism responsible for postural control, the present study made use of an experimental setup involving rats because they have more accessible neural structures. The experimental design requires rats to stand bipedally in order to obtain a water reward placed in a water supplier above them. Their motions can be measured in detail using a motion capture system and a force plate. Rats have the ability to stand bipedally for long durations (over 200 s), allowing for the construction of an experimental environment in which the steady standing motion of rats could be measured. The characteristics of the measured motion were evaluated based on aspects of the rats' intersegmental coordination and power spectrum density (PSD). These characteristics were compared with those of the human bipedal posture. The intersegmental coordination of the standing rats included two components that were similar to that of standing humans: center of mass and trunk motion. The rats' PSD showed a peak at approximately 1.8 Hz and the pattern of the PSD under the peak frequency was similar to that of the human PSD. However, the frequencies were five times higher in rats than in humans. Based on the analysis of the rats' bipedal standing motion, there were some common characteristics between rat and human standing motions. Thus, using standing rats is expected to be a powerful tool to reveal the neural basis of postural control.	[Funato, Tetsuro; Sato, Yota] Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo, Japan; [Fujiki, Soichiro; Yanagihara, Dai] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Sato, Yamato] Chiba Inst Technol, Dept Gen Educ, Narashino, Chiba, Japan; [Aoi, Shinya; Tsuchiya, Kazuo] Kyoto Univ, Dept Aeronaut & Astronaut, Kyoto, Japan	University of Electro-Communications - Japan; University of Tokyo; Chiba Institute of Technology; Kyoto University	Funato, T (corresponding author), Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo, Japan.	funato@uec.ac.jp	Funato, Tetsuro/A-4619-2018	Funato, Tetsuro/0000-0003-2964-5227; Fujiki, Soichiro/0000-0002-3307-321X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26289063, 15KT0015, 26120006, 17H05904]; Grants-in-Aid for Scientific Research [17H05904, 15KT0015] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper was partially supported by a Grant-in-Aid for Scientific Research (B) (No. 26289063 and 15KT0015) and for Scientific Research on Innovative Areas (No. 26120006 and 17H05904) funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2014, GAIT POSTURE, V40, P435, DOI 10.1016/j.gaitpost.2014.05.013; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Babu RS, 2008, SYNAPSE, V62, P432, DOI 10.1002/syn.20513; Babu RS, 2007, MOTOR CONTROL, V11, P322, DOI 10.1123/mcj.11.4.322; Bailey A S, 2001, Spine (Phila Pa 1976), V26, pE308, DOI 10.1097/00007632-200107150-00006; Bakker M, 2006, EXP NEUROL, V202, P21, DOI 10.1016/j.expneurol.2006.05.008; BENSEL CK, 1968, PERCEPT PSYCHOPHYS, V4, P285, DOI 10.3758/BF03210516; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chagdes JR, 2013, J BIOMECH, V46, P2593, DOI 10.1016/j.jbiomech.2013.08.012; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Conforto S, 2001, GAIT POSTURE, V14, P28, DOI 10.1016/S0966-6362(01)00112-6; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Druelle F., 2014, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V26, P111, DOI 10.1007/s13219-014-0105-2; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Funato T, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150570; Funato T, 2015, EXP BRAIN RES, V233, P1421, DOI 10.1007/s00221-015-4216-x; Funato T, 2010, EXP BRAIN RES, V205, P497, DOI 10.1007/s00221-010-2385-1; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hutchinson D, 2007, NEUROSCIENCE, V148, P825, DOI 10.1016/j.neuroscience.2007.07.025; Insperger T, 2015, SIAM J APPL DYN SYST, V14, P1258, DOI 10.1137/140975632; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Jeka JJ, 1997, PHYS THER, V77, P476, DOI 10.1093/ptj/77.5.476; JENKINS FA, 1972, SCIENCE, V178, P877, DOI 10.1126/science.178.4063.877; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kouzaki M, 2008, EXP BRAIN RES, V188, P153, DOI 10.1007/s00221-008-1426-5; Kowalczyk P, 2012, J R SOC INTERFACE, V9, P234, DOI 10.1098/rsif.2011.0212; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Loram ID, 2006, J PHYSIOL-LONDON, V577, P417, DOI 10.1113/jphysiol.2006.118786; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; MAH CD, 1994, J MOTOR BEHAV, V26, P83, DOI 10.1080/00222895.1994.9941664; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; Masani K, 2006, GAIT POSTURE, V23, P164, DOI 10.1016/j.gaitpost.2005.01.006; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; MORAVEC SJ, 1987, AM J ANAT, V180, P357, DOI 10.1002/aja.1001800406; Mori F, 2004, PROG BRAIN RES, V143, P191, DOI 10.1016/S0079-6123(03)43019-7; Nakajima K, 2004, PROG BRAIN RES, V143, P183, DOI 10.1016/S0079-6123(03)43018-5; Nessler JA, 2005, IEEE T NEUR SYS REH, V13, P497, DOI 10.1109/TNSRE.2005.858432; Nudo RJ, 2003, ILAR J, V44, P161, DOI 10.1093/ilar.44.2.161; Ogihara N, 2012, J R SOC INTERFACE, V9, P2181, DOI 10.1098/rsif.2012.0026; Ogihara N, 2010, J HUM EVOL, V58, P252, DOI 10.1016/j.jhevol.2009.11.009; Parkkinen S, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/410972; Peterka RJ, 2000, BIOL CYBERN, V82, P335, DOI 10.1007/s004220050587; Peterka RJ, 2003, IEEE ENG MED BIOL, V22, P63, DOI 10.1109/MEMB.2003.1195698; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Philippens IH, 2008, DDT DIS MODELS, V5, P105, DOI DOI 10.1016/J.DDM0D.2008.06.004; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rode C, 2016, J EXP BIOL, V219, P485, DOI 10.1242/jeb.127910; Sawada Y, 1997, MED BIOL ENG COMPUT, V35, P318, DOI 10.1007/BF02534083; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schmitt D, 2003, J EXP BIOL, V206, P1437, DOI 10.1242/jeb.00279; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; van Vliet SAM, 2006, BEHAV PHARMACOL, V17, P453, DOI 10.1097/00008877-200609000-00011; Wada N, 2008, BRAIN RES, V1243, P70, DOI 10.1016/j.brainres.2008.09.034; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Zhou M, 2015, NEUROSCI LETT, V584, P184, DOI 10.1016/j.neulet.2014.10.032	69	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189248	10.1371/journal.pone.0189248	http://dx.doi.org/10.1371/journal.pone.0189248			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244818	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700024
J	Ott, E; Kawaguchi, Y; Kolbl, D; Chaturvedi, P; Nakagawa, K; Yamagishi, A; Weckwerth, W; Milojevic, T				Ott, Emanuel; Kawaguchi, Yuko; Koelbl, Denise; Chaturvedi, Palak; Nakagawa, Kazumichi; Yamagishi, Akihiko; Weckwerth, Wolfram; Milojevic, Tetyana			Proteometabolomic response of Deinococcus radiodurans exposed to UVC and vacuum conditions: Initial studies prior to the Tanpopo space mission	PLOS ONE			English	Article							BASE-CHANGE MUTATIONS; ESCHERICHIA-COLI; EXTREME RADIORESISTANCE; INTERPLANETARY TRANSFER; PROTEOMIC ANALYSIS; DNA-REPAIR; RADIATION; PROTEIN; GENE; RESISTANCE	The multiple extremes resistant bacterium Deinococcus radiodurans is able to withstand harsh conditions of simulated outer space environment. The Tanpopo orbital mission performs a long-term space exposure of D. radiodurans aiming to investigate the possibility of interplanetary transfer of life. The revealing of molecular machinery responsible for survivability of D. radiodurans in the outer space environment can improve our understanding of underlying stress response mechanisms. In this paper, we have evaluated the molecular response of D. radiodurans after the exposure to space-related conditions of UVC irradiation and vacuum. Notably, scanning electron microscopy investigations showed that neither morphology nor cellular integrity of irradiated cells was affected, while integrated proteomic and metabolomic analysis revealed numerous molecular alterations in metabolic and stress response pathways. Several molecular key mechanisms of D. radiodurans, including the tricarboxylic acid cycle, the DNA damage response systems, ROS scavenging systems and transcriptional regulators responded in order to cope with the stressful situation caused by UVC irradiation under vacuum conditions. These results reveal the effectiveness of the integrative proteometabolomic approach as a tool in molecular analysis of microbial stress response caused by space-related factors.	[Ott, Emanuel; Koelbl, Denise; Chaturvedi, Palak; Milojevic, Tetyana] Univ Vienna, Dept Biophys Chem, Vienna, Austria; [Kawaguchi, Yuko; Yamagishi, Akihiko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan; [Chaturvedi, Palak; Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria; [Nakagawa, Kazumichi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Weckwerth, Wolfram] Univ Vienna, Vienna Metabol Ctr VIME, Vienna, Austria	University of Vienna; Tokyo University of Pharmacy & Life Sciences; University of Vienna; Kobe University; University of Vienna	Milojevic, T (corresponding author), Univ Vienna, Dept Biophys Chem, Vienna, Austria.; Weckwerth, W (corresponding author), Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria.; Weckwerth, W (corresponding author), Univ Vienna, Vienna Metabol Ctr VIME, Vienna, Austria.	wolfram.weckwerth@univie.ac.at; tetyana.milojevic@univie.ac.at	Milojevic, Tetyana/AFW-4158-2022; Weckwerth, Wolfram/G-5811-2010; Chaturvedi, Palak/J-2324-2015	Milojevic, Tetyana/0000-0001-8415-1890; Chaturvedi, Palak/0000-0002-5856-0348; Yamagishi, Akihiko/0000-0001-5162-3927; Weckwerth, Wolfram/0000-0002-9719-6358	FFG (Osterreischiche Forschungsforderungsgesellschaft)	FFG (Osterreischiche Forschungsforderungsgesellschaft)	The study was conducted within the MOMEDOS (molecular mechanisms of Deinococcus radiodurans survivability in outer space) project, funded by the FFG (Osterreischiche Forschungsforderungsgesellschafthttps://www.ffg.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2005, MOL MICROBIOL, V58, P1381, DOI 10.1111/j.1365-2958.2005.04903.x; Anaganti N, 2015, PROTEOMICS, V15, P89, DOI 10.1002/pmic.201400113; Arrhenius S., 1903, UMSCHAU, V7, P481; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Bauermeister A, 2009, ARCH MICROBIOL, V191, P913, DOI 10.1007/s00203-009-0522-7; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Chaturvedi P, 2013, J PROTEOME RES, V12, P4892, DOI 10.1021/pr400197p; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; DAINTON FS, 1948, J PHYS COLLOID CHEM, V52, P490, DOI 10.1021/j150459a010; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Dedieu A, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-3; Espitia LD, 2002, MUTAT RES-FUND MOL M, V503, P77, DOI 10.1016/S0027-5107(02)00093-3; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Fowler RG, 1997, FEMS MICROBIOL REV, V21, P43, DOI 10.1111/j.1574-6976.1997.tb00344.x; Frosler J, 2017, ASTROBIOLOGY, V17, P431, DOI 10.1089/ast.2015.1431; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Goosen N, 2008, DNA REPAIR, V7, P353, DOI 10.1016/j.dnarep.2007.09.002; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Gupta P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160575; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; GUTMAN PD, 1994, MUTAT RES, V314, P87, DOI 10.1016/0921-8777(94)90064-7; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; He Y, 2009, J IND MICROBIOL BIOT, V36, P539, DOI 10.1007/s10295-008-0524-5; Horneck G, 2007, COMPLETE COURSE ASTR, Vxx; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Joshi B, 2004, BIOCHEM BIOPH RES CO, V320, P1112, DOI 10.1016/j.bbrc.2004.06.062; Kawaguchi Y, 2016, ASTROBIOLOGY, V16, P363, DOI 10.1089/ast.2015.1415; Kawaguchi Y, 2013, ORIGINS LIFE EVOL B, V43, P411, DOI 10.1007/s11084-013-9346-1; Krisko A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012765; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Li TZ, 2015, INT J ASTROBIOL, V14, P435, DOI 10.1017/S1473550415000038; Liu Y, 2003, P NATL ACAD SCI US, V100; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mastroleo F, 2013, MICROBIOL-SGM, V159, P2456, DOI 10.1099/mic.0.066415-0; Mastroleo F, 2009, ISME J, V3, P1402, DOI 10.1038/ismej.2009.74; Meadows JA, 2015, MICROBIOL-SGM, V161, P1161, DOI 10.1099/mic.0.000080; Mebrhatu MT, 2011, NUCLEIC ACIDS RES, V39, P5991, DOI 10.1093/nar/gkr219; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Moeller R, 2010, ARCH MICROBIOL, V192, P521, DOI 10.1007/s00203-010-0579-3; MOSELEY BEB, 1983, J GEN MICROBIOL, V129, P2437; MOSELEY BEB, 1967, J GEN MICROBIOL, V49, P293, DOI 10.1099/00221287-49-2-293; MOSELEY BEB, 1975, J BACTERIOL, V121, P422, DOI 10.1128/JB.121.2.422-428.1975; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Munakata N, 1997, MUTAT RES-GEN TOX EN, V390, P189, DOI 10.1016/S0165-1218(97)00020-7; Murray R. G. E., 1992, PROKARYOTES, V4, P3732, DOI DOI 10.1007/978-1-4757-2191-1_42; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Obiero J, 2010, J BACTERIOL, V192, P494, DOI 10.1128/JB.01046-09; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Pogoda de la Vega U, 2008, RESIDUAL RESTORATION; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Shimizu K, 2014, METABOLITES, V4, P1, DOI 10.3390/metabo4010001; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Soberon-Chavez G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00959; Sprenger GA., 2006, AMINO ACID BIOSYNTHE, P93, DOI DOI 10.1007/7171_; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tanaka M, 2005, J BACTERIOL, V187, P3693, DOI 10.1128/JB.187.11.3693-3697.2005; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Wang YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122071; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Xu ZJ, 2007, MICROBIOL-SGM, V153, P1642, DOI 10.1099/mic.0.2006/002857-0; Yamagishi A, 2014, T JSASS AEROSP TECH, V12; Yang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155010; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zhang H, 2014, DNA REPAIR, V21, P111, DOI 10.1016/j.dnarep.2014.04.012; Zhang XJ, 2015, ARCH MED RES, V46, P181, DOI 10.1016/j.arcmed.2015.03.007; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x; Zhang YM, 2000, APPL ENVIRON MICROB, V66, P105, DOI 10.1128/AEM.66.1.105-112.2000	79	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189381	10.1371/journal.pone.0189381	http://dx.doi.org/10.1371/journal.pone.0189381			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244852	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700029
J	Schubert, MM; Palumbo, E; Seay, RF; Spain, KK; Clarke, HE				Schubert, Matthew M.; Palumbo, Elyse; Seay, Rebekah F.; Spain, Katie K.; Clarke, Holly E.			Energy compensation after sprint-and high-intensity interval training	PLOS ONE			English	Article							RESTING METABOLIC-RATE; WEIGHT-LOSS; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; FITNESS; TRIAL; IMPACT; MEN	Background Many individuals lose less weight than expected in response to exercise interventions when considering the increased energy expenditure of exercise (ExEE). This is due to energy compensation in response to ExEE, which may include increases in energy intake (EI) and decreases in non-exercise physical activity (NEPA). We examined the degree of energy compensation in healthy young men and women in response to interval training. Methods Data were examined from a prior study in which 24 participants (mean age, BMI, & VO(2)max = 28 yrs, 27.7 kg.m(-2), and 32 mL. kg(-1).min(-1)) completed either 4 weeks of sprint-interval training or high-intensity interval training. Energy compensation was calculated from changes in body composition (air displacement plethysmography) and exercise energy expenditure was calculated from mean heart rate based on the heart rate-VO2 relationship. Differences between high (>= 100%) and low (< 100%) levels of energy compensation were assessed. Linear regressions were utilized to determine associations between energy compensation and Delta VO(2)max, Delta EI, Delta NEPA, and Delta resting metabolic rate. Results Very large individual differences in energy compensation were noted. In comparison to individuals with low levels of compensation, individuals with high levels of energy compensation gained fat mass, lost fat-free mass, and had lower change scores for VO(2)max and NEPA. Linear regression results indicated that lower levels of energy compensation were associated with increases in Delta VO(2)max (p < 0.001) and Delta NEPA (p < 0.001). Conclusions Considerable variation exists in response to short-term, low dose interval training. In agreement with prior work, increases in Delta VO(2)max and Delta NEPA were associated with lower energy compensation. Future studies should focus on identifying if a dose-response relationship for energy compensation exists in response to interval training, and what underlying mechanisms and participant traits contribute to the large variation between individuals.	[Schubert, Matthew M.; Palumbo, Elyse] Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92096 USA; [Schubert, Matthew M.; Seay, Rebekah F.; Spain, Katie K.; Clarke, Holly E.] Auburn Univ, Dept Kinesiol, Montgomery, AL 36117 USA; [Seay, Rebekah F.] Univ Kentucky, Dept Kinesiol & Hlth Promot, Lexington, KY USA; [Spain, Katie K.] Edward Via Coll Osteopath Med, Auburn Campus, Auburn, AL USA; [Clarke, Holly E.] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA	California State University System; California State University San Marcos; Auburn University System; Auburn University; University of Kentucky; State University System of Florida; Florida State University	Schubert, MM (corresponding author), Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92096 USA.; Schubert, MM (corresponding author), Auburn Univ, Dept Kinesiol, Montgomery, AL 36117 USA.	mschubert@csusm.edu	; Schubert, Matthew/A-9799-2017	Clarke, Holly/0000-0002-3276-596X; Schubert, Matthew/0000-0002-0994-8805				Astorino TA, 2013, MED SCI SPORT EXER, V45, P1878, DOI 10.1249/MSS.0b013e3182936261; Atkinson G, 2015, EXP PHYSIOL, V100, P577, DOI 10.1113/EP085070; Beaulieu K, 2016, SPORTS MED, V46, P1897, DOI 10.1007/s40279-016-0518-9; BOUCHARD C, 1990, INT J OBESITY, V14, P57; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Brooks GA, 2005, EXERCISE PHYSL HUMAN, V4th; Church TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004515; Donnelly JE, 2013, OBESITY, V21, pE219, DOI 10.1002/oby.20145; Dugas LR, 2005, MED SCI SPORT EXER, V37, P2154, DOI 10.1249/01.mss.0000177742.12931.50; Earnest CP, 2013, INT J SPORTS MED, V34, P355, DOI 10.1055/s-0032-1311594; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gillen JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154075; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Hall KD, 2013, OBESITY, V21, P957, DOI 10.1002/oby.20065; Hecksteden A, 1985, J APPL PHYSL 1985, V118, P1450, DOI DOI 10.1152/JAPPLPHYSI0L.00714.2014; Herrmann SD, 2015, OBESITY, V23, P1539, DOI 10.1002/oby.21073; HILL DW, 1992, RES Q EXERCISE SPORT, V63, P85, DOI 10.1080/02701367.1992.10607561; Kelly B, 2013, EUR J APPL PHYSIOL, V113, P3039, DOI 10.1007/s00421-013-2741-5; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; Martins C, 2016, INT J SPORT NUTR EXE, V26, P197, DOI 10.1123/ijsnem.2015-0078; MAYER J, 1956, AM J CLIN NUTR, V4, P169, DOI 10.1093/ajcn/4.2.169; McNeil J, 2017, INT J OBESITY, V41, P1196, DOI 10.1038/ijo.2017.87; Melanson EL, 2013, MED SCI SPORT EXER, V45, P1600, DOI 10.1249/MSS.0b013e31828ba942; Riou ME, 2015, NUTRIENTS, V7, P3677, DOI 10.3390/nu7053677; Rosenkilde M, 2012, AM J PHYSIOL-REG I, V303, pR571, DOI 10.1152/ajpregu.00141.2012; Schubert MM, 2017, APPL PHYSIOL NUTR ME, V42, P1073, DOI 10.1139/apnm-2017-0268; Shook RP, 2015, AM J CLIN NUTR, V102, P1332, DOI 10.3945/ajcn.115.115360; Smith J C, 1991, Br J Sports Med, V25, P196; Thomas DM, 2012, OBES REV, V13, P835, DOI 10.1111/j.1467-789X.2012.01012.x; TREMBLAY A, 1990, INT J OBESITY, V14, P75; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Williamson PJ, 2017, SPORTS MED, V47, P1501, DOI 10.1007/s40279-017-0680-8	34	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189590	10.1371/journal.pone.0189590	http://dx.doi.org/10.1371/journal.pone.0189590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244836	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700041
J	Hase, K; Kanda, A; Hirose, L; Noda, K; Ishida, S				Hase, Keitaro; Kanda, Atsuhiro; Hirose, Lkuyo; Noda, Kousuke; Ishida, Susumu			Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy	PLOS ONE			English	Article							INDUCED RETINAL INFLAMMATION; ENDOTHELIAL GROWTH-FACTOR; MACULAR EDEMA; MONOCYTIC CELLS; COMPLICATIONS; ANGIOTENSIN; ANGIOGENESIS; PROGRESSION; ACTIVATION; INFLIXIMAB	(Pro)renin receptor [(P)RR], a new component of the tissue renin-angiotensin system (RAS), plays a crucial role in inflammation and angiogenesis in the eye, thus contributing to the development of proliferative diabetic retinopathy (PDR). In this study, we investigated systemic factors related to plasma levels of soluble form of (P) RR [s(P) RR] in patients with PDR. Twenty type II diabetic patients with PDR and 20 age-matched, non-diabetic patients with idiopathic macular diseases were enrolled, and plasma levels of various molecules were measured by enzyme-linked immunosorbent assays. Human retinal microvascular endothelial cells were stimulated with several diabetes-related conditions to evaluate changes in gene expression using real-time quantitative PCR. Of various systemic parameters examined, the PDR patients had significantly higher blood sugar and serum creatinine levels than non-diabetic controls. Protein levels of s(P) RR, prorenin, tumor necrosis factor (TNF)-alpha, complement factor D (CFD), and leucine-rich alpha-2-glycoprotein 1 (LRG1) significantly increased in the plasma of PDR subjects as compared to non-diabetes, with positive correlations detected between s(P)RR and these inflammatory molecules but not prorenin. Estimated glomerular filtration rate and serum creatinine were also correlated with plasma s (P)RR, but not prorenin, levels. Among the inflammatory molecules correlated with s(P)RR in the plasma, TNF-alpha, but not CFD or LRG1, application to retinal endothelial cells upregulated the mRNA expression of (P)RR but not prorenin, while stimulation with high glucose enhanced both (P)RR and prorenin expression. These findings suggested close relationships between plasma s(P)RR and diabetes-induced factors including chronic inflammation, renal dysfunction, and hyperglycemia in patients with PDR.	[Kanda, Atsuhiro] Hokkaido Univ, Fac Med, Dept Ophthalmol, Lab Ocular Cell Biol & Visual Sci, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kanda, A (corresponding author), Hokkaido Univ, Fac Med, Dept Ophthalmol, Lab Ocular Cell Biol & Visual Sci, Sapporo, Hokkaido, Japan.	kanda@med.hokudai.ac.jp		Kanda, Atsuhiro/0000-0001-7192-9974	Takeda Science Foundation; Institute of Science of Blood Pressure and Hormone; Ministry of Education, Science and Culture of Japan [16K11279, 16H05484]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute of Science of Blood Pressure and Hormone; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Takeda Science Foundation (to A.K.), Institute of Science of Blood Pressure and Hormone (to A.K.), and a grant-in-aid from the Ministry of Education, Science and Culture of Japan (A.K. #16K11279, S.I. #16H05484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158068; Biswas KB, 2011, HYPERTENS RES, V34, P735, DOI 10.1038/hr.2011.26; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Costantini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039486; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Doganay S, 2002, EYE, V16, P163, DOI 10.1038/sj.eye.6700095; El-Asrar A M, 2001, Int Ophthalmol, V24, P1, DOI 10.1023/A:1014409829614; Flyvbjerg A, 2010, NAT REV ENDOCRINOL, V6, P94, DOI 10.1038/nrendo.2009.266; Fujimoto M, 2015, ARTHRITIS RHEUMATOL, V67, P2056, DOI 10.1002/art.39164; Fujita T, 2013, DIABETES-METAB RES, V29, P220, DOI 10.1002/dmrr.2380; Fukushima A, 2013, INT J CARDIOL, V168, P4313, DOI 10.1016/j.ijcard.2013.04.176; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Graves DT, 2008, FRONT BIOSCI-LANDMRK, V13, P1227, DOI 10.2741/2757; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Hamada K, 2013, CLIN EXP NEPHROL, V17, P848, DOI 10.1007/s10157-013-0803-y; Honda H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162672; Huang JQ, 2009, ENDOCRINOLOGY, V150, P5557, DOI 10.1210/en.2009-0442; Inafuku S, 2015, INVEST OPHTH VIS SCI, V56, P5316, DOI 10.1167/iovs.15-16747; International Diabetes Federation IDF, 2015, IDF ATL; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Kanda A, 2012, DIABETOLOGIA, V55, P3104, DOI 10.1007/s00125-012-2702-2; Kanda A, 2013, BRIT J OPHTHALMOL, V97, P666, DOI 10.1136/bjophthalmol-2012-302680; Li CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089233; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Man REK, 2015, INVEST OPHTH VIS SCI, V56, P4810, DOI 10.1167/iovs.15-16987; Matavelli LC, 2010, CLIN EXP PHARMACOL P, V37, P277, DOI 10.1111/j.1440-1681.2009.05292.x; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; MOLITCH ME, 1993, KIDNEY INT, V43, P668, DOI 10.1038/ki.1993.96; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Ohashi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156165; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; Parving HH, 2005, QJM-INT J MED, V98, P119, DOI 10.1093/qjmed/hci017; Satofuka S, 2009, DIABETES, V58, P1625, DOI 10.2337/db08-0254; Sfikakis PP, 2010, DIABETES CARE, V33, P1523, DOI 10.2337/dc09-2372; Sfikakis PP, 2005, DIABETES CARE, V28, P445, DOI 10.2337/diacare.28.2.445; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shinzaki S, 2017, J CROHNS COLITIS, V11, P84, DOI 10.1093/ecco-jcc/jjw132; Takahashi K, 2010, PEPTIDES, V31, P1405, DOI 10.1016/j.peptides.2010.04.003; Tan P, 2014, OBESITY, V22, P2201, DOI 10.1002/oby.20844; Thomason J, 2015, AM J HYPERTENS, V28, P1277, DOI 10.1093/ajh/hpv019; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418; Wilkinson-Berka JL, 2006, INT J BIOCHEM CELL B, V38, P752, DOI 10.1016/j.biocel.2005.08.002; Wu L, 2011, RETINA-J RET VIT DIS, V31, P298, DOI 10.1097/IAE.0b013e3181eac7a6; Yoshikawa N, 2013, J DIABETES COMPLICAT, V27, P162, DOI 10.1016/j.jdiacomp.2012.09.001; Zhang JJ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0306-2	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189696	10.1371/journal.pone.0189696	http://dx.doi.org/10.1371/journal.pone.0189696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240802	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600065
J	Lee, CH; Chang, FC; Hsu, SD; Chi, HY; Huang, LJ; Yeh, MK				Lee, Chun-Hsien; Chang, Fong-Ching; Hsu, Sheng-Der; Chi, Hsueh-Yun; Huang, Li-Jung; Yeh, Ming-Kung			Inappropriate self-medication among adolescents and its association with lower medication literacy and substance use	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; OF-THE-LITERATURE; HEALTH-LITERACY; MEDICINE USE; RISK BEHAVIOR; PRESCRIPTION MEDICATIONS; DRUG-USE; POPULATION; CHILDREN; TAIWAN	Background While self-medication is common, inappropriate self-medication has potential risks. This study assesses inappropriate self-medication among adolescents and examines the relationships among medication literacy, substance use, and inappropriate selfmedication. Method In 2016, a national representative sample of 6,226 students from 99 primary, middle, and high schools completed an online self-administered questionnaire. Multiple logistic regression analysis was used to examine factors related to inappropriate self-medication. Results The prevalence of self-medication in the past year among the adolescents surveyed was 45.8%, and the most frequently reported drugs for self-medication included nonsteroidal anti-inflammatory drugs or pain relievers (prevalence = 31.1%), cold or cough medicines (prevalence = 21.6%), analgesics (prevalence = 19.3%), and antacids (prevalence = 17.3%). Of the participants who practiced self-medication, the prevalence of inappropriate self-medication behaviors included not reading drug labels or instructions (10.1%), using excessive dosages (21.6%), and using prescription and nonprescription medicine simultaneously without advice from a health provider (polypharmacy) (30.3%). The results of multiple logistic regression analysis showed that after controlling for school level, gender, and chronic diseases, the participants with lower medication knowledge, lower self-efficacy, lower medication literacy, and who consumed tobacco or alcohol were more likely to engage in inappropriate self-medication. Conclusion Lower medication literacy and substance use were associated with inappropriate self-medication among adolescents.	[Lee, Chun-Hsien; Chang, Fong-Ching] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Lee, Chun-Hsien] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pharm Practice, Taipei, Taiwan; [Hsu, Sheng-Der] Triserv Gen Hosp, Natl Def Med Ctr, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chi, Hsueh-Yun] Kainan Univ, Dept Hlth Developing & Mkt, Taoyuan, Taiwan; [Huang, Li-Jung] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Ming-Kung] Minist Hlth & Welf, Taipei, Taiwan	National Taiwan Normal University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Nan Kai University Technology; Chia Nan University of Pharmacy & Science	Chang, FC (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	fongchingchang@ntnu.edu.tw		Hsu, Sheng-Der/0000-0001-9698-8954; Lee, Chun-Hsien/0000-0002-6404-9167	Food and Drug Administration, Ministry of Health and Welfare, Taiwan [105-TFDA-D-061]	Food and Drug Administration, Ministry of Health and Welfare, Taiwan	This work was supported by a research grant from the Food and Drug Administration, Ministry of Health and Welfare, Taiwan (105-TFDA-D-061 to FCC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahussain E, 2005, MED PRIN PRACT, V14, P161, DOI 10.1159/000084633; Abahussain NA, 2007, SAUDI MED J, V28, P1723; Abuse S, 2008, NSDUH REPORT MISUSE; Andersen A, 2006, J ADOLESCENT HEALTH, V39, P362, DOI 10.1016/j.jadohealth.2005.12.023; [Anonymous], 1997, AM J HEALTH-SYST PH, V54, P2664; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bostock S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1602; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Carrasco-Garrido P, 2008, PHARMACOEPIDEM DR S, V17, P193, DOI 10.1002/pds.1455; Chang FC, 2015, J AM PHARM ASSOC, V55, P595, DOI 10.1331/JAPhA.2015.15053; Chi HY, 2014, J FOOD DRUG ANAL, V22, P271, DOI 10.1016/j.jfda.2013.09.013; Chi HY, 2012, J FOOD DRUG ANAL, V20, P561, DOI 10.6227/jfda.2012200301; Choo T, 2008, J DRUG ISSUES, V38, P467, DOI 10.1177/002204260803800205; Cooper RJ, 2013, J SUBST USE, V18, P82, DOI 10.3109/14659891.2011.615002; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; Furu Kari, 2005, Tidsskr Nor Laegeforen, V125, P2759; Gualano MR, 2015, EUR J PUBLIC HEALTH, V25, P444, DOI 10.1093/eurpub/cku207; Hameen-Anttila K, 2010, PHARMACOEPIDEM DR S, V19, P400, DOI 10.1002/pds.1887; Hansen EH, 2003, ANN PHARMACOTHER, V37, P361, DOI 10.1345/aph.1C111; Harris Interactive, 2002, ATTITUDES BELIEFS US; Hsiao YY, 2013, INT J QUAL HEALTH C, V25, P232, DOI 10.1093/intqhc/mzt029; Hughes CM, 2001, DRUG SAFETY, V24, P1027, DOI 10.2165/00002018-200124140-00002; Hughes GF, 2000, DRUG ABUSE MISUSE CO; Italia S, 2015, PHARMACOEPIDEM DR S, V24, P1133, DOI 10.1002/pds.3829; Kamran A, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.161264; Kanjanarat P, 2003, AM J HEALTH-SYST PH, V60, P1750, DOI 10.1093/ajhp/60.17.1750; Kirsch I, 1993, ADULT LITERACY AM 1; Kiyingi K, 1992, DRUGS HOME DANGER WA; Kuzman Marina, 2016, Psychiatr Danub, V28 Suppl 2, P223; Lam A, 2006, J AM PHARM ASSOC, V46, P574, DOI 10.1331/1544-3191.46.5.574.Lam; Lee SYD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-614; Liu C-H, 2016, GLOBAL HLTH PROMOTIO; Lukovic JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114644; MacArthur GJ, 2012, J PUBLIC HEALTH-UK, V34, pI20, DOI 10.1093/pubmed/fds006; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; McCabe SE, 2012, J ADOLESCENT HEALTH, V51, P445, DOI 10.1016/j.jadohealth.2012.02.004; Montagne M, 2013, RES SOC ADMIN PHARM, V9, P609, DOI 10.1016/j.sapharm.2013.04.003; Montastruc JL, 1997, THERAPIE, V52, P105; Ngoh LN, 2009, J AM PHARM ASSOC, V49, pE132, DOI 10.1331/JAPhA.2009.07075; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nydert P, 2011, EUR J PEDIATR, V170, P583, DOI 10.1007/s00431-010-1321-5; Saengcharoen W, 2016, INT J PHARM PRACT, V24, P22, DOI 10.1111/ijpp.12201; Sauceda JA, 2012, J AM PHARM ASSOC, V52, pE231, DOI 10.1331/JAPhA.2012.11264; Schabitz WR, 2001, EUR J ANAESTH, V18, P763, DOI 10.1046/j.1365-2346.2001.00913.x; Shehnaz SI, 2014, J ADOLESCENT HEALTH, V55, P467, DOI 10.1016/j.jadohealth.2014.07.001; Shehnaz Syed Ilyas, 2014, Int J Adolesc Med Health, V26, P423, DOI 10.1515/ijamh-2013-0315; Sihvo S, 2000, FAM PRACT, V17, P145, DOI 10.1093/fampra/17.2.145; Steinman KJ, 2006, J ADOLESCENT HEALTH, V38, P445, DOI 10.1016/j.jadohealth.2005.08.010; Stevenson R, 2001, SCOT MED J, V46, P84, DOI 10.1177/003693300104600307; THEO RAYNOR D, 2008, MEDICATION USE INNER; Tobi H, 2003, PHARM WORLD SCI, V25, P203, DOI 10.1023/A:1025836704150; Wazaify M, 2005, FAM PRACT, V22, P170, DOI 10.1093/fampra/cmh723; Weiss B., 1999, 20 COMMON PROBLEMS P; Wood DM, 2010, EMERG MED J, V27, P829, DOI 10.1136/emj.2009.085027; World Health Organization, 2000, REG GUID TEL PROD; Yin HS, 2010, ARCH PEDIAT ADOL MED, V164, P181, DOI 10.1001/archpediatrics.2009.269; Ylinen S, 2010, PHARMACOEPIDEM DR S, V19, P1000, DOI 10.1002/pds.1963; Yousef AMM, 2008, PHARM WORLD SCI, V30, P24, DOI 10.1007/s11096-007-9135-x; Zhong ZQ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070720	62	36	36	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189199	10.1371/journal.pone.0189199	http://dx.doi.org/10.1371/journal.pone.0189199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240799	gold, Green Published, Green Submitted			2022-12-26	WOS:000417905600020
J	Mishra, BP; Kumar, R; Mohan, A; Gill, KS				Mishra, Bhavya Priyadarshini; Kumar, Rajeev; Mohan, Amita; Gill, Kulvinder S.			Conservation and divergence of Starch Synthase III genes of monocots and dicots	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MAIZE ENDOSPERM; ENZYMES; DOMAIN; GRANULE; MUTANTS	Starch Synthase (SS) plays an important role in extending the alpha-1,4 glucan chains during starch biosynthesis by catalyzing the transfer of the glucosyl moiety from ADP-glucose to the non-reducing end of a pre-existing glucan chain. SS has five distinct isoforms of which SSIII is involved in the formation of longer glucan chain length. Here we report identification and detailed characterization of ` true' orthologs of the well-characterized maize SSIII (ZmSSIII), among six monocots and two dicot species. ZmSSIII orthologs have nucleotide sequence similarity ranging from 56 +/- 81%. Variation in gene size among various orthologs ranged from 5.49 kb in Arabidopsis to 11.62 kb in Brachypodium and the variation was mainly due to intron size and indels present in the exons 1 and 3. Number of exons and introns were highly conserved among all orthologs however. While the intron number was conserved, intron phase showed variation at group, genera and species level except for intron 1 and 5. Several species, genera, and class specific cis-acting regulatory elements were identified in the promoter region. The predicted protein size of the SSIII orthologs ranged from 1094 amino acid (aa) in Arabidopsis to 1688 aa in Brachypodium with sequence identity ranging from 60%-89%. The N-terminal region of the protein was highly variable whereas the C-terminal region containing the Glycosyltransferase domain was conserved with > 80% sequence similarity among the orthologs. In addition to confirming the known motifs, eleven novel motifs possibly providing species, genera and group specific functions, were identified in the three carbohydrate binding domains. Despite of significant sequence variation among orthologs, most of the motifs and their relative distances are highly conserved among the orthologs. The 3-D structure of catalytic region of SSIII orthologs superimposed with higher confidence confirming the presence of similar binding sites with five unidentified conserved regions in the catalytic (glycosyltransferase) domain including the pockets involved in catalysis and binding of ligands. Homeologs of wheat SSIII gene showed tissue and developmental stage specific expression pattern with the highest expression recorded in developing grains.	[Mishra, Bhavya Priyadarshini; Kumar, Rajeev] Dr Rajendra Prasad Cent Agr Univ, Dept Agr Biotechnol & Mol Biol, Pusa, Bihar, India; [Mohan, Amita; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Washington State University	Gill, KS (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ksgill@wsu.edu	Kumar, Rajeev/AAM-9314-2020	Kumar, Rajeev/0000-0002-6051-0059; Gill, Kulvinder S/0000-0001-7370-6184	United States Agency for International Development; Feed the Future Innovation Lab-Climate Resilient Wheat [AID-OAA-A-13-00008]	United States Agency for International Development(United States Agency for International Development (USAID)); Feed the Future Innovation Lab-Climate Resilient Wheat	The work was supported by United States Agency for International Development; Feed the Future Innovation Lab-Climate Resilient Wheat (Grant number AID-OAA-A-13-00008).	Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Busi MV, 2008, PROTEINS, V70, P31, DOI 10.1002/prot.21469; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Dhaliwal AK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00657; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Gao M, 1998, PLANT CELL, V10, P399, DOI 10.1105/tpc.10.3.399; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Huang B, 2016, ARCH BIOCHEM BIOPHYS, V16, P30051; Huang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27590; Jenner CF, 1993, J PLANT PHYSL, V22, P703; KEELING PL, 1993, PLANTA, V191, P342, DOI 10.1007/BF00195691; Li Z, PLANT PHYSL, V123, P613; Lin QH, 2012, PLANT PHYSIOL, V158, P679, DOI 10.1104/pp.111.189704; MARTIN C, 1995, PLANT CELL, V7, P971, DOI 10.1105/tpc.7.7.971; Morell MK, 2003, PLANT J, V34, P172, DOI 10.1046/j.1365-313X.2003.01712.x; NELSON O, 1995, ANNU REV PLANT PHYS, V46, P475, DOI 10.1146/annurev.pp.46.060195.002355; Palopoli N, 2006, PROTEINS, V65, P27, DOI 10.1002/prot.21007; Prakash Pravin, 2004, Indian Journal of Experimental Biology, V42, P227; PREISS J, 1979, MECH POLYSACCHARIDE, P161; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; SINGLETARY GW, 1994, AUST J PLANT PHYSIOL, V21, P829, DOI 10.1071/PP9940829; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Sreenivasulu N, 2015, J EXP BOT, V66, P1737, DOI 10.1093/jxb/eru544; Tetlow I, 2006, PLANT PHYSIOL, V146, P1878; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wayllace NZ, 2010, FEBS J, V277, P428, DOI 10.1111/j.1742-4658.2009.07495.x; Wu JD, 2015, GENET MOL RES, V14, P5468, DOI 10.4238/2015.May.22.17; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319	32	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189303	10.1371/journal.pone.0189303	http://dx.doi.org/10.1371/journal.pone.0189303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240782	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600027
J	Stefanelli, P; Vescio, MF; Landini, MP; Dal Conte, I; Matteelli, A; Cristaudo, A; Gaino, M; Cusini, M; Barbui, AM; Mencacci, A; De Nittis, R; Ghisetti, V; Stroppiana, E; Carannante, A				Stefanelli, Paola; Vescio, Maria Fenicia; Landini, Maria Paola; Dal Conte, Ivano; Matteelli, Alberto; Cristaudo, Antonio; Gaino, Marina; Cusini, Marco; Barbui, Anna Maria; Mencacci, Antonella; De Nittis, Rosella; Ghisetti, Valeria; Stroppiana, Elena; Carannante, Anna		Neisseria Gonorrhoeae	Time trend analysis (2009-2016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy	PLOS ONE			English	Article							HIGH-LEVEL RESISTANCE; DETAILED CHARACTERIZATION; AZITHROMYCIN RESISTANCE; TREATMENT FAILURE; CEFIXIME; CEPHALOSPORINS; GUIDELINE; DIAGNOSIS; STRAIN	Introduction Neisseria gonorrhoeae (NG) antimicrobial susceptibility trends to azithromycin, cefixime and ceftriaxone were analyzed, from 2009 to 2016, to monitor changing antimicrobial susceptibility concomitant with the change in prescribing practice in 2012 from cefixime, or ceftriaxone, to ceftriaxone plus azithromycin. Patient characteristics predictive to be infected by antibiotic resistant N. gonorrhoeae were estimated. Finally, the protocol for the treatment of gonorrhoea, in comparison with the international guidelines, was also evaluated. Materials and methods Data on NG antimicrobial resistance were obtained from a network of sexually transmitted diseases clinics and other laboratories in 12 cities in Italy. We tested the 1,433 gonococci for antimicrobial susceptibility to azithromycin, cefixime and ceftriaxone using a gradient diffusion method. Logistic-regression methods with cluster robust standard errors were used to investigate the association of resistance categories with demographic and clinical patient characteristics and to assess changes in prescribing practices. To minimize bias due to missing data, all statistical models were fitted to data with forty rounds of multiple imputation, using chained equations Results The percentage of isolates resistant to cefixime was 17.10% in 2009 and declined up to 1.39% in 2016; at the same time, those resistant to azithromycin was 23.68% in 2009 and 3.00% in 2012.Starting from 2013, azithromycin resistant gonococci tended to increase up to 7.44% in 2016.No ceftriaxone resistant isolates were observed.By multivariate analysis, the men who have sex with women (MSW) and women had a proportional adjusted OR of resistance of 1.25 (95% CI: 0.90; 1.73) and 1.67 (95% CI: 1.16; 2.40), respectively, in comparison with men who have sex with men (MSM).An aOR of resistance of 0.48 (95% CI: 0.21; 1.12) among NG isolated in the pharynx, compared with those isolated in genital sites, was calculated.The proportional aOR of resistance was 0.58 (95% CI: 0.38; 0.89) for presence vs absence of co-infection and 2.00 (95% CI: 1.36; 2.96) for past history vs no history of gonorrhoea.Finally, at least for the period 2013 +/- 2016, the older, subjects with anorectal or pharyngeal gonorrhoea infection, subjects with a co-infection, subjects with a previous gonorrhoea infection were not always correctly treated. Conclusions Overall, our findings suggest the shifts in N.gonorrhoeae susceptibility to cefixime and azithromycin in the time frame period.First of all, the increasing rate of azithromycin resistance in 2015 +/- 2016 in NG isolated in the country need to be monitor in the future.Finally, extensive information on treatment regimens may be useful to asses treatment adherence particularly for the older subjects, subjects with an anorectal or pharyngeal infection, subjects with a co-infection and subjects with a previous history of gonorrhoea.Gonorrhoea treatment strategy should be based on the evidence obtained by the local antimicrobial surveillance system and data about treatment failures.	[Stefanelli, Paola; Vescio, Maria Fenicia; Carannante, Anna] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Vescio, Maria Fenicia] Univ Hosp S Orsola Malpighi, Unit Clin Microbiol, Bologna, Italy; [Dal Conte, Ivano] Amedeo Savoia Hosp, STI Clin, Dept Infect Dis, Turin, Italy; [Matteelli, Alberto] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy; [Cristaudo, Antonio] IRCCS, San Gallicano Dermatol Inst, Rome, Italy; [Gaino, Marina] Santa Chiara Hosp, Microbiol & Virol Lab, Trento, Italy; [Cusini, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy; [Barbui, Anna Maria] Molinette Mauriziano Hosp, Microbiol & Virol Lab, Turin, Italy; [Mencacci, Antonella] Univ Perugia, Dept Med, Med Microbiol Sect, Perugia, Italy; [De Nittis, Rosella] Azienda Osped Univ OORR, Dept Clin Pathol, Foggia, Italy; [Ghisetti, Valeria] Amedeo Savoia Hosp, Lab Microbiol & Virol, Turin, Italy; [Stroppiana, Elena] AOU Citta Salute & Sci, Dermatol Clin, Turin, Italy	Istituto Superiore di Sanita (ISS); IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Brescia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Santa Chiara Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Perugia; A.O.U. Citta della Salute e della Scienza di Torino	Stefanelli, P (corresponding author), Ist Super Sanita, Dept Infect Dis, Rome, Italy.	paola.stefanelli@iss.it	Carannante, Anna/B-8720-2016; Vescio, Fenicia/N-5776-2017; Cristaudo, Antonio/K-5944-2016; Dal Conte, Ivano/L-7528-2018; GHISETTI, VALERIA/AAW-4460-2021; STEFANELLI, PAOLA/B-8729-2016; Ghisetti, Valeria/AAW-5140-2021	Carannante, Anna/0000-0002-2073-1869; Vescio, Fenicia/0000-0002-3285-919X; Cristaudo, Antonio/0000-0002-0737-983X; STEFANELLI, PAOLA/0000-0003-1620-4385; Ghisetti, Valeria/0000-0002-7808-190X; Ghisetti, Valeria/0000-0002-4698-598X	Ministry of Health-CCM Project "Sorveglianza di laboratorio della farmaco resistenza di Neisseria gonorrhoeae come malattia emergente"	Ministry of Health-CCM Project "Sorveglianza di laboratorio della farmaco resistenza di Neisseria gonorrhoeae come malattia emergente"	This work was funded by the Ministry of Health-CCM Project 2014 "Sorveglianza di laboratorio della farmaco resistenza di Neisseria gonorrhoeae come malattia emergente". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VG, 2014, ANTIMICROB AGENTS CH, V58, P2528, DOI 10.1128/AAC.02608-13; Allen VG, 2013, JAMA-J AM MED ASSOC, V309, P163, DOI 10.1001/jama.2012.176575; Anna Carannante Paola Stefanelli e Il Gruppo di Studio per l'antibiotico resistenza in gonococco, 2012, NOTIZIARIO I SUPERIO, V25, P11; Bercot B, 2014, EURO SURVEILL, V19; Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837; Bignell C, 2009, INT J STD AIDS, V20, P453, DOI 10.1258/ijsa.2009.009160; Carannante A, 2014, ANTIMICROB AGENTS CH, V58, P5871, DOI 10.1128/AAC.00103-14; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P335; Chisholm SA, 2016, SEX TRANSM INFECT, V92, P365, DOI 10.1136/sextrans-2015-052312; Cole MJ, 2014, SEX TRANSM DIS, V41, P716, DOI 10.1097/OLQ.0000000000000185; European Centre for Disease Prevention and Control, 2017, GONOCOCCAL ANTIMICRO; European Centre for Disease Prevention and Control, 2017, ANNUAL EPIDEMIOLOGIC; European Centre for Disease Prevention and Control, 2016, GONOCOCCAL ANTIMICRO; Gratrix J, 2013, SEX TRANSM DIS, V40, P877, DOI 10.1097/OLQ.0000000000000033; Ison CA, 2011, EUROSURVEILLANCE, V16, P7; Ison CA, 2013, LANCET INFECT DIS, V13, P762, DOI 10.1016/S1473-3099(13)70143-9; Jacobsson S, 2016, J ANTIMICROB CHEMOTH; Kirkcaldy RD, 2013, ANN INTERN MED, V158, P321, DOI 10.7326/0003-4819-158-5-201303050-00004; Lynagh Y, 2015, J ANTIMICROB CHEMOTH, V70, P2411, DOI 10.1093/jac/dkv106; Martin I, 2016, EMERG INFECT DIS, V22, P65, DOI 10.3201/eid2201.151247; MCFARLAND L, 1983, J CLIN MICROBIOL, V18, P121, DOI 10.1128/JCM.18.1.121-127.1983; Ni CS, 2016, J ANTIMICROB CHEMOTH, V71, P2355, DOI 10.1093/jac/dkw131; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; SHAFER WM, 1995, MICROBIOL-UK, V141, P907, DOI 10.1099/13500872-141-4-907; Spiteri G, 2013, SEX TRANSM INFECT, V89, P16, DOI 10.1136/sextrans-2013-051117; Starnino S, 2009, J ANTIMICROB CHEMOTH, V63, P1200, DOI 10.1093/jac/dkp118; StataCorp, 2013, STATA STATISTICAL SO; Stevens K, 2015, J ANTIMICROB CHEMOTH, V70, P1267, DOI 10.1093/jac/dku490; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2017, BREAKPOINTS TABLES F; Town K, 2015, SEX TRANSM DIS, V42, P37, DOI 10.1097/OLQ.0000000000000223; Unemo M, 2011, EUROSURVEILLANCE, V16, P9; Unemo M, 2010, EUROSURVEILLANCE, V15, P9; Unemo M., 2016, J ANTIMICROB CHEMOTH; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, ANTIMICROB AGENTS CH, V58, P624, DOI 10.1128/AAC.02093-13; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; WHO, 2012, WHO GLOBAL ACTION PL	38	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189484	10.1371/journal.pone.0189484	http://dx.doi.org/10.1371/journal.pone.0189484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240786	gold, Green Published, Green Submitted			2022-12-26	WOS:000417905600037
J	Fonseca, A; Ishoey, T; Espinoza, C; Perez-Pantoja, D; Manghisi, A; Morabito, M; Salas-Burgos, A; Gallardo, VA				Fonseca, Alexis; Ishoey, Thomas; Espinoza, Carole; Perez-Pantoja, Danilo; Manghisi, Antonio; Morabito, Marina; Salas-Burgos, Alexis; Gallardo, Victor A.			Genomic features of "Candidatus Venteria ishoeyi", a new sulfur-oxidizing macrobacterium from the Humboldt Sulfuretum off Chile	PLOS ONE			English	Article							ELECTRON-TRANSPORT PATHWAYS; C NITRITE REDUCTASE; SULFIDE OXIDATION; THIOPLOCA-ARAUCAE; SP-NOV; BEGGIATOA; NITRATE; BACTERIA; MARINE; 16S	The Humboldt Sulfuretum (HS), in the productive Humboldt Eastern Boundary Current Upwelling Ecosystem, extends under the hypoxic waters of the Peru-Chile Undercurrent (ca. 6 degrees S and ca. 36 degrees S). Studies show that primeval sulfuretums held diverse prokaryotic life, and, while rare today, still sustain species-rich giant sulfur-oxidizing bacterial communities. We here present the genomic features of a new bacteria of the HS, "Candidatus Venteria ishoeyi" ("Ca. V. ishoeyi") in the family Thiotrichaceae. Three identical filaments were micromanipulated from reduced sediments collected off central Chile; their DNA was extracted, amplified, and sequenced by a Roche 454 GS FLX platform. Using three sequenced libraries and through de novo genome assembly, a draft genome of 5.7 Mbp, 495 scaffolds, and a N50 of 70 kbp, was obtained. The 16S rRNA gene phylogenetic analysis showed that "Ca. V. ishoeyi" is related to non-vacuolate forms presently known as Beggiatoa or Beggiatoa-like forms. The complete set of genes involved in respiratory nitrate-reduction to dinitrogen was identified in "Ca. V. ishoeyi"; including genes likely leading to ammonification. As expected, the sulfur-oxidation pathway reported for other sulfur-oxidizing bacteria were deduced and also, key inorganic and organic carbon acquisition related genes were identified. Unexpectedly, the genome of "Ca. V. ishoeyi" contained numerous CRISPR repeats and an I-F CRISPR-Cas type system gene coding array. Findings further show that, as a member of an eons-old marine ecosystem, "Ca. V. ishoeyi" contains the needed metabolic plasticity for life in an increasingly oxygenated and variable ocean.	[Fonseca, Alexis; Salas-Burgos, Alexis] Univ Concepcion, Dept Pharmacol, Concepcion, Chile; [Fonseca, Alexis; Espinoza, Carole; Gallardo, Victor A.] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Espinoza, Carole; Gallardo, Victor A.] Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Coll Ocean Sci & Resources, Keelung, Taiwan; [Perez-Pantoja, Danilo] Univ Tecnol Metropolitana, Programa Inst Fomento Invest Desarrollo & Innovac, Santiago, Chile; [Manghisi, Antonio; Morabito, Marina] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy	Universidad de Concepcion; Universidad de Concepcion; National Taiwan Ocean University; Universidad Tecnologica Metropolitana; University of Messina	Fonseca, A; Salas-Burgos, A (corresponding author), Univ Concepcion, Dept Pharmacol, Concepcion, Chile.; Fonseca, A; Gallardo, VA (corresponding author), Univ Concepcion, Dept Oceanog, Concepcion, Chile.; Gallardo, VA (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Coll Ocean Sci & Resources, Keelung, Taiwan.	afonseca@udec.cl; alsalas@udec.cl; vagallar@gmail.com	Perez-Pantoja, Danilo/ABD-1286-2020; Manghisi, Antonio/T-3831-2019; Salas Burgos, Alexis/GWC-2563-2022; Pérez-Pantoja, Danilo/AAF-4197-2019; Fonseca, Alexis/GVU-1275-2022	Manghisi, Antonio/0000-0001-7727-6820; Pérez-Pantoja, Danilo/0000-0001-5720-2162; Salas-Burgos, Alexis/0000-0002-6577-9970; Fonseca, Alexis/0000-0003-4580-6270	National Fund for Scientific and Technological Development (FONDECYT) Project [1070552, 1110786]; VRID-Enlace [214.122117-1.0]; Synthetic Genomics, Inc. (SGI); National Commission for Scientific and Technological Research (CONICYT); international program Census of Marine Life (CoML); International Census of Marine Microbes (ICOMM)	National Fund for Scientific and Technological Development (FONDECYT) Project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); VRID-Enlace; Synthetic Genomics, Inc. (SGI); National Commission for Scientific and Technological Research (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); international program Census of Marine Life (CoML); International Census of Marine Microbes (ICOMM)	This work was supported by National Fund for Scientific and Technological Development (FONDECYT) Project 1070552 to VAG: Financed sampling and part of the sequencing costs; National Fund for Scientific and Technological Development (FONDECYT) Project 1110786 to VAG: Financed sampling and part of the sequencing costs; VRID-Enlace 214.122117-1.0 to VAG; Synthetic Genomics, Inc. (SGI): Financed half of the costs involved in sequencing into a cooperation agreement framework; Graduate Student Scholarship: National Commission for Scientific and Technological Research (CONICYT) to carry out M. Sc. Studies, period March 2014 to March of 2016: Allowed to the author AF for the preparation of the manuscript. We further acknowledge the valuable support from the international program Census of Marine Life (CoML) and its project International Census of Marine Microbes (ICOMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, APPL ENVIRON MICROB, V65, P270; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alcaino J, 2016, SUBCELL BIOCHEM, V79, P3, DOI 10.1007/978-3-319-39126-7_1; Gallardo VA, 2013, GAYANA, V77, P136, DOI 10.4067/S0717-65382013000200008; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baas-Becking LGM, 1925, ANN BOT-LONDON, V39, P613, DOI 10.1093/oxfordjournals.aob.a089968; BELL LC, 1990, FEBS LETT, V265, P85, DOI 10.1016/0014-5793(90)80889-Q; Blin K., 2013, NUCLEIC ACIDS RES; Brinkhoff T, 2005, THIOMICROSPIRA BERGE; Brock J, 2012, ANTON LEEUW INT J G, V101, P347, DOI 10.1007/s10482-011-9640-8; Brock J, 2011, ISME J, V5, P497, DOI 10.1038/ismej.2010.135; Burnett WC, PHOSPHORITE DEPOSITS; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Dahl C, 2006, BACTERIAL INCLUSIONS, P21; Dahl Christiane, 2008, V27, P289; Danovaro R, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0144; de Albuquerque JP, 2010, MICRON, V41, P507, DOI 10.1016/j.micron.2010.01.009; Dela Pierre F, 2014, MAR GEOL, V355, P71, DOI 10.1016/j.margeo.2014.05.010; Dubinina G, 2017, INT J SYST EVOL MICR, V67, P197, DOI 10.1099/ijsem.0.001584; DURAND P, 1993, ARCH MICROBIOL, V159, P39, DOI 10.1007/BF00244261; Einsle O, 2011, METHOD ENZYMOL, V496, P399, DOI 10.1016/B978-0-12-386489-5.00016-6; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flood BE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00603; Fomenkov A, 2015, GENOME ANNOUNCEMENTS, V3; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; FOX GE, 1977, INT J SYST BACTERIOL, V27, P44, DOI 10.1099/00207713-27-1-44; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Gallardo V, 2013, OCEANOGRAPHY OPEN AC; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; Gallardo VA, 2007, OPTICAL ENG APPL; Gallardo VA, 1977, ANALES I INVESTIGACI, P23; Gallardo VA, 2010, INT MICROBIOL, V10, P97; Gallese V, 2015, OPEN MIND, P1, DOI DOI 10.15502/9783958570269; Garrity GM, 2005, BERGEYS MANUAL SYSTE, V2, P131, DOI DOI 10.1007/0-387-28022-7; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Grimm F, 2008, MICROBIAL SULFUR METABOLISM, P101, DOI 10.1007/978-3-540-72682-1_9; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grunke S, 2012, BIOGEOSCIENCES, V9, P2947, DOI 10.5194/bg-9-2947-2012; Hagen KD, 1996, APPL ENVIRON MICROB, V62, P947, DOI 10.1128/AEM.62.3.947-953.1996; Hedderich R, 2005, BIOL CHEM, V386, P961, DOI 10.1515/BC.2005.112; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Heussler GE, 2016, J BACTERIOL, V198, P3080, DOI 10.1128/JB.00458-16; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kamp A, 2008, MICROB ECOL, V56, P484, DOI 10.1007/s00248-008-9367-x; Kamp A, 2006, APPL ENVIRON MICROB, V72, P4755, DOI 10.1128/AEM.00163-06; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kojima H, 2015, ISME J, V9, P1166, DOI 10.1038/ismej.2014.209; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee PA, 1999, J PHYCOL, V35, P8, DOI 10.1046/j.1529-8817.1999.3510008.x; Li X, 2013, J ANTIBIOT, V66, P443, DOI 10.1038/ja.2013.52; Li YJ, 2012, J BACTERIOL, V194, P4847, DOI 10.1128/JB.00903-12; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; MacGregor BJ, 2013, MAR GENOM, V11, P53, DOI 10.1016/j.margen.2013.08.001; MacGregor BJ, 2013, APPL ENV MICROBIOLOG; MAIER S, 1984, INT J SYST BACTERIOL, V34, P414, DOI 10.1099/00207713-34-4-414; MAIER S, 1990, CAN J MICROBIOL, V36, P438, DOI 10.1139/m90-077; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2015, NATURE REV MICROBIOL; McHatton SC, 1996, APPL ENVIRON MICROB, V62, P954, DOI 10.1128/AEM.62.3.954-958.1996; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Motomura K, 2014, APPL ENVIRON MICROB, V80, P2602, DOI 10.1128/AEM.03971-13; Muntyan MS, 2005, MICROBIOLOGY+, V74, P388, DOI 10.1007/s11021-005-0078-8; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; NELSON DC, 1982, ARCH MICROBIOL, V133, P172, DOI 10.1007/BF00414997; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Papaspyrou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094111; Rabenhorst, 1865, FLORA EUROPAEA ALGAR; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salman V., 2014, FAMILY BEGGIATOACEAE, P93; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; Salman-Carvalho V, 2016, FRONTIERS MICROBIOLO, V7; Schatz MC, 2013, BRIEF BIOINFORM, V14, P213, DOI 10.1093/bib/bbr074; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schopf JW, 2015, P NATL ACAD SCI USA, V112, P2087, DOI 10.1073/pnas.1419241112; Schultze H.-P., 1989, Revista Geologica de Chile, V16, P183; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Schwedt A, 2012, FRONTIERS MICROBIOLO, V2, P1; Seemann T, 2014, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BTU153; Simon J, 2000, MOL MICROBIOL, V35, P686, DOI 10.1046/j.1365-2958.2000.01742.x; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sobarzo M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002350; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Stojanowic A, 2003, ARCH MICROBIOL, V180, P194, DOI 10.1007/s00203-003-0577-9; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; SWEERTS JPRA, 1990, NATURE, V344, P762, DOI 10.1038/344762a0; Teske A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P784, DOI 10.1007/0-387-30746-x_27; Tremberger Jr G, 2010, SPIE OPTICAL ENG APP; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; Wall J, 2008, GENETICS GENOMICS SU, P1; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Winkel M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00964; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Yamada Y, 2015, P NATL ACAD SCI USA, V112, P62; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064; Zopfi J, 2008, GEOCHIM COSMOCHIM AC, V72, P827, DOI 10.1016/j.gca.2007.11.031	108	2	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188371	10.1371/journal.pone.0188371	http://dx.doi.org/10.1371/journal.pone.0188371			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236755	Green Submitted, gold, Green Published			2022-12-26	WOS:000417884100016
J	Wan, Q; Chen, SL; Shan, ZH; Yang, ZL; Chen, LM; Zhang, CJ; Yuan, SL; Hao, QN; Zhang, XJ; Qiu, DZ; Chen, HF; Zhou, XA				Wan, Qiao; Chen, Shuilian; Shan, Zhihui; Yang, Zhonglu; Chen, Limiao; Zhang, Chanjuan; Yuan, Songli; Hao, Qinnan; Zhang, Xiaojuan; Qiu, Dezhen; Chen, Haifeng; Zhou, Xinan			Stability evaluation of reference genes for gene expression analysis by RT-qPCR in soybean under different conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; STRESS CONDITIONS; ABIOTIC STRESS; QRT-PCR; SELECTION; NORMALIZATION; RESISTANCE	Real-time quantitative reverse transcription PCR is a sensitive and widely used technique to quantify gene expression. To achieve a reliable result, appropriate reference genes are highly required for normalization of transcripts in different samples. In this study, 9 previously published reference genes (60S, Fbox, ELF1A, ELF1B, ACT11, TUA5, UBC4, G6PD, CYP2) of soybean [Glycine max (L.) Merr.] were selected. The expression stability of the 9 genes was evaluated under conditions of biotic stress caused by infection with soybean mosaic virus, nitrogen stress, across different cultivars and developmental stages. Delta Ct and geNorm algorithms were used to evaluate and rank the expression stability of the 9 reference genes. Results obtained from two algorithms showed high consistency. Moreover, results of pairwise variation showed that two reference genes were sufficient to normalize the expression levels of target genes under each experimental setting. For virus infection, ELF1A and ELF1B were the most stable reference genes for accurate normalization. For different developmental stages, Fbox and G6PD had the highest expression stability between two soybean cultivars (Tanlong No. 1 and Tanlong No. 2). ELF1B and ACT11 were identified as the most stably expressed reference genes both under nitrogen stress and among different cultivars. The results showed that none of the candidate reference genes were uniformly expressed at different conditions, and selecting appropriate reference genes was pivotal for gene expression studies with particular condition and tissue. The most stable combination of genes identified in this study will help to achieve more accurate and reliable results in a wide variety of samples in soybean.	[Wan, Qiao; Chen, Shuilian; Shan, Zhihui; Yang, Zhonglu; Chen, Limiao; Zhang, Chanjuan; Yuan, Songli; Hao, Qinnan; Zhang, Xiaojuan; Qiu, Dezhen; Chen, Haifeng; Zhou, Xinan] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, HF; Zhou, XA (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	chenhaifeng@caas.cn; zhouocri@sina.com		Yuan, Songli/0000-0001-8558-1454	National Natural Science Foundation [31371653, 31401410]; National Transgenic Project of China [2014ZX0800930B-003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Transgenic Project of China	The study was supported by the National Natural Science Foundation (Grant No.31371653 and 31401410), http://www.nsfc.gov.cn/publish/portal1/, and the National Transgenic Project of China (Grant No.2014ZX0800930B-003), http://www.nmp.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aks F, 2017, PLOS ONE, V12; Alessandra L, 2010, J PLANT PHYSIOL, V167, P1398, DOI 10.1016/j.jplph.2010.05.015; Bansal R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134890; Basa B, 2009, FUNCT PLANT BIOL, V36, P1079, DOI 10.1071/FP09073; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Bracht AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146211; Chaouachi M, 2013, FOOD SCI BIOTECHNOL, V22, P1161, DOI 10.1007/s10068-013-0198-2; Chen HF, 2011, EUPHYTICA, V179, P485, DOI 10.1007/s10681-011-0382-5; Die JV, 2012, J EXP BOT, V63, P6069, DOI 10.1093/jxb/ers276; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Guo DanDan, 2012, Soybean Science, V31, P511; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Hu YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154384; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Karuppaiya P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172460; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140218; Li XS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00038; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Ma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064666; Martins PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28348; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Mikel P, 2015, FOOD ENVIRON VIROL, V7, P96, DOI 10.1007/s12560-015-9188-2; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Muller OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136499; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Saraiva KDC, 2014, PLANT CELL REP, V33, P1453, DOI 10.1007/s00299-014-1628-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wieczorek P, 2013, J VIROL METHODS, V194, P161, DOI 10.1016/j.jviromet.2013.08.010; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Yang YQ, 2013, THEOR APPL GENET, V126, P1783, DOI 10.1007/s00122-013-2092-y; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Zeringer EM, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-3387; Zhang CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125174; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	44	38	41	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189405	10.1371/journal.pone.0189405	http://dx.doi.org/10.1371/journal.pone.0189405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236756	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100066
J	Bogard, MJ; Finlay, K; Waiser, MJ; Tumber, VP; Donald, DB; Wiik, E; Simpson, GL; del Giorgio, PA; Leavitt, PR				Bogard, Matthew J.; Finlay, Kerri; Waiser, Marley J.; Tumber, Vijay P.; Donald, Derek B.; Wiik, Emma; Simpson, Gavin L.; del Giorgio, Paul A.; Leavitt, Peter R.			Effects of experimental nitrogen fertilization on planktonic metabolism and CO2 flux in a hypereutrophic hardwater lake	PLOS ONE			English	Article							HARD-WATER LAKES; FRESH-WATER; ORGANIC-MATTER; PHYTOPLANKTON PRODUCTION; UREA DECOMPOSITION; CARBON-DIOXIDE; COMMUNITY COMPOSITION; TEMPORAL VARIABILITY; INORGANIC CARBON; SURFACE WATERS	Hardwater lakes are common in human-dominated regions of the world and often experience pollution due to agricultural and urban effluent inputs of inorganic and organic nitrogen (N). Although these lakes are landscape hotspots for CO2 exchange and food web carbon (C) cycling, the effect of N enrichment on hardwater lake food web functioning and C cycling patterns remains unclear. Specifically, it is unknown if different eutrophication scenarios (e. g., modest non point vs. extreme point sources) yield consistent effects on auto-and heterotrophic C cycling, or how biotic responses interact with the inorganic C system to shape responses of air-water CO2 exchange. To address this uncertainty, we induced large metabolic gradients in the plankton community of a hypereutrophic hardwater Canadian prairie lake by adding N as urea (the most widely applied agricultural fertilizer) at loading rates of 0, 1, 3, 8 or 18 mg NL-1 week(-1) to 3240-L, in-situ mesocosms. Over three separate 21-day experiments, all treatments of N dramatically increased phytoplankton biomass and gross primary production (GPP) two-to six-fold, but the effects of N on autotrophs plateaued at similar to 3 mg N L-1. Conversely, heterotrophic metabolism increased linearly with N fertilization over the full treatment range. In nearly all cases, N enhanced net planktonic uptake of dissolved inorganic carbon (DIC), and increased the rate of CO2 influx, while planktonic heterotrophy and CO2 production only occurred in the highest N treatments late in each experiment, and even in these cases, enclosures continued to in-gas CO2. Chemical effects on CO2 through calcite precipitation were also observed, but similarly did not change the direction of net CO2 flux. Taken together, these results demonstrate that atmospheric exchange of CO2 in eutrophic hardwater lakes remains sensitive to increasing N loading and eutrophication, and that even modest levels of N pollution are capable of enhancing autotrophy and CO2 in-gassing in P-rich lake ecosystems.	[Bogard, Matthew J.; Finlay, Kerri; Donald, Derek B.; Wiik, Emma; Simpson, Gavin L.; Leavitt, Peter R.] Univ Regina, Dept Biol, Regina, SK, Canada; [Waiser, Marley J.; Tumber, Vijay P.] Environm Canada, Water Sci & Technol Directorate, Saskatoon, SK, Canada; [del Giorgio, Paul A.] Univ Quebec Montreal, Grp Rech Interuniv Limnol, Dept Sci Biol, Montreal, PQ, Canada; [Bogard, Matthew J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Regina; Environment & Climate Change Canada; University of Quebec; University of Quebec Montreal; University of Washington; University of Washington Seattle	Bogard, MJ (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.; Bogard, MJ (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	bogard.matt@gmail.com	del Giorgio, Paul/AAD-1315-2019; Leavitt, Peter R/A-1048-2013	del Giorgio, Paul/0000-0003-1866-8159; Leavitt, Peter R/0000-0001-9805-9307; Simpson, Gavin/0000-0002-9084-8413	Natural Sciences and Engineering Research Council of Canada Discovery Grants; Canada Research Chair Program, Canada Foundation for Innovation, Fulbright Canada; Province of Saskatchewan; University of Regina; Nature Regina	Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program, Canada Foundation for Innovation, Fulbright Canada; Province of Saskatchewan; University of Regina; Nature Regina	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grants, the Canada Research Chair Program, Canada Foundation for Innovation, Fulbright Canada, the Province of Saskatchewan, the University of Regina, and Nature Regina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MILLENNIUM ECOSYSTEM, V1; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Balmer MB, 2011, INLAND WATERS, V1, P125, DOI 10.5268/IW-1.2.366; BARICA J, 1980, CAN J FISH AQUAT SCI, V37, P1175, DOI 10.1139/f80-150; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; Bogard MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6350; Bogard MJ, 2012, FRESHWATER BIOL, V57, P1277, DOI 10.1111/j.1365-2427.2012.02775.x; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Bunting L, 2007, LIMNOL OCEANOGR, V52, P354, DOI 10.4319/lo.2007.52.1.0354; Burkholder JM, 1997, J ENVIRON QUAL, V26, P1451, DOI 10.2134/jeq1997.00472425002600060003x; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chrost RJ, 2006, LIMNOL OCEANOGR, V51, P749, DOI 10.4319/lo.2006.51.1_part_2.0749; CLOERN JE, 1983, ESTUARIES, V6, P399, DOI 10.2307/1351399; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Donald DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053277; Donald DB, 2011, LIMNOL OCEANOGR, V56, P2161, DOI 10.4319/lo.2011.56.6.2161; Droscher I, 2009, LIMNOL OCEANOGR, V54, P2469, DOI 10.4319/lo.2009.54.6_part_2.2469; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Environment Canada, 1979, 15413 NAQUADAT GOV C; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1551, DOI 10.4319/lo.2010.55.4.1551; Finlay K, 2009, LIMNOL OCEANOGR, V54, P2553, DOI 10.4319/lo.2009.54.6_part_2.2553; Finlay K, 2015, NATURE, V519, P215, DOI 10.1038/nature14172; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1213, DOI 10.4319/lo.2010.55.3.1213; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; Gu BH, 1997, J PLANKTON RES, V19, P759, DOI 10.1093/plankt/19.6.759; Hanson PC, 2006, ECOL MONOGR, V76, P343, DOI 10.1890/0012-9615(2006)076[0343:LDICAD]2.0.CO;2; HOOVER TE, 1969, J GEOPHYS RES, V74, P456, DOI 10.1029/JB074i002p00456; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jorgensen NOG, 2006, AQUAT MICROB ECOL, V42, P227, DOI 10.3354/ame042227; KLING GW, 1992, HYDROBIOLOGIA, V240, P23, DOI 10.1007/BF00013449; LATHROP RC, 1988, CAN J FISH AQUAT SCI, V45, P2061, DOI 10.1139/f88-240; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Levine SN, 1999, CAN J FISH AQUAT SCI, V56, P451, DOI 10.1139/cjfas-56-3-451; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Mallin MA, 1999, ESTUARIES, V22, P825, DOI 10.2307/1353064; Marce R, 2015, NAT GEOSCI, V8, P107, DOI [10.1038/ngeo2341, 10.1038/NGEO2341]; MCCONNAUGHEY TA, 1994, LIMNOL OCEANOGR, V39, P1319, DOI 10.4319/lo.1994.39.6.1319; McDonald CP, 2013, GLOBAL BIOGEOCHEM CY, V27, P285, DOI 10.1002/gbc.20032; McGowan S, 2005, ECOSYSTEMS, V8, P694, DOI 10.1007/s10021-003-0152-x; MELACK JM, 1974, LIMNOL OCEANOGR, V19, P743, DOI 10.4319/lo.1974.19.5.0743; MITAMURA O, 1994, ARCH HYDROBIOL, V131, P231; MITAMURA O, 1986, ARCH HYDROBIOL, V107, P23; Mitamura O, 2010, INT VER THEOR ANGEW, V30, P1531; Morales-Pineda M, 2014, J GEOPHYS RES-BIOGEO, V119, P509, DOI 10.1002/2013JG002317; Muller B, 2016, LIMNOL OCEANOGR, V61, P341, DOI 10.1002/lno.10213; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Park MG, 1997, AQUAT MICROB ECOL, V13, P303, DOI 10.3354/ame013303; Patoine A, 2006, LIMNOL OCEANOGR, V51, P1665, DOI 10.4319/lo.2006.51.4.1665; Petersen SO, 2004, APPL ENVIRON MICROB, V70, P6363, DOI 10.1128/AEM.70.11.6363-6369.2004; Pham SV, 2008, LIMNOL OCEANOGR, V53, P728, DOI 10.4319/lo.2008.53.2.0728; Pham SV, 2009, LIMNOL OCEANOGR, V54, P101, DOI 10.4319/lo.2009.54.1.0101; Quinones-Rivera ZJ, 2015, J GREAT LAKES RES, V41, P144, DOI 10.1016/j.jglr.2015.05.005; ROBARTS RD, 1994, CAN J FISH AQUAT SCI, V51, P2219, DOI 10.1139/f94-224; ROBARTS RD, 1989, LIMNOL OCEANOGR, V34, P213, DOI 10.4319/lo.1989.34.1.0213; Roberts BJ, 2006, LIMNOL OCEANOGR, V51, P288, DOI 10.4319/lo.2006.51.1.0288; Sanderson MP, 2008, AQUAT MICROB ECOL, V51, P153, DOI 10.3354/ame01178; SATOH Y, 1980, INT REV GES HYDROBIO, V65, P295, DOI 10.1002/iroh.19800650216; Silva RG, 2005, WATER AIR SOIL POLL, V164, P57, DOI 10.1007/s11270-005-2249-7; Siuda W, 2006, POL J MICROBIOL, V55, P211; Smith VH, 2006, LIMNOL OCEANOGR, V51, P377, DOI 10.4319/lo.2006.51.1_part_2.0377; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; Soumis N, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002197; Spivak AC, 2001, FRESHWATER BIOL, V56, P279; Stainton MP, 1977, FISH MAR SERV MISC S, V2, P25; Stets EG, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000783; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Swensen B, 1997, J ENVIRON QUAL, V26, P1516, DOI 10.2134/jeq1997.00472425002600060010x; Thoren AK, 2007, MICROB ECOL, V53, P221, DOI 10.1007/s00248-006-9098-9; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Trolle D, 2012, ECOSYSTEMS, V15, P336, DOI 10.1007/s10021-011-9513-z; TURPIN DH, 1985, PLANT PHYSIOL, V78, P746, DOI 10.1104/pp.78.4.746; Vinebrooke RD, 1998, CAN J FISH AQUAT SCI, V55, P668, DOI 10.1139/cjfas-55-3-668; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Waiser MJ, 2011, ENVIRON TOXICOL CHEM, V30, P496, DOI 10.1002/etc.399; Waiser MJ, 2004, AQUAT MICROB ECOL, V34, P279, DOI 10.3354/ame034279; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wanninkhof R, 1996, LIMNOL OCEANOGR, V41, P689, DOI 10.4319/lo.1996.41.4.0689; WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147; Yoshiyama K, 2006, LIMNOL OCEANOGR, V51, P424, DOI 10.4319/lo.2006.51.1_part_2.0424	87	12	13	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188652	10.1371/journal.pone.0188652	http://dx.doi.org/10.1371/journal.pone.0188652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232381	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200009
J	Caliskan, G; Baris, IC; Ayaydin, F; Dobson, MJ; Senarisoy, M; Boros, IM; Topcu, Z; Zencir, S				Caliskan, Gizem; Baris, Ikbal C.; Ayaydin, Ferhan; Dobson, Melanie J.; Senarisoy, Muge; Boros, Imre M.; Topcu, Zeki; Zencir, Sevil			Che1/AATF interacts with subunits of the histone acetyltransferase core module of SAGA complexes	PLOS ONE			English	Article							YEAST 2-HYBRID SYSTEM; P53 TRANSCRIPTION; HUMAN ADA3; PROTEIN; GCN5; IDENTIFICATION; ACETYLATION; CHROMATIN; APOPTOSIS; PARTNER	General Control Non-derepressible 5 (GCN5) and Alteration/Deficiency in Activation 2 and 3 proteins (ADA2 and ADA3, respectively) are subunits of the Histone AcetylTransferase (HAT) module of SAGA-and ATAC-type co-activators. We previously reported four new interacting partners of human ADA3 identified by screening a human fetal brain cDNA library using yeast two hybrid technology. One of these partners was Apoptosis-Antagonizing Transcription Factor (AATF), also known as Che-1, an RNA polymerase II-binding protein with a number of roles in different cellular processes including regulation of transcription, cell proliferation, cell cycle control, DNA damage responses and apoptosis. Che-1/AATF is a potential therapeutic target for cancer treatments. In this study, we aimed to identify whether besides ADA3, other components of the HAT modules of SAGA and ATAC complexes, human ADA2 and GCN5 also interact with Che-1/AATF. Co-immunoprecipitation and co-localization experiments were used to demonstrate association of AATF both with two ADA2 isoforms, ADA2A and ADA2B and with GCN5 proteins in human cells and yeast two-hybrid assays to delineate domains in the ADA2 and GCN5 proteins required for these interactions. These findings provide new insights into the pathways regulated by ADA-containing protein complexes.	[Caliskan, Gizem; Senarisoy, Muge; Topcu, Zeki] Ege Univ, Dept Pharmaceut Biotechnol, Fac Pharm, Izmir, Turkey; [Baris, Ikbal C.; Zencir, Sevil] Pamukkale Univ, Fac Med, Dept Med Biol, Denizli, Turkey; [Ayaydin, Ferhan] Hungarian Acad Sci, Biol Res Ctr, Cellular Imaging Lab, Szeged, Hungary; [Dobson, Melanie J.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Boros, Imre M.] Hungarian Acad Sci, Inst Biochem, Szeged, Hungary	Ege University; Pamukkale University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Dalhousie University; Hungarian Academy of Sciences; Hungarian Biological Research Center	Zencir, S (corresponding author), Pamukkale Univ, Fac Med, Dept Med Biol, Denizli, Turkey.	sevilz@pau.edu.tr	; Senarisoy, Muge/O-2528-2016	Boros, Imre/0000-0001-8504-9687; Zencir, Sevil/0000-0002-9937-5712; Ayaydin, Ferhan/0000-0002-9126-0865; YAYLI, Gizem/0000-0002-7299-2438; Senarisoy, Muge/0000-0002-6763-5209	Turkish Scientific and Technological Research Assembly [112T429]; Hungarian NRDIO [GINOP-2.3.2-15-2016-00020]	Turkish Scientific and Technological Research Assembly; Hungarian NRDIO(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the Turkish Scientific and Technological Research Assembly (112T429) (Dr. Sevil Zencir), and Hungarian NRDIO-GINOP-2.3.2-15-2016-00020 (Prof Imre M. Boros). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammert L, 2016, NUCLEIC ACIDS RES, V44, P9803, DOI 10.1093/nar/gkw790; Barton MC, 2001, ONCOGENE, V20, P3094, DOI 10.1038/sj.onc.1204334; Bennett G, 2015, DNA REPAIR, V30, P38, DOI 10.1016/j.dnarep.2015.03.006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Bruno T, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00034; Bruno T, 2010, CANCER CELL, V18, P122, DOI 10.1016/j.ccr.2010.05.027; Desantis A, 2015, EMBO J, V34, P1214, DOI 10.15252/embj.201489920; Donald PN Mac, 2001, 2 HYBRID SYSTEMS; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Ferraris SE, 2012, MOL BIOL CELL, V23, P4323, DOI 10.1091/mbc.E12-05-0419; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; Gong FD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006272; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Hopker K, 2012, EMBO J, V31, P3961, DOI 10.1038/emboj.2012.236; Jackson JG, 2012, EMBO J, V31, P3951, DOI 10.1038/emboj.2012.258; Johnsson A, 2006, EUKARYOT CELL, V5, P1337, DOI 10.1128/EC.00101-06; Kaul D, 2007, MOL CELL BIOCHEM, V297, P215, DOI 10.1007/s11010-006-9317-1; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Leister P, 2008, ONCOGENE, V27, P3292, DOI 10.1038/sj.onc.1210995; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mao YP, 2006, BBA-GENE STRUCT EXPR, V1759, P69, DOI 10.1016/j.bbaexp.2006.02.006; Mockli N, 2004, BIOTECHNIQUES, V36, P872; Muratoglu S, 2003, MOL CELL BIOL, V23, P306, DOI 10.1128/MCB.23.1.306-321.2003; Nag A, 2007, J BIOL CHEM, V282, P8812, DOI 10.1074/jbc.M610443200; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; Pinder JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060384; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; RuizGarcia AB, 1997, FEBS LETT, V403, P186, DOI 10.1016/S0014-5793(97)00049-5; Schram AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070035; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Srivastava R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134709; Topcu Z, 2000, PHARMACEUT RES, V17, P1049, DOI 10.1023/A:1026493310144; Topcu Z, 1999, ONCOGENE, V18, P7091, DOI 10.1038/sj.onc.1203201; Vamos EE, 2012, FEBS LETT, V586, P3279, DOI 10.1016/j.febslet.2012.06.051; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; Zencir S, 2013, BIOCHEM BIOPH RES CO, V432, P10, DOI 10.1016/j.bbrc.2013.01.098; Zencir S, 2013, BIOCHEM J, V450, P311, DOI 10.1042/BJ20120452; Zencir S, 2011, BIOCHEM BIOPH RES CO, V411, P792, DOI 10.1016/j.bbrc.2011.07.029	45	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189193	10.1371/journal.pone.0189193	http://dx.doi.org/10.1371/journal.pone.0189193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232376	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200025
J	Musilova, I; Pliskova, L; Gerychova, R; Janku, P; Simetka, O; Matlak, P; Jacobsson, B; Kacerovsky, M				Musilova, Ivana; Pliskova, Lenka; Gerychova, Romana; Janku, Petr; Simetka, Ondrej; Matlak, Petr; Jacobsson, Bo; Kacerovsky, Marian			Maternal white blood cell count cannot identify the presence of microbial invasion of the amniotic cavity or intra-amniotic inflammation in women with preterm prelabor rupture of membranes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PREMATURE RUPTURE; MYCOPLASMA-HOMINIS; OXIDATIVE STRESS; CERVICAL FLUID; IL-8 LEVELS; INTERLEUKIN-6; CHORIOAMNIONITIS; PREDICTION; LIPOCALIN	Objective The main aim of this study was to determine the relationship between the maternal white blood cell (WBC) count at the time of hospital admission in pregnancies complicated by pre-term prelabor rupture of membranes (PPROM) and the presence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI). The second aim was to test WBC diagnostic indices with respect to the presence of MIAC and/or IAI. Methods Four hundred and seventy-nine women with singleton pregnancies complicated by PPROM, between February 2012 and June 2017, were included in this study. Maternal blood and amniotic fluid samples were collected at the time of admission. Maternal WBC count was assessed. Amniotic fluid interleukin-6 (IL-6) concentration was measured using a point-of-care test, and IAI was characterized by an IL-6 concentration of >= 745 pg/mL. MIAC was diagnosed based on a positive polymerase chain reaction result for the Ureaplasma species, Mycoplasma hominis, and/or Chlamydia trachomatis and/or for the 16S rRNA gene. Results Women with MIAC or IAI had higher WBC counts than those without (with MIAC: median, 12.8 x 10(9) /L vs. without MIAC: median, 11.9 x 10(9) /L; p = 0.0006; with IAI: median, 13.7 x 10(9) /L vs. without IAI: median, 11.9 x 10(9)/L; p < 0.0001). When the women were divided into four sub-groups based on the presence of MIAC and/or IAI, the women with both MIAC and IAI had a higher WBC count than those with either IAI or MIAC alone, and those without MIAC and IAI [both MIAC and IAI: median, 14.0 x 10(9) /L; IAI alone: 12.1 x 10(9) /L (p = 0.03); MIAC alone: 12.1 x 10(9)/L (p = 0.0001); and without MIAC and IAI: median, 11.8 x 10(9)/L (p < 0.0001)]. No differences in the WBC counts were found among the women with IAI alone, MIAC alone, and without MIAC and IAI. Conclusion The women with both MIAC and IAI had a higher maternal WBC count at the time of hospital admission than the remaining women with PPROM. The maternal WBC count at the time of admission showed poor diagnostic indices for the identification of the presence of both MIAC and IAI. Maternal WBC count at the time of admission cannot serve as a non-invasive screening tool for identifying these complications in women with PPROM.	[Musilova, Ivana; Kacerovsky, Marian] Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Pliskova, Lenka] Univ Hosp Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Gerychova, Romana; Janku, Petr] Masaryk Univ, Fac Med, Univ Hosp Brno, Dept Obstet & Gynecol, Brno, Czech Republic; [Simetka, Ondrej; Matlak, Petr] Univ Hosp Ostrava, Dept Gynecol & Obstet, Ostrava, Czech Republic; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Norwegian Inst Publ Hlth, Domain Hlth Data & Digitalizat, Oslo, Norway; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Masaryk University Brno; University Hospital Brno; University Hospital Ostrava; University of Gothenburg; Norwegian Institute of Public Health (NIPH); University Hospital Hradec Kralove	Kacerovsky, M (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic.; Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Kacerovsky, Marian/ABE-3437-2020; Jacobsson, Bo/O-8007-2014; Janku, Petr/AAC-7947-2022; Kacerovsky, Marian/A-7586-2011	Jacobsson, Bo/0000-0001-5079-2374; Janku, Petr/0000-0002-6306-8294; Kacerovsky, Marian/0000-0001-9858-7900	Ministry of Health of the Czech Republic [16-28587A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by a grant from the Ministry of Health of the Czech Republic (16-28587A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrys C, 2017, J MATERN-FETAL NEO M, P1; Bankowska E Malgorzata, 2003, Ginekol Pol, V74, P1037; Berardi J C, 1991, Rev Fr Gynecol Obstet, V86, P229; CHAABAN M, 1988, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V17, P1045; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P349, DOI 10.3109/14767058.2015.1006620; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; Cobo T, 2013, ACTA OBSTET GYN SCAN, V92, P61, DOI 10.1111/aogs.12028; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Edelstam G, 2001, SCAND J CLIN LAB INV, V61, P583, DOI 10.1080/003655101753267937; Ferrazzi E, 2012, J MATERN-FETAL NEO M, V25, P54, DOI 10.3109/14767058.2012.716984; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; GARITE TJ, 1982, OBSTET GYNECOL, V59, P539; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; HAWRYLYSHYN P, 1983, AM J OBSTET GYNECOL, V147, P240, DOI 10.1016/0002-9378(83)91104-3; Higuchi Takakazu, 2016, Prev Med Rep, V4, P417, DOI 10.1016/j.pmedr.2016.08.009; ISMAIL MA, 1985, AM J OBSTET GYNECOL, V151, P541, DOI 10.1016/0002-9378(85)90285-6; Jacobsson B, 2009, ACTA OBSTET GYN SCAN, V88, P63, DOI 10.1080/00016340802572646; Johanzon M, 2008, OBSTET GYNECOL, V111, P42, DOI 10.1097/01.AOG.0000295866.97499.35; Kacerovsky M, 2017, FETAL DIAGN THER; Kacerovsky M, 2017, J MATERN-FETAL NEO M, P1; Kacerovsky M, 2015, AM J OBSTET GYNECOL, V213, P435, DOI 10.1016/j.ajog.2015.05.039; Kacerovsky M, 2015, J MATERN-FETAL NEO M, V28, P134, DOI 10.3109/14767058.2014.908179; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.069; Kacerovsky M, 2014, J MATERN-FETAL NEO M, V27, P1627, DOI 10.3109/14767058.2014.887068; Kacerovsky M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105882; Kacerovsky M, 2014, J MATERN-FETAL NEO M, V27, P155, DOI 10.3109/14767058.2013.806476; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kasper DC, 2010, DIAGN MICR INFEC DIS, V67, P117, DOI 10.1016/j.diagmicrobio.2009.12.023; Kidokoro K, 2006, ACTA OBSTET GYN SCAN, V85, P669, DOI 10.1080/01443610600604432; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kumar D, 2016, PLACENTA, V42, P59, DOI 10.1016/j.placenta.2016.03.015; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Murtha AP, 2015, AM J OBSTET GYNECOL, V213, P447, DOI 10.1016/j.ajog.2015.07.008; Musilova I, 2017, PLOS ONE IN PRESS; Musilova I, 2017, FETAL DIAGN THER; Musilova I, 2017, J MATERN-FETAL NEO M, P1; Musilova I, 2017, J MATERN-FETAL NEO M, V30, P2529, DOI 10.1080/14767058.2016.1255192; Musilova I, 2017, J MATERN-FETAL NEO M, V30, P900, DOI 10.1080/14767058.2016.1197900; Musilova I, 2016, AM J OBSTET GYNECOL, V215, DOI [10.1016/j.ajog.2016.07.005, 10.1016/j.ajog.2016.07.001]; Musilova I, 2016, J MATERN-FETAL NEO M, V29, P2915, DOI 10.3109/14767058.2015.1112372; Musilova I, 2016, J MATERN-FETAL NEO M, V29, P1900, DOI 10.3109/14767058.2015.1074997; Musilova I, 2016, J MATERN-FETAL NEO M, V29, P1, DOI 10.3109/14767058.2014.984606; Musilova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133929; Oh KJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.035; Pfeiffer KA, 1999, ACTA OBSTET GYN SCAN, V78, P774, DOI 10.1034/j.1600-0412.1999.780906.x; Popowski T, 2011, GYNECOL OBSTET FERTI, V39, P302, DOI 10.1016/j.gyobfe.2010.11.006; Rodriguez-Trujillo A, 2016, ACTA OBSTET GYN SCAN, V95, P926, DOI 10.1111/aogs.12905; ROMEM Y, 1984, AM J OBSTET GYNECOL, V150, P546, DOI 10.1016/S0002-9378(84)90437-X; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Sereepapong Wisan, 2001, Journal of the Medical Association of Thailand, V84, pS360; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Smith MR, 2003, ATHEROSCLEROSIS, V169, P331, DOI 10.1016/S0021-9150(03)00200-4; Stepan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150217; Torbe A, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/35782; Vajrychova M, 2016, J MATERN-FETAL NEO M, V29, P12, DOI 10.3109/14767058.2014.991305; Waters TP, 2011, CLIN OBSTET GYNECOL, V54, P307, DOI 10.1097/GRF.0b013e318217d4d3; Yoon BH, 1996, OBSTET GYNECOL, V88, P1034	60	23	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189394	10.1371/journal.pone.0189394	http://dx.doi.org/10.1371/journal.pone.0189394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232399	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200039
J	Rubin, SP; Miller, IM; Foley, MM; Berry, HD; Duda, JJ; Hudson, B; Elder, NE; Beirne, MM; Warrick, JA; McHenry, ML; Stevens, AW; Eidam, EF; Ogston, AS; Gelfenbaum, G; Pedersen, R				Rubin, Stephen P.; Miller, Ian M.; Foley, Melissa M.; Berry, Helen D.; Duda, Jeffrey J.; Hudson, Benjamin; Elder, Nancy E.; Beirne, Matthew M.; Warrick, Jonathan A.; McHenry, Michael L.; Stevens, Andrew W.; Eidam, Emily F.; Ogston, Andrea S.; Gelfenbaum, Guy; Pedersen, Rob			Increased sediment load during a large-scale dam removal changes nearshore subtidal communities	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ELWHA RIVER; KELP FOREST; CENTRAL CALIFORNIA; ORGANIC-MATTER; ROCKY-SHORE; GRAIN-SIZE; OPEN-COAST; FOOD WEBS; WASHINGTON	The coastal marine ecosystem near the Elwha River was altered by a massive sediment influx D over 10 million tonnes D during the staged three-year removal of two hydropower dams. We used time series of bathymetry, substrate grain size, remotely sensed turbidity, scuba dive surveys, and towed video observations collected before and during dam removal to assess responses of the nearshore subtidal community (3 m to 17 m depth). Biological changes were primarily driven by sediment deposition and elevated suspended sediment concentrations. Macroalgae, predominantly kelp and foliose red algae, were abundant before dam removal with combined cover levels greater than 50%. Where persistent sediment deposits formed, macroalgae decreased greatly or were eliminated. In areas lacking deposition, macroalgae cover decreased inversely to suspended sediment concentration, suggesting impacts from light reduction or scour. Densities of most invertebrate and fish taxa decreased in areas with persistent sediment deposition; however, bivalve densities increased where mud deposited over sand, and flatfish and Pacific sand lance densities increased where sand deposited over gravel. In areas without sediment deposition, most invertebrate and fish taxa were unaffected by increased suspended sediment or the loss of algae cover associated with it; however, densities of tubeworms and flatfish, and primary cover of sessile invertebrates increased suggesting benefits of increased particulate matter or relaxed competition with macroalgae for space. As dam removal neared completion, we saw evidence of macroalgal recovery that likely owed to water column clearing, indicating that long-term recovery from dam removal effects may be starting. Our results are relevant to future dam removal projects in coastal areas and more generally to understanding effects of increased sedimentation on nearshore subtidal benthic communities.	[Rubin, Stephen P.; Duda, Jeffrey J.; Elder, Nancy E.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Miller, Ian M.] Washington Sea Grant, Olymp Peninsula Field Off, Port Angeles, WA USA; [Foley, Melissa M.; Warrick, Jonathan A.; Stevens, Andrew W.; Gelfenbaum, Guy] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA USA; [Berry, Helen D.] Washington State Dept Nat Resources, Olympia, WA USA; [Hudson, Benjamin] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Beirne, Matthew M.; McHenry, Michael L.] Lower Elwha Klallam Tribe, Port Angeles, WA USA; [Eidam, Emily F.; Ogston, Andrea S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Pedersen, Rob] US EPA, Reg 10, Seattle, WA USA; [Foley, Melissa M.] Auckland Council, Res & Evaluat Unit RIMU, Auckland, New Zealand; [Hudson, Benjamin] Zillow, Seattle, WA USA; [Eidam, Emily F.] Univ Oregon, Dept Earth Sci, Eugene, OR 97403 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Environmental Protection Agency; University of Oregon	Rubin, SP (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA.	srubin@usgs.gov	Duda, Jeffrey J./A-7132-2009	Duda, Jeffrey J./0000-0001-7431-8634; Miller, Ian/0000-0002-3289-6337; Rubin, Stephen/0000-0003-3054-7173; Eidam, Emily/0000-0002-1906-8692	U.S. Geological Survey's Coastal Habitats in Puget Sound Program; USGS Mendenhall Research Fellowship Program; Coastal and Marine Geology and Ecosystems Mission Areas; U.S. Environmental Protection Agency (EPA)/Puget Sound Partnership Puget Sound Protection and Restoration Tribal Assistance Program (CFDA) [66.121]; Technical Investigations and Implementation Assistance Program (CFDA) [66.123]	U.S. Geological Survey's Coastal Habitats in Puget Sound Program; USGS Mendenhall Research Fellowship Program; Coastal and Marine Geology and Ecosystems Mission Areas; U.S. Environmental Protection Agency (EPA)/Puget Sound Partnership Puget Sound Protection and Restoration Tribal Assistance Program (CFDA); Technical Investigations and Implementation Assistance Program (CFDA)	This work was supported by funding from: U.S. Geological Survey's Coastal Habitats in Puget Sound Program, USGS Mendenhall Research Fellowship Program, and the Coastal and Marine Geology and Ecosystems Mission Areas; the U.S. Environmental Protection Agency (EPA)/Puget Sound Partnership Puget Sound Protection and Restoration Tribal Assistance Program (CFDA#66.121) and the Technical Investigations and Implementation Assistance Program (CFDA#66.123). Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; ALEXANDER RR, 1993, PALAIOS, V8, P289, DOI 10.2307/3515151; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Arkema KK, 2009, ECOLOGY, V90, P3126, DOI 10.1890/08-1213.1; Balamurugan G., 1991, THE ENVIRONMENTALIST, V11, P281, DOI DOI 10.1007/BF01266561; Balata D, 2007, ECOLOGY, V88, P2455, DOI 10.1890/07-0053.1; Bates D, 2017, LME4 LINEAR MIXED EF; Benedetti-Cecchi L, 2001, MARINE ECOLOGY PROGR, V214; Berry H.D, 2005, USING HIST DATA ESTI; Bizzarro JJ, 2016, FISH B-NOAA, V114, P445, DOI 10.7755/FB.114.4.7; Bracken MES, 2012, MAR ECOL PROG SER, V459, P53, DOI 10.3354/meps09764; BRANCH GM, 1990, T ROY SOC S AFR, V47, P331, DOI 10.1080/00359199009520246; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G, V3; Bukaveckas PA, 2014, J ENVIRON QUAL, V43, P1614, DOI 10.2134/jeq2013.12.0481; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; Carney D, 1999, POLAR BIOL, V22, P38, DOI 10.1007/s003000050388; Carney Laura T., 2006, Algae, V21, P161; Chandan HC, 2017, ADV FINANC ACCOUNT E, P1, DOI 10.4018/978-1-5225-1031-4.ch001; Cochrane GR, 2008, SEA FLOOR MAPPING BE, P320; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Curran C, SUSPENDED SEDIMENT C; DALY MA, 1977, MAR BIOL, V43, P45, DOI 10.1007/BF00392570; DANTONIO CM, 1986, MAR ECOL PROG SER, V27, P263, DOI 10.3354/meps027263; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DEYSHER LE, 1986, MAR BIOL, V93, P17, DOI 10.1007/BF00428650; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Duda J.J., 2011, COASTAL HABITATS ELW, P1; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V312, P67, DOI 10.1016/j.jembe.2004.06.005; Eidam EF, 2016, CONT SHELF RES, V116, P136, DOI 10.1016/j.csr.2016.01.009; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; Eriksson BK, 2005, OECOLOGIA, V143, P438, DOI 10.1007/s00442-004-1810-1; FARROW GE, 1983, CAN J FISH AQUAT SCI, V40, P273, DOI 10.1139/f83-289; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Figurski JD, 2016, MAR ECOL PROG SER, V552, P19, DOI 10.3354/meps11763; Finlayson D. P., 2005, COMBINED BATHYMETRY; Finlayson DP, 2011, BATHYMETRY ACOUSTIC, P2011; Fjeldstad HP, 2012, RIVER RES APPL, V28, P753, DOI 10.1002/rra.1529; Foley MM, 2017, WATER RESOUR RES, V53, P5229, DOI 10.1002/2017WR020457; Foley MM, 2017, ECOL MONOGR, V87, P552, DOI 10.1002/ecm.1268; Foley MM, 2015, LIMNOL OCEANOGR, V60, P1719, DOI 10.1002/lno.10129; Foley MM, 2017, EPHEMERAL SEAFLOOR S; Fryirs K, 2013, EARTH SURF PROC LAND, V38, P30, DOI 10.1002/esp.3242; Gelfenbaum G, 2009, MODELING SEDIMENT TR; Gelfenbaum G, 2015, GEOMORPHOLOGY, V246, P649, DOI 10.1016/j.geomorph.2015.01.002; GERARD VA, 1988, MAR BIOL, V97, P25, DOI 10.1007/BF00391242; Goff JR, 1997, MAR GEOL, V138, P105, DOI 10.1016/S0025-3227(97)00018-2; Graham MH, 2002, MAR BIOL, V140, P901, DOI 10.1007/s00227-001-0761-x; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Grant GE, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 3: RIVER BASINS, RESERVOIR SEDIMENTATION AND WATER RESOURCES, P31, DOI 10.1007/978-3-319-09054-2_7; Hawkins AJS, 1996, MAR ECOL PROG SER, V131, P179, DOI 10.3354/meps131179; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hudson B, 2014, CRYOSPHERE, V8, P1161, DOI 10.5194/tc-8-1161-2014; Ibisate A, 2016, EARTH SURF PROC LAND, V41, P2239, DOI 10.1002/esp.4023; Johansson G, 1998, HYDROBIOLOGIA, V385, P121, DOI 10.1023/A:1003405826222; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Komar P., 1997, BEACH PROCESSES SEDI; LEWIS JB, 1984, CAN J ZOOL, V62, P2023, DOI 10.1139/z84-296; LITTLER MM, 1984, J EXP MAR BIOL ECOL, V74, P13, DOI 10.1016/0022-0981(84)90035-2; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; Lohrer AM, 2004, MAR ECOL PROG SER, V273, P121, DOI 10.3354/meps273121; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; LUNING K, 1978, MAR BIOL, V45, P297, DOI 10.1007/BF00391816; LUNING K, 1980, J PHYCOL, V16, P1; Magilligan F, 2017, POLITICS FRESH WATER; Magirl CS, 2015, GEOMORPHOLOGY, V246, P669, DOI 10.1016/j.geomorph.2014.12.032; Major J. J., 2017, GRAVELBED RIVERS PRO, P355; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; MARINe, PAC ROCK INT MON TRE; McCulloch M, 2003, EARTH PLANET SC LETT, V210, P249, DOI 10.1016/S0012-821X(03)00145-6; Miller IM, 2011, MAR GEOL, V282, P201, DOI 10.1016/j.margeo.2011.02.012; NOAA. NOAA Center for Operational Products and Services (CO-OPS), 2016, 9444090 NOAA; Norris JG, 1997, AQUAT BOT, V58, P269, DOI 10.1016/S0304-3770(97)00040-5; Norris JG, 2011, DEFINING FISH USE SU; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; Page HM, 2008, MAR ECOL PROG SER, V360, P47, DOI 10.3354/meps07382; PETERSON CH, 1985, PALEOBIOLOGY, V11, P139; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Pizzuto J, 2002, BIOSCIENCE, V52, P683, DOI 10.1641/0006-3568(2002)052[0683:EODROR]2.0.CO;2; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Pulfrich A, 2003, AQUAT CONSERV, V13, P233, DOI 10.1002/aqc.542; Pulfrich A, 2014, ESTUAR COAST SHELF S, V150, P179, DOI 10.1016/j.ecss.2013.10.017; Pulfrich A, 2014, ESTUAR COAST SHELF S, V150, P165, DOI 10.1016/j.ecss.2013.08.002; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Reed DC, 2000, ECOLOGY, V81, P2011; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosario-Martinez HD, 2015, PHIA POSTHOC INTERAC; Rubin SP, 2011, COASTAL HABITATS ELW, P131; Ryan Bellmore J, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1164; SANTOS R, 1993, MAR ECOL PROG SER, V94, P181, DOI 10.3354/meps094181; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; SCHROETER SC, 1993, ECOL APPL, V3, P331, DOI 10.2307/1941836; Seavey F, 1995, MARINE RESOURCES ELW; Shaffer JA, 2008, NORTHWEST SCI, V82, P48, DOI 10.3955/0029-344X-82.S.I.48; Shaffer JA, 2017, AQUAT SCI, V79, P643, DOI 10.1007/s00027-017-0526-3; Slattery M, 1997, POLAR BIOL, V18, P172, DOI 10.1007/s003000050174; Spalding H, 2003, J PHYCOL, V39, P273, DOI 10.1046/j.1529-8817.2003.02010.x; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stevens AW, 2014, BATHYMETRY TOPOGRAPH; Stoner AW, 2007, J SEA RES, V57, P137, DOI 10.1016/j.seares.2006.08.005; Storlazzi CD, 2013, CONT SHELF RES, V55, P40, DOI 10.1016/j.csr.2013.01.013; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Team RC, 2017, THE R STATS PACKAGE; Thomson RE, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003925; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2003, ECOL APPL, V13, P1433, DOI 10.1890/02-5198; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; VADAS RL, 1988, J PHYCOL, V24, P338; VOGT H, 1991, MAR ECOL PROG SER, V69, P189, DOI 10.3354/meps069189; WADNR, 2015, PUG SOUND SUBM VEG M; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Warrick JA, 2007, BEACH MORPHOLOGY MON, P288; Warrick JA, 2015, GEOMORPHOLOGY, V246, P729, DOI 10.1016/j.geomorph.2015.01.010; Warrick JA, 2011, CONT SHELF RES, V31, P85, DOI 10.1016/j.csr.2010.11.007; Warrick JA, 2009, GEOMORPHOLOGY, V111, P136, DOI 10.1016/j.geomorph.2009.04.012; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Wood SN, 2017, MGCV MIXED GAM COMPU; Yorke AF, 2012, AQUAT BIOL, V16, P17, DOI 10.3354/ab00419; Young SM, 2014, ENVIRON EARTH SCI, V72, P2301, DOI 10.1007/s12665-014-3139-3	123	18	18	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187742	10.1371/journal.pone.0187742	http://dx.doi.org/10.1371/journal.pone.0187742			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220368	gold, Green Published			2022-12-26	WOS:000417469900006
J	Dedman, S; Officer, R; Clarke, M; Reid, DG; Brophy, D				Dedman, Simon; Officer, Rick; Clarke, Maurice; Reid, David G.; Brophy, Deirdre			Gbm.auto: A software tool to simplify spatial modelling and Marine Protected Area planning	PLOS ONE			English	Article							MANAGEMENT; JUVENILE; DESIGN; TRENDS	Boosted Regression Trees. Excellent for data-poor spatial management but hard to use Marine resource managers and scientists often advocate spatial approaches to manage data-poor species. Existing spatial prediction and management techniques are either insufficiently robust, struggle with sparse input data, or make suboptimal use of multiple explanatory variables. Boosted Regression Trees feature excellent performance and are well suited to modelling the distribution of data-limited species, but are extremely complicated and time-consuming to learn and use, hindering access for a wide potential user base and therefore limiting uptake and usage. BRTs automated and simplified for accessible general use with rich feature set We have built a software suite in R which integrates pre-existing functions with new tailor-made functions to automate the processing and predictive mapping of species abundance data: by automating and greatly simplifying Boosted Regression Tree spatial modelling, the gbm. auto R package suite makes this powerful statistical modelling technique more accessible to potential users in the ecological and modelling communities. The package and its documentation allow the user to generate maps of predicted abundance, visualise the representativeness of those abundance maps and to plot the relative influence of explanatory variables and their relationship to the response variables. Databases of the processed model objects and a report explaining all the steps taken within the model are also generated. The package includes a previously unavailable Decision Support Tool which combines estimated escapement biomass (the percentage of an exploited population which must be retained each year to conserve it) with the predicted abundance maps to generate maps showing the location and size of habitat that should be protected to conserve the target stocks (candidate MPAs), based on stakeholder priorities, such as the minimisation of fishing effort displacement. Gbm.auto for management in various settings By bridging the gap between advanced statistical methods for species distribution modelling and conservation science, management and policy, these tools can allow improved spatial abundance predictions, and therefore better management, decision-making, and conservation. Although this package was built to support spatial management of a data-limited marine elasmobranch fishery, it should be equally applicable to spatial abundance modelling, area protection, and stakeholder engagement in various scenarios.	[Dedman, Simon; Officer, Rick; Brophy, Deirdre] Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland; [Dedman, Simon; Clarke, Maurice; Reid, David G.] Inst Marine, Oranmore, Galway, Ireland	Galway Mayo Institute of Technology; Marine Institute Ireland	Dedman, S (corresponding author), Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland.; Dedman, S (corresponding author), Inst Marine, Oranmore, Galway, Ireland.	simondedman@gmail.com	Reid, David/ABC-5916-2021; Dedman, Simon/E-9668-2017	Dedman, Simon/0000-0002-9108-972X; Officer, Rick/0000-0003-4496-1367; Brophy, Deirdre/0000-0003-4111-762X	European Community's Seventh Framework Programme [289257]; Beaufort Marine Research Award; Marine Institute - Marine Research Sub-Programme of the National Development Plan	European Community's Seventh Framework Programme(European Commission); Beaufort Marine Research Award; Marine Institute - Marine Research Sub-Programme of the National Development Plan	Research funding was received from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH number 289257. DGR also acknowledges funding from a Beaufort Marine Research Award, carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeare SM, 2009, THESIS; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; CBD (Convention on Biological Diversity), 2012, AICH BIOD TARG; Christie P, 2004, AM FISH S S, V42, P155; Dedman S, 2016, ICES J MAR SCI; Dedman S, 2017, FISHES-BASEL, V2, DOI 10.3390/fishes2030012; Dedman S, 2015, ECOL MODEL, V312, P77, DOI 10.1016/j.ecolmodel.2015.05.010; Delavenne J, 2011, ICES J MAR SCI; Derous S, 2007, OCEANOLOGIA, V49; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellis J.R., 2010, UK FISHERIES SKATES; Ellis JR, 2008, ADVANCES IN FISHERIES SCIENCE: 50 YEARS ON FROM BEVERTON AND HOLT, P184, DOI 10.1002/9781444302653.ch9; Froeschke J., 2013, SEDAR34WP12; Froeschke JT, 2011, FISH RES, V111, P131, DOI 10.1016/j.fishres.2011.07.008; Fulton EA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0278; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; ICES WKLIFE, 2012, ICES IMPL RGLIFE ADV; International Council for the Exploration of the SeaWorking Group on Elasmobranch Fishes (ICES WGEF), 2012, REP WORK GROUP EL FI; International Council for the Exploration of the SeaWorking Group on Elasmobranch Fishes (ICES WGEF), 2012, ICES ADV RAYS SKAT S; IUCN, 2015, IUCN RED LIST CAT SU; Johnston G., 2014, SPAWNING NURSERY ARE; Kelleher G., 1999, GUIDELINES MARINE PR; Kendall MS, 2008, OCEAN COAST MANAGE, V51, P815, DOI 10.1016/j.ocecoaman.2008.09.004; Klein CJ, 2013, CONSERV LETT, V6, P324, DOI 10.1111/conl.12005; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Loos S.A., 2006, THESIS; Musick J.A, 2005, MANAGEMENT TECHNIQUE; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Rassweiler A, 2012, P NATL ACAD SCI USA, V109, P11884, DOI 10.1073/pnas.1116193109; Ridgeway G, 2006, GEN BOOSTED MODELS G, P1; Sale PF, 2008, MAR POLLUT BULL, V56, P805, DOI 10.1016/j.marpolbul.2008.04.009; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stortini CH, 2015, J NAT CONSERV, V23, P45, DOI 10.1016/j.jnc.2014.07.004; Suuronen P, 2010, MAR POLICY, V34, P237, DOI 10.1016/j.marpol.2009.07.001; Teh LCL, 2012, MAR POLICY, V36, P1290, DOI 10.1016/j.marpol.2012.04.010; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Vincent M. A., 2004, MARINE NATURE CONSER; Walsh JC, 2015, INVENTORY BARRIERS S; Walsh JC, 2013, ORYX, V47, P134, DOI 10.1017/S003060531100161X; Warton DI, 2015, PLANT ECOL, V216, P669, DOI 10.1007/s11258-014-0366-3; Young JC, 2013, BIOL CONSERV, V158, P359, DOI 10.1016/j.biocon.2012.08.018	50	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188955	10.1371/journal.pone.0188955	http://dx.doi.org/10.1371/journal.pone.0188955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216310	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800052
J	Nilsson, A; Johansson, C; Skarp, A; Kaden, R; Engstrand, L; Rautelin, H				Nilsson, Anna; Johansson, Cecilia; Skarp, Astrid; Kaden, Rene; Engstrand, Lars; Rautelin, Hilpi			Genomic and phenotypic characteristics of Swedish C. jejuni water isolates	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI; LOCUS CLASS; SURVIVAL; COLI; BIOFILMS; INVASION; IDENTIFICATION; INTERLEUKIN-8; ORGANIZATION; RESISTANCE	Campylobacter jejuni is the most common cause of bacterial gastroenteritis. Major reservoirs are warm-blooded animals, poultry in particular, but Campylobacter can also be transmitted via water. In this paper, we have taken a closer look at the biology and potential virulence of C. jejuni water isolates. Seven C. jejuni isolates from incoming surface water at water plants in Sweden were characterized with whole genome sequencing and phenotypical testing. Multi locus sequence typing analysis revealed that these isolates belonged to groups known to include both common (ST48CC) and uncommon (ST1275CC, ST683, ST793 and ST8853) human pathogens. Further genomic characterization revealed that these isolates had potential for arsenic resistance (due to presence of arsB gene in all isolates), an anaerobic dimethyl sulfoxide oxidoreductase (in three isolates) and lacked the MarR-type transcriptional regulator gene rrpB (in all but one isolate) earlier shown to be involved in better survival under oxidative and aerobic stress. As putative virulence factors were concerned, there were differences between the water isolates in the presence of genes coding for cytolethal distending toxin (cdtABC), Type VI secretion system and sialylated LOS, as well as in biofilm formation. However, all isolates were motile and could adhere to and invade the human HT-29 colon cancer cell line in vitro and induce IL-8 secretion suggesting potential to infect humans. This is, to the best of our knowledge, the first study where C. jejuni water isolates have been characterized using whole genome sequencing and phenotypical assays. We found differences and shared traits among the isolates but also potential to infect humans.	[Nilsson, Anna; Johansson, Cecilia; Skarp, Astrid; Kaden, Rene; Rautelin, Hilpi] Uppsala Univ, Clin Microbiol, Dept Med Sci, Uppsala, Sweden; [Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Engstrand, Lars] Sci Life Lab, Stockholm, Sweden; [Skarp, Astrid] Rotterdam Univ Appl Sci, Sch Engn & Appl Sci, Biol & Med Lab Res, Rotterdam, Netherlands	Uppsala University; Karolinska Institutet	Rautelin, H (corresponding author), Uppsala Univ, Clin Microbiol, Dept Med Sci, Uppsala, Sweden.	hilpi.rautelin@medsci.uu.se	Nilsson, Anna/AAJ-6974-2020; Nilsson, Anna/M-4660-2019; Johansson, Cecilia/B-4751-2019; Johansson, Cecilia/O-9433-2019; Kaden, Rene/T-8840-2017	Nilsson, Anna/0000-0001-9219-2385; Johansson, Cecilia/0000-0001-5965-2853; Kaden, Rene/0000-0002-2111-9751; Rautelin, Hilpi/0000-0002-9692-8473	Swedish Research Council FORMAS [221-2012-1442]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Swedish Research Council FORMAS www.formas.se (grant 221-2012-1442) (HR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048394; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Carter PE, 2009, APPL ENVIRON MICROB, V75, P6038, DOI 10.1128/AEM.01039-09; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Cools I, 2003, J APPL MICROBIOL, V94, P886, DOI 10.1046/j.1365-2672.2003.01916.x; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Curtis D, 2014, J FOOD SCI, V79, pR1871, DOI 10.1111/1750-3841.12646; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Ekseth OK, 2014, BIOINFORMATICS, V30, P734, DOI 10.1093/bioinformatics/btt582; Ellis-Iversen J, 2009, J FOOD PROTECT, V72, P490, DOI 10.4315/0362-028X-72.3.490; Ellstrom P, 2013, INT J MED MICROBIOL, V303, P134, DOI 10.1016/j.ijmm.2013.01.005; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; EVEREST PH, 1992, J MED MICROBIOL, V37, P319, DOI 10.1099/00222615-37-5-319; FAUCHERE JL, 1986, INFECT IMMUN, V54, P283, DOI 10.1128/IAI.54.2.283-287.1986; Gonzalez M, 2009, APPL ENVIRON MICROB, V75, P1208, DOI 10.1128/AEM.01879-08; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Gundogdu O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02117; Gundogdu O, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00724; Guzman-Herrador B, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21160; Habib I, 2009, APPL ENVIRON MICROB, V75, P4277, DOI 10.1128/AEM.02269-08; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Hanninen ML, 1998, J VET MED B, V45, P37, DOI 10.1111/j.1439-0450.1998.tb00764.x; HATTON AD, 1994, ANAL CHEM, V66, P4093, DOI 10.1021/ac00094a036; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; JONES DM, 1991, J GEN MICROBIOL, V137, P2477, DOI 10.1099/00221287-137-10-2477; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Pascoe B, 2015, ENVIRON MICROBIOL, V17, P4779, DOI 10.1111/1462-2920.13051; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Revez J, 2012, EUR J CLIN MICROBIOL, V31, P2203, DOI 10.1007/s10096-012-1556-3; Revez J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026880; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Schonberg-Norio D, 2004, EMERG INFECT DIS, V10, P1474, DOI 10.3201/eid1008.030924; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Shen ZQ, 2014, ANTIMICROB AGENTS CH, V58, P2021, DOI 10.1128/AAC.02137-13; Shen ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058894; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Skarp CPA, 2017, INT J MED MICROBIOL, V307, P233, DOI 10.1016/j.ijmm.2017.04.001; Skarp-de Haan CPA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-129; SKIRROW MB, 1991, INT J FOOD MICROBIOL, V12, P9, DOI 10.1016/0168-1605(91)90044-P; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; Thomas C, 1999, J APPL MICROBIOL, V85, p168S, DOI 10.1111/j.1365-2672.1998.tb05296.x; Trigui H, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1595-1; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189222	10.1371/journal.pone.0189222	http://dx.doi.org/10.1371/journal.pone.0189222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216271	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800098
J	van der Zwaard, S; van der Laarse, WJ; Weide, G; Bloemers, FW; Hofmijster, MJ; Levels, K; Noordhof, DA; de Koning, JJ; de Ruiter, CJ; Jaspers, RT				van der Zwaard, Stephan; van der Laarse, Willem J.; Weide, Guido; Bloemers, Frank W.; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Koning, Jos J.; de Ruiter, Cornelis J.; Jaspers, Richard T.			Critical determinants of combined sprint and endurance performance: an integrative analysis from muscle fiber to the human body	FASEB JOURNAL			English	Article						skeletal muscle; oxidative capacity; oxygen transport; muscle architecture; muscle biopsy	HUMAN SKELETAL-MUSCLE; QUADRICEPS FEMORIS MUSCLE; HEART-FAILURE PATIENTS; CALIBRATED HISTOCHEMISTRY; MYOGLOBIN CONCENTRATION; VELOCITY RELATIONSHIPS; CONTRACTILE PROPERTIES; EXERCISE PERFORMANCE; ANAEROBIC THRESHOLD; OXIDATIVE CAPACITY	Optimizing physical performance is a major goal in current physiology. However, basic understanding of combining high sprint and endurance performance is currently lacking. This study identifies critical determinants of combined sprint and endurance performance using multiple regression analyses of physiologic determinants at different biologic levels. Cyclists, including 6 international sprint, 8 team pursuit, and 14 road cyclists, completed a Wingate test and 15-km time trial to obtain sprint and endurance performance results, respectively. Performance was normalized to lean body mass(2/3) to eliminate the influence of body size. Performance determinants were obtained from whole-body oxygen consumption, blood sampling, knee-extensor maximal force, muscle oxygenation, whole-muscle morphology, and muscle fiber histochemistry of musculus vastus lateralis. Normalized sprint performance was explained by percentage of fast-type fibers and muscle volume (R-2 = 0.65; P < 0.001) and normalized endurance performance by performance oxygen consumption (V.o(2)), mean corpuscular hemoglobin concentration, and muscle oxygenation (R-2 = 0.92; P < 0.001). Combined sprint and endurance performance was explained by gross efficiency, performance V.o(2), and likely by muscle volume and fascicle length (P = 0.056; P = 0.059). High performance V.o(2) related to a high oxidative capacity, high capillarization x myoglobin, and small physiologic cross-sectional area (R-2 = 0.67; P < 0.001). Results suggest that fascicle length and capillarization are important targets for training to optimize sprint and endurance performance simultaneously.	[van der Zwaard, Stephan; Weide, Guido; Jaspers, Richard T.] VU Univ Med Ctr Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands; [van der Zwaard, Stephan; Weide, Guido; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Koning, Jos J.; de Ruiter, Cornelis J.; Jaspers, Richard T.] VU Univ Med Ctr Amsterdam, Fac Behav & Movement Sci, Lab Myol, Amsterdam, Netherlands; [Bloemers, Frank W.] VU Univ Med Ctr Amsterdam, Amsterdam Movement Sci, Dept Trauma Surg, Amsterdam, Netherlands; [van der Laarse, Willem J.] VU Univ Med Ctr Amsterdam, Inst Cardiovasc Res, Dept Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Jaspers, RT (corresponding author), Vrije Univ, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, De Boelelaan 1108,van der Boechorststr 9, NL-1081 BT Amsterdam, Netherlands.	r.t.jaspers@vu.nl	van der Zwaard, Stephan/J-9622-2019; Bloemers, Frank/P-5436-2019; Noordhof, Dionne/AFR-6657-2022	van der Zwaard, Stephan/0000-0002-8296-828X; Bloemers, Frank/0000-0002-8393-4946; Jaspers, Richard/0000-0002-6951-0952; van der Laarse, Willem J/0000-0002-8391-0354; de Koning, Jos J/0000-0002-5596-0282	Dutch Olympic Committee-Dutch Sports Federation (NOC*NSF); Royal Dutch Cycling Federation (KNSB); Royal Dutch Rowing Federation (KNRB); Center for Elite Sports and Education (CTO) Amsterdam; TulipMed; Artinis Medical Systems; SporterOnline; b-Cat High Altitude; Foundation for Technical Sciences (STW) of the Netherlands Organization for Scientific Research (NWO) [12891]	Dutch Olympic Committee-Dutch Sports Federation (NOC*NSF); Royal Dutch Cycling Federation (KNSB); Royal Dutch Rowing Federation (KNRB); Center for Elite Sports and Education (CTO) Amsterdam; TulipMed; Artinis Medical Systems; SporterOnline; b-Cat High Altitude; Foundation for Technical Sciences (STW) of the Netherlands Organization for Scientific Research (NWO)	The authors thank Wendy Noort, David Comerford, Wouter Ruchtie, Jelmer Nuijten, Victor Vane, Niels Daems, Niels Waterval, Nienke de Jong, Isabelle van Dongen and Myriam Sillevis Smitt (Vrije Universiteit Amsterdam) for their excellent assistance with the data collection. The authors thank the Dutch Olympic Committee-Dutch Sports Federation (NOC*NSF), The Royal Dutch Cycling Federation (KNSB), the Royal Dutch Rowing Federation (KNRB), the Center for Elite Sports and Education (CTO) Amsterdam, TulipMed, Artinis Medical Systems, SporterOnline, and b-Cat High Altitude for their support. This work was supported by the Foundation for Technical Sciences (STW) of the Netherlands Organization for Scientific Research (NWO) under Grant 12891. The authors declare no conflicts of interest.	Abe T, 2000, MED SCI SPORT EXER, V32, P1125, DOI 10.1097/00005768-200006000-00014; Andersen JL, 2010, SCAND J MED SCI SPOR, V20, P32, DOI 10.1111/j.1600-0838.2010.01196.x; Andersen JL, 2000, SCI AM, V283, P48, DOI 10.1038/scientificamerican0900-48; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Atkinson G, 2003, J SPORT SCI, V21, P767, DOI 10.1080/0264041031000102097; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bekedam MA, 2003, CLIN PHYSIOL FUNCT I, V23, P337, DOI 10.1046/j.1475-0961.2003.00517.x; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Blazevich AJ, 2003, MED SCI SPORT EXER, V35, P2013, DOI 10.1249/01.MSS.0000099092.83611.20; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Calbet JAL, 2003, J APPL PHYSIOL, V94, P668, DOI 10.1152/japplphysiol.00128.2002; Coffey VG, 2017, J PHYSIOL-LONDON, V595, P2883, DOI 10.1113/JP272270; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; COYLE EF, 1988, J APPL PHYSIOL, V64, P2622, DOI 10.1152/jappl.1988.64.6.2622; COYLE EF, 1991, MED SCI SPORT EXER, V23, P93; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; COYLE EF, 1986, J APPL PHYSIOL, V60, P95, DOI 10.1152/jappl.1986.60.1.95; Craig NP, 2001, SPORTS MED, V31, P457, DOI 10.2165/00007256-200131070-00001; de Koning JJ, 2012, INT J SPORTS MED, V33, P880, DOI 10.1055/s-0032-1306285; Des Tombe AL, 2002, MICROSC RES TECHNIQ, V58, P412, DOI 10.1002/jemt.10153; Dorel S, 2005, INT J SPORTS MED, V26, P739, DOI 10.1055/s-2004-830493; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ema R, 2016, SCAND J MED SCI SPOR, V26, P782, DOI 10.1111/sms.12511; Erskine RM, 2010, ACTA PHYSIOL, V199, P83, DOI 10.1111/j.1748-1716.2010.02085.x; Erskine RM, 2009, EUR J APPL PHYSIOL, V106, P827, DOI 10.1007/s00421-009-1085-7; Faria EW, 2005, SPORTS MED, V35, P313, DOI 10.2165/00007256-200535040-00003; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Franchi MV, 2014, ACTA PHYSIOL, V210, P642, DOI 10.1111/apha.12225; Gardner SA., 2005, INT J PERFORM ANAL S, V5, P149, DOI [10.1080/24748668.2005.11868345, DOI 10.1080/24748668.2005.11868345]; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Hautier CA, 1996, EUR J APPL PHYSIOL, V74, P114, DOI 10.1007/BF00376503; He ZH, 2000, BIOPHYS J, V79, P945, DOI 10.1016/S0006-3495(00)76349-1; Hill AV., 1965, TRAILS TRIALS PHYSL; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hoppeler H, 2001, J EXP BIOL, V204, P3133; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; Huijing PA, 1998, J ELECTROMYOGR KINES, V8, P61, DOI 10.1016/S1050-6411(97)00023-0; JACOBS I, 1983, J APPL PHYSIOL, V55, P365, DOI 10.1152/jappl.1983.55.2.365; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; KINDERMANN W, 1979, EUR J APPL PHYSIOL O, V42, P25, DOI 10.1007/BF00421101; Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Lee-de Groot MBE, 1998, J HISTOCHEM CYTOCHEM, V46, P1077; Lucia A, 2001, SPORTS MED, V31, P325, DOI 10.2165/00007256-200131050-00004; Martin JC, 2007, INT J SPORT PHYSIOL, V2, P5, DOI 10.1123/ijspp.2.1.5; Martin JC, 2000, J GERONTOL A-BIOL, V55, pM311, DOI 10.1093/gerona/55.6.M311; Martin JC, 1997, MED SCI SPORT EXER, V29, P1505, DOI 10.1097/00005768-199711000-00018; Mujika I, 2001, SPORTS MED, V31, P479, DOI 10.2165/00007256-200131070-00003; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Pearson SJ, 2006, MED SCI SPORT EXER, V38, P1601, DOI 10.1249/01.mss.0000227638.75983.9d; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Peters EL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091889; Plas RLC, 2015, J EXP BIOL, V218, P2166, DOI 10.1242/jeb.117655; POOL CW, 1979, HISTOCHEMISTRY, V64, P251, DOI 10.1007/BF00495025; Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004; Qu ZQ, 1997, HISTOCHEM CELL BIOL, V107, P169, DOI 10.1007/s004180050101; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P603, DOI 10.1111/sms.12104; Saltin B, 1977, Ann N Y Acad Sci, V301, P3, DOI 10.1111/j.1749-6632.1977.tb38182.x; Saltin B, 2010, COMPREHENSIVE PHYSL; Santalla A, 2012, INT J SPORT PHYSIOL, V7, P200, DOI 10.1123/ijspp.7.3.200; SCHENAU GJV, 1994, SPORTS MED, V17, P259, DOI 10.2165/00007256-199417040-00006; SIECK GC, 1995, J APPL PHYSIOL, V79, P1629, DOI 10.1152/jappl.1995.79.5.1629; Trappe S, 2015, J APPL PHYSIOL, V118, P1460, DOI 10.1152/japplphysiol.00037.2015; van Beek-Harmsen BJ, 2004, HISTOCHEM CELL BIOL, V121, P335, DOI 10.1007/s00418-004-0641-9; van der Laarse WJ, 2005, J APPL PHYSIOL, V99, P2173, DOI 10.1152/japplphysiol.00470.2005; van der Zwaard S, 2017, MED SCI SPORT EXER, V49, P768, DOI 10.1249/01.mss.0000519047.24644.bc; van der Zwaard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162914; van der Zwaard S, 2016, J APPL PHYSIOL, V121, P636, DOI 10.1152/japplphysiol.00355.2016; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; VONDOBELN W, 1956, ACTA PHYSIOL SCAND, V38, P193; WASSERMAN K, 1987, CIRCULATION, V76, P29; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Weide G, 2017, JOVE-J VIS EXP, DOI 10.3791/55943; WICKIEWICZ TL, 1984, J APPL PHYSIOL, V57, P435, DOI 10.1152/jappl.1984.57.2.435	81	28	28	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2110	2123		10.1096/fj.201700827R	http://dx.doi.org/10.1096/fj.201700827R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217665	Green Submitted			2022-12-26	WOS:000429051400031
J	Chung, RWS; Wang, ZN; Bursill, CA; Wu, BJ; Bailee, PJ; Rye, KA				Chung, Rosanna W. S.; Wang, Zeneng; Bursill, Christina A.; Wu, Ben J.; Bailee, Philip J.; Rye, Kerry-Anne			Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PLASMA SPHINGOMYELIN; SPHINGOLIPID METABOLISM; INTESTINAL-TRACT; LIVER STEATOSIS; GUT MICROBIOTA; RISK-FACTOR; SYNTHASE 2; CHOLESTEROL; PHOSPHATIDYLCHOLINE	Sphingomyelin (SM) levels in the circulation correlate positively with atherosclerosis burden. SM is a ubiquitous component of human diets, but it is unclear if dietary SM increases circulating SM levels. Dietary choline increases atherosclerosis by raising circulating trimethylamine N-oxide (TMAO) levels in mice and humans. As SM has a choline head group, we ask in this study if dietary SM accelerates atherosclerotic lesion development by increasing circulating SM and TMAO levels. Three studies were performed: (Study 1) C57BL/6 mice were maintained on a high fat diet with or without SM supplementation for 4 weeks prior to quantification of serum TMAO and SM levels; (Study 2) atherosclerosis was studied in apoE(-/-) mice after 16 weeks of a high fat diet without or with SM supplementation and (Study 3) apoE(-/-) mice were maintained on a chow diet for 19 weeks without or with SM supplementation and antibiotic treatment prior to quantification of atherosclerotic lesions and serum TMAO and SM levels. SM consumption did not increase circulating SM levels or atherosclerosis in high fat-fed apoE(-/-) mice. Serum TMAO levels in C57BL/6 mice were low and had no effect atherosclerosis lesion development. Dietary SM supplementation significantly reduced atherosclerotic lesion area in the aortic arch of chow-fed apoE(-/-) mice. This study establishes that dietary SM does not affect circulating SM levels or increase atherosclerosis in high fat-fed apoE(-/-) mice, but it is anti-atherogenic in chow-fed apoE(-/-) mice.	[Chung, Rosanna W. S.] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia; [Wang, Zeneng] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Bursill, Christina A.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Wu, Ben J.; Bailee, Philip J.; Rye, Kerry-Anne] Univ New South Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia; [Chung, Rosanna W. S.] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden	University of Sydney; Heart Research Institute; Cleveland Clinic Foundation; South Australian Health & Medical Research Institute (SAHMRI); University of New South Wales Sydney; Linkoping University	Rye, KA (corresponding author), Univ New South Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia.	k.rye@unsw.edu.au	Wang, Zeneng/AAK-6119-2021	Wu, Ben/0000-0003-2826-4190; Chung, Wing Shan Rosanna/0000-0001-9959-5849; Rye, Kerry-Anne/0000-0002-9751-917X; Bursill, Christina/0000-0002-0682-8760	National Health and Medical Research Council of Australia [APP1037903]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) Grant APP1037903 to PJB and KAR. The funding body had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Chung RWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055949; Duivenvoorden I, 2006, AM J CLIN NUTR, V84, P312; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Jenkins DJA, 2005, METABOLISM, V54, P103, DOI 10.1016/j.metabol.2004.07.019; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Murgia S, 2003, LIPIDS, V38, P585, DOI 10.1007/s11745-003-1500-3; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; NILSSON A, 1968, BIOCHIM BIOPHYS ACTA, V164, P575, DOI 10.1016/0005-2760(68)90187-2; Norris GH, 2016, J NUTR BIOCHEM, V30, P93, DOI 10.1016/j.jnutbio.2015.12.003; Nyberg L, 2000, J NUTR BIOCHEM, V11, P244, DOI 10.1016/S0955-2863(00)00069-3; Nyberg L, 1997, J NUTR BIOCHEM, V8, P112, DOI 10.1016/S0955-2863(97)00010-7; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Ramstedt B, 1999, EUR J BIOCHEM, V266, P997, DOI 10.1046/j.1432-1327.1999.00938.x; SAMUEL P, 1973, CIRC RES, V33, P393, DOI 10.1161/01.RES.33.4.393; Schlitt A, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-5; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yunki K, 2010, J AGR FOOD CHEM, V58, P7030, DOI 10.1021/jf100722f; Yunoki K, 2008, BIOSCI BIOTECH BIOCH, V72, P222, DOI 10.1271/bbb.70463; Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007; Zhang Y, 2011, J LIPID RES, V52, P771, DOI 10.1194/jlr.M012880	26	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189523	10.1371/journal.pone.0189523	http://dx.doi.org/10.1371/journal.pone.0189523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240800	Green Published, gold			2022-12-26	WOS:000417905600043
J	Tran, HM; Truong, VT; Ngo, TMN; Bui, QPV; Nguyen, HC; Le, TTQ; Mazur, W; Chung, E; Cafardi, JM; Pham, KPN; Duong, HHN; Nguyen, T; Nguyen, VT; Pham, VN				Tran, Hoang M.; Truong, Vien T.; Ngo, Tam M. N.; Bui, Quoc P. V.; Nguyen, Hoang C.; Le, Trung T. Q.; Mazur, Wojciech; Chung, Eugene; Cafardi, John M.; Pham, Khanh P. N.; Duong, Hoang H. N.; Thach Nguyen; Nguyen, Vu T.; Pham, Vinh N.			Microbiological profile and risk factors for inhospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; STAPHYLOCOCCUS-AUREUS; VALVE ENDOCARDITIS; DEVELOPING-COUNTRY; EPIDEMIOLOGY; MULTICENTER; GUIDELINES; PREDICTORS; DIAGNOSIS; ETIOLOGY	Objectives We aimed to evaluate the microbiological characteristics and risk factors for mortality of infective endocarditis in two tertiary hospitals in Ho Chi Minh City, south Vietnam. Materials and methods A retrospective study of 189 patients (120 men, 69 women; mean age 38 +/- 18 years) with the diagnosis of probable or definite infective endocarditis (IE) according to the modified Duke Criteria admitted to The Heart Institute or Tam Duc Hospital between January 2005 and December 2014. Results IE was related to a native valve in 165 patients (87.3%), and prosthetic valve in 24 (12.7%). Of the 189 patients in our series, the culture positive rate was 70.4%. The most common isolated pathogens were Streptococci (75.2%), Staphylococci (9.8%) followed by gram negative organism (4.5%). The sensitivity rate of Streptococci to ampicillin, ceftriaxone or vancomycin was 100%. The rate of methicillin resistant Staphylococcus aureus was 40%. There was a decrease in penicillin sensitivity for Streptococci over three eras: 2005 +/- 2007 (100%), 2008 +/- 2010 (94%) and 2010 +/- 2014 (84%). The in-hospital mortality rate was 6.9%. Logistic regression analysis found prosthetic valve and NYHA grade 3 or 4 heart failure and vegetation size of more than 15 mm as strong predictors of in-hospital mortality. Conclusion Streptococcal species were the major pathogen of IE in the recent years with low rates of antimicrobial resistance. Prosthetic valve involvement, moderate or severe heart failure and vegetation size of more than 15 mm were independent predictors for in-hospital mortality in IE.	[Tran, Hoang M.; Truong, Vien T.; Ngo, Tam M. N.; Bui, Quoc P. V.; Nguyen, Hoang C.; Le, Trung T. Q.; Pham, Khanh P. N.; Duong, Hoang H. N.; Nguyen, Vu T.; Pham, Vinh N.] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Mazur, Wojciech; Chung, Eugene; Cafardi, John M.] Christ Hosp, Cincinnati, OH 45219 USA; [Thach Nguyen] St Mary Hosp, Hobart, IN USA	Christ Hospital - Ohio	Tran, HM (corresponding author), Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam.	bacsitranminhhoang@gmail.com	Duong, Hoang/GYQ-7899-2022; Nguyen, Vu/HGV-1806-2022	Tran, Hoang/0000-0002-8620-800X; Cafardi, John/0000-0001-7335-4932				[Anonymous], 2000, NON TRADITIONAL REF; Baddour LM, 2015, INFECTIVE ENDOCARDIT; Bor DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060033; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; De Castro S, 2000, CLIN INFECT DIS, V30, P825, DOI 10.1086/313762; Do LG, 2011, ASIA-PAC J PUBLIC HE, V23, P217, DOI 10.1177/1010539509340047; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Hasbun R, 2003, JAMA-J AM MED ASSOC, V289, P1933, DOI 10.1001/jama.289.15.1933; Hill EE, 2007, EUR HEART J, V28, P196, DOI 10.1093/eurheartj/ehl427; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Lang T, 2006, CHEST, V130, P1263, DOI 10.1378/chest.130.4.1263; Letaief A, 2007, INT J INFECT DIS, V11, P430, DOI 10.1016/j.ijid.2006.10.006; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mao WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117710; Math RS, 2011, AM HEART J, V162, P633, DOI 10.1016/j.ahj.2011.07.014; Mirabel M, 2015, INT J CARDIOL, V180, P270, DOI 10.1016/j.ijcard.2014.11.184; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Naber CK, 2007, INT J ANTIMICROB AG, V29, P615, DOI 10.1016/j.ijantimicag.2007.01.016; Nguyen TC, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-2; Okumura J, 2002, SOC SCI MED, V54, P1875, DOI 10.1016/S0277-9536(01)00155-1; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Simsek-Yavuz S, 2015, INT J INFECT DIS, V30, P106, DOI 10.1016/j.ijid.2014.11.007; Slipczuk L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082665; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Xu HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166764	30	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189421	10.1371/journal.pone.0189421	http://dx.doi.org/10.1371/journal.pone.0189421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240776	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600033
J	Borne, F; Kasimatis, KR; Phillips, PC				Borne, Flora; Kasimatis, Katja R.; Phillips, Patrick C.			Quantifying male and female pheromone-based mate choice in Caenorhabditis nematodes using a novel microfluidic technique	PLOS ONE			English	Article							SEXUAL ATTRACTION; LIFE-SPAN; ELEGANS; SELECTION; BEHAVIOR	Pheromone cues are an important component of intersexual communication, particularly in regards to mate choice. Caenorhabditis nematodes predominant rely on pheromone production for mate finding and mate choice. Here we describe a new microfluidic paradigm for studying mate choice in nematodes. Specifically, the Pheromone Arena allows for a constant flow of odorants, including pheromones and other small molecules, to be passed in real time from signaling worms to those making a choice without any physical contact. We validated this microfluidic paradigm by corroborating previous studies in showing that virgin C. remanei and C. elegans males have a strong preference for virgin females over mated ones. Moreover, our results suggest that the strength of attraction is an additive effect of male receptivity and female signal production. We also explicitly examine female choice and find that females are more attracted to virgin males. However, a female's mate choice is strongly dependent on her mating status.	[Borne, Flora; Kasimatis, Katja R.; Phillips, Patrick C.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Borne, Flora] Univ Paris Saclay, Ecole Normale Super Paris Saclay, Cachan, France	University of Oregon; UDICE-French Research Universities; Universite Paris Saclay	Phillips, PC (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	pphil@uoregon.edu		Phillips, Patrick/0000-0001-7271-342X; Kasimatis, Katja/0000-0003-0025-5022	National Institutes of Health [T32 GM007413, R01 GM102511]; ARCS Foundation Oregon Chapter; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102511, T32GM007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation Oregon Chapter; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (training grant T32 GM007413 to KRK and R01 GM102511 to PCP) and the ARCS Foundation Oregon Chapter (KRK).	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; [Anonymous], 2014, PHEROMONES ANIMAL BE; Aprison EZ, 2016, CURR BIOL, V26, P2827, DOI 10.1016/j.cub.2016.08.024; Aprison EZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005729; Bakhtina NA, 2014, RSC ADV, V4, P4691, DOI 10.1039/c3ra43758b; BARR MM, 2006, MALE MATING BEHAV, P1; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; BRENNER S, 1974, GENETICS, V77, P71; Brent CS, 2017, ELIFE, V6, DOI 10.7554/eLife.24063; Chapman T, 2011, HEREDITY EDINB, V87, P511; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Chung K, 2011, LAB CHIP, V11, P3689, DOI 10.1039/c1lc20400a; Chute CD, 2014, SEMIN CELL DEV BIOL, V33, P18, DOI 10.1016/j.semcdb.2014.06.002; Dong L, 2016, LAB CHIP, V16, P4534, DOI 10.1039/c6lc01005a; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Gupta BP, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7070123; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Izrayelit Y, 2012, ACS CHEM BIOL, V7, P1321, DOI 10.1021/cb300169c; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; Leighton DHW, 2014, P NATL ACAD SCI USA, V111, P17905, DOI 10.1073/pnas.1420439111; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Maures TJ, 2014, SCIENCE, V343, P541, DOI 10.1126/science.1244160; McCormick KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025710; Morsci NS, 2011, GENETICS, V189, P1341, DOI 10.1534/genetics.111.133603; Narayan A, 2016, P NATL ACAD SCI USA, V113, pE1392, DOI 10.1073/pnas.1600786113; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Shi C, 2017, ELIFE, V6, DOI 10.7554/eLife.23493; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Yamane T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123770	43	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189679	10.1371/journal.pone.0189679	http://dx.doi.org/10.1371/journal.pone.0189679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236762	gold, Green Submitted, Green Published			2022-12-26	WOS:000417884100091
J	Rath, EC; Gill, H; Bai, YS				Rath, Ethan C.; Gill, Hunter; Bai, Yongsheng			Identification of potential antimicrobials against Salmonella typhimurium and Listeria monocytogenes using Quantitative Structure-Activity Relation modeling	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY DETERMINATION; QUATERNARY AMMONIUM-COMPOUNDS; CETYLPYRIDINIUM CHLORIDE; STAPHYLOCOCCUS-AUREUS; RESIDUE LEVELS; ADAPTATION; VALIDATION; RESISTANCE; OUTBREAK; ILLNESS	The shelf-life of fresh carcasses and produce depends on the chemical and physical properties of antimicrobials currently used for treatment. For many years the gold standard of these antimicrobials has been Cetylpyridinium Chloride (CPC) a quaternary ammonium compound (QAC). CPC is very effective at removing bacterial pathogens from the surface of chicken but has not been approved for other products due to a toxic residue left behind after treatment. Currently there is also a rising trend in QAC resistant bacteria. In order to find new compounds that can combat both antimicrobial resistance and the toxic residue we have developed two Quantitative Structure-Activity Relationship (QSAR) models for Salmonella typhimurium and Listeria monocytogenes. These models have been shown to be accurate and reliable through multiple internal and external validation techniques. In processing these models we have also identified important descriptors and structures that may be key in producing a viable compound. With these models, development and testing of new compounds should be greatly simplified.	[Rath, Ethan C.; Bai, Yongsheng] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Gill, Hunter] Indiana State Univ, Dept Chem & Phys, Terre Haute, IN 47809 USA; [Bai, Yongsheng] Indiana State Univ, Ctr Genom Advocacy, Terre Haute, IN 47809 USA	Indiana State University; Indiana State University; Indiana State University	Bai, YS (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.; Bai, YS (corresponding author), Indiana State Univ, Ctr Genom Advocacy, Terre Haute, IN 47809 USA.	Yongsheng.Bai@indstate.edu		Bai, Yongsheng/0000-0002-9944-5426	Yongsheng Bai's startup fund courtesy of Indiana State University; Indiana State University The Center for Genomic Advocacy (TCGA); Indiana State University Center for Student Research and Creativity (CSRC)	Yongsheng Bai's startup fund courtesy of Indiana State University; Indiana State University The Center for Genomic Advocacy (TCGA); Indiana State University Center for Student Research and Creativity (CSRC)	Funding for this project was provided by Yongsheng Bai's startup fund courtesy of Indiana State University and the SURE program funding provided by Indiana State University The Center for Genomic Advocacy (TCGA). This project was also partly supported by the Indiana State University Center for Student Research and Creativity (CSRC).	Ahn M, 2013, EUR J MED CHEM, V68, P10, DOI 10.1016/j.ejmech.2013.07.008; Bai Y., 2007, International Journal of Poultry Science, V6, P91; BODOR N, 1980, Journal of Medicinal Chemistry, V23, P469, DOI 10.1021/jm00179a001; Bowker KE, 2009, ANTIMICROB AGENTS CH, V53, P4949, DOI 10.1128/AAC.00845-09; Brown SD, 2010, ANTIMICROB AGENTS CH, V54, P2063, DOI 10.1128/AAC.01569-09; Buffett-Bataillon S, 2002, ANTIMICROBIAL AGENTS, V39, P381; CDC, 2014, BRAEND INF LINK NUT; CDC, 2012, SUSP FOODB ILLN SPEC; CDC, 2014, FOODB DIS ACT SURV N; Cutler RA, 1970, TOXICOLOGY CATIONIC; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; Denyer SP, 2002, J APPL MICROBIOL, V92, p35S, DOI 10.1046/j.1365-2672.92.5s1.19.x; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Fazlara A., 2012, AM EURASIAN J AGR EN, V12, P23, DOI DOI 10.1186/1471-2334-14-292; Gilbert C. D., 2015, International Journal of Poultry Science, V14, P120; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Gosselin RE, 1984, CLIN TOXICOLOGY COMM; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; Gramatica P, 2014, J COMPUT CHEM, V35, P1036, DOI 10.1002/jcc.23576; Gramatica P, 2013, J COMPUT CHEM, V34, P2121, DOI 10.1002/jcc.23361; Haas W, 2009, ANTIMICROB AGENTS CH, V53, P3552, DOI 10.1128/AAC.00418-09; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hattori Masahiro, 2003, Genome Inform, V14, P144; Hattori M, 2010, NUCLEIC ACIDS RES, V38, pW652, DOI 10.1093/nar/gkq367; Ioannou CJ, 2007, ANTIMICROB AGENTS CH, V51, P296, DOI 10.1128/AAC.00375-06; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Jang KH, 2012, BIOORG MED CHEM LETT, V22, P1078, DOI 10.1016/j.bmcl.2011.11.105; Jung ME, 1999, J MED CHEM, V42, P3899, DOI 10.1021/jm990015b; Kim HS, 2001, BIOORG MED CHEM LETT, V11, P3065, DOI 10.1016/S0960-894X(01)00632-1; Kwak KY, 1999, INVENTORSMETHOD DECR; Lemaire S, 2010, ANTIMICROB AGENTS CH, V54, P2549, DOI 10.1128/AAC.01724-09; Liu J, 2013, ARCH ORAL BIOL, V58, P1686, DOI 10.1016/j.archoralbio.2013.08.014; Martin TM, 2012, J CHEM INF MODEL, V52, P2570, DOI 10.1021/ci300338w; Martinez-Suarez JV, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00638; Mendez-Vilas A., 2015, MULTIDISCIPLINARY AP; Mereghetti L, 2000, APPL ENVIRON MICROB, V66, P5083, DOI 10.1128/AEM.66.11.5083-5086.2000; Mohamad I.B., 2013, RES J APPL SCI ENG T, V6, P3299; Mohamed MS, 2010, EUR J MED CHEM, V45, P3311, DOI 10.1016/j.ejmech.2010.04.014; Rath EC, 2016, J CHEM INFORM, V2, P3; RIEDO FX, 1994, J INFECT DIS, V170, P693, DOI 10.1093/infdis/170.3.693; Rodriguez-Morales S, 2005, J CHROMATOGR A, V1062, P285, DOI 10.1016/j.chroma.2004.11.039; Romanova NA, 2006, APPL ENVIRON MICROB, V72, P3498, DOI 10.1128/AEM.72.5.3498-3503.2006; Ryser ET, LISTERIA LISTERIOSIS; Scallan E, 2011, EMERG INFECT DIS, V17, P1339, DOI 10.3201/eid1707.110572; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Sharma S, 2009, EUR J MED CHEM, V44, P1751, DOI 10.1016/j.ejmech.2008.03.026; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Silverman K., 2004, ORGANIC CHEM DRUG DE; SMITH TJ, 1995, J MOL GRAPHICS, V13, P122, DOI 10.1016/0263-7855(94)00019-O; Sushko I, 2011, J COMPUT AID MOL DES, V25, P533, DOI 10.1007/s10822-011-9440-2; Taheri-Kafrani A, 2014, ACTA CHIM SLOV, V61, P645; Tezel U, 2015, CURR OPIN BIOTECH, V33, P296, DOI 10.1016/j.copbio.2015.03.018; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; Warren MR, 1942, J PHARMACOL EXP THER, V74, P401; Wessels S, 2013, REGUL TOXICOL PHARM, V67, P456, DOI 10.1016/j.yrtph.2013.09.006; Zhou X, 1999, J CHROMATOGR B, V728, P273, DOI 10.1016/S0378-4347(99)00100-0	56	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189580	10.1371/journal.pone.0189580	http://dx.doi.org/10.1371/journal.pone.0189580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236763	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100083
J	Yung, M; Lang, AE; Stobart, J; Kociolek, AM; Milosavljevic, S; Trask, C				Yung, Marcus; Lang, Angelica E.; Stobart, Jamie; Kociolek, Aaron M.; Milosavljevic, Stephan; Trask, Catherine			The combined fatigue effects of sequential exposure to seated whole body vibration and physical, mental, or concurrent work demands	PLOS ONE			English	Article							QUAD BIKE USE; MUSCULOSKELETAL DISORDERS; UPPER-LIMB; POSTURAL CONTROL; MUSCLE FATIGUE; BALANCE; FIELD; PERFORMANCE; REFLEX; WAKEFULNESS	Many occupations in agriculture, construction, transportation, and forestry are non-routine, involving non-cyclical tasks, both discretionary and non-discretionary work breaks, and a mix of work activities. Workers in these industries are exposed to seated whole body vibration (WBV) and tasks consisting of physical, mental, or a combination of demands. Risk assessment tools for non-routinized jobs have emerged but there remains a need to understand the combined effects of different work demands to improve risk assessment methods and ultimately inform ergonomists and workers on optimum work arrangement and scheduling strategies. The objective of this study was to investigate fatigue-related human responses of WBV sequentially combined with physical, mental, or concurrent physical and mental demands. Sixteen healthy participants performed four conditions on four separate days: (1) physically demanding work, (2) mentally demanding work, (3) concurrent work, and (4) control quiet sitting. For each condition, participants performed two 15-minute bouts of the experimental task, separated by 30-minutes of simulated WBV based on realistic allterrain vehicle (ATV) riding data. A test battery of fatigue measures consisting of biomechanical, physiological, cognitive, and sensorimotor measurements were collected at four interval periods: pre-session, after the first bout of the experimental task and before WBV, after WBV and before the second bout of the experimental task, and post-session. Nine measures demonstrated statistically significant time effects during the control condition; 11, 7, and 12 measures were significant in the physical, mental, and concurrent conditions, respectively. Overall, the effects of seated WBV in combination with different tasks are not additive but possibly synergistic or antagonistic. There appears to be a beneficial effect of seated ATV operation as a means of increasing task variation; but since excessive WBV may independently pose a health risk in the longer-term, these beneficial results may not be sensible as a long-term solution.	[Yung, Marcus; Stobart, Jamie; Trask, Catherine] Univ Saskatchewan, Coll Med, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada; [Lang, Angelica E.; Milosavljevic, Stephan] Univ Saskatchewan, Coll Med, Sch Phys Therapy, Saskatoon, SK, Canada; [Kociolek, Aaron M.] Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada	University of Saskatchewan; University of Saskatchewan; Nipissing University	Yung, M (corresponding author), Univ Saskatchewan, Coll Med, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada.	marcus.yung@usask.ca	Milosavljevic, Stephan/AAR-6127-2021	Milosavljevic, Stephan/0000-0001-8938-5290; Trask, Catherine/0000-0003-0799-1735; Yung, Marcus/0000-0003-3192-1470	Saskatchewan Health Research Foundation [3822]; College of Medicine Research Award (CoMRAD), University of Saskatchewan	Saskatchewan Health Research Foundation; College of Medicine Research Award (CoMRAD), University of Saskatchewan	This work was supported by Saskatchewan Health Research Foundation Postdoctoral Fellowship (#3822) - MY; College of Medicine Research Award (CoMRAD), University of Saskatchewan - CT (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2005, P 49 ANN M HUM FACT; ARMSTRONG TJ, 1993, SCAND J WORK ENV HEA, V19, P73, DOI 10.5271/sjweh.1494; Azizan Mohd Amzar, 2014, Nonlinear Engineering. Modeling and Application, V3, P163, DOI 10.1515/nleng-2014-0015; Bell-Krotoski J A, 1995, J Hand Ther, V8, P155; Berolo S., 2015, THESIS; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Boutcher YN, 2006, BIOL PSYCHOL, V73, P235, DOI 10.1016/j.biopsycho.2006.04.005; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Clay L, 2015, SAFETY, V1, P71, DOI 10.3390/safety1010071; Davis KG, 2007, AM J IND MED, V50, P501, DOI 10.1002/ajim.20479; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; DEGAIL P, 1966, J NEUROL NEUROSUR PS, V29, P1, DOI 10.1136/jnnp.29.1.1; Du BB, 2017, ERGONOMICS IN PRESS; Ebe K, 2000, ERGONOMICS, V43, P771, DOI 10.1080/001401300404742; Gold JE, 2006, ERGONOMICS, V49, P12, DOI 10.1080/00140130500356643; Goldcamp EM, 2001, CHILDREN YOUTH, V22, P308; HAGBARTH KE, 1973, NEW DEV ELECTROMYOGR, P428; Jahncke H, 2017, ERGONOMICS; JENSEN A R, 1979, Intelligence, V3, P121, DOI 10.1016/0160-2896(79)90010-2; Kociolek AM, 2017, INT J IND E IN PRESS; Lamond N, 2005, AVIAT SPACE ENVIR MD, V76, P486; LANDSTROM U, 1985, ELECTROEN CLIN NEURO, V61, P411, DOI 10.1016/0013-4694(85)91032-6; Lim GW, 2004, AM J IND MED, V45, P177, DOI 10.1002/ajim.10325; Lindberg E, 2001, AM J RESP CRIT CARE, V164, P2031, DOI 10.1164/ajrccm.164.11.2102028; Lings S, 2000, INT ARCH OCC ENV HEA, V73, P290, DOI 10.1007/s004200000118; Ljungberg JK, 2007, J OCCUP HEALTH, V49, P111, DOI 10.1539/joh.49.111; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mani R, 2015, INT J IND ERGONOM, V50, P158, DOI 10.1016/j.ergon.2015.08.007; Mani R, 2010, INT J IND ERGONOM, V40, P698, DOI 10.1016/j.ergon.2010.05.009; Mansfield N, 2014, ISRN AUTOMOTIVE ENG; MARTIN B, 1980, AVIAT SPACE ENVIR MD, V51, P778; Mathiassen S.E., 2004, WORKING POSTURES MOV, P330; McMillan M, 2015, J AGROMEDICINE, V20, P292, DOI 10.1080/1059924X.2015.1042611; Mehta RK, 2012, EUR J APPL PHYSIOL, V112, P2891, DOI 10.1007/s00421-011-2264-x; Milosavljevic S, 2011, INT J IND ERGONOM, V41, P317, DOI 10.1016/j.ergon.2011.02.010; Milosavljevic S, 2011, ANN OCCUP HYG, V55, P286, DOI 10.1093/annhyg/meq087; Milosavljevic S, 2010, APPL ERGON, V41, P530, DOI 10.1016/j.apergo.2009.11.002; Mizuno K, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-25; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Morris TL, 1996, BIOL PSYCHOL, V42, P343, DOI 10.1016/0301-0511(95)05166-X; Nahrgang JD, 2011, J APPL PSYCHOL, V96, P71, DOI 10.1037/a0021484; Newell GS, 2008, INT J IND ERGONOM, V38, P499, DOI 10.1016/j.ergon.2007.08.018; O'Connor T, 2009, AUST J RURAL HEALTH, V17, P251, DOI 10.1111/j.1440-1584.2009.01086.x; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; PARK HS, 1993, SCAND J WORK ENV HEA, V19, P35, DOI 10.5271/sjweh.1506; Pollard J, 2017, INT J IND ERGONOM, V57, P23, DOI 10.1016/j.ergon.2016.11.009; Pollock RD, 2011, EUR J APPL PHYSIOL, V111, P3069, DOI 10.1007/s00421-011-1943-y; RADWIN RG, 1987, ERGONOMICS, V30, P833, DOI 10.1080/00140138708969772; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; ROSA RR, 1988, HUM FACTORS, V30, P305, DOI 10.1177/001872088803000305; Sakamoto Kiyomi, 2010, J Hum Ergol (Tokyo), V39, P1; Santos BR, 2008, INT J IND ERGONOM, V38, P626, DOI 10.1016/j.ergon.2008.01.015; Satou Y, 2007, IND HEALTH, V45, P217, DOI 10.2486/indhealth.45.217; SNOOK SH, 1991, ERGONOMICS, V34, P1197, DOI 10.1080/00140139108964855; Sondergaard KHE, 2010, J BIOMECH, V43, P1997, DOI 10.1016/j.jbiomech.2010.03.009; Sonza A, 2015, SCI WORLD J; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; Thiffault P., 2001, ADDRESSING HUMAN FAC; Tian LG, 1996, INT J IND ERGONOM, V18, P221; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Vergara M, 2002, APPL ERGON, V33, P1, DOI 10.1016/S0003-6870(01)00056-4; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Waldenstrom M, 1998, J Occup Health Psychol, V3, P209; Waongenngarm P, 2015, J PHYS THER SCI, V27, P2183, DOI 10.1589/jpts.27.2183; Whatmore GB, 1974, PHYSIOPATHOLOGY TREA; WIKSTROM BO, 1994, INT J IND ERGONOM, V14, P273, DOI 10.1016/0169-8141(94)90017-5; Young E, 2009, INT ARCH OCC ENV HEA, V82, P551, DOI 10.1007/s00420-009-0403-z; Yung M, 2017, HUMAN FACTO IN PRESS; Yung M, 2017, ERGONOMICS, V60, P923, DOI 10.1080/00140139.2016.1243734; Yung M, 2017, ERGONOMICS, V60, P940, DOI 10.1080/00140139.2016.1242782; Yung M, 2014, ERGONOMICS, V57, P1562, DOI 10.1080/00140139.2014.934299	72	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188468	10.1371/journal.pone.0188468	http://dx.doi.org/10.1371/journal.pone.0188468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236752	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100018
J	Baumsteiger, J; Moyle, PB; Aguilar, A; O'Rourke, SM; Miller, MR				Baumsteiger, Jason; Moyle, Peter B.; Aguilar, Andres; O'Rourke, Sean M.; Miller, Michael R.			Genomics clarifies taxonomic boundaries in a difficult species complex	PLOS ONE			English	Article							CLIMATE-CHANGE; CALIFORNIA; DIFFERENTIATION; CYPRINIDAE; DIVERSITY; RIVER; HOMOGENIZATION; IDENTIFICATION; MITOCHONDRIAL; HYBRIDIZATION	Efforts to taxonomically delineate species are often confounded with conflicting information and subjective interpretation. Advances in genomic methods have resulted in a new approach to taxonomic identification that stands to greatly reduce much of this conflict. This approach is ideal for species complexes, where divergence times are recent (evolutionarily) and lineages less well defined. The California Roach/Hitch fish species complex is an excellent example, experiencing a convoluted geologic history, diverse habitats, conflicting species designations and potential admixture between species. Here we use this fish complex to illustrate how genomics can be used to better clarify and assign taxonomic categories. We performed restriction-site associated DNA (RAD) sequencing on 255 Roach and Hitch samples collected throughout California to discover and genotype thousands of single nucleotide polymorphism (SNPs). Data were then used in hierarchical principal component, admixture, and FST analyses to provide results that consistently resolved a number of ambiguities and provided novel insights across a range of taxonomic levels. At the highest level, our results show that the CA Roach/Hitch complex should be considered five species split into two genera (4 + 1) as opposed to two species from distinct genera (1 + 1). Subsequent levels revealed multiple subspecies and distinct population segments within identified species. At the lowest level, our results indicate Roach from a large coastal river are not native but instead introduced from a nearby river. Overall, this study provides a clear demonstration of the power of genomic methods for informing taxonomy and serves as a model for future studies wishing to decipher difficult species questions. By allowing for systematic identification across multiple scales, taxonomic structure can then be tied to historical and contemporary ecological, geographic or anthropogenic factors.	[Baumsteiger, Jason; Moyle, Peter B.; Miller, Michael R.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Baumsteiger, Jason; O'Rourke, Sean M.; Miller, Michael R.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Moyle, Peter B.] Univ Calif Davis, Dept Wildlife Fisheries & Conservat Biol, Davis, CA 95616 USA; [Aguilar, Andres] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State University Los Angeles	Baumsteiger, J; Miller, MR (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.; Baumsteiger, J; Miller, MR (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	jb4799@gmail.com; micmiller@ucdavis.edu		Aguilar, Andres/0000-0002-4409-9597				Adams M, 2014, SYST BIOL, V63, P518, DOI 10.1093/sysbio/syu017; Aguilar A, 2009, MOL PHYLOGENET EVOL, V51, P373, DOI 10.1016/j.ympev.2008.11.028; Ali OA, 2016, GENETICS, V202, P389, DOI 10.1534/genetics.115.183665; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Argue Brad J., 1999, Reviews in Fisheries Science, V7, P137, DOI 10.1080/10641269908951360; AVISE JC, 1975, EVOLUTION, V29, P411, DOI 10.1111/j.1558-5646.1975.tb00831.x; AVISE JC, 1976, EVOLUTION, V30, P46, DOI 10.1111/j.1558-5646.1976.tb00880.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Baird S. F., 1854, P ACAD NAT SCI PHILA, V7, P24; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Baumsteiger J, 2017, BIOSCIENCE, V67, P356, DOI 10.1093/biosci/bix001; Baumsteiger J, 2016, J HERED, V107, P504, DOI 10.1093/jhered/esw045; Baumsteiger J, 2014, MOL ECOL, V23, P2602, DOI 10.1111/mec.12758; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brown LR, 1997, ENVIRON BIOL FISH, V49, P271, DOI 10.1023/A:1007381027518; BROWN LR, 1992, BIOL CONSERV, V62, P1, DOI 10.1016/0006-3207(92)91146-J; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Edwards SV, 2000, EVOLUTION, V54, P1839; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Fumagalli M, 2014, BIOINFORMATICS, V30, P1486, DOI 10.1093/bioinformatics/btu041; Fumagalli M, 2013, GENETICS, V195, P979, DOI 10.1534/genetics.113.154740; GREENFIELD DW, 1973, COPEIA, P417; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Hopkirk JD., 1973, U CALIFORNIA PUBL ZO, V96; Hubbs CL., 1979, LIST FISHES CALIFORN; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Jones WJ, 2002, CONSERV GENET, V3, P261, DOI 10.1023/A:1019963826013; Jones WJ., 2001, THESIS; Keller I, 2013, MOL ECOL, V22, P2848, DOI 10.1111/mec.12083; Kim SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-231; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Korneliussen TS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-289; Leidy RA., 2007, ECOLOGY ASSEMBLAGE S; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lintermans M, 2004, NEW ZEAL J MAR FRESH, V38, P481, DOI 10.1080/00288330.2004.9517255; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Marchetti MP, 2006, BIOL CONSERV, V127, P310, DOI 10.1016/j.biocon.2005.04.025; Mayr E, 1996, PHILOS SCI, V63, P262, DOI 10.1086/289912; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; MILLER RR, 1945, COPEIA, P197; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle P.B., 2015, FISH SPECIES SPECIAL; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Moyle Peter B., 1996, P1493; MURPHY GARTH I., 1948, CALIFORNIA FISH AND GAME, V34, P101; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Page L. M., 2011, PETERSON FIELD GUIDE; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; Power ME, 2015, COPEIA, V103, P200, DOI 10.1643/CE-14-086; R Core Team, 2021, R LANGUAGE ENV STAT; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Righter Robert W, 2005, BATTLE HETCH HETCHY; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Saglam IK, 2016, MOL ECOL, V25, P3962, DOI 10.1111/mec.13732; Schonhuth S, 2012, MOL PHYLOGENET EVOL, V62, P427, DOI 10.1016/j.ympev.2011.10.011; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Snyder J.O., 1913, B US BUR FISH, V32, P49; TAJIMA F, 1983, GENETICS, V105, P437; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wiley EO, 2011, PHYLOGENETICS THEORY	79	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189417	10.1371/journal.pone.0189417	http://dx.doi.org/10.1371/journal.pone.0189417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232403	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200042
J	Mackert, GA; Schulte, M; Hirche, C; Kotsougiani, D; Vogelpohl, J; Hoener, B; Fiebig, T; Kirschner, S; Brockmann, MA; Lehnhardt, M; Kneser, U; Harhaus, L				Mackert, Gina A.; Schulte, Matthias; Hirche, Christoph; Kotsougiani, Dimitra; Vogelpohl, Julian; Hoener, Bernd; Fiebig, Teresa; Kirschner, Stefanie; Brockmann, Marc A.; Lehnhardt, Marcus; Kneser, Ulrich; Harhaus, Leila			Low-energy extracorporeal shockwave therapy (ESWT) improves metaphyseal fracture healing in an osteoporotic rat model	PLOS ONE			English	Article							SPATIAL EXPRESSION; WAVE PROMOTES; IN-VIVO; BONE; CELLS; DIFFERENTIATION; WEIGHT; PHASE; TIBIA	Purpose As result of the current demographic changes, osteoporosis and osteoporotic fractures are becoming an increasing social and economic burden. In this experimental study, extracorporeal shock wave therapy (ESWT), was evaluated as a treatment option for the improvement of osteoporotic fracture healing. Methods A well-established fracture model in the metaphyseal tibia in the osteoporotic rat was used. 132 animals were divided into 11 groups, with 12 animals each, consisting of one sham-operated group and 10 ovariectomized (osteoporotic) groups, of which 9 received ESWT treatment. Different energy flux intensities (0.15 mJ/mm(2), 0.35 mJ/mm(2), or 0.55 mJ/mm(2)) as well as different numbers of ESWT applications (once, three times, or five times throughout the 35-day healing period) were applied to the osteoporotic fractures. Fracture healing was investigated quantitatively and qualitatively using micro-CT imaging, quantitative realtime polymerase chain reaction (qRT-PCR) analysis, histomorphometric analysis and biomechanical analysis. Results The results of this study show a qualitative and quantitative improvement in the osteoporotic fracture healing under low-energy (energy flux intensity: 0,15 mJ/mm(2)) ESWT and with fewer treatment applications per healing period. Conclusion In conclusion, low-energy ESWT seems to exhibit a beneficial effect on the healing of osteoporotic fractures, leading to improved biomechanical properties, enhanced callus-quantity and -quality, and an increase in the expression of bone specific transcription factors. The results suggest that low-energy ESWT, as main treatment or as adjunctive treatment in addition to a surgical intervention, may prove to be an effective, simple to use, and cost-efficient option for the qualitative and quantitative improvement of osteoporotic fracture healing.	[Mackert, Gina A.; Schulte, Matthias; Hirche, Christoph; Kotsougiani, Dimitra; Vogelpohl, Julian; Kneser, Ulrich; Harhaus, Leila] Heidelberg Univ, BG Trauma Ctr, Dept Plast Surg, Dept Hand Plast & Reconstruct Surg,Burn Ctr, Ludwigshafen, Germany; [Hoener, Bernd] SRH Univ Heidelberg, Dept Social & Legal Sci, Heidelberg, Germany; [Fiebig, Teresa] Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Neuroradiol, Mannheim, Germany; [Kirschner, Stefanie; Brockmann, Marc A.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, Mainz, Germany; [Lehnhardt, Marcus] Univ Hosp Bochum, BG Hosp Bergmannsheil, Sarcoma Reference Ctr, Hand Ctr,Burn Ctr,Dept Plast Surg, Bochum, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Ruhr University Bochum	Mackert, GA (corresponding author), Heidelberg Univ, BG Trauma Ctr, Dept Plast Surg, Dept Hand Plast & Reconstruct Surg,Burn Ctr, Ludwigshafen, Germany.	gina_alicia_mackert@yahoo.com			"Deutsche Forschungsgemeinschaft"	"Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG))	This work was supported by "Deutsche Forschungsgemeinschaft" (http://www.dfg.de/), recipient: LH. The funders had no role in study design, data collectio and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Chen XF, 2015, INT J CLIN EXP MED, V8, P5044; Chen YJ, 2004, J ORTHOP RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005; Claes L, 2009, ARCH ORTHOP TRAUM SU, V129, P923, DOI 10.1007/s00402-008-0692-9; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; DELIUS M, 1995, ULTRASOUND MED BIOL, V21, P1219, DOI 10.1016/0301-5629(95)00030-5; Diamond TH, 2007, BONE, V40, P775, DOI 10.1016/j.bone.2006.10.009; Gerdesmeyer L, 2015, INT J SURG, V24, P115, DOI 10.1016/j.ijsu.2015.09.068; Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014; Ha CH, 2013, INT J CARDIOL, V168, P4168, DOI 10.1016/j.ijcard.2013.07.112; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; JOHANNES EJ, 1994, J SURG RES, V57, P246, DOI 10.1006/jsre.1994.1139; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Kolios L, 2010, CALCIFIED TISSUE INT, V86, P23, DOI 10.1007/s00223-009-9318-7; Ma HZ, 2008, ACTA ORTHOP, V79, P98, DOI 10.1080/17453670710014833; Macdonald HM, 2005, OSTEOPOROSIS INT, V16, P163, DOI 10.1007/s00198-004-1657-7; Mackert GA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-245; Maier M, 2002, J BONE JOINT SURG BR, V84B, P592, DOI 10.1302/0301-620X.84B4.11621; Mariotto S, 2005, NITRIC OXIDE-BIOL CH, V12, P89, DOI 10.1016/j.niox.2004.12.005; McCann RM, 2008, J ORTHOP RES, V26, P384, DOI 10.1002/jor.20505; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Rahn BA, 1976, NOVA ACTA LEOPOLDINA, V44, P249; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; TARTTELIN MF, 1973, ACTA ENDOCRINOL-COP, V72, P551, DOI 10.1530/acta.0.0720551; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; van der Jagt OP, 2013, J ORTHOP RES, V31, P768, DOI 10.1002/jor.22258; van der Jagt OP, 2009, J ORTHOP RES, V27, P1528, DOI 10.1002/jor.20910; von Rudena C, 2016, INJURY, V47, pS3, DOI 10.1016/S0020-1383(16)47002-6; Wang CJ, 2008, ARCH ORTHOP TRAUM SU, V128, P879, DOI 10.1007/s00402-008-0663-1; Wang CJ, 2007, ARCH ORTHOP TRAUM SU, V127, P137, DOI 10.1007/s00402-006-0236-0; Wang Ching-Jen, 2002, J Foot Ankle Surg, V41, P16; Wang CJ, 2009, NITRIC OXIDE-BIOL CH, V20, P298, DOI 10.1016/j.niox.2009.02.006; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wang CJ, 2004, BONE, V34, P225, DOI 10.1016/j.bone.2003.08.005; Wang CJ, 2001, CLIN ORTHOP RELAT R, P112; Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2; Wang FS, 2002, J BONE JOINT SURG BR, V84B, P457, DOI 10.1302/0301-620X.84B3.11609; Wronski TJ, 1995, CALCIFIED TISSUE INT, V37, P324; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811	47	6	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189356	10.1371/journal.pone.0189356	http://dx.doi.org/10.1371/journal.pone.0189356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232698	Green Submitted, Green Published, gold			2022-12-26	WOS:000417698200034
J	Phon, CK; Kirton, LG; Yusoff, NR				Phon, Chooi-Khim; Kirton, Laurence G.; Yusoff, Norma-Rashid			Monitoring butterflies using counts of puddling males: A case study of the Rajah Brooke's Birdwing (Trogonoptera brookiana albescens)	PLOS ONE			English	Article							LEPIDOPTERA; ABUNDANCE; BEHAVIOR; REGION; SODIUM	The Rajah Brooke's Birdwing, Trogonoptera brookiana, is a large, iconic butterfly that is facing heavy commercial exploitation and habitat loss. Males of some subspecies exhibit puddling behavior. A method of conservation monitoring was developed for subspecies albescens in Ulu Geroh, Peninsular Malaysia, where the males consistently puddle in single-species aggregations at stable geothermal springs, reaching well over 300 individuals when the population is at its highest. Digital photography was used to conduct counts of numbers of males puddling. The numbers of birdwings puddling were significantly correlated with counts of birdwings in flight, but were much higher. The numbers puddling during the peak hour were correlated with numbers puddling throughout the day and could be predicted using the numbers puddling at an alternative hour, enabling flexibility in the time of counts. Average counts for three images taken at each puddle at three peak hours between 1400-1600 hours over 2-3 days were used as a monthly population index. The numbers puddling were positively associated with higher relative humidity and brightness during monitoring hours. Monthly counts of birdwings from monitoring of puddles over a period of two years are presented. The minimum effort required for a monitoring program using counts of puddling males is discussed, as well as the potential of using the method to monitor other species of puddling butterflies.	[Phon, Chooi-Khim; Kirton, Laurence G.] FRIM, Trop Forest Biodivers Ctr, Kepong, Selangor, Malaysia; [Phon, Chooi-Khim; Yusoff, Norma-Rashid] Univ Malaya, Fac Sci, Inst Biol Sci, Zool & Ecol Res Network, Kuala Lumpur, Malaysia	Institute Penyelidikan Perhutanan Malaysia; Universiti Malaya	Phon, CK (corresponding author), FRIM, Trop Forest Biodivers Ctr, Kepong, Selangor, Malaysia.; Phon, CK (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Zool & Ecol Res Network, Kuala Lumpur, Malaysia.	phonchooikhim@frim.gov.my	Norma-Rashid, Y/B-8028-2010	Norma-Rashid, Y/0000-0002-1450-1995	Malaysian Forest Research and Development Board [GPP-0609-FA-02]; Postgraduate Research Fund from University of Malaya [PV131/2012A]; Malaysian Economic Planning Unit; Ministry of Natural Resources and Environment, Malaysia	Malaysian Forest Research and Development Board; Postgraduate Research Fund from University of Malaya; Malaysian Economic Planning Unit; Ministry of Natural Resources and Environment, Malaysia	This work was supported by Malaysian Forest Research and Development Board (Grant number: GPP-0609-FA-02) received by CK; Postgraduate Research Fund from University of Malaya (Grant number: PV131/2012A) received by NY; Malaysian Economic Planning Unit and Ministry of Natural Resources and Environment, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski P, 2004, EUR J ENTOMOL, V101, P341, DOI 10.14411/eje.2004.046; ADLER PH, 1982, CAN J ZOOL, V60, P322, DOI 10.1139/z82-043; Baioumy HM, 2014, GEOS 2014 P 3 INT C, P14; Basset Yves, 2011, Journal of Research on the Lepidoptera, V44, P17; BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; Chua LSL, 2006, MALAYSIAN PLANT RED; CITES, 2013, CONV INT TRAD END SP; Corbet A.S., 1992, BUTTERFLIES MALAY PE; Dahelmi S., 2008, FAR E ENTOMOLOGIST, V182, P1; Harding P.T., 1995, P3; IGARASHI S, 1997, LIFE HIST ASIAN BUTT; Kirton LG, 2012, INSECT CONSERV DIVER, V5, P244, DOI 10.1111/j.1752-4598.2011.00157.x; KIRTON LG, 2014, NATURALISTS GUIDE BU; Lindzey S, 2011, J INSECT CONSERV, V15, P765, DOI 10.1007/s10841-010-9375-2; Majumder Joydeb, 2012, Check List, V8, P432; MALLET J, 1987, J ANIM ECOL, V56, P377, DOI 10.2307/5054; Molleman F, 2005, BIOL J LINN SOC, V86, P345, DOI 10.1111/j.1095-8312.2005.00539.x; Morton A.C., 1984, Symposia of the Royal Entomological Society of London, P55; Nganso Beatrice T., 2012, Research in Zoology, V2, P38; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Pellet J, 2008, J INSECT CONSERV, V12, P155, DOI 10.1007/s10841-007-9075-8; Phon C-K, 2011, MALAYSIAN NATURALIST, V65, P24; PIVNICK KA, 1987, PHYSIOL ENTOMOL, V12, P461, DOI 10.1111/j.1365-3032.1987.tb00773.x; Pocock MJO, 2015, J APPL ECOL, V52, P686, DOI 10.1111/1365-2664.12423; Pocock MJO, 2014, CHOOSING USING CITIZ; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Pozo C, 2008, FLA ENTOMOL, V91, P407, DOI 10.1653/0015-4040(2008)91[407:SAPOTB]2.0.CO;2; Sands Don, 2008, Ecological Management & Restoration, V9, P4, DOI 10.1111/j.1442-8903.2008.00382.x; SCOTT JA, 1974, AM MIDL NAT, V91, P103, DOI 10.2307/2424514; Silberglied R.E., 1984, Symposia of the Royal Entomological Society of London, P207; SINGER MC, 1981, ECOL ENTOMOL, V6, P215, DOI 10.1111/j.1365-2311.1981.tb00609.x; Straatman R., 1961, Tijdschrift voor Entomologie Amsterdam, V104, P31; UNEP-WCMC, 2012, REV BUTT AS OC SUBJ; UNEP-WCMC, 2007, REV TRAD RANCH BIRDW; Van Swaay CAM, 2014, THESIS; Wheeler L. R., 1940, Entomologist London, V73, P269; Wiklund Christer, 2003, P67; Yao T.L., 2015, FLORA PENINSULAR M 2, V5, P5	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189450	10.1371/journal.pone.0189450	http://dx.doi.org/10.1371/journal.pone.0189450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232405	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200045
J	Ramonell, KM; Zhang, WX; Hadley, A; Chen, CW; Fay, KT; Lyons, JD; Klingensmith, NJ; McConnell, KW; Coopersmith, CM; Ford, ML				Ramonell, Kimberly M.; Zhang, Wenxiao; Hadley, Annette; Chen, Ching-wen; Fay, Katherine T.; Lyons, John D.; Klingensmith, Nathan J.; McConnell, Kevin W.; Coopersmith, Craig M.; Ford, Mandy L.			CXCR4 blockade decreases CD4(+) T cell exhaustion and improves survival in a murine model of polymicrobial sepsis	PLOS ONE			English	Article							BONE-MARROW; SEPTIC SHOCK; EXPRESSION; IMMUNOSUPPRESSION; MORTALITY; AMD3100; PD-1; MOBILIZATION; ANTAGONIST; TOLERANCE	Sepsis is a dysregulated systemic response to infection involving many inflammatory pathways and the induction of counter-regulatory anti-inflammatory processes that results in a state of immune incompetence and can lead to multi-organ failure. CXCR4 is a chemokine receptor that, following ligation by CXCL12, directs cells to bone marrow niches and also plays an important role in T cell cosignaling and formation of the immunological synapse. Here, we investigated the expression and function of CXCR4 in a murine model of polymicrobial sepsis. Results indicate that CXCR4 is selectively upregulated on naive CD4(+) and CD8(+) T cells and CD4(+) central memory T cells following the induction of sepsis, and that CXCR4 antagonism resulted in a significant decrease in sepsis-induced mortality. We probed the mechanistic basis for these findings and found that CXCR4 antagonism significantly increased the number of peripheral CD4(+) and CD8(+) T cells following sepsis. Moreover, mice treated with the CXCR4 antagonist contained fewer PD-1(+) LAG-3(+) 2B4(+) cells, suggesting that blockade of CXCR4 mitigates CD4(+) T cell exhaustion during sepsis. Taken together, these results characterize CXCR4 as an important pathway that modulates immune dysfunction and mortality following sepsis, which may hold promise as a target for future therapeutic intervention in septic patients.	[Ramonell, Kimberly M.; Zhang, Wenxiao; Hadley, Annette; Chen, Ching-wen; Fay, Katherine T.; Lyons, John D.; Klingensmith, Nathan J.; McConnell, Kevin W.; Coopersmith, Craig M.; Ford, Mandy L.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Crit Care Ctr, Atlanta, GA USA; [Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Ford, ML (corresponding author), Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA.; Ford, ML (corresponding author), Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA.	mancly.ford@emory.eclu	Chen, Ching-wen/ABH-8484-2020	Ramonell, Kimberly/0000-0003-4934-5723	National Institutes of Health [GM104323, GM109779, GM113228, GM072808, GM095442, GM117895, GM110537]; Shock Society Research Fellowship for Early Career Investigators; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, T32GM095442, R01GM113228, R01GM104323, R01GM109779, K08GM084143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shock Society Research Fellowship for Early Career Investigators; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grants GM104323, GM109779, and GM113228 (to MLF and CMC), GM072808 and GM095442 (to CMC), GM117895 (to JDL), GM110537 (to KWM) and Shock Society Research Fellowship for Early Career Investigators (to KWM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.26516, 10.4161/viru.27794]; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; De Clercq E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00276; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fan J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8596181; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Franchini S, 2015, AM J EMERG MED, V33, P1802, DOI 10.1016/j.ajem.2015.08.047; Fruehauf S, 2013, TRANSFUS MED HEMOTH, V40, P246, DOI 10.1159/000354229; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Golec DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053300; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hernandez-Lopez C, 2008, IMMUNOL LETT, V120, P72, DOI 10.1016/j.imlet.2008.07.006; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Hummel S, 2014, CURR OPIN HEMATOL, V21, P29, DOI 10.1097/MOH.0000000000000002; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; Kean LS, 2011, BLOOD, V118, P6580, DOI 10.1182/blood-2011-06-359331; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kobayashi N, 2004, EUR J IMMUNOL, V34, P3370, DOI 10.1002/eji.200425587; Kohara H, 2007, BLOOD, V110, P4153, DOI 10.1182/blood-2007-04-084210; Kremer KN, 2017, BLOOD; Kuksin CA, 2015, BLOOD, V125, P2087, DOI 10.1182/blood-2014-08-594796; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Liu Q, 2015, EUR J IMMUNOL, V45, P1855, DOI 10.1002/eji.201445245; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Nagafuchi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29338; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Payen D, 2013, CRIT CARE, V17, DOI 10.1186/cc12490; Seemann S, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0286-8; Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004018; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	46	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188882	10.1371/journal.pone.0188882	http://dx.doi.org/10.1371/journal.pone.0188882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232699	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200013
J	Silva, SD; Jara, ZP; Peres, R; Lima, LS; Scavone, C; Montezano, AC; Touyz, RM; Casarini, DE; Michelini, LC				Silva, Sebastiao D., Jr.; Jara, Zaira P.; Peres, Roseli; Lima, Larissa S.; Scavone, Cristoforo; Montezano, Augusto C.; Touyz, Rhian M.; Casarini, Dulce E.; Michelini, Lisete C.			Temporal changes in cardiac oxidative stress, inflammation and remodeling induced by exercise in hypertension: Role for local angiotensin II reduction	PLOS ONE			English	Article							DOWN-REGULATION; SYSTEM; EXPRESSION; HEART; RATS; HYPERTROPHY; TISSUE; AGE; DYSFUNCTION; MODULATION	Exercise training reduces renin-angiotensin system (RAS) activation, decreases plasma and tissue oxidative stress and inflammation in hypertension. However, the temporal nature of these phenomena in response to exercise is unknown. We sought to determine in spontaneously hypertensive rats (SHR) and age-matched WKY controls the weekly effects of training on blood pressure (BP), plasma and left ventricle (LV) Ang II and Ang-(1-7) content (HPLC), LV oxidative stress (DHE staining), gene and protein expression (qPCR and WB) of pro-inflammatory cytokines, antioxidant enzymes and their consequence on hypertension-induced cardiac remodeling. SHR and WKY were submitted to aerobic training (T) or maintained sedentary (S) for 8 weeks; measurements were made at weeks 0, 1, 2, 4 and 8. Hypertension-induced cardiac hypertrophy was accompanied by acute plasma Ang II increase with amplified responses during the late phase of LV hypertrophy. Similar pattern was observed for oxidative stress markers, TNF alpha and interleukin-18, associated with cardiomyocytes' diameter enlargement and collagen deposition. SHR-T exhibited prompt and marked decrease in LV Ang II content (T-1 vs T-4 in WKY-T), normalized oxidative stress (T-2), augmented antioxidant defense (T-4) and reduced both collagen deposition and inflammatory profile (T-8), without changing cardiomyocytes' diameter and LV hypertrophy. These changes were accompanied by decreased plasma Ang II content (T-2-T-4) and reduced BP (T-8). SHR-T and WKY-T showed parallel increases in LV and plasma Ang-(1-7) content. Our data indicate that early training-induced downregulation of LV ACE-AngII-AT1 receptor axis is a crucial mechanism to reduce oxidative/pro-inflammatory profile and improve antioxidant defense in SHR-T, showing in addition this effect precedes plasma RAS deactivation.	[Silva, Sebastiao D., Jr.; Michelini, Lisete C.] Univ Sao Paulo, Dept Physiol & Biophys, Biomed Sci Inst, Sao Paulo, SP, Brazil; [Silva, Sebastiao D., Jr.; Montezano, Augusto C.; Touyz, Rhian M.] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF GCRC, Glasgow, Lanark, Scotland; [Jara, Zaira P.; Peres, Roseli; Casarini, Dulce E.] Univ Fed Sao Paulo, Dept Med, Sao Paulo, SP, Brazil; [Lima, Larissa S.; Scavone, Cristoforo] Univ Sao Paulo, Dept Pharmacol, Biomed Sci Inst, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; University of Glasgow; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Michelini, LC (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Biomed Sci Inst, Sao Paulo, SP, Brazil.	michelin@usp.br	Touyz, Rhian/AAM-3564-2020; Scavone, Cristoforo/ABB-8279-2021; Scavone, Cristoforo/AFK-9950-2022; Scavone, Cristoforo/C-1580-2012	Touyz, Rhian/0000-0003-0670-0887; Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Casarini, Dulce/0000-0003-1912-4292; Michelini, Lisete/0000-0003-2978-5406; Silva Jr, Sebastiao/0000-0003-0376-3225	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/15681-8, 2011/51410-9, 2010/51904-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PDSE 9714-14-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [304060/2011-9]; British Heart Foundation Award [CH/4/29762]; British Heart Foundation [RG/13/7/30099] Funding Source: researchfish	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); British Heart Foundation Award; British Heart Foundation(British Heart Foundation)	This study was supported by the following research grants: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [www.fapesp.br.-grants 2011/15681-8 (fellowship to SDSJr), 2011/51410-9 (research grant to LCM) and 2010/51904-9(research grant to DEC)], Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br)-grant PDSE 9714-14-6 to SDSJr) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br-grant 304060/2011-9: research fellow to LCM). R. M. Touyz is supported through a Chair Award from the British Heart Foundation Award #CH/4/29762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Agarwal D, 2009, HYPERTENSION, V54, P1393, DOI 10.1161/HYPERTENSIONAHA.109.135459; Ahmadiasl N, 2007, J SPORT SCI MED, V6, P243; Ambarish V, 2012, Indian J Physiol Pharmacol, V56, P7; Aurelie NDC, 2011, PEPTIDES, V32, P2141, DOI 10.1016/j.peptides.2011.09.010; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Bechara LRG, 2014, INT J CARDIOL, V175, P499, DOI 10.1016/j.ijcard.2014.06.046; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Briones AM, 2009, HYPERTENSION, V54, P1206, DOI 10.1161/HYPERTENSIONAHA.109.136622; BUTTRICK P, 1991, CIRC RES, V68, P645, DOI 10.1161/01.RES.68.3.645; Campos JC, 2013, FOOD CHEM TOXICOL, V62, P107, DOI 10.1016/j.fct.2013.08.035; Carnes CA, 2004, J APPL PHYSIOL, V97, P446, DOI 10.1152/japplphysiol.00439.2003; Cavalleri MT, 2011, AM J PHYSIOL-REG I, V301, pR958, DOI 10.1152/ajpregu.00104.2011; Felix JVC, 2007, HYPERTENSION, V50, P780, DOI 10.1161/HYPERTENSIONAHA.107.094474; Chaar LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137395; Chang SP, 2004, CLIN EXP PHARMACOL P, V31, P506, DOI 10.1111/j.1440-1681.2004.04035.x; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Della Gatta PA, 2014, BRAIN BEHAV IMMUN, V39, P80, DOI 10.1016/j.bbi.2014.01.006; Fernandes T, 2015, AM J PHYSIOL-HEART C, V309, pH543, DOI 10.1152/ajpheart.00899.2014; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Filho AG, 2008, EXP PHYSIOL, V93, P589, DOI 10.1113/expphysiol.2007.014293; Frantz EDC, 2017, AM J PHYSL ENDOCRINO; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Guimaraes GG, 2012, PEPTIDES, V38, P54, DOI 10.1016/j.peptides.2012.05.024; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kumar R, 2009, CURR HYPERTENS REP, V11, P104, DOI 10.1007/s11906-009-0020-y; Lin L, 2016, J CELL MOL MED, V20, P48, DOI 10.1111/jcmm.12687; Lo J, 2013, EXP PHYSIOL, V98, P109, DOI 10.1113/expphysiol.2012.067165; Lopes RA, 2015, HYPERTENSION, V66, P1240, DOI 10.1161/HYPERTENSIONAHA.115.06163; Masson GS, 2014, PLOS ONE, P9; Montezano AC, 2012, ANN MED, V44, pS2, DOI 10.3109/07853890.2011.653393; Niebauer J, 2008, HEART FAIL REV, V13, P39, DOI 10.1007/s10741-007-9050-1; Nunes-Silva A, 2017, PROTEIN PEPT LETT; Oliveira V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113035; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rebelo RMD, 2012, J PHYSIOL-LONDON, V590, P5389, DOI 10.1113/jphysiol.2012.241141; Roncbi FA, 2007, J RENIN-ANGIO-ALDO S, V8, P34, DOI 10.3317/jraas.2007.005; Rosa RM, 2016, AM J PHYSIOL-RENAL, V311, pF496, DOI 10.1152/ajprenal.00121.2014; Rossoni LV, 2011, J HYPERTENS, V29, P2349, DOI 10.1097/HJH.0b013e32834d2532; Sangaleti CT, 2004, HYPERTENSION, V43, P317, DOI 10.1161/01.HYP.0000112030.79692.21; Schluter KD, 2010, HYPERTENS RES, V33, P1155, DOI 10.1038/hr.2010.155; Silva SD, 2015, CIRC J, V79, P1372, DOI 10.1253/circj.CJ-14-1179; Silver MA, 2006, CURR OPIN NEPHROL HY, V15, P14; Unger T, 2011, EUR HEART J, V32, P2739, DOI 10.1093/eurheartj/ehr253; Yamamoto T, 2003, COMP BIOCHEM PHYS C, V135, P163, DOI 10.1016/S1532-0456(03)00087-5; Zamo FS, 2011, LIFE SCI, V89, P93, DOI 10.1016/j.lfs.2011.05.004; Zhang SN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11342-6; Zucker IH, 2015, AM J PHYSIOL-HEART C, V308, pH781, DOI 10.1152/ajpheart.00026.2015	54	33	34	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189535	10.1371/journal.pone.0189535	http://dx.doi.org/10.1371/journal.pone.0189535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232407	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000417698200058
J	Hasenahuer, MA; Barletta, GP; Fernandez-Alberti, S; Parisi, G; Fornasari, MS				Anahi Hasenahuer, Marcia; Patricio Barletta, German; Fernandez-Alberti, Sebastian; Parisi, Gustavo; Silvina Fornasari, Maria			Pockets as structural descriptors of EGFR kinase conformations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LUNG-CANCER; INACTIVE CONFORMATIONS; PROTEIN; INHIBITOR; MECHANISM; ACTIVATION; DISCOVERY; DOMAIN; PLASTICITY	Epidermal Growth Factor Receptor (EGFR), a tyrosine kinase receptor, is one of the main tumor markers in different types of cancers. The kinase native state is mainly composed of two populations of conformers: active and inactive. Several sequence variations in EGFR kinase region promote the differential enrichment of conformers with higher activity. Some structural characteristics have been proposed to differentiate kinase conformations, but these considerations could lead to ambiguous classifications. We present a structural characterisation of EGFR kinase conformers, focused on active site pocket comparisons, and the mapping of known pathological sequence variations. A structural based clustering of this pocket accurately discriminates active from inactive, well-characterised conformations. Furthermore, this main pocket contains, or is in close contact with, approximate to 65% of cancer-related variation positions. Although the relevance of protein dynamics to explain biological function has been extensively recognised, the usage of the ensemble of conformations in dynamic equilibrium to represent the functional state of proteins and the importance of pockets, cavities and/or tunnels was often neglected in previous studies. These functional structures and the equilibrium between them could be structurally analysed in wild type as well as in sequence variants. Our results indicate that biologically important pockets, as well as their shape and dynamics, are central to understanding protein function in wild-type, polymorphic or disease-related variations.	[Anahi Hasenahuer, Marcia; Patricio Barletta, German; Fernandez-Alberti, Sebastian; Parisi, Gustavo; Silvina Fornasari, Maria] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina		Fornasari, MS (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina.	silvina@unq.edu.ar		parisi, gustavo/0000-0001-7444-1624	Argentine National Scientific and Technical Research Council (CONICET) [PIP 112201101-01002]; Agencia de Ciencia y Tecnologia (ANCyT) [PICT-2014-3430]; Universidad Nacional de Quilmes [1402/15]	Argentine National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Ciencia y Tecnologia (ANCyT); Universidad Nacional de Quilmes	Funded by Argentine National Scientific and Technical Research Council (CONICET), grant code: PIP 112201101-01002. Agencia de Ciencia y Tecnologia (ANCyT), grant code PICT-2014-3430. Universidad Nacional de Quilmes, grant code 1402/15. GP, SFA and SMF are researchers of CONICET and MAH and GPB are PhD fellows of the same institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Baum BR., 1989, Q REV BIOL, V64, P539, DOI DOI 10.1086/416571; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrera M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-8; Bickerton GR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-313; Cheng H, 2016, J MED CHEM, V59, P2005, DOI 10.1021/acs.jmedchem.5b01633; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Dixit A, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/653487; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Ferguson KM, 2004, BIOCHEM SOC T, V32, P742, DOI 10.1042/BST0320742; Forbes SA, 2008, INTRO COSMIC CATALOG; Forbes SA, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-62; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gora A, 2013, CHEM REV, V113, P5871, DOI 10.1021/cr300384w; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hasenahuer MA, 2015, ANN HUM GENET, V79, P385, DOI 10.1111/ahg.12127; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; James KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113488; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kancha RK, 2011, J THORAC ONCOL, V6, P387, DOI 10.1097/JTO.0b013e3182021f3e; Kingsley LJ, 2015, PROTEINS, V83, P599, DOI 10.1002/prot.24772; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Kumar S, 2000, PROTEIN SCI, V9, P10; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; KURIYAN J, 1987, PROTEINS, V2, P1, DOI 10.1002/prot.340020102; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Liu W, 2015, DRUG DES DEV THER, V9, P3837, DOI 10.2147/DDDT.S85357; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Monzon AM, 2013, BIOINFORMATICS, V29, P2512, DOI 10.1093/bioinformatics/btt405; Muller S, 2015, NAT CHEM BIOL, V11, P818, DOI 10.1038/nchembio.1938; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Pravda L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0379-x; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Russo A, 2015, ONCOTARGET, V6, P26814, DOI 10.18632/oncotarget.4254; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Tramontano A, 2006, FEBS LETT, V580, P2928, DOI 10.1016/j.febslet.2006.04.011; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; VERKHIVKER G, 1995, PROTEIN ENG, V8, P677, DOI 10.1093/protein/8.7.677; Vijayan RSK, 2015, J MED CHEM, V58, P466, DOI 10.1021/jm501603h; Wang Q, 2014, METHOD ENZYMOL, V548, P23, DOI 10.1016/B978-0-12-397918-6.00002-1; Wei GH, 2016, CHEM REV, V116, P6516, DOI 10.1021/acs.chemrev.5b00562; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang X, 2006, CRYSTAL STRUCTURE IN; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhou HX, 1998, P NATL ACAD SCI USA, V95, P9280, DOI 10.1073/pnas.95.16.9280	69	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189147	10.1371/journal.pone.0189147	http://dx.doi.org/10.1371/journal.pone.0189147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228029	Green Submitted, Green Published, gold			2022-12-26	WOS:000417648600036
J	Pilcher, W; Zandkamiri, H; Arceneaux, K; Harrison, S; Baisakh, N				Pilcher, Whitney; Zandkamiri, Hana; Arceneaux, Kelly; Harrison, Stephen; Baisakh, Niranjan			Genome-wide microarray analysis leads to identification of genes in response to herbicide, metribuzin in wheat leaves	PLOS ONE			English	Article							SPARTINA-ALTERNIFLORA LOISEL; ALKALINE ALPHA-GALACTOSIDASE; OXIDATIVE STRESS; TRANSGENIC RICE; SALT STRESS; ARABIDOPSIS; TOLERANCE; EXPRESSION; DROUGHT; PROTEIN	Herbicides are an important component of weed management in wheat, particularly in the southeastern US where weeds actively compete with wheat throughout the winter for nutrients and reduce tillering and ultimately the yield of the crop. Some wheat varieties are sensitive to metribuzin, a low-cost non-selective herbicide, leading to leaf chlorosis, stand loss, and decreased yield. Knowledge of the genetics of herbicide tolerance in wheat is very limited and most new varieties have not been screened for metribuzin tolerance. The identification of genes associated with metribuzin tolerance will lead to the development of molecular markers for use in screening breeding lines for metribuzin tolerance. AGS 2035 and AGS 2060 were identified as resistant and sensitive to metribuzin in several previous field screening experiments as well as controlled condition screening of nine varieties in the present study. Genome-wide transcriptome profiling of the genes in AGS 2035 and AGS 2060 through microarray analysis identified 169 and 127 genes to be significantly (2-fold, P>0.01) up-and down-regulated, respectively in response to metribuzin. Functional annotation revealed that genes involved in cell wall biosynthesis, photosynthesis and sucrose metabolism were highly responsive to metribuzin application. (Semi) quantitative RT-PCR of seven selected differentially expressed genes (DEGs) indicated that a gene coding for alkaline alpha-galactosidase 2 (AAG2) was specifically expressed in resistant varieties only after one and two weeks of metribuzin application. Integration of the DEGs into our ongoing mapping effort and identification of the genes within the QTL region showing significant association with resistance in future will aid in development of functional markers for metribuzin resistance.	[Pilcher, Whitney; Zandkamiri, Hana; Arceneaux, Kelly; Harrison, Stephen; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Harrison, S; Baisakh, N (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	sharrison@agcenter.lsu.edu; nbaisakh@agcenter.lsu.edu			Louisiana Grain and Soybean Research and Promotion Board; United State Department of Agriculture-National Institute of Food and Agriculture	Louisiana Grain and Soybean Research and Promotion Board; United State Department of Agriculture-National Institute of Food and Agriculture	This work was supported by the Louisiana Grain and Soybean Research and Promotion Board; United State Department of Agriculture-National Institute of Food and Agriculture.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the Louisiana Soybean and Grain Research and Promotion Board and the United States Department of Agriculture-National Institute of Food and Agriculture. This manuscript has been approved for publication by the Louisiana Agricultural Experiment Station as MS# 2017-306-31470.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; Besse I, 1996, P NATL ACAD SCI USA, V93, P3169, DOI 10.1073/pnas.93.8.3169; Burgess B, MAFES INFORM B; Cudney D. W., 1991, California Agriculture, V45, P22; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Daldoul S, 2012, ACTA PHYSIOL PLANT, V34, P731, DOI 10.1007/s11738-011-0873-y; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Dhammu H, 2015, P 20 AUSTR WEEDS C P; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Futamura N, 2006, TREE PHYSIOL, V26, P51, DOI 10.1093/treephys/26.1.51; Hara M, 2008, PLANT BIOTECHNOL, V25, P497, DOI 10.5511/plantbiotechnology.25.497; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hu X, 1997, PLANT MOL BIOL, V34, P949, DOI 10.1023/A:1005893119263; Jang JY, 2007, PLANT MOL BIOL, V64, P621, DOI 10.1007/s11103-007-9181-8; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Joshi R, 2014, PLANT CELL TISS ORG, V117, P17, DOI 10.1007/s11240-013-0416-x; Jung IL, 2003, ENVIRON TOXICOL PHAR, V15, P19, DOI 10.1016/j.etap.2003.08.001; Lee RH, 2009, NEW PHYTOL, V184, P596, DOI 10.1111/j.1469-8137.2009.02999.x; LEHLE L, 1973, EUR J BIOCHEM, V38, P103, DOI 10.1111/j.1432-1033.1973.tb03039.x; Li J, 2015, BIOCHEM BIOPH RES CO, V459, P208, DOI 10.1016/j.bbrc.2015.02.052; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Niemietz CM, 2002, FEBS LETT, V531, P443, DOI 10.1016/S0014-5793(02)03581-0; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Peters S, 2009, PLANT CELL ENVIRON, V32, P1099, DOI 10.1111/j.1365-3040.2009.01991.x; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Prather SP, 2012, U CALIF AGR NAT RES, V8012, P1; RATLIFF RL, 1991, WEED SCI, V39, P130, DOI 10.1017/S0043174500057994; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tsukamoto S, 2005, PLANT PHYSIOL, V137, P317, DOI 10.1104/pp.104.045658; Velikanov GA, 2015, PROTOPLASMA, V252, P1263, DOI 10.1007/s00709-015-0758-9; Villarroya M, 2000, WEED RES, V40, P293, DOI 10.1046/j.1365-3180.2000.00188.x; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; Wu J, 2016, PLANT PATHOLOGY J, V32, P552, DOI 10.5423/PPJ.OA.06.2016.0141; Ye Q, 2005, PLANT CELL ENVIRON, V28, P525, DOI 10.1111/j.1365-3040.2004.01298.x; Zhou ML, 2012, GLYCOBIOLOGY, V22, P1775, DOI 10.1093/glycob/cws121	40	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189639	10.1371/journal.pone.0189639	http://dx.doi.org/10.1371/journal.pone.0189639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228046	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600063
J	Hornum, L; Hansen, AJ; Tornehave, D; Fjording, MS; Colmenero, P; Watjen, IF; Nielsen, NHS; Bliddal, H; Bartels, EM				Hornum, Lars; Hansen, Anker Jon; Tornehave, Ditte; Fjording, Marianne Scheel; Colmenero, Paula; Watjen, Inger Falbe; Nielsen, Niels Henrik Soe; Bliddal, Henning; Bartels, Else Marie			C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid	PLOS ONE			English	Article							COMPLEMENT PATHWAY ACTIVATION; COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTOR; CARTILAGE DESTRUCTION; MONOCLONAL-ANTIBODY; FELTYS-SYNDROME; NEUTROPHILS; RECEPTOR; CELL; TISSUE	Complement activation correlates to rheumatoid arthritis disease activity, and increased amounts of the complement split product C5a is observed in synovial fluids from rheumatoid arthritis patients. Blockade of C5a or its receptor (C5aR) is efficacious in several arthritis models. The aim of this study was to investigate the role of C5a and C5aR in human rheumatoid arthritis and psoriatic arthritis-both with respect to expression and function. Synovial fluid, blood and synovial samples were obtained from rheumatoid arthritis, psoriatic arthritis and osteoarthritis patients as a less inflammatory arthritis type, and blood from healthy subjects. Cells infiltrating synovial tissue were analysed by immunohistochemistry and flow cytometry. SF and blood were analysed for biomarkers by flow cytometry or ELISA. The effect of a blocking anti-human C5aR mAb on leukocyte migration was determined using a Boyden chamber. Appropriate statistical tests were applied for comparisons. C5aR(+) cells were detected in most rheumatoid arthritis, in all psoriatic arthritis, but not in non-inflammatory control synovia. C5aR(+) cells were primarily neutrophils and macrophages. C5aR(+) macrophages were mainly found in lymphoid aggregates in close contact with T cells. C5a levels were increased in both rheumatoid arthritis and psoriatic arthritis synovial fluid compared to osteoarthritis, and in blood from rheumatoid arthritis compared to healthy subjects. Neutrophil and monocyte migration to rheumatoid arthritis synovial fluid was significantly inhibited by anti-C5aR. The data support that the C5a-C5aR axis may be driving the infiltration of inflammatory cells into the synovial fluid and synovium in both rheumatoid and psoriatic arthritis, and suggest that C5a or C5aR may be a promising treatment target in both diseases.	[Hornum, Lars; Hansen, Anker Jon; Tornehave, Ditte; Fjording, Marianne Scheel] Novo Nordisk AS, Malov, Denmark; [Colmenero, Paula] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Watjen, Inger Falbe; Bliddal, Henning; Bartels, Else Marie] Copenhagen Univ Hosp, Parker Inst, Frederiksberg, Denmark; [Nielsen, Niels Henrik Soe] Herlev & Gentofte Hosp, Hand Sect, Dept Orthopaed, Gentofte, Denmark; [Bliddal, Henning] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Novo Nordisk; University of Oxford; University of Copenhagen; University of Copenhagen	Bartels, EM (corresponding author), Copenhagen Univ Hosp, Parker Inst, Frederiksberg, Denmark.	else.marie.bartels@regionh.dk	Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668	OAK Foundation [OCAY-13-309]; Novo Nordisk A/S; Gentofte University Hospital, Denmark	OAK Foundation; Novo Nordisk A/S(Novo Nordisk); Gentofte University Hospital, Denmark	The Parker Institute is supported by an unspecified grant from the OAK Foundation (OCAY-13-309). Novo Nordisk A/S supported acquisition of antibodies and some technical assistance, and the funder provided support in the form of salaries for authors [LH, AJH, DT, MSF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The Parker Institute is supported by a grant from the OAK Foundation (OCAY-13-309).; We wish to thank the Staff of the Department of Anesthesiology and Day Care Surgery, Herlev and Gentofte University Hospital, Denmark for support when collecting the biopsy samples, and Pia Birn, Hanife Dzaferi Farizi and Steen Kryger, NOVO Nordisk A/S, and Eva Littrup Andersen and Jack Kvistgaard Olsen, the Parker Institute, for technical support.	Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Andersson C, 2014, CLIN EXP IMMUNOL, V177, P219, DOI 10.1111/cei.12338; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ballanti E, 2013, IMMUNOL RES, V56, P477, DOI 10.1007/s12026-013-8422-y; Ballanti E, 2011, AUTOIMMUN REV, V10, P617, DOI 10.1016/j.autrev.2011.04.012; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; CAPSONI F, 1995, HAEMATOLOGICA, V80, P123; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Cedergren J, 2007, J RHEUMATOL, V34, P2162; den Broeder AA, 2003, J RHEUMATOL, V30, P232; DOHERTY M, 1988, ANN RHEUM DIS, V47, P190, DOI 10.1136/ard.47.3.190; Dularay B, 1988, Autoimmunity, V1, P159, DOI 10.3109/08916938808997161; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; EDWARDS SW, 1988, BIOCHEM J, V250, P81, DOI 10.1042/bj2500081; EMERY P, 1988, ANN RHEUM DIS, V47, P34, DOI 10.1136/ard.47.1.34; Gerlag DM, 2004, ARTHRITIS RHEUM, V50, P3783, DOI 10.1002/art.20664; Giles JL, 2015, J IMMUNOL, V194, P3029, DOI 10.4049/jimmunol.1402956; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; HAYAT SQ, 1995, CLIN RHEUMATOL, V14, P211, DOI 10.1007/BF02214946; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; HOGASEN K, 1995, J RHEUMATOL, V22, P24; KAPLAN RA, 1980, ARTHRITIS RHEUM, V23, P911, DOI 10.1002/art.1780230806; Kessel C, 2014, ARTHRITIS RHEUMATOL, V66, P610, DOI 10.1002/art.38237; KITSIS E, 1991, CLIN ORTHOP RELAT R, P63; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Kraan MC, 2000, ARTHRITIS RHEUM, V43, P1820, DOI 10.1002/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D; Kwan WH, 2012, IMMUNOL RES, V54, P247, DOI 10.1007/s12026-012-8327-1; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; MAKINDE VA, 1989, ANN RHEUM DIS, V48, P302, DOI 10.1136/ard.48.4.302; MCMULLIN MF, 1995, CLIN RHEUMATOL, V14, P204, DOI 10.1007/BF02214945; Mehta G, 2015, J IMMUNOL, V194, P5446, DOI 10.4049/jimmunol.1403012; MENNINGER H, 1980, Z RHEUMATOL, V39, P145; MOHR W, 1978, Z RHEUMATOL, V37, P81; MOHR W, 1995, J RHEUMATOL, V22, P1436; Molenaar ETH, 2001, ARTHRITIS RHEUM, V44, P997, DOI 10.1002/1529-0131(200105)44:5<997::AID-ANR178>3.0.CO;2-C; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; NURCOMBE HL, 1991, ANN RHEUM DIS, V50, P147, DOI 10.1136/ard.50.3.147; PALMER DG, 1986, PATHOLOGY, V18, P431, DOI 10.3109/00313028609087564; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; Quayle JA, 1997, IMMUNOLOGY, V91, P266; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Song JJ, 2011, J CLIN INVEST, V121, P3517, DOI 10.1172/JCI46387; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; Trouw LA, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.125; VELVART M, 1981, RHEUMATOL INT, V1, P121, DOI 10.1007/BF00541256; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; VIDARSSON B, 1995, AM J MED, V98, P589, DOI 10.1016/S0002-9343(99)80019-9; WATSON F, 1993, ANN RHEUM DIS, V52, P354, DOI 10.1136/ard.52.5.354; Woodruff TM, 2002, ARTHRITIS RHEUM-US, V46, P2476, DOI 10.1002/art.10449; Wouters D, 2006, ARTHRITIS RHEUM, V54, P1143, DOI 10.1002/art.21729; Youssef PP, 1996, ARTHRITIS RHEUM, V39, P216, DOI 10.1002/art.1780390207	60	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189017	10.1371/journal.pone.0189017	http://dx.doi.org/10.1371/journal.pone.0189017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220376	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900025
J	Lin, TT; Wu, CK; Liao, MT; Yang, YH; Chen, PC; Yeih, DF; Lin, LY				Lin, Ting-Tse; Wu, Cho-Kai; Liao, Min-Tsun; Yang, Yao-Hsu; Chen, Pau-Chung; Yeih, Dong-Feng; Lin, Lian-Yu			Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis - A nationwide cohort study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIOVASCULAR EVENTS; PROPENSITY SCORE; RISK-FACTORS; INFLAMMATION; THERAPY; MORTALITY; DISEASE; METHOTREXATE; MORBIDITY	Background Rheumatoid arthritis (RA) is regarded as a high risk factor for myocardial infarction. Hypertension is a major modifiable risk factor contributing to increased risk of myocardial infarction (MI). Dual blood pressure (BP)-lowering and anti-inflammatory effect of renin-angiotensinsystem (RAS) inhibitors may possess protective effect from MI in RA population. However, treatment of hypertension with RAS inhibitors and MI in RA population remains unclear. Methods We investigated whether RAS blockade could decrease risk of incident MI in hypertensive patients with RA. We identified patients with RA and hypertension from the Registry for Catastrophic Illness, a nation-wide database encompassing almost all of the RA patients in Taiwan from 1995 to 2008. The primary endpoint was MI and the median duration of follow up was 2,986 days. Propensity score weighting and Cox proportional hazards regression models were used to estimate hazard ratios for MI. Results Among 27,335 subjects, 9.9% received angiotensin-converting enzyme inhibitors (ACEIs), 25.9% received angiotensin II receptor blockers (ARBs) and 20.0% received ACEIs or ARBs alternatively. The incidence of MI significantly decreased in patients treated with ACEIs (hazard ratio 0.707; 95% confidence interval 0.595 - 0.840), ARBs (0.641; 0.550 - 0.747) and ACEIs/ARBs (0.631; 0.539 - 0.739). The protective effect of ACEI or ARB therapy was significantly better in patients taking longer duration. The effect remained robust in subgroup analyses. Conclusions Therapy of ACEIs or ARBs is associated with a lower risk of MI among patients with RA. Hence, hypertension in patients with RA could comprise a compelling indication for RAS inhibitors.	[Lin, Ting-Tse; Liao, Min-Tsun] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Ting-Tse] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lin, Ting-Tse] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Wu, Cho-Kai; Lin, Lian-Yu] Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Yeih, Dong-Feng] Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Yeih, Dong-Feng] Fu Jen Catholic Univ, Dept Internal Med, Sch Med, New Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Fu Jen Catholic University	Lin, LY (corresponding author), Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.; Yeih, DF (corresponding author), Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan.; Yeih, DF (corresponding author), Fu Jen Catholic Univ, Dept Internal Med, Sch Med, New Taipei, Taiwan.	ocean0829@yahoo.com; h11151@hch.gov.tw	Chen, Pau-Chung/H-5686-2011; 楊, 曜旭/A-3450-2019	Chen, Pau-Chung/0000-0002-6242-5974; 楊, 曜旭/0000-0002-8080-0504; WU, CHO-KAI/0000-0002-3867-150X; LIN, TING-TSE/0000-0002-8810-5127; LIAO, MIN-TSUN/0000-0002-6283-6554	National Taiwan University College of Medicine [106-2314-B-002-046-MY2]; Ministry of Science and Technology, from the National Taiwan University Hospital Hsinchu Branch [105-HCH065, 106-HCH056]	National Taiwan University College of Medicine(National Taiwan University); Ministry of Science and Technology, from the National Taiwan University Hospital Hsinchu Branch	This work was supported by Grant 106-2314-B-002-046-MY2 from National Taiwan University College of Medicine and Ministry of Science and Technology, Grant 105-HCH065 and 106-HCH056 from the National Taiwan University Hospital Hsinchu Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant 106-2314-B-002-046-MY2 from National Taiwan University College of Medicine and Ministry of Science and Technology, Grant 105-HCH065 and 106-HCH056 from the National Taiwan University Hospital Hsinchu Branch.	Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; Dessein PH, 2006, ARTHRITIS RHEUM-US, V54, P2765, DOI 10.1002/art.22053; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Flammer AJ, 2008, CIRCULATION, V117, P2262, DOI 10.1161/CIRCULATIONAHA.107.734384; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Gamboa JL, 2012, J AM SOC NEPHROL, V23, P334, DOI 10.1681/ASN.2011030287; Hikosaka M, 2000, AM J CARDIOL, V86, P1241, DOI 10.1016/S0002-9149(00)01209-1; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Karpouzas GA, 2014, ANN RHEUM DIS, V73, P1797, DOI 10.1136/annrheumdis-2013-203617; Lazzerini PE, 2016, EUR HEART J, P1; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Lin TT, 2015, KIDNEY INT, V88, P378, DOI 10.1038/ki.2015.96; Linden A, 2014, J EVAL CLIN PRACT, V20, P1065, DOI 10.1111/jep.12254; Lopez-Mejias R, 2016, AUTOIMMUN REV, V15, P1013, DOI 10.1016/j.autrev.2016.07.026; Mancia G, 2014, BLOOD PRESSURE, V23, P3, DOI 10.3109/08037051.2014.868629; MARTIN MFR, 1984, LANCET, V1, P1325; Myasoedova E, 2011, J RHEUMATOL, V38, P1601, DOI 10.3899/jrheum.100979; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Panoulas VF, 2008, RHEUMATOLOGY, V47, P1286, DOI 10.1093/rheumatology/ken159; Perry ME, 2008, ANN RHEUM DIS, V67, P1646, DOI 10.1136/ard.2007.082917; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 1997, CIRCULATION, V95, P2643, DOI 10.1161/01.CIR.95.12.2643; Price A, 2007, ARTHRITIS RHEUM-US, V56, P441, DOI 10.1002/art.22335; Rakugi H, 1996, AM HEART J, V132, P213, DOI 10.1016/S0002-8703(05)80002-X; Refaat R, 2013, EUR J PHARMACOL, V698, P421, DOI 10.1016/j.ejphar.2012.10.024; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Sattar N, 2005, CURR OPIN RHEUMATOL, V17, P286, DOI 10.1097/01.bor.0000158150.57154.f9; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Souza DG, 2003, BRIT J PHARMACOL, V139, P129, DOI 10.1038/sj.bjp.0705200; Tikiz C, 2005, J RHEUMATOL, V32, P2095; Turnbull F, 2003, LANCET, V362, P1527; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; WILSON PWF, 1994, AM J HYPERTENS, V7, pS7, DOI 10.1093/ajh/7.7.7S; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145	45	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188720	10.1371/journal.pone.0188720	http://dx.doi.org/10.1371/journal.pone.0188720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216228	gold, Green Submitted, Green Published			2022-12-26	WOS:000417337800038
J	Yang, QH; Fujii, W; Kaji, N; Kakuta, S; Kada, K; Kuwahara, M; Tsubone, H; Ozaki, H; Hori, M				Yang, Qunhui; Fujii, Wataru; Kaji, Noriyuki; Kakuta, Shigeru; Kada, Kodai; Kuwahara, Masayoshi; Tsubone, Hirokazu; Ozaki, Hiroshi; Hori, Masatoshi			The essential role of phospho-T38 CPI-17 in the maintenance of physiological blood pressure using genetically modified mice	FASEB JOURNAL			English	Article						CRISPR/Cas9; aorta; radio telemetry; PKC; MYPT1	VASCULAR SMOOTH-MUSCLE; RHO-ASSOCIATED KINASE; MYOSIN LIGHT-CHAIN; TARGETING SUBUNIT-1 PHOSPHORYLATION; CONTRACTILE CA2+ SENSITIZATION; 3-KINASE ALPHA-ISOFORM; PROTEIN PHOSPHATASE-1; PHORBOL ESTER; UP-REGULATION; MYOSIN/MOESIN PHOSPHATASE	PKC-potentiated phosphorylation-dependent inhibitory protein of protein phosphatase 1 (CPI-17), an endogenous myosin phosphatase inhibitory protein, is considered a key molecule for Ca2+ sensitization of the contractile apparatus. Here, we have used clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 to generate CPI-17-deficient [knockout (KO)] and threonine 38 (T38)-phospho-resistant mice [threonine mutant into alanine (TA)], and then effects of CPI-17 on vascular contractility in vitro and mean blood pressure (MBP) in vivo were investigated. In isolated thoracic aorta, phorbol 12, 13-dibutyrate induced a sustained contraction of wild-type (WT) mice, whereas no contraction showed from TA or KO mice. A high concentration of KCl solution-induced contraction was not different between transgenic and WT mice. In contrast, phenylephrine (PE)-induced contractions in both mutant strains were significantly smaller than those of WT mice in association with a low level of myosin phosphorylation, suggesting that at least part of PE-induced contraction is regulated by phosphorylation of CPI-17 at T38. Finally, the physiologic role of CPI-17 in the regulation of blood pressure was investigated using radio telemetry. MBP was decreased significantly in both transgenic mice, even with a compensatory increase in heart rate. In summary, we generated KO and constitutively phospho-resistant mouse models of CPI-17 for the first time. p-CPI-17 at T38, possibly by PKC, could be important to maintain vascular contractility and blood pressure in vivo.	[Yang, Qunhui; Kaji, Noriyuki; Kada, Kodai; Ozaki, Hiroshi; Hori, Masatoshi] Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Fujii, Wataru] Univ Tokyo, Lab Appl Genet, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kakuta, Shigeru] Univ Tokyo, Dept Biomed Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kuwahara, Masayoshi] Univ Tokyo, Dept Vet Pathophysiol & Anim Hlth, Grad Sch Agr & Life Sci, Tokyo, Japan; [Tsubone, Hirokazu] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Hori, M (corresponding author), Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahori@mail.ecc.u-tokyo.ac.jp	Kakuta, Shigeru/L-2241-2018	Kakuta, Shigeru/0000-0002-5900-1425; Kaji, Noriyuki/0000-0001-7423-5679; Fujii, Wataru/0000-0002-6438-7350	Ministry of Education, Japan [24248050, 25221205, 26712025]; Salt Science Research Foundation [1645]; Grant for Joint Research Project of the Institute of Medical Science, The University of Tokyo [235]	Ministry of Education, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Grant for Joint Research Project of the Institute of Medical Science, The University of Tokyo	The authors thank Yoshiharu Tsuru (Primetech Corporation, Tokyo, Japan), for giving great technical support in regard to the telemetry system used to measure blood pressure. The authors thank Kosuke Takeya (Department of Physiology, Asahikawa Medical College) for technical support of protein extraction and Western blot from mouse thoracic aorta. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Japan (24248050 to M.H.; 25221205 to H.O.; and 26712025 to W.F.), and partly supported by the Salt Science Research Foundation (No. 1645 to M.H.) and Grant for Joint Research Project of the Institute of Medical Science, The University of Tokyo (No. 235 to S.K.). The authors declare no conflicts of interest.	Baek I, 2009, CLIN EXP PHARMACOL P, V36, P256, DOI 10.1111/j.1440-1681.2008.05045.x; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; Chen CP, 2015, J PHYSIOL-LONDON, V593, P681, DOI 10.1113/jphysiol.2014.283853; Dakshinamurti S, 2005, PEDIATR PULM, V40, P398, DOI 10.1002/ppul.20290; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Dubois T, 2003, BIOCHEM BIOPH RES CO, V302, P186, DOI 10.1016/S0006-291X(03)00130-X; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Eto Masumi, 2017, J Smooth Muscle Res, V53, P1, DOI 10.1540/jsmr.53.1; Eto M, 2013, BIOCHEM BIOPH RES CO, V434, P137, DOI 10.1016/j.bbrc.2013.03.055; Eto M, 2012, IUBMB LIFE, V64, P732, DOI 10.1002/iub.1067; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Gao N, 2017, J PHYSIOL-LONDON, V595, P6231, DOI 10.1113/JP274715; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HORI M, 1992, J PHARMACOL EXP THER, V261, P506; Iizuka M, 2011, AM J PHYSIOL-GASTR L, V300, pG1010, DOI 10.1152/ajpgi.00350.2010; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Karaki H, 1997, PHARMACOL REV, V49, P157; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kida T, 2011, ATHEROSCLEROSIS, V214, P288, DOI 10.1016/j.atherosclerosis.2010.11.001; Kim JI, 2017, KOREAN J PHYSIOL PHA, V21, P99, DOI 10.4196/kjpp.2017.21.1.99; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kitazawa T, 2004, J PHYSIOL-LONDON, V557, P515, DOI 10.1113/jphysiol.2004.064543; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; KUWAHARA M, 1991, EXP ANIM TOKYO, V40, P331, DOI 10.1538/expanim1978.40.3_331; MITSUI M, 1993, BRIT J PHARMACOL, V109, P229, DOI 10.1111/j.1476-5381.1993.tb13558.x; Miura M, 1997, PFLUG ARCH EUR J PHY, V434, P685, DOI 10.1007/s004240050452; Mori D, 2011, NEUROGASTROENT MOTIL, V23, P1111, DOI 10.1111/j.1365-2982.2011.01799.x; Ohama T, 2003, J BIOL CHEM, V278, P48794, DOI 10.1074/jbc.M310166200; Ohama T, 2008, J GASTROENTEROL, V43, P858, DOI 10.1007/s00535-008-2241-2; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Ozaki J, 2003, BRIT J PHARMACOL, V140, P1303, DOI 10.1038/sj.bjp.0705552; Pagiatakis C, 2012, J BIOL CHEM, V287, P8361, DOI 10.1074/jbc.M111.286203; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Qiao YN, 2014, J BIOL CHEM, V289, P22512, DOI 10.1074/jbc.M113.525444; Ringvold H C, 2017, Adv Pharmacol, V78, P203, DOI 10.1016/bs.apha.2016.06.002; Saito T, 2013, CIRCULATION, V127, P104, DOI 10.1161/CIRCULATIONAHA.112.135608; Sakai H, 2005, MOL PHARMACOL, V68, P145, DOI 10.1124/mol.104.004325; Sakamoto K, 2003, J PHARMACOL SCI, V92, P56; SATO K, 1992, J PHARMACOL EXP THER, V261, P497; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Su W, 2013, AM J PHYSIOL-HEART C, V305, pH104, DOI 10.1152/ajpheart.00597.2012; Tajimi M, 1997, JPN J PHARMACOL, V74, P195, DOI 10.1254/jjp.74.195; Wang FY, 2016, TRENDS CELL BIOL, V26, P875, DOI 10.1016/j.tcb.2016.08.004; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Watanabe Y, 2001, BLOOD, V97, P3798, DOI 10.1182/blood.V97.12.3798; Wei XN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-112; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yoshimoto R, 2000, JPN J PHARMACOL, V84, P474, DOI 10.1254/jjp.84.474; Yoshioka K, 2007, MOL PHARMACOL, V71, P912, DOI 10.1124/mol.106.032599	61	13	13	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2095	2109		10.1096/fj.201700794R	http://dx.doi.org/10.1096/fj.201700794R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29229685				2022-12-26	WOS:000429051400030
J	Cevallos, CG; Jones, LR; Pando, MA; Carr, JK; Avila, MM; Quarleri, J				Cevallos, Cintia G.; Jones, Leandro R.; Pando, Maria A.; Carr, Jean K.; Avila, Maria M.; Quarleri, Jorge			Genomic characterization and molecular evolution analysis of subtype B and BF recombinant HIV-1 strains among Argentinean men who have sex with men reveal a complex scenario	PLOS ONE			English	Article							NEWLY-DIAGNOSED INDIVIDUALS; DRUG-RESISTANCE; BUENOS-AIRES; TYPE-1; IDENTIFICATION; DIVERSITY; SEQUENCES; CRF12-BF; SPREAD	Currently, data on HIV-1 circulating strains among men who have sex with men (MSM) in Argentina is scarce. In South America, the distribution and the prevalence of BF recombinants are dissimilar and exhibit an underappreciated heterogeneity of recombinant structures. Here, we studied for the first time the genetic diversity of HIV-1 BF recombinants and their evolution over time through in-depth phylogenetic analysis and multiple recombination detection methods involving 337 HIV-1 nucleotide sequences (25 near full-length (NFL) and 312 partial pol gene) obtained from Argentinean MSM. The recombination profiles were studied using multiple in silico tools to characterize the genetic mosaicism, and phylogenetic approaches to infer their relationships. The evolutionary history of BF recombinants and subtype B sequences was reconstructed by a Bayesian coalescent-based method. By phylogenetic inference, 81/312 pol sequences clustered within BF clade. Of them, 46 sequences showed a genetic mosaic with CRF12_BF-like patterns, including plausible second-generation recombinants. Other CRFs_BF like (CRF17, 28, 29, 39, 42, 44, 47) and probable URFs_BF were less frequently found. Phylogenetic and recombination analyses on NFL sequences allowed a meticulous definition of new BF mosaics of genomic patterns. The Bayesian analyses pointed out quite consistent onset dates for the CRFs_BF clade based on B and F gene datasets (similar to 1986 and similar to 1991 respectively). These results indicate that the CRFs_BF variants have been circulating among Argentinean MSM for about 30 years. This study reveals, through growing evidence showing the importance of MSM in the dynamics of the HIV-1 epidemic in Argentina, the coexistence of CRF12_BF-like and high diversity of strains exhibiting several BF mosaic patterns, including non-reported URFs that may reflect active clusters as potential intervention targets to hinder HIV-1 transmission.	[Cevallos, Cintia G.; Pando, Maria A.; Avila, Maria M.; Quarleri, Jorge] UBA, Fac Med, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina; [Cevallos, Cintia G.; Jones, Leandro R.; Pando, Maria A.; Avila, Maria M.; Quarleri, Jorge] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Jones, Leandro R.] Univ Nacl Patagonia San Juan Bosco, Sede Trelew, Fac Ciencias Nat & Ciencias Salud, LVGM, Chubut, Argentina; [Carr, Jean K.] Lake Erie Coll Osteopath Med, Seton Hill, Greensburg, PA USA	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Quarleri, J (corresponding author), UBA, Fac Med, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.; Quarleri, J (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	quarleri@fmed.uba.ar	Quarleri, Jorge/AFR-0308-2022	Quarleri, Jorge/0000-0001-5110-8773; Jones, Leandro/0000-0002-5877-4194	Agencia Nacional de Promocion Cientifica y Tecnologica-Fondo Nacional para la Ciencia y Tecnica [PICT 2013/2229]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2012/1048]	Agencia Nacional de Promocion Cientifica y Tecnologica-Fondo Nacional para la Ciencia y Tecnica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by grants obtained by MMA from the Agencia Nacional de Promocion Cientifica y Tecnologica-Fondo Nacional para la Ciencia y Tecnica (grant number PICT 2013/2229) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (grant number PIP 2012/1048) to MMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Argentinean National Health Ministry; AIDS and STD Department, 2016, 33 B HIV AIDS ARG; Aulicino PC, 2012, INFECT GENET EVOL, V12, P443, DOI 10.1016/j.meegid.2012.01.003; Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008; Avila MM, 2002, J ACQ IMMUN DEF SYND, V29, P422, DOI 10.1097/00126334-200204010-00015; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; Delgado E, 2010, AIDS RES HUM RETROV, V26, P821, DOI 10.1089/aid.2010.0006; Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068; Dilernia DA, 2011, AIDS RES HUM RETROV, V27, P569, DOI 10.1089/aid.2010.0118; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Gomez-Carrillo M, 2004, AIDS RES HUM RETROV, V20, P885, DOI 10.1089/0889222041725172; Gomez-Carrillo M, 2006, AIDS RES HUM RETROV, V22, P1186, DOI 10.1089/aid.2006.22.1186; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guindon S, 2010, NEW ALGORITHMS METHO; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lantz CA, 1996, J CLIN EPIDEMIOL, V49, P431, DOI 10.1016/0895-4356(95)00571-4; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-59; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Quarleri JF, 2004, AIDS RES HUM RETROV, V20, P1100, DOI 10.1089/aid.2004.20.1100; Ristic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017485; Ruchansky D, 2009, AIDS RES HUM RETROV, V25, P351, DOI 10.1089/aid.2008.0248; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189705	10.1371/journal.pone.0189705	http://dx.doi.org/10.1371/journal.pone.0189705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244833	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700053
J	Nicoletti, A; Mostile, G; Stocchi, F; Abbruzzese, G; Ceravolo, R; Cortelli, P; D'Amelio, M; De Pandis, MF; Fabbrini, G; Pacchetti, C; Pezzoli, G; Tessitore, A; Canesi, M; Zappia, M				Nicoletti, Alessandra; Mostile, Giovanni; Stocchi, Fabrizio; Abbruzzese, Giovanni; Ceravolo, Roberto; Cortelli, Pietro; D'Amelio, Marco; De Pandis, Maria F.; Fabbrini, Giovanni; Pacchetti, Claudio; Pezzoli, Gianni; Tessitore, Alessandro; Canesi, Margherita; Zappia, Mario			Factors influencing psychological well-being in patients with Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; DISABILITY; VALIDATION; DIAGNOSIS; FATIGUE; HEALTH; SCALE; SLEEP	Background Both motor and non-motor symptoms could contribute to significant deterioration of psychological well-being in patients with Parkinson's disease (PD). However, its assessment has been only indirectly evaluated using tools based on health-related quality of life (HRQoL), such as the PDQ-39 scale. Objectives To evaluate psychological well-being in PD using a specific tool of assessment, the Psychological Well-being Scale (PWS), and its clinical correlates. Methods This article reports data of patients' perception of health state, as measured by means of the PWS, from an epidemiological, cross-sectional study conducted in Italian PD patients (FORTE Study). We tested possible relationship between well-being and clinical characteristics including fatigue, depression, sleep disruption and HRQoL. Results 272 patients completed the PWS questionnaire. Significant and clinically-relevant correlations were found between PWS total score and Parkinson's Fatigue Scale, Beck Depression Inventory, UPDRS Section I, PD Sleep Scale and PDQ-39 for HRQoL scores. Only clinically negligible correlations were found between PWS and motor scores. Conclusions Non-motor symptoms have a significant impact on psychological well-being in PD patients.	[Nicoletti, Alessandra; Mostile, Giovanni; Zappia, Mario] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy; [Stocchi, Fabrizio] IRCCS San Raffaele Pisana, Inst Neurol, Rome, Italy; [Abbruzzese, Giovanni] Univ Genoa, Ctr Parkinsons Dis & Movement Disorders, DINOGMI, Genoa, Italy; [Ceravolo, Roberto] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Cortelli, Pietro] IRCCS Inst Neurol Sci Bologna, Bologna, Italy; [Cortelli, Pietro] Univ Bologna, DIBINEM, Alma Mater Studiorum, Bologna, Italy; [D'Amelio, Marco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [De Pandis, Maria F.] San Raffaele Inst, Dept Neurorehabil, Parkinson Operat Unit, Cassino, FR, Italy; [Fabbrini, Giovanni] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy; [Fabbrini, Giovanni] Univ Roma La Sapienza, IRCSS Neuromed, Rome, Italy; [Pacchetti, Claudio] IRCCS Neurol Natl Inst C Mondino, Parkinsons Dis & Movement Disorders Unit, Pavia, Italy; [Pezzoli, Gianni; Canesi, Margherita] ASST G Pini CTO, Parkinson Inst, Milan, Italy; [Tessitore, Alessandro] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy	University of Catania; IRCCS San Raffaele Pisana; University of Genoa; University of Pisa; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Palermo; Sapienza University Rome; IRCCS Neuromed; Sapienza University Rome; IRCCS Fondazione Casimiro Mondino; Universita della Campania Vanvitelli	Zappia, M (corresponding author), Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy.	m.zappia@unict.it	pacchetti, claudio/AAA-5033-2020; De Pandis, Maria Francesca/GPC-8167-2022; D'Amelio, Marco/AAC-7288-2022; Zappia, Mario/AAB-7800-2019; Fabbrini, Giovanni/AAC-1875-2020; Mostile, Giovanni/AAA-9014-2022; Cortelli, Pietro/K-6063-2016; Tessitore, Alessandro/K-3124-2018; stocchi, fabrizio/K-5089-2016; Nicoletti, Alessandra/K-4486-2018	D'Amelio, Marco/0000-0002-2178-6749; Mostile, Giovanni/0000-0002-3556-7432; Tessitore, Alessandro/0000-0003-1740-8566; stocchi, fabrizio/0000-0002-5763-0033; Nicoletti, Alessandra/0000-0001-6757-340X; Fabbrini, Giovanni/0000-0001-7614-8771	Lund beck Italia SpA	Lund beck Italia SpA(Lundbeck Corporation)	Data analysis was based on the FORTE Study Dataset, provided from Lundbeck Italia Spa free of charge. The FORTE Study was sponsored by Lund beck Italia SpA. The Authors were responsible for study design, interpretation of data, writing and decision to publish. Authors had complete access to the data base and vouch for the quality of the analysis.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brown RG, 2005, PARKINSONISM RELAT D, V11, P49, DOI 10.1016/j.parkreldis.2004.07.007; Gomez-Esteban JC, 2011, J NEUROL, V258, P494, DOI 10.1007/s00415-010-5786-y; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Diener E., 2003, WELL BEING FDN HEDON; Fahn S., 1987, RECENT DEV PARKINSON, P153; Hagell Peter, 2009, Ther Adv Neurol Disord, V2, P205, DOI 10.1177/1756285609103726; Hinkle DE, 2003, APPL STAT BEHAV SCI; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Knauper B, 2003, QUAL LIFE RES, V12, P81, DOI 10.1023/A:1023589907955; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; MAGNUS K, 1993, J PERS SOC PSYCHOL, V65, P1046, DOI 10.1037/0022-3514.65.5.1046; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Opara J A, 2012, J Med Life, V5, P375; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; Pinto Sara, 2017, Porto Biomed J, V2, P6, DOI 10.1016/j.pbj.2016.11.003; Ruini C., 2003, RIV PSICHIATR, V38, P117, DOI DOI 10.1708/173.1864; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schrag A, 2010, J NEUROL NEUROSUR PS, V69, P308; Stocchi F, 2014, NEUROLOGY, V83, P215, DOI 10.1212/WNL.0000000000000587; Weintraub D, 2004, J AM GERIATR SOC, V52, P784, DOI 10.1111/j.1532-5415.2004.52219.x; WHO, 1948, BAS DOC, V1, P22; World Health Organization, 2014, MENT HLTH STAT WELL; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	28	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189682	10.1371/journal.pone.0189682	http://dx.doi.org/10.1371/journal.pone.0189682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244834	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700048
J	Barrand, S; Crowley, TM; Wood-Bradley, RJ; De Jong, KA; Armitage, JA				Barrand, Sanna; Crowley, Tamsyn M.; Wood-Bradley, Ryan J.; De Jong, Kirstie A.; Armitage, James A.			Impact of maternal high fat diet on hypothalamic transcriptome in neonatal Sprague Dawley rats	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; APPETITE REGULATORS; EXPERIMENTAL-MODELS; LEPTIN SENSITIVITY; METABOLIC SYNDROME; ARTERIAL-PRESSURE; GENE-EXPRESSION; ALTERS LEPTIN; EXPOSURE; DOPAMINE	Maternal consumption of a high fat diet during early development has been shown to impact the formation of hypothalamic neurocircuitry, thereby contributing to imbalances in appetite and energy homeostasis and increasing the risk of obesity in subsequent generations. Early in postnatal life, the neuronal projections responsible for energy homeostasis develop in response to appetite-related peptides such as leptin. To date, no study characterises the genome-wide transcriptional changes that occur in response to exposure to high fat diet during this critical window. We explored the effects of maternal high fat diet consumption on hypothalamic gene expression in Sprague Dawley rat offspring at postnatal day 10. RNAsequencing enabled discovery of differentially expressed genes between offspring of dams fed a high fat diet and offspring of control diet fed dams. Female high fat diet offspring displayed altered expression of 86 genes (adjusted P-value< 0.05), including genes coding for proteins of the extra cellular matrix, particularly Collagen 1a1 (Col1a1), Col1a2, Col3a1, and the imprinted Insulin-like growth factor 2 (Igf2) gene. Male high fat diet offspring showed significant changes in collagen genes (Col1a1 and Col3a1) and significant upregulation of two genes involved in regulation of dopamine availability in the brain, tyrosine hydroxylase (Th) and dopamine reuptake transporter Slc6a3 (also known as Dat1). Transcriptional changes were accompanied by increased body weight, body fat and body length in the high fat diet offspring, as well as altered blood glucose and plasma leptin. Transcriptional changes identified in the hypothalamus of offspring of high fat diet mothers could alter neuronal projection formation during early development leading to abnormalities in the neuronal circuitry controlling appetite in later life, hence priming offspring to the development of obesity.	[Barrand, Sanna; Crowley, Tamsyn M.; Wood-Bradley, Ryan J.; De Jong, Kirstie A.; Armitage, James A.] Deakin Univ, Sch Med, Fac Hlth, Waurn Ponds, Vic, Australia; [Crowley, Tamsyn M.] Deakin Univ, Sch Med, MMR, BCRG, Waurn Ponds, Vic, Australia	Deakin University; Deakin University	Barrand, S (corresponding author), Deakin Univ, Sch Med, Fac Hlth, Waurn Ponds, Vic, Australia.	s.barrand@deakin.edu.au	Armitage, James/AAX-1294-2021	Barrand, Sanna/0000-0001-5642-5196; Crowley, Tamsyn/0000-0002-3698-8917; Armitage, James/0000-0002-3762-0911	Deakin University Faculty Research Development Grant	Deakin University Faculty Research Development Grant	This study was supported by Deakin University Faculty Research Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1986, ADV ANAT EMBRYOL CEL, V100, P1; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Bouret S G, 2012, Int J Obes Suppl, V2, pS19, DOI 10.1038/ijosup.2012.17; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Breton C, 2013, J ENDOCRINOL, V216, pR19, DOI 10.1530/JOE-12-0157; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen H, 2009, OBESITY, V17, P1356, DOI 10.1038/oby.2009.56; Chen L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03819; Costa C, 2013, TRANSL LUNG CANCER R, V2, P87, DOI 10.3978/j.issn.2218-6751.2013.02.05; Dearden L, 2015, FRONT NEUROENDOCRIN, V39, P3, DOI 10.1016/j.yfrne.2015.08.001; Dearden L, 2014, ENDOCRINOLOGY, V155, P2144, DOI 10.1210/en.2014-1131; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Gupta A, 2009, J ENDOCRINOL, V200, P293, DOI 10.1677/JOE-08-0429; Habbout A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056981; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Hulsen T, 2008, BMC GENOMICS, P9; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Kukurba Kimberly R, 2015, Cold Spring Harb Protoc, V2015, P951, DOI 10.1101/pdb.top084970; Lan Xianyong, 2013, Frontiers in Genetics, V4, P49, DOI 10.3389/fgene.2013.00049; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Lopez M, 2005, DIABETOLOGIA, V48, P140, DOI 10.1007/s00125-004-1596-z; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Prior LJ, 2014, HYPERTENSION, V63, P338, DOI 10.1161/HYPERTENSIONAHA.113.02498; Prior LJ, 2010, HYPERTENSION, V55, P862, DOI 10.1161/HYPERTENSIONAHA.109.141119; Purcell RH, 2011, PHYSIOL BEHAV, V104, P474, DOI 10.1016/j.physbeh.2011.05.012; Ramamoorthy TG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00126; Robb JL, 2017, BEHAV BRAIN RES, V326, P187, DOI 10.1016/j.bbr.2017.02.049; Samuelsson AM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00014; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Vickers MH, 2005, PEDIATR RES, V58, P1128; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Zheng J, 2015, METAB BRAIN DIS, V30, P1129, DOI 10.1007/s11011-015-9678-9	48	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189492	10.1371/journal.pone.0189492	http://dx.doi.org/10.1371/journal.pone.0189492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240779	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600038
J	Conkle, J; Ramakrishnan, U; Flores-Ayala, R; Suchdev, PS; Martorell, R				Conkle, Joel; Ramakrishnan, Usha; Flores-Ayala, Rafael; Suchdev, Parminder S.; Martorell, Reynaldo			Improving the quality of child anthropometry: Manual anthropometry in the Body Imaging for Nutritional Assessment Study (BINA)	PLOS ONE			English	Article								Anthropometric data collected in clinics and surveys are often inaccurate and unreliable due to measurement error. The Body Imaging for Nutritional Assessment Study (BINA) evaluated the ability of 3D imaging to correctly measure stature, head circumference (HC) and arm circumference (MUAC) for children under five years of age. This paper describes the protocol for and the quality of manual anthropometric measurements in BINA, a study conducted in 2016 +/- 17 in Atlanta, USA. Quality was evaluated by examining digit preference, biological plausibility of z-scores, z-score standard deviations, and reliability. We calculated z-scores and analyzed plausibility based on the 2006 WHO Child Growth Standards (CGS). For reliability, we calculated intra-and inter-observer Technical Error of Measurement (TEM) and Intraclass Correlation Coefficient (ICC). We found low digit preference; 99.6% of z-scores were biologically plausible, with z-score standard deviations ranging from 0.92 to 1.07. Total TEM was 0.40 for stature, 0.28 for HC, and 0.25 for MUAC in centimeters. ICC ranged from 0.99 to 1.00. The quality of manual measurements in BINA was high and similar to that of the anthropometric data used to develop the WHO CGS. We attributed high quality to vigorous training, motivated and competent field staff, reduction of non-measurement error through the use of technology, and reduction of measurement error through adequate monitoring and supervision. Our anthropometry measurement protocol, which builds on and improves upon the protocol used for the WHO CGS, can be used to improve anthropometric data quality. The discussion illustrates the need to standardize anthropometric data quality assessment, and we conclude that BINA can provide a valuable evaluation of 3D imaging for child anthropometry because there is comparison to gold-standard, manual measurements.	[Conkle, Joel; Ramakrishnan, Usha; Flores-Ayala, Rafael; Suchdev, Parminder S.; Martorell, Reynaldo] Emory Univ, Doctoral Program Nutr & Hlth Sci, Laney Grad Sch, Atlanta, GA 30322 USA; [Ramakrishnan, Usha; Suchdev, Parminder S.; Martorell, Reynaldo] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Flores-Ayala, Rafael; Suchdev, Parminder S.] US Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Suchdev, Parminder S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Emory University	Conkle, J (corresponding author), Emory Univ, Doctoral Program Nutr & Hlth Sci, Laney Grad Sch, Atlanta, GA 30322 USA.	joelconkle@gmail.com	Martorell, Reynaldo/I-2539-2012; Suchdev, Parmi S/K-4851-2012	Conkle, Joel/0000-0003-2603-5052	Bill and Melinda Gates Foundation [OPP1132308]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007734] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Bill and Melinda Gates Foundation (www.gatesfoundation.org) funded the study (ID OPP1132308). Dr. Reynaldo Martorell was the Principal Investigator for the study. All authors do not have affiliations with or financial involvement with any organization or entity with a financial interest in the subject matter or materials discussed in the manuscript. Funding sources had no role in data analyses, data interpretation, or report writing. The corresponding author had full access to all data, final responsibility for the decision to submit for publication, and has no conflicts of interest to disclose. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Assaf S., 2015, DHS METHODOLOGICAL R, V16; Ayele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030345; Cogill B, 2003, ANTHROPOMETRIC INDIC; Corsi DJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1328185; De Onis M, 2006, WHO CHILD GROWTH STA; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Gerner B, 2006, J PAEDIATR CHILD H, V42, P206, DOI 10.1111/j.1440-1754.2006.00831.x; Grellety E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168585; International ICF, 2012, MEASURE DHS BIOM FIE; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Pullum TW., 2008, METHODOLOGICAL REPOR; SMART, 2015, ENA SOFTW SMART ACF; SMART Action Against Hunger D Canada and Technical Advisory Group, 2015, SMART PLAUS CHECK AN; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; UNICEF, 2014, MULT IND CLUST SURV; United Nations, 1986, WEIGH MEAS CHILDR AS; US CDC, 2007, NAT HLTH NUTR EX SUR; US CDC International Micronutrient Malnutrition Prevention and Control Program, 2016, MICR SURV TOOLK TOR; USAID, 2016, ANTHR DAT POP BAS SU; WHO, 2015, WHO ANTHR MACR; Wit JM, 2017, HORM RES PAEDIAT, V88, P79, DOI 10.1159/000456007; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR; Yin HY, 2013, ANN HUM BIOL, V40, P309, DOI 10.3109/03014460.2013.775343	26	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189332	10.1371/journal.pone.0189332	http://dx.doi.org/10.1371/journal.pone.0189332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240796	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600029
J	Loy, SL; Cheung, YB; Fortier, MV; Ong, CL; Tan, HH; Nadarajah, S; Chan, JKY; Viardot-Foucault, V				Loy, See Ling; Cheung, Yin Bun; Fortier, Marielle Valerie; Ong, Chiou Li; Tan, Heng Hao; Nadarajah, Sadhana; Chan, Jerry Kok Yen; Viardot-Foucault, Veronique			Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore	PLOS ONE			English	Article							OVARIAN RESERVE MARKERS; MENOPAUSE; DECLINE; NORMOGRAM; MIDLIFE; MODEL	Background Antral follicle count (AFC) and anti-Mullerian hormone (AMH) are known as the most reliable markers of a woman's ovarian reserve and are related to age. There is currently no specific local age-related centile charts for AFC and AMH. Therefore, we aim to examine the relationship between AFC and AMH with age and construct age-related nomograms among a subfertile Asian population. Methods This is a study involving Chinese women who had their AFC and AMH measured as part of their subfertility screening from December 2010 until November 2014 in KK Women's and Children's Hospital, Singapore. Ordinary least squares regression analysis was used to estimate the relationship of AFC and AMH with age, while age-related AFC and AMH nomograms for the 3rd, 10th, 25th, 50th, 75th, 90th and 97th percentiles were produced using the lambda-mu-sigma method. Results A total of 1,009 women, aged 26 to 44 year-old, were included. On average, the AFC and AMH decreased respectively by 0.79 follicle (95% confidence interval -0.93, -0.64) and 0.38 ng/mL (95% confidence interval -0.43, -0.32) per year of age. The age-related nomograms of AFC showed an approximately linear pattern, inversely correlated with age, regardless of the percentile. For AMH, the pattern is linear for the 75th percentile and below but shows a slightly accelerating decline for the 90th and 97th percentile. Overall, there were large inter-individual variations in AFC and AMH up to about 40 year-old. Conclusion The declines of AFC and AMH over age are mostly linear among subfertile Chinese women in Singapore. The age-related AFC and AMH nomograms could be used as a reference chart by fertility practitioners. However, future validation with longitudinal data is required.	[Loy, See Ling; Tan, Heng Hao; Nadarajah, Sadhana; Chan, Jerry Kok Yen; Viardot-Foucault, Veronique] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Loy, See Ling; Chan, Jerry Kok Yen] Duke NUS Med Sch, Singapore, Singapore; [Cheung, Yin Bun] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Cheung, Yin Bun] Univ Tampere, Tampere Ctr Child Hlth Res, Tampere, Finland; [Cheung, Yin Bun] Tampere Univ Hosp, Tampere, Finland; [Fortier, Marielle Valerie; Ong, Chiou Li] KK Womens & Childrens Hosp, Dept Diagnost & Intervent Imaging, Singapore, Singapore	KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; Tampere University; Tampere University; Tampere University Hospital; KK Women's & Children's Hospital	Viardot-Foucault, V (corresponding author), KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore.	veronique.viardot@singhealth.com.sg	Loy, SeeLing/AGW-6714-2022; Loy, See Ling/E-3812-2018	Loy, See Ling/0000-0002-9205-5580				Almog B, 2011, FERTIL STERIL, V95, P663, DOI 10.1016/j.fertnstert.2010.08.047; Bentzen JG, 2013, J CLIN ENDOCR METAB, V98, P1602, DOI 10.1210/jc.2012-1829; Bernardi LA, 2017, OBESITY, V25, P229, DOI 10.1002/oby.21681; Broekmans FJM, 2010, FERTIL STERIL, V94, P1044, DOI 10.1016/j.fertnstert.2009.04.040; Chang MY, 1998, J ASSIST REPROD GEN, V15, P12, DOI 10.1023/A:1022518103368; Dillon K, 2013, SEMIN REPROD MED, V31, P10; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Fong SL, 2012, J CLIN ENDOCR METAB, V97, P4650, DOI 10.1210/jc.2012-1440; Freour T, 2012, ARCH GYNECOL OBSTET, V285, P1177, DOI 10.1007/s00404-011-2172-7; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Iglesias C, 2014, FERTIL STERIL, V102, P244, DOI 10.1016/j.fertnstert.2014.03.050; Keane K, 2017, REPROD BIOL, V17, P51, DOI 10.1016/j.repbio.2016.12.002; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037; La Marca A, 2011, FERTIL STERIL, V95, P684, DOI 10.1016/j.fertnstert.2010.07.1069; Naasan MN, 2015, IRISH J MED SCI, V184, P213, DOI 10.1007/s11845-014-1089-0; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; Ng EHY, 2003, HUM REPROD, V18, P2169, DOI 10.1093/humrep/deg404; Reuss ML, 1996, AM J OBSTET GYNECOL, V174, P624, DOI 10.1016/S0002-9378(96)70439-8; Rosen MP, 2012, FERTIL STERIL, V97, P238, DOI 10.1016/j.fertnstert.2011.10.031; Rosen MP, 2010, FERTIL STERIL, V94, P2182, DOI 10.1016/j.fertnstert.2009.12.045; Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011; Wiweko B, 2013, J ASSIST REPROD GEN, V30, P1563, DOI 10.1007/s10815-013-0083-1	24	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189830	10.1371/journal.pone.0189830	http://dx.doi.org/10.1371/journal.pone.0189830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240820	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600075
J	Aguilera-Cogley, VA; Berbegal, M; Catala, S; Brentu, FC; Armengol, J; Vicent, A				Antonio Aguilera-Cogley, Vidal; Berbegal, Monica; Catala, Santiago; Brentu, Francis Collison; Armengol, Josep; Vicent, Antonio			Characterization of Mycosphaerellaceae species associated with citrus greasy spot in Panama and Spain	PLOS ONE			English	Article							CERCOSPOROID FUNGI; EUCALYPTUS; DISEASES; LEAVES; PHYLOGENY; INFERENCE; ETIOLOGY; RECORDS; MODELS; SPP.	Greasy spot of citrus, caused by Zasmidium citri-griseum (= Mycosphaerella citri), is widely distributed in the Caribbean Basin, inducing leaf spots, premature defoliation, and yield loss. Greasy spot-like symptoms were frequently observed in humid citrus-growing regions in Panama as well as in semi-arid areas in Spain, but disease aetiology was unknown. Citrus-growing areas in Panama and Spain were surveyed and isolates of Mycosphaerellaceae were obtained from citrus greasy spot lesions. A selection of isolates from Panama (n = 22) and Spain (n = 16) was assembled based on their geographical origin, citrus species, and affected tissue. The isolates were characterized based on multi-locus DNA (ITS and EF-1 alpha) sequence analyses, morphology, growth at different temperatures, and independent pathogenicity tests on the citrus species most affected in each country. Reference isolates and sequences were also included in the analysis. Isolates from Panama were identified as Z. citri-griseum complex, and others from Spain attributed to Amycosphaerella africana. Isolates of the Z. citri-griseum complex had a significantly higher optimal growth temperature (26.8 degrees C) than those of A. africana (19.3 degrees C), which corresponded well with their actual biogeographical range. The isolates of the Z. citri-griseum complex from Panama induced typical greasy spot symptoms in 'Valencia' sweet orange plants and the inoculated fungi were reisolated. No symptoms were observed in plants of the 'Ortanique' tangor inoculated with A. africana. These results demonstrate the presence of citrus greasy spot, caused by Z. citri-griseum complex, in Panama whereas A. africana was associated with greasy spot-like symptoms in Spain.	[Antonio Aguilera-Cogley, Vidal] Inst Invest Agr Panama IDIAP, Ctr Invest Agr Cent, Lab Protecc Vegetal, Herrera, Panama; [Berbegal, Monica; Catala, Santiago; Armengol, Josep] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Valencia, Spain; [Brentu, Francis Collison] Univ Ghana, Coll Basic & Appl Sci, Sch Agr, Forest & Hort Crops Res Ctr Kade, Legon, Accra, Ghana; [Vicent, Antonio] IVIA, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain	Universitat Politecnica de Valencia; University of Ghana	Vicent, A (corresponding author), IVIA, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain.	vicent_antciv@gva.es	Antonio, Vicent/W-6375-2019; Berbegal, Monica/M-2892-2014; Vicent, Antonio/D-1306-2014	Antonio, Vicent/0000-0002-3848-0631; Berbegal, Monica/0000-0002-5773-3104; Vicent, Antonio/0000-0002-3848-0631; Aguilera-Cogley, Vidal/0000-0001-7647-3208	INIA 'Programa de Formacion de los INIA Iberoamerica'; Programa de Formacion de los INIA Iberoamerica; INIA [RTA2010-00105-00-00-FEDER]	INIA 'Programa de Formacion de los INIA Iberoamerica'; Programa de Formacion de los INIA Iberoamerica; INIA(Instituto de Investigacion Agropecuaria (INIA))	Research was partially funded by INIA 'Programa de Formacion de los INIA Iberoamerica' and RTA2010-00105-00-00-FEDER to Vidal Aguilera Cogley.; Research partially funded by 'Programa de Formacion de los INIA Iberoamerica' and INIA RTA2010-00105-00-00-FEDER. We thank J. Martinez-Minaya (UV) for assistance with INLA.	Abdelfattah A, 2017, MICROB ECOL, V73, P739, DOI 10.1007/s00248-016-0874-x; Aguilera-Cogley V, 2015, ACTA HORTIC, V1065, P947; Aguin O, 2013, FOREST ECOL MANAG, V302, P379, DOI 10.1016/j.foreco.2013.03.021; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aptroot A., 2006, MYCOSPHAERELLA ITS 5, V5; Braun U, 2013, MYCOSPHERE, V4, P176, DOI 10.5943/mycosphere/4/2/3; Braun U, 2014, IMA FUNGUS, V5, P203, DOI 10.5598/imafungus.2014.05.02.04; Burgess TI, 2007, FUNGAL DIVERS, V24, P135; Christensen RHB, **DATA OBJECT**; Crous PW, 2009, PERSOONIA, V23, P99, DOI 10.3767/003158509X479487; Crous PW, 2004, STUD MYCOL, P457; Crous PW, 1996, MYCOLOGIA, V88, P441, DOI 10.2307/3760885; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FISHER FE, 1961, PHYTOPATHOLOGY, V51, P297; Grasso S, 2005, J PLANT PATHOL, V87, P295; Haggag W, 2012, J PLANT PATHOL, V94, P4; Honger J, 2004, THESIS; Huang F, 2015, MYCOLOGIA, V107, P1151, DOI 10.3852/15-059; Hunter GC, 2006, STUD MYCOL, P147, DOI 10.3114/sim.55.1.147; lvarez A, P 13 C SPAN PHYT SOC; MARCO GM, 1986, PLANT DIS, V70, P1074, DOI 10.1094/PD-70-1074a; Maxwell A, 2003, MYCOL RES, V107, P351, DOI 10.1017/S0953756203007354; Mondal SN, 2006, PLANT DIS, V90, P532, DOI 10.1094/PD-90-0532; Otero L, 2006, P 13 C SPAN PHYT SOC; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pretorius MC, 2003, SYDOWIA, V55, P286; Quaedvlieg W, 2014, PERSOONIA, V33, P1, DOI 10.3767/003158514X681981; Rambaut A., 2016, FIGTREE V1 4 0 GRAPH; Rayner R.W., 1970, MYCOLOGICAL COLOR CH; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sivanesan A, 1984, BITUNICATE ASCOMYCET; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; WELLINGS CR, 1981, T BRIT MYCOL SOC, V76, P495, DOI 10.1016/S0007-1536(81)80080-0; WHITESID.JO, 1970, PHYTOPATHOLOGY, V60, P1409, DOI 10.1094/Phyto-60-1409; Yamada S, 1956, BULLETIN, V3, P49; Zhan JS, 2011, MOL ECOL, V20, P1689, DOI 10.1111/j.1365-294X.2011.05023.x	38	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189585	10.1371/journal.pone.0189585	http://dx.doi.org/10.1371/journal.pone.0189585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236789	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100084
J	Baquero, E; Ledesma, E; Gilgado, JD; Ortuno, VM; Jordana, R				Baquero, Enrique; Ledesma, Enrique; Gilgado, Jose D.; Ortuno, Vicente M.; Jordana, Rafael			Distinctive Collembola communities in the Mesovoid Shallow Substratum: First data for the Sierra de Guadarrama National Park (Central Spain) and a description of two new species of Orchesella (Entomobryidae)	PLOS ONE			English	Article							SUBTERRANEAN HABITAT; COLEOPTERA; DIVERSITY; DIPLOPODA; MSS; CHORDEUMATIDA	Two new species of the genus Orchesella Templeton, 1836 have been identified following intensive sampling in the Colluvial Milieu Souterrain Superficiel (Mesovoid Shallow Substratum, or MSS) of the Sierra de Guadarrama using Subterranean Sampling Devices (SSD). The data were obtained from the first extraction of the traps between May and October of 2015. During a study of the Collembola taxon, 32 different genera (61 species) were identified. The highest representative genus presence in almost all traps was Orchesella, with two new species. One of the two species described had been misidentified until this study was carried out, indicating that their preferential habitat had not been sampled; the second species had never been identified. The community of the Orchesella species in the Colluvial MSS was investigated, leading to the conclusion that this environment has its own assemblage of characteristic species. The opportunity to study specimens that belong to five species of the genus Orchesella, including three previously recollected, has allowed for obtaining reliable information regarding their macrochaetotaxy. A part of this chaetotaxy is proposed as a useful diagnostic tool for the species of the genus. In conclusion, it can be affirmed that this study has demonstrated that the Colluvial Mesovoid Shallow Substratum (Colluvial MSS) has its own fauna, and it supports the hypothesis that it constitutes a new biotope, at least for Collembola.	[Baquero, Enrique; Jordana, Rafael] Univ Navarra, Dept Biol Anim, Pamplona, Spain; [Ledesma, Enrique; Gilgado, Jose D.; Ortuno, Vicente M.] Univ Alcala, Dept Ciencias Vida, Fac Biol Ciencias Ambientales & Quim, Madrid, Spain	University of Navarra; Universidad de Alcala	Baquero, E (corresponding author), Univ Navarra, Dept Biol Anim, Pamplona, Spain.	ebaquero@unav.es	Jordana, Rafael/F-6867-2017; Ledesma, Enrique/AHC-6812-2022	Jordana, Rafael/0000-0001-9088-787X; Ledesma, Enrique/0000-0002-5771-5993; Baquero, Enrique/0000-0002-2145-8606; Gilgado, Jose D./0000-0003-0484-4000	Spanish Ministry of Agriculture, Food and Environment - National Parks Autonomous Agency [SPIP2014-01143]	Spanish Ministry of Agriculture, Food and Environment - National Parks Autonomous Agency	This work is part of a research project supported by the Spanish Ministry of Agriculture, Food and Environment - National Parks Autonomous Agency (http://www.mapama.gob.es/es/parques-nacionales-oapn/) SPIP2014-01143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia estatal de meteorlogia (AEMET), 2012, GUIA RES CLIM ESP 19; [Anonymous], 1971, GRAELLSIA; [Anonymous], [No title captured]; Arenas R., 1991, REV SOC GEOL ESP, V4, P195; Barranco P, 2013, ZOOTAXA, V3691, P201, DOI 10.11646/zootaxa.3691.2.1; Bellinger P.F., CHECKLIST COLLEMBOLA; BONET F., 1929, MEM R SOC ESPANOLA HIST NAT, V15, P791; Christiansen K., 1980, P1; CHRISTIANSEN KENNETH A., 1958, BULL MUS COMP ZOOL HARVARD UNIV, V118, P437; CULVER D, 2014, SHALLOW SUBTERRANEAN; Culver David C., 2009, Cave and Karst Science, V35, P5; Culver DC, 2005, ENCY CAVES; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; de Pedraza J., 2005, ENSE ANZA CIENCIAS T, V13, P278; Frati F, 2000, MOL PHYLOGENET EVOL, V17, P456, DOI 10.1006/mpev.2000.0854; Gers C, 1998, ACTA OECOL, V19, P205, DOI 10.1016/S1146-609X(98)80025-8; Gers C., 1992, THESIS; Giachino P. M., 2010, WBA HDB, V3; Gilgado JD, 2015, ZOOL ANZ, V258, P13, DOI 10.1016/j.jcz.2015.06.001; Gilgado JD, 2015, ZOOTAXA, V4044, P391, DOI 10.11646/zootaxa.4044.3.4; Gilgado JD, 2015, ZOOTAXA, V3937, P337, DOI 10.11646/zootaxa.3937.2.5; Gilgado JD, 2014, ANN SOC ENTOMOL FR, V50, P264, DOI 10.1080/00379271.2014.981421; Hernando C, 1999, COLEOPTS BULL, V53, P31; Jimenez-Valverde A, 2015, J INSECT CONSERV, V19, P713, DOI 10.1007/s10841-015-9794-1; Jordana Rafael, 2005, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V76, P117; Jordana Rafael, 2012, Soil Organisms, V84, P3; Juberthie C., 1980, Memoires de Biospeologie, V7, P19; Juberthie C, 2000, ECOSY WORLD, V30, P17; Juberthie C., 1981, Memoires de Biospeologie, V8, P77; Lucianez MJ, 1988, ACTAS GREDOS BOL U, V7, P5; Lucianez MJ, 1989, EOS, V64, P57; Lucianez MJ, 1989, ACT 9 BIEN REAL SOC, P102; Mammola S, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1413-9; Martinez EDiaz, 2005, PASEOS GEOLOGIA MADR, V1; MUNOZ MUNICIO C., 2004, MEMORIA MAPA VEGETAC; Nitzu E, 2014, SYST BIODIVERS, V12, P65, DOI 10.1080/14772000.2013.878766; Nitzu Eugen, 2010, Travaux de l'Institut de Speologie "Emile Racovitza", V49, P41; Nitzu Eugen, 2007, Travaux de l'Institut de Speologie "Emile Racovitza", V45-46, P31; Oromi P., 1986, ACT 9 C INT ESP CAT, V2, P147; Ortuno VM, 2014, ZOOTAXA, V3802, P359, DOI 10.11646/zootaxa.3802.3.5; Ortuno VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076311; Ortuno Vicente M., 1994, Boletin de la Asociacion Espanola de Entomologia, V18, P204; Parisi V., 1960, Bollettino di Zoologia Agraria e Bachicoltura Milano, V(2), P117; Pipan T, 2011, J NAT HIST, V45, P253, DOI 10.1080/00222933.2010.523797; Potapov Mikhail, 2008, Soil Organisms, V80, P99; Rivas-Martinez S., 1990, ITINERA GEOBOT, V4, P3; Salazar Rincon A., 2003, CARACTERISTICAS CLIM; Sanz C., 1986, ATLAS GEOMORFOLOGIA, P239; Segovia M.Palomo, 2012, TEMPERATURA SUELO CU; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Stach I, 1960, APTERYGOTAN FAUNA PO, V8; Szeptycki A, 1979, MORPHOSYSTEMATIC STU; Ueno S.-I., 1981, Journal of the Speleological Society of Japan, V6, P11; UENO S-I, 1980, Bulletin of the National Science Museum Series A (Zoology), V6, P195; VIALETTE Y, 1987, NEUES JB MINER MONAT, P465; YOSHII R, 1989, Contributions from the Biological Laboratory Kyoto University, V27, P233; Zhang F, 2015, ZOOL SCR, V44, P298, DOI 10.1111/zsc.12100	57	12	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189205	10.1371/journal.pone.0189205	http://dx.doi.org/10.1371/journal.pone.0189205			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236758	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100049
J	Cole, BK; Scott, E; Ilikj, M; Bard, D; Akins, DR; Dyer, DW; Chavez-Bueno, S				Cole, Bryan K.; Scott, Edgar; Ilikj, Marko; Bard, David; Akins, Darrin R.; Dyer, David W.; Chavez-Bueno, Susana			Route of infection alters virulence of neonatal septicemia Escherichia coli clinical isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; PHYLOGENETIC DISTRIBUTION; BACTERIAL-MENINGITIS; EPITHELIAL-CELLS; TYPE-1 PILI; O-ANTIGEN; BACTEREMIA; INFANTS; K1; PATHOGENESIS	Escherichia coli is the leading cause of Gram-negative neonatal septicemia in the United States. Invasion and passage across the neonatal gut after ingestion of maternal E. coli strains produce bacteremia. In this study, we compared the virulence properties of the neonatal E. coli bacteremia clinical isolate SCB34 with the archetypal neonatal E. coli meningitis strain RS218. Whole-genome sequencing data was used to compare the protein coding sequences among these clinical isolates and 33 other representative E. coli strains. Oral inoculation of newborn animals with either strain produced septicemia, whereas intraperitoneal injection caused septicemia only in pups infected with RS218 but not in those injected with SCB34. In addition to being virulent only through the oral route, SCB34 demonstrated significantly greater invasion and transcytosis of polarized intestinal epithelial cells in vitro as compared to RS218. Protein coding sequences comparisons highlighted the presence of known virulence factors that are shared among several of these isolates, and revealed the existence of proteins exclusively encoded in SCB34, many of which remain uncharacterized. Our study demonstrates that oral acquisition is crucial for the virulence properties of the neonatal bacteremia clinical isolate SCB34. This characteristic, along with its enhanced ability to invade and transcytose intestinal epithelium are likely determined by the specific virulence factors that predominate in this strain.	[Cole, Bryan K.; Ilikj, Marko; Bard, David; Chavez-Bueno, Susana] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Scott, Edgar; Akins, Darrin R.; Dyer, David W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Cole, Bryan K.] Univ Arizona, Dept Pediat, Phoenix, AZ USA; [Chavez-Bueno, Susana] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Chavez-Bueno, Susana] UMKC, Dept Pediat, Kansas City, MO 64110 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Arizona; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	Chavez-Bueno, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA.; Chavez-Bueno, S (corresponding author), Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA.; Chavez-Bueno, S (corresponding author), UMKC, Dept Pediat, Kansas City, MO 64110 USA.	Schavezbueno@cmh.edu		Chavez-Bueno, Susana/0000-0001-8371-5463	Oklahoma INBRE program from NIH/NIGMS [8P20GM103447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	Oklahoma INBRE program from NIH/NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Oklahoma INBRE program, award 8P20GM103447 from NIH/NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00452; ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Bai JN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00168; Banerjee R, 2014, ANTIMICROB AGENTS CH, V58, P4997, DOI 10.1128/AAC.02824-14; Biondi E, 2013, PEDIATRICS, V132, P990, DOI 10.1542/peds.2013-1759; Birchenough GMH, 2013, INFECT IMMUN, V81, P3264, DOI 10.1128/IAI.00268-13; Blanc V, 2014, J ANTIMICROB CHEMOTH, V69, P1231, DOI 10.1093/jac/dkt519; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; Burdet C, 2014, PEDIATR INFECT DIS J, V33, P872, DOI 10.1097/INF.0000000000000309; Burns JL, 2001, PEDIATR RES, V49, P30, DOI 10.1203/00006450-200101000-00010; Chavez-Bueno S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00514-14; Cheng MF, 2015, PEDIATR INFECT DIS J, V34, P469, DOI 10.1097/INF.0000000000000623; Cotten CM, 2013, CURR OPIN PEDIATR, V25, P167, DOI 10.1097/MOP.0b013e32835e01f6; Crane JK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-145; Day MW, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01598-14; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Fagan RP, 2007, FEMS MICROBIOL LETT, V269, P248, DOI 10.1111/j.1574-6968.2006.00628.x; Feng PCH, 2010, FEMS MICROBIOL LETT, V308, P62, DOI 10.1111/j.1574-6968.2010.01990.x; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; GLODE MP, 1977, INFECT IMMUN, V16, P75, DOI 10.1128/IAI.16.1.75-80.1977; GLODE MP, 1977, J INFECT DIS, V136, pS93, DOI 10.1093/infdis/136.Supplement.S93; Greenhow TL, 2012, PEDIATRICS, V129, pE590, DOI 10.1542/peds.2011-1546; Huang Sheng-He, 2009, Int J Microbiol, V2009, P647862, DOI 10.1155/2009/647862; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson JR, 2002, J INFECT DIS, V185, P774, DOI 10.1086/339343; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2012, CURR OPIN INFECT DIS, V25, P273, DOI 10.1097/QCO.0b013e3283521eb0; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kohler H, 2007, AM J PHYSIOL-GASTR L, V293, pG178, DOI 10.1152/ajpgi.00535.2006; Korczak B, 2005, J CLIN MICROBIOL, V43, P1024, DOI 10.1128/JCM.43.3.1024-1031.2005; KORHONEN TK, 1985, INFECT IMMUN, V48, P486, DOI 10.1128/IAI.48.2.486-491.1985; Leyton DL, 2003, INFECT IMMUN, V71, P6307, DOI 10.1128/IAI.71.11.6307-6319.2003; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mahjoub-Messai F, 2011, J INFECT DIS, V203, P1844, DOI 10.1093/infdis/jir189; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Maltby R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053957; Martin P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003437; Martindale J, 2000, MOL MICROBIOL, V37, P1293, DOI 10.1046/j.1365-2958.2000.02088.x; McCarthy AJ, 2015, INFECT IMMUN, V83, P3704, DOI 10.1128/IAI.00716-15; Melican K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001298; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Nakane K, 2016, APPL ENVIRON MICROB, V82, P1818, DOI 10.1128/AEM.02929-15; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; Navarro-Garcia F, 2014, INFECT IMMUN, V82, P2255, DOI 10.1128/IAI.01386-13; Neelon BH, 2010, STAT MODEL, V10, P421, DOI 10.1177/1471082X0901000404; Nowrouzian FL, 2012, MICROB PATHOGENESIS, V53, P180, DOI 10.1016/j.micpath.2012.05.011; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Pettersen VK, 2016, MOL CELL PROTEOMICS, V15, P2890, DOI 10.1074/mcp.M116.060582; PLUSCHKE G, 1983, INFECT IMMUN, V39, P599, DOI 10.1128/IAI.39.2.599-608.1983; Robins-Browne RM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/tcimb.2016.00141; Sarkar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094786; Schilling JD, 2001, J INFECT DIS, V183, pS36, DOI 10.1086/318855; Selvarasu S, 2009, BIOTECHNOL BIOENG, V102, P923, DOI 10.1002/bit.22119; Shakir SM, 2014, AM J PERINAT, V31, P975, DOI 10.1055/s-0034-1370341; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Szijarto V, 2014, CLIN VACCINE IMMUNOL, V21, P930, DOI 10.1128/CVI.00685-13; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Wang MH, 2013, TOXINS, V5, P2270, DOI 10.3390/toxins5112270; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Wijetunge DSS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0203-9; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; WULLENWEBER M, 1993, INFECT IMMUN, V61, P2138, DOI 10.1128/IAI.61.5.2138-2144.1993; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zelmer A, 2008, MICROBIOL-SGM, V154, P2522, DOI 10.1099/mic.0.2008/017988-0	73	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189032	10.1371/journal.pone.0189032	http://dx.doi.org/10.1371/journal.pone.0189032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236742	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100037
J	Kim, BY; Son, Y; Lee, J; Choi, J; Kim, CD; Bae, SS; Eo, SK; Kim, K				Kim, Bo-Young; Son, Yonghae; Lee, Jeonga; Choi, Jeongyoon; Kim, Chi Dae; Bae, Sun Sik; Eo, Seong-Kug; Kim, Koanhoi			Dexamethasone inhibits activation of monocytes/macrophages in a milieu rich in 27-oxygenated cholesterol	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; MONOCYTIC CELLS; 27-HYDROXYCHOLESTEROL; CD14; EXPRESSION; 7-BETA-HYDROXYCHOLESTEROL; LIPOPOLYSACCHARIDE; METALLOPROTEINASES; INFLAMMATION; OXYSTEROLS	Molecular mechanisms underlying the decreased number of macrophages and T cells in the arteries of cholesterol-fed-rabbits following dexamethasone administration are unknown. We investigated the possibility that dexamethasone could affect activation of monocytic cells induced by oxygenated derivatives of cholesterol (oxysterols) using THP-1 monocyte/ macrophage cells. 27-Hydroxycholesterol (27OHChol), an oxysterol elevated with hypercholesterolemia, enhanced production of CCL2, known as MCP1, chemokine from monocytes/macrophages and migration of the monocytic cells, but the CCL2 production and the cell migration were reduced by treatment with dexamethasone. Dexamethasone inhibited superproduction of CCL2 induced by 27OHChol plus LPS and attenuated transcription of matrix metalloproteinase 9 as well as secretion of its active gene product induced by 27OHChol. The drug downregulated cellular and surface levels of CD14 and blocked release of soluble CD14 without altering transcription of the gene. Dexamethasone also inhibited expression and phosphorylation of the NF-KB p65 subunit enhanced by 27OHChol. Collectively, these results indicate that dexamethasone inhibits activation of monocytes/macrophages in response to 27OHChol, thereby leading to decreased migration of inflammatory cells in milieu rich in oxygenated derivatives of cholesterol.	[Kim, Bo-Young; Son, Yonghae; Lee, Jeonga; Choi, Jeongyoon; Kim, Chi Dae; Bae, Sun Sik; Kim, Koanhoi] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea; [Eo, Seong-Kug] Chonbuk Natl Univ, Coll Vet Med, Iksan, Jeonbuk, South Korea; [Eo, Seong-Kug] Chonbuk Natl Univ, Biosafety Res Inst, Iksan, Jeonbuk, South Korea	Pusan National University; Pusan National University Hospital; Jeonbuk National University; Jeonbuk National University	Kim, K (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea.	koanhoi@pusan.ac.kr	Son, Yonghae/R-6194-2019		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1A2B4002800]; National Research Foundation of Korea - Korean government [MSIP-2015R1A2A2A04005619]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1A2B4002800). This research was supported by a National Research Foundation of Korea grant funded by the Korean government (MSIP-2015R1A2A2A04005619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; ASAI K, 1993, ARTERIOSCLER THROMB, V13, P892, DOI 10.1161/01.ATV.13.6.892; Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; BURNHAM JA, 1991, NEUROLOGY, V41, P1349, DOI 10.1212/WNL.41.9.1349; CARPENTER KLH, 1995, BBA-LIPID LIPID MET, V1256, P141, DOI 10.1016/0005-2760(94)00247-V; Christian F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010012; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; GUYTON JR, 1994, ARTERIOSCLER THROMB, V14, P1305, DOI 10.1161/01.ATV.14.8.1305; Hailman E, 1996, J IMMUNOL, V156, P4384; Heo W, 2014, KOREAN J PHYSIOL PHA, V18, P475, DOI 10.4196/kjpp.2014.18.6.475; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; KIELIAN TL, 1995, IMMUNOPHARMACOLOGY, V29, P187, DOI 10.1016/0162-3109(95)00003-C; Kim SM, 2015, BBA-MOL BASIS DIS, V1852, P442, DOI 10.1016/j.bbadis.2014.12.003; Kim SM, 2014, TOXICOL APPL PHARM, V274, P462, DOI 10.1016/j.taap.2013.12.007; Kim SM, 2013, BIOCHEM BIOPH RES CO, V442, P159, DOI 10.1016/j.bbrc.2013.11.052; Lemaire S, 1998, FEBS LETT, V440, P434, DOI 10.1016/S0014-5793(98)01496-3; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; MARTIN TR, 1994, J LEUKOCYTE BIOL, V56, P1; NAITO M, 1992, J NUTR SCI VITAMINOL, V38, P255, DOI 10.3177/jnsv.38.255; NASHEL DJ, 1986, AM J MED, V80, P925, DOI 10.1016/0002-9343(86)90639-X; Ostos MA, 2002, FEBS LETT, V519, P23, DOI 10.1016/S0014-5793(02)02692-3; Poon M, 2001, ATHEROSCLEROSIS, V155, P371, DOI 10.1016/S0021-9150(00)00605-5; Rosenberg GA, 1996, NEUROLOGY, V46, P1626, DOI 10.1212/WNL.46.6.1626; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Senft AP, 2005, J IMMUNOL, V174, P4953, DOI 10.4049/jimmunol.174.8.4953; Sholter DE, 2000, CAN J CARDIOL, V16, P505; Umetani M, 2014, CELL METAB, V20, P172, DOI 10.1016/j.cmet.2014.05.013	35	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189643	10.1371/journal.pone.0189643	http://dx.doi.org/10.1371/journal.pone.0189643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236764	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100088
J	Feng, YG				Feng, Yingang			Compatible topologies and parameters for NMR structure determination of carbohydrates by simulated annealing	PLOS ONE			English	Article							CRYSTALLOGRAPHY; MECHANISM; DYNAMICS; INSIGHTS; SUITE	The use of NMR methods to determine the three-dimensional structures of carbohydrates and glycoproteins is still challenging, in part because of the lack of standard protocols. In order to increase the convenience of structure determination, the topology and parameter files for carbohydrates in the program Crystallography & NMR System (CNS) were investigated and new files were developed to be compatible with the standard simulated annealing protocols for proteins and nucleic acids. Recalculating the published structures of protein-carbohydrate complexes and glycosylated proteins demonstrates that the results are comparable to the published structures which employed more complex procedures for structure calculation. Integrating the new carbohydrate parameters into the standard structure calculation protocol will facilitate three-dimensional structural study of carbohydrates and glycosylated proteins by NMR spectroscopy.	[Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Lab Single Cell Oil, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao, Peoples R China.; Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao, Peoples R China.; Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Lab Single Cell Oil, Qingdao, Shandong, Peoples R China.	fengyg@qibebt.ac.cn	Feng, Yingang/B-6304-2008	Feng, Yingang/0000-0002-0879-1316	National Natural Science Foundation of China [31270784, 31670735]; Chinese Government Scholarship [201604910035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Government Scholarship	This work is supported by the National Natural Science Foundation of China (grant nos. 31270784 and 31670735) and Chinese Government Scholarship (201604910035) to YF.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaffey PK, 2017, BIOCHEMISTRY-US, V56, P2897, DOI 10.1021/acs.biochem.7b00195; De Gonzalo CVG, 2014, ACS CHEM BIOL, V9, P796, DOI 10.1021/cb4008106; Diaz Dolores, 2015, Methods Mol Biol, V1273, P261, DOI 10.1007/978-1-4939-2343-4_19; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Garcia-Mayoral MF, 2013, ACS CHEM BIOL, V8, P144, DOI 10.1021/cb300386v; Ghasriani H, 2013, J BIOL CHEM, V288, P247, DOI 10.1074/jbc.M112.413252; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Hiruma-Shimizu K, 2010, J AM CHEM SOC, V132, P14857, DOI 10.1021/ja105216u; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Schallus T, 2010, GLYCOBIOLOGY, V20, P1010, DOI 10.1093/glycob/cwq059; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189700	10.1371/journal.pone.0189700	http://dx.doi.org/10.1371/journal.pone.0189700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232406	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200065
J	Mason-Romo, ED; Farias, AA; Ceballos, G				David Mason-Romo, Edgard; Farias, Ariel A.; Ceballos, Gerardo			Two decades of climate driving the dynamics of functional and taxonomic diversity of a tropical small mammal community in western Mexico	PLOS ONE			English	Article							SPECIES RICHNESS; SPATIAL-PATTERNS; ECOSYSTEM; BIODIVERSITY; CONSERVATION; PROJECTIONS; EXTINCTION; FORESTS; EXTREMES; RODENT	Understanding the effects of global climate disruption on biodiversity is important to future conservation efforts. While taxonomic diversity is widely studied, functional diversity of plants, and recently animals, is receiving increasing attention. Most studies of mammals are short-term, focus on temperate habitats, and rely on traits described in the literature rather than generating traits from observations. Unlike previous studies, this long-term field study assessed the factors driving the functional and taxonomic diversity of small-mammal assemblages in dry tropical forests using both traits recorded from literature and a demographic database. We assessed the drivers (abundance and biomass, temperature and rainfall) of taxonomic richness and functional diversity for two rain-driven seasons in two adjacent but distinct forests-upland and lowland (arroyo or riparian) forests. Our analysis found that rainfall, both seasonal and atypical, was the primary factor driving functional and taxonomic diversity of small-mammal assemblages. Functional responses differed between the two types of forests, however, with effects being stronger in the harsher conditions of the upland forests than in the less severe conditions prevailing in the arroyo (riparian) forest. The latter also supports a richer, more diverse, and more stable small-mammal assemblage. These findings highlight the importance of climate to tropical biological diversity, as extreme climate events (hurricanes, droughts and floods) and disruption of rainfall patterns were shown to decrease biodiversity. They also support the need to preserve these habitats, as their high taxonomic diversity and functional redundancy makes them resilient against global climate disruption and local extreme events. Tropical dry forests constitute a potential reservoir for biodiversity and the ecosystem services they provide. Unfortunately, these forests are among the most endangered terrestrial ecosystems because of deforestation and the likely impacts of global climate disruption.	[David Mason-Romo, Edgard; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Lab Ecol & Conservac Fauna Silvestre, Inst Ecol, Mexico City, DF, Mexico; [Farias, Ariel A.] CURE, Maldonado, Punta Del Este, Uruguay	Universidad Nacional Autonoma de Mexico	Mason-Romo, ED (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Lab Ecol & Conservac Fauna Silvestre, Inst Ecol, Mexico City, DF, Mexico.	emason@iecologia.unam.mx	; Farias, Ariel/ABA-8072-2021	Mason-Romo, Edgard/0000-0001-6460-7504; Farias, Ariel/0000-0001-7510-2253	Consejo Nacional de Ciencia y Tecnologia, CONACyT; Edgard Mason-Romo family; Pontificia Universidad Catolica de Chile (Mauricio Lima and Fabian Jaksic);  [205321];  [202672]	Consejo Nacional de Ciencia y Tecnologia, CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Edgard Mason-Romo family; Pontificia Universidad Catolica de Chile (Mauricio Lima and Fabian Jaksic); ; 	The only institutional financial support received for this project was from the Consejo Nacional de Ciencia y Tecnologia, CONACyT (http://www.conacyt.gob.mx/) and it was divided in two parts. The first one was a PhD student grant (grant number 205321) for Edgard Mason-Romo, which lasted from 2011-2015) and it was destined to maintenance (the amount was 32,000 USD divided among four years) and a mobility grant (grant number 202672) and it was given for Edgard Mason-Romo to go to Santiago de Chile to work with Ariel Farias on the methodological and statistical analysis, the first half of 2013, (the amount was around 2,000 USD for six months abroad). Any other financial support was given directly either by Edgard Mason-Romo family and there searchers of the Pontificia Universidad Catolica de Chile (Mauricio Lima and Fabian Jaksic) who helped Edgard Mason-Romo financially to be working abroad analyzing the data for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Carreno-Rocabado G, 2012, J ECOL, V100, P1453, DOI 10.1111/j.1365-2745.2012.02015.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 1995, CONSERV BIOL, V9, P1349, DOI 10.1046/j.1523-1739.1995.09061349.x; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; CEBALLOS G, 1990, J MAMMAL, V71, P263, DOI 10.2307/1382182; Ceballos G., 2013, MAMMALS OF MEXICO; Ceballos G., 2010, J COSMOL, V8, P1821; Ceballos G, 2005, MAMIFEROS SILVESTRES; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Cumming GS, 2009, PHILOS T R SOC B, V364, P1683, DOI 10.1098/rstb.2008.0317; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; De Valpine P, 2001, ECOLOGY, V82, P637, DOI 10.1890/0012-9658(2001)082[0637:PRTEWI]2.0.CO;2; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2006, ECOSYSTEMS HUMAN WEL, P297; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Eigenbrod F, 2015, GLOBAL CHANGE BIOL, V21, P275, DOI 10.1111/gcb.12669; Farias AA, 2007, AUSTRAL ECOL, V32, P225, DOI 10.1111/j.1442-9993.2007.01684.x; Farias AA, 2011, J ANIM ECOL, V80, P809, DOI 10.1111/j.1365-2656.2011.01824.x; Farias AA, 2009, OIKOS, V118, P591, DOI 10.1111/j.1600-0706.2009.16859.x; Fleming PA, 2014, MAMMAL REV, V44, P94, DOI 10.1111/mam.12014; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Hall ER., 2005, MAMMALS N AM; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; International Union for Conservation of Nature and Natural Resources, IUCN RED LIST THREAT, P2307; Jaksic FM, 2003, AUSTRAL ECOL, V28, P237, DOI 10.1046/j.1442-9993.2003.01271.x; Janzen D.H., 1988, P130; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; Lima M, 2008, ECOLOGY, V89, P2594, DOI 10.1890/07-1246.1; LOTT EJ, 1987, BIOTROPICA, V19, P228, DOI 10.2307/2388340; Lucan RK, 2013, J ZOOL, V290, P151, DOI 10.1111/jzo.12021; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Maass JM, 2005, ECOL SOC, V10; Magnusson WE, 2010, GLOBAL CHANGE BIOL, V16, P2401, DOI 10.1111/j.1365-2486.2009.02140.x; Mason NWH, 2007, OECOLOGIA, V153, P441, DOI 10.1007/s00442-007-0727-x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Meehl GA, 2000, B AM METEOROL SOC, V81, P427, DOI 10.1175/1520-0477(2000)081<0427:TIEWAC>2.3.CO;2; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ortega-Huerta MA, 2004, DIVERS DISTRIB, V10, P39, DOI 10.1111/j.1472-4642.2004.00051.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parr CL, 2012, DIVERS DISTRIB, V18, P493, DOI 10.1111/j.1472-4642.2012.00882.x; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; R Core Team, 2021, R LANGUAGE ENV STAT; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Santos MJ, 2015, ECOGRAPHY, V38, P556, DOI 10.1111/ecog.00931; Schindler DE, 2007, P NATL ACAD SCI USA, V104, P5707, DOI 10.1073/pnas.0700426104; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Sherwin HA, 2013, MAMMAL REV, V43, P171, DOI 10.1111/j.1365-2907.2012.00214.x; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Soberon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019359; Sperr EB, 2011, J TROP ECOL, V27, P133, DOI 10.1017/S0266467410000714; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stenseth NC, 2002, POPUL ECOL, V44, P165, DOI 10.1007/s101440200020; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Stork NE, 2009, CONSERV BIOL, V23, P1438, DOI 10.1111/j.1523-1739.2009.01335.x; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Thibault KM, 2010, OIKOS, V119, P1719, DOI 10.1111/j.1600-0706.2010.18378.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; VALONE TJ, 1995, J MAMMAL, V76, P428, DOI 10.2307/1382353; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552; Yang DS, 2011, GLOBAL CHANGE BIOL, V17, P2559, DOI 10.1111/j.1365-2486.2011.02394.x	102	9	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189104	10.1371/journal.pone.0189104	http://dx.doi.org/10.1371/journal.pone.0189104			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228017	Green Submitted, gold, Green Published			2022-12-26	WOS:000417648600032
J	Liu, B; Olson, A; Wu, M; Broberg, A; Sandgren, M				Liu, Bing; Olson, Ake; Wu, Miao; Broberg, Anders; Sandgren, Mats			Biochemical studies of two lytic polysaccharide monooxygenases from the white-rot fungus Heterobasidion irregulare and their roles in lignocellulose degradation	PLOS ONE			English	Article							OXIDATIVE CLEAVAGE; CELLULOSE; DISCOVERY; GENOME; GH61	Lytic polysaccharide monooxygenases (LPMO) are important redox enzymes produced by microorganisms for the degradation of recalcitrant natural polysaccharides. Heterobasidion irregulare is a white-rot phytopathogenic fungus that causes wood decay in conifers. The genome of this fungus encodes 10 putative Auxiliary Activity family 9 (AA9) LPMOs. We describe the first biochemical characterization of H. irregulare LPMOs through heterologous expression of two CBM-containing LPMOs from this fungus (HiLPMO9H, HiLPMO9I) in Pichia pastoris. The oxidization preferences and substrate specificities of these two enzymes were determined. The two LPMOs were shown to cleave different carbohydrate components of plant cell walls. HiLPMO9H was active on cellulose and oxidized the substrate at the C1 carbon of the pyranose ring at beta-1,4-glycosidic linkages, whereas HiLPMO9I cleaved cellulose with strict oxidization at the C4 carbon of glucose unit at internal bonds, and also showed activity against glucomannan. We propose that the two LPMOs play different roles in the plant-cell-wall degrading system of H. irregulare for degradation of softwood and that the lignocellulose degradation mediated by this white-rot fungus may require collective efforts from multi-types of LPMOs.	[Liu, Bing; Wu, Miao; Broberg, Anders; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Olson, Ake] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden.	mats.sandgren@slu.se		Sandgren, Mats/0000-0002-2358-4534	Swedish Energy Agency [40144-1]	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This work was financially supported by the Swedish Energy Agency (http://www.energimyndigheten.se/) through the grant 40144-1 to M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Berlemont R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00258-w; Bey M, 2012, APPL ENVIRON MICROB; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; BLANCHETTE RA, 1990, ADV CHEM SER, P141; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; CAPRETTI P, 1990, EUR J FOREST PATHOL, V20, P231; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Johansen KS, 2016, TRENDS PLANT SCI, V21, P926, DOI 10.1016/j.tplants.2016.07.012; Jung S, 2015, ENZYME MICROB TECH, V77, P38, DOI 10.1016/j.enzmictec.2015.05.006; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kojima Y, 2016, APPL ENVIRON MICROB, V82, P6557, DOI 10.1128/AEM.01768-16; Korhonen K., 1978, COMMUN I FOREST FENN, V94, P25; Leggio LL, 2012, BIOTECHNOL J, V2; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Makela MR, 2014, FUNGAL GENET BIOL, V72, P2, DOI 10.1016/j.fgb.2014.08.010; Nekiunaite L, 2016, FEBS LETT, V590, P3346, DOI 10.1002/1873-3468.12385; O'Dell WB, 2017, ANGEW CHEM INT EDIT, V56, P767, DOI 10.1002/anie.201610502; Ochoa-Villarreal M, 2012, POLYMERIZATION, P64, DOI [DOI 10.5772/46094, 10.5772/46094]; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Patel I, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0520-3; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Rytioja J, 2014, MICROBIOL MOL BIOL R, V78, P614, DOI 10.1128/MMBR.00035-14; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Span EA, 2017, ACS CHEM BIOL, V12, P1095, DOI 10.1021/acschembio.7b00016; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Tan TC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8542; Ullman Michael T., NEUROBIOLOGY LANGUAG, P953, DOI [DOI 10.HTTPS://D0I.0RG/10.1016/B978-0-12-033706-4.50037-2, 10.1016/B978-0-12-407794-2.00076-6, DOI 10.1016/B978-0-12-407794-2.00076-6]; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Weninger A, 2016, J BIOTECHNOL, V235, P139, DOI 10.1016/j.jbiotec.2016.03.027; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wood T. M., 1988, METHOD ENZYMOL, P19, DOI 10.1016/0076-6879(88)60103-0; Woodward S, 1998, CAB INT CAMB; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x	50	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189479	10.1371/journal.pone.0189479	http://dx.doi.org/10.1371/journal.pone.0189479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228039	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600058
J	Guan, H; Li, WM; Li, YY; Wang, JC; Li, Y; Tang, YA; Lu, SY				Guan, Hao; Li, Weiming; Li, Yuanyuan; Wang, Jichang; Li, Yan; Tang, Yanan; Lu, Shaoying			MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; PROGRESSION; MIRNAS; TUMORIGENESIS; STATISTICS; MECHANISMS; PATHWAY; EMT	MicroRNAs (miRNAs) are important regulators of pathobiological processes in various cancer. In the present study, we demonstrated that miR-93 expression was significantly up-regulated in gastric cancer tissues compared with that in matched normal mucosal tissues. High expression of miR-93 was significantly associated with lymph node metastasis and tumor-node-metastasis (TNM) stage. Functionally, ectopic expression of miR-93 promoted cell proliferation, migration, invasion, EMT phenotypes, and repressed apoptosis and G1 cell cycle arrest in vitro, and promoted tumor formation in vivo. We further identified that tissue inhibitor of metalloproteinase 2 (TIMP2) was a direct target of miR-93 by using luciferase reporter assay, qRT-PCR, and immunoblotting assay. Furthermore, knockdown of TIMP2 with specific siRNA showed similar oncogenic effects in gastric cancer cells with that transfected with miR-93 mimics. Our findings indicated that miR-93 serves as a tumor promoter in human gastric carcinogenesis by targeting TIMP2, suggesting that miR-93 might be a promising biomarker and therapeutic target for treatment of gastric cancer.	[Guan, Hao; Li, Weiming; Wang, Jichang; Li, Yan; Tang, Yanan; Lu, Shaoying] Xi An Jiao Tong Univ, Dept Vasc Surg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Li, Yuanyuan] Shaanxi Univ Chinese Med, Dept Translat Med Ctr, Affiliated Hosp 2, Xianyang, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine	Lu, SY (corresponding author), Xi An Jiao Tong Univ, Dept Vasc Surg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	robertlu@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022; 黎, 伟/GXM-4040-2022; Wang, Ji-Chang/U-9675-2018	Wang, Ji-Chang/0000-0003-2987-8880	National Natural Science Foundation of China [81172359, 81472747]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (No. 81172359 and 81472747, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Chen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165776; Chen X, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0304-6; Chen X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160780; Cheng GF, 2015, ADV DRUG DELIVER REV, V81, P75, DOI 10.1016/j.addr.2014.09.001; He C, 2017, GASTROENTEROLOGY, V152, P1434, DOI 10.1053/j.gastro.2017.01.049; Jafri MA, 2017, SEMIN CANCER BIOL, V44, P117, DOI 10.1016/j.semcancer.2017.02.004; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CM, 2017, J CANCER, V8, P870, DOI 10.7150/jca.17958; Li FX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178427; Li FX, 2013, SURG ONCOL, V22, pE7, DOI 10.1016/j.suronc.2013.01.003; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Ohta K, 2015, ONCOTARGET, V6, P3211, DOI 10.18632/oncotarget.3085; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Shyamasundar S, 2016, INT J ONCOL, V49, P2629, DOI 10.3892/ijo.2016.3761; Sun HL, 2016, CANCER CELL, V30, P723, DOI 10.1016/j.ccell.2016.10.001; Thrumurthy SG, 2015, NAT REV CLIN ONCOL, V12, P676, DOI 10.1038/nrclinonc.2015.132; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang Z, 2015, ONCOGENE, V34, P1407, DOI 10.1038/onc.2014.75; Xiang Y, 2017, EXP CELL RES, V357, P135, DOI 10.1016/j.yexcr.2017.05.007; Yan A, 2015, CELL PHYSIOL BIOCHEM, V37, P55, DOI 10.1159/000430333; Yen CS, 2016, WORLD J GASTROENTERO, V22, P5183, DOI 10.3748/wjg.v22.i22.5183; Yu JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13884; Zhang L, 2017, ONCOL REP, V3; Zheng LL, 2016, NUCLEIC ACIDS RES, V44, pD196, DOI 10.1093/nar/gkv1273; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887	30	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189490	10.1371/journal.pone.0189490	http://dx.doi.org/10.1371/journal.pone.0189490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220395	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900062
J	Min, JL; Wang, P; Hu, JF				Min, Jianliang; Wang, Ping; Hu, Jianfeng			Driver fatigue detection through multiple entropy fusion analysis in an EEG-based system	PLOS ONE			English	Article							APPROXIMATE ENTROPY; SAMPLE ENTROPY; MENTAL FATIGUE; SLEEP; CLASSIFICATION; RELIABILITY; SENSITIVITY; FEATURES; ONSET	Driver fatigue is an important contributor to road accidents, and fatigue detection has major implications for transportation safety. The aim of this research is to analyze the multiple entropy fusion method and evaluate several channel regions to effectively detect a driver's fatigue state based on electroencephalogram (EEG) records. First, we fused multiple entropies, i.e., spectral entropy, approximate entropy, sample entropy and fuzzy entropy, as features compared with autoregressive (AR) modeling by four classifiers. Second, we captured four significant channel regions according to weight-based electrodes via a simplified channel selection method. Finally, the evaluation model for detecting driver fatigue was established with four classifiers based on the EEG data from four channel regions. Twelve healthy subjects performed continuous simulated driving for 1-2 hours with EEG monitoring on a static simulator. The leave-one-out cross-validation approach obtained an accuracy of 98.3%, a sensitivity of 98.3% and a specificity of 98.2%. The experimental results verified the effectiveness of the proposed method, indicating that the multiple entropy fusion features are significant factors for inferring the fatigue state of a driver.	[Min, Jianliang; Wang, Ping; Hu, Jianfeng] Jiangxi Univ Technol, Ctr Collaborat & Innovat, Nanchang, Jiangxi, Peoples R China		Hu, JF (corresponding author), Jiangxi Univ Technol, Ctr Collaborat & Innovat, Nanchang, Jiangxi, Peoples R China.	huguess211@hotmail.com	Min, liang jian/HHZ-1665-2022	Min, liang jian/0000-0002-3375-1148; Hu, Jianfeng/0000-0002-0669-4328	National Natural Science Foundation of China [61762045]; Project of Department of Science and Technology, Jiangxi Province [20171BAB202031]; Project of Department of Education, Jiangxi Province [GJJ151146, GJJ161143]; Project of Nanchang Science and Technology Program [113]; Project of Natural Science Research, Jiangxi University of Technology [ZR15QN01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Department of Science and Technology, Jiangxi Province; Project of Department of Education, Jiangxi Province; Project of Nanchang Science and Technology Program; Project of Natural Science Research, Jiangxi University of Technology	This work was supported by National Natural Science Foundation of China (61762045), Project of Department of Science and Technology, Jiangxi Province (20171BAB202031), Project of Department of Education, Jiangxi Province (GJJ151146 and GJJ161143), Project of Nanchang Science and Technology Program (No. 113), and Project of Natural Science Research, Jiangxi University of Technology (ZR15QN01). Patent transformation Project of Intellectual Property Office of Jiangxi Province [The application and popularization of the digital method to distinguish the direction of rotation photoelectric encoder in identification].	Acharya UR, 2015, KNOWL-BASED SYST, V88, P85, DOI 10.1016/j.knosys.2015.08.004; Acharya UR, 2012, BIOMED SIGNAL PROCES, V7, P401, DOI 10.1016/j.bspc.2011.07.007; Apker Gregory, 2013, Foundations of Augmented Cognition. 7th International Conference, AC 2013. Held as Part of HCI International 2013. Proceedings, P231, DOI 10.1007/978-3-642-39454-6_24; Azar AT, 2014, NEURAL COMPUT APPL, V24, P1163, DOI 10.1007/s00521-012-1324-4; Azarnoosh M, 2011, CHAOS SOLITON FRACT, V44, P1054, DOI 10.1016/j.chaos.2011.08.012; Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Borghini G, 2012, IEEE ENG MED BIO, P6442, DOI 10.1109/EMBC.2012.6347469; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Cao T, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-28; Chai RF, 2017, IEEE J BIOMED HEALTH, V21, P715, DOI 10.1109/JBHI.2016.2532354; Chen CX, 2013, DISPLAYS, V34, P81, DOI 10.1016/j.displa.2013.01.002; Chen LL, 2015, EXPERT SYST APPL, V42, P7344, DOI 10.1016/j.eswa.2015.05.028; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Convertino M, 2015, STOCH ENV RES RISK A, V29, P1085, DOI 10.1007/s00477-014-0999-8; Craig A, 2012, PSYCHOPHYSIOLOGY, V49, P574, DOI 10.1111/j.1469-8986.2011.01329.x; Davenne D, 2012, ACCIDENT ANAL PREV, V45, P677, DOI 10.1016/j.aap.2011.09.046; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Dong YC, 2011, IEEE T INTELL TRANSP, V12, P596, DOI 10.1109/TITS.2010.2092770; Ellis RS, 2012, ENTROPY LARGE DEVIAT; Figueiredo E, 2011, COMPUT-AIDED CIV INF, V26, P225, DOI 10.1111/j.1467-8667.2010.00685.x; Ftouni S, 2013, J SLEEP RES, V22, P58, DOI 10.1111/j.1365-2869.2012.01038.x; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Correa AG, 2014, MED ENG PHYS, V36, P244, DOI 10.1016/j.medengphy.2013.07.011; Gurudath N, 2014, PROCEDIA COMPUT SCI, V34, P400, DOI 10.1016/j.procs.2014.07.045; Hagan M. T, 2014, NEURAL NETWORK DESIG, V2nd; Han J, 2012, MOR KAUF D, P1; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Hu JF, 2015, J MED IMAG HEALTH IN, V5, P862, DOI 10.1166/jmihi.2015.1471; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Jagannath M, 2014, APPL ERGON, V45, P1140, DOI 10.1016/j.apergo.2014.02.001; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Jo J, 2014, EXPERT SYST APPL, V41, P1139, DOI 10.1016/j.eswa.2013.07.108; Kang HB, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOPS (ICCVW), P616, DOI 10.1109/ICCVW.2013.85; Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012; Kar S, 2010, TRANSPORT RES F-TRAF, V13, P297, DOI 10.1016/j.trf.2010.06.006; Ko LW, 2015, IEEE IJCNN, DOI 10.1109/IJCNN.2015.7280817; Kosmadopoulos A, 2015, ACCIDENT ANAL PREV, V99, P445; Lee BG, 2014, SENSORS-BASEL, V14, P17915, DOI 10.3390/s141017915; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Li W, 2012, NEUROSCI LETT, V506, P235, DOI 10.1016/j.neulet.2011.11.014; Liang SF, 2012, IEEE T INSTRUM MEAS, V61, P1649, DOI 10.1109/TIM.2012.2187242; Liu JP, 2010, BIOMED SIGNAL PROCES, V5, P124, DOI 10.1016/j.bspc.2010.01.001; Ludtke N, 2008, J R SOC INTERFACE, V5, P223, DOI 10.1098/rsif.2007.1079; Rodriguez-Sotelo JL, 2014, ENTROPY-SWITZ, V16, P6573, DOI 10.3390/e16126573; Matteo C, 2013, PLOS ONE, V8; Melnicuk V, 2016, IEEE INT VEH SYM, P1392, DOI 10.1109/IVS.2016.7535572; Mu Z, 2016, INT J PATTERN RECOGN; Mu ZD, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18120432; Nicolaou N, 2012, EXPERT SYST APPL, V39, P202, DOI 10.1016/j.eswa.2011.07.008; Nugraha B.T., 2016, J THEOR APPL INF TEC, V86, P54; Pal NR, 2008, EURASIP J ADV SIG PR, V2008, P192; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rigas G., 2011, INT J VEHICULAR TECH; Sahayadhas A, 2012, SENSORS-BASEL, V12, P16937, DOI 10.3390/s121216937; Saini V., 2014, INT J COMPUT SCI INF, V5, P4245; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Schmidt E, 2016, IEEE INT VEH SYM, P1380, DOI 10.1109/IVS.2016.7535570; Simon M, 2011, CLIN NEUROPHYSIOL, V122, P1168, DOI 10.1016/j.clinph.2010.10.044; Song YD, 2012, J NEUROSCI METH, V210, P132, DOI 10.1016/j.jneumeth.2012.07.003; Vapnik V.N., 2006, ESTIMATION DEPENDENC, VVolume 40; Wang H, 2015, MOBICOM '15: PROCEEDINGS OF THE 21ST ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P155, DOI 10.1145/2789168.2790121; Xiang J, 2015, J NEUROSCI METH, V243, P18, DOI 10.1016/j.jneumeth.2015.01.015; Xiong Y., 2016, INT J CONTROL AUTOMA, V9, P329, DOI [10.14257/ijca.2016.9.3.30, DOI 10.14257/IJCA.2016.9.3.30]; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Yin J, 2016, HEALTHCARE TECHNOLOG, P1; Yuan Wang, 2015, 2015 Fifth International Conference on Instrumentation and Measurement, Computer, Communication and Control (IMCCC), P715, DOI 10.1109/IMCCC.2015.156; Zhang C, 2014, IEEE T INTELL TRANSP, V15, P168, DOI 10.1109/TITS.2013.2275192; Zhao CL, 2011, INT J INNOV COMPUT I, V7, P1157; Zhendong M., 2015, METALL MIN IND, V7, P266	74	54	55	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188756	10.1371/journal.pone.0188756	http://dx.doi.org/10.1371/journal.pone.0188756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220351	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900015
J	Tshimanga, M; Makunike-Chikwinya, B; Mangwiro, T; Gundidza, PT; Chatikobo, P; Murenje, V; Herman-Roloff, A; Kilmarx, PH; Holec, M; Gwinji, G; Mugurungi, O; Murwira, M; Xaba, S; Barnhart, S; Feldacker, C				Tshimanga, Mufuta; Makunike-Chikwinya, Batsirai; Mangwiro, Tonderayi; Gundidza, Patricia Tapiwa; Chatikobo, Pesanai; Murenje, Vernon; Herman-Roloff, Amy; Kilmarx, Peter H.; Holec, Marrianne; Gwinji, Gerald; Mugurungi, Owen; Murwira, Munyaradzi; Xaba, Sinokuthemba; Barnhart, Scott; Feldacker, Caryl			Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; ADULT MALE CIRCUMCISION; RANDOMIZED CONTROLLED-TRIAL; RISK HUMAN-PAPILLOMAVIRUS; INFECTED MEN; SCALE-UP; YOUNG MEN; RAKAI; PREVENTION; HIV/AIDS	Male circumcision (MC) for sexually active, HIV-negative men reduces HIV transmission and averts HIV infections. Excluding HIV-positive men from MC decreases access to additional health and hygiene benefits. In settings where HIV-testing is, or is perceived to be, required for MC, testing may reduce MC uptake. Reducing promotion of HIV testing within MC settings and promoting device-based MC may speed MC scale-up. To assess safety and efficacy of PrePex MC device among HIV-positive men, we conducted a one-arm, open-label, prospective study in otherwise healthy HIV-positive men in Zimbabwe. Methods We aimed to determine if the adverse event (AE) rate was non-inferior to an AE rate of 2%, a rate considered the global standard of MC safety. Study procedures, AE definitions, and study staff were unchanged from previous PrePex Zimbabwe trials. After PrePex placement and removal, weekly visits assessed wound healing. Men returned on Day 90. Safety was defined as occurrence of moderate and serious clinical AEs. Efficacy was defined as ability to reach the endpoint of complete circumcision. Results Among 400 healthy, HIV-positive, consenting adults, median age was 40 years (IQR: 34, 46); 79.5% in WHO stage 2; median CD4 was 336.5c/mu l (IQR: 232, 459); 337 (85%) on anti-retroviral therapy. Among 385 (96%) observed completely healed, median days to complete healing was 42 (IQR: 35-49). There was no association between time to healing and CD4 (p = 0.66). Four study-related severe AEs and no moderate AEs were reported: severe/moderate AE rate of 1.0% (95% CI: 0.27% to 2.5). This was non-inferior to 2% AEs (p = 0.0003). All AEs were device displacements resulting in surgical MC and, subsequently, complete healing. Conclusion Male circumcision among healthy, HIV-positive men using PrePex is safe and effective. Reducing the barrier of HIV testing while improving counseling for safer sex practices among all MC clients could increase MC uptake and avert more HIV infections.	[Tshimanga, Mufuta; Gundidza, Patricia Tapiwa; Chatikobo, Pesanai] Zimbabwe Community Hlth Intervent Project ZiCHIRe, Harare, Zimbabwe; [Makunike-Chikwinya, Batsirai; Murenje, Vernon] Int Training & Educ Ctr Hlth I TECH, Harare, Zimbabwe; [Mangwiro, Tonderayi] Univ Zimbabwe, Dept Hlth Sci, Harare, Zimbabwe; [Herman-Roloff, Amy; Kilmarx, Peter H.] US Ctr Dis Control & Prevent, Harare, Zimbabwe; [Holec, Marrianne; Barnhart, Scott; Feldacker, Caryl] Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Gwinji, Gerald; Mugurungi, Owen; Xaba, Sinokuthemba] Minist Hlth & Child Care, Harare, Zimbabwe; [Murwira, Munyaradzi] Zimbabwe Natl Family Planning Council, Harare, Zimbabwe; [Barnhart, Scott] Univ Washington, Dept Med, Seattle, WA USA; [Barnhart, Scott; Feldacker, Caryl] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Zimbabwe; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Feldacker, C (corresponding author), Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA.; Feldacker, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	cfeld@uw.edu		Murenje, Vernon/0000-0002-0715-9837; Feldacker, Caryl/0000-0002-8152-6754	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH000972]	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID))	This work has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement #: U2GGH000972. Authors MT BM TM PTG PC VM MH SB and CF received funding under this grant to implement this research. The funders, specifically PHK, and AHR, contributed to design of the study and preparation of the manuscript but had no role in study data collection, analysis, or supervision.	Albero G, 2012, SEX TRANSM DIS, V39, P104, DOI 10.1097/OLQ.0b013e3182387abd; [Anonymous], 2011, STAT STAT SOFTW REL; Ashengo TA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-858; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Awad SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170641; Baggaley R, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21348; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Bochner AF, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21394; Byabagambi J, GUIDE IMPROVING QUAL; Chiringa IO, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i2.966; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Feldblum PJ, 2016, JAIDS-J ACQ IMM DEF, V72, pS24, DOI 10.1097/QAI.0000000000000736; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095357; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104893; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086631; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Go Zimbabwe, 2017, DHIS2; Godfrey K, 2013, BJU INT; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Innocent C, 2016, INT J HLTH SCI RES I, V6, P330; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Kigozi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100008; Kigozi G, 2014, BJU INT, V113, P127, DOI 10.1111/bju.12406; Kigozi G, 2014, UROLOGY, V83, P294, DOI 10.1016/j.urology.2013.08.038; Larke N, 2011, J INFECT DIS, V204, P1375, DOI 10.1093/infdis/jir523; Larke NL, 2011, CANCER CAUSE CONTROL, V22, P1097, DOI 10.1007/s10552-011-9785-9; Lebina L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138755; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mahomed M, 2014, AIDS RES HUM RETROV, V30, pA198, DOI 10.1089/aid.2014.5426b.abstract; Marongwe P., 2016, KEY VMMC FOLLOW UP V; Medical Research Council of Zimbabwe, 2012, TR025 MED RES COUNC; Ministry of Health and Child Care MOHCC Z, 2017, ZIMB POP BAS HIV IMP; Ministry of Health and Child Care Zimbabwe, 2014, ACC STRAT OP PLAN 20; Morris BJ, 2011, ADV UROL, V2011, DOI 10.1155/2011/812368; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Moyo S, 2015, MENS ATTITUDES HINDR, P1; Musiige AM, 2016, JAIDS-J ACQ IMM DEF, V72, pS73, DOI 10.1097/QAI.0000000000000765; Mutabazi Vincent, 2014, Urol Nurs, V34, P303; Mutabazi V, 2014, AFR J REPROD HEALTH, V18, P61; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Obiero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053380; Odoyo-June E, 1999, J ACQUIRED IMMUNE DE; Overview National, 2016, VMMC REV PLANN M KAD; Phili R, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19275; Population Services International CoSoE Central and Southern Africa (COSECSA) U.S. Centers for Disease Control and Prevention, 2016, ADV EV ACT GUID VOL; Reed J, 1999, J ACQ IMMUN DEF SYND, P2015; Rogers JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061725; Serwadda D, 2010, J INFECT DIS, V201, P1463, DOI 10.1086/652185; Skolnik L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1119; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V65, P447, DOI 10.1097/QAI.0000000000000061; Tobian AAR, 2014, ANNU REV MED, V65, P293, DOI 10.1146/annurev-med-092412-090539; Tshimanga M, RANDOMIZED CONTROLLE; Tshimanga M, 2013, EVALUATION SAFETY EF; Tshimanga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156220; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO,, 2016, WHO PROGR BRIEF VOL; WHO, 2013, GUID US DEV AD MAL C; WHO U., 2011, JOINT STRAT ACT FRAM; WHO/UNAIDS, 2010, FRAM CLIN EV DEV AD; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization, FRAM VOL MED MAL CIR; World Health Organization, 2015, WHO TECHN ADV GROUP; World Health Organization, 2013, WHO TECHN ADV GROUP; Zimbabwe Ministry of Health and Child Care, 2014, ACC STRAT OP PALN 20; 김현진, 2015, [The KSFM Journal of Fluid Machinery, 한국유체기계학회 논문집], V18, P12, DOI 10.5293/kfma.2015.18.3.012	75	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189146	10.1371/journal.pone.0189146	http://dx.doi.org/10.1371/journal.pone.0189146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220392	Green Submitted, Green Published, gold			2022-12-26	WOS:000417469900035
J	Heffer, A; Marquart, GD; Aquilina-Beck, A; Saleem, N; Burgess, HA; Dawid, IB				Heffer, Alison; Marquart, Gregory D.; Aquilina-Beck, Allisan; Saleem, Nabil; Burgess, Harold A.; Dawid, Igor B.			Generation and characterization of Kctd15 mutations in zebrafish	PLOS ONE			English	Article							HYPOTHALAMIC INFERIOR-LOBE; NEURAL CREST SPECIFICATION; CELL-DIFFERENTIATION; GUSTATORY SYSTEM; UBIQUITIN LIGASE; GENE; EXPRESSION; CONNECTIONS; PROTEIN; DOMAIN	Potassium channel tetramerization domain containing 15 (Kctd15) was previously found to have a role in early neural crest (NC) patterning, specifically delimiting the region where NC markers are expressed via repression of transcription factor AP-2a and inhibition of Wnt signaling. We used transcription activator-like effector nucleases (TALENs) to generate null mutations in zebrafish kctd15a and kctd15b paralogs to study the in vivo role of Kctd15. We found that while deletions producing frame-shift mutations in each paralog showed no apparent phenotype, kctd15a/b double mutant zebrafish are smaller in size and show several phenotypes including some affecting the NC, such as expansion of the early NC domain, increased pigmentation, and craniofacial defects. Both melanophore and xantho-phore pigment cell numbers and early markers are up-regulated in the double mutants. While we find no embryonic craniofacial defects, adult mutants have a deformed maxillary segment and missing barbels. By confocal imaging of mutant larval brains we found that the torus lateralis (TLa), a region implicated in gustatory networks in other fish, is absent. Ablation of this brain tissue in wild type larvae mimics some aspects of the mutant growth phenotype. Thus kctd15 mutants show deficits in the development of both neural crest derivatives, and specific regions within the central nervous system, leading to a strong reduction in normal growth rates.	[Heffer, Alison; Marquart, Gregory D.; Aquilina-Beck, Allisan; Saleem, Nabil; Burgess, Harold A.; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov		Marquart, Gregory David/0000-0001-9811-5372	National Institute of Child Health and Human Development, Division of Intramural Research [HD008809]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008884] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, Division of Intramural Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research has been funded in its entirety by the National Institute of Child Health and Human Development, Division of Intramural Research. The project number is HD008809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the manuscript was subjected to the clearing process required for all articles and other communications from this Institute.	Ahrens K, 2002, J COMP NEUROL, V449, P43, DOI 10.1002/cne.10264; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Camp E, 2001, DEV GENES EVOL, V211, P150, DOI 10.1007/s004270000125; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Castro A, 2009, J COMP NEUROL, V513, P685, DOI 10.1002/cne.21977; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dutta S, 2010, DEVELOPMENT, V137, P3013, DOI 10.1242/dev.047548; Folgueira M, 2003, J COMP NEUROL, V465, P604, DOI 10.1002/cne.10879; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Gharbi N, 2012, DEV GROWTH DIFFER, V54, P241, DOI 10.1111/j.1440-169X.2011.01326.x; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Johnson SL, 2011, DEV BIOL, V350, P405, DOI 10.1016/j.ydbio.2010.12.004; Kaltschmidt B, 2012, STEM CELL REV REP, V8, P658, DOI 10.1007/s12015-011-9340-9; Kato T, 2011, J COMP NEUROL, V519, P3102, DOI 10.1002/cne.22669; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knecht AK, 2001, DEV BIOL, V234, P365, DOI 10.1006/dbio.2001.0275; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; LeClair EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008737; LEDOUARIN N, 1991, GLIA, V4, P175; Leon-Mimila P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070640; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Liang SS, 2015, DOMEST ANIM ENDOCRIN, V50, P65, DOI 10.1016/j.domaniend.2014.09.006; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lister JA, 2011, DEV DYNAM, V240, P2529, DOI 10.1002/dvdy.22743; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; Lv D, 2015, GENE, V560, P149, DOI 10.1016/j.gene.2015.01.054; Marquart GD, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00078; McMenamin SK, 2013, ENDOCRINOLOGY, V154, P1476, DOI 10.1210/en.2012-1734; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Mork L, 2015, CURR TOP DEV BIOL, V115, P235, DOI 10.1016/bs.ctdb.2015.07.001; Muto A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15029; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Nord H, 2016, MOL BIOL CELL, V27, P1853, DOI 10.1091/mbc.E15-12-0821; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Pelletier I, 2001, MECH DEVELOP, V109, P99, DOI 10.1016/S0925-4773(01)00516-0; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Rink E, 1998, J COMP NEUROL, V394, P152, DOI 10.1002/(SICI)1096-9861(19980504)394:2<152::AID-CNE2>3.0.CO;2-1; Rogers CD, 2012, WIRES DEV BIOL, V1, P52, DOI 10.1002/wdev.8; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Skoblov M, 2013, BIOESSAYS, V35, P586, DOI 10.1002/bies.201300002; Steventon B, 2012, DEV BIOL, V367, P55, DOI 10.1016/j.ydbio.2012.04.025; Thisse B, 2004, FAST RELEASE C UNPUB; VANCE ML, 1990, CLIN CHEM, V36, P415; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004499; Williams MJ, 2014, GENETICS, V196, P349, DOI 10.1534/genetics.113.158402; Won MH, 2015, P NATL ACAD SCI USA, V112, P12426, DOI 10.1073/pnas.1517033112; Wong TCB, 2016, INT J DEV BIOL, V60, P159, DOI 10.1387/ijdb.160058id; Yoganathan P, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-65; Zarelli VE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075016; Zarelli VE, 2013, P NATL ACAD SCI USA, V110, P2870, DOI 10.1073/pnas.1300203110; Zhao XY, 2014, GENE, V535, P299, DOI 10.1016/j.gene.2013.11.006; Ziegler I, 2003, PIGM CELL RES, V16, P172, DOI 10.1034/j.1600-0749.2003.00044.x; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	79	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189162	10.1371/journal.pone.0189162	http://dx.doi.org/10.1371/journal.pone.0189162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216270	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800083
J	Gates-Tanzer, LT; Shisler, JL				Gates-Tanzer, Lauren T.; Shisler, Joanna L.			Cellular FLIP long isoform (cFLIP(L))-IKK interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFN expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cFLIP(L); IRF7; IKK; IFN; TLR9	TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTORS; I INTERFERON; C-FLIP; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; UBIQUITINATION; INDUCTION; CELLS; GENE	Interferon (IFN) is important for antiviral and anticancer defenses. However, overproduction is associated with autoimmune disorders. Thus, the cell must precisely up- and down-regulate IFN to achieve immune system homeostasis. The cellular FLICE-like inhibitory protein (cFLIP) is reported to inhibit IFN production. However, the mechanism for this antagonism remained unknown. The goal here was to identify this mechanism. Here we examined the signal transduction events that occur during TLR9-induced IRF7 activation. The cFLIP long isoform (cFLIP(L)) inhibited the expression of IRF7-controlled natural or synthetic genes in several cell lines, including those with abundant IRF7 protein levels (e.g. dendritic cells). cFLIP(L) inhibited IRF7 phosphorylation; however, cFLIP(L)-IRF7 interactions were not detectable, implying that cFLIP(L) acted upstream of IRF7 dimerization. Interestingly, cFLIP(L) co-immunoprecipitated with IKK, and these interactions correlated with a loss of IKK-IRF7 interactions. Thus, cFLIP appears to bind to IKK to prevent IKK from phosphorylating and activating IRF7. To the best of our knowledge, this is the first report of a cellular protein that uses this approach to inhibit IRF7 activation. Perhaps this cFLIP property could be engineered to minimize the deleterious effects of IFN expression that occur during certain autoimmune disorders.	[Gates-Tanzer, Lauren T.; Shisler, Joanna L.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Shisler, JL (corresponding author), Dept Microbiol, B103 Chem & Life Sci Bldg,601 S Goodwin Ave, Urbana, IL 61801 USA.	jshisler@illinois.edu			University of Illinois; National Institutes of Health	University of Illinois; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of Illinois and the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Balzarolo M, 2012, EUR J IMMUNOL, V42, P3019, DOI 10.1002/eji.201242385; Baratchian M, 2016, J BIOL CHEM, V291, P7608, DOI 10.1074/jbc.M116.718122; Buskiewicz IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096156; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chen RF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-340; Cheng XG, 2014, J BIOL CHEM, V289, P9146, DOI 10.1074/jbc.M113.534321; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Cortez-Gonzalez X, 2006, DNA CELL BIOL, V25, P253, DOI 10.1089/dna.2006.25.253; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Day TW, 2009, ANTICANCER RES, V29, P3883; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Gates LT, 2016, J IMMUNOL, V197, P923, DOI 10.4049/jimmunol.1502611; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Gordy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107724; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Hirai M, 2011, BLOOD, V117, P500, DOI 10.1182/blood-2010-05-284737; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kemper C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00306; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kitagawa Y, 2013, J VIROL, V87, P7966, DOI 10.1128/JVI.03525-12; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kui L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7462945; Li W, 2013, VIROLOGY, V439, P152, DOI 10.1016/j.virol.2013.02.015; Liang QM, 2011, J IMMUNOL, V186, P1001, DOI 10.4049/jimmunol.1002240; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Naiki Y, 2015, INNATE IMMUN-LONDON, V21, P770, DOI 10.1177/1753425915596844; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Pelka K, 2013, EUR J IMMUNOL, V43, P1693, DOI 10.1002/eji.201343739; Pradhan Vandana D, 2012, Indian J Hum Genet, V18, P155, DOI 10.4103/0971-6866.100750; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Randall CMH, 2014, P NATL ACAD SCI USA, V111, pE265, DOI 10.1073/pnas.1314569111; Reder AT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00281; Safa A. R., 2012, Experimental Oncology, V34, P176; Sasaki I, 2012, BLOOD, V120, P4733, DOI 10.1182/blood-2012-06-436527; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Song YJ, 2008, P NATL ACAD SCI USA, V105, P18448, DOI 10.1073/pnas.0809933105; Sun L, 2014, EUR J IMMUNOL, V44, P2153, DOI 10.1002/eji.201344310; Sweeney SE, 2011, CELL IMMUNOL, V271, P342, DOI 10.1016/j.cellimm.2011.07.014; Teofilovic NK, 2017, BIOORG MED CHEM LETT, V27, P1530, DOI 10.1016/j.bmcl.2017.02.048; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Wang Y., 2015, GETMOBILE MOBILE COM, V19, P10, DOI DOI 10.1016/j.febslet.2015.04.019; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Wu YH, 2014, CELL DEATH DIFFER, V21, P451, DOI 10.1038/cdd.2013.165; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; Yang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005500; Yang SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26605; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zhou QJ, 2015, J BIOL CHEM, V290, P14729, DOI 10.1074/jbc.M114.633065; Zouali M., 2005, MOL AUTOIMMUNITY COM, P329	79	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1745	1755		10.1074/jbc.RA117.000541	http://dx.doi.org/10.1074/jbc.RA117.000541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222334	Green Published, hybrid			2022-12-26	WOS:000424201700025
J	Wang, S; Xiao, SZ; Gu, FF; Tang, J; Guo, XK; Ni, YX; Qu, JM; Han, LZ				Wang, Su; Xiao, Shu-Zhen; Gu, Fei-Fei; Tang, Jin; Guo, Xiao-Kui; Ni, Yu-Xing; Qu, Jie-Ming; Han, Li-Zhong			Antimicrobial susceptibility and molecular epidemiology of clinical Enterobacter cloacae bloodstream isolates in Shanghai, China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; AMPC; RESISTANCE; CARBAPENEMASES; ASSOCIATION; INFECTIONS; PREVALENCE; EMERGENCE; SPREAD; GENES	Background Enterobacter cloacae is a major nosocomial pathogen causing bloodstream infections. We retrospectively conducted a study to assess antimicrobial susceptibility and phylogenetic relationships of E. cloacae bloodstream isolates in two tertiary university-affiliated hospitals in Shanghai, in order to facilitate managements of E. cloacae bloodstream infections and highlight some unknowns for future prevention. Methods Fifty-three non-duplicate E. cloacae bloodstream isolates were consecutively collected from 2013 to 2016. Antimicrobial susceptibility was determined by disk diffusion. PCR was performed to detect extended-spectrum beta-lactamase (ESBL), carbapenemase and colistin resistance (MCR-1) gene. Plasmid-mediated AmpC beta-lactamase (pAmpC) genes were detected using a multiplex PCR assay targeting MIR/ACT gene (closely related to chromosomal EBC family gene) and other plasmid-mediated genes, including DHA, MOX, CMY, ACC, and FOX. eBURST was applied to analyze multi-locus sequence typing (MLST). Results The rates of resistance to all tested antibiotics were < 40%. Among 53 E. cloacae isolates, 8 (15.1%) were ESBL producers, 3(5.7%) were carbapenemase producers and 18(34.0%) were pAmpC producers. ESBL producers bear significantly higher resistance to cefotaxime (100.0%), ceftazidime (100.0%), aztreonam (100.0%), piperacillin (87.5%), tetracycline (75.0%), and trimethoprim-sulfamethoxazole (62.5%) than non-producers (p<0.05). PAmpC- and non-producers both presented low resistance rates (< 40%) to all antibiotics (p>0.05). SHV (6/8, 75.0%) and MIR/ACT (15/18, 83.3%) predominated in ESBL and pAmpC producers respectively. Moreover, 2 isolates co-carried TEM-1, SHV-12, IMP-26 and DHA-1. MLST analysis distinguished the 53 isolates into 51 STs and only ST414 and ST520 were assigned two isolates of each (2/53). Conclusion The antimicrobial resistance rates were low among 53 E. cloacae bloodstream isolates in the two hospitals. Multiclonality disclosed no evidence on spread of these isolates in Shanghai. The simultaneous presence of ESBL, carbapenemase and pAmpC detected in 2 isolates was firstly reported in Shanghai, which necessitated active ongoing surveillances and consistent prevention and control of E. cloacae.	[Wang, Su; Xiao, Shu-Zhen; Gu, Fei-Fei; Ni, Yu-Xing; Han, Li-Zhong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai, Peoples R China; [Tang, Jin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Clin Lab, Shanghai, Peoples R China; [Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China; [Qu, Jie-Ming] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai, Peoples R China.; Qu, JM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm Med, Shanghai, Peoples R China.	jmqu0906@163.com; hanlizhong1107@163.com	Wang, Su/M-9344-2014	Wang, Su/0000-0003-1103-2641; Guo, Xiao-Kui/0000-0002-1595-9965	Special Fund for Health-scientific Research in the Public Interest of China Program [201002021]; National Natural Science Foundation of China [81472010]; Shanghai Three-Year Plan of the Key Subjects Construction in Public Health-Infectious Diseases and Pathogenic Microorganism [15GWZK0102]	Special Fund for Health-scientific Research in the Public Interest of China Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Three-Year Plan of the Key Subjects Construction in Public Health-Infectious Diseases and Pathogenic Microorganism	This work was supported by the Special Fund for Health-scientific Research in the Public Interest of China Program (201002021) to Yu-Xing Ni, the National Natural Science Foundation of China (81472010) to Yu-Xing Ni and the Shanghai Three-Year Plan of the Key Subjects Construction in Public Health-Infectious Diseases and Pathogenic Microorganism (15GWZK0102). The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision for publication.	[Anonymous], 2017, BREAKP TABL INT MICS; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Chen CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-417; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Flury BB, 2016, ANTIMICROB AGENTS CH, V60, P2383, DOI 10.1128/AAC.02835-15; FORSYTHE SJ, 2015, MANUAL CLIN MICROBIO, P722; Giammanco A, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00310-16; Girlich D, 2015, DIAGN MICR INFEC DIS, V81, P264, DOI 10.1016/j.diagmicrobio.2015.01.003; Goossens H, 2005, DIAGN MICR INFEC DIS, V53, P257, DOI 10.1016/j.diagmicrobio.2005.10.001; Guerin F, 2015, ANTIMICROB AGENTS CH, V59, P7753, DOI 10.1128/AAC.01729-15; Haenni M, 2016, J ANTIMICROB CHEMOTH, V71, P1497, DOI 10.1093/jac/dkw006; Hayakawa K, 2014, ANTIMICROB AGENTS CH, V58, P3441, DOI 10.1128/AAC.02652-13; Institute CaLS,, 2016, PERFORMANCE STANDARD; Izdebski R, 2015, J ANTIMICROB CHEMOTH, V70, P48, DOI 10.1093/jac/dku359; Gude MJ, 2013, INT J MED MICROBIOL, V303, P553, DOI 10.1016/j.ijmm.2013.07.007; Koh TH, 2010, J CLIN MICROBIOL, V48, P2563, DOI 10.1128/JCM.01905-09; Lahlaoui H, 2012, MICROB PATHOGENESIS, V53, P64, DOI 10.1016/j.micpath.2012.04.003; Li G, 2014, CHIN J INFECT CHEMOT, V14, P474; Liu CN, 2015, INT CONF INSTR MEAS, P1, DOI 10.1109/IMCCC.2015.7; Liu J, 2016, EXP THER MED, V11, P269, DOI 10.3892/etm.2015.2851; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; [吕媛 Lv Yuan], 2014, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V30, P278; Miyoshi-Akiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066358; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Potter RF, 2016, DRUG RESIST UPDATE, V29, P30, DOI 10.1016/j.drup.2016.09.002; Qureshi ZA, 2011, INT J ANTIMICROB AG, V37, P26, DOI 10.1016/j.ijantimicag.2010.09.009; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Seki LM, 2013, BRAZ J INFECT DIS, V17, P640, DOI 10.1016/j.bjid.2013.03.012; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Sidjabat HE, 2015, ANTIMICROB AGENTS CH, V59, P4059, DOI 10.1128/AAC.04378-14; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Villa J, 2014, INT J ANTIMICROB AG, V43, P451, DOI 10.1016/j.ijantimicag.2014.02.006; Wang JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121668; Wang SP, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON POWER AND RENEWABLE ENERGY (ICPRE), P10	36	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189713	10.1371/journal.pone.0189713	http://dx.doi.org/10.1371/journal.pone.0189713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244831	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700055
J	Tsuchiya, R; Taira, Y; Orita, M; Fukushima, Y; Endo, Y; Yamashita, S; Takamura, N				Tsuchiya, Rimi; Taira, Yasuyuki; Orita, Makiko; Fukushima, Yoshiko; Endo, Yuukou; Yamashita, Shunichi; Takamura, Noboru			Radiocesium contamination and estimated internal exposure doses in edible wild plants in Kawauchi Village following the Fukushima nuclear disaster	PLOS ONE			English	Article							POWER-PLANT; ENVIRONMENTAL CONTAMINATION; ACCIDENT; FOREST; RATES	Kawauchi Village, in Fukushima Prefecture, is located within a 30-km radius of the nuclear disaster site of the Fukushima Daiichi Nuclear Power Plant (FDNPP). "Sansai" (edible wild plants) in this village have been evaluated by gamma spectrometry after the residents had returned to their homes, to determine the residents risk of internal exposure to artificial radionuclides due to consumption of these plants. The concentrations of radiocesium (cesium-134 and cesium-137) were measured in all 364 samples collected in spring 2015. Overall, 34 (9.3%) samples exceeded the regulatory limit of 100 Bq/kg established by Japanese guidelines, 80 (22.0%) samples registered between 100 Bq/kg and 20 Bq/kg, and 250 (68.7%) registered below 20 Bq/kg (the detection limit). The internal effective doses from edible wild plants were sufficiently low (less than 1 mSv/y), at 3.5 +/- 1.2 mu Sv/y for males and 3.2 +/- 0.9 mu Sv/y for females (2.7 +/- 1.5 mu Sv/y for children and 3.7 +/- 0.7 mu Sv/y for adults in 2015). Thus, the potential internal exposure doses due to consumption of these edible wild plants were below the applicable radiological standard limits for foods. However, high radiocesium levels were confirmed in specific species, such as Eleutherococcus sciadophylloides ("Koshiabura") and Osmunda japonica (Asian royal fern, "Zenmai"). Consequently, a need still might exist for long-term follow-up such as environmental monitoring, physical and mental support to avoid unnecessary radiation exposure and to remove anxiety about adverse health effects due to radiation. The customs of residents, especially the satoyama (countryside) culture of ingesting sansai, also require consideration in the further reconstruction of areas such as Kawauchi Village that were affected by the nuclear disaster.	[Tsuchiya, Rimi; Taira, Yasuyuki; Orita, Makiko; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki, Japan; [Fukushima, Yoshiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nursing, Nagasaki, Japan; [Endo, Yuukou] Kawauchi Municipal Govt, Fukushima, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Taira, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki, Japan.	y-taira@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Takamura, Noboru/0000-0002-5552-3234; Taira, Yasuyuki/0000-0001-8451-142X	Japan Society for the Promotion of Science (JSPS) [15K00540, 26305025, 16K16192]; Grants-in-Aid for Scientific Research [15K00540, 26305025] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Japan Society for the Promotion of Science (JSPS) (No. 15K00540, No. 26305025, No. 16K16192); http//www.jsps.go.jp/english/.	Consumer Affairs Agency Government of Japan, WHIT PAP CONS AFF; Fukushima Prefectural Government, FUK REV SATAT ENV RE; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Hosokawa Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174549; Ikeda Y., 1984, KURASHINOSEKKEI, V157, P168; International Atomic Energy Agency, 2013, FOLL UP IAEA INT MIS; International Atomic Energy Agency (IAEA), 2015, DESCR CONT ACC, V4, P1; International Commission on Radiological Protection, 1995, V72; International Commission on Radiological Protection, 1992, ICRP PUBL, V22; Kawauchi Village Local Government, VILL HEAD; Kim E, 2016, J RADIAT RES, V57, pI118, DOI 10.1093/jrr/rrw061; Kiyono Y., 2013, JPN J FOR ENV, V55, P113, DOI DOI 10.18922/JJFE.55.2_113; Komatsu M, 2016, J ENVIRON RADIOACTIV, V161, P2, DOI 10.1016/j.jenvrad.2015.09.016; Loffredo N, 2015, J ENVIRON RADIOACTIV, V147, P100, DOI 10.1016/j.jenvrad.2015.05.018; Ministry of Agriculture Forestry and Fisheries, GREAT E JAP EARTHQ; Ministry of Agriculture Foresty and Fisheres of Japan, GREAT E JAP EARTHQ R; Ministry of Education Culture Sports Science and Technology of Japan, RAD MEAS SER; Ministry of Health Labor and Welfare, NEW STAND LIM RAD FO; Ministry of Health Labour and Welfare Japan, INF GREAT E JAP EART; Ministry of Health Labour and Welfare of Japan, 2 TERM NAT HLTH PROM; Nakashima K, 2015, PEERJ, V3, DOI 10.7717/peerj.1427; National Council on Radiation Protection and Measurements, 2008, 1611 NAT COUNC RAD P; Nuclear Regulation Authority Japan, MON INF ENV RAD LEV; Ohashi S, 2014, J ENVIRON RADIOACTIV, V134, P54, DOI 10.1016/j.jenvrad.2014.03.001; Orita M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05963-0; Orita M, 2017, RADIAT PROT DOSIM, V175, P295, DOI 10.1093/rpd/ncw301; Orita M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28470; Orita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121990; Orita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114407; Portal Site of Official Statistics of Japan (e-Stat), 2017, SEARCH RES TOP PAG S; Reconstruction Promotion Committee of Japan, REC PROM COMM FY2012; Taira Y, 2014, ENVIRON SCI TECHNOL, V48, P4556, DOI 10.1021/es404534y; Taira Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045816; Taira Y, 2012, RADIAT PROT DOSIM, V151, P537, DOI 10.1093/rpd/ncs040; Taira Y, 2011, J RADIAT RES, V52, P88, DOI 10.1269/jrr.10104; Teramage MT, 2014, SCI TOTAL ENVIRON, V490, P435, DOI 10.1016/j.scitotenv.2014.05.034; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; United Nations Scientific Committee on the Effects of Atomic Radiation, 2013, REP GEN ASS SCI ANN, VI; World Health Organization, 1976, GLOB ENV MON SYST GE; World Health Organization, 2013, HLTH RISK ASS NUCL A; Yoschenko V, 2017, J ENVIRON RADIOACTIV, V166, P45, DOI 10.1016/j.jenvrad.2016.02.017; Yoshida K, 2016, PEERJ, V4, DOI 10.7717/peerj.2353	43	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189398	10.1371/journal.pone.0189398	http://dx.doi.org/10.1371/journal.pone.0189398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240794	Green Submitted, gold, Green Published			2022-12-26	WOS:000417905600031
J	Vobruba, S; Kadlcik, S; Gazak, R; Janata, J				Vobruba, Simon; Kadlcik, Stanislav; Gazak, Radek; Janata, Jiri			Evolution-guided adaptation of an adenylation domain substrate specificity to an unusual amino acid	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; BIOSYNTHETIC GENE-CLUSTER; LINCOSAMIDE ANTIBIOTICS; SEQUENCE-ANALYSIS; CONFERRING CODE; LINCOMYCIN; DERIVATIVES; CLONING	Adenylation domains CcbC and LmbC control the specific incorporation of amino acid precursors in the biosynthesis of lincosamide antibiotics celesticetin and lincomycin. Both proteins originate from a common L-proline-specific ancestor, but LmbC was evolutionary adapted to use an unusual substrate, (2S, 4R)-4-propyl-proline (PPL). Using site-directed mutagenesis of the LmbC substrate binding pocket and an ATP-[P-32]PPi exchange assay, three residues, G308, A207 and L246, were identified as crucial for the PPL activation, presumably forming together a channel of a proper size, shape and hydrophobicity to accommodate the propyl side chain of PPL. Subsequently, we experimentally simulated the molecular evolution leading from L-proline-specific substrate binding pocket to the PPL-specific LmbC. The mere change of three amino acid residues in originally strictly L-proline-specific CcbC switched its substrate specificity to prefer PPL and even synthetic alkyl-L-proline derivatives with prolonged side chain. This is the first time that such a comparative study provided an evidence of the evolutionary relevant adaptation of the adenylation domain substrate binding pocket to a new sterically different substrate by a few point mutations. The herein experimentally simulated rearrangement of the substrate binding pocket seems to be the general principle of the de novo genesis of adenylation domains' unusual substrate specificities. However, to keep the overall natural catalytic efficiency of the enzyme, a more comprehensive rearrangement of the whole protein would probably be employed within natural evolution process.	[Vobruba, Simon; Kadlcik, Stanislav; Gazak, Radek; Janata, Jiri] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Janata, J (corresponding author), Czech Acad Sci, Inst Microbiol, Prague, Czech Republic.	Janata@biomed.cas.cz	Kadlčík, Stanislav/K-8851-2014	Kadlčík, Stanislav/0000-0001-8989-7157; Vobruba, Simon/0000-0003-0109-9500	Czech Science Foundation [17-13436Y]; Ministry of Education, Youth and Sports of CR [LQ1604]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of CR(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the project 17-13436Y from the Czech Science Foundation (https://gacr.cz/) and by the Ministry of Education, Youth and Sports of CR (http://www.msmt.cz/) within the LQ1604 National Sustainability Program II (project BIOCEV-FAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian XY, 2015, BIOTECHNOL BIOENG, V112, P1343, DOI 10.1002/bit.25560; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Cieslak J, 2017, PROTEINS, V85, P1238, DOI 10.1002/prot.25284; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Crusemann M, 2013, CHEM SCI, V4, P1041, DOI 10.1039/c2sc21722h; Eppelmann K, 2002, BIOCHEMISTRY-US, V41, P9718, DOI 10.1021/bi0259406; Fewer DP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-183; Garneau S, 2005, BIOCHEMISTRY-US, V44, P2770, DOI 10.1021/bi0476329; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Janata J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118850; Jiraskova P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00276; Kadlcik S, 2017, CHEM SCI, V8, P3349, DOI 10.1039/c6sc04235j; Kadlcik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084902; Kamenik Z, 2017, ACS CHEM BIOL, V12, P1993, DOI 10.1021/acschembio.7b00335; Kamenik Z, 2016, CHEM SCI, V7, P430, DOI 10.1039/c5sc03327f; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Kopp M, 2011, MOL BIOSYST, V7, P1549, DOI 10.1039/c0mb00240b; Kries H, 2014, ANGEW CHEM INT EDIT, V53, P10105, DOI 10.1002/anie.201405281; Kyselkova M, 2010, ARCH MICROBIOL, V192, P195, DOI 10.1007/s00203-010-0545-0; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; Magerlein B J, 1971, Adv Appl Microbiol, V14, P185, DOI 10.1016/S0065-2164(08)70544-6; Mejean A, 2010, BIOCHEMISTRY-US, V49, P103, DOI 10.1021/bi9018785; Najmanova L, 2014, FOLIA MICROBIOL, V59, P543, DOI 10.1007/s12223-014-0339-x; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Thirlway J, 2012, ANGEW CHEM INT EDIT, V51, P7181, DOI 10.1002/anie.201202043; Ulanova D, 2010, ANTIMICROB AGENTS CH, V54, P927, DOI 10.1128/AAC.00918-09; Ushimaru R, 2016, CHEMBIOCHEM, V17, P1606, DOI 10.1002/cbic.201600223; Villiers B, 2011, CHEM BIOL, V18, P1290, DOI 10.1016/j.chembiol.2011.06.014; Wang M, 2016, J AM CHEM SOC, V138, P6348, DOI 10.1021/jacs.6b01751; Zhang K, 2013, CHEM BIOL, V20, P92, DOI 10.1016/j.chembiol.2012.10.020; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06; Zhao QF, 2015, NATURE, V518, P115, DOI 10.1038/nature14137	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189684	10.1371/journal.pone.0189684	http://dx.doi.org/10.1371/journal.pone.0189684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240815	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600063
J	Wang, YT; Jiang, SL; Wang, HL; Bie, HY				Wang, Yingting; Jiang, Shulong; Wang, Hongli; Bie, Haiyan			A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases	PLOS ONE			English	Article							DRUG-DELIVERY; FORMING SYSTEMS; FORMULATION; POLOXAMER; HYDROGELS; OPTIMIZATION; TEMPERATURE; BIOADHESIVE; COPOLYMERS; CELLS	Neurodegenerative diseases are becoming prevalent as the population ages. Geniposide could inhibit oxidative stress, reduce apoptosis, protect neuron, and has been used for therapy of the neurodegenerative diseases. The bioavailability of geniposide by nasal route is greater than that by oral administration. However, mucociliary clearance is a rate-limiting factor for nasal route administration. The objective of this study was to develop and evaluate a mucoadhesive, thermoreversible in situ nasal gel of geniposide. The poloxamers (P407, P188) and the hydroxypropyl methylcellulose were used as thermoreversible and mucoadhesive polymers, respectively. Borneol was used as a permeation enhancer. The hydrogel was prepared with the cold method and optimized by the response surface methodologycentral composite design. Gelation temperature, pH, clarity, gel strength, mucoadhesive strength, in vitro and ex vivo release kinetics of formulations were evaluated. The optimized amounts of poloxamer407 (P407), poloxamer188 (P188) and hydroxypropyl methylcellulose were determined to be 19.4 +/- 20.5%, 1.1 +/- 4.0% and 0.3 +/- 0.6% respectively. The secondorder polynomial equation in terms of actual factors indicated a satisfactory correlation between the independent variables and the response (R-2 = 0.9760). An ANOVA of the empirical second-order polynomial model indicated the model was significant (P< 0.01). P407, P188, P407xP188, P407 2 and P188(2) were significant model terms. The effects of P407 on gelation temperature were greater than those of other independent variables. The pH values of all the formulations were found to be within 6.3 +/- 6.5 which was in the nasal physiological pH range 4.5 +/- 6.5. The drug content, gel strength, mucoadhesive strength of the optimized formulations were 97 +/- 101%, 25 +/- 50 sec and 4000 +/- 6000 dyn/cm(2) respectively. The in vitro release kinetics of cumulative release of geniposide was fitted to the zeroorder model. The ex vivo cumulative release kinetics of geniposide was fitted to the Weibull model. This study concludes that the release of geniposide is controlled by gel corrosion, and that the permeation of geniposide is time-dependent. The more residence time, mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases is of compliance and potential application.	[Wang, Yingting; Jiang, Shulong; Wang, Hongli; Bie, Haiyan] Jining 1 Peoples Hosp, Jining, Shandong, Peoples R China		Jiang, SL (corresponding author), Jining 1 Peoples Hosp, Jining, Shandong, Peoples R China.	3416048269@qq.com			Natural Science Foundation of Shandong Province [ZR2014HL095]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by The Natural Science Foundation of Shandong Province, ZR2014HL095 (http://www.sdnsf.gov.cn/sdnsfms/jsp/loginUp2.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asasutjarit R, 2011, INT J PHARMACEUT, V411, P128, DOI 10.1016/j.ijpharm.2011.03.054; Belgamwar VS, 2009, PHARM DEV TECHNOL, V14, P240, DOI 10.1080/10837450802498910; Bhandwalkar MJ, 2013, AAPS PHARMSCITECH, V14, P101, DOI 10.1208/s12249-012-9893-1; Bie HY, 2016, CHINESE JOURNAL NEW, V25, P1; Bryan L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153683; Callegari L, 2016, NEURODEGENER DIS, V16, P352; Chen P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113307; Chen ZZ, PLOS ONE; Chu KD, 2013, INT J MOL SCI, V14, P6499, DOI 10.3390/ijms14036499; Dash S, 2010, ACTA POL PHARM, V67, P217; De A, 2013, IJRPC, V3, P659; Dondeti P, 1996, INT J PHARM, V127, P115, DOI 10.1016/0378-5173(95)04115-X; Du SY, 2012, CHINESE J EXPT TRADI, V18, P146; Fernandez E, 2008, J POLYM SCI POL PHYS, V46, P322, DOI 10.1002/polb.21370; Galgatte UC, 2014, DRUG DELIV, V21, P62, DOI 10.3109/10717544.2013.849778; Gratieri T, 2010, EUR J PHARM BIOPHARM, V75, P186, DOI 10.1016/j.ejpb.2010.02.011; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Jabarian LE, 2013, EUR J PHARM SCI, V48, P87, DOI 10.1016/j.ejps.2012.09.017; Jadhav KR, 2007, CURR DRUG THER, V2, P27, DOI 10.2174/157488507779422374; Jagdale S, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/6401267; Jiang J, 2008, POLYMER, V49, P3561, DOI 10.1016/j.polymer.2008.05.038; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Karavasili C, 2016, DRUG DISCOV TODAY, V21, P157, DOI 10.1016/j.drudis.2015.10.016; Kempwade A, 2014, J SOL-GEL SCI TECHN, V72, P43, DOI 10.1007/s10971-014-3422-5; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Kuo CH, 2013, INT J ELECTROCHEM SC, V8, P9242; Lai MC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015011; Li L, 2015, NEURAL REGEN RES, V10, P1617, DOI 10.4103/1673-5374.167760; Liu JH, 2007, NEUROCHEM INT, V51, P361, DOI 10.1016/j.neuint.2007.04.021; Lu CC, 2015, EUR J PHARM SCI, V77, P24, DOI 10.1016/j.ejps.2015.05.014; Lu Y, 2012, INT J MOL SCI, V13, P14127, DOI 10.3390/ijms131114127; Lv C, 2014, CURR ALZHEIMER RES, V11, P430, DOI 10.2174/1567205011666140514111204; Madan M, 2009, INDIAN J PHARM SCI, V71, P242, DOI 10.4103/0250-474X.56015; Marwah H, 2016, DRUG DELIV, V23, P1636, DOI 10.3109/10717544.2016.1155243; dos Santos ACM, 2015, INT J NANOMED, V10, P2391, DOI 10.2147/IJN.S72337; Nour V, 2015, J FOOD BIOCHEM, V39, P179, DOI 10.1111/jfbc.12119; Patel N, 2015, J PHARM INNOV, V10, P357, DOI 10.1007/s12247-015-9232-7; Pathak R, 2014, ACTA PHARM SIN B, V4, P151, DOI 10.1016/j.apsb.2014.02.002; Phaechamud T, 2016, MATER DESIGN, V89, P294, DOI 10.1016/j.matdes.2015.09.138; Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79; Radivojsa M, 2013, EUR J PHARM SCI, V50, P93, DOI 10.1016/j.ejps.2013.03.002; Rao M, 2017, DRUG DEV IND PHARM, V43, P142, DOI 10.1080/03639045.2016.1225754; Rokade M, 2015, INT J PHARM SCI RES, V6, P4958, DOI 10.13040/IJPSR.0975-8232.6(12).4958-66; Seo HJ, 2012, J IND ENG CHEM, V18, P88, DOI 10.1016/j.jiec.2011.11.077; Sharma N, 2013, TROP J PHARM RES, V12, P149, DOI 10.4314/tjpr.v12i2.3; Shelke S, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5713-6; Shi XL, 2015, INT J BIOL MACROMOL, V72, P553, DOI 10.1016/j.ijbiomac.2014.09.009; Singh RMP, 2013, AAPS PHARMSCITECH, V14, P412, DOI 10.1208/s12249-013-9921-9; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; Ur-Rehman T, 2011, INT J PHARMACEUT, V409, P19, DOI 10.1016/j.ijpharm.2011.02.017; Wang CY, 2012, PROTEIN ENG DES SEL, V25, P1, DOI 10.1093/protein/gzs078; Wang HL, 2016, CHINA PHARM, V27, P98; [杨明 Yang Ming], 2010, [中国新药杂志, Chinese Journal New Drugs], V19, P746; Yapar EA, 2012, TROP J PHARM RES, V11, P855, DOI 10.4314/tjpr.v11i5.20; Yeole PG, 2011, RES J PHARM BIOL CHE, V2, P1048; Yong CS, 2001, INT J PHARM, V226, P195, DOI 10.1016/S0378-5173(01)00809-2; Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q; Yu ZG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173949; Zhang K, 2015, DRUG DELIV, V22, P375, DOI 10.3109/10717544.2014.891272; Zhao CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152551; Zhou TT, 2005, J CHROMATOGR A, V1100, P76, DOI 10.1016/j.chroma.2005.09.026	63	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189478	10.1371/journal.pone.0189478	http://dx.doi.org/10.1371/journal.pone.0189478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240797	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600035
J	Hoppe, M; Onning, G; Hulthen, L				Hoppe, Michael; Onning, Gunilla; Hulthen, Lena			Freeze-dried Lactobacillus plantarum 299v increases iron absorption in young females-Double isotope sequential single-blind studies in menstruating women	PLOS ONE			English	Article							NONHEME-IRON; ASCORBIC-ACID; DIETARY IRON; WHOLE DIET; DEFICIENCY; SUPPLEMENTATION; ANEMIA; FATIGUE; BIOAVAILABILITY; ASSOCIATION	Background The probiotic strain Lactobacillus plantarum 299v has earlier been shown to increase iron absorption when added to foods. However, it is not known if the same probiotic strain in a freeze-dried format included in a capsule increases the iron absorption. Objective The aim of this study was to test the hypotheses that non-heme iron absorption from a light meal is promoted by a simultaneous intake of freeze-dried Lactobacillus plantarum 299v (Lp299v, DSM 9843). Study design With a single blinded placebo controlled sequential design, iron absorption from a light breakfast meal administered with or without capsules containing 10(10) cfu freeze-dried Lp299v was studied in healthy female volunteers of fertile age. The methodology used was a double isotope technique (59 Fe and 55 Fe). Two studies were performed using the same protocol. Results In study 1, the absorption of iron from a meal without Lp299v was found to be 17.4 +/- 13.4%, and from an identical meal with Lp299v was found to be 22.4 +/- 17.3% (mean +/- SD). This difference was statistically significant (p = 0.040, n = 14). In study 2, the absorption of iron from a meal without Lp299v was found to be 20.9 +/- 13.1%, and from an identical meal with Lp299v found to be 24.5 +/- 12.0% (mean +/- SD, n = 28), which again was statistically significant (p = 0.003). Conclusion Freeze-dried Lp299v enhances the absorption of iron when administered together with a meal with a high iron bioavailability.	[Hoppe, Michael] Sahlgrens Univ Hosp, Sect Clin Nutr, Dept Gastroenterol & Hepatol, Gothenburg, Sweden; [Hoppe, Michael; Hulthen, Lena] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Onning, Gunilla] Lund Univ, Ctr Appl Life Sci, Biomed Nutr Pure & Appl Biochem, Lund, Sweden; [Onning, Gunilla] Probi AB, Ideon Gamma 1, Lund, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Lund University	Hoppe, M (corresponding author), Sahlgrens Univ Hosp, Sect Clin Nutr, Dept Gastroenterol & Hepatol, Gothenburg, Sweden.; Hoppe, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.	michael.hoppe@nutrition.gu.se		Hoppe, Michael/0000-0001-7831-8375	Probi AB, Sweden	Probi AB, Sweden	This work was funded by Probi AB, Sweden (http://probi.com). One of the authors (GO) is employed by Probi AB. GO contributed to the design of the clinical trial and the formulation of the study products. The funder and GO had no role in data collection and analysis, or decision to publish. The specific role of the authors are articulated in the 'authors contributions' section.	Ahluwalia N, 2004, AM J CLIN NUTR, V79, P516; Balamurugan R, 2010, BRIT J NUTR, V104, P931, DOI 10.1017/S0007114510001637; Belza A, 2005, BRIT J NUTR, V94, P551, DOI 10.1079/BJN20051461; Bering S, 2007, BRIT J NUTR, V98, P991, DOI 10.1017/S0007114507761809; Bering S, 2006, BRIT J NUTR, V96, P80, DOI 10.1079/BJN20061683; BJORNRASMUSSEN E, 1976, AM J CLIN NUTR, V29, P772; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; BRISE H, 1962, ACTA MED SCAND, V171, P7; Brownlie T, 2002, AM J CLIN NUTR, V75, P734, DOI 10.1093/ajcn/75.4.734; BRUNE M, 1992, J NUTR, V122, P442, DOI 10.1093/jn/122.3.442; Bruner AB, 1996, LANCET, V348, P992, DOI 10.1016/S0140-6736(96)02341-0; Brutsaert TD, 2003, AM J CLIN NUTR, V77, P441, DOI 10.1093/ajcn/77.2.441; CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; CUSTER EM, 1995, J LAB CLIN MED, V126, P88; Del Piano M, 2008, J CLIN GASTROENTEROL, V42, pS170, DOI 10.1097/MCG.0b013e3181815976; Ding WK, 2009, J FOOD SCI, V74, pM53, DOI 10.1111/j.1750-3841.2008.01030.x; EAKINS JD, 1966, INT J APPL RADIAT IS, V17, P391, DOI 10.1016/0020-708X(66)90065-2; Friedmann B, 2001, MED SCI SPORT EXER, V33, P741, DOI 10.1097/00005768-200105000-00010; Gibson S, 2003, PUBLIC HEALTH NUTR, V6, P341, DOI 10.1079/PHN2002442; GILLOOLY M, 1983, BRIT J NUTR, V49, P331, DOI 10.1079/BJN19830042; Gonzalez A, 2017, FOOD CHEM, V228, P374, DOI 10.1016/j.foodchem.2017.02.008; Goossens D, 2005, DIGEST LIVER DIS, V37, P44, DOI 10.1016/j.dld.2004.07.018; Goossens D, 2003, ALIMENT PHARM THER, V18, P495, DOI 10.1046/j.1365-2036.2003.01708.x; HALLBERG L, 1972, SCAND J HAEMATOL, V9, P193; HALLBERG L, 1986, HUM NUTR-APPL NUTR, V40A, P97; Hallberg L, 2000, AM J CLIN NUTR, V71, P1147; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; HALLBERG L, 1991, AM J CLIN NUTR, V53, P112, DOI 10.1093/ajcn/53.1.112; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; Hallberg L, 1980, METHODS HEMATOLOGY, P116; HALLBERG LEIF, 1955, SCAND JOUR CLIN AND LAB INVEST, V7, P1; Hercberg S, 2001, Public Health Nutr, V4, P537; Hinton PS, 2000, J APPL PHYSIOL, V88, P1103, DOI 10.1152/jappl.2000.88.3.1103; Hoppe M, 2008, EUR J CLIN NUTR, V62, P761, DOI 10.1038/sj.ejcn.1602776; Hoppe M, 2007, EUR J CLIN NUTR, V61, P1032, DOI 10.1038/sj.ejcn.1602614; Hoppe M, 2015, BRIT J NUTR, V114, P1195, DOI 10.1017/S000711451500241X; Hulthen L, 1998, EUR J CLIN NUTR, V52, P376, DOI 10.1038/sj.ejcn.1600573; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Landahl G, 2005, INT J SPORT NUTR EXE, V15, P689, DOI 10.1123/ijsnem.15.6.689; Lin Chuan-Sheng, 2014, Biomed J, V37, P259, DOI 10.4103/2319-4170.138314; MAGNUSSON B, 1981, SCAND J HAEMATOL, V27, P201; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nighswonger BD, 1996, J DAIRY SCI, V79, P212, DOI 10.3168/jds.S0022-0302(96)76353-1; Patterson AJ, 2001, J AM COLL NUTR, V20, P337, DOI 10.1080/07315724.2001.10719054; Prakash S, 2014, CURR PHARM DESIGN, V20, P1025, DOI 10.2174/138161282006140220145154; Pynaert I, 2009, PUBLIC HEALTH NUTR, V12, P1775, DOI 10.1017/S1368980008004369; Scheers N, 2016, EUR J NUTR, V55, P373, DOI 10.1007/s00394-015-0857-6; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Troost FJ, 2003, AM J PHYSIOL-GASTR L, V285, pG354, DOI 10.1152/ajpgi.00422.2002; TUNTAWIROON M, 1991, AM J CLIN NUTR, V53, P554, DOI 10.1093/ajcn/53.2.554; Umbreit J, 2005, AM J HEMATOL, V78, P225, DOI 10.1002/ajh.20249; Verdon F, 2003, BRIT MED J, V326, P1124, DOI 10.1136/bmj.326.7399.1124; WHO, 2001, REP JOINT FAO WHO EX; WHO, 2004, FOOD HLTH EUROPE NEW; WHO, 2002, RED RISKS PROM HLTH; WHO/CDC, 2007, INF PREV CONTR ASS F; WHO/UNICEF/UNU, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, GUID INT IR FOL AC S; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646	63	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189141	10.1371/journal.pone.0189141	http://dx.doi.org/10.1371/journal.pone.0189141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236734	gold, Green Submitted, Green Published			2022-12-26	WOS:000417884100045
J	Qu, FZ; Meng, L; Yu, JB; Liu, JT; Sun, JK; Yang, HJ; Dong, LS				Qu, Fanzhu; Meng, Ling; Yu, Junbao; Liu, Jingtao; Sun, Jingkuan; Yang, Hongjun; Dong, Linshui			Influences of micro-geomorphology on the stoichiometry of C, N and P in Chenier Island soils and plants in the Yellow River Delta, China	PLOS ONE			English	Article							COASTAL WETLANDS; ECOLOGICAL STOICHIOMETRY; CARBON; PHOSPHORUS; PATTERNS; ENRICHMENT; NITROGEN; BIOMASS; GROWTH	Studies have indicated that consistent or well-constrained (relatively low variability) carbon: nitrogen: phosphorus (C:N:P) ratios exist in large-scale ecosystems, including both marine and terrestrial ecosystems. Little is known about the C, N and P stoichiometric ratios that exist in the soils and plants of Chenier Island in the Yellow River Delta (YRD). We examined the distribution patterns and relationships of C, N and P stoichiometry in the soils and plants of Chenier Island, as well as the potential influences of the island's micro-geomorphology. Based on a study of four soil profile categories and Phragmites australis and Suaeda heteroptera plant tissues, our results showed that micro-geomorphology could leave a distinct imprint on the soil and plant elemental stoichiometry of Chenier Island; significant variation in the atomic C: N: P ratios (R-CNP) existed in soils and plants, indicating that the RCNP values in both the soil and plants are not well constrained at the Chenier Island scale. R-CN and R-CP in Chenier Island soils were high, whereas the R-NP values were comparatively low, indicating that the ecosystems of Chenier Island are nutrient-limited by N and P. However, the RNP values in P. australis and S. heteroptera plant tissues were high, suggesting that the plants of Chenier Island are nutrient-limited by P. Finally, we suggest that soil and plant N:P ratios may be good indicators of the soil and plant nutrient status during soil development and plant growth, which could be a useful reference for restoring the degraded soils of Chenier Island.	[Qu, Fanzhu; Meng, Ling; Liu, Jingtao; Sun, Jingkuan; Yang, Hongjun; Dong, Linshui] Binzhou Univ, Shandong Prov Key Lab Ecoenvironm Sci Yellow Rive, Binzhou, Shandong, Peoples R China; [Meng, Ling; Yu, Junbao] LuDong Univ, Inst coastal ecol, Yantai, Shanodng, Peoples R China	Binzhou University; Ludong University	Yu, JB (corresponding author), LuDong Univ, Inst coastal ecol, Yantai, Shanodng, Peoples R China.	junbao.yu@gmail.com		Qu, Fanzhu/0000-0002-7433-5319	National Key R&D Program of China [2017YFC0505900]; National Natural Science Foundation of China [41501088, 41401100]; Natural Science Foundation of Shandong Province [ZR2015CL013]; Project of Shandong Province Higher Educational Science and Technology Program [J15LE16]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Project of Shandong Province Higher Educational Science and Technology Program	Financial support for this work was provided by the National Key R&D Program of China (No.2017YFC0505900), the National Natural Science Foundation of China (No.41501088, No.41401100), the Natural Science Foundation of Shandong Province (No.ZR2015CL013), and the Project of Shandong Province Higher Educational Science and Technology Program (No. J15LE16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for support from the National Key R&D Program of China (No.2017YFC0505900), the National Natural Science Foundation of China (No.41501088, No.41401100), the Natural Science Foundation of Shandong Province (No.ZR2015CL013), and the Project of Shandong Province Higher Educational Science and Technology Program (No. J15LE16).	Audusseau H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124616; Bompy F, 2014, PLANT SOIL, V380, P399, DOI 10.1007/s11104-014-2100-2; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; DeLaune RD, 2008, J ENVIRON SCI HEAL A, V43, P300, DOI 10.1080/10934520701792837; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2000, ECOSYSTEMS, V3, P293, DOI 10.1007/s100210000027; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; Graham SA, 2016, J ECOL, V104, P249, DOI 10.1111/1365-2745.12498; Gruber N, 2014, NAT GEOSCI, V7, P853, DOI 10.1038/ngeo2308; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Klausmeier CA, 2008, ECOL RES, V23, P479, DOI 10.1007/s11284-008-0470-8; Li WP, 2016, ACS NANO, V10, P2017, DOI 10.1021/acsnano.5b06175; Martiny AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168291; Meng L, 2016, J COAST CONSERV, V20, P271, DOI 10.1007/s11852-016-0437-9; Michaels AF, 2003, SCIENCE, V300, P906, DOI 10.1126/science.1083140; Qu FZ, 2014, GEODERMA, V235, P227, DOI 10.1016/j.geoderma.2014.07.009; Rastetter EB, 2011, FRONT ECOL ENVIRON, V9, P68, DOI 10.1890/090223; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2012, EVOLUTION SYSTEMATIC, V14, P33; Schaller J, 2012, PLANT BIOLOGY, V14, P392, DOI 10.1111/j.1438-8677.2011.00537.x; Segura-Noguera M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154050; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Steyer GD, 2000, ECOL ENG, V15, P385, DOI 10.1016/S0925-8574(00)00088-4; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Xia CX, 2014, ECOL ENG, V70, P406, DOI 10.1016/j.ecoleng.2014.06.018; Zeng QC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168890; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]; Zhao FZ, 2015, ECOL ENG, V74, P415, DOI 10.1016/j.ecoleng.2014.11.010; Zhu JF, 2016, ARCH AGRON SOIL SCI, V62, P1614, DOI 10.1080/03650340.2016.1155702	31	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189431	10.1371/journal.pone.0189431	http://dx.doi.org/10.1371/journal.pone.0189431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236766	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100069
J	Schulte-Herbruggen, B; Cowlishaw, G; Homewood, K; Rowcliffe, JM				Schulte-Herbruggen, Bjorn; Cowlishaw, Guy; Homewood, Katherine; Rowcliffe, J. Marcus			Rural protein insufficiency in a wildlife-depleted West African farm-forest landscape	PLOS ONE			English	Article							ANIMAL PROTEIN; RIO-MUNI; BUSHMEAT; CONSUMPTION; HOUSEHOLD; AVAILABILITY; LIVELIHOODS; LINKAGES; CASSAVA; POVERTY	Introduction Wildlife is an important source of protein for many people in developing countries. Yet wildlife depletion due to overexploitation is common throughout the humid tropics and its effect on protein security, especially for vulnerable households, is poorly understood. This is problematic for both sustainable rural development and conservation management. Methods This study investigates a key dimension of protein security in a cash-crop farming community living in a wildlife-depleted farm-forest landscape in SW Ghana, a region where protein-energy malnutrition persists. Specifically, we monitored protein sufficiency, defined as whether consumption met daily requirements, as benchmarked by recommended daily allowance (RDA). We focus on whether more vulnerable households were less likely to be able to meet their protein needs, where vulnerability was defined by wealth, agricultural season and gender of the household head. Our central hypothesis was: (a) vulnerable households are less likely to consume sufficient protein. In the context that most plant proteins were home-produced, so likely relatively accessible to all households, while most animal proteins were purchased, so likely less accessible to vulnerable households, we tested two further hypotheses: (b) vulnerable households depend more on plant protein to cover their protein needs; and (c) vulnerable households are less likely to earn sufficient cash income to meet their protein needs through purchased animal sources. Results Between 14% and 60% of households (depending on plant protein content assumptions) consumed less than the RDA for protein, but neither protein consumption nor protein sufficiency co-varied with household vulnerability. Fish, livestock and food crops comprised 85% of total protein intake and strongly affected protein sufficiency. However, bushmeat remained an important protein source (15% of total consumption), especially during the post-harvest season when it averaged 26% of total protein consumption. Across the year, 89% of households experienced at least one occasion when they had insufficient income to cover their protein needs through animal protein purchases. The extent of this income shortage was highest during the lean season and among poorer households. Conclusions These findings indicate that despite wildlife depletion, bushmeat continues to make a substantial contribution to protein consumption, especially during the agricultural lean season. Income shortages among farmers limit their ability to purchase bushmeat or its substitutes, suggesting that wildlife depletion may cause malnutrition.	[Schulte-Herbruggen, Bjorn; Cowlishaw, Guy; Rowcliffe, J. Marcus] Zool Soc London, Inst Zool, London, England; [Schulte-Herbruggen, Bjorn; Homewood, Katherine] UCL, Dept Anthropol, London, England	Zoological Society of London; University of London; University College London	Schulte-Herbruggen, B (corresponding author), Zool Soc London, Inst Zool, London, England.; Schulte-Herbruggen, B (corresponding author), UCL, Dept Anthropol, London, England.	bsh103@gmail.com	Homewood, Katherine/K-6151-2019; Rowcliffe, Marcus/G-3713-2018	Homewood, Katherine/0000-0001-7391-985X; Rowcliffe, Marcus/0000-0002-4286-6887	U.K. Economic and Social Research Council (ESRC); National Environmental Research Council (NERC); Parkes Foundation	U.K. Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Parkes Foundation	This work was supported by a joint research studentship of the U.K. Economic and Social Research Council (ESRC) and the National Environmental Research Council (NERC) with additional support from The Parkes Foundation (http://www.parkesfoundation.org.uk/) to BSH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abernethy KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0303; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albrechtsen L, 2005, ENVIRON CONSERV, V32, P340, DOI 10.1017/S0376892906002694; Allebone-Webb SM, 2008, EVALUATING DEPENDENC; Ambrose-Oji B, 2003, INT FOREST REV, V5, P106, DOI 10.1505/IFOR.5.2.106.17420; [Anonymous], DIET REF INT EN CARB; Apaza L, 2002, ORYX, V36, P382, DOI 10.1017/S003060530200073X; ARMBRUSTER T, 1993, SMALL RUMINANT RES, V11, P289, DOI 10.1016/0921-4488(93)90001-X; ASIBEY E. O. A., 1966, Ghana Farmer, V10, P165; AYANKUNBI MA, 1991, FOOD CHEM, V41, P349, DOI 10.1016/0308-8146(91)90059-W; Barrientos SW, 2008, MAPPING SUSTAINABLE, P97; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Bennett Elizabeth L., 2002, Occasional Papers of the IUCN Species Survival Commission, V24, P39; Blaney S, 2009, FOOD NUTR BULL, V30, P49, DOI 10.1177/156482650903000105; Boni S., 1993, STUDY FERTILITY ANAL; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown D, 2007, CONSERV SCI PRACT, V2, P111; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cawthorn DM, 2015, FOOD RES INT, V76, P906, DOI 10.1016/j.foodres.2015.03.025; Chambers Robert., 1981, SEASONAL DIMENSIONS; COCK JH, 1982, SCIENCE, V218, P755, DOI 10.1126/science.7134971; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; DEI GJS, 1989, ECOL FOOD NUTR, V22, P225, DOI 10.1080/03670244.1989.9991071; Delgado C., 1999, Food, Agriculture and the Environment Discussion Paper - International Food Policy Research Institute; Dewey KG, 1997, ANNU REV NUTR, V17, P19, DOI 10.1146/annurev.nutr.17.1.19; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Elliott J., 2002, WILDLIFE POVERTY STU; ERINOSO HO, 1992, J TROP PEDIATRICS, V38, P329, DOI 10.1093/tropej/38.6.329; Fa JE, 2009, ANIM CONSERV, V12, P599, DOI 10.1111/j.1469-1795.2009.00289.x; Fa JE, 2003, ENVIRON CONSERV, V30, P71, DOI 10.1017/S0376892903000067; Fa JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep08168; FAO, 1997, AGR FOOD NUTR AFRICA; FAO/WHO, 1985, EN PROT REQ; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; GIAMI SY, 1994, FOOD CHEM, V50, P137, DOI 10.1016/0308-8146(94)90110-4; Gibson J, 2007, AM J AGR ECON, V89, P473, DOI 10.1111/j.1467-8276.2007.00978.x; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Gomna A, 2007, BRIT J NUTR, V97, P145, DOI 10.1017/S0007114507201734; Grandin Barbara, 1988, WEALTH RANKING SMALL; Hanson K. T., 2004, AFR TODAY, V51, P27, DOI [10.1353/at.2004.0066, DOI 10.1353/AT.2004.0066]; IFAD, 2001, ASS RUR POV W CENTR; ITTA, 1990, CASS TROP AFR REF MA; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; KYEREME SS, 1987, WORLD DEV, V15, P1189, DOI 10.1016/0305-750X(87)90187-2; Labadarios D, 2005, PUBLIC HEALTH NUTR, V8, P533, DOI 10.1079/PHN2005816; Lockwood Kathryn, 2001, DETERMINATION POVERT; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Nasi R, 2008, 33 SECR CONV BIOL DI, P50; National Research Council, 1991, MICR LITTL KNOWN AN; Nielsen MR, 2006, BIOL CONSERV, V128, P509, DOI 10.1016/j.biocon.2005.10.017; Nti C.A., 2002, INT J CONSUM STUD, V26, P7, DOI DOI 10.1046/J.1470-6431.2002.00211.X; OLIVIERA J F S, 1974, Ecology of Food and Nutrition, V3, P237, DOI 10.1080/03670244.1974.9990386; R Core Team, 2020, R LANG ENV STAT COMP; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Sarti FM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07934-200422; Schulte-Herbruggen B, 2013, HUM ECOL, V41, P795, DOI 10.1007/s10745-013-9609-5; Schulte-Herbruggen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072807; Schulte-Herbruggen B., 2011, THESIS; Starkey M.P, 2004, COMMERCE SUBSISTENCE; Struhsaker Thomas T., 1995, African Primates, V1, P5; Tambi NE, 1996, AGR ECON-BLACKWELL, V14, P11, DOI 10.1016/0169-5150(95)01175-7; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Van de Poel Ellen, 2007, Int J Equity Health, V6, P21, DOI 10.1186/1475-9276-6-21; Wilkie DS, 2005, CONSERV BIOL, V19, P268, DOI 10.1111/j.1523-1739.2005.00372.x; Wilkie DS, 2001, CONSERV BIOL, V15, P761, DOI 10.1046/j.1523-1739.2001.015003761.x; Wolfe RR, 2008, AM J CLIN NUTR, V87, p1582S, DOI 10.1093/ajcn/87.5.1582S; World Health Organization, NUTR LANDSC INF SYST; World Health Organization (WHO), 2014, WHO GLOB DAT CHILD G; Zuur Alain F., 2009, P1	73	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188109	10.1371/journal.pone.0188109	http://dx.doi.org/10.1371/journal.pone.0188109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236703	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100010
J	Baik, M; Kim, K; Yoo, J; Kim, HC; Jeong, SH; Kim, KH; Park, HJ; Kim, YD; Heo, JH; Nam, HS				Baik, Minyoul; Kim, Kyoungsub; Yoo, Joonsang; Kim, Hyeon Chang; Jeong, Seong Ho; Kim, Ki Hoon; Park, Hyung Jong; Kim, Young Dae; Heo, Ji Hoe; Nam, Hyo Suk			Differential impact of white matter hyperintensities on long-term outcomes in ischemic stroke patients with large artery atherosclerosis	PLOS ONE			English	Article							SMALL VESSEL DISEASE; ABNORMALITIES; STIFFNESS; PROGNOSIS; MORTALITY; RISK	Background The presence of white matter hyperintensity (WMH) is related to poor long-term outcomes in stroke patients. However, the long-term outcome is unknown in patients with both large artery atherosclerosis (LAA) and WMH. Methods We investigated the impact of WMH on long-term outcome in patients with LAA. Consecutive patients in a prospective stroke registry were included. Patients were followed for a median of 7.7 years (interquartile range, 5.6 +/- 9.7). The degree of WMH was assessed by Fazekas grade on fluid-attenuated inversion recovery images. Total WMH burden was calculated by summation of Fazekas scores in periventricular and deep white matter. Severe WMH was defined as total burden score >= 3. Results Among 2529 patients, 639 patients (25.3%) were classified with the LAA subtype. After applying exclusion criteria, the data from 538 patients were analyzed. The mean patient age was 65.7 +/- 10.3 years. Severe WMHs were found in 243 patients (45.2%). During follow-up, 200 patients (37.2%) died. Cox regression analysis showed that LAA patients with severe WMH had a 1.50-fold (95% CI, 1.12 +/- 2.00, p = 0.007) higher death rate compared to those without. In the older age group (>= 65 years), Cox regression revealed that patients with severe WMH had a 1.75-fold (95% CI, 1.15 +/- 2.65, p = 0.008) higher 5-year death rate, whereas the younger age group did not have this association. Conclusion The degree of WMH might be a surrogate marker for long-term outcome in patients with LAA. Atherosclerotic burdens in both small and large arteries might impact long-term prognosis in ischemic stroke patients.	[Baik, Minyoul; Kim, Kyoungsub; Yoo, Joonsang; Jeong, Seong Ho; Kim, Ki Hoon; Park, Hyung Jong; Kim, Young Dae; Heo, Ji Hoe; Nam, Hyo Suk] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Yoo, Joonsang] Keimyung Univ, Dept Neurol, Sch Med, Daegu, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Keimyung University; Yonsei University; Yonsei University Health System	Nam, HS (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.	hsnam@yuhs.ac	Kim, Hyeon Chang/F-8796-2019	Kim, Hyeon Chang/0000-0001-7867-1240; Baik, Minyoul/0000-0002-6582-0953; Jeong, Seong Ho/0000-0003-4439-4390; Kim, Young Dae/0000-0001-5750-2616; Heo, Ji Hoe/0000-0001-9898-3321; Kim, Ki Hoon/0000-0001-6428-061X; NAM, HYO SUK/0000-0002-4415-3995	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1056]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1056) to HSN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bokura Hirokazu, 2006, J Stroke Cerebrovasc Dis, V15, P57, DOI 10.1016/j.jstrokecerebrovasdis.2005.11.001; Cimminiello C, 2012, CEREBROVASC DIS, V33, P341, DOI 10.1159/000335833; Conijn MMA, 2011, STROKE, V42, P3105, DOI 10.1161/STROKEAHA.110.594853; Derex L, 2002, CEREBROVASC DIS, V13, P225, DOI 10.1159/000057847; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Nam HS, 2012, STROKE, V43, P2948, DOI 10.1161/STROKEAHA.112.661074; Kandiah N, 2014, J STROKE CEREBROVASC, V23, P136, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.007; Kissela B, 2009, STROKE, V40, P530, DOI 10.1161/STROKEAHA.108.521906; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lee SJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-31; Nyquist PA, 2015, NEUROBIOL AGING, V36, P1653, DOI 10.1016/j.neurobiolaging.2015.01.005; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Putaala J, 2011, NEUROLOGY, V76, P1742, DOI 10.1212/WNL.0b013e31821a44ad; Rundek T, 2017, NEUROLOGY, V88, P2036, DOI 10.1212/WNL.0000000000003951; Russo C, 2013, CIRCULATION, V128, P1105, DOI 10.1161/CIRCULATIONAHA.113.001984; Song TJ, 2016, J STROKE, V18, P312, DOI 10.5853/jos.2016.00171; Spilt A, 2006, AM J NEURORADIOL, V27, P1964; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Yakushiji Y, 2014, NEUROLOGY, V83, P2116, DOI 10.1212/WNL.0000000000001054	22	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189611	10.1371/journal.pone.0189611	http://dx.doi.org/10.1371/journal.pone.0189611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232701	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200061
J	Cheong, HSJ; VanBerkum, MFA				Cheong, Han S. J.; VanBerkum, Mark F. A.			Long disordered regions of the C-terminal domain of Abelson tyrosine kinase have specific and additive functions in regulation and axon localization	PLOS ONE			English	Article							ACTIN-BINDING DOMAINS; F-ACTIN; STRUCTURAL BASIS; PROTEIN-PROTEIN; EVOLUTIONARY CONSERVATION; INTRINSIC DISORDER; FLEXIBLE NETS; ABL PROTEIN; WEB SERVER; IDENTIFICATION	Abelson tyrosine kinase (Abl) is a key regulator of actin-related morphogenetic processes including axon guidance, where it functions downstream of several guidance receptors. While the long C-terminal domain (CTD) of Abl is required for function, its role is poorly understood. Here, a battery of mutants of Drosophila Abl was created that systematically deleted large segments of the CTD from Abl or added them back to the N-terminus alone. The functionality of these Abl transgenes was assessed through rescue of axon guidance defects and adult lethality in Abl loss-of-function, as well as through gain-of-function effects in sensitized slit or frazzled backgrounds that perturb midline guidance in the Drosophila embryonic nerve cord. Two regions of the CTD play important and distinct roles, but additive effects for other regions were also detected. The first quarter of the CTD, including a conserved PxxP motif and its surrounding sequence, regulates Abl function while the third quarter localizes Abl to axons. These regions feature long stretches of intrinsically disordered sequence typically found in hub proteins and are associated with diverse protein-protein interactions. Thus, the CTD of Abl appears to use these disordered regions to establish a variety of different signaling complexes required during formation of axon tracts.	[Cheong, Han S. J.; VanBerkum, Mark F. A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	VanBerkum, MFA (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mvb@wayne.edu		Cheong, Han/0000-0001-5233-3438; VanBerkum, Mark/0000-0003-1431-357X	National Science Foundation [IOS 1121025]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (http://www.nsf.gov/) (IOS 1121025) to MVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002560; Andresen C, 2012, NUCLEIC ACIDS RES, V40, P6353, DOI 10.1093/nar/gks263; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Antoku S, 2008, J CELL SCI, V121, P3071, DOI 10.1242/jcs.031575; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BENNETT RL, 1992, DEVELOPMENT, V116, P953; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Cameron C., 2005, MICROECONOMETRICS US, P1056; Campus-Ortega J. A., 1985, STAGES DROSOPHILA EM, P9; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Comer AR, 1998, MOL CELL BIOL, V18, P152, DOI 10.1128/MCB.18.1.152; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dorsten JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009822; Dosztanyi Z, 2005, FEBS J, V272, P360; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Fox J., 2019, R COMPANION APPL REG, V.; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grevengoed EE, 2003, J CELL BIOL, V163, P1267, DOI 10.1083/jcb.200307026; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Hantschel O, 2005, MOL CELL, V19, P461, DOI 10.1016/j.molcel.2005.06.030; Hartig F., DHARMA RESIDUAL DIAG; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Ibarra N, 2005, BIOCHEM SOC T, V33, P1243, DOI 10.1042/BST0331243; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kannan R, 2017, FLY AUSTIN; Kannan R, 2017, DEVELOPMENT, V144, P487, DOI 10.1242/dev.143776; Kannan R, 2014, MOL BIOL CELL, V25, P2993, DOI 10.1091/mbc.E14-02-0729; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Mahani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075057; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miao YJ, 1996, J BIOL CHEM, V271, P22823, DOI 10.1074/jbc.271.37.22823; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Moresco EMY, 2003, CURR OPIN NEUROBIOL, V13, P535, DOI 10.1016/j.conb.2003.08.002; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; O'Donnell MP, 2013, DEVELOPMENT, V140, P2724, DOI 10.1242/dev.093831; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Reichman C, 2005, ONCOGENE, V24, P8187, DOI 10.1038/sj.onc.1208988; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rogers EM, 2016, MOL BIOL CELL, V27, P2613, DOI 10.1091/mbc.E16-05-0292; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JK, 2010, DEVELOPMENT, V137, P3719, DOI 10.1242/dev.050948; Sterne GR, 2015, ELIFE, V4, DOI 10.7554/eLife.05196; Stevens TL, 2008, MOL BIOL CELL, V19, P378, DOI 10.1091/mbc.E07-01-0008; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Venables WN., 2002, MODERN APPL STAT S 4; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Xiong WJ, 2013, DEVELOPMENT, V140, P176, DOI 10.1242/dev.088799; Xiong WJ, 2011, DEV DYNAM, V240, P1745, DOI 10.1002/dvdy.22674; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zulueta-Coarasa T, 2014, DEVELOPMENT, V141, P2901, DOI 10.1242/dev.106898	108	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189338	10.1371/journal.pone.0189338	http://dx.doi.org/10.1371/journal.pone.0189338			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232713	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200031
J	Perugini, V; Meikle, ST; Guildford, AL; Santin, M				Perugini, Valeria; Meikle, Steve T.; Guildford, Anna L.; Santin, Matteo			Hyperbranched poly(is an element of-lysine) substrate presenting the laminin sequence YIGSR induces the formation of spheroids in adult bone marrow stem cells	PLOS ONE			English	Article							IN-VITRO; DIFFERENTIATION; NANOSCALE; ADHESION; MICROENVIRONMENT; MIGRATION; SURFACES; INTEGRINS; EXPANSION; INTERPLAY	Unlike the fibroblast-like cells formed upon monolayer culture of human mesenchymal stem cells, the natural stem cell niche of the bone marrow and other types of tissues favours the formation of 3-dimensional (3D) cell clusters. The structuring and biological activity of these clusters are regulated by the contacts established by cells with both the basement membrane and neighbour cells and results in their asymmetric division and the consequent maintenance of both a stem population and a committed progeny. The present work demonstrates the potential of a synthetic substrate to mimic the stem cell niche in vitro. The side amino groups of a linear Poly-L-lysine were modified with hyperbranched poly-(beta-lysine) peptides, named as dendrons, tethered with the laminin-mimicking sequence, YIGSR. These dendrons presented the YIGSR sequence at the uppermost molecular branching ensuring a controlled spacing of the bioligand. When used to coat the surface of tissue culture plates in a serumfree in vitro cell culture system, the substrate was able to mimic the most relevant features of the basement membrane of the stem cell niche, i.e. the mesh structure of Collagen Type IV and the availability of laminin bioligands relevant to integrin biorecognition. The substrate biomimetic properties were tested for their ability to support the formation of human bone marrow mesenchymal stem cells (hMSCs) 3D spheroids similar to those observed in the natural stem cell niches and their ability to maintain stem cell pluripotency markers. These features were related to the substrate-specific expression and localisation of (i) cell adhesion receptors (i.e.beta-integrin and N-cadherin), (ii) transcription factors of pluripotency markers and cytoskeleton protein and (iii) regulators of cell migration throughout cell culture passages 2 to 4. The results clearly demonstrate the formation of 3D spheroids starting from the asymmetric division of substrate-adhering spread cells, the clustering of relevant integrins and the expression of specific intracellular pathways controlling cytoskeleton formation suggesting their potential use as a substrate for the handling of stem cells prior to transplantation procedures.	[Perugini, Valeria; Meikle, Steve T.; Guildford, Anna L.; Santin, Matteo] Univ Brighton, Ctr Regenerat Med & Devices, Sch Pharm & Biomol Sci, Brighton, E Sussex, England	University of Brighton	Santin, M (corresponding author), Univ Brighton, Ctr Regenerat Med & Devices, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	m.santin@brighton.ac.uk		Santin, Matteo/0000-0002-5260-7088; Meikle, Steven/0000-0002-3846-5001	European Commission Grant under Framework Programme 7	European Commission Grant under Framework Programme 7	The authors received support from a European Commission Grant under Framework Programme 7.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Augello A, 2010, EUR CELLS MATER, V20, P121; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Bhakta S, 2006, CARDIOVASC REVASCULA, V7, P19, DOI 10.1016/j.carrev.2005.10.008; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chinga-Carrasco G, 2008, J MICROSC-OXFORD, V232, P212, DOI 10.1111/j.1365-2818.2008.02092.x; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Davis HE, 2009, J BIOMED MATER RES A, V90A, P1021, DOI 10.1002/jbm.a.32169; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Heo JS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8196078; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Janson IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090719; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jung S, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/123030; Khattak M, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5507-2; Lampe KJ, 2012, NEUROSCI LETT, V519, P138, DOI 10.1016/j.neulet.2012.01.042; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Leatherman Judith, 2013, Frontiers in Genetics, V4, P257, DOI 10.3389/fgene.2013.00257; Liras A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-131; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]; Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055; Matic Igor, 2016, Open Access Maced J Med Sci, V4, P9, DOI 10.3889/oamjms.2016.008; MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Meikle ST, 2011, MACROMOL BIOSCI, V11, P1761, DOI 10.1002/mabi.201100267; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; MonierGavelle F, 1997, J CELL BIOL, V137, P1663, DOI 10.1083/jcb.137.7.1663; Murtuza B, 2009, TISSUE ENG PART B-RE, V15, P443, DOI [10.1089/ten.teb.2009.0006, 10.1089/ten.TEB.2009.0006]; O'Reilly AM, 2008, J CELL BIOL, V182, P801, DOI 10.1083/jcb.200710141; Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207; Pattabhi SR, 2014, DIFFERENTIATION, V88, P131, DOI 10.1016/j.diff.2014.12.005; Preston SL, 2003, J CLIN PATHOL-MOL PA, V56, P86, DOI 10.1136/mp.56.2.86; Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]; Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013; Rao Shreyas S, 2009, Front Neuroeng, V2, P6, DOI 10.3389/neuro.16.006.2009; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R; Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Thrivikraman G, 2015, ACS APPL MATER INTER, V7, P23015, DOI 10.1021/acsami.5b06390; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153; Yim EKF, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt132; Zhang D, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0347-7	53	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0187182	10.1371/journal.pone.0187182	http://dx.doi.org/10.1371/journal.pone.0187182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232694	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200001
J	Bach, A; Aris, A; Guasch, I				Bach, Alex; Aris, Anna; Guasch, Isabel			Consequences of supplying methyl donors during pregnancy on the methylome of the offspring from lactating and non-lactating dairy cattle	PLOS ONE			English	Article							FOLIC-ACID; INSULIN-RESISTANCE; GENE-EXPRESSION; DNA METHYLATION; VITAMIN-B-12; PERFORMANCE; METABOLISM; METHIONINE; SUPPLEMENTATION; REPRODUCTION	The aim of this study was to evaluate the potential effects of methyl donor supplementation of pregnant animals in the presence or absence of a concomitant lactation on the methylome of the offspring. Twenty Holstein cows, 10 nulliparous (non-lactating while pregnant) and 10 multiparous (lactating while pregnant) were blocked by parity and randomly assigned to an i.m. weekly injections of a placebo (CTRL) or a solution containing methyl donors (MET). After calving, 5 calves randomly selected from each treatment (two born to non-lactating and three to lactating dams) were blood-sampled to determine their full methylome. There were more than 2,000 CpG differentially methylated between calves born to CTRL and those born to MET, and also between calves born to lactating and non-lactating dams. Most of the differences affected genes involved in immune function, cell growth regulation and differentiation, kinase activity, and ion channeling. We conclude that the coexistence of pregnancy and lactation affects the methylome of the offspring, and that supplementation of methyl donors early in gestation has also consequences on the methylome.	[Bach, Alex] ICREA, Barcelona, Spain; [Bach, Alex; Aris, Anna] IRTA, Dept Ruminant Prod, Caldes De Montbui, Spain	ICREA; IRTA	Bach, A (corresponding author), ICREA, Barcelona, Spain.; Bach, A (corresponding author), IRTA, Dept Ruminant Prod, Caldes De Montbui, Spain.	alex.bach@icrea.cat	Arís, Anna/AAB-2512-2019	Arís, Anna/0000-0001-7830-888X; Bach, Alex/0000-0001-6804-2002	Spanish Ministry of Economics, Industry, and Competitiveness [AGL201-238292]; CERCA Program (Generalitat de Catalunya); European Social Fund	Spanish Ministry of Economics, Industry, and Competitiveness; CERCA Program (Generalitat de Catalunya); European Social Fund(European Social Fund (ESF))	This research was partially funded by Spanish Ministry of Economics, Industry, and Competitiveness through the grant AGL201-238292. We are also indebted to CERCA Program (Generalitat de Catalunya) and European Social Fund for supporting our research.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; [Anonymous], 2014, LANG ENV STAT COMP; Ashworth CJ, 2001, REPRODUCTION, V122, P527, DOI 10.1530/rep.0.1220527; Bach A, 2012, J ANIM SCI, V90, P1835, DOI 10.2527/jas.2011-4516; Duplessis M, 2017, J DAIRY SCI, V100, P4051, DOI 10.3168/jds.2016-12381; Duplessis M, 2014, J DAIRY SCI, V97, P2346, DOI 10.3168/jds.2013-7369; Dwarkanath P, 2013, AM J CLIN NUTR, V98, P1450, DOI 10.3945/ajcn.112.056382; Erdman R. A., 1992, LARGE DAIRY HERD MAN, P297; Gagnon A, 2015, J DAIRY SCI, V98, P7797, DOI 10.3168/jds.2015-9623; Geraghty A, P NUTR SOC, V2916, pE131; Girard CL, 1998, J DAIRY SCI, V81, P1412, DOI 10.3168/jds.S0022-0302(98)75705-4; GIRARD CL, 1995, J DAIRY SCI, V78, P404, DOI 10.3168/jds.S0022-0302(95)76649-8; Gonzalez-Recio O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051816; Krishnaveni GV, 2014, DIABETOLOGIA, V57, P110, DOI 10.1007/s00125-013-3086-7; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kumar KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112991; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Moghadam H, 2015, J MAR SCI ENG, V3, P175, DOI 10.3390/jmse3020175; National Research Council, 2001, NUTR REQ DAIR CATTL, P184; Parle-McDermott A, 2011, ADV NUTR, V2, P463, DOI 10.3945/an.111.001008; Preynat A, 2009, J DAIRY SCI, V92, P677, DOI 10.3168/jds.2008-1525; Preynat A, 2010, J DAIRY SCI, V93, P2130, DOI 10.3168/jds.2009-2796; Simmer F, 2012, EPIGENETICS-US, V7, P1355, DOI 10.4161/epi.22562; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yunta C, 2015, LIVEST SCI, V181, P249, DOI 10.1016/j.livsci.2015.09.008	27	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189581	10.1371/journal.pone.0189581	http://dx.doi.org/10.1371/journal.pone.0189581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228040	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600062
J	Dorta-Estremera, S; Nehete, PN; Yang, GJ; He, H; Nehete, BP; Shelton, KK; Barry, MA; Sastry, KJ				Dorta-Estremera, Stephanie; Nehete, Pramod N.; Yang, Guojun; He, Hong; Nehete, Bharti P.; Shelton, Kathryn K.; Barry, Michael A.; Sastry, K. Jagannadha			Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques	PLOS ONE			English	Article							HIV; TRANSMISSION; IMMUNITY; TRIAL; STEP	Studies in nonhuman primates (NHP) for prospective immune cell monitoring subsequent to infection and/or vaccination usually rely on periodic sampling of the blood samples with only occasional collections of biopsies from mucosal tissues because of safety concerns and practical constraints. Here we present evidence in support of cytobrush sampling of oral, rectal, and genital mucosal tissues as a minimally invasive approach for the phenotypic analyses of different T cells subsets de novo as well as prospectively after intranasal immunization in rhesus macaques. Significant percentages of viable lymphocytes were obtained consistently from both naive and chronically SIV-infected rhesus macaques. The percentages of CD3+ T cells in the blood were significantly higher compared to those in the mucosal tissues analyzed in the naive animals, while in the SIV+ animals the CD3+ T cells were significantly elevated in the rectal tissues, relative to all other sites analyzed. In the naive, but not SIV+ macaques, the rectal and vaginal mucosal tissues, compared to oral mucosa and blood, showed higher diversity and percentages of CD4+ T cells expressing the HIV entry co-receptor CCR5 and mucosal specific adhesion (CD103) as well as activation (HLA-DR) and proliferation (Ki67) markers. Sequential daily cytobrush sampling from the oral, rectal, and genital mucosal tissues was performed in SIV+ animals from an ongoing study where they were administered intranasal immunization with adenoviral vectored vaccines incorporating the green fluorescent protein (GFP) reporter gene. We detected a transient increase in GFP+ CD4 T cells in only oral mucosa suggesting limited mucosal trafficking. In general, CD4+ and CD8+ T cells expressing Ki67 transiently increased in all mucosal tissues, but those expressing the CCR5, HLA-DR, and CD103 markers exhibited minor changes. We propose the minimally invasive cytobrush sampling as a practical approach for effective and prospective immune monitoring of the oral-genital mucosal tissues in NHP.	[Dorta-Estremera, Stephanie; Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Nehete, Pramod N.; Nehete, Bharti P.; Shelton, Kathryn K.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA; [Nehete, Pramod N.; Sastry, K. Jagannadha] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77004 USA; [He, Hong] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Barry, Michael A.] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Translat Immunol Virol & Biodef Program, Rochester, MN USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sastry, KJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sastry, KJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA.; Sastry, KJ (corresponding author), Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77004 USA.	jsastry@mdanderson.org		Nehete, Pramod/0000-0002-2815-2677; Sastry, Jagannadha/0000-0002-6987-4422; Dorta-Estremera, Stephanie/0000-0003-4440-6806	NIH [R01 A1096967, R01 CM 36945]; Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D., at Mayo Clinic; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA136945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D., at Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 A1096967 and R01 CM 36945 and the Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D., at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants R01 AI096967 and R01 CA136945 and the Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic. We would like to thank Mary Barry for excellent technical assistance.	Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burgener A, 2015, CURR OPIN IMMUNOL, V36, P22, DOI 10.1016/j.coi.2015.06.004; Byrareddy SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075556; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Gomez-Roman Victor Raul, 2003, AIDS Reviews, V5, P178; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hasselrot K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047570; Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X; Huot N, 2016, CURR OPIN VIROL, V19, P37, DOI 10.1016/j.coviro.2016.06.011; Juno JA, 2014, JOVE-J VIS EXP, DOI 10.3791/51906; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; McKinnon LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085675; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Shaw GM, 2012, COLD SPRING HARB PER, V2; Singh Shailbala, 2014, Methods Mol Biol, V1184, P417, DOI 10.1007/978-1-4939-1115-8_24; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Weaver EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067574; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	20	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188807	10.1371/journal.pone.0188807	http://dx.doi.org/10.1371/journal.pone.0188807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220358	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900018
J	Oh, SH; Kim, DK; Lee, SU; Jung, SH; Lee, SY				Oh, Sang-Ho; Kim, Don-Kyu; Lee, Shi-Uk; Jung, Se Hee; Lee, Sang Yoon			Association between exercise type and quality of life in a community-dwelling older people: A cross-sectional study	PLOS ONE			English	Article							FRAIL ELDERLY-PEOPLE; PHYSICAL-ACTIVITY; WATER EXERCISE; HEALTH; EUROQOL; EQ-5D; PREVENTION; PROGRAM; INTERVENTION; POPULATION	Objectives This study aimed to investigate the effects of three major representative exercises (resistance, flexibility, and walking) on quality of life (QoL) in a population of community-dwelling older adults. Materials and methods This cross-sectional study used public data from the Sixth Korean National Health and Nutrition Examination Survey in 2014 (n = 1,586 older people). Demographic factors, three types of exercise, five EuroQoL subsets (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), and QoL scores (EQ-VAS) were investigated. The independent associations between each exercise and the five QoL subsets were determined using odds ratios (OR) adjusted for three demographic factors (age group, sex, and area of residence), using multivariate logistic regression analysis. Results The EQ-VAS scores of the exercisers was significantly higher than those of the non-exercisers for all exercise types. Subjects with problems in mobility dimension performed less exercise of all types of than those with normal mobility (resistance: OR, 0.687; flexibility: OR, 0.733, and walking: OR, 0.489). The self-care dimension was independently correlated with flexibility (OR, 0.558) and walking (OR, 0.485). Conclusion All types of exercisers showed higher QoL scores than non-exercisers. Among the QoL dimensions, mobility and self-care were independently associated with flexibility and walking exercise in this older people, suggesting that engaging in regular flexibility and walking exercise is important for achieving higher QoL in the older people.	[Oh, Sang-Ho; Kim, Don-Kyu] Chung Ang Univ, Dept Phys Med & Rehabil, Coll Med, Seoul, South Korea; [Lee, Shi-Uk; Jung, Se Hee; Lee, Sang Yoon] Seoul Natl Univ, Dept Rehabil Med, Boramae Med Ctr, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Lee, SY (corresponding author), Seoul Natl Univ, Dept Rehabil Med, Boramae Med Ctr, Seoul, South Korea.	rehabilee@gmail.com	Lee, Sang Yoon/AAD-5045-2019	Lee, Sang Yoon/0000-0002-2906-3094; Jung, Se Hee/0000-0002-0623-8752				Bigley AB, 2013, MATURITAS, V76, P51, DOI 10.1016/j.maturitas.2013.06.010; Bullo V, 2018, REJUV RES, V21, P141, DOI 10.1089/rej.2017.1921; Chen CH, 2014, KAOHSIUNG J MED SCI, V30, P521, DOI 10.1016/j.kjms.2014.08.004; Cheung PWH, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0083-x; Dechamps A, 2010, ARCH INTERN MED, V170, P162, DOI 10.1001/archinternmed.2009.489; Eaglehouse YL, 2016, QUAL LIFE RES, V25, P1903, DOI 10.1007/s11136-016-1240-7; Fielding RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182155; Fortuno-Godes J, 2013, CURR GERONTOL GERIAT, V2013, DOI DOI 10.1155/2013/168482; Franco-Martin M, 2013, REV NEUROLOGIA, V56, P545, DOI 10.33588/rn.5611.2012570; Hagins Marshall, 2007, BMC Complement Altern Med, V7, P40, DOI 10.1186/1472-6882-7-40; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hatswell AJ, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0091-9; Heesch KC, 2016, PREV MED, V91, P299, DOI 10.1016/j.ypmed.2016.09.012; Horder H, 2013, QUAL LIFE RES, V22, P1213, DOI 10.1007/s11136-012-0267-7; Huppertz-Hauss G, 2016, GASTROENT RES PRACT, V2016; Janyacharoen T, 2017, J SPORT MED PHYS FIT, V57, P1344, DOI 10.23736/S0022-4707.16.06439-2; Katz P, 2001, J AM GERIATR SOC, V49, P808; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; Kim SH, 2012, SUPPORT CARE CANCER, V20, P3155, DOI 10.1007/s00520-012-1457-0; Kim SH, 2015, IEEE T COMP PACK MAN, V5, P3, DOI 10.1109/TCPMT.2014.2369053; King JT, 2009, NEUROSURGERY, V65, P565, DOI 10.1227/01.NEU.0000350980.01519.D8; Lattari Eduardo, 2014, Clin Pract Epidemiol Ment Health, V10, P126, DOI 10.2174/1745017901410010126; Neto GAM, 2015, CNS NEUROL DISORD-DR, V14, P1152, DOI 10.2174/1871527315666151111130045; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Mura Gioia, 2014, Clin Pract Epidemiol Ment Health, V10, P36, DOI 10.2174/1745017901410010036; Noradechanunt C, 2017, J SCI MED SPORT, V20, P494, DOI 10.1016/j.jsams.2016.10.007; Park SY, 2015, J PHYS THER SCI, V27, P2061, DOI 10.1589/jpts.27.2061; Park SW, 2012, UROLOGY, V80, P299, DOI 10.1016/j.urology.2011.12.060; Park Y, 2016, J PHYS THER SCI, V28, P190, DOI [10.1589/jpts.28.190, 10.1589/jpts.28.1904]; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pihl E, 2011, EUR J CARDIOVASC NUR, V10, P150, DOI 10.1016/j.ejcnurse.2011.03.002; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rugbeer Nivash, 2017, Pan Afr Med J, V26, P35, DOI 10.11604/pamj.2017.26.35.10518; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Sato D, 2009, DISABIL REHABIL, V31, P84, DOI 10.1080/09638280701817552; Savoia E, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-47; Schoenfeld BJ, 2016, SPORTS MED, V46, P1689, DOI 10.1007/s40279-016-0543-8; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2001, MEN AG HLTH	42	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188335	10.1371/journal.pone.0188335	http://dx.doi.org/10.1371/journal.pone.0188335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216283	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800020
J	Saade, S; Kutlu, B; Draba, V; Forster, K; Schumann, E; Tester, M; Pillen, K; Maurer, A				Saade, Stephanie; Kutlu, Burcu; Draba, Vera; Forster, Karin; Schumann, Erika; Tester, Mark; Pillen, Klaus; Maurer, Andreas			A donor-specific QTL, exhibiting allelic variation for leaf sheath hairiness in a nested association mapping population, is located on barley chromosome 4H	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; SERINE-PROTEASE; FLOWERING TIME; RNA-BINDING; GENE; HOMOLOG; GROWTH; RECOMBINANT; RESISTANCE; PUBESCENCE	Leaf sheath hairiness is a morphological trait associated with various advantages, including tolerance to both abiotic and biotic stresses, thereby increasing yield. Understanding the genetic basis of this trait in barley can therefore improve the agronomic performance of this economically important crop. We scored leaf sheath hairiness in a two-year field trial in 1,420 BC1S3 lines from the wild barley nested association mapping (NAM) population HEB-25. Leaf sheath hairiness segregated in six out of 25 families with the reference parent Barke being glabrous. We detected the major hairy leaf sheath locus Hs (syn. Hsh) on chromosome 4H (111.3 cM) with high precision. The effects of the locus varied across the six different wild barley donors, with donor of HEB family 11 conferring the highest score of leaf sheath hairiness. Due to the high mapping resolution present in HEB-25, we were able to discuss physically linked pentatricopeptide repeat genes and subtilisin-like proteases as potential candidate genes underlying this locus. In this study, we proved that HEB-25 provides an appropriate tool to further understand the genetic control of leaf sheath hairiness in barley. Furthermore, our work represents a perfect starting position to clone the gene responsible for the 4H locus observed.	[Saade, Stephanie; Tester, Mark] KAUST, BESE, Thuwal, Saudi Arabia; [Kutlu, Burcu] Ege Univ, Dept Biotechnol, Erzene, Bornova Izmir, Turkey; [Draba, Vera; Schumann, Erika; Pillen, Klaus; Maurer, Andreas] Martin Luther Univ Halle Wittenberg, Dept Plant Breeding, Inst Agr & Nutr Sci, Halle, Germany; [Forster, Karin] Martin Luther Univ Halle Wittenberg, Dept Agron & Organ Farming, Inst Agr & Nutr Sci, Halle, Germany	King Abdullah University of Science & Technology; Ege University; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Maurer, A (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Plant Breeding, Inst Agr & Nutr Sci, Halle, Germany.	andreas.maurer@landw.uni-halle.de	Pillen, Klaus/I-6511-2012; Tester, Mark/J-2368-2017	Pillen, Klaus/0000-0003-4646-6351; Maurer, Andreas/0000-0002-2916-7475; Tester, Mark/0000-0002-5085-8801; saade, stephanie/0000-0003-3817-7234	German Research Foundation (DFG) [Pi339/7-1, Pi339/8-1]; Interdisciplinary Centre for Crop Plant Research (IZN), Halle; King Abdullah University of Science and Technology (KAUST); Ege University Erasmus Programme	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Crop Plant Research (IZN), Halle; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Ege University Erasmus Programme	This project was funded by German Research Foundation (DFG) via Grants Pi339/7-1 and Pi339/8-1 (AM): http://www.dfg.de/; Interdisciplinary Centre for Crop Plant Research (IZN), Halle (VD): http://www.uni-halle.de/izn/; King Abdullah University of Science and Technology (KAUST) (SS): https://www./kaust.edu.sa/en; Ege University Erasmus Programme (BK): http://ebys. ege.edu.tr/ogrenci/ebp/llp-erasmus.htm.	Alqudah AM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00896; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Berger D, 2000, GENE DEV, V14, P1119; Cantalapiedra CP, 2015, MOL BREEDING, V35; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Dobrovolskaya O, 2007, EUPHYTICA, V155, P285, DOI 10.1007/s10681-006-9329-7; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; GRACE J, 1977, J EXP BOT, V28, P268, DOI 10.1093/jxb/28.2.268; Graham J, 2006, THEOR APPL GENET, V112, P818, DOI 10.1007/s00122-005-0184-z; Gutierrez-Marcos JF, 2007, PLANT CELL, V19, P196, DOI 10.1105/tpc.105.039594; Hameed M., 2002, International Journal of Agriculture and Biology, V4, P12; HOLM S, 1979, SCAND J STAT, V6, P65; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Jost M, 2016, PLANT PHYSIOL, V171, P1113, DOI 10.1104/pp.16.00124; Kim HJ, 2011, THEOR APPL GENET, V122, P1051, DOI 10.1007/s00122-010-1510-7; Korzun V, 1999, GENOME, V42, P960, DOI 10.1139/gen-42-5-960; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00037; Liu J, 2006, PLANT CELL PHYSIOL, V47, P1274, DOI 10.1093/pcp/pcj097; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Luo M, 2009, INT J MOL SCI, V10, P1896, DOI 10.3390/ijms10041896; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Marks MD, 1997, ANNU REV PLANT PHYS, V48, P137, DOI 10.1146/annurev.arplant.48.1.137; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mascher M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r78; Maurer A, 2017, HEREDITY, V118, P477, DOI 10.1038/hdy.2016.121; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Nakamura T, 2004, BIOCHEM SOC T, V32, P571, DOI 10.1042/BST0320571; PATTERSON FRED L., 1957, AGRON JOUR, V49, P218; Pickering RA, 1997, GENOME, V40, P195, DOI 10.1139/g97-028; Reif JC, 2010, THEOR APPL GENET, V121, P1489, DOI 10.1007/s00122-010-1405-7; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Spyropoulou EA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-402; Taketa S, 1997, GENES GENET SYST, V72, P101, DOI 10.1266/ggs.72.101; Tanaka H, 2001, DEVELOPMENT, V128, P4681; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165.V1]; Utz HF, 2000, GENETICS, V154, P1839; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Wan HS, 2015, EUPHYTICA, V205, P275, DOI 10.1007/s10681-015-1457-5; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wang SC, 2008, PLANT CELL PHYSIOL, V49, P1792, DOI 10.1093/pcp/pcn159; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Zeng YH, 2013, CHINESE SCI BULL, V58, P2992, DOI 10.1007/s11434-013-5737-y	54	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189446	10.1371/journal.pone.0189446	http://dx.doi.org/10.1371/journal.pone.0189446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216333	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800123
J	Yang, CP; Hsieh, ML; Chiang, JH; Chang, HY; Hsieh, VCR				Yang, Chun-Pai; Hsieh, Meng-Lun; Chiang, Jen-Huai; Chang, Hsing-Yi; Hsieh, Vivian Chia-Rong			Migraine and risk of narcolepsy in children: A nationwide longitudinal study	PLOS ONE			English	Article							INCREASED FREQUENCY; DISORDERS; HEADACHE; NEURONS; TAIWAN; SLEEP	Background The association between migraine and narcolepsy remains controversial. We aim to investigate whether migraine is associated with an increased risk of developing narcolepsy in children. Methods In this longitudinal study, nationwide medical-claims data of pediatric patients (0-17y) with migraine are identified using the National Health Insurance Research Database (NHIRD) between 1997 and 2010 in Taiwan. Two cohorts are selected: migraine cases (n = 8,923) and propensity score-matched non-migraine controls (n = 35,692). Children with previous history of narcolepsy or headache before the index date are excluded. Cohorts are followed until the end of 2012, their withdrawal from the NHI program, or incidence of narcolepsy (ICD-9-CM: 347). Cox proportional hazards regression models are used to estimate hazard ratios (HRs) and 95% confidence intervals of developing narcolepsy in children with migraine compared to their non-migraine controls. Results A total of 13 incident cases with narcolepsy are observed during follow-up, with incidence rates of 0.1915 and 0.0278 per 1,000 person-years in migraine and non-migraine children, respectively. After a mean follow-up period of 4.68 and 5.04 years in the case and control cohort, respectively, the former exhibited a greater risk of developing narcolepsy compared to the latter (adjusted hazard ratio (aHR) = 5.30, 95% confidence interval (CI): 1.61, 17.4; p = 0.006). This finding persisted after controlling for potential confounders like baseline comorbidities and concurrent medication uptake, and in our analyses with migraine subtypes. Conclusions Migraine is an independent risk factor for narcolepsy development in children. Further studies are needed to validate our findings and to explore the exact pathophysiological mechanisms linking migraine and narcolepsy.	[Yang, Chun-Pai] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Chun-Pai] Huang Kuang Univ, Dept Nutr, Taichung, Taiwan; [Hsieh, Meng-Lun] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan; [Hsieh, Meng-Lun] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Chiang, Jen-Huai] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chiang, Jen-Huai] China Med Univ, Coll Med, Taichung, Taiwan; [Chang, Hsing-Yi] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Hsieh, Vivian Chia-Rong] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan	Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Hsieh, VCR (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan.	hsiehchiarong@gmail.com		Hsieh, Vivian Chia-Rong/0000-0001-9635-0897	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW106-TDU-B-212-113004]; Bureau of Health Promotion, Department of Health, Taiwan [D0H99-HP-1205]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial Center; Bureau of Health Promotion, Department of Health, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), Bureau of Health Promotion, Department of Health, Taiwan (D0H99-HP-1205), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), Bureau of Health Promotion, Department of Health, Taiwan (DOH99-HP-1205), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Cevoli S, 2012, NEUROL SCI, V33, pS43, DOI 10.1007/s10072-012-1030-0; CHALLAMEL MJ, 1994, SLEEP, V17, pS17, DOI 10.1093/sleep/17.suppl_8.S17; Dahmen N, 1999, NEUROLOGY, V52, P1291, DOI 10.1212/WNL.52.6.1291; Dahmen N, 2003, CEPHALALGIA, V23, P14, DOI 10.1046/j.1468-2982.2003.00343.x; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Evers S, 2003, CEPHALALGIA, V23, P786, DOI 10.1046/j.1468-2982.2003.00594.x; Evers S, 2010, HEADACHE, V50, P1246, DOI 10.1111/j.1526-4610.2010.01730.x; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2012, ANN INDIAN ACAD NEUR, V15, P15, DOI 10.4103/0972-2327.99993; Holland PR, 2009, CEPHALALGIA, V29, P1, DOI 10.1111/j.1468-2982.2009.02027.x; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Malick A, 2000, J NEUROPHYSIOL, V84, P2078, DOI 10.1152/jn.2000.84.4.2078; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wang SJ, 2008, J FORMOS MED ASSOC, V107, P485, DOI 10.1016/S0929-6646(08)60157-6; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	17	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189231	10.1371/journal.pone.0189231	http://dx.doi.org/10.1371/journal.pone.0189231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216286	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800102
J	Cao, JY; Lu, KH; Powley, TL; Liu, ZM				Cao, Jiayue; Lu, Kun-Han; Powley, Terry L.; Liu, Zhongming			Vagal nerve stimulation triggers widespread responses and alters large-scale functional connectivity in the rat brain	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; ANTERIOR CINGULATE CORTEX; CEREBRAL-BLOOD-FLOW; LOCUS-COERULEUS; FMRI; BOLD; MRI; VNS; EFFICACY; MODEL	Vagus nerve stimulation (VNS) is a therapy for epilepsy and depression. However, its efficacy varies and its mechanism remains unclear. Prior studies have used functional magnetic resonance imaging (fMRI) to map brain activations with VNS in human brains, but have reported inconsistent findings. The source of inconsistency is likely attributable to the complex temporal characteristics of VNS-evoked fMRI responses that cannot be fully explained by simplified response models in the conventional model-based analysis for activation mapping. To address this issue, we acquired 7-Tesla blood oxygenation level dependent fMRI data from anesthetized Sprague +/- Dawley rats receiving electrical stimulation at the left cervical vagus nerve. Using spatially independent component analysis, we identified 20 functional brain networks and detected the network-wise activations with VNS in a datadriven manner. Our results showed that VNS activated 15 out of 20 brain networks, and the activated regions covered > 76% of the brain volume. The time course of the evoked response was complex and distinct across regions and networks. In addition, VNS altered the strengths and patterns of correlations among brain networks relative to those in the resting state. The most notable changes in network-network interactions were related to the limbic system. Together, such profound and widespread effects of VNS may underlie its unique potential for a wide range of therapeutics to relieve central or peripheral conditions.	[Cao, Jiayue; Powley, Terry L.; Liu, Zhongming] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cao, Jiayue; Lu, Kun-Han; Powley, Terry L.; Liu, Zhongming] Purdue Univ, Purdue Inst Integrat Neuroscience, W Lafayette, IN 47907 USA; [Lu, Kun-Han; Liu, Zhongming] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Powley, Terry L.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liu, ZM (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Liu, ZM (corresponding author), Purdue Univ, Purdue Inst Integrat Neuroscience, W Lafayette, IN 47907 USA.; Liu, ZM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	zmliu@purdue.edu		Cao, Jiayue/0000-0002-9040-1929; Liu, Zhongming/0000-0002-8773-4204	National Institutes of Health: Office of the Director [OT2TR001965]; National Institutes of Health: National Institute of Mental Health [R01MH104402]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104402] Funding Source: NIH RePORTER	National Institutes of Health: Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by the National Institutes of Health: Office of the Director, OT2TR001965 (to TL Powley), National Institute of Mental Health, R01MH104402 (to Z Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Elizabeth Baronowsky and Dr. Matthew Ward for their initial assistance in animal surgery. This work is supported by the National Institutes of Health: Office of the Director, OT2TR001965 (to TL Powley), National Institute of Mental Health, R01MH104402 (to Z Liu).	Anastassiou CA, 2016, PSYCHE SIGNALS SYSTE, P107; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bartolomei F, 2016, EPILEPSY RES, V126, P141, DOI 10.1016/j.eplepsyres.2016.06.008; Beaumont E, 2017, AMERICAN JOURNAL OF; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodenlos JS, 2007, APPETITE, V48, P145, DOI 10.1016/j.appet.2006.07.080; Bohning DE, 2001, INVEST RADIOL, V36, P470, DOI 10.1097/00004424-200108000-00006; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chae JH, 2003, J PSYCHIATR RES, V37, P443, DOI 10.1016/S0022-3956(03)00074-8; CHASE MICHAEL H., 1967, BRAIN RES, V5, P236, DOI 10.1016/0006-8993(67)90089-3; De Ridder D, 2014, NEUROMODULATION, V17, P170, DOI 10.1111/ner.12127; Devous MD, 2002, EUR PSYCHIAT, V17, p113S; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Fang JL, 2016, BIOL PSYCHIAT, V79, P266, DOI 10.1016/j.biopsych.2015.03.025; Frangos E, 2017, BRAIN STIMUL, V10, P19, DOI 10.1016/j.brs.2016.10.008; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; GARNETT ES, 1992, PACE, V15, P1579, DOI 10.1111/j.1540-8159.1992.tb02936.x; Gaskell W H, 1886, J Physiol, V7, P451; George MS, 2000, BIOL PSYCHIAT, V47, P287, DOI 10.1016/S0006-3223(99)00308-X; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Groves DA, 2005, NEUROSCI LETT, V379, P174, DOI 10.1016/j.neulet.2004.12.055; Henry TR, 1999, NEUROLOGY, V52, P1166, DOI 10.1212/WNL.52.6.1166; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Ko D, 1996, NEUROSURGERY, V39, P426, DOI 10.1097/00006123-199608000-00061; Krahl SE, 1998, EPILEPSIA, V39, P709, DOI 10.1111/j.1528-1157.1998.tb01155.x; Kraus T, 2007, J NEURAL TRANSM, V114, P1485, DOI 10.1007/s00702-007-0755-z; Kraus T, 2013, BRAIN STIMUL, V6, P798, DOI 10.1016/j.brs.2013.01.011; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Larsen LE, 2016, NEUROTHERAPEUTICS, V13, P592, DOI 10.1007/s13311-016-0432-8; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Li BW, 2010, J NEUROPHYSIOL, V104, P414, DOI 10.1152/jn.00270.2010; Liu WC, 2001, NEUROIMAGE, V13, pS810; Lomarev M, 2002, J PSYCHIATR RES, V36, P219, DOI 10.1016/S0022-3956(02)00013-4; Ma Y, 2016, P NATL ACAD SCI USA, V113, pE8463, DOI 10.1073/pnas.1525369113; Ma Z, 2016, NEUROIMAGE; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Murray BJ, 2001, NEUROLOGY, V57, P1523, DOI 10.1212/WNL.57.8.1523; Nahas Z, 2007, NEUROPSYCHOPHARMACOL, V32, P1649, DOI 10.1038/sj.npp.1301288; Nemeroff CB, 2006, NEUROPSYCHOPHARMACOL, V31, P1345, DOI 10.1038/sj.npp.1301082; Nichols JA, 2011, NEUROSCIENCE, V189, P207, DOI 10.1016/j.neuroscience.2011.05.024; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G., 2014, THE RAT NERVOUS SYST; Pena DF, 2013, BIOL PSYCHIAT, V73, P1071, DOI 10.1016/j.biopsych.2012.10.021; Renvall V, 2009, P NATL ACAD SCI USA, V106, P20510, DOI 10.1073/pnas.0911265106; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Reyt S, 2010, NEUROIMAGE, V52, P1456, DOI 10.1016/j.neuroimage.2010.05.021; Robinson GC, 1912, J EXP MED, V15, P14, DOI 10.1084/jem.15.1.14; Ruffoli R, 2011, J CHEM NEUROANAT, V42, P288, DOI 10.1016/j.jchemneu.2010.12.002; Sackeim HA, 2001, NEUROPSYCHOPHARMACOL, V25, P713, DOI 10.1016/S0893-133X(01)00271-8; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schwarz LA, 2015, CURR BIOL, V25, pR1051, DOI 10.1016/j.cub.2015.09.039; Sierakowiak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120345; Sjogren MJC, 2002, J CLIN PSYCHIAT, V63, P972, DOI 10.4088/JCP.v63n1103; Sucholeiki R, 2002, SEIZURE-EUR J EPILEP, V11, P157, DOI 10.1053/seiz.2001.0601; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Tyler CW, 2008, BRAIN RES, V1229, P72, DOI 10.1016/j.brainres.2008.06.050; Valdes-Hernandez PA, 2011, FRONTIERS IN NEUROIN, V5; Van Bockstaele EJ, 1999, BIOL PSYCHIAT, V46, P1352, DOI 10.1016/S0006-3223(99)00213-9; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Zaaimi B, 2008, AUTON NEUROSCI-BASIC, V143, P20, DOI 10.1016/j.autneu.2008.07.002; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x; Zobel A, 2005, PSYCHIAT RES-NEUROIM, V139, P165, DOI 10.1016/j.pscychresns.2005.02.010	73	36	36	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189518	10.1371/journal.pone.0189518	http://dx.doi.org/10.1371/journal.pone.0189518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240833	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600042
J	Wang, WB; Liu, Y; Zhou, YF; Gu, LQ; Zhang, L; Zhang, XL; Chen, MM; Zou, ZY; Qiu, W; Hu, XB; Fan, QS				Wang, Wenbo; Liu, Yuan; Zhou, Yifan; Gu, Liangqi; Zhang, Lin; Zhang, Xuelian; Chen, Maomao; Zou, Ziying; Qiu, Wei; Hu, Xiaobing; Fan, Quanshui			Whole-genome analyses of human adenovirus type 55 emerged in Tibet, Sichuan and Yunnan in China, in 2016	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; EPIDEMIOLOGY; PNEUMONIA; PATHOGEN	Three outbreaks of acute respiratory disease occurred at military camps in 2016 at Tibet, Sichuan and Yunnan province, China. The pathogen induced these three outbreaks were all confirmed as HAdV-55 by genotype-specific PCR. The outbreak in Tibet was the first report that HAdV-55 occurred in the high altitude (HA, above sea level 3658 m). This study aims to determine the gene variation and evolution characteristics of these viral strains. Three strains of adenoviruses, LS89/Tibet/2016 (GenBank accession no. KY002683), SF04/SC/2016 (GenBank accession no. KY002684) and KM03/YN/2016 (GenBank accession no. KY002685) were obtained and confirmed by wholegenome sequencing. No multi-gene fragments recombination were found in these isolated HAdV-55 virus compared with previous reported HAdV-55 strains in China. The outbreaks in Tibet and in Sichuan continuously occurred. Virus isolated from Tibet (LS89/Tibet/2016) and Sichuan (SF04/SC/2016) had a similar mutation pattern and had a closer genetic evolutionary distance than KM03/YN/2016 strain, which indicates that the pathogens causing these two outbreaks may be of the same origin. Moreover, we found that heating was an effective way to inactive these viruses, which provide valuable information for the development of HAdV-55 vaccines. Our data provide new information for genetic evolution of HAdV-55, and contribute to the prevention and control of HAdV-55 infection in the future.	[Wang, Wenbo; Zhou, Yifan; Gu, Liangqi; Zhang, Lin; Zhang, Xuelian; Chen, Maomao; Qiu, Wei; Hu, Xiaobing; Fan, Quanshui] Ctr Dis Control & Prevent Chengdu Mil Reg, Chengdu, Sichuan, Peoples R China; [Liu, Yuan; Zou, Ziying] Chengdu Mil Gen Hosp, Dept Clin Lab, Chengdu, Sichuan, Peoples R China		Qiu, W; Hu, XB; Fan, QS (corresponding author), Ctr Dis Control & Prevent Chengdu Mil Reg, Chengdu, Sichuan, Peoples R China.	qiuwei1971@126.com; 18981715872@189.cn; 13888254888@126.com		wang, wen bo/0000-0001-7693-3331	PLA Logistics Research Program [BWS14J025]; PLA Medical Science Youth Training Project [14QNP057]; National Natural Science Foundation of China [81301445]; 12th Five Years Major Special Projects of Chinese PLA [AWS11L009]; Open Research Fund Program of Shanghai Key Laboratory of Medical Biodefense [SKLM1401]	PLA Logistics Research Program; PLA Medical Science Youth Training Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five Years Major Special Projects of Chinese PLA; Open Research Fund Program of Shanghai Key Laboratory of Medical Biodefense	This study was funded by PLA Logistics Research Program (BWS14J025), PLA Medical Science Youth Training Project (14QNP057), National Natural Science Foundation of China (81301445), the 12th Five Years Major Special Projects of Chinese PLA (AWS11L009) and Open Research Fund Program of Shanghai Key Laboratory of Medical Biodefense (SKLM1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Jones GJ, 2016, VET IMMUNOL IMMUNOP, V182, P85, DOI 10.1016/j.vetimm.2016.10.010; Kajon AE, 2010, J INFECT DIS, V202, P93, DOI 10.1086/653083; Kim JS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1602054; Li XY, 2014, INT J INFECT DIS, V28, P117, DOI 10.1016/j.ijid.2014.06.019; Liu JW, 2014, IEEE ENG MED BIO, P14, DOI 10.1109/EMBC.2014.6943517; Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandkovsky U, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0416-y; Sarkadi J, 2015, CLIN VACCINE IMMUNOL, V22, P570, DOI 10.1128/CVI.00773-14; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Trei JS, 2010, EMERG INFECT DIS, V16, P769, DOI 10.3201/eid1605.091633; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Wo Y, 2015, ARCH VIROL, V160, P633, DOI 10.1007/s00705-014-2308-8; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zhang QW, 2012, J VIROL, V86, P12441, DOI 10.1128/JVI.02225-12	18	10	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189625	10.1371/journal.pone.0189625	http://dx.doi.org/10.1371/journal.pone.0189625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240811	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600054
J	Bondar, G; Togashi, R; Cadeiras, M; Schaenman, J; Cheng, RK; Masukawa, L; Hai, J; Bao, TM; Chu, D; Chang, E; Bakir, M; Kupiec-Weglinski, S; Groysberg, V; Grogan, T; Meltzer, J; Kwon, M; Rossetti, M; Elashoff, D; Reed, E; Ping, PP; Deng, MC				Bondar, Galyna; Togashi, Ryan; Cadeiras, Martin; Schaenman, Joanna; Cheng, Richard K.; Masukawa, Lindsay; Hai, Josephine; Bao, Tra-Mi; Chu, Desai; Chang, Eleanor; Bakir, Maral; Kupiec-Weglinski, Sophie; Groysberg, Victoria; Grogan, Tristan; Meltzer, Joseph; Kwon, Murray; Rossetti, Maura; Elashoff, David; Reed, Elaine; Ping, Pei Pei; Deng, Mario C.			Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; VENTRICULAR ASSIST DEVICE; STAGE LIVER-DISEASE; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; PREDICTING SURVIVAL; PRACTICE GUIDELINES; RISK SCORE; TASK-FORCE; T-CELLS	Background Multiorgan dysfunction syndrome contributes to adverse outcomes in advanced heart failure (AdHF) patients after mechanical circulatory support (MCS) implantation and is associated with aberrant leukocyte activity. We tested the hypothesis that preoperative peripheral blood mononuclear cell (PBMC) gene expression profiles (GEP) can predict early postoperative improvement or non-improvement in patients undergoing MCS implantation. We believe this information may be useful in developing prognostic biomarkers. Methods & design We conducted a study with 29 patients undergoing MCS-surgery in a tertiary academic medical center from 2012 to 2014. PBMC samples were collected one day before surgery (day -1). Clinical data was collected on day -1 and day 8 postoperatively. Patients were classified by Sequential Organ Failure Assessment score and Model of End-stage Liver Disease Except INR score (measured eight days after surgery): Group I = improving (both scores improved from day -1 to day 8, n = 17) and Group II = not improving (either one or both scores did not improve from day -1 to day 8, n = 12). RNA-sequencing was performed on purified mRNA and analyzed using Next Generation Sequencing Strand. Differentially expressed genes (DEGs) were identified by Mann-Whitney test with Benjamini-Hochberg correction. Preoperative DEGs were used to construct a support vector machine algorithm to predict Group I vs. Group II membership. Results Out of 28 MCS-surgery patients alive 8 days postoperatively, one-year survival was 88% in Group I and 27% in Group II. We identified 28 preoperative DEGs between Group I and II, with an average 93% prediction accuracy. Out of 105 DEGs identified preoperatively between year 1 survivors and non-survivors, 12 genes overlapped with the 28 predictive genes. Conclusions In AdHF patients following MCS implantation, preoperative PBMC-GEP predicts early changes in organ function scores and correlates with long-term outcomes. Therefore, gene expression lends itself to outcome prediction and warrants further studies in larger longitudinal cohorts.	[Bondar, Galyna; Togashi, Ryan; Cadeiras, Martin; Schaenman, Joanna; Masukawa, Lindsay; Hai, Josephine; Bao, Tra-Mi; Chu, Desai; Chang, Eleanor; Bakir, Maral; Groysberg, Victoria; Grogan, Tristan; Meltzer, Joseph; Kwon, Murray; Rossetti, Maura; Elashoff, David; Reed, Elaine; Ping, Pei Pei; Deng, Mario C.] Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Los Angeles, CA 90095 USA; [Cheng, Richard K.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Kupiec-Weglinski, Sophie] Cornell Univ, Ithaca, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle; Cornell University	Deng, MC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Los Angeles, CA 90095 USA.	mdeng@mednet.ucla.edu	Rossetti, Maura/I-5905-2019	Rossetti, Maura/0000-0003-3347-6200; Bao, Tra-Mi/0000-0002-9071-0916; Cheng, Richard/0000-0001-5994-5998	UCLA NIH [R21 1R21HL120040-01]; UCLA RO1; UCLA DOM Internal Funds; Advanced HF Research Gift; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL120040] Funding Source: NIH RePORTER	UCLA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA RO1; UCLA DOM Internal Funds; Advanced HF Research Gift; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for the study was obtained by UCLA NIH R21 1R21HL120040-01 (MCD) (PI Deng), UCLA RO1 (PI Weiss, Joint PI Deng), UCLA RO1 (PI Ping, Co-I Deng), UCLA DOM Internal Funds and the Advanced HF Research Gift to Columbia University (Philip Geier, John Tocco and Robert Milo) and Advanced HF Research Gift to UCLA (Juan Mulder, Peter Schultz, and Larry Layne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson K.D., 1997, J HEART LUNG TRANSPL, V95, P2660; Abe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100618; Adigopula S, 2014, CARDIOL CLIN, V32, P73, DOI 10.1016/j.ccl.2013.09.012; Aziz NAA, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0218-1; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bondar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115097; Burton DGA, 2015, AGE, V37, DOI 10.1007/s11357-015-9764-2; Caba O, 2014, DIGEST DIS SCI, V59, P2714, DOI 10.1007/s10620-014-3291-3; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7184; Chyu J, 2014, CIRC-HEART FAIL, V7, P88, DOI 10.1161/CIRCHEARTFAILURE.113.000404; Cowger J, 2013, J AM COLL CARDIOL, V61, P313, DOI 10.1016/j.jacc.2012.09.055; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Deng MC, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12900; Deng MC, 2014, TRANSPLANTATION, V97, P708, DOI 10.1097/01.TP.0000443897.29951.cf; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Deng MC, 2005, J HEART LUNG TRANSPL, V24, P1182, DOI 10.1016/j.healun.2005.07.002; Deng MC, 2001, CIRCULATION, V103, P231; Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540; Deng MC, 2007, MECH CIRCULATORY SUP; Deng MC., 2004, HEART TRANSPLANTATIO, V43, P803; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Dunlay SM, 2014, J HEART LUNG TRANSPL, V33, P359, DOI 10.1016/j.healun.2013.12.014; Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013; Flint KM, 2012, CIRC-HEART FAIL, V5, P286, DOI 10.1161/CIRCHEARTFAILURE.111.963215; Fujiwara Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23981; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Guler R, 2015, ONCOTARGET, V6, P26575, DOI 10.18632/oncotarget.5576; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kariuki SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159779; Ketchum ES, 2010, J HEART LUNG TRANSPL, V29, P1021, DOI 10.1016/j.healun.2010.05.002; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Kucuk C, 2016, AM J PATHOL, V186, P1435, DOI 10.1016/j.ajpath.2016.02.011; Laitaoja M, 2016, PROTEIN SCI, V25, P572, DOI 10.1002/pro.2849; Larbi A, 2014, CYTOM PART A, V85A, P25, DOI 10.1002/cyto.a.22351; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Liu J, 2014, NAT IMMUNOL, V15, P612, DOI 10.1038/ni.2898; Lui ELH, 2005, BIOMED PHARMACOTHER, V59, pS363, DOI 10.1016/S0753-3322(05)80079-4; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Martinez-Selles M, 2009, REV ESP CARDIOL, V62, P409, DOI 10.1016/S0300-8932(09)70898-X; Matthews JC, 2010, CIRCULATION, V121, P214, DOI 10.1161/CIRCULATIONAHA.108.838656; Mazzon C, 2012, BLOOD, V119, P5502, DOI 10.1182/blood-2011-09-382812; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Ng SB, 2011, J PATHOL, V223, P496, DOI 10.1002/path.2823; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rajagopalan S, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000467; Roy S, 2015, J IMMUNOL, V194, P6035, DOI 10.4049/jimmunol.1402521; Sartipy U, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000998; Sartipy U, 2014, EUR J HEART FAIL, V16, P173, DOI 10.1111/ejhf.32; Schulten HJ, 2016, AM J CANCER RES, V6, P2140; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; Sinha A, 2010, HUM IMMUNOL, V71, P164, DOI 10.1016/j.humimm.2009.10.012; Smits JM, 2013, J HEART LUNG TRANSPL, V32, P873, DOI 10.1016/j.healun.2013.03.015; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thonnart N, 2014, BLOOD, V124, P3330, DOI 10.1182/blood-2014-09-598995; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weiss JN, 2012, CIRC RES, V111, P493, DOI 10.1161/CIRCRESAHA.112.269084; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wisniewski N, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0288-8; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	72	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189420	10.1371/journal.pone.0189420	http://dx.doi.org/10.1371/journal.pone.0189420			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236770	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100067
J	Memari, N; Ramli, AR; Bin Saripan, MI; Mashohor, S; Moghbel, M				Memari, Nogol; Ramli, Abd Rahman; Bin Saripan, M. Iqbal; Mashohor, Syamsiah; Moghbel, Mehrdad			Supervised retinal vessel segmentation from color fundus images based on matched filtering and AdaBoost classifier	PLOS ONE			English	Article							BLOOD-VESSELS; GRAY-LEVEL; INFORMATION; EXTRACTION; SET	The structure and appearance of the blood vessel network in retinal fundus images is an essential part of diagnosing various problems associated with the eyes, such as diabetes and hypertension. In this paper, an automatic retinal vessel segmentation method utilizing matched filter techniques coupled with an AdaBoost classifier is proposed. The fundus image is enhanced using morphological operations, the contrast is increased using contrast limited adaptive histogram equalization (CLAHE) method and the inhomogeneity is corrected using Retinex approach. Then, the blood vessels are enhanced using a combination of B-COSFIRE and Frangi matched filters. From this preprocessed image, different statistical features are computed on a pixel-wise basis and used in an AdaBoost classifier to extract the blood vessel network inside the image. Finally, the segmented images are post-processed to remove the misclassified pixels and regions. The proposed method was validated using publicly accessible Digital Retinal Images for Vessel Extraction (DRIVE), Structured Analysis of the Retina (STARE) and Child Heart and Health Study in England (CHASE_DB1) datasets commonly used for determining the accuracy of retinal vessel segmentation methods. The accuracy of the proposed segmentation method was comparable to other state of the art methods while being very close to the manual segmentation provided by the second human observer with an average accuracy of 0.972, 0.951 and 0.948 in DRIVE, STARE and CHASE_DB1 datasets, respectively.	[Memari, Nogol; Ramli, Abd Rahman; Bin Saripan, M. Iqbal; Mashohor, Syamsiah; Moghbel, Mehrdad] Univ Putra Malaysia, Fac Engn, Dept Comp & Commun Syst, Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Memari, N (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Comp & Commun Syst, Serdang, Selangor, Malaysia.	nogolmemari@gmail.com	Memari, Nogol/AAE-8348-2020; Saripan, M Iqbal/A-9582-2010	Saripan, M Iqbal/0000-0002-3005-5331; Memari, Nogol/0000-0003-3427-8310				Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Al-Diri B, 2008, IEEE ENG MED BIO, P2262, DOI 10.1109/IEMBS.2008.4649647; Asad AH, 2016, INTEL SYST REF LIBR, V96, P181, DOI 10.1007/978-3-319-21212-8_8; Aslani S, 2016, BIOMED SIGNAL PROCES, V30, P1, DOI 10.1016/j.bspc.2016.05.006; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Azzopardi G, 2013, PATTERN RECOGN LETT, V34, P922, DOI 10.1016/j.patrec.2012.11.002; Azzopardi G, 2013, IEEE T PATTERN ANAL, V35, P490, DOI 10.1109/TPAMI.2012.106; BahadarKhan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158996; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Bonenberg L., 2011, USE GABOR FILTERS TE, P22; Chakraborti T, 2015, MACH VISION APPL, V26, P55, DOI 10.1007/s00138-014-0636-z; Chanwimaluang T., 2003, P INT S CIRC SYST, V5, P21, DOI DOI 10.1109/ISCAS.2003.1206162; CHAUDHURI S, 1989, IEEE T MED IMAGING, V8, P263, DOI 10.1109/42.34715; Cheng EK, 2014, MACH VISION APPL, V25, P1779, DOI 10.1007/s00138-014-0638-x; Clausi DA, 2000, PATTERN RECOGN, V33, P1835, DOI 10.1016/S0031-3203(99)00181-8; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Dai PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127748; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; Elad M, 2005, LECT NOTES COMPUT SC, V3459, P217; Fan Z, 2017, ARXIV1701008922017; Fang B, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 2, PROCEEDINGS, P157; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Fraz MM, 2012, IEEE T BIO-MED ENG, V59, P2538, DOI 10.1109/TBME.2012.2205687; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; GLATARD T, 2004, P 6 ACM SIGMM INT WO, P135, DOI DOI 10.1145/1026711.1026734; Grisan E, 2008, IEEE T MED IMAGING, V27, P310, DOI 10.1109/TMI.2007.904657; Han Z, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P960, DOI 10.1109/ICDMW.2014.16; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P965, DOI 10.1109/83.597272; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Khan KB, 2016, COMP EL EL ENG ICE C, DOI [10.1109/ICECUBE.2016.7495210, DOI 10.1109/ICECUBE.2016.7495210]; Kuse M, 2011, J PATHOL INFORM, V2; Lam BSY, 2010, IEEE T MED IMAGING, V29, P1369, DOI 10.1109/TMI.2010.2043259; Lam BSY, 2008, IEEE T MED IMAGING, V27, P237, DOI 10.1109/TMI.2007.909827; LAND EH, 1986, VISION RES, V26, P7, DOI 10.1016/0042-6989(86)90067-2; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Lupascu CA, 2010, IEEE T INF TECHNOL B, V14, P1267, DOI 10.1109/TITB.2010.2052282; Maharjan A, 2016, THESIS; Mapayi T., 2015, COMPUT MATH METHODS; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Meng XJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0089-2; Miri MS, 2011, IEEE T BIO-MED ENG, V58, P1183, DOI 10.1109/TBME.2010.2097599; Nguyen UTV, 2013, PATTERN RECOGN, V46, P703, DOI 10.1016/j.patcog.2012.08.009; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Olabarriaga SD, 2003, INT CONGR SER, V1256, P1191, DOI 10.1016/S0531-5131(03)00307-8; Oliveira WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149943; Owen CG, 2009, INVEST OPHTH VIS SCI, V50, P2004, DOI 10.1167/iovs.08-3018; Park YK, 2008, SIGNAL PROCESS, V88, P1929, DOI 10.1016/j.sigpro.2008.01.028; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qinmu Peng, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1489, DOI 10.1109/ICPR.2010.368; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Rodrigues J, 2016, SIBGRAPI, P17, DOI [10.1109/SIBGRAPI.2016.012, 10.1109/SIBGRAPI.2016.11]; Roychowdhury S, 2015, IEEE J BIOMED HEALTH, V19, P1118, DOI 10.1109/JBHI.2014.2335617; Salazar-Gonzalez AG, 2010, I C CONT AUTOMAT ROB, P225, DOI 10.1109/ICARCV.2010.5707265; Setiawan A. W., 2013, ICT SMART SOC ICISS, P1, DOI [10.1109/ICTSS.2013.6588092, DOI 10.1109/ICTSS.2013.6588092]; Singh N, 2015, 2015 INTERNATIONAL CONFERENCE ON ELECTRONIC DESIGN, COMPUTER NETWORKS & AUTOMATED VERIFICATION (EDCAV), P23, DOI 10.1109/EDCAV.2015.7060532; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sofka M, 2006, IEEE T MED IMAGING, V25, P1531, DOI 10.1109/TMI.2006.884190; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Solkar SD, 2017, SURVEY RETINAL BLOOD; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Tang SY, 2015, J MED IMAG HEALTH IN, V5, P1571, DOI 10.1166/jmihi.2015.1565; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Vazquez SC, 2010, LECT NOTES COMPUT SC, V6112, P50, DOI 10.1007/978-3-642-13775-4_6; Vlachos M, 2010, COMPUT MED IMAG GRAP, V34, P213, DOI 10.1016/j.compmedimag.2009.09.006; Wang SL, 2015, NEUROCOMPUTING, V149, P708, DOI 10.1016/j.neucom.2014.07.059; Wang YF, 2013, PATTERN RECOGN, V46, P2117, DOI 10.1016/j.patcog.2012.12.014; Wang YP, 2016, COLD REG SCI TECHNOL, V126, P10, DOI 10.1016/j.coldregions.2016.02.013; Wink O, 2004, IEEE T MED IMAGING, V23, P130, DOI 10.1109/TMI.2003.819920; Yin Y, 2012, PATTERN RECOGN, V45, P1235, DOI 10.1016/j.patcog.2011.09.019; You XG, 2011, PATTERN RECOGN, V44, P2314, DOI 10.1016/j.patcog.2011.01.007; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhang X., 1997, Journal of the Society for Information Display, V5, P61, DOI 10.1889/1.1985127; Zhao YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122332; Zhao YQ, 2014, PATTERN RECOGN, V47, P2437, DOI 10.1016/j.patcog.2014.01.006; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106; Zhu CZ, 2017, COMPUT MED IMAG GRAP, V55, P68, DOI 10.1016/j.compmedimag.2016.05.004; Zhu CZ, 2016, CHINESE J ELECTRON, V25, P503, DOI 10.1049/cje.2016.05.016; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	86	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188939	10.1371/journal.pone.0188939	http://dx.doi.org/10.1371/journal.pone.0188939			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228036	Green Submitted, Green Published, gold			2022-12-26	WOS:000417648600019
J	Mave, V; Kinikar, A; Kagal, A; Nimkar, S; Koli, H; Khwaja, S; Bharadwaj, R; Gerona, R; Wen, A; Ramachandran, G; Kumar, H; Bacchetti, P; Dooley, KE; Gupte, N; Gupta, A; Gandhi, M				Mave, Vidya; Kinikar, Aarti; Kagal, Anju; Nimkar, Smita; Koli, Hari; Khwaja, Sultanat; Bharadwaj, Renu; Gerona, Roy; Wen, Anita; Ramachandran, Geetha; Kumar, Hemanth; Bacchetti, Peter; Dooley, Kelly E.; Gupte, Nikhil; Gupta, Amita; Gandhi, Monica			Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis	PLOS ONE			English	Article							DRUG; INTERMITTENT; VARIABILITY; EFAVIRENZ; FAILURE; HISTORY	We measured hair and plasma concentrations of isoniazid among sixteen children with tuberculosis who underwent personal or video-assisted directly observed therapy and thus had 100% adherence. This study therefore defined typical isoniazid exposure parameters after two months of treatment among fully-adherent patients in both hair and plasma ( plasma area under the concentration-time curve, AUC, estimated using pharmacokinetic data collected 0, 2, 4, and 6 hours after drug administration). We found that INH levels in hair among highly-adherent individuals did not correlate well with plasma AUC or trough concentrations, suggesting that each measure may provide incremental and complementary information regarding drug exposure in the context of TB treatment.	[Mave, Vidya; Kinikar, Aarti; Kagal, Anju; Nimkar, Smita; Koli, Hari; Khwaja, Sultanat; Bharadwaj, Renu; Gupte, Nikhil; Gupta, Amita] Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clin Res Site, Pune, Maharashtra, India; [Mave, Vidya; Dooley, Kelly E.; Gupte, Nikhil; Gupta, Amita] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Kinikar, Aarti; Kagal, Anju; Bharadwaj, Renu] Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India; [Gerona, Roy; Wen, Anita; Bacchetti, Peter; Gandhi, Monica] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ramachandran, Geetha; Kumar, Hemanth] Natl Inst Res TB, Madras, Tamil Nadu, India	B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; Johns Hopkins University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; University of California System; University of California San Francisco; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Mave, V (corresponding author), Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clin Res Site, Pune, Maharashtra, India.; Mave, V (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	vidyamave@gmail.com		Gupta, Amita/0000-0001-7036-2718	JHU CFAR NIH/NIAID fund [1P30AI094189-01A1, 1R21AI127149-01]; Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); United States National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research (OAR); NIH BWI Clinical Trials Unit for NIAID Networks (UM1) [UM1A1069465]; NIAID/NIH [2R01 AI098472, R01AI123024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, R01AI123024] Funding Source: NIH RePORTER	JHU CFAR NIH/NIAID fund; Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH BWI Clinical Trials Unit for NIAID Networks (UM1); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was primarily supported by JHU CFAR NIH/NIAID fund 1P30AI094189-01A1 and 1R21AI127149-01 (P.I. Mave). Data in this manuscript in part were collected as part of the Regional Prospective Observational Research for Tuberculosis (RePORT) India Consortium. This project has been funded in whole or in part with Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the United States National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR), and distributed in part by CRDF Global. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the DBT, the ICMR, the NIH, or CRDF Global and R03 HD061059 (P.I. Jain S/Bharadwaj R). VM, NG, SM, HK, SK, AG are also supported by the NIH BWI Clinical Trials Unit for NIAID Networks (UM1) (P.I. Flexner/Gupta, UM1A1069465). MG, RG, and AW are supported by NIAID/NIH 2R01 AI098472 and hair assay development was partially supported by NIAID/NIH R01AI123024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any mention of trade names, commercial projects, or organizations does not imply endorsement by any of the sponsoring organizations. The content of this paper is solely the responsibility of the authors and does not necessary represent the official views of the funders.	Alffenaar JWC, 2012, J INFECT DIS, V205, P1765, DOI 10.1093/infdis/jis270; Baxi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129100; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; Edelbroek PM, 2009, THER DRUG MONIT, V31, P327, DOI 10.1097/FTD.0b013e31819e91ce; Eisenhut M., 2012, TUBERC RES TREAT; Gandhi M, 2002, ANN INTERN MED, V137, P696, DOI 10.7326/0003-4819-137-8-200210150-00016; Gandhi M, 2015, J INFECT DIS, V212, P1402, DOI 10.1093/infdis/jiv239; Gandhi M, 2013, JAIDS-J ACQ IMM DEF, V63, P578, DOI 10.1097/QAI.0b013e31829c48ad; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; Gerona R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155887; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Kumar AKH, 2015, INT J TUBERC LUNG D, V19, P805, DOI 10.5588/ijtld.14.0702; Kumar AKH, 2012, SAARC J TB LUNG DIS, V9, P13, DOI DOI 10.3126/SAARCTB.V9I1.6960; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Mave V, 2016, INT J TUBERC LUNG D, V20, P844, DOI 10.5588/ijtld.15.0882; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Pasipanodya JG, 2012, CLIN INFECT DIS, V55, P169, DOI 10.1093/cid/cis353; Peloquin C, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0029-2016; Podsadecki TJ, 2008, HIV CLIN TRIALS, V9, P238, DOI 10.1310/hct0904-238; Ramachandran G, 2015, ANTIMICROB AGENTS CH, V59, P1162, DOI 10.1128/AAC.04338-14; Swaminathan S, 2016, CLIN INFECT DIS, V63, pS63, DOI 10.1093/cid/ciw471; Tsatsakis AM, 2000, J CLIN PSYCHOPHARM, V20, P560, DOI 10.1097/00004714-200010000-00012; WHO, 2016, GLOB TUB REP; WHO, ROADM CHILDH TB ZER; Wiltshire CS, 2014, J INT AIDS SOC, V17, P65, DOI 10.7448/IAS.17.4.19585	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189101	10.1371/journal.pone.0189101	http://dx.doi.org/10.1371/journal.pone.0189101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216273	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000417337800072
J	Yoo, L; Chung, KC				Yoo, Lang; Chung, Kwang Chul			The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); cell death; E3 ubiquitin ligase; PTEN-induced putative kinase 1 (PINK1); ubiquitylation; ubiquitination; CHIP; Hsp70; staurosporine	QUALITY-CONTROL; MITOCHONDRIAL; IDENTIFICATION; CHAPERONES; MUTATIONS; STABILITY; APOPTOSIS; COMPLEX; PARKIN; MUTANT	Mutations in the gene for the serine/threonine protein kinase PTEN-induced putative kinase 1 (PINK1) are the second most frequent cause of autosomal recessive Parkinson's disease (PD). Via its kinase activity, PINK1 regulates neuronal cell survival and mitochondrial quality control. Numerous reports have revealed that PINK1 has diverse and physiologically significant functions, and therefore its activity should be tightly regulated. However, the molecular mechanisms regulating PINK1 stability and the modulator(s) involved have not been elucidated. In this study, we demonstrate that the ubiquitin E3 ligase carboxyl terminus of Hsp70-interacting protein (CHIP) promotes PINK1 ubiquitination and decreases its steady-state levels. Moreover, PINK1 levels were strongly reduced in HEK293 and SH-SY5Y cells exposed to the apoptosis-inducer staurosporine. Of note, we found that this reduction resulted from CHIP-mediated PINK1 ubiquitination. Accordingly, siRNA-mediated CHIP knockdown reduced susceptibility to staurosporine-induced cell death. Taken together, these findings suggest that CHIP plays a role in negative regulation of PINK1 stability and may suppress PINK1's cytoprotective effect during staurosporine-induced mammalian cell death. We propose that this PINK1 regulatory pathway might contribute to Parkinson's disease pathogenesis.	[Yoo, Lang; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 03722, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Ro 50, Seoul 03722, South Korea.	kchung@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014M3C7A1064545]; Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C0936]; NRF [2015R1A2A2A01003080]; Yonsei University Future-leading Research Initiative [2015-22-0055]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; NRF; Yonsei University Future-leading Research Initiative	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning Grant 2014M3C7A1064545 (to K. C. C.) and the Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare Grant HI17C0936 (to K. C. C.), Republic of Korea. This work was also supported in part by the NRF Grant 2015R1A2A2A01003080 (to K. C. C.) and by the Yonsei University Future-leading Research Initiative of 2015 Grant 2015-22-0055 (to K. C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Anand R, 2013, BBA-MOL CELL RES, V1833, P195, DOI 10.1016/j.bbamcr.2012.06.025; Ando M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0174-z; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Berthier A, 2011, HUM PATHOL, V42, P75, DOI 10.1016/j.humpath.2010.05.016; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Paul I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/918183; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Sun C, 2014, J CANCER RES CLIN, V140, P189, DOI 10.1007/s00432-013-1571-5; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	39	16	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1286	1297		10.1074/jbc.M117.803890	http://dx.doi.org/10.1074/jbc.M117.803890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242192	hybrid, Green Published			2022-12-26	WOS:000423515000015
J	Alvarez-Quinto, RA; Cornejo-Franco, JF; Quito-Avila, DF				Alvarez-Quinto, Robert A.; Cornejo-Franco, Juan F.; Quito-Avila, Diego F.			Characterization of a not so new potexvirus from babaco (Vasconcellea x heilbornii)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MOSAIC-VIRUS RNA; MINUS-STRAND; PLANT; IDENTIFICATION; PENTAGONA; PROTEINS; ELEMENTS; ISOLATE	A new member of the genus Potexvirus was fully sequenced and characterized. The virus was isolated from babaco (Vasconcellea x heilbornii), a natural hybrid native to Ecuador. The virus contains a 6,692 nt long genome organized in five open reading frames in an arrangement typical of other potexviruses. Sequence comparisons revealed close related-ness with Papaya mosaic virus (PapMV), Alternathera mosaic virus (AltMV) and Senna mosaic virus (SenMV), exhibiting nucleotide identities up to 67% for the polymerase (Pol) and 68% for the coat protein (CP), with deduced amino acid identities of 70% and 72% for the Pol and CP, respectively. The presence of an AlkB domain, in the polymerase region, was observed. Terminal nucleotide sequences were conserved across potexviruses with characteristic motifs and predicted secondary structures at the 3' UTR. Although serologically undistinguishable from PapMV and AltMV, the new virus showed differences in host range and symptom induction. The name babaco mosaic virus is proposed for this newly characterized Potexvirus. The complete genome sequence of the new virus has been deposited in NCBI GenBank under accession number MF978248.	[Alvarez-Quinto, Robert A.; Quito-Avila, Diego F.] Escuela Super Politecn Litoral ESPOL, Ctr Invest Biotecnol Ecuador, Guayaquil, Ecuador; [Cornejo-Franco, Juan F.; Quito-Avila, Diego F.] Escuela Super Politecn Litoral ESPOL, Fac Ciencias Vida, Guayaquil, Ecuador	Escuela Superior Politecnica del Litoral; Escuela Superior Politecnica del Litoral	Quito-Avila, DF (corresponding author), Escuela Super Politecn Litoral ESPOL, Ctr Invest Biotecnol Ecuador, Guayaquil, Ecuador.; Quito-Avila, DF (corresponding author), Escuela Super Politecn Litoral ESPOL, Fac Ciencias Vida, Guayaquil, Ecuador.	dquito@espol.edu.ec		Alvarez-Quinto, Robert/0000-0002-8524-0067	CIBE-ESPOL	CIBE-ESPOL	Funding for this project was provided by CIBE-ESPOL.	Adams M, 2012, VIRUS TAXONOMY, P904; Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; Alvarez-Quinto RA, 2017, ARCH VIROL, V162, P1083, DOI 10.1007/s00705-016-3159-2; BANCROFT JB, 1991, J GEN VIROL, V72, P2173, DOI 10.1099/0022-1317-72-9-2173; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Chen IH, 2005, J VIROL, V79, P14555, DOI 10.1128/JVI.79.23.14555-14561.2005; Cotillon AC, 2002, ARCH VIROL, V147, P2231, DOI 10.1007/s00705-002-0873-8; Dhuique-Mayer C, 2001, BIOTECHNOL LETT, V23, P1021, DOI 10.1023/A:1010552605097; DOLJA VV, 1991, VIROLOGY, V184, P79, DOI 10.1016/0042-6822(91)90823-T; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Fuji S, 2005, ARCH VIROL, V150, P2377, DOI 10.1007/s00705-005-0574-1; Halgren A, 2007, PHYTOPATHOLOGY, V97, P44, DOI 10.1094/PHYTO-97-0044; Hammond J, 2006, ARCH VIROL, V151, P477, DOI 10.1007/s00705-005-0646-2; Hu B, 2007, RNA, V13, P267, DOI 10.1261/rna.243607; Huang YW, 2009, VIROLOGY, V386, P139, DOI 10.1016/j.virol.2009.01.019; ICTV, 2017, VIR TAX CLASS NOM VI; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; King A. M. Q., 2012, VIRUS TAXONOMY CLASS, P912; Marina B., 1989, Acta Horticulturae, P149; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Ochoa J., 2000, Plant Disease, V84, P199, DOI 10.1094/PDIS.2000.84.2.199A; Park MR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00060; Rezende JAM, 2017, ARCH VIROL, V162, P529, DOI 10.1007/s00705-016-3114-2; Robles-Carrion AR, 2016, CENT AGRIC, V43, P83; SIT TL, 1989, J GEN VIROL, V70, P2325, DOI 10.1099/0022-1317-70-9-2325; Thompson JR, 2004, ARCH VIROL, V149, P1897, DOI 10.1007/s00705-004-0353-4; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; WHITE KA, 1992, VIROLOGY, V189, P817, DOI 10.1016/0042-6822(92)90614-U; Wong SM, 1997, ARCH VIROL, V142, P383, DOI 10.1007/s007050050084; Wylie SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105044	31	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189519	10.1371/journal.pone.0189519	http://dx.doi.org/10.1371/journal.pone.0189519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244846	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700036
J	Hinson, KR; Reukov, V; Benson, EP; Zungoli, PA; Bridges, WC; Ellis, BR; Song, JB				Hinson, Kevin R.; Reukov, Vladimir; Benson, Eric P.; Zungoli, Patricia A.; Bridges, William C.; Ellis, Brittany R.; Song, Jinbo			Climbing ability of teneral and sclerotized adult bed bugs and assessment of adhesive properties of the exoskeletal fluid using atomic force microscopy	PLOS ONE			English	Article							CIMEX-LECTULARIUS HEMIPTERA; CIMICIDAE; CELLS	We observed that teneral adults (< 1 h post-molt) of Cimex lectularius L. appeared more adept at climbing a smooth surface compared to sclerotized adults. Differences in climbing ability on a smooth surface based on sclerotization status were quantified by measuring the height to which bed bugs climbed when confined within a glass vial. The average maximum height climbed by teneral (T) bed bugs (n = 30, height climbed = 4.69 cm) differed significantly (P< 0.01) from recently sclerotized (RS) bed bugs (n = 30, height climbed = 1.73 cm at similar to 48 h post molt), sclerotized group 1 (S1) bed bugs (n = 30, S1 = 2.42 cm at > 72 h), and sclerotized group 2 (S2) bed bugs (n = 30, height climbed = 2.64 cm at > 72 h post molt). When heights from all climbing events were summed, teneral bed bugs (650.8 cm climbed) differed significantly (P< 0.01) from recently sclerotized (82 cm climbed) and sclerotized (group 1 = 104.6 cm climbed, group 2 = 107.8 cm climbed) bed bugs. These findings suggested that the external surface of teneral bed bug exoskeletons possess an adhesive property. Using atomic force microscopy (AFM), we found that adhesion force of an exoskeletal (presumably molting) fluid decreased almost five-fold from 88 to 17 nN within an hour of molting. Our findings may have implications for laboratory safety and the effectiveness of bed bug traps, barriers, and biomimetic-based adhesives.	[Hinson, Kevin R.; Benson, Eric P.; Zungoli, Patricia A.; Ellis, Brittany R.; Song, Jinbo] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29631 USA; [Reukov, Vladimir] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Bridges, William C.] Clemson Univ, Dept Math Sci, Clemson, SC USA	Clemson University; Clemson University; Clemson University	Benson, EP (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29631 USA.	ebenson@clemson.edu	Reukov, Vladimir/J-6897-2017	Reukov, Vladimir/0000-0003-1695-6712	National Institute of Food and Agriculture, United States Department of Agriculture [SC-1700479]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA))	This publication is Technical Contribution No. 6562 of the Clemson University Experiment Station. This material is based upon work supported by National Institute of Food and Agriculture, United States Department of Agriculture, under project number SC-1700479.	A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3; ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bhattacharyya A, 2016, J APIC SCI, V60, P87, DOI [10.1515/JAS-2016-0008, 10.1515/jas-2016-0008]; BUSVINE JR, 1953, NATURE, V171, P118, DOI 10.1038/171118a0; DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Dokukin ME, 2011, J INSECT PHYSIOL, V57, P260, DOI 10.1016/j.jinsphys.2010.11.012; Foottit R.G., 2009, INSECT BIODIVERSITY, DOI 10.1002/9781118945582; Guz NV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012834; Hecht FM, 2015, SOFT MATTER, V11, P4584, DOI 10.1039/c4sm02718c; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hottel BA, 2015, J MED ENTOMOL, V52, P289, DOI 10.1093/jme/tjv012; Kim DY, 2017, J ECON ENTOMOL, V110, P1179, DOI 10.1093/jee/tox039; Krueger L, 2000, PEST CONTROL, V68, P58; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lekka M, 2016, BIONANOSCIENCE, V6, P65, DOI 10.1007/s12668-016-0191-3; Lyapunova E, 2016, PHYS CANC INTERDISCI, P1760; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Potter M. F., 2005, Pest Control Technology, V33, P82; Potter MF, 2010, BUGS BORDERS EXECUTI; Reinhardt K, 2008, J MED ENTOMOL, V45, P956, DOI 10.1603/0022-2585(2008)45[956:WKTBBK]2.0.CO;2; Triplehorn C. A., 2005, BORROR DELONGS INTRO, V7th; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Wagner R, 2012, APPL SURF SCI, V259, P225, DOI 10.1016/j.apsusc.2012.07.023; Wang CL, 2011, J ECON ENTOMOL, V104, P274, DOI 10.1603/EC10141; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang CL, 2009, J MED ENTOMOL, V46, P566, DOI 10.1603/033.046.0322; Wigglesworth VB, 1938, NATURE, V141, P974, DOI 10.1038/141974c0	31	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189215	10.1371/journal.pone.0189215	http://dx.doi.org/10.1371/journal.pone.0189215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244819	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700022
J	Dan, H; Ikeda, N; Fujikami, M; Nakabachi, A				Dan, Hiroki; Ikeda, Naoya; Fujikami, Masaya; Nakabachi, Atsushi			Behavior of bacteriome symbionts during transovarial transmission and development of the Asian citrus psyllid	PLOS ONE			English	Article							BROWN PLANTHOPPER; HEMIPTERA; ENDOSYMBIONTS; GENOME; COSPECIATION; EVOLUTION; INSECTS	The Asian citrus psyllid Diaphorina citri Kuwayama (Hemiptera: Liviidae) is a serious pest worldwide, transmitting Candidatus Liberibacter spp. (Alphaproteobacteria), the causative agents of a devastating citrus disease known as huanglongbing or greening disease. In a symbiotic organ called the bacteriome, D. citri possesses an organelle-like defensive symbiont, Candidatus Profftella armatura (Betaproteobacteria), and a nutritional symbiont, Ca. Carsonella ruddii (Gammaproteobacteria). Drastically reduced symbiont genomes and metabolic complementarity among the symbionts and D. citri indicate their mutually indispensable association. Moreover, horizontal gene transfer between the Profftella and Liberibacter lineages suggests ecological and evolutionary interactions between the bacteriome symbiont and the HLB pathogen. Using fluorescence in situ hybridization, we examined the behavior of Profftella and Carsonella during transovarial transmission and the development of D. citri. In the bacteriomes of sexually-mature female adults, symbionts transformed from an extremely elongated tubular form into spherical or short-rod forms, which migrated toward the ovary. The symbionts then formed mosaic masses, which entered at the posterior pole of the vitellogenic oocytes. After anatrepsis, Carsonella and Profftella migrated to the central and peripheral parts of the mass, respectively. Following the appearance of host nuclei, the mass cellularized, segregating Carsonella and Profftella in the central syncytium and peripheral uninucleate bacteriocytes, respectively. Subsequently, the uninucleate bacteriocytes harboring Profftella assembled at the posterior pole, while the syncytium, containing Carsonella, sat on the anterior side facing the germ band initiating katatrepsis. During dorsal closure, the syncytium was divided into uninuclear bacteriocytes, which surrounded the mass of bacteriocytes containing Profftella. Once fully surrounded, the bacteriocyte mass containing Profftella was fused into a syncytium. Prior to hatching, a pair of wing-like protrusions arose from both lateral sides of the bacteriome, which continued to grow throughout the nymphal stages. These findings provide a foundation for better understanding the intricate relationship between D. citri and its microbiota.	[Dan, Hiroki; Ikeda, Naoya; Fujikami, Masaya; Nakabachi, Atsushi] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi, Japan; [Nakabachi, Atsushi] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi, Japan	Toyohashi University of Technology; Toyohashi University of Technology	Nakabachi, A (corresponding author), Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi, Japan.; Nakabachi, A (corresponding author), Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi, Japan.	nakabachi@eiiris.tut.ac.jp	Nakabachi, Atsushi/H-1661-2011	Nakabachi, Atsushi/0000-0003-0281-1723	Japan Society for the Promotion of Science KAKENHI [26292174]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.isps.go.ip) KAKENHI grant number 26292174 to AN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dossi FCA, 2014, ZOOLOGIA-CURITIBA, V31, P162, DOI 10.1590/S1984-46702014000200007; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Burckhardt D, 2012, ZOOTAXA, P1; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Kobialka M, 2016, PROTOPLASMA, V253, P903, DOI 10.1007/s00709-015-0854-x; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Kuechler SM, 2013, ENVIRON MICROBIOL, V15, P2031, DOI 10.1111/1462-2920.12101; Matsuura Y, 2012, ISME J, V6, P397, DOI 10.1038/ismej.2011.103; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2010, B ENTOMOL RES, V100, P27, DOI 10.1017/S0007485309006737; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakabachi A, 2015, CURR OPIN INSECT SCI, V7, P24, DOI 10.1016/j.cois.2015.03.006; Nakabachi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082612; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; NODA H, 1977, Applied Entomology and Zoology, V12, P134; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; PROFFT JOACHIM, 1937, ZEITSCHR MORPH U OKOL TIERE, V32, P289, DOI 10.1007/BF00403077; Sauer C, 2000, INT J SYST EVOL MICR, V50, P1877, DOI 10.1099/00207713-50-5-1877; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; STEEDMAN HF, 1957, NATURE, V179, P1345, DOI 10.1038/1791345a0; Szklarzewicz T, 2017, PROTOPLASMA, P1; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Yukuhiro F, 2014, J INSECT PHYSIOL, V60, P111, DOI 10.1016/j.jinsphys.2013.11.010	25	21	23	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189779	10.1371/journal.pone.0189779	http://dx.doi.org/10.1371/journal.pone.0189779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240843	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600071
J	Costa, A; Petrenko, AA; Guizien, K; Doglioli, AM				Costa, Andrea; Petrenko, Anne A.; Guizien, Kate; Doglioli, Andrea M.			On the calculation of betweenness centrality in marine connectivity studies using transfer probabilities	PLOS ONE			English	Article							TRANSPORT; CURRENTS; GULF; SEA	Betweenness has been used in a number of marine studies to identify portions of sea that sustain the connectivity of whole marine networks. Herein we highlight the need of methodological exactness in the calculation of betweenness when graph theory is applied to marine connectivity studies based on transfer probabilities. We show the inconsistency in calculating betweeness directly from transfer probabilities and propose a new metric for the node-to-node distance that solves it. Our argumentation is illustrated by both simple theoretical examples and the analysis of a literature data set.	[Costa, Andrea; Petrenko, Anne A.; Doglioli, Andrea M.] Aix Marseille Univ, CNRS, Univ Toulon, OSU Pytheas,Mediterranean Inst Oceanog,UM 110,IRD, F-13288 Marseille, France; [Guizien, Kate] Univ Paris 06, CNRS, Lab Ecogeochim Environm Benth, UMR 8222, Av Fontaule, F-66651 Banyuls Sur Mer, France; [Costa, Andrea] Pusan Natl Univ, IBS Ctr Climate Phys, Busan, South Korea	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institute for Basic Science - Korea (IBS); Pusan National University	Costa, A (corresponding author), Aix Marseille Univ, CNRS, Univ Toulon, OSU Pytheas,Mediterranean Inst Oceanog,UM 110,IRD, F-13288 Marseille, France.; Costa, A (corresponding author), Pusan Natl Univ, IBS Ctr Climate Phys, Busan, South Korea.	andrea.costa@pusan.ac.kr	Model, Symphonie/C-2758-2013; PETRENKO, Anne/AAN-7210-2021	Model, Symphonie/0000-0002-4506-5209; PETRENKO, Anne/0000-0002-2519-9285; Costa, Andrea/0000-0002-1495-7060; Guizien, Katell/0000-0001-9884-7506; Doglioli, Andrea/0000-0003-1309-9954	MENRT Ph.D. grant; European Union [287844]; European FEDER Fund [1166-39417]	MENRT Ph.D. grant; European Union(European Commission); European FEDER Fund	Andrea Costa was financed by a MENRT Ph.D. grant. The research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under Grant Agreement No. 287844 for the project 'Towards COast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential' (COCONET). The project leading to this publication has received funding from European FEDER Fund under project 1166-39417.	Andrello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068564; Bacher C, 2016, J MARINE SYST, V153, P25, DOI 10.1016/j.jmarsys.2015.09.002; Berline L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111978; Bondy J. A, 2008, GRAPH THEORY APPL; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brandes U, 2008, SOC NETWORKS, V30, P136, DOI 10.1016/j.socnet.2007.11.001; Costa A, TUNING INTERPR UNPUB; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Doglioli AM, 2004, AQUACULTURE, V231, P215, DOI 10.1016/j.aquaculture.2003.09.030; Ghezzo M, 2015, ESTUAR COAST, V38, P1764, DOI 10.1007/s12237-014-9908-0; Guizien K, 2014, DIVERS DISTRIB, V20, P1392, DOI 10.1111/ddi.12254; Jacobi MN, 2012, ECOGRAPHY, V35, P1004, DOI 10.1111/j.1600-0587.2012.07281.x; Jonsson P. R, 2015, DIVERS DISTRIB, V22, P1; Kininmonth S, 2010, ECOL MODEL, V221, P2870, DOI 10.1016/j.ecolmodel.2010.08.042; Kininmonth SJ, 2010, THEOR ECOL-NETH, V3, P75, DOI 10.1007/s12080-009-0055-3; Lee C.-Y., PHYSICS060522 ARXIV; Mansui J, 2015, MAR POLLUT BULL, V91, P249, DOI 10.1016/j.marpolbul.2014.11.037; Marsaleix P, 2006, J ATMOS OCEAN TECH, V23, P1604, DOI 10.1175/JTECH1930.1; MILLOT C, 1990, CONT SHELF RES, V10, P885, DOI 10.1016/0278-4343(90)90065-T; Moilanen A, 2011, J APPL ECOL, V48, P1543, DOI 10.1111/j.1365-2664.2011.02062.x; Moore E.F., 1959, P INT S THEOR SWITCH, P285; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Petrenko A, 2008, J MARINE SYST, V74, P406, DOI 10.1016/j.jmarsys.2008.03.004; Pinardi N., 2004, SEA, V14; Rossi V, 2014, GEOPHYS RES LETT, V41, P2883, DOI 10.1002/2014GL059540; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Valente Thomas W, 2008, Connect (Tor), V28, P16	28	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189021	10.1371/journal.pone.0189021	http://dx.doi.org/10.1371/journal.pone.0189021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232386	gold, Green Submitted, Green Published			2022-12-26	WOS:000417698200018
J	Larocca, TF; Macedo, CT; Noya-Rabelo, M; Correia, LCL; Moreira, MI; Caldas, AC; Torreao, JA; Souza, BSD; Vasconcelos, JF; da Silva, ASC; dos Santos, RR; Soares, MBP				Larocca, Ticiana Ferreira; Macedo, Carolina The; Noya-Rabelo, Marcia; Lemos Correia, Luis Claudio; Moreira, Moises Imbassahy; Caldas, Alessandra Carvalho; Torreao, Jorge Andion; de Freitas Souza, Bruno Solano; Vasconcelos, Juliana Fraga; Carvalho da Silva, Alexandre Schaer; dos Santos, Ricardo Ribeiro; Pereira Soares, Milena Botelho			Lack of association between serum syndecan-4, myocardial fibrosis and ventricular dysfunction in subjects with chronic Chagas disease	PLOS ONE			English	Article							EXPRESSION; CARDIOMYOPATHY	Background Syndecan-4 is a transmembrane glycoprotein associated with inflammation and fibrosis. Increased syndecan-4 levels were previously detected after acute myocardial infarction and in subjects with heart failure. However, the levels of syndecan-4 in subjects with Chagas disease have not so far been investigated. The aim of this study was to investigate the potential role of serum sydencan-4 as a novel biomarker for myocardial fibrosis and cardiac dysfunction in subjects with Chagas disease. Methods This study comprised subjects with Chagas disease (n = 56), being 14 (25%) with the indeterminate form, 16 (29%) with the cardiac form without ventricular dysfunction, and 26 (46%) with the cardiac form with ventricular dysfunction. Results Syndecan-4 serum concentrations did not correlate with presence or absence of myocardial fibrosis (P = 0.386) nor disease severity in subjects with Chagas disease (P = 0.918). Additionally, no correlation was found either between the degree of myocardial fibrosis and serum syndecan-4 [r = 0.08; P = 0.567] or between left ventricular ejection fraction and syndecan-4 [r = 0.02; P = 0.864]. In contrast, NT-proBNP levels correlated with ejection fraction and myocardial fibrosis. Conclusions Our results demonstrate the lack of correlations between serum syndecan-4, myocardial fibrosis and cardiac dysfunction in subjects with Chagas disease. Further studies are required to show if syndecan-4 concentrations can be marker for prognosis assessment or disease progression.	[Larocca, Ticiana Ferreira; Macedo, Carolina The; de Freitas Souza, Bruno Solano; Vasconcelos, Juliana Fraga; Carvalho da Silva, Alexandre Schaer; dos Santos, Ricardo Ribeiro; Pereira Soares, Milena Botelho] Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, Salvador, BA, Brazil; [Larocca, Ticiana Ferreira; de Freitas Souza, Bruno Solano; Vasconcelos, Juliana Fraga; Pereira Soares, Milena Botelho] IGM Fiocruz BA, Gonealo Moniz Inst, Salvador, BA, Brazil; [Macedo, Carolina The; Noya-Rabelo, Marcia; Lemos Correia, Luis Claudio; Moreira, Moises Imbassahy; Caldas, Alessandra Carvalho; Torreao, Jorge Andion] Sao Rafael Hosp, Dept Cardiol, Salvador, BA, Brazil; [Lemos Correia, Luis Claudio] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil	Escola Bahiana de Medicina e Saude Publica	Soares, MBP (corresponding author), Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, Salvador, BA, Brazil.; Soares, MBP (corresponding author), IGM Fiocruz BA, Gonealo Moniz Inst, Salvador, BA, Brazil.	milena@bahia.fiocruz.br	Noya-Rabelo, Marcia M/AAG-2270-2019; Santos, Ricardo/AAQ-1631-2021; Souza, Bruno/AAO-4601-2021; Soares, Milena B. P./O-3771-2018; Vasconcelos, Juliana/AAN-5274-2021	Noya-Rabelo, Marcia M/0000-0002-6800-8100; Souza, Bruno/0000-0003-3771-0439; Torreao, Jorge/0000-0002-3418-3226; Vasconcelos, Juliana/0000-0003-4553-0315	FAPESB; CNPq	FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Brazilian government agencies: FAPESB and CNPq, through grants conceded to MBPS	Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bielecka-Dabrowa A, 2013, INT J CARDIOL, V168, P2404, DOI 10.1016/j.ijcard.2013.01.157; CHAGAS Carlos, 1916, Memorias do Instituto Oswaldo Cruz, V8, P5, DOI 10.1590/S0074-02761916000200002; CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P172, DOI 10.1161/01.ATV.17.1.172; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dobra K, 2003, ANTICANCER RES, V23, P2435; Garcia-Alvarez A, 2011, J CARD FAIL, V17, P1028, DOI 10.1016/j.cardfail.2011.08.007; Kojima T, 2001, THROMB HAEMOSTASIS, V85, P793; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li L, 2002, ARTERIOSCL THROM VAS, V22, P61, DOI 10.1161/hq0102.100314; Ma Xiaoling, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P866; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; McEvoy JW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003079; Mello Ronaldo Peixoto de, 2012, Arq Bras Cardiol, V98, P421; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; Noya-Rabelo MM, 2017, CARDIOLOGY, V136, P33, DOI 10.1159/000447529; Regueiro A, 2013, INT J CARDIOL, V165, P107, DOI 10.1016/j.ijcard.2011.07.089; Rochitte CE, 2005, J AM COLL CARDIOL, V46, P1553, DOI 10.1016/j.jacc.2005.06.067; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Silva CP, 2008, ARQ BRAS CARDIOL, V91, P358; Soares MBP, 2011, CELL CYCLE, V10, P1448, DOI 10.4161/cc.10.9.15487; Takahashi R, 2011, J CARDIOL, V57, P325, DOI 10.1016/j.jjcc.2011.01.012; Veeranna V, 2013, INT J CARDIOL, V166, P487, DOI 10.1016/j.ijcard.2011.11.034; Wettersten N, 2016, AM J MED, V129, P560, DOI 10.1016/j.amjmed.2016.01.013; WHO, 2010, WHO TECH REP SER, V949, P1; Zhang YF, 1999, J BIOL CHEM, V274, P14786, DOI 10.1074/jbc.274.21.14786	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189408	10.1371/journal.pone.0189408	http://dx.doi.org/10.1371/journal.pone.0189408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232393	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200041
J	Straub, MH; Roy, AN; Martin, A; Sholty, KE; Stephenson, N; Foley, JE				Straub, Mary H.; Roy, Austin N.; Martin, Amanda; Sholty, Kathleen E.; Stephenson, Nicole; Foley, Janet E.			Distribution and prevalence of vector-borne diseases in California chipmunks (Tamias spp.)	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; BORRELIA-BURGDORFERI; ANAPLASMA-PHAGOCYTOPHILUM; SPOTTED-FEVER; RELAPSING FEVER; SEROLOGIC EVIDENCE; IMMUNE-RESPONSES; ACARI IXODIDAE; RESERVOIR HOST; INFECTION	California, with 13 chipmunk (Tamias) species, has more than any other state or country, occupying habitats ranging from chaparral to the high peaks of the Sierra Nevada. Chipmunks host zoonotic pathogens including Yersinia pestis, Anaplasma phagocytophilum, relapsing fever (RF) Borrelia spp., Borrelia burgdorferi, and spotted fever group (SFG) Rickettsia species. Chipmunk species are often not differentiated by public health workers, yet different species utilize different ecological niches and may have intrinsically different capacities for maintaining vector-borne pathogens and infecting vectors. We surveyed over 700 individuals from nine species of chipmunks throughout California for exposure to and infection by Y. pestis, A. phagocytophilum, RF Borrelia spp., Borrelia burgdorferi, and SFG Rickettsia species. DNA of all five pathogens was found and all chipmunks except Merriam's chipmunk (T. merriami) were PCR-positive for at least one of the pathogens. Anaplasma phagocytophilum was most common (40.0%, 2/5) in Sonoma chipmunks (T. sonomae) from Marin county and B. burgdorferi most common (37.5%, 27/72) in redwood chipmunks (T. ochrogenys) from Mendocino county. RF Borrelia spp. was detected in 2% (6/297) of redwood chipmunks in Mendocino county and 10% (1/10) of both least (T. minimus) and lodgepole (T. speciosus) chipmunks in the western Sierra. Exposure to SFG Rickettsia spp. was found in the Northern Coastal region (Del Norte, Humboldt and Mendocino counties) and in the northern and western Sierra in several species of chipmunks. Y. pestis infection was found only in the western Sierra D in a yellow-pine (T. amoenus) and a long-eared (T. quadrimaculatus) chipmunk. Though more data are needed to thoroughly understand the roles that different chipmunk species play in disease transmission, our findings suggest that some chipmunk species may be more important to the maintenance of vector-borne diseases than others within each geographic area.	[Straub, Mary H.; Roy, Austin N.; Stephenson, Nicole; Foley, Janet E.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Martin, Amanda] Univ Calif Davis, Museum Wildlife & Fish Biol, Davis, CA 95616 USA; [Sholty, Kathleen E.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [Martin, Amanda] Salk Inst Biol Studies, La Jolla, CA USA; [Sholty, Kathleen E.] Swaim Biol, Livermore, CA USA; [Stephenson, Nicole] Metabiota, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; Salk Institute	Foley, JE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA.	jefoley@ucdavis.edu		Roy, Austin/0000-0002-2519-6455	Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis	Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis	This project was supported by a student fellowship (awarded to MHS) from the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis. http://www.vetmed.ucdavis.edu/whc/index.cfm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian JZ, 2008, J WILDLIFE DIS, V44, P737, DOI 10.7589/0090-3558-44.3.737; Alvarez-Castaneda ST, IUCN RED LIST THREAT; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; BROADBOOKS HE, 1974, J MAMMAL, V55, P630, DOI 10.2307/1379551; BURGDORFER W, 1962, AM J HYG, V76, P293, DOI 10.1093/oxfordjournals.aje.a120284; BURGDORFER W, 1975, INFECT IMMUN, V12, P205, DOI 10.1128/IAI.12.1.205-210.1975; BURGDORFER W, 1970, Infection and Immunity, V2, P256; California Department of Public Health, 2016, CAL COMP PLAG CONTR; California Department of Public Health, 2014, VECT BORN DIS SECT; Cassola F, NEOTAMIAS MINIMUS 20; Centers for Disease Control and Prevention, TICK BORN REL FEV TR; Centers for Disease Control and Prevention, PLAG EC TRANSM 2015; Centers for Disease Control and Prevention, AN SYMPT DIAGN TREAT; CLOVER JR, 1989, J WILDLIFE DIS, V25, P52, DOI 10.7589/0090-3558-25.1.52; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cutler SJ, 2006, EMERG INFECT DIS, V12, P369, DOI 10.3201/eid1203.050899; Danforth M, 2016, EMERG INFECT DIS, V22, P2045, DOI 10.3201/eid2212.160560; DeNatale CE, 2002, J WILDLIFE DIS, V38, P478, DOI 10.7589/0090-3558-38.2.478; Drazenovich N, 2006, VECTOR-BORNE ZOONOT, V6, P83, DOI 10.1089/vbz.2006.6.83; Eisen L, 2009, J VECTOR ECOL, V34, P81, DOI [10.1111/j.1948-7134.2009.00010.x, 10.3376/038.034.0110]; Eremeeva ME, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00055; Fairlie-Clarke KJ, 2009, EVOL APPL, V2, P122, DOI 10.1111/j.1752-4571.2008.00052.x; Fleer KA, 2011, J MED ENTOMOL, V48, P101, DOI 10.1603/ME10040; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Foley J, 2016, TICKS TICK-BORNE DIS, V7, P243, DOI 10.1016/j.ttbdis.2015.10.017; Foley J, 2014, TICKS TICK-BORNE DIS, V5, P299, DOI 10.1016/j.ttbdis.2013.12.003; Foley JE, 2008, EMERG INFECT DIS, V14, P1147, DOI 10.3201/eid1407.071599; Foley JE, 2008, VECTOR-BORNE ZOONOT, V8, P49, DOI 10.1089/vbz.2007.0175; Forrester JD, 2015, MMWR-MORBID MORTAL W, V64, P58; Fritz CL, 2013, VECTOR-BORNE ZOONOT, V13, P376, DOI 10.1089/vbz.2012.1137; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; KURTENBACH K, 1994, INFECT IMMUN, V62, P5344, DOI 10.1128/IAI.62.12.5344-5352.1994; Lane RS, 2009, J VECTOR ECOL, V34, P252, DOI [10.1111/j.1948-7134.2009.00034.x, 10.3376/038.034.0212]; Lane RS, 2005, J MED ENTOMOL, V42, P388, DOI 10.1603/0022-2585(2005)042[0388:WGSRSA]2.0.CO;2; Laws JM, 2007, LAWS FIELD GUIDE SIE; Lowrey C, 2008, IUCN RED LIST THREAT; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Magurran A.E, 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0_4; MENHINICK EF, 1964, ECOLOGY, V45, P859, DOI 10.2307/1934933; Merrit JF, 2010, BIOL SMALL MAMMALS; Milhano N, 2010, TICKS TICK-BORNE DIS, V1, P172, DOI 10.1016/j.ttbdis.2010.09.003; Nieto NC, 2008, J MED ENTOMOL, V45, P763, DOI 10.1603/0022-2585(2008)45[763:EOSRSA]2.0.CO;2; Nieto NC, 2007, J MED ENTOMOL, V44, P328, DOI 10.1603/0022-2585(2007)44[328:EDAETV]2.0.CO;2; Nieto NC, 2014, J MED ENTOMOL, V51, P1029, DOI 10.1603/ME14021; Nieto NC, 2010, J WILDLIFE DIS, V46, P291, DOI 10.7589/0090-3558-46.1.291; Nieto NC, 2009, VECTOR-BORNE ZOONOT, V9, P573, DOI 10.1089/vbz.2008.0142; Nieto NC, 2009, VECTOR-BORNE ZOONOT, V9, P93, DOI 10.1089/vbz.2008.0072; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Reid FA, 2006, MAMMALS N AM; Rejmanek D, 2011, TICKS TICK-BORNE DIS, V2, P81, DOI 10.1016/j.ttbdis.2010.12.003; Roy AN, 2017, VECTOR-BORNE ZOONOT, V17, P735, DOI 10.1089/vbz.2017.2134; Rubidge EM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-34; Salkeld DJ, 2008, AM J TROP MED HYG, V79, P535, DOI 10.4269/ajtmh.2008.79.535; Schicht S, 2012, J MED ENTOMOL, V49, P766, DOI 10.1603/ME11204; Schwanz LE, 2011, VECTOR-BORNE ZOONOT, V11, P117, DOI 10.1089/vbz.2009.0215; Smith C.R., 1984, Proceedings of the Vertebrate Pest Conference, V11, P71; Smith MF, 1998, MOL PHYLOGENET EVOL, V9, P1, DOI 10.1006/mpev.1997.0459; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Stephenson Nicole, 2016, Vet Sci, V3, DOI 10.3390/vetsci3040026; Stephenson N, 2016, EXP APPL ACAROL, V70, P239, DOI 10.1007/s10493-016-0068-8; Tilly K, 2008, INFECT DIS CLIN N AM, V22, P217, DOI 10.1016/j.idc.2007.12.013; Voordouw MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118265; Vourc'h G, 2007, VECTOR-BORNE ZOONOT, V7, P637, DOI 10.1089/vbz.2007.0111; WERNER SB, 1984, JAMA-J AM MED ASSOC, V251, P929, DOI 10.1001/jama.251.7.929; Wikswo ME, 2008, J MED ENTOMOL, V45, P509, DOI 10.1603/0022-2585(2008)45[509:DAIOSF]2.0.CO;2; WILLEBERG PW, 1979, AM J EPIDEMIOL, V110, P328, DOI 10.1093/oxfordjournals.aje.a112818; ZIELINSKI WJ, 1984, GREAT BASIN NAT, V44, P170	70	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189352	10.1371/journal.pone.0189352	http://dx.doi.org/10.1371/journal.pone.0189352			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232397	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200033
J	Guran, R; Vanickova, L; Horak, V; Krizkova, S; Michalek, P; Heger, Z; Zitka, O; Adam, V				Guran, Roman; Vanickova, Lucie; Horak, Vratislav; Krizkova, Sona; Michalek, Petr; Heger, Zbynek; Zitka, Ondrej; Adam, Vojtech			MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; INDUCED BREAKDOWN SPECTROSCOPY; CUTANEOUS MALIGNANT-MELANOMA; METALLOTHIONEIN-OVEREXPRESSION; TOF MS; CANCER; TISSUES; EXPRESSION; TOOL; METASTASIS	Background Treatment of advanced cutaneous melanoma remains challenging, and new data on melanoma biology are required. The most widely accepted criteria for the prognostic evaluation of melanoma are histopathological and clinical parameters, and the identification of additional tumor markers is thus of paramount importance. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI), an important tool in cancer research, is useful for unraveling the molecular profile of melanoma. Methodology/Principal findings In this report, we used the melanoma-bearing Libechov minipig (MeLiM), a unique animal model that allows observation of the complete spontaneous regression of invasive cutaneous melanoma, to investigate i) the differences between melanoma and healthy skin protein profiles and ii) the proteins potentially involved in spontaneous regression. The MeLiM tissues were cryosected, histologically characterized, analyzed by MALDI MSI, and immunohistologically stained. Multivariate statistical analyses of the MALDI MSI data revealed ten relevant m/z ions, of which the expression levels varied significantly among the studied MeLiM tissues. These ion peaks were used to create mass ion images/maps and visualize the differences between tumor and healthy skin specimens, as well as among histologically characterized tissue regions. Conclusions/Significance Protein profiles comprising ten statistically significant mass ion peaks useful for differentiating cutaneous melanoma and healthy skin tissues were determined. Peaks at m/z 3044, 6011, 6140 and 10180 were overexpressed in melanoma compared with healthy skin tissue. More specifically, m/z 6140 was expressed at significantly (p < 0.05) higher levels in normally growing melanoma regions than in regions with early and late spontaneous regression. This study demonstrates the clinical utility of MALDI MSI for the analysis of tissue cryosections at a molecular level.	[Guran, Roman; Vanickova, Lucie; Krizkova, Sona; Michalek, Petr; Heger, Zbynek; Zitka, Ondrej; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic; [Guran, Roman; Krizkova, Sona; Michalek, Petr; Heger, Zbynek; Zitka, Ondrej; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Horak, Vratislav] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Vvi, Libechov, Czech Republic	Mendel University in Brno; Brno University of Technology; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences	Adam, V (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic.; Adam, V (corresponding author), Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic.	vojtech.adam@mendelu.cz	Horak, Vratislav/G-7172-2014; Zitka, Ondrej/L-5588-2019; Heger, Zbyněk/D-1973-2013; Guran, Roman/C-2610-2016; Adam, Vojtech/D-7686-2012; Zitka, Ondrej/E-1107-2012; Vanickova, Lucie/L-7034-2016; Krizkova, Sona/E-9617-2012	Horak, Vratislav/0000-0002-5878-3138; Zitka, Ondrej/0000-0001-7607-5058; Heger, Zbyněk/0000-0002-3915-7270; Guran, Roman/0000-0002-2912-714X; Adam, Vojtech/0000-0002-8527-286X; Zitka, Ondrej/0000-0001-7607-5058; Michalek, Petr/0000-0002-0121-0128; Vanickova, Lucie/0000-0001-7744-3246; Krizkova, Sona/0000-0002-0479-8369	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]; National Sustainability Program [LO1609]; RVO [67985904]; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie [6SA17676]; South Moravian Region [665860]	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC; National Sustainability Program; RVO; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie; South Moravian Region	This research has been financially supported by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) and the National Sustainability Program (project No. LO1609), and RVO 67985904. LV was supported by project 6SA17676 that received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie and which is co financed by the South Moravian Region under grant agreement No. 665860.	Aichler M, 2015, LAB INVEST, V95, P422, DOI 10.1038/labinvest.2014.156; Anyz J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40169; Borovansky J, 2003, MELANOMA RES, V13, P543, DOI 10.1097/01.cmr.0000056276.15046.21; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Casadonte R, 2014, PROTEOMICS, V14, P956, DOI 10.1002/pmic.201300430; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Donato R., 2003, MICROSC RES TECH, V60; Elsner M, 2012, J PROTEOMICS, V75, P4693, DOI 10.1016/j.jprot.2012.02.012; Emri E, 2013, J EUR ACAD DERMATOL, V27, pe320, DOI 10.1111/j.1468-3083.2012.04653.x; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Geffrotin C, 2000, BBA-GEN SUBJECTS, V1524, P196, DOI 10.1016/S0304-4165(00)00158-6; Hardesty WM, 2011, J PROTEOMICS, V74, P1002, DOI 10.1016/j.jprot.2011.04.013; Konecna M, 2014, SPECTROCHIM ACTA B, V101, P220, DOI 10.1016/j.sab.2014.08.037; Kriegsmann J, 2015, INT J ONCOL, V46, P893, DOI 10.3892/ijo.2014.2788; Krizkova S, 2008, SENSORS-BASEL, V8, P3106, DOI 10.3390/s8053106; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Moncayo S, 2017, SPECTROCHIM ACTA B, V133, P40, DOI 10.1016/j.sab.2017.04.013; Mueller L, 2017, ANAL BIOANAL CHEM, V409, P3667, DOI 10.1007/s00216-017-0310-1; Nylund C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045382; Oetjen J, 2016, ANAL BIOANAL CHEM, V408, P6729, DOI 10.1007/s00216-016-9793-4; Pote N, 2013, HEPATOLOGY, V58, P983, DOI 10.1002/hep.26433; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Rodrigo MAM, 2014, J PHARMACEUT BIOMED, V95, P245, DOI 10.1016/j.jpba.2014.03.007; Sabel Michael S, 2011, Int J Proteomics, V2011, P181890, DOI 10.1155/2011/181890; Sasaki M, 2004, EXP DERMATOL, V13, P465, DOI 10.1111/j.0906-6705.2004.00204.x; Shen HW, 2015, APPL IMMUNOHISTO M M, V23, P303, DOI 10.1097/PAI.0000000000000075; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugita K, 2001, AM J DERMATOPATH, V23, P29, DOI 10.1097/00000372-200102000-00005; Tomalova I, 2014, ANAL CHEM, V86, P647, DOI 10.1021/ac402941e; Veselkov KA, 2014, P NATL ACAD SCI USA, V111, P1216, DOI 10.1073/pnas.1310524111; Vincent-Naulleau S, 2004, PIGM CELL RES, V17, P24, DOI 10.1046/j.1600-0749.2003.00101.x; Weinlich G, 2007, J EUR ACAD DERMATOL, V21, P669, DOI 10.1111/j.1468-3083.2006.02051.x; Weinlich G, 2006, BRIT J CANCER, V94, P835, DOI 10.1038/sj.bjc.6603028; Weinlich G, 2009, GIORN ITAL DERMAT V, V144, P27; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111	36	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189305	10.1371/journal.pone.0189305	http://dx.doi.org/10.1371/journal.pone.0189305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220390	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900046
J	Silvent, J; Akiva, A; Brumfeld, V; Reznikov, N; Rechav, K; Yaniv, K; Addadi, L; Weiner, S				Silvent, Jeremie; Akiva, Anat; Brumfeld, Vlad; Reznikov, Natalie; Rechav, Katya; Yaniv, Karina; Addadi, Lia; Weiner, Steve			Zebrafish skeleton development: High resolution micro-CT and FIB-SEM block surface serial imaging for phenotype identification	PLOS ONE			English	Article							DANIO-RERIO OSTARIOPHYSI; 3-DIMENSIONAL STRUCTURE; AXIAL SKELETON; LAMELLAR BONE; INNER-EAR; MUTATIONS; CALCEIN; MODEL; MINERALIZATION; PIGMENTATION	Although bone is one of the most studied living materials, many questions about the manner in which bones form remain unresolved, including fine details of the skeletal structure during development. In this study, we monitored skeleton development of zebrafish larvae, using calcein fluorescence, high-resolution micro-CT 3D images and FIB-SEM in the block surface serial imaging mode. We compared calcein staining of the skeletons of the wild type and nacre mutants, which are transparent zebrafish, with micro-CT for the first 30 days post fertilization embryos, and identified significant differences. We quantified the bone volumes and mineral contents of bones, including otoliths,during development, and showed that such developmental differences, including otolith development, could be helpful in identifying phenotypes. In addition, high-resolution imaging revealed the presence of mineralized aggregates in the notochord, before the formation of the first bone in the axial skeleton. These structures might play a role in the storage of the mineral. Our results highlight the potential of these high-resolution 3D approaches to characterize the zebrafish skeleton, which in turn could prove invaluable information for better understanding the development and the characterization of skeletal phenotypes.	[Silvent, Jeremie; Akiva, Anat; Addadi, Lia; Weiner, Steve] Weizmann Inst Sci, Dept Biol Struct, Rehovot, Israel; [Brumfeld, Vlad; Rechav, Katya] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Reznikov, Natalie] Imperial Coll London, Inst Biomed Engn, Dept Mat, London, England; [Reznikov, Natalie] Imperial Coll London, Inst Biomed Engn, Dept Bioengn, London, England; [Yaniv, Karina] Weizmann Inst Sci, Dept Regulat Biol, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Imperial College London; Imperial College London; Weizmann Institute of Science	Silvent, J (corresponding author), Weizmann Inst Sci, Dept Biol Struct, Rehovot, Israel.	silvent.jeremie@gmail.com	Akiva, Anat/A-2086-2017	Reznikov, Natalie/0000-0001-5293-4647; Akiva, Anat/0000-0003-0414-889X	ISRAEL SCIENCE FOUNDATION [875/15]; Clore-Krenter-Katz postdoctoral fellowship	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation); Clore-Krenter-Katz postdoctoral fellowship	This research was supported by the ISRAEL SCIENCE FOUNDATION (grant number 875/15). J.S. is supported by a Clore-Krenter-Katz postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva A, 2015, BONE, V75, P192, DOI 10.1016/j.bone.2015.02.020; Antinucci P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29490; Atkins A, 2015, ACTA BIOMATER, V13, P311, DOI 10.1016/j.actbio.2014.10.025; Baker CVH, 1997, DEVELOPMENT, V124, P3077; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bennet M, 2014, BIOPHYS J, V106, pL17, DOI 10.1016/j.bpj.2014.01.002; Bensimon-Brito A, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0102-4; Bensimon-Brito A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-28; Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Borovansky J, 1994, Sb Lek, V95, P309; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Eames BF, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-23; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; FRENZ DA, 1991, DEV BIOL, V144, P38, DOI 10.1016/0012-1606(91)90476-J; GERAUDIE J, 1984, TISSUE CELL, V16, P217, DOI 10.1016/0040-8166(84)90046-6; Geurtzen K, 2014, DEVELOPMENT, V141, P2225, DOI 10.1242/dev.105817; Goldsmith JR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/817341; Goodrich ES, 1904, Q J MICROSC SCI, V47, P465; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101; Hayes M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5777; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Inoue M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02114; Jarvik E., 2016, ANAT REC; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kanazawa T, 2016, J ORTHOP RES, V34, P969, DOI 10.1002/jor.23111; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lister JA, 1999, DEVELOPMENT, V126, P3757; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Mackay Eirinn W, 2013, Bonekey Rep, V2, P445, DOI 10.1038/bonekey.2013.179; Magal RA, 2014, J STRUCT BIOL, V186, P253, DOI 10.1016/j.jsb.2014.03.007; MILOS N, 1978, J EXP ZOOL, V205, P205, DOI 10.1002/jez.1402050205; Moran AL, 2000, MAR BIOL, V137, P893, DOI 10.1007/s002270000390; Naveh GRS, 2013, J STRUCT BIOL, V181, P108, DOI 10.1016/j.jsb.2012.10.008; Neues F, 2006, MATERIALWISS WERKST, V37, P426, DOI 10.1002/mawe.200600009; Nicenboim J, 2015, NATURE, V522, P56, DOI 10.1038/nature14425; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Odenthal J, 1996, DEVELOPMENT, V123, P391; Otis JP, 2015, DIS MODEL MECH, V8, P295, DOI 10.1242/dmm.018754; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parker MO, 2013, ZEBRAFISH, V10, P466, DOI 10.1089/zeb.2013.0878; Pasco-Viel E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011293; PAUL H, 1983, ARTHRITIS RHEUM, V26, P191, DOI 10.1002/art.1780260211; Reznikov N, 2014, ACTA BIOMATER, V10, P3815, DOI 10.1016/j.actbio.2014.05.024; Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Riley BB, 2000, J NEUROBIOL, V43, P329, DOI 10.1002/1097-4695(20000615)43:4<329::AID-NEU2>3.3.CO;2-8; Sassen W. A., 2015, Advances in Genomics and Genetics, V5, P151; Schneider P, 2011, BONE, V49, P304, DOI 10.1016/j.bone.2011.04.005; Seritrakul P, 2012, FASEB J, V26, P5014, DOI 10.1096/fj.12-209304; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Storer NY, 2013, DEVELOPMENT, V140, P3040, DOI 10.1242/dev.087858; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Wang S, 2013, J ANAT, V223, P159, DOI 10.1111/joa.12067; Weiner A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005602; Wenner M, 2009, NAT MED, V15, P1106, DOI 10.1038/nm1009-1106; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Whitfield TT, 1996, DEVELOPMENT, V123, P241; WILSON CA, 1987, T AM FISH SOC, V116, P668, DOI 10.1577/1548-8659(1987)116<668:CAAFMO>2.0.CO;2; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	68	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0177731	10.1371/journal.pone.0177731	http://dx.doi.org/10.1371/journal.pone.0177731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220379	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900001
J	Wu, XH; Wang, W; Yin, CM; Hou, HJ; Xie, KJ; Xie, XL				Wu, Xiao Hong; Wang, Wei; Yin, Chun Mei; Hou, Hai Jun; Xie, Ke Jun; Xie, Xiao Li			Water consumption, grain yield, and water productivity in response to field water management in double rice systems in China	PLOS ONE			English	Article							IRRIGATED LOWLAND RICE; PHILIPPINES; MOVEMENT; ENERGY; CROP; ASIA	Rice cultivation has been challenged by increasing food demand and water scarcity. We examined the responses of water use, grain yield, and water productivity to various modes of field water managements in Chinese double rice systems. Four treatments were studied in a long-term field experiment (1998-2015): continuous flooding (CF), flooding-midseason drying-flooding (F-D-F), flooding-midseason drying-intermittent irrigation without obvious standing water (F-D-S), and flooding-rain-fed (F-RF). The average precipitation was 483 mm in early-rice season and 397 mm in late-rice season. The irrigated water for CF, F-D-F, F-D-S, and F-RF, respectively, was 263, 340, 279, and 170 mm in early-rice season, and 484, 528, 422, and 206 mm in late-rice season. Grain yield for CF, F-D-F, F-D-S, and F-RF, respectively, was 4,722, 4,597, 4,479, and 4,232 kgha(-1) in early-rice season, and 5,420, 5,402, 5,366, and 4,498 kgha(-1) in late-rice season. Compared with CF, F-D-F consumed more irrigated water, which still decreased grain yield, leading to a decrease in water productivity by 25% in early-rice season and by 8% in late-rice season. Compared with F-D-F, F-D-S saved much irrigated water with a small yield reduction, leading to an increase in water productivity by 22% in early-rice season and by 26% in late-rice season. The results indicate that CF is best for early-rice and FDS is best for late-rice in terms of grain yield and water productivity.	[Wu, Xiao Hong] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China; [Wang, Wei; Yin, Chun Mei; Hou, Hai Jun; Xie, Xiao Li] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Xie, Ke Jun] Hunan Agr Resources & Environm Protect Management, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Wang, W (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	wangw@isa.ac.cn	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628; , Wang/0000-0003-0542-661X	National Natural Science Foundation of China [41401292, 41503081]; International Science & Technology Cooperation Program of China [2015DFA90450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by the National Natural Science Foundation of China (grant numbers 41401292) to WW (http:/www.nsfc.gov.cn/); International Science & Technology Cooperation Program of China (grant number 2015DFA90450) to WW (http://www.istcp.org.cn/) and the National Natural Science Foundation of China (grant number 41503081) to XHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto MCR, 2011, AGR WATER MANAGE, V98, P1417, DOI 10.1016/j.agwat.2011.04.011; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Belder P, 2004, AGR WATER MANAGE, V65, P193, DOI 10.1016/j.agwat.2003.09.002; Bouman BAM, 2007, ADV AGRON, V92, P187, DOI 10.1016/S0065-2113(04)92004-4; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; Bouman BAM, 2007, WATER MANAGEMENT IRR, P44; Cabangon RJ, 2004, PADDY WATER ENVIRON, V2, P195, DOI 10.1007/s10333-004-0062-3; Chen SK, 2002, J HYDROL, V268, P259, DOI 10.1016/S0022-1694(02)00180-4; Chen SK, 2002, J HYDROL, V260, P206, DOI 10.1016/S0022-1694(01)00615-1; Dawe D, 2005, PLANT PROD SCI, V8, P221, DOI 10.1626/pps.8.221; Escasinas RO, 2011, PHILIPP J CROP SCI, V36, P37; Fong JDM, 2016, PADDY WATER ENVIRON, V14, P211, DOI 10.1007/s10333-015-0491-1; Frolking S., 2002, GLOBAL BIOGEOCHEM CY, V16; Janssen M, 2007, SOIL TILL RES, V94, P133, DOI 10.1016/j.still.2006.07.010; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Lampayan RM, 2015, FIELD CROP RES, V170, P95, DOI 10.1016/j.fcr.2014.10.013; Lu J, 2000, PLANT SOIL, V223, P209, DOI 10.1023/A:1004898504550; Nguyen HT, 2009, FIELD CROP RES, V112, P189, DOI 10.1016/j.fcr.2009.03.004; Pan SG, 2009, J FOOD AGRIC ENVIRON, V7, P559; Shao GC, 2015, AGR WATER MANAGE, V149, P156, DOI 10.1016/j.agwat.2014.11.002; Singh YV, 2013, PADDY WATER ENVIRON, V11, P531, DOI 10.1007/s10333-012-0346-y; Stuerz S, 2014, FIELD CROP RES, V163, P74, DOI 10.1016/j.fcr.2014.04.001; Tabbal DF, 2002, AGR WATER MANAGE, V56, P93, DOI 10.1016/S0378-3774(02)00007-0; Tan XZ, 2013, PADDY WATER ENVIRON, V11, P381, DOI 10.1007/s10333-012-0328-0; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Xiong W, 2010, AGR ECOSYST ENVIRON, V135, P58, DOI 10.1016/j.agee.2009.08.015; Yan TT, 2015, ECOL MODEL, V318, P226, DOI 10.1016/j.ecolmodel.2014.12.021; Zhang QT, 2013, J INTEGR AGR, V12, P1363, DOI 10.1016/S2095-3119(13)60544-4	29	19	19	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189280	10.1371/journal.pone.0189280	http://dx.doi.org/10.1371/journal.pone.0189280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216292	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800112
J	Zavrel, T; Ocenasova, P; Cerveny, J				Zavrel, Tomas; Ocenasova, Petra; Cerveny, Jan			Phenotypic characterization of Synechocystis sp PCC 6803 substrains reveals differences in sensitivity to abiotic stress	PLOS ONE			English	Article							SP STRAIN PCC-6803; HIGH-TEMPERATURE; SP PCC6803; CYANOBACTERIUM; GROWTH; RESPONSES; ACCLIMATION; GENE; PHOTOBIOREACTOR; IDENTIFICATION	Synechocystis sp. PCC 6803 is a widely used model cyanobacterium, whose substrains can vary on both genotype and phenotype levels. Previously described phenotypic variations include ability of mixotrophic growth, ability of movement on agar plates and variations in pigments composition or cell size. In this study, we report for the first time significant variation among Synechocystis substrains in complex cellular traits such as growth rate, photosynthesis efficiency, cellular dry weight and cellular composition (including protein or carbohydrates content). We also confirmed previously reported differences in cell size. Synechocystis cultures were cultivated in controlled environment of flat panel photobioreactors under red, blue and white light of intensities up to 790 mu mol(photons) m(-2) s(-1), temperatures 23 degrees C-60 degrees C, input CO2 concentrations ranging from 400 to 15 000 ppm and in BG11 cultivation medium with and without addition of NaCl. Three Synechocystis substrains were used for the comparative experiments: GT-L, GT-B (Brno, CZ) and PCC-B (Brno, CZ). Growth rates of Synechocystis GT-B were inhibited under high intensities of red light (585-670 nm), and growth rates of both substrains GT-B and PCC-B were inhibited under photons of wavelengths 485-585 nm and 670-700 nm. Synechocystis GT-B was more sensitive to low temperatures than the other two tested substrains, and Synechocystis GT-L was sensitive to the presence of NaCl in the cultivation media. The results suggest that stress sensitivity of commonly used Synechocystis substrains can strongly vary, similarly as glucose tolerance or motility as reported previously. Our study further supports the previous statement that emphasizes importance of proper Synechocystis substrains selection and awareness of phenotypical differences among Synechocystis substrains which is crucial for comparative and reproducible research. This is highly relevant for studies related to stress physiology and development of sustainable biotechnological applications.	[Zavrel, Tomas; Ocenasova, Petra; Cerveny, Jan] Global Change Res Inst CAS, Dept Adapt Biotechnol, Brno, Czech Republic	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Zavrel, T (corresponding author), Global Change Res Inst CAS, Dept Adapt Biotechnol, Brno, Czech Republic.	zavrel.t@czechglobe.cz	Zavřel, Tomáš/L-5814-2019; Červený, Jan/J-1911-2012	Zavřel, Tomáš/0000-0002-0849-3503; Červený, Jan/0000-0002-5046-3105	Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I) [LO1415]; GA CR [15-17367S]; Czech research infrastructure for systems biology C4SYS [LM2015055]	Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I); GA CR(Grant Agency of the Czech Republic); Czech research infrastructure for systems biology C4SYS	T.Z and J.O. were supported by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I), grant number LO1415. J.C. and P.O. were also supported by GA CR, Grant number 15-17367S and J.O. was also supported by the Czech research infrastructure for systems biology C4SYS (project no LM2015055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Maria Sinetova for valuable advices on experimental setup and discussion of the results, Petra Litera A kova A for technical assistance and Dr. Kristy A na Vecerova A for analysis of cellular fatty acid composition. T.Z and J.C. were supported by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I), grant number LO1415. J.C. and P.O. were also supported by GA CR, Grant number 15-17367S. Access to instruments and other facilities was supported by the Czech research infrastructure for systems biology C4SYS (project no LM2015055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Cerveny Jan, 2015, Life-Basel, V5, P676, DOI 10.3390/life5010676; Cerveny J, 2009, ENG LIFE SCI, V9, P247, DOI 10.1002/elsc.200800123; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Dilley RA, 2001, J BIOENERG BIOMEMBR, V33, P135, DOI 10.1023/A:1010752531909; Ding QL, 2015, INT J MOL SCI, V16, P24081, DOI 10.3390/ijms161024081; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fang F, 2003, CURR MICROBIOL, V47, P341, DOI 10.1007/s00284-002-4015-z; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Hihara Y, 1997, PHOTOSYNTH RES, V53, P243, DOI 10.1023/A:1005879905365; HUFLEJT ME, 1990, PLANT PHYSIOL, V94, P1512, DOI 10.1104/pp.94.4.1512; Ikeuchi M, 2001, PHOTOSYNTH RES, V70, P73, DOI 10.1023/A:1013887908680; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; Joseph A, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0017-z; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Kana R, 2012, BBA-BIOENERGETICS, V1817, P1237, DOI 10.1016/j.bbabio.2012.02.024; Kaneko T, 1996, DNA Res, V3, P109; Kaneko T, 1995, DNA Res, V2, P153, DOI 10.1093/dnares/2.4.153; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; Kirilovsky D., 2014, NONPHOTOCHEMICAL QUE; Kreslavski VD, 2012, J PHOTOCH PHOTOBIO C, V13, P190, DOI 10.1016/j.jphotochemrev.2012.01.002; Marin K, 2004, PLANT PHYSIOL, V136, P300, DOI DOI 10.1104/PP.104.045047; Mironov KS, 2016, LIGHT REGULATION COL, P881; Morris JN, 2014, NEW ZEAL J BOT, V52, P36, DOI 10.1080/0028825X.2013.846267; Morris JN, 2016, NZ J BOT; Nanjo Y, 2010, BBA-BIOENERGETICS, V1797, P1483, DOI 10.1016/j.bbabio.2010.03.014; Nazarenko LV, 2003, MICROBIOL-SGM, V149, P1147, DOI 10.1099/mic.0.26074-0; Nedbal L, 2008, BIOTECHNOL BIOENG, V100, P902, DOI 10.1002/bit.21833; Pade Nadin, 2015, Life-Basel, V5, P25, DOI 10.3390/life5010025; PLATT T, 1980, J MAR RES, V38, P687; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sarsekeyeva F, 2015, PHOTOSYNTH RES, V125, P329, DOI 10.1007/s11120-015-0103-3; Sheng J, 2011, BIORESOURCE TECHNOL, V102, P11218, DOI 10.1016/j.biortech.2011.09.083; Sinetova MA, 2016, MOL BIOL+, V50, P606, DOI 10.1134/S0026893316040117; Sinetova MA, 2016, BBA-GEN SUBJECTS, V1860, P2391, DOI 10.1016/j.bbagen.2016.07.006; Sinetova MA, 2012, J BIOTECHNOL, V162, P148, DOI 10.1016/j.jbiotec.2012.04.009; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Tajima N, 2011, DNA RES, V18, P393, DOI 10.1093/dnares/dsr026; Tichy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00648; Torrecilla I, 2001, PLANT CELL ENVIRON, V24, P641, DOI 10.1046/j.0016-8025.2001.00708.x; Touloupakis E, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0319-7; WADA H, 1990, PLANT PHYSIOL, V92, P1062, DOI 10.1104/pp.92.4.1062; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zavrel T., 2015, BIO-PROTOCOL, V5, P1, DOI [10.21769/BioProtoc.1467, DOI 10.21769/BIOPROTOC.1467]; Zavrel T, 2015, ENG LIFE SCI, V15, P122, DOI 10.1002/elsc.201300165; Zerulla K, 2016, MICROBIOL-SGM, V162, P730, DOI 10.1099/mic.0.000264	50	24	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189130	10.1371/journal.pone.0189130	http://dx.doi.org/10.1371/journal.pone.0189130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216280	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800079
J	Im, JY; Kim, BK; Lee, JY; Park, SH; Ban, HS; Jung, KE; Won, M				Im, Joo-Young; Kim, Bo-Kyung; Lee, Ji-Young; Park, Seung-Ho; Ban, Hyun Seung; Jung, Kyeong Eun; Won, Misun			DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells	ONCOGENE			English	Article							DEATH RECEPTOR; DNA-DAMAGE; IN-VIVO; C-JUN; SIGNALING COMPLEX; LUNG-CARCINOMA; PROTEIN-KINASE; KEY REGULATOR; DOCKING SITE; EXPRESSION	DNA damage-induced apoptosis suppressor (DDIAS) has an anti-apoptotic function during DNA damage in lung cancer. However, the anti-apoptotic mechanism of DDIAS in cancer cells under other conditions has not been reported. We report here that DDIAS protects cancer cells from tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by two distinct mechanisms in non-small cell lung cancer (NSCLC) and hepatocellular carcinoma (HCC) cells. DDIAS depletion sensitized NSCLC and HCC cells to TRAIL-mediated apoptosis, an effect that was abrogated by pharmacological or genetic inhibition of caspase-8 and was independent of caspase-9, p53, or mitogen-activated protein kinase signaling. Interestingly, we found that the N terminus of DDIAS interacted with the death effector domain of Fas-associated protein death domain (FADD) and prevented its recruitment to the death-inducing signaling complex (DISC), thereby blocking caspase-8 activation. DDIAS knockdown also suppressed epidermal growth factor-induced phosphorylation of p90 ribosomal S6 kinase (RSK) 2 and stabilized caspase-8 by preventing its ubiquitination and proteasomal degradation. This effect was abolished by RSK2 overexpression. Taken together, DDIAS has dual functions in inhibiting DISC formation as well as in destabilizing caspase-8, thereby suppressing TRAIL-mediated apoptosis of cancer cells. Thus, we suggest that DDIAS can serve as an effective therapeutic target in the treatment of NSCLC and HCC.	[Im, Joo-Young; Kim, Bo-Kyung; Lee, Ji-Young; Park, Seung-Ho; Won, Misun] KRIBB, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Ban, Hyun Seung] KRIBB, Metab Regulat Res Ctr, Daejeon, South Korea; [Jung, Kyeong Eun] ST Pharm Co Ltd, Sihwa Ind Complex 1, Kyunggido, South Korea; [Won, Misun] Korea Univ Sci & Technol UST, KRIBB Sch Biotechnol, Dept Funct Genom, 217 Gajeong Ro, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Won, M (corresponding author), KRIBB, Personalized Genom Med Res Ctr, Daejeon, South Korea.; Won, M (corresponding author), Korea Univ Sci & Technol UST, KRIBB Sch Biotechnol, Dept Funct Genom, 217 Gajeong Ro, Daejeon, South Korea.	misun@kribb.re.kr	Ban, Hyun Seung/F-9526-2014	Ban, Hyun Seung/0000-0002-2698-6037	KRIBB Initiative Program [KGM4751713]; National Research Foundation (NRF) [2017R1A2B2011936, 2017M3A9F9030565]; Health Technology RD [HI13C2162]	KRIBB Initiative Program; National Research Foundation (NRF); Health Technology RD	This work was supported by the KRIBB Initiative Program (KGM4751713), National Research Foundation (NRF; 2017R1A2B2011936 and 2017M3A9F9030565), and Health Technology R&D (HI13C2162).	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cheng HR, 2012, CELL CYCLE, V11, P3312, DOI 10.4161/cc.21670; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2012, CARCINOGENESIS, V33, P2529, DOI 10.1093/carcin/bgs271; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fu K, 2012, ONCOGENE, V31, P1311, DOI 10.1038/onc.2011.315; Gibson SB, 2000, MOL CELL BIOL, V20, P205, DOI 10.1128/MCB.20.1.205-212.2000; Guan BX, 2001, J CELL PHYSIOL, V188, P98, DOI 10.1002/jcp.1101; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Im JY, 2016, BBA-GENE REGUL MECH, V1859, P1449, DOI 10.1016/j.bbagrm.2016.07.003; Im JY, 2016, BBA-MOL CELL RES, V1863, P40, DOI 10.1016/j.bbamcr.2015.10.011; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kim BK, 2014, BBA-GENE REGUL MECH, V1839, P364, DOI 10.1016/j.bbagrm.2014.03.004; Kitsberg D, 1999, J NEUROSCI, V19, P8244; Lee MW, 2002, FEBS LETT, V512, P313, DOI 10.1016/S0014-5793(02)02225-1; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagane M, 2000, CANCER RES, V60, P847; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Peng C, 2011, J BIOL CHEM, V286, P6946, DOI 10.1074/jbc.M110.172338; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Sun BK, 2011, ONCOL REP, V25, P537, DOI 10.3892/or.2010.1079; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Won KJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.488; Won KJ, 2014, INT J CANCER, V134, P2595, DOI 10.1002/ijc.28600; Zhang ZZ, 2015, INT J CANCER, V137, P765, DOI 10.1002/ijc.29451	40	18	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1251	1262		10.1038/s41388-017-0025-y	http://dx.doi.org/10.1038/s41388-017-0025-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29242605				2022-12-26	WOS:000426505400009
J	Kim, CM; Jeon, SH; Choi, JH; Lee, JH; Park, HH				Kim, Chang Min; Jeon, Sun Hee; Choi, Jun-Hyuk; Lee, Jun Hyuck; Park, Hyun Ho			Interaction mode of CIDE family proteins in fly: DREP1 and DREP3 acidic surfaces interact with DREP2 and DREP4 basic surfaces	PLOS ONE			English	Article							APOPTOTIC DNA FRAGMENTATION; CASPASE-ACTIVATED DNASE; DROSOPHILA-MELANOGASTER; N DOMAIN; ICAD; INHIBITOR; COMPLEX; SYSTEM; FSP27; LOCALIZATION	Cell death-inducing DNA fragmentation factor 45 (DFF45)-like effector (CIDE) domains were initially identified as protein interaction modules in apoptotic nucleases and are now known to form a highly conserved family with diverse functions that range from cell death to lipid homeostasis. In the fly, four CIDE domain-containing proteins (DFF-related protein [DREP]-1-4) and their functions, including interaction relationships, have been identified. In this study, we introduced and investigated acidic side-disrupted mutants of DREP1, DREP2, and DREP3. We discovered that the acidic surface patches of DREP1 and DREP3 are critical for the homo-dimerization. In addition, we found that the acidic surface sides of DREP1 and DREP3 interact with the basic surface sides of DREP2 and DREP4. Our current study provides clear evidence demonstrating the mechanism of the interactions between four DREP proteins in the fly.	[Kim, Chang Min; Jeon, Sun Hee; Park, Hyun Ho] Yeungnam Univ, Dept Chem & Biochem, Sch Nat Sci, Gyongsan, South Korea; [Kim, Chang Min; Jeon, Sun Hee] Yeungnam Univ, Grad Sch Biochem, Gyongsan, South Korea; [Choi, Jun-Hyuk] Korea Res Inst Stand & Sci, Ctr Bioanal, Dept Metrol Qual Life, Daejeon, South Korea; [Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Inchon, South Korea	Yeungnam University; Yeungnam University; Korea Research Institute of Standards & Science (KRISS); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Park, HH (corresponding author), Yeungnam Univ, Dept Chem & Biochem, Sch Nat Sci, Gyongsan, South Korea.	hyunho@ynu.ac.kr		park, hyun ho/0000-0001-9928-0847	Yeungnam University	Yeungnam University	This research was supported by the Yeungnam University research grant at 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JY, 2017, P NATL ACAD SCI USA, V114, P7361, DOI 10.1073/pnas.1705949114; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fukushima K, 2002, J MOL BIOL, V321, P317, DOI 10.1016/S0022-2836(02)00588-0; Inohara N, 1999, CELL DEATH DIFFER, V6, P823, DOI 10.1038/sj.cdd.4400570; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Lechardeur D, 2000, J CELL BIOL, V150, P321, DOI 10.1083/jcb.150.2.321; Lee SM, 2014, APOPTOSIS, V19, P428, DOI 10.1007/s10495-013-0941-4; Lee SM, 2013, BIOCHEM BIOPH RES CO, V439, P564, DOI 10.1016/j.bbrc.2013.09.018; Lee SM, 2013, FEBS LETT, V587, P854, DOI 10.1016/j.febslet.2013.02.031; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Mukae N, 2000, J BIOL CHEM, V275, P21402, DOI 10.1074/jbc.M909611199; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Otomo T, 2000, NAT STRUCT BIOL, V7, P658, DOI 10.1038/77957; Park HH, 2015, APOPTOSIS, V20, P240, DOI 10.1007/s10495-014-1067-z; Park OK, 2012, FEBS LETT, V586, P3085, DOI 10.1016/j.febslet.2012.07.056; Park OK, 2011, ACTA CRYSTALLOGR F, V67, P457, DOI 10.1107/S1744309111003113; Park OK, 2013, APOPTOSIS, V18, P385, DOI 10.1007/s10495-013-0815-9; Sakahira H, 1999, J BIOL CHEM, V274, P15740, DOI 10.1074/jbc.274.22.15740; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yokoyama H, 2000, J BIOL CHEM, V275, P12978, DOI 10.1074/jbc.275.17.12978; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	28	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189819	10.1371/journal.pone.0189819	http://dx.doi.org/10.1371/journal.pone.0189819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240809	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600073
J	Lian, GW; Kanaujia, S; Wong, T; Sheen, V				Lian, Gewei; Kanaujia, Sneha; Wong, Timothy; Sheen, Volney			FilaminA and Formin2 regulate skeletal, muscular, and intestinal formation through mesenchymal progenitor proliferation	PLOS ONE			English	Article							PERIVENTRICULAR HETEROTOPIA; INTELLECTUAL DISABILITY; NEURONAL MIGRATION; MISSENSE MUTATION; DEFECTS; PHOSPHORYLATION; ACTIVATION; PATHWAY; PROTEIN; DOMAIN	The effects of actin dependent molecular mechanisms in coordinating cellular proliferation, migration and differentiation during embryogenesis are not well-understood. We have previously shown that actin-binding Filamin A (FlnA) and actin-nucleating Formin 2 (Fmn2) influence the development of the brain causing microcephaly in mice. In this study, we broaden this phenotype to explore the effects of these two proteins in the development of extra-CNS organ systems, including the gut, muscle, and skeleton. We observed defects in rib and sternum midline closure leading to thoracoabdominal schisis in FlnA+Fmn2 knockout mice, reminiscent of the pentalogy of Cantrell syndrome. These mice exhibit shortened guts, as well as thinned thoracic muscle mass. Immunostaining showed these changes are partially caused by a decrease in the number of presumptive mesenchymal proliferating cells with loss of either FlnA or FlnA+Fmn2. This proliferation defect appears to be in part due to delayed differentiation in these regions. While both FlnA and FlnA+Fmn2 mice show reduced cell death relative to WT control, increased caspase staining was seen in the double null relative to FlnA null suggesting that this could also contribute to the FlnA+Fmn2 phenotype. Therefore FlnA and Fmn2 are likely essential to cell proliferation, differentiation and cell death in a variety of tissues and organs, further reiterating the importance of vesicle trafficking in regulation of development.	[Sheen, Volney] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sheen, V (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	vsheen@bidmc.harvard.edu			National Institutes of Health [1R01NS092062]; Doris Duke Charitable Foundation [2016073]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health 1R01NS092062 to VS and by Grant 2016073 from the Doris Duke Charitable Foundation to TW and VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Almuqbil M, 2013, EUR J MED GENET, V56, P686, DOI 10.1016/j.ejmg.2013.10.003; Avila-Smirnow D, 2016, REV NEUROL-FRANCE, V172, P594, DOI 10.1016/j.neurol.2016.07.017; CANTRELL JR, 1958, SURG GYNECOL OBSTET, V107, P602; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; HAQUE KN, 1984, CLIN GENET, V25, P362; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Hu JJ, 2017, HUM MOL GENET, V26, P1294, DOI 10.1093/hmg/ddx047; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Law R, 2014, AM J HUM GENET, V95, P721, DOI 10.1016/j.ajhg.2014.10.016; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lian GW, 2016, DEVELOPMENT, V143, P4509, DOI 10.1242/dev.139295; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Lu J, 2006, J COMP NEUROL, V494, P476, DOI 10.1002/cne.20806; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Regard J. B., 2012, COLD SPRING HARB PER, V4; van der Werf CS, 2015, BBA-MOL BASIS DIS, V1852, P2352, DOI 10.1016/j.bbadis.2015.08.007; Washington RW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-10; Zhang JP, 2013, J NEUROSCI, V33, P15735, DOI 10.1523/JNEUROSCI.1939-13.2013; Zhang JP, 2012, J NEUROSCI, V32, P12619, DOI 10.1523/JNEUROSCI.1063-12.2012; Zhao YT, 2016, AM J PHYSIOL-CELL PH, V310, pC89, DOI 10.1152/ajpcell.00274.2015	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189285	10.1371/journal.pone.0189285	http://dx.doi.org/10.1371/journal.pone.0189285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240780	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600025
J	Carro-Temboury, MR; Arppe, R; Hempel, C; Vosch, T; Sorensen, TJ				Carro-Temboury, Miguel R.; Arppe, Riikka; Hempel, Casper; Vosch, Tom; Sorensen, Thomas Just			Creating infinite contrast in fluorescence microscopy by using lanthanide centered emission	PLOS ONE			English	Article							TIME-RESOLVED FLUOROIMMUNOASSAY; LOCK-IN DETECTION; NEAR-IR EMISSION; IMAGING MICROSCOPY; ENERGY-TRANSFER; LIGAND-BINDING; LIVING CELLS; LUMINESCENCE; COMPLEXES; AUTOFLUORESCENCE	The popularity of fluorescence microscopy arises from the inherent mode of action, where the fluorescence emission from probes is used to visualize selected features on a presumed dark background. However, the background is rarely truly dark, and image processing and analysis is needed to enhance the fluorescent signal that is ascribed to the selected feature. The image acquisition is facilitated by using considerable illumination, bright probes at a relatively high concentration in order to make the fluorescent signal significantly more intense than the background signal. Here, we present two methods for completely removing the background signal in spectrally resolved fluorescence microscopy. The methodology is applicable for all probes with narrow and well-defined emission bands (Full width half-maximum < 20 nm). Here, we use two lanthanide based probes exploiting the narrow emission lines of europium(III) and terbium(III) ions. We used a model system with zeolites doped with lanthanides immobilized in a polymer stained with several fluorescent dyes regularly used in bioimaging. After smoothing the spectral data recorded in each pixel, they are differentiated. Method I is based on the direct sum of the gradient, while method II resolves the fluorescent signal by subtracting a background calculated via the gradient. Both methods improve signal-to-background ratio significantly and we suggest that spectral imaging of lanthanide-centered emission can be used as a tool to obtain absolute contrast in bioimaging.	[Carro-Temboury, Miguel R.; Arppe, Riikka; Vosch, Tom; Sorensen, Thomas Just] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Carro-Temboury, Miguel R.; Arppe, Riikka; Vosch, Tom; Sorensen, Thomas Just] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Hempel, Casper] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark	Vosch, T; Sorensen, TJ (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.; Vosch, T; Sorensen, TJ (corresponding author), Univ Copenhagen, Dept Chem, Copenhagen, Denmark.; Hempel, C (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark.	casperhempel@gmail.com; tom@chem.ku.dk; TJS@chem.ku.dk	Hempel, Casper/ABE-7065-2020; Vosch, Tom/AAT-3852-2020; Sørensen, Thomas Just/C-2521-2013; Arppe, Riikka/J-2249-2016; Vosch, Tom/B-4234-2015	Hempel, Casper/0000-0002-9816-4673; Vosch, Tom/0000-0001-5435-2181; Sørensen, Thomas Just/0000-0003-1491-5116; Arppe, Riikka/0000-0002-9930-1676; Vosch, Tom/0000-0001-5435-2181	UNIK research initiative of the Danish Ministry of Higher Education Science [09-065274]; Danish Council of Independent Research [DFF-1323-00352, DFF-6110-00554]; Villum Fonden [00014922] Funding Source: researchfish	UNIK research initiative of the Danish Ministry of Higher Education Science; Danish Council of Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	We thank bio-SYNergy University of Copenhagens Excellence Programme for Interdisciplinary Research, Villum Fonden, the Center for Synthetic Biology at Copenhagen University funded by the UNIK research initiative of the Danish Ministry of Higher Education & Science (09-065274), and the Danish Council of Independent Research (DFF-1323-00352 to TV and DFF-6110-00554 to CH) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bui AT, 2015, CHEM-EUR J, V21, P17757, DOI 10.1002/chem.201503711; Arppe R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188359; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Baggaley E, 2014, CHEM SCI, V5, P879, DOI 10.1039/c3sc51875b; Barnhill HN, 2007, J AM CHEM SOC, V129, P7799, DOI 10.1021/ja069148u; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; BEVERLOO HB, 1990, CYTOMETRY, V11, P784, DOI 10.1002/cyto.990110704; Cadusch PJ, 2013, J RAMAN SPECTROSC, V44, P1587, DOI 10.1002/jrs.4371; Charbonniere LJ, 2006, J AM CHEM SOC, V128, P12800, DOI 10.1021/ja062693a; Delbianco M, 2014, ANGEW CHEM INT EDIT, V53, P10718, DOI 10.1002/anie.201406632; Foucault-Collet A, 2013, P NATL ACAD SCI USA, V110, P17199, DOI 10.1073/pnas.1305910110; Frawley AT, 2016, CHEM COMMUN, V52, P13349, DOI 10.1039/c6cc07313a; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grichine A, 2014, CHEM SCI, V5, P3475, DOI 10.1039/c4sc00473f; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HEMMILA I, 1984, ANAL BIOCHEM, V137, P335, DOI 10.1016/0003-2697(84)90095-2; Hemmila I, 2008, CRIT REV CLIN LAB SC, V38, P441; Hung CS, 2016, MULTIMED TOOLS APPL, V75, P1243, DOI 10.1007/s11042-014-2366-7; Liao ZY, 2015, RSC ADV, V5, P70282, DOI 10.1039/c5ra15759e; Liao ZY, 2015, CHEM COMMUN, V51, P2372, DOI 10.1039/c4cc09618e; Liao ZY, 2013, J AM CHEM SOC, V135, P19180, DOI 10.1021/ja407431w; Mao S, 2008, BIOPHYS J, V94, P4515, DOI 10.1529/biophysj.107.124859; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; Montgomery CP, 2009, ACCOUNTS CHEM RES, V42, P925, DOI 10.1021/ar800174z; Moore EG, 2009, ACCOUNTS CHEM RES, V42, P542, DOI 10.1021/ar800211j; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; PETTERSSON K, 1983, CLIN CHEM, V29, P60; Rich RM, 2013, ANAL BIOANAL CHEM, V405, P2065, DOI 10.1007/s00216-012-6623-1; Richards CI, 2009, J AM CHEM SOC, V131, P4619, DOI 10.1021/ja809785s; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; SIITARI H, 1983, NATURE, V301, P258, DOI 10.1038/301258a0; SOINI E, 1979, CLIN CHEM, V25, P353; Solni E., 1983, CLIN CHEM, V29, P65; Tarolli JG, 2017, ANALYST, V142, P1499, DOI 10.1039/c7an00175d; Vereb G, 1998, BIOPHYS J, V74, P2210, DOI 10.1016/S0006-3495(98)77930-5; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	38	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189529	10.1371/journal.pone.0189529	http://dx.doi.org/10.1371/journal.pone.0189529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236769	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100077
J	Kanguru, L; McCaw-Binns, A; Bell, J; Yonger-Coleman, N; Wilks, R; Hussein, J				Kanguru, Lovney; McCaw-Binns, Affette; Bell, Jacqueline; Yonger-Coleman, Novie; Wilks, Rainford; Hussein, Julia			The burden of obesity in women of reproductive age and in pregnancy in a middle-income setting: A population based study from Jamaica	PLOS ONE			English	Article							MATERNAL MORTALITY SURVEILLANCE; OVERWEIGHT; DEATH; RISK	Introduction Obesity is rising globally and is associated with increased risk of adverse pregnancy outcomes. This study aims to investigate overweight and obesity and its consequences among Jamaican women of reproductive age, particularly development of diabetes, hypertension and the risk of maternal death. Materials and methods A national lifestyle survey (2007/8) of 1371 women of reproductive age provided data on the prevalence of high BMI, associated risk factors and co-morbidities. A national maternal mortality surveillance database (1998-2012) of 798 maternal deaths was used to investigate maternal deaths in obese women. Chi-squared and Fisher exact tests were used. Results High BMI (> = 25kg/m(2)) occurred in 63% of women aged between 15 and 49 years. It was associated with increasing age, high gravidity and parity, and full time employment (p<0.001). Of those with high BMI, 5.5% were diabetic, 19.3% hypertensive and 2.8% were both diabetic and hypertensive. Obesity was recorded in 10.5% of maternal deaths, with higher proportions of deaths due to hypertension in pregnancy (27.5%), circulatory/cardiovascular disorders (13.0%), and diabetes (4.3%) compared to 21.9%, 6.9% and 2.6% respectively in non-obese women. Conclusions This is one of a few studies from a middle-income setting to explore maternal burden of obesity during pregnancy, which contributes to improving the knowledge base, identifying the gaps in information and increasing awareness of the growing problem of maternal overweight and obesity. While survey diagnostic conditions require cautious interpretation of findings, it is clear that obesity and related medical conditions present a substantial public health problem for emerging LMICs like Jamaica. There is an urgent need for global consensus on routine measures of the burden and risk factors associated with obesity and development of culturally appropriate interventions.	[Kanguru, Lovney] Univ Edinburgh, USHER Inst Populat Hlth Sci & Informat, Sch Med & Vet Med, Edinburgh, Midlothian, Scotland; [McCaw-Binns, Affette] Univ West Indies, Dept Community Hlth & Psychiat, Mona, Jamaica; [Bell, Jacqueline] NHS Grampian, Aberdeen, Scotland; [Yonger-Coleman, Novie; Wilks, Rainford] Univ West Indies, Caribbean Inst Hlth Res, Mona, Jamaica	University of Edinburgh; University West Indies Mona Jamaica; University West Indies Mona Jamaica	Kanguru, L (corresponding author), Univ Edinburgh, USHER Inst Populat Hlth Sci & Informat, Sch Med & Vet Med, Edinburgh, Midlothian, Scotland.	Lovney.Kanguru@ed.ac.uk		Kanguru, Lovney/0000-0002-8474-8731; Bell, Jacqueline/0000-0003-1784-0180	AFZ Giles Scholarship (Dugald Baird Centre, Aberdeen Maternity Hospital); Principal's Excellence Funds (University of Aberdeen)	AFZ Giles Scholarship (Dugald Baird Centre, Aberdeen Maternity Hospital); Principal's Excellence Funds (University of Aberdeen)	The field visit for LK was funded by the AFZ Giles Scholarship (Dugald Baird Centre, Aberdeen Maternity Hospital) and the Principal's Excellence Funds (University of Aberdeen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association (AMA), 2013, AMA AD NEW POL 2 DAY; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; De Silva AP, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0140-8; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garmendia ML, 2014, PUBLIC HEALTH NUTR, V17, P667, DOI 10.1017/S1368980013000098; Gray L, 2012, NATL STAT PUBLICATIO, V1; Hagley K, 2007, GUIDELINES MANAGEMEN; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lopez-Arana S, 2013, OBES REV, V14, P806, DOI 10.1111/obr.12051; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; McCaw-Binns A, 2008, INT J GYNECOL OBSTET, V100, P31, DOI 10.1016/j.ijgo.2007.06.054; McCaw-Binns A, 2009, W INDIAN MED J, V58, P518; McCaw-Binns AM, 2015, INT J GYNECOL OBSTET, V128, P62, DOI 10.1016/j.ijgo.2014.07.023; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Organization WH, 2009, GLOB HLTH RISKS MORT; Organization WH, 2016, GLOBAL STATUS REPORT; Pan American Health Organisation (PAHO), 2009, BAS IND COUNTR PROF; Poulter N, 2003, HEART, V89, pII2, DOI 10.1136/heart.89.suppl_2.ii2; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Van Hook J, 2013, PUBLIC HEALTH NUTR, V16, P573, DOI 10.1017/S1368980012001164; Weycker D, 2009, J DIABETES COMPLICAT, V23, P330, DOI 10.1016/j.jdiacomp.2008.04.002; WHO Europe, 2015, DAT STAT CHALL DIAB; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Wilks R, 2008, TECHNICAL REPORT; World Bank, 2011, GROW DANG NONC DIS A; World Health Organisation, 1994, INT CLASS DIS REL HL, V2, P139; World Health Organisation, 2014, JAM HLTH PROF; World Health Organization,, 2015, OB OV; World Health Organization, 2012, WHO APPL ICD 10 DEAT; Wright-Pascoe R, 2007, GUIDELINES MANAGEMEN; Ziraba AK, 2009, BMC PUBLIC HEALTH, V9, P465, DOI DOI 10.1186/1471-2458-9-465	33	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188677	10.1371/journal.pone.0188677	http://dx.doi.org/10.1371/journal.pone.0188677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236710	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100023
J	Kim, ES; Baran, AM; Mondo, EL; Rodgers, TD; Nielsen, GC; Dougherty, DW; Pandya, KJ; Rich, DQ; van Wijngaarden, E				Kim, Eric S.; Baran, Andrea M.; Mondo, Esther L.; Rodgers, Thomas D.; Nielsen, Gradon C.; Dougherty, David W.; Pandya, Kishan J.; Rich, David Q.; van Wijngaarden, Edwin			Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer	PLOS ONE			English	Article							HEALTH ADMINISTRATION DATA; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; CHEMOTHERAPY; THROMBOSIS; EVENTS; LEUKOCYTOSIS; METAANALYSIS; REGIMENS	Introduction Carboplatin is widely used to treat lung cancer in the United States as an alternative to cisplatin. Several studies have demonstrated that cisplatin-based regimen is associated with a high frequency of thromboembolic complications. However, there has been limited investigation directly comparing the risk of thromboembolic events (TEEs) between cisplatin-and carboplatin-treated patients with lung cancer. Methods All lung cancer patients treated with cisplatin or carboplatin at Wilmot Cancer Center, University of Rochester between 2011 and 2014 were included. Patient characteristics including exposure (cisplatin vs. carboplatin) and outcome (TEEs between the time of the first dose of cisplatin or carboplatin and 4 weeks after the last dose) were collected by reviewing electronic medical records. A Fisher's exact test was used to compare the proportion of incident TEEs between cisplatin and carboplatin groups. The risk of TEE associated with carboplatin compared to cisplatin was assessed using multiple logistic regression. Results Among 415 subjects, 317 patients (76.4%) received carboplatin and 98 (23.6%) patients received cisplatin. In the carboplatin group, 10.9% (33/302) of evaluable patients developed treatment-related TEEs vs. 14.7% (14/95) in the cisplatin group. There was no significant difference in the risk of developing TEEs between the two groups (P = 0.32). However, 15.2% of carboplatin-related TEEs were arterial thromboses compared to none in the cisplatin group. Conclusions The incidence of carboplatin-related TEEs was high in lung cancer patients without significant difference in the risk of developing TEEs between cisplatin and carboplatin groups. Potential use of prophylactic anticoagulation in all platinum-treated patients should be further investigated.	[Kim, Eric S.; Mondo, Esther L.; Rodgers, Thomas D.; Nielsen, Gradon C.; Dougherty, David W.; Pandya, Kishan J.] Univ Rochester, Dept Med, Rochester, NY 14642 USA; [Kim, Eric S.; Mondo, Esther L.; Rodgers, Thomas D.; Nielsen, Gradon C.; Dougherty, David W.; Pandya, Kishan J.] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Baran, Andrea M.] Univ Rochester, Biostat & Computat Biol, Rochester, NY USA; [Rich, David Q.; van Wijngaarden, Edwin] Univ Rochester, Dept Publ Hlth Sci, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kim, ES (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14642 USA.; Kim, ES (corresponding author), Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY 14642 USA.	esy_kim@yahoo.com	Rodgers, Thomas/AAG-9657-2020; van Wijngaarden, Edwin/Q-2073-2019	Rodgers, Thomas/0000-0002-8937-8231; van Wijngaarden, Edwin/0000-0001-7583-4630; Baran, Andrea/0000-0002-7975-8919	James P.Wilmot Cancer Foundation Grant	James P.Wilmot Cancer Foundation Grant	This work was supported by the James P.Wilmot Cancer Foundation Grant and was awarded to Eric S.Kim. The funder had no rolein study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal A, 1999, CHEST, V115, P1329, DOI 10.1378/chest.115.5.1329; Chew HK, 2006, ARCH INTERN MED, V166, P458; Connolly GC, 2010, THROMB RES, V126, P113, DOI 10.1016/j.thromres.2010.05.012; DOLL DC, 1986, J CLIN ONCOL, V4, P1405, DOI 10.1200/JCO.1986.4.9.1405; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; ILLARRAMENDI JJ, 1991, LANCET, V338, P705, DOI 10.1016/0140-6736(91)91288-6; Karam C, 2008, J CLIN NEUROSCI, V15, P1274, DOI 10.1016/j.jocn.2008.01.015; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2009, J CLIN ONCOL, V27, P4839, DOI 10.1200/JCO.2009.22.3271; Lyman GH, 2009, J CLIN ONCOL, V27, P4821, DOI 10.1200/JCO.2009.22.3032; Mellema WW, 2014, LUNG CANCER, V86, P73, DOI 10.1016/j.lungcan.2014.07.017; Moore RA, 2011, J CLIN ONCOL, V29, P3466, DOI 10.1200/JCO.2011.35.5669; Numico G, 2005, CANCER, V103, P994, DOI 10.1002/cncr.20893; Rossi A, 2012, J CLIN ONCOL, V30, P1692, DOI 10.1200/JCO.2011.40.4905; Sallah S, 2002, THROMB HAEMOSTASIS, V87, P575; Santana-Davila R, 2015, J CLIN ONCOL, V33, P567, DOI 10.1200/JCO.2014.56.2587; Santana-Davila R, 2014, J THORAC ONCOL, V9, P702, DOI 10.1097/JTO.0000000000000146; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Seng S, 2012, J CLIN ONCOL, V30, P4416, DOI 10.1200/JCO.2012.42.4358	20	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189410	10.1371/journal.pone.0189410	http://dx.doi.org/10.1371/journal.pone.0189410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228042	gold, Green Submitted, Green Published			2022-12-26	WOS:000417648600054
J	Morera-Fumero, AL; Diaz-Mesa, E; Abreu-Gonzalez, P; Fernandez-Lopez, L; Guillen-Pino, F				Morera-Fumero, Armando L.; Diaz-Mesa, Estefania; Abreu-Gonzalez, Pedro; Fernandez-Lopez, Lourdes; Guillen-Pino, Fernando			A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia	PLOS ONE			English	Article							NEGATIVE SYMPTOMS; OXIDATIVE STRESS; MELATONIN; SYSTEMS	Free radicals and an oxidant/antioxidant imbalance have been involved in the schizophrenia pathophysiology. The total antioxidant capacity (TAC) is a measure of the antioxidant capacity of a system. Day/night changes are a biological characteristic of hormones such as melatonin or cortisol. There is little information about TAC day/night changes in schizophrenia patients. The aim of this research is to study if there are day/night changes in serum TAC levels of schizophrenia patients. Thirty-two DSM-IV schizophrenia paranoid patients were studied. Blood was sampled at 12:00 and 00:00 h at admission, discharge and three months after hospital discharge (TMAHD). TAC results are expressed as mmol of Trolox/L. Patients did not have day/night TAC differences at admission (12:00:0.67 +/- 0.12 vs. 00:00:0.61 +/- 0.14, p > 0.14) or discharge (12:00:0.65 +/- 0.15 vs. 00:00:0.65 +/- 0.12, p > 0.99). At TMHD, patients had significantly higher TAC levels at midday than midnight (12:00:0.83 +/- 0.10 vs. 00:00:0.74 +/- 0.12, p < 0.006) as it has been reported in healthy subjects. There were no significant TAC differences at 12.00 and 00:00 between admission and discharge. At TMAHD, patients had significantly higher TAC levels than at admission and discharge, both at 12:00 and 00:00 h. In conclusion, the absence of day/night serum TAC changes when clinically relapsed and the normalization of day/night serum TAC changes at TMHD can be considered as a biological marker of schizophrenia evolution.	[Morera-Fumero, Armando L.; Fernandez-Lopez, Lourdes; Guillen-Pino, Fernando] Univ La Laguna, Fac Ciencias Salud, Dept Med Interna Dermatol & Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain; [Morera-Fumero, Armando L.] Consultoria Psiquiatr SC, Santa Cruz De Tenerife, Spain; [Diaz-Mesa, Estefania] Hosp Univ Canarias, Serv Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Ciencias Salud, Unidad Fisiol, Dept Ciencias Med Basicas, San Cristobal la Laguna, Santa Cruz De T, Spain; [Fernandez-Lopez, Lourdes] Soc Invest & Asistencia Salud Mental, Santa Cruz De Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Morera-Fumero, AL (corresponding author), Univ La Laguna, Fac Ciencias Salud, Dept Med Interna Dermatol & Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain.; Morera-Fumero, AL (corresponding author), Consultoria Psiquiatr SC, Santa Cruz De Tenerife, Spain.	amorera@ull.es	Fumero, Armando Morera/M-3394-2019; Abreu-Gonzalez, Pedro/AAC-7790-2020	Fumero, Armando Morera/0000-0002-7663-1154; Abreu-Gonzalez, Pedro/0000-0002-7553-1784	Fundacion Canaria de Investigacion y Salud (FUNCIS) [PI: 08/115]; Consultoria Psiquiatrica SC	Fundacion Canaria de Investigacion y Salud (FUNCIS); Consultoria Psiquiatrica SC	This work was partly supported by a research grant (PI: 08/115) of the Fundacion Canaria de Investigacion y Salud (FUNCIS), which is part of the local government of the Canary Islands. The Consultoria Psiquiatrica SC provided support in the form of salary for authors (ALMF) but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Al-Chalabi BM, 2009, NEUROPSYCHOBIOLOGY, V59, P8, DOI 10.1159/000202823; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x; Chen DC, 2010, J PSYCHIATR RES, V44, P1111, DOI 10.1016/j.jpsychires.2010.03.008; Dietrich-Muszalska A, 2010, PSYCHIAT CLIN NEUROS, V64, P469, DOI 10.1111/j.1440-1819.2010.02132.x; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Falkai P, 2012, EUR ARCH PSY CLIN N, V262, P93, DOI 10.1007/s00406-012-0294-y; Flatow J, 2013, BIOL PSYCHIAT, V74, P400, DOI 10.1016/j.biopsych.2013.03.018; Gunes M, 2017, PSYCHIAT CLIN PSYCH, V27, P54, DOI 10.1080/24750573.2017.1293243; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; International Union of Pure and Applied Chemistry (IUPAC), 1997, RAD FREE RAD COMP CH, P1234; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Morera AL, 2007, J PINEAL RES, V43, P313, DOI 10.1111/j.1600-079X.2007.00467.x; Morera AL, 2009, WORLD J BIOL PSYCHIA, V10, P576, DOI 10.1080/15622970801901802; Morera-Fumero AL, 2018, MED CHEM, V14, P225, DOI 10.2174/1573406413666171002123158; Morera-Fumero AL, 2017, PSYCHIAT RES, V249, P200, DOI 10.1016/j.psychres.2017.01.043; Morera-Fumero AL, 2013, INT J MOL SCI, V14, P9037, DOI 10.3390/ijms14059037; Nakano Y, 2010, HUM PSYCHOPHARM CLIN, V25, P139, DOI 10.1002/hup.1102; Pazvantoglu O, 2009, PSYCHIAT CLIN NEUROS, V63, P693, DOI 10.1111/j.1440-1819.2009.02015.x; Raffa M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-124; Raffa M, 2012, PROG NEURO-PSYCHOPH, V39, P52, DOI 10.1016/j.pnpbp.2012.05.005; Sarandol A, 2007, PROG NEURO-PSYCHOPH, V31, P1164, DOI 10.1016/j.pnpbp.2007.03.008; Ustundag B, 2006, PSYCHIAT CLIN NEUROS, V60, P458, DOI 10.1111/j.1440-1819.2006.01532.x; Virit O, 2009, NEUROPSYCHOBIOLOGY, V60, P87, DOI 10.1159/000239684; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wu JQ, 2013, PROG NEURO-PSYCHOPH, V46, P200, DOI 10.1016/j.pnpbp.2013.02.015; Yao JK, 1998, SCHIZOPHR RES, V32, P1, DOI 10.1016/S0920-9964(98)00030-9; Zhang XY, 2012, SCHIZOPHR RES, V139, P66, DOI 10.1016/j.schres.2012.04.009	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189348	10.1371/journal.pone.0189348	http://dx.doi.org/10.1371/journal.pone.0189348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220388	gold, Green Submitted, Green Published			2022-12-26	WOS:000417469900052
J	Zheng, XW; Li, XH; Ge, C; Chang, JZ; Shi, MM; Chen, JL; Qiao, LY; Chang, ZJ; Zheng, J; Zhang, JC				Zheng, Xingwei; Li, Xiaohua; Ge, Chuan; Chang, Jianzhong; Shi, Mengmeng; Chen, Jianli; Qiao, Linyi; Chang, Zhijian; Zheng, Jun; Zhang, Jiancheng			Characterization of the CCT family and analysis of gene expression in Aegilops tauschii	PLOS ONE			English	Article							CONSTANS-LIKE GENE; PHOTOPERIOD SENSITIVITY; RESPONSE REGULATOR; NATURAL VARIATION; RICE CULTIVATION; PERIOD LENGTH; PROTEIN; ENCODES; TOC1; FT	Flowering is crucial for reproductive success in flowering plant. The CCT domain-containing genes widely participate in the regulation of flowering process in various plant species. So far, the CCT family in common wheat is largely unknown. Here, we characterized the structure, organization, molecular evolution and expression of the CCT genes in Aegilops tauschii, which is the D genome donor of hexaploid wheat. Twenty-six CCT genes (AetCCT) were identified from the full genome of A. tauschii and these genes were distributed on all 7 chromosomes. Phylogenetic analysis classified these AetCCT genes into 10 subgroups. Thirteen AetCCT members in group A, C, H and G achieved rapid evolution based on evolutionary rate analysis. The AetCCT genes respond to different exogenous hormones and abiotic treatments, the expression of AetCCT4, 7, 8, 11, 12, 16, 17, 19, 21 and 22 showed a significant 24 h rhythm. This study may provide a reference for common wheat's evolution, domestication and evolvement rules, and also help us to understand the ecological ability of A. tauschii.	[Zheng, Xingwei; Li, Xiaohua; Shi, Mengmeng; Zheng, Jun; Zhang, Jiancheng] Shanxi Acad Agr Sci, Inst Wheat Res, Linfen, Peoples R China; [Ge, Chuan; Chang, Jianzhong; Qiao, Linyi; Chang, Zhijian] Shanxi Acad Agr Sci, Inst Crop Sci, Shanxi Key Lab Crop Genet & Mol Improvement, Taiyuan, Shanxi, Peoples R China; [Chen, Jianli] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA	Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University; Idaho; University of Idaho	Zheng, J; Zhang, JC (corresponding author), Shanxi Acad Agr Sci, Inst Wheat Res, Linfen, Peoples R China.	sxnkyzj@126.com; zhangjc@126.com			National Natural Science Foundation of China [31601307]; Natural Science Foundation of Shanxi Province, China [2016011001]; National Key Research Project [2017YFD0100600]; Shanxi Academy of Agricultural Sciences [17yzgc010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); National Key Research Project; Shanxi Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (31601307); Natural Science Foundation of Shanxi Province, China (2016011001); The National Key Research Project (2017YFD0100600); Breeding Project of Shanxi Academy of Agricultural Sciences (17yzgc010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fang F., 2013, CIRP ANN-MANUF TECHN, V62, P2; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Grundy J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00648; Harmon F, 2008, PLANT J, V55, P568, DOI 10.1111/j.1365-313X.2008.03527.x; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kappler BF, 2002, WEED TECHNOL, V16, P102, DOI 10.1614/0890-037X(2002)016[0102:WPDIJG]2.0.CO;2; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kim J, 2008, PLANT CELL, V20, P307, DOI 10.1105/tpc.107.055715; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kim SK, 2013, PLANT SCI, V199, P71, DOI 10.1016/j.plantsci.2012.09.019; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Lee YS, 2010, PLANT J, V63, P18, DOI 10.1111/j.1365-313X.2010.04226.x; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Li JH, 2007, PLANT J, V51, P18, DOI 10.1111/j.1365-313X.2007.03125.x; Liu JH, 2016, J EXP BOT, V67, P5785, DOI 10.1093/jxb/erw344; Lu SX, 2011, PLANT PHYSIOL, V157, P1537, DOI 10.1104/pp.111.179846; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Nakamura Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1183, DOI 10.1271/bbb.60643; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Panda S, 2002, DEV CELL, V3, P51, DOI 10.1016/S1534-5807(02)00200-9; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Strader LC, 2010, PLANT J, V64, P874, DOI 10.1111/j.1365-313X.2010.04373.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; [苏亚蕊 SU Yarui], 2010, [生态学报, Acta Ecologica Sinica], V30, P969; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76; Weng XY, 2014, PLANT PHYSIOL, V164, P735, DOI 10.1104/pp.113.231308; Wu FQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085754, 10.1371/journal.pone.0087251]; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Yan WH, 2013, CELL RES, V23, P969, DOI 10.1038/cr.2013.43; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Young FL, 2010, WEED TECHNOL, V24, P430, DOI 10.1614/WT-D-10-00046.1; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663	45	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189333	10.1371/journal.pone.0189333	http://dx.doi.org/10.1371/journal.pone.0189333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220383	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900050
J	Nuwagaba, S; Zhang, F; Hui, C				Nuwagaba, Savannah; Zhang, Feng; Hui, Cang			Robustness of rigid and adaptive networks to species loss	PLOS ONE			English	Article							II FUNCTIONAL-RESPONSE; PREDATOR-PREY MODEL; FOOD WEBS; BIODIVERSITY LOSS; STABILITY; BEHAVIOR; COMPLEX; EXTINCTIONS; INCREASES; DYNAMICS	Controversies in the complexity-stability debate have been attributed to the methodologies used such as topological vs. dynamical approaches or rigid vs. adaptive foraging behaviour of species. Here, we use a bipartite network model that incorporates both topological and population dynamics to investigate the robustness of 60 real ecological networks to the loss of generalist and specialist species. We compare the response in both adaptive and rigid networks. Our results show that the removal of generalists leads to the most secondary extinctions, implying that conservation strategies should aim to protect generalist species in the ecosystem. We also show that adaptive behaviour renders networks vulnerable to species loss at initial stages but enhances long term stability of the system. However, whether adaptive networks are more robust to species loss than rigid ones depends on the structure of the network. Specifically, adaptive networks with modularity < 0.3 are more robust than rigid networks of the same modularity. Interestingly, the more modular a network is, the less robust it is to external perturbations.	[Nuwagaba, Savannah; Hui, Cang] Stellenbosch Univ, Dept Math Sci, Ctr Invas Biol, Stellenbosch, South Africa; [Zhang, Feng] Gansu Agr Univ, MOE Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China; [Zhang, Feng] Gansu Agr Univ, Ctr Quantitat Biol, Lanzhou, Gansu, Peoples R China; [Hui, Cang] African Inst Math Sci, Math & Phys Biosci, Muizenberg, South Africa	Stellenbosch University; Gansu Agricultural University; Gansu Agricultural University	Hui, C (corresponding author), Stellenbosch Univ, Dept Math Sci, Ctr Invas Biol, Stellenbosch, South Africa.; Zhang, F (corresponding author), Gansu Agr Univ, MOE Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China.; Zhang, F (corresponding author), Gansu Agr Univ, Ctr Quantitat Biol, Lanzhou, Gansu, Peoples R China.; Hui, C (corresponding author), African Inst Math Sci, Math & Phys Biosci, Muizenberg, South Africa.	fzhang188@163.com; chui@sun.ac.za	Hui, Cang/A-1781-2008	Hui, Cang/0000-0002-3660-8160	National Natural Science Foundation of China [31360104]; South African Research Chair Initiative (SARChI); National Research Foundation of South Africa [81825, 76912]; DST-NRF Centre of Excellence for Invasion Biology (C.I.B); African Institute for Mathematical Sciences (AIMS); German Academic Exchange Service (DAAD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South African Research Chair Initiative (SARChI); National Research Foundation of South Africa(National Research Foundation - South Africa); DST-NRF Centre of Excellence for Invasion Biology (C.I.B); African Institute for Mathematical Sciences (AIMS); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This project is supported by National Natural Science Foundation of China (No. 31360104), South African Research Chair Initiative (SARChI), National Research Foundation of South Africa (grants 81825 and 76912), DST-NRF Centre of Excellence for Invasion Biology (C.I.B), African Institute for Mathematical Sciences (AIMS). SN receives a PhD Scholarship from the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Baskaran N, 2012, J NAT CONSERV, V20, P56, DOI 10.1016/j.jnc.2011.08.004; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brose U, 2011, BASIC APPL ECOL, V12, P557, DOI 10.1016/j.baae.2011.09.010; Cai GQ, 2007, ECOL COMPLEX, V4, P242, DOI 10.1016/j.ecocom.2007.06.011; de Visser SN, 2011, J ANIM ECOL, V80, P484, DOI 10.1111/j.1365-2656.2010.01787.x; Donohue I, 2013, ECOL LETT, V16, P421, DOI 10.1111/ele.12086; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Estrada E, 2007, J THEOR BIOL, V244, P296, DOI 10.1016/j.jtbi.2006.08.002; FRYXELL JM, 1994, EVOL ECOL, V8, P407, DOI 10.1007/BF01238191; Gilljam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9412; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Hui C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3454; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Kimbrell T, 2005, EVOL ECOL RES, V7, P53; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Ko W, 2006, J DIFFER EQUATIONS, V231, P534, DOI 10.1016/j.jde.2006.08.001; Krivan V, 1999, THEOR POPUL BIOL, V55, P111, DOI 10.1006/tpbi.1998.1399; Landi P, 2015, J THEOR BIOL, V365, P204, DOI 10.1016/j.jtbi.2014.10.017; Liu B, 2006, J COMPUT APPL MATH, V193, P347, DOI 10.1016/j.cam.2005.06.023; Loeuille N, 2010, FUNCT ECOL, V24, P18, DOI 10.1111/j.1365-2435.2009.01617.x; May R.M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Minoarivelo HO, 2014, OIKOS, V123, P1250, DOI 10.1111/oik.00857; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Nuwagaba S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0320; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Staniczenko PPA, 2010, ECOL LETT, V13, P891, DOI 10.1111/j.1461-0248.2010.01485.x; Stephens D.W., 1986, pi; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thierry A, 2011, BASIC APPL ECOL, V12, P562, DOI 10.1016/j.baae.2011.09.005; TILMAN D, 1986, AM ZOOL, V26, P5; Uchida S, 2007, J THEOR BIOL, V247, P713, DOI 10.1016/j.jtbi.2007.04.019; Valdovinos FS, 2010, ECOL LETT, V13, P1546, DOI 10.1111/j.1461-0248.2010.01535.x; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; Vincent TLS, 1996, AM NAT, V148, P1038, DOI 10.1086/285970; Visser AW, 2012, J R SOC INTERFACE, V9, P1373, DOI 10.1098/rsif.2011.0686; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0; Zhang F, 2011, ECOL LETT, V29, P47; Zhang F, 2014, ANIM BEHAV, V88, P13, DOI 10.1016/j.anbehav.2013.11.002	51	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189086	10.1371/journal.pone.0189086	http://dx.doi.org/10.1371/journal.pone.0189086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216245	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800068
J	Yassin, AF; Langenberg, S; Huntemann, M; Clum, A; Pillay, M; Palaniappan, K; Varghese, N; Mikhailova, N; Mukherjee, S; Reddy, TBK; Daum, C; Shapiro, N; Ivanova, N; Woyke, T; Kyrpides, NC				Yassin, Atteyet F.; Langenberg, Stefan; Huntemann, Marcel; Clum, Alicia; Pillay, Manoj; Palaniappan, Krishnaveni; Varghese, Neha; Mikhailova, Natalia; Mukherjee, Supratim; Reddy, T. B. K.; Daum, Chris; Shapiro, Nicole; Ivanova, Natalia; Woyke, Tanja; Kyrpides, Nikos C.			Draft genome sequence of Actinotignum schaalii DSM 15541(T): Genetic insights into the lifestyle, cell fitness and virulence	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ENTNER-DOUDOROFF PATHWAY; CYTOCHROME BD OXIDASE; GRAM-POSITIVE COCCI; ESCHERICHIA-COLI; OXIDATIVE STRESS; ACTINOBACULUM-SCHAALII; METRONIDAZOLE RESISTANCE; AZOTOBACTER-VINELANDII; BACTEROIDES-FRAGILIS	The permanent draft genome sequence of Actinotignum schaalii DSM 15541(T) is presented. The annotated genome includes 2,130,987 bp, with 1777 protein-coding and 58 rRNA-coding genes. Genome sequence analysis revealed absence of genes encoding for: components of the PTS systems, enzymes of the TCA cycle, glyoxylate shunt and gluconeogensis. Genomic data revealed that A. schaalii is able to oxidize carbohydrates via glycolysis, the nonoxidative pentose phosphate and the Entner-Doudoroff pathways. Besides, the genome harbors genes encoding for enzymes involved in the conversion of pyruvate to lactate, acetate and ethanol, which are found to be the end products of carbohydrate fermentation. The genome contained the gene encoding Type I fatty acid synthase required for de novo FAS biosynthesis. The plsY and plsX genes encoding the acyltransferases necessary for phosphatidic acid biosynthesis were absent from the genome. The genome harbors genes encoding enzymes responsible for isoprene biosynthesis via the mevalonate (MVA) pathway. Genes encoding enzymes that confer resistance to reactive oxygen species (ROS) were identified. In addition, A. schaalii harbors genes that protect the genome against viral infections. These include restriction-modification (RM) systems, type II toxin-antitoxin (TA), CRISPR-Cas and abortive infection system. A. schaalii genome also encodes several virulence factors that contribute to adhesion and internalization of this pathogen such as the tad genes encoding proteins required for pili assembly, the nanI gene encoding exo-alpha-sialidase, genes encoding heat shock proteins and genes encoding type VII secretion system. These features are consistent with anaerobic and pathogenic lifestyles. Finally, resistance to ciprofloxacin occurs by mutation in chromosomal genes that encode the subunits of DNA-gyrase (GyrA) and topisomerase IV (ParC) enzymes, while resistant to metronidazole was due to the frxA gene, which encodes NADPH-flavin oxidoreductase.	[Yassin, Atteyet F.] Univ Bonn, Inst Med Mikrobiol & Immunol, Bonn, Germany; [Langenberg, Stefan; Varghese, Neha] Klin & Poliklin Hals Nasen Ohrenheilkunde Chirurg, Bonn, Germany; [Huntemann, Marcel; Clum, Alicia; Pillay, Manoj; Palaniappan, Krishnaveni; Mikhailova, Natalia; Mukherjee, Supratim; Reddy, T. B. K.; Daum, Chris; Shapiro, Nicole; Ivanova, Natalia; Woyke, Tanja; Kyrpides, Nikos C.] US DOE, Joint Genome Inst, Genome Biol Program, Walnut Creek, DC USA	University of Bonn; University of Bonn; United States Department of Energy (DOE)	Yassin, AF (corresponding author), Univ Bonn, Inst Med Mikrobiol & Immunol, Bonn, Germany.	yassin@mibi03.meb.uni-bonn.de	Mukherjee, Supratim/K-1151-2019; Langenberg, Stefan/O-4526-2016; Huntemann, Marcel/HCH-8928-2022; Kyrpides, Nikos C./A-6305-2014	Mukherjee, Supratim/0000-0002-6322-2271; Langenberg, Stefan/0000-0001-5817-5469; Huntemann, Marcel/0000-0002-1284-3748; Kyrpides, Nikos C./0000-0002-6131-0462; Reddy, TBK/0000-0002-0871-5567; Varghese, Neha/0000-0003-0580-0675	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System)	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231.	ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; ANDREESEN JR, 1969, ARCH MIKROBIOL, V69, P160, DOI 10.1007/BF00409760; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; Bank S, 2010, EMERG INFECT DIS, V16, P76, DOI 10.3201/eid1601.090761; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Bempt IV, 2011, J CLIN MICROBIOL, V49, P2369, DOI 10.1128/JCM.00272-11; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carlier JP, 1997, ANTIMICROB AGENTS CH, V41, P1495, DOI 10.1128/AAC.41.7.1495; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Cattoir V, 2010, J ANTIMICROB CHEMOTH, V65, P2514, DOI 10.1093/jac/dkq383; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Das A, 2005, J BACTERIOL, V187, P2020, DOI 10.1128/JB.187.6.2020-2029.2005; EGAN SE, 1992, J BACTERIOL, V174, P4638, DOI 10.1128/JB.174.14.4638-4646.1992; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Field D, 2014, STAND GENOMIC SCI, V9; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Giuffre A, 2014, BBA-BIOENERGETICS, V1837, P1178, DOI 10.1016/j.bbabio.2014.01.016; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; Goldman BS, 1996, J BACTERIOL, V178, P6348, DOI 10.1128/jb.178.21.6348-6351.1996; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILL S, 1990, J BACTERIOL, V172, P2071, DOI 10.1128/jb.172.4.2071-2078.1990; Hoenigl M, 2010, EMERG INFECT DIS, V16, P1171, DOI 10.3201/eid1607.100349; Hooper DC, 2002, LANCET INFECT DIS, V2, P530, DOI 10.1016/S1473-3099(02)00369-9; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Hung GC, 2012, J CLIN MICROBIOL, V50, P2770, DOI 10.1128/JCM.01155-12; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INFERNAL, INF RNA AL; JUKES T H, 1969, P21; KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Klemm P, 1996, J BACTERIOL, V178, P61, DOI 10.1128/jb.178.1.61-67.1996; Kristiansen R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00880-14; Kwon DH, 2000, ANTIMICROB AGENTS CH, V44, P2133, DOI 10.1128/AAC.44.8.2133-2142.2000; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Kyrpides NC, 2014, STAND GENOMIC SCI, V9, P628, DOI 10.4056/sigs.5068949; Laabei M, 2014, GENOME RES, V24, P839, DOI 10.1101/gr.165415.113; Lawson PA, 1997, INT J SYST BACTERIOL, V47, P899, DOI 10.1099/00207713-47-3-899; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Li M, 2011, DUK FAST EF IN PRESS; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Mukherjee S, 2017, NAT BIOTECHNOL, V35, P676, DOI 10.1038/nbt.3886; Olsen AB, 2013, BJU INT, V112, P394, DOI 10.1111/j.1464-410X.2012.11739.x; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Theron MM, 2004, J ANTIMICROB CHEMOTH, V54, P240, DOI 10.1093/jac/dkh270; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170; Tschudin-Sutter S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-289; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Yassin AF, 2015, INT J SYST EVOL MICR, V65, P615, DOI 10.1099/ijs.0.069294-0; Yassin AF, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0036-7; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	90	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188914	10.1371/journal.pone.0188914	http://dx.doi.org/10.1371/journal.pone.0188914			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216246	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800048
J	Zahouli, JBZ; Koudou, BG; Muller, P; Malone, D; Tano, Y; Utzinger, J				Zahouli, Julien B. Z.; Koudou, Benjamin G.; Mueller, Pie; Malone, David; Tano, Yao; Utzinger, Juerg			Effect of land-use changes on the abundance, distribution, and host-seeking behavior of Aedes arbovirus vectors in oil palm-dominated landscapes, southeastern Cote d'Ivoire	PLOS ONE			English	Article							MOSQUITO; MONOCULTURE; ALBOPICTUS; EMERGENCE; IMPACTS; EASTERN; FEVER; RISK	Background Identifying priority areas for vector control is of considerable public health relevance. Arthropod-borne viruses (arboviruses) spread by Aedes mosquitoes are (re) emerging in many parts of the tropics, partially explained by changes in agricultural land-use. We explored the effects of land-use changes on the abundance, distribution, and host-seeking behavior of Aedes mosquitoes along a gradient of anthropogenic disturbance in oil palm-dominated landscapes in southeastern Cote d'Ivoire. Methodology Between January and December 2014, eggs, larvae, pupae, and adults of Aedes mosquitoes were sampled in four types of macrohabitats (rainforest, polyculture, oil palm monoculture, and rural housing areas), using standard procedures (bamboo-ovitraps, metallicovitraps, larval surveys, and human-baited double-net traps). Immature stages were reared and adult mosquitoes identified at species level. Principal findings A total of 28,276 Aedes specimens belonging to 11 species were collected. No Aedes-positive microhabitat and only four specimens of Ae. aegypti were found in oil palm monoculture. The highest abundance of Aedes mosquitoes (60.9%) was found in polyculture, while the highest species richness (11 species) was observed in rainforest. Ae. aegypti was the predominant Aedes species, and exhibited high anthropophilic behavior inflicting 93.0% of total biting to humans. The biting rate of Aedes mosquitoes was 34.6 and 7.2-fold higher in polyculture and rural housing areas, respectively, compared to rainforest. Three species (Ae. aegypti, Ae. dendrophilus, and Ae. vittatus) bit humans in polyculture and rural housing areas, with respective biting rates of 21.48 and 4.48 females/person/day. Unexpectedly, all three species were also feeding during darkness. Aedes females showed bimodal daily feeding cycles with peaks at around 08: 00 a. m. and 05: 00 p. m. Host-seeking activities were interrupted between 11: 00 a. m. and 02: 00 p. m. in rural housing areas, while no such interruption was observed in polyculture. Some rainforest-dwelling Aedes species displayed little preference to feed on humans. Conclusions In southeastern Co A te d'Ivoire, the agricultural land-use/land-cover changes due to the conversion of rainforest into oil palm monocultures influence the abundance, distribution, and host-seeking behaviors of anthropophagic and non-anthropophagic Aedes vectors. As a result, there is higher risk of humans to arbovirus transmission in polyculture and rural housing areas. There is a need for integrated vector management, including landscape epidemiology and ecotope-based vector control.	[Zahouli, Julien B. Z.; Mueller, Pie; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Zahouli, Julien B. Z.; Mueller, Pie; Utzinger, Juerg] Univ Basel, Basel, Switzerland; [Zahouli, Julien B. Z.; Koudou, Benjamin G.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Zahouli, Julien B. Z.; Tano, Yao] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Koudou, Benjamin G.] Univ Liverpool Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool, Merseyside, England; [Koudou, Benjamin G.] Univ Nangui Abrogoua, Unite Format & Rech Sci Nat, Abidjan, Cote Ivoire; [Malone, David] Univ Liverpool Liverpool Sch Trop Med, Innovat Vector Control Consortium, Liverpool, Merseyside, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine	Zahouli, JBZ (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Zahouli, JBZ (corresponding author), Univ Basel, Basel, Switzerland.; Zahouli, JBZ (corresponding author), Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire.; Zahouli, JBZ (corresponding author), Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire.	zahouli2julien@yahoo.fr	Muller, Pie/R-7275-2018	Muller, Pie/0000-0003-0181-5781	Centre Suisse de Recherches Scientifiques en Cote dIvoire, Abidjan, Cote d'Ivoire; Swiss Tropical and Public Health Institute, Basel, Switzerland; Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), Bern, Switzerland [2014.0567]	Centre Suisse de Recherches Scientifiques en Cote dIvoire, Abidjan, Cote d'Ivoire; Swiss Tropical and Public Health Institute, Basel, Switzerland; Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), Bern, Switzerland	The work was funded by the Centre Suisse de Recherches Scientifiques en Cote dIvoire, Abidjan, Cote d'Ivoire; Swiss Tropical and Public Health Institute, Basel, Switzerland; Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), Bern, Switzerland (no 2014.0567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Centre Suisse de Recherches Scientifiques en Cote dIvoire (Abidjan, Cote dIvoire), the Swiss Tropical and Public Health Institute (Basel, Switzerland); the Swiss government, through the Federal Commission for Scholarships for Foreign Students (Bern, Switzerland; no 2014.0567), which funded the study and supported its execution. The authors would also like to extend their thanks to PALMCI staff, health authorities, local authorities, and residents in the study areas and the mosquito collection teams.	Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227; Barton M, 2014, J THERM BIOL, V41, P65, DOI 10.1016/j.jtherbio.2014.02.004; Bernues-Baneres Alberto, 2013, Biodiversity Journal, V4, P335; Birkhofer K, 2017, J ANIM ECOL, V86, P511, DOI 10.1111/1365-2656.12641; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; CORDELLIER R, 1983, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V21, P165; CORDELLIER R, 1977, GUIDE PRATIQUE ETUDE; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095; Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286; Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649; Diarrassouba S, 1997, B SOC PATHOL EXOT, V90, P361; Dieng H, 2015, ACTA TROP, V145, P68, DOI 10.1016/j.actatropica.2015.01.004; Dislich C, 2017, BIOL REV, V92, P1539, DOI 10.1111/brv.12295; Dorville LFM, 1996, STUD NEOTROP FAUNA E, V31, P68, DOI 10.1076/snfe.31.2.68.13331; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Ghazali A, 2016, J ASIA-PAC ENTOMOL, V19, P415, DOI 10.1016/j.aspen.2016.04.016; HARBACH RE, 2007, ZOOTAXA, V1668, P1; Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703; Kaewwaen W., 2015, INTERDISCIP PERSPECT, V2015, P1, DOI [10.1155/2015/909106, DOI 10.1155/2015/909106]; Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18; N'go A. Y., 2013, Journal of Environmental Protection, V4, P1373, DOI 10.4236/jep.2013.412158; Palmafrique, PALM OIL IV EC; Rochlin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13604; Sadia-Kacou CMA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1804-1; de Abreu FVS, 2015, MEM I OSWALDO CRUZ, V110, P669, DOI 10.1590/0074-02760140490; Savilaakso S, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-4; Steiger DBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1675-2; Syafiq M, 2016, ACTA OECOL, V74, P11, DOI 10.1016/j.actao.2016.06.005; Tangena JAA, 2016, TRENDS PARASITOL, V32, P402, DOI 10.1016/j.pt.2016.01.009; Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735; van Strien AJ, 2012, ECOL INDIC, V14, P202, DOI 10.1016/j.ecolind.2011.07.007; Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632; Zahouli Julien B.Z., 2017, PLoS Neglected Tropical Diseases, V11, pe0005751, DOI 10.1371/journal.pntd.0005751; Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9	40	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189082	10.1371/journal.pone.0189082	http://dx.doi.org/10.1371/journal.pone.0189082			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216248	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000417337800067
J	Hu, Y; Semova, I; Sun, XW; Kang, H; Chahar, S; Hollenberg, AN; Masson, D; Hirschey, MD; Miao, J; Biddinger, SB				Hu, Yue; Semova, Ivana; Sun, Xiaowei; Kang, Hong; Chahar, Satyapal; Hollenberg, Anthony N.; Masson, David; Hirschey, Matthew D.; Miao, Ji; Biddinger, Sudha B.			Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dyslipidemia; fructose; glucose; lipogenesis; mammalian target of rapamycin (mTOR); metabolic syndrome	FATTY-ACID SYNTHESIS; HEPATIC STEATOSIS; CELL-GROWTH; NUCLEAR COREPRESSOR; INSULIN SENSITIVITY; METABOLIC SYNDROME; UNITED-STATES; UP-REGULATION; X-RECEPTOR; LIVER	Although calorically equivalent to glucose, fructose appears to be more lipogenic, promoting dyslipidemia, fatty liver disease, cardiovascular disease, and diabetes. To better understand how fructose induces lipogenesis, we compared the effects of fructose and glucose on mammalian target of rapamycin complex 1 (mTORC1), which appeared to have both positive and negative effects on lipogenic gene expression. We found that fructose acutely and transiently suppressed mTORC1 signaling in vitro and in vivo. The constitutive activation of mTORC1 reduced hepatic lipogenic gene expression and produced hypotriglyceridemia after 1 week of fructose feeding. In contrast, glucose did not suppress mTORC1, and the constitutive activation of mTORC1 failed to suppress plasma triglycerides after 1 week of glucose feeding. Thus, these data reveal fundamental differences in the signaling pathways used by fructose and glucose to regulate lipid metabolism.	[Hu, Yue; Semova, Ivana; Sun, Xiaowei; Kang, Hong; Chahar, Satyapal; Miao, Ji; Biddinger, Sudha B.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Metab & Diabet, Boston, MA 02215 USA; [Hollenberg, Anthony N.] Harvard Med Sch, Boston, MA 02215 USA; [Masson, David] INSERM, Lipid Nutr Canc UMR 1231, F-21000 Dijon, France; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Duke University; Duke University	Miao, J; Biddinger, SB (corresponding author), Boston Childrens Hosp, 3 Blackfan Circle CLS16023-2, Boston, MA 02115 USA.	ji.miao@childrens.harvard.edu; sudha.biddinger@childrens.harvard.edu	Miao, Ji/F-9398-2015; Masson, David/R-6633-2019; Semova, Ivana/AAL-3392-2020; MASSON, David/AAC-8896-2022	Miao, Ji/0000-0003-0869-4492; MASSON, David/0000-0003-1692-0699	National Institutes of Health [DK094162, DK100539, DK056123]; China Scholarship Council; Boston Children's Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK100539, R01DK094162, R01DK056123, R56DK056123, K99DK100539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Boston Children's Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK094162 (to S. B. B.), DK100539 (to J. M.), and DK056123 (to A. N. H.) as well as a fellowship from the China Scholarship Council (to Y. H.) and a career development award from Boston Children's Hospital (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Astapova I, 2014, J CLIN INVEST, V124, P1976, DOI 10.1172/JCI73419; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Baena M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26149; Baena M, 2015, BBA-MOL CELL BIOL L, V1851, P107, DOI 10.1016/j.bbalip.2014.11.003; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen Q, 2016, J BIOL CHEM, V291, P2371, DOI 10.1074/jbc.M115.677351; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2012, P NATL ACAD SCI USA, V109, pE1619, DOI 10.1073/pnas.1204298109; Kim MS, 2016, J CLIN INVEST, V126, P4372, DOI 10.1172/JCI81993; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee MN, 2009, MOL CELL BIOL, V29, P3991, DOI 10.1128/MCB.00165-09; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Mori T, 2011, J NUTR, V141, P2003, DOI 10.3945/jn.111.143602; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Sapp V, 2014, HEPATOLOGY, V60, P1581, DOI 10.1002/hep.27284; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067; Wang H, 2015, ENDOCRINOLOGY, V156, P169, DOI 10.1210/en.2014-1454; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	58	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2006	2014		10.1074/jbc.M117.782557	http://dx.doi.org/10.1074/jbc.M117.782557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29222328	Green Published, hybrid			2022-12-26	WOS:000424948000014
J	Xu, HM; Gong, JW; Liu, H				Xu, Haiming; Gong, Jingwen; Liu, Hui			High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma	PLOS ONE			English	Article							NONCODING RNA PVT1; CANCER CELL-GROWTH; GASTRIC-CANCER; BREAST-CANCER; UP-REGULATION; MELANOGENESIS; INVASION; OVEREXPRESSION; PIGMENTATION; PROGRESSION	The plasmacytoma variant translocation 1 gene (PVT1) plays an oncogenic role in the initiation and progression of multiple cancers. In this study, by using deep-sequencing data and follow-up data in the Cancer Genome Atlas-Uveal melanomas (TCGA-UVM), we assessed the association between the expression of PVT1 and clinicopathological characteristics of patients with uveal melanoma, the mechanism of its dysregulation and its prognostic value. Results showed that high PVT1 expression group had a higher proportion of epithelioid cell dominant disease (a more malignant histological subtype than spindle cell dominant disease) and more cases of extrascleral extension (a risk factor for metastasis) compared with the low PVT1 expression group. 61 out of 80 cases (76.3%) of primary uveal melanoma had PVT1 amplification in TCGA-UVM. In addition, PVT1 expression was strongly and negatively correlated with its methylation status (Pearson's r = -0.712, Spearman's r = -0.806). By performing univariate and multivariate analysis, we found that high PVT1 expression was an independent predictor of poor OS in patients with uveal melanoma (HR: 12.015, 95% CI: 1.854-77.876, p = 0.009). Based on these findings, we infer that PVT1 expression is modulated by both DNA amplification and methylation and its expression might serve as a valuable and specific prognostic biomarker in terms of OS in uveal melanoma.	[Xu, Haiming; Gong, Jingwen; Liu, Hui] Zhejiang Prov Peoples Hosp, Peoples Hosp, Dept Ophthalmol, Hangzhou Med Coll, Hangzhou, Zhejiang, Peoples R China	Hangzhou Medical College; Zhejiang Provincial People's Hospital	Liu, H (corresponding author), Zhejiang Prov Peoples Hosp, Peoples Hosp, Dept Ophthalmol, Hangzhou Med Coll, Hangzhou, Zhejiang, Peoples R China.	omegahui@gmail.com			Experimental Animal Science Project of Science Technology Department of Zhejiang, Province of China [2015C37132]; Chinese Medicine Scientific Research Foundation of Zhejiang Province of China [2016ZA033]; Medical scientific Research Foundation of Zhejiang Province of China [2018233958, 2018273482]	Experimental Animal Science Project of Science Technology Department of Zhejiang, Province of China; Chinese Medicine Scientific Research Foundation of Zhejiang Province of China; Medical scientific Research Foundation of Zhejiang Province of China	This study was supported by Experimental Animal Science Project of Science Technology Department of Zhejiang, Province of China (no. 2015C37132) Recipient: Haiming Xu; Chinese Medicine Scientific Research Foundation of Zhejiang Province of China (no. 2016ZA033). Recipient: Hui Liu; Medical scientific Research Foundation of Zhejiang Province of China (no.2018233958). Recipient: Hui Liu; and Medical scientific Research Foundation of Zhejiang Province of China, (no.2018273482). Recipient: Haiming Xu.	Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen X, 2017, STRUCTURES, V10, P1, DOI 10.1016/j.istruc.2016.11.001; Cheng GC, 2016, TUMOR BIOL, V37, P12779, DOI 10.1007/s13277-016-5243-3; Conte F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171661; Ding X, 2016, FEBS LETT, V590, P1729, DOI 10.1002/1873-3468.12220; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Harbour JW, 2004, BRIT J OPHTHALMOL, V88, P39, DOI 10.1136/bjo.88.1.39; Huang CS, 2016, AM J TRANSL RES, V8, P5025; Huang T, 2017, BIOMED PHARMACOTHER, V88, P302, DOI 10.1016/j.biopha.2017.01.049; Iden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156274; Li PD, 2017, ONCOTARGET, V8, P34164, DOI 10.18632/oncotarget.15878; Liu FT, 2017, CELL PHYSIOL BIOCHEM, V43, P1077, DOI 10.1159/000481719; Liu HT, 2016, CANCER MED-US, V5, P3512, DOI 10.1002/cam4.900; Lu DP, 2017, CLIN CHIM ACTA, V474, P1, DOI 10.1016/j.cca.2017.08.038; Lu QK, 2017, DNA CELL BIOL, V36, P837, DOI 10.1089/dna.2017.3808; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Nagoshi H, 2012, CANCER RES, V72, P4954, DOI 10.1158/0008-5472.CAN-12-0213; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski RM, 2015, EXP DERMATOL, V24, P258, DOI 10.1111/exd.12618; Wan L, 2016, MOL CANCER THER, V15, P1082, DOI 10.1158/1535-7163.MCT-15-0707; Wang B.J., 2017, ONCOL RES; Wang Y, 2017, BIOCHEM BIOPH RES CO, V493, P429, DOI 10.1016/j.bbrc.2017.09.005; Xing Y, 2017, MOL THER, V25, P1209, DOI 10.1016/j.ymthe.2017.02.016; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Yuan CL, 2016, NEOPLASMA, V63, P442, DOI 10.4149/314_150825N45; Zhao L., 2017, J CELL PHYSL	33	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189675	10.1371/journal.pone.0189675	http://dx.doi.org/10.1371/journal.pone.0189675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244840	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700047
J	Liu, SW; Li, X; Wu, YR; Duan, RX; Zhang, JX; Dui, F; Zhang, Q; Li, YB; Li, NS				Liu, Shiwei; Li, Xin; Wu, Yaru; Duan, Ruixue; Zhang, Jiaxin; Dui, Fang; Zhang, Qi; Li, Yuanbin; Li, Naishi			Effects of vaspin on pancreatic beta cell secretion via PI3K/Akt and NF-kappa B signaling pathways	PLOS ONE			English	Article							ISLET-ASSOCIATED MACROPHAGES; SERINE-PROTEASE INHIBITOR; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MAMMALIAN TARGET; FATTY-ACIDS; GLUCOSE; ACTIVATION; OBESITY	Vaspin (visceral adipose tissue-derived serine protease inhibitor) is a recently discovered adipokine that has been implicated in diabetes mellitus and other metabolic disorders. However, the effects of vaspin on pancreatic beta cell function and related mechanisms are not fully understood. Thus, the present study was performed to investigate the effects of vaspin on pancreatic beta cell function and the potential underlying mechanisms. Both in vitro (rat insulinoma cells, INS-1) and in vivo (high fat diet fed rats) experiments were conducted. The results showed that vaspin significantly increased INS-1 cell secretory function. Potential mechanisms were explored using inhibitors, western blot and real-time PCR techniques. We found that vaspin increased the levels of IRS-2 mRNA and IRS-2 total protein, while decreased the serine phosphorylation level of IRS-2 protein. Moreover, vaspin increased the Akt phosphorylation protein level which was reversed by PI3K inhibitor ly294002. In addition, vaspin increased the phosphorylation levels of mTOR and p70S6K, which was inhibited by rapamycin. Meanwhile, we found that the NF-kappa B mRNA and protein levels were reduced after vaspin treatment, similar to the effect of NF-kappa B inhibitor TPCK. Furthermore, vaspin increased the glucose stimulated insulin secretion (GSIS) level, lowered blood glucose level and improved the glucose tolerance and insulin sensitivity of high fat diet fed rats. Hyperglycemic clamp test manifested that vaspin improved islet beta cell function. Together, these findings provide a new understanding of the function of vaspin on pancreatic beta cell and suggest that it may serve as a potential agent for the prevention and treatment of type 2 diabetes.	[Liu, Shiwei] Shanxi Med Univ, Shanxi DAYI Hosp, Dept Endocrinol, Taiyuan, Peoples R China; [Liu, Shiwei; Wu, Yaru] Shanxi Med Univ, Taiyuan Cent Hosp, Cent Lab, Taiyuan, Peoples R China; [Li, Xin; Wu, Yaru; Duan, Ruixue; Zhang, Jiaxin; Dui, Fang; Zhang, Qi] Shanxi Med Univ, Grad Sch, Taiyuan, Peoples R China; [Li, Yuanbin] Shanxi Med Univ, Taiyuan Cent Hosp, Dept Endocrinol, Taiyuan, Peoples R China; [Li, Naishi] Chinese Acad Med Sci, Dept Endocrinol, Peking Union Med Coll Hosp, Key Lab Endocrinol, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Liu, SW (corresponding author), Shanxi Med Univ, Shanxi DAYI Hosp, Dept Endocrinol, Taiyuan, Peoples R China.; Liu, SW (corresponding author), Shanxi Med Univ, Taiyuan Cent Hosp, Cent Lab, Taiyuan, Peoples R China.	lswspring6@aliyun.com	Li, Naishi/ABI-7607-2020	Li, Naishi/0000-0002-2261-7349	National Natural Science Foundation of China [81200591, 81471025]; Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province [2013-251]; International Science and Technology Cooperation Project in Shanxi Province [2015081029]; Research Project Supported Shanxi Scholarship Council of China [2015-109]; Transformation of Scientific and Technological Achievements in Shanxi Province [201604D131003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province; International Science and Technology Cooperation Project in Shanxi Province; Research Project Supported Shanxi Scholarship Council of China; Transformation of Scientific and Technological Achievements in Shanxi Province	This research was supported by the National Natural Science Foundation of China (#81200591 & 81471025), Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province (#2013-251), International Science and Technology Cooperation Project in Shanxi Province (#2015081029), Research Project Supported Shanxi Scholarship Council of China (#2015-109), Transformation of Scientific and Technological Achievements in Shanxi Province (#201604D131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Morales NB, 2012, COLOMB MEDICA, V43, P235; Barbour LA, 2011, J CLIN ENDOCR METAB, V96, P1431, DOI 10.1210/jc.2010-2116; Bluher M, 2012, ENDOCRINE, V41, P176, DOI 10.1007/s12020-011-9572-0; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Crook M, 2004, DIABETIC MED, V21, P203, DOI 10.1046/j.1464-5491.2003.01030.x; Cui W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059921; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jia GH, 2010, EXP MOL PATHOL, V89, P20, DOI 10.1016/j.yexmp.2010.04.002; JUNG CH, 2014, CARDIOVASC DIABETOL, V13; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317, DOI 10.1016/0168-8227(94)90269-0; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Li HL, 2013, ATHEROSCLEROSIS, V228, P61, DOI 10.1016/j.atherosclerosis.2013.02.013; Li Q, 2008, J INT MED RES, V36, P625, DOI 10.1177/147323000803600402; Liu SW, 2014, DIABETES RES CLIN PR, V103, P482, DOI 10.1016/j.diabres.2013.12.002; Liu SW, 2016, BASIC CLIN MED, V35, P1020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maassen JA, 2008, DIABETOLOGIA, V51, P907, DOI 10.1007/s00125-008-0963-6; Marchetti P, 2009, DIABETES CARE, V32, pS178, DOI 10.2337/dc09-S306; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; National Research Council, 2011, GUIDE CARE USE LAB A; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Peterson TR, 2005, MOL CELL, V20, P655, DOI 10.1016/j.molcel.2005.11.016; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Saha AK, 2011, CELL CYCLE, V10, P3447, DOI 10.4161/cc.10.20.17886; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Singh G, 1998, AM J MED, V105, p31S, DOI DOI 10.1016/S0002-9343(98)00072-2; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	56	35	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189722	10.1371/journal.pone.0189722	http://dx.doi.org/10.1371/journal.pone.0189722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240812	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600069
J	Perez-Diaz, F; Diaz, E; Sanchez, N; Vargas, JP; Pearce, JM; Lopez, JC				Perez-Diaz, Francisco; Diaz, Estrella; Sanchez, Natividad; Pedro Vargas, Juan; Pearce, John M.; Carlos Lopez, Juan			Different involvement of medial prefrontal cortex and dorso-lateral striatum in automatic and controlled processing of a future conditioned stimulus	PLOS ONE			English	Article							LATENT INHIBITION; BASAL GANGLIA; DORSAL STRIATUM; ATTENTIONAL PERFORMANCE; TASTE-AVERSION; DOPAMINE; REINFORCEMENT; RATS; REPRESENTATION; ARCHITECTURE	Recent studies support the idea that stimulus processing in latent inhibition can vary during the course of preexposure. Controlled attentional mechanisms are said to be important in the early stages of preexposure, while in later stages animals adopt automatic processing of the stimulus to be used for conditioning. Given this distinction, it is possible that both types of processing are governed by different neural systems, affecting differentially the retrieval of information about the stimulus. In the present study we tested if a lesion to the dorso-lateral striatum or to the medial prefrontal cortex has a selective effect on exposure to the future conditioned stimulus (CS). With this aim, animals received different amounts of exposure to the future CS. The results showed that a lesion to the medial prefrontal cortex enhanced latent inhibition in animals receiving limited preexposure to the CS, but had no effect in animals receiving extended preexposure to the CS. The lesion of the dorso-lateral striatum produced a decrease in latent inhibition, but only in animals with an extended exposure to the future conditioned stimulus. These results suggest that the dorsal striatum and medial prefrontal cortex play essential roles in controlled and automatic processes. Automatic attentional processes appear to be impaired by a lesion to the dorso-lateral striatum and facilitated by a lesion to the prefrontal cortex.	[Perez-Diaz, Francisco; Diaz, Estrella; Sanchez, Natividad; Pedro Vargas, Juan; Carlos Lopez, Juan] Univ Seville, Anim Behav & Neurosci Lab, Dept Psicol Expt, C Camilo Jose Cela S-N, Seville, Spain; [Pearce, John M.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Pearce, John M.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia	University of Sevilla; Cardiff University; University of Sydney	Lopez, JC (corresponding author), Univ Seville, Anim Behav & Neurosci Lab, Dept Psicol Expt, C Camilo Jose Cela S-N, Seville, Spain.	jclopez@us.es	Lopez, Juan C/H-6028-2015; Vargas, Juan Pedro/H-6950-2015	Vargas, Juan Pedro/0000-0002-4358-5737; Perez-Diaz Capea, Francisco Jose/0000-0002-0589-087X; Lopez-Garcia, Juan-Carlos/0000-0001-8106-5006	MINECO, FEDER, UE [PSI2015-65500-P]	MINECO, FEDER, UE	This research was supported by PSI2015-65500-P grant (MINECO, FEDER, UE).; We thank Dr. Michael Grannan and Dra. Catherine Thorn for their suggestions and the critical reading of an early version of the manuscript. This research was supported by PSI2015-65500-P grant (MINECO, FEDER, UE). The authors declare no conflict of interest.	Agnoli L, 2013, NEUROPSYCHOPHARMACOL, V38, P701, DOI 10.1038/npp.2012.236; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Badre D, 2012, CEREB CORTEX, V22, P527, DOI 10.1093/cercor/bhr117; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; Lopez JC, 2015, NEUROPSYCHOPHARMACOL, V40, P2096, DOI 10.1038/npp.2015.68; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Diaz E, 2015, PSYCHOPHARMACOLOGY, V232, P4337, DOI 10.1007/s00213-015-4063-2; Diaz E, 2014, NEUROBIOL LEARN MEM, V111, P19, DOI 10.1016/j.nlm.2014.02.008; Ellenbroek BA, 1997, PSYCHOPHARMACOLOGY, V129, P112, DOI 10.1007/s002130050170; Escobar M, 2002, J EXP PSYCHOL-ANIM B, V28, P123, DOI 10.1037//0097-7403.28.2.123; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; George DN, 2010, EUR J NEUROSCI, V31, P1474, DOI 10.1111/j.1460-9568.2010.07178.x; Haber SN, 2000, J NEUROSCI, V20, P2369; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Homayoun H, 2009, EUR J NEUROSCI, V29, P1461, DOI 10.1111/j.1460-9568.2009.06679.x; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Ikeda H, 2013, NEUROSCIENCE, V241, P126, DOI 10.1016/j.neuroscience.2013.03.023; Ito M, 2011, CURR OPIN NEUROBIOL, V21, P368, DOI 10.1016/j.conb.2011.04.001; Jahanshahi M, 2015, NAT REV NEUROSCI, V16, P719, DOI 10.1038/nrn4038; Jeanblanc J, 2003, NEUROSCIENCE, V118, P233, DOI 10.1016/S0306-4522(02)00823-0; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; LaBerge D., 1975, ATTENTION PERFORM, P50; Lacroix L, 2000, BEHAV BRAIN RES, V107, P111, DOI 10.1016/S0166-4328(99)00118-7; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Lara AH, 2014, NAT NEUROSCI, V17, P876, DOI 10.1038/nn.3702; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lubow R, 2010, LATENT INHIBITION CO; Lubow RE., 1989, LATENT INHIBITION CO; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Millett R., 1988, Proceedings of the 1988 DCLASS Conference, P51, DOI 10.1016/S0079-7421(08)60038-9; Molero-Chamizo A, 2015, NEUROSCI RES, V91, P8, DOI 10.1016/j.neures.2014.09.006; Nelson AJD, 2010, NEUROSCIENCE, V170, P99, DOI 10.1016/j.neuroscience.2010.06.066; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Quintero E, 2011, BEHAV PROCESS, V86, P242, DOI 10.1016/j.beproc.2010.12.011; Quintero E, 2011, PHYSIOL BEHAV, V102, P414, DOI 10.1016/j.physbeh.2010.12.002; Redgrave P, 2011, NEUROSCIENCE, V198, P138, DOI 10.1016/j.neuroscience.2011.07.060; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Vargas JP, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00206; Wagner A.R., 1981, P5; Weiner I, 2003, PSYCHOPHARMACOLOGY, V169, P257, DOI 10.1007/s00213-002-1313-x; Willcocks AL, 2013, EUR J NEUROSCI, V37, P259, DOI 10.1111/ejn.12031; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	51	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189630	10.1371/journal.pone.0189630	http://dx.doi.org/10.1371/journal.pone.0189630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240804	Green Submitted, gold, Green Published			2022-12-26	WOS:000417905600055
J	Mollgaard, A; Lehmann, S; Mathiesen, J				Mollgaard, Anders; Lehmann, Sune; Mathiesen, Joachim			Correlations between human mobility and social interaction reveal general activity patterns	PLOS ONE			English	Article							HEAVY TAILS; NETWORK	A day in the life of a person involves a broad range of activities which are common across many people. Going beyond diurnal cycles, a central question is: to what extent do individuals act according to patterns shared across an entire population? Here we investigate the interplay between different activity types, namely communication, motion, and physical proximity by analyzing data collected from smartphones distributed among 638 individuals. We explore two central questions: Which underlying principles govern the formation of the activity patterns? Are the patterns specific to each individual or shared across the entire population? We find that statistics of the entire population allows us to successfully predict 71% of the activity and 85% of the inactivity involved in communication, mobility, and physical proximity. Surprisingly, individual level statistics only result in marginally better predictions, indicating that a majority of activity patterns are shared across our sample population. Finally, we predict short-term activity patterns using a generalized linear model, which suggests that a simple linear description might be sufficient to explain a wide range of actions, whether they be of social or of physical character.	[Mollgaard, Anders; Mathiesen, Joachim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Lehmann, Sune] Tech Univ Denmark, DK-2800 Lyngby, Denmark	University of Copenhagen; Niels Bohr Institute; Technical University of Denmark	Mathiesen, J (corresponding author), Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark.	mathies@nbi.dk		Mathiesen, Joachim/0000-0002-5621-5487; Lehmann, Sune/0000-0001-6099-2345	University of Copenhagen UCPH Excellence Programme for Interdisciplinary Research through the grant "Social Fabric"; Villum Fonden [00007192] Funding Source: researchfish	University of Copenhagen UCPH Excellence Programme for Interdisciplinary Research through the grant "Social Fabric"; Villum Fonden(Villum Fonden)	The study received funding through the University of Copenhagen UCPH 2016 Excellence Programme for Interdisciplinary Research. through the grant "Social Fabric".	Calabrese F., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P312, DOI 10.1109/ITSC.2010.5625119; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Cuttone A, 2016, ARXIV160801939; Di Lorenzo G, 2012, ENVIRON PLANN B, V39, P838, DOI 10.1068/b37147; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu XF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02955; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Mathiesen J, 2013, P NATL ACAD SCI USA, V110, P17259, DOI 10.1073/pnas.1304179110; Matsubara Y., 2012, P 18 ACM SIGKDD INT, P6, DOI 10.1145/2339530.2339537; Mollgaard A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154442; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Powers D. M, 2011, ARXIV201016061; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Sekara V, 2016, P NATL ACAD SCI USA, V113, P9977, DOI 10.1073/pnas.1602803113; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zhou T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28002	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188973	10.1371/journal.pone.0188973	http://dx.doi.org/10.1371/journal.pone.0188973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236739	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100036
J	Wszola, LS; Simonsen, VL; Stuber, EF; Gillespie, CR; Messinger, LN; Decker, KL; Lusk, JJ; Jorgensen, CF; Bishop, AA; Fontaine, JJ				Wszola, Lyndsie S.; Simonsen, Victoria L.; Stuber, Erica F.; Gillespie, Caitlyn R.; Messinger, Lindsey N.; Decker, Karie L.; Lusk, Jeffrey J.; Jorgensen, Christopher F.; Bishop, Andrew A.; Fontaine, Joseph J.			Translating statistical species-habitat models to interactive decision support tools	PLOS ONE			English	Article							SCIENTIFIC EVIDENCE; CONSERVATION; MANAGEMENT; PRACTITIONERS; PHEASANTS; SCIENCE; SYSTEMS; ACCESS; POLICY; GAP	Understanding species-habitat relationships is vital to successful conservation, but the tools used to communicate species-habitat relationships are often poorly suited to the information needs of conservation practitioners. Here we present a novel method for translating a statistical species-habitat model, a regression analysis relating ring-necked pheasant abundance to landcover, into an interactive online tool. The Pheasant Habitat Simulator combines the analytical power of the R programming environment with the user-friendly Shiny web interface to create an online platform in which wildlife professionals can explore the effects of variation in local landcover on relative pheasant habitat suitability within spatial scales relevant to individual wildlife managers. Our tool allows users to virtually manipulate the landcover composition of a simulated space to explore how changes in landcover may affect pheasant relative habitat suitability, and guides users through the economic tradeoffs of landscape changes. We offer suggestions for development of similar interactive applications and demonstrate their potential as innovative science delivery tools for diverse professional and public audiences.	[Wszola, Lyndsie S.; Simonsen, Victoria L.; Stuber, Erica F.; Gillespie, Caitlyn R.; Messinger, Lindsey N.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA; [Decker, Karie L.; Lusk, Jeffrey J.] Nebraska Game & Pk Commiss, Lincoln, NE USA; [Jorgensen, Christopher F.] Olsson Associates, Lincoln, NE USA; [Bishop, Andrew A.] US Fish & Wildlife Serv, Rainwater Basin Joint Venture, Grand Isl, NE USA; [Fontaine, Joseph J.] Univ Nebraska, US Geol Survey, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE USA; [Gillespie, Caitlyn R.] Klamath Bird Observ, Ashland, OR USA; [Messinger, Lindsey N.] Minnesota Dept Nat Resources, Madelia, MN USA	University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Wszola, LS (corresponding author), Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA.	lyndsiewszola5@gmail.com	Fontaine, Joseph J/F-6557-2010; Stuber, Erica/AAT-2803-2020	Fontaine, Joseph J/0000-0002-7639-9156; Stuber, Erica/0000-0002-2687-6874	Federal Aid in Wildlife Restoration [W-98-R]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service; Wildlife Management Institute; Olsson Associates	Federal Aid in Wildlife Restoration; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute; Olsson Associates	Funding for this project was received from Federal Aid in Wildlife Restoration projects W-98-R, administered by the Nebraska Game and Parks Commission. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The Nebraska Cooperative Fish and Wildlife Research Unit is supported by a cooperative agreement among the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. The authors declare no conflicts of interest. Olsson Associates provided support in the form of salary for author CFJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2021, LANG ENV STAT COMP; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Baruch-Mordo S, 2013, BIOL CONSERV, V160, P263, DOI 10.1016/j.biocon.2013.02.002; Bishop A., 2011, RAINWATER BASIN JOIN; Cartwright SJ, 2016, ECOL MODEL, V338, P51, DOI 10.1016/j.ecolmodel.2016.07.012; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Cumming GS, 2006, ECOL SOC, V11; Dye AS, 2007, J RETAIL CONSUM SERV, V14, P269, DOI 10.1016/j.jretconser.2006.07.005; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Esler KJ, 2010, BIOL INVASIONS, V12, P4065, DOI 10.1007/s10530-010-9812-x; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Fontaine JJ, 2017, WILDLIFE SOC B, V41, P194, DOI 10.1002/wsb.763; Gibbons Philip, 2008, Ecological Management & Restoration, V9, P182, DOI 10.1111/j.1442-8903.2008.00416.x; Hiller TL, 2015, WILDLIFE SOC B, V39, P529, DOI 10.1002/wsb.568; Huijser MP, 2009, ECOL SOC, V14; Johnson CJ, 2005, ENVIRON CONSERV, V32, P117, DOI 10.1017/S0376892905002171; Kilen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095025; Likens GE, 2010, FRONT ECOL ENVIRON, V8, pE1, DOI 10.1890/090132; Pabian SE, 2015, J WILDLIFE MANAGE, V79, P641, DOI 10.1002/jwmg.870; Pang L, 2016, ODD HYPOTHESIS DESKT; Pullin AS, 2005, CONSERV BIOL, V19, P1989, DOI 10.1111/j.1523-1739.2005.00287.x; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; Rao M, 2007, ENVIRON MODELL SOFTW, V22, P1270, DOI 10.1016/j.envsoft.2006.08.003; Roux DJ, 2006, ECOL SOC, V11; Seavy NE, 2010, BIODIVERS CONSERV, V19, P1261, DOI 10.1007/s10531-009-9752-x; Sunderland T, 2009, BIOTROPICA, V41, P549, DOI 10.1111/j.1744-7429.2009.00557.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Walsh JC, 2015, CONSERV BIOL, V29, P88, DOI 10.1111/cobi.12370; Whateley S, 2015, ENVIRON MODELL SOFTW, V73, P64, DOI 10.1016/j.envsoft.2015.08.001; Wickham H, 2017, RSTUDIO PACKAGE TIDY; Wickham H, 2016, PACKAGE DPLYR; Wickham H, 2016, RSTUDIO PACKAGE GGPL; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127001	33	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188244	10.1371/journal.pone.0188244	http://dx.doi.org/10.1371/journal.pone.0188244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236707	Green Published, gold			2022-12-26	WOS:000417884100012
J	Zhu, ZD; Yang, FJ; Li, DN; Zhou, LJ; Liu, Y; Zhang, Y; Chen, XZ				Zhu, Zude; Yang, Fengjun; Li, Dongning; Zhou, Lianjun; Liu, Ying; Zhang, Ying; Chen, Xuezhi			Age-related reduction of adaptive brain response during semantic integration is associated with gray matter reduction	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; OLDER-ADULTS; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; LANGUAGE; COMPREHENSION; SYSTEM; METAANALYSIS; MODULATION; EFFICIENCY	While aging is associated with increased knowledge, it is also associated with decreased semantic integration. To investigate brain activation changes during semantic integration, a sample of forty-eight 25-75 year-old adults read sentences with high cloze (HC) and low cloze (LC) probability while functional magnetic resonance imaging was conducted. Significant age-related reduction of cloze effect (LC vs. HC) was found in several regions, especially the left middle frontal gyrus (MFG) and right inferior frontal gyrus (IFG), which play an important role in semantic integration. Moreover, when accounting for global gray matter volume reduction, the age-cloze correlation in the left MFG and right IFG was absent. The results suggest that brain structural atrophy may disrupt brain response in aging brains, which then show less brain engagement in semantic integration.	[Zhu, Zude] Jiangsu Normal Univ, Sch Linguist Sci & Arts, Xuzhou, Peoples R China; [Zhu, Zude] Jiangsu Normal Univ, Collaborat Innovat Ctr Language Competence, Xuzhou, Peoples R China; [Yang, Fengjun; Li, Dongning; Zhou, Lianjun; Liu, Ying; Chen, Xuezhi] Ningcheng Cent Hosp, Chifeng, Peoples R China; [Zhang, Ying] Sucheng Peoples Hosp, Suqian, Peoples R China	Jiangsu Normal University; Jiangsu Normal University	Zhu, ZD (corresponding author), Jiangsu Normal Univ, Sch Linguist Sci & Arts, Xuzhou, Peoples R China.; Zhu, ZD (corresponding author), Jiangsu Normal Univ, Collaborat Innovat Ctr Language Competence, Xuzhou, Peoples R China.; Chen, XZ (corresponding author), Ningcheng Cent Hosp, Chifeng, Peoples R China.	zhuzude@163.com; chenduezhi666@163.com			Natural Science Foundation of China [NSF 31571156]; "333" Project of Jiangsu Province; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (2nd round), Jiangsu	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "333" Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (2nd round), Jiangsu	This work was supported by grants from the Natural Science Foundation of China (NSF 31571156), the "333" Project of Jiangsu Province and Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (2nd round), Jiangsu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Campbell KL, 2016, J NEUROSCI, V36, P5214, DOI 10.1523/JNEUROSCI.4561-15.2016; Davis SW, 2014, NEUROPSYCHOLOGIA, V63, P107, DOI 10.1016/j.neuropsychologia.2014.08.017; DeCaro R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00236; DeLong KA, 2012, BRAIN LANG, V121, P226, DOI 10.1016/j.bandl.2012.02.006; Deschamps I, 2014, NEUROPSYCHOLOGIA, V53, P39, DOI 10.1016/j.neuropsychologia.2013.10.015; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Erb J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00116; Faustmann A, 2007, EXP AGING RES, V33, P439, DOI 10.1080/03610730701525378; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Federmeier KD, 2005, PSYCHOPHYSIOLOGY, V42, P133, DOI 10.1111/j.1469-8986.2005.00274.x; Federmeier KD, 2003, PSYCHOL AGING, V18, P858, DOI 10.1037/0882-7974.18.4.858; Feng GY, 2016, CEREB CORTEX, V26, P3169, DOI 10.1093/cercor/bhv148; Gold BT, 2009, CEREB CORTEX, V19, P2671, DOI 10.1093/cercor/bhp018; Grossman M, 2002, BRAIN LANG, V80, P296, DOI 10.1006/brln.2001.2581; Grossman M, 2002, NEUROIMAGE, V15, P302, DOI 10.1006/nimg.2001.0971; Hagoort P, PERSPECTIVES SENTENC; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; Hakun JG, 2015, CORTEX, V64, P352, DOI 10.1016/j.cortex.2014.12.006; Huang J, 2012, BRAIN RES, V1440, P56, DOI 10.1016/j.brainres.2011.11.060; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kalpouzos G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.021; Kemmotsu N, 2012, J NEUROSCI, V32, P12204, DOI 10.1523/JNEUROSCI.0136-12.2012; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lacombe J, 2015, BRAIN LANG, V149, P118, DOI 10.1016/j.bandl.2015.07.003; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Meunier D, 2014, NEUROBIOL AGING, V35, P42, DOI 10.1016/j.neurobiolaging.2013.07.003; Montembeault M, 2012, NEUROIMAGE, V63, P754, DOI 10.1016/j.neuroimage.2012.06.052; Nardone R, 2012, BRAIN LANG, V120, P422, DOI 10.1016/j.bandl.2012.01.001; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Peelle JE, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00046; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Peelle JE, 2010, CEREB CORTEX, V20, P773, DOI 10.1093/cercor/bhp142; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Tremblay P, 2013, NEUROBIOL AGING, V34, P1935, DOI 10.1016/j.neurobiolaging.2013.02.004; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wlotko EW, 2010, LANG LINGUIST COMPAS, V4, P623, DOI 10.1111/j.1749-818x.2010.00224.x; Wu CY, 2012, NEUROIMAGE, V63, P381, DOI 10.1016/j.neuroimage.2012.06.047; Xu NN, 2017, NEUROSCI LETT, V645, P74, DOI 10.1016/j.neulet.2017.02.074; Zhu Z, 2014, NEUROSCIENCE, V278, P51, DOI 10.1016/j.neuroscience.2014.07.076; Zhu Z, 2015, CEREB CORTEX, V25, P138, DOI 10.1093/cercor/bht212; Zhu ZD, 2013, NEUROIMAGE, V76, P325, DOI 10.1016/j.neuroimage.2013.02.060; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	52	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189462	10.1371/journal.pone.0189462	http://dx.doi.org/10.1371/journal.pone.0189462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236772	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100071
J	Chakona, G; Shackleton, CM				Chakona, Gamuchirai; Shackleton, Charlie M.			Local setting influences the quantity of household food waste in mid-sized South African towns	PLOS ONE			English	Article							SUPPLY CHAINS; COSTS	The world faces a food security challenge with approximately 868 million people undernourished and about two billion people suffering from the negative health consequences of micronutrient deficiencies. Yet, it is believed that at least 33% of food produced for human consumption is lost or wasted along the food chain. As food waste has a negative effect on food security, the present study sought to quantify household food waste along the rural-urban continuum in three South African mid-sized towns situated along an agro-ecological gradient. We quantified the types of foods and drinks that households threw away in the previous 48 hours and identified the causes of household food waste in the three sites. More households wasted prepared food (27%) than unprepared food (15%) and drinks (8%). However, households threw away greater quantities of unprepared food in the 48-hour recall period (268.6 +/- 610.1 g, 90% confidence interval: 175.5 to 361.7 g) compared to prepared food (121.0 +/- 132.4 g, 90% confidence interval: 100.8 to 141.3 g) and drinks (77.0 +/- 192.5 ml, 90% confidence interval: 47.7 to 106.4 ml). The estimated per capita food waste (5-10 kg of unprepared food waste, 3-4 kg of prepared food waste and 1-3 litres of drinks waste per person per year) overlaps with that estimated for other developing countries, but lower than most developed countries. However, the estimated average amount of food waste per person per year for this study (12.35 kg) was higher relative to that estimated for developing countries (8.5 kg per person per year). Household food waste was mainly a result of consumer behavior concerning food preparation and storage. Integrated approaches are required to address this developmental issue affecting South African societies, which include promoting sound food management to decrease household food waste. Also, increased awareness and educational campaigns for household food waste reduction interventions are discussed.	[Chakona, Gamuchirai; Shackleton, Charlie M.] Rhodes Univ, Dept Environm Sci, Grahamstown, South Africa	Rhodes University	Chakona, G (corresponding author), Rhodes Univ, Dept Environm Sci, Grahamstown, South Africa.	matarutseg@yahoo.com	Shackleton, Charlie/GLV-1260-2022; Shackleton, Charlie M/F-4177-2014	Shackleton, Charlie/0000-0002-8489-6136; Chakona, Gamuchirai/0000-0003-3784-8980	VW foundation under the Livelihoods Urbanisation and Natural Resources in Africa (LUNA) project through Freiburg University, Germany	VW foundation under the Livelihoods Urbanisation and Natural Resources in Africa (LUNA) project through Freiburg University, Germany	The research was funded by VW foundation under the Livelihoods Urbanisation and Natural Resources in Africa (LUNA) project through Freiburg University, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Acham H., 2012, INT J NUTR METAB, V4, P24, DOI DOI 10.5897/IJNAM11.059; [Anonymous], 2008, THE FOOD WE WAST; Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; Bloom J, 2007, FOOD NOT EATEN FOOD; Buzby JC, 2014, EC INFORM B; Chakona G., 2017, THESIS; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; FAO, 2013, SUST EUR 2030; FAO, 1981, FAO AGR SERV B, V43; FAO, 2013, STATE HUNGER BUILDIN; Gibb Engineering & Science, 2008, STUD WAST CAT SOL WA; Griffin M, 2009, AGR HUM VALUES, V26, P67, DOI 10.1007/s10460-008-9178-1; Grolleaud M, 2002, POSTHARVEST LOSSES D; Gustavsson J, 2011, INT C SAVE FOOD INT; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hamilton C., 2005, 77 AUSTR I; Hanson C., 2016, FOOD LOSS WASTE ACCO; HarvestPlus, 2011, BREAK GROUND 2011 AN; Hoornweg D., 2010, AN EV WAST RED SCOP; Jorissen J, 2015, SUSTAINABILITY-BASEL, V7, P2695, DOI 10.3390/su7032695; Jones A, 2002, ENVIRON MANAGE, V30, P560, DOI 10.1007/s00267-002-2383-6; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Lundqvist J., 2008, 13 SIWI, P5; Meeusen M, 2008014 RAPP LANDB E; Nahman A, 2013, WASTE MANAGE, V33, P2493, DOI 10.1016/j.wasman.2013.07.012; Nahman A, 2012, WASTE MANAGE, V32, P2147, DOI 10.1016/j.wasman.2012.04.012; Oelofse SH, 2014, FOOD WASTE S AFRICA; Oelofse SHH, 2013, WASTE MANAGE RES, V31, P80, DOI 10.1177/0734242X12457117; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Pekcan G., 2006, HOUSEHOLD FOOD WASTA; Pereira LM, 2014, FUTURE S AFRICAS FOO; Quested TE, 2013, RESOUR CONSERV RECY, V79, P43, DOI 10.1016/j.resconrec.2013.04.011; Quested TE, 2011, NUTR BULL, V36, P460, DOI 10.1111/j.1467-3010.2011.01924.x; Rathje W., 2001, RUBBISH ARCHAEOLOGY; Ridoutt BG, 2010, J CLEAN PROD, V18, P1714, DOI 10.1016/j.jclepro.2010.07.011; Schneider F, 2008, P WAST SOC CONT, P8; Shisana O, 2013, S AFRICAN NATL HLTH; Silbernagl P, 2011, WASTE REVOLUTION HDB, P136; Statistics South Africa (Stats SA), 2012, CENS 2011; Taghipour H, 2016, J MATER CYCLES WASTE, V18, P790, DOI 10.1007/s10163-015-0365-z; Thonissen R, 2010, FACT SHEET FOOD WAST; uMhlathuze Municipality, 2012, UMHLATHUZE INT DEV P; VANGARDE SJ, 1987, J AM DIET ASSOC, V87, P322; World Food Program, 2009, WORLD HUNG SER HUNG; WRAP, 2017, HOUS FOOD WAST UK; WRAP, 2007, UND FOOD WAST KEY FI; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST	47	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189407	10.1371/journal.pone.0189407	http://dx.doi.org/10.1371/journal.pone.0189407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232709	Green Published, gold			2022-12-26	WOS:000417698200040
J	Gini, R; Schuemie, MJ; Pasqua, A; Carlini, E; Profili, F; Cricelli, I; Dazzi, P; Barletta, V; Francesconi, P; Lapi, F; Donatini, A; Dal Co, G; Visca, M; Bellentani, M; Sturkenboom, M; Klazinga, N				Gini, Rosa; Schuemie, Martijn J.; Pasqua, Alessandro; Carlini, Emanuele; Profili, Francesco; Cricelli, Iacopo; Dazzi, Patrizio; Barletta, Valentina; Francesconi, Paolo; Lapi, Francesco; Donatini, Andrea; Dal Co, Giulia; Visca, Modesta; Bellentani, Mariadonata; Sturkenboom, Miriam; Klazinga, Niek			Monitoring compliance with standards of care for chronic diseases using healthcare administrative databases in Italy: Strengths and limitations	PLOS ONE			English	Article								Background A recent comprehensive report on healthcare quality in Italy published by the Organization of Economic Co-operation and Development (OECD) recommended that regular monitoring of quality of primary care by means of compliance with standards of care for chronic diseases is performed. A previous ecological study demonstrated that compliance with standards of care could be reliably estimated on regional level using administrative databases. This study compares estimates based on administrative data with estimates based on GP records for the same persons, to understand whether ecological fallacy played a role in the results of the previous study. Methods We compared estimates of compliance with diagnostic and therapeutic standards of care for type 2 diabetes (T2DM), hypertension and ischaemic heart disease (IHD) from administrative data (IAD) with estimates from medical records (MR) for the same persons registered with 24 GP's in 2012. Data were linked at an individual level. Results 32,688 persons entered the study, 12,673 having at least one of the three diseases according to at least one data source. Patients not detected by IAD were many, for all three conditions: adding MR increased the number of cases of T2DM, hypertension, and IHD by + 40%, 42%, and + 104%, respectively. IAD had imperfect sensitivity in detecting population compliance with therapies (adding MR increased the estimate, from + 11.5% for statins to + 14.7% for antithrombotics), and, more substantially, with diagnostic recommendations (adding MR increased the estimate, from + 23.7% in glycated hemoglobin tests, to + 50.5% in electrocardiogram). Patients not detected by IAD were less compliant with respect to those that IAD correctly identified (from -4.8 percentage points in proportion of IHD patients compliant with a yearly glycated hemoglobin test, to -40.1 points in the proportion of T2DM patients compliant with the same recommendation). IAD overestimated indicators of compliance with therapeutic standards (significant differences ranged from 3.3. to 3.6 percentage points) and underestimated indicators of compliance with diagnostic standards (significant differences ranged from -2.3 to -14.1 percentage points). Conclusion IAD overestimated the percentage of patients compliant with therapeutic standards by less than 6 percentage points, and underestimated the percentage of patients compliant with diagnostic standards by a maximum of 14 percentage points. Therefore, both discussions at local level between GP's and local health unit managers and discussions at central level between national and regional policy makers can be informed by indicators of compliance estimated by IAD, which, based on those results, have the ability of signalling critical or excellent clusters. However, this study found that estimates are partly flawed, because a high number of patients with chronic diseases are not detected by IAD, patients detected are not representative of the whole population of patients, and some categories of diagnostic tests are markedly underrecorded in IAD (up to 50% in the case of electrocardiograms). Those results call to caution when interpreting IAD estimates. Audits based on medical records, on the local level, and an interpretation taking into account information external to IAD, on the central level, are needed to assess a more comprehensive compliance with standards.	[Gini, Rosa; Profili, Francesco; Barletta, Valentina; Francesconi, Paolo; Sturkenboom, Miriam] Agenzia Reg Sanita Toscana, Osservatorio Epidemiol, Florence, Italy; [Gini, Rosa] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Schuemie, Martijn J.] Janssen Res & Dev, Epidemiol, Titusville, NJ USA; [Schuemie, Martijn J.] OHDSI, New York, NY USA; [Pasqua, Alessandro; Lapi, Francesco] Italian Coll Gen Practitioners & Primary Care, Hlth Search, Florence, Italy; [Carlini, Emanuele; Dazzi, Patrizio] CNR, Ist Sci & Tecnol Informaz, Pisa, Italy; [Cricelli, Iacopo] Genomedics, Florence, Italy; [Donatini, Andrea] Assessorato Polit Salute, Bologna, Italy; [Dal Co, Giulia; Visca, Modesta; Bellentani, Mariadonata] Agenzia Nazl Serv Sanit Reg, Rome, Italy; [Klazinga, Niek] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" (ISTI-CNR); University of Amsterdam; Academic Medical Center Amsterdam	Gini, R (corresponding author), Agenzia Reg Sanita Toscana, Osservatorio Epidemiol, Florence, Italy.; Gini, R (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	rosa.gini@ars.toscana.it	Dazzi, Patrizio/ABD-7124-2021; Carlini, Emanuele/AAY-3451-2020	Dazzi, Patrizio/0000-0001-8504-1503; Carlini, Emanuele/0000-0003-3643-5404; Sturkenboom, Miriam/0000-0003-1360-2388; Schuemie, Martijn/0000-0002-0817-5361; Gini, Rosa/0000-0002-6250-877X	project named "Integrazione dei contenuti informativi per la gestione sul territorio di pazienti con patologie complesse o con patologie croniche"; Italian Ministry of Health	project named "Integrazione dei contenuti informativi per la gestione sul territorio di pazienti con patologie complesse o con patologie croniche"; Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the project named "Integrazione dei contenuti informativi per la gestione sul territorio di pazienti con patologie complesse o con patologie croniche", short name MATRICE, funded by the Italian Ministry of Health to M Bellentani. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. I Cricelli, A Pasqua and F Lapi are employed by Genomedics, which is a commercial company, and M J Schuemie is employed by Janssen Research and Development LLC, which is a commercial company. Genomedics and Janssen Research and Development LLC provided support in the form of salaries for authors I Cricelli, A Pasqua, F Lapi and M J Schuemie, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Barletta V, 2016, EUR J PUBLIC HLTH; Chien AT, 2012, PREV MED, V55, pS80, DOI 10.1016/j.ypmed.2012.05.004; Gini R., 2016, VALIDATION ODYSSEY B; Gini R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012413; Gini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095419; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Health Search, 8 HLTH SEARCH; Hirsch AG, 2013, AM J MED QUALITY; Italian National Institute of Statistics, COND SAL RIC SERV SA; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; OECD, 2015, OECD REV HLTH CAR QU; Sakshaug JW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-150; Sultana J, 2014, EUR J CLIN PHARMACOL, V70, P469, DOI 10.1007/s00228-013-1636-z; Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016	17	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188377	10.1371/journal.pone.0188377	http://dx.doi.org/10.1371/journal.pone.0188377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232365	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200004
J	Kangsamaksin, T; Chaithongyot, S; Wootthichairangsan, C; Hanchaina, R; Tangshewinsirikul, C; Svasti, J				Kangsamaksin, Thaned; Chaithongyot, Supattra; Wootthichairangsan, Chanida; Hanchaina, Rattanavinan; Tangshewinsirikul, Chayada; Svasti, Jisnuson			Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-alpha	PLOS ONE			English	Article							BREAST-CANCER CELLS; BETA-SITOSTEROL; IN-VITRO; IDENTIFICATION; PHYTOSTEROLS; MACROPHAGES; MECHANISMS; THERAPY	Lupeol and stigmasterol, major phytosterols in various herbal plants, possess anti-inflammatory activities and have been proposed as candidates for anti-cancer agents, but their molecular mechanisms are still unclear. Here, we investigated the effects of lupeol and stigmasterol on tumor and endothelial cells in vitro and their anti-cancer activities in vivo. Our results demonstrated that lupeol and stigmasterol suppressed cell viability, migration, and morphogenesis of human umbilical vein endothelial cells (HUVECs) but not cholangiocarcinoma (CCA) cells. Expression analyses showed that the treatment of both compounds significantly reduced the transcript level of tumor necrosis factor-alpha (TNF-alpha), and Western blot analyses further revealed a decrease in downstream effector levels of VEGFR-2 signaling, including phosphorylated forms of Src, Akt, PCL, and FAK, which were rescued by TNF-alpha treatment. In vivo, lupeol and stigmasterol disrupted tumor angiogenesis and reduced the growth of CCA tumor xenografts. Immunohistochemical analyses confirmed a decrease in CD31-positive vessel content and macrophage recruitment upon treatment. These findings indicate that lupeol and stigmasterol effectively target tumor endothelial cells and suppress CCA tumor growth by their anti-inflammatory activities and are attractive candidates for anticancer treatment of CCA tumors.	[Kangsamaksin, Thaned; Chaithongyot, Supattra; Wootthichairangsan, Chanida; Hanchaina, Rattanavinan; Svasti, Jisnuson] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Tangshewinsirikul, Chayada] Mahidol Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Fac Med,Ramathibodi Hosp, Bangkok, Thailand; [Svasti, Jisnuson] Chulabhorn Res Inst, Lab Biochem, Bangkok, Thailand	Mahidol University; Mahidol University; Chulabhorn Research Institute	Kangsamaksin, T (corresponding author), Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand.	thanect.kan@mahiciol.edu	Svasti, Jisnuson/J-9262-2016	Svasti, Jisnuson/0000-0002-2217-4517	Thailand Research Fund [TRG5780200]; Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University	This work was supported by the Thailand Research Fund, Grant No. TRG5780200 (http://academic.trf.or.th) and Mahidol University (http://www.mahidol.ac.th) to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the Thailand Research Fund (TRG5780200) and Mahidol University (T.K.).	Alam A., 2016, CLINACANTHUS NUTANS, V9, P402, DOI DOI 10.1016/j.apjtm.2016.03.011; Awad AB, 2007, PHYTOMEDICINE, V14, P747, DOI 10.1016/j.phymed.2007.01.003; Awad AB, 2001, NUTR CANCER, V40, P157, DOI 10.1207/S15327914NC402_12; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Choi JM, 2007, PHYTOTHER RES, V21, P954, DOI 10.1002/ptr.2189; De Stefani E, 2000, NUTR CANCER, V37, P140, DOI 10.1207/S15327914NC372_4; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Folkman J., 1971, N ENGL J MED; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Imaizumi TA, 1997, AM J RESP CELL MOL, V17, P181, DOI 10.1165/ajrcmb.17.2.2818; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Ju YH, 2004, J NUTR, V134, P1145, DOI 10.1093/jn/134.5.1145; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Moon E J, 1999, Angiogenesis, V3, P117, DOI 10.1023/A:1009058232389; Park C, 2007, BIOL PHARM BULL, V30, P1317, DOI 10.1248/bpb.30.1317; Rattanasinganchan P, 2006, WORLD J GASTROENTERO, V12, P6500, DOI 10.3748/wjg.v12.i40.6500; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sirica AE, 2014, HEPATOLOGY, V59, P2397, DOI 10.1002/hep.26762; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Vivancos M, 2005, FREE RADICAL BIO MED, V39, P91, DOI 10.1016/j.freeradbiomed.2005.02.025; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Woyengo TA, 2009, EUR J CLIN NUTR, V63, P813, DOI 10.1038/ejcn.2009.29; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	32	83	91	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12								10.1371/journal.pone.0189628	http://dx.doi.org/10.1371/journal.pone.0189628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232409	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200063
J	Wang, FF; Zhang, YM; Wu, SH; He, Y; Dai, Z; Ma, SC; Liu, B				Wang, Feifei; Zhang, Yumei; Wu, Shouhai; He, Yi; Dai, Zhong; Ma, Shuangcheng; Liu, Bin			Studies of the structure-antioxidant activity relationships and antioxidant activity mechanism of iridoid valepotriates and their degradation products	PLOS ONE			English	Article							VALERIANA-JATAMANSI; IN-VITRO; MASS-SPECTROMETRY; VALERENIC ACID; CELL-LINES; CANCER; GLECHOMIFOLIA; OFFICINALIS; EXTRACT; PROLIFERATION	Oxidative stress has been associated with diverse diseases, including obesity, cancer and neurodegeneration. In fact, Valeriana jatamansi Jones (valerian) and its extracts possess strong antioxidant activities that extend their application in clinical practice to the treatment of these illnesses, even though the underlying mechanisms are not well understood. Iridoid valepotriate, a characteristic iridoid ester in valerian with poor chemical stability, possesses considerable antioxidant components. The original compounds and their degradation products have been found to exhibit strong antioxidant activities. However, the relationship between their structure and antioxidant effects and the mechanism underlying their oxidation resistance remain unclear. A forced degradation study using three iridoid valepotriates (valtrate, acevaltrate and 1-beta acevaltrate) was performed in this work, and the structures of their degradation products were estimated by TLC-MS and LC-MS. Comparison of the antioxidant activities of the iridoid valepotriates before and after forced degradation revealed that degradation reduced the activities of the iridoid valepotriates in free radical scavenging and cytotoxic and cell apoptosis tests. The results suggested that the oxirane nucleus is important for defining the antioxidant profile of iridoid valepotriate. We uncovered possible mechanisms that could explain the antioxidant activities, including the generation of two hydroxyl groups through intramolecular transfer of an H-center dot from an oxirane ring and a reduction in ROS levels through interactions with GABAergic signalling pathways.	[Wang, Feifei; Liu, Bin] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Wang, Feifei; Zhang, Yumei; He, Yi; Dai, Zhong; Ma, Shuangcheng] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Wu, Shouhai] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Beijing University of Chinese Medicine; National Institute of Food & Drug Control - China; Guangzhou University of Chinese Medicine	Liu, B (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.; Zhang, YM; Ma, SC (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	zhangyumei@nifdc.org.cn; masc@nifdc.org.cn; liubinyn67@163.com			National Natural Science Foundation of China [81774101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China [grant number 81774101].	Armania N, 2013, MOLECULES, V18, P13320, DOI 10.3390/molecules181113320; Bettero GM, 2011, PLANTA MED, V77, P1702, DOI 10.1055/s-0030-1271084; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chen YC, 1998, J CHROMATOGR A, V826, P77, DOI 10.1016/S0021-9673(98)00726-2; China Pharmacopoeia Committee, 2015, PHARMACOPOEIA PEOPLE; Cohen-Karni D, 2017, BIOCONJUGATE CHEM, V28, P1251, DOI 10.1021/acs.bioconjchem.7b00078; Dugaheh MA, 2013, PAK J PHARM SCI, V26, P53; Fernandez S, 2004, PHARMACOL BIOCHEM BE, V77, P399, DOI 10.1016/j.pbb.2003.12.003; Glaser J, 2015, MOLECULES, V20, P5740, DOI 10.3390/molecules20045740; HOLZL J, 1984, PLANTA MED, V50, P458, DOI 10.1055/s-2007-969771; ICH guidelines, 2003, INT C HARM; Isa NM, 2012, BRAZ J MED BIOL RES, V45, P524, DOI 10.1590/S0100-879X2012007500022; Jugran AK, 2016, APPL BIOCHEM BIOTECH, V179, P911, DOI 10.1007/s12010-016-2039-2; Kakehashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113610; KOCH U, 1985, PLANTA MED, V51, P172, DOI 10.1055/s-2007-969443; Li XG, 2013, CURR CANCER DRUG TAR, V13, P472, DOI 10.2174/1568009611313040009; Lin S, 2017, J ASIAN NAT PROD RES, V19, P15, DOI 10.1080/10286020.2016.1258065; Lin S, 2015, J ASIAN NAT PROD RES, V17, P455, DOI 10.1080/10286020.2015.1041933; Lin S, 2015, PLANTA MED, V81, P56, DOI 10.1055/s-0034-1383369; Lin S, 2013, PHYTOCHEMISTRY, V85, P185, DOI 10.1016/j.phytochem.2012.08.015; Lin S, 2009, J NAT PROD, V72, P650, DOI 10.1021/np800716f; Maheswaran R., 2012, J GXP COMPLIANCE; Masic A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142386; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Montana M, 2014, MOLECULES, V19, P14987, DOI 10.3390/molecules190914987; Muller LG, 2012, PHYTOCHEM ANALYSIS, V23, P222, DOI 10.1002/pca.1346; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ramesh T, 2014, J SEP SCI, V37, P368, DOI 10.1002/jssc.201300959; Salles LD, 2000, BIOCHEM SYST ECOL, V28, P907, DOI 10.1016/S0305-1978(99)00124-6; Sangeetha P, 2012, J PHARM RES, V5, P2636; Setoyama D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165267; Song YL, 2014, J PHARMACEUT BIOMED, V89, P183, DOI 10.1016/j.jpba.2013.11.001; Sridharan S, 2015, NEUROTOXICOLOGY, V51, P172, DOI 10.1016/j.neuro.2015.10.012; Sudati JH, 2009, NEUROCHEM RES, V34, P1372, DOI 10.1007/s11064-009-9917-8; Tamura S, 2010, CHEMINFORM, V41, P2159; THIES PW, 1981, PLANTA MED, V41, P15, DOI 10.1055/s-2007-971667; Trauner G, 2008, PLANTA MED, V74, P19, DOI 10.1055/s-2007-993761; Wills RBH, 2000, NUTR RES REV, V13, P47, DOI 10.1079/095442200108729007; Xu YM, 2007, J NAT PROD, V70, P2045, DOI 10.1021/np0704553; Yang L, 2016, FREE RADICAL BIO MED, V101, P1, DOI 10.1016/j.freeradbiomed.2016.09.016; Yang Y, 2010, BIORESOURCE TECHNOL, V101, P4205, DOI 10.1016/j.biortech.2009.12.131; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Yowtak J, 2011, PAIN, V152, P844, DOI 10.1016/j.pain.2010.12.034; Zhang B, 2017, RSC ADV, V7, P31899, DOI 10.1039/c6ra27478a; Zhong HQ, 2017, FREE RADICAL BIO MED, V102, P67, DOI 10.1016/j.freeradbiomed.2016.10.494	45	8	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189198	10.1371/journal.pone.0189198	http://dx.doi.org/10.1371/journal.pone.0189198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232391	Green Submitted, Green Published, gold			2022-12-26	WOS:000417698200026
J	Zhou, XN; Jiang, RZ; Dong, YC; Wang, LF				Zhou, Xiaona; Jiang, Runzhu; Dong, Yucai; Wang, Lifeng			Remote ischemic preconditioning attenuates cardiopulmonary bypass-induced lung injury	PLOS ONE			English	Article							CARDIAC-SURGERY; RAT MODEL; PROTECTS	The use of cardiopulmonary bypass (CPB) in cardiac surgeries is known to induce pathological changes in vital organs such as lungs. Remote ischemic preconditioning (RIPC) is a protective strategy that has shown to be able to reduce tissue damage related to ischemiareperfusion injury (IRI). The current study seeks to evaluate the beneficial effects of limb RIPC on lung tissues and function in a rat CPB model. RIPC, which consisted of three cycles of 5-min ischemia and subsequently 5-min reperfusion, was induced in the hind limbs of the animals via a tourniquet. Bronchoalveolar lavage (BAL) fluid analysis and hematoxylin and eosin staining revealed that limb RIPC could significantly attenuate CPB-induced pulmonary injury, as evidenced by a combination of lower total BAL protein content, less severe alveolar wall thickening and reduced intra-alveolar neutrophil infiltration. Consistently, RIPC was also found to improve the proliferation capacity of the bronchioalveolar stem cells isolated from the lung tissues in rats subjected to surgical procedure with CPB. These beneficial effects translated into significantly improved lung function. Further investigation suggested that RIPC could up-regulate the serum levels of several anti-inflammatory cytokines such as interleukin (IL)-4 and 10, which might play a role in its pulmonoprotective effects. Taken together, the current study provided convincing evidence that limb RIPC could be a useful strategy for minimizing CPB-induced organ injuries in patients undergoing CPB surgery.	[Zhou, Xiaona] Guizhou Prov People Hosp, Dept Anesthesiol, Guiyang, Guizhou, Peoples R China; [Jiang, Runzhu] Women & Childrens Hlth Care Hosp Linyi, Dept Ansthesiol, Linyi, Shandong, Peoples R China; [Dong, Yucai] Linyi Peoples Hosp, Dept Rehabil, Linyi, Shandong, Peoples R China; [Wang, Lifeng] Linyi Peoples Hosp, Dept Anesthesiol, Linyi, Shandong, Peoples R China		Wang, LF (corresponding author), Linyi Peoples Hosp, Dept Anesthesiol, Linyi, Shandong, Peoples R China.	406495702@qq.com						Cai ZQP, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0277-1; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Clark SC, 2006, PERFUSION-UK, V21, P225, DOI 10.1191/0267659106pf872oa; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Jones BO, 2013, J THORAC CARDIOV SUR, V146, P1334, DOI 10.1016/j.jtcvs.2013.01.003; Knight PR, 2000, AM J PHYSIOL-LUNG C, V278, pL1240, DOI 10.1152/ajplung.2000.278.6.L1240; Lee JC, 2016, BRAIN PATHOL, V106, pe92; Li C, 2014, ANESTHESIOLOGY, V121, P249, DOI 10.1097/ALN.0000000000000266; Min JJ, 2016, HEART LUNG CIRC, V25, P484, DOI 10.1016/j.hlc.2015.09.008; Olguner C, 2006, ACTA ANAESTH SCAND, V50, P150, DOI 10.1111/j.1399-6576.2006.00938.x; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Punjabi Prakash P, 2013, Glob Cardiol Sci Pract, V2013, P249, DOI 10.5339/gcsp.2013.32; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Russo TA, 2002, AM J PHYSIOL-LUNG C, V283, pL655, DOI 10.1152/ajplung.00071.2002; Schlensak C, 2002, J THORAC CARDIOV SUR, V123, P1199, DOI 10.1067/mtc.2002.121977; Tork O, 2016, ANTIINFLAMMATORY MET; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; VDB Olivier Wv, 2014, J PAEDIATR CHILD H, V50, P63; Yang YU, 2005, J TRAUMATIC SURG	20	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189501	10.1371/journal.pone.0189501	http://dx.doi.org/10.1371/journal.pone.0189501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232398	Green Submitted, Green Published, gold			2022-12-26	WOS:000417698200052
J	Schubert, JTW; Badde, S; Roder, B; Heed, T				Schubert, Jonathan T. W.; Badde, Stephanie; Roeder, Brigitte; Heed, Tobias			Task demands affect spatial reference frame weighting during tactile localization in sighted and congenitally blind adults	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; CROSSED-HANDS DEFICIT; DEVELOPMENTAL VISION; OSCILLATORY ACTIVITY; DECISION-MAKING; REACH TARGETS; MIXED MODELS; BODY POSTURE; ATTENTION; INTEGRATION	Task demands modulate tactile localization in sighted humans, presumably through weight adjustments in the spatial integration of anatomical, skin-based, and external, posture-based information. In contrast, previous studies have suggested that congenitally blind humans, by default, refrain from automatic spatial integration and localize touch using only skin-based information. Here, sighted and congenitally blind participants localized tactile targets on the palm or back of one hand, while ignoring simultaneous tactile distractors at congruent or incongruent locations on the other hand. We probed the interplay of anatomical and external location codes for spatial congruency effects by varying hand posture: the palms either both faced down, or one faced down and one up. In the latter posture, externally congruent target and distractor locations were anatomically incongruent and vice versa. Target locations had to be reported either anatomically ("palm" or "back" of the hand), or externally ("up" or "down" in space). Under anatomical instructions, performance was more accurate for anatomically congruent than incongruent target-distractor pairs. In contrast, under external instructions, performance was more accurate for externally congruent than incongruent pairs. These modulations were evident in sighted and blind individuals. Notably, distractor effects were overall far smaller in blind than in sighted participants, despite comparable target-distractor identification performance. Thus, the absence of developmental vision seems to be associated with an increased ability to focus tactile attention towards a non-spatially defined target. Nevertheless, that blind individuals exhibited effects of hand posture and task instructions in their congruency effects suggests that, like the sighted, they automatically integrate anatomical and external information during tactile localization. Moreover, spatial integration in tactile processing is, thus, flexibly adapted by top-down information-here, task instruction-even in the absence of developmental vision.	[Schubert, Jonathan T. W.; Badde, Stephanie; Roeder, Brigitte; Heed, Tobias] Univ Hamburg, Fac Psychol & Human Movement Sci, Biol Psychol & Neuropsychol, Hamburg, Germany; [Badde, Stephanie] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Heed, Tobias] Bielefeld Univ, Fac Psychol & Sports Sci, Biopsychol & Cognit Neurosci, Bielefeld, Germany; [Heed, Tobias] Bielefeld Univ, Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany	University of Hamburg; New York University; University of Bielefeld; University of Bielefeld	Heed, T (corresponding author), Univ Hamburg, Fac Psychol & Human Movement Sci, Biol Psychol & Neuropsychol, Hamburg, Germany.; Heed, T (corresponding author), Bielefeld Univ, Fac Psychol & Sports Sci, Biopsychol & Cognit Neurosci, Bielefeld, Germany.; Heed, T (corresponding author), Bielefeld Univ, Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany.	tobias.heed@uni-bielefeld.de	Heed, Tobias/C-5330-2008	Heed, Tobias/0000-0001-5632-6091	German Research Foundation's (DFG) [SFB 936]; Emmy Noether grant [Hed 6368/1-1]; DFG [Ba 5600/1-1]; Deutsche Forschungsgemeinschaft; Bielefeld University	German Research Foundation's (DFG)(German Research Foundation (DFG)); Emmy Noether grant(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	This work was supported through the German Research Foundation's (DFG) Research Collaborative SFB 936 (project B1), and Emmy Noether grant Hed 6368/1-1, by which TH was funded. SB was supported by a DFG research fellowship Ba 5600/1-1. We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Azanon E, 2007, EXP BRAIN RES, V182, P537, DOI 10.1007/s00221-007-1011-3; Azanon E, 2015, CURR BIOL, V25, P512, DOI 10.1016/j.cub.2014.12.038; Azanon E, 2010, EUR J NEUROSCI, V31, P1858, DOI 10.1111/j.1460-9568.2010.07233.x; Badde S, 2016, PSYCHON B REV, P1; Badde S, 2016, COGN NEUROPSYCHOL, V33, P26, DOI 10.1080/02643294.2016.1168791; Badde S, 2015, NEUROPSYCHOLOGIA, V70, P367, DOI 10.1016/j.neuropsychologia.2014.10.001; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2015, ARXIV 150604967; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bottini R, 2015, COGNITION, V141, P67, DOI 10.1016/j.cognition.2015.04.004; Brandes J, 2015, J NEUROSCI, V35, P13648, DOI 10.1523/JNEUROSCI.1873-14.2015; Buchholz VN, 2013, J NEUROSCI, V33, P3492, DOI 10.1523/JNEUROSCI.3208-12.2013; Buchholz VN, 2011, J NEUROSCI, V31, P16864, DOI 10.1523/JNEUROSCI.3404-11.2011; Cadieux ML, 2013, MULTISENS RES, V26, P465, DOI 10.1163/22134808-00002423; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Collignon O, 2006, BRAIN RES, V1075, P175, DOI 10.1016/j.brainres.2005.12.079; Collignon O, 2009, NEUROPSYCHOLOGIA, V47, P3236, DOI 10.1016/j.neuropsychologia.2009.07.025; Crollen V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01158-9; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; Eardley AF, 2011, EUR J NEUROSCI, V33, P1897, DOI 10.1111/j.1460-9568.2011.07672.x; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Forster B, 2007, BRAIN RES, V1131, P149, DOI 10.1016/j.brainres.2006.11.004; Gallace A, 2008, EXP BRAIN RES, V191, P171, DOI 10.1007/s00221-008-1510-x; Gherri E, 2012, BIOL PSYCHOL, V91, P172, DOI 10.1016/j.biopsycho.2012.06.007; Gherri E, 2012, NEUROPSYCHOLOGIA, V50, P2303, DOI 10.1016/j.neuropsychologia.2012.05.034; Heed T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158829; Heed T, 2015, TRENDS COGN SCI, V19, P251, DOI 10.1016/j.tics.2015.03.001; Heed T, 2015, MULTISENS RES, V28, P173, DOI 10.1163/22134808-00002485; Heed T, 2014, COGNITION, V132, P1, DOI 10.1016/j.cognition.2014.03.005; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; Hermosillo R, 2011, J NEUROSCI, V31, P10019, DOI 10.1523/JNEUROSCI.0037-11.2011; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Hotting K, 2004, EXP BRAIN RES, V159, P370, DOI 10.1007/s00221-004-1965-3; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; MILLAR S, 1981, PERCEPTION, V10, P255, DOI 10.1068/p100255; Mueller S, 2014, NEUROPSYCHOLOGIA, V62, P184, DOI 10.1016/j.neuropsychologia.2014.07.025; Mueller S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00066; Newport R, 2002, CURR BIOL, V12, P1661, DOI 10.1016/S0960-9822(02)01178-8; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Pritchett LM, 2012, EXP BRAIN RES, V222, P437, DOI 10.1007/s00221-012-3231-4; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 2008, EUR J NEUROSCI, V28, P475, DOI 10.1111/j.1460-9568.2008.06352.x; Schicke T, 2009, EXP BRAIN RES, V192, P703, DOI 10.1007/s00221-008-1587-2; Schubert JTW, 2015, NEUROIMAGE, V117, P417, DOI 10.1016/j.neuroimage.2015.05.068; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Soto-Faraco S, 2004, PERCEPT PSYCHOPHYS, V66, P1077, DOI 10.3758/BF03196837; Trommershauser J., 2011, SENSORY CUE INTEGRAT; Wickham H, 2017, GRAMMAR DATA MANIPUL; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189067	10.1371/journal.pone.0189067	http://dx.doi.org/10.1371/journal.pone.0189067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP5GS	29228023	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600031
J	Eigenbrod, S; Frick, P; Bertsch, U; Mitteregger-Kretzschmar, G; Mielke, J; Maringer, M; Piening, N; Hepp, A; Daude, N; Windl, O; Levin, J; Giese, A; Sakthivelu, V; Tatzelt, J; Kretzschmar, H; Westaway, D				Eigenbrod, Sabina; Frick, Petra; Bertsch, Uwe; Mitteregger-Kretzschmar, Gerda; Mielke, Janina; Maringer, Marko; Piening, Niklas; Hepp, Alexander; Daude, Nathalie; Windl, Otto; Levin, Johannes; Giese, Armin; Sakthivelu, Vignesh; Tatzelt, Joerg; Kretzschmar, Hans; Westaway, David			Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; CREUTZFELDT-JAKOB-DISEASE; OCTAREPEAT REGION; COPPER-BINDING; FULL-LENGTH; BETA-CLEAVAGE; IN-VITRO; AMINO-TERMINUS; INFECTED MICE; REPEAT REGION	Prion diseases have been linked to impaired copper homeostasis and copper induced-oxidative damage to the brain. Divalent metal ions, such as Cu2+ and Zn2+, bind to cellular prion protein (PrPC) at octapeptide repeat (OR) and non-OR sites within the N-terminal half of the protein but information on the impact of such binding on conversion to the misfolded isoform often derives from studies using either OR and non-OR peptides or bacterially-expressed recombinant PrP. Here we created new transgenic mouse lines expressing PrP with disrupted copper binding sites within all four histidine-containing OR's (sites 1-4, H60G, H68G, H76G, H84G, "TetraH>G" allele) or at site 5 (composed of residues His-95 and His-110; "H95G" allele) and monitored the formation of misfolded PrP in vivo. Novel transgenic mice expressing PrP(TetraH>G) at levels comparable to wild-type (wt) controls were susceptible to mouse-adapted scrapie strain RML but showed significantly prolonged incubation times. In contrast, amino acid replacement at residue 95 accelerated disease progression in corresponding PrP(H95G) mice. Neuropathological lesions in terminally ill transgenic mice were similar to scrapie-infected wt controls, but less severe. The pattern of PrPSc deposition, however, was not synaptic as seen in wt animals, but instead dense globular plaque-like accumulations of PrPSc in TgPrP (TetraH>G) mice and diffuse PrPSc deposition in (TgPrP(H95G) mice), were observed throughout all brain sections. We conclude that OR and site 5 histidine substitutions have divergent phenotypic impacts and that cis interactions between the OR region and the site 5 region modulate pathogenic outcomes by affecting the PrP globular domain.	[Eigenbrod, Sabina; Frick, Petra; Bertsch, Uwe; Mitteregger-Kretzschmar, Gerda; Mielke, Janina; Maringer, Marko; Piening, Niklas; Hepp, Alexander; Windl, Otto; Levin, Johannes; Giese, Armin; Kretzschmar, Hans] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Daude, Nathalie; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Sakthivelu, Vignesh; Tatzelt, Joerg] Ludwig Maximilians Univ Munchen, Dept Metab Biochem Neurobiochem, Adolf Butenandt Inst, Munich, Germany; [Eigenbrod, Sabina] Servier Deutschland GmbH, Munich, Germany; [Frick, Petra] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Bertsch, Uwe] Louisenlund Sch, Guby, Germany; [Maringer, Marko] MFD Diagnost GmbH, Wendelsheim, Germany; [Piening, Niklas] BASF SE, Ludwigshafen, Germany; [Hepp, Alexander] Klenze Secondary Sch Munich, Munich, Germany; [Levin, Johannes] Univ Hosp Munich, Dept Neurol, Munich, Germany; [Sakthivelu, Vignesh] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, Cologne, Germany; [Tatzelt, Joerg] Ruhr Univ Bochum, Dept Biochem Neurodegenerat Dis, Bochum, Germany	University of Munich; University of Alberta; University of Munich; Servier; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); BASF; University of Munich; University of Cologne; Ruhr University Bochum	Frick, P (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany.; Frick, P (corresponding author), German Ctr Neurodegenerat Dis, Tubingen, Germany.	petra.frick@dzne.de	Giese, Armin/F-3271-2010; Levin, Johannes/E-4052-2010; Hepp, Alexander/M-7731-2016	Giese, Armin/0000-0002-8238-4102; Levin, Johannes/0000-0001-5092-4306; Hepp, Alexander/0000-0003-1288-925X; Tatzelt, Jorg/0000-0001-5017-5528	State of Bavaria (ForPrion grants) [LMU2, LMU9]; German Research Foundation [TA 167/6]	State of Bavaria (ForPrion grants); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the State of Bavaria (ForPrion grants LMU2 and LMU9) and German Research Foundation (TA 167/6) to JT. The funder provided support in the form of salaries for authors (SE, PF, UB, MM, AH, NP, AG, JM, GM, OW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; BRUCE ME, 1996, PRION DIS, P223; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; CARLSON GA, 1986, CLIN RES, V34, pA675; Caughey B, 1999, METHOD ENZYMOL, V309, P122; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cox DL, 2006, BIOPHYS J, V91, pL11, DOI 10.1529/biophysj.106.083642; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; DICKINSON AG, 1971, MOL GEN GENET, V112, P73, DOI 10.1007/BF00266934; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; FRASER H, 1967, NATURE, V216, P1310, DOI 10.1038/2161310a0; Giachin G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15253; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Haigh CL, 2005, MOL CELL NEUROSCI, V30, P186, DOI 10.1016/j.mcn.2005.07.001; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jansen K, 2001, BIOL CHEM, V382, P683, DOI 10.1515/BC.2001.081; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kong Qingzhong, 2004, VVolume 41, P673; KRASEMANN S, 1995, MOL BRAIN RES, V34, P173, DOI 10.1016/0169-328X(95)00175-R; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leliveld SR, 2008, BIOCHEMISTRY-US, V47, P6267, DOI 10.1021/bi800253c; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Malaise M, 2008, FREE RADICAL BIO MED, V45, P1622, DOI 10.1016/j.freeradbiomed.2008.08.024; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MCCARTHY K, 1963, LANCET, V2, P593; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Miura T, 1996, FEBS LETT, V396, P248, DOI 10.1016/0014-5793(96)01104-0; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; PRUSINER SB, 1986, BIOESSAYS, V5, P281, DOI 10.1002/bies.950050612; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pushie MJ, 2008, BIOPHYS J, V95, P5084, DOI 10.1529/biophysj.108.139568; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Pushie MJ, 2009, J TOXICOL ENV HEAL A, V72, P1040, DOI 10.1080/15287390903084389; Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Stevens DJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000390; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Walter ED, 2009, CURR PROTEIN PEPT SC, V10, P529, DOI 10.2174/138920309789352056; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; Wong BS, 2001, J NEUROCHEM, V79, P689, DOI 10.1046/j.1471-4159.2001.00625.x; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xu K, 2011, J MOL NEUROSCI, V43, P225, DOI 10.1007/s12031-010-9387-0; Yamamoto N, 2009, J BIOL INORG CHEM, V14, P1209, DOI 10.1007/s00775-009-0564-y; Yen CF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600014; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Yu SL, 2008, FEBS J, V275, P5564, DOI 10.1111/j.1742-4658.2008.06680.x	79	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188989	10.1371/journal.pone.0188989	http://dx.doi.org/10.1371/journal.pone.0188989			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220360	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900024
J	Glass, DG; McAlinden, N; Millington, OR; Wright, AJ				Glass, David G.; McAlinden, Niall; Millington, Owain R.; Wright, Amanda J.			A minimally invasive optical trapping system to understand cellular interactions at onset of an immune response	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; INTERACTION FORCES; ACTIVATION; TWEEZERS; KINASE; PHASE	T-cells and antigen presenting cells are an essential part of the adaptive immune response system and how they interact is crucial in how the body effectively fights infection or responds to vaccines. Much of the experimental work studying interaction forces between cells has looked at the average properties of bulk samples of cells or applied microscopy to image the dynamic contact between these cells. In this paper we present a novel optical trapping technique for interrogating the force of this interaction and measuring relative interaction forces at the single-cell level. A triple-spot optical trap is used to directly manipulate the cells of interest without introducing foreign bodies such as beads to the system. The optical trap is used to directly control the initiation of cell-cell contact and, subsequently to terminate the interaction at a defined time point. The laser beam power required to separate immune cell pairs is determined and correlates with the force applied by the optical trap. As proof of concept, the antigen-specific increase in interaction force between a dendritic cell and a specific T-cell is demonstrated. Furthermore, it is demonstrated that this interaction force is completely abrogated when T-cell signalling is blocked. As a result the potential of using optical trapping to interrogate cellular interactions at the single cell level without the need to introduce foreign bodies such as beads is clearly demonstrated.	[Glass, David G.; McAlinden, Niall] Univ Strathclyde, Inst Photon, SUPA, Glasgow, Lanark, Scotland; [Glass, David G.; Millington, Owain R.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Wright, Amanda J.] Univ Nottingham, Dept Elect & Elect Engn, Opt & Photon Grp, Nottingham, England	University of Strathclyde; University of Strathclyde; University of Nottingham	Wright, AJ (corresponding author), Univ Nottingham, Dept Elect & Elect Engn, Opt & Photon Grp, Nottingham, England.	amanda.wright@nottingham.ac.uk	McAlinden, Niall/AAM-9767-2021	McAlinden, Niall/0000-0002-0369-8788; Wright, Amanda/0000-0002-4866-5699	EPSRC [EP/H024891/1]; Engineering and Physical Sciences Research Council [EP/H024891/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC, https://www.epsc.ac.uk/, EP/H024891/1.	Addae-Mensah KA, 2008, EXP BIOL MED, V233, P792, DOI 10.3181/0710-MR-278; Andersson M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2752606; Anvari B, 2004, J BIOMED OPT, V9, P865, DOI 10.1117/1.1778178; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Bowman RW, 2014, COMPUT PHYS COMMUN, V185, P268, DOI 10.1016/j.cpc.2013.08.008; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Hoffmann S, 2011, IMMUNOL LETT, V136, P13, DOI 10.1016/j.imlet.2010.11.005; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Koike T, 2003, J BIOL CHEM, V278, P15685, DOI 10.1074/jbc.M210829200; Lim TS, 2011, J IMMUNOL, V187, P258, DOI 10.4049/jimmunol.1100267; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maklygin AY, 2012, QUANTUM ELECTRON+, V42, P500, DOI 10.1070/QE2012v042n06ABEH014886; McAlinden N, 2014, BIOMED OPT EXPRESS, V5, P1026, DOI 10.1364/BOE.5.001026; McAlinden N, 2011, PROC SPIE, V8097, DOI 10.1117/12.895232; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Millington OR, 2007, PLOS PATHOG, V3, P1380, DOI 10.1371/journal.ppat.0030143; Morrison VL, 2014, NATURE COMMUNICATION, V5, P1; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Oddos S, 2008, BIOPHYS J, V95, pL66, DOI 10.1529/biophysj.108.143198; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Rush CM, 2009, IMMUNOLOGY, V128, P463, DOI 10.1111/j.1365-2567.2009.03124.x; SEEGER S, 1991, CYTOMETRY, V12, P497, DOI 10.1002/cyto.990120606; Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1; Tam JM, 2010, CONTROL MANIPULATION, V5, P15251; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wei XB, 2000, CELL IMMUNOL, V201, P6, DOI 10.1006/cimm.2000.1637; Wright AJ, 2003, J MOD OPTIC, V50, P1521, DOI 10.1080/0950034021000036232; Wright AJ, 2011, P SOC PHOTO-OPT INS, V8097; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052	39	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188581	10.1371/journal.pone.0188581	http://dx.doi.org/10.1371/journal.pone.0188581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220398	Green Published, Green Accepted, gold			2022-12-26	WOS:000417469900011
J	Rathleff, MS; Rathleff, CR; Stephenson, A; Mellor, R; Matthews, M; Crossley, K; Vicenzino, B				Rathleff, Michael Skovdal; Rathleff, Camilla Rams; Stephenson, Aoife; Mellor, Rebecca; Matthews, Mark; Crossley, Kay; Vicenzino, Bill			Adults with patellofemoral pain do not exhibit manifestations of peripheral and central sensitization when compared to healthy pain-free age and sex matched controls - An assessor blinded cross-sectional study	PLOS ONE			English	Article							KNEE PAIN; MODULATION; OSTEOARTHRITIS; ADOLESCENCE; MECHANISMS; FEMALES	Patellofemoral Pain (PFP) is highly prevalent among adults and adolescents. Localized mechanical hyperalgesia around the knee and tibialis anterior have been observed in people with PFP, but limited knowledge of potential manifestations of central sensitisation exists. The aims of this study were to study conditioned pain modulation (CPM) and wide-spread hyperalgesia in adults with PFP. This assessor-blinded cross-sectional study design compared CPM and mechanical pressure pain thresholds (PPT) between 33 adults (23 females) diagnosed with PFP and 32 age and sex matched pain-free controls. The investigator taking the PPT measurements was blinded to which participants had PFP. PPTs were reliably measured using a Somedic hand-held pressure algometer at three sites: 1) The centre of the patella, 2) the tibialis anterior muscle and 3) a remote site on the lateral epicondyle. For the assessment of CPM, experimental pain was induced to the contralateral hand by immersion into a cold water bath (conditioning stimulus), and assessment of PPTs (the test stimulus) was performed before and immediately after the conditioning stimulation. On average, the CPM paradigm induced a significant increase in PPTs across the three sites (6.3-13.5%, P<0.05), however there was no difference in CPM between young adults with PFP compared to the control group, (F(1,189) = 0.39, P = 0.89). There was no difference in mechanical PPTs between the two groups (F(1,189) = 0.03, P = 0.86). Contrary to our a-priori hypothesis, we found no difference in CPM or PPT between young adults with PFP and age and sex matched pain-free controls.	[Rathleff, Michael Skovdal] Aalborg Univ, Res Unit Gen Practice Aalborg, Dept Clin Med, Aalborg, Denmark; [Rathleff, Michael Skovdal; Rathleff, Camilla Rams] Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark; [Stephenson, Aoife; Mellor, Rebecca; Matthews, Mark; Crossley, Kay; Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehabil Sci Physiotherapy, Brisbane, Qld, Australia; [Crossley, Kay] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic, Australia	Aalborg University; Aalborg University; Aalborg University Hospital; University of Queensland; La Trobe University	Rathleff, MS (corresponding author), Aalborg Univ, Res Unit Gen Practice Aalborg, Dept Clin Med, Aalborg, Denmark.; Rathleff, MS (corresponding author), Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark.	misr@hst.aau.dk	Mellor, Rebecca/A-1363-2011; Vicenzino, Bill/A-8492-2011; Mellor, Rebecca/N-1502-2019	Vicenzino, Bill/0000-0003-0253-5933; Mellor, Rebecca/0000-0001-8198-5291; Crossley, Kay/0000-0001-5892-129X; Stephenson, Aoife/0000-0001-8766-5272; Rathleff, Michael Skovdal/0000-0003-1173-0335				Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Boudreau SA, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1521-5; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Crossley KM, 2016, BRIT J SPORT MED, V50, P839, DOI 10.1136/bjsports-2016-096384; de Lalouviere LL, 2014, NAT REV RHEUMATOL, V10, P205, DOI 10.1038/nrrheum.2014.4; Granovsky Y, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0361-8; Graven-Nielsen T, 2012, ARTHRITIS RHEUM-US, V64, P2907, DOI 10.1002/art.34466; Graven-Nielsen T, 2010, NAT REV RHEUMATOL, V6, P599, DOI 10.1038/nrrheum.2010.107; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; KUJALA UM, 1993, ARTHROSCOPY, V9, P159, DOI 10.1016/S0749-8063(05)80366-4; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lewis GN, 2012, J PAIN, V13, P936, DOI 10.1016/j.jpain.2012.07.005; Liao TC, 2015, MED SCI SPORT EXER, V47, P1775, DOI 10.1249/MSS.0000000000000617; Maclachlan LR, 2017, BRIT J SPORT MED, V51, P732, DOI 10.1136/bjsports-2016-096705; Molgaard C, 2011, J AM PODIAT MED ASSN, V101, P215, DOI 10.7547/1010215; Noehren B, 2016, CLIN J PAIN, V32, P915, DOI 10.1097/AJP.0000000000000331; Oono Y, 2011, SCAND J PAIN, V2, P162, DOI 10.1016/j.sjpain.2011.05.006; Rathleff MS, 2015, SPORTS MED, V45, P1489, DOI 10.1007/s40279-015-0364-1; Rathleff MS, 2015, BRIT J SPORT MED, V49, P406, DOI 10.1136/bjsports-2014-093929; Rathleff MS, 2016, AM J SPORT MED, V44, P1165, DOI 10.1177/0363546515622456; Rathleff MS, 2013, J ORTHOP SPORT PHYS, V43, P414, DOI 10.2519/jospt.2013.4383; Rathleff MS, 2016, PAIN MED, V17, P980, DOI 10.1093/pm/pnv017; Thompson LR, 2009, ARTHRIT RHEUM-ARTHR, V61, P725, DOI 10.1002/art.24543; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701; Wood Laurence, 2011, Prim Health Care Res Dev, V12, P157, DOI 10.1017/S1463423610000460	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188930	10.1371/journal.pone.0188930	http://dx.doi.org/10.1371/journal.pone.0188930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220355	gold, Green Published			2022-12-26	WOS:000417469900021
J	Lee, SK; Jung, JI; Hyun, JO; Kim, HW; Youn, HJ				Lee, Seul Ki; Jung, Jung Im; Hyun, Joo O.; Kim, Hwan Wook; Youn, Ho Joong			Coronary-to-pulmonary artery fistula in adults: Evaluation with thallium-201 myocardial perfusion SPECT	PLOS ONE			English	Article							EMISSION COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; CT; ANGIOGRAPHY; INFARCTION; SCINTIGRAPHY; PREVALENCE; PREDICTORS; EXPERIENCE; SECONDARY	Objectives With the increasing use of multi-detector CT, the number of detected cases with coronary-to-pulmonary artery fistula (CPAF) has increased. Several previous studies reported severe cases of angina, but no appropriate tests to evaluate myocardial perfusion for patients with CPAF have been established. We evaluated the hemodynamic characteristics of CPAF using thallium-201 (Tl-201) single photon emission computed tomography (SPECT). Materials and methods Tl-201 SPECT was performed in 17 patients with CPAF, but without evidence of coronary artery disease on coronary computed tomography angiography (CCTA) (age, 58.5 +/- 13.3 years; 8 men). Quantitative analysis of scintigraphic data was performed. Additionally, perfusion abnormalities were compared with CCTA findings. Medical records were obtained to define clinical data, diagnostic findings, symptoms, management, follow-up data, and major adverse cardiac events (MACE). Results Six patients (35.2%) showed perfusion abnormalities on SPECT studies and could be classified as follows: 3 patients, no reversible ischemia (3/17, 17.6%); 1 patient, mild ischemia (1/17, 5.8%); and 2 patients, moderate ischemia (2/17, 11.7%). During the follow-up, ten patients (58.8%) improved under medical management and 5 patients (29.4%) underwent surgical ligation for CPAF with symptomatic improvement in 4 patients. Seven patients performed follow-up myocardial perfusion SPECT, and symptomatic improvement correlated well with scintigraphic perfusion improvement in 6 patients No MACE was observed. Clinical significance Tl-201 myocardial perfusion SPECT might be useful for determining the hemodynamic status and for risk stratification in patients with CPAF.	[Lee, Seul Ki; Jung, Jung Im] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea; [Hyun, Joo O.] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Nucl Med, Seoul, South Korea; [Kim, Hwan Wook] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Youn, Ho Joong] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Seul Ki] Dongguk Univ, Ilsan Hosp, Dept Radiol, Goyang Si, Gyeonggi Do, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Dongguk University; NHIS Ilsan Hospital	Jung, JI (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea.	jijung@catholic.ac.kr		Jung, Jung Im/0000-0001-8264-9388; Lee, Seul Ki/0000-0002-6296-5559				Angelini P, 2002, TEX HEART I J, V29, P271; BARTORELLI AL, 1994, AM HEART J, V127, P207, DOI 10.1016/0002-8703(94)90527-4; Canga Y, 2012, CARDIOL J, V19, P278, DOI 10.5603/CJ.2012.0050; Chen ML, 2009, CLIN NUCL MED, V34, P96, DOI 10.1097/RLU.0b013e318192c497; Chiu CZ, 2008, CIRC J, V72, P1242, DOI 10.1253/circj.72.1242; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Goto Y, 1998, CARDIOLOGY, V89, P252, DOI 10.1159/000006796; Hachamovitch R, 1998, CIRCULATION, V97, P535; Harle T, 2012, CLIN RES CARDIOL, V101, P313, DOI 10.1007/s00392-011-0405-1; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; HOUGHTON JL, 1993, AM HEART J, V125, P886, DOI 10.1016/0002-8703(93)90187-E; Keeley EC, 2001, J AM COLL CARDIOL, V38, P659, DOI 10.1016/S0735-1097(01)01420-6; Kim MS, 2010, INT J CARDIOVAS IMAG, V26, P273, DOI 10.1007/s10554-010-9711-3; Konopka A, 2011, KARDIOL POL, V69, P940; LADENHEIM ML, 1986, J AM COLL CARDIOL, V7, P464, DOI 10.1016/S0735-1097(86)80454-5; Latson LA, 2007, CATHETER CARDIO INTE, V70, P110, DOI 10.1002/ccd.21125; Lee CM, 2016, J COMPUT ASSIST TOMO, V40, P398, DOI 10.1097/RCT.0000000000000370; Lim JJ, 2014, AM J ROENTGENOL, V203, pW237, DOI 10.2214/AJR.13.11613; Lindner O, 2007, DTSCH ARZTEBL, V104, P952; Palloshi A, 2008, J CARDIOVASC MED, V9, P1163, DOI 10.2459/JCM.0b013e3283117d1f; Papadopoulos DP, 2008, HELL J CARDIOL, V49, P111; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Rubini G, 1998, ANGIOLOGY, V49, P55, DOI 10.1177/000331979804900107; Said SAM, 2011, NETH HEART J, V19, P183, DOI 10.1007/s12471-011-0088-2; Said SAM, 2014, CLIN CARDIOL, V37, P536, DOI 10.1002/clc.22297; SAID SAM, 1992, INT J CARDIOL, V35, P270, DOI 10.1016/0167-5273(92)90189-A; Said SAM, 2006, INT J CARDIOL, V106, P323, DOI 10.1016/j.ijcard.2005.01.047; Saito Aya, 2006, Asian Cardiovasc Thorac Ann, V14, pe4; Sato F, 2005, INT HEART J, V46, P355, DOI 10.1536/ihj.46.355; Svensson A, 2004, EUR J NUCL MED MOL I, V31, P229, DOI 10.1007/s00259-003-1361-4; Umana E, 2002, ANGIOLOGY, V53, P353, DOI 10.1177/000331970205300315; Vijayvergiya R, 2010, INT J CARDIOL, V140, pE30, DOI 10.1016/j.ijcard.2008.11.074; Yang SW, 2013, BMJ CASE REPORTS, V2013; Yun H, 2011, CHINESE MED J-PEKING, V124, P4172, DOI 10.3760/cma.j.issn.0366-6999.2011.24.010; Zellweger MJ, 2014, JACC-CARDIOVASC INTE, V7, P615, DOI 10.1016/j.jcin.2014.01.161; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zhang LJ, 2014, ACTA RADIOL, V55, P1031, DOI 10.1177/0284185113512299	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189269	10.1371/journal.pone.0189269	http://dx.doi.org/10.1371/journal.pone.0189269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216309	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800111
J	Ribeiro, T; Lemos, F; Preto, M; Azevedo, J; Sousa, ML; Leao, PN; Campos, A; Linder, S; Vitorino, R; Vasconcelos, V; Urbatzka, R				Ribeiro, Tiago; Lemos, Filipa; Preto, Marco; Azevedo, Joana; Sousa, Maria Ligla; Leao, Pedro N.; Campos, Alexandre; Linder, Stig; Vitorino, Rui; Vasconcelos, Vitor; Urbatzka, Ralph			Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; KAPPA-B ACTIVITIES; COMPLEX-I; DEATH; CYANOBACTERIUM; MITOCHONDRIA; PROTEINS; INSIGHTS; DISEASE; VITRO	Portoamides are cyclic peptides produced and released by the cyanobacterial strain Phormidium sp. presumably to interfere with other organisms in their ecosystems (" allelopathy"). Portoamides were previously demonstrated to have an antiproliferative effect on human lung carcinoma cells, but the underlying mechanism of this activity has not been described. In the present work, the effects of portoamides on proliferation were examined in eight human cancer cell lines and two non-carcinogenic cell lines, and major differences in sensitivities were observed. To generate hypotheses with regard to molecular mechanisms of action, quantitative proteomics using 2D gel electrophoresis and MALDI-TOF/ TOF were performed on the colon carcinoma cell line HT-29. The expression of proteins involved in energy metabolism (mitochondrial respiratory chain and pentose phosphate pathway) was found to be affected. The hypothesis of altered energy metabolism was tested in further experiments. Exposure to portoamides resulted in reduced cellular ATP content, likely due to decreased mitochondrial energy production. Mitochondrial hyperpolarization and reduced mitochondrial reductive capacity was observed in treated cells. Furthermore, alterations in the expression of peroxiredoxins (PRDX4, PRDX6) and components of proteasome subunits (PSB4, PSA6) were observed in portoamide-treated cells, but these alterations were not associated with detectable increases in oxidative stress. We conclude that the cytotoxic activity of portoamides is associated with disturbance of energy metabolism, and alterations in mitochondrial structure and function.	[Ribeiro, Tiago; Lemos, Filipa; Preto, Marco; Azevedo, Joana; Sousa, Maria Ligla; Leao, Pedro N.; Campos, Alexandre; Vasconcelos, Vitor; Urbatzka, Ralph] CIIMAR, Interdisciplinary Ctr Marine & Environm Res, Oporto, Portugal; [Linder, Stig] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Linder, Stig] Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, Linkoping, Sweden; [Vitorino, Rui] Univ Aveiro, Inst Biomed iBiMED, Dept Med Sci, Aveiro, Portugal; [Vitorino, Rui] Univ Porto, Dept Physiol & Cardiothorac Surg, Fac Med, Oporto, Portugal; [Vasconcelos, Vitor] Univ Porto, Dept Biol, Fac Sci, FCUP, Oporto, Portugal	Universidade do Porto; Karolinska Institutet; Linkoping University; Universidade de Aveiro; Universidade do Porto; Universidade do Porto	Urbatzka, R (corresponding author), CIIMAR, Interdisciplinary Ctr Marine & Environm Res, Oporto, Portugal.	rurbatzka@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008; Vitorino, Rui/AAJ-3621-2021; Vitorino, Rui/G-7356-2014; azevedo, joana/AAE-4868-2020; Campos, Alexandre/AGP-3558-2022; Urbatzka, Ralph/G-8907-2013; Leão, Pedro N./E-1630-2011; Sousa, Maria Lígia/AAC-9071-2020; CIIMAR, BYT/N-6498-2017	Vasconcelos, Vitor/0000-0003-3585-2417; Vitorino, Rui/0000-0003-3636-5805; Vitorino, Rui/0000-0003-3636-5805; azevedo, joana/0000-0002-3757-8143; Campos, Alexandre/0000-0003-4621-885X; Urbatzka, Ralph/0000-0001-7476-9195; Leão, Pedro N./0000-0001-5064-9164; Sousa, Maria Lígia/0000-0003-0012-7493; Ribeiro, Tiago/0000-0002-2457-8339; CIIMAR, BYT/0000-0002-3703-4402; Correia Preto, Marco Aurelio/0000-0002-9697-5579	Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources - Northern Regional Operational Program (NORTE) through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000035]; national funds (FCT, Foundation for Science and Technology) [UID/Multi/04423/2013, UID/BIM/04501/2013, UID/IC/00051/2013]; RNEM (National Mass Spectrometry Network); FCT [IF/01358/2014, SFRH/BPD/112287/2015]	Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources - Northern Regional Operational Program (NORTE) through the European Regional Development Fund (ERDF); national funds (FCT, Foundation for Science and Technology); RNEM (National Mass Spectrometry Network); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by the Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the European Regional Development Fund (ERDF). The project was additionally supported by national funds (FCT, Foundation for Science and Technology) with the reference UID/Multi/04423/2013, UID/BIM/04501/2013, UID/IC/00051/2013 and RNEM (National Mass Spectrometry Network). PNL was supported by grant IF/01358/2014 (FCT), and Ralph Urbatrka by grant SFRH/BPD/112287/2015 (FCT).; This research was supported by the Structured Program of R&D&I INNOVMAR-Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the European Regional Development Fund (ERDF). The project was additionally supported by national funds (FCT, Foundation for Science and Technology) with the reference UID/Multi/04423/2013, UID/BIM/04501/2013, UID/IC/00051/2013 and RNEM (National Mass Spectrometry Network). PNL was supported by grant IF/01358/2014 (FCT), and Ralph Urbatzka by grant SFRH/BPD/112287/2015 (FCT). We thank Dr. Jonathan Mark Wilson (Wilfrid Laurier University, Waterloo, Canada) for the correction of the English in the manuscript.	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Balaji S, 2013, ALGAL RES, V2, P278, DOI 10.1016/j.algal.2013.03.002; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Eakins J, 2016, TOXICOL IN VITRO, V34, P161, DOI 10.1016/j.tiv.2016.03.016; Erwin PM, 2010, ECOL ECON, V70, P445, DOI 10.1016/j.ecolecon.2010.09.030; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Freitas S, 2016, MAR DRUGS, V14, DOI 10.3390/md14090158; Freitas S, 2016, TOXICON, V119, P140, DOI 10.1016/j.toxicon.2016.05.016; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Johansson K, 2017, ANTIOXID REDOX SIGN, V26, P229, DOI 10.1089/ars.2015.6419; Kamalian L, 2015, TOXICOL IN VITRO, V29, P732, DOI 10.1016/j.tiv.2015.02.011; Katz J, 2011, CLIN CANCER RES, V17, P6428, DOI 10.1158/1078-0432.CCR-11-0488; Kipp AP, 2017, REDOX BIOL, V12, P403, DOI 10.1016/j.redox.2017.03.013; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leao PN, 2010, P NATL ACAD SCI USA, V107, P11183, DOI 10.1073/pnas.0914343107; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liu D, 2014, INT IMMUNOPHARMACOL, V21, P509, DOI 10.1016/j.intimp.2014.06.014; Mallikarjun V, 2012, FREE RADICAL BIO MED, V53, P280, DOI 10.1016/j.freeradbiomed.2012.04.034; Mevers E, 2011, J NAT PROD, V74, P928, DOI 10.1021/np200077f; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PAGE B, 1993, INT J ONCOL, V3, P473; Paul S, 2015, FREE RADICAL BIO MED, V89, P1218, DOI 10.1016/j.freeradbiomed.2015.11.006; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295	33	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188817	10.1371/journal.pone.0188817	http://dx.doi.org/10.1371/journal.pone.0188817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216224	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800041
J	Tornyos, A; Aradi, D; Horvath, IG; Konyi, A; Magyari, B; Pinter, T; Vorobcsuk, A; Tornyos, D; Komocsi, A				Tornyos, Adrienn; Aradi, Daniel; Horvath, Ivan G.; Konyi, Attila; Magyari, Balazs; Pinter, Tunde; Vorobcsuk, Andras; Tornyos, Daniel; Komocsi, Andras			Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity	PLOS ONE			English	Article							ASSOCIATION/AMERICAN STROKE ASSOCIATION; OPTICAL COHERENCE TOMOGRAPHY; HEALTH-CARE PROFESSIONALS; FOLLOW-UP; MYOCARDIAL-INFARCTION; DEFINITION; INTERVENTION; METAANALYSIS; CLOPIDOGREL; CATHETER	Background The impact of high platelet reactivity (HPR) on clinical outcomes after elective percutaneous coronary interventions (PCI) with drug-eluting balloons (DEB) due to in-stent restenosis (ISR) is unknown. Objective We sought to evaluate the prognostic importance of HPR together with conventional risk factors in patients treated with DEB. Methods Patients treated with DEB due to ISR were enrolled in a single-centre, prospective registry between October 2009 and March 2015. Only patients with recent myocardial infarction (MI) received prasugrel, others were treated with clopidogrel. HPR was defined as an ADP-test >46U with the Multiplate assay and no adjustments were done based on results. The primary endpoint of the study was a composite of cardiovascular mortality, MI, any revascularization or stroke during one-year follow-up. Results 194 stable angina patients were recruited of whom 90% were treated with clopidogrel. Clinical characteristics and procedural data were available for all patients; while platelet function testing was performed in 152 subjects of whom 32 (21%) had HPR. Patients with HPR had a higher risk for the primary endpoint (HR: 2.45; CI: 1.01-5.92; p = 0.03). The difference was primarily driven by a higher risk for revascularization and MI. According to the multivariate analysis, HPR remained a significant, independent predictor of the primary endpoint (HR: 2.88; CI: 1.02-8.14; p = 0.04), while total DEB length and statin treatment were other independent correlates of the primary outcome. Conclusion HPR was found to be an independent predictor of repeat revascularization and MI among elective patients with ISR undergoing PCI with DEB.	[Tornyos, Adrienn; Horvath, Ivan G.; Konyi, Attila; Magyari, Balazs; Pinter, Tunde; Vorobcsuk, Andras; Tornyos, Daniel; Komocsi, Andras] Univ Pecs, Inst Heart, Dept Intervent Cardiol, Pecs, Hungary; [Aradi, Daniel] Semmelweis Univ, Ctr Heart, Balatonfured & Heart & Vasc Ctr, Budapest, Hungary	University of Pecs; Semmelweis University	Komocsi, A (corresponding author), Univ Pecs, Inst Heart, Dept Intervent Cardiol, Pecs, Hungary.	komocsi.andras@pte.hu	Vorobcsuk, András Dr./AAR-9971-2020	Vorobcsuk, András Dr./0000-0002-6884-3130	University of Pecs, Hungary [AOK-KA 2015-17]	University of Pecs, Hungary	The research was supported by the University of Pecs, Hungary [AOK-KA 2015-17 to Andras Komocsi].	Agostoni P, 2013, JACC-CARDIOVASC INTE, V6, P569, DOI 10.1016/j.jcin.2012.12.132; Aradi D, 2014, J AM COLL CARDIOL, V63, P1061, DOI 10.1016/j.jacc.2013.12.023; Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004; Bossi I, 2000, J AM COLL CARDIOL, V35, P1569, DOI 10.1016/S0735-1097(00)00584-2; Cale R, 2013, REV PORT CARDIOL, V32, P361, DOI 10.1016/j.repc.2012.09.006; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Frohlich GM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-123; Giacoppo D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5392; Indermuehle A, 2013, HEART, V99, P327, DOI 10.1136/heartjnl-2012-302945; Lupi A, 2013, INT J CARDIOL, V168, P4608, DOI 10.1016/j.ijcard.2013.07.161; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nayak AK, 2006, CIRC J, V70, P1026, DOI 10.1253/circj.70.1026; Poerner TC, 2014, CIRC-CARDIOVASC INTE, V7, P760, DOI 10.1161/CIRCINTERVENTIONS.113.001146; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2008, CLIN RES CARDIOL, V97, P773, DOI 10.1007/s00392-008-0682-5; Scheller B, 2012, JACC-CARDIOVASC INTE, V5, P323, DOI 10.1016/j.jcin.2012.01.008; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Valenti R, 2015, J THROMB THROMBOLYS, V40, P76, DOI 10.1007/s11239-014-1159-1; Walters DL, 2002, AM J CARDIOL, V89, P491, DOI 10.1016/S0002-9149(01)02285-8	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188493	10.1371/journal.pone.0188493	http://dx.doi.org/10.1371/journal.pone.0188493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216314	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800027
J	Yong, HS; Song, SL; Lim, PE; Eamsobhana, P				Yong, Hoi-Sen; Song, Sze-Looi; Lim, Phaik-Eem; Eamsobhana, Praphathip			Complete mitochondrial genome of Zeugodacus tau (Insecta: Tephritidae) and differentiation of Z. tau species complex by mitochondrial cytochrome c oxidase subunit I gene	PLOS ONE			English	Article							PUMPKIN FRUIT-FLY; DIPTERA TEPHRITIDAE; MOLECULAR PHYLOGENY; TRANSFER-RNA; SOUTHEAST-ASIA; WALKER DIPTERA; COI SEQUENCES; FLIES DIPTERA; DACINI TRIBE; BACTROCERA	The tephritid fruit fly Zeugodacus tau (Walker) is a polyphagous fruit pest of economic importance in Asia. Studies based on genetic markers indicate that it forms a species complex. We report here (1) the complete mitogenome of Z. tau from Malaysia and comparison with that of China as well as the mitogenome of other congeners, and (2) the relationship of Z. tau taxa from different geographical regions based on sequences of cytochrome c oxidase subunit I gene. The complete mitogenome of Z. tau had a total length of 15631 bp for the Malaysian specimen (ZT3) and 15835 bp for the China specimen (ZT1), with similar gene order comprising 37 genes (13 protein-coding genes-PCGs, 2 rRNA genes, and 22 tRNA genes) and a non-coding A + T-rich control region (D-loop). Based on 13 PCGs and 15 mt-genes, Z. tau NC_027290 (China) and Z. tau ZT1 (China) formed a sister group in the lineage containing also Z. tau ZT3 (Malaysia). Phylogenetic analysis based on partial sequences of cox1 gene indicates that the taxa from China, Japan, Laos, Malaysia, Bangladesh, India, Sri Lanka, and Z. tau sp. A from Thailand belong to Z. tau sensu stricto. A complete cox1 gene (or 13 PCGs or 15 mt-genes) instead of partial sequence is more appropriate for determining phylogenetic relationship.	[Yong, Hoi-Sen] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Song, Sze-Looi; Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok, Thailand	Universiti Malaya; Universiti Malaya; Mahidol University	Song, SL; Lim, PE (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	szelooi@um.edu.my; phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; song, sl/GRS-1884-2022; Yong, Hoi Sen/C-1548-2010; Song, Sze-Looi/E-7939-2015; Eamsobhana, Praphathip/H-3343-2012	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Song, Sze Looi/0000-0002-1188-9728	University of Malaya Research Grant [H-5620009]	University of Malaya Research Grant	Funding for this work was provided in part by University of Malaya Research Grant H-5620009.	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Baimai V, 2000, BIOL J LINN SOC, V69, P399, DOI 10.1111/j.1095-8312.2000.tb01213.x; CARROLL LE, 2004, PEST FRUIT FLIES WOR; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; Choudhary JS, 2015, GENE, V569, P191, DOI 10.1016/j.gene.2015.05.066; Chua TH, 2010, PEST MANAG SCI, V66, P379, DOI 10.1002/ps.1886; CLARY DO, 1985, NUCLEIC ACIDS RES, V13, P4029, DOI 10.1093/nar/13.11.4029; De Re FC, 2014, GENETICA, V142, P525, DOI 10.1007/s10709-014-9799-9; Drosopoulou E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05132-3; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Isaza JP, 2017, MITOCHONDRIAL DNA B, V2, P210, DOI 10.1080/23802359.2017.1307706; Jamnongluk W, 2003, GENOME, V46, P112, DOI 10.1139/G02-113; Jeong SY, 2017, MITOCHONDRIAL DNA B, V2, P85, DOI 10.1080/23802359.2017.1285212; Jiang F, 2014, MOL ECOL RESOUR, V14, P1114, DOI 10.1111/1755-0998.12259; Jiang F, 2013, B ENTOMOL RES, V103, P363, DOI 10.1017/S0007485312000806; Jiang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36426; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Khan M, 2011, RES J AGR BIOL SCI, V7, P343; Kitthawee S, 2010, ZOOLOGY, V113, P243, DOI 10.1016/j.zool.2009.12.002; Leblanc L, 2015, ZOOKEYS, P339, DOI 10.3897/zookeys.540.9786; Lim PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037276; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Prabhakar CS, 2013, BIOCHEM SYST ECOL, V51, P291, DOI 10.1016/j.bse.2013.09.008; Saelee Anchalee, 2006, Songklanakarin Journal of Science and Technology, V28, P249; Shi W, 2014, J ECON ENTOMOL, V107, P1256, DOI 10.1603/EC13266; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Tan MH, 2016, MITOCHONDRIAL DNA A, V27, P2502, DOI 10.3109/19401736.2015.1036249; Thanaphum S, 2003, ANN ENTOMOL SOC AM, V96, P44, DOI 10.1603/0013-8746(2003)096[0044:ROFWTB]2.0.CO;2; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Virgilio M, 2015, MOL PHYLOGENET EVOL, V85, P171, DOI 10.1016/j.ympev.2015.01.007; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Yong H-S, 2014, J SCI TECHNOLOGY TRO, V10, P95; Yong HS, 2016, GENETICA, V144, P513, DOI 10.1007/s10709-016-9919-9; Yong HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148201; Yong HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15155; Yong HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129455; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308; Zhang KJ, 2016, MITOCHONDRIAL DNA A, V27, P4314, DOI 10.3109/19401736.2015.1089479; Zhang LJ, 2016, MITOCHONDRIAL DNA B, V1, P680, DOI 10.1080/23802359.2016.1219638	44	7	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189325	10.1371/journal.pone.0189325	http://dx.doi.org/10.1371/journal.pone.0189325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216281	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800118
J	Zhang, XY; Qiu, BS; Wei, ZJ; Yan, F; Shi, CY; Su, S; Liu, X; Ji, JX; Xie, GX				Zhang, Xiaoyong; Qiu, Bensheng; Wei, Zijun; Yan, Fei; Shi, Caiyun; Su, Shi; Liu, Xin; Ji, Jim X.; Xie, Guoxi			Three-dimensional self-gated cardiac MR imaging for the evaluation of myocardial infarction in mouse model on a 3T clinical MR system	PLOS ONE			English	Article							CINE MRI; MICE; HEART; QUANTIFICATION; RECONSTRUCTION; ACQUISITION; SCANNER; TESLA	Purpose To develop and assess a three-dimensional (3D) self-gated technique for the evaluation of myocardial infarction (MI) in mouse model without the use of external electrocardiogram (ECG) trigger and respiratory motion sensor on a 3T clinical MR system. Methods A 3D T1-weighted GRE sequence with stack-of-stars sampling trajectories was developed and performed on six mice with MIs that were injected with a gadolinium-based contrast agent at a 3T clinical MR system. Respiratory and cardiac self-gating signals were derived from the Cartesian mapping of the k-space center along the partition encoding direction by bandpass filtering in image domain. The data were then realigned according to the predetermined self-gating signals for the following image reconstruction. In order to accelerate the data acquisition, image reconstruction was based on compressed sensing (CS) theory by exploiting temporal sparsity of the reconstructed images. In addition, images were also reconstructed from the same realigned data by conventional regridding method for demonstrating the advantageous of the proposed reconstruction method. Furthermore, the accuracy of detecting MI by the proposed method was assessed using histological analysis as the standard reference. Linear regression and Bland-Altman analysis were used to assess the agreement between the proposed method and the histological analysis. Results Compared to the conventional regridding method, the proposed CS method reconstructed images with much less streaking artifact, as well as a better contrast-to-noise ratio (CNR) between the blood and myocardium (4.1 +/- 2.1 vs. 2.9 +/- 1.1, p = 0.031). Linear regression and Bland-Altman analysis demonstrated that excellent correlation was obtained between infarct sizes derived from the proposed method and histology analysis. Conclusion A 3D T1-weighted self-gating technique for mouse cardiac imaging was developed, which has potential for accurately evaluating MIs in mice at 3T clinical MR system without the use of external ECG trigger and respiratory motion sensor.	[Zhang, Xiaoyong; Qiu, Bensheng] Univ Sci & Technol China, Ctr Biomed Engn, Hefei, Anhui, Peoples R China; [Zhang, Xiaoyong; Wei, Zijun; Yan, Fei; Shi, Caiyun; Su, Shi; Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Ji, Jim X.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Xie, Guoxi] Guangzhou Med Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Xie, Guoxi] Guangzhou Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Texas A&M University System; Texas A&M University College Station; Guangzhou Medical University; Guangzhou Medical University	Qiu, BS (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Hefei, Anhui, Peoples R China.; Xie, GX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China.; Xie, GX (corresponding author), Guangzhou Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	bqiu@ustc.edu.cn; guoxixie@163.com			International Cooperation and Exchange of the National Science Foundation of China [81371537, 81571669, 81571701]; SIAT [Y5G003]; Natural Science Foundation of Shenzhen [JCYJ20140417113430603, JCYJ20160531174850658, JCYJ20160331185933583, KQCX2015033117354154]	International Cooperation and Exchange of the National Science Foundation of China; SIAT; Natural Science Foundation of Shenzhen	This project was supported by the International Cooperation and Exchange of the National Science Foundation of China (http://www.nsfc.gov.cn): (81371537(BQ), 81571669(GX), 81571701(FY)); the Excellent Youth Scholars of SIAT (http://www.siat.ac.cn): (Y5G003(CS)), and the Natural Science Foundation of Shenzhen (http://www.szsti.gov.cn): (JCYJ20140417113430603 (GX), JCYJ20160531174850658(CS), JCYJ20160331185933583(GX), and KQCX2015033117354154(GX)).	Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Bovens SM, 2011, NMR BIOMED, V24, P307, DOI 10.1002/nbm.1593; Buonincontri G, 2014, NMR BIOMED, V27, P733, DOI 10.1002/nbm.3116; Buonincontri G, 2013, J MAGN RESON IMAGING, V38, P468, DOI 10.1002/jmri.24001; Croisille P, 2007, INVEST RADIOL, V42, P1, DOI 10.1097/01.rli.0000248892.35531.ea; Delattre BMA, 2010, NMR BIOMED, V23, P503, DOI 10.1002/nbm.1489; Deng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058371; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Feng L, 2014, MAGN RESON MED, V72, P707, DOI 10.1002/mrm.24980; Gaurav, 2011, SCI PROGRAMMING-NETH, V19, P199, DOI 10.3233/SPR-2011-0328; Gilson WD, 2007, METHODS, V43, P35, DOI 10.1016/j.ymeth.2007.03.012; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hiba B, 2007, MAGN RESON MED, V58, P745, DOI 10.1002/mrm.21355; Higano NS, 2017, MAGN RESON MED, V77, P1284, DOI 10.1002/mrm.26212; James JF, 1998, CIRC RES, V82, P407, DOI 10.1161/01.RES.82.4.407; Kramer M, 2015, NMR BIOMED, V28, P162, DOI 10.1002/nbm.3234; Lauzon ML, 1998, MAGNET RESON MED, V40, P769, DOI 10.1002/mrm.1910400519; Liu J, 2010, MAGN RESON MED, V63, P1230, DOI 10.1002/mrm.22306; Mao YJ, 2012, ENDOCRINOLOGY, V153, P3426, DOI 10.1210/en.2012-1065; Montesinos P, 2014, MAGN RESON MED, V72, P369, DOI 10.1002/mrm.24936; Nahrendorf M, 2007, AM J PHYSIOL-HEART C, V292, pH3172, DOI 10.1152/ajpheart.01307.2006; Nieman BJ, 2009, MAGN RESON MED, V61, P1148, DOI 10.1002/mrm.21945; Pang JN, 2014, MAGN RESON MED, V72, P1208, DOI 10.1002/mrm.25450; Pang JN, 2014, MAGN RESON MED, V71, P67, DOI 10.1002/mrm.24628; Polson M J, 1982, Clin Phys Physiol Meas, V3, P231, DOI 10.1088/0143-0815/3/3/008; Ratering D, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-43; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; Ruff J, 2000, J MAGN RESON, V146, P290, DOI 10.1006/jmre.2000.2147; Schneider JE, 2003, J MAGN RESON IMAGING, V18, P691, DOI 10.1002/jmri.10411; SHETTY AN, 1988, MAGNET RESON MED, V8, P84, DOI 10.1002/mrm.1910080110; Sintorn E, 2008, J PARALLEL DISTR COM, V68, P1381, DOI 10.1016/j.jpdc.2008.05.012; Sun DD, 2012, PLOS ONE, V7; Timmers L, 2009, CIRC RES, V104, P699, DOI 10.1161/CIRCRESAHA.108.189746; Trotier AJ, 2016, J MAGN RESON IMAGING, V44, P355, DOI 10.1002/jmri.25150; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; Voelkl JGJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/185683; Wech T, 2016, IEEE T MED IMAGING, V35, P912, DOI 10.1109/TMI.2015.2501832; Wech T, 2011, J MAGN RESON IMAGING, V34, P1072, DOI 10.1002/jmri.22718; Wildgruber M, 2012, J MAGN RESON IMAGING, V36, P1372, DOI 10.1002/jmri.23789; Zhang XQ, 2010, SIAM J IMAGING SCI, V3, P253, DOI 10.1137/090746379	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189286	10.1371/journal.pone.0189286	http://dx.doi.org/10.1371/journal.pone.0189286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216303	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800113
J	Omoto, T; Kim-Kaneyama, J; Lei, XF; Orimo, A; Ohnishi, K; Yoshihara, K; Miyauchi, A; Li, S; Gao, L; Umemoto, T; Tanaka, J; Nakahara, K; Takeya, M; Ishida, F; Kudo, S; Haraguchi, S; Miyazaki, T; Miyazaki, A				Omoto, Tomokatsu; Kim-Kaneyama, Joo-ri; Lei, Xiao-Feng; Orimo, Akira; Ohnishi, Koji; Yoshihara, Kosuke; Miyauchi, Aya; Li, Shuo; Gao, Lin; Umemoto, Takahiro; Tanaka, Junichi; Nakahara, Kenta; Takeya, Motohiro; Ishida, Fumio; Kudo, Shin-ei; Haraguchi, Shogo; Miyazaki, Takuro; Miyazaki, Akira			The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling	ONCOGENE			English	Article							PROSTATE-CANCER; FIBROBLASTS; ACTIVATION; ROLES; CELLS	Carcinoma-associated fibroblasts (CAFs) influence tumor initiation, progression, and metastasis within the tumor-associated stroma. This suggests that CAFs would be a potential target for tumor therapy. Here we found that Hydrogen peroxide- inducible clone-5 (Hic-5), also named transforming growth factor beta-1-induced transcript 1 protein (Tgfb1i1), was strongly induced in CAFs found in human colorectal cancer. To investigate the role of Hic-5 in CAFs, we isolated CAFs and the control counterpart normal fibroblasts (NFs) from human colorectal cancer and non-cancerous regions, respectively. Hic-5 was highly expressed in isolated human CAFs and strongly induced in NFs in culture by the supernatant from cultured colorectal cancer cells as well as cytokines such as TGF-beta, IL-1 beta and stromal cell-derived factor 1 (SDF-1/CXCL12). Furthermore, tumor growth was inhibited in a co-culture assay with Hic-5 knockdown fibroblasts compared with control fibroblasts. To clarify the function and significance of Hic-5 in colorectal cancer in vivo, we utilized a mouse model of azoxymethane (AOM)-induced colorectal cancer using Hic-5-dehcient mice. Lack of Hic-5 in CAFs completely prevented AOM-induced colorectal cancer development in the colon tissues of mice. Mechanistic investigation revealed that Hic-5 promoted the expression of lysyl oxidase and collagen I in human control counterpart fibroblasts. Taken together, these results demonstrate that Hic-5 in CAFs is responsible for orchestrating or generating a tumor-promoting stroma.	[Omoto, Tomokatsu; Kim-Kaneyama, Joo-ri; Lei, Xiao-Feng; Miyauchi, Aya; Li, Shuo; Gao, Lin; Haraguchi, Shogo; Miyazaki, Takuro; Miyazaki, Akira] Showa Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Orimo, Akira] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo, Japan; [Ohnishi, Koji; Takeya, Motohiro] Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan; [Yoshihara, Kosuke] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Umemoto, Takahiro; Tanaka, Junichi] Showa Univ, Fujigaoka Hosp, Dept Gastroenterol & Gen Surg, Yokohama, Kanagawa, Japan; [Nakahara, Kenta; Ishida, Fumio; Kudo, Shin-ei] Showa Univ, Northern Yokohama Hosp, Digest Dis Ctr, Tsuzuki Ku, Yokohama, Kanagawa, Japan	Showa University; Juntendo University; Kumamoto University; Niigata University; Showa University; Showa University	Kim-Kaneyama, J (corresponding author), Showa Univ, Sch Med, Dept Biochem, Tokyo, Japan.	shuri@pharm.showa-u.ac.jp	Yoshihara, Kosuke/AAU-9874-2020	Yoshihara, Kosuke/0000-0002-2254-3378; Orimo, Akira/0000-0001-5330-7282; Miyazaki, Takuro/0000-0003-3354-0292; Haraguchi, Shogo/0000-0002-8731-3311	Japan Society for the Promotion of Science [26461149, 16K10553, 17K10713]; Japan-China Medical Association; Takeda Science Foundation; Private University Research Branding Project; MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [15K15611, 15K14385] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan-China Medical Association; Takeda Science Foundation(Takeda Science Foundation (TSF)); Private University Research Branding Project; MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (26461149 to J-rK-K; 16K10553 to TO; 17K10713 to X-FL) from Japan Society for the Promotion of Science, a research grant from Japan-China Medical Association (to J-rK-K), a research grant from Takeda Science Foundation (to J-rK-K and X-FL) and Private University Research Branding Project. This work was also supported in part by the MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016.	Allaoui R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13050; Arita-Okubo S, 2015, CARDIOVASC RES, V105, P361, DOI 10.1093/cvr/cvv003; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Goreczny GJ, 2017, ONCOGENE, V36, P2693, DOI 10.1038/onc.2016.422; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jamba A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122773; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lei XF, 2016, J HEPATOL, V64, P110, DOI 10.1016/j.jhep.2015.08.026; Lei XF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000747; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Shola DTN, 2012, ONCOGENE, V31, P2480, DOI 10.1038/onc.2011.422; Solomon JD, 2014, MOL CANCER RES, V12, P1166, DOI 10.1158/1541-7786.MCR-13-0395; Takai K, 2016, ONCOTARGET, V7, P82889, DOI 10.18632/oncotarget.12658; Varney SD, 2016, J CELL SCI, V129, P774, DOI 10.1242/jcs.170589; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; Wang TH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010062; Wu JR, 2015, ONCOTARGET, V6, P32526, DOI 10.18632/oncotarget.5322; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhou LL, 2015, J CANCER, V6, P717, DOI 10.7150/jca.10865	35	24	24	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1205	1219		10.1038/s41388-017-0033-y	http://dx.doi.org/10.1038/s41388-017-0033-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29242607				2022-12-26	WOS:000426505400006
J	Krishnan, N; Konidaris, KF; Gasser, G; Tonks, NK				Krishnan, Navasona; Konidaris, Konstantis F.; Gasser, Gilles; Tonks, Nicholas K.			A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug discovery; obesity; phosphorylation; signal transduction; type 2 diabetes; tyrosine-protein phosphatase (tyrosine phosphatase); drug discovery	MICROINJECTION; SENSITIVITY; DISEASE; OBESITY; DRUGS	The protein-tyrosine phosphatase PTP1B is a negative regulator of insulin and leptin signaling and a highly validated therapeutic target for diabetes and obesity. Conventional approaches to drug development have produced potent and specific PTP1B inhibitors, but these inhibitors lack oral bioavailability, which limits their potential for drug development. Here, we report that DPM-1001, an analog of the specific PTP1B inhibitor trodusquemine (MSI-1436), is a potent, specific, and orally bioavailable inhibitor of PTP1B. DPM-1001 also chelates copper, which enhanced its potency as a PTP1B inhibitor. DPM-1001 displayed anti-diabetic properties that were associated with enhanced signaling through insulin and leptin receptors in animal models of diet-induced obesity. Therefore, DPM-1001 represents a proof of concept for a new approach to therapeutic intervention in diabetes and obesity. Although the PTPs have been considered undruggable, the findings of this study suggest that allosteric PTP inhibitors may help reinvigorate drug development efforts that focus on this important family of signal-transducing enzymes.	[Krishnan, Navasona; Tonks, Nicholas K.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Konidaris, Konstantis F.] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Gasser, Gilles] PSL Res Univ, ChimieParisTech, Lab Inorgan Chem Biol, F-75005 Paris, France	Cold Spring Harbor Laboratory; University of Zurich; UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu	Konidaris, Konstantis/W-3256-2019	Konidaris, Konstantis/0000-0002-7366-5682	National Institutes of Health [CA53840, GM55989]; Cold Spring Harbor Laboratory Cancer Centre Support Grant from the National Institutes of Health [CA45508]; CSHL-Northwell Alliance; ANR [ANR-10-IDEX-0001-02 PSL]; NATIONAL CANCER INSTITUTE [P30CA045508, R37CA053840, R01CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Centre Support Grant from the National Institutes of Health; CSHL-Northwell Alliance; ANR(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA53840 and GM55989 (to N.K.T.), Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508 from the National Institutes of Health, the CSHL-Northwell Alliance, and the "Investissements d'Avenir" Program launched by the French Government and implemented by the ANR with reference ANR-10-IDEX-0001-02 PSL (to G.G.). N.K. and N.K.T. serve on the Scientific Advisory Board of DepYmed Inc., a company that focuses on inhibitors of PTP1B in various disease indications. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chatterjee D, 2008, CHEM COMMUN, P2864, DOI 10.1039/b803261k; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cooper GJS, 2012, CURR MED CHEM, V19, P2828; Das A, 2015, MIDDLE EAST AFR J OP, V22, P133, DOI 10.4103/0974-9233.154385; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; Fricker SP, 2007, DALTON T, P4903, DOI 10.1039/b705551j; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; HORLEIN D, 1982, BIOCHEMISTRY-US, V21, P5577; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Marin-Penalver JJ, 2016, WORLD J DIABETES, V7, P354, DOI 10.4239/wjd.v7.i17.354; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Krishnamurthy D, 2008, J MED CHEM, V51, P4790, DOI 10.1021/jm800101w; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Levina A, 2011, DALTON T, V40, P11675, DOI 10.1039/c1dt10380f; Lu LP, 2014, ANTIOXID REDOX SIGN, V20, P2210, DOI 10.1089/ars.2013.5720; Maheswari N., 2017, CURR DRUG TARGETS, DOI [10. 2174/1389450118666170222143739 28228082, DOI 10.2174/138945011866617022214373928228082]; Martin KR, 2014, METHODS, V65, P219, DOI 10.1016/j.ymeth.2013.08.013; MCNEILL JH, 1992, J MED CHEM, V35, P1489, DOI 10.1021/jm00086a020; Meggers E, 2009, CHEM COMMUN, P1001, DOI 10.1039/b813568a; Mjos KD, 2014, CHEM REV, V114, P4540, DOI 10.1021/cr400460s; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Squitti R, 2017, J ALZHEIMERS DIS, V56, P1055, DOI 10.3233/JAD-161033; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Tanaka A, 2009, ENDOCR J, V56, P699, DOI 10.1507/endocrj.K09E-051; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; TONKS NK, 1990, MOL CELL BIOL, V10, P458, DOI 10.1128/MCB.10.2.458; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	38	57	62	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1517	1525		10.1074/jbc.C117.819110	http://dx.doi.org/10.1074/jbc.C117.819110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29217773	Green Published, hybrid			2022-12-26	WOS:000424201700004
J	Schuhmacher, LN; Callejo, G; Srivats, S; Smith, ES				Schuhmacher, Laura-Nadine; Callejo, Gerard; Srivats, Shyam; Smith, Ewan St John			Naked mole-rat acid-sensing ion channel 3 forms nonfunctional homomers, but functional heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid sensing ion channel (ASIC); ion channel; neuron; neurophysiology; pain	SENSORY NEURONS; INFLAMMATORY PAIN; NONPROTON LIGAND; ASIC3; SUBUNITS; MOUSE; MICE; DESENSITIZATION; INSENSITIVITY; SENSITIZATION	Acid-sensing ion channels (ASICs) form both homotrimeric and heterotrimeric ion channels that are activated by extracellular protons and are involved in a wide range of physiological and pathophysiological processes, including pain and anxiety. ASIC proteins can form both homotrimeric and heterotrimeric ion channels. The ASIC3 subunit has been shown to be of particular importance in the peripheral nervous system with pharmacological and genetic manipulations demonstrating a role in pain. Naked mole-rats, despite having functional ASICs, are insensitive to acid as a noxious stimulus and show diminished avoidance of acidic fumes, ammonia, and carbon dioxide. Here we cloned naked mole-rat ASIC3 (nmrASIC3) and used a cell-surface biotinylation assay to demonstrate that it traffics to the plasma membrane, but using whole-cell patch clamp electrophysiology we observed that nmrASIC3 is insensitive to both protons and the non-proton ASIC3 agonist 2-guanidine-4-methylquinazoline. However, in line with previous reports of ASIC3 mRNA expression in dorsal root ganglia neurons, we found that the ASIC3 antagonist APETx2 reversibly inhibits ASIC-like currents in naked mole-rat dorsal root ganglia neurons. We further show that like the proton-insensitive ASIC2b and ASIC4, nmrASIC3 forms functional, proton-sensitive heteromers with other ASIC subunits. An amino acid alignment of ASIC3s between 9 relevant rodent species and human identified unique sequence differences that might underlie the proton insensitivity of nmrASIC3. However, introducing nmrASIC3 differences into rat ASIC3 (rASIC3) produced only minor differences in channel function, and replacing the nmrASIC3 sequence with that of rASIC3 did not produce a proton-sensitive ion channel. Our observation that nmrASIC3 forms nonfunctional homomers may reflect a further adaptation of the naked mole-rat to living in an environment with high-carbon dioxide levels.	[Schuhmacher, Laura-Nadine; Callejo, Gerard; Srivats, Shyam; Smith, Ewan St John] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Schuhmacher, Laura-Nadine] UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England	University of Cambridge; University of London; University College London	Smith, ES (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	es336@cam.ac.uk	Martín, Gerard Callejo/F-8757-2019; St. John Smith, Ewan/G-1776-2011	Martín, Gerard Callejo/0000-0003-4366-0482; St. John Smith, Ewan/0000-0002-2699-1979	Biotechnology and Biological Sciences Research Council [BB/J014540/1]; David James Pharmacology Award; Arthritis Research UK Grant [20930]; Cambridge International; European Trust; Royal Society [RG130110]; Biotechnology and Biological Sciences Research Council [1223845] Funding Source: researchfish; Versus Arthritis [20930] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); David James Pharmacology Award; Arthritis Research UK Grant(Versus Arthritis); Cambridge International; European Trust; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	Supported by Biotechnology and Biological Sciences Research Council Doctoral Training Programme Grant BB/J014540/1 and a recipient of the David James Pharmacology Award.; Supported by Arthritis Research UK Grant 20930.; Supported by the Cambridge International and European Trust.; Supported by Royal Society Research Grant RG130110.	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Callejo G, 2015, PAIN, V156, P483, DOI 10.1097/01.j.pain.0000460335.49525.17; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Garbarino VR, 2015, ARCH BIOCHEM BIOPHYS, V576, P8, DOI 10.1016/j.abb.2015.01.029; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Grunder S, 2000, NEUROREPORT, V11, P1607; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hiasa M, 2017, CANCER RES, V77, P1283, DOI 10.1158/0008-5472.CAN-15-3545; Ikeuchi M, 2008, PAIN, V137, P662, DOI 10.1016/j.pain.2008.01.020; Izumi M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-77; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeggle P, 2015, BIOCHEM BIOPH RES CO, V464, P38, DOI 10.1016/j.bbrc.2015.05.091; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kapoor N, 2011, AM J PHYSIOL-CELL PH, V300, pC1246, DOI 10.1152/ajpcell.00199.2010; Kweon HJ, 2016, BMB REP, V49, P542, DOI 10.5483/BMBRep.2016.49.10.057; Kweon HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30684; LaVinka PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045060; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Lee JYP, 2018, BRIT J PHARMACOL, V175, P2204, DOI 10.1111/bph.14089; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu Z, 2013, J CHEM, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0066666; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Omerbasic D, 2016, CELL REP, V17, P748, DOI 10.1016/j.celrep.2016.09.035; Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Peng Z, 2015, CELL REP, V13, P387, DOI 10.1016/j.celrep.2015.09.002; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reimers C, 2017, P NATL ACAD SCI USA, V114, pE3507, DOI 10.1073/pnas.1616232114; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schuhmacher LN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0279-2; Schuhmacher LN, 2015, MOL PHARMACOL, V87, P561, DOI 10.1124/mol.114.096909; Schumacher L, 2015, OPEN ACCESS ANIM PHY, V7, P137, DOI [DOI 10.2147/OAAP.S50376, 10.2147/OAAP.S50376, 10.2147/oaap.s50376]; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wu WL, 2010, GENES BRAIN BEHAV, V9, P603, DOI 10.1111/j.1601-183X.2010.00591.x; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	55	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1756	1766		10.1074/jbc.M117.807859	http://dx.doi.org/10.1074/jbc.M117.807859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29237731	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000424201700026
J	Wang, DS; Liu, CY; Wang, JQ; Jia, YY; Hu, X; Jiang, H; Shao, ZM; Zeng, YA				Wang, Daisong; Liu, Chunye; Wang, Jingqiang; Jia, Yingying; Hu, Xin; Jiang, Hai; Shao, Zhi-ming; Zeng, Yi Arial			Protein C receptor stimulates multiple signaling pathways in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell signaling; mammary gland; signal transduction; stem cells; PROCR; breast cancer; TNBC; ERK; Akt; RhoA	HEMATOPOIETIC STEM-CELLS; ACTIVATED RECEPTOR-1; GROWTH-FACTOR; IDENTIFICATION; ANTICOAGULANT; EXPRESSION; MIGRATION; PROMOTE; EPCR	The protein C receptor (PROCR) has emerged as a stem cell marker in several normal tissues and has also been implicated in tumor progression. However, the functional role of PROCR and the signaling mechanisms downstream of PROCR remain poorly understood. Here, we dissected the PROCR signaling pathways in breast cancer cells. Combining protein array, knockdown, and overexpression methods, we found that PROCR concomitantly activates multiple pathways. We also noted that PROCR-dependent ERK and PI3k-Akt-mTOR signaling pathways proceed through Src kinase and transactivation of insulin-like growth factor 1 receptor (IGF-1R). These pathway activities led to the accumulation of c-Myc and cyclin D1. On the other hand, PROCR-dependent RhoA-ROCK-p38 signaling relied on coagulation factor II thrombin receptor (F2R). We confirmed these findings in primary cells isolated from triple-negative breast cancer-derived xenografts (PDX) that have high expression of PROCR. To the best our knowledge, this is the first comprehensive study of PROCR signaling in breast cancer cells, and its findings also shed light on the molecular mechanisms of PROCR in stem cells in normal tissue.	[Wang, Daisong; Liu, Chunye; Wang, Jingqiang; Jia, Yingying; Zeng, Yi Arial] Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Hu, Xin; Shao, Zhi-ming] Fudan Univ, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai Canc Ctr,Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China; [Jiang, Hai] Chinese Acad Sci, Shanghai Inst Biol Sci, Innovat Ctr Cell Signaling Network, Key Lab Syst Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zeng, YA (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.; Shao, ZM (corresponding author), Fudan Univ, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai Canc Ctr,Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China.	zhimingshao@yahoo.com; yzeng@sibcb.ac.cn			National Natural Science Foundation of China [31530045, 31371500]; Ministry of Science and Technology of China [2014CB964800]; Chinese Academy of Sciences [XDB19000000, XDA12020349]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31530045 and 31371500 (to Y. A. Z.), Ministry of Science and Technology of China Grant 2014CB964800 (to Y. A. Z.), and Chinese Academy of Sciences Grants XDB19000000 and XDA12020349 (to Y. A. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Anton I, 2012, AM J RESP CRIT CARE, V186, P96, DOI 10.1164/rccm.201110-1826OC; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Beaulieu LM, 2007, EXP CELL RES, V313, P677, DOI 10.1016/j.yexcr.2006.11.019; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Fares I, 2017, BLOOD, V129, P3344, DOI 10.1182/blood-2016-11-750729; Feistritzer C, 2006, J IMMUNOL, V176, P1019, DOI 10.4049/jimmunol.176.2.1019; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gramling MW, 2010, EXP CELL RES, V316, P314, DOI 10.1016/j.yexcr.2009.10.024; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Hiscox S, 2008, EXPERT OPIN THER TAR, V12, P757, DOI [10.1517/14728222.12.6.757, 10.1517/14728222.12.6.757 ]; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Keshava S, 2013, CANCER RES, V73, P3963, DOI 10.1158/0008-5472.CAN-12-1690; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Polyak Kornelia, 2012, Cancer Cell, V22, P562, DOI 10.1016/j.ccr.2012.06.021; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sato K, 2003, GENES CELLS, V8, P995, DOI 10.1046/j.1356-9597.2003.00691.x; Schaffner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061071; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Xue ML, 2007, J BIOL CHEM, V282, P13610, DOI 10.1074/jbc.M610740200; Xue ML, 2011, J BIOL CHEM, V286, P6742, DOI 10.1074/jbc.M110.181388; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Yu QC, 2016, CELL RES, V26, P1079, DOI 10.1038/cr.2016.85; Yunokawa M, 2012, CANCER SCI, V103, P1665, DOI 10.1111/j.1349-7006.2012.02359.x; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	39	18	18	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1413	1424		10.1074/jbc.M117.814046	http://dx.doi.org/10.1074/jbc.M117.814046			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29217770	Green Published, hybrid			2022-12-26	WOS:000423515000026
J	Jun, DY; Lee, JY; Park, HS; Lee, YH; Kim, YH				Jun, Do Youn; Lee, Ji Young; Park, Hae Sun; Lee, Yun Han; Kim, Young Ho			Tumor suppressor protein p53-mediated repression of human mitotic centromere-associated kinesin gene expression is exerted via down-regulation of Sp1 level	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; TRANSCRIPTION FACTORS; BINDING DOMAIN; MITHRAMYCIN-A; CELL-LINE; SP-FAMILY; MCAK; P53; CANCER; MITOSIS	The repressive role of p53 on the human mitotic centromere-associated kinesin (MCAK) core promoter from -266 to +54, relative to the transcription start site, has been determined. The MCAK mRNA and protein levels were 2.1- and 3.0-fold higher, respectively, in HCT116 (p53(-/-)) than in HCT116 (p53(+/+)) cells. Enforced down-regulation of p53 levels either in HCT116 (p53(+/+)) cells by p53 RNAi treatment or in MCF-7 cells using shRNA for p53 (shp53) resulted in a remarkable increase in the MCAK protein level. Site-directed mutagenesis and ChIP analyses showed that p53-mediated repression of the MCAK core promoter activity was not directly exerted by p53-binding to putative p53-response elements (p53RE1 at -173/-166 and p53-RE2 at -245/-238), but indirectly by attenuating Sp1 binding to GC-motifs (GC1 at -93/-84 and GC2 at -119/-110). Treatment of HEK-293 cells bearing the MCAK core promoter-reporter (pGL2-320-Luc) with mithramycin A, which down-regulates Sp1 gene expression, reduced the promoter activity as well as endogenous MCAK levels. Exposure of HCT116 (p53(+/+)) cells to nutlin-3a, a validated activator of p53, caused a simultaneous reduction in Sp1 and MCAK protein levels, but not in HCT116 (p53(-/-)) cells. In contrast to wild-type (wt)-p53, tumor-derived p53 mutants (p53(V143A), p53(R248W), and p53(R273H)) failed to repress the Sp1-dependent activation of the MCAK promoter and to down-regulate endogenous levels of Sp1 and MCAK proteins. Collectively, these findings demonstrate that p53 can repress MCAK promoter activity indirectly via down-regulation of Sp1 expression level, and suggest that MCAK elevation in human tumor cells might be due to p53 mutation.	[Jun, Do Youn; Lee, Ji Young; Park, Hae Sun; Kim, Young Ho] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunol, Daegu, South Korea; [Lee, Yun Han] Keimyung Univ, Sch Med, Dept Mol Med, Daegu, South Korea	Kyungpook National University; Keimyung University	Kim, YH (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunol, Daegu, South Korea.	ykim@knu.ac.kr			Korea Research Foundation - Korean government (MOEHRD, Basic Research Promotion Fund) [KRF-2010-0006341]	Korea Research Foundation - Korean government (MOEHRD, Basic Research Promotion Fund)	This work was supported by a grant from the Korea Research Foundation funded by the Korean government (MOEHRD, Basic Research Promotion Fund; KRF-2010-0006341) to DYJ.	Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Holmfeldt P, 2004, EMBO J, V23, P627, DOI 10.1038/sj.emboj.7600076; Ishikawa K, 2008, BRIT J CANCER, V98, P1824, DOI 10.1038/sj.bjc.6604379; Iwao C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04419; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jun DY, 2008, BBA-GENE REGUL MECH, V1779, P356, DOI 10.1016/j.bbagrm.2008.03.013; Jun DY, 2003, J MICROBIOL BIOTECHN, V13, P912; Jun DY, 2005, J LIFE SCI, V15, P253; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Sanhaji M, 2011, ONCOTARGET, V2, P935; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Strano S, 2007, HEAD NECK-J SCI SPEC, V29, P488, DOI 10.1002/hed.20531; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Tanaka K, 2012, J BIOCHEM, V152, P415, DOI 10.1093/jb/mvs109; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Wordeman L, 1999, CELL BIOL INT, V23, P275, DOI 10.1006/cbir.1999.0359; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	42	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189698	10.1371/journal.pone.0189698	http://dx.doi.org/10.1371/journal.pone.0189698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244835	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700052
J	Montiel-Davalos, A; Sanchez, GJS; Huerta-Garcia, E; Rueda-Romero, C; Chafre, GS; Mitre-Aguilar, IB; Alfaro-Moreno, E; Pedraza-Chaverri, J; Lopez-Marure, R				Montiel-Davalos, Angelica; Silva Sanchez, Guadalupe Jazmin; Huerta-Garcia, Elizabeth; Rueda-Romero, Cristhiam; Soca Chafre, Giovanny; Mitre-Aguilar, Irma B.; Alfaro-Moreno, Ernesto; Pedraza-Chaverri, Jose; Lopez-Marure, Rebeca			Curcumin inhibits activation induced by urban particulate material or titanium dioxide nanoparticles in primary human endothelial cells	PLOS ONE			English	Article							INDUCED NEPHROTOXICITY; ANTIOXIDANT MECHANISM; ADHESION MOLECULES; TIO2 NANOPARTICLES; IN-VITRO; EXPRESSION; PM10; DYSFUNCTION; RESPONSES; EXPOSURE	Curcumin has protective effects against toxic agents and shows preventive properties for various diseases. Particulate material with an aerodynamic diameter of similar to 10 mu m (PM10) and titanium dioxide nanoparticles (TiO2-NPs) induce endothelial dysfunction and activation. We explored whether curcumin is able to attenuate different events related to endothelial activation. This includes adhesion, expression of adhesion molecules and oxidative stress induced by PM10 and TiO2-NPs. Human umbilical vein endothelial cells (HUVEC) were treated with 1, 10 and 100 mu M curcumin for 1 h and then exposed to PM10 at 3 mu g/cm(2) or TiO2-NPs at 10 mu g/cm(2). Cell adhesion was evaluated by co-culture with U937 human myelomonocytic cells. Adhesion molecules expression was measured by flow cytometry after 3 or 24 h of exposure. Oxidative stress was determined by 2,7-dichlorodihydrofluorescein (H2DCF) oxidation. PM10 and TiO2-NPs induced the adhesion of U937 cells and the expression of E-and P-selectins, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and platelet-endothelial cell adhesion molecule-1 (PECAM-1). The expression of E-and P-selectins matched the adhesion of monocytes to HUVEC after 3 h. In HUVEC treated with 1 or 10 mu M curcumin, the expression of adhesion molecules and monocytes adhesion was significantly diminished. Curcumin also partially reduced the H2DCF oxidation induced by PM10 and TiO2-NPs. Our results suggest an anti-inflammatory and antioxidant role by curcumin attenuating the activation caused on endothelial cells by exposure to particles. Therefore, curcumin could be useful in the treatment of diseases where an inflammatory process and endothelial activation are	[Montiel-Davalos, Angelica; Silva Sanchez, Guadalupe Jazmin; Rueda-Romero, Cristhiam; Soca Chafre, Giovanny] Inst Nacl Cancerol, Subdirecc Invest Basica, Mexico City, DF, Mexico; [Huerta-Garcia, Elizabeth; Lopez-Marure, Rebeca] Inst Nacl Cardiol Ignacio Chavez, Dept Fisiol Biol Celular, Mexico City, DF, Mexico; [Mitre-Aguilar, Irma B.] INCMNSZ, Unidad Bioquim, Mexico City, DF, Mexico; [Alfaro-Moreno, Ernesto] Karolinska Inst, Swetox, Unit Toxicol Sci, Forskargatan, Se Sodertalje, Sweden; [Pedraza-Chaverri, Jose] Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); National Institute of Cardiology - Mexico; Karolinska Institutet; Universidad Nacional Autonoma de Mexico	Lopez-Marure, R (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Dept Fisiol Biol Celular, Mexico City, DF, Mexico.	rlmarure@yahoo.com.mx	Alfaro-Moreno, Ernesto/AAB-8481-2019	Alfaro-Moreno, Ernesto/0000-0003-1132-7992; Lopez:Marure, Rebeca/0000-0003-1090-5084; Huerta Garcia, Elizabeth/0000-0001-8700-305X	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [182341, 106057]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by Consejo Nacional de Ciencia y Tecnologia (CONACyT), grants 182341 (RLM) and 106057 (EAM), https://www.conacyt.gob.mx/.	Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Alfaro-Moreno E, 2002, ENVIRON HEALTH PERSP, V110, P715, DOI 10.1289/ehp.02110715; Alfaro-Moreno E, 2007, ENVIRON RES, V103, P221, DOI 10.1016/j.envres.2006.05.004; Alfaro-Moreno E, 2009, ENVIRON RES, V109, P528, DOI 10.1016/j.envres.2009.02.010; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Bielli A, 2015, LIFE SCI, V143, P209, DOI 10.1016/j.lfs.2015.11.012; Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5; Das KC, 2002, BIOCHEM BIOPH RES CO, V295, P62, DOI 10.1016/S0006-291X(02)00633-2; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dinikova-Kostova AT, 2004, METHOD ENZYMOL, V382, P423; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Gimbrone MA, 1997, J CLIN INVEST, V99, P1809, DOI 10.1172/JCI119346; Gonzalez-Reyes S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/801418; Han SG, 2013, TOXICOLOGY, V306, P1, DOI 10.1016/j.tox.2013.01.014; Heiss EH, 2009, J BIOL CHEM, V284, P31579, DOI 10.1074/jbc.M109.009175; Hernandez-Resendiz S, 2015, CARDIOVASC DRUG THER, V29, P111, DOI 10.1007/s10557-015-6581-x; Jaisin Y, 2011, NEUROSCI LETT, V489, P192, DOI 10.1016/j.neulet.2010.12.014; Jawad H, 2011, NANOTOXICOLOGY, V5, P372, DOI 10.3109/17435390.2010.516844; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; Kim JE, 2003, PHYTOTHER RES, V17, P481, DOI 10.1002/ptr.1179; Kim YS, J CARDIOVASC PHARM, V200, P41; Lacasana M, 2005, EUR J EPIDEMIOL, V20, P183, DOI 10.1007/s10654-004-3005-9; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li SQ, 2008, FOOD CHEM TOXICOL, V46, P3626, DOI 10.1016/j.fct.2008.09.012; Liao JK, 2013, J CLIN INVEST, V123, P540, DOI 10.1172/JCI66843; Liu K, 2013, INT J NANOMED, V8, P2509, DOI 10.2147/IJN.S46919; LopezMarure R, 1997, BIOCHEM BIOPH RES CO, V236, P819, DOI 10.1006/bbrc.1997.7056; Manjunatha H, 2007, CAN J PHYSIOL PHARM, V85, P588, DOI 10.1139/Y07-044; Reyes-Fermin LM, 2012, NUTR NEUROSCI, V15, P34, DOI 10.1179/1476830512Y.0000000011; Masuda T, 1999, J AGR FOOD CHEM, V47, P71, DOI 10.1021/jf9805348; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; Monn C, 1999, TOXICOL APPL PHARM, V155, P245, DOI 10.1006/taap.1998.8591; Montiel-Davalos A, 2007, INHAL TOXICOL, V19, P91, DOI 10.1080/08958370701495212; Montiel-Davalos A, 2012, CHEM RES TOXICOL, V25, P920, DOI 10.1021/tx200551u; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nohynek GJ, 2007, CRIT REV TOXICOL, V37, P251, DOI 10.1080/10408440601177780; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079084; Pirvulescu MM, 2011, PHYTOTHER RES, V25, P1737, DOI 10.1002/ptr.3463; Garcia-Nino WR, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/424692; Riedl MA, 2005, J IMMUNOL, V174, P7440, DOI 10.4049/jimmunol.174.11.7440; Romero-Hernandez MA, 2013, TOXICOL MECH METHOD, V23, P650, DOI 10.3109/15376516.2013.826768; Jimenez-Osorio AS, 2015, CLIN CHIM ACTA, V448, P182, DOI 10.1016/j.cca.2015.07.009; Sarkar FH, 2010, CURR PHARM DESIGN, V16, P1801, DOI 10.2174/138161210791208956; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Skocaj M, 2011, RADIOL ONCOL, V45, P227, DOI 10.2478/v10019-011-0037-0; Sreejayan N, 1996, ARZNEIMITTEL-FORSCH, V46, P169; Tapia E, 2014, FREE RADICAL RES, V48, P1342, DOI 10.3109/10715762.2014.954109; Trujillo J, 2016, FOOD FUNCT, V7, P279, DOI [10.1039/c5fo00624d, 10.1039/C5FO00624D]; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Ueki M, 2013, J BIOSCI BIOENG, V115, P547, DOI 10.1016/j.jbiosc.2012.11.007; Vachharajani V, 2010, MICROCIRCULATION, V17, P407, DOI 10.1111/j.1549-8719.2010.00039.x; Vineis P, 2006, INT J EPIDEMIOL, V35, P1151, DOI 10.1093/ije/dyl185; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Zhang L, 2008, ACTA PHARMACOL SIN, V29, P800, DOI [10.1111/j.1745-7254.2008.00813.x, 10.1111/j.1745-7254.2008.00803.x]; Zhao JS, 2011, J TOXICOL ENV HEAL B, V14, P593, DOI 10.1080/10937404.2011.615113	58	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188169	10.1371/journal.pone.0188169	http://dx.doi.org/10.1371/journal.pone.0188169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244817	gold, Green Submitted, Green Published			2022-12-26	WOS:000418184700003
J	DeWind, NK; Peng, JY; Luo, A; Brannon, EM; Platt, ML				DeWind, Nicholas K.; Peng, Jiyun; Luo, Andrew; Brannon, Elizabeth M.; Platt, Michael L.			Pharmacological inactivation does not support a unique causal role for intraparietal sulcus in the discrimination of visual number	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; PURSUIT EYE-MOVEMENTS; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; NUMERICAL INFORMATION; PERCEPTUAL DECISION; RESPONSE PROPERTIES; SINGLE NEURONS; MACAQUE MONKEY; RHESUS-MONKEY	The "feminine ordinal indicator" number sense describes the intuitive ability to quantify without counting. Single neuron recordings in non-human primates and functional imaging in humans suggest the intraparietal sulcus is an important neuroanatomical locus of numerical estimation. Other lines of inquiry implicate the IPS in numerous other functions, including attention and decision making. Here we provide a direct test of whether IPS has functional specificity for numerosity judgments. We used muscimol to reversibly and independently inactivate the ventral and lateral intraparietal areas in two monkeys performing a numerical discrimination task and a color discrimination task, roughly equilibrated for difficulty. Inactivation of either area caused parallel impairments in both tasks and no evidence of a selective deficit in numerical processing. These findings do not support a causal role for the IPS in numerical discrimination, except insofar as it also has a role in the discrimination of color. We discuss our findings in light of several alternative hypotheses of IPS function, including a role in orienting responses, a general cognitive role in attention and decision making processes and a more specific role in ordinal comparison that encompasses both number and color judgments.	[DeWind, Nicholas K.; Brannon, Elizabeth M.; Platt, Michael L.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Peng, Jiyun] Mayo Clin, Dept Neurol, Rochester, MN USA; [Luo, Andrew] Duke Univ, Dept Biol, Durham, NC USA; [Platt, Michael L.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Platt, Michael L.] Univ Penn, Wharton Sch, Dept Mkt, Philadelphia, PA 19104 USA	University of Pennsylvania; Mayo Clinic; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	DeWind, NK (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	dewind@sas.upenn.edu		Luo, Andrew/0000-0002-8367-7185	Ruth K. Broad Biomedical Research Foundation, Inc.; James S. McDonnell Foundation; National Eye Institute [NEI R01 EY019303]; Broad Research Award for Graduate Students; McDonnell Scholar award; NEI [1R0 lEY019303]	Ruth K. Broad Biomedical Research Foundation, Inc.; James S. McDonnell Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Broad Research Award for Graduate Students; McDonnell Scholar award; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Ruth K. Broad Biomedical Research Foundation, Inc. funded a Broad Research Award for Graduate Students to N.K.D. (https://sites.duke.edu/broadfoundation/); James S. McDonnell Foundation funded a McDonnell Scholar award to E.M.B. (https://www.jsmf.org/); The National Eye Institute funded NEI R01 EY019303 to M.L.P. (https://nei.nih.gov/). We also acknowledge our funding sources: Broad Research Award for Graduate Students to N.K.D., McDonnell Scholar award to E.M.B., and NEI 1R0 lEY019303 to M.L.P.	Andres M, 2011, NEUROIMAGE, V54, P3048, DOI 10.1016/j.neuroimage.2010.11.009; [Anonymous], ENVIRONMENTAL ENRICH; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; Cappelletti M, 2009, NEUROIMAGE, V46, P522, DOI 10.1016/j.neuroimage.2009.02.016; Carey S., 2011, THE ORIGIN OF CONCEP; Cavdaroglu S, 2015, NEUROIMAGE, V116, P135, DOI 10.1016/j.neuroimage.2015.04.019; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Churchland MM, 2000, J NEUROPHYSIOL, V84, P216, DOI 10.1152/jn.2000.84.1.216; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Kadosh RC, 2006, EXP PSYCHOL, V53, P87, DOI 10.1027/1618-3769.53.2.87; Cohen L, 2009, THE BEHAVIORAL AND C, P126; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 1997, THE NUMBER SENSE HOW; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; Diester I, 2007, PLOS BIOL, V5, P2684, DOI 10.1371/journal.pbio.0050294; Dormal V, 2008, CORTEX, V44, P462, DOI 10.1016/j.cortex.2007.08.011; Dormal V, 2012, HUM BRAIN MAPP, V33, P1490, DOI 10.1002/hbm.21300; Dormal V, 2012, CORTEX, V48, P623, DOI 10.1016/j.cortex.2011.05.019; Drucker CB, 2016, ANIM COGN, V19, P75, DOI 10.1007/s10071-015-0914-9; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Durif C, 2003, EXP BRAIN RES, V153, P614, DOI 10.1007/s00221-003-1613-3; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Harvey BM, 2015, P NATL ACAD SCI USA, V112, P13525, DOI 10.1073/pnas.1515414112; Hayashi MJ, 2013, J NEUROSCI, V33, P883, DOI 10.1523/JNEUROSCI.6257-11.2013; HONIG WK, 1989, ANIM LEARN BEHAV, V17, P134, DOI 10.3758/BF03207628; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Ibos G, 2014, NEURON, V83, P1468, DOI 10.1016/j.neuron.2014.08.020; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jacob SN, 2009, EUR J NEUROSCI, V30, P1432, DOI 10.1111/j.1460-9568.2009.06932.x; Kadosh RC, 2007, CURR BIOL, V17, P689, DOI 10.1016/j.cub.2007.02.056; Katz LN, 2016, NATURE, V535, P285, DOI 10.1038/nature18617; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lecce F, 2015, CORTEX, V73, P73, DOI 10.1016/j.cortex.2015.08.007; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Livingstone MS, 2010, ANIM COGN, V13, P711, DOI 10.1007/s10071-010-0321-1; MADDISON S, 1980, J COMP PHYSIOL PSYCH, V94, P365, DOI 10.1037/h0077664; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE FOR THE CARE A; National Research Council (US) Committee on Well-Being of Nonhuman Primates, 1998, THE PSYCHOLOGICAL WE; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2012, P NATL ACAD SCI USA, V109, P11860, DOI 10.1073/pnas.1204580109; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prescott MJ, 2010, J NEUROSCI METH, V193, P167, DOI 10.1016/j.jneumeth.2010.09.003; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Sandrini M, 2009, CORTEX, V45, P796, DOI 10.1016/j.cortex.2008.09.002; Sawamura H, 2010, J NEUROPHYSIOL, V104, P902, DOI 10.1152/jn.01014.2009; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Spelke ES, 2003, BRADFORD BOOKS, P277; Tokita M, 2010, ATTEN PERCEPT PSYCHO, V72, P1839, DOI 10.3758/APP.72.7.1839; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Viswanathan P, 2015, CURR BIOL, V25, P1259, DOI 10.1016/j.cub.2015.03.025; Viswanathan P, 2013, P NATL ACAD SCI USA, V110, P11187, DOI 10.1073/pnas.1308141110; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wardak C, 2002, J NEUROSCI, V22, P9877; WOOD RJ, 1980, J COMP PHYSIOL PSYCH, V94, P1135, DOI 10.1037/h0077745; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zago L, 2008, NEUROPSYCHOLOGIA, V46, P2403, DOI 10.1016/j.neuropsychologia.2008.03.001	93	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188820	10.1371/journal.pone.0188820	http://dx.doi.org/10.1371/journal.pone.0188820			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240774	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600011
J	Martin, RM; Dearth, SP; LeCleir, GR; Campagna, SR; Fozo, EM; Zinser, ER; Wilhelm, SW				Martin, Robbie M.; Dearth, Stephen P.; LeCleir, Gary R.; Campagna, Shawn R.; Fozo, Elizabeth M.; Zinser, Erik R.; Wilhelm, Steven W.			Microcystin-LR does not induce alterations to transcriptomic or metabolomic profiles of a model heterotrophic bacterium	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; STRESS-RESPONSE; CYANOBACTERIAL TOXINS; MOLECULAR-MECHANISMS; ANTIOXIDANT SYSTEM; OXIDATIVE STRESS; GROWTH; BIOSYNTHESIS; ENVELOPE	Microcystins are secondary metabolites produced by several freshwater, bloom-forming cyanobacterial species. Microcystin-producing cyanobacteria co-occur with a complex community of heterotrophic bacteria. Though conflicting, studies suggest that microcystins affect the physiology of heterotrophic bacteria by inducing oxidative stress and increasing cell envelope permeability. Based on these observations, we hypothesized that exposure to microcystin should induce differential expression in genes responding to oxidative and envelope stress and trigger shifts in metabolite pools. We tested this hypothesis by exposing Escherichia coli MG1655 to 1 and 10 mg/L microcystin-LR and monitored global changes to gene expression, cellular metabolite pools, and lipid composition using RNA-sequencing and UPLC-MS. Contrary to reported studies, we observed no evidence that microcystin-LR induced oxidative or cell envelope stress in E. coli under the tested conditions. Our results suggest a potential difference in mechanism by which microcystin-LR interacts with heterotrophic bacteria vs. cyanobacteria.	[Martin, Robbie M.; LeCleir, Gary R.; Fozo, Elizabeth M.; Zinser, Erik R.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Dearth, Stephen P.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	Wilhelm, Steven W/B-8963-2008	Wilhelm, Steven W/0000-0001-6283-8077; LeCleir, Gary/0000-0002-0228-7557; Fozo, Elizabeth/0000-0002-6928-2275; Martin, Robbie/0000-0001-5284-7156	National Science Foundation: Division of Environmental Biology grant [1240870]; Integrative Organismal Systems grant [1451428]; Kenneth AMP; Blaire Mossman Endowment at the University of Tennessee; Direct For Biological Sciences [1240870] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1451528] Funding Source: National Science Foundation	National Science Foundation: Division of Environmental Biology grant(National Science Foundation (NSF)); Integrative Organismal Systems grant; Kenneth AMP; Blaire Mossman Endowment at the University of Tennessee; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation: Division of Environmental Biology grant 1240870 to SWW, Integrative Organismal Systems grant 1451428 to SWW and the Kenneth & Blaire Mossman Endowment at the University of Tennessee to SWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Belenky P, 2015, CELL REP, V13, P968, DOI 10.1016/j.celrep.2015.09.059; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Blattner FR, 1997, SCIENCE, P277; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; CAMPBELL DL, 1994, ENVIRON TOXIC WATER, V9, P71, DOI 10.1002/tox.2530090109; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Clasquin MF, 2012, CURR PROTOC BIOINFOR; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dittmann E, 2006, MOL NUTR FOOD RES, V50, P7, DOI 10.1002/mnfr.200500162; Dixon RA, 2004, FEMS MICROBIOL LETT, V230, P167, DOI 10.1016/S0378-1097(03)00910-8; Dong TG, 2015, P NATL ACAD SCI USA, V112, P2181, DOI 10.1073/pnas.1425007112; Foxhall T, 1981, WATER ENV ALGAL TOXI; Gierlinski M, 2015, BIOINFORMATICS, V31, P3625, DOI 10.1093/bioinformatics/btv425; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Heng SS, 2011, ISRN MICROBIOL, V2011; Hu ZQ, 2005, HYDROBIOLOGIA, V534, P23, DOI 10.1007/s10750-004-1319-y; Humbert JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070747; Hyenstrand P, 2001, TOXICON, V39, P589, DOI 10.1016/S0041-0101(00)00168-9; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kardinaal WEA, 2007, AQUAT MICROB ECOL, V48, P1, DOI 10.3354/ame048001; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; LAHTI K, 1995, LETT APPL MICROBIOL, V21, P109, DOI 10.1111/j.1472-765X.1995.tb01019.x; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Li HY, 2009, TOXICON, V53, P595, DOI 10.1016/j.toxicon.2008.11.005; Louati I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140614; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Miguens D, 2015, LIMNETICA, V34, P215; Ostensvik O, 1998, J APPL MICROBIOL, V84, P1117; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Pflugmacher S, 2002, ENVIRON TOXICOL, V17, P407, DOI 10.1002/tox.10071; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; RINEHART KL, 1994, J APPL PHYCOL, V6, P159, DOI 10.1007/BF02186070; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sambrook J., 2001, MOL CLONING LAB MANU; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Seo SW, 2015, CELL REP, V12, P1289, DOI 10.1016/j.celrep.2015.07.043; Singh DP, 2001, WORLD J MICROB BIOT, V17, P15, DOI 10.1023/A:1016622414140; Sivonen K., 1999, TOXIC CYANOBACTERIA, P43; Stirling DJ, 2016, MARINE ALGAL TOXIN C; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; VAARA M, 1983, NATURE, V303, P526, DOI 10.1038/303526a0; Valdor R, 2007, TOXICON, V49, P769, DOI 10.1016/j.toxicon.2006.11.025; van der Heijden J, 2016, FREE RADICAL BIO MED, V91, P34, DOI 10.1016/j.freeradbiomed.2015.11.029; Vassilakaki M, 2008, J APPL PHYCOL, V20, P219, DOI 10.1007/s10811-007-9222-3; Wen J, 2014, NUCLEIC ACIDS RES, V42, P1930, DOI 10.1093/nar/gkt1018; Wilhelm SW, 2011, NAT CLIM CHANGE, V1, P300, DOI 10.1038/nclimate1202; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Yan T, 2007, APPL ENVIRON MICROB, V73, P890, DOI 10.1128/AEM.01395-06; Yang CY, 2008, B ENVIRON CONTAM TOX, V81, P427, DOI 10.1007/s00128-008-9436-3; Yang CY, 2010, CHINESE SCI BULL, V55, P1894, DOI 10.1007/s11434-010-3169-5; Zanchett G, 2013, TOXINS, V5, P1896, DOI 10.3390/toxins5101896; Zhou J, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI DOI 10.1093/NAR/GKS1235; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	77	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189608	10.1371/journal.pone.0189608	http://dx.doi.org/10.1371/journal.pone.0189608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240841	gold, Green Published, Green Submitted			2022-12-26	WOS:000417905600053
J	Elliott, SAM; Sabatino, AD; Heath, MR; Turrell, WR; Bailey, DM				Elliott, Sophie A. M.; Sabatino, Alessandro D.; Heath, Michael R.; Turrell, William R.; Bailey, David M.			Landscape effects on demersal fish revealed by field observations and predictive seabed modelling	PLOS ONE			English	Article							COD GADUS-MORHUA; JUVENILE ATLANTIC COD; MARINE BENTHOS; HABITAT USE; SETTLEMENT; SCALE; AREA; MANAGEMENT; DIVERSITY; SELECTION	Nature conservation and fisheries management often focus on particular seabed features that are considered vulnerable or important to commercial species. As a result, individual seabed types are protected in isolation, without any understanding of what effect the mixture of seabed types within the landscape has on ecosystem functions. Here we undertook predictive seabed modelling within a coastal marine protected area using observations from underwater stereo-video camera deployments and environmental information (depth, wave fetch, maximum tidal speeds, distance from coast and underlying geology). The effect of the predicted substratum type, extent and heterogeneity or the diversity of substrata, within a radius of 1500 m around each camera deployment of juvenile gadoid relative abundance was analysed. The predicted substratum model performed well with wave fetch and depth being the most influential predictor variables. Gadus morhua (Atlantic cod) were associated with relatively more rugose substrata (Algal-gravel-pebble and seagrass) and heterogeneous landscapes, than Melanogrammus aeglefinus (haddock) or Merlangius merlangus (whiting) (sand and mud). An increase in M. merlangus relative abundance was observed with increasing substratum extent. These results reveal that landscape effects should be considered when protecting the seabed for fish and not just individual seabed types. The landscape approach used in this study therefore has important implications for marine protected area, fisheries management and monitoring advice concerning demersal fish populations.	[Elliott, Sophie A. M.; Bailey, David M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Sabatino, Alessandro D.; Heath, Michael R.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Turrell, William R.] Marine Scotland Sci, Marine Lab, Aberdeen, Scotland; [Elliott, Sophie A. M.] Museum Natl Hist Nat, Serv Stn Marines, UMR BOREA 7208, Dinard, France	University of Glasgow; University of Strathclyde; Marine Scotland Science (MSS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Elliott, SAM (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.; Elliott, SAM (corresponding author), Museum Natl Hist Nat, Serv Stn Marines, UMR BOREA 7208, Dinard, France.	sophie_elliott@yahoo.com	Heath, Michael R/D-5765-2013; Bailey, David/A-6240-2008	Elliott, Sophie/0000-0001-6169-1560; Bailey, David/0000-0002-0824-8823; Turrell, William/0000-0002-1889-1468; Heath, Michael/0000-0001-6602-3107	Marine Scotland (Clyde); Scottish Natural Heritage; ClimateXChange PhD scholarship; Natural Environment Research Council National Facility for Scientific Diving grant [NFSD/13/01]	Marine Scotland (Clyde); Scottish Natural Heritage; ClimateXChange PhD scholarship; Natural Environment Research Council National Facility for Scientific Diving grant	This work was funded by Marine Scotland (Clyde 2020) field work funding to SE, Scottish Natural Heritage grant fieldwork funding to SE, The ClimateXChange PhD scholarship to SE, and Natural Environment Research Council National Facility for Scientific Diving grant (Grant NFSD/13/01) to SE.	Armstrong CW, 2008, ICES J MAR SCI, V65, P817, DOI 10.1093/icesjms/fsn092; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Bastrikin DK, 2014, ICES J MAR SCI, V71, P2101, DOI 10.1093/icesjms/fsu029; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Buckland ST, 2017, ASTA-ADV STAT ANAL, V101, P461, DOI 10.1007/s10182-017-0308-1; Buckland S. T., 2011, Ecosphere, V2, part100, DOI 10.1890/ES11-00186.1; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Burrows MT, 2008, MAR ECOL PROG SER, V353, P1, DOI 10.3354/meps07284; Burrows MT, 2012, MAR ECOL PROG SER, V445, P193, DOI 10.3354/meps09422; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Chave Jerome, 2013, Ecology Letters, V16, P4, DOI 10.1111/ele.12048; Chen CS, 2003, J ATMOS OCEAN TECH, V20, P159, DOI 10.1175/1520-0426(2003)020<0159:AUGFVT>2.0.CO;2; Christie H, 2009, MAR ECOL PROG SER, V396, P221, DOI 10.3354/meps08351; Clarke J, 2015, ICES J MAR SCI, V72, P2627, DOI 10.1093/icesjms/fsv144; Cote D, 2004, J FISH BIOL, V64, P665, DOI 10.1111/j.1095-8649.2004.00331.x; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elliott SAM, 2016, J FISH BIOL, V89, P1190, DOI 10.1111/jfb.12998; Elliott SAM, 2016, OCEANOGR MAR BIOL, V54, P173; Elliott SAM, 2017, MAR ECOL PROG SER, V568, P123, DOI 10.3354/meps12068; Fernandes PG, 2013, CURR BIOL, V23, P1432, DOI 10.1016/j.cub.2013.06.016; Fromentin JM, 1997, MAR ECOL PROG SER, V155, P209, DOI 10.3354/meps155209; Gibb FM, 2007, MAR BIOL, V151, P1185, DOI 10.1007/s00227-006-0565-0; Gorman AM, 2009, J EXP MAR BIOL ECOL, V371, P1, DOI 10.1016/j.jembe.2008.12.008; Grant SM, 1998, CAN J FISH AQUAT SCI, V55, P1317, DOI 10.1139/cjfas-55-6-1317; Gregory RS, 1997, MAR ECOL PROG SER, V146, P9, DOI 10.3354/meps146009; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hall-Spencer JM, 2003, AQUAT CONSERV, V13, pS33, DOI 10.1002/aqc.566; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Hosmer DW, 2004, N AM J FISH MANAGE, V24, P282; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kamenos NA, 2003, J MAR BIOL ASSOC UK, V83, P411, DOI 10.1017/S0025315403007264h; Kritzer JP, 2016, BIOSCIENCE, V66, P274, DOI 10.1093/biosci/biw014; Laurel BJ, 2016, ICES J MAR SCI, V73, P2227, DOI 10.1093/icesjms/fsw039; Laurel BJ, 2009, J EXP MAR BIOL ECOL, V377, P28, DOI 10.1016/j.jembe.2009.06.010; Laurel BJ, 2004, MAR ECOL PROG SER, V272, P257, DOI 10.3354/meps272257; Laurel BJ, 2003, MAR ECOL PROG SER, V262, P241, DOI 10.3354/meps262241; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lokkeborg S, 2002, HYDROBIOLOGIA, V483, P259, DOI 10.1023/A:1021312503220; Magurran A.E., 2004, MEASURING BIOL DIVER; Mangel M, 2006, ECOL APPL, V16, P797, DOI 10.1890/1051-0761(2006)016[0797:ULHAPC]2.0.CO;2; Moore C, 2016, MAR POLICY, V69, P32, DOI 10.1016/j.marpol.2016.03.021; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Nagelkerken I, 2013, FISH FISH, V16, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1111/FAF.12057; Olsen EM, 2011, EVOL ECOL, V25, P695, DOI 10.1007/s10682-010-9427-9; PRIEDE IG, 1994, J MAR BIOL ASSOC UK, V74, P481, DOI 10.1017/S0025315400047615; Ralph GM, 2013, MAR ECOL PROG SER, V488, P51, DOI 10.3354/meps10417; Reiss H, 2015, ICES J MAR SCI, V72, P297, DOI 10.1093/icesjms/fsu107; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Sabatino AD, 2016, NAT HAZARDS, V84, P1601, DOI 10.1007/s11069-016-2506-7; Schubert PR, 2015, MAR ECOL PROG SER, V522, P79, DOI 10.3354/meps11133; Seitz RD, 2014, ICES J MAR SCI, V71, P648, DOI 10.1093/icesjms/fst152; Sundblad G, 2014, ICES J MAR SCI, V71, P672, DOI 10.1093/icesjms/fst056; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008	70	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189011	10.1371/journal.pone.0189011	http://dx.doi.org/10.1371/journal.pone.0189011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228035	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600028
J	Kharkwal, H; Batool, F; Koentgen, F; Bell, DR; Kendall, DA; Ebling, FJP; Duce, IR				Kharkwal, Himanshu; Batool, Farhat; Koentgen, Frank; Bell, David R.; Kendall, David A.; Ebling, Francis J. P.; Duce, Ian R.			Generation and phenotypic characterisation of a cytochrome P450 4x1 knockout mouse	PLOS ONE			English	Article							ENERGY HOMEOSTASIS; FAMILY 4; EXPRESSION; METABOLISM; P450; MONOOXYGENASES; IDENTIFICATION; ENZYMES; CYP4X1; BRAIN	Cytochrome P450 4x1 (Cyp4x1) is expressed at very high levels in the brain but the function of this protein is unknown. It has been hypothesised to regulate metabolism of fatty acids and to affect the activity of endocannabinoid signalling systems, which are known to influence appetite and energy metabolism. The objective of the present investigation was to determine the impact of Cyp4x1 on body weight and energy metabolism by developing a line of transgenic Cyp4x1-knock out mice. Mice were developed with a global knock-out of the gene; the full-length RNA was undetectable, and mice were viable and fertile. Both male and female Cyp4x1-knock out mice gained significantly more body weight on normal lab chow diet compared to control flox mice on the same genetic background. At necropsy, Cyp4x1-knock out male mice had significantly greater intra-abdominal fat deposits (P<0.01), and enlarged adipocytes. Metabolic rate and locomotor activity as inferred from VO2 measures and crossing of infrared beams in metabolic cages were not significantly affected by the mutation in either gender. The respiratory exchange ratio was significantly decreased in male knock out mice (P<0.05), suggesting a greater degree of fat oxidation, consistent with their higher adiposity. When mice were maintained on a high fat diet, VO2 was significantly decreased in both male and female Cyp4x1-knock out mice. We conclude that the Cyp4x1-knock out mouse strain demonstrates a mildly obese phenotype, consistent with the view that cytochrome P450 4x1 plays a role in regulating fat metabolism.	[Kharkwal, Himanshu; Batool, Farhat; Bell, David R.; Kendall, David A.; Ebling, Francis J. P.; Duce, Ian R.] Univ Nottingham, Sch Life Sci, Nottingham, England; [Batool, Farhat] Univ Karachi, Dept Biochem, Karachi, Pakistan; [Koentgen, Frank] Ozgene Pty Ltd, Bentley Dc, Australia; [Bell, David R.] European Chem Agcy, Helsinki, Finland	University of Nottingham; University of Karachi; European Chemicals Agency	Duce, IR (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham, England.	ian.duce@nottingham.ac.uk	Ebling, Francis/Q-6193-2019	Ebling, Francis/0000-0002-7316-9582; Duce, Ian/0000-0001-9619-3174	Pakistan Program for Collaborative Research; University of Nottingham; University of Nottingham Faculty of Medicine and Health Sciences	Pakistan Program for Collaborative Research; University of Nottingham; University of Nottingham Faculty of Medicine and Health Sciences	Ozgene Pty Ltd generated and supplied transgenic mouse strains for the study. FK is Chief Executive Officer of Ozgene Pty. FB was supported by a grant from the Pakistan Program for Collaborative Research. HK received student financial support from the University of Nottingham. The work was funded by the University of Nottingham Faculty of Medicine and Health Sciences. The funder provided support in the form of salaries for authors (DRB, DAK, FJPE, IRD) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of the authors are articulated in the authors contribution section	Al-Anizy M, 2006, FEBS J, V273, P936, DOI 10.1111/j.1742-4658.2006.05119.x; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Bylund J, 2002, BIOCHEM BIOPH RES CO, V296, P677, DOI 10.1016/S0006-291X(02)00918-X; Capdevila JH, 2001, BIOCHEM BIOPH RES CO, V285, P571, DOI 10.1006/bbrc.2001.5167; Capdevila JH, 2002, CELL MOL LIFE SCI, V59, P780, DOI 10.1007/s00018-002-8466-y; Carver KA, 2014, AM J PHYSIOL-CELL PH, V307, pC989, DOI 10.1152/ajpcell.00401.2013; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; Davis CM, 2017, PHARMACOL THERAPEUT, V179, P31, DOI 10.1016/j.pharmthera.2017.05.004; ESCALANTE B, 1993, EUR J PHARMACOL, V235, P1, DOI 10.1016/0014-2999(93)90812-V; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Harder DR, 2000, ACTA PHYSIOL SCAND, V168, P543, DOI 10.1046/j.1365-201x.2000.00707.x; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kikuta Y, 2002, PROSTAG OTH LIPID M, V68-9, P345, DOI 10.1016/S0090-6980(02)00039-4; Kirischian NL, 2012, MOL PHYLOGENET EVOL, V62, P458, DOI 10.1016/j.ympev.2011.10.016; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kumar Suresh, 2015, BMC Res Notes, V8, P9, DOI 10.1186/s13104-015-0976-4; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Richard D, 2015, NAT REV ENDOCRINOL, V11, P489, DOI 10.1038/nrendo.2015.103; Savas O, 2005, ARCH BIOCHEM BIOPHYS, V436, P377, DOI 10.1016/j.abb.2005.02.022; Shibata M, 1999, TOXICOL SCI, V49, P290, DOI 10.1093/toxsci/49.2.290; Stark K, 2008, FEBS J, V275, P3706, DOI 10.1111/j.1742-4658.2008.06518.x; Stark K, 2007, DRUG METAB REV, V39, P627, DOI 10.1080/03602530701467708; Suzuki N, 2005, APPL MICROBIOL BIOT, V67, P225, DOI 10.1007/s00253-004-1772-6	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0187959	10.1371/journal.pone.0187959	http://dx.doi.org/10.1371/journal.pone.0187959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29227996	Green Submitted, Green Published, gold			2022-12-26	WOS:000417648600004
J	Huang, MF; Lin, SJ; Ko, TP; Liao, YT; Hsu, KC; Wang, HC				Huang, Ming-Fen; Lin, Shin-Jen; Ko, Tzu-Ping; Liao, Yi-Ting; Hsu, Kai-Cheng; Wang, Hao-Ching			The monomeric form of Neisseria DNA mimic protein DMP19 prevents DNA from binding to the histone-like HU protein	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASS-SPECTROMETRY; GLYCOSYLASE; SYSTEM; SAUGI	DNA mimicry is a direct and effective strategy by which the mimic competes with DNA for the DNA binding sites on other proteins. Until now, only about a dozen proteins have been shown to function via this strategy, including the DNA mimic protein DMP19 from Neisseria meningitides. We have shown previously that DMP19 dimer prevents the operator DNA from binding to the transcription factor NHTF. Here, we provide new evidence that DMP19 monomer can also interact with the Neisseria nucleoid-associated protein HU. Using BS3 crosslinking, gel filtration and isothermal titration calorimetry assays, we found that DMP19 uses its monomeric form to interact with the Neisseria HU dimer. Crosslinking conjugated mass spectrometry was used to investigate the binding mode of DMP19 monomer and HU dimer. Finally, an electrophoretic mobility shift assay (EMSA) confirmed that the DNA binding affinity of HU is affected by DMP19. These results showed that DMP19 is bifunctional in the gene regulation of Neisseria through its variable oligomeric forms.	[Huang, Ming-Fen; Liao, Yi-Ting; Wang, Hao-Ching] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan; [Lin, Shin-Jen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan, Taiwan; [Ko, Tzu-Ping] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Liao, Yi-Ting; Wang, Hao-Ching] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Liao, Yi-Ting; Wang, Hao-Ching] Acad Sinica, Taipei, Taiwan; [Hsu, Kai-Cheng] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; National Cheng Kung University; Academia Sinica - Taiwan; Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University	Wang, HC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan.; Wang, HC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.; Wang, HC (corresponding author), Acad Sinica, Taipei, Taiwan.	wanghc@tmu.edu.tw		Liao, Yi-Ting/0000-0001-5050-7481; Wang, Hao-Ching/0000-0003-2396-717X	Ministry of Science and Technology [MOST 103-2311-B-038 -005, MOST 106-2311-B-038 -002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported financially by Ministry of Science and Technology (Grant MOST 103-2311-B-038 -005 and MOST 106-2311-B-038 -002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported financially by the Ministry of Science and Technology (Grant MOST 103-2311-B-038-005 and MOST 106-2311-B-038-002). LTQ-Orbitrap data and additional technical assistance were provided by Dr Shu-Yu Lin of the Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry. We also thank Dr Shu-Chuan Jao of the Biophysics Core Facility, Department of Academic Affairs and Instrument Service at Academia Sinica for her help in ITC analysis.	Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Chodavarapu S, 2008, MOL MICROBIOL, V67, P781, DOI 10.1111/j.1365-2958.2007.06094.x; Dorman CJ, 2003, CURR OPIN GENET DEV, V13, P179, DOI 10.1016/S0959-437X(03)00025-X; Dryden DTF, 2006, TRENDS BIOTECHNOL, V24, P378, DOI 10.1016/j.tibtech.2006.06.004; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Hammel M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600650; Ho CH, 2014, J BIOL CHEM, V289, P27046, DOI 10.1074/jbc.M114.590851; Lee CC, 2014, ANGEW CHEM INT EDIT, V53, P13054, DOI 10.1002/anie.201405664; Lee HL, 2016, MOL CELL PROTEOMICS, V15, P1572, DOI 10.1074/mcp.M115.053603; Macvanin M, 2012, J BACTERIOL, V194, P6046, DOI 10.1128/JB.00961-12; Muller MQ, 2009, J MED CHEM, V52, P2875, DOI 10.1021/jm9000665; Naveen V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157165; Parsons LM, 2005, PROTEIN SCI, V14, P1684, DOI 10.1110/ps.041275705; Parsons LX, 2004, PROTEINS, V54, P375, DOI 10.1002/prot.10607; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Putnam CD, 2005, DNA REPAIR, V4, P1410, DOI 10.1016/j.dnarep.2005.08.007; Qian Z, 2015, MBIO, V6, DOI 10.1128/mBio.00998-15; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Wang HC, 2016, NUCLEIC ACIDS RES, V44, P4440, DOI 10.1093/nar/gkw185; Wang HC, 2014, BIOCHEMISTRY-US, V53, P2865, DOI 10.1021/bi5002689; Wang HC, 2014, NUCLEIC ACIDS RES, V42, P1354, DOI 10.1093/nar/gkt964; Wang HC, 2013, NUCLEIC ACIDS RES, V41, P5127, DOI 10.1093/nar/gkt201; Wang HC, 2012, NUCLEIC ACIDS RES, V40, P5718, DOI 10.1093/nar/gks177; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189461	10.1371/journal.pone.0189461	http://dx.doi.org/10.1371/journal.pone.0189461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220372	Green Submitted, gold, Green Published			2022-12-26	WOS:000417469900059
J	Moreels, L; Bhat, C; Voracova, M; Peigneur, S; Goovaerts, H; Maki-Lohiluoma, E; Zahed, F; Pardo, LA; Yli-Kauhaluoma, J; Kiuru, P; Tytgat, J				Moreels, Lien; Bhat, Chinmay; Voracova, Manuela; Peigneur, Steve; Goovaerts, Hannah; Maki-Lohiluoma, Eero; Zahed, Farrah; Pardo, Luis A.; Yli-Kauhaluoma, Jari; Kiuru, Paula; Tytgat, Jan			Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancerrelevant potassium channel K(V)10.1	PLOS ONE			English	Article							SPONGE PSAMMAPLYSILLA-PURPUREA; MARINE SPONGE; BROMOTYROSINE ALKALOIDS; CANCER; METABOLITES; APOPTOSIS; CELLS	In the search for novel anticancer drugs, the potassium channel K(V)10.1 has emerged as an interesting cancer target. Here, we report a new group of K(V)10.1 inhibitors, namely the purpurealidin analogs. These alkaloids are produced by the Verongida sponges and are known for their wide variety of bioactivities. In this study, we describe the synthesis and characterization of 27 purpurealidin analogs. Structurally, bromine substituents at the central phenyl ring and a methoxy group at the distal phenyl ring seem to enhance the activity on K(V)10.1. The mechanism of action of the most potent analog 5 was investigated. A shift of the activation curve to more negative potentials and an apparent inactivation was observed. Since K(V)10.1 inhibitors can be interesting anticancer drug lead compounds, the effect of 5 was evaluated on cancerous and non-cancerous cell lines. Compound 5 showed to be cytotoxic and appeared to induce apoptosis in all the evaluated cell lines.	[Moreels, Lien; Peigneur, Steve; Goovaerts, Hannah; Tytgat, Jan] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Toxicol & Pharmacol, KU Leuven, Leuven, Belgium; [Bhat, Chinmay; Voracova, Manuela; Maki-Lohiluoma, Eero; Yli-Kauhaluoma, Jari; Kiuru, Paula] Univ Helsinki, Div Pharmaceut Chem & Technol, Drug Res Program, Fac Pharm, Helsinki, Finland; [Zahed, Farrah] Max Planck Inst Expt Med, Oncophysiol Grp, Gottingen, Germany; [Bhat, Chinmay] Univ Mysore, Govt Grade Coll Chamarajanagar 1, Mysore, Karnataka, India	KU Leuven; University of Helsinki; Max Planck Society; University of Mysore	Tytgat, J (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Toxicol & Pharmacol, KU Leuven, Leuven, Belgium.	jan.tytgat@kuleuven.be	Pardo, Luis/C-5066-2013; Voráčová, Manuela/AAY-6190-2021; Moreels, Lien/P-6865-2017	Pardo, Luis/0000-0003-1375-4349; Voracova, Manuela/0000-0002-3404-8147; Kiuru, Paula/0000-0001-6084-684X; Moreels, Lien/0000-0002-7173-7195; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702; Bhat, Chinmay/0000-0002-5142-0115	Agency for Innovation by Science and Technology in Flanders [IWT 131231]; Marie Curie Initial Training Network lon TraC [289648]; Academy of Finland [285103]	Agency for Innovation by Science and Technology in Flanders; Marie Curie Initial Training Network lon TraC; Academy of Finland(Academy of Finland)	The project MAREX, Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications 2010-2014, was funded by the European Union Seventh Framework Programme grant no. FP7-KBBE-2009-3-245137 and is sincerely acknowledged (http://cordis.eurapa.eu/project/rcn/950066_en. htm). LM is a recipient of a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT 131231) (hittps://www.iwt.be.english/welcomNt.be/english/welcome). FZ was funded by Marie Curie Initial Training Network lon TraC(Grant# 289648) (https://campus.uni-b m uensteb0e/ontratitiomei). PK and JY-K thank Academy of Finland for the project No. 285103 (http://www.aka.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599; Dai JQ, 2016, BIOORG MED CHEM LETT, V26, P499, DOI 10.1016/j.bmcl.2015.11.086; Dyshlovoy SA, 2015, MAR DRUGS, V13, P5657, DOI 10.3390/md13095657; Essack M, 2011, MAR DRUGS, V9, P1580, DOI 10.3390/md9091580; Gomez-Lagunas F, 2017, J CELL PHYSIOL, V232, P2019, DOI 10.1002/jcp.25448; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hartung F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-109; Kim S., 2014, HDB ANTICANCER DRUGS, P1; Kotoku N, 2005, TETRAHEDRON, V61, P7211, DOI 10.1016/j.tet.2005.05.038; Kottakota SK, 2012, J NAT PROD, V75, P1090, DOI 10.1021/np300102z; Mebs D., 2002, VENOMOUS POISONOUS A; Mora FD, 2006, J NAT PROD, V69, P547, DOI 10.1021/np050397q; Pardo LA, 2012, CURR MED CHEM, V19, P675, DOI 10.2174/092986712798992011; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Peng Jiangnan, 2005, Alkaloids Chem Biol, V61, P59, DOI 10.1016/S1099-4831(05)61002-4; Pina IC, 2003, J ORG CHEM, V68, P3866, DOI 10.1021/jo034248t; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Tilvi S, 2004, TETRAHEDRON, V60, P10207, DOI 10.1016/j.tet.2004.09.009; Tilvi S, 2012, EUR J MASS SPECTROM, V18, P333, DOI 10.1255/ejms.1181; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; World Health Organization, 2017, CANC FACT SHEET; Yoshida M, 2008, CHEM PHARM BULL, V56, P1362, DOI 10.1248/cpb.56.1362; Zhang Y, 2013, ADV MECH ENG, V2013, P1, DOI [DOI 10.4225/08/58B5BAAD4FCC2, DOI 10.3864/J.ISSN.0578-1752.2013.10.014]	23	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188811	10.1371/journal.pone.0188811	http://dx.doi.org/10.1371/journal.pone.0188811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220359	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900019
J	Tobino, K; Hirai, T; Johkoh, T; Fujimoto, K; Kawaguchi, A; Tomiyama, N; Takahashi, K; Seyama, K				Tobino, Kazunori; Hirai, Toyohiro; Johkoh, Takeshi; Fujimoto, Kiminori; Kawaguchi, Atsushi; Tomiyama, Noriyuki; Takahashi, Kazuhisa; Seyama, Kuniaki			Difference of the progression of pulmonary cysts assessed by computed tomography among COPD, lymphangioleiomyomatosis, and Birt-Hogg-Dube A syndrome	PLOS ONE			English	Article							THIN-SECTION CT; MATRIX METALLOPROTEINASES; SPONTANEOUS PNEUMOTHORAX; TUBEROUS SCLEROSIS; CHEST CT; EMPHYSEMA; MUTATIONS; GENE; PATHOGENESIS; FAMILIES	Many groups developed the methods to quantitatively analyze low attenuation area (LAA) on chest CT in patients with cystic lung diseases. Especially in COPD, it was reported that the cumulative size distribution of LAA clusters follows a power law characterized by the exponent D, which reflect the fractal dimension of terminal airspace geometry. We hypoyhesized that the quantitative charateristics of LAA clusters including fractal property might indicate the different features of the progression of cysts in cystic lung diseases. The aim of this study was to apply the CT image-based method of characterizing the size distribution of LAA clusters for lymphangioleiomyomatosis (LAM) and Birt-Hogg-Dube A syndrome (BHDS) to disclose their features of the progression of pulmonary cysts. 40 patients with COPD, 52 patients with LAM, and 18 patients with BHDS who had undergone CT scans at our institute between January 2002 and August 2009 were included. Differences among these diseases in the quantitative characteristics of LAA clusters {i.e., extent, number, size, fractal property, and the relationship between these quantitatives} were assessed. The Chi-sqsuare test, unpaired t-test, and one-way analyses of variance with Tukey post-hoc tests were used to compare groups, spline model with an interaction terms were used to assess the relationship between extent and number, and exponential regression model was used to assess the relationship between extent and size. Statistically significant differences separated the three diseases in extent and number (P < 0.001). Number was significantly correlated with extent in COPD (P < 0.001), but was not so in LAM and BHDS when extent exceeded 11.5% and 20.8%, respectively. Size was significantly correlated with extent in COPD and LAM (P < 0.001), but was not so in BHDS. The percentage of CT images with fractal property was higher in COPD than that in LAM and BHDS (95.8%, 92.9% and 63.0%, respectively). In conclusion, our study has demonstrated for the first time the different characteristics of the size distribution of LAA clusters among COPD, LAM and BHDS, and indicated that this method is useful for exploration of the pathophysiology in cystic lung diseases.	[Tobino, Kazunori] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan; [Tobino, Kazunori; Takahashi, Kazuhisa; Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Tobino, Kazunori; Takahashi, Kazuhisa; Seyama, Kuniaki] Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Tobino, Kazunori; Seyama, Kuniaki] Study Grp Pneumothorax & Cyst Lung Dis, Setagaya Ku, Tokyo, Japan; [Hirai, Toyohiro] Kyoto Univ, Dept Resp Med, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Johkoh, Takeshi] Kinki Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Dept Radiol, Itami, Hyogo, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka, Japan; [Fujimoto, Kiminori] Kurume Univ Hosp, Ctr Diagnost Imaging, Kurume, Fukuoka, Japan; [Kawaguchi, Atsushi] Saga Univ, Fac Med, Ctr Comprehens Community Med, Saga, Saga, Japan; [Tomiyama, Noriyuki] Osaka Univ, Dept Radiol, Grad Sch Med, Osaka, Japan	Juntendo University; Kyoto University; Kurume University; Kurume University; Saga University; Osaka University	Tobino, K (corresponding author), Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan.; Tobino, K (corresponding author), Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan.; Tobino, K (corresponding author), Grad Sch Med, Bunkyo Ku, Tokyo, Japan.; Tobino, K (corresponding author), Study Grp Pneumothorax & Cyst Lung Dis, Setagaya Ku, Tokyo, Japan.	tobino@juntendo.ac.jp						Avila NA, 2002, RADIOLOGY, V223, P189, DOI 10.1148/radiol.2231010315; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; Goncharova EA, 2014, CELL REP, V7, P412, DOI 10.1016/j.celrep.2014.03.025; Graham RB, 2005, AM J RESP CRIT CARE, V172, P39, DOI 10.1164/rccm.200501-143OC; Gunji Y, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049874; Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Kumasaka T, 2014, HISTOPATHOLOGY, V65, P100, DOI 10.1111/his.12368; LENOIR S, 1990, RADIOLOGY, V175, P329, DOI 10.1148/radiology.175.2.2326456; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1440-1843.2006.00899.x; Painter JN, 2005, AM J HUM GENET, V76, P522, DOI 10.1086/428455; Pallisa E, 2002, RADIOGRAPHICS, V22, pS185, DOI 10.1148/radiographics.22.suppl_1.g02oc13s185; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAKAI N, 1994, CHEST, V106, P1319, DOI 10.1378/chest.106.5.1319; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Suki B, 2003, AM J RESP CRIT CARE, V168, P516, DOI 10.1164/rccm.200208-908PP; Sullivan EJ, 1998, CHEST, V114, P1689, DOI 10.1378/chest.114.6.1689; Tanabe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044993; Tobino K, 2012, EUR J RADIOL, V81, P1340, DOI 10.1016/j.ejrad.2011.03.039; Tonan T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033868; Travis WD, 1999, LUNG BIOL HEALTH DIS, V131, P171; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20; Zhe XN, 2003, AM J RESP CELL MOL, V28, P504, DOI 10.1165/rcmb.2002-0124OC	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188771	10.1371/journal.pone.0188771	http://dx.doi.org/10.1371/journal.pone.0188771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220357	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900016
J	Mauro, F; Monleon, VJ; Temesgen, H; Ford, KR				Mauro, Francisco; Monleon, Vicente J.; Temesgen, Hailemariam; Ford, Kevin R.			Analysis of area level and unit level models for small area estimation in forest inventories assisted with LiDAR auxiliary information	PLOS ONE			English	Article							TIMBER VOLUME; PREDICTION	Forest inventories require estimates and measures of uncertainty for subpopulations such as management units. These units often times hold a small sample size, so they should be regarded as small areas. When auxiliary information is available, different small area estimation methods have been proposed to obtain reliable estimates for small areas. Unit level empirical best linear unbiased predictors (EBLUP) based on plot or grid unit level models have been studied more thoroughly than area level EBLUPs, where the modelling occurs at the management unit scale. Area level EBLUPs do not require a precise plot positioning and allow the use of variable radius plots, thus reducing fieldwork costs. However, their performance has not been examined thoroughly. We compared unit level and area level EBLUPs, using LiDAR auxiliary information collected for inventorying 98,104 ha coastal coniferous forest. Unit level models were consistently more accurate than area level EBLUPs, and area level EBLUPs were consistently more accurate than field estimates except for large management units that held a large sample. For stand density, volume, basal area, quadratic mean diameter, mean height and Lorey's height, root mean squared errors (rmses) of estimates obtained using area level EBLUPs were, on average, 1.43, 2.83, 2.09, 1.40, 1.32 and 1.64 times larger than those based on unit level estimates, respectively. Similarly, direct field estimates had rmses that were, on average, 1.37, 1.45, 1.17, 1.17, 1.26, and 1.38 times larger than rmses of area level EBLUPs. Therefore, area level models can lead to substantial gains in accuracy compared to direct estimates, and unit level models lead to very important gains in accuracy compared to area level models, potentially justifying the additional costs of obtaining accurate field plot coordinates.	[Mauro, Francisco; Temesgen, Hailemariam] Oregon State Univ, Coll Forestry, Forest Engn Resources & Management Dept, Corvallis, OR 97331 USA; [Monleon, Vicente J.] US Forest Serv, Pacific Northwest Res Stn, Forestry Sci Lab, Corvallis, OR USA; [Ford, Kevin R.] Bur Land Management Oregon, Washington State Off, Portland, OR USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Mauro, F (corresponding author), Oregon State Univ, Coll Forestry, Forest Engn Resources & Management Dept, Corvallis, OR 97331 USA.	francisco.mauro@oregonstate.edu	Mauro, Francisco/AEP-2302-2022; Mauro, Francisco/F-9484-2016	Mauro, Francisco/0000-0002-7832-6268	US Bureau of Land Management [17-JV-11261989-018]	US Bureau of Land Management	This work was funded by the US Bureau of Land Management grant #17-JV-11261989-018. The funder participated in the study design and data collection.	Andersen HE, 2005, REMOTE SENS ENVIRON, V94, P441, DOI 10.1016/j.rse.2004.10.013; BATTESE GE, 1988, J AM STAT ASSOC, V83, P28, DOI 10.2307/2288915; Boubeta M, 2015, J ENVIRON MANAGE, V154, P151, DOI 10.1016/j.jenvman.2015.02.009; Breidenbach J., 2012, EUROPEAN J FOREST RE, V131, P1; Breidenbach J, 2016, REMOTE SENS ENVIRON, V173, P274, DOI 10.1016/j.rse.2015.07.026; Datta GS, 2015, J AM STAT ASSOC, V110, P1735, DOI 10.1080/01621459.2015.1016526; FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505; Goerndt ME, 2013, FOREST SCI, V59, P536, DOI 10.5849/forsci.12-073; Goerndt ME, 2011, CAN J FOREST RES, V41, P1189, DOI [10.1139/X11-033, 10.1139/x11-033]; Gonzalez-Ferreiro E., 2012, FORESTRY; Hawbaker TJ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000870; Hayashi R, 2014, FORESTS, V5, P363, DOI 10.3390/f5020363; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Magnussen S, EUR J FOR R IN PRESS; Mauro F, 2016, ENVIRONMETRICS, V27, P225, DOI 10.1002/env.2387; Mauro F, 2017, CAN J FOR RES; Mcgaughey R, 2014, FUSION LDV SOFTWARE, V3; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Rahlf J, 2014, REMOTE SENS ENVIRON, V155, P325, DOI 10.1016/j.rse.2014.08.036; Rao JB, 2015, IEEE T VEH TECHNOL, P1; Rao JNK, 2003, EMPIRICAL BEST LINEA, P115; Rao JNK, 2015, EMPIRICAL BEST LINEA, P123; Sarndal C-E, 2003, SPRINGER SERIES STAT, P694; Shin J, 2016, CAN J REMOTE SENS, V42, P739, DOI 10.1080/07038992.2016.1252908; Sinha SK, 2009, CAN J STAT, V37, P381, DOI 10.1002/cjs.10029; Sugasawa S, 2017, J MULTIVARIATE ANAL, V153, P52, DOI 10.1016/j.jmva.2016.09.011; United States Department of Interior, 2016, PROP RES MAN PLAN W, V1; Valbuena R., 2013, SPANISH J AGR RES, DOI [10.5424/sjar/2010084-1242, DOI 10.5424/SJAR/2010084-1242]; Yingfang W., 2015, VOLUME ESTIMATOR LIB	29	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189401	10.1371/journal.pone.0189401	http://dx.doi.org/10.1371/journal.pone.0189401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216290	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800121
J	Wang, Y; Wang, Q; Taylor, JE				Wang, Yan; Wang, Qi; Taylor, John E.			Aggregated responses of human mobility to severe winter storms: An empirical study	PLOS ONE			English	Article							WEATHER; IMPACT	Increasing frequency of extreme winter storms has resulted in costly damages and a disruptive impact on the northeastern United States. It is important to understand human mobility patterns during such storms for disaster preparation and relief operations. We investigated the effects of severe winter storms on human mobility during a 2015 blizzard using 2.69 million Twitter geolocations. We found that displacements of different trip distances and radii of gyration of individuals' mobility were perturbed significantly. We further explored the characteristics of perturbed mobility during the storm, and demonstrated that individuals' recurrent mobility does not have a higher degree of similarity with their perturbed mobility, when comparing with its similarity to non-perturbed mobility. These empirical findings on human mobility impacted by severe winter storms have potential long-term implications on emergency response planning and the development of strategies to improve resilience in severe winter storms.	[Wang, Yan] Virginia Tech, Charles E Via Jr Dept Civil & Environm Engn, Blacksburg, VA USA; [Wang, Qi] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Taylor, John E.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	Virginia Polytechnic Institute & State University; Northeastern University; University System of Georgia; Georgia Institute of Technology	Taylor, JE (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	jet@gatech.edu		Taylor, John/0000-0002-8949-3248; Wang, Yan/0000-0002-3946-9418	National Science Foundation [1142379]; Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant; Directorate For Engineering [1733695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	J.E.T. was supported by a National Science Foundation (https://www.nsf.gov/) under Grant No. 1142379. J.E.T. received and Y.W. and Q.W. were supported by a Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Science Foundation under Grant No. 1142379 and by the Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant. Correspondence and requests for material should be addressed to J.E.T. (jet@gatech.edu).	Alessandretti L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171686; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Call DA, 2011, WEATHER CLIM SOC, V3, P71, DOI 10.1175/WCAS-D-10-05008.1; Cools M, 2010, TRANSPORT RES REC, P22, DOI 10.3141/2157-03; Datla S, 2008, J TRANSP GEOGR, V16, P358, DOI 10.1016/j.jtrangeo.2007.12.003; de Montigny L, 2011, ENV BEHAV; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Department of Homeland Security Office of Cyber and Infrastructure Analysis, 2014, CRITICAL INFRASTRUCT; FEMA, 2015, 2015 DECL DIS; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Koetse MJ, 2009, TRANSPORT RES D-TR E, V14, P205, DOI 10.1016/j.trd.2008.12.004; Kunkel KE, 2013, B AM METEOROL SOC, V94, P499, DOI 10.1175/BAMS-D-11-00262.1; Lu XF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02955; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Maze TH, 2006, TRANSPORT RES REC, P170; National Oceanic and Atmospheric Administration (NOAA), STORM EV DAT; NOAA, 2016, CLIM CHANG EXTR SNOW; NOAA, REG SNOWF IND RSI; Pappalardo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9166; Pavalanathan U., 2015, ARXIV150602275; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Song X, 2014, P 20 ACM SIGKDD INT; Squires MF, 2014, B AM METEOROL SOC, V95, P1835, DOI 10.1175/BAMS-D-13-00101.1; Swier N, 2015, USING GEOLOCATED TWI; Wang Q, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000469; Wang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147299; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Zhao K, 2015, SCI REPORTS, V5	35	26	26	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188734	10.1371/journal.pone.0188734	http://dx.doi.org/10.1371/journal.pone.0188734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216236	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800040
J	Shoemark, DK; Sessions, RB; Brancaccio, A; Bigotti, MG				Shoemark, Deborah K.; Sessions, Richard B.; Brancaccio, Andrea; Bigotti, Maria Giulia			Intraring allostery controls the function and assembly of a hetero-oligomeric class II chaperonin	FASEB JOURNAL			English	Article						molecular chaperones; protein folding; molecular dynamics	TRANSIENT KINETIC-ANALYSIS; CRYO-EM STRUCTURE; EUKARYOTIC CHAPERONIN; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; CCT; COOPERATIVITY; MECHANISM; THERMOSOME; REVEALS	Class II chaperonins are essential multisubunit complexes that aid the folding of nonnative proteins in the cytosol of archaea and eukarya. They use energy derived from ATP to drive a series of structural rearrangements that enable polypeptides to fold within their central cavity. These events are regulated by an elaborate allosteric mechanism in need of elucidation. We employed mutagenesis and experimental analysis in concert with in silico molecular dynamics simulations and interface-binding energy calculations to investigate the class II chaperonin from Thermoplasma acidophilum. Here we describe the effects on the asymmetric allosteric mechanism and on hetero-oligomeric complex formation in a panel of mutants in the ATP-binding pocket of the alpha and beta subunits. Our observations reveal a potential model for a nonconcerted folding mechanism optimized for protecting and refolding a range of nonnative substrates under different environmental conditions, starting to unravel the role of subunit heterogeneity in this folding machine and establishing important links with the behavior of the most complex eukaryotic chaperonins..	[Shoemark, Deborah K.; Sessions, Richard B.; Brancaccio, Andrea; Bigotti, Maria Giulia] Univ Bristol, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England; [Brancaccio, Andrea] Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, Rome, Italy	University of Bristol; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Bigotti, MG (corresponding author), Univ Bristol, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	g.bigotti@bristol.ac.uk	Brancaccio, Andrea/C-5876-2009; Shoemark, Deborah K/S-6236-2018	Brancaccio, Andrea/0000-0003-4690-8826; Sessions, Richard/0000-0003-0320-0895; /0000-0002-1240-8463; Bigotti, Giulia/0000-0001-9595-3338	Wellcome Trust Research Career Reentry Fellowship [097350/Z/11/Z]; BBSRC [BB/L01386X/1, BB/K004050/1] Funding Source: UKRI; EPSRC [EP/L000253/1, EP/M022609/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K004050/1, BB/L01386X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M022609/1, EP/L000253/1] Funding Source: researchfish	Wellcome Trust Research Career Reentry Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Advanced Computing Research Centre at Bristol University (BlueCrystal) for access to computational resources and High-End Computing (HEC)Bioism for allocating time on Archer, the UK Supercomputer. This work was supported by Wellcome Trust Research Career Reentry Fellowship (097350/Z/11/Z to M.G.B). The authors declare no conflicts of interest.	Amit M, 2010, J MOL BIOL, V401, P532, DOI 10.1016/j.jmb.2010.06.037; Bigotti MG, 2006, J MOL BIOL, V362, P835, DOI 10.1016/j.jmb.2006.07.064; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Chaston JJ, 2016, STRUCTURE, V24, P364, DOI 10.1016/j.str.2015.12.016; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; de Macario EC, 2017, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00084; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gruber R, 2017, P NATL ACAD SCI USA, V114, P5189, DOI 10.1073/pnas.1617746114; Gutsche I, 2000, J MOL BIOL, V300, P187, DOI 10.1006/jmbi.2000.3833; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Huo YW, 2010, STRUCTURE, V18, P1270, DOI 10.1016/j.str.2010.07.009; Jiang Y, 2011, P NATL ACAD SCI USA, V108, P16962, DOI 10.1073/pnas.1112244108; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kafri G, 2003, J MOL BIOL, V326, P981, DOI 10.1016/S0022-2836(03)00046-9; Kalisman N, 2013, STRUCTURE, V21, P540, DOI 10.1016/j.str.2013.01.017; Kapatai G, 2006, MOL MICROBIOL, V61, P1583, DOI 10.1111/j.1365-2958.2006.05324.x; Korobko I, 2016, J MOL BIOL, V428, P4520, DOI 10.1016/j.jmb.2016.09.017; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lin P, 1997, GENETICS, V147, P1609; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Lopez T, 2017, NAT STRUCT MOL BIOL, V24, P726, DOI 10.1038/nsmb.3440; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; McIntosh-Smith S, 2015, INT J HIGH PERFORM C, V29, P119, DOI 10.1177/1094342014528252; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; Paul DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20696; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; Schoehn G, 2000, J MOL BIOL, V301, P323, DOI 10.1006/jmbi.2000.3952; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Skjaerven L, 2015, FEBS LETT, V589, P2522, DOI 10.1016/j.febslet.2015.06.019; Staniforth RA, 1998, J MOL BIOL, V275, P133, DOI 10.1006/jmbi.1997.1409; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; WEISS C, 1995, J BIOL CHEM, V270, P13956, DOI 10.1074/jbc.270.23.13956; Wood CW, 2017, BIOINFORMATICS, V33, P3043, DOI 10.1093/bioinformatics/btx352; Wood CW, 2014, BIOINFORMATICS, V30, P3029, DOI 10.1093/bioinformatics/btu502; Yamamoto YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176054; Zang YX, 2016, NAT STRUCT MOL BIOL, V23, P1083, DOI 10.1038/nsmb.3309; Zhang JJ, 2011, STRUCTURE, V19, P633, DOI 10.1016/j.str.2011.03.005; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	47	0	0	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2223	2234		10.1096/fj.201701061R	http://dx.doi.org/10.1096/fj.201701061R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29233859	Green Published, Green Submitted			2022-12-26	WOS:000429051400040
J	Yang, WL; Mei, FC; Cheng, XD				Yang, Wenli; Mei, Fang C.; Cheng, Xiaodong			EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation	FASEB JOURNAL			English	Article						fibrinolysis; PLC; plasmin; cAMP; PKC	PROTEIN-KINASE-C; PHOSPHOLIPASE-C; CYCLIC-AMP; CAMP EPAC; PHOSPHORYLATION; RECEPTOR; P36; FIBRINOLYSIS; SUBSTRATE; PATHWAY	Annexins, a family of highly conserved calcium- and phospholipid-binding proteins, play important roles in a wide range of physiologic functions. Among the 12 known annexins in humans, annexin A2 (AnxA2) is one of the most extensively studied and has been implicated in various human diseases. AnxA2 can exist as a monomer or a heterotetrameric complex with S100A10 (P11) and plays a critical role in many cellular processes, including exocytosis, endocytosis, and membrane organization. At the endothelial cell surface, the (AnxA2P11)(2) tetrameracting as a coreceptor for plasminogen and tissue plasminogen activator (tPA)-accelerates tPA-dependent activation of the fibrinolytic protease, plasmin, the enzyme that is responsible for thrombus dissolution and the degradation of fibrin. This study demonstrates that EPAC1 (exchange proteins directly activated by cAMP isoform 1) interacts with AnxA2 and regulates its biologic functions by modulating its membrane translocation in endothelial cells. By using genetic and pharmacologic approaches, we demonstrate that EPAC1acting via the PLC epsilon-PKC pathwayinhibits AnxA2 surface translocation and plasminogen activation. These results suggest that EPAC1 plays a role in the regulation of fibrinolysis in endothelial cells and may represent a novel therapeutic target for disorders of fibrinolysis.	[Yang, Wenli; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Texas Therapeut Inst, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cheng, XD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	xiaodong.cheng@uth.tmc.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	U.S. National Institutes of Health [R01-GM066170, R35-GM122536, R01-AI111464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R35GM122536] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Pei Luo (University of Texas Health Science Center) for helping designing the real-time PCR primers. The authors are indebted to Dr. Alan V. Smrcka's laboratory (University of Michigan, Ann Arbor, MI, USA) for generous gifts of anti-PLC epsilon Ab and other related reagents for this study. This work was supported by U.S. National Institutes of Health Grants R01-GM066170, R35-GM122536 (National Institute of General Medical Sciences), and R01-AI111464 (National Institute of Allergy and Infectious Diseases). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Brandherm I, 2013, BLOOD, V122, P1042, DOI 10.1182/blood-2012-12-475251; Canas F, 2015, THROMB RES, V135, P226, DOI 10.1016/j.thromres.2014.11.034; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chen HJ, 2013, TETRAHEDRON LETT, V54, P1546, DOI 10.1016/j.tetlet.2013.01.024; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Foley JH, 2017, SEMIN THROMB HEMOST, V43, P135, DOI 10.1055/s-0036-1592302; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; Grindheim AK, 2017, BBA-GEN SUBJECTS, V1861, P2515, DOI 10.1016/j.bbagen.2017.08.024; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hajjar Katherine A, 2015, Trans Am Clin Climatol Assoc, V126, P144; He KL, 2011, J BIOL CHEM, V286, P15428, DOI 10.1074/jbc.M110.185058; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; ISACKE CM, 1986, MOL CELL BIOL, V6, P2745, DOI 10.1128/MCB.6.7.2745; JOHNSSON N, 1986, EMBO J, V5, P3455, DOI 10.1002/j.1460-2075.1986.tb04669.x; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; KHANNNA NC, 1986, BIOCHEM BIOPH RES CO, V137, P397, DOI 10.1016/0006-291X(86)91223-4; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Luo M, 2017, J EXP MED, V214, P2535, DOI 10.1084/jem.20160652; Luo W, 2008, MOL CARCINOGEN, V47, P934, DOI 10.1002/mc.20445; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Nygaard G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08975-y; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Parnell E, 2014, BIOCHEM SOC T, V42, P274, DOI 10.1042/BST20130271; Parnell E, 2012, BRIT J PHARMACOL, V166, P434, DOI 10.1111/j.1476-5381.2011.01808.x; Peterson EA, 2003, J CELL SCI, V116, P2399, DOI 10.1242/jcs.00434; RADKE K, 1979, P NATL ACAD SCI USA, V76, P5212, DOI 10.1073/pnas.76.10.5212; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Sands WA, 2005, BIOCHEM SOC T, V33, P1126, DOI 10.1042/BST0331126; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; THIEL C, 1992, J CELL SCI, V103, P733; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369; Ye N, 2015, J MED CHEM, V58, P6033, DOI 10.1021/acs.jmedchem.5b00635	43	11	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2212	2222		10.1096/fj.201701027R	http://dx.doi.org/10.1096/fj.201701027R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217666	Green Submitted, Green Published			2022-12-26	WOS:000429051400039
J	Xue, CL; Lam, KH; Zhang, HW; Sun, KL; Lee, SH; Chen, X; Au, SWN				Xue, Chaolun; Lam, Kwok Ho; Zhang, Huawei; Sun, Kailei; Lee, Sai Hang; Chen, Xin; Au, Shannon Wing Ngor			Crystal structure of the FliF-FliG complex from Helicobacter pylori yields insight into the assembly of the motor MS-C ring in the bacterial flagellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; Helicobacter pylori; molecular motor; protein assembly; protein structure; flagellar motor; bacterial motility	SWITCH PROTEIN FLIG; SALMONELLA-TYPHIMURIUM; SYSTEM; CONSERVATION	The bacterial flagellar motor is a self-assembling supramolecular nanodevice. Its spontaneous biosynthesis is initiated by the insertion of the MS ring protein FliF into the inner membrane, followed by attachment of the switch protein FliG. Assembly of this multiprotein complex is tightly regulated to avoid nonspecific aggregation, but the molecular mechanisms governing flagellar assembly are unclear. Here, we present the crystal structure of the cytoplasmic domain of FliF complexed with the N-terminal domain of FliG (FliF(C)-FliG(N)) from the bacterium Helicobacter pylori. Within this complex, FliF(C) interacted with FliG(N) through extensive hydrophobic contacts similar to those observed in the FliF(C)-FliG(N) structure from the thermophile Thermotoga maritima, indicating conservation of the FliF(C)-FliG(N) interaction across bacterial species. Analysis of the crystal lattice revealed that the heterodimeric complex packs as a linear superhelix via stacking of the armadillo repeat-like motifs (ARM) of FliG(N). Notably, this linear helix was similar to that observed for the assembly of the FliG middle domain. We validated the in vivo relevance of the FliG(N) stacking by complementation studies in Escherichia coli. Furthermore, structural comparison with apo FliG from the thermophile Aquifex aeolicus indicated that FliF regulates the conformational transition of FliG and exposes the complementary ARM-like motifs of FliG(N), containing conserved hydrophobic residues. FliF apparently both provides a template for FliG polymerization and spatiotemporally controls subunit interactions within FliG. Our findings reveal that a small protein fold can serve as a versatile building block to assemble into a multiprotein machinery of distinct shapes for specific functions.	[Xue, Chaolun; Lam, Kwok Ho; Zhang, Huawei; Sun, Kailei; Lee, Sai Hang; Chen, Xin; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Lam, Kwok Ho] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Chinese University of Hong Kong; University of California System; University of California Irvine	Au, SWN (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	shannon-au@cuhk.edu.hk	zhang, huawei/S-6761-2019	zhang, huawei/0000-0002-5625-5809	General Research Fund Project [460112]; NSFC-RGC Joint Research Scheme Project [N_CUHK454/13]; Research Grants Council, Hong Kong; Chinese University of Hong Kong	General Research Fund Project; NSFC-RGC Joint Research Scheme Project; Research Grants Council, Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the General Research Fund Project Grant 460112 and NSFC-RGC Joint Research Scheme Project Grant N_CUHK454/13, Research Grants Council, Hong Kong, and the Direct Grant from The Chinese University of Hong Kong. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker M. A. B., 2016, NAT STRUCT MOL BIOL; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; Kim EA, 2017, J MOL BIOL, V429, P1305, DOI 10.1016/j.jmb.2017.02.014; Kubori T, 1997, J BACTERIOL, V179, P813, DOI 10.1128/jb.179.3.813-817.1997; Lam KH, 2013, MOL MICROBIOL, V88, P798, DOI 10.1111/mmi.12222; Lam KH, 2012, STRUCTURE, V20, P315, DOI 10.1016/j.str.2011.11.020; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Levenson R, 2012, BIOCHEMISTRY-US, V51, P5052, DOI 10.1021/bi3004582; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Lynch MJ, 2017, STRUCTURE, V25, P317, DOI 10.1016/j.str.2016.12.006; Marykwas DL, 1996, J MOL BIOL, V256, P564, DOI 10.1006/jmbi.1996.0109; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	28	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2066	2078		10.1074/jbc.M117.797936	http://dx.doi.org/10.1074/jbc.M117.797936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29229777	hybrid, Green Published			2022-12-26	WOS:000424948000019
J	Nicolussi, A; Dunn, JD; Mlynek, G; Bellei, M; Zamocky, M; Battistuzzi, G; Djinovic-Carugo, K; Furtmuller, PG; Soldati, T; Obinger, C				Nicolussi, Andrea; Dunn, Joe Dan; Mlynek, Georg; Bellei, Marzia; Zamocky, Marcel; Battistuzzi, Gianantonio; Djinovic-Carugo, Kristina; Furtmueller, Paul G.; Soldati, Thierry; Obinger, Christian			Secreted heme peroxidase from Dictyostelium discoideum: Insights into catalysis, structure, and biological role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dictyostelium; post-translational modification (PTM); heme; peroxidase; heme peroxidase; oxidation-reduction (redox); X-ray crystallography; kinetics; antibacterial activity; halide oxidation; modified heme-modified heme; antibacterial activity; fruiting body	BACTERIAL PEROXIDASE; REDOX THERMODYNAMICS; COVALENT HEME; PROTEIN BONDS; COMPOUND-I; MYELOPEROXIDASE; MODEL; LACTOPEROXIDASE; THIOCYANATE; MECHANISMS	Oxidation of halides and thiocyanate by heme peroxidases to antimicrobial oxidants is an important cornerstone in the innate immune system of mammals. Interestingly, phylogenetic and physiological studies suggest that homologous peroxidases are already present in mycetozoan eukaryotes such as Dictyostelium discoideum. This social amoeba kills bacteria via phagocytosis for nutrient acquisition at its single-cell stage and for antibacterial defense at its multicellular stages. Here, we demonstrate that peroxidase A from D. discoideum (DdPoxA) is a stable, monomeric, glycosylated, and secreted heme peroxidase with homology to mammalian peroxidases. The first crystal structure (2.5 resolution) of a mycetozoan peroxidase of this superfamily shows the presence of a post-translationally-modified heme with one single covalent ester bond between the 1-methyl heme substituent and Glu-236. The metalloprotein follows the halogenation cycle, whereby compound I oxidizes iodide and thiocyanate at high rates (>10(8) m(-1) s(-1)) and bromide at very low rates. It is demonstrated that DdPoxA is up-regulated and likely secreted at late multicellular development stages of D. discoideum when migrating slugs differentiate into fruiting bodies that contain persistent spores on top of a cellular stalk. Expression of DdPoxA is shown to restrict bacterial contamination of fruiting bodies. Structure and function of DdPoxA are compared with evolutionary-related mammalian peroxidases in the context of non-specific immune defense.	[Nicolussi, Andrea; Zamocky, Marcel; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria; [Dunn, Joe Dan; Soldati, Thierry] Univ Geneva, Fac Sci, Dept Biochem, CH-1211 Geneva, Switzerland; [Mlynek, Georg; Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy; [Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, Via Campi 103, I-41125 Modena, Italy; [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana 1000, Slovenia	University of Natural Resources & Life Sciences, Vienna; University of Geneva; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Slovak Academy of Sciences; University of Ljubljana	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	SOLDATI, Thierry/U-6494-2019; Djinovic-Carugo, Kristina/AAW-1167-2021; Battistuzzi, Gianantonio/L-7183-2015; Obinger, Christian/AAV-3173-2021; SOLDATI, Thierry/A-2902-2009; Furtmüller, Paul G./Y-5819-2018; Zamocky, Marcel/AAC-2882-2019	SOLDATI, Thierry/0000-0002-2056-7931; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Battistuzzi, Gianantonio/0000-0003-4716-5745; SOLDATI, Thierry/0000-0002-2056-7931; Furtmüller, Paul G./0000-0002-1199-2469; Zamocky, Marcel/0000-0002-2443-2823; Dunn, Joe Dan/0000-0002-5091-4527; Obinger, Christian/0000-0002-7133-3430	Austrian Science Fund (FWF) Doctoral Program BioToP-Molecular Technology of Proteins Grant [W1224]; Swiss National Science Foundation; Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise" [253275]	Austrian Science Fund (FWF) Doctoral Program BioToP-Molecular Technology of Proteins Grant(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise"	This work was supported in part by Austrian Science Fund (FWF) Doctoral Program BioToP-Molecular Technology of Proteins Grant W1224 and multiple grants from the Swiss National Science Foundation (to the T. Soldati laboratory). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise," funding the Center of Optimized Structural Studies, Grant 253275.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Bafort F, 2014, ENZYME RES, V2014, DOI DOI 10.1155/2014/517164; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; BETTS PM, 1979, CAN J MICROBIOL, V25, P1277, DOI 10.1139/m79-201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley CM, 2016, P NATL ACAD SCI USA, V113, pE5906, DOI 10.1073/pnas.1524532113; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Chandler JD, 2015, FREE RADICAL RES, V49, P695, DOI 10.3109/10715762.2014.1003372; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Cosson P, 2014, CELL MICROBIOL, V16, P816, DOI 10.1111/cmi.12291; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Montellano PRO, 2016, RSC METALLOBIO SER, V4, P3; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Desjardins M, 2005, IMMUNOL REV, V207, P158, DOI 10.1111/j.0105-2896.2005.00319.x; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2004, JPN J INFECT DIS, V57, pS30; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Hagedorn Monica, 2006, V346, P327; Hofbauer S, 2014, BIOTECHNOL J, V9, P461, DOI 10.1002/biot.201300210; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; KLEBANOFF SJ, 1967, J EXP MED, V126, P1063, DOI 10.1084/jem.126.6.1063; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leiba J, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12722; Li SI, 2011, TRENDS GENET, V27, P48, DOI 10.1016/j.tig.2010.11.003; Lin YW, 2015, BBA-PROTEINS PROTEOM, V1854, P844, DOI 10.1016/j.bbapap.2015.04.019; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Malik A, 2012, CRIT REV MICROBIOL, V38, P168, DOI 10.3109/1040841X.2011.645519; Monnat J, 1997, FEBS LETT, V418, P357, DOI 10.1016/S0014-5793(97)01415-4; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; Nicolussi A, 2017, BIOCHEMISTRY-US, V56, P4525, DOI 10.1021/acs.biochem.7b00632; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Paumann-Page M, 2017, J BIOL CHEM, V292, P4583, DOI 10.1074/jbc.M117.775213; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Romeralo M, 2012, PROTIST, V163, P327, DOI 10.1016/j.protis.2011.09.004; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Shetaya WH, 2012, GEOCHIM COSMOCHIM AC, V77, P457, DOI 10.1016/j.gca.2011.10.034; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Skaff O, 2009, BIOCHEM J, V422, P111, DOI 10.1042/BJ20090276; Stajdohar M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1706-9; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang XZ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00269; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938	68	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1330	1345		10.1074/jbc.RA117.000463	http://dx.doi.org/10.1074/jbc.RA117.000463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242189	Green Published, hybrid			2022-12-26	WOS:000423515000019
J	Jagdagsuren, D; Hayashida, T; Takano, M; Gombo, E; Zayasaikhan, S; Kanayama, N; Tsuchiya, K; Oka, S				Jagdagsuren, Davaalkham; Hayashida, Tsunefusa; Takano, Misao; Gombo, Erdenetuya; Zayasaikhan, Setsen; Kanayama, Naomi; Tsuchiya, Kiyoto; Oka, Shinichi			The second molecular epidemiological study of HIV infection in Mongolia between 2010 and 2016	PLOS ONE			English	Article							IDENTIFICATION; RESISTANCE; GENOME	Objective Our previous 2005 +/- 2009 molecular epidemiological study in Mongolia identified a hot spot of HIV-1 transmission in men who have sex with men (MSM). To control the infection, we collaborated with NGOs to promote safer sex and HIV testing since mid-2010. In this study, we carried out the second molecular epidemiological survey between 2010 and 2016 to determine the status of HIV-1 infection in Mongolia. Methods The study included 143 new cases of HIV-1 infection. Viral RNA was extracted from stocked plasma samples and sequenced for the pol and the env regions using the Sanger method. Near-full length sequencing using MiSeq was performed in 3 patients who were suspected to be infected with recombinant HIV-1. Phylogenetic analysis was performed using the neighbor-joining method and Bayesian Markov chain Monte Carlo method. Results MSM was the main transmission route in the previous and current studies. However, heterosexual route showed a significant increase in recent years. Phylogenetic analysis documented three taxa; Mongolian B, Korean B, and CRF51_01B, though the former two were also observed in the previous study. CRF51_01B, which originated from Singapore and Malaysia, was confirmed by near-full length sequencing. Although these strains were mainly detected in MSM, they were also found in increasing numbers of heterosexual males and females. Bayesian phylogenetic analysis estimated transmission of CRF51_01B into Mongolia around early 2000s. An extended Bayesian skyline plot showed a rapid increase in the effective population size of Mongolian B cluster around 2004 and that of CRF51_01B cluster around 2011. Conclusions HIV-1 infection might expand to the general population in Mongolia. Our study documented a new cluster of HIV-1 transmission, enhancing our understanding of the epidemiological status of HIV-1 in Mongolia.	[Jagdagsuren, Davaalkham; Gombo, Erdenetuya; Zayasaikhan, Setsen] Natl Ctr Communicable Dis, AIDS STI Surveillance & Res Dept, Ulaanbaatar, Mongolia; [Hayashida, Tsunefusa; Takano, Misao; Kanayama, Naomi; Tsuchiya, Kiyoto; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Communicable Diseases of Mongolia; National Center for Global Health & Medicine - Japan; Kumamoto University	Oka, S (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.; Oka, S (corresponding author), Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan.	oka@acc.ncgm.go.jp	Tsuchiya, Kiyoto/L-8650-2013	Tsuchiya, Kiyoto/0000-0002-8233-6653; Oka, Shinichi/0000-0002-9283-2167	National Center for Global Health and Medicine [25-A-6, 28-A-2]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was supported by grants for National Center for Global Health and Medicine (25-A-6 and 28-A-2), which were received by SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bang JIH, 2008, AIDS RES HUM RETROV, V24, P83, DOI 10.1089/aid.2007.0116; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Cheong HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111236; Cho YK, 2011, AIDS RES HUM RETROV, V27, P613, DOI [10.1089/AID.2010.0174, 10.1089/aid.2010.0174]; Davaalkham J, 2011, AIDS RES HUM RETROV, V27, P1073, DOI [10.1089/aid.2010.0196, 10.1089/AID.2010.0196]; de Silva TI, 2013, AIDS, V27, P125, DOI 10.1097/QAD.0b013e32835ab12c; Enkhbat E, 2017, MONG J INF DIS RES, V74, P7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Kim GJ, 2012, AIDS RES HUM RETROV, V28, P880, DOI [10.1089/aid.2011.0267, 10.1089/AID.2011.0267]; Ng KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080884; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; Ode H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01258; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475	17	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189605	10.1371/journal.pone.0189605	http://dx.doi.org/10.1371/journal.pone.0189605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244859	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700042
J	Zbucka-Kretowska, M; Charkiewicz, K; Goscik, J; Wolczynski, S; Laudanski, P				Zbucka-Kretowska, Monika; Charkiewicz, Karol; Goscik, Joanna; Wolczynski, Slawomir; Laudanski, Piotr			Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; PLASMINOGEN; EXPRESSION; CELLS; BETA	Objective and design Angiogenic factors are proteins that are related to certain foetal chromosomal abnormalities. The aim of this study was to determine the concentration of 60 angiogenic factors in the plasma of women with offspring possessing trisomy 21/Down syndrome (DS). Method After analysing karyotyping results, we selected 20 patients with foetuses possessing DS, and for the control group, we selected 28 healthy patients with uncomplicated pregnancies who delivered healthy newborns at term (i.e., 15 +/- 18 weeks of gestation). To assess the concentration of proteins in the blood plasma, we used a protein macroarray which enabled simultaneous determination of 60 angiogenic factors per sample. Results We observed a statistically significant increase in the concentration of these five angiogenic and inflammatory factors: TGFb1 (p = 0.039), angiostatin (p = 0.0142), I-309 (p = 0.0476), TGFb3 (p = 0.0395), and VEGF-D (p = 0.0173) D compared to concentrations in patients with healthy foetuses. Conclusion Our findings suggest that angiogenic factors may play role in DS pathogenesis.	[Zbucka-Kretowska, Monika; Wolczynski, Slawomir] Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, Bialystok, Poland; [Charkiewicz, Karol; Laudanski, Piotr] Med Univ Bialystok, Dept Perinatol & Obstet, Bialystok, Poland; [Goscik, Joanna] Bialystok Tech Univ, Fac Comp Sci, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; Bialystok University of Technology	Laudanski, P (corresponding author), Med Univ Bialystok, Dept Perinatol & Obstet, Bialystok, Poland.	plauda@umb.edu.pl	Goscik, Joanna/S-6541-2018; Wołczyński, Sławomir/T-6326-2018	Goscik, Joanna/0000-0003-0433-6145; Wołczyński, Sławomir/0000-0002-7806-1394; Laudanski, Piotr/0000-0001-8955-8198	Leading National Scientific Center, Medical University of Bialystok, Poland [101/KNOW/2015]; Ministry of Higher Education [N/ST/MN/16/001/1133]; Leading National Scientific Center, Medical University of Bialystok, Poland	Leading National Scientific Center, Medical University of Bialystok, Poland; Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Leading National Scientific Center, Medical University of Bialystok, Poland	This work was supported by grant numbers 101/KNOW/2015 from The Leading National Scientific Center, Medical University of Bialystok, Poland, and N/ST/MN/16/001/1133 from the Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from The Leading National Scientific Center, Medical University of Bialystok, Poland and N/ST/MN/16/001/1133 from the Ministry of Higher Education.	[Anonymous], 2016, VEGFD VASC END GROWT; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bahado-Singh RO, 2013, AM J OBSTET GYNECOL, V208, p58e1, DOI DOI 10.1016/J.AJ0G.2012.11.003; Bernardini G, 2000, BLOOD, V96, P4039, DOI 10.1182/blood.V96.13.4039.h8004039_4039_4045; Bromage SJ, 2000, AM J REPROD IMMUNOL, V44, P205, DOI 10.1111/j.8755-8920.2000.440403.x; Bush D, 2017, J PEDIATR-US, V180, P156, DOI 10.1016/j.jpeds.2016.08.063; Charkiewicz K, 2017, CYTOKINE; Charkiewicz K, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9362169; Charkiewicz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127732; Charkiewicz K, 2015, POSTEP HIG MED DOSW, V69, P562, DOI 10.5604/17322693.1151286; Costa V, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-40; Dalgliesh GL, 2001, PLACENTA, V22, P227, DOI 10.1053/plac.2000.0598; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Galambos C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159005; Ghosh S, 2009, AM J MED GENET A, V149A, P1415, DOI 10.1002/ajmg.a.32932; Hattori H, 2001, BRIT J HAEMATOL, V115, P472, DOI 10.1046/j.1365-2141.2001.03093.x; Hopkins WE, 2000, AM J CARDIOL, V85, P784, DOI 10.1016/S0002-9149(99)00864-4; Lambert-Messerlian GM, 1998, CLIN CHEM, V44, P205; Laudanski P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/835837; Laudanski P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/185758; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Ryeom S, 2009, J CRANIOFAC SURG, V20, P595, DOI 10.1097/SCS.0b013e3181927f47; Shapiro SS, 2012, APPROXIMATE ANAL VAR; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; VANDERWAL EA, 1993, NEUROREPORT, V4, P69, DOI 10.1097/00001756-199301000-00018; Vesce F, 2002, HUM REPROD, V17, P803, DOI 10.1093/humrep/17.3.803; Warejcka D, 2005, MOL VIS, V11, P859; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Zbucka-Kretowska M, 2017, FETAL DIAGN THER	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189762	10.1371/journal.pone.0189762	http://dx.doi.org/10.1371/journal.pone.0189762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244857	Green Submitted, Green Published, gold			2022-12-26	WOS:000418184700061
J	Godino-Llorente, JI; Shattuck-Hufnagel, S; Choi, JY; Moro-Velazquez, L; Gomez-Garcia, JA				Godino-Llorente, J. I.; Shattuck-Hufnagel, S.; Choi, J. Y.; Moro-Velazquez, L.; Gomez-Garcia, J. A.			Towards the identification of Idiopathic Parkinson's Disease from the speech. New articulatory kinetic biomarkers	PLOS ONE			English	Article							ACOUSTIC CHARACTERISTICS; VOWEL ARTICULATION; LARGE-SAMPLE; INDIVIDUALS; RECOGNITION; INTONATION; SEVERITY; SPOKEN; SCALE; VOICE	Although a large amount of acoustic indicators have already been proposed in the literature to evaluate the hypokinetic dysarthria of people with Parkinson's Disease, the goal of this work is to identify and interpret new reliable and complementary articulatory biomarkers that could be applied to predict/evaluate Parkinson's Disease from a diadochokinetic test, contributing to the possibility of a further multidimensional analysis of the speech of parkinsonian patients. The new biomarkers proposed are based on the kinetic behaviour of the envelope trace, which is directly linked with the articulatory dysfunctions introduced by the disease since the early stages. The interest of these new articulatory indicators stands on their easiness of identification and interpretation, and their potential to be translated into computer based automatic methods to screen the disease from the speech. Throughout this paper, the accuracy provided by these acoustic kinetic biomarkers is compared with the one obtained with a baseline system based on speaker identification techniques. Results show accuracies around 85% that are in line with those obtained with the complex state of the art speaker recognition techniques, but with an easier physical interpretation, which open the possibility to be transferred to a clinical setting.	[Godino-Llorente, J. I.; Shattuck-Hufnagel, S.; Choi, J. Y.] MIT, Elect Res Lab, Speech Commun Grp, Cambridge, MA 02139 USA; [Godino-Llorente, J. I.; Moro-Velazquez, L.; Gomez-Garcia, J. A.] Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain	Massachusetts Institute of Technology (MIT); Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Godino-Llorente, JI (corresponding author), MIT, Elect Res Lab, Speech Commun Grp, Cambridge, MA 02139 USA.; Godino-Llorente, JI (corresponding author), Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain.	igodino@mit.edu	Gómez-García, Jorge Andrés/J-4359-2017; Llorente, Juan Ignacio Godino/F-5855-2016	Gómez-García, Jorge Andrés/0000-0002-6060-387X; Llorente, Juan Ignacio Godino/0000-0001-7348-3291; MORO VELAZQUEZ, LAUREANO/0000-0002-3033-7005	Spanish Ministry of Education [PRX15/00385]; Fulbright Program	Spanish Ministry of Education(Spanish Government); Fulbright Program	This work has been funded by the Spanish Ministry of Education under grant PRX15/00385. Juan I. Godino-Llorente has developed the work at the Speech Communication Group of the MIT with a grant of the Fulbright Program.	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; [Anonymous], 2000, ACOUSTC PHONETICS; Asgari M, 2010, IEEE ENG MED BIO, P5201, DOI 10.1109/IEMBS.2010.5626104; Bang YI, 2013, NEUROREHABILITATION, V32, P649, DOI 10.3233/NRE-130887; Bayestehtashk A, 2015, COMPUT SPEECH LANG, V29, P172, DOI 10.1016/j.csl.2013.12.001; Benke T, 2000, J NEUROL NEUROSUR PS, V69, P319, DOI 10.1136/jnnp.69.3.319; Benotez-Burraco A, 2016, NEUROLOGIA, V31, P223; Blanchet PG, 2009, J MED SPEECH-LANG PA, V17, P1; Bocanegra Y, 2015, CORTEX, V69, P237, DOI 10.1016/j.cortex.2015.05.022; Bocklet T, 2013, INTERSPEECH, P1148; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Chenausky K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/435232; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Darley FL, 1975, MOTOR SPEECH DISORDE; DAVIS SB, 1980, IEEE T ACOUST SPEECH, V28, P357, DOI 10.1109/TASSP.1980.1163420; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Defazio G, 2016, NEUROL SCI, V37, P443, DOI 10.1007/s10072-015-2422-8; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Diaferia GL, 2016, 20 INT C MOV DIS S2, P31; Duffy J., 2019, MOTOR SPEECH DISORDE; ENDERBY P, 1980, BRIT J DISORD COMMUN, V15, P165; FEIJOO S, 1990, J SPEECH HEAR RES, V33, P324, DOI 10.1044/jshr.3302.324; Feijoo S, 1998, J ACOUST SOC AM, V103, P2933; Ferreiros J, 1999, SPEECH COMMUN, V29, P65, DOI 10.1016/S0167-6393(99)00013-8; FLETCHER SG, 1972, J SPEECH HEAR RES, V15, P763, DOI 10.1044/jshr.1504.763; Freed M, 2000, SINGULAR TEXTBOOK SE; Gadesmann M, 2008, INT J LANG COMM DIS, V43, P41, DOI 10.1080/13682820701234444; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hermansky H, 1994, IEEE T SPEECH AUDI P, V2, P578, DOI 10.1109/89.326616; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Huici HD, 2016, BIOMED SIGNAL PROCES, V27, P1, DOI 10.1016/j.bspc.2016.01.005; ILLES J, 1988, BRAIN LANG, V33, P146, DOI 10.1016/0093-934X(88)90059-4; Jannetts S, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.01.013; Kantz H, 2003, NONLINEAR TIME SERIE, V7; Kegl J, 1999, BRAIN COGNITION, V40, P355, DOI 10.1006/brcg.1998.1086; Kent RD, 2003, J COMMUN DISORD, V36, P281, DOI 10.1016/S0021-9924(03)00016-9; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; Kent RD, 1999, J COMMUN DISORD, V32, P141, DOI 10.1016/S0021-9924(99)00004-0; Kim Y, 2009, FOLIA PHONIATR LOGO, V61, P329, DOI 10.1159/000252849; Kirchner Robert, 1998, THESIS; LEDORZE G, 1994, J COMMUN DISORD, V27, P1; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; LUCE PA, 1985, J ACOUST SOC AM, V78, P1949, DOI 10.1121/1.392651; MATISON R, 1982, NEUROLOGY, V32, P567, DOI 10.1212/WNL.32.5.567; Midi I, 2008, ACTA NEUROL SCAND, V117, P26, DOI 10.1111/j.1600-0404.2007.00965.x; Moreno A., 1993, P 3 EUR C SPEECH COM, V1, p[21, 175]; Novotny M, 2014, IEEE-ACM T AUDIO SPE, V22, P1366, DOI 10.1109/TASLP.2014.2329734; Orozco-Arroyave JR, 2016, J ACOUST SOC AM, V139, P481, DOI 10.1121/1.4939739; Orozco-Arroyave JR, 2014, P INT C LANG RES EV, P342; Ozkan H, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18040115; Perez KS, 1996, J VOICE, V10, P354, DOI 10.1016/S0892-1997(96)80027-0; Poellabauer C, 2015, IEEE ACCESS, V3, P1143, DOI 10.1109/ACCESS.2015.2457392; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Reynolds DA, 2000, DIGIT SIGNAL PROCESS, V10, P19, DOI 10.1006/dspr.1999.0361; Rusz J., 2015, FRONT BIOENG BIOTECH, V3; Rusz J, 2013, J ACOUST SOC AM, V134, P2171, DOI 10.1121/1.4816541; Sadjadi S., 2013, MSR IDENTITY TOOLBOX; Sapir S, 2010, J SPEECH LANG HEAR R, V53, P114, DOI 10.1044/1092-4388(2009/08-0184); Schulz GM, J VOICE, V14, P58; Sidtis DV, 2015, J SPEECH LANG HEAR R, V58, P1493, DOI 10.1044/2015_JSLHR-L-14-0341; Skodda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032132; Skodda S, 2011, J VOICE, V25, pE199, DOI 10.1016/j.jvoice.2010.04.007; Skodda S, 2011, J VOICE, V25, P467, DOI 10.1016/j.jvoice.2010.01.009; Stepp CE, 2013, J ACOUST SOC AM, V133, P1637, DOI 10.1121/1.4776207; Tanaka Y, 2011, FOLIA PHONIATR LOGO, V63, P223, DOI 10.1159/000322059; Theodoros D. G., 1995, J MED SPEECH-LANG PA, V3, P73; Tjaden K, 2013, J SPEECH LANG HEAR R, V56, P1485, DOI 10.1044/1092-4388(2013/12-0259); Tsanas A, 2011, J R SOC INTERFACE, V8, P842, DOI 10.1098/rsif.2010.0456; Walsh B, 2012, MOVEMENT DISORD, V27, P843, DOI 10.1002/mds.24888; WEISMER G, 1992, J ACOUST SOC AM, V91, P1085, DOI 10.1121/1.402635; Weismer G., 1998, J ACOUST SOC AM, V103, P2892, DOI DOI 10.1121/1.421814; Weismer G, 2006, CLIN LINGUIST PHONET, V20, P315, DOI 10.1080/02699200400024806; WESTBURY JR, 1986, J LINGUIST, V22, P145, DOI 10.1017/S0022226700010598; Whitfield JA, 2014, J COMMUN DISORD, V51, P19, DOI 10.1016/j.jcomdis.2014.06.005; Zanin M, 2012, ENTROPY-SWITZ, V14, P1553, DOI 10.3390/e14081553	78	36	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189583	10.1371/journal.pone.0189583	http://dx.doi.org/10.1371/journal.pone.0189583			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240814	gold, Green Submitted, Green Published			2022-12-26	WOS:000417905600050
J	Dong, H; Li, J; Yuan, YB; You, L; Chen, C				Dong, Heng; Li, Jun; Yuan, Yanbin; You, Lin; Chen, Chao			A component-based system for agricultural drought monitoring by remote sensing	PLOS ONE			English	Article							WATER INDEX NDWI; SOIL-MOISTURE; MODIS; TEMPERATURE; SPECTRUM; IMAGES	In recent decades, various kinds of remote sensing-based drought indexes have been proposed and widely used in the field of drought monitoring. However, the drought-related software and platform development lag behind the theoretical research. The current drought monitoring systems focus mainly on information management and publishing, and cannot implement professional drought monitoring or parameter inversion modelling, especially the models based on multi-dimensional feature space. In view of the above problems, this paper aims at fixing this gap with a component-based system named RSDMS to facilitate the application of drought monitoring by remote sensing. The system is designed and developed based on Component Object Model (COM) to ensure the flexibility and extendibility of modules. RSDMS realizes general image-related functions such as data management, image display, spatial reference management, image processing and analysis, and further provides drought monitoring and evaluation functions based on internal and external models. Finally, China's Ningxia region is selected as the study area to validate the performance of RSDMS. The experimental results show that RSDMS provide an efficient and scalable support to agricultural drought monitoring.	[Dong, Heng; Yuan, Yanbin] Wuhan Univ Technol, Sch Resources & Environm Engn, Wuhan, Hubei, Peoples R China; [Li, Jun] China Univ Min & Technol, Coll Geosci & Surveying Engn, Beijing, Peoples R China; [You, Lin] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing, Peoples R China; [Chen, Chao] Zhejiang Ocean Univ, Marine Sci & Technol Coll, Zhoushan, Zhejiang, Peoples R China	Wuhan University of Technology; China University of Mining & Technology; Peking University; Zhejiang Ocean University	Li, J (corresponding author), China Univ Min & Technol, Coll Geosci & Surveying Engn, Beijing, Peoples R China.	junli_geo@126.com			National Natural Science Foundation of China [41701483, 41571514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant No. 41701483 & 41571514. The authors thank the Ningxia Key Laboratory for Meteorological Disaster Prevention and Reduction for providing support during the field measurement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AghaKouchak A, 2015, REV GEOPHYS, V53, P452, DOI 10.1002/2014RG000456; [Anonymous], AGR RES ARID AREA; Bin G, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Carlson T. N., 1994, REMOTE SENS REV, V9, P161; Chen C, 2015, J OPT SOC AM A, V32, P2409, DOI 10.1364/JOSAA.32.002409; Chen C, 2014, INT J REMOTE SENS, V35, P3664, DOI 10.1080/01431161.2014.915437; Chen YD, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-015-0957-4; China Weather, 2010, STAT STAND MET DROUG; Deering D.W., 1978, THESIS TEXAS A M U C; Deng MX, 2012, INT GEOSCI REMOTE SE, P958, DOI 10.1109/IGARSS.2012.6351392; DRACUP JA, 1991, STOCH HYDROL HYDRAUL, V5, P261, DOI 10.1007/BF01543134; Easterling D.R., 2013, EXTREMES CHANGING CL, P347, DOI [DOI 10.1007/978-94-007-4479-012, 10.1007/978-94-007-4479-0_12, DOI 10.1007/978-94-007-4479-0_12]; Feng HX, 2011, SPECTROSC SPECT ANAL, V31, P3069, DOI 10.3964/j.issn.1000-0593(2011)11-3069-05; Fensholt R, 2003, REMOTE SENS ENVIRON, V87, P111, DOI 10.1016/j.rse.2003.07.002; Fox GA, 2004, SOIL SCI SOC AM J, V68, P1326, DOI 10.2136/sssaj2004.1326; Gao MF, 2008, SENSORS-BASEL, V8, P4687, DOI 10.3390/s8084687; Ghulam A, 2007, J APPL REMOTE SENS, V1, P1; Ghulam A, 2007, SCI CHINA SER D, V37, P957; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Golian S, 2015, THEOR APPL CLIMATOL, V119, P679, DOI 10.1007/s00704-014-1139-6; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Gu B, 2015, NEURAL NETWORKS, V67, P140, DOI 10.1016/j.neunet.2015.03.013; Hao ZC, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.1; Hayes MJ, 1999, B AM METEOROL SOC, V80, P429, DOI 10.1175/1520-0477(1999)080<0429:MTDUTS>2.0.CO;2; JACKSON RD, 1981, WATER RESOUR RES, V17, P1133, DOI 10.1029/WR017i004p01133; KOGAN FN, 1995, ADV SPACE RES-SERIES, V15, P91, DOI 10.1016/0273-1177(95)00079-T; Kong Y, 2017, KNOWL-BASED SYST, V115, P123, DOI 10.1016/j.knosys.2016.10.016; Kotchenova SY, 2008, APPL OPTICS, V47, P2215, DOI 10.1364/AO.47.002215; Li J, 2015, IEEE T INF FOREN SEC, V10, P507, DOI 10.1109/TIFS.2014.2381872; Liang S.L., 2004, QUANTITATIVE REMOTE, P413; Liu Q, 2016, SECUR COMMUN NETW, V9, P4002, DOI 10.1002/sec.1582; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Moran MS, 2000, AGR FOREST METEOROL, V105, P69, DOI 10.1016/S0168-1923(00)00189-1; Qin QM, 2006, INT GEOSCI REMOTE SE, P4104, DOI 10.1109/IGARSS.2006.1052; Sandholt I, 2002, REMOTE SENS ENVIRON, V79, P213, DOI 10.1016/S0034-4257(01)00274-7; Santos JF, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008071; Sheffield J, 2014, B AM METEOROL SOC, V95, P861, DOI 10.1175/BAMS-D-12-00124.1; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Shen XY, 2013, IEEE T GEOSCI REMOTE, V51, P3931, DOI 10.1109/TGRS.2012.2228209; Su ZB, 2003, PHYS CHEM EARTH, V28, P89, DOI 10.1016/S1474-7065(03)00010-X; Thenkabail P.S., 2004, USE REMOTE SENSING D, V85; Tian GL, 1992, REMOTE SENSING ENV C, V7, P83; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987; Xia ZH, 2016, MULTIMED TOOLS APPL, V75, P1947, DOI 10.1007/s11042-014-2381-8; Xia ZH, 2014, SECUR COMMUN NETW, V7, P1283, DOI 10.1002/sec.864; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yan NN, 2016, GEOMAT NAT HAZ RISK, V7, P264, DOI 10.1080/19475705.2014.895964; Yang Xuebin, 2011, Geomatics and Information Science of Wuhan University, V36, P195; You L., 2011, STUDY OPERATIONAL MO; You L, 2010, INT GEOSCI REMOTE SE, P3849, DOI 10.1109/IGARSS.2010.5651766; Zhan ZM, 2007, SCI CHINA SER D, V36, P1020; Zhao SH, 2013, J ENVIRON INFORM, V21, P102, DOI 10.3808/jei.201300237; Zhou ZL, 2017, IEEE T INF FOREN SEC, V12, P48, DOI 10.1109/TIFS.2016.2601065	54	3	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188687	10.1371/journal.pone.0188687	http://dx.doi.org/10.1371/journal.pone.0188687			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236700	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100025
J	Ververs, C; Langhout, MV; Hostens, M; Otto, M; Govaere, J; Durrant, B; Van Soom, A				Ververs, Cyrillus; Langhout, Martine van Zijll; Hostens, Miel; Otto, Michelle; Govaere, Jan; Durrant, Barbara; Van Soom, Ann			Reproductive performance parameters in a large population of game-ranched white rhinoceroses (Ceratotherium simum simum)	PLOS ONE			English	Article							DICEROS-BICORNIS; ASSISTED REPRODUCTION; BLACK RHINOCEROS; SEX-RATIO; CONSERVATION; MANAGEMENT; ENDOCRINE; PROGESTIN; PREGNANCY; BEHAVIOR	The population of free-roaming white rhinoceroses (Ceratotherium simum) is under serious threat. Captive breeding of this species is therefore becoming more important, but this is challenging and often not successful. Obtaining reproductive reference values is a crucial aspect of improving these breeding results. In this study performed between 2008 and 2016, reproductive performance was analysed in 1,354 animals kept in a 8000 hectares game-ranched environment. Descriptive statistics of this captive population showed an average annual herd growth (%) of 7.0 +/- 0.1 (min -9-max 15). Average calving rates were calculated as an annual calving rate of 20% and biennial calving rate of 37% adult females calving per year. Females had a median age of 83.2 months at first calving (IQR 72.9-110.7) and inter-calving intervals of 29.2 (IQR 24.6-34.8) months. Furthermore, translocations of animals did not interfere with reproductive success in terms of inter-calving periods or age at first calving. Multivariate models showed a clear seasonal calving pattern with a significant increase of the number of calvings during December-April when compared to April-December. Our results did not show any significant skewed progeny sex ratios. Weather observations showed no significant influence of rain or season on sex ratios of the calves.	[Ververs, Cyrillus; Hostens, Miel; Govaere, Jan; Van Soom, Ann] Univ Ghent, Dept Reprod Obstet & Herd Hlth, Fac Vet Med, Salisburylaan, B-9820 Merelbeke, Belgium; [Langhout, Martine van Zijll] WildlifeVet Nl, Amsterdam, Netherlands; [Otto, Michelle] Wildlife Vet, Buffalo Dream Ranch, Klerksdorp, South Africa; [Durrant, Barbara] San Diego Zoo, Inst Conservat Res, San Diego, CA USA	Ghent University; Zoological Society of San Diego	Ververs, C (corresponding author), Univ Ghent, Dept Reprod Obstet & Herd Hlth, Fac Vet Med, Salisburylaan, B-9820 Merelbeke, Belgium.	Cyrillus.ververs@ugent.be	Hostens, Miel/W-3713-2019; Durrant, Barbara/AAF-7451-2021	Hostens, Miel/0000-0001-5376-976X; Ververs, Cyriel/0000-0002-6994-7687				Amin R., 2006, International Zoo Yearbook, V40, P96, DOI 10.1111/j.1748-1090.2006.00096.x; Dennis PM, 2007, J ZOO WILDLIFE MED, V38, P533, DOI 10.1638/MS05-011.1; Du Toit J, 1998, RHINO RANCHING MANUA; du Toit R., 2006, GUIDELINES IMPLEMENT; Emslie R., 1999, AFRICAN RHINO STATUS; Emslie R, 2012, AFR AS RHIN SPEC GRO; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Foose T. J., 2006, International Zoo Yearbook, V40, P174, DOI 10.1111/j.1748-1090.2006.00174.x; Fouraker M., 1996, AZA RHINOCEROS HUSBA; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; Hermes R, 2007, REPROD DOMEST ANIM, V42, P33, DOI 10.1111/j.1439-0531.2007.00924.x; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R., 2011, FOWLERS ZOO WILD ANI, V7, P546; LINDBURG DG, 1994, ZOO BIOL, V13, P433, DOI 10.1002/zoo.1430130506; Lindemann H, 1982, THESIS; Metrione LC, 2007, ZOO BIOL, V26, P487, DOI 10.1002/zoo.20143; Metrione LC, 2011, GEN COMP ENDOCR, V171, P283, DOI 10.1016/j.ygcen.2011.02.010; Mills A, 2006, ORYX, V40, P319, DOI 10.1017/S0030605306000901; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; OWENSMIT.N, 1971, NATURE, V231, P294, DOI 10.1038/231294a0; OWENSMITH RN, 1973, BEHAV ECOLOGY WHITE; Patisaul HB, 2012, INFERTILITY SO WHITE; Patisaul HB, 2013, ADV EXP MED BIOL, V784, P455, DOI 10.1007/978-1-4614-6199-9_21; Patton ML, 1999, ZOO BIOL, V18, P111, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;111::AID-ZOO3&gt;3.0.CO;2-0; Portas TJ, 2010, AUST VET J, V88, P57, DOI 10.1111/j.1751-0813.2009.00532.x; Portas TJ, 2005, VET REC, V157, P556, DOI 10.1136/vr.157.18.556; Rachlow JL, 1998, ANIM CONSERV, V1, P101, DOI 10.1111/j.1469-1795.1998.tb00017.x; Radcliffe RW, 1997, ZOO BIOL, V16, P445, DOI 10.1002/(SICI)1098-2361(1997)16:5<445::AID-ZOO7>3.0.CO;2-A; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Roth TL, 2004, ZOO BIOL, V23, P219, DOI 10.1002/zoo.10131; Skinner JD, 2006, ONDERSTEPOORT J VET, V73, P237; Soule ME, 1980, CONSERVATION BIOL EV, V111, P124; Stoops MA, 2004, REPRODUCTION, V128, P843, DOI 10.1530/rep.1.00328; Swaisgood RR, 2007, APPL ANIM BEHAV SCI, V102, P139, DOI 10.1016/j.applanim.2006.05.027; Swaisgood RR, 2006, BIOL CONSERV, V129, P468, DOI 10.1016/j.biocon.2005.11.015; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tubbs C, 2012, ENDOCRINOLOGY, V153, P1444, DOI 10.1210/en.2011-1962; Tubbs CW, 2016, GEN COMP ENDOCRINOLO; Ververs C, 2015, VLAAMS DIERGEN TIJDS, V84, P175; Wielebnowski N, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P130; Wolf CM, 1998, BIOL CONSERV, V86, P243	42	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0187751	10.1371/journal.pone.0187751	http://dx.doi.org/10.1371/journal.pone.0187751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236723	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100006
J	Hung, CY; Volkmar, B; Baker, JD; Bauer, JW; Gussoni, E; Hainzl, S; Klausegger, A; Lorenzo, J; Mihalek, I; Rittinger, O; Tekin, M; Dallman, JE; Bodamer, OA				Hung, Christina Y.; Volkmar, Barbara; Baker, James D.; Bauer, Johann W.; Gussoni, Emanuela; Hainzl, Stefan; Klausegger, Alfred; Lorenzo, Jose; Mihalek, Ivana; Rittinger, Olaf; Tekin, Mustafa; Dallman, Julia E.; Bodamer, Olaf A.			A defect in the inner kinetochore protein CENPT causes a new syndrome of severe growth failure	PLOS ONE			English	Article							PRIMORDIAL DWARFISM; GENE PRIORITIZATION; OUTER KINETOCHORE; PLATFORM; COMPLEX; DNA; ARCHITECTURE; INTEGRITY; PATHWAYS; DISEASE	Primordial growth failure has been linked to defects in the biology of cell division and replication. The complex processes involved in microtubule spindle formation, organization and function have emerged as a dominant patho-mechanism in these conditions. The majority of reported disease genes encode for centrosome and centriole proteins, leaving kinetochore proteins by which the spindle apparatus interacts with the chromosomes largely unaccounted for. We report a novel disease gene encoding the constitutive inner kinetochore member CENPT, which is involved in kinetochore targeting and assembly, resulting in severe growth failure in two siblings of a consanguineous family. We herein present studies on the molecular and cellular mechanisms that explain how genetic mutations in this gene lead to primordial growth failure. In both, affected human cell lines and a zebrafish knockdown model of Cenpt, we observed aberrations in cell division with abnormal accumulation of micronuclei and of nuclei with increased DNA content arising from incomplete and/or irregular chromosomal segregation. Our studies underscore the critical importance of kinetochore function for overall body growth and provide new insight into the cellular mechanisms implicated in the spectrum of these severe growth disorders.	[Hung, Christina Y.; Gussoni, Emanuela; Mihalek, Ivana; Bodamer, Olaf A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Hung, Christina Y.; Gussoni, Emanuela; Bodamer, Olaf A.] Harvard Med Sch, Boston, MA 02115 USA; [Volkmar, Barbara; Rittinger, Olaf] Paracelsus Med Univ Salzburg, Dept Pediat, Salzburg, Austria; [Baker, James D.; Dallman, Julia E.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Bauer, Johann W.; Hainzl, Stefan; Klausegger, Alfred] Paracelsus Med Univ Salzburg, Dept Dermatol, Univ Hosp, EB House Austria, Salzburg, Austria; [Lorenzo, Jose; Tekin, Mustafa] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Paracelsus Private Medical University; University of Miami; Paracelsus Private Medical University; University of Miami	Bodamer, OA (corresponding author), Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA.; Bodamer, OA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	olaf.bodamer@childrens.harvard.edu	Dallman, Julia/AGG-3507-2022; Klausegger, Alfred/R-2078-2019; Klausegger, Alfred/G-8001-2018; Gussoni, Emanuela/AAL-6150-2021; Tekin, Mustafa/ABG-7627-2020	Dallman, Julia/0000-0002-5839-807X; Klausegger, Alfred/0000-0001-6160-9934; Gussoni, Emanuela/0000-0002-9915-3677; Tekin, Mustafa/0000-0002-3525-7960; Hung, Christina/0000-0003-1323-700X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; [Anonymous], 2010, R LANG ENV STAT COMP; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Chavali PL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0468; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Genin A, 2012, HUM MOL GENET, V21, P5306, DOI 10.1093/hmg/dds386; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Giunta S, 2017, P NATL ACAD SCI USA, V114, P1928, DOI 10.1073/pnas.1615133114; Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Jackson A., 2009, HEIGHT HEAD CIRCUMFE; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mirzaa GM, 2014, HUM GENET, V133, P1023, DOI 10.1007/s00439-014-1443-3; Nigg EA, 2014, FEBS LETT, V588, P2366, DOI 10.1016/j.febslet.2014.06.030; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Novorol C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130065; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pesenti ME, 2016, CURR OPIN STRUC BIOL, V37, P152, DOI 10.1016/j.sbi.2016.03.003; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Prendergast L, 2016, GENE DEV, V30, P1313, DOI 10.1101/gad.275073.115; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Statistics NCfH. Clinical Growth Charts, 2016, CLIN GROWTH CHARTS; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189324	10.1371/journal.pone.0189324	http://dx.doi.org/10.1371/journal.pone.0189324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228025	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600045
J	Ma, Z; Li, J; Zhang, Y; Shan, C; Gao, XW				Ma, Zhuo; Li, Jing; Zhang, Yi; Shan, Chao; Gao, Xiwu			Inheritance mode and mechanisms of resistance to imidacloprid in the house fly Musca domestica (Diptera: Muscidae) from China	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; BETA-CYPERMETHRIN RESISTANCE; INSECTICIDE RESISTANCE; REALIZED HERITABILITY; PESTICIDE RESISTANCE; CROSS-RESISTANCE; UNITED-STATES; FLIES; GENETICS; L.	Imidacloprid is a neonicotinoid insecticide that is effective against house fly, Musca domestica L., which is a major pest with the ability to develop resistance to insecticides. In the present study, we investigated the inheritance mode, the cross-resistance pattern and the mechanisms of resistance to imidacloprid. A near-isogenic house fly line (N-IRS) with 78-fold resistance to imidacloprid was used to demonstrate the mode of inheritance. The overlapping confidence limits of LC50 values and the slopes of the log concentration-probit lines between the reciprocal F1 and F1' progenies suggest that imidacloprid resistance is inherited autosomally in the house fly. There was incomplete dominant inheritance in the F1 and F1' progenies, based on dominance values of 0.77 and 0.75, respectively. A monogenic inheritance model revealed that imidacloprid resistance is governed by more than one factor. Compared to the field strain (CFD), the N-IRS strain developed more cross-resistance to chlorfenapyr and no cross-resistance to chlorpyrifos and acetamiprid, but showed negative cross-resistance to beta-cypermethrin and azamethiphos. Three synergists, diethyl malate (DEM), s,s,s-tributylphosphorotrithioate (DEF), and piperonyl butoxide (PBO), showed significant synergism against to imidacloprid (4.55-, 4.46- and 3.34-fold respectively) in the N-IRS strain. However, both DEM and PBO had no synergism and DEF only exhibited slight synergism in the CSS strain. The activities of carboxylesterase (CarE), glutathione S-transferases (GSTs) and cytochrome P450 in the N-IRS strain were significantly higher than in the CSS strain. But similar synergistic potential of DEF to imidacloprid between the CSS and N-IRS strain suggested that GSTs and cytochrome P450 played much more important role than esterase for the N-IRS strain resistance to imidacloprid. These results should be helpful for developing an improved management strategy to delay the development of imidacloprid resistance in house fly.	[Ma, Zhuo; Li, Jing; Zhang, Yi; Shan, Chao; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing, Peoples R China	China Agricultural University	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	gaoxiwu@263.net.cn			National Basic Research Programme of China [2012CB114103]	National Basic Research Programme of China(National Basic Research Program of China)	This research was supported by the National Basic Research Programme of China (Contract No.2012CB114103). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Basic Research Programme of China (Contract No.2012CB114103).	Abbas N, 2015, PARASITOL RES, V114, P247, DOI 10.1007/s00436-014-4186-0; Abbas N, 2014, ECOTOXICOLOGY, V23, P791, DOI 10.1007/s10646-014-1217-7; Ai GM, 2009, CHINESE J ANAL CHEM, V37, P1157, DOI 10.1016/S1872-2040(08)60123-1; AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2; Axtell R., 1985, LIVESTOCK ENTOMOLOGY, P269; BARNES EH, 1995, PARASITOL TODAY, V11, P56, DOI 10.1016/0169-4758(95)80117-0; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Bouvier JC, 2001, HEREDITY, V87, P456, DOI 10.1046/j.1365-2540.2001.00928.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; DENHOLM I, 1983, GENET RES, V42, P311, DOI 10.1017/S0016672300021790; Forster M, 2007, PARASITOL RES, V101, P243, DOI 10.1007/s00436-007-0522-y; Gao JR, 2007, INSECT MOL BIOL, V16, P691, DOI 10.1111/j.1365-2583.2007.00770.x; Gao JR, 2007, INSECT MOL BIOL, V16, P325, DOI 10.1111/j.1365-2583.2007.00730.x; Gao JR, 2007, ARCH INSECT BIOCHEM, V64, P30, DOI 10.1002/arch.20158; GEORGHIOU GP, 1969, EXP PARASITOL, V26, P224, DOI 10.1016/0014-4894(69)90116-7; HABIG WH, 1976, ARCH BIOCHEM BIOPHYS, V175, P710, DOI 10.1016/0003-9861(76)90563-4; Hamm RL, 2009, J MED ENTOMOL, V46, P169, DOI 10.1603/033.046.0121; Hojland DH, PLOS ONE, V12; Hojland DH, 2014, PEST MANAG SCI, V70, P1237, DOI 10.1002/ps.3681; ISHAAYA I, 1980, PESTIC BIOCHEM PHYS, V14, P178, DOI 10.1016/0048-3575(80)90109-1; Kaufman PE, 2006, J AGR URBAN ENTOMOL, V23, P195; Kavi LAK, 2014, PESTIC BIOCHEM PHYS, V109, P64, DOI 10.1016/j.pestbp.2014.01.006; Khan HAA, 2013, PARASITOL RES, V112, P2049, DOI 10.1007/s00436-013-3365-8; Khan H, 2014, PESTIC BIOCHEM PHYS, V114, P38, DOI 10.1016/j.pestbp.2014.07.005; Kozielska M, 2008, GENET RES, V90, P157, DOI 10.1017/S001667230700907X; LEE SST, 1989, J ECON ENTOMOL, V82, P1559, DOI 10.1093/jee/82.6.1559; Li J, 2012, PESTIC BIOCHEM PHYS, V102, P109, DOI 10.1016/j.pestbp.2011.10.012; Liu NN, 2002, PESTIC BIOCHEM PHYS, V73, P157, DOI 10.1016/S0048-3575(02)00101-3; Mahmood K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151434; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Mu Wei, 2004, Acta Entomologica Sinica, V47, P591; Ong SQ, 2016, J ECON ENTOMOL, V109, P352, DOI 10.1093/jee/tov326; PREISLER HK, 1990, J ECON ENTOMOL, V83, P1649, DOI 10.1093/jee/83.5.1649; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045; Schmidt R, 1997, GENETICS, V147, P271; Scott JG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0466-3; Scott JG, 2013, PESTIC BIOCHEM PHYS, V107, P377, DOI 10.1016/j.pestbp.2013.10.006; Scott JG, 2000, PEST MANAG SCI, V56, P147, DOI 10.1002/1526-4998(200002)56:2<147::AID-PS106>3.0.CO;2-7; Shan C, 2016, J ECON ENTOMOL, V109, P873, DOI 10.1093/jee/tow001; SHANAHAN GJ, 1979, B ENTOMOL RES, V69, P225, DOI 10.1017/S0007485300017685; Sharma A, 2017, SCIENCE, V356, P642, DOI 10.1126/science.aam5498; Shi J, 2011, PEST MANAG SCI, V67, P335, DOI 10.1002/ps.2073; Sokal R. R, 1981, BIOMETRY; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Tian L, 2011, INT J BIOL SCI, V7, P902, DOI 10.7150/ijbs.7.902; Tsukamoto M., 1983, Pest resistance to pesticides, P71; Zhang AG, 2000, J NEUROCHEM, V75, P1294, DOI 10.1046/j.1471-4159.2000.751294.x; Zhang L, 2008, PEST MANAG SCI, V64, P185, DOI 10.1002/ps.1510; Zhang L, 2007, PESTIC BIOCHEM PHYS, V89, P65, DOI 10.1016/j.pestbp.2007.03.001	51	38	40	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189343	10.1371/journal.pone.0189343	http://dx.doi.org/10.1371/journal.pone.0189343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228021	gold, Green Submitted, Green Published			2022-12-26	WOS:000417648600046
J	Islam, MM; Shareef, H; Mohamed, A				Islam, Md. Mainul; Shareef, Hussain; Mohamed, Azah			Improved approach for electric vehicle rapid charging station placement and sizing using Google maps and binary lightning search algorithm	PLOS ONE			English	Article								The electric vehicle (EV) is considered a premium solution to global warming and various types of pollution. Nonetheless, a key concern is the recharging of EV batteries. Therefore, this study proposes a novel approach that considers the costs of transportation loss, buildup, and substation energy loss and that incorporates harmonic power loss into optimal rapid charging station (RCS) planning. A novel optimization technique, called binary lightning search algorithm (BLSA), is proposed to solve the optimization problem. BLSA is also applied to a conventional RCS planning method. A comprehensive analysis is conducted to assess the performance of the two RCS planning methods by using the IEEE 34-bus test system as the power grid. The comparative studies show that the proposed BLSA is better than other optimization techniques. The daily total cost in RCS planning of the proposed method, including harmonic power loss, decreases by 10% compared with that of the conventional method.	[Islam, Md. Mainul] Uttara Univ, Dept Elect & Elect Engn, Dhaka, Bangladesh; [Shareef, Hussain] United Arab Emirates Univ, Dept Elect Engn, Al Ain 1, U Arab Emirates; [Mohamed, Azah] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia	Uttara University; Universiti Kebangsaan Malaysia	Islam, MM (corresponding author), Uttara Univ, Dept Elect & Elect Engn, Dhaka, Bangladesh.	mhsm.eee@gmail.com	Shareef, Hussain/AAN-5968-2020; Shareef, Hussain/AFK-9223-2022	Shareef, Hussain/0000-0001-7708-6904; Shareef, Hussain/0000-0001-7708-6904; Islam, Md Mainul/0000-0002-8079-2065	UAEU	UAEU	The authors gratefully acknowledge the UAEU under Research Start-up (3) 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrle M., 2013, INT MONETARY FUND, V2013, P1; [Anonymous], 2012, P IEEE PES INN SMART; [Anonymous], 2010, MOD ELECT POWER; Dharmakeerthi CH, 2012, IEEE POW ENER SOC GE; Dharmakeerthi CH, 2014, INT J ELEC POWER, V57, P241, DOI 10.1016/j.ijepes.2013.12.005; Ge S, 2011, 2011 INT C EL CONTR, P2726, DOI DOI 10.1109/ICECENG.2011.6057636; Hu XS, 2017, IEEE POWER ENERGY M, V15, P20, DOI 10.1109/MPE.2017.2708812; Hu XS, 2017, MECH SYST SIGNAL PR, V87, P4, DOI 10.1016/j.ymssp.2016.03.004; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Islam Md Mainul, 2015, Przeglad Elektrotechniczny, V91, P122, DOI 10.15199/48.2015.08.29; Islam MM, 2017, SOFT COMPUT, V21, P2971, DOI 10.1007/s00500-016-2171-5; Islam MM, 2016, TURK J ELECTR ENG CO, V24, P3933, DOI 10.3906/elk-1412-136; Jia L, 2014, 2014 INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON), P3354, DOI 10.1109/POWERCON.2014.6993928; Liu ZP, 2013, IEEE T POWER DELIVER, V28, P102, DOI 10.1109/TPWRD.2012.2223489; Mainul Islam Md, 2015, Applied Mechanics and Materials, V785, P697, DOI 10.4028/www.scientific.net/AMM.785.697; Phonrattanasak P., 2012, INT J INNOV MANAGE T, V3, P675; Sadeghi-Barzani P, 2014, APPL ENERG, V125, P289, DOI 10.1016/j.apenergy.2014.03.077; Shareef H, 2016, RENEW SUST ENERG REV, V64, P403, DOI 10.1016/j.rser.2016.06.033; Teng JH, 2007, IEEE T POWER DELIVER, V22, P1665, DOI 10.1109/TPWRD.2007.899523; Wang GB, 2013, IEEE T POWER DELIVER, V28, P2363, DOI 10.1109/TPWRD.2013.2269142; Watson N. R., 2015, P EEA C EXH WELL, P1; Wu XH, 2017, J POWER SOURCES, V363, P277, DOI 10.1016/j.jpowsour.2017.07.086; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Yan X., 2014, P INT C EL SCI TECHN, P1; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170	26	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189170	10.1371/journal.pone.0189170	http://dx.doi.org/10.1371/journal.pone.0189170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220396	gold, Green Submitted, Green Published			2022-12-26	WOS:000417469900036
J	Mussbacher, M; Schrottmaier, WC; Salzmann, M; Brostjan, C; Schmid, JA; Starlinger, P; Assinger, A				Mussbacher, Marion; Schrottmaier, Waltraud C.; Salzmann, Manuel; Brostjan, Christine; Schmid, Johannes A.; Starlinger, Patrick; Assinger, Alice			Optimized plasma preparation is essential to monitor platelet-stored molecules in humans	PLOS ONE			English	Article							FLOW-CYTOMETRIC EVALUATION; HUMAN BLOOD; P-SELECTIN; ANGIOGENESIS; ACTIVATION; SECRETION; ADENOSINE; MONOPHOSPHATE; THEOPHYLLINE; AGGREGATION	Platelets store a plethora of different molecules within their granules, modulating numerous pathways, not only in coagulation, but also in angiogenesis, wound healing, and inflammatory diseases. These molecules get rapidly released upon activation and therefore represent an easily accessible indirect marker for platelet activation. Accurate analysis of platelet-derived molecules in the plasma requires appropriate anticoagulation to avoid in vitro activation and subsequent degranulation of platelets, potentially causing artificially high levels and masking biologically relevant differences within translational research studies. However, there is still enormous heterogeneity among anticoagulants used to prevent unwanted platelet activation, so that plasma levels reported for platelet granule contents range over several orders of magnitude. To address this problem and to define the most robust method of plasma preparation to avoid in vitro platelet activation during processing, we compared plasma concentrations of the three platelet-stored factors thrombospondin (TSP-1), platelet factor 4 (PF4), and soluble P-selectin (sCD62P) between human blood samples anticoagulated with either citrate-theophylline-adenosinedipyridamole (CTAD), acid-citrate-dextrose (ACD), citrate, ethylenediaminetetraacetic acid (EDTA) or heparin. Additionally, we assessed the effect of storage temperature and time between blood drawing and sample processing within the differentially anticoagulated samples. Our data strongly support the use of CTAD as anticoagulant for determining plasma concentrations of platelet-stored molecules, as anticoagulation with heparin or EDTA led to a 12.4-or 8.3-fold increase in plasma levels of PF4, respectively. Whereas ACD was similar effective as CTAD, citrate only showed comparable PF4 plasma levels when plasma was kept at 4 degrees C. Moreover, blood sampling with CTAD as anticoagulant resulted in the most reproducible values, even when samples were processed at ambient temperature or after storage over 6 hours. In the latter case, anticoagulation with heparin or EDTA led to artificially high plasma levels indicative of in vitro platelet activation. Therefore, we want to raise scientific awareness for choosing CTAD as optimal anticoagulant for the detection of platelet-stored molecules in plasma.	[Mussbacher, Marion; Schrottmaier, Waltraud C.; Salzmann, Manuel; Schmid, Johannes A.; Assinger, Alice] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Brostjan, Christine; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Starlinger, P (corresponding author), Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria.	patrick.starlinger@meduniwien.ac.at	Schrottmaier, Waltraud Cornelia/ADY-2164-2022; Mussbacher, Marion/AAF-3788-2021; Salzmann, Manuel/ABC-3916-2021; Schmid, Johannes A./C-7659-2009	Schrottmaier, Waltraud Cornelia/0000-0003-0550-4120; Mussbacher, Marion/0000-0001-5346-6785; Salzmann, Manuel/0000-0001-5477-3533; Schmid, Johannes A./0000-0002-6586-3507; Brostjan, Christine/0000-0003-1462-5397; Assinger, Alice/0000-0002-5670-5910	Austrian Science Fund FWF [FWF-P24978, SFB-F54]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	The work was supported by Austrian Science Fund FWF (FWF-P24978, SFB-F54).	Ammerlaan W, 2014, BIOPRESERV BIOBANK, V12, P269, DOI 10.1089/bio.2014.0003; Assinger A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00649; ASTER RH, 1964, J CLIN INVEST, V43, P843, DOI 10.1172/JCI104970; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bowen RAR, 2014, BIOCHEM MEDICA, V24, P31, DOI 10.11613/BM.2014.006; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; KUHNE T, 1995, AM J HEMATOL, V50, P40, DOI 10.1002/ajh.2830500108; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; MILLS DCB, 1971, BIOCHEM J, V121, P185, DOI 10.1042/bj1210185; Mody M, 1999, TRANSFUSION MED, V9, P147; Mohamadkhani Ashraf, 2015, Middle East J Dig Dis, V7, P61; Neufeld M, 1999, CLIN CHEM, V45, P2030; Ogundele MO, 2000, BRIT J BIOMED SCI, V57, P312; PAUL S, 1990, MOL PHARMACOL, V37, P870; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; SALZMAN EW, 1972, ANN NY ACAD SCI, V201, P61, DOI 10.1111/j.1749-6632.1972.tb16287.x; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Starlinger P, 2016, HEPATOLOGY, V63, P1675, DOI 10.1002/hep.28331; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Yokota M, 2003, J AUTOM METHOD MANAG, V25, P17, DOI [10.1155/S1463924603000038, 10.1080/1463924031000066212]	28	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188921	10.1371/journal.pone.0188921	http://dx.doi.org/10.1371/journal.pone.0188921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220362	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900020
J	Scire, A; Annovazzi-Lodi, V				Scire, Alessandro; Annovazzi-Lodi, Valerio			Self-organization in a diversity induced thermodynamics	PLOS ONE			English	Article							SYNCHRONIZATION; BEHAVIOR; DYNAMICS; NETWORK	In this work we show how global self-organized patterns can come out of a disordered ensemble of point oscillators, as a result of a deterministic, and not of a random, cooperative process. The resulting system dynamics has many characteristics of classical thermodynamics. To this end, a modified Kuramoto model is introduced, by including Euclidean degrees of freedom and particle polarity. The standard deviation of the frequency distribution is the disorder parameter, diversity, acting as temperature, which is both a source of motion and of disorder. For zero and low diversity, robust static phase-synchronized patterns (crystals) appear, and the problem reverts to a generic dissipative many-body problem. From small to moderate diversity crystals display vibrations followed by structure disintegration in a competition of smaller dynamic patterns, internally synchronized, each of which is capable to manage its internal diversity. In this process a huge variety of self-organized dynamic shapes is formed. Such patterns can be seen again as (more complex) oscillators, where the same description can be applied in turn, renormalizing the problem to a bigger scale, opening the possibility of pattern evolution. The interaction functions are kept local because our idea is to build a system able to produce global patterns when its constituents only interact at the bond scale. By further increasing the oscillator diversity, the dynamics becomes erratic, dynamic patterns show short lifetime, and finally disappear for high diversity. Results are neither qualitatively dependent on the specific choice of the interaction functions nor on the shape of the probability function assumed for the frequencies. The system shows a phase transition and a critical behaviour for a specific value of diversity.	[Scire, Alessandro; Annovazzi-Lodi, Valerio] Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Ferrata 5, I-27100 Pavia, Italy	University of Pavia	Annovazzi-Lodi, V (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Ferrata 5, I-27100 Pavia, Italy.	valerio.annovazzi@unipv.it						Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; ADLER R, 1946, P IRE, V34, P351, DOI 10.1109/JRPROC.1946.229930; Ansari MH, 2008, CLASSICAL QUANT GRAV, V25, DOI 10.1088/0264-9381/25/9/095016; Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-152423, 10.1146/annurev-bioeng-071812-15242]; Atmanspacher H., 2007, CHANCE CHOICE INTERD; Axel HE, 2011, SELF ORG NANOSTRUCTU; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Chen HS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026207; Chen JX, 2018, COMMUN NONLINEAR SCI, V54, P202, DOI 10.1016/j.cnsns.2017.05.034; Chen JX, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/38004; Chen JX, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/38001; Fatima B, 2015, COMPLEX ADAPT SYST M, V3, DOI 10.1186/s40294-015-0008-1; Gerstman BS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1990110; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Horsthemke W., 1984, NOISE INDUCED TRANSI; Jantsch E, 1980, SELF ORG UNIVERSE; Kauffman S.A., 1993, ORIGINS ORDER; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Lipowski A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052811; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2017, NONLINEAR DYNAM, V89, P1569, DOI 10.1007/s11071-017-3565-3; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Miguel M. S., 2000, INSTABILITIES NONEQU, P35, DOI DOI 10.1007/978-94-011-4247-2_; Millor J, 1999, P NATL ACAD SCI USA, V96, P12611, DOI 10.1073/pnas.96.22.12611; Naka K, 2007, TOP CURR CHEM, V270, P1, DOI 10.1007/978-3-540-46380-1; Orlik M., 2012, SELF ORG ELECTROCHEM; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; RIGER S, 1981, AM J COMMUN PSYCHOL, V9, P55, DOI 10.1007/BF00896360; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; Sweetman AM, 2014, NATURE COMMUNICATION, V5, P3921; Tadros T.F, 2011, SELF ORG SURFACTANT; Tessone CJ, 2008, EUR PHYS J B, V62, P319, DOI 10.1140/epjb/e2008-00162-5; Tessone CJ, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016203; Ulrich H, 2012, SELF ORG MANAGEMENT; Wang CN, 2014, COMPLEXITY, V20, P64, DOI 10.1002/cplx.21497; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; WINFREE AT, 1984, J CHEM EDUC, V61, P661, DOI 10.1021/ed061p661	40	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188753	10.1371/journal.pone.0188753	http://dx.doi.org/10.1371/journal.pone.0188753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220363	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900014
J	Bruno, W; Andreotti, V; Bisio, A; Pastorino, L; Fornarini, G; Sciallero, S; Bianchi-Scarra, G; Inga, A; Ghiorzo, P				Bruno, William; Andreotti, Virginia; Bisio, Alessandra; Pastorino, Lorenza; Fornarini, Giuseppe; Sciallero, Stefania; Bianchi-Scarra, Giovanna; Inga, Alberto; Ghiorzo, Paola			Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MESSENGER-RNA TRANSLATION; MELANOMA FAMILIES; RISK; MUTATIONS; SEQUENCE; PATHWAY; HUMANS; IMPACT	CDKN2A coding region germline variants are associated with pancreatic adenocarcinoma (PC) susceptibility. Recently, we described functional germline 5'UTR CDKN2A variants from melanoma patients affecting the post-transcriptional regulation of p16(INK4a) mRNA that is dependent, at least in part, on an Internal Ribosome Entry Site (IRES) in the 5'UTR region. Here we describe a 5'UTR c.-201_-198delinsCTTT CDKN2A variant (frequency 0.0028 based on 350 PC patients), which seems to be private to PC, since it has never been found in public databases nor in thousands of melanoma patients tested. Functional analyses confirmed IRES activity of the 5'UTR in BX-PC3 PC cells and revealed a functional impact of the identified variant. Using gene reporter assays we observed reduced translation potential in cells treated with the mTOR inhibitor Torin1, a condition that favors the assessment of IRES activity. At the endogenous gene level we quantified allelic imbalance among polysome-associated mRNAs using a patient-derived cell line heterozygous for the c.-201_-198delinsCTTT. Overall, we conclude that this very rare private variant can be considered a potential mutation, specifically associated with PC. Our data indicate that sequencing of the entire 5'UTR of CDKN2A should be included in routine screening of PC cases with suspected inherited susceptibility.	[Bruno, William; Andreotti, Virginia; Pastorino, Lorenza; Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genet Rare Canc, Genoa, Italy; [Bruno, William; Andreotti, Virginia; Pastorino, Lorenza; Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Osped Policlin San Martino, Genoa, Italy; [Bisio, Alessandra; Inga, Alberto] Ctr Integrat Biol CIBIO, Trento, Italy; [Bisio, Alessandra; Inga, Alberto] Univ Trento, Trento, Italy; [Fornarini, Giuseppe; Sciallero, Stefania] Osped Policlin San Martino, Med Oncol Unit, Genoa, Italy	University of Genoa; University of Trento	Ghiorzo, P (corresponding author), Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genet Rare Canc, Genoa, Italy.; Ghiorzo, P (corresponding author), Osped Policlin San Martino, Genoa, Italy.	paola.ghiorzo@unige.it	Pastorino, Lorenza/E-6084-2018; Andreotti, Virginia/K-4506-2016; Bruno, William/N-7477-2013; Fornarini, Giuseppe/AAB-1921-2020; Inga, Alberto/AAC-3815-2022; Sciallero, Maria Stefania/AAC-4875-2020; Ghiorzo, Paola/CAG-0673-2022	Pastorino, Lorenza/0000-0002-2575-8331; Andreotti, Virginia/0000-0002-2569-0832; Bruno, William/0000-0002-0337-0168; Fornarini, Giuseppe/0000-0003-4754-6572; Inga, Alberto/0000-0002-8767-1637; Sciallero, Maria Stefania/0000-0002-1325-1701; Ghiorzo, Paola/0000-0002-3651-8173; BISIO, Alessandra/0000-0002-3326-1923	IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente; Italian Association for Cancer Research [AIRC IG15460]	IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by: IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente to PG, Italian Association for Cancer Research AIRC IG15460 to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente to PG, Italian Association for Cancer Research AIRC IG15460 to PG.	Andreotti V, 2016, PIGM CELL MELANOMA R, V29, P210, DOI 10.1111/pcmr.12444; Bisio A, 2015, ONCOTARGET, V6, P39980, DOI 10.18632/oncotarget.5387; Bisio A, 2010, HUM MOL GENET, V19, P1479, DOI 10.1093/hmg/ddq022; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bruno W, 2016, J AM ACAD DERMATOL, V74, P325, DOI 10.1016/j.jaad.2015.09.053; Bruno W, 2009, J AM ACAD DERMATOL, V61, P775, DOI 10.1016/j.jaad.2009.03.039; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Feigin ME, 2017, NAT GENET, V49, P825, DOI 10.1038/ng.3861; Ghiorzo P, 1999, INT J CANCER, V83, P441, DOI 10.1002/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO;2-R; Ghiorzo P, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12047; Ghiorzo P, 2004, ANN ONCOL, V15, P70, DOI 10.1093/annonc/mdg498; Ghiorzo P, 2006, HUM MOL GENET, V15, P2682, DOI 10.1093/hmg/ddl199; Ghiorzo P, 2014, WORLD J GASTROENTERO, V20, P10778, DOI 10.3748/wjg.v20.i31.10778; Ghiorzo P, 2012, J MED GENET, V49, P164, DOI 10.1136/jmedgenet-2011-100281; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Leachman SA, 2017, CANCER METAST REV, V36, P77, DOI 10.1007/s10555-017-9661-5; Petersen GM, 2016, SEMIN ONCOL, V43, P548, DOI 10.1053/j.seminoncol.2016.09.002; Ransohoff KJ, 2016, J AM ACAD DERMATOL, V74, P423, DOI 10.1016/j.jaad.2015.09.070; Scaini MC, 2014, HUM MUTAT, V35, P828, DOI 10.1002/humu.22550; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Yang XH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2968462	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189123	10.1371/journal.pone.0189123	http://dx.doi.org/10.1371/journal.pone.0189123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216274	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800075
J	Sugano, Y; Keetels, M; Vroomen, J				Sugano, Yoshimori; Keetels, Mirjam; Vroomen, Jean			Audio-motor but not visuo-motor temporal recalibration speeds up sensory processing	PLOS ONE			English	Article							DELAYED AUDITORY-FEEDBACK; REACTION-TIME; CROSSMODAL INTERACTION; BEAT PERCEPTION; INTERNAL CLOCK; CAUSAL BINDING; NEURAL BASIS; ADAPTATION; ORDER; ATTENTION	Perception of synchrony between one's own action (a finger tap) and the sensory feedback thereof (a visual flash or an auditory pip) can be recalibrated after exposure to an artificially inserted delay between them (temporal recalibration effect: TRE). TRE might be mediated by a compensatory shift of motor timing (when did I tap?) and/or the sensory timing of the feedback (when did I hear/see the feedback?). To examine this, we asked participants to voluntarily tap their index finger at a constant pace while receiving visual or auditory feedback (a flash or pip) that was either synced or somewhat delayed relative to the tap. Following this exposure phase, they then performed a simple reaction time (RT) task to measure the sensory timing of the exposure stimulus, and a sensorimotor synchronization (SMS) task (tapping in synchrony with a flash or pip as pacing stimulus) to measure the point of subjective synchrony between the tap and pacing stimulus. The results showed that after exposure to delayed auditory feedback, participants tapped earlier (similar to 21.5 ms) relative to auditory pacing stimuli (= temporal recalibration) and reacted faster (similar to 5.6 ms) to auditory stimuli. For visual exposure and test stimuli, there were no such compensatory effects. These results indicate that adjustments of audio-motor synchrony can to some extent be explained by a change in the speed of auditory sensory processing. We discuss this in terms of an attentional modulation of sensory processing.	[Sugano, Yoshimori] Kyushu Sangyo Univ, Dept Ind Management, Fukuoka, Japan; [Keetels, Mirjam; Vroomen, Jean] Tilburg Univ, Dept Cognit Neuropsychol, Tilburg, Netherlands	Tilburg University	Sugano, Y (corresponding author), Kyushu Sangyo Univ, Dept Ind Management, Fukuoka, Japan.; Vroomen, J (corresponding author), Tilburg Univ, Dept Cognit Neuropsychol, Tilburg, Netherlands.	sugano@ip.kyusan-u.ac.jp; J.Vroomen@uvt.nl	Vroomen, Jean/K-1033-2013	Vroomen, Jean/0000-0001-5923-5988; Keetels, Mirjam/0000-0002-1554-9229	Kyushu Sangyo University; Tilburg University; JSPS KAKENHI [JP26380998, 26380998]	Kyushu Sangyo University; Tilburg University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Kyushu Sangyo University, Tilburg University and JSPS KAKENHI Grant Number JP26380998. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Kyushu Sangyo University, Tilburg University and JSPS KAKENHI Grant Number 26380998. We thank the editor and two anonymous reviewers for their helpful comments and suggestions on a previous version of this manuscript.	Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; [Anonymous], 1990, PSYCHOL RES, V52, P28; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Aschersleben G, 1997, J MOTOR BEHAV, V29, P35, DOI 10.1080/00222899709603468; Balota DA, 1999, J EXP PSYCHOL GEN, V128, P32, DOI 10.1037/0096-3445.128.1.32; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Buhusi CV, 2009, PHILOS T R SOC B, V364, P1875, DOI 10.1098/rstb.2009.0022; Burge J, 2010, J NEUROSCI, V30, P7714, DOI 10.1523/JNEUROSCI.6427-09.2010; Cai MB, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00470; Cardoso-Leite P, 2007, J VISION, V7, DOI 10.1167/7.6.11; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, COGNITIVE BRAIN RES, V21, P216, DOI 10.1016/j.cogbrainres.2004.02.011; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; ELLIOTT R, 1968, PSYCHON SCI, V10, P335; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fraisse Paul, INTERSENSORY PERCEPT, P217, DOI DOI 10.1007/978-1-4615-9197-9_7; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00061; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; GRONDIN S, 1993, PERCEPT PSYCHOPHYS, V54, P383, DOI 10.3758/BF03205274; Grondin S, 1998, PSYCHOL RES-PSYCH FO, V61, P261, DOI 10.1007/s004260050030; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Harrar V, 2017, EXP BRAIN RES, V235, P763, DOI 10.1007/s00221-016-4822-2; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; Heron J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007681; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Hughes RW, 2005, J EXP PSYCHOL LEARN, V31, P736, DOI 10.1037/0278-7393.31.4.736; Humphreys GR, 2009, J EXP PSYCHOL HUMAN, V35, P1542, DOI 10.1037/a0014492; Ikumi N, 2014, PLOS ONE, V9; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Jaskowski P., 1999, ADV PSYCHOL, V129, DOI [10.1016/S0166- 4115(99)80026-0, DOI 10.1016/S0166-4115(99)80026-0]; Keetels M., 2012, NEURAL BASEMULTISE, P147; Keetels M, 2007, EXP BRAIN RES, V182, P559, DOI 10.1007/s00221-007-1012-2; Keetels M, 2012, EXP BRAIN RES, V219, P431, DOI 10.1007/s00221-012-3081-0; Kennedy JS, 2009, Q J EXP PSYCHOL, V62, P453, DOI 10.1080/17470210801985235; Kieffaber PD, 2006, SCHIZOPHR RES, V84, P345, DOI 10.1016/j.schres.2006.01.022; KOLERS PA, 1985, J EXP PSYCHOL HUMAN, V11, P150, DOI 10.1037/0096-1523.11.2.150; Large EW, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00159; Leiva A, 2015, EXP PSYCHOL, V62, P54, DOI 10.1027/1618-3169/a000273; Luce RD, 1986, RESPONSE TIMES THEIR; LUPP U, 1976, VISION RES, V16, P969, DOI 10.1016/0042-6989(76)90228-5; Matzke D, 2009, PSYCHON B REV, V16, P798, DOI 10.3758/PBR.16.5.798; McDonald JJ, 2005, NAT NEUROSCI, V8, P1197, DOI 10.1038/nn1512; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; Navarra J, 2009, P NATL ACAD SCI USA, V106, P9169, DOI 10.1073/pnas.0810486106; NIEMI P, 1979, ACTA PSYCHOL, V43, P299, DOI 10.1016/0001-6918(79)90038-6; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Parsons BD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00046; Perruchoud D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00458; Pesavento MJ, 2006, EXP BRAIN RES, V174, P435, DOI 10.1007/s00221-006-0476-9; Pfordresher PQ, 2011, J EXP PSYCHOL HUMAN, V37, P566, DOI 10.1037/a0021487; Pfordresher PQ, 2002, PSYCHOL RES-PSYCH FO, V66, P71, DOI 10.1007/s004260100075; Pikovsky A, 2001, SYNCHRONIZATION UNIV; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; RATCLIFF R, 1976, PSYCHOL REV, V83, P190, DOI 10.1037/0033-295X.83.3.190; Repp BH, 2000, PSYCHOL RES-PSYCH FO, V63, P106, DOI 10.1007/PL00008170; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Rohde M., 2013, FRONT PSYCHOL, V3, P599, DOI [10.3389/fpsyg.2012.00599, DOI 10.3389/fpsyg.2012.00599]; Rohde M, 2014, J VISION, V14, DOI 10.1167/14.3.4; Rohde M, 2014, ACTA PSYCHOL, V147, P127, DOI 10.1016/j.actpsy.2013.07.011; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; SANFORD AJ, 1974, J EXP PSYCHOL, V102, P443, DOI 10.1037/h0035871; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stauffer CC, 2012, PSYCHOL RES-PSYCH FO, V76, P20, DOI 10.1007/s00426-011-0333-8; Stekelenburg JJ, 2011, BRAIN RES, V1397, P46, DOI 10.1016/j.brainres.2011.04.045; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Sugano Y, 2015, IEICE TECHNICAL REPO, V115, P71; Sugano Y, 2017, P 33 ANN M INT SOC P, P118; Sugano Y, 2016, EXP BRAIN RES, V234, P1249, DOI 10.1007/s00221-015-4497-0; Sugano Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00140; Sugano Y, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00246; Sugano Y, 2010, EXP BRAIN RES, V201, P393, DOI 10.1007/s00221-009-2047-3; Takahashi K, 2008, NEUROREPORT, V19, P319, DOI 10.1097/WNR.0b013e3282f4f039; Teki S, 2012, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00090; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Timm J, 2014, CONSCIOUS COGN, V23, P42, DOI 10.1016/j.concog.2013.11.002; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; Toida K, 2014, P 15 INT MULT RES FO, P216; Toida K, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00688; Tsujita M, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00064; Tsujita M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00487; ULRICH R, 1984, PERCEPT PSYCHOPHYS, V36, P545, DOI 10.3758/BF03207515; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vercillo T, 2015, DEVELOPMENTAL SCI, V18, P703, DOI 10.1111/desc.12247; Vibell J, 2007, J COGNITIVE NEUROSCI, V19, P109, DOI 10.1162/jocn.2007.19.1.109; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wenke D, 2009, EXP BRAIN RES, V196, P311, DOI 10.1007/s00221-009-1848-8; Winter R, 2008, BRAIN RES, V1242, P54, DOI 10.1016/j.brainres.2008.06.090; Wohlschlager A, 2003, CONSCIOUS COGN, V12, P708, DOI 10.1016/S1053-8100(03)00083-7; Wohlschlager A., 2000, RHYTHM PERCEPTION PE, P115; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yabe Y, 2015, J NEUROSCI, V35, P5023, DOI 10.1523/JNEUROSCI.4386-14.2015; Yamamoto K, 2014, EXP BRAIN RES, V232, P3707, DOI 10.1007/s00221-014-4055-1; Yamamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029414; Yarrow K, 2013, J EXP PSYCHOL HUMAN, V39, P1678, DOI 10.1037/a0032534; Yuan XY, 2015, ATTEN PERCEPT PSYCHO, V77, P1321, DOI 10.3758/s13414-015-0856-y	131	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189242	10.1371/journal.pone.0189242	http://dx.doi.org/10.1371/journal.pone.0189242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216307	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800106
J	Zhou, YF; Li, YN; Jin, HJ; Wu, JH; He, QW; Wang, XX; Lei, H; Hu, B				Zhou, Yi-Fan; Li, Ya-Nan; Jin, Hui-Juan; Wu, Jie-Hong; He, Quan-Wei; Wang, Xu-Xia; Lei, Hao; Hu, Bo			Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats	FASEB JOURNAL			English	Article						ischemic stroke; pericytes; inflammatory response; BBB permeability; brain	CEREBRAL-ARTERY OCCLUSION; SEMAPHORIN 4D; SEMA4D; PERICYTES; PERMEABILITY; MICROGLIA; ISCHEMIA; INFLAMMATION; ANGIOGENESIS; DISEASE	The inflammatory process in stroke is the major contributor to blood-brain barrier (BBB) breakdown. Previous studies indicated that semaphorin 4D (Sema4D), an axon guidance molecule, initiated inflammatory microglial activation and disrupted endothelial function in the CNS. However, whether Sema4D disrupts BBB integrity after stroke remains unclear. To study the effect of Sema4D on BBB disruption in stroke, rats were subjected to transient middle cerebral artery occlusion and targeted injection of lentivirus-mediated clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene disruption of PlexinB1. We found that Sema4D synchronously increased with BBB permeability and accumulated in the perivascular area after stroke. Suppressing Sema4D/PlexinB1 signaling in the periinfarct cortex significantly decreased BBB permeability as detected by MRI and fibrin deposition, and thereby improved stroke outcome. In vitro, we confirmed that Sema4D disrupted BBB integrity and endothelial tight junctions. Moreover, we found that Sema4D induced pericytes to acquire a CD11b-positive phenotype and express proinflammatory cytokines. In addition, Sema4D inhibited AUF1-induced proinflammatory mRNA decay effect. Taken together, our data provides evidence that Sema4D disrupts BBB integrity and promotes an inflammatory response by binding to PlexinB1 in pericytes after transient middle cerebral artery occlusion. Our study indicates that Sema4D may be a novel therapeutic target for treatment in the acute phase of stroke.	[Zhou, Yi-Fan; Li, Ya-Nan; Jin, Hui-Juan; Wu, Jie-Hong; He, Quan-Wei; Hu, Bo] Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China; [Wang, Xu-Xia; Lei, Hao] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Natl Ctr Magnet Resonance Wuhan, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China.	hubo@mail.hust.edu.cn	Lei, Hao/A-7004-2008	Lei, Hao/0000-0003-3412-1241	Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST [5001530026]; New Century Excellent Talents in University [NCET-10-0406]; National Natural Science Foundation of China [81571119, 81301002, 81601027, 81571139, 81301001, 81371311, 81400969, 81400970]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; National Key Research and Development Program of China [2016YFC1300600]	Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China (Grants 81571119 and 81371311 to B.H., 81601027 to Y.-N.L., 81400969 to Q.-W.H., 81571139, 81301002, 81400970, and 81301001); Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST (5001530026); National Research Foundation for the Doctoral Program of Higher Education of China (Grant 20120142110068 to B.H.); New Century Excellent Talents in University (NCET-10-0406 to B.H.); and National Key Research and Development Program of China (Grant 2016YFC1300600). The authors declare no conflicts of interest.	Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Babu SS, 2015, TRENDS CARDIOVAS MED, V25, P676, DOI 10.1016/j.tcm.2015.02.006; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bohara M, 2014, J CEREBR BLOOD F MET, V34, P589, DOI 10.1038/jcbfm.2013.234; Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251; Chen CYA, 2004, RNA, V10, P669, DOI 10.1261/rna.5269304; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chenette DM, 2016, CELL REP, V16, P1379, DOI 10.1016/j.celrep.2016.06.095; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Desilles JP, 2013, NEUROLOGY, V80, P844, DOI 10.1212/WNL.0b013e31828406de; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Evans EE, 2015, CANCER IMMUNOL RES, V3, P689, DOI 10.1158/2326-6066.CIR-14-0171; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Gong HX, 2017, SCI REP-UK, V7, DOI 10.1038/srep42127; Hasegawa Y, 2013, TRANSL STROKE RES, V4, P524, DOI 10.1007/s12975-013-0260-7; Hsieh CH, 2017, J PATHOL, V241, P337, DOI 10.1002/path.4838; Hu XM, 2017, CIRC RES, V120, P449, DOI 10.1161/CIRCRESAHA.116.308427; Jander S, 2007, STROKE, V38, P642, DOI 10.1161/01.STR.0000250048.42916.ad; Jolivel V, 2015, ACTA NEUROPATHOL, V129, P279, DOI 10.1007/s00401-014-1372-1; Lambertsen KL, 2011, J NEUROPATH EXP NEUR, V70, P481, DOI 10.1097/NEN.0b013e31821db3aa; Li YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13316; Liu KH, 2005, FREE RADICAL BIO MED, V39, P71, DOI 10.1016/j.freeadbiomed.2005.03.033; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mao L, 2014, CNS NEUROSCI THER, V20, P460, DOI 10.1111/cns.12238; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Mou PP, 2013, BLOOD, V121, P4221, DOI 10.1182/blood-2012-11-470609; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rustenhoven J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0503-0; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sawano T, 2015, GLIA, V63, P2249, DOI 10.1002/glia.22890; Siniscalchi A, 2016, CURR VASC PHARMACOL, V14, P98, DOI 10.2174/1570161113666150923111329; Sladojevic N, 2014, NEUROBIOL DIS, V67, P57, DOI 10.1016/j.nbd.2014.03.010; Smith ES, 2015, NEUROBIOL DIS, V73, P254, DOI 10.1016/j.nbd.2014.10.008; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taniguchi Y, 2009, J NEUROSCI RES, V87, P2833, DOI 10.1002/jnr.22124; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Toguchi M, 2009, NEUROCHEM INT, V55, P573, DOI 10.1016/j.neuint.2009.05.013; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Voloshanenko O, 2017, FASEB J, V31, P4832, DOI 10.1096/fj.201700144R; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; White EJF, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1393; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhou H, 2014, ANGIOGENESIS, V17, P261, DOI 10.1007/s10456-013-9395-0; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	66	29	31	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2181	2196		10.1096/fj.201700786RR	http://dx.doi.org/10.1096/fj.201700786RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242274				2022-12-26	WOS:000429051400037
J	Hasegawa, M; Fushimi, K; Miyake, K; Nakajima, T; Oikawa, Y; Enomoto, G; Sato, M; Ikeuchi, M; Narikawa, R				Hasegawa, Masumi; Fushimi, Keiji; Miyake, Keita; Nakajima, Takahiro; Oikawa, Yuki; Enomoto, Gen; Sato, Moritoshi; Ikeuchi, Masahiko; Narikawa, Rei			Molecular characterization of DXCF cyanobacteriochromes from the cyanobacterium Acaryochloris marina identifies a blue-light power sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; photobiology; photoreceptor; site-directed mutagenesis; spectroscopy; cyanobacteriochrome; phytochrome	PHOTOACTIVE GAF DOMAIN; REVERSIBLE PHOTOCONVERSION; NEGATIVE PHOTOTAXIS; SPECTRAL PROPERTIES; PHYTOCHROME-B; PHYCOVIOLOBILIN; PHOTORECEPTORS; PHYCOCYANOBILIN; PHOTOCYCLES; CHROMOPHORE	Cyanobacteriochromes (CBCRs) are linear tetrapyrrole-binding photoreceptors that sense a wide range of wavelengths from ultraviolet to far-red. The primary photoreaction in these reactions is a Z/E isomerization of the double bond between rings C and D. After this isomerization, various color-tuning events establish distinct spectral properties of the CBCRs. Among the various CBCRs, the DXCF CBCR lineage is widely distributed among cyanobacteria. Because the DXCF CBCRs from the cyanobacterium Acaryochloris marina vary widely in sequence, we focused on these CBCRs in this study. We identified seven DXCF CBCRs in A. marina and analyzed them after isolation from Escherichia coli that produces phycocyanobilin, a main chromophore for the CBCRs. We found that six of these CBCRs covalently bound a chromophore and exhibited variable properties, including blue/green, blue/teal, green/teal, and blue/orange reversible photoconversions. Notably, one CBCR, AM1_1870g4, displayed unidirectional photoconversion in response to blue-light illumination, with a rapid dark reversion that was temperature-dependent. Furthermore, the photoconversion took place without Z/E isomerization. This observation indicated that AM1_1870g4 likely functions as a blue-light power sensor, whereas typical CBCRs reversibly sense two light qualities. We also found that AM1_1870g4 possesses a GDCF motif in which the Asp residue is swapped with the next Gly residue within the DXCF motif. Site-directed mutagenesis revealed that this swap is essential for the light power-sensing function of AM1_1870g4. This is the first report of a blue-light power sensor from the CBCR superfamily and of photoperception without Z/E isomerization among the bilin-based photoreceptors.	[Hasegawa, Masumi; Fushimi, Keiji; Miyake, Keita; Oikawa, Yuki; Narikawa, Rei] Shizuoka Univ, Fac Sci, Dept Biol Sci, Suruga Ku, Shizuoka 4228529, Japan; [Narikawa, Rei] Shizuoka Univ, Res Inst Green Sci & Technol, Green Biol Res Div, Suruga Ku, Shizuoka 4228529, Japan; [Nakajima, Takahiro; Enomoto, Gen; Sato, Moritoshi; Ikeuchi, Masahiko] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Fushimi, Keiji; Nakajima, Takahiro; Enomoto, Gen; Sato, Moritoshi; Ikeuchi, Masahiko; Narikawa, Rei] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Shizuoka University; Shizuoka University; University of Tokyo; Japan Science & Technology Agency (JST)	Narikawa, R (corresponding author), Shizuoka Univ, Fac Sci, Dept Biol Sci, Suruga Ku, Shizuoka 4228529, Japan.; Narikawa, R (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Green Biol Res Div, Suruga Ku, Shizuoka 4228529, Japan.; Narikawa, R (corresponding author), Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	narikawa.rei@shizuoka.ac.jp	Enomoto, Gen/ABE-4194-2021; Fushimi, Keiji/U-2974-2019; Narikawa, Rei/AAA-5829-2021; Sato, Moritoshi/O-2735-2018	Enomoto, Gen/0000-0002-9492-7557; Sato, Moritoshi/0000-0002-3095-5831; Hasegawa, Masumi/0000-0002-4227-8321	Japan Science and Technology Agency, CREST Grant [JPMJCR1653]; Japan Society for the Promotion of Science KAKENHI Grant [26702036]	Japan Science and Technology Agency, CREST Grant(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency, CREST Grant JPMJCR1653 (to R. N.), and Japan Society for the Promotion of Science KAKENHI Grant 26702036 (to R. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abatedaga I, 2017, PHOTOCHEM PHOTOBIOL, V93, P805, DOI 10.1111/php.12760; Anders K, 2015, CURR OPIN STRUC BIOL, V35, P7, DOI 10.1016/j.sbi.2015.07.005; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Bai YN, 2016, J PHOTOCH PHOTOBIO B, V161, P192, DOI 10.1016/j.jphotobiol.2016.05.014; Burgie ES, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14037-0; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Cho SM, 2015, J BIOL CHEM, V290, P28502, DOI 10.1074/jbc.M115.669150; Enomoto G, 2015, P NATL ACAD SCI USA, V112, P8082, DOI 10.1073/pnas.1504228112; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Enomoto G, 2012, BIOCHEMISTRY-US, V51, P3050, DOI 10.1021/bi300020u; Fujii Y, 2017, P NATL ACAD SCI USA, V114, P9206, DOI 10.1073/pnas.1704462114; Fujisawa T, 2017, NUCLEIC ACIDS RES, V45, pD551, DOI 10.1093/nar/gkw1131; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P903, DOI 10.1111/php.12764; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P681, DOI 10.1111/php.12732; Fushimi K, 2016, BIOCHEMISTRY-US, V55, P6981, DOI 10.1021/acs.biochem.6b00940; Fushimi K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00588; GROMBEIN S, 1975, H-S Z PHYSIOL CHEM, V356, P1709, DOI 10.1515/bchm2.1975.356.2.1709; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Jung JH, 2016, SCIENCE, V354, P886, DOI 10.1126/science.aaf6005; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legris M, 2016, SCIENCE, V354, P897, DOI 10.1126/science.aaf5656; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Loughlin PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27547; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Mukougawa K, 2006, FEBS LETT, V580, P1333, DOI 10.1016/j.febslet.2006.01.051; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Narikawa R, 2006, PHOTOCHEM PHOTOBIOL, V82, P1627, DOI 10.1562/2006-05-02-RA-888; Narikawa R, 2008, PHOTOCH PHOTOBIO SCI, V7, P1253, DOI 10.1039/b811214b; Narikawa R, 2015, BIOCHEM BIOPH RES CO, V461, P390, DOI 10.1016/j.bbrc.2015.04.045; Narikawa R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07950; Narikawa R, 2014, BIOCHEMISTRY-US, V53, P5051, DOI 10.1021/bi500376b; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Narikawa R, 2011, PLANT CELL PHYSIOL, V52, P2214, DOI 10.1093/pcp/pcr155; Njimona I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109794; Njimona I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025977; Oka Y, 2004, PLANT CELL, V16, P2104, DOI 10.1105/tpc.104.022350; Okajima K, 2005, J BIOCHEM, V137, P741, DOI 10.1093/jb/mvi089; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2017, PHOTOCHEM PHOTOBIOL, V93, P741, DOI 10.1111/php.12708; Rockwell NC, 2015, PHOTOCH PHOTOBIO SCI, V14, P929, DOI 10.1039/c4pp00486h; Rockwell NC, 2014, BIOCHEMISTRY-US, V53, P3118, DOI 10.1021/bi500037a; Rockwell NC, 2014, P NATL ACAD SCI USA, V111, P3871, DOI 10.1073/pnas.1401871111; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Singh NK, 2015, EXCLI J, V14, P268, DOI 10.17179/excli2014-723; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Wiltbank LB, 2016, MBIO, V7, DOI 10.1128/mBio.02130-15; Yoshihara S, 2006, BIOCHEMISTRY-US, V45, P3775, DOI 10.1021/bi051983l; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P235, DOI 10.1016/0005-2728(94)00181-4	59	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1713	1727		10.1074/jbc.M117.816553	http://dx.doi.org/10.1074/jbc.M117.816553			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29229775	Green Published, hybrid			2022-12-26	WOS:000424201700022
J	Bliss, DP; D'Esposito, M				Bliss, Daniel P.; D'Esposito, Mark			Synaptic augmentation in a cortical circuit model reproduces serial dependence in visual working memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; PERSISTENT ACTIVITY; NEURONAL-ACTIVITY; PERCEPTION; MECHANISMS; NETWORK; PRECISION; INTERFERENCE; VARIABILITY; MEMBERSHIP	Recent work has established that visual working memory is subject to serial dependence: current information in memory blends with that from the recent past as a function of their similarity. This tuned temporal smoothing likely promotes the stability of memory in the face of noise and occlusion. Serial dependence accumulates over several seconds in memory and deteriorates with increased separation between trials. While this phenomenon has been extensively characterized in behavior, its neural mechanism is unknown. In the present study, we investigate the circuit-level origins of serial dependence in a biophysical model of cortex. We explore two distinct kinds of mechanisms: stable persistent activity during the memory delay period and dynamic "feminine ordinal indicator" activity-silent" synaptic plasticity. We find that networks endowed with both strong reverberation to support persistent activity and dynamic synapses can closely reproduce behavioral serial dependence. Specifically, elevated activity drives synaptic augmentation, which biases activity on the subsequent trial, giving rise to a spatio-temporally tuned shift in the population response. Our hybrid neural model is a theoretical advance beyond abstract mathematical characterizations, offers testable hypotheses for physiological research, and demonstrates the power of biological insights to provide a quantitative explanation of human behavior.	[Bliss, Daniel P.; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bliss, DP (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	dbliss@berkeley.edu			National Institutes of Health [MH63901]; Department of Defense Army Research Office (National Defense Science and Engineering Graduate Fellowship)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Army Research Office (National Defense Science and Engineering Graduate Fellowship)	This work was supported by the National Institutes of Health (grant number MH63901 to MD) and the Department of Defense Army Research Office (National Defense Science and Engineering Graduate Fellowship to DPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Almeida R, 2015, J NEUROPHYSIOL, V114, P1806, DOI 10.1152/jn.00362.2015; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Barak O, 2014, CURR OPIN NEUROBIOL, V25, P20, DOI 10.1016/j.conb.2013.10.008; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2016, J VISION, V16, DOI 10.1167/16.11.4; Bays PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19203; Bays PM, 2015, TRENDS COGN SCI, V19, P431, DOI 10.1016/j.tics.2015.06.004; Bays PM, 2014, J NEUROSCI, V34, P3632, DOI 10.1523/JNEUROSCI.3204-13.2014; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Bliss DP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15199-7; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Carter E, 2007, CEREB CORTEX, V17, pI16, DOI 10.1093/cercor/bhm103; Cicchini GM, 2014, P NATL ACAD SCI USA, V111, P7867, DOI 10.1073/pnas.1402785111; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 2004, NEUROSCIENTIST, V10, P553, DOI 10.1177/1073858404268742; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Corbett JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016701; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Engel TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7454; Engel TA, 2011, J NEUROSCI, V31, P6982, DOI 10.1523/JNEUROSCI.6150-10.2011; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Fischer J, 2014, NAT NEUROSCI, V17, P738, DOI 10.1038/nn.3689; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Fritsche M, 2017, CURR BIOL, V27, P590, DOI 10.1016/j.cub.2017.01.006; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Funahashi S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00002; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Huang J, 2010, J VISION, V10, DOI 10.1167/10.2.24; Jones E., SCIPY OPEN SOURCE SC; Kiyonaga A, 2017, TRENDS COGN SCI, V21, P493, DOI 10.1016/j.tics.2017.04.011; Kondo A, 2012, PERCEPTION, V41, P43, DOI 10.1068/p7116; Kondo A, 2013, ATTEN PERCEPT PSYCHO, V75, P1347, DOI 10.3758/s13414-013-0533-y; Liberman A, 2016, J VISION, V16, DOI 10.1167/16.15.16; Liberman A, 2014, CURR BIOL, V24, P2569, DOI 10.1016/j.cub.2014.09.025; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Myers NE, 2017, TRENDS COGN SCI, V21, P449, DOI 10.1016/j.tics.2017.03.010; Papadimitriou C, 2017, CEREB CORTEX, V27, P2513, DOI 10.1093/cercor/bhw106; Papadimitriou C, 2015, J NEUROPHYSIOL, V113, P567, DOI 10.1152/jn.00402.2014; Petzold P, 2004, PERCEPT PSYCHOPHYS, V66, P665, DOI 10.3758/BF03194910; Petzold P, 2001, PERCEPT PSYCHOPHYS, V63, P969, DOI 10.3758/BF03194516; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Riley MR, 2015, FRONTIERS SYSTEMS NE, V9; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Stimberg M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00006; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Taubert J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32239; van den Berg R, 2014, PSYCHOL REV, V121, P124, DOI 10.1037/a0035234; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WARD LM, 1971, PERCEPT PSYCHOPHYS, V9, P73, DOI 10.3758/BF03213031; WARD LM, 1985, ATTEN PERCEPT PSYCHO, V38, P512; Watanabe K, 2014, NAT NEUROSCI, V17, P601, DOI 10.1038/nn.3667; Wei W, 2016, NEURAL COMPUT, V28, P652, DOI 10.1162/NECO_a_00818; Wei ZQ, 2012, J NEUROSCI, V32, P11228, DOI 10.1523/JNEUROSCI.0735-12.2012; Whitmire CJ, 2016, NEURON, V92, P298, DOI 10.1016/j.neuron.2016.09.046; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Xia Y, 2016, J VISION, V16, DOI 10.1167/16.15.28; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	71	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188927	10.1371/journal.pone.0188927	http://dx.doi.org/10.1371/journal.pone.0188927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244810	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700012
J	Kim, JH; Kim, AR; Choi, YH; Jong, S; Woo, GH; Cha, JH; Bak, EJ; Yoo, YJ				Kim, Ji-Hye; Kim, Ae Ri; Choi, Yun Hui; Jong, Sungil; Woo, Gye-Hyeong; Cha, Jeong-Heon; Bak, Eun-Jung; Yoo, Yun-Jung			Tumor necrosis factor-alpha antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis	PLOS ONE			English	Article							KAPPA-B LIGAND; LIGATURE-INDUCED PERIODONTITIS; GINGIVAL CREVICULAR FLUID; HUMAN OSTEOBLASTIC CELLS; RECEPTOR ACTIVATOR; TNF-ALPHA; GENE-EXPRESSION; BONE FRAGILITY; ALVEOLAR BONE; IN-VIVO	Type 1 diabetes with periodontitis shows elevated TNF-alpha expression. Tumor necrosis factor (TNF)-alpha stimulates the expression of receptor activator of nuclear factor-kappa B ligand (RANKL) and sclerostin. The objective of this study was to determine the effect of TNF-alpha expression of osteocytic RANKL and sclerostin in type 1 diabetes rats with periodontitis using infliximab (IFX), a TNF-alpha antagonist. Rats were divided into two timepoint groups: day 3 and day 20. Each timepoint group was then divided into four subgroups: 1) control (C, n = 6 for each time point); 2) periodontitis (P, n = 6 for each time point); 3) diabetes with periodontitis (DP, n = 8 for each time point); and 4) diabetes with periodontitis treated with IFX (DP+IFX, n = 8 for each time point). To induce type 1 diabetes, rats were injected with streptozotocin (50 mg/kg dissolved in 0.1 M citrate buffer). Periodontitis was then induced by ligature of the mandibular first molars at day 7 after STZ injection (day 0). IFX was administered once for the 3 day group (on day 0) and twice for the 20 day group (on days 7 and 14). The DP group showed greater alveolar bone loss than the P group on day 20 (P = 0.020). On day 3, higher osteoclast formation and RANKL-positive osteocytes in P group (P = 0.000 and P = 0.011, respectively) and DP group (P = 0.006 and P = 0.017, respectively) than those in C group were observed. However, there was no significant difference in osteoclast formation or RANKL-positive osteocytes between P and DP groups. The DP+IFX group exhibited lower alveolar bone loss (P = 0.041), osteoclast formation (P = 0.019), and RANKL-positive osteocytes (P = 0.009) than that of the DP group. On day 20, DP group showed a lower osteoid area (P = 0.001) and more sclerostin-positive osteocytes (P = 0.000) than P group. On days 3 and 20, the DP+IFX group showed more osteoid area (P = 0.048 and 0.040, respectively) but lower sclerostin-positive osteocytes (both P = 0.000) than DP group. Taken together, these results suggest that TNF-alpha antagonist can diminish osteocytic RANKL/sclerostin expression and osteoclast formation, eventually recovering osteoid formation. Therefore, TNF-alpha might mediate alveolar bone loss via inducing expression of osteocytic RANKL and sclerostin in type 1 diabetes rats with periodontitis.	[Kim, Ji-Hye; Kim, Ae Ri; Choi, Yun Hui; Jong, Sungil; Cha, Jeong-Heon; Bak, Eun-Jung; Yoo, Yun-Jung] Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul, South Korea; [Kim, Ae Ri; Cha, Jeong-Heon; Yoo, Yun-Jung] Yonsei Univ, Grad Sch, Dept Appl Life Sci, Seoul, South Korea; [Kim, Ae Ri; Cha, Jeong-Heon] Yonsei Univ, PLUS Project BK21, Coll Dent, Seoul, South Korea; [Woo, Gye-Hyeong] Semyung Univ, Dept Clin Lab Sci, Jecheon, South Korea; [Kim, Ji-Hye] Jeonju Kijeon Coll, Dept Dent Hyg, Jeonju, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Semyung University	Bak, EJ; Yoo, YJ (corresponding author), Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul, South Korea.; Yoo, YJ (corresponding author), Yonsei Univ, Grad Sch, Dept Appl Life Sci, Seoul, South Korea.	ejbak@yuhs.ac; yu618@yuhs.ac	Yoo, Yun-Jung/HDN-0946-2022	Jang, Sungil/0000-0001-6144-6899; Yoo, Yun-Jung/0000-0002-0045-9597; Cha, Jeong-Heon/0000-0002-9385-2653	National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A6A3A01053590]; Ministry of Science, ICT and Future Planning [NRF-2014R1A2A1A11049412]; Yonsei University College of Dentistry Fund [6-2016-0015]	National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Yonsei University College of Dentistry Fund	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A6A3A01053590) to JHK and the Ministry of Science, ICT and Future Planning (NRF-2014R1A2A1A11049412) to YJY. This study was supported by the Yonsei University College of Dentistry Fund (6-2016-0015) to YJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblowi J, 2013, BONE, V53, P294, DOI 10.1016/j.bone.2012.12.006; Alblowi J, 2009, AM J PATHOL, V175, P1574, DOI 10.2353/ajpath.2009.090148; Allam E, 2010, J PERIODONTAL RES, V45, P136, DOI 10.1111/j.1600-0765.2009.01210.x; Almeida M, 2013, J GERONTOL A-BIOL, V68, P1197, DOI 10.1093/gerona/glt079; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Balli U, 2015, J PERIODONTOL, V86, P1396, DOI 10.1902/jop.2015.150270; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; BRISCOE DM, 1992, J IMMUNOL, V149, P2954; CHEN B, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/731039; da Costa TA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/983782; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Grattendick KJ, 2008, INT IMMUNOPHARMACOL, V8, P679, DOI 10.1016/j.intimp.2008.01.013; Hodge PJ, 2012, J CLIN PERIODONTOL, V39, P20, DOI 10.1111/j.1600-051X.2011.01791.x; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Hough FS, 2016, EUR J ENDOCRINOL, V174, pR127, DOI 10.1530/EJE-15-0820; Jiang ZL, 2013, DIS MARKERS, V34, P295, DOI [10.1155/2013/156798, 10.3233/DMA-130974]; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Kalaitzoglou E, 2016, CURR OSTEOPOROS REP, V14, P310, DOI 10.1007/s11914-016-0329-9; Kang J, 2015, J PERIODONTAL IMPLAN, V45, P101, DOI 10.5051/jpis.2015.45.3.101; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kayal RA, 2010, J BONE MINER RES, V25, P1604, DOI 10.1002/jbmr.59; Kim JH, 2015, J PERIODONTOL, V86, P1005, DOI 10.1902/jop.2015.150083; Kim JH, 2014, J PERIODONTOL, V85, pE370, DOI 10.1902/jop.2014.140230; Lalla E, 2007, J PERIODONTAL RES, V42, P345, DOI 10.1111/j.1600-0765.2006.00955.x; Lim JC, 2017, BONE, V99, P26, DOI 10.1016/j.bone.2017.02.014; Llambes F, 2015, WORLD J DIABETES, V6, P927, DOI 10.4239/wjd.v6.i7.927; Musacchio E, 2009, J RHEUMATOL, V36, P1575, DOI 10.3899/jrheum.081321; Nagasawa T, 2007, PERIODONTOL 2000, V43, P65, DOI 10.1111/j.1600-0757.2006.00185.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Napimoga MH, 2014, J CLIN PERIODONTOL, V41, P550, DOI 10.1111/jcpe.12245; Napoli N, 2017, NAT REV ENDOCRINOL, V13, P208, DOI 10.1038/nrendo.2016.153; Pacios S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16694; Pacios S, 2012, FASEB J, V26, P1423, DOI 10.1096/fj.11-196279; Salvi G E, 1998, Ann Periodontol, V3, P40, DOI 10.1902/annals.1998.3.1.40; Sharifi M, 2015, REV ENDOCR METAB DIS, V16, P149, DOI 10.1007/s11154-015-9311-6; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Wada N, 2004, BONE, V35, P629, DOI 10.1016/j.bone.2004.04.023; Wara-aswapati N, 2007, J PERIODONTOL, V78, P1062, DOI 10.1902/jop.2007.060398; Wu YY, 2015, INT J ORAL SCI, V7, P63, DOI 10.1038/ijos.2015.2; Yang JH, 2010, CELL BIOCHEM FUNCT, V28, P334, DOI 10.1002/cbf.1668; Yang XR, 2016, J ORAL SCI, V58, P271, DOI 10.2334/josnusd.15-0690; Yee CS, 2016, BONE, V82, P122, DOI 10.1016/j.bone.2015.04.048; Zofkova I, 2014, PHYSIOL RES, V63, P421, DOI 10.33549/physiolres.932668	45	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189702	10.1371/journal.pone.0189702	http://dx.doi.org/10.1371/journal.pone.0189702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240821	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600066
J	Fountas, Z; Shanahan, M				Fountas, Zafeirios; Shanahan, Murray			The role of cortical oscillations in a spiking neural network model of the basal ganglia	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS NEURONS; ACTION-POTENTIAL GENERATION; SUBSTANTIA-NIGRA NEURONS; PARS RETICULATA NEURONS; DEEP BRAIN-STIMULATION; BETA-BAND OSCILLATIONS; SHORT-TERM PLASTICITY; MEDIUM SPINY NEURONS; PRIMARY MOTOR CORTEX; GLOBUS-PALLIDUS	Although brain oscillations involving the basal ganglia (BG) have been the target of extensive research, the main focus lies disproportionally on oscillations generated within the BG circuit rather than other sources, such as cortical areas. We remedy this here by investigating the influence of various cortical frequency bands on the intrinsic effective connectivity of the BG, as well as the role of the latter in regulating cortical behaviour. To do this, we construct a detailed neural model of the complete BG circuit based on fine-tuned spiking neurons, with both electrical and chemical synapses as well as short-term plasticity between structures. As a measure of effective connectivity, we estimate information transfer between nuclei by means of transfer entropy. Our model successfully reproduces firing and oscillatory behaviour found in both the healthy and Parkinsonian BG. We found that, indeed, effective connectivity changes dramatically for different cortical frequency bands and phase offsets, which are able to modulate (or even block) information flow in the three major BG pathways. In particular, alpha (8-12Hz) and beta (13-30Hz) oscillations activate the direct BG pathway, and favour the modulation of the indirect and hyper-direct pathways via the subthalamic nucleus D globus pallidus loop. In contrast, gamma (30-90Hz) frequencies block the information flow from the cortex completely through activation of the indirect pathway. Finally, below alpha, all pathways decay gradually and the system gives rise to spontaneous activity generated in the globus pallidus. Our results indicate the existence of a multimodal gating mechanism at the level of the BG that can be entirely controlled by cortical oscillations, and provide evidence for the hypothesis of cortically-entrained but locally-generated subthalamic beta activity. These two findings suggest new insights into the pathophysiology of specific BG disorders.	[Fountas, Zafeirios; Shanahan, Murray] Imperial Coll London, Dept Comp, London, England	Imperial College London	Fountas, Z (corresponding author), Imperial Coll London, Dept Comp, London, England.	zfountas@imperial.ac.uk	Fountas, Zafeirios/J-9589-2019	Fountas, Zafeirios/0000-0002-6312-3409	Doctoral Training Account (DTA) Studentship; UK Engineering and Physical Sciences Research Council (EPSRC)	Doctoral Training Account (DTA) Studentship; UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a Doctoral Training Account (DTA) Studentship, provided by the UK Engineering and Physical Sciences Research Council (EPSRC: www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00134; Ahn S, 2015, EUR J NEUROSCI, V42, P2164, DOI 10.1111/ejn.12980; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], 1956, MODERN MATH ENG; Atherton JF, 2013, J NEUROSCI, V33, P7130, DOI 10.1523/JNEUROSCI.3576-12.2013; Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Bahuguna J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004233; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Baufreton J, 2005, J NEUROSCI, V25, P8505, DOI 10.1523/JNEUROSCI.1163-05.2005; BAUSWEIN E, 1989, BRAIN RES, V493, P198, DOI 10.1016/0006-8993(89)91018-4; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Benhamou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045421; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Beste C, 2014, BRAIN STRUCTURE FUNC, P1; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999; Bevan MD, 2002, J NEUROPHYSIOL, V87, P1348, DOI 10.1152/jn.00582.2001; Bevan MD, 2000, J NEUROPHYSIOL, V83, P3169, DOI 10.1152/jn.2000.83.5.3169; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; Brinkman L, 2014, J NEUROSCI, V34, P14783, DOI 10.1523/JNEUROSCI.2039-14.2014; Brittain JS, 2014, NEUROIMAGE, V85, P637, DOI 10.1016/j.neuroimage.2013.05.084; Brooks SP, 2013, BRAIN RES BULL, V92, P29, DOI 10.1016/j.brainresbull.2012.04.011; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brucke C, 2007, EUR J NEUROSCI, V26, P767, DOI 10.1111/j.1460-9568.2007.05683.x; Bugaysen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012001; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Buzsaki G., 2006, RHYTHMS BRAIN; Cagnan H, 2015, BRAIN, V138, P1667, DOI 10.1093/brain/awv093; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Celada P, 1999, NEUROSCIENCE, V89, P813, DOI 10.1016/S0306-4522(98)00356-X; Connelly WM, 2010, J NEUROSCI, V30, P14854, DOI 10.1523/JNEUROSCI.3895-10.2010; Connolly AT, 2015, J NEUROSCI, V35, P6231, DOI 10.1523/JNEUROSCI.4137-14.2015; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Dayan P, 2001, COMPUTATIONAL NEUROS; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; Delaville C, 2014, BASAL GANGLIA, V3, P221, DOI 10.1016/j.baga.2013.12.001; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DELONG MR, 1972, BRAIN RES, V40, P127, DOI 10.1016/0006-8993(72)90118-7; Dvorzhak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082191; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Farries MA, 2010, J NEUROSCI, V30, P13180, DOI 10.1523/JNEUROSCI.1909-10.2010; FEGER J, 1991, EUR J NEUROSCI, V3, P947, DOI 10.1111/j.1460-9568.1991.tb00030.x; Fountas Z., 2015, 2015 INT JOINT C NEU, P1, DOI [DOI 10.1109/IJCNN.2015.7280668, 10.1109/IJCNN.2015.7280668]; Fountas Z, 2014, IEEE IJCNN, P2407, DOI 10.1109/IJCNN.2014.6889687; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gernert M, 2004, EUR J NEUROSCI, V20, P2377, DOI 10.1111/j.1460-9568.2004.03699.x; Gernert M, 1999, J NEUROSCI RES, V57, P894, DOI 10.1002/(SICI)1097-4547(19990915)57:6<894::AID-JNR15>3.0.CO;2-4; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Gotz T, 1997, J NEUROSCI, V17, P204; Gurney KN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002034; Hallworth NE, 2003, J NEUROSCI, V23, P7525; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Helie S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00174; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; Humphries MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001011; Humphries MD, 2009, NEURAL NETWORKS, V22, P1174, DOI 10.1016/j.neunet.2009.07.018; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kerr CC, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00039; Kim J, 2013, J NEUROPHYSIOL, V109, P932, DOI 10.1152/jn.00459.2012; Kita H, 2004, J NEUROPHYSIOL, V92, P3069, DOI 10.1152/jn.00346.2004; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Ligot N, 2011, J CEREBR BLOOD F MET, V31, P41, DOI 10.1038/jcbfm.2010.186; Lindahl M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00076; Little Simon, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS44, DOI 10.1016/S1353-8020(13)70013-0; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Loucif AJC, 2008, NEUROPHARMACOLOGY, V55, P94, DOI 10.1016/j.neuropharm.2008.04.025; Mailly P, 2003, J NEUROSCI, V23, P5247; Mandali A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00191; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; McCarthy MM, 2011, P NATL ACAD SCI USA, V108, P11620, DOI 10.1073/pnas.1107748108; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montoya A, 2006, NEUROPSYCHOLOGIA, V44, P1984, DOI 10.1016/j.neuropsychologia.2006.01.015; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Moran A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00021; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Nagel SJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00032; Nakanishi H, 1997, NEUROSCIENCE, V77, P1021, DOI 10.1016/S0306-4522(96)00555-6; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Park C, 2011, PHYS REV E, V83; Park C, 2011, CHAOS, V21, DOI 10.1063/1.3633078; Pavlides A, 2012, EUR J NEUROSCI, V36, P2229, DOI 10.1111/j.1460-9568.2012.08105.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reed JL, 2010, J NEUROPHYSIOL, V103, P2139, DOI 10.1152/jn.00709.2009; Reiner A, 1998, BRAIN RES REV, V28, P235, DOI 10.1016/S0165-0173(98)00016-2; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Rohrbacher J, 2000, NEUROSCIENCE, V97, P703, DOI 10.1016/S0306-4522(00)00046-4; Sadek AR, 2007, J NEUROSCI, V27, P6352, DOI 10.1523/JNEUROSCI.0953-07.2007; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schroll H, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00122; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shimamoto SA, 2013, J NEUROSCI, V33, P7220, DOI 10.1523/JNEUROSCI.4676-12.2013; Sims RE, 2008, EUR J NEUROSCI, V28, P2401, DOI 10.1111/j.1460-9568.2008.06546.x; Singh A, 2011, EXP NEUROL, V232, P162, DOI 10.1016/j.expneurol.2011.08.019; Steigerwald F, 2008, J NEUROPHYSIOL, V100, P2515, DOI 10.1152/jn.90574.2008; Steiner H, 2010, HBK BEHAV NEUROSCI, V20, P501; Tachibana Y, 2011, EUR J NEUROSCI, V34, P1470, DOI 10.1111/j.1460-9568.2011.07865.x; Tateno T, 2011, J NEUROPHYSIOL, V106, P1901, DOI 10.1152/jn.00162.2011; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Temel Y, 2006, NEUROSCI LETT, V406, P138, DOI 10.1016/j.neulet.2006.07.036; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tomkins A, 2013, FRONTIERS COMPUTATIO, V7; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; Tzagarakis C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00246; van de Vijver I, 2011, J COGNITIVE NEUROSCI, V23, P4106, DOI 10.1162/jocn_a_00110; van Elk M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.008.2010; Van Geit W, 2008, BIOL CYBERN, V99, P241, DOI 10.1007/s00422-008-0257-6; van Vugt MK, 2007, J NEUROSCI METH, V162, P49, DOI 10.1016/j.jneumeth.2006.12.004; Voytek B, 2015, NAT NEUROSCI, V18, P1318, DOI 10.1038/nn.4071; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Wickens J., 1993, THEORY STRIATUM; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308; Wollstadt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102833; Zahr NM, 2004, SYNAPSE, V54, P119, DOI 10.1002/syn.20064; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848; Zavala B, 2017, CEREB CORTEX, V27, P496, DOI 10.1093/cercor/bhv244; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061; Zhou FM, 2011, NEUROSCIENCE, V198, P69, DOI 10.1016/j.neuroscience.2011.07.061	162	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189109	10.1371/journal.pone.0189109	http://dx.doi.org/10.1371/journal.pone.0189109			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236724	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100042
J	Roik, EE; Sharashova, EE; Nieboer, E; Kharkova, OA; Postoev, VA; Odland, JO				Roik, Elena E.; Sharashova, Ekaterina E.; Nieboer, Evert; Kharkova, Olga A.; Postoev, Vitaly A.; Odland, Jon O.			Knowledge about human papillomavirus and prevention of cervical cancer among women of Arkhangelsk, Northwest Russia	PLOS ONE			English	Article							AWARENESS; VACCINATION; INFECTION; ATTITUDES; HPV	Background Knowledge about cervical cancer (CC) risk factors and benefits of CC prevention motivates women to participate in its screening. However, several studies show that there is a significant knowledge deficit worldwide about human papillomavirus (HPV). The current study explores the level of knowledge about HPV and CC prevention in the context of sociodemographic and behavioral characteristics of women who visited an antenatal clinic in Arkhangelsk, Russia. Methods This cross-sectional study was conducted in the city of Arkhangelsk, which seats the administrative center of Arkhangelsk County, Northwest Russia. It included women who consulted a gynecologist for any reason between January 1, 2015 and April 30, 2015, were residents of Arkhangelsk, 25 to 65 years of age and sexually active (N = 300). Student's t-test for continuous variables and Pearson's chi(2) test for categorical variables were used in the comparisons of women grouped as having either poor or sufficient knowledge. Linear regression analysis was also employed. Results The level of knowledge about HPV and CC prevention was associated with education, parity, age of initiating of intercourse, and sources of information. After adjustment, women with university education were more likely to have higher knowledge about HPV and CC prevention compared to those with lower education. Conclusions We observed that most participants had a sufficient level of knowledge. Educational gaps were identified that potentially could be used to tailor interventions in CC prevention.	[Roik, Elena E.; Sharashova, Ekaterina E.; Kharkova, Olga A.; Odland, Jon O.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Roik, Elena E.; Kharkova, Olga A.; Postoev, Vitaly A.] Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia; [Nieboer, Evert] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	UiT The Arctic University of Tromso; Northern State Medical University; McMaster University	Roik, EE (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.; Roik, EE (corresponding author), Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia.	elena.e.roik@uit.no	Postoev, Vitaly/AAE-2805-2020; Kharkova, Olga/AAO-8495-2020	Postoev, Vitaly/0000-0003-4982-4169; Kharkova, Olga/0000-0002-3130-2920; Roik, Elena/0000-0001-7226-2198				Aniebue PN, 2010, J CANCER EDUC, V25, P106, DOI 10.1007/s13187-009-0023-z; Borovikova O. I., 2012, MODERN PROBLEMS SCI, P80; Bruni L, 20160226 ICO INF CTR; Bruni L, 20150408 ICO INF CTR; Capogrosso P, 2015, WORLD J UROL, V33, P873, DOI 10.1007/s00345-014-1379-1; Center for disease control and prevention, MAN SURV VACC PREV D; Center for disease control and prevention, QUESTIONS ANSWERS; Haesebaert J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1034; Hanisch R, 2008, INT J GYNECOL CANCER, V18, P1020, DOI 10.1111/j.1525-1438.2007.01131.x; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Holcomb B, 2004, J AM BOARD FAM PRACT, V17, P26, DOI 10.3122/jabfm.17.1.26; Kahn JA, 2005, J ADOLESCENT HEALTH, V37, P502, DOI 10.1016/j.jadohealth.2005.07.014; Kataeva OA, 2014, HPV SCREENING STATUS, V4, P19; Kharkova OA, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0144-x; KJAER SK, 1992, CANCER CAUSE CONTROL, V3, P339, DOI 10.1007/BF00146887; Kobayashi D, 2013, ARCH GYNECOL OBSTET, V287, P549, DOI 10.1007/s00404-012-2588-8; Lima Erika Galvao, 2013, ISRN Obstet Gynecol, V2013, P930479, DOI 10.1155/2013/930479; Maklecova SA, 2015, STATUSPRAESENS, V1, P73; Marlow LAV, 2013, VACCINE, V31, P763, DOI 10.1016/j.vaccine.2012.11.083; Massad LS, 2010, GYNECOL ONCOL, V117, P70, DOI 10.1016/j.ygyno.2009.12.030; Moreira ED, 2006, INT J GYNECOL CANCER, V16, P599, DOI 10.1111/j.1525-1438.2006.00377.x; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Tiro JA, 2007, CANCER EPIDEM BIOMAR, V16, P288, DOI 10.1158/1055-9965.EPI-06-0756; Volchenko A. N., 2014, DYNAMICS CERVICAL CA, P25; Voloshin M. V., 2013, SCI ASPIRATIONS  MAY, P120; Waller J, 2013, PREV MED, V56, P35, DOI 10.1016/j.ypmed.2012.10.028; WHO World Health Organization, HUM PAP HPV CERV CAN; Williams MU, 2015, OTOLARYNG HEAD NECK, V152, P1029, DOI 10.1177/0194599815577781	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189534	10.1371/journal.pone.0189534	http://dx.doi.org/10.1371/journal.pone.0189534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236761	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100079
J	Sigut, M; Kostovcik, M; Sigutova, H; Hulcr, J; Drozd, P; Hrcek, J				Sigut, Martin; Kostovcik, Martin; Sigutova, Hana; Hulcr, Jiri; Drozd, Pavel; Hrcek, Jan			Performance of DNA metabarcoding, standard barcoding, and morphological approach in the identification of host-parasitoid interactions	PLOS ONE			English	Article							TAXONOMIC CLASSIFICATION; BIODIVERSITY ASSESSMENT; NATURAL-HISTORY; DIVERSITY; SYMBIONTS; PRIMERS; PLANTS; GENUS	Understanding interactions between herbivores and parasitoids is essential for successful biodiversity protection and monitoring and for biological pest control. Morphological identifications employ insect rearing and are complicated by insects' high diversity and crypsis. DNA barcoding has been successfully used in studies of host-parasitoid interactions as it can substantially increase the recovered real host-parasitoid diversity distorted by overlooked species complexes, or by species with slight morphological differences. However, this approach does not allow the simultaneous detection and identification of host(s) and parasitoid(s). Recently, high-throughput sequencing has shown high potential for surveying ecological communities and trophic interactions. Using mock samples comprising insect larvae and their parasitoids, we tested the potential of DNA metabarcoding for identifying individuals involved in host-parasitoid interactions to different taxonomic levels, and compared it to standard DNA barcoding and morphological approaches. For DNA metabarcoding, we targeted the standard barcoding marker cytochrome oxidase subunit I using highly degenerate primers, 2*300 bp sequencing on a MiSeq platform, and RTAX classification using paired-end reads. Additionally, using a large host-parasitoid dataset from a Central European floodplain forest, we assess the completeness and usability of a local reference library by confronting the number of Barcoding Index Numbers obtained by standard barcoding with the number of morphotypes. Overall, metabarcoding recovery was high, identifying 92.8% of the taxa present in mock samples, and identification success within individual taxonomic levels did not significantly differ among metabarcoding, standard barcoding, and morphology. Based on the current local reference library, 39.4% parasitoid and 90.7% host taxa were identified to the species level. DNA barcoding estimated higher parasitoid diversity than morphotyping, especially in groups with high level of crypsis. This study suggests the potential of metabarcoding for effectively recovering host-parasitoid diversity, together with more accurate identifications obtained from building reliable and comprehensive reference libraries, especially for parasitoids.	[Sigut, Martin; Sigutova, Hana; Drozd, Pavel] Univ Ostrava, Inst Environm Technol, Dept Biol & Ecol, Ostrava, Czech Republic; [Kostovcik, Martin] Charles Univ Prague, Dept Genet & Microbiol, Prague, Czech Republic; [Kostovcik, Martin] Acad Sci Czech Republ, Inst Microbiol, BIOCEV, Vestec, Czech Republic; [Hulcr, Jiri] Univ Florida IFAS, Sch Forest Resources & Conservat, Gainesville, FL USA; [Hulcr, Jiri] Univ Florida IFAS, Dept Entomol & Nematol, Gainesville, FL USA; [Hrcek, Jan] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic	University of Ostrava; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Sigutova, H; Drozd, P (corresponding author), Univ Ostrava, Inst Environm Technol, Dept Biol & Ecol, Ostrava, Czech Republic.	sigutova.hanka@gmail.com; pavel.drozd@osu.cz	Hulcr, Jiri/AAE-4210-2019; Šigut, Martin/T-2926-2019; Sigutova, Hana/AGX-5626-2022; Hrček, Jan/D-7335-2015; Drozd, Pavel/J-3943-2013; Šigutová, Hana/AAB-3478-2022	Hulcr, Jiri/0000-0002-8706-4618; Šigut, Martin/0000-0003-4876-9794; Hrček, Jan/0000-0003-0711-6447; Drozd, Pavel/0000-0002-4602-8856; Šigutová, Hana/0000-0003-1134-248X	European Regional Development Fund BIOCEV [CZ.1.05/1.1.00/02.0109]; Ministry of Education, Youth and Sports of the Czech Republic [L01208]; Institute of Environmental Technologies [CZ.1.05/ 2.1.00/03.0100]; Czech Science Foundation [GA14-04258S, P506/11/2302]; NextGenProject [CZ.1.07/2.3120.0303]; Grant Agency of University of Ostrava [SGS28/PrF/2014, SGS20/PrF/2015]	European Regional Development Fund BIOCEV; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institute of Environmental Technologies; Czech Science Foundation(Grant Agency of the Czech Republic); NextGenProject; Grant Agency of University of Ostrava	This work was supported by the European Regional Development Fund BIOCEV (CZ.1.05/1.1.00/02.0109) (MK), http://www.biocev.eu/en/; Ministry of Education, Youth and Sports of the Czech Republic (L01208) (MS, PD), http://www.msmt.cz/?lang=2; Institute of Environmental Technologies (CZ.1.05/ 2.1.00/03.0100) MS PD); Czech Science Foundation (GA14-04258S; P506/11/2302) PD), https.//gacr.cz/eni; NextGenProject (CZ.1.07/2.3120.0303) (MS), http://nextgen.ivb.cz/; Grant Agency of University of Ostrava (No. SGS28/PrF/2014 and SGS20/PrF/2015) (MS), http://www.osu.eu/, and Institute of Environmental Technologies (CZ.1.05/ 2.1.00/03.0100) (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakraborty C, 2014, APPL MICROBIOL BIOT, V98, P3425, DOI 10.1007/s00253-014-5550-9; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Condon MA, 2014, SCIENCE, V343, P1240, DOI 10.1126/science.1245007; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Cruaud P, 2017, SCI REP-UK, V7, DOI 10.1038/srep41948; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DeWaard Jeremy R., 2008, V410, P275; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epp LS, 2012, MOL ECOL, V21, P1821, DOI 10.1111/j.1365-294X.2012.05537.x; Evans DM, 2016, FUNCT ECOL, V30, P1904, DOI 10.1111/1365-2435.12659; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Gnanamanickam SS, 2006, PLANT-ASSOCIATED BACTERIA, P131; Gonzalez-Chang M., 2016, FOOD WEBS, V9, P4, DOI 10.1016/j.fooweb.2016.04.003; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hansson C, 2015, ZOOKEYS, P1, DOI [10.3897/zookeys.458.9124, 10.3897/zookeys.485.9124]; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Hausmann A, 2013, BIOSYST EU 2013 GLOB; Hausmann A, 2009, ZOOTAXA, P1; Hawkins B. A., 1994, PATTERN PROCESS HOST; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hrcek J, 2015, TRENDS PARASITOL, V31, P30, DOI 10.1016/j.pt.2014.10.008; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Hu X, 2014, FORESTS, V5, P455, DOI 10.3390/f5030455; HUBER J, 2009, INSECT BIODIVERSITY, V843, P303, DOI DOI 10.1002/9781444308211.CH12; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kitson JJN, 2016, NESTED METABARCODE T; La Salle J., 1993, HYMENOPTERA BIODIVER; Lastuvka Z, 2010, CHECKLIST LEPIDOPTER; Littlefair JE, 2016, GENOME, V59, P946, DOI 10.1139/gen-2016-0028; McLean AHC, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0325; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razowski J, 2010, FOLIA BIOL-KRAKOW, V58, P189, DOI 10.3409/fb58_3-4.189-194; Richardson RT, 2016, MOL ECOL RE IN PRESS; Roslin T, 2016, GENOME, V59, P603, DOI 10.1139/gen-2015-0229; Santos AMC, 2011, MOL ECOL RESOUR, V11, P46, DOI 10.1111/j.1755-0998.2010.02889.x; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Sedivy J., 1989, Acta Faunistica Entomologica Musei Nationalis Pragae, V19, P1; Sint D, 2016, METHODS ECOL EVOL, V7, P1548, DOI 10.1111/2041-210X.12621; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Somervuo P, 2016, BIOINFORMATICS, V32, P2920, DOI 10.1093/bioinformatics/btw346; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Takada H, 2010, ENTOMOL SCI, V13, P269, DOI 10.1111/j.1479-8298.2010.00373.x; Tscharntke Teja, 2002, P1, DOI 10.1017/CBO9780511542190.001; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Vanhara J., 2004, STUD DIPTEROL, V10, P679; Veijalainen A, 2012, P ROY SOC B-BIOL SCI, V279, P4694, DOI 10.1098/rspb.2012.1664; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x	70	21	26	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0187803	10.1371/journal.pone.0187803	http://dx.doi.org/10.1371/journal.pone.0187803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236697	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100007
J	Smith, JW; Kroker-Lobos, MF; Lazo, M; Rivera-Andrade, A; Egner, PA; Wedemeyer, H; Torres, O; Freedman, ND; McGlynn, KA; Guallar, E; Groopman, JD; Ramirez-Zea, M				Smith, Joshua W.; Kroker-Lobos, Maria F.; Lazo, Mariana; Rivera-Andrade, Alvaro; Egner, Patricia A.; Wedemeyer, Heiner; Torres, Olga; Freedman, Neal D.; McGlynn, Katherine A.; Guallar, Eliseo; Groopman, John D.; Ramirez-Zea, Manuel			Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DIETARY EXPOSURE; ALBUMIN ADDUCTS; B-VIRUS; POPULATION; SERUM; DOSIMETRY; CONTAMINATION; DETERMINANTS; MORTALITY	Liver cancer is an emerging global health issue, with rising incidence in both the United States and the economically developing world. Although Guatemala experiences the highest rates of this disease in the Western hemisphere and a unique 1: 1 distribution in men and women, few studies have focused on this population. Thus, we determined the prevalence and correlates of aflatoxin B1 (AFB(1)) exposure and hepatitis virus infection in Guatemalan adults. Healthy men and women aged >= 40 years (n = 461), residing in five departments of Guatemala, were enrolled in a cross-sectional study from May D October of 2016. Serum AFB(1)-albumin adducts were quantified using isotope dilution mass spectrometry. Multivariate linear regression was used to assess relationships between AFB(1)-albumin adduct levels and demographic factors. Biomarkers of hepatitis B virus and hepatitis C virus infection were assessed by immunoassay and analyzed by Fisher's exact test. AFB(1)-albumin adducts were detected in 100% of participants, with a median of 8.4 pg/mg albumin (range, 0.2-814.8). Exposure was significantly higher (p< 0.05) in male, rural, low-income, and lesseducated participants than in female, urban, and higher socioeconomic status participants. Hepatitis B and C seropositivity was low (0.9% and 0.5%, respectively). Substantial AFB(1) exposure exists in Guatemalan adults, concurrent with low prevalence of hepatitis virus seropositivity. Quantitatively, AFB(1) exposures are similar to those previously found to increase risk for liver cancer in Asia and Africa. Mitigation of AFB(1) exposure may reduce liver cancer incidence and mortality in Guatemala, warranting further investigation.	[Smith, Joshua W.; Egner, Patricia A.; Groopman, John D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21218 USA; [Kroker-Lobos, Maria F.; Rivera-Andrade, Alvaro; Ramirez-Zea, Manuel] Inst Nutr Cent Amer & Panama, Res Ctr Prevent Chron Dis, Guatemala City, Guatemala; [Lazo, Mariana; Guallar, Eliseo] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lazo, Mariana; Guallar, Eliseo] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Torres, Olga] Lab Diagnost Mol, Guatemala City, Guatemala; [Freedman, Neal D.; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institute of Nutrition of Central America & Panama (INCAP); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Groopman, JD (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21218 USA.	jgroopm1@jhu.edu	Lazo, Mariana/A-9227-2018; Freedman, Neal David/B-9741-2015; /X-4205-2019	Lazo, Mariana/0000-0002-3178-6734; Freedman, Neal David/0000-0003-0074-1098; /0000-0003-4690-2133; Smith, Josh/0000-0002-8636-8097	National Institutes of Health [P30CA006973-52S3, T32ES007141]; NATIONAL CANCER INSTITUTE [ZIACP010158, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30CA006973-52S3 (JDG) and T32ES007141 (departmental award, supported JWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-832922; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P429, DOI 10.3851/IMP2595; Alvarez AMR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4227-6; BEASLEY RP, 1981, LANCET, V2, P1129; Bowden S, 2006, SEMIN LIVER DIS, V26, P97, DOI 10.1055/s-2006-939756; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; CAMPOS MD, 1979, B ENVIRON CONTAM TOX, V22, P350, DOI 10.1007/BF02026954; Carvajal M, 2012, FOOD ADDIT CONTAM A, V29, P258, DOI 10.1080/19440049.2011.647098; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chen JG, 2013, CANCER PREV RES, V6, P1038, DOI 10.1158/1940-6207.CAPR-13-0168; Cupid BC, 2004, FOOD CHEM TOXICOL, V42, P559, DOI 10.1016/j.fct.2003.10.015; de Carvalho FM, 2013, MOL BIOL REP, V40, P4883, DOI 10.1007/s11033-013-2587-2; DECAMPOS M, 1980, B ENVIRON CONTAM TOX, V24, P789, DOI 10.1007/BF01608190; Diaz GJ, 2015, FOOD ADDIT CONTAM A, V32, P1192, DOI 10.1080/19440049.2015.1049563; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gong YY, 2003, INT J EPIDEMIOL, V32, P556, DOI 10.1093/ije/dyg109; GROOPMAN JD, 1992, CANCER EPIDEM BIOMAR, V1, P221; GROOPMAN JD, 1992, CANCER RES, V52, P45; Groopman JD, 2014, FOOD CHEM TOXICOL, V74, P184, DOI 10.1016/j.fct.2014.09.016; Heidrich B, 2014, EUR J GASTROEN HEPAT, V26, P1090, DOI 10.1097/MEG.0000000000000164; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P489; International Agency for Research on Cancer monographs, 2002, IARC MONOGRAPHS EVAL, V82, P1; International Agency for Research on Cancer WHO, 2014, WORLD CANC REPORT, V2014; Islami F, 2017, CA-CANCER J CLIN, V67, P273, DOI 10.3322/caac.21402; Jager AV, 2016, INT J HYG ENVIR HEAL, V219, P294, DOI 10.1016/j.ijheh.2015.12.003; Jiao J, 2016, PLOS ONE, V11, P1; Johnson NM, 2010, SCI TOTAL ENVIRON, V408, P6027, DOI 10.1016/j.scitotenv.2010.09.005; Jubert C, 2009, CANCER PREV RES, V2, P1015, DOI 10.1158/1940-6207.CAPR-09-0099; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Makarova-Rusher OV, 2016, CANCER-AM CANCER SOC, V122, P1757, DOI 10.1002/cncr.29971; McCoy LF, 2005, RAPID COMMUN MASS SP, V19, P2203, DOI 10.1002/rcm.2045; McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001; Noguier L, 2015, JAMA-J AM MED ASSOC, V313, P26; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrick JL, 2016, INT J CANCER, V139, P1534, DOI 10.1002/ijc.30211; Petrick JL, 2016, J CLIN ONCOL, V34, P1787, DOI 10.1200/JCO.2015.64.7412; Pinheiro PS, 2017, CANCER EPIDEM BIOMAR, V26, P376, DOI 10.1158/1055-9965.EPI-16-0684; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; Ramirez AG, 2014, PLOS ONE, V9, P1; Rivera-Andrade A, 2017, J GLOBAL ONCOLOGY, p10s; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; SABBIONI G, 1987, CARCINOGENESIS, V8, P819, DOI 10.1093/carcin/8.6.819; SABBIONI G, 1990, CARCINOGENESIS, V11, P2063, DOI 10.1093/carcin/11.11.2063; Sabbioni G, 2017, CHEM RES TOXICOL, V30, P332, DOI 10.1021/acs.chemrestox.6b00366; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shirima CP, 2013, MOL NUTR FOOD RES, V57, P1874, DOI 10.1002/mnfr.201300116; SKIPPER PL, 1990, CARCINOGENESIS, V11, P507, DOI 10.1093/carcin/11.4.507; Soini Y, 1996, CARCINOGENESIS, V17, P1007, DOI 10.1093/carcin/17.5.1007; Sun CA, 2002, BRIT J CANCER, V87, P966, DOI 10.1038/sj.bjc.6600584; Sun G-A, 2002, BRIT J CANCER, V87, P966; Sun ZT, 2013, CARCINOGENESIS, V34, P1800, DOI 10.1093/carcin/bgt007; Torres O, 2015, WORLD MYCOTOXIN J, V8, P143, DOI 10.3920/WMJ2014.1736; Wild CP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju353; WILD CP, 1986, CARCINOGENESIS, V7, P853, DOI 10.1093/carcin/7.6.853; Wild CP, 2015, MYCOTOXIN CONTROL LO; Wu HC, 2009, CANCER EPIDEM BIOMAR, V18, P846, DOI 10.1158/1055-9965.EPI-08-0697	60	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189255	10.1371/journal.pone.0189255	http://dx.doi.org/10.1371/journal.pone.0189255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236788	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100052
J	Wang, F; Wang, LQ; Wu, J; Sokirniy, I; Nguyen, P; Bregnard, T; Weinstock, J; Mattern, M; Bersonova, I; Hancock, WW; Kumar, S				Wang, Feng; Wang, Liqing; Wu, Jian; Sokirniy, Ivan; Phuong Nguyen; Bregnard, Thomas; Weinstock, Joseph; Mattern, Michael; Bersonova, Irina; Hancock, Wayne W.; Kumar, Suresh			Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+T-regulatory cells by promoting ubiquitination of Tip60	PLOS ONE			English	Article							REGULATORY T-CELLS; PROTEASOME SYSTEM; TRANSCRIPTIONAL ACTIVITY; DEUBIQUITINATING ENZYME; PROTEIN; CANCER; HAUSP; USP7/HAUSP; APOPTOSIS; PATHWAY	Accumulation of Foxp3+ T-regulatory (Treg) cells in the tumor microenvironment is associated with tumor immune evasion and poor patient outcome in the case of many solid tumors. Current therapeutic strategies for blocking Treg functions are not Treg-specific, and display only modest and transient efficacy. Recent studies revealed that ubiquitin-specific protease 7 (USP7) is essential for Treg functions by stabilizing expression of Tip60 and Foxp3, which together are central to the development and maintenance of the Treg cell lineage. Pharmacological inhibition of USP7 is therefore a promising strategy for suppressing Treg functions and promoting anti-tumor immunity. Previously, we reported the P5091 series of small molecule USP7 inhibitors and demonstrated their direct anti-tumor activity in vivo using xenograft models. However, the precise mechanism of action of these compounds was not well defined. In this study, we report the development and characterization of P217564, a second-generation USP7 inhibitor with improved potency and selectivity. P217564 selectively targets the catalytic cleft of USP7 and modifies its active site cysteine (C223) by forming a covalent adduct. Irreversible inhibition of USP7 results in durable downstream biological responses in cells, including down-regulation of Tip60 and consequent impairment of Treg suppressive function. In addition, we demonstrate that both USP7 and various USP7 substrates are subjected to Lys48-mediated ubiquitin modification, consistent with increased proteasomal degradation of these proteins because of USP7 inhibition.	[Wang, Feng; Wu, Jian; Sokirniy, Ivan; Phuong Nguyen; Weinstock, Joseph; Mattern, Michael; Kumar, Suresh] Progenra Inc, Malvern, PA 19355 USA; [Wang, Liqing; Hancock, Wayne W.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Wang, Liqing; Hancock, Wayne W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bregnard, Thomas; Bersonova, Irina] UCONN Hlth, Dept Mol Biol & Biophys, Farmington, CT USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Kumar, S (corresponding author), Progenra Inc, Malvern, PA 19355 USA.	kumar@progenra.com		Sokirniy, Ivan/0000-0002-1846-5469; Kumar, Suresh/0000-0001-5682-0938	NIH [1R43CA174037]; National Institutes of Health [1R01CA177852]; National Science Foundation [1616184]; Progenra Inc.; NATIONAL CANCER INSTITUTE [R01CA177852] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Progenra Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Progenra was supported by NIH (https://www.nih.gov/),1R43CA174037. Wayne W Hancock was supported by National Institutes of Health (https://www.nih.gov/), 1R01CA177852. Irina Bezsonova is funded by National Science Foundation (https://www.nsf.gov/), award #1616184. Progenra Inc. provided support in the form of salaries for authors [FW, LW, JW, IS, JW, MM, and SK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. FW, JW, IS, JW, MM and SK are also employees at Progenra. PN is a formal employee at Progenra. These authors played various roles in the study design, data collection and analysis, decision to publish as well as preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; Cai JB, 2015, HEPATOLOGY, V61, P1603, DOI 10.1002/hep.27682; Cano F, 2010, BIOCHEM SOC T, V38, P1621, DOI 10.1042/BST0381621; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dranoff G, 2005, CLIN CANCER RES, V11, P8226, DOI 10.1158/1078-0432.CCR-05-2035; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Fan YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.400; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Hadaschik EN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0538-0; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hock AK, 2014, J BIOL CHEM, V289, P34862, DOI 10.1074/jbc.M114.589267; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; KNELLER DG, 1993, J CELL BIOCHEM, P254; Knutson KL, 2006, J IMMUNOL, V177, P84, DOI 10.4049/jimmunol.177.1.84; Laroia G, 2002, P NATL ACAD SCI USA, V99, P1842, DOI 10.1073/pnas.042575699; Lee G, 2016, BIOCHEM BIOPH RES CO, V470, P181, DOI 10.1016/j.bbrc.2016.01.021; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Ma JH, 2010, ARCH BIOCHEM BIOPHYS, V503, P207, DOI 10.1016/j.abb.2010.08.020; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; O'Callaghan DS, 2015, EUR RESPIR J, V46, P1762, DOI 10.1183/13993003.00176-2014; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Pozhidaeva AK, 2015, J BIOL CHEM, V290, P22907, DOI 10.1074/jbc.M115.664805; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; Sakaguchi S, 2003, J CLIN INVEST, V112, P1310, DOI 10.1172/JCI200320274; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tavana O, 2016, NAT MED, V22, P1180, DOI 10.1038/nm.4180; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Wang LQ, 2016, EBIOMEDICINE, V13, P99, DOI 10.1016/j.ebiom.2016.10.018; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Weinstock J, 2012, ACS MED CHEM LETT, V3, P789, DOI 10.1021/ml200276j; Xiao Y, 2014, CELL REP, V7, P1471, DOI 10.1016/j.celrep.2014.04.021; Yao TT, 2012, SEMIN CELL DEV BIOL, V23, P523, DOI 10.1016/j.semcdb.2012.02.006; Zaman MMU, 2013, MOL CELL BIOL, V33, P4971, DOI 10.1128/MCB.00465-13; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046	53	33	36	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189744	10.1371/journal.pone.0189744	http://dx.doi.org/10.1371/journal.pone.0189744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236775	gold, Green Submitted, Green Published			2022-12-26	WOS:000417884100092
J	Hessler, MJ; Cyrs, A; Krenzke, SC; Mahmoud, E; Sikasunge, C; Mwansa, J; Lodh, N				Hessler, Megan J.; Cyrs, Austin; Krenzke, Steven C.; Mahmoud, El Shaimaa; Sikasunge, Chummy; Mwansa, James; Lodh, Nilanjan			Detection of duo-schistosome infection from filtered urine samples from school children in Zambia after MDA	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; HAEMATOBIUM; MANSONI; DNA; CHEMOTHERAPY	Schistosomiasis is one of the major Neglected Tropical Diseases (NTDs) in sub-Saharan Africa. In sub-Saharan Africa, two major human schistosome species namely Schistosoma mansoni and S. haematobium often occur sympatrically largely affecting children. Recognizing the public health impact of Schistosomiasis, the World Health Organization (WHO) is urging member states to regularly treat at least 75% and up to 100%, of all school-aged children at risk of morbidity. For control strategies based on targeted mass drug administration (MDA) to succeed it is essential to have a simple and sensitive test for monitoring the success of these interventions. Current available diagnostic tests, such as egg detection in stool by Kato-Katz (KK) for S. mansoni and detection of eggs or blood (hematuria) in urine for S. haematobium have reduced sensitivity in low intensity settings. The objective of the study was to evaluate active single or duo schistosome infections in school children following MDA using molecular diagnostics (PCR) on filtered urine samples and comparing that against traditional diagnostic tests. This cross-sectional study was conducted among 111 school children aged 7-15 years in Chongwe and Siavonga Districts in Zambia. Species-specific cell-free repeat DNA fragment were amplified from 111 filtered urine samples. Our approach detected eight times more positive cases (total 77) than by KK (9) for S. mansoni and six times more (total 72) than by hematuria (11) for S. haematobium and even more against urine filtration (77 compared to only 6). The same pattern was observed when stratified for age group and sex specific analysis with 100% sensitivity and specificity devoid of any cross amplification. In addition, 69 individuals (62%) were co-infected by both parasites. We have demonstrated a significantly higher prevalence of both species than indicated by the traditional tests and the persistent maintenance of reservoir of infection after MDA. Our approach is an effective means of detecting low intensity infection, which will enhance the effectiveness of surveillance and assess the impact of MDA control programs against schistosomiasis.	[Hessler, Megan J.; Cyrs, Austin; Mahmoud, El Shaimaa; Lodh, Nilanjan] Marquette Univ, Dept Clin Lab Sci, Milwaukee, WI 53233 USA; [Krenzke, Steven C.] Marquette Univ, Dept Biol, Milwaukee, WI 53233 USA; [Sikasunge, Chummy] Univ Zambia, Dept Paraclin Studies, Lusaka, Zambia; [Mwansa, James] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia	Marquette University; Marquette University; University of Zambia; University of Zambia	Lodh, N (corresponding author), Marquette Univ, Dept Clin Lab Sci, Milwaukee, WI 53233 USA.	nilanjan.lodh@marquette.edu		Lodh, Nilanjan/0000-0002-0363-3538	Thrasher Research Fund	Thrasher Research Fund	NL received an Early Career Research award from Thrasher Research Fund. The study was possible because of this funding. The Foundation had no role in designing or conceptualization of the study. https://www.thrasherresearch.org/default.aspx.	Abbasi I, 2010, AM J TROP MED HYG, V83, P427, DOI 10.4269/ajtmh.2010.09-0764; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P53; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; King CH, 2007, J INFECT DIS, V196, P653, DOI 10.1086/520522; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Koukounari A, 2009, AM J TROP MED HYG, V80, P435, DOI 10.4269/ajtmh.2009.80.435; Krampe A, 2007, COMPUT STAT DATA AN, V51, P4124, DOI 10.1016/j.csda.2007.01.021; Lamberton PHL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003139; Lodh N, 2017, ACTA TROP, V173, P125, DOI 10.1016/j.actatropica.2017.06.015; Lodh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091144; Lodh N, 2013, AM J TROP MED HYG, V89, P46, DOI 10.4269/ajtmh.13-0104; Navaratnam AMD, 2012, T ROY SOC TROP MED H, V106, P619, DOI 10.1016/j.trstmh.2012.06.010; Norton AJ, 2010, AM J TROP MED HYG, V83, P951, DOI 10.4269/ajtmh.2010.10-0283; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Rosser A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1055-3; SHIFF CJ, 1968, J PARASITOL, V54, P1133, DOI 10.2307/3276977; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; Webbe G., 1982, P16; WHO, 2012, EL SOIL TRANSM HELM	25	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189400	10.1371/journal.pone.0189400	http://dx.doi.org/10.1371/journal.pone.0189400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228024	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600052
J	Pang, TT; Huang, LD; Deng, YY; Wang, TF; Chen, SP; Gong, XH; Liu, WX				Pang, Tiantian; Huang, Leidan; Deng, Yingyuan; Wang, Tianfu; Chen, Siping; Gong, Xuehao; Liu, Weixiang			Logistic regression analysis of conventional ultrasonography, strain elastosonography, and contrast-enhanced ultrasound characteristics for the differentiation of benign and malignant thyroid nodules	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; DIAGNOSTIC PERFORMANCE; SONOGRAPHIC CRITERIA; SCALE US; ELASTOGRAPHY; FEATURES	The aim of the study is to screen the significant sonographic features by logistic regression analysis and fit a model to diagnose thyroid nodules. A total of 525 pathological thyroid nodules were retrospectively analyzed. All the nodules underwent conventional ultrasonography (US), strain elastosonography (SE), and contrast - enhanced ultrasound (CEUS). Those nodules' 12 suspicious sonographic features were used to assess thyroid nodules. The significant features of diagnosing thyroid nodules were picked out by logistic regression analysis. All variables that were statistically related to diagnosis of thyroid nodules, at a level of p < 0.05 were embodied in a logistic regression analysis model. The significant features in the logistic regression model of diagnosing thyroid nodules were calcification, suspected cervical lymph node metastasis, hypoenhancement pattern, margin, shape, vascularity, posterior acoustic, echogenicity, and elastography score. According to the results of logistic regression analysis, the formula that could predict whether or not thyroid nodules are malignant was established. The area under the receiver operating curve (ROC) was 0.930 and the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 83.77%, 89.56%, 87.05%, 86.04%, and 87.79% respectively.	[Pang, Tiantian; Wang, Tianfu; Chen, Siping; Liu, Weixiang] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China; [Pang, Tiantian; Wang, Tianfu; Chen, Siping; Liu, Weixiang] Shenzhen Univ, Sch Biomed Engn, Shenzhen 518060, Peoples R China; [Pang, Tiantian; Wang, Tianfu; Chen, Siping; Liu, Weixiang] Natl Reg Key Technol Engn Lab Med Ultrasound, Shenzhen 518060, Peoples R China; [Pang, Tiantian; Wang, Tianfu; Chen, Siping; Liu, Weixiang] Guangdong Key Lab Biomed Measurements & Ultrasoun, Shenzhen 518060, Peoples R China; [Huang, Leidan; Deng, Yingyuan; Gong, Xuehao] Shenzhen Univ, Peoples Hosp Shenzhen 2, Dept Ultrasound, Affiliated Hosp 1, Shenzhen 518035, Peoples R China; [Huang, Leidan] Guangzhou Med Univ, Guangzhou 510182, Guangdong, Peoples R China	Shenzhen University; Shenzhen University; Shenzhen University; Guangzhou Medical University	Liu, WX (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.; Liu, WX (corresponding author), Shenzhen Univ, Sch Biomed Engn, Shenzhen 518060, Peoples R China.; Liu, WX (corresponding author), Natl Reg Key Technol Engn Lab Med Ultrasound, Shenzhen 518060, Peoples R China.; Liu, WX (corresponding author), Guangdong Key Lab Biomed Measurements & Ultrasoun, Shenzhen 518060, Peoples R China.; Gong, XH (corresponding author), Shenzhen Univ, Peoples Hosp Shenzhen 2, Dept Ultrasound, Affiliated Hosp 1, Shenzhen 518035, Peoples R China.	fox_gxh@sina.com; wxliu@szu.edu.cn	CHEN, SI/GZL-4800-2022	Wang, Tianfu/0000-0002-1248-1214	Shenzhen Science and Technology Innovation Committee [JCYJ20140414170821285, JCYJ2015052916415 4046]; Shenzhen Fundamental Research Project [JCYJ2016042211311 9640]	Shenzhen Science and Technology Innovation Committee; Shenzhen Fundamental Research Project	This work was supported by Shenzhen Science and Technology Innovation Committee (JCYJ20140414170821285 to XG and JCYJ20150529164154046 to XG), and Shenzhen Fundamental Research Project (JCYJ20160422113119640 to WL), http://www.szsti.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by Grants JCYJ20140414170821285 and JCYJ2015052916415 4046 from Shenzhen Science and Technology Innovation Committee and JCYJ2016042211311 9640 from Shenzhen Fundamental Research Project.	Batawil N, 2014, EJSO-EUR J SURG ONC, V40, P182, DOI 10.1016/j.ejso.2013.11.015; Cantisani V, 2012, EUR J RADIOL, V81, P2678, DOI 10.1016/j.ejrad.2011.11.056; Cappelli C, 2007, QJM-INT J MED, V100, P29, DOI 10.1093/qjmed/hcl121; Cappelli C, 2006, EUR J ENDOCRINOL, V155, P27, DOI 10.1530/eje.1.02177; Chang YC, 2014, J MED ULTRASOUND, V22, P145, DOI 10.1016/j.jmu.2014.06.004; Chng CL, 2014, CLIN ENDOCRINOLOGY; Greis C, 2011, CLIN HEMORHEOL MICRO, V49, P137, DOI 10.3233/CH-2011-1464; Jiang J, 2015, KAOHSIUNG J MED SCI, V31, P138, DOI 10.1016/j.kjms.2014.12.001; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim HG, 2013, THYROID, V23, P1583, DOI 10.1089/thy.2012.0586; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Mohey N, 2013, EGYPT J RADIOL NUC M, V44, P505, DOI 10.1016/j.ejrnm.2013.04.008; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Papini E, 2013, J CLIN ENDOCRINOLOGY, V87, P1941; Park JY, 2009, THYROID, V19, P1257, DOI 10.1089/thy.2008.0021; Rago T, 2014, BEST PRACT RES CL EN, V28, P519, DOI 10.1016/j.beem.2014.02.003; Shweel M, 2013, EUR J RADIOL, V82, P995, DOI 10.1016/j.ejrad.2013.02.002; Tay SY, 2015, J FORMOS MED ASSOC, V114, P590, DOI 10.1016/j.jfma.2014.03.015; Zhang YF, 2014, J ULTRAS MED, V33, P585, DOI 10.7863/ultra.33.4.585; Zhao RN, 2015, ULTRASOUND MED BIOL	20	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188987	10.1371/journal.pone.0188987	http://dx.doi.org/10.1371/journal.pone.0188987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228030	gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600025
J	Stoeckle, BC; Beggel, S; Cerwenka, AF; Motivans, E; Kuehn, R; Geist, J				Stoeckle, Bernhard C.; Beggel, Sebastian; Cerwenka, Alexander F.; Motivans, Elena; Kuehn, Ralph; Geist, Juergen			A systematic approach to evaluate the influence of environmental conditions on eDNA detection success in aquatic ecosystems	PLOS ONE			English	Article							MARINE-SEDIMENTS; MICROBIAL DNA; INHIBITION; PCR; EXTRACTION; CONSERVATION; PURIFICATION; DEGRADATION; GOBIIDAE; IMPACT	The use of environmental DNA (eDNA) to determine the presence and distribution of aquatic organisms has become an important tool to monitor and investigate freshwater communities. The successful application of this method in the field, however, is dependent on the effectiveness of positive DNA verification, which is influenced by site-specific environmental parameters. Factors affecting eDNA concentrations in aquatic ecosystems include flow conditions, and the presence of substances that possess DNA-binding properties or inhibitory effects. In this study we investigated the influence of different environmental parameters on the detection success of eDNA using the invasive goby Neogobius melanostomus. In a standardized laboratory setup, different conditions of flow, sediment-properties, and fish density were compared, as well as different potential natural inhibitors such as algae, humic substances, and suspended sediment particles. The presence of sediment was mainly responsible for lower eDNA detection in the water samples, regardless of flow-through or standing water conditions and a delayed release of eDNA was detected in the presence of sediment. Humic substances had the highest inhibitory effect on eDNA detection followed by algae and siliceous sediment particles. The results of our study highlight that a successful application of eDNA methods in field surveys strongly depends on site-specific conditions, such as water flow conditions, sediment composition, and suspended particles. All these factors should be carefully considered when sampling, analyzing, and interpreting eDNA detection results.	[Stoeckle, Bernhard C.; Beggel, Sebastian; Motivans, Elena; Geist, Juergen] Tech Univ Munich, Aquat Syst Biol Unit, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Cerwenka, Alexander F.] SNSB Bavarian State Collect Zool ZSM, Munich, Germany; [Kuehn, Ralph] Tech Univ Munich, Dept Anim Sci, Chair Zool, Unit Mol Zool, Freising Weihenstephan, Germany; [Kuehn, Ralph] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA	Technical University of Munich; Technical University of Munich; New Mexico State University	Geist, J (corresponding author), Tech Univ Munich, Aquat Syst Biol Unit, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany.	geist@wzw.tum.de	Beggel, Sebastian/AAF-8068-2021; Geist, Juergen/C-4933-2008; Cerwenka, Alexander/ABF-3106-2020	Beggel, Sebastian/0000-0002-7653-1073; Geist, Juergen/0000-0001-7698-3443; Cerwenka, Alexander/0000-0002-9393-0885; Motivans Svara, Elena/0000-0002-2407-9564; Kuehn, Ralph/0000-0001-9518-0590	Chair of Aquatic Systems Biology	Chair of Aquatic Systems Biology	Funding for this study was provided by the Chair of Aquatic Systems Biology, i.e., by the institution where most of the authors work. There was no external funding.	Adrian-Kalchhauser I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147558; Albers CN, 2013, GEOMICROBIOL J, V30, P675, DOI 10.1080/01490451.2012.758193; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Boeker C, 2016, HYDROBIOLOGIA, V777, P171, DOI 10.1007/s10750-016-2774-y; Brandner J, 2013, HYDROBIOLOGIA, V703, P113, DOI 10.1007/s10750-012-1349-9; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Cerwenka AF, 2017, ECOL EVOL, V7, P4076, DOI 10.1002/ece3.2942; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Cullen DW, 1998, SOIL BIOL BIOCHEM, V30, P983, DOI 10.1016/S0038-0717(98)00001-7; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Elzea J., 1990, APPL CLAY SCI, V3, P229, DOI [10.1016/0169-1317(90)90012-E, DOI 10.1016/0169-1317(90)90012-E]; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Graf G, 1997, J MARINE SYST, V11, P269, DOI 10.1016/S0924-7963(96)00126-1; Haertl M, 2012, SPIXIANA, V35, P155; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hartmann JT, 2016, AQUAT TOXICOL, V170, P279, DOI 10.1016/j.aquatox.2015.06.014; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; Lorenz MG, 1996, APPL ENVIRON MICROB, V53, P2948; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Matisoo-Smith E, 2008, QUATERN INT, V184, P139, DOI 10.1016/j.quaint.2007.09.013; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; McKnight D.M., 1998, AQUATIC HUMIC SUBSTA, P9, DOI DOI 10.1007/978-3-662-03736-2_; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; PENNAK RW, 1971, HYDROBIOLOGIA, V38, P321, DOI 10.1007/BF00036842; Piggott MP, 2016, ECOL EVOL, V6, P2739, DOI 10.1002/ece3.2083; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Shafer ABA, 2015, TRENDS ECOL EVOL, V30, P78, DOI 10.1016/j.tree.2014.11.009; Shogren AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05223-1; Sidstedt M, 2015, ANAL BIOCHEM, V487, P30, DOI 10.1016/j.ab.2015.07.002; STEWART GJ, 1991, FEMS MICROBIOL ECOL, V85, P1; Stoeckle BC, 2016, AQUAT CONSERV, V26, P1120, DOI 10.1002/aqc.2611; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Su WB, 2003, SCI CHINA SER D, V46, P1121, DOI 10.1360/01yd0225; SU X, 1988, ANAL BIOCHEM, V174, P650, DOI 10.1016/0003-2697(88)90068-1; Sutlovic D, 2005, CROAT MED J, V46, P556; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; TSAI YL, 1992, APPL ENVIRON MICROB, V58, P754, DOI 10.1128/AEM.58.2.754-757.1992; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Unger H. J., 1981, VERHANDLUNGEN GEOLOG, V1981, P193; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	60	51	52	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189119	10.1371/journal.pone.0189119	http://dx.doi.org/10.1371/journal.pone.0189119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220394	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900034
J	Huang, J; Jin, N; Qin, H; Shi, X; Liu, YY; Cheung, WC; Wang, CC; Chan, TF; Li, TC				Huang, Jin; Jin, Nana; Qin, Hao; Shi, Xiao; Liu, Yingyu; Cheung, Wingching; Wang, Chi Chiu; Chan, Ting Fung; Li, Tin Chiu			Transcriptomic profiles in peripheral blood between women with unexplained recurrent implantation failure and recurrent miscarriage and the correlation with endometrium: A pilot study	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTIVITY; IDENTIFICATION; BIOMARKERS	Aim To study the transcriptome profiles in the blood of recurrent implantation failure (RIF), recurrent miscarriage (RM) and fertile women during the window of implantation, and further analysis the correlation of transcriptome profiles between blood and endometrium. Methods This is an observational prospective study. In total 9 subjects were recruited, 3 RIF, 3 RM, and 3 controls. Paired samples (endometrium and peripheral blood) from the same subjects were precisely timed on the 7th days after luteal hormone surge (LH+7). RNA sequencing was applied to investigate the transcriptome profiles. Results The results of transcriptome in peripheral blood cannot be used to characterize women with RIF and unexplained RM. There was a medium level correlation between transcriptome in peripheral blood and endometrium during the window of implantation. Conclusion The differential transcriptome patterns in blood are not representative of those in endometrium, and the blood transcriptome cannot differentiate among the women with RIF, RM or fertile.	[Huang, Jin; Shi, Xiao; Liu, Yingyu; Cheung, Wingching; Wang, Chi Chiu; Li, Tin Chiu] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Jin, Nana; Qin, Hao; Chan, Ting Fung] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, TC (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	tinchiu.li@cuhk.edu.hk	Chan, TingFung/A-6161-2013; Wang, Ronald/C-6541-2014; Yingyu, LIU/O-5676-2015	Chan, TingFung/0000-0002-0489-3884; Wang, Ronald/0000-0002-3928-7278; Yingyu, LIU/0000-0003-4211-026X; Li, Tin Chiu/0000-0002-0554-2031	Chinese University of Hong Kong [2014.1.042]; Hong Kong Government [GRF14102014]	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Government	Direct Grant for Research (Ref No. 2014.1.042) from the Chinese University of Hong Kong. HQ is supported by a General Research Fund (GRF14102014) from the Hong Kong Government to TFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Altmae S, 2010, MOL HUM REPROD, V16, P178, DOI 10.1093/molehr/gap102; Chim SSC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081709; Coughlan C, 2014, REPROD BIOMED ONLINE, V28, P14, DOI 10.1016/j.rbmo.2013.08.011; Farina A, 2011, PRENATAL DIAG, V31, P181, DOI 10.1002/pd.2675; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Haouzi D, 2009, HUM REPROD, V24, P198, DOI 10.1093/humrep/den360; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang J, 2017, REPRODUCTION, V153, P749, DOI 10.1530/REP-16-0574; Jalbrzikowski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132542; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Koot YEM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19411; Kosova G, 2015, HUM REPROD, V30, P519, DOI 10.1093/humrep/deu355; Krjutskov K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31584; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Othman R, 2012, REPROD BIOL, V12, P183, DOI 10.1016/S1642-431X(12)60085-0; Paiva P, 2011, J CLIN ENDOCR METAB, V96, pE1807, DOI 10.1210/jc.2011-1233; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrov PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155361; Riad ON, 2014, GYNECOL ENDOCRINOL, V30, P70, DOI 10.3109/09513590.2013.859668; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Rumsey DJ, 2015, U CAN STAT DUMMIES; Saravelos SH, 2012, HUM REPROD, V27, P1882, DOI 10.1093/humrep/des102; Song FH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182294; Tsui NBY, 2014, CLIN CHEM, V60, P954, DOI 10.1373/clinchem.2014.221648; Warnes G.R., 2009, GPLOTS VARIOUS R PRO; Whitehead C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-256; Whitehead CL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.191; Zeller T, 2017, HYPERTENSION, V70, P743, DOI 10.1161/HYPERTENSIONAHA.117.09458	32	6	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189159	10.1371/journal.pone.0189159	http://dx.doi.org/10.1371/journal.pone.0189159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216287	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800082
J	Koyama, K; Yamauchi, J				Koyama, Keiji; Yamauchi, Junichiro			Altered postural sway following fatiguing foot muscle exercises	PLOS ONE			English	Article							TOE FLEXOR STRENGTH; BALANCE; PLANTAR; ARCH	This study investigated the acute effects of fatiguing foot muscle exercises on the maximum muscle strength of the foot and postural control ability. Eighteen healthy young individuals performed fatiguing foot muscle strength exercises, and their toe flexor and ankle plantar flexor strength and postural control ability were measured before and after the exercises. Postural control ability was evaluated using the path of the center of pressure (COP) during three balance tasks: double-leg standing with eyes open; double-leg standing with eyes closed; and single-leg standing with eyes open. After the exercises, the muscle strength of both the toe and ankle plantar flexor significantly decreased. Under all of the conditions, most COP variables did not significantly differ before and after the exercises; however, the total length and mean velocity in the single-leg standing with eyes open significantly decreased after the exercises. Postural sway velocities in the anteroposterior direction of double-leg standing with eyes closed and in both anteroposterior and mediolateral directions of singleleg standing with eyes open significantly decreased after the exercises. The associations between relative changes in muscle strength after the exercise and relative changes in COP variables after the exercise were not found. These results indicate that postural control while standing could be maintained even though foot muscle strength is decreased after fatiguing foot muscle exercises.	[Koyama, Keiji] Toin Univ Yokohama, Yokohama, Kanagawa, Japan; [Yamauchi, Junichiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo, Japan; [Yamauchi, Junichiro] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand	Toin University of Yokohama; Tokyo Metropolitan University; Khon Kaen University	Yamauchi, J (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo, Japan.; Yamauchi, J (corresponding author), Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand.	yamauchi@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology - Grant-in-Aid for Young Scientists (A) to JY; Grant-in-Aid for Exploratory Research to JY; and Grant-in-Aid for Scientists (C) to KK.	Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Bisson EJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-39; BOJSENMOLLER F, 1979, ACTA ORTHOP SCAND, V50, P471, DOI 10.3109/17453677908989792; Boyas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072482; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; de Ruiter CJ, 2010, EUR J APPL PHYSIOL, V108, P247, DOI 10.1007/s00421-009-1209-0; DUCHATEAU J, 1986, EUR J APPL PHYSIOL, V55, P476, DOI 10.1007/BF00421640; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Goldmann JP, 2013, J SPORT SCI, V31, P424, DOI 10.1080/02640414.2012.736627; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Hess DM, 2001, J SPORT REHABIL, V10, P24, DOI 10.1123/jsr.10.1.24; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Johnston RB, 1998, MED SCI SPORT EXER, V30, P1703, DOI 10.1097/00005768-199812000-00008; Kaji A, 2010, J STRENGTH COND RES, V24, P382, DOI 10.1519/JSC.0b013e3181c06bdd; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kurihara T, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-26; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; MANN R, 1964, J BONE JOINT SURG AM, V46, P469, DOI 10.2106/00004623-196446030-00001; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Mochizuki G, 2006, EXP BRAIN RES, V175, P584, DOI 10.1007/s00221-006-0575-7; Morita N, 2015, MED SCI SPORT EXER, V47, P350, DOI 10.1249/MSS.0000000000000402; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Otsuka M., 2015, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V174, P307; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; SCHIEPPATI M, 1994, ELECTROEN CLIN NEURO, V93, P286, DOI 10.1016/0168-5597(94)90031-0; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Wang TY, 2008, CLIN BIOMECH, V23, P493, DOI 10.1016/j.clinbiomech.2007.11.014; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Yamauchi J, 2015, INT J SPORTS MED, V36, P592, DOI 10.1055/s-0034-1396824; Zhang SQ, 2013, GAIT POSTURE, V37, P532, DOI 10.1016/j.gaitpost.2012.09.012	36	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189184	10.1371/journal.pone.0189184	http://dx.doi.org/10.1371/journal.pone.0189184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216267	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800090
J	Holdbrooks, AT; Britain, CM; Bellis, SL				Holdbrooks, Andrew T.; Britain, Colleen M.; Bellis, Susan L.			ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; -galactoside 2-6 sialyltransferase 1 (ST6Gal-I); cell signaling; glycosylation; tumor cell biology; tumor necrosis factor (TNF); TNFR1; death receptor	MESENCHYMAL TRANSITION; MEDIATED APOPTOSIS; CARCINOMA CELLS; EXPRESSION; ALPHA; ADHESION; ACTIVATION; INDUCTION; PHENOTYPE; LIFE	Activation of the tumor necrosis factor receptor 1 (TNFR1) death receptor by TNF induces either cell survival or cell death. However, the mechanisms mediating these distinct outcomes remain poorly understood. In this study, we report that the ST6Gal-I sialyltransferase, an enzyme up-regulated in numerous cancers, sialylates TNFR1 and thereby protects tumor cells from TNF-induced apoptosis. Using pancreatic and ovarian cancer cells with ST6Gal-I knockdown or overexpression, we determined that 2-6 sialylation of TNFR1 had no effect on early TNF-induced signaling events, including the rapid activation of NF-B, c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and Akt (occurring within 15 min). However, upon extended TNF treatment (6-24 h), cells with high ST6Gal-I levels exhibited resistance to TNF-induced apoptosis, as indicated by morphological evidence of cell death and decreased activation of caspases 8 and 3. Correspondingly, at these later time points, high ST6Gal-I expressers displayed sustained activation of the survival molecules Akt and NF-B. Additionally, extended TNF treatment resulted in the selective enrichment of clonal variants with high ST6Gal-I expression, further substantiating a role for ST6Gal-I in cell survival. Given that TNFR1 internalization is known to be essential for apoptosis induction, whereas survival signaling is initiated by TNFR1 at the plasma membrane, we examined TNFR1 localization. The 2-6 sialylation of TNFR1 was found to inhibit TNF-induced TNFR1 internalization. Thus, by restraining TNFR1 at the cell surface via sialylation, ST6Gal-I acts as a functional switch to divert signaling toward survival. These collective findings point to a novel glycosylation-dependent mechanism that regulates the cellular response to TNF and may promote cancer cell survival within TNF-rich tumor microenvironments.	[Holdbrooks, Andrew T.; Britain, Colleen M.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@uab.edu			National Institutes of Health [R01 GM111093, R21 CA192629]; cardiovascular pathophysiology training grant fellowship [T32 HL007918]; American Heart Association predoctoral fellowship; NATIONAL CANCER INSTITUTE [R21CA192629] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111093, T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); cardiovascular pathophysiology training grant fellowship; American Heart Association predoctoral fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM111093 and R21 CA192629 (to S. L. B.), a T32 HL007918 cardiovascular pathophysiology training grant fellowship (to A. T. H.), and an American Heart Association predoctoral fellowship (to A. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; BRADLEY JR, 1995, AM J PATHOL, V146, P27; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; ChambautGuerin AM, 1997, NEUROREPORT, V8, P1451, DOI 10.1097/00001756-199704140-00025; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Chhibber-Goel J, 2016, J BIOL CHEM, V291, P5971, DOI 10.1074/jbc.M115.679076; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Fukumori T, 2003, CANCER RES, V63, P8302; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Ham Boram, 2016, Trends Cancer Res, V11, P1; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Jones SJ, 1999, J IMMUNOL, V162, P1042; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Puimege L, 2014, CYTOKINE GROWTH F R, V25, P285, DOI 10.1016/j.cytogfr.2014.03.004; Recchi MA, 1998, CANCER RES, V58, P4066; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	51	51	51	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1610	1622		10.1074/jbc.M117.801480	http://dx.doi.org/10.1074/jbc.M117.801480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29233887	Green Published, hybrid			2022-12-26	WOS:000424201700014
J	Liu, XM; Wang, YK; Liu, YH; Yu, XX; Wang, PC; Li, X; Du, ZQ; Yang, CX				Liu, Xiao-Man; Wang, Yan-Kui; Liu, Yun-Hua; Yu, Xiao-Xia; Wang, Pei-Chao; Li, Xuan; Du, Zhi-Qiang; Yang, Cai-Xia			Single-cell transcriptome sequencing reveals that cell division cycle 5-like protein is essential for porcine oocyte maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; embryo; gene expression; meiosis; oocyte; brilliant cresyl blue; CDC5L; pig; single cell RNA-seq	BRILLIANT CRESYL BLUE; IN-VITRO MATURATION; GENE-EXPRESSION PATTERN; DEVELOPMENTAL COMPETENCE; RNA-SEQ; EMBRYONIC-DEVELOPMENT; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; BOVINE OOCYTES; MOUSE OOCYTES; STEM-CELLS	The brilliant cresyl blue (BCB) test is used in both basic biological research and assisted reproduction to identify oocytes likely to be developmentally competent. However, the underlying molecular mechanism targeted by the BCB test is still unclear. To explore this question, we first confirmed that BCB-positive porcine oocytes had higher rates of meiotic maturation, better rates of cleavage and development into blastocysts, and lower death rates. Subsequent single-cell transcriptome sequencing on porcine germinal vesicle (GV)-stage oocytes identified 155 genes that were significantly differentially expressed between BCB-negative and BCB-positive oocytes. These included genes such as cdc5l, ldha, spata22, rgs2, paip1, wee1b, and hsp27, which are enriched in functionally important signaling pathways including cell cycle regulation, oocyte meiosis, spliceosome formation, and nucleotide excision repair. In BCB-positive GV oocytes that additionally had a lower frequency of DNA double-strand breaks, the CDC5L protein was significantly more abundant. cdc5l/CDC5L inhibition by short interference (si)RNA or antibody microinjection significantly impaired porcine oocyte meiotic maturation and subsequent parthenote development. Taken together, our single-oocyte sequencing data point to a potential new role for CDC5L in porcine oocyte meiosis and early embryo development, and supports further analysis of this protein in the context of the BCB test.	[Liu, Xiao-Man; Wang, Yan-Kui; Liu, Yun-Hua; Yu, Xiao-Xia; Wang, Pei-Chao; Li, Xuan; Du, Zhi-Qiang; Yang, Cai-Xia] Northeast Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Du, ZQ; Yang, CX (corresponding author), 600 Changjiang Rd, Harbin 150030, Heilongjiang, Peoples R China.	zhqdu@neau.edu.cn; caixiayang@neau.edu.cn	Yang, Cai-Xia/HGC-2198-2022		National Natural Science Foundation of China [31472098]; Northeast Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeast Agricultural University	This work was supported by National Natural Science Foundation of China Grant 31472098 and a Start-up grant from the Northeast Agricultural University (to C. X. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Alcoba DD, 2016, ZYGOTE, V24, P83, DOI 10.1017/S0967199415000052; Alvarez GM, 2013, REPROD DOMEST ANIM, V48, P545, DOI 10.1111/rda.12123; Ashry M, 2015, MOL REPROD DEV, V82, P251, DOI 10.1002/mrd.22468; Attner MA, 2013, P NATL ACAD SCI USA, V110, P14278, DOI 10.1073/pnas.1311845110; Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Bai L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153093; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Bonnet-Garnier A, 2012, INT J DEV BIOL, V56, P877, DOI 10.1387/ijdb.120149ab; Castaneda CA, 2013, THERIOGENOLOGY, V79, P417, DOI 10.1016/j.theriogenology.2012.10.006; Chen WJ, 2016, TUMOR BIOL, V37, P4093, DOI 10.1007/s13277-015-4088-5; Coticchio G, 2015, J ASSIST REPROD GEN, V32, P1509, DOI 10.1007/s10815-015-0547-6; DESCHEPPER GG, 1987, HISTOCHEM J, V19, P467, DOI 10.1007/BF01675415; Egerszegi I, 2010, REPROD FERT DEVELOP, V22, P830, DOI 10.1071/RD09140; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Fakruzzaman M, 2013, ANIM REPROD SCI, V142, P19, DOI 10.1016/j.anireprosci.2013.08.012; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36008; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Grupen CG, 2014, THERIOGENOLOGY, V81, P24, DOI 10.1016/j.theriogenology.2013.09.022; Gu L, 2015, CELL MOL LIFE SCI, V72, P251, DOI 10.1007/s00018-014-1739-4; Gutnisky C, 2014, REPROD FERT DEVELOP, V26, P931, DOI 10.1071/RD12397; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127512; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishishita S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06148; Ishizaki C, 2009, THERIOGENOLOGY, V72, P72, DOI 10.1016/j.theriogenology.2009.02.015; Janowski D, 2012, THERIOGENOLOGY, V78, P656, DOI 10.1016/j.theriogenology.2012.03.012; Jiang MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159535; Keefe D, 2015, FERTIL STERIL, V103, P317, DOI 10.1016/j.fertnstert.2014.12.115; Kumar P, 2017, DEVELOPMENT, V144, P17, DOI 10.1242/dev.133058; LASALLE S, 2012, BIOL REPROD, V86; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158074; Liu JJ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-47; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Mohammadi-Sangcheshmeh A, 2014, REPROD FERT DEVELOP, V26, P441, DOI 10.1071/RD12303; Mohapatra SK, 2015, CELL REPROGRAM, V17, P141, DOI 10.1089/cell.2014.0077; Moussa M, 2015, ANIM REPROD SCI, V155, P11, DOI 10.1016/j.anireprosci.2015.01.011; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Opiela J, 2013, REPROD BIOL, V13, P177, DOI 10.1016/j.repbio.2013.07.004; Pawlak P, 2014, J REPROD DEVELOP, V60, P28, DOI 10.1262/jrd.2013-092; Reyes JM, 2015, MOL REPROD DEV, V82, P103, DOI 10.1002/mrd.22445; Rodriguez-Gonzalez E, 2002, THERIOGENOLOGY, V57, P1397, DOI 10.1016/S0093-691X(02)00645-3; Sadeesh EM, 2014, J ASSIST REPROD GEN, V31, P1541, DOI 10.1007/s10815-014-0316-y; Salimi M, 2014, CELL J, V15, P294; Salviano MB, 2016, ZYGOTE, V24, P245, DOI 10.1017/S0967199415000118; Santos ECS, 2015, ZYGOTE, V23, P352, DOI 10.1017/S0967199413000610; Sha QQ, 2017, DEVELOPMENT, V144, P452, DOI 10.1242/dev.144410; Shaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064192; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Su JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036181; Sun MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23555; Sun XS, 2004, MOL REPROD DEV, V69, P228, DOI 10.1002/mrd.20123; Tabandeh MR, 2012, ANIM REPROD SCI, V131, P30, DOI 10.1016/j.anireprosci.2012.02.006; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Torner H, 2008, REPRODUCTION, V135, P197, DOI 10.1530/REP-07-0348; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trombetta J.J., 2014, CURR PROTOC MOL BIOL, V107, P1; Wongsrikeao P, 2006, THERIOGENOLOGY, V66, P366, DOI 10.1016/j.theriogenology.2005.12.001; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang CX, 2012, MOL REPROD DEV, V79, P541, DOI 10.1002/mrd.22059; Yuan Y, 2017, P NATL ACAD SCI USA, V114, pE5796, DOI 10.1073/pnas.1703998114; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122	70	15	16	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1767	1780		10.1074/jbc.M117.809608	http://dx.doi.org/10.1074/jbc.M117.809608			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222335	Green Published, hybrid			2022-12-26	WOS:000424201700027
J	Zhou, M; Xue, L; Chen, YR; Li, HY; He, QF; Wang, BB; Meng, FL; Wang, M; Guan, MX				Zhou, Mi; Xue, Ling; Chen, Yaru; Li, Haiying; He, Qiufen; Wang, Bibin; Meng, Feilong; Wang, Meng; Guan, Min-Xin			A hypertension-associated mitochondrial DNA mutation introduces an m(1)G37 modification into tRNA(Met), altering its structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mutation; nucleotide modification; oxidative phosphorylation; oxygen consumption rates; translation	TRANSFER-RNA MODIFICATION; MATERNALLY INHERITED HYPERTENSION; PHENOTYPIC MANIFESTATION; POSTTRANSCRIPTIONAL MODIFICATIONS; 4435A-GREATER-THAN-G MUTATION; HYPERTROPHIC CARDIOMYOPATHY; MODIFICATION DEFECT; NUCLEAR MODIFIER; OXIDATIVE STRESS; LACTIC-ACIDOSIS	Defective nucleotide modifications of mitochondrial tRNAs have been associated with several human diseases, but their pathophysiology remains poorly understood. In this report, we investigated the pathogenic molecular mechanism underlying a hypertension-associated 4435AG mutation in mitochondrial tRNA(Met). The m.4435AG mutation affected a highly conserved adenosine at position 37, 3 adjacent to the tRNA's anticodon, which is important for the fidelity of codon recognition and stabilization. We hypothesized that the m.4435AG mutation introduced an m(1)G37 modification of tRNA(Met), altering its structure and function. Primer extension and methylation activity assays indeed confirmed that the m.4435AG mutation created a tRNA methyltransferase 5 (TRMT5)-catalyzed m(1)G37 modification of tRNA(Met). We found that this mutation altered the tRNA(Met) structure, indicated by an increased melting temperature and electrophoretic mobility of the mutated tRNA compared with the wildtype molecule. We demonstrated that cybrid cell lines carrying the m.4435AG mutation exhibited significantly decreased efficiency in aminoacylation and steady-state levels of tRNA(Met), as compared with those of control cybrids. The aberrant tRNA(Met) metabolism resulted in variable decreases in mitochondrial DNA (mtDNA)-encoded polypeptides in the mutant cybrids. Furthermore, we found that the m.4435AG mutation caused respiratory deficiency, markedly diminished mitochondrial ATP levels and membrane potential, and increased the production of reactive oxygen species in mutant cybrids. These results demonstrated that an aberrant m(1)G37 modification of mitochondrial tRNA(Met) affected the structure and function of its tRNA and consequently altered mitochondrial function. Our findings provide critical insights into the pathophysiology of maternally inherited hypertension, which is manifested by the deficient tRNA nucleotide modification.	[Zhou, Mi; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Div Med Genet & Genom, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Mi; He, Qiufen; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Xue, Ling; Chen, Yaru; Wang, Bibin] Wenzhou Med Univ, Affiliated Hosp 1, Attardi Inst Mitochondrial Biomed, Wenzhou 325035, Zhejiang, Peoples R China; [Li, Haiying] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325035, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Joining Inst Genet & Genom Med Zhejiang Univ & Un, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736; He, Qiufen/0000-0002-1175-1913	National Basic Research Priorities Program of China [2014CB541704]; National Natural Science Foundation of China [81600326]; Postdoctoral Science Foundation of China [2016M591987]; Fundamental Research Funds for the Central Universities [2017QNA7026]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Priorities Program of China Grant 2014CB541704 (to M. X. G.), National Natural Science Foundation of China Grant 81600326 (to M. Z.), Postdoctoral Science Foundation of China Grant 2016M591987 (to M. Z.), and Fundamental Research Funds for the Central Universities Grant 2017QNA7026 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bjork G. R., 2014, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus, DOI 10.1128/ECOSALPLUS]; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; BUCK M, 1982, NUCLEIC ACIDS RES, V10, P2609, DOI 10.1093/nar/10.8.2609; Chen DN, 2016, INT J BIOCHEM CELL B, V77, P1, DOI 10.1016/j.biocel.2016.05.012; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Eirin A, 2015, HYPERTENSION, V65, P264, DOI 10.1161/HYPERTENSIONAHA.114.04598; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Goto-Ito S, 2008, PROTEINS, V72, P1274, DOI 10.1002/prot.22019; Goto-Ito S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010032; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702; Long T, 2016, J BIOL CHEM, V291, P24293, DOI 10.1074/jbc.M116.742569; Lu ZQ, 2011, EUR J HUM GENET, V19, P1181, DOI 10.1038/ejhg.2011.111; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.3.CO;2-Y; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Vare VYP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010029; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; YARUS M, 1986, J MOL BIOL, V192, P235, DOI 10.1016/0022-2836(86)90362-1; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; Zhang JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05571-y; Zhang XD, 2016, TRENDS MOL MED, V22, P1025, DOI 10.1016/j.molmed.2016.10.009; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028; Zhou M, 2015, RNA BIOL, V12, P900, DOI 10.1080/15476286.2015.1050576	83	45	47	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1425	1438		10.1074/jbc.RA117.000317	http://dx.doi.org/10.1074/jbc.RA117.000317			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29222331	Green Published, hybrid			2022-12-26	WOS:000423515000027
J	Tripathi, R; Sullivan, R; Fan, THM; Wang, D; Sun, Y; Reed, GL; Gladysheva, IP				Tripathi, Ranjana; Sullivan, Ryan; Fan, Tai-Hwang M.; Wang, Dong; Sun, Yao; Reed, Guy L.; Gladysheva, Inna P.			Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; LEFT-VENTRICULAR DYSFUNCTION; GENDER-DIFFERENCES; CARDIAC FIBROSIS; GENETIC ARCHITECTURE; SEX-DIFFERENCES; OVEREXPRESSION; DISEASE; MODEL; MECHANISMS	Dilated cardiomyopathy (DCM) is the major cause of heart failure affecting both women and men. Limited clinical studies show conflicting data in sex-related differences in the progression of dilated cardiomyopathy and heart failure (HF) outcomes. We examined the comparative sex-related progression of cardiomyopathy and the development of HF (at 4, 7, 13 weeks of age) in a well-established, transgenic mouse model of DCM that recapitulates the progressive stages of human HF. By 13 weeks of age, female mice with DCM had more severe left ventricular systolic dysfunction, left ventricular dilation and wall thinning (P< 0.001 for all) than age-matched male mice with DCM. Female mice also had greater lung edema (P< 0.001), cardiac fibrosis (P< 0.01) and pleural effusions, which were not rescued by ovariectomy. By comparison to DCM male mice at 13 weeks, these pathological changes in female mice with DCM, were associated with significant increases in plasma active renin (P< 0.01), angiotensin II (P< 0.01) and aldosterone levels (P< 0.001). In comparison to DCM male mice, DCM female mice also showed differential expression of the natriuretic peptide system with lower corin and higher ANP, BNP and cGMP levels at 13 weeks of age. We conclude, that female mice with experimental DCM have an accelerated progression of cardiomyopathy and HF, which was not corrected by early ovariectomy. These alterations are associated with early renin activation with increased angiotensin II and aldosterone levels, and altered expression of the natriuretic peptide system.	[Tripathi, Ranjana; Fan, Tai-Hwang M.; Wang, Dong; Sun, Yao; Reed, Guy L.; Gladysheva, Inna P.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA; [Sullivan, Ryan] Univ Tennessee, Dept Comparat Med, Hlth Sci Ctr, Memphis, TN USA; [Tripathi, Ranjana; Wang, Dong; Reed, Guy L.; Gladysheva, Inna P.] Univ Arizona, Dept Med, Coll Med Phoenix, Phoenix, AZ 85004 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Arizona	Gladysheva, IP (corresponding author), Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA.; Gladysheva, IP (corresponding author), Univ Arizona, Dept Med, Coll Med Phoenix, Phoenix, AZ 85004 USA.	innagladysheva@email.arizona.edu	Gladysheva, Inna/AAU-9465-2020; Sullivan, Ryan D./AAX-6919-2020	Gladysheva, Inna/0000-0002-2501-9029; Sullivan, Ryan D./0000-0001-7633-2210	NIH [HL092750, NS089707, HL115036]; Scientist Development Grant from AHA [14SDG20510068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL092750, R01HL115036, R43HL137514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientist Development Grant from AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants (HL092750, NS089707 to G.L.Reed and HL115036 to I. P. Gladysheva); and Scientist Development Grant from AHA (14SDG20510068 to D. Wang).	Azevedo A, 2008, HEART, V94, P264, DOI 10.1136/hrt.2006.110668; Bello N, 2004, PROG CARDIOVASC DIS, V46, P287, DOI 10.1016/j.pcad.2003.08.001; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Cunningham MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00031; Delcayre C, 2002, J MOL CELL CARDIOL, V34, P1577, DOI 10.1006/jmcc.2002.2088; DERKX FHM, 1987, J BIOL CHEM, V262, P2472; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Duprez DA, 2006, J HYPERTENS, V24, P983, DOI 10.1097/01.hjh.0000226182.60321.69; DZAU VJ, 1981, CIRCULATION, V63, P645, DOI 10.1161/01.CIR.63.3.645; Fairweather D, 2013, CURR PROB CARDIOLOGY, V38, P7, DOI 10.1016/j.cpcardiol.2012.07.003; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Gao XM, 2003, ENDOCRINOLOGY, V144, P4097, DOI 10.1210/en.2002-0214; Gladysheva IP, 2013, HYPERTENSION, V61, P327, DOI 10.1161/HYPERTENSIONAHA.112.193631; HARRIS PJ, 1987, NATURE, V326, P697, DOI 10.1038/326697a0; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; HIRSCH AT, 1990, AM J CARDIOL, V66, pD22, DOI 10.1016/0002-9149(90)90473-E; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066; Huggins GS, 2007, AM J PHYSIOL-HEART C, V293, pH1877, DOI 10.1152/ajpheart.00516.2007; Huntley BK, 2015, CIRC-HEART FAIL, V8, P89, DOI 10.1161/CIRCHEARTFAILURE.114.001174; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; InanlooRahatloo K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183874; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Kwon DH, 2009, EUR J HEART FAIL, V11, P937, DOI 10.1093/eurjhf/hfp118; LECKIE BJ, 1982, CLIN EXP HYPERTENS A, V4, P2133, DOI 10.3109/10641968209062377; Lemire I, 2001, AM J PHYSIOL-HEART C, V281, pH931, DOI 10.1152/ajpheart.2001.281.2.H931; Lenzen MJ, 2008, HEART, V94, DOI 10.1136/hrt.2006.099523; LEVINE TB, 1982, AM J CARDIOL, V49, P1659, DOI 10.1016/0002-9149(82)90243-0; Louridas GE, 2012, CURR CARDIOL REV, V8, P220, DOI 10.2174/157340312803217238; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; MACFADYEN RJ, 1993, CARDIOLOGY, V83, P38, DOI 10.1159/000175946; Meyer S, 2014, EUR J HEART FAIL, V16, P238, DOI 10.1002/ejhf.15; Mizuno Y, 2001, CIRCULATION, V103, P72; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; OELKERS W, 1988, HYPERTENSION, V12, P462, DOI 10.1161/01.HYP.12.4.462; Patten R D, 2000, Congest Heart Fail, V6, P187, DOI 10.1111/j.1527-5299.2000.80159.x; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; Rumsfeld JS, 2004, EUR HEART J, V25, P101, DOI 10.1016/j.ehj.2003.11.006; Schnee JM, 2000, CARDIOVASC RES, V46, P264, DOI 10.1016/S0008-6363(00)00044-4; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Schroten NF, 2012, HEART FAIL REV, V17, P191, DOI 10.1007/s10741-011-9262-2; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Silvestre JS, 1999, CIRCULATION, V99, P2694, DOI 10.1161/01.CIR.99.20.2694; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Tripathi R, 2016, HYPERTENSION, V67, P362, DOI 10.1161/HYPERTENSIONAHA.115.06300; Unger T, 2004, J RENIN-ANGIO-ALDO S, V5, pS7, DOI 10.3317/jraas.2004.024; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; Vasan RS, 2004, HYPERTENSION, V43, P957, DOI 10.1161/01.HYP.0000124251.06056.8e; von Lueder TG, 2013, CIRC-HEART FAIL, V6, P594, DOI 10.1161/CIRCHEARTFAILURE.112.000289; Wang D, 2014, HYPERTENSION, V63, P514, DOI 10.1161/HYPERTENSIONAHA.113.02164; Watson PA, 2010, AM J PHYSIOL-HEART C, V299, pH2056, DOI 10.1152/ajpheart.00394.2010; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5; Wijchers PJ, 2011, TRENDS GENET, V27, P132, DOI 10.1016/j.tig.2011.01.004; Winham SJ, 2015, ATHEROSCLEROSIS, V241, P219, DOI 10.1016/j.atherosclerosis.2015.03.021; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Zhou X, 2016, JACC-HEART FAIL, V4, P664, DOI 10.1016/j.jchf.2016.03.006	61	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189315	10.1371/journal.pone.0189315	http://dx.doi.org/10.1371/journal.pone.0189315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240788	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600028
J	Warfel, JD; Vandanmagsar, B; Wicks, SE; Zhang, JY; Noland, RC; Mynatt, RL				Warfel, Jaycob D.; Vandanmagsar, Bolormaa; Wicks, Shawna E.; Zhang, Jingying; Noland, Robert C.; Mynatt, Randall L.			A low fat diet ameliorates pathology but retains beneficial effects associated with CPT1b knockout in skeletal muscle	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; INSULIN-RESISTANCE; ACID OXIDATION; ADIPOSE-TISSUE; EXPRESSION; MICE; INHIBITION; ADIPOCYTES; ISOFORM; GROWTH	Inhibiting fatty acid oxidation is one approach to lowering glucose levels in diabetes. Skeletal muscle specific Carnitine Palmitoyltransferase 1b knockout mice (Cpt1b m(-/-)) comprise a model of impaired fat oxidation; and have decreased fat mass and enhanced glucose disposal and muscle oxidative capacity compared to controls. However, unfavorable effects occur relative to controls when Cpt1b m(-/-) mice are fed a 25% fat diet, including decreased activity and fat free mass and increased intramuscular lipid and serum myoglobin. In this study we explore if a low fat, high carbohydrate diet can ablate the unfavorable effects while maintaining the favorable phenotype in Cpt1b m-/- mice. Mice were fed either 10% fat (low fat) or 25% fat (chow) diet. Body composition was measured biweekly and indirect calorimetry was performed. Low fat diet abolishes the decreased activity, fat, and fat free mass seen in Cpt1b m(-/-) mice fed chow diet. Low fat diet also reduces serum myoglobin levels in Cpt1b m(-/-) mice and diminishes differences in IGF- 1 seen between Cpt1b m(-/-) mice and control mice fed chow diet. Glucose tolerance tests reveal that glucose clearance is improved in Cpt1b m(-/-) mice relative to controls regardless of diet, and serum analysis shows increased levels of muscle derived FGF21. Electron microscopic analyses and measurements of mRNA transcripts show increased intramuscular lipids, FGF21, mitochondrial and oxidative capacity markers regardless of diet. The favorable metabolic phenotype of Cpt1b m-/- mice therefore remains consistent regardless of diet; and a combination of a low fat diet and pharmacological inhibition of CPT1b may offer remedies to reduce blood glucose.	[Warfel, Jaycob D.; Vandanmagsar, Bolormaa; Wicks, Shawna E.; Zhang, Jingying; Noland, Robert C.; Mynatt, Randall L.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Mynatt, RL (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	mynattrl@pbrc.edu	Mynatt, Randall L/N-1980-2017; Warfel, Jaycob/R-4495-2018; zhang, jingying R/R-4262-2018; Vandanmagsar, Bolormaa/R-4565-2018; Noland, Robert/N-1982-2017	Mynatt, Randall L/0000-0003-4399-0019; Warfel, Jaycob/0000-0001-7501-0631; Noland, Robert/0000-0001-5543-3450	NIDDK [T32DK-6458413, R01DK-089641]; COBRE (National Institute of General Medical Sciences Grant) [8P2OGM-103528]; Nutrition Obesity Research Centers (National Institute of Diabetes and Digestive and Kidney Diseases Grant) [2P30-DK-072476-11A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, T32DK064584] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); COBRE (National Institute of General Medical Sciences Grant); Nutrition Obesity Research Centers (National Institute of Diabetes and Digestive and Kidney Diseases Grant); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this work was provided by NIDDK Fellowship T32DK-6458413 to J.D.W., and grant R01DK-089641 to R.L.M. This work used the Pennington Biomedical Research Center facilities of the Transgenic, Comparative Biology, and Genomics Cores supported in part by COBRE (National Institute of General Medical Sciences Grant 8P2OGM-103528) and the Nutrition Obesity Research Centers (National Institute of Diabetes and Digestive and Kidney Diseases Grant 2P30-DK-072476-11A1).	Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Brown NF, 1997, BIOCHEM J, V327, P225, DOI 10.1042/bj3270225; Esser V, 1996, J BIOL CHEM, V271, P6972, DOI 10.1074/jbc.271.12.6972; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Haynie KR, 2014, DIABETES OBES METAB, V16, P757, DOI 10.1111/dom.12248; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Kim T, 2014, J DIABETES METAB, V5; Kim T, 2014, J DIABETES METAB, V5, DOI [10.4172/2155-6156.1000401, 10.4172/2155-6156.1000361]; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Kruger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041709; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488; STEPHENS TW, 1985, BIOCHEM J, V227, P651, DOI 10.1042/bj2270651; STRAUS DS, 1991, J NUTR, V121, P1279, DOI 10.1093/jn/121.8.1279; STRAUS DS, 1994, FASEB J, V8, P6, DOI 10.1096/fasebj.8.1.8299891; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Warfel JD, 2017, AM J PHYSIOL-REG I, V312, pR816, DOI 10.1152/ajpregu.00520.2016; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wicks SE, 2011, BEHAV BRAIN RES, V225, P415, DOI 10.1016/j.bbr.2011.07.051	22	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188850	10.1371/journal.pone.0188850	http://dx.doi.org/10.1371/journal.pone.0188850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240830	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600012
J	Koester, DC; Wildt, DE; Maly, M; Comizzoli, P; Crosier, AE				Koester, Diana C.; Wildt, David E.; Maly, Morgan; Comizzoli, Pierre; Crosier, Adrienne E.			Non-invasive identification of protein biomarkers for early pregnancy diagnosis in the cheetah (Acinonyx jubatus)	PLOS ONE			English	Article							SECRETORY IMMUNE-SYSTEM; CAT FELIS-CATUS; DOMESTIC CAT; ARTIFICIAL-INSEMINATION; ADRENOCORTICAL FUNCTION; OVARIAN ACTIVITY; ESTROUS-CYCLE; J-CHAIN; RELAXIN; SPERMATOZOA	Approximately 80% of cheetahs living in typical zoological collections never reproduce. In more than 60% of breedings, the female is confirmed to ovulate, but parturition fails to occur. It is unknown if these non-pregnant intervals of elevated progesterone (deemed luteal phases) are conception failures or a pregnancy terminating in embryonic/ fetal loss. There have been recent advances in metabolic profiling and proteome analyses in many species with mass spectrometry used to identify 'biomarkers' and mechanisms indicative of specific physiological states (including pregnancy). Here, we hypothesized that protein expression in voided cheetah feces varied depending on pregnancy status. We: 1) identified the expansive protein profile present in fecal material of females; and 2) isolated proteins that may be candidates playing a role in early pregnancy establishment and diagnosis. Five hundred and seventy unique proteins were discovered among samples from pregnant (n = 8), nonpregnant, luteal phase (n = 5), and non-ovulatory control (n = 5) cheetahs. Four protein candidates were isolated that were significantly up-regulated and two were down-regulated in samples from pregnant compared to non-pregnant or control counterparts. One up-regulated candidate, immunoglobulin J chain (IGJ; an important component of the secretory immune system) was detected using a commercially available antibody via immunoblotting. Findings revealed that increased IGJ abundance could be used to detect pregnancy successfully in >80% of 23 assessed females within 4 weeks after mating. The discovery of a novel fecal pregnancy marker improves the ability to determine reproductive, especially gestational, status in cheetahs managed in an ex situ insurance and source population.	[Koester, Diana C.; Wildt, David E.; Maly, Morgan; Crosier, Adrienne E.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Comizzoli, Pierre] Natl Zool Pk, Ctr Species Survival, Washington, DC USA; [Koester, Diana C.] Cleveland Metropk Zoo, Conservat & Sci Dept, Cleveland, OH USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Crosier, AE (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.	CrosierA@si.edu		, Morgan/0000-0001-6284-2092	JoGayle Howard Post-Doctoral Fellowship in Felid Reproduction; Riverbanks Conservation Support Fund; C2S2's Cheetah Sustainability Program; William H. Donner Foundation; Smithsonian Institution	JoGayle Howard Post-Doctoral Fellowship in Felid Reproduction; Riverbanks Conservation Support Fund; C2S2's Cheetah Sustainability Program; William H. Donner Foundation; Smithsonian Institution(Smithsonian Institution)	This research was supported by a JoGayle Howard Post-Doctoral Fellowship in Felid Reproduction to the first author (DCK) and from the Riverbanks Conservation Support Fund (DCK; https://society.riverbanks.org/donate/conservation-support-fund), C2S2's Cheetah Sustainability Program (DCK, MM, and AEC; http://conservationcenters.org/programs/cheetah-grants), the William H. Donner Foundation (AEC), and the Smithsonian Institution (DCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2011, J REPROD DEVELOP, V57, P262, DOI 10.1262/jrd.10-057T; Aldred S, 2004, CLIN BIOCHEM, V37, P943, DOI 10.1016/j.clinbiochem.2004.09.002; Ang CS, 2010, J CHROMATOGR A, V1217, P3330, DOI 10.1016/j.chroma.2009.10.007; Bauman JE, 2008, ZOO BIOL, V27, P406, DOI 10.1002/zoo.20196; Ben-Hur H, 2001, IN VIVO, V15, P429; BJERCKE S, 1993, HUM REPROD, V8, P1420, DOI 10.1093/oxfordjournals.humrep.a138271; Braun BC, 2012, REPRODUCTION, V143, P399, DOI 10.1530/REP-11-0316; Brown JL, 1996, J REPROD FERTIL, V106, P337, DOI 10.1530/jrf.0.1060337; Brown JL, 2001, J REP FER S, P71; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Burke Harry B, 2016, Biomark Cancer, V8, P89, DOI 10.4137/BIC.S33380; CARLSTEAD K, 1992, ZOO BIOL, V11, P165, DOI 10.1002/zoo.1430110305; Chandramouli Kondethimmanahalli, 2009, Hum Genomics Proteomics, V2009, DOI 10.4061/2009/239204; Chaurand P, 2004, ANAL CHEM, V76, p86A, DOI 10.1021/ac0415197; Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P47, DOI 10.1111/j.1439-0531.2009.01373.x; Crosier AE, 2007, REPROD FERT DEVELOP, V19, P370, DOI 10.1071/RD06057; Crosier AE, 2011, BIOL REPROD, V85, P243, DOI 10.1095/biolreprod.110.089417; Crosier AE, 2009, J ANDROL, V30, P298, DOI 10.2164/jandrol.108.006239; Crosier AE, 2006, CRYOBIOLOGY, V52, P169, DOI 10.1016/j.cryobiol.2005.10.011; Crosier AE, 2016, REPROD FERTIL DEV; Curry E, 2012, THERIOGENOLOGY, V78, P308, DOI 10.1016/j.theriogenology.2012.02.004; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; DONOGHUE AM, 1992, BIOL REPROD, V46, P1047, DOI 10.1095/biolreprod46.6.1047; DOWNEY BR, 1980, CAN VET J, V21, P301; Durant SM, 2017, P NATL ACAD SCI USA, V114, P528, DOI 10.1073/pnas.1611122114; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; FORESMAN KR, 1983, J REPROD FERTIL, V68, P235; Galazis N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053801; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Grisham J, 2013, CHEETAH ACINONYX JUB; Gurevich P, 2003, AM J REPROD IMMUNOL, V50, P13, DOI 10.1034/j.1600-0897.2003.01201.x; Harris LA, 2008, J ZOO WILDLIFE MED, V39, P170, DOI 10.1638/2007-0093R.1; Hein M, 2005, ACTA OBSTET GYN SCAN, V84, P734, DOI 10.1111/j.0001-6349.2005.00525.x; Horgan RP, 2011, J PROTEOME RES, V10, P3660, DOI 10.1021/pr2002897; HOWARD JG, 1992, J ZOO WILDLIFE MED, V23, P288; Howard JG, 1997, BIOL REPROD, V56, P1059, DOI 10.1095/biolreprod56.4.1059; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Koester DC, 2015, REPROD FERT DEVELOP, V29, P496; Koester DC, 2017, GEN COMP ENDOCR, V243, P120, DOI 10.1016/j.ygcen.2016.11.010; Koester DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135847; Koga Y, 2015, JPN J CLIN PATHOL, V63, P361; Kuribayashi T, 2003, EXP ANIM TOKYO, V52, P377, DOI 10.1538/expanim.52.377; Li SH, 2002, BIOL REPROD, V66, P322, DOI 10.1095/biolreprod66.2.322; Mansouri-Attia N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101121; Marker L, 2012, INT CHEETAH STUDBOOK; Marker LL, 2008, J HERED, V99, P2, DOI 10.1093/jhered/esm081; Mastorci F, 2009, NEUROSCI BIOBEHAV R, V33, P191, DOI 10.1016/j.neubiorev.2008.08.001; Munerato MS, 2010, VET CLIN PATH, V39, P454, DOI 10.1111/j.1939-165X.2010.00264.x; Myers JE, 2013, HYPERTENSION, V61, P1281, DOI 10.1161/HYPERTENSIONAHA.113.01168; Nagaoka K, 2000, ASIAN AUSTRAL J ANIM, V13, P845, DOI 10.5713/ajas.2000.845; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Pang T, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00006; Pelican KM, 2006, THERIOGENOLOGY, V66, P37, DOI 10.1016/j.theriogenology.2006.03.013; Pukazhenthi BS, 2001, J REP FER S, P423; Pukazhenthi BS, 2006, THERIOGENOLOGY, V66, P112, DOI 10.1016/j.theriogenology.2006.03.020; Samson MH, 2008, SCAND J CLIN LAB INV, V68, P369, DOI 10.1080/00365510701767862; Terio KA, 1999, J ZOO WILDLIFE MED, V30, P484; Terrell KA, 2012, CRYOBIOLOGY, V64, P110, DOI 10.1016/j.cryobiol.2011.12.006; Terrell KA, 2010, BIOL REPROD, V83, P833, DOI 10.1095/biolreprod.110.085639; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; van Dorsser FJD, 2006, BIOL REPROD, V74, P1090, DOI [10.1095/biolreprd.105.050146, 10.1095/biolreprod.105.050146]; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wells A, 2004, J ZOO WILDLIFE MED, V35, P8, DOI 10.1638/02-084; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; WILDT DE, 1993, ZOO BIOL, V12, P45, DOI 10.1002/zoo.1430120107; Wright EK, 2014, INFLAMM BOWEL DIS, V20, P1668, DOI 10.1097/MIB.0000000000000087; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Yasuhara M, 1992, J Clin Lab Immunol, V38, P137; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Ziegler-Meeks, 2009, HUSBANDRY MANUAL CHE; Zusman I, 2005, INT J MOL MED, V16, P127	78	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188575	10.1371/journal.pone.0188575	http://dx.doi.org/10.1371/journal.pone.0188575			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236714	gold, Green Published			2022-12-26	WOS:000417884100019
J	Lei, L; Ding, LJ; Su, J; Liu, MY; Shi, QQ; Zhou, JJ; Sun, HX; Yan, GJ				Lei, Lei; Ding, Lijun; Su, Jing; Liu, Mengyuan; Shi, Qingqing; Zhou, Jianjun; Sun, Haixiang; Yan, Guijun			Attenuated expression of MTR in both prenatally androgenized mice and women with the hyperandrogenic phenotype of PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; CONTROLLED CLINICAL-TRIAL; GENOME-WIDE ASSOCIATION; METHIONINE SYNTHASE; FOLIC-ACID; HOMOCYSTEINE CONCENTRATIONS; FOLATE SUPPLEMENTATION; MICROARRAY ANALYSIS; DEFICIENT MICE; DOUBLE-BLIND	Polycystic ovary syndrome (PCOS) is a common endocrine, metabolic and heterogeneous disorder in women of reproductive age, the exact etiology of which remains unknown. To unravel the molecular mechanisms underlying the hyperandrogenic phenotype of PCOS, prenatally androgenized (PNA) mice were used to mimic this phenotype in women with PCOS. Using microarray analysis, 1188 differentially expressed genes, including 671 upregulated and 517 downregulated genes, were identified in ovaries from PNA mice. Five differentially expressed genes (Aldh1a7, Bhmt, Mtr, Nrcam, Ptprg) were validated, and decreased MTR expression was shown in ovaries of PNA mice. In addition, results from qRT-PCR showed decreased MTR expression in granulosa cells (GCs) from women with the hyperandrogenic phenotype of PCOS. Serum levels of S-adenosyl methionine (SAM), the downstream product of MTR, were also decreased in PNA mice and women with the hyperandrogenic phenotype of PCOS. Our study provides evidence that the hyperandrogenic phenotype of PCOS is linked to abnormal folate one-carbon metabolism.	[Lei, Lei; Sun, Haixiang] Nanjing Med Univ, Ctr Reprod Med, Drum Tower Clin, Med Coll, Nanjing, Jiangsu, Peoples R China; [Lei, Lei] Nanjing Med Univ, Dept Obstet & Gynecol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Ding, Lijun; Su, Jing; Liu, Mengyuan; Shi, Qingqing; Zhou, Jianjun; Yan, Guijun] Nanjing Univ, Med Sch, Ctr Reprod Med, Dept Obstet & Gynecol,Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University	Sun, HX (corresponding author), Nanjing Med Univ, Ctr Reprod Med, Drum Tower Clin, Med Coll, Nanjing, Jiangsu, Peoples R China.; Yan, GJ (corresponding author), Nanjing Univ, Med Sch, Ctr Reprod Med, Dept Obstet & Gynecol,Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	stevensunz@163.com; yanguijun55@163.com		Lei, Lei/0000-0002-2971-1880	National Nature Science Foundation of China [81590391, 31590189, 30900847]; Health Department of Jiangsu Province [LJ201102]; Natural Science Foundation of Jiangsu Province [BK20141087, BL2014003]; Nanjing Medical Science Development Project, China [JQ2014004, ZKX16042]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Nanjing Medical Science Development Project, China	This study was funded by the National Nature Science Foundation of China (81590391, 31590189, and 30900847), the Health Department of Jiangsu Province (LJ201102), the Natural Science Foundation of Jiangsu Province (BK20141087 and BL2014003), and the Nanjing Medical Science Development Project (JQ2014004 and ZKX16042), China.	Asemi Z, 2014, MOL NUTR FOOD RES, V58, P1465, DOI 10.1002/mnfr.201400033; Azziz R, 2016, NAT REV ENDOCRINOL, V12, P184, DOI 10.1038/nrendo.2016.9; Bahmani F, 2014, CLIN ENDOCRINOL, V81, P582, DOI 10.1111/cen.12451; Berker B, 2009, HUM REPROD, V24, P2293, DOI 10.1093/humrep/dep069; Cattrall FR, 2005, FERTIL STERIL, V84, P1689, DOI 10.1016/j.fertnstert.2005.05.061; Chazenbalk G, 2012, J CLIN ENDOCR METAB, V97, pE765, DOI 10.1210/jc.2011-2377; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Dayal S, 2005, CIRCULATION, V112, P737, DOI 10.1161/CIRCULATIONAHA.104.529248; Diao FY, 2004, J MOL ENDOCRINOL, V33, P59, DOI 10.1677/jme.0.0330059; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Kazerooni T, 2008, INT J GYNECOL OBSTET, V101, P156, DOI 10.1016/j.ijgo.2007.10.024; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Lee EJ, 2008, FERTIL STERIL, V89, P1213, DOI 10.1016/j.fertnstert.2007.05.026; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111; Moore AM, 2013, ENDOCRINOLOGY, V154, P796, DOI 10.1210/en.2012-1954; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Palep-Singh M, 2008, EUR J OBSTET GYN R B, V138, P180, DOI 10.1016/j.ejogrb.2007.12.015; Pasquali R, 2016, J CLIN ENDOCR METAB, V101, P2013, DOI 10.1210/jc.2015-4009; Peral B, 2002, J CLIN ENDOCR METAB, V87, P3977, DOI 10.1210/jc.87.8.3977; Roland AV, 2011, ENDOCRINOLOGY, V152, P618, DOI 10.1210/en.2010-0823; Sato Y, 2012, MOL ENDOCRINOL, V26, P1158, DOI 10.1210/me.2012-1027; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Shirodaria C, 2007, CIRCULATION, V115, P2262, DOI 10.1161/CIRCULATIONAHA.106.679084; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Sun LY, 2012, J PROTEOME RES, V11, P2937, DOI 10.1021/pr3000317; Tosi F, 2016, J CLIN ENDOCR METAB, V101, P610, DOI 10.1210/jc.2015-2807; Toulis KA, 2011, HUM REPROD UPDATE, V17, P741, DOI 10.1093/humupd/dmr025; Twigt JM, 2015, EUR J CLIN INVEST, V45, P833, DOI 10.1111/eci.12478; Unni CSN, 2015, INDIAN J MED RES, V142, P549, DOI 10.4103/0971-5916.171281; Witham EA, 2012, ENDOCRINOLOGY, V153, P4522, DOI 10.1210/en.2012-1283; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200; Yu YY, 2015, FERTIL STERIL, V104, P145, DOI 10.1016/j.fertnstert.2015.04.005; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang ZL, 2012, EUR J MED CHEM, V58, P228, DOI 10.1016/j.ejmech.2012.09.027	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0187427	10.1371/journal.pone.0187427	http://dx.doi.org/10.1371/journal.pone.0187427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232372	gold, Green Submitted, Green Published			2022-12-26	WOS:000417698200002
J	Sargin, ZG; Erin, N; Tazegul, G; Elpek, GO; Yildirim, B				Sargin, Zeynep Gok; Erin, Nuray; Tazegul, Gokhan; Elpek, Gulsum Ozlem; Yildirim, Bulent			Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; SUBSTANCE-P; BIOACTIVE FRAGMENTS; INFLAMMATION; MUCOSA; POLYPEPTIDE; MICE; VIP; CONVERSION; RECEPTOR	Neprilysin (NEP, CD10) acts to limit excessive inflammation partly by hydrolyzing neuropeptides. Although deletion of NEP exacerbates intestinal inflammation in animal models, its role in ulcerative colitis (UC) is not well explored. Herein, we aimed to demonstrate changes in NEP and associated neuropeptides at the same time in colonic tissue. 72 patients with UC and 27 control patients were included. Patients' demographic data and laboratory findings, five biopsy samples from active colitis sites and five samples from uninvolved mucosa were collected. Substance P (SP), calcitonin gene related peptide (CGRP) and vasoactive intestinal peptide (VIP) were extracted from freshly frozen tissues and measured using ELISA. Levels of NEP expression were determined using immunohistochemistry and immunoreactivity scores were calculated. GEBOES grading system was also used. We demonstrated a profound loss (69.4%) of NEP expression in UC, whereas all healthy controls had NEP expression. Patients with UC had lower neuronal SP; however non-neuronal SP remained similar. UC patients had also lower neuronal and non-neuronal VIP levels. CGRP were low in general and no significant changes were observed. Additionally, CRP positive patients with UC had higher rates of NEP loss (80% vs 51.9%) and lower SP levels when compared with CRP negative patients with UC. Concurrent decreases in SP and VIP with profound loss of NEP expression observed in UC is likely to be one of the factors in pathogenesis. Further studies are required to define the role of neuropeptides and NEP in UC.	[Sargin, Zeynep Gok; Tazegul, Gokhan; Yildirim, Bulent] Akdeniz Univ, Dept Internal Med, Div Gastroenterol, Fac Med, Antalya, Turkey; [Erin, Nuray] Akdeniz Univ, Dept Med Pharmacol, Fac Med, Antalya, Turkey; [Elpek, Gulsum Ozlem] Akdeniz Univ, Dept Pathol, Fac Med, Antalya, Turkey	Akdeniz University; Akdeniz University; Akdeniz University	Erin, N (corresponding author), Akdeniz Univ, Dept Med Pharmacol, Fac Med, Antalya, Turkey.	nerin@akdeniz.edu.tr	Özlem Elpek, Gülsüm/AAA-8262-2022; , Zeynep/AAI-7139-2021; Elpek, Gulsum/C-4878-2016; Tazegul, Gokhan/C-3050-2018; Erin, Nuray/B-8616-2012	, Zeynep/0000-0001-9193-4105; Elpek, Gulsum/0000-0002-1237-5454; Tazegul, Gokhan/0000-0002-0737-9450; Erin, Nuray/0000-0002-6116-1970	Akdeniz University Scientific Studies Fund [2011.01.0103.014]	Akdeniz University Scientific Studies Fund	Akdeniz University Scientific Studies Fund, Project Number: 2011.01.0103.014 to BY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; BERNSTEIN CN, 1993, AM J GASTROENTEROL, V88, P908; Castagliuolo I, 2002, BRIT J PHARMACOL, V136, P271, DOI 10.1038/sj.bjp.0704697; De Araujo JE, 1999, PEPTIDES, V20, P1437, DOI 10.1016/S0196-9781(99)00154-0; De Araujo JE, 2001, EUR J PHARMACOL, V432, P43, DOI 10.1016/S0014-2999(01)01460-1; Delgado M, 2003, TRENDS IMMUNOL, V24, P221, DOI 10.1016/S1471-4906(03)00069-3; DUFFY LC, 1989, DIGEST DIS SCI, V34, P1528, DOI 10.1007/BF01537105; Engel MA, 2011, INFLAMM BOWEL DIS, V17, P1030, DOI 10.1002/ibd.21422; Erin N, 2004, BIOTECHNIQUES, V37, P232, DOI 10.2144/04372ST04; Erin N, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2016.08.010; Erin N, 2009, REGUL PEPTIDES, V152, P108, DOI 10.1016/j.regpep.2008.10.006; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gross KJ, 2007, INFLAMM BOWEL DIS, V13, P918, DOI 10.1002/ibd.20129; Hallberg M, 2003, CURR PROTEIN PEPT SC, V4, P31, DOI 10.2174/1389203033380313; Hallberg M, 2015, MED RES REV, V35, P464, DOI 10.1002/med.21323; Jonsson M, 2007, ANN NY ACAD SCI, V1107, P280, DOI 10.1196/annals.1381.030; KIMURA M, 1994, PATHOL INT, V44, P624, DOI 10.1111/j.1440-1827.1994.tb01723.x; KincyCain T, 1996, J IMMUNOL, V157, P255; Kirkwood KS, 2001, AM J PHYSIOL-GASTR L, V281, pG544, DOI 10.1152/ajpgi.2001.281.2.G544; KOCH TR, 1987, DIGEST DIS SCI, V32, P369, DOI 10.1007/BF01296290; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; KUBOTA Y, 1992, GASTROENTEROLOGY, V102, P1242; Lai NY, 2017, J INTERN MED, V282, P5, DOI 10.1111/joim.12591; Lloyd JM, 2011, MODERN PATHOL, V24, P1627, DOI 10.1038/modpathol.2011.122; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Massironi S, 2016, NEUROPEPTIDES, V58, P127, DOI 10.1016/j.npep.2016.01.002; MAZUMDAR S, 1992, AM J GASTROENTEROL, V87, P176; Nyberg F, 2007, CURR DRUG TARGETS, V8, P147, DOI 10.2174/138945007779315597; Pavlovic S, 2011, J IMMUNOL, V186, P848, DOI 10.4049/jimmunol.0903878; Renzi D, 1998, ITAL J GASTROENTEROL, V30, P62; Schultz BM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00191; STEWART JM, 1982, PEPTIDES, V3, P851, DOI 10.1016/0196-9781(82)90027-4; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; SURRENTI C, 1993, J PHYSIOL-PARIS, V87, P307, DOI 10.1016/0928-4257(93)90037-T; Tavano F, 2012, J CROHNS COLITIS, V6, P563, DOI 10.1016/j.crohns.2011.11.004; ter Beek WP, 2007, NEUROPEPTIDES, V41, P301, DOI 10.1016/j.npep.2007.05.002; Vento P, 2001, J HISTOCHEM CYTOCHEM, V49, P749, DOI 10.1177/002215540104900608; Vu JP, 2014, J MOL NEUROSCI, V52, P37, DOI 10.1007/s12031-013-0205-3; Watanabe T, 1997, DIS COLON RECTUM, V40, P718, DOI 10.1007/BF02140903; Wiktelius D, 2006, PEPTIDES, V27, P1490, DOI 10.1016/j.peptides.2005.12.004	40	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189526	10.1371/journal.pone.0189526	http://dx.doi.org/10.1371/journal.pone.0189526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232715	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200055
J	Hueber, S; Kuehlein, T; Gerlach, R; Tauscher, M; Schedlbauer, A				Hueber, Susann; Kuehlein, Thomas; Gerlach, Roman; Tauscher, Martin; Schedlbauer, Angela			"What they see is what you get": Prescribing antibiotics for respiratory tract infections in primary care: Do high prescribers diagnose differently? An analysis of German routine data	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; EUROPE; INDEX; RATES	Background Characteristics of high and low prescribers of antibiotics in German primary care were analysed using population data. We aimed to evaluate differences in prescribing rates and factors being associated with high prescribing, and whether high prescribers made the diagnosis of perceived bacterial infections more often. Methods Routine data were provided by the Bavarian Association of Statutory Health Insurance Physicians. Routine data are delivered by primary care practices on a quarterly basis. We analysed data from 2011 and 2012. Patients older than 15 years with respiratory tract infections consulting a primary care physician were selected (6.647 primary care practices). Patient and physician characteristics associated with high prescribing were identified using stepwise logistic regression. Results Mean prescribing rate of antibiotics was 24.9%. Prescribing rate for high prescribers was 43.5% compared to 8.5% for low prescribers. High prescribers made the diagnosis of perceived bacterial infections more often (Mhigh = 64.5%, Mlow = 45.2%). In the adjusted regression model, perceived bacterial infections were strongly associated with high prescribing (OR = 13.9, 95% CI [10.2, 18.8]). Treating patients with comorbidities was associated with lower prescribing of antibiotics (OR = 0.6, 95% CI [0.4, 0.8]). High prescribers had a higher practice volume, a higher degree of prescribing dominance, and were situated more often in deprived areas and in rural settings. Interpretation Compared to findings of studies in other European countries, prescribing rates were low. There was a considerable difference between prescribing rates of high and low prescribers. Diagnostic labelling was the best predictor for high prescribing. Current guidelines recommend considering antibiotic treatment for patients with co-morbidities. In our study, treating a large number of high-risk patients was not associated with high prescribing.	[Hueber, Susann; Kuehlein, Thomas; Schedlbauer, Angela] Univ Klinikum Erlangen, Erlangen, Germany; [Gerlach, Roman; Tauscher, Martin] Kassenarztl Vereinigung Bayern, Munich, Germany	University of Erlangen Nuremberg	Hueber, S (corresponding author), Univ Klinikum Erlangen, Erlangen, Germany.	susann.hueber@uk-erlangen.de	Hueber, Susann/U-9754-2018	Hueber, Susann/0000-0003-0844-0919				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; [Anonymous], 2005, ICPC 2 R INT CLASSIF; Aspinall SL, 2009, AM J EMERG MED, V27, P544, DOI 10.1016/j.ajem.2008.04.015; Barlam TF, 2015, INFECT CONT HOSP EP, V36, P153, DOI 10.1017/ice.2014.21; Blommaert A, 2014, J ANTIMICROB CHEMOTH, V69, P535, DOI 10.1093/jac/dkt377; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Coenen Samuel, 2002, BMC Fam Pract, V3, P16, DOI 10.1186/1471-2296-3-16; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Sutter AI, 2001, FAM PRACT, V18, P209, DOI 10.1093/fampra/18.2.209; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Deschepper R, 2002, PATIENT EDUC COUNS, V48, P161, DOI 10.1016/S0738-3991(02)00017-4; Duijn HJ, 2007, BMC FAMILY PRACTICE, V8, P1; Fiegen H, 2002, Z ALLG MED, V81, P372; GERRITY MS, 1990, MED CARE, V28, P724, DOI 10.1097/00005650-199008000-00005; Gerrity MS, 1995, MOTIV EMOTION, V19, P175, DOI 10.1007/BF02250510; Gjelstad S, 2011, J ANTIMICROB CHEMOTH, V66, P2425, DOI 10.1093/jac/dkr295; Gjelstad S, 2009, SCAND J PRIM HEALTH, V27, P208, DOI 10.3109/02813430903438718; Grover ML, 2012, J FAM PRACTICE, V61, P330; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Gulliford MC, 2014, ANN FAM MED, V12, P344, DOI 10.1370/afm.1659; Hering R, 2014, ENTWICKLUNG AMBULANT; Howie J G, 1972, J R Coll Gen Pract, V22, P310; Hutchinson JM, 2001, CAN FAM PHYSICIAN, V47, P1217; Hutchinson JM, 1999, CAN MED ASSOC J, V160, P1013; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Linder JA, 2003, CLIN THER, V25, P2419, DOI 10.1016/S0149-2918(03)80284-9; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Mainous AG, 1998, ARCH PEDIAT ADOL MED, V152, P349; Mazzaglia G, 2003, EUR J CLIN PHARMACOL, V59, P651, DOI 10.1007/s00228-003-0669-0; NICE CfCPa, 2008, RESP TRACT INF ANT P; Schulz M, 2014, ANTIBIOTIKAVERORDU 2; Steffensen FH, 1997, SCAND J INFECT DIS, V29, P409, DOI 10.3109/00365549709011839; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tell D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008096; Velasco E, 2011, Infection, V39, P289, DOI 10.1007/s15010-011-0137-1; VERHEIJ TJM, 1990, FAM PRACT, V7, P175, DOI 10.1093/fampra/7.3.175; Wang KY, 2009, BRIT J GEN PRACT, V59, P724, DOI 10.3399/bjgp09X472593	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188521	10.1371/journal.pone.0188521	http://dx.doi.org/10.1371/journal.pone.0188521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220399	Green Published, gold			2022-12-26	WOS:000417469900010
J	Amiri, P; Jalali-Farahani, S; Karimi, M; Taherian, R; Kazempour-Ardebili, S; Hosseini-Esfahani, F; Mirmiran, P; Azizi, F				Amiri, Parisa; Jalali-Farahani, Sara; Karimi, Mehrdad; Taherian, Reza; Kazempour-Ardebili, Sara; Hosseini-Esfahani, Firoozeh; Mirmiran, Parvin; Azizi, Fereidoun			Factors associated with pre-diabetes in Tehranian men and women: A structural equations modeling	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; SEX-DIFFERENCES; FOLLOW-UP; POPULATION; DISEASE; QUESTIONNAIRE	Objective To examine associations of sex-specific related factors with pre-diabetes in Tehranian nondiabetic adults. Methods This study has been conducted within the framework of the Tehran Lipid and Glucose Study (TLGS) between 2008-2010. A total of 5568 (55.4% female) non-diabetic adults, aged >= 20 years, selected from among participants of the TLGS, were recruited for the study. Data on socio-behavioral factors, family history of diabetes and cardio-metabolic risk factors were included in the hypothesized model to test their direct and indirect associations with pre-diabetes in men and women separately, using structural equation modeling. Results Pre-diabetes was diagnosed in 23.6% of participants, with significantly higher prevalence in men compared to women (27.4% and 20.5%, respectively; p < 0.001). Body mass index (BMI) and triglycerides (TG) in both sexes and hypertension and high density lipoprotein only in women, were directly associated with pre-diabetes (p < 0.05). Poor diet in women was the only behavioral factor directly associated with pre-diabetes (p < 0.05). Age in both sexes and education, only in women, were directly associated with pre-diabetes. In both genders, age, marital status, education, employment, poor diet and leisure time physical activity were indirectly associated with pre-diabetes through cardio-metabolic risk factors. Conclusions The main modifiable factors directly associated with pre-diabetes were TG in women and BMI in men, which need to be prioritized in health policies for diabetes prevention programs in Tehranian adults. Future research should focus on the gender-specific determinants and underlying mechanisms for TG levels and BMI status among this population.	[Amiri, Parisa; Jalali-Farahani, Sara; Karimi, Mehrdad; Taherian, Reza] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran; [Jalali-Farahani, Sara; Taherian, Reza] Shahid Beheshti Univ Med Sci, Student Res Comm, Tehran, Iran; [Karimi, Mehrdad] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Kazempour-Ardebili, Sara; Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran; [Hosseini-Esfahani, Firoozeh; Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Azizi, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.	azizi@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; Mirmiran, Parvin/V-1433-2019; amiri, parisa/K-1575-2017	Azizi, Fereidoun/0000-0002-6470-2517; amiri, parisa/0000-0002-6693-1057; JalaliFarahani, Sara/0000-0003-4905-0191; Dehbozorgian, Forough/0000-0002-1943-8198; Mirmiran, Parvin/0000-0003-2391-4924; Karimi, Mehrdad/0000-0001-8952-5839				Al-Shafaee MA, 2011, INT J DIABETES DEV C, V31, P166, DOI 10.1007/s13410-011-0038-y; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bardenheier BH, 2013, DIABETES CARE, V36, P2655, DOI 10.2337/dc12-2608; CASTELLI WP, 1992, AM J CARDIOL, V70, pH3, DOI 10.1016/0002-9149(92)91083-G; Diaz-Redondo A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0216-3; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Esteghamati A, 2014, DIABETES RES CLIN PR, V103, P319, DOI 10.1016/j.diabres.2013.12.034; Farni K, 2014, PEERJ, V2, DOI 10.7717/peerj.499; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Ghazali SM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1432-z; Golozar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026725; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Hadaegh F, 2017, DIABETIC MED, V34, P69, DOI 10.1111/dme.13034; Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-176; Haffner SM, 1997, DIABETOLOGIA, V40, P711, DOI 10.1007/s001250050738; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Karastergiou K, 2013, J CLIN ENDOCR METAB, V98, P362, DOI 10.1210/jc.2012-2953; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Lee DS, 2013, PUBLIC HEALTH, V127, P554, DOI 10.1016/j.puhe.2013.02.001; Li SX, 2014, J DIABETES COMPLICAT, V28, P470, DOI 10.1016/j.jdiacomp.2014.03.015; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McNaughton SA, 2009, J NUTR, V139, P734, DOI 10.3945/jn.108.096784; Mohieldein AH, 2014, DIABETES METABOLIC S; Murray CJ, 2015, LANCET, V386, pP2145; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Rezazadeh A, 2010, NUTRITION, V26, P337, DOI 10.1016/j.nut.2009.06.019; Roche MM, 2014, J CLIN TRANSL ENDOCR, V1, P77, DOI 10.1016/j.jcte.2014.07.002; Roman-Urrestarazu A, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000231; Sadeghi M, 2015, J DIABETES; stenson C-G, 2014, DIABETES RES CLIN PR; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y; Zheng J, 2014, FRONT MED-PRC, V8, P477, DOI 10.1007/s11684-014-0346-y; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	39	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188898	10.1371/journal.pone.0188898	http://dx.doi.org/10.1371/journal.pone.0188898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216229	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800046
J	Shin, JE; Choi, CH; Lee, JM; Kwon, JS; Lee, SH; Kim, HC; Han, NY; Choi, SH; Yoo, SY				Shin, Jung Eun; Choi, Chi-Hoon; Lee, Jong Min; Kwon, Jun Soo; Lee, So Hee; Kim, Hyun-Chung; Han, Na Young; Choi, Soo-Hee; Yoo, So Young			Association between memory impairment and brain metabolite concentrations in North Korean refugees with posttraumatic stress disorder	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIPPOCAMPAL N-ACETYLASPARTATE; PERFORMANCE VALIDITY; WHITE-MATTER; PTSD; VETERANS; CORTISOL; EXTINCTION; COGNITION; SYMPTOMS	Individuals with posttraumatic stress disorder (PTSD) had experiences of enormous psychological stress that can result in neurocognitive and neurochemical changes. To date, the causal relationship between them remains unclear. The present study is to investigate the association between neurocognitive characteristics and neural metabolite concentrations in North Korean refugees with PTSD. A total of 53 North Korean refugees with or without PTSD underwent neurocognitive function tests. For neural metabolite scanning, magnetic resonance spectroscopy of the hippocampus and anterior cingulate cortex (ACC) has been conducted. We assessed between-group differences in neurocognitive test scores and metabolite levels. Additionally, a multiple regression analysis was carried out to evaluate the association between neurocognitive function and metabolite levels in patients with PTSD. Memory function, but not other neurocognitive functions, was significantly lower in the PTSD group compared with the non-PTSD group. Hippocampal N-acetylaspartate (NAA) levels were not different between groups; however, NAA levels were significantly lower in the ACC of the PTSD group than the non-PTSD group (t = 2.424, p = 0.019). The multiple regression analysis showed a negative association between hippocampal NAA levels and delayed recall score on the auditory verbal learning test (beta = -1.744, p = 0.011) in the non-PTSD group, but not in the PTSD group. We identified specific memory impairment and the role of NAA levels in PTSD. Our findings suggest that hippocampal NAA has a protective role in memory impairment and development of PTSD after exposure to traumatic events.	[Shin, Jung Eun; Kwon, Jun Soo; Han, Na Young; Choi, Soo-Hee] Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; [Choi, Chi-Hoon] Chungbuk Natl Univ Hosp, Dept Radiol, Cheongju, South Korea; [Lee, Jong Min] Hanyang Univ, Dept Biomed Engn, Computat NeuroImage Anal Lab, Seoul, South Korea; [Kwon, Jun Soo; Choi, Soo-Hee] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kwon, Jun Soo; Choi, Soo-Hee] Seoul Natl Univ, Coll Med, Inst Human Behav Med SNU MRC, Seoul, South Korea; [Lee, So Hee; Kim, Hyun-Chung; Yoo, So Young] Natl Med Ctr, Dept Psychiat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Hanyang University; Seoul National University (SNU); Seoul National University (SNU); National Medical Center - Korea	Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Inst Human Behav Med SNU MRC, Seoul, South Korea.; Yoo, SY (corresponding author), Natl Med Ctr, Dept Psychiat, Seoul, South Korea.	soohchoi@snu.ac.kr; soyoung.yoo@nmc.or.kr	Lee, Jeong Min/V-3429-2019; Lee, So Hee/B-5940-2016	Lee, Jeong Min/0000-0003-0561-8777; Lee, So Hee/0000-0002-9005-3207; Choi, Chi-Hoon/0000-0003-4137-7376	National Medical Center, Research Institute [NMC2012-MS-03]	National Medical Center, Research Institute	This work was supported by Research Program funded by National Medical Center, Research Institute (grant number: NMC2012-MS-03). The funding sources had no further role in the study design, collection, analysis, interpretation of the data, writing of the report, and in the decision to submit this report for publication. The corresponding authors had full access to the data in the study and had final responsibility for the decision to submit for publication.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Arnold DL, 2001, ANN NEUROL, V50, P823, DOI 10.1002/ana.10013; Bae SM, 2014, CLIN PSYCHOPHARM NEU, V12, P41, DOI 10.9758/cpn.2014.12.1.41; Bartlett DJ, 2004, SLEEP MED, V5, P593, DOI 10.1016/j.sleep.2004.08.004; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bertholdo D, 2013, NEUROIMAG CLIN N AM, V23, P359, DOI 10.1016/j.nic.2012.10.002; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Bremner JD, 2006, ANN NY ACAD SCI, V1071, P80, DOI 10.1196/annals.1364.008; Brown ES, 2004, BIOL PSYCHIAT, V55, P538, DOI 10.1016/j.biopsych.2003.09.010; Conrad CD, 1999, NEUROBIOL LEARN MEM, V72, P39, DOI 10.1006/nlme.1998.3898; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gilbertson MW, 1997, ANN NY ACAD SCI, V821, P476, DOI 10.1111/j.1749-6632.1997.tb48309.x; Hamner M B, 1999, Depress Anxiety, V9, P1; Heim C, 2009, CNS SPECTRUMS, V14, P13; Jeon WT, 2008, PSYCHIAT INVEST, V5, P213, DOI 10.4306/pi.2008.5.4.213; JOELS M, 1990, P NATL ACAD SCI USA, V87, P4495, DOI 10.1073/pnas.87.12.4495; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Karl A, 2010, NEUROSCI BIOBEHAV R, V34, P7, DOI 10.1016/j.neubiorev.2009.06.008; KEANE TM, 1984, J CONSULT CLIN PSYCH, V52, P888, DOI 10.1037/0022-006X.52.5.888; Kim H.K., 1999, REY KIM MEMORY TEST; Kim HK, 1999, FRONTAL EXECUTIVE NE; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kozaric-Kovacic D, 2001, MIL MED, V166, P677, DOI 10.1093/milmed/166.8.677; Krysinska Karolina, 2009, J Trauma Nurs, V16, P103, DOI 10.1097/JTN.0b013e3181ac921f; Lee Y, 2001, AM J PREV MED, V20, P225, DOI 10.1016/S0749-3797(00)00282-8; Maddock Richard J, 2012, Curr Top Behav Neurosci, V11, P199; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Miller B., 1999, HUMAN FRONTAL LOBES; Ministry of Unification, 2017, UN WHIT PAP; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Neylan TC, 2003, BIOL PSYCHIAT, V54, P1118, DOI 10.1016/S0006-3223(02)01974-1; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Olff M, 2014, NEUROBIOL LEARN MEM, V112, P114, DOI 10.1016/j.nlm.2014.01.003; Park YS, 2014, PSYCHIAT INVEST, V11, P363, DOI 10.4306/pi.2014.11.4.363; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RYABININ AE, 1995, J NEUROSCI, V15, P721; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM, 1992, STRESS AGING BRAIN M; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Siegmund A, 2009, BIOL PSYCHIAT, V65, P258, DOI 10.1016/j.biopsych.2008.08.023; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; SPIELBERGER CD, 1970, STAI MANUAL STAIT TR; Trzesniak C, 2008, ACTA NEUROPSYCHIATR, V20, P56, DOI 10.1111/j.1601-5215.2008.00270.x; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Villarreal G, 2002, CAN J PSYCHIAT, V47, P666, DOI 10.1177/070674370204700709; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059; Xi GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028686; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; Yeum TH, 1992, KOREAN WECHSLER ADUL	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188953	10.1371/journal.pone.0188953	http://dx.doi.org/10.1371/journal.pone.0188953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216235	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800051
J	Lombardo, G; Gili, M; Grange, C; Cavallari, C; Dentelli, P; Togliatto, G; Taverna, D; Camussi, G; Brizzi, MF				Lombardo, Giusy; Gili, Maddalena; Grange, Cristina; Cavallari, Claudia; Dentelli, Patrizia; Togliatto, Gabriele; Taverna, Daniela; Camussi, Giovanni; Brizzi, Maria Felice			IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the beta-catenin pathway	ONCOGENE			English	Article							STAT5/PPAR-GAMMA TRANSCRIPTIONAL COMPLEX; F-BOX PROTEIN; WNT/BETA-CATENIN; STEM-CELLS; SIGNALING PATHWAY; PROGENITOR-CELL; PROMOTES ANGIOGENESIS; HELICOBACTER-PYLORI; COLORECTAL-CANCER; POTENTIAL ROLE	The proangiogenic cytokine Interleukin-3 (IL-3) is released by inflammatory cells in breast and ovarian cancer tissue microenvironments and also acts as an autocrine factor for human breast and kidney tumor-derived endothelial cells (TECs). We have previously shown that IL-3-treated endothelial cells (ECs) release extracellular vesicles (EVs), which serve as a paracrine mechanism for neighboring ECs, by transferring active molecules. The impact of an anti-IL-3R-alpha blocking antibody on the proangiogenic effect of EVs released from TECs (anti-IL-3R-EVs) has therefore been investigated in this study. We have found that anti-IL-3R-EV treatment prevented neovessel formation and, more importantly, also induced the regression of in vivo TEC-derived neovessels. Two miRs that target the canonical wingless (Wnt)/beta-catenin pathway, at different levels, were found to be differentially regulated when comparing the miR-cargo of naive TEC-derived EVs (EVs) and anti-IL-3R-EVs. miR-214-3p, which directly targets beta-catenin, was found to be upregulated, whereas miR-24-3p, which targets adenomatous polyposis coli (APC) and glycogen synthase kinase-3 beta (GSK3 beta), was found to be downregulated. In fact, upon their transfer into the cell, low beta-catenin content and high levels of the two members of the "beta-catenin destruction complex" were detected. Moreover, c-myc downregulation was found in TECs treated with anti-IL-3R-EVs, pre-miR-214-3p-EVs and antago-miR-24-3p-EVs, which is consistent with network analyses of miR-214-3p and miR-24-3p gene targeting. Finally, in vivo studies have demonstrated the impaired growth of vessels in pre-miR-214-3p-EV- and antago-miR-24-3p-EV-treated animals. These effects became much more evident when combo treatment was applied. The results of the present study identify the canonical Wnt/beta-catenin pathway as a relevant mechanism of TEC-derived EV proangiogenic action. Furthermore, we herein provide evidence that IL-3R blockade may yield some significant advantages, than miR targeting, in inhibiting the proangiogenic effects of naive TEC-derived EVs by changing TEC-EV-miR cargo.	[Lombardo, Giusy; Gili, Maddalena; Grange, Cristina; Cavallari, Claudia; Dentelli, Patrizia; Togliatto, Gabriele; Camussi, Giovanni; Brizzi, Maria Felice] Univ Turin, Dept Med Sci, Turin, Italy; [Taverna, Daniela; Camussi, Giovanni; Brizzi, Maria Felice] Univ Torino, MBC, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Camussi, G; Brizzi, MF (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.; Camussi, G; Brizzi, MF (corresponding author), Univ Torino, MBC, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	giovanni.camussi@unito.it; mariafelice.brizzi@unito.it	Brizzi, Maria Felice/J-7882-2016; Togliatto, Gabriele/K-5668-2016; Camussi, Giovanni/J-7624-2016	Togliatto, Gabriele/0000-0002-3123-7823; Camussi, Giovanni/0000-0003-2795-232X; GRANGE, CRISTINA/0000-0002-6960-5476	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 2015.16973, IG 2015.17630]; Ministero dell'Istruzione, Universita e Ricerca (MIUR)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by grants obtained by GC and MFB from the Associazione Italiana per la Ricerca sul Cancro (AIRC) projects IG 2015.16973 and IG 2015.17630 and by grants obtained by MFB from Ministero dell'Istruzione, Universita e Ricerca (MIUR) ex 60%. We thank Professor Paolo Provero from the University of Turin for his useful advice on using Ingenuity Pathway Analysis (IPA) Software.	Bastakoty D, 2016, FASEB J, V30, P3271, DOI 10.1096/fj.201600502R; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Brizzi MF, 2004, FASEB J, V18, P1249, DOI 10.1096/fj.03-1053fje; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Bruno S, 2017, TISSUE ENG PT A, V23, P1262, DOI [10.1089/ten.tea.2017.0069, 10.1089/ten.TEA.2017.0069]; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cavallari C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08250-0; Chang HC, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0242-3; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collino F, 2017, STEM CELL REV REP, V13, P226, DOI 10.1007/s12015-016-9713-1; D'Angelo B, 2016, ANTICANCER RES, V36, P5571, DOI 10.21873/anticanres.11142; Dai X, 2015, ADV DRUG DELIVER REV, V81, P184, DOI 10.1016/j.addr.2014.09.010; Dentelli P, 2005, ONCOGENE, V24, P6394, DOI 10.1038/sj.onc.1208786; Dentelli P, 2004, ONCOGENE, V23, P1681, DOI 10.1038/sj.onc.1207290; Dentelli P, 2011, ONCOGENE, V30, P4930, DOI 10.1038/onc.2011.204; Dentelli P, 1999, J IMMUNOL, V163, P2151; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Dentelli P, 2009, ARTERIOSCL THROM VAS, V29, P114, DOI 10.1161/ATVBAHA.108.172247; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Florea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073146; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gacche RN, 2013, PROG BIOPHYS MOL BIO, V113, P333, DOI 10.1016/j.pbiomolbio.2013.10.001; Gallo S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162417; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Giusti I, 2016, TUMOR BIOL, V37, P12743, DOI 10.1007/s13277-016-5165-0; Gomes FG, 2013, LIFE SCI, V92, P101, DOI 10.1016/j.lfs.2012.10.008; Grange C, 2006, ONCOL REP, V15, P381; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; GREENBERGER JS, 1983, FED PROC, V42, P2762; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He MY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122087; He SZ, 2015, LEUKEMIA LYMPHOMA, V56, P1406, DOI 10.3109/10428194.2014.956316; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; IHLE JN, 1992, CHEM IMMUNOL, V51, P65; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Kiewisz J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854056; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Lee E, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.2; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lin HY, 2017, EBIOMEDICINE, V18, P62, DOI 10.1016/j.ebiom.2017.03.012; Liu NN, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2351-9; Lombardo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25689; Marikawa Y, 1998, MECH DEVELOP, V77, P75, DOI 10.1016/S0925-4773(98)00134-8; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; METCALF D, 1986, BLOOD, V68, P46; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Moldenhauer LM, 2015, STEM CELL RES, V14, P380, DOI 10.1016/j.scr.2015.04.002; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Penfornis P, 2016, INT J CANCER, V138, P14, DOI 10.1002/ijc.29417; Pillai MM, 2014, BREAST CANCER RES TR, V146, P85, DOI 10.1007/s10549-014-3004-9; ROTHENBERG ME, 1988, J CLIN INVEST, V81, P1986, DOI 10.1172/JCI113547; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Schepeler T, 2012, ONCOGENE, V31, P2750, DOI 10.1038/onc.2011.453; Song XW, 2015, ONCOTARGET, V6, P35579, DOI 10.18632/oncotarget.5758; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun X, 2013, CELL SIGNAL, V25, P2805, DOI 10.1016/j.cellsig.2013.09.006; Takahashi RU, 2017, CLIN CHEM LAB MED, V55, P648, DOI 10.1515/cclm-2016-0708; Tickner JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00127; Togliatto G, 2016, INT J OBESITY, V40, P102, DOI 10.1038/ijo.2015.123; Trombetta A, 2013, DIABETES, V62, P1245, DOI 10.2337/db12-0646; Uberti B, 2010, ONCOGENE, V29, P6581, DOI 10.1038/onc.2010.384; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang WF, 2015, LIFE SCI, V136, P28, DOI 10.1016/j.lfs.2015.06.025; Wang XJ, 2012, BIOCHEM BIOPH RES CO, V428, P525, DOI 10.1016/j.bbrc.2012.10.039; Yang K, 2016, LAB INVEST, V96, P116, DOI 10.1038/labinvest.2015.144; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215; Zhang B, 2015, STEM CELL TRANSL MED, V4, P513, DOI 10.5966/sctm.2014-0267	73	28	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1175	1191		10.1038/s41388-017-0034-x	http://dx.doi.org/10.1038/s41388-017-0034-x			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29238040	Green Published, hybrid			2022-12-26	WOS:000426505400004
J	Chang, YJ; Li, NW; Wang, W; Liu, XJ; Du, FF; Yao, DR				Chang, Yajun; Li, Naiwei; Wang, Wei; Liu, Xiaojing; Du, Fengfeng; Yao, Dongrui			Nutrients resorption and stoichiometry characteristics of different-aged plantations of Larix kaempferi in the Qinling Mountains, central China	PLOS ONE			English	Article							LITTER DECOMPOSITION; NITROGEN RESORPTION; LEAF NITROGEN; FOREST; TERRESTRIAL; EFFICIENCY; PATTERNS; LEAVES; TEMPERATURE; CARBON	Elucidating the stoichiometry and resorption patterns of multiple nutrients is of essential importance to holistically understanding plant nutrition and biogeochemical cycling. Although many studies on ecological stoichiometry have been carried out, surprisingly few of them were simultaneously done on the investigation of both nutrient resorption efficiency and stoichiometry for different-aged plantations of a perennial tree. Here, both green and senesced leaf samples were collected from four Larix kaempfer plantations aged of 8, 15, 22, and 32 years in the Qinling Mountains to examine nutrients resorption efficiency and stoichiometry characteristics. The results suggested that the nutrient concentrations of N, P, K, Ca, Mg, Al, and Fe in both green and senesced leaves of L. kaempferi (a deciduous conifer tree) did not show a regular change trends along the plantation ages in the Qinling Mountains. The concentrations of the most nutrients examined, except for Fe, in the green leaves were relatively lower than or close to the required physiological concentrations, suggesting a relative limitation of multiple nutrients exists in L. kaempferi for its above-ground biomass growth. The rank order of resorption efficiencies of four key nutrients (N, P, K, and Mg) was K (80.89%) > N (67.42%) > P (65.34%) > Mg (41.16%), whereas the nutrient Ca and Fe tended to accumulate in senesced leaves. Overall, the nutrient resorption efficiency of all examined elements did not exhibit a regular trend corresponding to the change of the plantation ages in L. kaempferi, but it was positively related to the nutrient concentrations in green leaves. The mean C: N and C: P ratios in the green and senesced leaves were significantly higher than those reported globally (on average). By contrast, the N: P ratio, at <14, was not only much lower than that reported for both China's flora and globally (on average), but it did suggest that the N nutrient limits growth of L. kaempferi in these plantations. Taken together, the results of this study are of substantial interest and value to forest managers and for the sustainable development of the Qinling forest ecosystems.	[Yao, Dongrui] Inst Bot, Jiangsu Key Lab Bioresources Saline Soils, Nanjing, Jiangsu, Peoples R China; Chinese Acad Sci, Nanjing Bot Garden Mem Sun Yat Sen, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences	Yao, DR (corresponding author), Inst Bot, Jiangsu Key Lab Bioresources Saline Soils, Nanjing, Jiangsu, Peoples R China.	shuishengzu@126.com			Jiangsu Key Laboratory for Bioresources of Saline Soils [YT2014-02]; Jiangsu Provincial Environmental Protection Research Project [2016044]; National Natural Science Foundation of China [30671666]	Jiangsu Key Laboratory for Bioresources of Saline Soils; Jiangsu Provincial Environmental Protection Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by Jiangsu Key Laboratory for Bioresources of Saline Soils, No. YT2014-02 and Jiangsu Provincial Environmental Protection Research Project No. 2016044, and National Natural Science Foundation of China No. 30671666, thus the funders (Yajun CHANG) could taken study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the National Natural Science Foundation of China (No. 30671666), Jiangsu Key Laboratory for Bioresources of Saline Soils (No. YT2014-02), Jiangsu Provincial Environmental Protection Research Project (No. 2016044).	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Amatangelo KL, 2008, OECOLOGIA, V157, P619, DOI 10.1007/s00442-008-1108-9; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berg B., 2013, PLANT LITTER DECOMPO; Conn C, 2000, SOIL BIOL BIOCHEM, V32, P489, DOI 10.1016/S0038-0717(99)00178-9; CUEVAS E, 1986, OECOLOGIA, V68, P466, DOI 10.1007/BF01036756; Dodds WK, 2004, OECOLOGIA, V140, P458, DOI 10.1007/s00442-004-1599-y; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; FAWCETT J K, 1954, J Med Lab Technol, V12, P1; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Hagen-Thorn A, 2006, FOREST ECOL MANAG, V228, P33, DOI 10.1016/j.foreco.2006.02.021; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Huang JY, 2012, J ARID ENVIRON, V76, P1, DOI 10.1016/j.jaridenv.2011.08.018; HUANG JWW, 1992, PLANTA, V188, P414, DOI 10.1007/BF00192809; Kazakou E, 2007, FUNCT ECOL, V21, P235, DOI 10.1111/j.1365-2435.2006.01242.x; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kozovits AR, 2007, FUNCT ECOL, V21, P1034, DOI 10.1111/j.1365-2435.2007.01325.x; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Landsberg JJ, 1997, J APPL ECOL, V21, P21; Li SL, 2016, J W CHINA FORESTRY S, V3, P128; Li YL, 2013, ECOL ENG, V53, P299, DOI 10.1016/j.ecoleng.2012.12.061; Lu XT, 2012, J ECOL, V100, P144, DOI 10.1111/j.1365-2745.2011.01881.x; [马丰丰 Ma Fengfeng], 2016, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V36, P94; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MAY JD, 1992, ECOLOGY, V73, P1868, DOI 10.2307/1940038; Moe SJ, 2005, OIKOS, V109, P29, DOI 10.1111/j.0030-1299.2005.14056.x; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Norris MD, 2009, PLANT SOIL, V316, P193, DOI 10.1007/s11104-008-9770-6; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Pastor-Pastor A, 2015, IND CROP PROD, V65, P227, DOI 10.1016/j.indcrop.2014.11.044; Reed SC, 2012, NEW PHYTOL, V196, P173, DOI 10.1111/j.1469-8137.2012.04249.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Shi Yan, 2016, Forest Research, V29, P430; van Heerwaarden LM, 2003, OIKOS, V101, P664, DOI 10.1034/j.1600-0706.2003.12351.x; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Watanabe T, 2007, NEW PHYTOL, V174, P516, DOI 10.1111/j.1469-8137.2007.02078.x; Yuan ZY, 2010, PLANT SOIL, V327, P121, DOI 10.1007/s11104-009-0036-8; Yuan ZY, 2009, GLOBAL ECOL BIOGEOGR, V18, P11, DOI 10.1111/j.1466-8238.2008.00425.x; Yuan ZYY, 2009, GLOBAL ECOL BIOGEOGR, V18, P532, DOI 10.1111/j.1466-8238.2009.00474.x; Yuan ZY, 2004, ACTA BOT SIN, V46, P889; Zhang SB, 2012, GLOBAL ECOL BIOGEOGR, V21, P809, DOI 10.1111/j.1466-8238.2011.00729.x; [赵亚芳 Zhao Yafang], 2014, [植物学报, Chinese Bulletin of Botany], V49, P560	55	14	16	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189424	10.1371/journal.pone.0189424	http://dx.doi.org/10.1371/journal.pone.0189424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244849	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700033
J	Ko, Y; Kim, J; Park, JKH; Kim, H; Cho, JY; Kang, SB; Ahn, S; Lee, KJ; Lee, KH				Ko, Yousun; Kim, Jihang; Park, Joseph Kyu-Hyung; Kim, Haeryoung; Cho, Jai Young; Kang, Sung-Bum; Ahn, Soyeon; Lee, Kyong Joon; Lee, Kyoung Ho			Limited detection of small (<= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection	PLOS ONE			English	Article							GADOXETIC ACID; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC-ACCURACY; HEPATIC METASTASES; PHASE CT; CANCER; MRI; METAANALYSIS; SURVIVAL; LESIONS	Objective To retrospectively determine the sensitivity of preoperative CT in the detection of small (<= 10 mm) colorectal liver metastasis (CRLM) nodules in patients undergoing liver resection. Methods The institutional review board approved the study and waived informed consent. We included 461 pathologically confirmed CRLM nodules in 211 patients (including 71 women; mean age, 66.4 years) who underwent 229 liver resections following abdominal CT. Prior to 163 resections, gadoxetic acid-enhanced liver MR imaging was also performed. Nodules were matched between pathology reports and prospective CT reports following a predefined algorithm. Per-nodule sensitivity of CT was calculated by nodule-size category. Generalized estimating equations were used to adjust for within-case correlation. Results Fourteen nodule sizes were missing in the pathology report. Nodules of 1 +/- 5 mm and 6 +/- 10 mm accounted for 8.1% (n = 36) and 23.5% (n = 105) of the remaining 447 nodules, and the number of nodules gradually decreased as nodule size increased beyond 10 mm. The overall sensitivity of CT was 81.2% (95% confidence interval, 77.1%, 85.2%; 365/461). The sensitivity was 8% (0%, 17%; 3/36), 55% (45%, 65%; 59/105), 91%, 95%, and 100% for nodules of 1 +/- 5 mm, 6 +/- 10 mm, 11 +/- 15 mm, 16 +/- 20 mm, and > 20 mm, respectively. The nodule- size distribution was similar between resections undergoing gadoxetic acid-enhanced MR imaging and those not undergoing the MR imaging. Conclusion CT has limited sensitivity for nodules of <= 10 mm and particularly of <= 5 mm.	[Ko, Yousun; Kim, Jihang; Lee, Kyong Joon; Lee, Kyoung Ho] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Gyeonggi Do, South Korea; [Ko, Yousun; Lee, Kyoung Ho] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Program Biomed Radiat Sci, Seoul, South Korea; [Park, Joseph Kyu-Hyung] Seoul Natl Univ Hosp, Seoul, South Korea; [Kim, Haeryoung] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pathol, Coll Med, Seoul, South Korea; [Cho, Jai Young; Kang, Sung-Bum] Seoul Natl Univ, Dept Surg, Bundang Hosp, Gyeonggi Do, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Div Stat, Med Res Collaborating Ctr, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, J (corresponding author), Seoul Natl Univ, Dept Radiol, Bundang Hosp, Gyeonggi Do, South Korea.	radio622@gmail.com		Kim, Jihang/0000-0003-0077-3655; Kim, Haeryoung/0000-0002-4205-9081; Park, Joseph Kyu-hyung/0000-0002-0812-6228; Lee, Kyong Joon/0000-0002-0658-433X; Lee, Kyoung Ho/0000-0001-6045-765X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C0004, HI15C1052]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (No. HI13C0004 and HI15C1052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388; Bartolozzi C, 2004, EUR RADIOL, V14, P14, DOI 10.1007/s00330-003-1966-9; Bashir MR, 2013, J MAGN RESON IMAGING, V37, P398, DOI 10.1002/jmri.23818; Bipat S, 2005, RADIOLOGY, V237, P123, DOI 10.1148/radiol.2371042060; Cho JY, 2015, WORLD J SURG, V39, P1161, DOI 10.1007/s00268-015-2944-5; Costa EAC, 2015, RADIOLOGY, V276, P775, DOI 10.1148/radiol.2015142069; Elias D, 2010, ANN SURG, V251, P307, DOI 10.1097/SLA.0b013e3181bdf8cf; Floriani I, 2010, J MAGN RESON IMAGING, V31, P19, DOI 10.1002/jmri.22010; Genders TSS, 2012, RADIOLOGY, V265, P910, DOI 10.1148/radiol.12120509; Haider MA, 2002, RADIOLOGY, V225, P137, DOI 10.1148/radiol.2251011225; Jeong HT, 2012, J MAGN RESON IMAGING, V35, P635, DOI 10.1002/jmri.22880; Jhaveri K, 2015, AM J ROENTGENOL, V204, P498, DOI 10.2214/AJR.13.12399; Kim HJ, 2015, RADIOLOGY, V274, P712, DOI 10.1148/radiol.14140390; Kim HD, 2015, GASTROENTEROLOGY, V148, P1371, DOI 10.1053/j.gastro.2015.02.051; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Merkle EM, 2016, EUR RADIOL, V26, P674, DOI 10.1007/s00330-015-3873-2; Nakamura Y, 2013, J MAGN RESON IMAGING, V37, P684, DOI 10.1002/jmri.23855; National Comprehensive Cancer Network, 2014, CLIN PRACT ONC COL C; Neri E, 2016, EUR RADIOL, V26, P921, DOI 10.1007/s00330-015-3900-3; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Nomura K, 2007, J CLIN GASTROENTEROL, V41, P789, DOI 10.1097/01.mcg.0000225676.22218.08; Ong KO, 2007, SURG ONCOL, V16, P7, DOI 10.1016/j.suronc.2007.04.001; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Regge D, 2006, CLIN RADIOL, V61, P338, DOI 10.1016/j.crad.2005.12.010; Rosai J, 2011, ROSAI ACKERMANS SURG; Scharitzer M, 2013, EUR RADIOL, V23, P2187, DOI 10.1007/s00330-013-2824-z; Selzner MK, 2004, ANN SURG, V240, P1027, DOI 10.1097/01.sla.0000146145.69835.c5; Tamandl D, 2008, SURGERY, V143, P648, DOI 10.1016/j.surg.2007.11.020; Vilgrain V, 2016, EUR RADIOL, V26, P4595, DOI 10.1007/s00330-016-4250-5; Ward J, 1999, RADIOLOGY, V210, P459, DOI 10.1148/radiology.210.2.r99fe05459	30	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189797	10.1371/journal.pone.0189797	http://dx.doi.org/10.1371/journal.pone.0189797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244853	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700066
J	Ferreira, MJ; Mendes, AL; de Sa-Nogueira, I				Ferreira, Mario J.; Mendes, Aristides L.; de Sa-Nogueira, Isabel			The MsmX ATPase plays a crucial role in pectin mobilization by Bacillus subtilis	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; ABC TRANSPORTERS; FUNCTIONAL-ANALYSIS; DEGRADATION; GENE; MALTOSE; PROTEIN; SEQUENCE; ARABINANASE; ADAPTATIONS	Carbohydrates from plant cell walls are often found as heteropolysaccharides intertwined with each other. For competitive advantage against other microorganisms, and ability to fully exploit available carbon and energy sources, Bacillus subtilis possesses a high number of proteins dedicated to the uptake of mono-and oligosaccharides. Here, we characterize transporter complexes, belonging to the ATP-binding cassette (ABC) superfamily, involved in the uptake of oligosaccharides commonly found in pectin. The uptake of these carbohydrates is shown to be MsmX-dependent, assigning a key role in pectin mobilization for MsmX, a multipurpose ATPase serving several distinct ABC-type I sugar importers. Mutagenesis analysis of the transmembrane domains of the AraNPQ MsmX-dependent importer revealed putative residues for MsmX interaction. Interestingly however, although MsmX is shown to be essential for energizing various ABC transporters we found that a second B. subtilis ATPase, YurJ, is able to complement its function when placed in trans at a different locus of the chromosome.	[Ferreira, Mario J.; Mendes, Aristides L.; de Sa-Nogueira, Isabel] Univ Nova Lisboa, UCIBIO, REQUIMTE, Dept Ciencias Vida,Fac Ciencias & Tecnol, Caparica, Portugal; [Mendes, Aristides L.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Antonio Xavier, ITQB NOVA, Oeiras, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	de Sa-Nogueira, I (corresponding author), Univ Nova Lisboa, UCIBIO, REQUIMTE, Dept Ciencias Vida,Fac Ciencias & Tecnol, Caparica, Portugal.	isn@tct.unl.pt	Ferreira, Mário/AAD-4604-2020; de Sá-Nogueira, Isabel/AAC-4189-2020; de Sá-Nogueira, Isabel/B-9139-2011	Ferreira, Mário/0000-0002-5147-8659; de Sá-Nogueira, Isabel/0000-0001-6665-7994; de Sá-Nogueira, Isabel/0000-0001-6665-7994; Lopes Mendes, Aristides/0000-0002-9002-2232	Fundacao para a Ciencia e a Tecnologia (FCT/MCTES) [PEst-OE/BIA/UI0457/2011, UID/Multi/04378/2013, SFRH/BD/73039/2010]	Fundacao para a Ciencia e a Tecnologia (FCT/MCTES)(Portuguese Foundation for Science and Technology)	This work was supported by Fundagao para a Ciencia e a Tecnologia (FCT/MCTES http://www.fct.pt/index.phtml.pt) [PEst-OE/BIA/U10457/2011 to Centro de Recursos Microbiologicos (CREM); UID/Multi/04378/2013 to Unidade de Ciencias Biomoleculares Aplicadas (UCIBIO); fellowship SFRH/BD/73039/2010 to M.J.F.].; Lia Godinho constructed pLG31, Grac E a Susete constructed pGS1 and strain IQB622, Liliana Brito constructed pLB1 and strain IQB623, and Joana Lima constructed pJL1. Lu o A s Jaime Mota, Adriano O. Henriques, and Mariana G. Pinho provided the antibodies used for immunoblotting. This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT/MCTES) [PEst-OE/BIA/UI0457/2011 to Centro de Recursos Microbiologicos (CREM); UID/Multi/04378/2013 to Unidade de Ciencias Biomoleculares Aplicadas (UCIBIO); fellowship SFRH/BD/73039/2010 to M.J.F.].	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Chai YR, 2012, MBIO, V3, DOI 10.1128/mBio.00184-12; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deppe VM, 2011, APPL ENVIRON MICROB, V77, P2839, DOI 10.1128/AEM.02515-10; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Edwards MC, 2012, APPL MICROBIOL BIOT, V95, P565, DOI 10.1007/s00253-012-4173-2; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; GILSON E, 1982, NUCLEIC ACIDS RES, V10, P7449, DOI 10.1093/nar/10.22.7449; HURTUBISE Y, 1995, MOL MICROBIOL, V17, P367, DOI 10.1111/j.1365-2958.1995.mmi_17020367.x; Inacio JM, 2008, MICROBIOL-SGM, V154, P2719, DOI 10.1099/mic.0.2008/018978-0; Inacio JM, 2008, J BACTERIOL, V190, P4272, DOI 10.1128/JB.00162-08; Kamionka A, 2001, FEMS MICROBIOL LETT, V204, P55, DOI 10.1111/j.1574-6968.2001.tb10862.x; KEMPF B, 1995, J BIOL CHEM, V270, P16701, DOI 10.1074/jbc.270.28.16701; Kim JH, 2010, APPL MICROBIOL BIOT, V85, P1839, DOI 10.1007/s00253-009-2210-6; Krispin O, 1998, J BACTERIOL, V180, P3250, DOI 10.1128/JB.180.12.3250-3252.1998; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leal TF, 2004, FEMS MICROBIOL LETT, V241, P41, DOI 10.1016/j.femsle.2004.10.003; Lewinson O, 2017, J MOL BIOL, V429, P606, DOI 10.1016/j.jmb.2017.01.010; Leyn SA, 2013, J BACTERIOL, V195, P2463, DOI 10.1128/JB.00140-13; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Loque D, 2015, CURR OPIN PLANT BIOL, V25, P151, DOI 10.1016/j.pbi.2015.05.018; Marciniak BC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-401; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; MARTIN I, 1987, MOL GEN GENET, V208, P177, DOI 10.1007/BF00330439; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Muntel J, 2014, MOL CELL PROTEOMICS, V13, P1008, DOI 10.1074/mcp.M113.032631; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SaNogueira I, 1997, J BACTERIOL, V179, P7705, DOI 10.1128/jb.179.24.7705-7711.1997; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Serra CR, 2014, J BACTERIOL, V196, P4184, DOI 10.1128/JB.01993-14; Shipkowski S, 2006, APPL ENVIRON MICROB, V72, P7730, DOI 10.1128/AEM.01306-06; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Song YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054090; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; Tam NKM, 2006, J BACTERIOL, V188, P2692, DOI 10.1128/JB.188.7.2692-2700.2006; Tan MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130792; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Watzlawick H, 2016, J BACTERIOL, V198, P2887, DOI 10.1128/JB.00468-16; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189483	10.1371/journal.pone.0189483	http://dx.doi.org/10.1371/journal.pone.0189483			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240795	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600036
J	Ji, CC; Jia, YH; Gao, ZH; Wei, HD; Li, XS				Ji, Cuicui; Jia, Yonghong; Gao, Zhihai; Wei, Huaidong; Li, Xiaosong			Nonlinear spectral mixture effects for photosynthetic/non-photosynthetic vegetation cover estimates of typical desert vegetation in western China	PLOS ONE			English	Article							ESTIMATING FRACTIONAL COVER; HYPERSPECTRAL DATA; NONPHOTOSYNTHETIC VEGETATION; ENDMEMBER VARIABILITY; EO-1 HYPERION; SOIL; MODEL; VALIDATION; REGION	Desert vegetation plays significant roles in securing the ecological integrity of oasis ecosystems in western China. Timely monitoring of photosynthetic/non-photosynthetic desert vegetation cover is necessary to guide management practices on land desertification and research into the mechanisms driving vegetation recession. In this study, nonlinear spectral mixture effects for photosynthetic/non-photosynthetic vegetation cover estimates are investigated through comparing the performance of linear and nonlinear spectral mixture models with different endmembers applied to field spectral measurements of two types of typical desert vegetation, namely, Nitraria shrubs and Haloxylon. The main results were as follows. (1) The correct selection of endmembers is important for improving the accuracy of vegetation cover estimates, and in particular, shadow endmembers cannot be neglected. (2) For both the Nitraria shrubs and Haloxylon, the Kernel-based Nonlinear Spectral Mixture Model (KNSMM) with nonlinear parameters was the best unmixing model. In consideration of the computational complexity and accuracy requirements, the Linear Spectral Mixture Model (LSMM) could be adopted for Nitraria shrubs plots, but this will result in significant errors for the Haloxylon plots since the nonlinear spectral mixture effects were more obvious for this vegetation type. (3) The vegetation canopy structure (planophile or erectophile) determines the strength of the nonlinear spectral mixture effects. Therefore, no matter for Nitraria shrubs or Haloxylon, the non-linear spectral mixing effects between the photosynthetic / non-photosynthetic vegetation and the bare soil do exist, and its strength is dependent on the three-dimensional structure of the vegetation canopy. The choice of linear or nonlinear spectral mixture models is up to the consideration of computational complexity and the accuracy requirement.	[Ji, Cuicui; Jia, Yonghong] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Hubei, Peoples R China; [Ji, Cuicui; Li, Xiaosong] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Gao, Zhihai] Chinese Acad Forestry, Inst Forest Resources Informat Tech, Beijing, Peoples R China; [Wei, Huaidong] Gansu Desert Control Res Inst, State Key Lab Desertificat & Aeolian Sand Disaste, Lanzhou, Gansu, Peoples R China	Wuhan University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Forestry	Li, XS (corresponding author), Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	lixs@radi.ac.cn		li, xiao song/0000-0002-6048-1577	National Key Research and Development Program [2016YFC0500806]; National Natural Science Foundation of China [1360204, 41571421]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by National Key Research and Development Program (NO. 2016YFC0500806, http//program.most.gov.cn/), National Natural Science Foundation of China (No.1360204, http/www.nsfc.gov.cn/), National Natural Science Foundation of China (No. 41571421, http.//www.nsfc.gov.cn/).; The work was funded by National Key Research and Development Program (NO. 2016YFC0500806, http://program.most.gov.cn/),National Natural Science Foundation of China (No.1360204, http://program.nsfc.gov.cn/), National Natural Science Foundation of China (No. 41571421, http://program.nsfc.gov.cn/ ).	Adams J.B., 1993, REMOTE GEOCHEMICAL A; ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; Ammanouil R, 2017, IEEE T IMAGE PROCESS, V26, P340, DOI 10.1109/TIP.2016.2627815; [Anonymous], HYPERSPECTRAL REMOTE; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Asner GP, 2002, INT J REMOTE SENS, V23, P3939, DOI 10.1080/01431160110115960; Bastin G, 2012, REMOTE SENS ENVIRON, V121, P443, DOI 10.1016/j.rse.2012.02.021; Bhatia R., 2009, POSITIVE DEFINITE MA; Boardman J. W., 1993, SUMM 4 JPL AIRB GEOS, V1, P11; BOREL CC, 1994, REMOTE SENS ENVIRON, V47, P403, DOI 10.1016/0034-4257(94)90107-4; Broadwater J, 2007, GEOSC REM SENS S 200; Camps-Valls G, 2005, IEEE T GEOSCI REMOTE, V43, P1351, DOI 10.1109/TGRS.2005.846154; Camps-Valls G., 2009, KERNEL METHODS REMOT; Chang CI, 2000, IEEE T GEOSCI REMOTE, V38, P1144, DOI 10.1109/36.843007; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; Chen J, 2013, IEEE T SIGNAL PROCES, V61, P480, DOI 10.1109/TSP.2012.2222390; Chen XX, 2006, REMOTE SENS ENVIRON, V103, P338, DOI 10.1016/j.rse.2005.05.023; Elmore AJ, 2000, REMOTE SENS ENVIRON, V73, P87, DOI 10.1016/S0034-4257(00)00100-0; Fan WY, 2009, INT J REMOTE SENS, V30, P2951, DOI 10.1080/01431160802558659; Fitzgerald GJ, 2005, REMOTE SENS ENVIRON, V97, P526, DOI 10.1016/j.rse.2005.05.020; Gao ZhiHai, 2011, Scientia Silvae Sinicae, V47, P9; Gillespie A., 1990, 2 AIRBORNE VISIBLEIN, P243; Gries D, 2005, PLANT ECOL, V181, P23, DOI 10.1007/s11258-004-7808-2; Guerschman JP, 2015, REMOTE SENS ENVIRON, V161, P12, DOI 10.1016/j.rse.2015.01.021; Guerschman JP, 2009, REMOTE SENS ENVIRON, V113, P928, DOI 10.1016/j.rse.2009.01.006; Halimi A, 2011, IEEE T GEOSCI REMOTE, V49, P4153, DOI 10.1109/TGRS.2010.2098414; Heinz DC, 2001, IEEE T GEOSCI REMOTE, V39, P529, DOI 10.1109/36.911111; Heylen R, 2014, IEEE J-STARS, V7, P1844, DOI 10.1109/JSTARS.2014.2320576; [吉小敏 Ji Xiaomin], 2012, [中国沙漠, Journal of Desert Research], V32, P399; Jia Xiao-hong, 2008, Huanjing Kexue, V29, P2046; Jiao YQ, 2015, STUDY SPATIAL VARIAB, P70; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Lelong CCD, 1998, REMOTE SENS ENVIRON, V66, P179, DOI 10.1016/S0034-4257(98)00049-2; [李涛 Li Tao], 2015, [生态学报, Acta Ecologica Sinica], V35, P3643; Li Xiao-run, 2011, Journal of Zhejiang University, V45, P607, DOI 10.3785/j.issn.1008-973X.2011.04.004; Li XR, 2014, SIGNAL IMAGE VIDEO P, V8, P1555, DOI 10.1007/s11760-012-0392-3; Li XS, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100800; [刘发民 Liu Famin], 2002, [干旱区研究, Arid Zone Research], V19, P27; Liu KH, 2015, IEEE T GEOSCI REMOTE, V53, P2254, DOI 10.1109/TGRS.2014.2358620; McGwire K, 2000, REMOTE SENS ENVIRON, V72, P360, DOI 10.1016/S0034-4257(99)00112-1; Mercer J, 1909, PHILOS T R SOC LOND, V209, P415, DOI 10.1098/rsta.1909.0016; Mishra NB, 2014, GEOCARTO INT, V29, P860, DOI 10.1080/10106049.2013.868041; Nascimento JMP, 2009, P SOC PHOTO-OPT INS, P7477; Okin GS, 2013, REMOTE SENS ENVIRON, V130, P266, DOI 10.1016/j.rse.2012.11.021; Peddle DR, 2005, INT J REMOTE SENS, V26, P4959, DOI 10.1080/01431160500213979; Qiu XY, 2008, SELECTION KERNEL BAS; Ray TW, 1996, REMOTE SENS ENVIRON, V55, P59, DOI 10.1016/0034-4257(95)00171-9; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; ROBERTS DA, 1990, REMOTE SENS ENVIRON, V34, P1, DOI 10.1016/0034-4257(90)90080-6; ROBERTS DA, 1992, IEEE J QUANTUM ELECT, V28, P2057, DOI 10.1109/3.159516; Roberts DA, 2004, ECOSYSTEMS, V7, P545, DOI 10.1007/s10021-004-0144-5; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Settle JJ, 2005, IEEE T GEOSCI REMOTE, V43, P398, DOI 10.1109/TGRS.2004.841485; SETTLE JJ, 1993, INT J REMOTE SENS, V14, P1159, DOI 10.1080/01431169308904402; SMITH MO, 1990, REMOTE SENS ENVIRON, V31, P1, DOI 10.1016/0034-4257(90)90074-V; Somers B, 2009, INT J REMOTE SENS, V30, P139, DOI 10.1080/01431160802304625; Somers B, 2014, IEEE J-STARS, V7, P1956, DOI 10.1109/JSTARS.2013.2289989; Somers B, 2011, REMOTE SENS ENVIRON, V115, P1603, DOI 10.1016/j.rse.2011.03.003; Somers B, 2009, REMOTE SENS ENVIRON, V113, P1183, DOI 10.1016/j.rse.2009.02.003; Sun DX, 2011, J GANSU FORESTRY SCI, V36, P42; [唐晓燕 Tang Xiaoyan], 2013, [遥感技术与应用, Remote Sensing Technology and Application], V28, P731; Theseira MA, 2002, INT J REMOTE SENS, V23, P687, DOI 10.1080/01431160010019652; Vikhamar D, 2003, REMOTE SENS ENVIRON, V88, P309, DOI 10.1016/j.rse.2003.06.004; [王涛 WANG Tao], 2009, [中国沙漠, Journal of Desert Research], V29, P1; Wu CS, 2003, REMOTE SENS ENVIRON, V84, P493, DOI 10.1016/S0034-4257(02)00136-0; Wu ZY, 1998, FLORA REPUBLICAE POP; Wu ZY, 1979, FLORA REPUBLICAE POP; Zaanen AC, 1956, LINEAR ANAL BIBLIOTH; Zhang KC, 2017, LAND DEGRAD DEV, V28, P142, DOI 10.1002/ldr.2584; Zhang L, 2007, INT J REMOTE SENS, V28, P4157, DOI 10.1080/01431160600993454; Zheng GX, 2016, SPECTROSC SPECT ANAL, V36, P1063, DOI 10.3964/j.issn.1000-0593(2016)04-1063-06	73	4	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189292	10.1371/journal.pone.0189292	http://dx.doi.org/10.1371/journal.pone.0189292			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240777	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600026
J	Michelessi, M; Lucenteforte, E; Miele, A; Oddone, F; Crescioli, G; Fameli, V; Korevaar, DA; Virgili, G				Michelessi, Manuele; Lucenteforte, Ersilia; Miele, Alba; Oddone, Francesco; Crescioli, Giada; Fameli, Valeria; Korevaar, Daniel A.; Virgili, Gianni			Diagnostic accuracy research in glaucoma is still incompletely reported: An application of Standards for Reporting of Diagnostic Accuracy Studies (STARD) 2015	PLOS ONE			English	Article							QUALITY; TRIALS; BIAS	Background Research has shown a modest adherence of diagnostic test accuracy (DTA) studies in glaucoma to the Standards for Reporting of Diagnostic Accuracy Studies (STARD). We have applied the updated 30-item STARD 2015 checklist to a set of studies included in a Cochrane DTA systematic review of imaging tools for diagnosing manifest glaucoma. Methods Three pairs of reviewers, including one senior reviewer who assessed all studies, independently checked the adherence of each study to STARD 2015. Adherence was analyzed on an individual-item basis. Logistic regression was used to evaluate the effect of publication year and impact factor on adherence. Results We included 106 DTA studies, published between 2003-2014 in journals with a median impact factor of 2.6. Overall adherence was 54.1% for 3,286 individual rating across 31 items, with a mean of 16.8 (SD: 3.1; range 8-23) items per study. Large variability in adherence to reporting standards was detected across individual STARD 2015 items, ranging from 0 to 100%. Nine items (1: identification as diagnostic accuracy study in title/abstract; 6: eligibility criteria; 10: index test (a) and reference standard (b) definition; 12: cut-off definitions for index test (a) and reference standard (b); 14: estimation of diagnostic accuracy measures; 21a: severity spectrum of diseased; 23: cross-tabulation of the index and reference standard results) were adequately reported in more than 90% of the studies. Conversely, 10 items (3: scientific and clinical background of the index test; 11: rationale for the reference standard; 13b: blinding of index test results; 17: analyses of variability; 18; sample size calculation; 19: study flow diagram; 20: baseline characteristics of participants; 28: registration number and registry; 29: availability of study protocol; 30: sources of funding) were adequately reported in less than 30% of the studies. Only four items showed a statistically significant improvement over time: missing data (16), baseline characteristics of participants (20), estimates of diagnostic accuracy (24) and sources of funding (30). Conclusions Adherence to STARD 2015 among DTA studies in glaucoma research is incomplete, and only modestly increasing over time.	[Michelessi, Manuele; Oddone, Francesco] IRCSS Fdn GB Bietti, Rome, Italy; [Lucenteforte, Ersilia; Crescioli, Giada] Univ Florence, Dept Translat Surg & Med, Florence, Italy; [Miele, Alba; Virgili, Gianni] Univ Florence, Neurosci Psychol Drug Res & Child Hlth NEUROFARBA, Florence, Italy; [Fameli, Valeria] Univ Rome Sapienza, Dept Sens, Ophthalmol Unit, Organs, Rome, Italy; [Korevaar, Daniel A.] Univ Amsterdam, AMC, Dept Clin Epidemiol Biostat & Bioinformat KEBB, Amsterdam, Netherlands	University of Florence; University of Florence; Sapienza University Rome; University of Amsterdam; Academic Medical Center Amsterdam	Michelessi, M (corresponding author), IRCSS Fdn GB Bietti, Rome, Italy.	manuele_michelessi@yahoo.it	Lucenteforte, Ersilia/AAB-9055-2019; Oddone, Francesco/K-8876-2016; Korevaar, Daniël A./O-5809-2019; Crescioli, Giada/L-6736-2019; Virgili, Gianni/P-6607-2014	Lucenteforte, Ersilia/0000-0001-5608-5902; Oddone, Francesco/0000-0002-2504-0004; Virgili, Gianni/0000-0002-9960-2989; Crescioli, Giada/0000-0002-1071-6120	Italian Ministry of Health; Fondazione Roma	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	The contribution of the IRCCS Fondazione Bietti in this paper was supported by the Italian Ministry of Health and by Fondazione Roma. The supporting organization had no role in the design or conduct of this research.; The contribution of the IRCCS Fondazione Bietti in this paper was supported by the Italian Ministry of Health and by Fondazione Roma.	Banister K, 2016, OPHTHALMOLOGY, V123, P930, DOI 10.1016/j.ophtha.2016.01.041; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bussel II, 2014, BRIT J OPHTHALMOL, V98, P15, DOI 10.1136/bjophthalmol-2013-304326; Choi YJ, 2016, KOREAN J RADIOL, V17, P706, DOI 10.3348/kjr.2016.17.5.706; Chong GT, 2012, CURR OPIN OPHTHALMOL, V23, P79, DOI 10.1097/ICU.0b013e32834ff431; Cohen JF, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3751; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Fidalgo BMR, 2015, OPHTHAL PHYSL OPT, V35, P315, DOI 10.1111/opo.12208; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hong PJ, 2017, J MAGN RESON IMAGING; Johnson ZK, 2007, OPHTHALMOLOGY, V114, P1607, DOI 10.1016/j.ophtha.2006.11.036; Korevaar Daniel A, 2014, Evid Based Med, V19, P47, DOI 10.1136/eb-2013-101637; Lisboa R, 2013, CURR OPIN PHARMACOL, V13, P115, DOI 10.1016/j.coph.2012.10.010; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; Michelessi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008803.pub2; Paranjothy B, 2007, J GLAUCOMA, V16, P670, DOI 10.1097/IJG.0b013e3180457c6d; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053; Rao HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108992; Siddiqui MAR, 2005, BRIT J OPHTHALMOL, V89, P261, DOI 10.1136/bjo.2004.051862; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting PF, 2013, J CLIN EPIDEMIOL, V66, P1093, DOI 10.1016/j.jclinepi.2013.05.014; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	23	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189716	10.1371/journal.pone.0189716	http://dx.doi.org/10.1371/journal.pone.0189716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240827	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600067
J	Tome-Stangl, L; Schaetzel, C; Tenzer, S; Bernhard, F; Schneider, D				Tome-Stangl, Lydia; Schaetzel, Cornelia; Tenzer, Stefan; Bernhard, Frank; Schneider, Dirk			The soluble loop BC region guides, but not dictates, the assembly of the transmembrane cytochrome b(6)	PLOS ONE			English	Article							HELIX-HELIX INTERACTIONS; DE-NOVO DESIGN; EXPRESSED POLYPEPTIDE FRAGMENTS; INTEGRAL MEMBRANE-PROTEIN; INDUCED ELECTRON-TRANSFER; HEME-BINDING; IN-VITRO; ESCHERICHIA-COLI; 4-HELIX BUNDLE; INTERHELICAL LOOPS	Studying folding and assembly of naturally occurring alpha-helical transmembrane proteins can inspire the design of membrane proteins with defined functions. Thus far, most studies have focused on the role of membrane-integrated protein regions. However, to fully understand folding pathways and stabilization of a +/- helical membrane proteins, it is vital to also include the role of soluble loops. We have analyzed the impact of interhelical loops on folding, assembly and stability of the heme-containing four-helix bundle transmembrane protein cytochrome b(6) that is involved in charge transfer across biomembranes. Cytochrome b6 consists of two transmembrane helical hairpins that sandwich two heme molecules. Our analyses strongly suggest that the loop connecting the helical hairpins is not crucial for positioning the two protein "halves' for proper folding and assembly of the holo-protein. Furthermore, proteolytic removal of any of the remaining two loops, which connect the two transmembrane helices of a hairpin structure, appears to also not crucially effect folding and assembly. Overall, the transmembrane four-helix bundle appears to be mainly stabilized via interhelical interactions in the transmembrane regions, while the soluble loop regions guide assembly and stabilize the holo-protein. The results of this study might steer future strategies aiming at designing heme-binding four-helix bundle structures, involved in transmembrane charge transfer reactions.	[Tome-Stangl, Lydia; Schaetzel, Cornelia; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany; [Tenzer, Stefan] Univ Med Ctr Mainz, Inst Immunol, Mainz, Germany; [Bernhard, Frank] Goethe Univ Frankfurt Main, Inst Biophys Chem, Frankfurt, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Goethe University Frankfurt	Schneider, D (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020	Tenzer, Stefan/0000-0003-3034-0017; Bernhard, Frank/0000-0002-4860-1783	Centre of Complex Matter (COMATT); University of Mainz	Centre of Complex Matter (COMATT); University of Mainz	D.S. was supported by grants from the Centre of Complex Matter (COMATT) and from the University of Mainz.	Akdogan Y, 2012, BIOCHEMISTRY-US, V51, P7149, DOI 10.1021/bi300489s; Allen SJ, 2001, J MOL BIOL, V308, P423, DOI 10.1006/jmbi.2001.4604; BABCOCK GT, 1985, BIOCHEMISTRY-US, V24, P3638, DOI 10.1021/bi00335a036; Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; Booth PJ, 2001, CRIT REV BIOCHEM MOL, V36, P501, DOI 10.1080/20014091074246; Boronowsky U, 2001, BBA-BIOENERGETICS, V1506, P55, DOI 10.1016/S0005-2728(01)00184-0; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Choi YJ, 2013, PEERJ, V1, DOI 10.7717/peerj.1; CHOMA CT, 1994, J AM CHEM SOC, V116, P856, DOI 10.1021/ja00082a005; Cramer WA, 2005, PHOTOSYNTH RES, V85, P133, DOI 10.1007/s11120-004-2149-5; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]; Dreher C, 2008, J MOL BIOL, V382, P1057, DOI 10.1016/j.jmb.2008.07.025; Dreher C, 2007, FEBS LETT, V581, P2647, DOI 10.1016/j.febslet.2007.05.007; Dreher C, 2010, J BIOENERG BIOMEMBR, V42, P517, DOI 10.1007/s10863-010-9279-6; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; FLORY PJ, 1967, J AM CHEM SOC, V89, P6807, DOI 10.1021/ja01002a001; Francke C, 1999, FEBS LETT, V442, P75, DOI 10.1016/S0014-5793(98)01629-9; Ghirlanda G, 2004, J AM CHEM SOC, V126, P8141, DOI 10.1021/ja039935g; Gibney BR, 1998, BIOCHEMISTRY-US, V37, P4635, DOI 10.1021/bi971856s; Goparaju G, 2016, BBA-BIOENERGETICS, V1857, P503, DOI 10.1016/j.bbabio.2015.12.002; Hasan SS, 2013, BBA-BIOENERGETICS, V1827, P1295, DOI 10.1016/j.bbabio.2013.03.002; Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009; HUANG KS, 1981, J BIOL CHEM, V256, P3802; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; HURT E, 1982, J BIOENERG BIOMEMBR, V14, P405, DOI 10.1007/BF00743067; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; Kim JM, 2001, J MOL BIOL, V308, P409, DOI 10.1006/jmbi.2001.4603; Koch HG, 2016, ADV PHOTOSYNTH RESPI; Korendovych IV, 2010, J AM CHEM SOC, V132, P15516, DOI 10.1021/ja107487b; Kramer DM, 1994, BIOCHIMICA ET BIOPHY, V1184; Kroliczewski J, 2005, BIOCHEMISTRY-US, V44, P7570, DOI 10.1021/bi047422w; Kroliczewski J, 2002, BBA-PROTEINS PROTEOM, V1598, P177, DOI 10.1016/S0167-4838(02)00369-2; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landin JS, 2001, BIOCHEMISTRY-US, V40, P11176, DOI 10.1021/bi0100539; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lujan MA, 2012, PHOTOSYNTH RES, V112, P193, DOI 10.1007/s11120-012-9772-3; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Martinez-Gil L, 2015, VIRUSES-BASEL, V7, P3462, DOI 10.3390/v7072781; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; OZOLS J, 1964, J BIOL CHEM, V239, P1018; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Prodohl A, 2007, PROTEIN EXPRES PURIF, V56, P279, DOI 10.1016/j.pep.2007.08.007; Prodohl A, 2007, BIOCHIMIE, V89, P1433, DOI 10.1016/j.biochi.2007.06.006; Prodohl A, 2005, J MOL BIOL, V350, P744, DOI 10.1016/j.jmb.2005.05.016; Rath A, 2013, ANAL BIOCHEM, V434, P67, DOI 10.1016/j.ab.2012.11.007; Rau HK, 1998, P NATL ACAD SCI USA, V95, P11526, DOI 10.1073/pnas.95.20.11526; Rau HK, 1998, J AM CHEM SOC, V120, P468, DOI 10.1021/ja973018r; Rau HK, 1996, BER BUNSEN PHYS CHEM, V100, P2052, DOI 10.1002/bbpc.19961001222; Ridge KD, 1996, J BIOL CHEM, V271, P7860, DOI 10.1074/jbc.271.13.7860; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rojas NRL, 1997, PROTEIN SCI, V6, P2512; Saint-Marcoux D, 2009, J CELL BIOL, V185, P1195, DOI 10.1083/jcb.200812025; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider D, 2007, CURR PROTEIN PEPT SC, V8, P45, DOI 10.2174/138920307779941578; Schneider S, 2007, NAT PROD REP, V24, P621, DOI 10.1039/b604186h; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Sehgal P, 2005, BBA-BIOMEMBRANES, V1716, P59, DOI 10.1016/j.bbamem.2005.08.006; Shifman JM, 2000, BIOCHEMISTRY-US, V39, P14813, DOI 10.1021/bi000927b; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solomon LA, 2014, J AM CHEM SOC, V136, P3192, DOI 10.1021/ja411845f; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; STUART AL, 1973, BIOCHIM BIOPHYS ACTA, V314, P284, DOI 10.1016/0005-2728(73)90113-8; Tastan O, 2009, BIOPHYS J, V96, P2299, DOI 10.1016/j.bpj.2008.12.3894; Tome L, 2014, MOL MEMBR BIOL, V31, P37, DOI 10.3109/09687688.2013.867079; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Ulmschneider MB, 2005, PROTEIN ENG DES SEL, V18, P563, DOI 10.1093/protein/gzi059; Volkmer T, 2006, BBA-BIOMEMBRANES, V1758, P1815, DOI 10.1016/j.bbamem.2006.05.009; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; Ye SX, 2005, NANO LETT, V5, P1658, DOI 10.1021/nl050542k	77	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189532	10.1371/journal.pone.0189532	http://dx.doi.org/10.1371/journal.pone.0189532			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240839	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600044
J	Zhang, W; Cao, JE; Xu, J				Zhang, Wen; Cao, Jieer; Xu, Jun			How to quantitatively evaluate safety of driver behavior upon accident? A biomechanical methodology	PLOS ONE			English	Article							HEAD-INJURIES; LOGIT MODEL; ROAD USERS; ON-ROAD; COLLISION; OPTIMIZATION; MOTORCYCLIST; PERFORMANCE; CYCLIST; ALCOHOL	How to evaluate driver spontaneous reactions in various collision patterns in a quantitative way is one of the most important topics in vehicle safety. Firstly, this paper constructs representative numerical crash scenarios described by impact velocity, impact angle and contact position based on finite element (FE) computation platform. Secondly, a driver cabin model is extracted and described in the well validated multi-rigid body (MB) model to compute the value of weighted injury criterion to quantitatively assess drivers' overall injury under certain circumstances. Furthermore, based on the coupling of FE and MB, parametric studies on various crash scenarios are conducted. It is revealed that the WIC (Weighted Injury Criteria) value variation law under high impact velocities is quite distinct comparing with the one in low impact velocities. In addition, the coupling effect can be elucidated by the fact that the difference of WIC value among three impact velocities under smaller impact angles tends to be distinctly higher than that under larger impact angles. Meanwhile, high impact velocity also increases the sensitivity of WIC under different collision positions and impact angles. Results may provide a new methodology to quantitatively evaluate driving behaviors and serve as a significant guiding step towards collision avoidance for autonomous driving vehicles.	[Zhang, Wen; Xu, Jun] Beihang Univ, Dept Automot Engn, Sch Transportat Sci & Engn, Beijing, Peoples R China; [Zhang, Wen; Xu, Jun] Beihang Univ, Adv Vehicle Res Ctr, Beijing, Peoples R China; [Zhang, Wen] Beihang Univ, Shenyuan Honors Coll, Beijing, Peoples R China; [Cao, Jieer] Chalmers Univ Technol, Dept Appl Mech, Gothenburg, Sweden	Beihang University; Beihang University; Beihang University; Chalmers University of Technology	Xu, J (corresponding author), Beihang Univ, Dept Automot Engn, Sch Transportat Sci & Engn, Beijing, Peoples R China.; Xu, J (corresponding author), Beihang Univ, Adv Vehicle Res Ctr, Beijing, Peoples R China.	junxu@buaa.edu.cn	Xu, Jun/B-2260-2016	Xu, Jun/0000-0002-8619-8737	Fundamental Research Funds for the Central Universities, Beihang University; start-up funds of "The Recruitment Program of Global Experts" awardee, Beihang University [YWF-16-RSC-011]	Fundamental Research Funds for the Central Universities, Beihang University; start-up funds of "The Recruitment Program of Global Experts" awardee, Beihang University	This work is financially supported by Fundamental Research Funds for the Central Universities, Beihang University and start-up funds of "The Recruitment Program of Global Experts" awardee (YWF-16-RSC-011), Beihang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is financially supported by Fundamental Research Funds for the Central Universities, Beihang University and start-up funds of "The Recruitment Program of Global Experts" awardee (YWF-16-RSC-011), Beihang University. The authors appreciate Dr. Ciaran Simms at Trinity College Dublin for the valuable discussions and suggestions for this paper.	Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; Aust ML, 2012, ACCIDENT ANAL PREV, V45, P782, DOI 10.1016/j.aap.2011.11.001; Automotive T., 2001, MANUAL MADYMO HUMAN; Behr M, 2010, ACCIDENT ANAL PREV, V42, P797, DOI 10.1016/j.aap.2009.04.010; Brannstrom M, 2010, IEEE T INTELL TRANSP, V11, P658, DOI 10.1109/TITS.2010.2048314; Bunce D, 2012, ACCIDENT ANAL PREV, V49, P293, DOI 10.1016/j.aap.2012.01.001; Chung YS, 2015, ACCIDENT ANAL PREV, V82, P79, DOI 10.1016/j.aap.2015.05.003; Deng XQ, 2013, ACCIDENT ANAL PREV, V55, P232, DOI 10.1016/j.aap.2013.03.016; Ehsani JP, 2015, J SAFETY RES, V54, P83, DOI 10.1016/j.jsr.2015.06.015; Harb R, 2009, ACCIDENT ANAL PREV, V41, P98, DOI 10.1016/j.aap.2008.09.009; Hasselberg M, 2009, ACCIDENT ANAL PREV, V41, P734, DOI 10.1016/j.aap.2009.03.012; Hault-Dubrulle A, 2011, ACCIDENT ANAL PREV, V43, P75, DOI 10.1016/j.aap.2010.07.013; Hault-Dubrulle A, 2011, ACCIDENT ANAL PREV, V43, P66, DOI 10.1016/j.aap.2010.07.012; Hillenbrand J, 2006, IEEE T INTELL TRANSP, V7, P528, DOI 10.1109/TITS.2006.883115; Hjelkrem OA, 2016, ACCIDENT ANAL PREV, V95, P227, DOI 10.1016/j.aap.2016.07.006; Ito D, 2015, TRAFFIC INJ PREV, V16, P260, DOI 10.1080/15389588.2014.937805; Jurecki R, 2009, VEHICLE SYST DYN, V47, P589, DOI 10.1080/00423110802276028; Jurecki RS, 2014, TRANSPORT RES F-TRAF, V27, P22, DOI 10.1016/j.trf.2014.08.006; Kaempchen N, 2009, IEEE T INTELL TRANSP, V10, P678, DOI 10.1109/TITS.2009.2026452; Leung S, 2005, ACCIDENT ANAL PREV, V37, P1056, DOI 10.1016/j.aap.2005.06.004; Li ZG, 2014, SAFETY SCI, V62, P441, DOI 10.1016/j.ssci.2013.10.009; Liang YL, 2010, ACCIDENT ANAL PREV, V42, P881, DOI 10.1016/j.aap.2009.05.001; Liao XT, 2008, INT J CRASHWORTHINES, V13, P279, DOI 10.1080/13588260801933659; Malta L, 2009, IEEE T INTELL TRANSP, V10, P201, DOI 10.1109/TITS.2009.2018321; Mann RE, 2010, ACCIDENT ANAL PREV, V42, P1538, DOI 10.1016/j.aap.2010.03.010; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Markkula G, 2016, ACCIDENT ANAL PREV, V95, P209, DOI 10.1016/j.aap.2016.07.007; Matsumoto AT, 2012, INT J CRASHWORTHINES, V17, P479, DOI 10.1080/13588265.2012.678693; Milton JC, 2008, ACCIDENT ANAL PREV, V40, P260, DOI 10.1016/j.aap.2007.06.006; Morgan A, 2011, ACCIDENT ANAL PREV, V43, P1852, DOI 10.1016/j.aap.2011.04.024; Mueller AS, 2012, ACCIDENT ANAL PREV, V48, P472, DOI 10.1016/j.aap.2012.03.003; NCAC, 2013, CHECKL RUNN TOYOT YA; Norris FH, 2000, ACCIDENT ANAL PREV, V32, P505, DOI 10.1016/S0001-4575(99)00068-8; Salmon PM, 2014, ERGONOMICS, V57, P191, DOI 10.1080/00140139.2013.867077; Salmon PM, 2013, SAFETY SCI, V56, P6, DOI 10.1016/j.ssci.2012.02.008; Scialfa CT, 2011, ACCIDENT ANAL PREV, V43, P204, DOI 10.1016/j.aap.2010.08.010; STODUTO G, 1993, ACCIDENT ANAL PREV, V25, P411, DOI 10.1016/0001-4575(93)90070-D; Tencer AF, 2002, ACCIDENT ANAL PREV, V34, P1, DOI 10.1016/S0001-4575(00)00097-X; Wagstrom L, 2013, INT J CRASHWORTHINES, V18, P385, DOI 10.1080/13588265.2013.801292; Wang XS, 2016, TRANSPORT RES C-EMER, V71, P419, DOI 10.1016/j.trc.2016.08.014; Wu Q, 2016, TRAFFIC INJ PREV, V17, P413, DOI 10.1080/15389588.2015.1100722; Xie SC, 2013, TRAFFIC INJ PREV, V14, P816, DOI 10.1080/15389588.2013.768341; Xu J, 2016, ACCIDENT ANAL PREV, V89, P128, DOI 10.1016/j.aap.2016.01.013; Yan X, 2016, PLOS ONE, V11; Zoller I, 2015, TRANSPORT RES F-TRAF, V31, P54, DOI 10.1016/j.trf.2015.03.004	45	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189455	10.1371/journal.pone.0189455	http://dx.doi.org/10.1371/journal.pone.0189455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240789	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600034
J	Ye, F				Ye, Fei			Particle swarm optimization-based automatic parameter selection for deep neural networks and its applications in large-scale and high-dimensional data	PLOS ONE			English	Article							LEFT-VENTRICLE; SEGMENTATION; MODEL; ALGORITHM	In this paper, we propose a new automatic hyperparameter selection approach for determining the optimal network configuration (network structure and hyperparameters) for deep neural networks using particle swarm optimization (PSO) in combination with a steepest gradient descent algorithm. In the proposed approach, network configurations were coded as a set of real-number m-dimensional vectors as the individuals of the PSO algorithm in the search procedure. During the search procedure, the PSO algorithm is employed to search for optimal network configurations via the particles moving in a finite search space, and the steepest gradient descent algorithm is used to train the DNN classifier with a few training epochs (to find a local optimal solution) during the population evaluation of PSO. After the optimization scheme, the steepest gradient descent algorithm is performed with more epochs and the final solutions (pbest and gbest) of the PSO algorithm to train a final ensemble model and individual DNN classifiers, respectively. The local search ability of the steepest gradient descent algorithm and the global search capabilities of the PSO algorithm are exploited to determine an optimal solution that is close to the global optimum. We constructed several experiments on hand-written characters and biological activity prediction datasets to show that the DNN classifiers trained by the network configurations expressed by the final solutions of the PSO algorithm, employed to construct an ensemble model and individual classifier, outperform the random approach in terms of the generalization performance. Therefore, the proposed approach can be regarded an alternative tool for automatic network structure and parameter selection for deep neural networks.	[Ye, Fei] Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University	Ye, F (corresponding author), Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Sichuan, Peoples R China.	122404504@gq.com						Ahn CW, 2002, IEEE T EVOLUT COMPUT, V6, P566, DOI 10.1109/TEVC.2002.804323; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Avendi MR, 2016, MED IMAGE ANAL, V30, P108, DOI 10.1016/j.media.2016.01.005; Baly R, 2016, ACM T INFORM SYST, V35, DOI 10.1145/2950050; Carneiro G., 2012, SEGMENTATION LEFT VE; Cha KH, 2016, MED PHYS, V43, P1882, DOI 10.1118/1.4944498; Chaturvedi I, 2016, KNOWL-BASED SYST, V108, P144, DOI 10.1016/j.knosys.2016.07.019; Chen HZ, 2016, PATTERN RECOGN, V55, P148, DOI 10.1016/j.patcog.2016.01.020; Chen HL, 2014, APPL MATH COMPUT, V239, P180, DOI 10.1016/j.amc.2014.04.039; Chen SH, 2017, IEEE T MED IMAGING, V36, P802, DOI 10.1109/TMI.2016.2629462; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Dhungel N, 2017, MED IMAGE ANAL, V37, P114, DOI 10.1016/j.media.2017.01.009; Ding S., 2017, BOLTZMANN MACHINE IT; Dorigo M., 1997, IEEE Transactions on Evolutionary Computation, V1, P53, DOI 10.1109/4235.585892; Esmin AAA, 2005, IEEE T POWER SYST, V20, P859, DOI 10.1109/TPWRS.2005.846049; Fan XN, 2015, MOL BIOSYST, V11, P892, DOI 10.1039/c4mb00650j; Gaing ZL, 2004, IEEE T ENERGY CONVER, V19, P384, DOI 10.1109/TEC.2003.821821; Golkov V, 2016, IEEE T MED IMAGING, V35, P1344, DOI 10.1109/TMI.2016.2551324; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Huang CL, 2008, APPL SOFT COMPUT, V8, P1381, DOI 10.1016/j.asoc.2007.10.007; Ijjina E. P., 2016, HUMAN ACTION RECOGNI; Ishaque K, 2012, IEEE T POWER ELECTR, V27, P3627, DOI 10.1109/TPEL.2012.2185713; Ithapu V. K., 2015, COMPUTER SCI, P488; Ji XP, 2017, KNOWL-BASED SYST, V122, P64, DOI 10.1016/j.knosys.2017.01.035; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Klein S, 2009, INT J COMPUT VISION, V81, P227, DOI 10.1007/s11263-008-0168-y; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lei T., 2015, INDIANA U MATH J, V58, P1151; Li QD, 2016, KNOWL-BASED SYST, V107, P289, DOI 10.1016/j.knosys.2016.06.017; Lodhi H, 2012, WIRES COMPUT STAT, V4, P455, DOI 10.1002/wics.1223; Murtaza F, 2016, IET COMPUT VIS, V10, P758, DOI 10.1049/iet-cvi.2015.0416; Nasef A., 2017, STOCHASTIC GRADIENT; Needell D, 2016, MATH PROGRAM, V155, P549, DOI 10.1007/s10107-015-0864-7; Pan J., 2013, INT S CHIN SPOK LANG, V7196, P301; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Park JB, 2005, IEEE T POWER SYST, V20, P34, DOI 10.1109/TPWRS.2004.831275; Poria S., 2016, ASPECT EXTRACTION OP; Ratnaweera A., 2004, SELF ORGANIZING HIER; Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5; Ritchie D., 2016, NEURALLY GUIDED PROC; Romo-Bucheli D, 2017, CYTOM PART A, V91A, P566, DOI 10.1002/cyto.a.23065; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Singh R., 2016, BIOINFORMATICS; Tang Y., 2013, ARXIV; Ting TO, 2006, IEEE T POWER SYST, V21, P411, DOI 10.1109/TPWRS.2005.860907; Tsuji S., 2015, AACR SPEC C COMP SYS, V75; Ngo TA, 2017, MED IMAGE ANAL, V35, P159, DOI 10.1016/j.media.2016.05.009; Venter G., 2013, AIAA J, V41, P129; Wang PC, 2016, IEEE T HUM-MACH SYST, V46, P498, DOI 10.1109/THMS.2015.2504550; Xu J, 2016, IEEE T MED IMAGING, V35, P119, DOI 10.1109/TMI.2015.2458702; Yan ZN, 2016, IEEE T MED IMAGING, V35, P1332, DOI 10.1109/TMI.2016.2524985; Yao TT, 2017, PATTERN RECOGN, V64, P236, DOI 10.1016/j.patcog.2016.11.012; Yi Y, 2016, PATTERN RECOGN, V53, P148, DOI 10.1016/j.patcog.2015.11.022; Zhang N., 2016, APPL SOFT COMPUTING; Zhang S., 2014, DEEP LEARNING ELASTI, P685; Zhang S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1025	62	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188746	10.1371/journal.pone.0188746	http://dx.doi.org/10.1371/journal.pone.0188746			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236718	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100028
J	Brakemeier, S; Vogt, L; Adams, L; Zukunft, B; Diederichs, G; Hamm, B; Budde, K; Makowski, MR				Brakemeier, Susanne; Vogt, Lars; Adams, Lisa; Zukunft, Bianca; Diederichs, Gerd; Hamm, Bernd; Budde, Klemens; Makowski, Marcus R.			Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC)	PLOS ONE			English	Article							CONTROLLED-TRIAL; MINIMAL FAT; LYMPHANGIOLEIOMYOMATOSIS; EVEROLIMUS; LESIONS	Purpose Tuberous sclerosis complex (TSC)-associated renal angiomyolipoma (AML) have a high lifetime risk of acute bleeding. MTOR-inhibitors are a promising novel treatment for TSC-AML, however adequate response to therapy can be difficult to assess. Early changes in MRI signal may serve as a novel early indicator for a satisfactory response to mTOR-inhibitor therapy of AML. Materials and methods Thirty-eight patients with the definite diagnosis of tuberous sclerosis receiving everolimus therapy and n = 19 patients without specific therapy were included. 1.5 Tesla MRI was performed including sequences with a selective fat suppression. Patients were investigated prior to the initiation of therapy (baseline) and after <3 months (n = 21 patients), 3 to 6 months (n = 32) and 18 to 24 months (n = 28). Signal and size changes of renal AMLs were assessed at all different timepoints. Signal-to-noise-ratio (SNR), contrast-to-noise-ratio (CNR) and size of angiomyolipomas were evaluated. Results Signal changes in 273 AMLs were evaluated. A significant and strong decrease of the CNR of AMLs following the initiation of therapy was measured in the fat-suppressed MR sequence at all time points, compared to the baseline: From 7.41 +/- 6.98 to 3.84 +/- 6.25 (p <= 0.05p = 0.002), 3.36 +/- 6.93 (p<0.0001), and 2.50 +/- 6.68 (p<0.0001) after less than 3 months, 3-6 months or 18-24 months of everolimus treatment, respectively. Also, a significant, however less pronounced, reduction of angiomyolipoma size in the different groups was measured (from baseline 2022.2 +/- 2657.7 mm2 to 1854.4 +/- 1670.9 mm2 (p = 0.009), 1875.5 +/- 3190.1 mm2 (p<0.001), and 1365.8 +/- 1628.8 mm2 (p<0.0001) after less than 3 months, 3-6 months or 18-24 months of everolimus treatment, respectively). No significant changes in CNR (p>0.05) and size (p>0.05) were measured in the control group. Conclusion mTOR inhibitor therapy in TSC patients results in an early and pronounced fatty transformation of AMLs on MRI. Fatty transformation could represent a novel early indicator of response to therapy in this patient collective.	[Brakemeier, Susanne; Zukunft, Bianca; Budde, Klemens] Charite, Dept Nephrol & Med Intens Care, Berlin, Germany; [Vogt, Lars; Adams, Lisa; Diederichs, Gerd; Hamm, Bernd; Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany; [Makowski, Marcus R.] Kings Coll London, Div Imaging Sci, London, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London	Brakemeier, S (corresponding author), Charite, Dept Nephrol & Med Intens Care, Berlin, Germany.	susanne@brakemeier@charite.de	Makowski, Marcus R/Q-7957-2018; Budde, Klemens/AAD-2170-2020; Adams, Lisa C./AAC-7163-2021	Budde, Klemens/0000-0002-7929-5942; Adams, Lisa C./0000-0001-5836-4542				Bissler JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180939; Bissler JJ, 2016, NEPHROL DIAL TRANSPL, V31, P111, DOI 10.1093/ndt/gfv249; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Budde K, 2012, AM J KIDNEY DIS, V59, P276, DOI 10.1053/j.ajkd.2011.10.013; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Dixon BP, 2011, NEPHRON EXP NEPHROL, V118, pE15, DOI 10.1159/000320891; Eijkemans MJC, 2015, AM J KIDNEY DIS, V66, P638, DOI 10.1053/j.ajkd.2015.05.016; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Hafron J, 2005, UROLOGY, V66, P1155, DOI 10.1016/j.urology.2005.06.119; Henske EP, 1996, AM J HUM GENET, V59, P400; Jinzaki M, 1997, RADIOLOGY, V205, P497, DOI 10.1148/radiology.205.2.9356635; Lane HA, 2009, CLIN CANCER RES, V15, P1612, DOI 10.1158/1078-0432.CCR-08-2057; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; Williams JM, 2006, AM J KIDNEY DIS, V47, P95, DOI 10.1053/j.ajkd.2005.09.028	15	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189132	10.1371/journal.pone.0189132	http://dx.doi.org/10.1371/journal.pone.0189132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232371	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200022
J	Oki, N; Kaga, A; Shimizu, T; Takahashi, M; Kono, Y; Takahashi, M				Oki, Nobuhiko; Kaga, Akito; Shimizu, Takehiko; Takahashi, Masakazu; Kono, Yuhi; Takahashi, Motoki			QTL mapping of antixenosis resistance to common cutworm (Spodoptera litura Fabricius) in wild soybean (Glycine soja)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ANTIBIOSIS RESISTANCE; INSECT RESISTANCE; CORN-EARWORM; DOMESTICATION; CRY1AC; RANGE	The common cutworm (CCW; Spodoptera litura Fabricius) is a serious herbivorous insect pest of soybean (Glycine max) in Asia and Oceania. Previously, we identified quantitative trait loci (QTLs) for CCW-antibiosis-resistance, CCW-1 and CCW-2, and antixenosis-resistance, qRslx1 and qRslx2, in the cultivar 'Himeshirazu'. The effects of these QTLs are useful in the breeding of CCW-resistant cultivars. In this study, we conducted an antixenosis bioassay on CCW using recombinant inbred lines derived from a cross between a wild soybean (Glycine soja) and the leading cultivar 'Fukuyutaka' to identify CCW-resistance genes in G. soja. The QTL analysis revealed six and four novel antixenosis-resistance QTLs in 2012 and 2013, respectively. Among them, the QTLs on chromosomes 2 and 7, designated qRslx4 and qRslx3, respectively, were stably detected in both years. qRslx3 exhibited the largest effect in both years, suggesting that qRslx3 can be exploited in the breeding of CCW-resistant soybean. Furthermore, qRslx3 and qRslx4 can be used, along with previously reported QTLs from 'Himeshirazu', to enhance the CCW-resistance of soybean cultivars because their chromosomal positions are unique. These new CCW-resistance QTLs from G. soja should play important roles in the breeding of CCW-resistant soybean cultivars.	[Oki, Nobuhiko; Takahashi, Masakazu; Kono, Yuhi] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Koushi, Kumamoto, Japan; [Kaga, Akito; Shimizu, Takehiko; Takahashi, Motoki] Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Kaga, A (corresponding author), Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki, Japan.	kaga@affre.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [SFC1009]	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was supported by grants from Ministry of Agriculture, Forestry, and Fisheries of Japan (http://www.maff.go.jp/; Genomics-based Technology for Agricultural Improvement, SFC1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter TE, 2004, BIOLOGICAL RESOURCES AND MIGRATION, P47; CHURCHILL GA, 1994, GENETICS, V138, P963; Ellis S. E., 2004, NEW PEST RESPONSE GU; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Kaga A, 2005, ANN REPORT EXPLORATI, V21, P59; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Kaga A, 2011, BREEDING SCI, V61, P566, DOI 10.1270/jsbbs.61.566; Kao CH, 1999, GENETICS, V152, P1203; Khosla S, 1999, NUCLEIC ACIDS RES, V27, P3745, DOI 10.1093/nar/27.18.3745; Kim H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0267-8; Kim HJ, 2014, EUPHYTICA, V196, P137, DOI 10.1007/s10681-013-1021-0; KOGAN M, 1970, ANN ENTOMOL SOC AM, V63, P1175, DOI 10.1093/aesa/63.4.1175; Komatsu K, 2005, CROP SCI, V45, P2044, DOI 10.2135/cropsci2004.0744; Komatsu K, 2004, BREEDING SCI, V54, P27, DOI 10.1270/jsbbs.54.27; Komatsu K, 2008, CROP SCI, V48, P527, DOI 10.2135/cropsci2006.12.0770; Kuroda Y, 2005, ANN REP EXPLOR INTRO, V21, P73; Kuroda Y, 2006, ANN REPORT EXPLORATI, V22, P1; Kuroda Y, 2007, ANN REPORT EXPLORATI, V23, P9; Kuroda Y, 2013, ECOL EVOL, V3, P2150, DOI 10.1002/ece3.606; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Narvel JM, 2001, CROP SCI, V41, P1931, DOI 10.2135/cropsci2001.1931; Oki N, 2015, CROP SCI, V55, P624, DOI 10.2135/cropsci2014.05.0364; Oki N, 2011, BREEDING SCI, V61, P608, DOI 10.1270/jsbbs.61.608; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Rector BG, 1998, THEOR APPL GENET, V96, P786, DOI 10.1007/s001220050803; Rector BG, 2000, CROP SCI, V40, P233, DOI [10.2135/cropsci2000.401233x, 10.2135/cropsci1999.0011183X003900020038x]; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Tarry LI, 2000, CROP SCI, V40, P375, DOI 10.2135/cropsci2000.402375x; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; VANDUYN JW, 1971, CROP SCI, V11, P572, DOI 10.2135/cropsci1971.0011183X001100040035x; Walker D, 2002, MOL BREEDING, V9, P43, DOI 10.1023/A:1018923925003; Walker DR, 2004, THEOR APPL GENET, V109, P1051, DOI 10.1007/s00122-004-1714-9; Xing GN, 2012, THEOR APPL GENET, V125, P859, DOI 10.1007/s00122-012-1878-7; Zhu S, 2008, THEOR APPL GENET, V116, P455, DOI 10.1007/s00122-007-0682-2; Zhu S, 2006, CROP SCI, V46, P1094, DOI 10.2135/cropsci2005.06-0109	36	10	10	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189440	10.1371/journal.pone.0189440	http://dx.doi.org/10.1371/journal.pone.0189440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232719	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200043
J	Wester, MJ; Lin, J; Neumann, AK				Wester, Michael J.; Lin, Jia; Neumann, Aaron K.			A computational model for regulation of nanoscale glucan exposure in Candida albicans	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; IMMUNE RECEPTOR DECTIN-1; CELL-WALL INTEGRITY; PROTEIN COMPLEXES; DENDRITIC CELLS; HEMITAM; GENE; RECOGNITION; ACTIVATION; SYK	Candida albicans is a virulent human opportunistic pathogen. It evades innate immune surveillance by masking an immunogenic cell wall polysaccharide, beta-glucan, from recognition by the immunoreceptor Dectin-1. Glucan unmasking by the antifungal drug caspofungin leads to changes in the nanostructure of glucan exposure accessible to Dectin-1. The physical mechanism that regulates glucan exposure is poorly understood, but it controls the nanobiology of fungal pathogen recognition. We created computational models to simulate hypothetical physical processes of unmasking glucan in a biologically realistic distribution of cell wall glucan fibrils. We tested the predicted glucan exposure nanostructural features arising from these models against experimentally measured values. A completely spatially random unmasking process, reflective of random environmental damage to the cell wall, cannot account for experimental observations of glucan unmasking. However, the introduction of partially edge biased unmasking processes, consistent with an unmasking contribution from active, local remodeling at glucan exposure sites, produces markedly more accurate predictions of experimentally observed glucan nanoexposures in untreated and caspofungin-treated yeast. These findings suggest a model of glucan unmasking wherein cell wall remodeling processes in the local nanoscale neighborhood of glucan exposure sites are an important contributor to the physical process of drug-induced glucan unmasking in C. albicans.	[Wester, Michael J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Wester, Michael J.] Univ New Mexico, Ctr Spatiotemporal Modeling Cell Signaling, Albuquerque, NM 87131 USA; [Lin, Jia; Neumann, Aaron K.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Neumann, AK (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	akneumann@salud.unm.edu		Wester, Michael/0000-0002-3520-7605	National Cancer Institute [P30CA118100]; National Institute of General Medical Sciences [P50GM085273]; National Institute of Allergy and Infectious Disease [R01AI116894]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute, https://www.cancer.gov/, Grant #: P30CA118100, Author recipients of funding: MJW; National Institute of General Medical Sciences, https://www.nigms.nih.gov/Pages/default.aspx, Grant #: P50GM085273, Author recipients of funding: MJW, AKN; National Institute of Allergy and Infectious Disease, http://niaid.nih.gov/, Grant #: R01AI116894, Author recipients of funding: AKN, JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P767, DOI 10.1086/518518; [Anonymous], 2012, ARCHITECTURE BIOSYNT; BACON JSD, 1969, BIOCHEM J, V114, P557, DOI 10.1042/bj1140557; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer B, 2017, J BIOL CHEM, V292, P3213, DOI 10.1074/jbc.M116.759977; Blanco-Menendez N, 2015, J IMMUNOL, V195, P4466, DOI 10.4049/jimmunol.1402874; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Buntru A, 2012, ARCH BIOCHEM BIOPHYS, V524, P77, DOI 10.1016/j.abb.2012.03.020; Ene IV, 2015, MBIO, V6, DOI 10.1128/mBio.00986-15; Esteban PF, 2005, CURR MICROBIOL, V51, P385, DOI 10.1007/s00284-005-0066-2; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; FLEET GH, 1976, J GEN MICROBIOL, V94, P180, DOI 10.1099/00221287-94-1-180; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Galao RP, 2014, CELL HOST MICROBE, V16, P291, DOI 10.1016/j.chom.2014.08.005; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garfoot ALS, 2016, AM SOC MICROBIOLOGY, V7, P1, DOI DOI 10.1128/mBio.01388-15; Gil-Bona A, 2015, J PROTEOMICS, V127, P340, DOI 10.1016/j.jprot.2015.06.006; GOLDMAN RC, 1995, EUR J BIOCHEM, V227, P372, DOI 10.1111/j.1432-1033.1995.tb20399.x; Gomez MJ, 1996, INFECT IMMUN, V64, P2577, DOI 10.1128/IAI.64.7.2577-2584.1996; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Gonzalez MD, 1997, MICROBIOL-UK, V143, P3023, DOI 10.1099/00221287-143-9-3023; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Hasim S, 2016, INFECTECTION IMMUNUN, V85; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Hopke A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005644; Itano MS, 2014, FRONT PHYS, V2, DOI 10.3389/fphy.2014.00046; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; KAPTEYN JC, 1994, EUR J CELL BIOL, V65, P402; KESSLER G, 1959, J BIOL CHEM, V234, P2281; Kimura Y, 2014, J BIOL CHEM, V289, P31565, DOI 10.1074/jbc.M114.581322; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; KOLAROVA N, 1973, BIOCHIM BIOPHYS ACTA, V328, P221, DOI 10.1016/0005-2795(73)90348-6; KOPECKA M, 1974, J CELL BIOL, V62, P66, DOI 10.1083/jcb.62.1.66; Krysan DJ, 2005, EUKARYOT CELL, V4, P1364, DOI 10.1128/EC.4.8.1364-1374.2005; Lee RH, 2016, J THROMB HAEMOST, V14, P645, DOI 10.1111/jth.13250; Lin JF, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9213034; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MASLER L, 1966, FOLIA MICROBIOL, V11, P373, DOI 10.1007/BF02887694; Mendez-Vilas A, 2006, ANTON LEEUW INT J G, V89, P495, DOI 10.1007/s10482-005-9048-4; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Osumi M, 1998, MICRON, V29, P207; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; Sandini S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-106; Sarthy AV, 1997, MICROBIOL-SGM, V143, P367, DOI 10.1099/00221287-143-2-367; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Vazquez HM, 2014, MOL BIOL CELL, V25, P3375, DOI 10.1091/mbc.E14-06-1033; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188599	10.1371/journal.pone.0188599	http://dx.doi.org/10.1371/journal.pone.0188599			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232689	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200006
J	Cho, S; Jang, H; Park, K				Cho, Sukyung; Jang, Haeun; Park, Kyong			Trends in the management levels of metabolic risk factors in middle-aged and elderly patients with type 2 diabetes mellitus: The Korean National Health and Nutrition Examination Survey 1998-2014	PLOS ONE			English	Article							GLYCEMIC CONTROL; OLDER-ADULTS; CHOLESTEROL; COMPLICATIONS; ASSOCIATION; ADHERENCE; BARRIERS; DENSITY; BURDEN	The present study examined the temporal trends in the management of blood pressure, glucose, and lipid levels among middle-aged and elderly patients with type 2 diabetes using data from the Korean National Health and Nutrition Examination Survey (1998-2014). A total of 3,689 patients with diabetes were included and divided into middle-aged (30-64 years old) and elderly (>= 65 years old) groups. Demographic and lifestyle data were obtained using a self-reported questionnaire, and trained medical staff obtained fasting blood samples and blood pressure data. Laboratory testing was performed to determine blood glucose, cholesterol, and triglyceride levels. In the multivariable adjusted models, significant decreasing trends in the prevalences of hyperglycemia and hypertension were observed in both age groups during 1998-2014, although no trends were observed for lipid levels. Based on the most recent survey, approximately 50% of patients with diabetes had hyperglycemia, and one-third of patients with diabetes and hypertension did not appropriately manage their blood pressure. In addition, 50% of the patients in both age groups did not manage their lipid profiles, and the management of lipid profiles did not improve in recent years. These results suggest that continuous follow-up is needed to effectively manage metabolic risk factors, especially lipid profiles, among patients with diabetes.	[Cho, Sukyung; Jang, Haeun; Park, Kyong] Yeungnam Univ, Dept Food & Nutr, Gyeongbuk, South Korea	Yeungnam University	Park, K (corresponding author), Yeungnam Univ, Dept Food & Nutr, Gyeongbuk, South Korea.	kypark@ynu.ac.kr	Park, Kyong/AFJ-9812-2022; Jang, Haeun/HCH-4439-2022; Park, Kyong/AAF-6888-2022	Park, Kyong/0000-0002-4681-1584; Park, Kyong/0000-0002-4681-1584; Jang, Haeun/0000-0003-1787-8402; cho, sukyung/0000-0003-1401-3067	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICTFuture Planning [NRF2014R1A1A3049866]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICTFuture Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT&Future Planning (NRF2014R1A1A3049866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Berkowitz SA, 2013, DIABETOLOGIA, V56, P2593, DOI 10.1007/s00125-013-3036-4; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chew BH, 2013, EXP GERONTOL, V48, P485, DOI 10.1016/j.exger.2013.02.017; Chiu CJ, 2010, PREV CHRONIC DIS, V7; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CORESH J, 1993, J LIPID RES, V34, P1687; El-Kebbi IM, 2003, ARCH INTERN MED, V163, P69, DOI 10.1001/archinte.163.1.69; Elderly Diabetes Investigation Team, 2010, ELD DIAB MELL, P11; Glasgow RE, 1997, DIABETES CARE, V20, P556, DOI 10.2337/diacare.20.4.556; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; Hwang JY, 2011, DIABETES METAB J, V35, P628, DOI 10.4093/dmj.2011.35.6.628; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Katakura M, 2007, DIABETES RES CLIN PR, V78, P108, DOI 10.1016/j.diabres.2007.02.019; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Korean Diabetes Association, 2011, DIABETES, P909; Krauss RM, 2004, DIABETES CARE, V27, P1496, DOI 10.2337/diacare.27.6.1496; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee EH, 2011, DIABETES METAB J, V35, P578, DOI 10.4093/dmj.2011.35.6.578; Lipska KJ, 2016, JAMA-J AM MED ASSOC, V315, P1034, DOI 10.1001/jama.2016.0299; MEADE LT, 2007, US PHARM, V32, P66; Ministry of Heath and Welfare Korea Centers for Disease Control and Prevention, 2014, QUAL CONTR CLIN LAB; Ministry of Heath and Welfare Korea Centers for Disease Control and Prevention, 2007, KOR HLTH STAT 2007 K; Ministry of Heath and Welfare Korea Centers for Disease Control and Prevention, 2014, QUAL CONTR ASS BLOOD; Ministry of Heath and Welfare Korea Centers for Disease Control and Prevention, 2014, KOR HLTH STAT 2014 K, P250; Nagrebetsky A, 2012, DIABETES RES CLIN PR, V96, P119, DOI 10.1016/j.diabres.2011.12.003; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; ORTIZALONSO FJ, 1994, AM J PHYSIOL-ENDOC M, V267, pE497, DOI 10.1152/ajpendo.1994.267.4.E497; Park K, 2015, NUTR RES PRACT, V9, P658, DOI 10.4162/nrp.2015.9.6.658; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Rothenbacher D, 2003, BRIT J GEN PRACT, V53, P389; Selvin E, 2013, DIABETOLOGIA, V56, P2549, DOI 10.1007/s00125-013-3078-7; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Strizich G, 2016, DIABETES RES CLIN PR, V117, P64, DOI 10.1016/j.diabres.2016.04.052; Subramanian U, 2009, J GEN INTERN MED, V24, P327, DOI 10.1007/s11606-008-0888-2; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; WHO, GLOB REP DIAB; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Zhang LH, 2015, DIABETES TECHNOL THE, V17, P816, DOI 10.1089/dia.2015.0094	43	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189361	10.1371/journal.pone.0189361	http://dx.doi.org/10.1371/journal.pone.0189361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228048	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600049
J	Guo, HR; Ding, EM; Bai, Y; Zhang, HD; Shen, HX; Wang, J; Song, XP; Cai, WY; Guo, JD; Zhu, BL				Guo, Haoran; Ding, Enmin; Bai, Ying; Zhang, Hengdong; Shen, Huanxi; Wang, Jun; Song, Xianping; Cai, Wenyan; Guo, Jiadi; Zhu, Baoli			Association of genetic variations in FOXO3 gene with susceptibility to noise induced hearing loss in a Chinese population	PLOS ONE			English	Article							OXIDATIVE STRESS; MICE; MECHANISMS; DISEASE; CANCER; LOCI	Noise induced hearing loss (NIHL), a multifactorial disease involving both genetic and environmental factors, is one of the most important occupational health hazards. Nonetheless, the influence of FOXO3 variants on NIHL risk have not been illuminated. This research was conducted to explore the effects of FOXO3 polymorphisms on individual susceptibility to NIHL. A total of 2689 industrial workers from one textile factory of east China were recruited to participate in the current research. Venous blood was collected, questionnaire and pure-tone audiometry (PTA) was conducted by specialist physicians. Then, we performed genotyping of three selected SNPs (rs2802292, rs10457180, and rs12206094) in FOXO3 gene in 566 NIHL patients and 566 controls. Subsequently, the main effects of genotype and its interactions were evaluated. Our results revealed that individuals with the G allele of rs2802292, G allele of rs10457180, T allele of rs12206094 (OR = 1.43, 1.43, and 1.31 respectively) and the haplotype GAC and others (TGT/GGT/GGC/GAT) (rs2802292-rs10457180-rs12206094) (OR = 1.49 and 2.09 respectively) are associated with an increased risk of NIHL in a Chinese population. Stratified analysis showed that an increased NIHL risk was found in the subjects who exposed to noise > 16 years with rs2802292 GG/GT and rs10457180 AG/GG genotype with an OR of 1.62 and 1.66 respectively. Multifactor dimensionality reduction analysis indicated that rs10457180, rs2802292, and rs12206094 have interactions and are related to increased NIHL risk (OR = 1.53). The genetic polymorphism rs2802292, rs10457180, and rs12206094 within FOXO3 gene are associated with an increased risk of NIHL in a Chinese population and have potential to be biomarkers for noise exposed workers.	[Guo, Haoran; Wang, Jun; Zhu, Baoli] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Guo, Haoran; Ding, Enmin; Bai, Ying; Zhang, Hengdong; Zhu, Baoli] Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Shen, Huanxi] Kunshan Ctr Dis Prevent & Control, Kunshan, Jiangsu, Peoples R China; [Song, Xianping; Cai, Wenyan; Guo, Jiadi] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University	Zhu, BL (corresponding author), Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.; Zhu, BL (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China.	zhubl@jscdc.cn			Jiangsu Provinces Outstanding Medical Academic Leader program [CXTDA2017029]; Huanxi Shen was funded by Jiangsu Program for Young Medical Talents [QNRC2016528]	Jiangsu Provinces Outstanding Medical Academic Leader program; Huanxi Shen was funded by Jiangsu Program for Young Medical Talents	Baoli Zhu was funded by Jiangsu Provinces Outstanding Medical Academic Leader program (CXTDA2017029) and Huanxi Shen was funded by Jiangsu Program for Young Medical Talents (QNRC2016528).	Carlsson PI, 2005, HEARING RES, V202, P87, DOI 10.1016/j.heares.2004.09.005; Chang NC, 2011, AUDIOL NEURO-OTOL, V16, P168, DOI 10.1159/000317119; Davis RR, 2001, HEARING RES, V155, P82, DOI 10.1016/S0378-5955(01)00250-7; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilels F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01142-3; Gilels F, 2013, J NEUROSCI, V33, P18409, DOI 10.1523/JNEUROSCI.2529-13.2013; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; HENDERSON D, 1993, EAR HEARING, V14, P152, DOI 10.1097/00003446-199306000-00002; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hwang JW, 2011, J IMMUNOL, V187, P987, DOI 10.4049/jimmunol.1001861; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jiang RH, 2003, PHARMACOGENOMICS, V4, P779; Konings A, 2009, EAR HEARING, V30, P151, DOI 10.1097/AUD.0b013e3181987080; Kowalski TJ, 2014, OTOL NEUROTOL, V35, P358, DOI 10.1097/MAO.0b013e3182a00332; Le Prell C G, 2003, Noise Health, V5, P1; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Shen HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089662; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340; White CH, 2009, MAMM GENOME, V20, P207, DOI 10.1007/s00335-009-9178-5; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang XH, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0063-2	27	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189186	10.1371/journal.pone.0189186	http://dx.doi.org/10.1371/journal.pone.0189186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220389	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900037
J	Kuwabara, WMT; Panveloski-Costa, AC; Yokota, CNF; Pereira, JNB; Mancini, J; Torres, RP; Hirabara, SM; Curi, R; Alba-Loureiro, TC				Tatagiba Kuwabara, Wilson Mitsuo; Panveloski-Costa, Ana Carolina; Fukusawa Yokota, Caroline Naomi; Bertaglia Pereira, Joice Naiara; Mancini Filho, Jorge; Torres, Rosangela Pavan; Hirabara, Sandro Massao; Curi, Rui; Alba-Loureiro, Tatiana Carolina			Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: Are they reliable models to study Type 2 Diabetes mellitus?	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; BETA-CELL MASS; INSULIN-RESISTANCE; GK RAT; ADIPOSE-TISSUE; GLUCOSE; INFLAMMATION; PROTEIN; PLASMA; LIVER	Type 2 Diabetes mellitus (T2DM) is an evident growing disease that affects different cultures throughout the world. T2DM occurs under the influence of three main factors: the genetic background, environmental and behavioral components. Obesity is strongly associated to the development of T2DM in the occident, while in the orient most of the diabetic patients are considered lean. Genetics may be a key factor in the development of T2DM in societies where obesity is not a recurrent public health problem. Herein, two different models of rats were used to understand their differences and reliability as experimental models to study the pathophysiology of T2DM, in two different approaches: the genetic (GK rats) and the environmental (HFD-induced obese rats) influences. GK rats were resistant to weight gain even though food/energy consumption (relative to body weight) was higher in this group. HFD, on the other hand, induced obesity in Wistar rats. White adipose tissue (WAT) expansion in this group was accompanied by immune cells infiltration, inflammation and insulin resistance. GK rats also presented WAT inflammation and insulin resistance; however, no immune cells infiltration was observed in the WAT of this group. Liver of HFD group presented fat accumulation without differences in inflammatory cytokines content, while liver of GK rats didn't present fat accumulation, but showed an increase of IL-6 and IL-10 content and glycogen. Also, GK rats showed increased plasma GOT and GPT. Soleus muscle of HFD presented normal insulin signaling, contrary to GK rats, which presented higher content of basal phosphorylation of GSK-3 beta. Our results demonstrated that HFD developed a mild insulin resistance in Wistar rats, but was not sufficient to develop T2DM. In contrast, GK rats presented all the typical hallmarks of T2DM, such as insulin resistance, defective insulin production, fasting hyperglycemia/hyperinsulinemia and lipid plasma alteration. Thus, on the given time point of this study, we may conclude that only GK rats shown to be a reliable model to study T2DM.	[Tatagiba Kuwabara, Wilson Mitsuo; Panveloski-Costa, Ana Carolina; Fukusawa Yokota, Caroline Naomi; Bertaglia Pereira, Joice Naiara; Curi, Rui; Alba-Loureiro, Tatiana Carolina] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Bertaglia Pereira, Joice Naiara; Hirabara, Sandro Massao; Curi, Rui] Cruzeiro do Sul Univ, Sao Paulo, Brazil; [Mancini Filho, Jorge; Torres, Rosangela Pavan] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Kuwabara, WMT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	wilsonk@icb.usp.br	Kuwabara, Wilson MT/H-9492-2017; Hirabara, Sandro Massao/C-4014-2012; Curi, Rui/AAT-7970-2021; Mancini-Filho, Jorge/F-3950-2018; Loureiro, Tatiana C Alba/U-9436-2018	Kuwabara, Wilson MT/0000-0001-5307-6218; Hirabara, Sandro Massao/0000-0002-7392-0444; Curi, Rui/0000-0001-5095-9154; Panveloski-Costa, Ana Carolina/0000-0003-4025-6644	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 2015/03175-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES 88881.068515/2014-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 163439/2013-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2015/03175-1), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES 88881.068515/2014-01) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 163439/2013-3). There was no additional external funding received for this study.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Barbu A, 2009, MOL CELL ENDOCRINOL, V299, P163, DOI 10.1016/j.mce.2008.11.019; Berthelier C, 1997, METABOLISM, V46, P890, DOI 10.1016/S0026-0495(97)90075-5; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BISBIS S, 1993, AM J PHYSIOL, V265, pE807, DOI 10.1152/ajpendo.1993.265.5.E807; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; CERASI E, 1995, DIABETOLOGIA, V38, P992, DOI 10.1007/BF00400591; CHALLISS RAJ, 1983, BIOSCIENCE REP, V3, P675, DOI 10.1007/BF01172878; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; CRETTAZ M, 1980, BIOCHEM J, V186, P525, DOI 10.1042/bj1860525; Dadke SS, 2000, BIOCHEM BIOPH RES CO, V274, P583, DOI 10.1006/bbrc.2000.3188; Del Prato S, 2010, INT J CLIN PRACT, V64, P295, DOI 10.1111/j.1742-1241.2009.02227.x; Dourmashkin JT, 2005, INT J OBESITY, V29, P1368, DOI 10.1038/sj.ijo.0803017; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Giroix MH, 2011, DIABETOLOGIA, V54, P2451, DOI 10.1007/s00125-011-2223-4; Golson ML, 2010, OPEN ENDOCRINOL, V4, P66, DOI [10.2174/1874216501004010066, DOI 10.2174/1874216501004010066]; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Granhall C, 2006, DIABETES, V55, P3494, DOI 10.2337/db06-0796; Helrich K, 2012, OFFICIAL METHODS ANA, P20; Hirabara SM, 2013, J NUTR BIOCHEM, V24, P1136, DOI 10.1016/j.jnutbio.2012.08.014; Hirabara SM, 2006, BBA-BIOENERGETICS, V1757, P57, DOI 10.1016/j.bbabio.2005.11.007; Jiang MH, 2011, ENDOCRINOLOGY, V152, P1284, DOI 10.1210/en.2010-1162; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Keller MP, 2010, ANNU REV NUTR, V30, P341, DOI 10.1146/annurev.nutr.012809.104747; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leibowitz G, 2011, J DIABETES INVEST, V2, P82, DOI 10.1111/j.2040-1124.2010.00094.x; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liu TW, 2015, LIPIDS, V50, P997, DOI 10.1007/s11745-015-4061-5; Mandarim-De-Lacerda CA, 1995, METODOS QUANTITATIVO, P195; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Miralles F, 2001, DIABETES, V50, pS84, DOI 10.2337/diabetes.50.2007.S84; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Movassat J, 2007, DIABETES OBES METAB, V9, P187, DOI 10.1111/j.1463-1326.2007.00786.x; Padilla DJ, 2007, RESP PHYSIOL NEUROBI, V156, P187, DOI 10.1016/j.resp.2006.08.008; Pan M, 2006, J PINEAL RES, V41, P79, DOI 10.1111/j.1600-079X.2006.00346.x; Panveloski-Costa AC, 2016, ACTA PHYSIOL, V217, P130, DOI 10.1111/apha.12647; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Pettersson US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022480; PicarelBlanchot F, 1996, AM J PHYSIOL-ENDOC M, V271, pE755; Plachot C, 2001, HISTOCHEM CELL BIOL, V116, P131; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Portha B, 2001, DIABETES, V50, pS89, DOI 10.2337/diabetes.50.2007.S89; Portha Bernard, 2012, Methods Mol Biol, V933, P125, DOI 10.1007/978-1-62703-068-7_9; Portha Bernard, 2007, Expert Rev Endocrinol Metab, V2, P785, DOI 10.1586/17446651.2.6.785; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shirai N, 2005, ANAL BIOCHEM, V343, P48, DOI 10.1016/j.ab.2005.04.037; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinitskaya N, 2007, CLIN SCI, V113, P417, DOI 10.1042/CS20070182; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tanaka S, 2011, J ATHEROSCLER THROMB, V18, P115, DOI 10.5551/jat.5926; Tziomalos Konstantinos, 2015, Rev Diabet Stud, V12, P110, DOI 10.1900/RDS.2015.12.110; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wongchitrat P, 2017, NUTR RES, V42, P51, DOI 10.1016/j.nutres.2017.04.011; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Xue B, 2015, GENE REGUL SYST BIO, V9, P15, DOI 10.4137/GRSB.S25172; Xue B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017386	78	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189622	10.1371/journal.pone.0189622	http://dx.doi.org/10.1371/journal.pone.0189622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220408	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900063
J	Brinkmann, C; Hoffmann, M; Lubke, A; Nehlmeier, I; Kramer-Kuhl, A; Winkler, M; Pohlmann, S				Brinkmann, Constantin; Hoffmann, Markus; Luebke, Anastasia; Nehlmeier, Inga; Kraemer-Kuehl, Annika; Winkler, Michael; Poehlmann, Stefan			The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells	PLOS ONE			English	Article							MATRIX PROTEIN; HIV-1 VPU; RESTRICTION FACTOR; HEALTHY-ADULTS; VIRAL FUSION; INTERFERON; GENE; IMMUNOGENICITY; BST-2/TETHERIN; TRANSCRIPTION	Vesicular stomatitis virus (VSV) release from infected cells is inhibited by the interferon (IFN)-inducible antiviral host cell factor tetherin (BST-2, CD317). However, several viruses encode tetherin antagonists and it is at present unknown whether residual VSV spread in tetherin-positive cells is also promoted by a virus-encoded tetherin antagonist. Here, we show that the viral glycoprotein (VSV-G) antagonizes tetherin in transfected cells, although with reduced efficiency as compared to the HIV-1 Vpu protein. Tetherin antagonism did not involve alteration of tetherin expression and was partially dependent on a GXXXG motif in the transmembrane domain of VSV-G. However, mutation of the GXXXG motif did not modulate tetherin sensitivity of infectious VSV. These results identify VSV-G as a tetherin antagonist in transfected cells but fail to provide evidence for a contribution of tetherin antagonism to viral spread.	[Brinkmann, Constantin; Hoffmann, Markus; Luebke, Anastasia; Nehlmeier, Inga; Kraemer-Kuehl, Annika; Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany; [Kraemer-Kuehl, Annika] Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany	Deutsches Primatenzentrum (DPZ); Boehringer Ingelheim	Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany.	spoehlmann@dpz.eu	Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011	Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Winkler, Michael/0000-0002-6198-554X	Deutsche Forschungsgemeinschaft (DFG) [PO -716/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding has been obtained from Deutsche Forschungsgemeinschaft (DFG, PO -716/8-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2011, J VIROL, V85, P2611, DOI 10.1128/JVI.02080-10; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; Berger RM, 2011, PLOS ONE, V6; Brinkmann C, 2016, J VIROL, V90, P11075, DOI 10.1128/JVI.01563-16; Butler John M, 2007, Biotechniques, V43, pii; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; ElSherif MS, 2017, CAN MED ASSOC J, V189, pE819, DOI 10.1503/cmaj.170074; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Hacke M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8688; HALLUM JV, 1970, J VIROL, V6, P156, DOI 10.1128/JVI.6.2.156-162.1970; Halperin SA, 2017, J INFECT DIS; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Heppner DG, 2017, LANCET INFECT DIS, V17, P854, DOI [10.1016/s1473-3099(17)30313-4, 10.1016/S1473-3099(17)30313-4]; Hoffmann M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149651; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kopecky SA, 2003, J VIROL, V77, P5524, DOI 10.1128/JVI.77.9.5524-5528.2003; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Liberatore RA, 2017, J VIROL, V91, DOI 10.1128/JVI.02286-16; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; LYLES DS, 1992, J VIROL, V66, P349, DOI 10.1128/JVI.66.1.349-358.1992; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Marzi A, 2006, VIROLOGY, V352, P345, DOI 10.1016/j.virol.2006.04.038; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mead DG, 2000, SCIENCE, V287, P485, DOI 10.1126/science.287.5452.485; Melzer MK, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5010008; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2013, CURR TOP MICROBIOL, V371, P67, DOI 10.1007/978-3-642-37765-5_3; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Rodriguez LL, 2002, VIRUS RES, V85, P211, DOI 10.1016/S0168-1702(02)00026-6; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sun X, 2008, J BIOL CHEM, V283, P6418, DOI 10.1074/jbc.M708955200; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Taylor JK, 2015, J VIROL, V89, P11820, DOI 10.1128/JVI.02274-15; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10	55	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189073	10.1371/journal.pone.0189073	http://dx.doi.org/10.1371/journal.pone.0189073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216247	Green Published, gold			2022-12-26	WOS:000417337800066
J	Huang, CN; Wang, CJ; Lin, CL; Lin, HT; Peng, CH				Huang, Chien-Ning; Wang, Chau-Jong; Lin, Chih-Li; Lin, Hui-Ting; Peng, Chiung-Huei			The nutraceutical benefits of subfractions of Abelmoschus esculentus in treating type 2 diabetes mellitus	PLOS ONE			English	Article							POLYSACCHARIDE AMELIORATES HYPERGLYCEMIA; INDUCED INSULIN-RESISTANCE; LIPOPROTEIN-LIPASE; SKELETAL-MUSCLE; CELL; GLUCOSIDASE; PATHWAY; AMYLASE; MOENCH; ALPHA	Abelmoschus esculentus (AE), a commonly consumed vegetable, is well-known for its antihyperglycemic effects. However, few scientific reports have identified its targets because mucilage increases the difficulty of manipulation. We recently reported extraction steps to obtain subfractions of AE, which were found to attenuate the adverse effects of high glucose and fatty acid in vitro. In this study, we used modified extraction steps and type 2 diabetic rats to explore whether AE subfractions can improve the metabolic disturbances caused by insulin resistance in vivo. AE subfractions (F1, F2, and FR) were prepared. The type 2 diabetes model was induced by feeding male Sprague-Dawley rats with a high-fat diet and injecting them with 35 mg/kgbw streptozotocin when their body weight reached 475 +/- 15 g. After a hyperglycemic status had been confirmed, the rats were tube-fed with or without different doses of AE subfractions. Serum glucose, lipid markers, insulin, HbA1c and HOMAIR were measured in the following 12 weeks. Serum glucose promptly increased and insulin resistance was noted in the diabetic rats (glucose: 360-500 mg/dl, HOMA-IR 9.8-13.8). F2, rich in polysaccharides and carbohydrates, was most effective in attenuating hyperglycemia and insulin resistance (glucose: 200 mg/dl; HOMA-IR: 5.3) and especially HbA1C (from 8.0% to 6.5%). All of the AE subfractions lowered the level of triglycerides and free fatty acid, but not the level of total cholesterol. FR significantly increased the high-density lipoprotein/low-density lipoprotein ratio, indicating its benefits for lipoprotein profiles. While F2 and FR were associated with weight gain, F1 possessed an anti-obese effect. In conclusion, whether it is consumed as a vegetable or as a nutraceutical, AE has the potential to be an adjuvant therapy for diabetes. AE subfractions could be developed individually and deserve further investigation.	[Huang, Chien-Ning] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Chien-Ning; Lin, Chih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Chau-Jong; Lin, Hui-Ting] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Peng, Chiung-Huei] Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Hungkuang University	Peng, CH (corresponding author), Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan.	a222907@sunrise.hk.edu.tw	Lin, Chih-Li/GQZ-6480-2022; Lin, Chih-Li/H-9515-2019	Lin, Chih-Li/0000-0003-4553-3727; Peng, Chiung-Huei/0000-0003-1833-5522	Ministry of Science and Techonology, Taiwan [MOST 104-2320-B-241-001, MOST 105-2320-B-241-004-MY2]	Ministry of Science and Techonology, Taiwan	This work was supported by the grant MOST 104-2320-B-241-001, and MOST 105-2320-B-241-004-MY2 of Ministry of Science and Techonology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Chiu N, 1995, ILLUSTRATED MED PLAN, VI.; Corrado F, 2011, DIABETIC MED, V28, P972, DOI 10.1111/j.1464-5491.2011.03284.x; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Huang CN, 2017, PLOS ONE, V12; Kitajima S, 2004, DIABETOLOGIA, V47, P1202, DOI 10.1007/s00125-004-1429-0; Li WJ, 2015, J AGR FOOD CHEM, V63, P8182, DOI 10.1021/acs.jafc.5b03462; Lu YY, 2016, J FUNCT FOODS, V20, P463, DOI 10.1016/j.jff.2015.10.037; Ma XL, 2014, GLYCOCONJUGATE J, V31, P355, DOI 10.1007/s10719-014-9526-x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Panarotto D, 2002, EUR J CLIN INVEST, V32, P84, DOI 10.1046/j.1365-2362.2002.00945.x; Peng CH, 2016, FOOD FUNCT, V7, P728, DOI [10.1039/C5FO01214G, 10.1039/c5fo01214g]; Peng CH, 2009, J AGR FOOD CHEM, V57, P8812, DOI 10.1021/jf902143x; Ravelojaona V, 2006, BIOMED PHARMACOTHER, V60, P359, DOI 10.1016/j.biopha.2006.06.019; Sabitha V., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS162; Sabitha V, 2011, J PHARM BIOALLIED SC, V3, P397, DOI 10.4103/0975-7406.84447; Sabitha Vijayakumar, 2012, J Ayurveda Integr Med, V3, P188, DOI 10.4103/0975-9476.104432; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Yang YS, 2013, J FUNCT FOODS, V5, P810, DOI 10.1016/j.jff.2013.01.027; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Zhao M, 2012, MOLECULES, V17, P7083, DOI 10.3390/molecules17067083; Zhou J, 2015, J ETHNOPHARMACOL, V164, P229, DOI 10.1016/j.jep.2015.02.026; Zhu KX, 2013, INT J BIOL MACROMOL, V57, P142, DOI 10.1016/j.ijbiomac.2013.03.009	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189065	10.1371/journal.pone.0189065	http://dx.doi.org/10.1371/journal.pone.0189065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216237	gold, Green Submitted, Green Published			2022-12-26	WOS:000417337800063
J	Khairallah, RJ; O'Shea, KM; Ward, CW; Butteiger, DN; Mukherjea, R; Krul, ES				Khairallah, Ramzi J.; O'Shea, Karen M.; Ward, Christopher W.; Butteiger, Dustie N.; Mukherjea, Ratna; Krul, Elaine S.			Chronic dietary supplementation with soy protein improves muscle function in rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; WHEY-PROTEIN; ISOFLAVONE GENISTEIN; RESISTANCE EXERCISE; MASS INDEX; MDX MICE; ACTIVATION; BLEND; ISOLATE; MEN	Athletes as well as elderly or hospitalized patients use dietary protein supplementation to maintain or grow skeletal muscle. It is recognized that high quality protein is needed for muscle accretion, and can be obtained from both animal and plant-based sources. There is interest to understand whether these sources differ in their ability to maintain or stimulate muscle growth and function. In this study, baseline muscle performance was assessed in 50 adult Sprague-Dawley rats after which they were assigned to one of five semi-purified "Western" diets (n = 10/group) differing only in protein source, namely 19 kcal% protein from either milk protein isolate (MPI), whey protein isolate (WPI), soy protein isolate (SPI), soy protein concentrate (SPC) or enzyme-treated soy protein (SPE). The diets were fed for 8 weeks at which point muscle performance testing was repeated and tissues were collected for analysis. There was no significant difference in food consumption or body weights over time between the diet groups nor were there differences in terminal organ and muscle weights or in serum lipids, creatinine or myostatin. Compared with MPI-fed rats, rats fed WPI and SPC displayed a greater maximum rate of contraction using the in vivo measure of muscle performance (p<0.05) with increases ranging from 13.3-27.5% and 22.8-29.5%, respectively at 60, 80, 100 and 150 Hz. When the maximum force was normalized to body weight, SPC-fed rats displayed increased force compared to MPI (p<0.05), whereas when normalized to gastrocnemius weight, WPI-fed rats displayed increased force compared to MPI (p<0.05). There was no difference between groups using in situ muscle performance. In conclusion, soy protein consumption, in high-fat diet, resulted in muscle function comparable to whey protein and improved compared to milk protein. The benefits seen with soy or whey protein were independent of changes in muscle mass or fiber cross-sectional area.	[Khairallah, Ramzi J.; O'Shea, Karen M.; Ward, Christopher W.] Myol LLC, New Market, MD 21774 USA; [Ward, Christopher W.] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA; [Butteiger, Dustie N.; Mukherjea, Ratna; Krul, Elaine S.] DuPont Nutr & Hlth, St Louis, MO USA	University System of Maryland; University of Maryland Baltimore; DuPont	Khairallah, RJ (corresponding author), Myol LLC, New Market, MD 21774 USA.	rkhairallah@myologica.com			DuPont Nutrition Health	DuPont Nutrition Health	The funder, DuPont Nutrition & Health, provided support in the form of salaries to DNB, ESK and RM, and in the form fee for service to Myologica LLC (KMO, RJK). The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The funder, DuPont Nutrition & Health provided support in the form of salaries to DNB, ESK and RM, and in the form fee for service to Myologica LLC (KMO, RJK). The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Anthony TG, 2007, J NUTR, V137, P357, DOI 10.1093/jn/137.2.357; Aubertin-Leheudre M, 2009, BRIT J NUTR, V102, P1803, DOI 10.1017/S0007114509991310; Beavers KM, 2015, J NUTR HEALTH AGING, V19, P87, DOI 10.1007/s12603-015-0438-7; Borack MS, 2016, J NUTR, V146, P2468, DOI 10.3945/jn.116.231159; Butteiger DN, 2013, CLIN NUTR, V32, P585, DOI 10.1016/j.clnu.2012.10.001; Chan R, 2014, J NUTR HEALTH AGING, V18, P171, DOI 10.1007/s12603-013-0379-y; Elia D, 2006, EUR J NUTR, V45, P259, DOI 10.1007/s00394-006-0593-z; Hashimoto R, 2015, J MED INVESTIG, V62, P177, DOI 10.2152/jmi.62.177; Hirasaka K, 2013, J NUTR SCI VITAMINOL, V59, P317, DOI 10.3177/jnsv.59.317; Hoffman JR, 2004, J SPORT SCI MED, V3, P118; Kojima N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132523; Kraemer WJ, 2013, J AM COLL NUTR, V32, P66, DOI 10.1080/07315724.2013.770648; Malarde L, 2013, J MED FOOD, V16, P176, DOI 10.1089/jmf.2012.0095; Matta J, 2016, J NUTR HEALTH AGING, V20, P90, DOI 10.1007/s12603-015-0554-4; Messina S, 2015, BIOFACTORS, V41, P324, DOI 10.1002/biof.1226; Messina S, 2011, NEUROMUSCULAR DISORD, V21, P579, DOI 10.1016/j.nmd.2011.04.014; Millward D. Joe, 1995, Nutrition Research Reviews, V8, P93, DOI 10.1079/NRR19950008; Morse CI, 1985, J APPL PHYSIOL, V2005, P1050; Palacios-Gonzalez B, 2014, BBA-MOL CELL BIOL L, V1841, P132, DOI 10.1016/j.bbalip.2013.08.018; Reidy PT, 2017, MED SCI SPORT EXER, V49, P1197, DOI 10.1249/MSS.0000000000001224; Reidy PT, 2013, J NUTR, V143, P410, DOI 10.3945/jn.112.168021; TANG JE, 1985, J APPL PHYSIOL, V107, P987, DOI DOI 10.1152/JAPPLPHYSI0L; Tomlinson DJ, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12030; WHO, 2007, WHO TECH REP SER, V935, P1	24	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189246	10.1371/journal.pone.0189246	http://dx.doi.org/10.1371/journal.pone.0189246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216301	gold, Green Published			2022-12-26	WOS:000417337800107
J	Li, ZL; Yang, AJ; Yin, XL; Dong, SW; Luo, F; Dou, C; Lan, X; Xie, Z; Hou, TY; Xu, JZ; Xing, JC				Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Dong, Shiwu; Luo, Fei; Dou, Ce; Lan, Xu; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao			Mesenchymal stem cells promote endothelial progenitor cell migration, vascularization, and bone repair in tissue-engineered constructs via activating CXCR2-Src-PKL/Vav2-Rac1	FASEB JOURNAL			English	Article						bone tissue engineering; signal pathway; vasculogenesis	FOCAL ADHESION KINASE; FUNCTIONAL-PROPERTIES; SIGNALING PATHWAYS; GROWTH-FACTOR; LINKER PKL; RECEPTOR 2; CXCR2; MOBILIZATION; CANCER; OSTEOGENESIS	Tissue-engineered constructs (TECs) hold great promise for treating large bone defects. Incorporated mesenchymal stem cells (MSCs) can facilitate the vascularization of TECs. Nevertheless, the underlying mechanism remains ambiguous. Here we analyzed the roles of C-X-C chemokine receptor 2 (CXCR2) and its downstream signal pathways in MSC-induced endothelial progenitor cell (EPC) migration. Transwell assays and immunofluorescence staining were performed for cell migration analysis in vitro and in vivo, respectively. A series of signal inhibitors and short hairpin RNA was used for screening essential signaling molecules. We found that blockade of CXCR2 abolished the migration of EPCs toward MSCs as well as subsequent vascularization and bone repair in TECs. Moreover, screening results suggested that steroid receptor coactivator (Src) acted as a predominant downstream effector of CXCR2. Further molecular biologic and histomorphological experiments revealed that the action of Src required the phosphorylation of ras-related C3 botulinum toxin substrate 1 (Rac1), which was pivotal for the development of lamellipodia and filopodia. The phosphorylation and colocalization of paxillin kinase linker (PKL) and vav guanine nucleotide exchange factor 2 (Vav2) were essential for the activation of Rac1. Therefore, we demonstrated that MSCs promoted EPC migration via activating CXCR2 and its downstream Src-PKL/Vav2-Rac1 signaling pathway. These findings unveiled the molecular mechanism in the vascularization of TECs and were expected to provide novel targets for efficacy improvement.	[Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Dong, Shiwu; Luo, Fei; Dou, Ce; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao] Southwest Hosp, Dept Orthoped, Natl & Reg United Engn Lab Tissue Engn, Chongqing, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, Dept Biomed Mat Sci, Coll Biomed Engn, Chongqing, Peoples R China; [Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Luo, Fei; Dou, Ce; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao] Ctr Regenerat & Reconstruct Engn Technol Chongqin, Chongqing, Peoples R China; [Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Luo, Fei; Dou, Ce; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao] Tissue Engn Lab Chongqing City, Chongqing, Peoples R China; [Li, Zhilin; Lan, Xu] Chinese Peoples Liberat Army, Lanzhou Command, Lanzhou Gen Hosp, Dept Spine, Lanzhou, Gansu, Peoples R China	Army Medical University; Army Medical University	Xu, JZ; Xing, JC (corresponding author), Third Mil Med Univ, Southwest Hosp, 29 Gaotanyan St, Chongqing 400038, Peoples R China.	prof_jianzhongxu@163.com; 46327289@qq.com	Xing, Junchao/GWN-0403-2022; Dou, Ce/B-8841-2012	Dou, Ce/0000-0002-6983-6354	National High Technology Research and Development Program of China (863 Program) [2015AA020315]; Natural Science Foundation of China [81471802]; Foundation of Southwest Hospital [SWH2015QN05]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Southwest Hospital	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2015AA020315), the Natural Science Foundation of China (81471802), and the Foundation of Southwest Hospital (SWH2015QN05). The authors declare no conflicts of interest.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Almeida CR, 2016, STEM CELL REP, V6, P466, DOI 10.1016/j.stemcr.2016.02.012; Atesok K, 2012, KNEE SURG SPORT TR A, V20, P1366, DOI 10.1007/s00167-012-1940-7; Bolland BJRF, 2008, BONE, V43, P195, DOI 10.1016/j.bone.2008.02.013; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; Chen QA, 2010, CYTOTHERAPY, V12, P831, DOI 10.3109/14653249.2010.495980; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Di Cioccio V, 2004, IMMUNOLOGY, V111, P407, DOI 10.1111/j.1365-2567.2004.01822.x; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fedorovich NE, 2010, TISSUE ENG PT A, V16, P2355, DOI [10.1089/ten.tea.2009.0603, 10.1089/ten.TEA.2009.0603]; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Gao XQ, 2014, FASEB J, V28, P3792, DOI 10.1096/fj.13-247965; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Goligorsky MS, 2014, SEMIN NEPHROL, V34, P365, DOI 10.1016/j.semnephrol.2014.06.003; Gray EJ, 2014, J BIOL CHEM, V289, P35397, DOI 10.1074/jbc.M114.615112; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Ha J, 2011, CYTOKINE, V55, P48, DOI 10.1016/j.cyto.2011.03.026; Hauck CR, 2000, J BIOL CHEM, V275, P41092, DOI 10.1074/jbc.M005450200; Herrmann M, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00079; Hou YN, 2015, STEM CELL RES, V14, P133, DOI 10.1016/j.scr.2014.12.001; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Hu MM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005171; Jones MC, 2013, MOL BIOL CELL, V24, P1882, DOI 10.1091/mbc.E12-09-0654; Ju L, 2017, CELL PHYSIOL BIOCHEM, V41, P1346, DOI 10.1159/000465389; Kamprom W, 2016, EUR J CELL BIOL, V95, P153, DOI 10.1016/j.ejcb.2016.02.001; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kimura H, 2013, CELL PHYSIOL BIOCHEM, V32, P899, DOI 10.1159/000354493; Kurtagic E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145115; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Li AH, 2011, TRANSL ONCOL, V4, P20, DOI 10.1593/tlo.10184; Li Z, 2014, CYTOKINE, V69, P6, DOI 10.1016/j.cyto.2014.05.004; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Pang H, 2013, INT ORTHOP, V37, P753, DOI 10.1007/s00264-012-1751-y; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715; Sobolik T, 2014, MOL BIOL CELL, V25, P566, DOI 10.1091/mbc.E13-07-0360; Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Wu XH, 2013, TISSUE ENG PT A, V19, P2486, DOI [10.1089/ten.TEA.2013.0124, 10.1089/ten.tea.2013.0124]; Xing JC, 2017, ACTA BIOMATER, V53, P470, DOI 10.1016/j.actbio.2017.02.016; Xing JC, 2014, J SURG RES, V192, P454, DOI 10.1016/j.jss.2014.05.037; Xing JC, 2014, CELL PHYSIOL BIOCHEM, V33, P905, DOI 10.1159/000358663; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye DW, 2016, J HEPATOL, V65, P988, DOI 10.1016/j.jhep.2016.05.041; Yu BQ, 2016, STEM CELLS, V34, P2368, DOI 10.1002/stem.2410	57	29	31	3	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2197	2211		10.1096/fj.201700895R	http://dx.doi.org/10.1096/fj.201700895R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29229683				2022-12-26	WOS:000429051400038
J	Xu, TJ; Chu, Q; Cui, JX; Zhao, XY				Xu, Tianjun; Chu, Qing; Cui, Junxia; Zhao, Xueyan			The inducible microRNA-203 in fish represses the inflammatory responses to Gram-negative bacteria by targeting IL-1 receptor-associated kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); translation regulation; Toll-like receptor (TLR); innate immunity; lipopolysaccharide (LPS); IRAK4; microRNA-203; negative regulation; NF-kappaB; teleost fish	KAPPA-B PATHWAY; TOLL-LIKE RECEPTORS; MIIUY CROAKER; TELEOST FISH; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTOR; MIICHTHYS-MIIUY; GENE-EXPRESSION; INNATE IMMUNE; MACROPHAGES	Innate immune responses are the first defense against pathogenic invaders. Activation and termination of these immune responses are regulated by several mechanisms. MicroRNAs (miRNAs), a group of small non-coding RNAs, have been implicated in the regulation of a spectrum of both physiological and pathological conditions, including immune responses. Although the immune regulatory miRNA networks in higher vertebrates have been well described, regulation of these responses in fish species is poorly understood. In the present study, we investigated the role of the miRNA miR-203 involved in inflammatory responses in miiuy croaker (Miichthys miiuy). We found that the Gram-negative bacterium Vibrio anguillarum and lipopolysaccharide significantly up-regulated host miR-203 expression. The increased miR-203 expression suppressed the production of inflammatory cytokines and thereby prevented mounting of a full immune response. Mechanistically, we identified and validated IL-1 receptor-associated kinase 4 (IRAK4) as a target of miR-203. We observed that miR-203 post-transcriptionally controls IRAK4 expression and thereby inhibits the activation of nuclear factor B (NF-B) signaling. In summary, our findings reveal that miR-203 in fish is a critical suppressor of innate immune responses to bacterial infection by suppressing a feedback to IRAK4-NF-B-mediated signaling.	[Xu, Tianjun; Chu, Qing] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China; [Xu, Tianjun; Cui, Junxia; Zhao, Xueyan] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan 316022, Peoples R China	Shanghai Ocean University; Zhejiang Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China.; Xu, TJ (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan 316022, Peoples R China.	tianjunxu@163.com	Xia, Cui/AAA-2699-2022		National Natural Science Foundation of China [31672682, 31370049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China Grants 31672682 and 31370049. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Chu Q, 2017, DEV COMP IMMUNOL, V67, P117, DOI 10.1016/j.dci.2016.11.004; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Wang YJ, 2016, DEV COMP IMMUNOL, V63, P181, DOI 10.1016/j.dci.2016.06.004; Wang YJ, 2016, DEV COMP IMMUNOL, V62, P102, DOI 10.1016/j.dci.2016.05.001; Wang YJ, 2016, DEV COMP IMMUNOL, V61, P25, DOI 10.1016/j.dci.2016.03.005; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wei J, 2013, MOL IMMUNOL, V55, P303, DOI 10.1016/j.molimm.2013.03.004; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Xu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21902; Zhang Fengping, 2010, Weishengwu Xuebao, V50, P304; Zhang L, 2015, J IMMUNOL, V195, P5404, DOI 10.4049/jimmunol.1402933; Zhao XY, 2017, MOL IMMUNOL, V85, P123, DOI 10.1016/j.molimm.2017.02.009; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	45	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1386	1396		10.1074/jbc.RA117.000158	http://dx.doi.org/10.1074/jbc.RA117.000158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242191	hybrid, Green Published			2022-12-26	WOS:000423515000024
J	Martin, P; Newton, AC; Cantarello, E; Evans, PM				Martin, Philip; Newton, Adrian C.; Cantarello, Elena; Evans, Paul M.			Analysis of ecological thresholds in a temperate forest undergoing dieback	PLOS ONE			English	Article							WESTERN UNITED-STATES; LARGE OLD TREES; TIPPING POINTS; MORTALITY; DROUGHT; ECOSYSTEMS; BIODIVERSITY; RESILIENCE; MANAGEMENT; DYNAMICS	Positive feedbacks in drivers of degradation can cause threshold responses in natural ecosystems. Though threshold responses have received much attention in studies of aquatic ecosystems, they have been neglected in terrestrial systems, such as forests, where the long time-scales required for monitoring have impeded research. In this study we explored the role of positive feedbacks in a temperate forest that has been monitored for 50 years and is undergoing dieback, largely as a result of death of the canopy dominant species (Fagus sylvatica, beech). Statistical analyses showed strong non-linear losses in basal area for some plots, while others showed relatively gradual change. Beech seedling density was positively related to canopy openness, but a similar relationship was not observed for saplings, suggesting a feedback whereby mortality in areas with high canopy openness was elevated. We combined this observation with empirical data on size-and growth-mediated mortality of trees to produce an individual-based model of forest dynamics. We used this model to simulate changes in the structure of the forest over 100 years under scenarios with different juvenile and mature mortality probabilities, as well as a positive feedback between seedling and mature tree mortality. This model produced declines in forest basal area when critical juvenile and mature mortality probabilities were exceeded. Feedbacks in juvenile mortality caused a greater reduction in basal area relative to scenarios with no feedback. Non-linear, concave declines of basal area occurred only when mature tree mortality was 3-5 times higher than rates observed in the field. Our results indicate that the longevity of trees may help to buffer forests against environmental change and that the maintenance of old, large trees may aid the resilience of forest stands. In addition, our work suggests that dieback of forests may be avoidable providing pressures on mature and juvenile trees do not pass critical thresholds.	[Martin, Philip; Newton, Adrian C.; Cantarello, Elena; Evans, Paul M.] Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England; [Martin, Philip] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Bournemouth University; University of Cambridge	Martin, P (corresponding author), Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England.; Martin, P (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England.	phil.martin.research@gmail.com	Martin, Philip Anthony/R-5843-2019	Martin, Philip Anthony/0000-0002-5346-8868	NERC via the Biodiversity & Ecosystem Service Sustainability (BESS) programme [NE/K01322X/1]; Natural Environment Research Council as part of the BESS program [NE/K01322X/1]; NERC [NE/K01322X/1] Funding Source: UKRI; Natural Environment Research Council [NE/K01322X/1] Funding Source: researchfish	NERC via the Biodiversity & Ecosystem Service Sustainability (BESS) programme; Natural Environment Research Council as part of the BESS program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Natural Environment Research Council as part of the BESS program (project ref: NE/K01322X/1- http://gotw.nerc.ac.uk/list_full.asp?pcode=NE%2FK01322X% 2F1&classtype=Science+Topic&classification=Complexity+Science&cookieConsent=A).; We thank Martin Dymond, Chris Moody, Lisa Malter and Ed Mountford for assistance with the fieldwork in Denny Wood, and the latter for access to historical data as well as four anonymous reviewers for their comments. This research was funded by NERC via the Biodiversity & Ecosystem Service Sustainability (BESS) programme (project ref. NE/K01322X/1). The opinions and views expressed here do not necessarily represent those of the main BESS programme and its directorate.	Acacio V, 2007, ECOSYSTEMS, V10, P1220, DOI 10.1007/s10021-007-9089-9; Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Agra H, 2017, WHAT WORKS CONSERVAT, P285; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Ammer C, 1996, FOREST ECOL MANAG, V88, P43, DOI 10.1016/S0378-1127(96)03808-X; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barton K., 2014, MUMIN MULTIMODEL INF; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Blicharska M, 2014, CONSERV BIOL, P1; Bottero A, 2017, J APPL ECOL, V54, P1605, DOI 10.1111/1365-2664.12847; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Briske D. D., 2010, ECOL SOC, P15; Brook BW, 2013, TRENDS ECOL EVOL, V28, P396, DOI 10.1016/j.tree.2013.01.016; Burnham P., 2000, MODEL SELECTION MULT; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cantarello E, 2017, ECOL EVOL, P1; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Dodds WK, 2010, J N AM BENTHOL SOC, V29, P988, DOI 10.1899/09-148.1; Evans PM, 2017, SCI REP, V7, P1; Filotas E, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00182.1; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Foley MM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00095; Fortin M, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007088; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; GILL RMA, 1992, INT J RES, V65, P363; Greenwood DL, 2008, FOREST ECOL MANAG, V255, P2129, DOI 10.1016/j.foreco.2007.12.048; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holzwarth F, 2013, J ECOL, V101, P220, DOI 10.1111/1365-2745.12015; Huggett AJ, 2005, BIOL CONSERV, V124, P301, DOI 10.1016/j.biocon.2005.01.037; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Jung T, 2009, FOREST PATHOL, V39, P73, DOI 10.1111/j.1439-0329.2008.00566.x; Karr KA, 2015, J APPL ECOL, V52, P402, DOI 10.1111/1365-2664.12388; KUIJPER DPJ, 2009, ECOL MANAGE, V258, P1528, DOI DOI 10.1016/J.FORECO.2009.07.010; Lachat T, 2013, INTEGR APPROACHES OP, V92, P129; Lauvaux CA, 2016, FOREST ECOL MANAG, V363, P74, DOI 10.1016/j.foreco.2015.12.016; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lindenmayer DB, 2016, TRENDS ECOL EVOL, V31, P416, DOI 10.1016/j.tree.2016.03.003; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2013, CONSERV LETT; Martin PA, 2015, FOREST ECOL MANAG, V358, P130, DOI 10.1016/j.foreco.2015.08.033; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Mountford Ed P., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P223, DOI 10.1078/1433-8319-00072; Mountford EP, 2003, FORESTRY, V76, P19, DOI 10.1093/forestry/76.1.19; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Netlogo Wilensky U., 1999, ENTER CONNECTED LEAR; Newton A., 2011, SOCIAL ECOLOGICAL RE, V16; Newton AC, 2013, TREES FORESTED LANDS, P163; Packham JR, 2012, J ECOL, V100, P1557, DOI 10.1111/j.1365-2745.2012.02017.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reyer CPO, 2015, J ECOL, V103, P5, DOI 10.1111/1365-2745.12337; Rogers PC, 2014, J VEG SCI, V25, P457, DOI 10.1111/jvs.12099; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Seidl R, 2016, J APPL ECOL, V53, P120, DOI 10.1111/1365-2664.12511; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; SHEIL D, 1995, J ECOL, V83, P331, DOI 10.2307/2261571; Teskey R, 2015, PLANT CELL ENVIRON, V38, P1699, DOI 10.1111/pce.12417; Thrush SF, 2014, ECOLOGY, V95, P1451, DOI 10.1890/13-1879.1; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vanoni M, 2016, FOREST ECOL MANAG, V382, P51, DOI 10.1016/j.foreco.2016.10.001; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3	72	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189578	10.1371/journal.pone.0189578	http://dx.doi.org/10.1371/journal.pone.0189578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240842	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000417905600049
J	Sawyer, ADM; Jones, R; Ucci, M; Smith, L; Kearns, A; Fisher, A				Sawyer, Alexia D. M.; Jones, Russell; Ucci, Marcella; Smith, Lee; Kearns, Ade; Fisher, Abi			Cross-sectional interactions between quality of the physical and social environment and self-reported physical activity in adults living in income-deprived communities	PLOS ONE			English	Article							BUILT ENVIRONMENT; HEALTH; RELIABILITY; DISPARITIES; VALIDITY	Background Understanding the environmental determinants of physical activity in populations at high risk of inactivity could contribute to the development of effective interventions. Socioecological models of activity propose that environmental factors have independent and interactive effects of physical activity but there is a lack of research into interactive effects. Objectives This study aimed to explore independent and interactive effects of social and physical environmental factors on self-reported physical activity in income-deprived communities. Methods Participants were 5,923 adults in Glasgow, United Kingdom. Features of the social environment were self-reported. Quality of the physical environment was objectively-measured. Neighbourhood walking and participation in moderate physical activity [MPA] on similar to 5 days/week was self-reported. Multilevel multivariate logistic regression models tested independent and interactive effects of environmental factors on activity. Results 'Social support' (walking: OR: 1.22,95% CI = 1.06 +/- 1.41, p < 0.01; MPA: OR: 0.79,95% CI = 0.67 +/- 0.94, p< 0.01), ` social interaction' (walking: OR: 1.25,95% CI = 1.10 +/- 1.42, p < 0.01; MPA: OR: 6.16,95% CI = 5.14 +/- 7.37, p < 0.001) and ` cohesion and safety' (walking: OR: 1.78,95% CI = 1.56 +/- 2.03, p < 0.001; MPA: OR: 1.93,95% CI = 1.65 +/- 2.27, p < 0.001), but not ` trust and empowerment', had independent effects on physical activity. 'Aesthetics of built form' (OR: 1.47,95% CI = 1.22 +/- 1.77, p < 0.001) and 'aesthetics and maintenance of open space' (OR: 1.32, 95% CI = 1.13 +/- 1.54, p < 0.01) were related to walking. 'Physical disorder' (OR: 1.63,95% CI = 1.31 +/- 2.03, p < 0.001) had an independent effect on MPA. Interactive effects of social and physical factors on walking and MPA were revealed. Conclusions Findings suggest that intervening to create activity-supportive environments in deprived communities may be most effective when simultaneously targeting the social and physical neighbourhood environment.	[Sawyer, Alexia D. M.; Fisher, Abi] UCL, Dept Behav Sci & Hlth, London, England; [Jones, Russell] Glasgow Ctr Populat Hlth, Third Floor,Olympia Bldg, Glasgow, Lanark, Scotland; [Ucci, Marcella] UCL, UCL Inst Environm Design & Engn, Bartlett Fac Built Environm, Cent House, London, England; [Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Cambridge, England; [Kearns, Ade] Univ Glasgow, Urban Studies, Glasgow, Lanark, Scotland	University of London; University College London; University of London; University College London; Anglia Ruskin University; University of Glasgow	Sawyer, ADM (corresponding author), UCL, Dept Behav Sci & Hlth, London, England.	alexia.sawyer@ucl.ac.uk		Ucci, Marcella/0000-0001-5618-7247; Sawyer, Alexia/0000-0002-9079-4814	University College London and Glasgow Centre for Population Health; Glasgow Housing Association (Wheatley Group); Scottish Government; NHS Health Scotland; NHS Greater Glasgow and Clyde; EPSRC [EP/P022405/1] Funding Source: UKRI; Cancer Research UK [14133] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/P022405/1] Funding Source: researchfish	University College London and Glasgow Centre for Population Health; Glasgow Housing Association (Wheatley Group); Scottish Government; NHS Health Scotland; NHS Greater Glasgow and Clyde; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a studentship funded by University College London and Glasgow Centre for Population Health, received by AS. GoWell is sponsored by Glasgow Housing Association (Wheatley Group), the Scottish Government, NHS Health Scotland and NHS Greater Glasgow and Clyde. The sponsors had no role in the study design, analyses, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Bracy NL, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-24; Chief Medical Office, UK PHYS ACT GUID PUB; Corseuil MW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/641010; Crawford F, 2010, WIDER RELEVANCE GOWE; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Egan M, 2006, WORKING PAPER 3 COMM; Egan M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-41; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Gubbels JS, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-52; Harper R, 2003, MEASURING SOCIAL CAP; Health and Social Care Information Centre, 2009, HLTH SURV ENGL 2008; Jack E, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-71; Jia YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090078; Kaczynski AT, 2012, J PUBLIC HEALTH-UK, V34, P382, DOI 10.1093/pubmed/fds011; Keizer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065137; Kelly P, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0351-4; Kerr J, 2016, ENVIRON HEALTH PERSP, V124, P290, DOI 10.1289/ehp.1409466; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Lorenc T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-496; Mason P, 2016, MENT HEALTH PHYS ACT, V11, P19, DOI 10.1016/j.mhpa.2016.07.001; Mason P, 2011, HEALTH PLACE, V17, P727, DOI 10.1016/j.healthplace.2011.01.010; McCormack G.R., 2011, INT J BEHAV NUTR PHY, V8; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Milton K, 2013, BRIT J SPORT MED, V47, P44, DOI 10.1136/bjsports-2011-090899; Mueller N, 2015, PREV MED, V76, P103, DOI 10.1016/j.ypmed.2015.04.010; Neckerman KM, 2009, J PUBLIC HEALTH POL, V30, pS264, DOI 10.1057/jphp.2008.47; NHS Choices, 10000 STEPS CHALL LI; Petticrew M., 2008, SHARP STUDY OBJECTIV; Prince SA, 2011, INT J ENV RES PUB HE, V8, P3953, DOI 10.3390/ijerph8103953; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rosenberg DE, 2011, J AGING RES, V2011; Rutter H, 2016, OBES REV, V17, P108, DOI 10.1111/obr.12382; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356; Samuel LJ, 2014, HEALTH EDUC BEHAV, V41, P359, DOI 10.1177/1090198113504412; Scottish Government, 2012, SCOTL PEOPL ANN REP; Shelton RC, 2011, AM J PUBLIC HEALTH, V101, P2102, DOI 10.2105/AJPH.2010.196030; Shoham DA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1435-9; Sport England, 2015, ACT DES; Strath SJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-40; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Thornton CM, 2016, SSM-POPUL HLTH, V2, P206, DOI 10.1016/j.ssmph.2016.03.004; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; UK Active, 2014, TURN TID IN; Walsh D., 2008, HLTH WELLBEING GLASG	52	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188962	10.1371/journal.pone.0188962	http://dx.doi.org/10.1371/journal.pone.0188962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240791	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000417905600013
J	Ufarte, L; Laville, E; Duquesne, S; Morgavi, D; Robe, P; Klopp, C; Rizzo, A; Pizzut-Serin, S; Potocki-Veronese, G				Ufarte, Lisa; Laville, Elisabeth; Duquesne, Sophie; Morgavi, Diego; Robe, Patrick; Klopp, Christophe; Rizzo, Angeline; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle			Discovery of carbamate degrading enzymes by functional metagenomics	PLOS ONE			English	Article							POLYESTER-POLYURETHANE; MICROBIAL DIVERSITY; LIPOLYTIC ENZYMES; PURIFICATION; BIODEGRADATION; HYDROLASE; ESTERASE; INSECTICIDES; DEGRADATION; LIBRARY	Bioremediation of pollutants is a major concern worldwide, leading to the research of new processes to break down and recycle xenobiotics and environment contaminating polymers. Among them, carbamates have a very broad spectrum of uses, such as toxinogenic pesticides or elastomers. In this study, we mined the bovine rumen microbiome for carbamate degrading enzymes. We isolated 26 hit clones exhibiting esterase activity, and were able to degrade at least one of the targeted polyurethane and pesticide carbamate compounds. The most active clone was deeply characterized. In addition to Impranil, this clone was active on Tween 20, pNP-acetate, butyrate and palmitate, and on the insecticide fenobucarb. Sequencing and sub-cloning of the best target revealed a novel carboxyl-ester hydrolase belonging to the lipolytic family IV, named CE_Ubrb. This study highlights the potential of highly diverse microbiota such as the ruminal one for the discovery of promiscuous enzymes, whose versatility could be exploited for industrial uses.	[Ufarte, Lisa; Laville, Elisabeth; Duquesne, Sophie; Rizzo, Angeline; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle] Univ Toulouse, LISBP, CNRS, INRA,INSA, Toulouse, France; [Morgavi, Diego] INRA, UMRH, Vetagro Sup, Paris, France; [Robe, Patrick] LibraGen SA, Toulouse, France; [Klopp, Christophe] INRA, UBIA, Plateforme Bioinformat Toulouse Genopole, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); INRAE; VetAgro Sup; INRAE	Potocki-Veronese, G (corresponding author), Univ Toulouse, LISBP, CNRS, INRA,INSA, Toulouse, France.	veronese@insa-toulouse.fr	Klopp, Christophe/J-3164-2019; Veronese, Gabrielle/GTF-3473-2022; Morgavi, Diego P./C-2191-2013	Klopp, Christophe/0000-0001-7126-5477; Morgavi, Diego P./0000-0002-3883-0937	French Ministry of Education and Research (Ministere de l'Enseignement superieur et de la Recherche); INRA metaprogramme M2E; European Union's framework programme Horizon [LEITBIO-2015-685474]; Region Midi-Pyrenees; European Regional Development Fund; Institut National de la Recherche Agronomique (INRA)	French Ministry of Education and Research (Ministere de l'Enseignement superieur et de la Recherche); INRA metaprogramme M2E; European Union's framework programme Horizon; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund(European Commission); Institut National de la Recherche Agronomique (INRA)	We confirm that this research was funded by the French Ministry of Education and Research (Ministere de l'Enseignement superieur et de la Recherche), the INRA metaprogramme M2E (project Metascreen), and the European Union's framework programme Horizon 2020 (LEITBIO-2015-685474, Metafluidics). The French Ministry of Education and Research provided support in the form of salaries for [LU]. INRA provided support in the form of salaries for [SPS], [GPV] and [EL]. The high throughput screening work was carried out at the Laboratory for BioSystems & Process Engineering (Toulouse, France) with the equipment of the ICEO facility, dedicated to the screening and the discovery of original enzymes. ICEO is supported by grants from the Region Midi-Pyrenees, the European Regional Development Fund and the Institut National de la Recherche Agronomique (INRA). One of the authors, Patrick Robe [PR], is employed by the commercial company LibraGen. LibraGen provided support in the form of salaries for [PR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of [PR] are articulated in the 'author contributions' section.; This research was funded by the French Ministry of Education and Research (Ministere de l'Enseignement superieur et de la Recherche), the INRA metaprogramme M2E (project Metascreen), and the European Union's framework programme Horizon 2020 (LEIT-BIO-2015-685474, Metafluidics).	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bemis JC, 2015, MUTAGENESIS, V30, P343, DOI 10.1093/mutage/geu084; Ben Ali Y, 2012, METHODS MOL BIOL, V861, P31, DOI 10.1007/978-1-61779-600-5_2; Biffinger JC, 2015, POLYM DEGRAD STABIL, V120, P178, DOI 10.1016/j.polymdegradstab.2015.06.020; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766; Chahinian H, 2005, BBA-MOL CELL BIOL L, V1738, P29, DOI 10.1016/j.bbalip.2005.11.003; Choi JE, 2013, EXTREMOPHILES, V17, P1013, DOI 10.1007/s00792-013-0583-z; Courtois S, 2003, APPL ENVIRON MICROB, V69, P49, DOI 10.1128/AEM.69.1.49-55.2003; Cregut M, 2013, BIOTECHNOL ADV, V31, P1634, DOI 10.1016/j.biotechadv.2013.08.011; Doddamani HP, 2001, CURR MICROBIOL, V43, P69, DOI 10.1007/s002840010262; ENGELHARDT G, 1973, APPL MICROBIOL, V26, P709, DOI 10.1128/AEM.26.5.709-718.1973; Faulds CB, 2010, PHYTOCHEM REV, V9, P121, DOI 10.1007/s11101-009-9156-2; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Grube A, 2011, PESTICIDES INDUSTRY; Hausmann S, 2010, HDB HYDROCARBON LIPI, P1099, DOI DOI 10.1007/978-3-540-77587-4_77; HAYATSU M, 1993, APPL ENVIRON MICROB, V59, P2121, DOI 10.1128/AEM.59.7.2121-2125.1993; Hertfordshire, 2013, PPDB PEST PROP DATAB; Hong Kyung Sik, 2007, J Microbiol Biotechnol, V17, P1655; Howard GT, 1998, INT BIODETER BIODEGR, V42, P213, DOI 10.1016/S0964-8305(98)00051-1; Howard GT, 2002, INT BIODETER BIODEGR, V49, P245, DOI 10.1016/S0964-8305(02)00051-3; Hu YF, 2010, FEMS MICROBIOL ECOL, V72, P228, DOI 10.1111/j.1574-6941.2010.00851.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kang CH, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-41; KARNS JS, 1991, J AGR FOOD CHEM, V39, P1004, DOI 10.1021/jf00005a041; Kim I, 2014, BIODEGRADATION, V25, P383, DOI 10.1007/s10532-013-9667-9; Kim YJ, 2006, PROTEIN EXPRES PURIF, V45, P315, DOI 10.1016/j.pep.2005.06.008; Kruger NJ, 1994, NEW PROTEIN TECHNIQU, V32, P9, DOI DOI 10.1385/0-89603-268-X:9; Kuhr RJ, 1976, CARBAMATE INSECTICID; Lam KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098968; Lee SW, 2004, APPL MICROBIOL BIOT, V65, P720, DOI 10.1007/s00253-004-1722-3; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Liu KL, 2009, BIOCHEM BIOPH RES CO, V385, P605, DOI 10.1016/j.bbrc.2009.05.110; Loredo-Trevino A, 2012, J POLYM ENVIRON, V20, P258, DOI 10.1007/s10924-011-0390-5; MULBRY WW, 1991, APPL ENVIRON MICROB, V57, P3679, DOI 10.1128/AEM.57.12.3679-3682.1991; Nakajima-Kambe T, 1999, APPL MICROBIOL BIOT, V51, P134, DOI 10.1007/s002530051373; NAKAJIMAKAMBE T, 1995, FEMS MICROBIOL LETT, V129, P39, DOI 10.1111/j.1574-6968.1995.tb07554.x; Nunes GS, 1999, TRAC-TREND ANAL CHEM, V18, P99, DOI 10.1016/S0165-9936(98)00076-4; Okano H, 2015, PROTEIN SCI, V24, P93, DOI 10.1002/pro.2591; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Peng S, 2015, J APPL GENET, V56, P393, DOI 10.1007/s13353-014-0258-1; PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207; PlasticsEurope, 2015, PLASTICS THE FACTS 2; POHLENZ HD, 1992, J BACTERIOL, V174, P6600, DOI 10.1128/JB.174.20.6600-6607.1992; Prive F, 2015, APPL MICROBIOL BIOT, V99, P5475, DOI 10.1007/s00253-014-6355-6; Rahimi A, 2013, PLAST RUBBER COMPOS, V42, P223, DOI 10.1179/1743289811Y.0000000063; Rashamuse K, 2009, J APPL MICROBIOL, V106, P1532, DOI 10.1111/j.1365-2672.2008.04114.x; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Smith MJ, 2012, ENVIRON INT, V49, P38, DOI 10.1016/j.envint.2012.08.005; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Tauzin AS, 2016, MOL MICROBIOL, V102, P579, DOI 10.1111/mmi.13480; U.S. National Library of Medicine, 2014, CHEMIDPLUS ADV CHEM; Ufarte L, 2015, BIOTECHNOL ADV, V33, P1845, DOI 10.1016/j.biotechadv.2015.10.009; Urgun-Demirtas M, 2007, POLYM DEGRAD STABIL, V92, P1599, DOI 10.1016/j.polymdegradstab.2007.04.013; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078507; Wang QQ, 2003, J AGR FOOD CHEM, V51, P5382, DOI 10.1021/jf034311f; ZHAO CJ, 1994, BIOL PHARM BULL, V17, P773	65	18	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189201	10.1371/journal.pone.0189201	http://dx.doi.org/10.1371/journal.pone.0189201			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240834	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600021
J	Beckett, TJ; Morales, AJ; Koehler, KL; Rocheford, TR				Beckett, Travis J.; Morales, A. Jason; Koehler, Klaus L.; Rocheford, Torbert R.			Genetic relatedness of previously Plant-Variety-Protected commercial maize inbreds	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; NORTH-AMERICAN; DENT CORN; MOLECULAR CHARACTERIZATION; SEQUENCE DIVERSITY; LINES; SELECTION; CLASSIFICATION; SIMILARITIES; ASSOCIATION	The emergence of high-throughput, high-density genotyping methods combined with increasingly powerful computing systems has created opportunities to further discover and exploit the genes controlling agronomic performance in elite maize breeding populations. Understanding the genetic basis of population structure in an elite set of materials is an essential step in this genetic discovery process. This paper presents a genotype-based population analysis of all maize inbreds whose Plant Variety Protection certificates had expired as of the end of 2013 (283 inbreds) as well as 66 public founder inbreds. The results provide accurate population structure information and allow for important inferences in context of the historical development of North American elite commercial maize germplasm. Genotypic data was obtained via genotyping-by-sequencing on 349 inbreds. After filtering for missing data, 77,314 high-quality markers remained. The remaining missing data (average per individual was 6.22 percent) was fully imputed at an accuracy of 83 percent. Calculation of linkage disequilibrium revealed that the average r(2) of 0.20 occurs at approximately 1.1 Kb. Results of population genetics analyses agree with previously published studies that divide North American maize germplasm into three heterotic groups: Stiff Stalk, Non-Stiff Stalk, and Iodent. Principal component analysis shows that population differentiation is indeed very complex and present at many levels, yet confirms that division into three main sub-groups is optimal for population description. Clustering based on Nei's genetic distance provides an additional empirical representation of the three main heterotic groups. Overall fixation index (FST), indicating the degree of genetic divergence between the three main heterotic groups, was 0.1361. Understanding the genetic relationships and population differentiation of elite germplasm may help breeders to maintain and potentially increase the rate of genetic gain, resulting in higher overall agronomic performance.	[Beckett, Travis J.; Rocheford, Torbert R.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Morales, A. Jason; Koehler, Klaus L.] Dow AgroSci, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Dow Chemical Company	Beckett, TJ (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	travisbeckett@purdue.edu			Dow AgroSciences	Dow AgroSciences	This research was funded by a grant from Dow AgroSciences (www.dowagro.com). The funder provided additional support in the form of salaries for authors AJM and KLK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barata C, 2006, EUPHYTICA, V151, P339, DOI 10.1007/s10681-006-9155-y; Beckett TJ, 2016, THESIS; Bernardo R., 2014, ESSENTIALS PLANT BRE; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Crabb AR, 1947, HYBRID CORN MAKERS; CROSS H Z, 1989, North Dakota Farm Research, V47, P19; Deschamps Stephane, 2012, Biology (Basel), V1, P460, DOI 10.3390/biology1030460; DUDLEY JW, 1991, CROP SCI, V31, P718, DOI 10.2135/cropsci1991.0011183X003100030036x; East EM, 1912, HETEROZYGOSIS EVOLUT; East EM, 1913, BOT GAZ, V55, P404; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fan XM, 2009, AGRON J, V101, P106, DOI 10.2134/agronj2008.0217; Gerdes, 1993, COMPILATION N AM MAI; Gethi JG, 2002, CROP SCI, V42, P951, DOI 10.2135/cropsci2002.0951; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hayes HK, 1911, IMPROVEMENT IN CORN; Hayes HK, 1915, FURTHER EXPT INHERIT; He S, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1366-y, 10.1186/s12864-015-1217-x]; Herrmann E., 2013, LOKERN KERNEL REGRES; Jung M, 2004, THEOR APPL GENET, V109, P681, DOI 10.1007/s00122-004-1695-8; Kahler AL, 2010, CROP SCI, V50, P486, DOI 10.2135/cropsci2009.03.0121; Kaufman L., 2009, FINDING GROUPS DATA; Kurtz B, 2016, CROP SCI, V56, P931, DOI 10.2135/cropsci2015.07.0439; Lamkey CM, 2014, CROP SCI, V54, P576, DOI 10.2135/cropsci2013.07.0484; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LIVINI C, 1992, THEOR APPL GENET, V84, P17, DOI 10.1007/BF00223976; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; MELCHINGER AE, 1991, CROP SCI, V31, P669, DOI 10.2135/cropsci1991.0011183X003100030025x; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Mikel MA, 2006, CROP SCI, V46, P2555, DOI 10.2135/cropsci2006.05.0358; Mikel MA, 2011, CROP SCI, V51, P592, DOI 10.2135/cropsci2010.06.0332; Morales AJ., 2013, THESIS; Moschini GC., 2010, COMPETITION ISSUES S, V25; MUMM RH, 1994, CROP SCI, V34, P842, DOI 10.2135/cropsci1994.0011183X003400040005x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Olmos SE, 2014, MAYDICA, V59, P298; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Porto-Neto Laercio R, 2013, Methods Mol Biol, V1019, P423, DOI 10.1007/978-1-62703-447-0_19; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Richey F. D., 1922, AGRON J, V14, P1; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Senior ML, 1998, CROP SCI, V38, P1088, DOI 10.2135/cropsci1998.0011183X003800040034x; Shull G., 1909, AM BREEDERS ASS REPO, V5, P51, DOI 10.1093/jhered/os-5.1.51; Shull GH, 1910, J HERED, V1, P98; SMITH OS, 1990, THEOR APPL GENET, V80, P833, DOI 10.1007/BF00224201; Smith SD, 2015, MAYDICA, V60; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Team RC, 2015, R LANG ENV STAT COMP; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thorndike RL., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; Truntzler M, 2012, THEOR APPL GENET, V125, P731, DOI 10.1007/s00122-012-1866-y; United States Patent and Trademark Office, 2015, PAT SUBJ MATT LIV SU; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; USDA, 2013, PLANT VAR PROT ACT R; USDA Germplasm Resources Information Network-(GRIN), 2013, USDA GERMPL RES INF; USDA United States Department of Agriculture National Agricultural Statistics Service, 2016, QUICK STATS ONL DAT; van Heerwaarden J, 2012, P NATL ACAD SCI USA, V109, P12420, DOI 10.1073/pnas.1209275109; VANBRUNT J, 1985, BIO-TECHNOL, V3, P1059; Wallace HA, 1957, SOIL SCI, V83, P160; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu YS, 2016, THEOR APPL GENET, V129, P753, DOI 10.1007/s00122-016-2664-8; Xavier A, 2015, BIOINFORMATICS, V31, P3862, DOI 10.1093/bioinformatics/btv448; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077; Zhao W, 2006, NUCLEIC ACIDS RES, V34, pD752, DOI 10.1093/nar/gkj011; Ziegler GR, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.3	73	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189277	10.1371/journal.pone.0189277	http://dx.doi.org/10.1371/journal.pone.0189277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236738	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100053
J	Lin, ZJ; Huang, SY; Huang, P; Guo, L; Shen, X; Zhong, YS				Lin, Zhongjing; Huang, Shouyue; Huang, Ping; Guo, Lei; Shen, Xi; Zhong, Yisheng			The diagnostic use of choroidal thickness analysis and its correlation with visual field indices in glaucoma using spectral domain optical coherence tomography	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; BLOOD-FLOW; NERVE HEAD; OCULAR HYPERTENSION; VESSEL DENSITY; ANGIOGRAPHY; PATHOPHYSIOLOGY; PERIMETRY; DEFECTS; HEALTHY	Purpose To evaluate the quantitative characteristics of choroidal thickness in primary open-angle glaucoma (POAG), normal tension glaucoma (NTG) and in normal eyes using spectraldomain optical coherence tomography (SD-OCT). To evaluate the diagnostic ability of choroidal thickness in glaucoma and to determine the correlation between choroidal thickness and visual field parameters in glaucoma. Methods A total of 116 subjects including 40 POAG, 30 NTG and 46 healthy subjects were enrolled in this study. Choroidal thickness measurements were acquired in the macular and peripapillary regions using SD-OCT. All subjects underwent white-on-white (W/W) and blue-onyellow (B/Y) visual field tests using Humphrey Field Analyzer. The receiver operating characteristic (ROC) curve and the area under curve (AUC) were generated to assess the discriminating power of choroidal thickness for glaucoma. Pearson's correlation coefficients were calculated to assess the structure function correlation for glaucoma patients. Results No significant differences were observed for macular choroidal thickness among the different groups (all P > 0.05). Regarding the peripapillary choroidal thickness (PPCT), significant differences were observed among the three groups (all P < 0.05). Post hoc tests for multiple comparisons revealed a significant difference in the NTG-normal comparison group (all P < 0.01). The inferior and temporal PPCT in POAG patients were significantly thinner than those in normal subjects (P = 0.007, P = 0.002, respectively). Different parameters of PPCT showed significantly low diagnostic values to detect POAG from normal subjects (AUC: 0.555 to 0.652) and to discriminate NTG from POAG (AUC: 0.462 to 0.702), but moderate diagnostic power to detect NTG from normal subjects (AUC: 0.708 to 0.771). Regarding the diagnosis of early glaucoma, different parameters of PPCT showed relatively low diagnostic power (AUC: 0.606 to 0.698). In all the glaucoma subjects, PPCT was not significantly correlated with W/W mean deviation (MD) (all P > 0.05), but showed significant correlations with B/Y MD (all P < 0.05). In the early glaucomatous eyes, PPCT showed significant correlations with W/W MD and B/Y MD (all P < 0.05). Conclusions In our study, peripapillary choroidal thickness measured on OCT showed a low to moderate but statistically significant diagnostic power and a significant correlation with blue-on-yellow visual field indices in glaucoma. This may indicate a potential adjunct for peripapillary choroidal thickness in glaucoma diagnosis.	[Lin, Zhongjing; Huang, Shouyue; Shen, Xi; Zhong, Yisheng] Shanghai Jiao Tong Univ, Ruijin Hosp, Affiliated Med Sch, Dept Ophthalmol, Shanghai, Peoples R China; [Huang, Ping; Guo, Lei] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Bone & Joint Dis,Affiliated Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, X; Zhong, YS (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Affiliated Med Sch, Dept Ophthalmol, Shanghai, Peoples R China.	carl_shen2005@126.com; yszhong68@126.com						Adhi M, 2013, CURR OPIN OPHTHALMOL, V24, P213, DOI 10.1097/ICU.0b013e32835f8bf8; Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049; Anderson DR, 1999, AUTOMATED STATIC PER, P152; Ferreras A, 2007, J GLAUCOMA, V16, P372, DOI 10.1097/IJG.0b013e31803bbb17; Flammer J, 2007, SURV OPHTHALMOL, V52, pS162, DOI 10.1016/j.survophthal.2007.08.012; Goharian I, 2016, J GLAUCOMA, V25, P452, DOI 10.1097/IJG.0000000000000166; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS144, DOI 10.1016/j.survophthal.2007.08.010; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Johnson C A, 1996, Curr Opin Ophthalmol, V7, P54, DOI 10.1097/00055735-199604000-00010; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P645, DOI 10.1001/archopht.1993.01090050079034; Karahan E, 2016, SEMIN OPHTHALMOL; Koustenis A, 2017, BRIT J OPHTHALMOL, V101, P16, DOI 10.1136/bjophthalmol-2016-309389; Li L, 2013, AM J OPHTHALMOL, V156, P1277, DOI 10.1016/j.ajo.2013.07.011; Lin Z, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/4182693; Lutjen-Drecoll E, 2006, EXP EYE RES, V82, P357, DOI 10.1016/j.exer.2005.09.015; Mallick Jyotiranjan, 2016, J Ophthalmic Vis Res, V11, P204, DOI 10.4103/2008-322X.183914; Mammo Z, 2016, AM J OPHTHALMOL, V170, P41, DOI 10.1016/j.ajo.2016.07.015; Meng NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062723; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Nakakura S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110265; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Plange N, 2006, OPHTHAL PHYSL OPT, V26, P26, DOI 10.1111/j.1475-1313.2005.00349.x; Polak K, 2007, ARCH OPHTHALMOL-CHIC, V125, P494, DOI 10.1001/archopht.125.4.494; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; Song YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157333; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Suh W, 2014, JPN J OPHTHALMOL, V58, P62, DOI 10.1007/s10384-013-0290-4; Teesalu P, 1998, OPHTHALMOLOGY, V105, P2077, DOI 10.1016/S0161-6420(98)91128-9; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Vasconcelos De Moraes C, 2009, GRAEF ARCH CLIN EXP, V247, P385, DOI 10.1007/s00417-008-0969-2; Vuong VS, 2016, AM J OPHTHALMOL, V169, P104, DOI 10.1016/j.ajo.2016.06.023; Wang W, 2014, INVEST OPHTH VIS SCI, V55, P6007, DOI 10.1167/iovs.14-14996; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Xiong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096103; Xu SZ, 2015, J ELECTR COMPUT ENG, V2015, DOI 10.1155/2015/571209; Yannuzzi LA, 2011, AM J OPHTHALMOL, V151, P745, DOI 10.1016/j.ajo.2011.01.043; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Zhang ZW, 2016, J GLAUCOMA, V25, pE446, DOI 10.1097/IJG.0000000000000275; Zhao J, 2016, INT J MOL MED, V38, P995, DOI 10.3892/ijmm.2016.2714	44	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189376	10.1371/journal.pone.0189376	http://dx.doi.org/10.1371/journal.pone.0189376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236748	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100064
J	Stujanna, EN; Murakoshi, N; Tajiri, K; Xu, DZ; Kimura, T; Qin, RJ; Feng, D; Yonebayashi, S; Ogura, Y; Yamagami, F; Sato, A; Nogami, A; Aonuma, K				Stujanna, Endin Nokik; Murakoshi, Nobuyuki; Tajiri, Kazuko; Xu, DongZhu; Kimura, Taizo; Qin, Rujie; Feng, Duo; Yonebayashi, Saori; Ogura, Yukino; Yamagami, Fumi; Sato, Akira; Nogami, Akihiko; Aonuma, Kazutaka			Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism	PLOS ONE			English	Article							TARGETED DELETION; ALPHA; EXPRESSION; CAPACITY; RECEPTOR; INJURY; REPAIR; GENE	Rev-erb alpha, known as nuclear receptor 1D1 (NR1D1), regulates circadian rhythm, modulates glucose and lipid metabolism, and inflammatory response. However, little is known about the effect of Rev-erb agonist on the progression of myocardial infarction (MI) and heart failure. To investigate it, wild-type male mice underwent sham-operation or permanent ligation of the left anterior descending coronary artery to create MI model. Rev-erb agonist SR9009 (100 mg/kg/day) or vehicle was intraperitoneally administered. Echocardiography was performed to evaluate cardiac function 1 week after surgery. The gene and protein expression levels in the left ventricles (LVs) were determined with real-time PCR, western blotting, and immunofluorescence. Moreover, immune cell infiltration into the LVs was analyzed by flow cytometry. Survival rate and reduced LV function were significantly improved by the treatment with SR9009 after MI. The expression level and plasma concentration of brain natriuretic peptide were significantly lower in MI mice treated with SR9009 (MI+SR) than in MI mice treated with vehicle (MI+V). Moreover, the mRNA expression levels of inflammatory-related molecules such as Il6, Mcp1, Ly6g, Cd11b, matrix metallopeptidase (Mmp) 9, and the protein expression levels of phosphorylated NF-kappa B p65, phosphorylated ERK, and phosphorylated p38 were also significantly lower in MI+SR than in MI+V. Immunofluorescence intensity for MMP-9 was enhanced in the LVs, but was less so in MI+SR than in MI+V. Furthermore, infiltrations of neutrophils and proinflammatory macrophages in the LVs were dramatically increased in MI+V and were significantly suppressed in MI+SR. Rev-erb agonist SR9009 treatment inhibited post-MI mortality and improved cardiac function through modulating inflammation and remodeling process.	[Stujanna, Endin Nokik; Murakoshi, Nobuyuki; Tajiri, Kazuko; Xu, DongZhu; Kimura, Taizo; Qin, Rujie; Feng, Duo; Yonebayashi, Saori; Ogura, Yukino; Yamagami, Fumi; Sato, Akira; Nogami, Akihiko; Aonuma, Kazutaka] Univ Tsukuba, Grad Sch Comprehens Human Sci, Fac Med, Dept Cardiol, Tsukuba, Ibaraki, Japan	University of Tsukuba	Murakoshi, N (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Fac Med, Dept Cardiol, Tsukuba, Ibaraki, Japan.	n.murakoshi@md.tsukuba.ac.jp	Sato, Akira/CAJ-4644-2022; Sato, Akira/R-1244-2018	Stujanna, Endin/0000-0002-1203-8773; Sato, Akira/0000-0002-2438-1464; Nogami, Akihiko/0000-0003-0359-4601	MSD; University of Tsukuba	MSD; University of Tsukuba	This research was supported by a grant from MSD K.K. 2016 and a grant from University of Tsukuba 2015-2016. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai T, 2013, CIRC J, V77, P580, DOI 10.1253/circj.CJ-13-0013; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Frangogiannis NG, 2015, COMPR PHYSIOL, V5, P1841, DOI 10.1002/cphy.c150006; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Jaramillo C, 2007, SCIENCE, V318, P1786; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Machino-Ohtsuka T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001052; Matsui Yutaka, 2010, World J Biol Chem, V1, P69, DOI 10.4331/wjbc.v1.i5.69; Mollmann H, 2010, CARDIOVASC RES, V87, P395, DOI 10.1093/cvr/cvq186; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Romanic AM, 2002, CARDIOVASC RES, V54, P549, DOI 10.1016/S0008-6363(02)00254-7; Sato S., 2014, THESCIENTIFICWORLDJO, V2014, P685854, DOI [10.1155/2014/685854, DOI 10.1155/2014/685854]; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Sitaula S, 2015, BIOCHEM BIOPH RES CO, V460, P1; Solt LA, 2012, NATURE, V485, P123; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Weiford BC, BRAUNWALDS HEART DIS, V294, P376; Wen B, 2009, CIRC RES, V104, P403; Whittington HJ, 2013, CARDIOVASC DRUG THER, V27, P5, DOI 10.1007/s10557-012-6425-x; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Xu DZ, 2012, J CARDIOVASC ELECTR, V23, P209, DOI 10.1111/j.1540-8167.2011.02186.x; Yang F, 2013, J ATHEROSCLER THROMB, V20, P267, DOI 10.5551/jat.14381; Yeh CC, 2010, J CELL BIOCHEM, V109, P1185, DOI 10.1002/jcb.22498	31	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189330	10.1371/journal.pone.0189330	http://dx.doi.org/10.1371/journal.pone.0189330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232411	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200030
J	Yeh, JJ; Lin, CL; Hsu, WH; Kao, CH				Yeh, Jun-Jun; Lin, Cheng-Li; Hsu, Wu-Huei; Kao, Chia-Hung			The relationship of depression in asthma - chronic obstructive pulmonary disease overlap syndrome	PLOS ONE			English	Article							QUALITY-OF-LIFE; COPD; PREVALENCE; CORTICOSTEROIDS; ANXIETY; IMPACT	Purpose To clarify the relationship between asthma - chronic obstructive pulmonary disease overlap syndrome (ACOS) and depression. Methods We identified 10,911 patients who received an ACOS diagnosis and concurrent treatment between January 2000 and December 2009. Subjects without ACOS were included in the non-ACOS cohort (n = 10,911). Cox proportional hazard regression analysis was performed to compare the risk of depression between the ACOS and non-ACOS cohorts. Results The risk of depression was higher in the ACOS cohort than in the non-ACOS cohort (adjusted hazard ratios (aHRs) = 1.67, 95% confidence interval [CI] = 1.48 - 1.88). In the ACOS cohort, the aHRs for depression were [2.44 (95% CI = 1.45 - 4.11); 2.36 (95% CI = 1.58 - 3.52)] in patients [aged 20 - 39 years; without comorbidity]. In the ACOS cohort, the aHRs for depression were 1.70 (95% CI = 1.51 - 1.93) and 1.84 (95% CI = 1.55 - 2.19) in patients without inhaled corticosteroids (ICSs) and oral steroids (OSs) use, respectively. Moreover, the aHRs for the risk of depression were 1.16 (95% CI = 0.95 - 1.41) and 1.12 (95% CI = 0.96 - 1.29) in patients with ICSs and OSs use, respectively. Conclusion The risk of depression is higher in ACOS patients, even in those without comorbidities or in young adults. The events of the depression were not significant difference in patients receiving the ICSs/OSs between the ACOS and the non-ACOS cohorts.	[Yeh, Jun-Jun] Ditmanson Med Fdn, Chia Yi Christian Hosp, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Hsu, Wu-Huei; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsu, Wu-Huei; Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Yeh, JJ (corresponding author), Ditmanson Med Fdn, Chia Yi Christian Hosp, Chiayi, Taiwan.; Yeh, JJ (corresponding author), Chia Nan Univ Pharm & Sci, Tainan, Taiwan.; Yeh, JJ (corresponding author), Meiho Univ, Pingtung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	anvin.funlan@msa.hinet.net; d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barrecheguren M, 2015, COPD RES PRACTICE, V1, P1; Barrecheguren M, 2015, INT J CHRONIC OBSTR, V10, P1745, DOI 10.2147/COPD.S87025; Bjornsdottir E, 2016, J CLIN SLEEP MED, V12, P105, DOI 10.5664/jcsm.5406; Bonala SB, 2003, J ASTHMA, V40, P691, DOI 10.1081/JAS-120023491; Bozek A, 2016, J ASTHMA, V53, P943, DOI 10.3109/02770903.2016.1170139; Changchien TC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002401; Chong MY, 2001, BRIT J PSYCHIAT, V178, P29, DOI 10.1192/bjp.178.1.29; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000755; Dahlen I, 2002, CHEST, V122, P1633, DOI 10.1378/chest.122.5.1633; Dalal AA, 2012, INT J CHRONIC OBSTR, V7, P11, DOI 10.2147/COPD.S27846; Dalal AA, 2011, COPD, V8, P293, DOI 10.3109/15412555.2011.586659; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Feng JX, 2017, J KOREAN MED SCI, V32, P439, DOI 10.3346/jkms.2017.32.3.439; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Ghebre MA, 2015, J ALLERGY CLIN IMMUN, V135, P63, DOI 10.1016/j.jaci.2014.06.035; Hekking PP, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA1045; Iglesias P, 2014, J ENDOCRINOL INVEST, V37, P135, DOI 10.1007/s40618-013-0009-x; Iyer AS, 2016, ANN AM THORAC SOC, V13, P197, DOI 10.1513/AnnalsATS.201507-439OC; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kenna HA, 2011, PSYCHIAT CLIN NEUROS, V65, P549, DOI 10.1111/j.1440-1819.2011.02260.x; Kumbhare S, 2016, ANN AM THORAC SOC, V13, P803, DOI 10.1513/AnnalsATS.201508-554OC; Lange Peter, 2016, Int J Chron Obstruct Pulmon Dis, V11 Spec Iss, P3, DOI 10.2147/COPD.S85976; Mao HF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148414; Najafipour H, 2016, ASIAN J PSYCHIATR, V20, P55, DOI 10.1016/j.ajp.2016.01.004; O'Byrne PM, 2013, CHEST, V143, P511, DOI 10.1378/chest.12-0412; Papaiwannou A, 2014, J THORAC DIS, V6, pS146, DOI 10.3978/j.issn.2072-1439.2014.03.04; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Poh TY, 2017, EXPERT REV RESP MED, V11, P285, DOI 10.1080/17476348.2017.1305895; Pols DHJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182664; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Santana MJ, 2013, CAN RESPIR J, V20, pE17, DOI 10.1155/2013/265406; Thew GR, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116659604; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002; Vogelmeier CF, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-38; Warrington TP, 2006, MAYO CLIN PROC, V81, P1361, DOI 10.4065/81.10.1361; Yamauchi Y, 2015, RESPIROLOGY, V20, P940, DOI 10.1111/resp.12556; Yeh JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162483; Yeh JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159012; Yohannes AM, 2016, CHEST, V149, P916, DOI 10.1016/j.chest.2015.10.081; Zeki Amir A, 2011, J Allergy (Cairo), V2011, P861926, DOI 10.1155/2011/861926; Zoorob RJ, 1998, AM FAM PHYSICIAN, V58, P443	45	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188017	10.1371/journal.pone.0188017	http://dx.doi.org/10.1371/journal.pone.0188017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232717	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200003
J	Garcia-Beltran, O; Mena, NP; Aguirre, P; Barriga-Gonzalez, G; Galdamez, A; Nagles, E; Adasme, T; Hidalgo, C; Nunez, MT				Garcia-Beltran, Olimpo; Mena, Natalia P.; Aguirre, Pabla; Barriga-Gonzalez, German; Galdamez, Antonio; Nagles, Edgar; Adasme, Tatiana; Hidalgo, Cecilia; Nunez, Marco T.			Development of an iron-selective antioxidant probe with protective effects on neuronal function	PLOS ONE			English	Article							PARKINSONS-DISEASE; LABILE IRON; MITOCHONDRIAL FRAGMENTATION; FLUORESCENCE PROBES; OXIDATIVE STRESS; ON FLUORESCENCE; SH-SY5Y CELLS; DEFICIENCY; COUMARINS; CALCIUM	Iron accumulation, oxidative stress and calcium signaling dysregulation are common pathognomonic signs of several neurodegenerative diseases, including Parkinson's and Alzheimer's diseases, Friedreich ataxia and Huntington's disease. Given their therapeutic potential, the identification of multifunctional compounds that suppress these damaging features is highly desirable. Here, we report the synthesis and characterization of N-(1,3-dihydroxy- 2-(hydroxymethyl) propan-2-yl)-2-(7-hydroxy-2-oxo-2H-chromen-4-yl) acetamide, named CT51, which exhibited potent free radical neutralizing activity both in vitro and in cells. CT51 bound Fe2+ with high selectivity and Fe3+ with somewhat lower affinity. Cyclic voltammetric analysis revealed irreversible binding of Fe3+ to CT51, an important finding since stopping Fe2+/Fe3+ cycling in cells should prevent hydroxyl radical production resulting from the Fenton-Haber-Weiss cycle. When added to human neuroblastoma cells, CT51 freely permeated the cell membrane and distributed to both mitochondria and cytoplasm. Intracellularly, CT51 bound iron reversibly and protected against lipid peroxidation. Treatment of primary hippocampal neurons with CT51 reduced the sustained calcium release induced by an agonist of ryanodine receptor-calcium channels. These protective properties of CT51 on cellular function highlight its possible therapeutic use in diseases with significant oxidative, iron and calcium dysregulation.	[Garcia-Beltran, Olimpo; Adasme, Tatiana; Hidalgo, Cecilia] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Mena, Natalia P.; Aguirre, Pabla; Nunez, Marco T.] Univ Chile, Dept Biol, Fac Sci, Santiago, Chile; [Barriga-Gonzalez, German] Univ Metropolitana Ciencias Educ, Fac Ciencias Basicas, Dept Quim, Santiago, Chile; [Galdamez, Antonio] Univ Chile, Dept Chem, Fac Sci, Santiago, Chile; [Garcia-Beltran, Olimpo; Nagles, Edgar] Univ Ibague, Fac Ciencias Nat & Matemat, Ibague, Colombia; [Adasme, Tatiana] Univ Bernardo OHiggins, Integrat Ctr Appl Biol & Chem CIBQA, Santiago, Chile; [Hidalgo, Cecilia] Univ Chile, Fac Med, Dept Neurosci, CEMC, Santiago, Chile; [Hidalgo, Cecilia] Univ Chile, Fac Med, Dept Neurosci, ICBM, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad Metropolitana de Ciencias de la Educacion (UMCE); Universidad de Chile; Universidad  Bernardo O'Higgins; Universidad de Chile; Universidad de Chile	Hidalgo, C (corresponding author), Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile.; Nunez, MT (corresponding author), Univ Chile, Dept Biol, Fac Sci, Santiago, Chile.; Hidalgo, C (corresponding author), Univ Chile, Fac Med, Dept Neurosci, CEMC, Santiago, Chile.; Hidalgo, C (corresponding author), Univ Chile, Fac Med, Dept Neurosci, ICBM, Santiago, Chile.	chidalgo@med.uchile.cl; mnunez@uchile.cl	Nagles Vidal, Edgar Orlando/AGK-9352-2022; Adasme, Tatiana/ABB-6697-2020; HIDALGO, Cecilia/H-7107-2013; Garcia-Beltran, Olimpo/O-1846-2017	Nagles Vidal, Edgar Orlando/0000-0002-2957-2817; Adasme, Tatiana/0000-0002-0840-1912; Hidalgo, Cecilia/0000-0003-1256-9651; Garcia-Beltran, Olimpo/0000-0003-3312-1776; Barriga-Gonzalez, German/0000-0002-9628-2414	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile [3149451]; Fondo Nacional de Desarrollo Cientifico y Tecnologica (FONDECYT), Chile [1149545, 1130068, 11140580]; Instituto de Neurociencia Biomedica, Iniciativa Cientifica Milenio, Chile [BNI P-09-015F]; Program for Research, Faculty of Sciences (PAIFAC); VID, Universidad de Chile [U-APOYA 2236]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrollo Cientifico y Tecnologica (FONDECYT), Chile; Instituto de Neurociencia Biomedica, Iniciativa Cientifica Milenio, Chile; Program for Research, Faculty of Sciences (PAIFAC); VID, Universidad de Chile	This study was supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile (http://spl.conicyt.cl/auth/), which provided a postdoctoral research grant (No 3149451) to Dr. Olimpo Garcia-Beltran; Fondo Nacional de Desarrollo Cientifico y Tecnologica (FONDECYT), Chile (http://www.conicyt.cl/fondecyt/), which provided research grants to Cecilia Hidalgo (No 1149545), Marco T. Nunez (No 1130068) and Tatiana Adasme (No 11140580); Instituto de Neurociencia Biomedica, Iniciativa Cientifica Milenio, Chile (www.iniciativamilenio.cl/), which provided research funds to Cecilia Hidalgo (No BNI P-09-015F). Financial support to Prof. Marco T Nunez was provided by the Program for Research, Faculty of Sciences (PAIFAC) and by U-APOYA 2236, VID, Universidad de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre P, 2007, AM J PHYSIOL-CELL PH, V292, pC2197, DOI 10.1152/ajpcell.00620.2006; Aguirre P, 2017, ACS CHEM NEUROSCI, V8, P178, DOI 10.1021/acschemneuro.6b00309; Aguirre P, 2012, BIOMETALS, V25, P795, DOI 10.1007/s10534-012-9525-y; Bailly F, 2004, BIOORGAN MED CHEM, V12, P5611, DOI 10.1016/j.bmc.2004.07.066; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Barriga G, 2010, BIOORGAN MED CHEM, V18, P795, DOI 10.1016/j.bmc.2009.11.053; Belaidi AA, 2016, J NEUROCHEM, V139, P179, DOI 10.1111/jnc.13425; BERGSTEN P, 1990, J BIOL CHEM, V265, P2584; Brugnara C, 2003, CLIN CHEM, V49, P1573, DOI 10.1373/49.10.1573; Choi YW, 2014, SENSOR ACTUAT B-CHEM, V194, P343, DOI 10.1016/j.snb.2013.12.114; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; DANIELSSON LG, 1978, ANAL CHIM ACTA, V98, P47, DOI 10.1016/S0003-2670(01)83237-2; DAVIES MJ, 1988, BIOCHEM J, V255, P513; Dusek P, 2016, J TRACE ELEM MED BIO, V38, P81, DOI 10.1016/j.jtemb.2016.03.010; En D, 2014, RSC ADV, V4, P248, DOI 10.1039/c3ra44843f; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Fischer E., 1895, CHEM BER-RECL, V28, P3252, DOI [10.1002/cber.189502803176, DOI 10.1002/CBER.189502803176]; Garcia-Beltran O, 2013, EUR J MED CHEM, V67, P60, DOI 10.1016/j.ejmech.2013.06.022; Garcia-Beltran O, 2012, TETRAHEDRON LETT, V53, P5280, DOI 10.1016/j.tetlet.2012.07.082; Ghosh K, 2013, TETRAHEDRON LETT, V54, P6460, DOI 10.1016/j.tetlet.2013.09.066; GRAF E, 1984, J BIOL CHEM, V259, P3620; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hidalgo C, 2007, IUBMB LIFE, V59, P280, DOI 10.1080/15216540701222906; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kim KB, 2014, INORG CHEM COMMUN, V46, P237, DOI 10.1016/j.inoche.2014.06.009; Kimmel DW, 2012, ANAL CHEM, V84, P685, DOI 10.1021/ac202878q; Knorle R., 2017, NEUROTOXICITY RES; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lee DG, 2016, TOXICOLOGY, V365, P17, DOI 10.1016/j.tox.2016.07.022; Lee JA, 2012, B KOREAN CHEM SOC, V33, P3625, DOI 10.5012/bkcs.2012.33.11.3625; Liu HY, 2014, TETRAHEDRON, V70, P7527, DOI 10.1016/j.tet.2014.08.008; MOORE TA, 1971, J MOL SPECTROSC, V40, P144, DOI 10.1016/0022-2852(71)90016-6; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Munoz Y, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/7049108; MUTHURAMU K, 1984, J PHOTOCHEM, V26, P57, DOI 10.1016/0047-2670(84)85026-1; Nad S, 2000, J PHOTOCH PHOTOBIO A, V134, P9, DOI 10.1016/S1010-6030(00)00240-9; Neilands JB., 1984, METHODOLOGY SIDEROPH, P1; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Park J, 2015, TOXICOLOGY, V337, P39, DOI 10.1016/j.tox.2015.08.009; Paula-Lima AC, 2014, ANTIOXID REDOX SIGN, V21, P892, DOI 10.1089/ars.2013.5796; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; PAYA M, 1992, BIOCHEM PHARMACOL, V44, P205, DOI 10.1016/0006-2952(92)90002-Z; Pchitskaya E., 2017, CELL CALCIUM; Popova D, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0151-8; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Pulido-Tofino P, 2000, TALANTA, V51, P537, DOI 10.1016/S0039-9140(99)00308-2; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rouault TA, 2001, PEDIATR NEUROL, V25, P130, DOI 10.1016/S0887-8994(01)00260-0; Salvador GA, 2011, NEUROTOXICOLOGY, V32, P75, DOI 10.1016/j.neuro.2010.11.006; SanMartin CD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00013; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sriram K, 1997, BRAIN RES, V749, P44, DOI 10.1016/S0006-8993(96)01271-1; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; Surmeier DJ, 2017, EXPT NEUROLOGY; Velapoldi RA, 2004, J FLUORESC, V14, P465, DOI 10.1023/B:JOFL.0000031828.96368.c1; Watabe M, 2007, J PHARMACOL EXP THER, V323, P499, DOI 10.1124/jpet.107.127597; Wegner SV, 2010, J AM CHEM SOC, V132, P2567, DOI 10.1021/ja9097324; WIGGLESWORTH JM, 1988, BRAIN IRON NEUROCHEM, P25; Wu D, 2009, J AGR FOOD CHEM, V57, P1697, DOI 10.1021/jf8030343; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xicoy H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0149-0; Youdim MBH, 2008, NEUROTOX RES, V14, P45, DOI 10.1007/BF03033574; Yu W, 1999, J CHEM SOC PERK T 2, P969, DOI 10.1039/a810022e; Zeng ZT, 2000, ANALYST, V125, P1661, DOI 10.1039/b004231p; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhu Q, 2003, ORG LETT, V5, P1257, DOI 10.1021/ol034233h	68	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189043	10.1371/journal.pone.0189043	http://dx.doi.org/10.1371/journal.pone.0189043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228015	gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600030
J	Moinuddin, M; Christou, A; Hoque, DME; Tahsina, T; Salam, SS; Billah, SM; Kuppens, L; Matin, MZ; El Arifeen, S				Moinuddin, Md; Christou, Aliki; Hoque, Dewan Md Emdadul; Tahsina, Tazeen; Salam, Shumona Sharmin; Billah, Sk Masum; Kuppens, Lianne; Matin, Md Ziaul; El Arifeen, Shams			Birth preparedness and complication readiness (BPCR) among pregnant women in hard-to-reach areas in Bangladesh	PLOS ONE			English	Article							HEALTH-SERVICE DELIVERY; MATERNAL MORTALITY; DISTRICT; CARE; STRATEGIES; TANZANIA	Background Birth preparedness and complication readiness aims to reduce delays in care seeking, promote skilled birth attendance, and facility deliveries. Little is known about birth preparedness practices among populations living in hard-to-reach areas in Bangladesh. Objectives To describe levels of birth preparedness and complication readiness among recently delivered women, identify determinants of being better prepared for birth, and assess the impact of greater birth preparedness on maternal and neonatal health practices. Methods A cross-sectional survey with 2,897 recently delivered women was undertaken in 2012 as part of an evaluation trial done in five hard-to-reach districts in rural Bangladesh. Mothers were considered well prepared for birth if they adopted two or more of the four birth preparedness components. Descriptive statistics and multivariable logistic regression were used for analysis. Results Less than a quarter (24.5%) of women were considered well prepared for birth. Predictors of being well-prepared included: husband's education (OR = 1.3; CI: 1.1 - 1.7), district of residence, exposure to media in the form of reading a newspaper (OR = 2.2; CI: 1.2-3.9), receiving home visit by a health worker during pregnancy (OR = 1.5; CI: 1.2-1.8), and receiving at least 3 antenatal care visits from a qualified provider (OR = 1.4; CI: 1.0-1.9). Well-prepared women were more likely to deliver at a health facility (OR = 2.4; CI: 1.9-3.1), use a skilled birth attendant (OR = 2.4, CI: 1.9-3.1), practice clean cord care (OR = 1.3, CI: 1.0-1.5), receive post-natal care from a trained provider within two days of birth for themselves (OR = 2.6, CI: 2.0-3.2) or their newborn (OR = 2.6, CI: 2.1-3.3), and seek care for delivery complications (OR = 1.8, CI: 1.3-2.6). Conclusion Greater emphasis on BPCR interventions tailored for hard to reach areas is needed to improve skilled birth attendance, care seeking for complications and essential newborn care and facilitate reductions in maternal and neonatal mortality in low performing districts in Bangladesh.	[Moinuddin, Md; Christou, Aliki; Hoque, Dewan Md Emdadul; Tahsina, Tazeen; Salam, Shumona Sharmin; Billah, Sk Masum; El Arifeen, Shams] Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Kuppens, Lianne; Matin, Md Ziaul] UNICEF, Hlth Sect, Dhaka, Bangladesh; [Christou, Aliki] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of Sydney	Moinuddin, M (corresponding author), Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh.	moinuddin@icddrb.org	Christou, Aliki/D-1249-2018; Hoque, Dewan/O-3606-2015; Hoque, Dewan Md. Emdadul/J-1999-2019; Moinuddin, Mohammed/AAP-4454-2021	Christou, Aliki/0000-0001-9525-8255; Hoque, Dewan/0000-0001-8219-9196; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Moinuddin, Mohammed/0000-0001-9364-390X; Salam, Shumona/0000-0001-9517-7041; Arifeen, Shams/0000-0002-5372-5932	Australian Agency for International Development through UNICEF (SEA) [GR-00699]	Australian Agency for International Development through UNICEF (SEA)	This study was financially supported by Australian Agency for International Development through UNICEF (SEA). The grant number and URL is GR-00699 and www.unicef.org.bd. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Ahmed S, 2011, B WORLD HEALTH ORGAN, V89, P12, DOI 10.2471/BLT.10.076851; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Asp G, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.22904; August F, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26922; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Callaghan-Koru JA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-198; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; El-Saharty S, 2015, PATH UNIVERSAL HLTH; Emma-Ukaegbu UC N H, 2014, IOSR J DENTAL MED SC, V13, P90, DOI DOI 10.9790/0853-131109094; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; JHPIEGO, 2004, IMPR SAF MOTH SHAR R; JHPIEGO, 2004, MON BIRTH PREP COMPL; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kruger C, 2011, RURAL REMOTE HEALTH, V11, P1; Lee SH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010401; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; Magoma M, 2013, TROP MED INT HEALTH, V18, P435, DOI 10.1111/tmi.12069; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Miltenburg AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143382; Ministry of Health and Family Welfare Government of Bangladesh, 2017, PROGR IMPLM PLAN HLT; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; National Institute of Population Research and Training,, 2012, BANGL MAT MORT HEALT; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation ICDDR B., 2011, BANGL DISTR LEV SOC; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; NGO Forum for Public Health, 2013, BEING BES HARD REACH; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Roth D M, 2001, Afr J Reprod Health, V5, P10, DOI 10.2307/3583426; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Sarker M.H., 2003, INT J RIVER BASIN MA, V1, P61, DOI [10.1080/15715124.2003.9635193, DOI 10.1080/15715124.2003.9635193]; Sarwar MR, 2015, IDS BULL-I DEV STUD, V46, P17, DOI 10.1111/1759-5436.12141; Sondaal SFV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154664; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The White Ribbon Alliance for Safe Motherhood/India, 2002, SAV MX LIV WHAT WORK; Tura G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-60; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; United Nations Development Program (UNDP) Bangladesh, 2012, IMPR HLTH NUTR POP C; Urassa DP, 2012, TANZAN J HLTH RES, V14, P42; WHO, 1989, PREV MAT DEATHS; World Health Organisation, 2015, WHO RECOMM HLTH PROM; World Health Organization, 2007, INT MAN PREGN CHILDB; World Health Organization, 2010, WORK IND FAM COMM IM; World Health Organization, 2002, BIRTH EM PREP ANT CA	49	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189365	10.1371/journal.pone.0189365	http://dx.doi.org/10.1371/journal.pone.0189365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228050	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600050
J	Sun, HX; Zhao, JY; Zhong, D; Li, GZ				Sun, Hongxue; Zhao, Jiaying; Zhong, Di; Li, Guozhong			Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS	PLOS ONE			English	Article							URIC-ACID; METABOLOMIC ANALYSIS; N-ACYLETHANOLAMINES; CHAIN; RISK; METABOLITES	Background Stroke still has a high incidence with a tremendous public health burden and it is a leading cause of mortality and disability. However, biomarkers for early diagnosis are absent and the metabolic alterations associated with ischemic stroke are not clearly understood. The objectives of this case-control study are to identify serum biomarkers and explore the metabolic alterations of ischemic stroke. Methods Metabonomic analysis was performed using ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry and multivariate statistical analysis was employed to study 60 patients with or without ischemic stroke (30 cases and 30 controls). Results Serum metabolic profiling identified a series of 12 metabolites with significant alterations, and the related metabolic pathways involved glycerophospholipid, sphingolipid, phospholipid, fat acid, acylcarnitine, heme, and purine metabolism. Subsequently, multiple logistic regression analyses of these metabolites showed uric acid, sphinganine and adrenoyl ethanolamide were potential biomarkers of ischemic stroke with an area under the receiver operating characteristic curve of 0.941. Conclusions These findings provide insights into the early diagnosis and potential pathophysiology of ischemic stroke.	[Sun, Hongxue; Zhong, Di; Li, Guozhong] Harbin Med Univ, Dept Neurol, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Zhao, Jiaying] Harbin Med Univ, Dept Thorac Surg, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Li, GZ (corresponding author), Harbin Med Univ, Dept Neurol, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China.	lgzhrbmu1962@163.com		Li, Guo-Zhong/0000-0002-5482-393X				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Berger C, 2004, J NEUROCHEM, V88, P1159, DOI 10.1046/j.1471-4159.2003.02244.x; Chen Y, 2015, J ATHEROSCLER THROMB, V22, P823, DOI 10.5551/jat.26260; Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a; Darabi M, 2016, BIOCHIMIE, V120, P81, DOI 10.1016/j.biochi.2015.06.022; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Esposito E, 2014, PHARMACOL RES, V86, P26, DOI 10.1016/j.phrs.2014.05.009; Fan LJ, 2012, ACTA ONCOL, V51, P473, DOI 10.3109/0284186X.2011.648338; Fretts AM, 2014, BRIT J NUTR, V112, P1206, DOI 10.1017/S0007114514001925; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Geng HH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070636; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Guasch-Ferre M, 2016, AM J CLIN NUTR, V103, P1408, DOI 10.3945/ajcn.116.130492; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Jena Itishri, 2017, J Nat Sci Biol Med, V8, P110, DOI 10.4103/0976-9668.198346; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Kim YJ, 2012, ATHEROSCLEROSIS, V225, P418, DOI 10.1016/j.atherosclerosis.2012.09.007; Kimberly WT, 2013, STROKE, V44, P1389, DOI 10.1161/STROKEAHA.111.000397; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Liu LY, 2013, CLIN CHEM, V59, P1338, DOI 10.1373/clinchem.2012.200527; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Makrecka M, 2014, MOL CELL BIOCHEM, V395, P1, DOI 10.1007/s11010-014-2106-3; Meilhac O, 2015, HANDB EXP PHARMACOL, V224, P509, DOI 10.1007/978-3-319-09665-0_16; Mendis S, 2010, INT J STROKE, V5, P86, DOI 10.1111/j.1747-4949.2010.00406.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Park KS, 2007, FEBS LETT, V581, P4411, DOI 10.1016/j.febslet.2007.08.014; Peng YF, 2016, J CLIN LAB ANAL, V30, P982, DOI 10.1002/jcla.21967; Saric J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.49; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sun N, 2016, TRANSL STROKE RES, V7, P420, DOI 10.1007/s12975-016-0477-3; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang C, 2011, J CHROMATOGR B, V879, P2871, DOI 10.1016/j.jchromb.2011.08.014; Wang MQ, 2014, J PROTEOME RES, V13, P4131, DOI 10.1021/pr500517u; Wang Y, 2016, BIOMED CHROMATOGR, V30, P48, DOI 10.1002/bmc.3491; Wasilewski M, 2005, FEBS LETT, V579, P4724, DOI 10.1016/j.febslet.2005.07.047; World Health Organization, STROKE; Wu R, 2012, P NATL ACAD SCI USA, V109, P3259, DOI 10.1073/pnas.1119155109; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	40	29	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189009	10.1371/journal.pone.0189009	http://dx.doi.org/10.1371/journal.pone.0189009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228037	gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600027
J	Hwang, IC; Chang, J; Park, SM				Hwang, In Cheol; Chang, Jooyoung; Park, Sang Min			Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study	PLOS ONE			English	Article							GASTRIN; CARCINOMA; THERAPY; SAFETY; DRUGS; ASIA	Purpose Despite plausible mechanisms, the clinical significance of long-term proton pump inhibitor (PPI) use to colorectal cancer (CRC) remains unknown. The purpose of this study was to investigate the association between PPI use and CRC development. Methods We conducted a population-based prospective cohort study using the Korean nationwide claims database merged with national health examination data. The study cohort included a total of 451,284 participants who were tracked to identify cases of CRC since 2007. We assessed and standardized PPI use before the index date using the Defined Daily Dose system. We calculated the hazard ratios and their 95% confidence intervals to assess the association between PPI use and CRC occurrence using Cox proportional hazard regression models with adjustment for potential confounders. We performed subgroup analyses of the effect of PPI exposure on CRC development stratified by the CRC risk. Results There were 5,304 cases of CRC during the study period of 2,908,152 person-years. PPI use was not associated with CRC risk overall. The incidence of CRC was higher among individuals who were elderly, male, more obese, and drank alcohol more frequently and among those who had more comorbidities. Further subgroup analyses revealed that the hazard effect of PPI use increased linearly in a dose-dependent manner with the number of CRC risk factors for which the risk level was considered low. Conclusion Within the low-risk population, PPI use was associated with an increased risk of CRC, although the association did not weigh the effects of conventional risk factors.	[Hwang, In Cheol] Gachon Univ, Gil Med Ctr, Dept Family Med, Incheon, South Korea; [Chang, Jooyoung] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Gachon University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, SM (corresponding author), Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1 B03033721]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant no. 2017R1D1A1 B03033721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2012, KOREAN J FAM MED, V33, P272, DOI 10.4082/kjfm.2012.33.5.272; Attwood SE, 2015, ALIMENT PHARM THER, V41, P1162, DOI 10.1111/apt.13194; Boursi B, 2016, DIGEST LIVER DIS, V48, P1386, DOI 10.1016/j.dld.2016.07.011; Byun Ju-Young, 2014, J Prev Med Public Health, V47, P84, DOI 10.3961/jpmph.2014.47.2.84; Chubak J, 2009, PHARMACOEPIDEM DR S, V18, P540, DOI 10.1002/pds.1749; CICCOTOSTO GD, 1995, GASTROENTEROLOGY, V109, P1142, DOI 10.1016/0016-5085(95)90572-3; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; Goh LY, 2014, J DIGEST DIS, V15, P463, DOI 10.1111/1751-2980.12164; Han YM, 2015, J PHYSIOL PHARMACOL, V66, P159; La Vecchia C, 2002, EUR J CANCER PREV, V11, P117, DOI 10.1097/00008469-200204000-00002; Lai SW, 2013, ASIA-PAC J CLIN ONCO, V9, P192, DOI 10.1111/ajco.12054; Lowery JT, 2016, CANCER-AM CANCER SOC, V122, P2633, DOI 10.1002/cncr.30080; Lundell L, 2015, ALIMENT PHARM THER, V42, P649, DOI 10.1111/apt.13324; Maddalo G, 2014, EUR J CANCER PREV, V23, P258, DOI 10.1097/CEJ.0000000000000008; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raghunath AS, 2005, ALIMENT PHARM THERAP, V22, P55, DOI 10.1111/j.1365-2036.2005.02611.x; Robertson DJ, 2007, GASTROENTEROLOGY, V133, P755, DOI 10.1053/j.gastro.2007.06.014; Shin JY, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3517; Siersema PD, 2006, GASTROINTEST ENDOSC, V63, P581, DOI 10.1016/j.gie.2005.08.043; Thorburn CM, 1998, GASTROENTEROLOGY, V115, P275, DOI 10.1016/S0016-5085(98)70193-3; Van Soest EM, 2006, ALIMENT PHARM THERAP, V24, P377, DOI 10.1111/j.1365-2036.2006.02982.x; van Soest EM, 2008, AM J GASTROENTEROL, V103, P966, DOI 10.1111/j.1572-0241.2007.01665.x; WATSON SA, 1995, INT J CANCER, V61, P233, DOI 10.1002/ijc.2910610216; Watson SA, 2002, BRIT J CANCER, V87, P567, DOI 10.1038/sj.bjc.6600509; Watson SA, 2001, CANCER RES, V61, P625; Wedemeyer RS, 2014, DRUG SAFETY, V37, P201, DOI 10.1007/s40264-014-0144-0; Yang YX, 2007, GASTROENTEROLOGY, V133, P748, DOI 10.1053/j.gastro.2007.06.022; Yang YX, 2010, GASTROENTEROLOGY, V139, P1115, DOI 10.1053/j.gastro.2010.08.023; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zumkeller N, 2006, HELICOBACTER, V11, P75, DOI 10.1111/j.1523-5378.2006.00381.x	30	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189114	10.1371/journal.pone.0189114	http://dx.doi.org/10.1371/journal.pone.0189114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216279	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800074
J	Munoz-Gutierrez, C; Caceres-Rojas, D; Adasme-Carreno, F; Palomo, I; Fuentes, E; Caballero, J				Munoz-Gutierrez, Camila; Caceres-Rojas, Daniela; Adasme-Carreno, Francisco; Palomo, Ivaan; Fuentes, Eduardo; Caballero, Julio			Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BRONCHODILATORY ACTIVITY; ACCURATE DOCKING; TEMPLATE COMFA; MOLECULES; PROTEINS; PREDICTION; DESIGN; PLATELETS; PROGRAM	PDE3s belong to the phosphodiesterases family, where the PDE3A isoform is the major subtype in platelets involved in the cAMP regulation pathway of platelet aggregation. PDE3A inhibitors have been designed as potential antiplatelet agents. In this work, a homology model of PDE3A was developed and used to obtain the binding modes of bicyclic heteroaromatic pyridazinones and pyrazolones. Most of the studied compounds adopted similar orientations within the PDE3A active site, establishing hydrogen bonds with catalytic amino acids. Besides, the structure-activity relationship of the studied inhibitors was described by using a field-based 3D-QSAR method. Different structure alignment strategies were employed, including template-based and docking-based alignments. Adequate correlation models were obtained according to internal and external validations. In general, QSAR models revealed that steric and hydrophobic fields describe the different inhibitory activities of the compounds, where the hydrogen bond donor and acceptor fields have minor contributions. It should be stressed that structural elements of PDE3A inhibitors are reported here, through descriptions of their binding interactions and their differential affinities. In this sense, the present results could be useful in the future design of more specific and potent PDE3A inhibitors that may be used for the treatment of cardiovascular diseases.	[Munoz-Gutierrez, Camila; Caceres-Rojas, Daniela; Adasme-Carreno, Francisco; Caballero, Julio] Univ Talca, CBSM, Talca, Chile; [Palomo, Ivaan; Fuentes, Eduardo] Univ Talca, Fac Hlth Sci, Interdisciplinary Excellence Res Program Hlth Agi, Platelet Res Lab,Dept Clin Biochem & Immunohemato, Talca, Chile; [Fuentes, Eduardo] Univ Talca, Nucleo Cient Multidisciplinario, Talca, Chile	Universidad de Talca; Universidad de Talca; Universidad de Talca	Caballero, J (corresponding author), Univ Talca, CBSM, Talca, Chile.	jcaballero@utalca.cl	Palomo, Iván/I-4321-2018; Caballero, Julio/G-3654-2014	Caballero, Julio/0000-0003-0182-1444; Fuentes Quinteros, Eduardo/0000-0003-0099-4108; Adasme Carreno, Francisco/0000-0003-0971-9081; Munoz Gutierrez, Camila/0000-0003-0919-6903; Palomo, Ivan/0000-0002-9618-8778	'Fondo Nacional de Desarrollo Cientifico y Tecnologico' (Fondecyt), Chile [1170718]	'Fondo Nacional de Desarrollo Cientifico y Tecnologico' (Fondecyt), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the grant no. 1170718 (J.C.) from 'Fondo Nacional de Desarrollo Cientifico y Tecnologico' (Fondecyt), Chile. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock RW, 2011, BIOORG MED CHEM LETT, V21, P3307, DOI 10.1016/j.bmcl.2011.04.021; ALVAREZ R, 1981, MOL PHARMACOL, V20, P302; Aptula AO, 2005, QSAR COMB SCI, V24, P385, DOI 10.1002/qsar.200430909; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P84, DOI DOI 10.1145/1188455.1188544; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Cramer RD, 2014, J CHEM INF MODEL, V54, P660, DOI 10.1021/ci400696v; Dawson DL, 2001, AM J CARDIOL, V87, p19D; Edmondson SD, 2003, BIOORG MED CHEM LETT, V13, P3983, DOI 10.1016/j.bmcl.2003.08.056; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Guasch L, 2012, J MOL GRAPH MODEL, V36, P1, DOI 10.1016/j.jmgm.2012.03.001; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KLEBE G, 1994, J MED CHEM, V37, P4130, DOI 10.1021/jm00050a010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; Munoz-Gutierrez C, 2016, RSC ADV, V6, P64756, DOI 10.1039/c6ra12084a; Navarro-Retamal C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161111; Ochiai K, 2013, BIOORG MED CHEM LETT, V23, P375, DOI 10.1016/j.bmcl.2012.08.121; Ochiai K, 2012, BIOORG MED CHEM LETT, V22, P5833, DOI 10.1016/j.bmcl.2012.07.088; Ochiai K, 2012, BIOORGAN MED CHEM, V20, P1644, DOI 10.1016/j.bmc.2012.01.033; Ochiai K, 2011, BIOORG MED CHEM LETT, V21, P5451, DOI 10.1016/j.bmcl.2011.06.118; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; TANI T, 1992, ADV SEC MESS PHOSPH, V25, P215; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vorchheimer DA, 2006, MAYO CLIN PROC, V81, P59, DOI 10.4065/81.1.59; Wendt B, 2014, J COMPUT AID MOL DES, V28, P803, DOI 10.1007/s10822-014-9761-z; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189213	10.1371/journal.pone.0189213	http://dx.doi.org/10.1371/journal.pone.0189213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216268	gold, Green Submitted, Green Published			2022-12-26	WOS:000417337800096
J	Munshi, SU; Tran, TTT; Vo, TNT; Tabassum, S; Sultana, N; Nguyen, TH; Jahan, M; Le, CN; Baker, S; Rahman, M				Munshi, Saif Ullah; Thanh Thi Thanh Tran; Truc Nhu Thanh Vo; Tabassum, Shahina; Sultana, Nahida; Trang Hoa Nguyen; Jahan, Munira; Chau Ngoc Le; Baker, Stephen; Rahman, Motiur			Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population	PLOS ONE			English	Article							SURFACE-ANTIGEN; HBV INFECTION; GENOTYPE D; MUTATIONS; REGION; IDENTIFICATION; SUBGENOTYPES; PREVALENCE; SEQUENCES; VARIANTS	The natural history and treatment outcome of hepatitis B viruses (HBV) infection is largely dependent on genotype, subgenotype, and the presence or absence of virulence associated mutations. We have studied the prevalence of genotype and subgenotype as well as virulence and drug resistance associated mutations and prevalence of recombinant among HBV from Bangladesh. A prospective cross-sectional study was conducted among treatment naive chronic HBV patients attending at Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh for HBV viral load assessment between June and August 2015. Systematical selected 50% of HBV DNA positive patients (every second patient) were enrolled. Biochemical and serological markers for HBV infection and whole genome sequencing (WGS) was performed on virus positive sample. Genotype, subgenotype, virulence, nucleos(t)ide analogue (NA) resistance (NAr) mutations, and the prevalence of recombinant isolates were determined. Among 114 HBV DNA positive patients, 57 were enrolled in the study and 53 HBV WGS were generated for downstream analysis. Overall, 38% (22/57) and 62% (35/57) of patients had acute and chronic HBV infections, respectively. The prevalence of genotypes A, C, and D was 18.9% (10/53), 45.3% (24/53), and 35.8% (19/53), respectively. Among genotype A, C and D isolates subgenotype A1 (90%; 9/10), C1 (87.5%; 21/24) and D2 (78.9%; 15/19) predominates. The acute infection, virulence associated mutations, and viral load was higher in the genotype D isolates. Evidence of recombination was identified in 22.6% (12/53) of the HBV isolates including 20.0% (2/10), and 16.7% (4/24) and 31.6% (6/19) of genotype A, C and D isolates, respectively. The prevalence of recombination was higher in chronic HVB patients (32.2%; 10/31 versus 9.1%; 2/22); p<0.05. NAr mutations were identified in 47.2% (25/53) of the isolates including 33.9% novel mutations (18/53). HBV genotype C and D predominated in this population in Bangladesh; a comparatively high prevalence of recombinant HBV are circulating in this setting.	[Munshi, Saif Ullah; Tabassum, Shahina; Sultana, Nahida; Jahan, Munira] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh; [Thanh Thi Thanh Tran; Truc Nhu Thanh Vo; Trang Hoa Nguyen; Chau Ngoc Le; Baker, Stephen; Rahman, Motiur] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; Rahman, Motiur] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Bangabandhu Sheikh Mujib Medical University (BSMMU); University of Oxford; University of Oxford	Rahman, M (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam.; Rahman, M (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England.	mrahman@oucru.org		Jahan, Munira/0000-0002-5976-0122; Baker, Stephen/0000-0003-1308-5755	Oxford University Clinical Research Unit Core funding	Oxford University Clinical Research Unit Core funding	This study was supported by Oxford University Clinical Research Unit Core funding to Motiur Rahman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar SMF, 1997, HEPATOL RES, V7, P113, DOI 10.1016/S0928-4346(97)00027-3; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Chen JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155654; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; Coleman PF, 2006, EMERG INFECT DIS, V12, P198, DOI 10.3201/eid1203.050038; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedt M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-11; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huy TTT, 2004, J MED VIROL, V74, P228, DOI 10.1002/jmv.20175; Kim H, 2015, INT J MOL SCI, V16, P13595, DOI 10.3390/ijms160613595; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Liu BM, 2010, ANTIVIR RES, V85, P512, DOI 10.1016/j.antiviral.2009.12.006; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Moradi A, 2012, VIRUS GENES, V44, P382, DOI 10.1007/s11262-012-0715-z; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Qu LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098257; Rahman MA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1840-2; Ramezani F, 2013, IRAN J ALLERGY ASTHM, V12, P269; Lay LAR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125052; Saikia A, 2015, J MED VIROL, V87, P1539, DOI 10.1002/jmv.24207; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Shi WF, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-116; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Shih HH, 2008, J VIROL, V82, P2250, DOI 10.1128/JVI.02155-07; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Zhang X, 2015, WORLD J HEPATOL, V7, P1282, DOI 10.4254/wjh.v7.i9.1282; Ziaee M, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.37806	36	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188944	10.1371/journal.pone.0188944	http://dx.doi.org/10.1371/journal.pone.0188944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216251	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800050
J	Sorrig, R; Klausen, TW; Salomo, M; Vangsted, AJ; Frolund, UC; Andersen, KT; Klostergaard, A; Helleberg, C; Pedersen, RS; Pedersen, PT; Helm-Petersen, S; Teodorescu, EM; Preiss, B; Abildgaard, N; Gimsing, P				Sorrig, Rasmus; Klausen, Tobias W.; Salomo, Morten; Vangsted, Annette J.; Frolund, Ulf Christian; Andersen, Kristian T.; Klostergaard, Anja; Helleberg, Carsten; Pedersen, Robert S.; Pedersen, Per T.; Helm-Petersen, Sissel; Teodorescu, Elena Manuela; Preiss, Birgitte; Abildgaard, Niels; Gimsing, Peter		Danish Myeloma Study Grp	Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population	PLOS ONE			English	Article							UNINVOLVED IMMUNOGLOBULINS; RISK STRATIFICATION; SUPPRESSION; MECHANISMS; CRITERIA	Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly diagnosed Multiple myeloma (MM) patients. However, this finding has not been validated in an unselected population-based cohort. We analyzed 2558 newly diagnosed MM patients in the Danish Multiple Myeloma Registry representing the entire MM population in Denmark from 2005-2013. Two-thousand two hundred and fifty three patients (90%) presented with reduction below lower normal levels of at least one uninvolved immunoglobulin. Using multivariable Cox regression we found that high age, high ISS score, high LDH and IgA MM were associated to both shorter overall survival and progression free survival. Furthermore, bone marrow plasma cell% was associated to short progression free survival. Immunoparesis had no independent significant effect on OS (HR 0.9 (95% CI: 0.7; 1.0; p = 0.12)). Likewise, the number of suppressed immunoglobulins or the relative degree of suppressed uninvolved immunoglobulins from lower normal level (quantitative immunoparesis) was not associated to OS in the multivariable analysis. However, quantitative immunoparesis with at least 25% reduction (from lower normal level) of uninvolved immunoglobulins was associated to shorter PFS for the entire population. The impact of quantitative immunoparesis on PFS was present irrespective of calendar periods 2005-2008 and 2009-2013. Our population-based study does not confirm that immunoparesis at diagnosis is an independent prognostic factor regarding OS. However, quantitative immunoparesis is associated to a shorter PFS.	[Sorrig, Rasmus; Salomo, Morten; Vangsted, Annette J.; Helm-Petersen, Sissel; Gimsing, Peter] Rigshosp, Dept Hematol, Copenhagen, Denmark; [Sorrig, Rasmus] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Klausen, Tobias W.] Herlev Hosp, Hematol Res Lab, Herlev, Denmark; [Frolund, Ulf Christian] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark; [Andersen, Kristian T.] Vejle Hosp, Dept Internal Med, Hematol Sect, Vejle, Denmark; [Klostergaard, Anja] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark; [Helleberg, Carsten] Herlev Hosp, Dept Hematol, Herlev, Denmark; [Pedersen, Robert S.] Holstebro Hosp, Dept Internal Med, Hematol Sect, Holsterbro, Denmark; [Pedersen, Per T.] Esbjerg Cent Hosp, Dept Hematol, Esbjerg, Denmark; [Teodorescu, Elena Manuela] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark; [Preiss, Birgitte] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Abildgaard, Niels] Odense Univ Hosp, Dept Hematol, Odense, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Lillebaelt Hospital; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Sorrig, R (corresponding author), Rigshosp, Dept Hematol, Copenhagen, Denmark.; Sorrig, R (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.	soerrig@gmail.com		Pedersen, Per Trollund/0000-0002-8821-7807; Klostergaard, Anja/0000-0002-5477-746X; Johnsen, Hans Erik/0000-0001-8253-2913; Salomo, Morten/0000-0002-1660-1607	University of Copenhagen Faculty of Health and Medical Sciences [620-0032/14-3000]; The Danish Cancer Society [R152-A9822, R94-A5689] Funding Source: researchfish	University of Copenhagen Faculty of Health and Medical Sciences; The Danish Cancer Society(Danish Cancer Society)	University of Copenhagen Faculty of Health and Medical Sciences funded a PhD Schlarship to RS, Grant no 620-0032/14-3000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard N, 2016, 21 C EUR HEM ASS JUN; Blimark C, 2015, HAEMATOLOGICA, V100, P107, DOI 10.3324/haematol.2014.107714; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; Dansk Myelomatose Studiegruppe, 2015, DIAGN BEH MYEL RETN; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Gimsing P, 2016, CLIN EPIDEMIOL, V8, P583, DOI 10.2147/CLEP.S99463; De La Calle VG, 2015, BLOOD, V126; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Heaney J.L.J., 2014, EUR SOC HAEM 2 INT C; Holmstrom MO, 2015, AM J HEMATOL, V90, pE73, DOI 10.1002/ajh.23932; Kastritis E, 2014, LEUKEMIA, V28, P2075, DOI 10.1038/leu.2014.110; Katzmann JA, 2013, LEUKEMIA, V27, P208, DOI 10.1038/leu.2012.189; KAWANO M, 1989, AM J HEMATOL, V30, P91, DOI 10.1002/ajh.2830300208; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyrtsonis MC, 1999, MED ONCOL, V16, P73, DOI 10.1007/BF02785839; Munshi NC, 1997, HEMATOL ONCOL CLIN N, V11, P51, DOI 10.1016/S0889-8588(05)70415-9; Paiva B, 2009, BLOOD, V114, P4369, DOI 10.1182/blood-2009-05-221689; Palumbo A., 2015, J CLIN ONCOL, V33; Perez-Persona E, 2007, BLOOD, V110, P2586, DOI 10.1182/blood-2007-05-088443; PILARSKI LM, 1986, J CLIN IMMUNOL, V6, P491, DOI 10.1007/BF00915255; Ritchie RF, 1998, J CLIN LAB ANAL, V12, P371, DOI 10.1002/(SICI)1098-2825(1998)12:6<371::AID-JCLA7>3.3.CO;2-K; Sanchez E, 2016, CLIN CANC RES; Sari M, 2017, TURK J HEMATOL, V34, P131, DOI 10.4274/tjh.2016.0161; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sorrig R, 2016, EUR J HAEMATOL, V97, P303, DOI 10.1111/ejh.12728; van de Donk NWCJ, 2014, HEMATOL ONCOL CLIN N, V28, P791, DOI 10.1016/j.hoc.2014.06.007; Walchner M, 1997, CLIN EXP IMMUNOL, V109, P310, DOI 10.1046/j.1365-2249.1997.4451342.x	28	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188988	10.1371/journal.pone.0188988	http://dx.doi.org/10.1371/journal.pone.0188988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216227	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800055
J	Li, YN; Li, XP; He, KY; Li, B; Liu, K; Qi, JS; Wang, H; Wang, Y; Luo, WG				Li, Yanning; Li, Xiaoping; He, Kunyu; Li, Bin; Liu, Kun; Qi, Jinsheng; Wang, Hui; Wang, Yu; Luo, Weigang			C-peptide prevents NF-kappa B from recruiting p300 and binding to the inos promoter in diabetic nephropathy	FASEB JOURNAL			English	Article						transcriptional regulation; oxidative stress; peptide; high glucose	GENE-TRANSCRIPTION; OXIDATIVE STRESS; ACETYLATION; INHIBITION; INJURY; MEMORY; RATS	C-peptide (CP) has demonstrated unique beneficial effects in diabetic nephropathy (DN), but whether and how CP regulates NF-kappa B and its coactivator, p300, to suppress inducible iNOS and antagonize DN are unknown. iNOS expression, NF-kappa B nuclear translocation, colocalization and binding of NF-kappa B to p300, binding of NF-kappa B to the inos promoter, and the bound NF-kappa B, p300, and histone 3 lysine 9 acetylation (H3K9ac) at binding sites were measured in high glucose-stimulated mesangial cells. We evaluated pathologic changes, iNOS expression, NF-kappa B, and p300 contents in diabetic rats. We found that CP inhibited iNOS expression and notably prevented colocalization and binding of NF-kappa B and p300. CP prevented NF-kappa B from binding to the inos promoter, especially at the distal site, and reduced bound NF-kappa B, p300, and H3K9ac. N-terminal plus middle fragment could mostly mimic the antagonizing effects of CP against the pathologic changes of DN and equally suppresses renal iNOS expression as CP. In conclusion, CP prevented NF-kappa B from recruiting p300 and binding to the inos promoter, and decreased H3K9ac at the binding sites to suppress iNOS expression and antagonize DN, with the effect region identified as N-terminal plus middle fragment.	[Li, Yanning; Wang, Yu; Luo, Weigang] Hebei Med Univ, Dept Biochem, Hebei Key Lab Med Biotechnol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China; [Li, Xiaoping; He, Kunyu; Li, Bin; Liu, Kun; Qi, Jinsheng] Hebei Med Univ, Dept Mol Biol, Hebei Key Lab Lab Anim, Shijiazhuang, Hebei, Peoples R China; [Wang, Hui] Hebei Med Univ, Dept Pathol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Qi, JS (corresponding author), Hebei Med Univ, Dept Biochem, Hebei Key Lab Med Biotechnol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	qijinsheng777@163.com			Hebei Natural Science Foundation [H2015206101]; National Natural Science Foundation of China [81070658, 81470595]	Hebei Natural Science Foundation(Natural Science Foundation of Hebei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 81070658 and 81470595) and the Hebei Natural Science Foundation (Grant H2015206101). The authors declare no conflicts of interest.	Al-Waili N, 2017, REDOX REP, V22, P99, DOI 10.1080/13510002.2017.1297885; Ansley DM, 2013, J PATHOL, V229, P232, DOI 10.1002/path.4113; Bhatt MP, 2016, J ENDOCRINOL, V231, P97, DOI 10.1530/JOE-16-0349; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Brunskill NJ, 2017, J INTERN MED, V281, P41, DOI 10.1111/joim.12548; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Fineberg D, 2013, NAT REV ENDOCRINOL, V9, P713, DOI 10.1038/nrendo.2013.184; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Garcia-Serrano S, 2015, OBESITY, V23, P1607, DOI 10.1002/oby.21137; Guo Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146640; Hills CE, 2010, AM J NEPHROL, V31, P389, DOI 10.1159/000289864; Ho HJ, 2012, CELL SIGNAL, V24, P2166, DOI 10.1016/j.cellsig.2012.07.018; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Inagi R, 2006, DIABETES, V55, P356, DOI 10.2337/diabetes.55.02.06.db05-0702; Ishii T, 2012, J BIOCHEM, V152, P53, DOI 10.1093/jb/mvs052; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kim SW, 2013, IEEE ICCE, P65, DOI 10.1109/ICCE.2013.6486797; Landreh M, 2014, BIOCHEM BIOPH RES CO, V450, P1433, DOI 10.1016/j.bbrc.2014.07.012; Li YN, 2013, MOL CELL ENDOCRINOL, V381, P255, DOI 10.1016/j.mce.2013.08.007; Li YN, 2013, MOL CELL ENDOCRINOL, V370, P78, DOI 10.1016/j.mce.2013.02.015; Li YN, 2010, MOL MED, V16, P335, DOI 10.2119/molmed.2010.00034; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Lin CL, 2014, J AM SOC NEPHROL, V25, P1698, DOI 10.1681/ASN.2013050527; Lindahl E, 2010, J BIOL CHEM, V285, P3462, DOI 10.1074/jbc.M109.053587; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Luppi P, 2017, J INTERN MED, V281, P7, DOI 10.1111/joim.12522; Luppi P, 2009, DIABETOLOGIA, V52, P2218, DOI 10.1007/s00125-009-1476-7; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Rahangdale S, 2009, FRONT BIOSCI-LANDMRK, V14, P192, DOI 10.2741/3240; Reddy MA, 2014, KIDNEY INT, V85, P362, DOI 10.1038/ki.2013.387; Shaw JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127439; Sun W, 2010, ACTA BIOCH BIOPH SIN, V42, P893, DOI 10.1093/abbs/gmq100; Tavafi Majid, 2013, J Nephropathol, V2, P20, DOI 10.5812/nephropathol.9093; Wahren J, 2016, DIABETES CARE, V39, P596, DOI 10.2337/dc15-2068; Wahren J, 2015, DIABETES RES CLIN PR, V107, P309, DOI 10.1016/j.diabres.2015.01.016; Wahren J, 2012, DIABETES, V61, P761, DOI 10.2337/db11-1423; Wang YT, 2015, 2ND INTERNATIONAL CONFERENCE ON SIMULATION AND MODELING METHODOLOGIES, TECHNOLOGIES AND APPLICATIONS (SMTA 2015), P34; Xu SQ, 2015, BIOCHEM BIOPH RES CO, V458, P674, DOI 10.1016/j.bbrc.2015.02.022; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	41	15	17	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2269	2279		10.1096/fj.201700891R	http://dx.doi.org/10.1096/fj.201700891R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29229684				2022-12-26	WOS:000429051400044
J	Guo, H; Sun, JH; Li, X; Xiong, Y; Wang, HT; Shu, H; Zhu, RM; Liu, Q; Huang, YM; Madley, R; Wang, YL; Cui, JQ; Arvan, P; Liu, M				Guo, Huan; Sun, Jinhong; Li, Xin; Xiong, Yi; Wang, Heting; Shu, Hua; Zhu, Ruimin; Liu, Qi; Huang, Yumeng; Madley, Rachel; Wang, Yulun; Cui, Jingqiu; Arvan, Peter; Liu, Ming			Positive charge in the n-region of the signal peptide contributes to efficient post-translational translocation of small secretory preproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						positive charge; signal peptide; n-region; secretory preprotein; translocation; signal peptide; n-region; protein translocation; protein translocation; protein synthesis; protein translocation; protein domain; protein translocation; protein export; protein inport; protein processing; protein targeting	ENDOPLASMIC-RETICULUM; RECOGNITION PARTICLE; TRANSLATION ELONGATION; PROTEIN TRANSLOCATION; MEMBRANE-PROTEINS; MUTATIONS; GENE; INHIBITION; TRANSPORT; CHAPERONE	Increasing evidence indicates that many small secretory preproteins can undergo post-translational translocation across the membrane of the endoplasmic reticulum. Although the cellular machinery involved in post-translational translocation of small secretory preproteins has begun to be elucidated, the intrinsic signals contained within these small secretory preproteins that contribute to their efficient post-translational translocation remain unknown. Here, we analyzed the eukaryotic secretory proteome and discovered the small secretory preproteins tend to have a higher probability to harbor the positive charge in the n-region of the signal peptide (SP). Eliminating the positive charge of the n-region blocked post-translational translocation of newly synthesized preproteins and selectively impaired translocation efficiency of small secretory preproteins. The pathophysiological significance of the positive charge in the n-region of SP was underscored by recently identified preproinsulin SP mutations that impair translocation of preproinsulin and cause maturity onset diabetes of youth (MODY). Remarkably, we have found that slowing the polypeptide elongation rate of small secretory preproteins could alleviate the translocation defect caused by loss of the n-region positive charge of the signal peptide. Together, these data reveal not only a previously unrecognized role of the n-region's positive charge in ensuring efficient post-translational translocation of small secretory preproteins, but they also highlight the molecular contribution of defects in this process to the pathogenesis of genetic disorders such as MODY.	[Guo, Huan; Sun, Jinhong; Li, Xin; Wang, Heting; Shu, Hua; Zhu, Ruimin; Liu, Qi; Huang, Yumeng; Cui, Jingqiu; Liu, Ming] Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Guo, Huan; Sun, Jinhong; Xiong, Yi; Madley, Rachel; Arvan, Peter; Liu, Ming] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Wang, Yulun] Tianjin Peoples Hosp, Div Endocrinol, Tianjin 300120, Peoples R China	Tianjin Medical University; University of Michigan System; University of Michigan	Liu, M (corresponding author), Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Arvan, P (corresponding author), Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.	parvan@umich.edu; mingliu@tmu.edu.cn		Liu, Ming/0000-0003-2665-4072	National Natural Science Foundation of China [81070629, 81570699, 81620108004, 81370895]; National Institutes of Health [RO1-DK088856, RO1-DK-48280, R01-DK111174]; Protein Folding Disease Initiative of the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, P30DK020572, R01DK111174, R01DK088856] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding Disease Initiative of the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Research Grants 81070629, 81570699, 81620108004, and 81370895, National Institutes of Health Grants RO1-DK088856 (to M. L.), RO1-DK-48280 (to P. A.), and R01-DK111174, and the Protein Folding Disease Initiative of the University of Michigan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; CHOO KH, 2008, BMC BIOINFORMATI S12, V9, pS15, DOI DOI 10.1186/1471-2105-9-S12-S15; Clerico EM, 2008, BIOPOLYMERS, V90, P307, DOI 10.1002/bip.20856; Cui JQ, 2015, J BIOL CHEM, V290, P28131, DOI 10.1074/jbc.M115.692350; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Fujita H, 2010, MOL BIOL CELL, V21, P2045, DOI 10.1091/mbc.E09-12-1060; GENNITY J, 1990, J BIOENERG BIOMEMBR, V22, P233, DOI 10.1007/BF00763167; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Ikegawa S, 1997, HUM MUTAT, V9, P131, DOI 10.1002/(SICI)1098-1004(1997)9:2<131::AID-HUMU5>3.3.CO;2-U; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; KARAPLIS AC, 1995, J BIOL CHEM, V270, P1629, DOI 10.1074/jbc.270.4.1629; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2015, MOL ASPECTS MED, V42, P3, DOI 10.1016/j.mam.2014.12.001; Liu M, 2014, VITAM HORM, V95, P35, DOI 10.1016/B978-0-12-800174-5.00002-8; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Rapoport TA, 2008, FEBS J, V275, P4471, DOI 10.1111/j.1742-4658.2008.06588.x; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Symoens S, 2009, HUM MUTAT, V30, pE395, DOI 10.1002/humu.20887; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Zhang DW, 2012, J BIOL CHEM, V287, P7652, DOI 10.1074/jbc.M111.325001; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	46	24	25	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1899	1907		10.1074/jbc.RA117.000922	http://dx.doi.org/10.1074/jbc.RA117.000922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29229776	Green Published, hybrid			2022-12-26	WOS:000424948000005
J	Hitchcott, PK; Fastame, MC; Langiu, D; Penna, MP				Hitchcott, Paul Kenneth; Fastame, Maria Chiara; Langiu, Dalila; Penna, Maria Pietronilla			Cognitive failures in late adulthood: The role of age, social context and depressive symptoms	PLOS ONE			English	Article							MINI-MENTAL-STATE; METACOGNITIVE EFFICIENCY; OLDEST-OLD; QUESTIONNAIRE; COMPLAINTS; MEMORY; IMPAIRMENT; CAPACITY; PEOPLE; IMPACT	The incidence of self-reported cognitive failures among older adults may be an index of successful cognitive aging. However, self-reported cognitive failures are biased by variation in depressive symptomatology. This study examined age-related and socio-cultural context effects on cognitive failures while controlling for depressive symptoms. Both overall and specific factors of cognitive failures were determined. A further goal was to investigate the relationship between working memory and cognitive efficiency measures and cognitive failures. One hundred and thirty-nine cognitively healthy adults were recruited from two populations known to differ in their dispositions toward cognitive failures and depressive symptoms (Sardinia and northern Italy). The participants were assigned to Young Old (65-74 years old), Old (75-84 years of age) or Oldest Old (>= 85 years of age) groups, and individually presented with a test battery including the Cognitive Failures Questionnaire, the Centre for Epidemiological Studies of Depression Scale, and Forward and Backward Digit Span tests. Specific factors of cognitive failures were differentially associated with measures of depression and working memory. While age had no impact on any aspect of cognitive failures, overall and specific dispositions varied between the two populations. The overall liability to cognitive failure was lower in participants from Sardinia, however, this group also had a higher liability to lapses of action (Blunders factor). Overall, these findings highlight that richer information about cognitive failures may be revealed through the investigation of specific factors of cognitive failures. They also confirm that the absence of changes in cognitive failures across old age is independent of variation in depressive symptoms, at least among cognitively healthy elders.	[Hitchcott, Paul Kenneth; Fastame, Maria Chiara; Langiu, Dalila; Penna, Maria Pietronilla] Univ Cagliari, Dept Pedag Psychol Philosophy, Cagliari, Italy	University of Cagliari	Hitchcott, PK (corresponding author), Univ Cagliari, Dept Pedag Psychol Philosophy, Cagliari, Italy.	paul.hitchcott@unica.it	Penna, Maria Pietronilla/S-3275-2019	Penna, Maria Pietronilla/0000-0002-0982-3893	Sardinia Regional Government [CRP-78543]	Sardinia Regional Government(Regione Sardegna)	This work was supported by the Sardinia Regional Government grant CRP-78543 entitled Invecchiamento attivo in Sardegna: quali fattori influenzano il benessere psicologico negli anziani? [Active ageing in Sardinia: What factors influence psychological well-being in the elderly?] awarded to MPP, http://www.sardegnaricerche.it/documenti/13_398_20150512095145.pdf.	Amer Psychological Assoc, 2004, AM PSYCHOL, V59, P236, DOI [10.1037/0003-066X.59.4.236, 10.1037/a0035063]; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cargin JW, 2008, J CLIN EXP NEUROPSYC, V30, P245, DOI 10.1080/13803390701377829; Carrigan N, 2016, NEUROSCI BIOBEHAV R, V63, P29, DOI 10.1016/j.neubiorev.2016.01.010; De Beni R, 2007, BAC BENESSERE ADULTA; De Winter JCF, 2015, ERGONOMICS, V58, P1471, DOI 10.1080/00140139.2015.1019937; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Fastame MC, 2013, RES AGING, V35, P736, DOI 10.1177/0164027512462411; Fastame MC, 2012, CLIN GERONTOLOGIST, V35, P239, DOI 10.1080/07317115.2012.660411; Fastame MC, 2015, APPL RES QUAL LIFE, V10, P459, DOI 10.1007/s11482-014-9323-5; Fastame MC, 2015, AGING MENT HEALTH, V19, P698, DOI 10.1080/13607863.2014.962003; Fastame MC, 2014, J ADULT DEV, V21, P173, DOI 10.1007/s10804-014-9189-7; Fastame MC, 2014, AGING MENT HEALTH, V18, P648, DOI 10.1080/13607863.2013.866635; FAVA GA, 1983, J CLIN PSYCHOL, V39, P249, DOI 10.1002/1097-4679(198303)39:2<249::AID-JCLP2270390218>3.0.CO;2-Y; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries BE, 2000, J GERONTOL A-BIOL, V55, pM336, DOI 10.1093/gerona/55.6.M336; GATZ M, 1990, PSYCHOL AGING, V5, P284, DOI 10.1037/0882-7974.5.2.284; Gerstenecker A, 2016, ASSESSMENT, V23, P232, DOI 10.1177/1073191115599053; GILLEY DW, 1995, PSYCHOL ASSESSMENT, V7, P42; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; ISTAT, DISTR REDD COND VIT; Jeste DV, 2013, AM J PSYCHIAT, V170, P188, DOI 10.1176/appi.ajp.2012.12030386; KESSLER RC, 1992, PSYCHOL AGING, V7, P119, DOI 10.1037/0882-7974.7.1.119; Kite ME, 2005, J SOC ISSUES, V61, P241, DOI 10.1111/j.1540-4560.2005.00404.x; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Lange S, 2014, CONSCIOUS COGN, V24, P1, DOI 10.1016/j.concog.2013.12.008; Lezak MD, NEUROPSYCHOLOGICAL A, V5; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; Mahoney AM, 1998, PSYCHOL REP, V82, P1432, DOI 10.2466/PR0.82.3.1432-1434; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; MATTHEWS G, 1990, J PSYCHOPATHOL BEHAV, V12, P49, DOI 10.1007/BF00960453; Mecacci L, 2006, PERS INDIV DIFFER, V40, P1453, DOI 10.1016/j.paid.2005.11.022; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Poulain M., 2013, VIENNA YB POPUL RES, V11, P87, DOI [10.1553/populationyearbook2013s87, DOI 10.1553/POPULATIONYEARBOOK2013S87]; RABBITT P, 1990, BRIT J PSYCHOL, V81, P1, DOI 10.1111/j.2044-8295.1990.tb02342.x; RABBITT P, 1991, BRIT J PSYCHOL, V82, P137, DOI 10.1111/j.2044-8295.1991.tb02389.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rast P, 2009, ASSESSMENT, V16, P145, DOI 10.1177/1073191108324440; Reese CM, 2006, J GENET PSYCHOL, V167, P221, DOI 10.3200/GNTP.167.2.221-240; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Sullivan B, 2007, AM J PSYCHIAT, V164, P1663, DOI 10.1176/appi.ajp.2007.06111792; Tabachnick BG., USING MULTIVARIATE S; Tucker-Drob EM, 2011, NEUROPSYCHOLOGY, V25, P368, DOI 10.1037/a0022348; Wallace JC, 2004, PERS INDIV DIFFER, V37, P307, DOI 10.1016/j.paid.2003.09.005; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Weschler D., 1974, MANUAL WECHSLER INTE; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189683	10.1371/journal.pone.0189683	http://dx.doi.org/10.1371/journal.pone.0189683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244847	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700049
J	Oh, SW; Koo, HS; Han, KH; Han, SY; Chin, HJ				Oh, Se Won; Koo, Ho Seok; Han, Kum Hyun; Han, Sang Youb; Chin, Ho Jun			Associations of sodium intake with obesity, metabolic disorder, and albuminuria according to age	PLOS ONE			English	Article							POTASSIUM EXCRETION; URINARY SODIUM; SALT INTAKE; MORTALITY; RISK; CONSUMPTION; CHILDREN; HEALTH	Sodium intake is associated with obesity and metabolic disorder in the general population. However, sodium intake is significantly reduced according to the decrease of energy intake in older adults although the prevalence of obesity is higher than younger adults. We evaluate the association of sodium excretion (UNa) with blood pressure, obesity, metabolic disorders, and albuminuria according to age. An observational study using data from the Korean National Health and Nutrition Examination Survey IV-V (2008-2011) was performed (N = 18,146). The 24 hour UNa was estimated from a single fasting urine sample. Participants aged >= 75 years showed the highest risk for hypertension (HTN) in the highest quartile of UNa (1.769, 95% CI, 1.174-2.665), and the risks for HTN increased with advancing age. Obesity was not associated with UNa in participants aged >= 75 years, and hypertriglyceridemia and body fat were not related to UNa in participants aged >= 65 years, although these values were significantly associated with UNa in participants aged <= 65 years. Impaired fasting glucose (IFG) and insulin resistance (IR) were associated with UNa only in participants aged 20-39 years. The highest quartile of UNa showed a 3.777 fold increased risk for albuminuria in those aged 20-39 years (95% CI, 1.130-12.630), and a 1.885 fold increased risk (95% CI, 1.156-3.075) among participants aged 40-64 years. In participants aged >= 65 years, albuminuria was not associated with UNa. In contrast with HTN, UNa was not associated with albuminuria, obesity, hypertriglyceridemia, IFG, and IR in older adults despite a strong association in younger adults.	[Oh, Se Won] Korea Univ, Dept Internal Med, Anam Hosp, Coll Med, Seoul, South Korea; [Koo, Ho Seok] Inje Univ, Dept Internal Med, Seoul Paik Hosp, Coll Med, Gimhae, South Korea; [Han, Kum Hyun; Han, Sang Youb] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Goyang, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea	Korea University; Korea University Medicine (KU Medicine); Inje University; Inje University; Seoul National University (SNU)	Oh, SW (corresponding author), Korea Univ, Dept Internal Med, Anam Hosp, Coll Med, Seoul, South Korea.	hisy81@hanmail.net	koo, hoseok/Y-3228-2019; Oh, Se Won/G-2632-2017	koo, hoseok/0000-0001-7856-8083; Oh, Se Won/0000-0003-3795-9322				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Eiam-Ong S, 1999, GERONTOLOGY, V45, P254, DOI 10.1159/000022098; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; HALLFRISCH J, 1990, J GERONTOL, V45, pM186, DOI 10.1093/geronj/45.6.M186; He F. J., 2013, BMJ, V346; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Hickson M, 2006, POSTGRAD MED J, V82, P2, DOI 10.1136/pgmj.2005.037564; Imoscopi A, 2012, AGING CLIN EXP RES, V24, P570, DOI 10.3275/8520; Kalogeropoulos AP, 2015, JAMA INTERN MED, V175, P410, DOI 10.1001/jamainternmed.2014.6278; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P199; Kennedy RL, 2004, CURR OPIN CLIN NUTR, V7, P3, DOI 10.1097/00075197-200401000-00002; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.48]; Libuda L, 2012, PUBLIC HEALTH NUTR, V15, P433, DOI 10.1017/S1368980011002138; Mathus-Vliegen EMH, 2012, OBESITY FACTS, V5, P460, DOI 10.1159/000341193; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mills KT, 2016, JAMA-J AM MED ASSOC, V315, P2200, DOI 10.1001/jama.2016.4447; MULKERRIN EC, 1993, AM J KIDNEY DIS, V22, P538, DOI 10.1016/S0272-6386(12)80926-7; O'Donnell MJ, 2013, EUR HEART J, V34, P1034, DOI 10.1093/eurheartj/ehs409; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Oh SW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001650; Schmidt RJ, 2001, AM J KIDNEY DIS, V37, P900, DOI 10.1016/S0272-6386(05)80004-6; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; ZEMEL MB, 1988, AM J CARDIOL, V61, pH7, DOI 10.1016/0002-9149(88)91098-3	29	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188770	10.1371/journal.pone.0188770	http://dx.doi.org/10.1371/journal.pone.0188770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244825	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700009
J	Ge, LQ; Gu, HT; Huang, B; Song, QS; Stanley, D; Liu, F; Yang, GQ; Wu, JC				Ge, LinQuan; Gu, HaoTian; Huang, Bo; Song, Qisheng; Stanley, David; Liu, Fang; Yang, Guo-Qing; Wu, Jin-Cai			An adenylyl cyclase like-9 gene (NIAC9) influences growth and fecundity in the brown planthopper, Nilaparvata lugens (Stal) (Hemiptera: Delphacidae)	PLOS ONE			English	Article							PROTHORACIC GLANDS; RNA INTERFERENCE; CELL-DEATH; TRANSCRIPTION; VITELLOGENIN; HOMOPTERA; INSTAR	The cAMP/PKA intracellular signaling pathway is launched by adenylyl cyclase (AC) conversion of adenosine triphosphate (ATP) to 3', 5'-cyclic AMP (cAMP) and cAMP-dependent activation of PKA. Although this pathway is very well known in insect physiology, there is little to no information on it in some very small pest insects, such as the brown planthopper (BPH), Nilaparvata lugens Stal. BPH is a destructive pest responsible for tremendous crop losses in rice cropping systems. We are investigating the potentials of novel pest management technologies from RNA interference perspective. Based on analysis of transcriptomic data, the BPH AC like-9 gene (NIAC9) was up-regulated in post-mating females, which led us to pose the hypothesis that NIAC9 is a target gene that would lead to reduced BPH fitness and populations. Targeting NIAC9 led to substantially decreased soluble ovarian protein content, yeast-like symbiont abundance, and vitellogenin gene expression, accompanied with stunted ovarian development and body size. Eggs laid were decreased and oviposition period shortened. Taken together, our findings indicated that NIAC9 exerted pronounced effects on female fecundity, growth and longevity, which strongly supports our hypothesis.	[Ge, LinQuan; Gu, HaoTian; Huang, Bo; Liu, Fang; Yang, Guo-Qing; Wu, Jin-Cai] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	Yangzhou University; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Ge, LQ; Wu, JC (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	lqge1027@163.com; jincaiwu1952@sina.com		Ge, LinQuan/0000-0002-8539-9182	National Key R&D Program of China [2017YFD0200400]; Natural Science Foundation of Jiangsu Province, China [BK20171283]; Science and Technology Innovation Foundation of Yangzhou University [2016CXJ065]; Natural Science Foundation of China [31201507]; Jiangsu Agricultural Scientific Self-innovation Foundation [CX(15)1057]; Foundation of Science and Technology of Jiangsu Province, People's Republic of China [BE2015342]	National Key R&D Program of China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Science and Technology Innovation Foundation of Yangzhou University; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Agricultural Scientific Self-innovation Foundation; Foundation of Science and Technology of Jiangsu Province, People's Republic of China	This work was co-financed by National Key R&D Program of China (2017YFD0200400), the Natural Science Foundation of Jiangsu Province, China (BK20171283), the Science and Technology Innovation Foundation of Yangzhou University (2016CXJ065), the Natural Science Foundation of China (31201507), the Jiangsu Agricultural Scientific Self-innovation Foundation (CX(15)1057), and the Foundation of Science and Technology of Jiangsu Province, People's Republic of China (BE2015342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was co-financed by National Key R & D Program of China (2017YFD0200400), the Natural Science Foundation of Jiangsu Province, China (BK20171283), the Science and Technology innovation of Foundation of Yangzhou University (2016CXJ065), the Natural Science Foundation of China (31201507), the Jiangsu Agricultural Scientific Self-innovation Foundation (CX(15)1057), and the Foundation of Science and Technology of Jiangsu Province, People's Republic of China (BE2015342).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CH, 2001, INSECT BIOCHEM MOLEC, V31, P659, DOI 10.1016/S0965-1748(00)00171-5; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; DJERASSI C, 1974, SCIENCE, V186, P596, DOI 10.1126/science.186.4164.596; Dong SZ, 2011, ENTOMOL EXP APPL, V139, P103, DOI 10.1111/j.1570-7458.2011.01109.x; Erion R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00353; Frederik H, 1974, J EXP BIOL, V61, P493; Fu Q, 2001, APPL ENTOMOL ZOOL, V36, P111, DOI 10.1303/aez.2001.111; Fuss N, 2010, INSECT BIOCHEM MOLEC, V40, P573, DOI 10.1016/j.ibmb.2010.05.004; Ge LQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12194; Hansson V, 2000, J STEROID BIOCHEM, V73, P79, DOI 10.1016/S0960-0760(00)00057-1; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jing YP, 2016, J BIOL CHEM, V291, P12771, DOI 10.1074/jbc.M115.706028; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2015, J INSECT PHYSIOL, V73, P20, DOI 10.1016/j.jinsphys.2015.01.007; MELLER VH, 1988, MOL CELL ENDOCRINOL, V59, P67, DOI 10.1016/0303-7207(88)90196-7; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; NELSON DR, 1980, INSECT BIOCHEM, V10, P163, DOI 10.1016/0020-1790(80)90068-2; Pang K, 2012, INSECT SCI, V19, P477, DOI 10.1111/j.1744-7917.2011.01486.x; Prasannakumar NR, 2014, PHYTOPARASITICA, V42, P387, DOI 10.1007/s12600-013-0375-0; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; SASS M, 1983, GEN COMP ENDOCR, V50, P116, DOI 10.1016/0016-6480(83)90248-4; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Suzuki Y, 2013, P NATL ACAD SCI USA, V110, P12518, DOI 10.1073/pnas.1311405110; Tang QY., 2002, DPS DATA PROCESSING; Wang LP, 2010, CROP PROT, V29, P1280, DOI 10.1016/j.cropro.2010.07.009; Wang YH, 2008, PEST MANAG SCI, V64, P1278, DOI 10.1002/ps.1629; Ying Hue Lee, 1987, Journal of Insect Physiology, V33, P851; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhang YX, 2014, PESTIC BIOCHEM PHYS, V115, P53, DOI 10.1016/j.pestbp.2014.07.012	33	7	7	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189214	10.1371/journal.pone.0189214	http://dx.doi.org/10.1371/journal.pone.0189214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236776	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100050
J	Liu, DY; Liu, JX; Wang, JH; Guo, LS; Liu, CC; Jiang, YF; Wang, HF; Yang, SR				Liu, Deying; Liu, Jinxiang; Wang, Jinghua; Guo, Lishuang; Liu, Congcong; Jiang, Yanfang; Wang, Haifeng; Yang, Sirui			Distribution of circulating T follicular helper cell subsets is altered in immunoglobulin A vasculitis in children	PLOS ONE			English	Article							HENOCH-SCHONLEIN PURPURA; TH17 CELLS; PERIPHERAL-BLOOD; CLASSIFICATION; NEPHRITIS	Background Immunoglobulin A vasculitis (IgAV) is the most common vasculitis in children. Previously, we demonstrated that patients with IgAV show abnormal proliferation of cluster of differentiation (CD)4(+)C-X-C chemokine receptor type (CXCR)5(+) follicular helper T (Tfh) cells. Here, we explored the status of Tfh cell subsets and plasma cytokine levels in patients with IgAV. Methods CD4(+)CXCR5(+)CD45RA(-), CD45RA(-)CXCR3(+)CCR6(-), CD45RA(-)CXCR3(-)CCR6(-), CD45RA(-)CXCR3(-)CCR6(+), and CD45RA(-)CXCR3(+)CCR6(+) Tfh cell fractions and plasma concentrations of interferon-gamma, interleukin (IL)-4, and IL-17A were evaluated by flow cytometry and a flow cytometric bead array, respectively, in 30 patients with IgAV and 15 healthy controls (HCs). Results Tfh2 and Tfh17 cell fractions were larger and the Tfh2+Tfh17/Tfh1 ratio and plasmaIL-4 and -17A levels were higher in patients with IgAV than in the HCs. Only Tfh1 cell counts were reduced in the abdominal subtype. The elevations in Tfh2 and Tfh17 cell counts and plasma IL-4 levels were abrogated by treatment. Tfh2 cell number was positively correlated with serum IgA and plasma IL-4 levels, but negatively correlated with the serum C4 concentration, while Tfh17 cell number was positively correlated with the serum IgA level and Tfh2 cell counts. Conclusions Abnormally high numbers of Tfh2 and Tfh17 cells are linked to the occurrence and development of IgAV, but are not specific to the abdominal type. Only Tfh1 cells play a critical role in abdominal-type IgAV.	[Liu, Deying; Liu, Jinxiang; Wang, Jinghua; Guo, Lishuang; Liu, Congcong; Yang, Sirui] Jilin Univ, Hosp 1, Dept Pediat Rheumatol & Allergy, Changchun, Jilin, Peoples R China; [Liu, Deying] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Childrens Hosp, Dept Rheumatol & Immunol, Wuhan, Hubei, Peoples R China; [Jiang, Yanfang; Wang, Haifeng] Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonoses Res, Changchun, Jilin, Peoples R China; [Jiang, Yanfang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Jilin University; Huazhong University of Science & Technology; Jilin University	Yang, SR (corresponding author), Jilin Univ, Hosp 1, Dept Pediat Rheumatol & Allergy, Changchun, Jilin, Peoples R China.; Wang, HF (corresponding author), Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonoses Res, Changchun, Jilin, Peoples R China.	wanghaifeng1994@163.com; JLUsiriyang@163.com			Natural Science Foundation of Jilin Provincial Science and Technology Department [20160101065JC]	Natural Science Foundation of Jilin Provincial Science and Technology Department	This work was supported by the Natural Science Foundation of Jilin Provincial Science and Technology Department (no. 20160101065JC) to Sirui Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PLOS ONE, V8; Bautista-Caro MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107086; Chen MG, 2012, CELL MOL IMMUNOL, V9, P375, DOI 10.1038/cmi.2012.18; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Cubas R, 2014, CURR OPIN HIV AIDS, V9, P485, DOI 10.1097/COH.0000000000000095; Davin JC, 2014, NAT REV NEPHROL, V10, P563, DOI 10.1038/nrneph.2014.126; Davin JC, 2011, CLIN J AM SOC NEPHRO, V6, P679, DOI 10.2215/CJN.06710810; Deenick EK, 2011, IMMUNOLOGY, V134, P361, DOI 10.1111/j.1365-2567.2011.03487.x; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Espinosa-Ortega F, 2015, CLIN EXP IMMUNOL, V179, P520, DOI 10.1111/cei.12475; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Holdsworth SR, 2015, CLIN J AM SOC NEPHRO, V10, P2243, DOI 10.2215/CJN.07590714; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Jen HY, 2011, PEDIAT ALLERG IMM-UK, V22, P862, DOI 10.1111/j.1399-3038.2011.01198.x; Johnson EF, 2015, BRIT J DERMATOL, V172, P1358, DOI 10.1111/bjd.13472; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Li YY, 2012, RHEUMATOL INT, V32, P3785, DOI 10.1007/s00296-011-2266-3; Liu Dengfeng, 2016, J RISK ANAL CRISIS R, V6-1, P10, DOI DOI 10.1186/S12865-016-0176-6; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Pan YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115261; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Piram M, 2013, CURR OPIN RHEUMATOL, V25, P171, DOI 10.1097/BOR.0b013e32835d8e2a; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Rodeghero R, 2013, J IMMUNOL, V190, P5423, DOI 10.4049/jimmunol.1203045; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Wang Chun-Mei, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P1084; Xiao F, 2013, J RHEUMATOL, V40, P2029, DOI 10.3899/jrheum.130125; Xie J, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/742535; Yang YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120411; Yang YH, 2014, AUTOIMMUN REV, V13, P355, DOI 10.1016/j.autrev.2014.01.031; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	37	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189133	10.1371/journal.pone.0189133	http://dx.doi.org/10.1371/journal.pone.0189133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236760	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100043
J	Meyer, MJ; Seitz, T; Brockmoller, J; Tzvetkov, MV				Meyer, Marleen Julia; Seitz, Tina; Brockmoeller, Jurgen; Tzvetkov, Mladen Vassilev			Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; RENAL CLEARANCE; FUNCTIONAL-CHARACTERIZATION; MORPHINE PHARMACOKINETICS; DRUG-INTERACTIONS; HUMAN KIDNEY; HUMAN LIVER; METFORMIN; VARIANTS; EXPRESSION	Background Ranitidine (Zantac (R)) is a H-2-receptor antagonist commonly used for the treatment of acid-related gastrointestinal diseases. Ranitidine was reported to be a substrate of the organic cation transporters OCT1 and OCT2. The hepatic transporter OCT1 is highly genetically variable. Twelve major alleles confer partial or complete loss of OCT1 activity. The effects of these polymorphisms are highly substrate-specific and therefore difficult to predict. The renal transporter OCT2 has a common polymorphism, Ala270Ser, which was reported to affect OCT2 activity. Aim In this study we analyzed the effects of genetic polymorphisms in OCT1 and OCT2 on the uptake of ranitidine and on its potency to inhibit uptake of other drugs. Methods and results We characterized ranitidine uptake using HEK293 and CHO cells stably transfected to overexpress wild type OCT1, OCT2, or their naturally occurring allelic variants. Ranitidine was transported by wild-type OCT1 with a Km of 62.9 mu M and a v(max) of 1125 pmol/min/mg protein. Alleles OCT1*5, *6, *12, and *13 completely lacked ranitidine uptake. Alleles OCT1*2, *3, *4, and *10 had v(max) values decreased by more than 50%. In contrast, OCT1*8 showed an increase of v(max) by 25%. The effects of OCT1 alleles on ranitidine uptake strongly correlated with the effects on morphine uptake suggesting common interaction mechanisms of both drugs with OCT1. Ranitidine inhibited the OCT1-mediated uptake of metformin and morphine at clinically relevant concentrations. The inhibitory potency for morphine uptake was affected by the OCT1*2 allele. OCT2 showed only a limited uptake of ranitidine that was not significantly affected by the Ala270Ser polymorphism. Conclusions We confirmed ranitidine as an OCT1 substrate and demonstrated that common genetic polymorphisms in OCT1 strongly affect ranitidine uptake and modulate ranitidine's potential to cause drug-drug interactions. The effects of the frequent OCT1 polymorphisms on ranitidine pharmacokinetics in humans remain to be analyzed.	[Meyer, Marleen Julia; Seitz, Tina; Brockmoeller, Jurgen; Tzvetkov, Mladen Vassilev] Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany	University of Gottingen	Tzvetkov, MV (corresponding author), Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany.	mtzvetk@gwdg.de		Tzvetkov, Mladen/0000-0003-1670-5534; Leggas, Markos/0000-0003-4314-4533	German Research Foundation (DFG) [TZ 74/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financially supported by the German Research Foundation (DFG) grant TZ 74/1-1.; This study was financially supported by the German Research Foundation (DFG; www.dfg.de) grant TZ 74/1-1 to MVT and JB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin G, 2011, PHARMACOGENOMICS J, V11, P400, DOI 10.1038/tpj.2010.54; Arimany-Nardi C, 2015, PHARMACOGENOMICS J, V15, P363, DOI 10.1038/tpj.2014.77; Bachmakov L, 2008, DIABETES, V57, P1463, DOI 10.2337/db07-1515; Boom SPA, 1998, BIOPHARM DRUG DISPOS, V19, P199, DOI 10.1002/(SICI)1099-081X(199804)19:3<199::AID-BDD1>3.0.CO;2-2; Bourdet DL, 2005, J PHARMACOL EXP THER, V315, P1288, DOI 10.1124/jpet.105.091223; Chen EC, 2017, J MED CHEM, V60, P2685, DOI 10.1021/acs.jmedchem.6b01317; Chen J, 2016, BIOL CHEM; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Cho SK, 2016, INT J CLIN PHARM TH, V54, P253, DOI 10.5414/CP202473; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2012, CLIN CANCER RES, V18, P1101, DOI 10.1158/1078-0432.CCR-11-2503; Deng XM, 2009, PHARMACOL REV, V61, P262, DOI 10.1124/pr.109.001727; Donnellan C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003245.pub2; Dresser MJ, 2002, PHARMACEUT RES, V19, P1244, DOI 10.1023/A:1019870831174; Drozdzik M, 2014, MOL PHARMACEUT, V11, P3547, DOI 10.1021/mp500330y; Franke RM, 2010, CLIN CANCER RES, V16, P4198, DOI 10.1158/1078-0432.CCR-10-0949; Fukuda T, 2013, PHARMACOGENOMICS, V14, P1141, DOI [10.2217/PGS.13.94, 10.2217/pgs.13.94]; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Han T, 2013, MOL PHARMACOL, V84, P182, DOI 10.1124/mol.112.084517; Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v; Herraez E, 2013, HEPATOLOGY, V58, P1065, DOI 10.1002/hep.26425; Ito K, 1998, PHARMACOL REV, V50, P387; KANASHIMA R, 1985, AM J SURG, V149, P223, DOI 10.1016/S0002-9610(85)80074-X; Kang HJ, 2007, DRUG METAB DISPOS, V35, P667, DOI 10.1124/dmd.106.013581; Kerb R, 2002, PHARMACOGENETICS, V12, P591, DOI 10.1097/00008571-200211000-00002; Kindla J, 2011, DRUG METAB DISPOS, V39, P1047, DOI 10.1124/dmd.110.037622; KIRCH W, 1984, CLIN PHARMACOKINET, V9, P493, DOI 10.2165/00003088-198409060-00002; KLOTZ U, 1990, EUR J CLIN PHARMACOL, V39, P91, DOI 10.1007/BF02657067; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Leabman MK, 2002, PHARMACOGENETICS, V12, P395, DOI 10.1097/00008571-200207000-00007; Matthaei J., 2015, CLIN PHARM THER; Mills JG, 1997, ALIMENT PHARM THER, V11, P129, DOI 10.1046/j.1365-2036.1997.136312000.x; MITCHARD M, 1987, PHARMACOL THERAPEUT, V32, P293, DOI 10.1016/0163-7258(87)90078-7; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Muller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011; Nielsen LM, 2017, EUR J PHARM SCI, V99, P337, DOI 10.1016/j.ejps.2016.12.039; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Okuda M, 1996, BIOCHEM BIOPH RES CO, V224, P500, DOI 10.1006/bbrc.1996.1056; Organization WH, 2015, WHO MOD LIST ESS MED; Pereira JND, 2014, AAPS J, V16, P1247, DOI 10.1208/s12248-014-9649-9; Reznichenko A, 2013, PHYSIOL GENOMICS, V45, P201, DOI 10.1152/physiolgenomics.00087.2012; Ribeiro JM, 2000, AM J GASTROENTEROL, V95, P559; ROBERTS CJC, 1984, CLIN PHARMACOKINET, V9, P211, DOI 10.2165/00003088-198409030-00003; Saadatmand AR, 2012, BIOCHEM PHARMACOL, V83, P1427, DOI 10.1016/j.bcp.2012.01.032; Sadhasivam Senthilkumar, 2012, J Opioid Manag, V8, P217, DOI 10.5055/jom.2012.0119; Schaeffeler E, 2011, GENOME MED, V3, DOI 10.1186/gm298; Schiller C, 2005, ALIMENT PHARM THER, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0; Shu Y, 2003, P NATL ACAD SCI USA, V100, P5902, DOI 10.1073/pnas.0730858100; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61; Song IS, 2008, XENOBIOTICA, V38, P1252, DOI [10.1080/00498250802130039, 10.1080/00498250802130039 ]; Song IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036637; Sundelin EIO, 2017, CLIN PHARMACOL THER, V102, P841, DOI 10.1002/cpt.701; Tahara H, 2005, J PHARMACOL EXP THER, V315, P337, DOI 10.1124/jpet.105.088104; Tu MJ, 2013, TOXICOLOGY, V311, P225, DOI 10.1016/j.tox.2013.06.009; Tzvetkov MV, 2012, PHARMACOGENOMICS J, V12, P22, DOI 10.1038/tpj.2010.75; Tzvetkov MV, 2011, CLIN PHARMACOL THER, V90, P143, DOI 10.1038/clpt.2011.56; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Tzvetkov M. V, 2017, CLIN PHARM THER; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Tzvetkov MV, 2016, ORGANIC CATION TRANS; VANCRUGTEN J, 1986, J PHARMACOL EXP THER, V236, P481; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wisniewski JR, 2016, ANAL BIOCHEM, V509, P82, DOI 10.1016/j.ab.2016.06.006; Xie Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015735; YOUNG CJ, 1982, GUT, V23, P819, DOI 10.1136/gut.23.10.819; Zolk O, 2009, DRUG METAB DISPOS, V37, P1312, DOI 10.1124/dmd.108.023762	71	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189521	10.1371/journal.pone.0189521	http://dx.doi.org/10.1371/journal.pone.0189521			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236753	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100076
J	Jack, BN; Roeber, U; O'Shea, RP				Jack, Bradley N.; Roeber, Urte; O'Shea, Robert P.			Do early neural correlates of visual consciousness show the oblique effect? A binocular rivalry and event-related potential study	PLOS ONE			English	Article							CAT STRIATE CORTEX; SPATIAL-FREQUENCY; STIMULUS ORIENTATION; BRAIN ACTIVITY; RECEPTIVE-FIELDS; STOCHASTIC PROPERTIES; SELECTIVE ATTENTION; OCULAR DOMINANCE; GRATING STIMULI; NECKER-CUBE	When dissimilar images are presented one to each eye, we do not see both images; rather, we see one at a time, alternating unpredictably. This is called binocular rivalry, and it has recently been used to study brain processes that correlate with visual consciousness, because perception changes without any change in the sensory input. Such studies have used various types of images, but the most popular have been gratings: sets of bright and dark lines of orthogonal orientations presented one to each eye. We studied whether using cardinal rival gratings (vertical, 0 degrees, and horizontal, 90 degrees) versus oblique rival gratings (left-oblique, -45 degrees, and right-oblique, 45 degrees) influences early neural correlates of visual consciousness, because of the oblique effect: the tendency for visual performance to be greater for cardinal gratings than for oblique gratings. Participants viewed rival gratings and pressed keys indicating which of the two gratings they perceived, was dominant. Next, we changed one of the gratings to match the grating shown to the other eye, yielding binocular fusion. Participants perceived the rivalry-to-fusion change to the dominant grating and not to the other, suppressed grating. Using event-related potentials (ERPs), we found neural correlates of visual consciousness at the P1 for both sets of gratings, as well as at the P1-N1 for oblique gratings, and we found a neural correlate of the oblique effect at the N1, but only for perceived changes. These results show that the P1 is the earliest neural activity associated with visual consciousness and that visual consciousness might be necessary to elicit the oblique effect.	[Jack, Bradley N.; Roeber, Urte; O'Shea, Robert P.] Southern Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia; [Jack, Bradley N.] UNSW Sydney, Sch Psychol, Sydney, NSW, Australia; [Roeber, Urte; O'Shea, Robert P.] Univ Leipzig, Inst Psychol, Leipzig, Germany; [Roeber, Urte] Univ Sydney, Discipline Biomed Sci, Sydney, NSW, Australia; [Roeber, Urte; O'Shea, Robert P.] Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia	Southern Cross University; University of New South Wales Sydney; Leipzig University; University of Sydney; Murdoch University	Jack, BN (corresponding author), Southern Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia.; Jack, BN (corresponding author), UNSW Sydney, Sch Psychol, Sydney, NSW, Australia.	bradley.jack@unsw.edu.au	O'Shea, Robert P./C-5723-2008	O'Shea, Robert P./0000-0003-3132-7199; Roeber, Urte/0000-0002-6631-5828				Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Alais D., 2004, BINOCULAR RIVALRY; Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Arakawa K, 2000, EXP BRAIN RES, V131, P121, DOI 10.1007/s002219900274; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; BAUER R, 1993, VISION RES, V33, P1447, DOI 10.1016/0042-6989(93)90138-M; BERKLEY MA, 1975, VISION RES, V15, P239, DOI 10.1016/0042-6989(75)90213-8; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 1998, J COGNITIVE NEUROSCI, V10, P46, DOI 10.1162/089892998563770; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; BLAKE R, 1977, J EXP PSYCHOL HUMAN, V3, P251, DOI 10.1037/0096-1523.3.2.251; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Blake R., 2015, ENCY NEUROSCIENCE, V2, P179; Borra T, 2010, PERCEPTION, V39, P909, DOI 10.1068/p6338; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001497; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; Britz J, 2011, PSYCHOPHYSIOLOGY, V48, P1489, DOI 10.1111/j.1469-8986.2011.01222.x; Britz J, 2011, HUM BRAIN MAPP, V32, P1432, DOI 10.1002/hbm.21117; Britz J, 2009, CEREB CORTEX, V19, P55, DOI 10.1093/cercor/bhn056; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; COGAN AI, 1987, VISION RES, V27, P2125, DOI 10.1016/0042-6989(87)90127-1; COGAN R, 1973, J GEN PSYCHOL, V89, P297, DOI 10.1080/00221309.1973.9710832; Crick F, 1996, NATURE, V379, P485, DOI 10.1038/379485a0; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Du Tour EF., 1760, MIM MATH PHYS ACAD R, V3, P514; Emsley E. E., 1925, T OPTICAL SOC, V27, P28; FAHLE M, 1982, VISION RES, V22, P787, DOI 10.1016/0042-6989(82)90010-4; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Grossberg S, 2008, VISION RES, V48, P2232, DOI 10.1016/j.visres.2008.06.024; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hayashi R, 2004, VISION RES, V44, P2367, DOI 10.1016/j.visres.2004.04.017; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; HIGGINS GC, 1950, J OPT SOC AM, V40, P135, DOI 10.1364/JOSA.40.000135; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hohwy J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00096; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jack BN, 2017, PSYCHOPHYSIOLOGY, V54, P755, DOI 10.1111/psyp.12831; Jack BN, 2015, J VISION, V15, DOI 10.1167/15.13.9; Jastrow J., 1892, AM J PSYCHOL, V5, P214, DOI [10.2307/1410867, DOI 10.2307/1410867]; Kaernbach C, 1999, NEUROREPORT, V10, P713, DOI 10.1097/00001756-199903170-00010; Kalarickal GJ, 2000, NEUROCOMPUTING, V32, P843, DOI 10.1016/S0925-2312(00)00252-6; KALIA M, 1973, J PHYSIOL-LONDON, V232, P275, DOI 10.1113/jphysiol.1973.sp010269; KENNEDY H, 1979, J PHYSIOL-LONDON, V296, pP61; Kimura M, 2010, NEUROSCI LETT, V485, P198, DOI 10.1016/j.neulet.2010.09.011; Kleiner M, 2007, PERCEPTION, V36, P14; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Koch Christof, 2004, QUEST CONSCIOUSNESS; Koivisto M, 2006, CEREB CORTEX, V16, P415, DOI 10.1093/cercor/bhi121; Kornmeier J, 2005, VISION RES, V45, P955, DOI 10.1016/j.visres.2004.10.006; Kornmeier J, 2004, PSYCHOPHYSIOLOGY, V41, P1, DOI 10.1046/j.1469-8986.2003.00126.x; Kornmeier J, 2006, INT J PSYCHOPHYSIOL, V62, P345, DOI 10.1016/j.ijpsycho.2006.04.007; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lankheet MJM, 2006, J VISION, V6, P304, DOI 10.1167/6.4.1; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1967, BRIT J PSYCHOL, V58, P143, DOI 10.1111/j.2044-8295.1967.tb01068.x; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; MAFFEI L, 1970, SCIENCE, V167, P386, DOI 10.1126/science.167.3917.386; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; MATSUOKA K, 1984, BIOL CYBERN, V49, P201, DOI 10.1007/BF00334466; MAY JG, 1979, VISION RES, V19, P1395, DOI 10.1016/0042-6989(79)90213-X; McDougall W., 1901, BRAIN, V24, P579, DOI DOI 10.1093/BRAIN/24.4.579; Miller SM, 2013, CONSTITUTION VISUAL; MOSKOWITZ A, 1985, INVEST OPHTH VIS SCI, V26, P246; Muller D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00259; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; MYERSON J, 1981, BEHAV ANAL LETT, V1, P149; NACHMIAS J, 1960, J OPT SOC AM, V50, P569, DOI 10.1364/JOSA.50.000569; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; O'Shea R. P., 2009, ENCY PERCEPTION, P399, DOI DOI 10.4135/9781412972000.N126; OShea RP, 1997, VISION RES, V37, P175, DOI 10.1016/S0042-6989(96)00113-7; OSHEA RP, 1984, PERCEPT PSYCHOPHYS, V36, P266, DOI 10.3758/BF03206368; OSHEA RP, 1983, PERCEPT PSYCHOPHYS, V34, P599, DOI 10.3758/BF03205917; OSHEA RP, 1987, VISION RES, V27, P781, DOI 10.1016/0042-6989(87)90075-7; OSHEA RP, 1981, PERCEPTION, V10, P283, DOI 10.1068/p100283; PAYNE BR, 1983, J NEUROPHYSIOL, V49, P1051, DOI 10.1152/jn.1983.49.4.1051; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P391; Pitts MA, 2007, J VISION, V7, DOI 10.1167/7.1.6; Pitts MA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00107; Pitts MA, 2010, J VISION, V10, DOI 10.1167/10.14.25; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pourtois G, 2006, J COGNITIVE NEUROSCI, V18, P2108, DOI 10.1162/jocn.2006.18.12.2108; Pratt H., 2011, OXFORD HDB EVENT REL, DOI [DOI 10.1093/OXFORDHB/9780195374148.013.0050, 10.1093/oxfordhb/9780195374148.013.0050]; Proverbio AM, 2002, COGNITIVE BRAIN RES, V13, P139, DOI 10.1016/S0926-6410(01)00103-3; Railo H, 2011, CONSCIOUS COGN, V20, P972, DOI 10.1016/j.concog.2011.03.019; Roeber U, 2004, NEUROSCI LETT, V371, P51, DOI 10.1016/j.neulet.2004.08.038; Roeber U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022612; Roeber U, 2008, J VISION, V8, DOI 10.1167/8.3.21; Said C.P., 2013, PLOS COMPUT BIOL, V9, P1, DOI DOI 10.1371/J0URNAL.PCBI.1002991; SCHOR CM, 1977, PERCEPTION, V6, P583, DOI 10.1068/p060583; SKRANDIES W, 1984, ELECTROEN CLIN NEURO, V58, P325, DOI 10.1016/0013-4694(84)90058-0; Stollenwerk L, 2003, NEURAL COMPUT, V15, P2863, DOI 10.1162/089976603322518777; Takacs E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00591; TAYLOR MM, 1963, J OPT SOC AM, V53, P763, DOI 10.1364/JOSA.53.000763; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; van Boxtel JJA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00217; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; Veser S, 2008, VISION RES, V48, P2359, DOI 10.1016/j.visres.2008.07.024; WADE NJ, 1974, PERCEPT PSYCHOPHYS, V15, P227, DOI 10.3758/BF03213937; WADE NJ, 1984, PERCEPT PSYCHOPHYS, V35, P111, DOI 10.3758/BF03203891; WALKER P, 1975, PERCEPT PSYCHOPHYS, V18, P467, DOI 10.3758/BF03204122; Watanabe M, 2011, SCIENCE, V334, P829, DOI 10.1126/science.1203161; WESTENDORF DH, 1989, J EXP PSYCHOL HUMAN, V15, P485, DOI 10.1037/0096-1523.15.3.485; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilenius ME, 2007, PSYCHOPHYSIOLOGY, V44, P703, DOI 10.1111/j.1469-8986.2007.00546.x; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WILSON JR, 1976, J NEUROPHYSIOL, V39, P512, DOI 10.1152/jn.1976.39.3.512; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447; World Medical Association, 2004, DECL HELS ETH PRINC; YOSHIDA S, 1975, ELECTROEN CLIN NEURO, V39, P53, DOI 10.1016/0013-4694(75)90126-1; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223; Zhou YH, 2004, BIOL CYBERN, V90, P256, DOI 10.1007/s00422-004-0472-8	132	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188979	10.1371/journal.pone.0188979	http://dx.doi.org/10.1371/journal.pone.0188979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP5YF	29232704	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200016
J	Koenig, A; Krug, S; Mueller, D; Barth, PJ; Koenig, U; Scharf, M; Ellenrieder, V; Michl, P; Moll, R; Homayunfar, K; Kann, PH; Stroebel, P; Gress, TM; Rinke, A				Koenig, Alexander; Krug, Sebastian; Mueller, Daniela; Barth, Peter J.; Koenig, Ute; Scharf, Michael; Ellenrieder, Volker; Michl, Patrick; Moll, Roland; Homayunfar, Kia; Kann, Peter Herbert; Stroebel, Philipp; Gress, Thomas M.; Rinke, Anja			Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; RECTAL CARCINOID-TUMORS; PLASMA CHROMOGRANIN-A; ENDOCRINE TUMORS; CARCINOEMBRYONIC ANTIGEN; GASTROINTESTINAL-TRACT; ACETIC-ACID; DISEASE; MARKER; CLASSIFICATION	Chromogranin A (CgA) is a well-established marker for diagnosis and follow up of patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). Recently, it has been shown that plasma levels of CgA correlate with tumor load and predict survival of patients with NEN of the small bowel. It is assumed that this is as well valid for NEN of the colon and rectum, however, this is not supported by data. To evaluate this assumption, we analyzed 62 patients with NEN of the colon and rectum listed in the Marburg GEP-NEN registry for clinicopathological characteristics, expression and plasma levels of CgA. The present study demonstrates that immunohistochemical CgA and synaptophysin are good markers for histological diagnosis in patients with NEN of the colon and rectum. However, plasma CgA is a poor marker to follow-up these patients because only a minority exhibited increased levels which did not increase significantly during tumor progression. In contrast to NEN of the small bowel, there is no correlation of CgA plasma levels with tumor burden or survival. Patients with NEN of the colon and rectum displayed a relatively good prognosis resulting in a median survival of 8.5 years. However, a subset of patients affected by G3 neoplasms, exhibited a poorer prognosis with a median survival of 2.5 years. Taken together, CgA is a valuable marker for immunohistochemical diagnosis, but CgA plasma concentration is not suitable to mirror tumor burden or prognosis in patients with NEN of the colon and rectum.	[Koenig, Alexander; Krug, Sebastian; Mueller, Daniela; Scharf, Michael; Kann, Peter Herbert; Gress, Thomas M.; Rinke, Anja] Philipps Univers Marburg, Dept Gastroenterol & Endocrinol, Marburg, Germany; [Koenig, Alexander; Koenig, Ute; Ellenrieder, Volker] Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany; [Krug, Sebastian; Michl, Patrick] Univ Halle, Dept Internal Med 1, Halle, Germany; [Barth, Peter J.] Univ Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Barth, Peter J.; Moll, Roland] Philipps Univ Marburg, Dept Pathol, Marburg, Germany; [Homayunfar, Kia] Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Stroebel, Philipp] Univ Med Ctr Goettingen, Dept Pathol, Gottingen, Germany	University of Gottingen; Martin Luther University Halle Wittenberg; University of Munster; Philipps University Marburg; University of Gottingen; University of Gottingen	Koenig, A; Rinke, A (corresponding author), Philipps Univers Marburg, Dept Gastroenterol & Endocrinol, Marburg, Germany.; Koenig, A (corresponding author), Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany.	alexander.koenig@med.uni-goettingen.de; sprengea@staff.uni-marburg.de	Krug, Sebastian/ABE-2890-2020; Michl, Patrick/HDN-4172-2022; Michl, Patrick/AAG-3987-2021	Krug, Sebastian/0000-0003-1672-7995; Gress, Thomas/0000-0002-9333-5461	YING program of Novartis Oncology; Novartis Oncology; Anneliese Pohl Stiftung	YING program of Novartis Oncology; Novartis Oncology; Anneliese Pohl Stiftung	A.K. was supported by the YING program of Novartis Oncology. S.K. was supported by Novartis Oncology. A.R. was supported by the Anneliese Pohl Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no funding for this work.	Arnold CN, 2008, INT J CANCER, V123, P1556, DOI 10.1002/ijc.23690; Arnold CN, 2007, INT J CANCER, V120, P2157, DOI 10.1002/ijc.22569; Arnold R, 2008, CLIN GASTROENTEROL H, V6, P820, DOI 10.1016/j.cgh.2008.02.052; Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8; Boo YJ, 2007, J SURG ONCOL, V95, P110, DOI 10.1002/jso.20616; Campana D, 2007, J CLIN ONCOL, V25, P1967, DOI 10.1200/JCO.2006.10.1535; Capdevila J, 2011, CANCER DISCOV, V1, P213, DOI 10.1158/2159-8290.CD-11-0151; CAPELLA C, 1995, VIRCHOWS ARCH, V425, P547; Carling RS, 2002, ANN CLIN BIOCHEM, V39, P577, DOI 10.1258/000456302760413351; Cubelos Beatriz, 2010, Commun Integr Biol, V3, P483, DOI 10.4161/cib.3.6.12755; de Herder WW, 2005, BEST PRACT RES CL GA, V19, P705, DOI 10.1016/j.bpg.2005.05.007; FEDERSPIEL BH, 1990, MODERN PATHOL, V3, P586; Frilling A, 2012, ENDOCR-RELAT CANCER, V19, pR163, DOI 10.1530/ERC-12-0024; Gupta S, 2005, CANCER-AM CANCER SOC, V104, P1590, DOI 10.1002/cncr.21389; Halperin DM, 2017, LANCET ONCOL, V18, P525, DOI 10.1016/S1470-2045(17)30110-9; Jann H, 2011, CANCER-AM CANCER SOC, V117, P3332, DOI 10.1002/cncr.25855; Kaplan E, 1958, J AM STAT ASSOC, V53, P281; Kwaan MR, 2008, ARCH SURG-CHICAGO, V143, P471, DOI 10.1001/archsurg.143.5.471; Leon A, 2005, INT J BIOL MARKER, V20, P156, DOI 10.1177/172460080502000303; Lordick F, 2016, ANN ONCOL, V27, pv50, DOI 10.1093/annonc/mdw329; Massironi S, 2010, AM J GASTROENTEROL, V105, P2072, DOI 10.1038/ajg.2010.154; Mitsuhashi K, 2015, ONCOTARGET, V6, P22114, DOI 10.18632/oncotarget.4294; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; Modlin IM, 2006, J CLIN GASTROENTEROL, V40, P572, DOI 10.1097/00004836-200608000-00003; Modlin IM, 2016, BEST PRACT RES CL EN, V30, P59, DOI 10.1016/j.beem.2016.01.002; Modlin IM, 2016, SURGERY, V159, P336, DOI 10.1016/j.surg.2015.06.056; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Nobels FRE, 1997, J CLIN ENDOCR METAB, V82, P2622, DOI 10.1210/jc.82.8.2622; Nolting Svenja, 2012, Cancers (Basel), V4, P141, DOI 10.3390/cancers4010141; NORHEIM I, 1987, EUR J CANCER CLIN ON, V23, P689, DOI 10.1016/0277-5379(87)90264-1; Nuttall KL, 1998, ANN CLIN LAB SCI, V28, P167; Oberg Kjell, 2003, Expert Rev Anticancer Ther, V3, P863, DOI 10.1586/14737140.3.6.863; Panzuto F, 2011, J CLIN ONCOL, V29, P2372, DOI 10.1200/JCO.2010.33.0688; Pavel M, 2016, NEUROENDOCRINOLOGY, V103, P172, DOI 10.1159/000443167; Pavel M, 2017, NEUROENDOCRINOLOGY, V104, P170, DOI 10.1159/000446025; PRINZ RA, 1983, SURGERY, V94, P1019; Rindi G, 2007, VIRCHOWS ARCH, V451, P757, DOI 10.1007/s00428-007-0452-1; Rindi G, 2014, ENDOCR PATHOL, V25, P186, DOI 10.1007/s12022-014-9313-z; Rindi G, 2012, JNCI-J NATL CANCER I, V104, P764, DOI 10.1093/jnci/djs208; Shebani KO, 1999, ANN SURG, V229, P815, DOI 10.1097/00000658-199906000-00008; Stridsberg M, 2003, J ENDOCRINOL, V177, P337, DOI 10.1677/joe.0.1770337; Strosberg JR, 2015, ENDOCR-RELAT CANCER, V22, P933, DOI 10.1530/ERC-15-0314; Turner GB, 2006, GUT, V55, P1586, DOI 10.1136/gut.2006.092320; Van Gompel JJ, 2004, WORLD J SURG, V28, P387, DOI 10.1007/s00268-003-7019-3; Vogelsang SH, 2005, BEST PRACT RES CL GA, V19, P739, DOI 10.1016/j.bpg.2005.06.001; Williams GT, 2007, HISTOPATHOLOGY, V50, P30, DOI 10.1111/j.1365-2559.2006.02570.x; Woltering EA, 2006, PANCREAS, V33, P250, DOI 10.1097/01.mpa.0000235302.73615.d4; Yada Kazuhiro, 2003, J Hepatobiliary Pancreat Surg, V10, P382, DOI 10.1007/s00534-002-0826-3; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, J CLIN ENDOCR METAB, V96, P3741, DOI 10.1210/jc.2011-0666; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P473, DOI 10.1677/ERC-07-0001; Zuetenhorst JM, 2003, CANCER, V97, P1609, DOI 10.1002/cncr.11226	52	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188876	10.1371/journal.pone.0188876	http://dx.doi.org/10.1371/journal.pone.0188876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232390	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200012
J	Carwardine, D; Prager, J; Neeves, J; Muir, EM; Uney, J; Granger, N; Wong, LF				Carwardine, Darren; Prager, Jonathan; Neeves, Jacob; Muir, Elizabeth M.; Uney, James; Granger, Nicolas; Wong, Liang-Fong			Transplantation of canine olfactory ensheathing cells producing chondroitinase ABC promotes chondroitin sulphate proteoglycan digestion and axonal sprouting following spinal cord injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; FUNCTIONAL RECOVERY; EXTRACELLULAR-MATRIX; CORTICOSPINAL TRACT; FORELIMB FUNCTION; CONTUSION INJURY; REGENERATION; REPAIR; PLASTICITY	Olfactory ensheathing cell (OEC) transplantation is a promising strategy for treating spinal cord injury (SCI), as has been demonstrated in experimental SCI models and naturally occurring SCI in dogs. However, the presence of chondroitin sulphate proteoglycans within the extracellular matrix of the glial scar can inhibit efficient axonal repair and limit the therapeutic potential of OECs. Here we have used lentiviral vectors to genetically modify canine OECs to continuously deliver mammalian chondroitinase ABC at the lesion site in order to degrade the inhibitory chondroitin sulphate proteoglycans in a rodent model of spinal cord injury. We demonstrate that these chondroitinase producing canine OECs survived at 4 weeks following transplantation into the spinal cord lesion and effectively digested chondroitin sulphate proteoglycans at the site of injury. There was evidence of sprouting within the corticospinal tract rostral to the lesion and an increase in the number of corticospinal axons caudal to the lesion, suggestive of axonal regeneration. Our results indicate that delivery of the chondroitinase enzyme can be achieved with the genetically modified OECs to increase axon growth following SCI. The combination of these two promising approaches is a potential strategy for promoting neural regeneration following SCI in veterinary practice and human patients.	[Carwardine, Darren; Prager, Jonathan; Neeves, Jacob; Granger, Nicolas] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Muir, Elizabeth M.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Uney, James; Wong, Liang-Fong] Univ Bristol, Bristol Med Sch, Bristol, Avon, England; [Granger, Nicolas] Royal Vet Coll, Hatfield Hertfordshire & Cave Vet Specialists, West Buckland, Wellington, England	University of Bristol; University of Cambridge; University of Bristol; University of London; University of London Royal Veterinary College	Wong, LF (corresponding author), Univ Bristol, Bristol Med Sch, Bristol, Avon, England.	l.wong@bristol.ac.uk	Carwardine, Darren/ABG-1778-2021	Carwardine, Darren/0000-0002-5207-6619; Wong, Liang-Fong/0000-0003-4348-698X; Prager, Jon/0000-0003-0488-5478; Granger, Nicolas/0000-0002-3036-3908	Elizabeth Blackwell Institute for Health Research (University of Bristol); Wellcome Trust Institutional Strategic Support Fund; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M017532/1]; BBSRC [BB/M017532/1] Funding Source: UKRI	Elizabeth Blackwell Institute for Health Research (University of Bristol); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Elizabeth Blackwell Institute for Health Research (University of Bristol), the Wellcome Trust Institutional Strategic Support Fund (DC, NG), and The Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/M017532/1 (JBU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NATURE REV, V7; Bradbury Elizabeth J, 2012, Exp Neurol, V235, P1, DOI 10.1016/j.expneurol.2012.03.004; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Burnside ER, 2014, NEUROPATH APPL NEURO, V40, P26, DOI 10.1111/nan.12114; Carwardine D, 2016, J NEUROL SCI, V367, P311, DOI 10.1016/j.jns.2016.06.011; Choi D, 2008, NEUROSURGERY, V62, P1140, DOI 10.1227/01.neu.0000325876.90623.df; Choi D, 2015, WORLD NEUROSURG, V83, P251, DOI 10.1016/j.wneu.2013.07.016; Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deng C, 2006, J NEUROSCI RES, V83, P1201, DOI 10.1002/jnr.20817; Dlouhy BJ, 2014, J NEUROSURG-SPINE, V21, P618, DOI 10.3171/2014.5.SPINE13992; Ekberg JAK, 2012, NEUROSIGNALS, V20, P147, DOI 10.1159/000330895; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Franklin Robin J M, 2003, Anat Rec B New Anat, V271, P71, DOI 10.1002/ar.b.10013; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949, DOI 10.1038/79432; Ito D, 2006, AM J VET RES, V67, P1050, DOI 10.2460/ajvr.67.6.1050; James ND, 2015, EXP NEUROL, V271, P131, DOI 10.1016/j.expneurol.2015.05.022; Jefferson SC, 2011, J NEUROSCI, V31, P5710, DOI 10.1523/JNEUROSCI.4459-10.2011; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kachramanoglou C, 2013, NEUROSURGERY, V72, P170, DOI 10.1227/NEU.0b013e31827b99be; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kawahara T, 2010, TRANSPL INT, V23, P934, DOI 10.1111/j.1432-2277.2010.01063.x; Khankan RR, 2016, J NEUROSCI, V36, P6269, DOI 10.1523/JNEUROSCI.0085-16.2016; Kueh JLL, 2011, GLIA, V59, P1658, DOI 10.1002/glia.21213; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/0897715042664867; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 1998, J NEUROSCI, V18, P10514; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2; Moore SA, 2017, J NEUROTRAUM, V34, P2007, DOI 10.1089/neu.2016.4745; Morgan WTJ, 1934, BIOCHEM J, V28, P988, DOI 10.1042/bj0280988; Muir EM, 2010, J BIOTECHNOL, V145, P103, DOI 10.1016/j.jbiotec.2009.11.002; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nash HH, 2002, J NEUROSCI, V22, P7111; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Oprych K, 2017, BRAIN STRUCT FUNCT, V222, P1877, DOI 10.1007/s00429-016-1313-y; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Reginensi D, 2015, CELL MOL LIFE SCI, V72, P2719, DOI 10.1007/s00018-015-1869-3; Roet KCD, 2014, EXP NEUROL, V261, P594, DOI 10.1016/j.expneurol.2014.05.007; Roloff F, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-141; Romero MI, 2000, J NEUROSCI, V20, P4435, DOI 10.1523/JNEUROSCI.20-12-04435.2000; Ruitenberg MJ, 2002, GENE THER, V9, P135, DOI 10.1038/sj.gt.3301626; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Tabakow P, 2013, CELL TRANSPLANT, V22, P1591, DOI 10.3727/096368912X663532; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tester NJ, 2008, EXP NEUROL, V209, P483, DOI 10.1016/j.expneurol.2007.07.019; Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wang Y, 2012, EXP CELL RES, V318, P1889, DOI 10.1016/j.yexcr.2012.05.024; Watzlawick R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002468; Weaver LC, 2006, PROG BRAIN RES, V152, P245, DOI 10.1016/S0079-6123(05)52016-8; Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2	76	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188967	10.1371/journal.pone.0188967	http://dx.doi.org/10.1371/journal.pone.0188967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228020	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600022
J	Smatti, MK; Yassine, HM; AbuOdeh, R; AlMarawani, A; Taleb, SA; Althani, AA; Nasrallah, GK				Smatti, Maria K.; Yassine, Hadi M.; AbuOdeh, Raed; AlMarawani, Asmaa; Taleb, Sara A.; Althani, Asmaa A.; Nasrallah, Gheyath K.			Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; TRANSPLANT RECIPIENTS; HODGKIN LYMPHOMA; INFECTION; DNA; ANTIBODY; IMMUNOCOMPETENT; INDIVIDUALS; ASSOCIATION; SERUM	Background The Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis. EBV is highly prevalent lymphotropic herpesvirus and has been linked to several malignancies. Transmission is generally by oral secretions, but can be through blood transfusions and organ transplantations. This study aimed to determine the seroprevalence, viremia rates, and circulating genotypes of EBV in healthy blood donors in Qatar. Methods Blood samples from 673 blood donors of different nationalities residing in Qatar (mainly Qatar, Egypt, Syria, Jordan, Pakistan, and India) were collected and tested for anti-EBV capsid (VCA; IgG & IgM), nuclear (EBNA; IgG), and early (EA-D; IgG) antigens. Avidity testing was determined when active infection was suspected. DNA was extracted from the buffy coat and subjected to EBV-DNA quantification using qRT-PCR. Genotyping was performed using nested-PCR targeting EBV-EBNA2 gene, and phylogeny by sequence analysis of the LMP-1 gene. Results 97.9% (673/659) of the samples were seropositive as indicated by the presence VCA-IgG, while 52.6% (354/673) had detectible EBV-DNA. EBV seroprevalence and viremia rates increased significantly with age. Genotyping of 51 randomly selected samples showed predominance of Genotype 1 (72.5%, 37/51) as compared to genotype 2 (3.5%), and mixed infections were detected in 4% of the samples. Sub-genotyping for these samples revealed that the Mediterranean strain was predominant (65.3%), followed by B95.8 prototype and North Carolina strains (12.2% each), and China1 strain (6%). Conclusion As a first study to evaluate EBV infection in highly diverse population in Qatar, where expatriates represent more than 85% of the population, our results indicated high seroprevalence and viremia rate of EBV in different nationalities, with genotype 1 and Mediterranean strain being predominant. Clinical significance of these finding have not been investigated and shall be evaluated in future studies.	[Smatti, Maria K.; Yassine, Hadi M.; Althani, Asmaa A.; Nasrallah, Gheyath K.] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Yassine, Hadi M.; Taleb, Sara A.; Althani, Asmaa A.; Nasrallah, Gheyath K.] Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Doha, Qatar; [AbuOdeh, Raed] Univ Sharjah, Dept Med Lab Sci, Coll Hlth Sci, Sharjah, U Arab Emirates; [AlMarawani, Asmaa] Aspetar Orthopaed & Sports Med Hosp, Dept Lab, Doha, Qatar	Qatar University; Qatar University; University of Sharjah; Aspetar Orthopaedic & Sports Medicine Hospital	Nasrallah, GK (corresponding author), Qatar Univ, Biomed Res Ctr, Doha, Qatar.; Nasrallah, GK (corresponding author), Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Doha, Qatar.	gheyath.nasrallah@qu.edu.qa	Nasrallah, Gheyath K/H-7949-2019; YASSINE, HADI M./AAW-6475-2020; AbuOdeh, Raed/GOP-3161-2022; Taleb, Sara/E-6468-2018; Galgiani, John/GLT-7012-2022	YASSINE, HADI M./0000-0001-7592-2788; Taleb, Sara/0000-0003-1795-0064; AbuOdeh, Raed/0000-0001-9123-6956; Smatti, Maria/0000-0002-7621-0130; Nasrallah, Gheyath/0000-0001-9252-1038	UREP from the Qatar National Research Fund (a member of Qatar Foundation) [UREP18-001-3-001]	UREP from the Qatar National Research Fund (a member of Qatar Foundation)	This work was made possible by UREP grant # (UREP18-001-3-001) from the Qatar National Research Fund (a member of Qatar Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to: Ms. Enas Al Absi, Mr. Mohamed El Zowalaty and Mrs. Nadima Ali, and the following students: Mariam Nofal, Rana Al Disi and Soumaya Harche for their technical support. This work was made possible by UREP grant # (UREP18-001-3-001) from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the author(s). This sample collection was approved by the Hamad Medical Center Research Committee (Protocol # 13422/13).	AbuOdeh RO, 2015, J MED VIROL, V87, P2074, DOI 10.1002/jmv.24289; Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Al Moustafa AE, 2016, HUM VACC IMMUNOTHER, V12, P1936, DOI 10.1080/21645515.2016.1139255; Al-Diab AI, 2003, SAUDI MED J, V24, P617; Al-Salam S, 2008, LEUKEMIA LYMPHOMA, V49, P1769, DOI 10.1080/10428190802270894; Alfieri C, 1996, BLOOD, V87, P812, DOI 10.1182/blood.V87.2.812.bloodjournal872812; Audouin Josee, 2010, J Hematop, V3, P11, DOI 10.1007/s12308-010-0059-3; Balfou HH, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.1; Bauer CC, 2005, J MED VIROL, V75, P54, DOI 10.1002/jmv.20237; Bauer G, 2001, Clin Lab, V47, P223; Bel-Air FD, 2014, GULF RES CTR, V2014, P8; Blake SMS, 2001, VIROLOGY, V282, P278, DOI 10.1006/viro.2001.0828; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chan KH, 2001, J CLIN MICROBIOL, V39, P4152, DOI 10.1128/JCM.39.11.4152-4154;2001; Chapman ALN, 1998, ANN ONCOL, V9, P5, DOI 10.1023/A:1008445720368; de Ory F, 2011, CLIN VACCINE IMMUNOL, V18, P444, DOI 10.1128/CVI.00486-10; De Paschale Massimo, 2012, World J Virol, V1, P31, DOI 10.5501/wjv.v1.i1.31; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Dunmire SK, 2015, CURR TOP MICROBIOL, V390, P211, DOI 10.1007/978-3-319-22822-8_9; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Farrell PJ, 2015, CURR TOP MICROBIOL, V390, P45, DOI 10.1007/978-3-319-22822-8_4; GAN YJ, 1994, J INFECT DIS, V170, P436, DOI 10.1093/infdis/170.2.436; Gartner BC, 2003, CLIN DIAGN LAB IMMUN, V10, P78, DOI 10.1128/CDLI.10.1.78-82.2003; Gartzonika C, 2012, MED MICROBIOLOGY DIA; GERBER P, 1969, LANCET, V1, P593; Guerrero-Ramos A, 2014, CLIN VACCINE IMMUNOL, V21, P817, DOI 10.1128/CVI.00754-13; HANTO DW, 1981, CANCER RES, V41, P4253; HENLE W, 1981, CANCER RES, V41, P4222; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; Hjalgrim H, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P929; HOFFMAN GJ, 1980, P NATL ACAD SCI-BIOL, V77, P2979, DOI 10.1073/pnas.77.5.2979; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Kasahara Y, 2002, CRIT REV ONCOL HEMAT, V44, P283, DOI 10.1016/S1040-8428(02)00119-1; Khan G, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-38; Klutts JS, 2009, J CLIN MICROBIOL, V47, P3204, DOI 10.1128/JCM.00164-09; Kondo S, 2004, CANCER SCI, V95, P508, DOI 10.1111/j.1349-7006.2004.tb03241.x; Kwok H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120710; Lazda VA, 2006, TRANSPLANT P, V38, P3404, DOI 10.1016/j.transproceed.2006.10.066; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Loutfy SA, 2006, SAUDI MED J, V27, P1139; MAGRATH IT, 1991, AM J PEDIAT HEMATOL, V13, P222; Makar RR, 2003, PATHOL ONCOL RES, V9, P159, DOI 10.1007/BF03033730; Maurmann S, 2003, J CLIN MICROBIOL, V41, P5419, DOI 10.1128/JCM.41.12.5419-5428.2003; Mendes TM, 2008, BRAZ J INFECT DIS, V12, P186, DOI 10.1590/S1413-86702008000300005; Munz C, 2015, EPSTEIN BARR VIRUS, V1; Niedobitek G, 1992, Diagn Mol Pathol, V1, P103, DOI 10.1097/00019606-199203000-00016; Niesters HGM, 2000, J CLIN MICROBIOL, V38, P712, DOI 10.1128/JCM.38.2.712-715.2000; Nishiwaki M, 2006, J MED VIROL, V78, P1635, DOI 10.1002/jmv.20748; Nystad TW, 2007, J CLIN VIROL, V38, P292, DOI 10.1016/j.jcv.2007.01.006; Polz D, 2014, POL J MICROBIOL, V63, P105; Saechan V, 2006, J CLIN VIROL, V36, P119, DOI 10.1016/j.jcv.2006.01.018; Saechan V, 2010, J GEN VIROL, V91, P2054, DOI 10.1099/vir.0.021105-0; Santpere G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/gbe/evu054; SHIBATA D, 1992, AM J PATHOL, V140, P769; Sousa H, 2011, ACTA MEDICA PORT, V 24, P707; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Suntornlohanakul Rabporn, 2015, Asian Pac J Cancer Prev, V16, P7583; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Traore L, 2014, BMC INFECT DIS S2, V14, P99; Trottier H, 2016, VOX SANG, V110, P199, DOI 10.1111/vox.12330; Trottier H, 2012, TRANSFUSION, V52, P2653, DOI 10.1111/j.1537-2995.2012.03611.x; Tzellos S, 2012, PATHOGENS, V1, P156, DOI 10.3390/pathogens1020156; Vasef MA, 2004, SOUTH MED J, V97, P273, DOI 10.1097/01.SMJ.0000090035.09019.8D; VENKITARAMAN AR, 1985, J MED VIROL, V15, P11, DOI 10.1002/jmv.1890150103; Vilibic-Cavlek T, 2011, ACTA MICROBIOL IMM H, V58, P351, DOI 10.1556/AMicr.58.2011.4.10; Walling DM, 2003, J VIROL, V77, P6546, DOI 10.1128/JVI.77.11.6546-6550.2003; Yakovleva L S, 2015, Mol Biol (Mosk), V49, P800, DOI 10.7868/S0026898415050213; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	72	30	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189033	10.1371/journal.pone.0189033	http://dx.doi.org/10.1371/journal.pone.0189033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228016	Green Submitted, Green Published, gold			2022-12-26	WOS:000417648600029
J	Bini, F; Pica, A; Marinozzi, A; Marinozzi, F				Bini, Fabiano; Pica, Andrada; Marinozzi, Andrea; Marinozzi, Franco			3D diffusion model within the collagen apatite porosity: An insight to the nanostructure of human trabecular bone	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC TOMOGRAPHY; MECHANICAL-PROPERTIES; POROUS-MEDIA; TORTUOSITY; WATER; ORGANIZATION; CRYSTALS; ORIENTATION; FIBRILS; SAMPLES	Bone tissue at nanoscale is a composite mainly made of apatite crystals, collagen molecules and water. This work is aimed to study the diffusion within bone nanostructure through Monte-Carlo simulations. To this purpose, an idealized geometric model of the apatite-collagen structure was developed. Gaussian probability distribution functions were employed to design the orientation of the apatite crystals with respect to the axes (length L, width W and thickness T) of a plate-like trabecula. We performed numerical simulations considering the influence of the mineral arrangement on the effective diffusion coefficient of water. To represent the hindrance of the impermeable apatite crystals on the water diffusion process, the effective diffusion coefficient was scaled with the tortuosity, the constrictivity and the porosity factors of the structure. The diffusion phenomenon was investigated in the three main directions of the single trabecula and the introduction of apatite preferential orientation allowed the creation of an anisotropic medium. Thus, different diffusivities values were observed along the axes of the single trabecula. We found good agreement with previous experimental results computed by means of a genetic algorithm.	[Bini, Fabiano; Pica, Andrada; Marinozzi, Franco] Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy; [Marinozzi, Andrea] Campus Biomed Univ, Orthopedy & Traumatol Area, Rome, Italy	Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Bini, F (corresponding author), Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy.	fabiano.bini@uniroma1.it	Pica, Andrada/GRY-3154-2022	Pica, Andrada/0000-0002-6877-4120	"Sapienza" University of Rome [C26A14FWJL]	"Sapienza" University of Rome	This work was supported by grant from the "Sapienza" University of Rome (Research Program 2014 - C26A14FWJL).	Burger C, 2008, BIOPHYS J, V95, P1985, DOI 10.1529/biophysj.107.128355; Chiavazzo E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4565; Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4; CURRIE JA, 1960, BRIT J APPL PHYS, V11, P314, DOI 10.1088/0508-3443/11/8/302; Danilchenko SN, 2002, CRYST RES TECHNOL, V37, P1234, DOI 10.1002/1521-4079(200211)37:11<1234::AID-CRAT1234>3.0.CO;2-X; Di Tommaso D, 2017, CRYSTALS, V7, DOI 10.3390/cryst7020057; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Georgiadis M, 2015, BONE, V71, P42, DOI 10.1016/j.bone.2014.10.002; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Giannini C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00435; Guo PJ, 2012, TRANSPORT POROUS MED, V95, P285, DOI 10.1007/s11242-012-0043-8; Hambli R, 2012, J THEOR BIOL, V301, P28, DOI 10.1016/j.jtbi.2012.02.007; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; Hong SI, 2009, J MATER SCI-MATER M, V20, P1419, DOI 10.1007/s10856-009-3708-2; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; Jaschouz D, 2003, J APPL CRYSTALLOGR, V36, P494, DOI 10.1107/S0021889803000566; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Lemaire T, 2015, J BIOMECH, V48, P3066, DOI 10.1016/j.jbiomech.2015.07.025; Liebi M, 2015, NATURE, V527, P349, DOI 10.1038/nature16056; Marinozzi F., 2013, EUR CELLS MAT S6, V26, P109; Marinozzi F, 2014, COMPUT METHOD BIOMEC, V10, P1, DOI DOI 10.4161/BI0M.28237; Marinozzi F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/796519; Marinozzi F, 2013, ANN I SUPER SANITA, V49, P300, DOI 10.4415/ANN_13_03_11; Marinozzi F, 2012, ANN I SUPER SANITA, V48, P19, DOI 10.4415/ANN_12_01_04; Marinozzi F, 2011, J BIOMECH, V44, P988, DOI 10.1016/j.jbiomech.2010.11.030; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Rai RK, 2015, J PHYS CHEM B, V119, P201, DOI 10.1021/jp511288g; Reznikov N, 2015, BONE, V71, P189, DOI 10.1016/j.bone.2014.10.017; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Saripalli KP, 2002, GROUND WATER, V40, P346, DOI 10.1111/j.1745-6584.2002.tb02512.x; Seidel R, 2012, BIOINSPIR BIOMIM NAN, V1, P123, DOI 10.1680/bbn.11.00014; Shen L, 2007, CHEM ENG SCI, V62, P3748, DOI 10.1016/j.ces.2007.03.041; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Tong W, 2003, CALCIFIED TISSUE INT, V72, P592, DOI 10.1007/s00223-002-1077-7; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Valdes-Parada FJ, 2011, TRANSPORT POROUS MED, V88, P1, DOI 10.1007/s11242-010-9613-9; VANBRAKEL J, 1974, INT J HEAT MASS TRAN, V17, P1093, DOI 10.1016/0017-9310(74)90190-2; Vercher-Martinez A, 2015, J MECH BEHAV BIOMED, V42, P243, DOI 10.1016/j.jmbbm.2014.11.022; Wang Y, 2013, NAT MATER, V12, P1144, DOI [10.1038/NMAT3787, 10.1038/nmat3787]; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F; Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243; Yun MJ, 2006, CAN J CHEM ENG, V84, P301	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189041	10.1371/journal.pone.0189041	http://dx.doi.org/10.1371/journal.pone.0189041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220377	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900029
J	Clark, R; Kimbrough, SO				Clark, Robin; Kimbrough, Steven O.			Social structure, opportunistic punishment and the evolution of honest signaling	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; CONSEQUENCES; AVERSION	Honest signaling is generally taken to be a necessary pre-condition for a stable signaling system, because deceptive signaling at a high enough rate should cause receivers to ignore the signal, which in turn undermines the utility of sending signals. Deception is normally thought to occur because of benefits it has to the deceiver. This raises the question of why signaling systems should exist and persist over time, especially in cases in which the interests of the senders and receivers are not well aligned. Punishment has been seen as a way of imposing costs on deceptive signalers. We investigate the effects of opportunistic D that is, non-altruistic punishment D on the evolution of an honest signaling system. Our model is based on research done on social insects. We model a society of agents, divided into three castes differing in aggressiveness. Under severe punishment deception is indeed asymptotically eliminated. Under somewhat less severe punishment, deception persists and the rates of deception correlate with social structure. We find that social structure robustly mediates the level of deception under regimes of punishment and that this is evident except in the most stringent of punishment regimes.	[Clark, Robin] Univ Penn, Dept Linguist, Philadelphia, PA 19104 USA; [Kimbrough, Steven O.] Univ Penn, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Clark, R (corresponding author), Univ Penn, Dept Linguist, Philadelphia, PA 19104 USA.; Kimbrough, SO (corresponding author), Univ Penn, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA.	rclark@sas.upenn.edu; kimbrough@wharton.upenn.edu						Ahern C, 2015, THESIS; Ahern C, SEMANTICS P IN PRESS; Austin J., 1975, DO THINGS WORDS; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Clark H.H., 1996, USING LANGUAGE; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gambetta D, 2009, CODES OF THE UNDERWORLD: HOW CRIMINALS COMMUNICATE, P1; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gneezy U, 2013, J ECON BEHAV ORGAN, V93, P293, DOI 10.1016/j.jebo.2013.03.025; Godfrey-Smith P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003282; Granovetter M, 2005, J ECON PERSPECT, V19, P33, DOI 10.1257/0895330053147958; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Harsanyi J.C., 1967, MANAGE SCI, V14, P159, DOI [DOI 10.1287/MNSC.14.3.159, 10.1287/mnsc.14.3.159]; HARSANYI JC, 1968, MANAGE SCI, V14, P486, DOI 10.1287/mnsc.14.7.486; HARSANYI JC, 1968, MANAGE SCI, V14, P320, DOI 10.1287/mnsc.14.5.320; Heim Irene, 1998, SEMANTICS GENERATIVE; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Hobson EA, 2015, PLOS COMPUTATIONAL B, V11, P1; Irlenbusch B, 2013, J ECON BEHAV ORGAN, V93, P321, DOI 10.1016/j.jebo.2013.03.023; Jacobson P., 2014, COMPOSITIONAL SEMANT; Levinson S. C., 1983, PRAGMATICS; Lightle JP, 2013, J ECON BEHAV ORGAN, V93, P347, DOI 10.1016/j.jebo.2013.04.006; Montague R., 1974, FORMAL PHILOS SELECT; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Panasiti MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019465; Parreira BR, 2015, P NATL ACAD SCI USA, V112, pE3318, DOI 10.1073/pnas.1414463112; Pettit M., 2013, SCI DECEPTION PSYCHO; Reich W, 2011, J PRAGMATICS, V43, P1349, DOI 10.1016/j.pragma.2010.10.024; Samuelson L, 2006, REPEATED GAMES REPUT; Santos FC, 2006, PLOS COMPUTATIONAL B, V2, P1; Santos FP, 2016, PLOS COMPUTATIONAL B, V12, P1, DOI DOI 10.1371/J0URNAL.PCBI.1004709; SCOTT-PHILLIPS T., 2014, SPEAKING OUR MINDS W; Scott-Phillips T.C., 2011, LECT NOTES ARTIFICIA, P117; Searcy WA., 2005, EVOLUTION ANIMAL COM; Smith J. Maynard, 2003, OXFORD SERIES ECOLOG; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Thompson D.W., 1943, GROWTH FORM; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Trivers R., 2011, FOLLY FOOLS LOGIC DE; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188249	10.1371/journal.pone.0188249	http://dx.doi.org/10.1371/journal.pone.0188249			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220400	Green Submitted, gold, Green Published			2022-12-26	WOS:000417469900008
J	Wells, G; Palethorpe, S; Pesci, EC				Wells, Greg; Palethorpe, Samantha; Pesci, Everett C.			PsrA controls the synthesis of the Pseudomonas aeruginosa quinolone signal via repression of the FadE homolog, PA0506	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; QUORUM-SENSING SYSTEMS; TRANSCRIPTIONAL REGULATOR; NUTRIENT ACQUISITION; ESCHERICHIA-COLI; FATTY-ACIDS; GENES; EXPRESSION; PATHOGENESIS; OPERON	Pseudomonas aeruginosa is a ubiquitous, Gram-negative opportunistic pathogen that can cause disease in various sites within the human body. This bacterium is a major source of nosocomial infections that are often difficult to treat due to high intrinsic antibiotic resistance and coordinated virulence factor production. P. aeruginosa utilizes three cell-to-cell signaling systems to regulate numerous genes in response to cell density. One of these systems utilizes the small molecule 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas quinolone signal [PQS]) as a signal that acts as a co-inducer for the transcriptional regulator PqsR. Quinolone signaling is required for virulence in multiple infection models, and PQS is produced during human infections, making this system an attractive target for potential drug development. In this study we have examined the role of a TetR-type transcriptional regulator, PsrA, in the regulation of PQS production by P. aeruginosa. Previous studies showed that PsrA regulates genes of the fatty acid beta-oxidation pathway, including PA0506, which encodes a FadE homolog. In this report, we show that deletion of psrA resulted in a large decrease in PQS production and that co-deletion of PA0506 allowed PQS production to be restored to a wild type level. We also found that PQS production could be restored to the psrA mutant by the addition of oleic or octanoic acid. Taken together, our data suggest that psrA positively affects PQS production by repressing the transcription of PA0506, which leads to a decrease in the conversion of acyl-CoA compounds to enoyl-CoA compounds, thereby allowing some octanoyl-CoA to escape the beta-oxidation pathway and serve as a PQS precursor.	[Wells, Greg; Palethorpe, Samantha; Pesci, Everett C.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Pesci, EC (corresponding author), East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	pescie@ecu.edu		Palethorpe, Samantha/0000-0002-3317-6534; Pesci, Everett/0000-0002-7490-7591	National Institute of Allergy and Infectious Disease [R01-AI076272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076272] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institute of Allergy and Infectious Disease grant number R01-AI076272.	Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Cerceo E, 2016, MICROB DRUG RESIST, V22, P412, DOI 10.1089/mdr.2015.0220; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Collier DN, 2002, FEMS MICROBIOL LETT, V215, P41, DOI 10.1111/j.1574-6968.2002.tb11367.x; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; Enderle PJ, 1998, BIOTECHNIQUES, V25, P954, DOI 10.2144/98256bm05; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Farrow JM, 2017, MOL MICROBIOL, V104, P78, DOI 10.1111/mmi.13611; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; Gooderham WJ, 2008, J BACTERIOL, V190, P5624, DOI 10.1128/JB.00594-08; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557; Kang Y, 2009, MOL MICROBIOL, V73, P120, DOI 10.1111/j.1365-2958.2009.06757.x; Knoten CA, 2011, J BACTERIOL, V193, P6567, DOI 10.1128/JB.05803-11; Kojic M, 2005, FEMS MICROBIOL LETT, V246, P175, DOI 10.1016/j.femsle.2005.04.003; LEISINGER T, 1979, MICROBIOL REV, V43, P422, DOI 10.1128/MMBR.43.3.422-442.1979; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Tipton KA, 2013, J BACTERIOL, V195, P3433, DOI 10.1128/JB.00448-13; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Weir TL, 2008, APPL ENVIRON MICROB, V74, P5784, DOI 10.1128/AEM.00860-08; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189331	10.1371/journal.pone.0189331	http://dx.doi.org/10.1371/journal.pone.0189331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220387	Green Submitted, Green Published, gold			2022-12-26	WOS:000417469900049
J	Mikhaylova, VV; Eronina, TB; Chebotareva, NA; Kleymenov, SY; Shubin, VV; Kurganov, BI				Mikhaylova, Valeriya V.; Eronina, Tatiana B.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Shubin, Vladimir V.; Kurganov, Boris I.			A thermal after-effect of UV irradiation of muscle glycogen phosphorylase b	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; DIFFERENTIAL SCANNING CALORIMETRY; RABBIT SKELETAL-MUSCLE; ALPHA-CRYSTALLIN; PROTEIN AGGREGATION; CIRCULAR-DICHROISM; KINETICS; DENATURATION; MECHANISM; INACTIVATION	Different test systems are used to characterize the anti-aggregation efficiency of molecular chaperone proteins and of low-molecular-weight chemical chaperones. Test systems based on aggregation of UV-irradiated protein are of special interest because they allow studying the protective action of different agents at physiological temperatures. The kinetics of UV-irradiated glycogen phosphorylase b (UV-Phb) from rabbit skeletal muscle was studied at 37 degrees C using dynamic light scattering in a wide range of protein concentrations. It has been shown that the order of aggregation with respect to the protein is equal to unity. A conclusion has been made that the rate-limiting stage of the overall process of aggregation is heat-induced structural reorganization of a UV-Phb molecule, which contains concealed damage.	[Mikhaylova, Valeriya V.; Eronina, Tatiana B.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Shubin, Vladimir V.; Kurganov, Boris I.] Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, Fed State Inst, Dept Struct Biochem Prot,Bach Inst Biochem, Moscow, Russia; [Kleymenov, Sergey Yu.] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Mikhaylova, VV; Kurganov, BI (corresponding author), Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, Fed State Inst, Dept Struct Biochem Prot,Bach Inst Biochem, Moscow, Russia.	mikhaylova.inbi@inbox.ru; kurganov@inbi.ras.ru	Mikhaylova, Valeriya/V-1209-2017; Kleymenov, Sergey/R-1195-2018; Kurganov, Boris/M-1286-2019	Mikhaylova, Valeriya/0000-0002-2148-1697; Kleymenov, Sergey/0000-0001-5085-0327; 	Russian Science Foundation of Russian Academy of Sciences [16-14-10055]; Russian Science Foundation [16-14-10055] Funding Source: Russian Science Foundation	Russian Science Foundation of Russian Academy of Sciences; Russian Science Foundation(Russian Science Foundation (RSF))	This work was funded by the Russian Science Foundation (grant number 16-14-10055) of Russian Academy of Sciences (http://grant/rscf.ru/bids/asmaster).Authors who received the fundung: BIK, WM, TBE, NAC.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Amani M, 2011, J CHEM ENG DATA, V56, P1158, DOI 10.1021/je101087j; Bekasova OD, 2013, INT J BIOL MACROMOL, V62, P623, DOI 10.1016/j.ijbiomac.2013.10.010; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chebotareva Natalia A, 2016, Biophys Rev, V8, P397, DOI 10.1007/s12551-016-0220-z; Clark JH, 1935, J GEN PHYSIOL, V19, P199, DOI 10.1085/jgp.19.2.199; Eronina TB, 2016, INT J BIOL MACROMOL, V92, P1252, DOI 10.1016/j.ijbiomac.2016.08.038; Eronina TB, 2009, BIOPHYS CHEM, V141, P66, DOI 10.1016/j.bpc.2008.12.007; Fujii N, 2004, MOL VIS, V10, P814; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Ibarra-Molero B, 2016, METHOD ENZYMOL, V567, P281, DOI 10.1016/bs.mie.2015.08.027; KASTENSCHMIDT LL, 1968, BIOCHEMISTRY-US, V7, P3590, DOI 10.1021/bi00850a037; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Krivandin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P633, DOI 10.1134/S0006297909060078; KURGANOV B. I., 1965, BIOFIZIKA, V10, P875; Kurganov B. I., 2015, BIOCH ANAL BIOCH, V4, pe 155, DOI [10.4172/2161-1009.1000e155, DOI 10.4172/2161-1009.1000E155]; Kurganov B.I., 2002, USP BIOL KHIM, V42, P89; Kurganov B.I., 2005, CHEM BIOL KINETICS N, V2, P251; Kurganov BI, 2000, BIOCHEMISTRY-US, V39, P13144, DOI 10.1021/bi000975w; Kurganov BI, 1997, BIOPHYS CHEM, V69, P125, DOI 10.1016/S0301-4622(97)80552-2; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Kurganov BI, 2017, INT J BIOL MACROMOL, V100, P104, DOI 10.1016/j.ijbiomac.2016.07.066; Laue TM, 1992, ROYAL SOC CHEM, P90; LUZIKOV V. N., 1966, BIOFIZIKA, V11, P701; Lyubarev A.E., 2000, USP BIOL KHIM, V40, P43; Lyubarev AE, 2000, J THERM ANAL CALORIM, V62, P51, DOI 10.1023/A:1010102525964; LYUBAREV AE, 2001, RRD BIOPHYS CHEM, V2, P141; Maloletkina OI, 2012, BIOPHYS CHEM, V163, P11, DOI 10.1016/j.bpc.2012.02.001; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Muranov KO, 2011, EXP EYE RES, V92, P76, DOI 10.1016/j.exer.2010.11.005; Podzimek S, 2011, LIGHT SCATTERING SIZ, DOI DOI 10.1002/9780470877975; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; ROBERTS CJ, 2006, MISBEHAVING PROTEINS, P17; Roman SG, 2012, INT J BIOL MACROMOL, V50, P1341, DOI 10.1016/j.ijbiomac.2012.03.015; Roman SG, 2011, BIOCHEMISTRY-US, V50, P10607, DOI 10.1021/bi201030y; Scientist for Experimental Data Fitting, 1995, MICR WIND VERS 2 0; SETLOW R, 1957, BIOCHIM BIOPHYS ACTA, V24, P27, DOI 10.1016/0006-3002(57)90142-7; SETLOW R, 1954, ARCH BIOCHEM BIOPHYS, V48, P441, DOI 10.1016/0003-9861(54)90361-6; SHARMA Y, 1993, PHOTOCHEM PHOTOBIOL, V57, P739, DOI 10.1111/j.1751-1097.1993.tb02947.x; SUGROBOVA N P, 1982, Biokhimiya, V47, P1883; SUGROBOVA NP, 1983, J BIOCHEM BIOPH METH, V8, P299, DOI 10.1016/0165-022X(83)90004-0; VLADIMIROV YA, 1970, PHOTOCHEM PHOTOBIOL, V11, P227, DOI 10.1111/j.1751-1097.1970.tb05992.x; Wang KY, 2003, BIOPHYS CHEM, V106, P97, DOI 10.1016/S0301-4622(03)00134-0; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189125	10.1371/journal.pone.0189125	http://dx.doi.org/10.1371/journal.pone.0189125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216272	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800077
J	Yang, JB; Zhao, ZB; Liu, QZ; Hu, TD; Long, J; Yan, K; Lian, ZX				Yang, Jing-Bo; Zhao, Zhi-Bin; Liu, Qing-Zhi; Hu, Tai-Dou; Long, Jie; Yan, Kai; Lian, Zhe-Xiong			FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages	ONCOGENE			English	Article							DENDRITIC CELLS; MYELOID CELLS; IN-VIVO; PROGRESSION; CANCER; POLARIZATION; METASTASIS; HYPOXIA; MICE; INVASION	Macrophages are a critical component in host immune responses against tumor. In this work we investigated the role of forkhead box O1 (FoxO1) in the transcriptional regulation in macrophages, which affects the anti-tumor functions of tumor-associated macrophages (TAMs). First, we showed that TAMs expressed reduced levels of FoxO1, which was associated with their protumoral M2 polarization state. The suppression of FoxO1 expression in TAM was induced by the hypoxic condition in the tumor microenviroment. Next, we confirmed that FoxO1 positively regulates MHC-II genes by binding to the promoter region of Ciita gene, the master activator of multiple MHC-II genes. Loss of FoxO1 in TAMs resulted in reduced MHC-II expression. Furthermore, we used FoxO1 conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth. These results demonstrate that the protumoral property of TAMs is induced by the hypoxia-triggered FoxO1 deficiency, which could be a potential target of novel anti-tumor therapies.	[Yang, Jing-Bo; Zhao, Zhi-Bin; Liu, Qing-Zhi; Hu, Tai-Dou; Long, Jie; Yan, Kai; Lian, Zhe-Xiong] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Liver Immunol Lab, Hefei, Anhui, Peoples R China; [Yang, Jing-Bo; Zhao, Zhi-Bin; Liu, Qing-Zhi; Hu, Tai-Dou; Long, Jie; Yan, Kai; Lian, Zhe-Xiong] Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China; [Zhao, Zhi-Bin; Liu, Qing-Zhi; Hu, Tai-Dou; Long, Jie; Yan, Kai; Lian, Zhe-Xiong] South China Univ Technol, Inst Life Sci, Chron Dis Lab, Guangzhou, Guangdong, Peoples R China; [Zhao, Zhi-Bin; Liu, Qing-Zhi; Hu, Tai-Dou; Long, Jie; Yan, Kai; Lian, Zhe-Xiong] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Lian, Zhe-Xiong] Hefei Natl Lab Phys Sci Microscale, Innovat Ctr Cell Signaling Network, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; South China University of Technology; South China University of Technology	Lian, ZX (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Liver Immunol Lab, Hefei, Anhui, Peoples R China.; Lian, ZX (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China.; Lian, ZX (corresponding author), South China Univ Technol, Inst Life Sci, Chron Dis Lab, Guangzhou, Guangdong, Peoples R China.; Lian, ZX (corresponding author), South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China.; Lian, ZX (corresponding author), Hefei Natl Lab Phys Sci Microscale, Innovat Ctr Cell Signaling Network, Hefei, Anhui, Peoples R China.	zxlian1@ustc.edu.cn	Liu, Qing-zhi/B-3140-2019; 刘, 清枝/GLR-7060-2022; Zhao, Zhi-Bin/V-3278-2017	Zhao, Zhi-Bin/0000-0003-0691-2556	National Natural Science Foundation of China [81430034, 91542123]; National Basic Research Program of China under Grant 973 Program [2013CB944900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China under Grant 973 Program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China under Grant 81430034 and 91542123; National Basic Research Program of China under Grant 973 Program-2013CB944900.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chen J, 2014, TUMOR BIOL, V35, P7195, DOI 10.1007/s13277-014-1913-1; Chung S, 2016, ONCOTARGET, V7, P17532, DOI 10.18632/oncotarget.8162; Chung S, 2015, J LEUKOCYTE BIOL, V97, P327, DOI 10.1189/jlb.3A0514-251R; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coates PJ, 2008, CANCER RES, V68, P450, DOI 10.1158/0008-5472.CAN-07-3050; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fukuda Koji, 2012, Front Biosci (Schol Ed), V4, P787; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Jiang GS, 2016, CANCER PREV RES, V9, P567, DOI 10.1158/1940-6207.CAPR-15-0338; Kode A, 2016, LEUKEMIA, V30, P1, DOI 10.1038/leu.2015.161; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Li QS, 2004, CANCER RES, V64, P1130, DOI 10.1158/0008-5472.CAN-03-1715; Lu HR, 2011, NEOPLASIA, V13, P854, DOI 10.1593/neo.11594; Maiese K, 2009, OXID MED CELL LONGEV, V2, P119, DOI 10.4161/oxim.2.3.8916; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Moritoki Y, 2009, GASTROENTEROLOGY, V136, P1037, DOI 10.1053/j.gastro.2008.11.035; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Orsini G, 2013, INT J MOL SCI, V14, P22022, DOI 10.3390/ijms141122022; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pardee AD, 2014, J IMMUNOL, V193, P5723, DOI 10.4049/jimmunol.1400725; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Schartner JM, 2005, GLIA, V51, P279, DOI 10.1002/glia.20201; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Wang BF, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-43; Wang YC, 2016, CLIN REV ALLERG IMMU, V51, P353, DOI 10.1007/s12016-016-8531-1; White JR, 2004, GENOMICS, V83, P1, DOI 10.1016/S0888-7543(03)00215-5; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang YQ, 2016, ONCOTARGET, V7, P26992, DOI 10.18632/oncotarget.8853; Yao Y, 2014, J AUTOIMMUN, V51, P99, DOI 10.1016/j.jaut.2014.02.009; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	49	25	27	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1192	1204		10.1038/s41388-017-0048-4	http://dx.doi.org/10.1038/s41388-017-0048-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29238041				2022-12-26	WOS:000426505400005
J	Bitra, A; Doukov, T; Wang, J; Picarda, G; Benedict, CA; Croft, M; Zajonc, DM				Bitra, Aruna; Doukov, Tzanko; Wang, Jing; Picarda, Gaelle; Benedict, Chris A.; Croft, Michael; Zajonc, Dirk M.			Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; galectin; N-linked glycosylation; protein structure; protein-protein interaction; recombinant protein expression; site-directed mutagenesis; surface plasmon resonance (SPR); tumor necrosis factor (TNF); X-ray crystallography	TNF RECEPTOR-LIGAND; T-CELL RESPONSES; FACTOR-KAPPA-B; DEATH RECEPTORS; SUPERFAMILY; BINDING; MEMBERS; COSTIMULATION; COMPLEX; FAMILY	4-1BB (CD137) is a TNF receptor superfamily (TNFRSF) member that is thought to undergo receptor trimerization upon binding to its trimeric TNF superfamily ligand (4-1BBL) to stimulate immune responses. 4-1BB also can bind to the tandem repeat-type lectin galectin-9 (Gal-9), and signaling through mouse (m)4-1BB is reduced in galectin-9 (Gal-9)-deficient mice, suggesting a pivotal role of Gal-9 in m4-1BB activation. Here, using sulfur-SAD phasing, we determined the crystal structure of m4-1BB to 2.2- resolution. We found that similar to other TNFRSFs, m4-1BB has four cysteine-rich domains (CRDs). However, the organization of CRD1 and the orientation of CRD3 and CRD4 with respect to CRD2 in the m4-1BB structure distinctly differed from those of other TNFRSFs. Moreover, we mapped two Asn residues within CRD4 that are N-linked glycosylated and mediate m4-1BB binding to Gal-9. Kinetics studies of m4-1BB disclosed a very tight nanomolar binding affinity to m4-1BBL with an unexpectedly strong avidity effect. Both N- and C-terminal domains of Gal-9 bound m4-1BB, but with lower affinity compared with m4-1BBL. Although the TNF homology domain (THD) of human (h)4-1BBL forms non-covalent trimers, we found that m4-1BBL formed a covalent dimer via 2 cysteines absent in h4-1BBL. As multimerization and clustering is a prerequisite for TNFR intracellular signaling, and as m4-1BBL can only recruit two m4-1BB monomers, we hypothesize that m4-1BBL and Gal-9 act together to aid aggregation of m4-1BB monomers to efficiently initiate m4-1BB signaling.	[Bitra, Aruna; Wang, Jing; Picarda, Gaelle; Benedict, Chris A.; Croft, Michael; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Doukov, Tzanko] Stanford Synchrotron Radiat Light Source, Menlo Pk, CA 94025 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Dept Internal Med, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 9420 Athena Cir, La Jolla, CA 92037 USA.	dzajonc@lji.org		Doukov, Tzanko/0000-0001-8625-2572; Zajonc, Dirk/0000-0001-7215-1981	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS Grant [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI110929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Lightsource (SSRL) for access to remote data collection and the SSRL beamline scientists for support. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by National Institutes of Health, NIGMS Grant P41GM103393.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bansal-Pakala P, 2002, J IMMUNOL, V169, P5005, DOI 10.4049/jimmunol.169.9.5005; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Eldredge J, 2006, BIOCHEMISTRY-US, V45, P10117, DOI 10.1021/bi060210+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukumori T, 2004, CANCER RES, V64, P3376, DOI 10.1158/0008-5472.CAN-04-0336; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Lang I, 2016, J BIOL CHEM, V291, P5022, DOI 10.1074/jbc.M115.683946; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Loo DT, 1997, J BIOL CHEM, V272, P6448, DOI 10.1074/jbc.272.10.6448; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Mazurek N, 2012, CELL DEATH DIFFER, V19, P523, DOI 10.1038/cdd.2011.123; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Nemcovicova I, 2014, ACTA CRYSTALLOGR D, V70, P851, DOI 10.1107/S1399004713033750; Nemoviova I., 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003224, DOI 10.1371/JOURNAL.PPAT.100322423555243]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Rossmann M. G., 1972, MOL REPLACEMENT METH; Ru H, 2012, ACTA CRYSTALLOGR D, V68, P521, DOI 10.1107/S0907444912004490; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith W, 2013, CELL HOST MICROBE, V13, P324, DOI 10.1016/j.chom.2013.02.003; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Starck L, 2005, EUR J IMMUNOL, V35, P1257, DOI 10.1002/eji.200425686; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P641, DOI 10.1073/pnas.0711206105	59	23	24	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1317	1329		10.1074/jbc.M117.814905	http://dx.doi.org/10.1074/jbc.M117.814905			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242193	hybrid, Green Published			2022-12-26	WOS:000423515000018
J	Aboagye, E; Hagberg, J; Axen, I; Kwak, L; Lohela-Karlsson, M; Skillgate, E; Dahlgren, G; Jensen, I				Aboagye, Emmanuel; Hagberg, Jan; Axen, Iben; Kwak, Lydia; Lohela-Karlsson, Malin; Skillgate, Eva; Dahlgren, Gunilla; Jensen, Irene			Individual preferences for physical exercise as secondary prevention for non-specific low back pain: A discrete choice experiment	PLOS ONE			English	Article							FINANCIAL INCENTIVES; HEALTH; ADULTS; INTERVENTIONS; CARE; DETERMINANTS; TRIAL; YOGA	Background Exercise is effective in improving non-specific low back pain (LBP). Certain components of physical exercise, such as the type, intensity and frequency of exercise, are likely to influence participation among working adults with non-specific LBP, but the value and relative importance of these components remain unknown. The study's aim was to examine such specific components and their influence on individual preferences for exercise for secondary prevention of non-specific LBP among working adults. Methods In a discrete choice experiment, working individuals with non-specific LBP answered a webbased questionnaire. Each respondent was given ten pairs of hypothetical exercise programs and asked to choose one option from each pair. The choices comprised six attributes of exercise (i.e., type of training, design, intensity, frequency, proximity and incentives), each with either three or four levels. A conditional logit regression that reflected the random utility model was used to analyze the responses. Results The final study population consisted of 112 participants. The participants' preferred exercise option was aerobic (i.e., cardiovascular) rather than strength training, group exercise with trainer supervision, rather than individual or unsupervised exercise. They also preferred high intensity exercise performed at least once or twice per week. The most popular types of incentive were exercise during working hours and a wellness allowance rather than coupons for sports goods. The results show that the relative value of some attribute levels differed between young adults (age <= 44 years) and older adults (age <= 45 years) in terms of the level of trainer supervision required, exercise intensity, travel time to exercise location and financial incentives. For active study participants, exercise frequency (i.e., twice per week, 1.15; CI: 0.25; 2.06) influenced choice of exercise. For individuals with more than one child, travel time (i.e., 20 minutes, - 0.55; CI: 0.65; 3.26) was also an influential attribute for choice of exercise, showing that people with children at home preferred to exercise close to home. Conclusions This study adds to our knowledge about what types of exercise working adults with back pain are most likely to participate in. The exercise should be a cardiovascular type of training carried out in a group with trainer supervision. It should also be of high intensity and preferably performed twice per week during working hours. Coupons for sports goods do not appear to motivate physical activity among workers with LBP. The findings of the study could have a substantial impact on the planning and development of exercise provision and promotion strategies to improve non-specific LBP. Providers and employers may be able to improve participation in exercise programs for adults with non-specific LBP by focusing on the exercise components which are the most attractive. This in turn would improve satisfaction and adherence to exercise interventions aimed at preventing recurrent non-specific LBP.	[Aboagye, Emmanuel; Hagberg, Jan; Axen, Iben; Kwak, Lydia; Lohela-Karlsson, Malin; Jensen, Irene] Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Res Worker Hlth, Stockholm, Sweden; [Skillgate, Eva] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Epidemiol, Stockholm, Sweden; [Dahlgren, Gunilla] Umea Univ, Dept Publ Hlth & Clin Med, Unit Occupat & Environm Med, Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University	Aboagye, E (corresponding author), Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Res Worker Hlth, Stockholm, Sweden.	emmanuel.aboagye@ki.se	Axén, Iben/AAC-8638-2020; Aboagye, Emmanuel/K-3269-2019; Jensen, Irene B/B-6012-2012	Axén, Iben/0000-0001-5251-5995; Aboagye, Emmanuel/0000-0001-5709-5387; Jensen, Irene B/0000-0003-1745-866X; Kwak, Lydia/0000-0003-3117-6765; Lohela Karlsson, Malin/0000-0002-9376-846X	AFA Insurance [2013-130153]; Swedish Research Council for Health, Working Life and Welfare (FORTE) [2011-01743]	AFA Insurance; Swedish Research Council for Health, Working Life and Welfare (FORTE)	Financial support was received from AFA Insurance (grant no.: 2013-130153; https://www.afaforsakring.se/andra-sprak/engelska/) and the Swedish Research Council for Health, Working Life and Welfare (FORTE, grant no.: 2011-01743; http://forte.se/en/) to conduct the study. Irene Jensen (IJ) received the financial support. No individual(s) employed or contracted by the funders (other than the named authors) played any role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors' retained independence in designing the study, interpreting the data, writing, and publishing the report.	Aboagye E, 2017, PAIN THER, V6, P85, DOI 10.1007/s40122-017-0067-4; Aboagye E, 2015, J REHABIL MED, V47, P167, DOI 10.2340/16501977-1910; Adamson SJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1864; Axen I, 2013, BEST PRACT RES CL RH, V27, P601, DOI 10.1016/j.berh.2013.10.004; Babcock P, 2015, J EUR ECON ASSOC, V13, P841, DOI 10.1111/jeea.12131; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Bernhardsson S, 2015, J EVAL CLIN PRACT, V21, P1169, DOI 10.1111/jep.12380; Chuang LH, 2012, SPINE, V37, P1593, DOI 10.1097/BRS.0b013e3182545937; Coggon D, 2013, OCCUP ENVIRON MED, V70, P575, DOI 10.1136/oemed-2012-101316; de Bekker-Grob EW, 2015, PATIENT, V8, P373, DOI 10.1007/s40271-015-0118-z; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Ekkekakis P, 2005, J SPORT EXERCISE PSY, V27, P350, DOI 10.1123/jsep.27.3.350; Finkelstein EA, 2008, PREV MED, V47, P182, DOI 10.1016/j.ypmed.2008.05.002; Franco MR, 2015, J PHYSIOTHER, V61, P34, DOI 10.1016/j.jphys.2014.11.001; George SZ, 2010, J PAIN, V11, P1074, DOI 10.1016/j.jpain.2010.02.016; Giles EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157403; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hainmueller J, 2014, POLIT ANAL, V22, P1, DOI 10.1093/pan/mpt024; Hauber AB, 2016, VALUE HEALTH, V19, P300, DOI 10.1016/j.jval.2016.04.004; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Jordan JL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005956.pub2; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Louviere JJ, 2009, HEALTH ECON POLICY L, V4, P527, DOI 10.1017/S1744133109990193; Marcus B H, 1992, Am J Health Promot, V6, P424; Marshall D, 2010, PATIENT, V3, P249, DOI 10.2165/11539650-000000000-00000; Mitchell MS, 2013, AM J PREV MED, V45, P658, DOI 10.1016/j.amepre.2013.06.017; Orme B.K., 2006, GETTING STARTED CONJ; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ryan Mandy, 2003, Appl Health Econ Health Policy, V2, P55; Sackett D., 2002, EVIDENCE BASED MED P; Scheers T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-136; Smith E, 2014, ANN RHEUM DIS, V73, P1462, DOI 10.1136/annrheumdis-2013-204680; Steffens D, 2016, JAMA INTERN MED, V176, P199, DOI 10.1001/jamainternmed.2015.7431; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Sutin AR, 2016, J RES PERS, V63, P22, DOI 10.1016/j.jrp.2016.05.001; Tveito TH, 2004, OCCUP MED-OXFORD, V54, P3, DOI 10.1093/occmed/kqg109; Von Korff M, 1990, PAIN, V279, P91, DOI DOI 10.1016/0304-3959(90)91125-3; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x	46	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0187709	10.1371/journal.pone.0187709	http://dx.doi.org/10.1371/journal.pone.0187709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244841	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700002
J	Avila-Martin, G; Mata-Roig, M; Galan-Arriero, I; Taylor, JS; Busquets, X; Escriba, PV				Avila-Martin, Gerardo; Mata-Roig, Manuel; Galan-Arriero, Iriana; Taylor, Julian S.; Busquets, Xavier; Escriba, Pablo V.			Treatment with albumin-hydroxyoleic acid complex restores sensorimotor function in rats with spinal cord injury: Efficacy and gene expression regulation	PLOS ONE			English	Article							2-HYDROXYOLEIC ACID; MEMBRANE-STRUCTURE; UP-REGULATION; FATTY-ACIDS; PAIN; SPASTICITY; REFLEX; HYPERSENSITIVITY; INFLAMMATION; REGENERATION	Sensorimotor dysfunction following incomplete spinal cord injury (SCI) is often characterized by paralysis, spasticity and pain. Previously, we showed that intrathecal (i.t.) administration of the albumin-oleic acid (A-OA) complex in rats with SCI produced partial improvement of these symptoms and that oral 2-hydroxyoleic acid (HOA, a non-hydrolyzable OA analogue), was efficacious in the modulation and treatment of nociception and pain-related anxiety, respectively. Here we observed that intrathecal treatment with the complex albumin-HOA (A-HOA) every 3 days following T9 spinal contusion injury improved locomotor function assessed with the Rotarod and inhibited TA noxious reflex activity in Wistar rats. To investigate the mechanism of action of A-HOA, microarray analysis was carried out in the spinal cord lesion area. Representative genes involved in pain and neuroregeneration were selected to validate the changes observed in the microarray analysis by quantitative real-time RT-PCR. Comparison of the expression between healthy rats, SCI rats, and SCI treated with A-HOA rats revealed relevant changes in the expression of genes associated with neuronal morphogenesis and growth, neuronal survival, pain and inflammation. Thus, treatment with A-HOA not only induced a significant overexpression of growth and differentiation factor 10 (GDF10), tenascin C (TNC), aspirin (ASPN) and sushi-repeat-containing X-linked 2 (SRPX2), but also a significant reduction in the expression of prostaglandin E synthase (PTGES) and phospholipases A1 and A2 (PLA1/2). Currently, SCI has very important unmet clinical needs. A-HOA down-regulated genes involved with inflammation and upregulated genes involved in neuronal growth, and may serve to promote recovery of function after experimental SCI.	[Avila-Martin, Gerardo; Galan-Arriero, Iriana; Taylor, Julian S.] Hosp Nacl Paraplej, Toledo, Spain; [Mata-Roig, Manuel] Univ Valencia, Dept Pathol, Valencia, Spain; [Taylor, Julian S.] NHS, Buckinghamshire Healthcare Trust, Natl Spinal Injuries Ctr, Stoke Mandeville Spinal Res, Aylesbury, Bucks, England; [Taylor, Julian S.] Univ Oxford, Harris Manchester Coll, Oxford, England; [Busquets, Xavier; Escriba, Pablo V.] Univ Balear Isl, Lab Mol Cell Biomed, Palma De Mallorca, Spain	Hospital Nacional de Paraplejicos; University of Valencia; University of Oxford; Universitat de les Illes Balears	Avila-Martin, G (corresponding author), Hosp Nacl Paraplej, Toledo, Spain.	gavila@sescam.jccm.es	Arriero, Iriana Galan/S-2050-2019; Roig, Manuel Mata/G-4338-2015; Morcillo, Esteban/I-1552-2015; Busquets, Xavier/M-5574-2018; Taylor, Julian/AAC-2802-2021	Arriero, Iriana Galan/0000-0002-3291-1963; Roig, Manuel Mata/0000-0002-1506-7983; Morcillo, Esteban/0000-0003-4373-9457; Busquets, Xavier/0000-0003-1157-5590; Taylor, Julian/0000-0003-2553-2348; Avila Martin, Gerardo/0000-0001-8982-7634; Escriba, Pablo/0000-0001-9795-182X	Mutua Madrilena Foundation; Spanish Ministry for Science and Innovation [IPT-010000-2010-016]; Spanish Ministry for Economy and Competition [BIO2010-21132, BIO2013-49006-C2-1-R, RTC-2015-3542, RTC-2015-4094]; European Union FEDER funds; Govern de les Illes Balears Research Grants for Groups of Excellence; Marathon Foundation	Mutua Madrilena Foundation; Spanish Ministry for Science and Innovation(Spanish Government); Spanish Ministry for Economy and Competition; European Union FEDER funds(European Commission); Govern de les Illes Balears Research Grants for Groups of Excellence; Marathon Foundation	This study was financed from several sources including: Mutua Madrilena Foundation (2010 and 2013) and Spanish Ministry for Science and Innovation (IPT-010000-2010-016) with co-financial support from European Union FEDER funds to Dr. Taylor and Dr. Avila-Martin. Spanish Ministry for Economy and Competition (BIO2010-21132, BIO2013-49006-C2-1-R, RTC-2015-3542, RTC-2015-4094), Govern de les Illes Balears Research Grants for Groups of Excellence and Marathon Foundation project awarded to Dr. Pablo V. Escriba.	Alemany R, 2004, HYPERTENSION, V43, P249, DOI 10.1161/01.HYP.0000107778.85528.b5; Alemany R, 2006, J LIPID RES, V47, P1762, DOI 10.1194/jlr.M500520-JLR200; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Arlt O, 2014, CELL PHYSIOL BIOCHEM, V34, P27, DOI 10.1159/000362982; Avila-Martin G, 2015, EUR J PAIN, V19, P111, DOI 10.1002/ejp.528; Avila-Martin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026107; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bollaerts I, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9478542; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bravo-Esteban E, 2013, NEUROREHABILITATION, V33, P531, DOI 10.3233/NRE-131000; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Dangaria SJ, 2011, STEM CELLS DEV, V20, P39, DOI 10.1089/scd.2010.0180; David S, 2015, NEUROSCIENCE, V307, P311, DOI 10.1016/j.neuroscience.2015.08.064; Dietz V, 2009, BRAIN, V132, P2196, DOI 10.1093/brain/awp124; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Echeverry S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-16; Escriba PV, 2015, PROG LIPID RES, V59, P38, DOI 10.1016/j.plipres.2015.04.003; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; ESCRIBA PV, 1990, BIOCHEMISTRY-US, V29, P7275, DOI 10.1021/bi00483a017; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; Finnerup NB, 2007, EXP NEUROL, V207, P139, DOI 10.1016/j.expneurol.2007.06.001; Finnerup NB, 2004, EUR J NEUROL, V11, P73, DOI 10.1046/j.1351-5101.2003.00725.x; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Funari SS, 2003, J LIPID RES, V44, P567, DOI 10.1194/jlr.M200356-JLR200; Gao ZY, 2015, INT J CLIN EXP PATHO, V8, P4791; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Gomez-Soriano J, 2016, SPINAL CORD, V54, P687, DOI 10.1038/sc.2016.9; Gomez-Soriano J, 2012, SPINAL CORD, V50, P711, DOI 10.1038/sc.2012.69; Gomez-Soriano J, 2010, BRIT J PHARMACOL, V161, P972, DOI 10.1111/j.1476-5381.2010.00964.x; Gris P, 2009, J NEUROIMMUNOL, V209, P104, DOI 10.1016/j.jneuroim.2009.02.002; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hefferan MP, 2007, J NEUROSCI, V27, P11179, DOI 10.1523/JNEUROSCI.0989-07.2007; Hino J, 2012, INT J OBESITY, V36, P725, DOI 10.1038/ijo.2011.124; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Ibarguren M, 2014, BBA-BIOMEMBRANES, V1838, P1518, DOI 10.1016/j.bbamem.2013.12.021; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Jasmin L, 2001, J NEUROSCI METH, V110, P81, DOI 10.1016/S0165-0270(01)00420-4; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kuge H, 2014, J BIOL CHEM, V289, P26783, DOI 10.1074/jbc.M114.571075; Kulinski JM, 2016, EUR J PHARMACOL, V778, P56, DOI 10.1016/j.ejphar.2015.02.058; Kunori S, 2011, GLIA, V59, P208, DOI 10.1002/glia.21090; Kwon BK, 2011, J NEUROTRAUM, V28, P1589, DOI 10.1089/neu.2009.1150; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li S, 2015, NAT NEUROSCI, V18, P1737, DOI 10.1038/nn.4146; Liu N, 2004, J NEUROSCI RES, V77, P391, DOI 10.1002/jnr.20167; Liu NK, 2011, TRANSL STROKE RES, V2, P608, DOI 10.1007/s12975-011-0089-x; Mabuchi T, 2004, NEUROREPORT, V15, P1395, DOI 10.1097/01.wnr.0000129372.89000.31; Mandrekar-Colucci S, 2013, ASN NEURO, V5, DOI 10.1042/AN20130030; Martinez J, 2005, MOL PHARMACOL, V67, P531, DOI 10.1124/mol.104.000778; Mata M, 2003, EUR RESPIR J, V22, P900, DOI 10.1183/09031936.03.00018003; Mata M, 2012, FREE RADICAL RES, V46, P690, DOI 10.3109/10715762.2012.669040; Miljkovic-Licina M, 2009, FASEB J, V23, P4105, DOI 10.1096/fj.09-135202; MINAMI T, 1994, BRIT J PHARMACOL, V112, P735, DOI 10.1111/j.1476-5381.1994.tb13139.x; Minami T, 1999, EUR J NEUROSCI, V11, P1849, DOI 10.1046/j.1460-9568.1999.00602.x; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; Nishimura S, 2014, EXP NEUROL, V261, P171, DOI 10.1016/j.expneurol.2014.05.021; Oskeritzian CA, 2015, MOL IMMUNOL, V63, P104, DOI 10.1016/j.molimm.2014.03.018; Rank MM, 2011, J NEUROPHYSIOL, V105, P410, DOI 10.1152/jn.00775.2010; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; SANDLER AN, 1976, BRAIN RES, V118, P181, DOI 10.1016/0006-8993(76)90707-1; Santiago JM, 2009, J NEUROTRAUM, V26, P1783, DOI 10.1089/neu.2007.0502; Sarrion I, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/792846; Schreiber J, 2013, ACTA HISTOCHEM, V115, P865, DOI 10.1016/j.acthis.2013.04.009; Siddall PJ, 2006, SPINAL CORD, V44, P67, DOI 10.1038/sj.sc.3101824; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Spalice A, 2009, ACTA PAEDIATR, V98, P421, DOI 10.1111/j.1651-2227.2008.01160.x; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Svensson CI, 2005, NEUROSCIENCE, V133, P543, DOI 10.1016/j.neuroscience.2005.01.024; Taylor J, 2012, PAIN MED, V13, P1457, DOI 10.1111/j.1526-4637.2012.01483.x; Torres-Espin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076141; Vogler O, 2008, INT J OBESITY, V32, P464, DOI 10.1038/sj.ijo.0803768; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; Yang Q, 2005, MOL PHARMACOL, V68, P210, DOI 10.1124/mol.105.011692; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6; Young W, 2002, PROG BRAIN RES, V137, P231	89	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189151	10.1371/journal.pone.0189151	http://dx.doi.org/10.1371/journal.pone.0189151			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244816	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700018
J	De San Eustaquio-Campillo, A; Cornilleau, C; Guerin, C; Carballido-Lopez, R; Chastanet, A				De San Eustaquio-Campillo, Alba; Cornilleau, Charlene; Guerin, Cyprien; Carballido-Lopez, Rut; Chastanet, Arnaud			PamR, a new MarR-like regulator affecting prophages and metabolic genes expression in Bacillus subtilis	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; STATIONARY-PHASE; MOLECULAR-MECHANISMS; BIOFILM FORMATION; STRESS-RESPONSE; CELL-CYCLE; SPORULATION; TRANSITION; INDUCTION; SEQUENCE	B. subtilis adapts to changing environments by reprogramming its genetic expression through a variety of transcriptional regulators from the global transition state regulators that allow a complete resetting of the cell genetic expression, to stress specific regulators controlling only a limited number of key genes required for optimal adaptation. Among them, MarR-type transcriptional regulators are known to respond to a variety of stresses including antibiotics or oxidative stress, and to control catabolic or virulence gene expression. Here we report the characterization of the ydcFGH operon of B. subtilis, containing a putative MarR-type transcriptional regulator. Using a combination of molecular genetics and high-throughput approaches, we show that this regulator, renamed PamR, controls directly its own expression and influence the expression of large sets of prophage-related and metabolic genes. The extent of the regulon impacted by PamR suggests that this regulator reprograms the metabolic landscape of B. subtilis in response to a yet unknown signal.	[De San Eustaquio-Campillo, Alba; Cornilleau, Charlene; Carballido-Lopez, Rut; Chastanet, Arnaud] Univ Paris Saclay, MICALIS, INRA, AgroParisTech, Jouy En Josas, France; [Guerin, Cyprien] Univ Paris Saclay, MaIAGE, INRA, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chastanet, A (corresponding author), Univ Paris Saclay, MICALIS, INRA, AgroParisTech, Jouy En Josas, France.	arnaud.chastanet@inra.fr	LOPEZ, RUT CARBALLIDO/G-2283-2015	LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; CHASTANET, Arnaud/0000-0003-0320-4861; Guerin, Cyprien/0000-0001-6102-7002	European Research Council [ERC-StG 311231]; Marie Curie IRG grant from the European Commission [IRG-249018]; French "Ministere de l'enseignement superieur et de la recherche"	European Research Council(European Research Council (ERC)European Commission); Marie Curie IRG grant from the European Commission; French "Ministere de l'enseignement superieur et de la recherche"	This work was supported by a starting grant from the European Research Council (ERC-StG 311231) to R.C.-L. and a Marie Curie IRG grant from the European Commission (IRG-249018) to A.C. A.D.S.E.C. was the recipient of a fellowship from the French "Ministere de lenseignement superieur et de la recherche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auchtung JM, 2007, MOL MICROBIOL, V64, P1515, DOI 10.1111/j.1365-2958.2007.05748.x; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Bertonati C, 2009, PROTEINS, V75, P760, DOI 10.1002/prot.22287; Billaudeau C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15370; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Chastanet A, 2010, P NATL ACAD SCI USA, V107, P8486, DOI 10.1073/pnas.1002499107; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Chumsakul O, 2011, NUCLEIC ACIDS RES, V39, P414, DOI 10.1093/nar/gkq780; Dominguez-Cuevas P, 2012, MOL MICROBIOL, V83, P52, DOI 10.1111/j.1365-2958.2011.07920.x; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Grove A, 2013, CURR BIOL, V23, pR142, DOI 10.1016/j.cub.2013.01.013; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Harwood CR, 1990, MOL BIOL METHODS BAC, DOI [10.1093/bib/bbs012, DOI 10.1093/BIB/BBS012]; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Imamovic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032393; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Kumarevel T, 2012, ANTIBIOTIC RESISTANT BACTERIA - A CONTINUOUS CHALLENGE IN THE NEW MILLENNIUM, P403; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lazarevic V, 1999, MICROBIOL-UK, V145, P1055, DOI 10.1099/13500872-145-5-1055; Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006; MARTINVERSTRAETE I, 1990, J MOL BIOL, V214, P657, DOI 10.1016/0022-2836(90)90284-S; MCDONNELL GE, 1994, J BACTERIOL, V176, P5820, DOI 10.1128/JB.176.18.5820-5830.1994; Mielich-Suss B, 2015, ENVIRON MICROBIOL, V17, P555, DOI 10.1111/1462-2920.12527; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Nanda AM, 2015, J BACTERIOL, V197, P410, DOI 10.1128/JB.02230-14; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schirner K, 2009, J BACTERIOL, V191, P1404, DOI 10.1128/JB.01497-08; Shafikhani SH, 2004, FEMS MICROBIOL LETT, V231, P99, DOI 10.1016/S0378-1097(03)00936-4; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; STRAUCH MA, 1993, MOL MICROBIOL, V7, P337, DOI 10.1111/j.1365-2958.1993.tb01125.x; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Wang XD, 2014, P NATL ACAD SCI USA, V111, P12877, DOI 10.1073/pnas.1407461111; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189694	10.1371/journal.pone.0189694	http://dx.doi.org/10.1371/journal.pone.0189694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240826	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600064
J	Barragan-Barrera, DC; May-Collado, LJ; Tezanos-Pinto, G; Islas-Villanueva, V; Correa-Cardenas, CA; Caballero, S				Barragan-Barrera, Dalia C.; May-Collado, Laura J.; Tezanos-Pinto, Gabriela; Islas-Villanueva, Valentina; Correa-Cardenas, Camilo A.; Caballero, Susana			High genetic structure and low mitochondrial diversity in bottlenose dolphins of the Archipelago of Bocas del Toro, Panama: A population at risk?	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; TOUR BOATS; MICROSATELLITE MARKERS; CONTROL REGION; DNA; CONSERVATION; GENUS; SIZE; DIFFERENTIATION; SOFTWARE	The current conservation status of the bottlenose dolphin (Tursiops truncatus) under the IUCN is 'least concern'. However, in the Caribbean, small and localized populations of the 'inshore form' may be at higher risk of extinction than the 'worldwide distributed form' due to a combination of factors including small population size, high site fidelity, genetic isolation, and range overlap with human activities. Here, we study the population genetic structure of bottlenose dolphins from the Archipelago of Bocas del Toro in Panama. This is a small population characterized by high site fidelity and is currently heavily-impacted by the local dolphin- watching industry. We collected skin tissue samples from 25 dolphins to study the genetic diversity and structure of this population. We amplified a portion of the mitochondrial Control Region (mtDNA-CR) and nine microsatellite loci. The mtDNA-CR analyses revealed that dolphins in Bocas del Toro belong to the 'inshore form', grouped with the BahamasColombia- Cuba-Mexico population unit. They also possess a unique haplotype new for the Caribbean. The microsatellite data indicated that the Bocas del Toro dolphin population is highly structured, likely due to restricted movement patterns. Previous abundance estimates obtained with mark-recapture methods reported a small population of 80 dolphins (95% CI = 72-87), which is similar to the contemporary effective population size estimated in this study (Ne = 73 individuals; CI = 18.0 - infinity; 0.05). The combination of small population size, high degree of genetic isolation, and intense daily interactions with dolphin-watching boats puts the Bocas del Toro dolphin to at high risk of extinction. Despite national guidelines to regulate the dolphin-watching industry in Bocas del Toro and ongoing educational programs for tour operators, only in 2012 seven animals have died due to boat collisions. Our results suggest that the conservation status of bottlenose dolphins in Bocas del Toro should be elevated to 'endangered' at the national level, as a precautionary measure while population and viability estimates are conducted.	[Barragan-Barrera, Dalia C.; Caballero, Susana] Univ Los Andes, Dept Ciencias Biol, LEMVA, Lab J 202, Bogota, Colombia; [Barragan-Barrera, Dalia C.] Fdn Macuat Colombia, Medellin, Colombia; [May-Collado, Laura J.] Univ Vermont, Dept Biol, Burlington, VT USA; [May-Collado, Laura J.] Univ Costa Rica, Ctr Invest Mar & Limnol, San Jose, Costa Rica; [Tezanos-Pinto, Gabriela] Massey Univ, INMS, Coastal Marine Res Grp, Auckland, New Zealand; [Islas-Villanueva, Valentina] Univ Mar, Inst Genet, CONACYT, Ciudad Univ, Dist De San Pedro Pochut, Oaxaca, Mexico; [Correa-Cardenas, Camilo A.] Univ Cent, Dept Ciencias Nat, Fac Ingn & Ciencias Basicas, Bogota, Colombia; [Correa-Cardenas, Camilo A.] Univ La Salle, Dept Ciencias Basicas, Bogota, Colombia	Universidad de los Andes (Colombia); University of Vermont; Universidad Costa Rica; Massey University; Universidad de La Salle	Barragan-Barrera, DC (corresponding author), Univ Los Andes, Dept Ciencias Biol, LEMVA, Lab J 202, Bogota, Colombia.; Barragan-Barrera, DC (corresponding author), Fdn Macuat Colombia, Medellin, Colombia.	dc.barragan140@uniandes.edu.co	Islas-Villanueva, Valentina/AAX-4413-2020; Correa-Cárdenas, Camilo A/ABF-1490-2020; Barragán-Barrera, Dalia C./ABA-2913-2020	Correa-Cárdenas, Camilo A/0000-0001-5009-6213; Barragán-Barrera, Dalia C./0000-0003-4023-9908	Society for Marine Mammalogy; Sciences Faculty of Universidad de los Andes [2012-1]; Rufford Foundation; Universidad de los Andes;  [SC/A-11-12];  [SC/A-43-12];  [SC/A-17-14]	Society for Marine Mammalogy; Sciences Faculty of Universidad de los Andes; Rufford Foundation; Universidad de los Andes; ; ; 	This work was supported by the Society for Marine Mammalogy provided a Small-in-Aid Research grant by US$1000; The Sciences Faculty of Universidad de los Andes provided a Research Grant Proyecto Semilla in the 2012-1 Call for Funding of Research Category: Master and Doctoral students, project Genetic structure and diversity of bottlenose dolphins Tursiops truncatus (Montagu, 1821) (Cetacea: Delphinidae) in Bocas del Toro, Caribbean Coast of Panama. They provide COP$ 3213.600 (similar to US$1700) and the Rufford Small Grant Foundation provided two grants for this research: the Rufford Small Grant by sic6000, and the Second Rufford Small Grant by sic6000. Funds for this study were generously provided by the Rufford Foundation, Society for Marine Mammalogy, and Universidad de los Andes (Sciences Faculty) to DCBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the STRI Marine Biological Station and Panacetacea for their logistical support. We want to thank to Gabriel Jacome, Rachel Collin, Plinio Gondola, Marlon Smith, Arcadio Castillo, Urania Gonzalez, Gilberto Murray, Deyvis Gonzalez, Zurenayka Alain, and Orelis Arosemena at the STRI Bocas del Toro Research Station. Special thanks to boat captains Demetrio Georget, Arnulfo Record, and Christian Harris for their support on the small-scale surveys out of Bocas del Toro. We also thank to several people that assisted in the field: Shakira Quinones-LebrOn, Monica Gamboa-Poveda, Monica Acosta, Ayshah Kassamali-Fox, Betzi Perez, Jose Julio Casas, Lissette Trejos, Joel Sanchez, Whitney Kwiers, Evelin Mosquera, Roberto Santamaria, Andrea Luna, Maria Paula Hernandez, Julie Tomczyk, Giselle Veve, Cole Tanner, and Ashley Sitar. Special thanks to Gerriet Janssen and Kathleen Ann Sheridan for their comments that improved the writing of manuscript. We thank to Federico Riet-Sapriza for his support preparing the maps, and Leidy Rache-Cardenal for her support analyzing microsatellite data. We would like to thank the anonymous reviewers for their valuable comments that contributed to improving the final version of the manuscript. This project was carried out with permission from the Autoridad Nacional del Ambiente Panama (ANAM; permits SC/A-11-12, SC/A-43-12, SC/A-17-14).	Allen SJ, 2016, MOL ECOL, V25, P2735, DOI 10.1111/mec.13622; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; AMOS B, 1991, P99; Anonymous, 2013, Journal of Cetacean Research and Management, V14, P1; Anonymous, 2015, Journal of Cetacean Research and Management, V16, P1; [Anonymous], 2007, THESIS; [Anonymous], 2004, ECOL SOC; Baird RW, 2009, MAR MAMMAL SCI, V25, P251, DOI 10.1111/j.1748-7692.2008.00257.x; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Barragan-Barrera DC, 2015, INT WHAL COMM; Barragan-Barrera DC, 2013, INT WHAL COMM; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2012, IUCN RED LIST THREAT, V2012, DOI DOI 10.2305/1UCN.UK.2012-1.RLTS.T16674437A16674052.EN; Bearzi G, 2009, MAMMAL REV, V39, P92, DOI 10.1111/j.1365-2907.2008.00133.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BEERLI P, 2003, MIGRATE MAXIMUM LIKE; Birkun A, 2012, IUCN RED LIST THREAT, V2012; Caballero S, 2012, ANIM CONSERV, V15, P95, DOI 10.1111/j.1469-1795.2011.00493.x; Caley MJ, 2001, ECOLOGY, V82, P3435, DOI 10.2307/2680163; Castilho CS, 2015, GENET MOL RES, V14, P3387, DOI 10.4238/2015.April.15.2; Connor RC, 2000, CETACEAN SOCIETIES, P91; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Cowen Robert K., 2002, P149, DOI 10.1016/B978-012615185-5/50010-4; Culik BM, 2004, MARINE MAMMAL ACTION, V177, P315; Currey RJC, 2011, IUCN RED LIST THREAT, V2011; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; D'Croz L, 2005, CARIBB J SCI, V41, P414; D'Croz L, 2007, ECOLOGIA EVOLUCION T, P309; Do Amaral KB, 2016, J MAMMAL EVOL; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Donovan Greg, 2016, Journal of Cetacean Research and Management, V17, P1; Drummond A.J., 2009, GENEIOUS PRO V4 8 5; DUFFIELD DA, 1983, CAN J ZOOL, V61, P930, DOI 10.1139/z83-123; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez R, 2011, HYDROBIOLOGIA, V670, P111, DOI 10.1007/s10750-011-0669-5; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Franklin IR, 1998, CONSERVATION BIOL EV, P135; Fruet Pedro F., 2016, Latin American Journal of Aquatic Mammals, V11, P121; Fruet PF, 2014, CONSERV GENET, V15, P879, DOI 10.1007/s10592-014-0586-z; Gilson A, 1998, CALIF FISH GAME, V84, P159; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hammond PS, 2012, IUCN RED LIST THREAT, V2012; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, P ROY SOC B-BIOL SCI, V265, P1177, DOI 10.1098/rspb.1998.0416; Jimenez PJ, 2013, LAT AM J AQUAT MAMM, V10, P33; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kopps AM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3245; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Krutzen M, 2004, MAR MAMMAL SCI, V20, P28, DOI 10.1111/j.1748-7692.2004.tb01139.x; Lebron SG, 2014, INT WHAL COMM; Lebron SG, 2015, INT WHAL COMM; Lopes PC, 1998, REV BRAS ZOOL, V15, P709; Lowther-Thieleking JL, 2015, MAR MAMMAL SCI, V31, P1, DOI 10.1111/mms.12135; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Martien KK, 2012, MAR MAMMAL SCI, V28, pE208, DOI 10.1111/j.1748-7692.2011.00506.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; May-Collado LJ, 2008, J MAMMAL, V89, P1229, DOI 10.1644/07-MAMM-A-310.1; May-Collado LJ, 2014, J ACOUST SOC AM, V135, pEL193, DOI 10.1121/1.4869255; May-Collado LJ, 2015, INT WHAL COMM; May-Collado LJ, 2012, INT WHAL COMM; Mirimin L, 2011, ANIM CONSERV, V14, P342, DOI 10.1111/j.1469-1795.2010.00432.x; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Moura AE, 2013, SYST BIOL, V62, P865, DOI 10.1093/sysbio/syt051; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; Oliveira Larissa R., 2016, Latin American Journal of Aquatic Mammals, V11, P162; Ott PH, 2009, ILHAS OCEANICAS BRAS, P283; Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x; Parsons KM, 2002, BIOL CONSERV, V108, P175, DOI 10.1016/S0006-3207(02)00103-9; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Rizzo Ester, 2011, Latin American Journal of Aquatic Mammals, V9, P179; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards VP, 2013, J HERED, V104, P765, DOI 10.1093/jhered/est070; Riet-Sapriza F, 17 WORK M EXP MAR MA; Rooney AP, 1999, J HERED, V90, P228, DOI 10.1093/jhered/90.1.228; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Segura I, 2006, BIOL CONSERV, V133, P336, DOI 10.1016/j.biocon.2006.06.017; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Silva MA, 2008, MAR BIOL, V156, P179, DOI 10.1007/s00227-008-1075-z; Sitar A, 2016, MAR POLICY, V68, P221, DOI 10.1016/j.marpol.2016.03.011; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; Summers K, 1997, J HERED, V88, P8, DOI 10.1093/oxfordjournals.jhered.a023065; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tezanos-Pinto G, 2011, NEW ZEAL J MAR FRESH, V1, P1; Tezanos-Pinto G, 2013, MAR MAMMAL SCI, V29, pE390, DOI 10.1111/mms.12008; Tezanos-Pinto G, 2009, J HERED, V100, P11, DOI 10.1093/jhered/esn039; Torres LG, 2003, MAR MAMMAL SCI, V19, P502, DOI 10.1111/j.1748-7692.2003.tb01317.x; Trejos L, 2015, INT WHAL COMM; Tyne JA, 2012, MAR ECOL PROG SER, V444, P143, DOI 10.3354/meps09410; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Van Waerebeek Koen, 2006, Latin American Journal of Aquatic Mammals, V5, P39; Vermeulen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119182; Wang JY, 1999, MOL ECOL, V8, P1603, DOI 10.1046/j.1365-294x.1999.00741.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; Waring G.T., 2015, US ATLANTIC GULF MEX; Weller David W., 1997, Aquatic Mammals, V23, P49; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Whitehead H, 2017, P NATL ACAD SCI USA, V114, P7814, DOI 10.1073/pnas.1620736114; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; 2014, J CETACEAN RES MAN S, V15, P1	123	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189370	10.1371/journal.pone.0189370	http://dx.doi.org/10.1371/journal.pone.0189370			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236757	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100063
J	Liu, SL; Yin, YJ; Cheng, FY; Hou, XY; Dong, SK; Wu, X				Liu, Shiliang; Yin, Yijie; Cheng, Fangyan; Hou, Xiaoyun; Dong, Shikui; Wu, Xue			Spatio-temporal variations of conservation hotspots based on ecosystem services in Xishuangbanna, Southwest China	PLOS ONE			English	Article							LAND-USE; BIODIVERSITY; RUBBER; IMPACTS; YUNNAN; AREA; WELL	Integrating biodiversity and ecosystem services (BES) has been viewed as an appropriate approach to identifying conservation priorities. Taking Xishuangbanna tropical region in Southwest China, different BESs (habitat quality [used as a proxy for biodiversity], carbon storage, and water yield) were quantified using the InVEST model and conservation hotspots from 1976, 1990, and 2010 were identified by overlapping and ranking the service layers. Results showed that BESs areas were unevenly distributed. High habitat quality and carbon storage areas located in the eastern part of the region were mainly occupied by broad-leaved forest, while high water yield areas were covered by grassland and tropical forests. Recognized hotspots were primarily composed of the broad-leaved forest and shrub grassland. However, these habitat types declined by nearly 50% from 1.25x10(5) ha to 0.63x10(5) ha and became more fragmented during the study period. We also found that the sub-watersheds which decreased in BES had fewer hotspots distributed and suffered greater landscape fragmentation. Our study further explored the impacts of land-use conversion on BES, and illustrated the necessity and feasibility of BESs in identifying potential conservation areas.	[Liu, Shiliang; Yin, Yijie; Cheng, Fangyan; Hou, Xiaoyun; Dong, Shikui; Wu, Xue] Beijing Normal Univ, Sch Environm, Beijing, Peoples R China	Beijing Normal University	Liu, SL (corresponding author), Beijing Normal Univ, Sch Environm, Beijing, Peoples R China.	shiliangliu@bnu.edu.cn	Dong, Shikui/GQA-6626-2022; Liu, Shiliang/N-1885-2019		National key research and development project of China [2016YFC0502103]; National Natural Science Foundation of China [41571173]	National key research and development project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National key research and development project of China (No.2016YFC0502103) and National Natural Science Foundation of China (No.41571173). Shiliang Liu is the recipient of these two National Fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; Balvanera P, 2001, SCIENCE, V291, P2047, DOI 10.1126/science.291.5511.2047; Behm JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073688; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Budyko M.I., 1974, CLIMATE LIFE; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Burkhard B, 2010, ECOL COMPLEX, V7, P257, DOI 10.1016/j.ecocom.2010.07.001; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Deng X., 2015, IMPACTS LAND USE CHA, P1; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; [傅伯杰 Fu Bojie], 2014, [地理科学进展, Progress in Geography], V33, P441; Fu BJ, 2013, CURR OPIN ENV SUST, V5, P4, DOI 10.1016/j.cosust.2012.12.002; Gardner TA, 2010, BIOL CONSERV, V143, P2293, DOI 10.1016/j.biocon.2010.05.017; Gret-Regamey A, 2014, LANDSCAPE ECOL, V29, P201, DOI 10.1007/s10980-013-9957-y; He CG, 2008, YUNNAN GEOGR ENV RES, V20, P12; He QC, 2014, BIOCULTURAL LANDSCAP, P69; Hua Z., 2006, FOR STUD CHINA, V8, P1, DOI [10.1007/s11632-006-0014-7, DOI 10.1007/S11632-006-0014-7]; Jobbagy EG, ECOLOGICAL APPL, V10, P423; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; [李红梅 LI Hongmei], 2007, [山地学报, Journal of Mountain Science], V25, P280; Li XW, 2015, RANGELAND J, V37, P31, DOI 10.1071/RJ14084; LIN L, 2015, ACTA THERIOL SIN, V35, P1; [刘晓娜 Liu Xiaona], 2014, [资源科学, Resources Science], V36, P233; Luo A.D., 1998, CHINESE J ECOL, V17, P6, DOI [DOI 10.13292/J.1000-4890.1998.0065, 10.13292/j.1000-4890.1998.0065]; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Meng QingFan, 2006, World Forestry Research, V19, P1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Nackoney J., 2012, J CONSERV PLAN, V8, P25; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Nosetto MD, 2005, GLOBAL CHANGE BIOL, V11, P1101, DOI 10.1111/j.1365-2486.2005.00975.x; Ojea E, 2015, J FOREST ECON, V21, P97, DOI 10.1016/j.jfe.2015.02.001; Pan Tao, 2013, Yingyong Shengtai Xuebao, V24, P183; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Portillo-Quintero C, 2015, REG ENVIRON CHANGE, V15, P1039, DOI 10.1007/s10113-014-0689-6; Ramamurthy P, 2014, WATER RESOUR RES, V50, P2889, DOI 10.1002/2013WR013909; Rojas C, 2013, APPL GEOGR, V39, P93, DOI 10.1016/j.apgeog.2012.12.007; Sanchez-Canales M, 2012, SCI TOTAL ENVIRON, V440, P140, DOI 10.1016/j.scitotenv.2012.07.071; Sharp R., 2014, INVEST 3 1 1 USERS G; Singh SP, 2002, CURR SCI INDIA, V82, P1331; Smajgl A, 2015, ENVIRON MODELL SOFTW, V69, P187, DOI 10.1016/j.envsoft.2015.03.014; Song Qing-hai, 2010, Shengtaixue Zazhi, V29, P1887; Sun Chuan-zhun, 2015, Changjiang Liuyu Ziyuan Yu Huanjing, V24, P1119; Tardieu L, 2015, J ENVIRON MANAGE, V152, P145, DOI 10.1016/j.jenvman.2015.01.034; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Vigerstol KL, 2011, J ENVIRON MANAGE, V92, P2403, DOI 10.1016/j.jenvman.2011.06.040; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhang Li, 2003, Acta Theriologica Sinica, V23, P185; Zhang PF, 2006, REMOTE SENSING LAND, V3, P51; Zhu Hua, 2001, Acta Botanica Yunnanica, V23, P415; Zomer RJ, 2014, BIOL CONSERV, V170, P264, DOI 10.1016/j.biocon.2013.11.028	55	9	9	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189368	10.1371/journal.pone.0189368	http://dx.doi.org/10.1371/journal.pone.0189368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232370	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200035
J	Malik, A; Adland, E; Laker, L; Klenferpris, H; Fardoos, R; Roider, J; Severinsen, MC; Chen, FB; Riddell, L; Edwards, A; Buus, S; Jooste, P; Matthews, PC; Goulder, PJR				Malik, Amna; Adland, Emily; Laker, Leana; Klenferpris, Henrik; Fardoos, Rabiah; Roider, Julia; Severinsen, Mai C.; Chen, Fabian; Riddell, Lynn; Edwards, Anne; Buus, Soren; Jooste, Pieter; Matthews, Philippa C.; Goulder, Philip J. R.			Immunodominant cytomegalovirus-specific CD8+T-cell responses in sub-Saharan African populations	PLOS ONE			English	Article							CD8(+) T-CELLS; DISEASE PROGRESSION; HLA ALLELES; INFECTION; IDENTIFICATION; HIV; INFLATION; PATTERNS; EPITOPES; IMPACT	More than 90% of children in Africa are infected with cytomegalovirus (CMV) by the age of 12 months. However, the high-frequency, immunodominant CD8+ T-cell responses that control CMV infection have not been well studied in African populations. We therefore sought to define the immunodominant CMV-specific CD8+ T-cell responses within sub-Saharan African study subjects. Among 257 subjects, we determined the CD8+ T-cell responses to overlapping peptides spanning three of the most immunogenic CMV proteins, pp65, IE-1 and IE-2, using IFN-gamma ELISpot assays. A bioinformatics tool was used to predict optimal epitopes within overlapping peptides whose recognition was statistically associated with expression of particular HLA class I molecules. Using this approach, we identified 16 predicted novel CMV-specific epitopes within CMV-pp65, IE-1 and IE-2. The immunodominant pp65-specific, IE-1, IE-2 responses were all either previously well characterised or were confirmed using peptide-MHC tetramers. The novel epitopes identified included an IE-2-specific epitope restricted by HLA*B* 44: 03 that induced high-frequency CD8+ T-cell responses (mean 3.4% of CD8+ T-cells) in 95% of HLA-B* 44:03-positive subjects tested, in one individual accounting for 18.8% of all CD8+ T-cells. These predicted novel CMV-specific CD8+ T-cell epitopes identified in an African cohort will facilitate future analyses of immune responses in African populations where CMV infection is almost universal during infancy.	[Malik, Amna; Adland, Emily; Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford, England; [Laker, Leana; Jooste, Pieter] Kimberley Gen Hosp, Kimberley, South Africa; [Klenferpris, Henrik; Fardoos, Rabiah; Roider, Julia] AHRI, Durban, South Africa; [Klenferpris, Henrik; Fardoos, Rabiah; Severinsen, Mai C.; Buus, Soren] Univ Copenhagen, Lab Expt Immunol, Fac Hlth Sci, Copenhagen, Denmark; [Klenferpris, Henrik] UCL, Dept Infect & Immun, London, England; [Chen, Fabian] Royal Berkshire Hosp, Dept Sexual Hlth, Reading, Berks, England; [Riddell, Lynn] Northamptonshire Healthcare NHS Trust, Northampton Gen Hosp, Dept Genitourinary Med, Northampton, England; [Edwards, Anne] Churchill Hosp, Oxford Dept Genitourinary Med, Oxford, England; [Matthews, Philippa C.] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford; Africa Health Research Institute; University of Copenhagen; University of London; University College London; Royal Berkshire Hospital; University of Oxford; University of Oxford	Goulder, PJR (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	phiiip.goulder@paediatrics.ox.ac.uk	Laker, Leana/AAW-1247-2020; Roider, Julia/ADV-9989-2022; Matthews, Philippa/P-7810-2019	Matthews, Philippa/0000-0002-4036-4269; Severinsen, Marianne Tang/0000-0003-0996-1812; Roider, Julia/0000-0002-1347-2838; Kloverpris, Henrik/0000-0002-2165-3313	Wellcome Trust [WT104748MA]; National Institutes of Health [NIH R01 AI46995]	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Wellcome Trust (WT104748MA) and National Institutes of Health (NIH R01 AI46995) to PJRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adland E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01016; Adland E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004954; Akiyama Y, 2002, IMMUNOL LETT, V83, P21, DOI 10.1016/S0165-2478(02)00073-1; Ameres S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003383; Braendstrup P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094892; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Chen SF, 2004, J INFECT DIS, V189, P1619, DOI 10.1086/383249; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; DETELS R, 1994, J INFECT DIS, V169, P766, DOI 10.1093/infdis/169.4.766; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; GAVIN MA, 1993, J IMMUNOL, V151, P3971; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; Huygens A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00552; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Longmate J, 2001, IMMUNOGENETICS, V52, P165, DOI 10.1007/s002510000271; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; O'Hara GA, 2012, TRENDS IMMUNOL, V33, P84, DOI 10.1016/j.it.2011.11.005; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; REUSSER P, 1991, BLOOD, V78, P1373; Riddell SR, 1997, REV MED VIROL, V7, P181, DOI 10.1002/(SICI)1099-1654(199709)7:3<181::AID-RMV200>3.0.CO;2-W; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189612	10.1371/journal.pone.0189612	http://dx.doi.org/10.1371/journal.pone.0189612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232408	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200062
J	Na, MK; Won, YD; Kim, CH; Kim, JM; Cheong, JH; Ryu, JI; Han, MH				Na, Min Kyun; Won, Yu Deok; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon			Early variations of laboratory parameters predicting shunt-dependent hydrocephalus after subarachnoid hemorrhage	PLOS ONE			English	Article							RUPTURED INTRACRANIAL ANEURYSMS; HYPERNATREMIA; HYPERGLYCEMIA; RISK; METAANALYSIS; HYPONATREMIA; MORTALITY; COILING; BRAIN; TERM	Background and purpose Hydrocephalus is a frequent complication following subarachnoid hemorrhage. Few studies investigated the association between laboratory parameters and shunt-dependent hydrocephalus. This study aimed to investigate the variations of laboratory parameters after subarachnoid hemorrhage. We also attempted to identify predictive laboratory parameters for shunt-dependent hydrocephalus. Methods Multiple imputation was performed to fill the missing laboratory data using Bayesian methods in SPSS. We used univariate and multivariate Cox regression analyses to calculate hazard ratios for shunt-dependent hydrocephalus based on clinical and laboratory factors. The area under the receiver operating characteristic curve was used to determine the laboratory risk values predicting shunt-dependent hydrocephalus. Results We included 181 participants with a mean age of 54.4 years. Higher sodium (hazard ratio, 1.53; 95% confidence interval, 1.13-2.07; p = 0.005), lower potassium, and higher glucose levels were associated with higher shunt-dependent hydrocephalus. The receiver operating characteristic curve analysis showed that the areas under the curve of sodium, potassium, and glucose were 0.649 (cutoff value, 142.75 mEq/L), 0.609 (cutoff value, 3.04 mmol/L), and 0.664 (cutoff value, 140.51 mg/dL), respectively. Conclusions Despite the exploratory nature of this study, we found that higher sodium, lower potassium, and higher glucose levels were predictive values for shunt -dependent hydrocephalus from postoperative day (POD) 1 to POD 12-16 after subarachnoid hemorrhage. Strict correction of electrolyte imbalance seems necessary to reduce shunt-dependent hydrocephalus. Further large studies are warranted to confirm our findings.	[Na, Min Kyun; Won, Yu Deok; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon] Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea	Hanyang University	Han, MH (corresponding author), Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea.	gksmh80@gmail.com	Ryu, Je Il/E-5511-2018; Won, Yu Deok/CAF-2646-2022	Ryu, Je Il/0000-0003-2885-5839; Won, Yu Deok/0000-0002-8822-6631	Hanyang University [HY-201600000002777]	Hanyang University	This work was supported by the research fund of Hanyang University (HY-201600000002777) URLs: http://www.hanyang.ac.kr/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams H, 2016, STROKE, V47, P2488, DOI 10.1161/STROKEAHA.116.013739; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Alimohamadi Maysam, 2016, Asian J Neurosurg, V11, P29, DOI 10.4103/1793-5482.154978; Andres RH, 2010, J NEUROSURG, V113, P82, DOI 10.3171/2009.10.JNS09845; Beseoglu K, 2014, CLIN NEUROL NEUROSUR, V123, P164, DOI 10.1016/j.clineuro.2014.05.022; Chen I, 2016, BRIT J NEUROSURG, V30, P554, DOI 10.1080/02688697.2016.1181151; de Oliveira JG, 2007, NEUROSURGERY, V61, P924, DOI 10.1227/01.neu.0000303188.72425.24; Dehdashti AR, 2004, J NEUROSURG, V101, P402, DOI 10.3171/jns.2004.101.3.0402; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; DOCZI T, 1983, NEUROSURGERY, V12, P435, DOI 10.1227/00006123-198304000-00011; DOSHI R, 1980, J NEUROSURG, V52, P295, DOI 10.3171/jns.1980.52.3.0295; ELLINGTON E, 1969, Journal of Neurosurgery, V30, P651, DOI 10.3171/jns.1969.30.6.0651; Erixon HO, 2014, ACTA NEUROCHIR, V156, P2059, DOI 10.1007/s00701-014-2200-z; Fahrbach J, 2006, J NEUROSURG, V104, P192, DOI 10.3171/ped.2006.104.3.192; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Fukagawa A, 2001, ENDOCR J, V48, P233, DOI 10.1507/endocrj.48.233; Fukui S, 2003, CRIT CARE, V7, pR7, DOI 10.1186/cc2160; Martinez TG, 2017, FARM HOSP, V41, P667, DOI 10.7399/fh.10784; George U, 2011, AJNR Am J Neuroradiol, V32, pE16, DOI 10.3174/ajnr.A2262; GRABB PA, 1994, NEUROSURGERY, V35, P406, DOI 10.1227/00006123-199409000-00007; Gruber TJ, 2008, PEDIATR NEUROSURG, V44, P496, DOI 10.1159/000187124; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jeong TS, 2017, TURK NEUROSURG; Kruyt ND, 2008, J NEUROL NEUROSUR PS, V79, P1382, DOI 10.1136/jnnp.2007.142034; Kruyt ND, 2010, J CEREBR BLOOD F MET, V30, P1577, DOI 10.1038/jcbfm.2010.102; Kruyt ND, 2009, STROKE, V40, pE424, DOI 10.1161/STROKEAHA.108.529974; Kurtz P, 2014, CRIT CARE, V18, DOI 10.1186/cc13857; Lee SH, 2008, J NEUROL SCI, V275, P18, DOI 10.1016/j.jns.2008.05.024; Li H, 2013, STROKE, V44, P29, DOI 10.1161/STROKEAHA.112.663559; Machino T, 2006, NEUROLOGY, V67, P880, DOI 10.1212/01.wnl.0000221726.41727.06; Mulla ZD, 2009, ANN EPIDEMIOL, V19, P908, DOI 10.1016/j.annepidem.2009.08.002; PANG DL, 1994, NEUROSURGERY, V35, P643, DOI 10.1227/00006123-199410000-00010; Pasquel FJ, 2010, DIABETES CARE, V33, P739, DOI 10.2337/dc09-1748; Pfaffel A, 2016, PRACT ASSESS RES EVA, P21; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Ray B, 2017, WORLD NEUROSURG, V100, P208, DOI 10.1016/j.wneu.2017.01.008; Rincon F, 2010, J NEUROSURG, V113, P774, DOI 10.3171/2010.2.JNS09376; Rodriguez DR, 2017, NEUROLOGIA, V32, P15, DOI 10.1016/j.nrl.2014.12.006; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Shigematsu H, 2016, NEUROL RES, V38, P600, DOI 10.1080/01616412.2016.1199184; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; Tso MK, 2016, WORLD NEUROSURG, V86, P226, DOI 10.1016/j.wneu.2015.09.056; Vale FL, 1997, J NEUROSURG, V86, P462, DOI 10.3171/jns.1997.86.3.0462; von der Brelie C, 2016, J NEUROSCI RURAL PRA, V7, P48, DOI 10.4103/0976-3147.172159; Widenka D C, 2000, Neurol Neurochir Pol, V34, P56; Ybanez N, 2014, AM J KIDNEY DIS, V63, P530, DOI 10.1053/j.ajkd.2013.07.005	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189499	10.1371/journal.pone.0189499	http://dx.doi.org/10.1371/journal.pone.0189499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232410	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200051
J	Chao, WC; Yen, CL; Hsieh, CY; Huang, YF; Tseng, YL; Nigrovic, PA; Shieh, CC				Chao, Wen-Cheng; Yen, Chia-Liang; Hsieh, Cheng-Yuan; Huang, Ya-Fang; Tseng, Yau-Lin; Nigrovic, Peter Andrija; Shieh, Chi-Chang			Mycobacterial infection induces higher interleukin-1 beta and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase	PLOS ONE			English	Article							HOST-DIRECTED THERAPY; PROGRAMMED DEATH 1; PULMONARY TUBERCULOSIS; T-CELLS; NEUTROPHILS; ACTIVATION; IL-1-BETA; IMMUNITY; EXPANSION; MARINUM	Granulomatous inflammation causes severe tissue damage in mycobacterial infection while redox status was reported to be crucial in the granulomatous inflammation. Here, we used a NADPH oxidase 2 (NOX2)-deficient mice (Ncf1(-/-)) to investigate the role of leukocyte-produced reactive oxygen species (ROS) in mycobacterium-induced granulomatous inflammation. We found poorly controlled mycobacterial proliferation, significant body weight loss, and a high mortality rate after M. marinum infection in Ncf1(-/-) mice. Moreover, we noticed loose and neutrophilic granulomas and higher levels of interleukin (IL)-1 beta and neutrophil chemokines in Ncf1(-/-) mice when compared with those in wild type mice. The lack of ROS led to reduced production of IL-1 beta in macrophages, whereas neutrophil elastase (NE), an abundant product of neutrophils, may potentially exert increased inflammasome-independent protease activity and lead to higher IL-1 beta production. Moreover, we showed that the abundant NE and IL-1 beta were present in the caseous granulomatous inflammation of human TB infection. Importantly, blocking of IL-1 beta with either a specific antibody or a recombinant IL-1 receptor ameliorated the pulmonary inflammation. These findings revealed a novel role of ROS in the early pathogenesis of neutrophilic granulomatous inflammation and suggested a potential role of IL-1 blocking in the treatment of mycobacterial infection in the lung.	[Chao, Wen-Cheng; Yen, Chia-Liang; Hsieh, Cheng-Yuan; Shieh, Chi-Chang] Natl Cheng Kung Univ, Med Coll, Inst Clin Med, Tainan, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Ya-Fang] Natl Lab Anim Ctr, Natl Appl Res Labs, Tainan, Taiwan; [Tseng, Yau-Lin] Natl Cheng Kung Univ Hosp, Dept Surg, Div Thorac Surg, Tainan, Taiwan; [Nigrovic, Peter Andrija] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Nigrovic, Peter Andrija] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Shieh, Chi-Chang] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan	National Cheng Kung University; Taichung Veterans General Hospital; National Applied Research Laboratories - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Shieh, CC (corresponding author), Natl Cheng Kung Univ, Med Coll, Inst Clin Med, Tainan, Taiwan.; Shieh, CC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan.	cshieh@mail.ncku.edu.tw		Chao, Wen-Cheng/0000-0001-9631-8934; Hsieh, Ching-Lin/0000-0002-3665-5717; Yen, Chia-Liang/0000-0002-7676-5400	Taichung Veterans General Hospital Chiayi branch, Taiwan [RVHCY102005, RVHCY103005, RVHCY104005, RVHCY105005, TCVGH-VHCY1068604]; Ministry of Science and Technology (MOST)	Taichung Veterans General Hospital Chiayi branch, Taiwan; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This work was supported by the Taichung Veterans General Hospital Chiayi branch, Taiwan (RVHCY102005, RVHCY103005, RVHCY104005, RVHCY105005, and TCVGH-VHCY1068604) to WCC and research grants from Ministry of Science and Technology (MOST) to CCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Professors Po-Ren Hsueh (National Taiwan University), Jaw-Ji Tsai (National Yang-Ming University), Wen-Chien Ko (National Cheng Kung University), and Jing-Jou Yan (National Cheng Kung University) for helpful discussion. This work was supported by the Taichung Veterans General Hospital Chiayi branch, Taiwan (RVHCY102005, RVHCY103005, RVHCY104005, RVHCY105005, and TCVGH-VHCY1068604) to WCC and research grants from Ministry of Science and Technology (MOST) to CCS.	Andrade BB, 2014, CHEST, V145, P1244, DOI 10.1378/chest.13-1799; [Anonymous], 2016, GLOBAL REPORT DIABET; Cadena AM, 2016, MBIO, V7, DOI 10.1128/mBio.00342-16; Cantini F, 2014, J RHEUMATOL, V41, P56, DOI 10.3899/jrheum.140103; Chao WC, 2015, MICROBES INFECT, V17, P195, DOI 10.1016/j.micinf.2014.11.009; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Deffert C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004325; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Dorhoi A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00036; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Huang Y. M., 2015, INT J ANTENN PROPAG, V2015, P1, DOI DOI 10.1155/2015/216983; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Marakalala MJ, 2016, NATURE MED; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Marzo E, 2014, TUBERCULOSIS, V94, P55, DOI 10.1016/j.tube.2013.09.004; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Mohammadi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160249; Myllymaki H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00196; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Stephen-Victor E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00465; Stephen-Victor E, 2015, J INFECT DIS, V211, P1027, DOI 10.1093/infdis/jiu532; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; TRAVIS WD, 1985, ARCH PATHOL LAB MED, V109, P1109; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Warren E, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020015; WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723	44	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189453	10.1371/journal.pone.0189453	http://dx.doi.org/10.1371/journal.pone.0189453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228045	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600057
J	Alampalli, SV; Thomson, MM; Sampathkumar, R; Sivaraman, K; Jesuraj, UKJA; Dhar, C; Souza, GD; Berry, N; Vyakarnam, A				Alampalli, Shuba Varshini; Thomson, Michael M.; Sampathkumar, Raghavan; Sivaraman, Karthi; Jesuraj, Anto U. K. J.; Dhar, Chirag; Souza, George D.; Berry, Neil; Vyakarnam, Annapurna			Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; MONOPHYLETIC LINEAGE; DRUG-USERS; CLONES; STRAINS; INFECTIONS; MUTATIONS; ALIGNMENT	India has the third largest number of HIV-1-infected individuals accounting for approximately 2.1 million people, with a predominance of circulating subtype C strains and a low prevalence of subtype A and A1C and BC recombinant forms, identified over the past two decades. Recovery of near full-length HIV-1 genomes from a plasma source coupled with advances in next generation sequencing (NGS) technologies and development of universal methods for amplifying whole genomes of HIV-1 circulating in a target geography or population provides the opportunity for a detailed analysis of HIV-1 strain identification, evolution and dynamics. Here we describe the development and implementation of approaches for HIV-1 NGS analysis in a southern Indian cohort. Plasma samples (n = 20) were obtained from HIV-1-confirmed individuals living in and around the city of Bengaluru. Near full-length genome recovery was obtained for 9 Indian HIV-1 patients, with recovery of full-length gag and env genes for 10 and 2 additional subjects, respectively. Phylogenetic analyses indicate the majority of sequences to be represented by subtype C viruses branching within a monophyletic clade, comprising viruses from India, Nepal, Myanmar and China and closely related to a southern African cluster, with a low prevalence of the A1C recombinant form also present. Development of algorithms for bespoke recovery and analysis at a local level will further aid clinical management of HIV-1 infected Indian subjects and delineate the progress of the HIV-1 pandemic in this and other geographical regions.	[Alampalli, Shuba Varshini; Sampathkumar, Raghavan; Sivaraman, Karthi; Vyakarnam, Annapurna] Indian Inst Sci, CIDR, Bengaluru, India; [Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Ctra Majadahonda Pozuelo, Madrid, Spain; [Jesuraj, Anto U. K. J.; Dhar, Chirag; Souza, George D.] St Johns Res Inst, Dept Infect Dis, Bengaluru, India; [Souza, George D.] St Johns Res Inst, Dept Pulm Med, Bengaluru, India; [Berry, Neil] NIBSC, Div Virol, S Mimms, Herts, England; [Vyakarnam, Annapurna] Kings Coll London, Dept Infect Dis, London, England	Indian Institute of Science (IISC) - Bangalore; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; National Institute for Biological Standards & Control; University of London; King's College London	Vyakarnam, A (corresponding author), Indian Inst Sci, CIDR, Bengaluru, India.; Vyakarnam, A (corresponding author), Kings Coll London, Dept Infect Dis, London, England.	anna.vyakarnam@kcl.ac.uk	Thomson, Michael M/P-8949-2017; Dhar, Chirag/AAL-6327-2021	Thomson, Michael M/0000-0002-0622-7527; Dhar, Chirag/0000-0002-7351-485X; Vyakarnam, Annapurna/0000-0003-4260-258X; Sampathkumar, Raghavan/0000-0003-3500-9083	EC FP7 EURIPRED (FP7-INFRA) [312661]; Department of Biotechnology (DBT), India [BT/01/CEIB/12/ 111/09]	EC FP7 EURIPRED (FP7-INFRA); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was funded partly by a EC FP7 EURIPRED (FP7-INFRA-2012 Grant Agreement No. 312661) to AV, MMT, GDS and a Centre for Excellence award from the Department of Biotechnology (DBT), India to AV (BT/01/CEIB/12/ 111/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded partly by a EC FP7 EURIPRED (FP7-INFRA-2012 Grant Agreement No. 312661) to AV, MMT, GDS and a Centre for Excellence award from the Department of Biotechnology (DBT), India to AV (BT/01/CEIB/12/III/09). We thank Mark Preston, NIBSC for discussions relating to some aspects of the study.	Andrews S., 2017, FASTQC QUALITY CONTR; Aralaguppe SG, 2016, J VIROL METHODS, V236, P98, DOI 10.1016/j.jviromet.2016.07.010; Azam M, 2013, VIRUS GENES, V47, P422, DOI 10.1007/s11262-013-0961-8; Berg Michael G, 2016, J Clin Microbiol, V54, P868, DOI 10.1128/JCM.02479-15; Bhusal N, 2016, CURR HIV RES, V14, P517, DOI 10.2174/1570162X14666161003141950; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079193; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; GREZ M, 1994, J VIROL, V68, P2161, DOI 10.1128/JVI.68.4.2161-2168.1994; Grossmann S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20035; Halani N, 2001, AIDS RES HUM RETROV, V17, P637, DOI 10.1089/088922201300119743; Hanna LE, 2014, AIDS RES HUM RETROV, V30, P586, DOI [10.1089/aid.2013.0275, 10.1089/AID.2013.0275]; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lakhashe S, 2008, AIDS RES HUM RETROV, V24, P229, DOI 10.1089/aid.2007.0229; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mandal D, 2002, AIDS RES HUM RETROV, V18, P1219, DOI 10.1089/08892220260387968; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; Ode H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01258; Oelrichs RB, 2000, J VIROL, V74, P1149, DOI 10.1128/JVI.74.3.1149-1157.2000; Pandey S, 2013, AIDS RES HUM RETROV, V29, P1245, DOI [10.1089/aid.2013.0150, 10.1089/AID.2013.0150]; Pandey SS, 2016, AIDS RES HUM RETROV, V32, P489, DOI [10.1089/AID.2015.0207, 10.1089/aid.2015.0207]; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Sengupta S, 2005, ARCH VIROL, V150, P2117, DOI 10.1007/s00705-005-0562-5; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Siddappa NB, 2004, J CLIN MICROBIOL, V42, P2742, DOI 10.1128/JCM.42.6.2742-2751.2004; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Tripathy SP, 2005, AIDS RES HUM RETROV, V21, P152, DOI 10.1089/aid.2005.21.152; Wilkinson E, 2015, AIDS RES HUM RETROV, V31, P412, DOI [10.1089/aid.2014.0230, 10.1089/AID.2014.0230]; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zanini F, 2015, ELIFE, V4, DOI 10.7554/eLife.11282	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188603	10.1371/journal.pone.0188603	http://dx.doi.org/10.1371/journal.pone.0188603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220350	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900013
J	Ishii, T; Kimura, Y; Ichise, M; Takahata, K; Kitamura, S; Moriguchi, S; Kubota, M; Zhang, MR; Yamada, M; Higuchi, M; Okubo, Y; Suhara, T				Ishii, Tatsuya; Kimura, Yasuyuki; Ichise, Masanori; Takahata, Keisuke; Kitamura, Soichiro; Moriguchi, Sho; Kubota, Manabu; Zhang, Ming-Rong; Yamada, Makiko; Higuchi, Makoto; Okubo, Yoshinori; Suhara, Tetsuya			Anatomical relationships between serotonin 5-HT2A and dopamine D-2 receptors in living human brain	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; SUPPLEMENTARY MOTOR AREA; FRONTAL-CORTEX; DOUBLE-BLIND; RAT-BRAIN; IN-VIVO; BINDING; MEMORY; PET; MODULATION	Serotonin 2A (5-HT2A) receptors and dopamine D-2 receptors are intimately related to the physiology and pathophysiology of neuropsychiatric disorders. A large number of studies have reported the effectiveness of psychotropic agents targeting 5-HT2A and D-2 receptors in these disorders. In addition to the individual functions of these receptors, the interaction between the two neurotransmitter systems has been studied in the living brain. However, little is known about their regional relationship in individual human brains. We investigated regional relationships between 5-HT2A and D-2 receptors using positron emission tomography (PET) and a bicluster analysis of the correlation matrix of individual variation in the two receptor densities to identify groups of distinctive regional correlations between the two receptors. Methods Seven healthy volunteers underwent PET scans with [F-18] altanserin and [C-11] FLB 457 for 5-HT2A and D-2 receptors, respectively. As a measure of receptor density, a binding potential (BP) was calculated from PET data for 76 cerebral cortical regions. A correlation matrix was calculated between the binding potentials of [F-18] altanserin and [C-11] FLB 457 for those regions. The regional relationships were investigated using a bicluster analysis of the correlation matrix with an iterative signature algorithm. Results We identified two clusters of regions. The first cluster identified a distinct profile of correlation coefficients between 5-HT2A and D-2 receptors, with the former in regions related to sensorimotor integration (supplementary motor area, superior parietal gyrus, and paracentral lobule) and the latter in most cortical regions. The second cluster identified another distinct profile of correlation coefficients between 5-HT2A receptors in the bilateral hippocampi and D-2 receptors in most cortical regions. Conclusions The observation of two distinct clusters in the correlation matrix suggests regional interactions between 5-HT2A and D-2 receptors in sensorimotor integration and hippocampal function. A bicluster analysis of the correlation matrix of these neuroreceptors may be beneficial in understanding molecular networks in the human brain.	[Ishii, Tatsuya; Kimura, Yasuyuki; Ichise, Masanori; Takahata, Keisuke; Kitamura, Soichiro; Moriguchi, Sho; Kubota, Manabu; Zhang, Ming-Rong; Yamada, Makiko; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan; [Ishii, Tatsuya; Okubo, Yoshinori] Nippon Med Sch, Dept Neuropsychiat, Tokyo, Japan; [Kimura, Yasuyuki] Natl Ctr Geriatr & Gerontol, Dept Clin & Expt Neuroimaging, Ctr Dev Adv Med Dementia, Obu, Japan	National Institutes for Quantum Science & Technology; Nippon Medical School; National Center for Geriatrics & Gerontology	Kimura, Y (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan.; Kimura, Y (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Clin & Expt Neuroimaging, Ctr Dev Adv Med Dementia, Obu, Japan.	kimura.yasuyuki@qst.go.jp	Kimura, Yasuyuki/ABC-5158-2020	Kimura, Yasuyuki/0000-0002-7927-9483; Takahata, Keisuke/0000-0002-0884-4924				Adams KH, 2004, NEUROIMAGE, V21, P1105, DOI 10.1016/j.neuroimage.2003.10.046; Asselin MC, 2007, J CEREBR BLOOD F MET, V27, P378, DOI 10.1038/sj.jcbfm.9600340; Bauer EP, 2015, BEHAV BRAIN RES, V277, P68, DOI 10.1016/j.bbr.2014.07.028; Berman RM, 2009, CNS SPECTRUMS, V14, P197, DOI 10.1017/S1092852900020216; Blasi G, 2015, NEUROPSYCHOPHARMACOL, V40, P1600, DOI 10.1038/npp.2015.5; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; BURNET PWJ, 1995, BRAIN RES, V676, P157, DOI 10.1016/0006-8993(95)00104-X; Christensen R, 2008, EXP NEUROL, V210, P164, DOI 10.1016/j.expneurol.2007.10.009; Egerton A, 2008, PSYCHOPHARMACOLOGY, V200, P487, DOI 10.1007/s00213-008-1226-4; Gobert A, 1999, NEUROPHARMACOLOGY, V38, P315, DOI 10.1016/S0028-3908(98)00188-9; GOLDBERG G, 1985, BEHAV BRAIN SCI, V8, P567, DOI 10.1017/S0140525X00045167; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Hasselbalch SG, 2008, NEUROBIOL AGING, V29, P1830, DOI 10.1016/j.neurobiolaging.2007.04.011; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Inoue M, 2001, LIFE SCI, V69, P1079, DOI 10.1016/S0024-3205(01)01205-X; Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20; Ito H, 2008, NEUROIMAGE, V39, P555, DOI 10.1016/j.neuroimage.2007.09.011; Khan ZU, 2001, P NATL ACAD SCI USA, V98, P1964, DOI 10.1073/pnas.98.4.1964; Kimura Y, 2017, PSYCHOPHARMACOLOGY, V234, P323, DOI 10.1007/s00213-016-4464-x; Kroll T, 2013, MOL IMAGING BIOL, V15, P456, DOI 10.1007/s11307-013-0621-3; Li Z, 2005, PSYCHOPHARMACOLOGY, V183, P144, DOI 10.1007/s00213-005-0170-9; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Marcus RN, 2008, J CLIN PSYCHOPHARM, V28, P156, DOI 10.1097/JCP.0b013e31816774f9; Meneses A, 2007, BEHAV BRAIN RES, V184, P81, DOI 10.1016/j.bbr.2007.06.026; MORILAK DA, 1994, NEUROPSYCHOPHARMACOL, V11, P157, DOI 10.1038/sj.npp.1380102; Moses-Kolko EL, 2011, NEUROPSYCHOPHARMACOL, V36, P2729, DOI 10.1038/npp.2011.163; Muguruza C, 2013, EUR NEUROPSYCHOPHARM, V23, P852, DOI 10.1016/j.euroneuro.2012.10.006; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Padich RA, 1996, PSYCHOPHARMACOLOGY, V124, P107, DOI 10.1007/BF02245610; Perani D, 2008, NEUROIMAGE, V42, P306, DOI 10.1016/j.neuroimage.2008.04.233; Pinborg LH, 2003, J CEREBR BLOOD F MET, V23, P985, DOI 10.1097/01.WCB.0000074092.59115.23; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Savli M, 2012, NEUROIMAGE, V63, P447, DOI 10.1016/j.neuroimage.2012.07.001; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V20, P424, DOI 10.1016/S0893-133X(98)00108-0; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zhang GL, 2017, HIPPOCAMPUS, V27, P558, DOI 10.1002/hipo.22712; Zhang GL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00225	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189318	10.1371/journal.pone.0189318	http://dx.doi.org/10.1371/journal.pone.0189318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220382	Green Submitted, gold, Green Published			2022-12-26	WOS:000417469900048
J	Liu, H; Liu, N; Cheng, YD; Jin, WL; Zhang, PX; Wang, X; Yang, HW; Xu, XS; Wang, Z; Tu, YY				Liu, Hui; Liu, Nan; Cheng, Yingduan; Jin, Weilin; Zhang, Pengxing; Wang, Xin; Yang, Hongwei; Xu, Xiaoshan; Wang, Zhen; Tu, Yanyang			Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway	PLOS ONE			English	Article							BREAST-CANCER; RNA INTERFERENCE; II INHIBITOR; GLIOBLASTOMA; WARBURG; GLYCOLYSIS; METABOLISM; INVASION; MITOCHONDRIA; EXPRESSION	In cancer, glycolysis driving enzymes and their regulating microRNAs are one of the key focus of oncology research lately. The glycolytic enzyme hexokinase 2 (HK2) is crucial for the Warburg effect in human glioma, the most common malignant brain tumor. In the present study, we studied the tumorigenic role of HK2 in glioma, and clarified the mechanism of miR-218 induced HK2 regulation in glioma development. The HK2 expression in patient derived glioma and non neoplastic brain tissue was quantified. The HK2 silenced U87 and U251 cell lines were assessed for their proliferation, migration and invasive potential in vitro, while the tumor forming potential of U87 cells was evaluated in vivo. The untreated cell lines served as control. The HK2 expression in (a) lentivirus-infected, miR-218 overexpressing and (b) shRNA mediated Bmi1 silenced U87 and U251 glioma cell lines were quantified. Luciferase reporter assay, qRT-PCR analysis and WB were employed as required. The HK2 expression was significantly increased in glioma tissues comparing with the non neoplastic brain tissues and was positively correlated with the glioma grade. Silencing HK2 in glioma cell lines significantly decreased their proliferation, migration, invasion and tumorigenic abilities. Although, overexpression of miR-218 significantly downregulated the HK2 expression, luciferase reporter assay failed to show HK2 as the direct target of miR-218. A direct correlation, however, was observed between HK2 and Bmi-1, the direct target of miR-218. Taken together, our findings confirmed the tumorigenic activity of HK2 in glioma, and the involvement of the miR218/Bmi1 pathway in the regulation of its expression.	[Liu, Hui; Liu, Nan; Cheng, Yingduan; Zhang, Pengxing; Xu, Xiaoshan; Wang, Zhen; Tu, Yanyang] Fourth Mil Med Univ, Tangdu Hosp, Dept Expt Surg, Xian, Shaanxi, Peoples R China; [Cheng, Yingduan] Cipher Ground, Dept Res, North Brunswick, NJ USA; [Jin, Weilin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Jin, Weilin] Shanghai Jiao Tong Univ, Inst Micronano Sci & Technol, Dept Bionanosci & Engn, Shanghai, Peoples R China; [Wang, Xin; Yang, Hongwei] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA	Air Force Military Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tu, YY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Expt Surg, Xian, Shaanxi, Peoples R China.	ayonst@163.com	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405	National Natural Science Foundation of China [81272419, 81572983]; Social Development of Technology Research Projects in Shaanxi Province [2016SF191, 2015SF027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development of Technology Research Projects in Shaanxi Province	This work was supported by the National Natural Science Foundation of China (81272419, 81572983 to Yanyang Tu) and the Social Development of Technology Research Projects in Shaanxi Province (2016SF191 to Hui Liu, 2015SF027 to Pengxing Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2016, NEURO-ONCOLOGY, V18, P160, DOI 10.1093/neuonc/nov125; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fack F, 2015, ACTA NEUROPATHOL, V129, P115, DOI 10.1007/s00401-014-1352-5; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Ge X, 2015, BIOCHEM BIOPH RES CO, V463, P1115, DOI 10.1016/j.bbrc.2015.06.068; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Katabi MM, 1999, HUM GENE THER, V10, P155, DOI 10.1089/10430349950018959; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim JE, 2011, J NUCL MED, V52, P1756, DOI 10.2967/jnumed.111.090266; Kim W, 2007, MOL CANCER THER, V6, P2554, DOI 10.1158/1535-7163.MCT-07-0115; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kwee SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046591; Liu G, 2016, ONCOL LETT, V11, P2903, DOI 10.3892/ol.2016.4316; Liu LF, 2016, 2016 13TH ANNUAL IEEE INTERNATIONAL CONFERENCE ON SENSING, COMMUNICATION, AND NETWORKING (SECON), P10; Liu N, 2015, CANCER TRANSL MED, P55, DOI DOI 10.4103/2395-3977.155924; Liu YW, 2012, ONCOL REP, V28, P1013, DOI 10.3892/or.2012.1902; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Otero-Albiol D, 2016, CANC TRANSL MED, V2, P175, DOI DOI 10.3892/OL.2016.4316; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Peng QP, 2008, CANCER BIOL THER, V7, P1128, DOI 10.4161/cbt.7.7.6199; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Rempel A, 1996, CANCER RES, V56, P2468; Rho M, 2007, ANTICANCER RES, V27, P251; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wicks RT, 2015, NEURO-ONCOLOGY, V17, P70, DOI 10.1093/neuonc/nou143; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yang J, 2016, AM J CANCER RES, V6, P473; Yang LQ, 2012, BIOMED PHARMACOTHER, V66, P535, DOI 10.1016/j.biopha.2012.04.006; Yoshino H, 2013, CANCER SCI, V104, P1567, DOI 10.1111/cas.12280; Yu SJ, 2011, ACTA PHARMACOL SIN, V32, P912, DOI 10.1038/aps.2011.24; Zhang Y, 2012, FRONT BIOSCI-LANDMRK, V17, P700, DOI 10.2741/3952; Zhuo BB, 2015, BIOCHEM BIOPH RES CO, V464, P401, DOI 10.1016/j.bbrc.2015.06.092	52	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189353	10.1371/journal.pone.0189353	http://dx.doi.org/10.1371/journal.pone.0189353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220380	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900053
J	Pons, ED; Knauth, DR; Vigo, A; Mengue, SS				Pons, Emilia da Silva; Knauth, Daniela Riva; Vigo, Alvaro; Mengue, Sotero Serrate		PNAUM Res Grp	Predisposing factors to the practice of self-medication in Brazil: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM)	PLOS ONE			English	Article							HEALTH	Objective To understand the predisposing factors that lead to the practice of self-medication and the factors associated with the use of medicines via self-medication in the adult population of Brazil. Methods The analyzed data are part of the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM), a survey whose population consisted of individual residents permanently domiciled in urban areas in Brazil. In this work, the data references the 31 573 respondents aged 20 or higher (76.2% of the final PNAUM sample). Poisson regression models with robust variance were used for estimating the independent effect of each variable with medicine use via self-medication. Results Of the interviewees, 73.6% stated they had used some medication without medical recommendation if they had previously used the same product; 73.8% stated they had used non-prescribed medicine when the medicine was already present at home; and 35.5% stated they had used some non-prescribed medication when they knew someone who had already taken the same medication. The prevalence of self-medication was 18.3%. The variables associated with the highest probability of using medicine via self-medication were: geographic region within Brazil, gender, age group, per capita income, self-assessment of health, self-reported use of previously used non-prescribed medication, and self-reported use of non-prescribed medication when that medication was already present at home. Conclusions The use of medicines via self-medication in Brazil is relatively frequent and influenced by previous experience and familiarity with the medications, and is more common among women and individuals with low self-assessment of health.	[Pons, Emilia da Silva; Knauth, Daniela Riva; Vigo, Alvaro; Mengue, Sotero Serrate; PNAUM Res Grp] Univ Fed Rio Grande do Sul, Grad Program Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Pons, ED (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Epidemiol, Porto Alegre, RS, Brazil.	emiliapons@yahoo.com.br	Vigo, Alvaro/S-2243-2019	Vigo, Alvaro/0000-0002-5797-9470; GADELHA, CARLOS A. G./0000-0002-9148-8819; Mengue, Sotero/0000-0002-3349-8541	Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia [25000.111834/2]; CNPq Phd scholarship	Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia; CNPq Phd scholarship	This study was supported by Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia (Processo 25000.111834/2) to SSM PNAUM; and a CNPq Phd scholarship to ESP.	Arrais PSD, 1997, REV SAUDE PUBL, V31, P71, DOI 10.1590/S0034-89101997000100010; Bolanos H, 2005, DRUG INF J, V39, P99, DOI 10.1177/009286150503900113; BOLTANSKI Luc, 2004, CLASSES SOCIAIS CORP; Britten N., 1996, MODERN MED PERSPECTI; BUSH PJ, 1976, MED CARE, V14, P1014; BUSH PJ, 1978, J HEALTH SOC BEHAV, V19, P179, DOI 10.2307/2136533; Carrasco-Garrido P, 2008, PHARMACOEPIDEM DR S, V17, P193, DOI 10.1002/pds.1455; Carrera-Lasfuentes P, 2013, ATEN PRIM, V45, P528, DOI 10.1016/j.aprim.2013.05.006; Carvalho MF, 2005, CAD SAUDE PUBLICA S, V21, P100; de Loyola AI, 2002, REV SAUDE PUBL, V36, P55, DOI 10.1590/S0034-89102002000100009; Fainzang S, 2014, DRUG SAFETY, V37, P333, DOI 10.1007/s40264-014-0153-z; Figueiras A, 2000, EUR J EPIDEMIOL, V16, P19, DOI 10.1023/A:1007608702063; HAAK H, 1989, REV SAUDE PUBL, V23, P143, DOI 10.1590/S0034-89101989000200008; JOHNSON RE, 1983, MED CARE, V21, P225, DOI 10.1097/00005650-198302000-00009; Kaufert P, 2000, LIVING WORKING NEW M; Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8; LAM CLK, 1994, SOC SCI MED, V39, P1641, DOI 10.1016/0277-9536(94)90078-7; Laure P, 1998, THERAPIE, V53, P127; LEVIN LS, 1983, ANNU REV PUBL HEALTH, V4, P181, DOI 10.1146/annurev.pu.04.050183.001145; Lowy I, 2010, HIST CIENC SAUDE-MAN, V17, P53, DOI 10.1590/S0104-59702010000500004; Lopes N, 2003, THESIS; Lopes NM, 2009, RCCS ANN REV, P1; Martin E, 1996, GENDER SCI AUTHORITY; Mengue SS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006156, 10.1590/S1518-8787.2016050006156]; Montastruc JL, 1997, THERAPIE, V52, P105; Nielsen MW, 2003, EUR J CLIN PHARMACOL, V59, P677, DOI 10.1007/s00228-003-0678-z; SEGALL A, 1990, MED CARE, V28, P301, DOI 10.1097/00005650-199004000-00002; Vilarino JF, 1998, REV SAUDE PUBL, V32, P43, DOI 10.1590/S0034-89101998000100006; World Health Organization, 2000, REG GUID TEL PROD; World Health Organization, 1986, GUID ASS MED PROD US; World Health Organization, 1998, ROL PHARM SELF CAR S	31	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189098	10.1371/journal.pone.0189098	http://dx.doi.org/10.1371/journal.pone.0189098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220378	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900032
J	Qu, MN; Bunce, JA; Sicher, RC; Zhu, XC; Gao, B; Chen, GY				Qu, Mingnan; Bunce, James A.; Sicher, Richard C.; Zhu, Xiaocen; Gao, Bo; Chen, Genyun			An attempt to interpret a biochemical mechanism of C-4 photosynthetic thermotolerance under sudden heat shock on detached leaf in elevated CO2 grown maize	PLOS ONE			English	Article							HIGH-TEMPERATURE; ATMOSPHERIC CO2; PHOTOSYSTEM-II; CARBON-DIOXIDE; GAS-EXCHANGE; STRESS; WATER; METABOLITES; ACCLIMATION; ACTIVATION	Detached leaves at top canopy structures always experience higher solar irradiance and leaf temperature under natural conditions. The ability of tolerance to high temperature represents thermotolerance potential of whole-plants, but was less of concern. In this study, we used a heat-tolerant (B76) and a heat-susceptible (B106) maize inbred line to assess the possible mitigation of sudden heat shock (SHS) effects on photosynthesis (PN) and C-4 assimilation pathway by elevated [CO2]. Two maize lines were grown in field-based open top chambers (OTCs) at ambient and elevated (+ 180 ppm) [CO2]. Top-expanded leaves for 30 days after emergence were suddenly exposed to a 45 E C SHS for 2 hours in midday during measurements. Analysis on thermostability of cellular membrane showed there was 20% greater electrolyte leakage in response to the SHS in B106 compared to B76, in agreement with prior studies. Elevated [CO2] protected PN from SHS in B76 but not B106. The responses of PN to SHS among the two lines and grown CO2 treatments were closely correlated with measured decreases of NADP-ME enzyme activity and also to its reduced transcript abundance. The SHS treatments induced starch depletion, the accumulation of hexoses and also disrupted the TCA cycle as well as the C-4 assimilation pathway in the both lines. Elevated [CO2] reversed SHS effects on citrate and related TCA cycle metabolites in B106 but the effects of elevated [CO2] were small in B76. These findings suggested that heat stress tolerance is a complex trait, and it is difficult to identify biochemical, physiological or molecular markers that accurately and consistently predict heat stress tolerance.	[Qu, Mingnan; Zhu, Xiaocen; Chen, Genyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Qu, Mingnan; Bunce, James A.; Sicher, Richard C.] USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD USA; [Gao, Bo] Chinese Acad Med Sci, Inst Basic Med Sci, Centralab, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; United States Department of Agriculture (USDA); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Qu, MN (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China.; Qu, MN (corresponding author), USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD USA.	qmn@sippe.ac.cn		Bunce, James/0000-0002-6825-7510	National Natural Science Foundation of China [31700201]; Sailing Project, Shanghai Municipal Science and Technology Commission, China [17YF1421800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sailing Project, Shanghai Municipal Science and Technology Commission, China	This work is supported by National Natural Science Foundation of China (31700201) and Sailing Project, Shanghai Municipal Science and Technology Commission, China (17YF1421800).	Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Bunce JA, 2014, CROP SCI, V54, P1744, DOI 10.2135/cropsci2013.12.0803; Chen J, 2012, J SOIL WATER CONSERV, V67, P354, DOI 10.2489/jswc.67.5.354; Chen JP, 2010, CROP SCI, V50, P2506, DOI 10.2135/cropsci2009.12.0716; Crafts-Brandner SJ, 2002, PLANT PHYSIOL, V129, P1773, DOI 10.1104/pp.002170; Crafts-Brandner SJ, 2000, PLANTA, V212, P67, DOI 10.1007/s004250000364; Fancy Sally-Ann, 2008, P317, DOI 10.1007/978-1-59745-463-6_15; Fangmeier A, 1991, VEREINIGUNG ANGEW BO, V66, P97; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Heckathorn SA, 2002, FUNCT PLANT BIOL, V29, P933, DOI 10.1071/PP01191; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; LAVOLA A, 1994, OECOLOGIA, V99, P315, DOI 10.1007/BF00627744; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Maroco JP, 1999, PLANTA, V210, P115, DOI 10.1007/s004250050660; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MEARNS LO, 1984, J CLIM APPL METEOROL, V23, P1601, DOI 10.1175/1520-0450(1984)023<1601:EHTECI>2.0.CO;2; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu MN, 2014, PHOTOSYNTHETICA, V52, P211, DOI 10.1007/s11099-014-0022-0; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Ripley B, 2010, ANN BOT-LONDON, V105, P493, DOI 10.1093/aob/mcp307; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SAGE RF, 1994, PHOTOSYNTH RES, V39, P351, DOI 10.1007/BF00014591; Sage RF, 1999, C4 PLANT BIOL; Sharp RE, 2004, J EXP BOT, V55, P9; Sicher R, 2015, PHOTOSYNTHETICA, V53, P3, DOI 10.1007/s11099-015-0074-9; Sicher R, 2013, PLANTA, V238, P369, DOI 10.1007/s00425-013-1899-8; Sicher RC, 2008, PHYSIOL PLANTARUM, V134, P31, DOI 10.1111/j.1399-3054.2008.01127.x; Sicher RC, 2012, PHYSIOL PLANTARUM, V144, P238, DOI 10.1111/j.1399-3054.2011.01555.x; Song YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089725; Wang D, 2008, AM J BOT, V95, P165, DOI 10.3732/ajb.95.2.165	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187437	10.1371/journal.pone.0187437	http://dx.doi.org/10.1371/journal.pone.0187437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220364	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900005
J	Pan, WF; Sun, K; Tang, K; Xiao, QP; Ma, CX; Yu, C; Wei, ZY				Pan, Wenfei; Sun, Kang; Tang, Kun; Xiao, Qingpin; Ma, Chenxue; Yu, Cong; Wei, Zhiyi			Structural insights into ankyrin repeat-mediated recognition of the kinesin motor protein KIF21A by KANK1, a scaffold protein in focal adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; focal adhesion; protein complex; scaffold protein; tumor suppressor gene; KANK; ankyrin repeat	CELL; GROWTH; GENE; MICROTUBULES; ASSOCIATION; APOPTOSIS; MIGRATION; MUTATION; DELETION; MATRIX	Kidney ankyrin repeat-containing proteins (KANK1/2/3/4) belong to a family of scaffold proteins, playing critical roles in cytoskeleton organization, cell polarity, and migration. Mutations in KANK proteins are implicated in cancers and genetic diseases, such as nephrotic syndrome. KANK proteins can bind various target proteins through different protein regions, including a highly conserved ankyrin repeat domain (ANKRD). However, the molecular basis for target recognition by the ANKRD remains elusive. In this study, we solved a high-resolution crystal structure of the ANKRD of KANK1 in complex with a short sequence of the motor protein kinesin family member 21A (KIF21A), revealing that the highly specific target-binding mode of the ANKRD involves combinatorial use of two interfaces. Mutations in either interface disrupted the KANK1-KIF21A interaction. Cellular immunofluorescence localization analysis indicated that binding-deficient mutations block recruitment of KIF21A to focal adhesions by KANK1. In conclusion, our structural study provides mechanistic explanations for the ANKRD-mediated recognition of KIF21A and for many disease-related mutations identified in human KANK proteins.	[Pan, Wenfei; Sun, Kang; Tang, Kun; Xiao, Qingpin; Ma, Chenxue; Yu, Cong; Wei, Zhiyi] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Sun, Kang; Yu, Cong] Shenzhen Key Lab Cell Microenvironm, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Tang, Kun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Xiao, Qingpin] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Southern University of Science & Technology; Nankai University; University of Macau	Wei, ZY (corresponding author), Southern Univ Sci & Technol, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China.	weizy@sustc.edu.cn	Tang, Kun/GSD-3218-2022; Wei, Zhiyi/C-4315-2014; yu, cong/V-5140-2018; , 余聪/AAK-9457-2020; Wei, Zhiyi/N-9995-2019	Wei, Zhiyi/0000-0002-4446-6502; yu, cong/0000-0003-2912-6347; Wei, Zhiyi/0000-0002-4446-6502; sun, kang/0000-0003-4632-0176	Recruitment Program of Global Youth Experts of China; National Natural Science Foundation of China [31770791, 31570741, 31600612]; Natural Science Foundation of Guangdong Province [2016A030312016]; Science and Technology Planning Project of Guangdong Province [2017B030301018]; Shenzhen Science and Technology Innovation Commission [JCYJ20160229153100269, ZDSYS20140509142721429]	Recruitment Program of Global Youth Experts of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Shenzhen Science and Technology Innovation Commission	This work was supported in part by National Natural Science Foundation of China Grants 31770791 and 31570741 (to Z. W.) and 31600612 (to K. T.), Natural Science Foundation of Guangdong Province Grant 2016A030312016, Science and Technology Planning Project of Guangdong Province Grant 2017B030301018, and Shenzhen Science and Technology Innovation Commission Grants JCYJ20160229153100269 and ZDSYS20140509142721429. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Recruitment Program of Global Youth Experts of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Chen T, 2017, ONCOL REP, V38, P1663, DOI 10.3892/or.2017.5823; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; Cui ZB, 2017, SCI REP-UK, V7, DOI 10.1038/srep40325; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Guo XH, 2014, INT J ONCOL, V44, P797, DOI 10.3892/ijo.2014.2247; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Kakinuma N, 2009, BIOCHEM BIOPH RES CO, V386, P639, DOI 10.1016/j.bbrc.2009.06.109; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li CC, 2011, P NATL ACAD SCI USA, V108, P19228, DOI 10.1073/pnas.1117011108; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Ramot Y, 2014, J MED GENET, V51, P388, DOI 10.1136/jmedgenet-2014-102346; Roy BC, 2009, J CELL BIOL, V184, P253, DOI 10.1083/jcb.200805147; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Wang CY, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862798; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	34	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1944	1956		10.1074/jbc.M117.815779	http://dx.doi.org/10.1074/jbc.M117.815779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29217769	Green Published, hybrid			2022-12-26	WOS:000424948000010
J	Condon, SGF; Deena-Al Mahbuba; Armstrong, CR; Diaz-Vazquez, G; Craven, SJ; LaPointe, LM; Khadria, AS; Chadda, R; Crooks, JA; Rangarajan, N; Weibel, DB; Hoskins, AA; Robertson, JL; Cui, Q; Senes, A				Condon, Samson G. F.; Deena-Al Mahbuba; Armstrong, Claire R.; Diaz-Vazquez, Gladys; Craven, Samuel J.; LaPointe, Loren M.; Khadria, Ambalika S.; Chadda, Rahul; Crooks, John A.; Rangarajan, Nambirajan; Weibel, Douglas B.; Hoskins, Aaron A.; Robertson, Janice L.; Cui, Qiang; Senes, Alessandro			The FtsLB subcomplex of the bacterial divisome is a tetramer with an uninterrupted FtsL helix linking the transmembrane and periplasmic regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						co-evolution; divisome; cell division; bacteria; Escherichia coli (E; coli); membrane protein; computational biology; molecular modeling; fluorescence resonance energy transfer (FRET); bioinformatics; molecular dynamics; bacterial genetics	CELL-DIVISION PROTEIN; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; COILED-COILS; IMPROVED PREDICTION; SEPTAL RING; MOLECULAR-DYNAMICS; CONFORMER LIBRARY; CYTOKINETIC RING; TRIMERIC COMPLEX	In Escherichia coli, FtsLB plays a central role in the initiation of cell division, possibly transducing a signal that will eventually lead to the activation of peptidoglycan remodeling at the forming septum. The molecular mechanisms by which FtsLB operates in the divisome, however, are not understood. Here, we present a structural analysis of the FtsLB complex, performed with biophysical, computational, and in vivo methods, that establishes the organization of the transmembrane region and proximal coiled coil of the complex. FRET analysis in vitro is consistent with formation of a tetramer composed of two FtsL and two FtsB subunits. We predicted subunit contacts through co-evolutionary analysis and used them to compute a structural model of the complex. The transmembrane region of FtsLB is stabilized by hydrophobic packing and by a complex network of hydrogen bonds. The coiled coil domain probably terminates near the critical constriction control domain, which might correspond to a structural transition. The presence of strongly polar amino acids within the core of the tetrameric coiled coil suggests that the coil may split into two independent FtsQ-binding domains. The helix of FtsB is interrupted between the transmembrane and coiled coil regions by a flexible Gly-rich linker. Conversely, the data suggest that FtsL forms an uninterrupted helix across the two regions and that the integrity of this helix is indispensable for the function of the complex. The FtsL helix is thus a candidate for acting as a potential mechanical connection to communicate conformational changes between periplasmic, membrane, and cytoplasmic regions.	[Condon, Samson G. F.; Deena-Al Mahbuba; Armstrong, Claire R.; Diaz-Vazquez, Gladys; Craven, Samuel J.; LaPointe, Loren M.; Khadria, Ambalika S.; Crooks, John A.; Rangarajan, Nambirajan; Weibel, Douglas B.; Hoskins, Aaron A.; Senes, Alessandro] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Condon, Samson G. F.; Deena-Al Mahbuba; Craven, Samuel J.; LaPointe, Loren M.; Khadria, Ambalika S.; Crooks, John A.] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [Diaz-Vazquez, Gladys] Univ Wisconsin, Biophys Grad Program, Madison, WI 53706 USA; [Cui, Qiang] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Chadda, Rahul; Robertson, Janice L.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Senes, A (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	senes@wisc.edu	Chadda, Rahul/AAM-2085-2020; Rangarajan, Nambirajan/AAU-1349-2020	Rangarajan, Nambirajan/0000-0002-8332-2448; SENES, ALESSANDRO/0000-0002-3807-2275; Robertson, Janice/0000-0002-5499-9943; Condon, Samson/0000-0001-5072-9316	National Institutes of Health (NIH) [R01-GM099752]; National Science Foundation (NSF) [CHE-1415910]; NSF [DMS-1661900]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099752, R21GM126476, R01GM120260] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by National Institutes of Health (NIH) Grant R01-GM099752, National Science Foundation (NSF) Grant CHE-1415910 (to A. S.), and NSF Grant DMS-1661900 (to Q. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Alexeeva S, 2010, MOL MICROBIOL, V77, P384, DOI 10.1111/j.1365-2958.2010.07211.x; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Bramkamp M, 2006, MOL MICROBIOL, V62, P580, DOI 10.1111/j.1365-2958.2006.05402.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown JH, 1996, PROTEINS, V26, P134; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Du SS, 2016, P NATL ACAD SCI USA, V113, pE5052, DOI 10.1073/pnas.1606656113; Egan AJF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00455; Emami K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.253; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; Ghigo JM, 1999, MOL MICROBIOL, V31, P725, DOI 10.1046/j.1365-2958.1999.01213.x; Glas M, 2015, J BIOL CHEM, V290, P21498, DOI 10.1074/jbc.M115.654756; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; Kim JK, 2015, NUCLEIC ACIDS RES, V43, pW413, DOI 10.1093/nar/gkv360; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kulp DW, 2012, J COMPUT CHEM, V33, P1645, DOI 10.1002/jcc.22968; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mannik J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006638; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mohammadi T, 2014, J BIOL CHEM, V289, P14707, DOI 10.1074/jbc.M114.557371; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; North B, 2001, J MOL BIOL, V311, P1081, DOI 10.1006/jmbi.2001.4900; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robichon C, 2008, J BACTERIOL, V190, P6048, DOI 10.1128/JB.00462-08; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schmidt NW, 2017, PROTEIN SCI, V26, P414, DOI 10.1002/pro.3095; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramaniam S, 2014, PROTEINS, V82, P3177, DOI 10.1002/prot.24685; Subramaniam S, 2012, PROTEINS, V80, P2218, DOI 10.1002/prot.24111; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; van Saparoea HBV, 2013, J BIOL CHEM, V288, P24340, DOI 10.1074/jbc.M113.485888; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yang DC, 2011, P NATL ACAD SCI USA, V108, pE1052, DOI 10.1073/pnas.1107780108; Yang JC, 2004, MOL MICROBIOL, V52, P651, DOI 10.1111/j.1365-2958.2004.03991.x; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995	93	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1623	1641		10.1074/jbc.RA117.000426	http://dx.doi.org/10.1074/jbc.RA117.000426			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29233891	Green Published, hybrid			2022-12-26	WOS:000424201700015
J	Kitzberger, T; Falk, DA; Westerling, AL; Swetnam, TW				Kitzberger, Thomas; Falk, Donald A.; Westerling, Anthony L.; Swetnam, Thomas W.			Direct and indirect climate controls predict heterogeneous early-mid 21st century wildfire burned area across western and boreal North America	PLOS ONE			English	Article							FIRE REGIMES; ROCKY-MOUNTAINS; UNITED-STATES; FUTURE; VARIABILITY; SEVERITY; INCREASE; FORESTS; TRENDS; CALIFORNIA	Predicting wildfire under future conditions is complicated by complex interrelated drivers operating across large spatial scales. Annual area burned (AAB) is a useful index of global wildfire activity. Current and antecedent seasonal climatic conditions, and the timing of snowpack melt, have been suggested as important drivers of AAB. As climate warms, seasonal climate and snowpack co-vary in intricate ways, influencing fire at continental and sub-continental scales. We used independent records of seasonal climate and snow cover duration (last date of permanent snowpack, LDPS) and cell-based Structural Equation Models (SEM) to separate direct (climatic) and indirect (snow cover) effects on relative changes in AAB under future climatic scenarios across western and boreal North America. To isolate seasonal climate variables with the greatest effect on AAB, we ran multiple regression models of log-transformed AAB on seasonal climate variables and LDPS. We used the results of multiple regressions to project future AAB using GCM ensemble climate variables and LDPS, and validated model predictions with recent AAB trends. Direct influences of spring and winter temperatures on AAB are larger and more widespread than the indirect effect mediated by changes in LDPS in most areas. Despite significant warming trends and reductions in snow cover duration, projected responses of AAB to early-mid 21 st century are heterogeneous across the continent. Changes in AAB range from strongly increasing (one order of magnitude increases in AAB) to moderately decreasing (more than halving of baseline AAB). Annual wildfire area burned in coming decades is likely to be highly geographically heterogeneous, reflecting interacting regional and seasonal climate drivers of fire occurrence and spread.	[Kitzberger, Thomas] Univ Nacl Comahue, Lab Ecotono, CONICET INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina; [Falk, Donald A.; Swetnam, Thomas W.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Falk, Donald A.] Univ Arizona, Sch Nat Resources & Environm, Environm & Nat Resources Bldg, Tucson, AZ USA; [Westerling, Anthony L.] Univ Calif Merced, Sierra Nevada Res Inst, Merced, CA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; University of Arizona; University of Arizona; University of California System; University of California Merced	Kitzberger, T (corresponding author), Univ Nacl Comahue, Lab Ecotono, CONICET INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina.	kitzberger@comahue-conicet.gob.ar	Kitzberger, Thomas/H-9209-2015	Kitzberger, Thomas/0000-0002-9754-4121	US Forest Service Global Change Program; Rocky Mountain Research Station Grant [RJVA 08-JV-11221633-282]; Joint Fire Science Program [JFSP 09-2-01-10]	US Forest Service Global Change Program(United States Department of Agriculture (USDA)United States Forest Service); Rocky Mountain Research Station Grant; Joint Fire Science Program	This work was supported by the US Forest Service Global Change Program, Rocky Mountain Research Station Grant RJVA 08-JV-11221633-282 and the Joint Fire Science Program JFSP 09-2-01-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Abatzoglou JT, 2013, INT J WILDLAND FIRE, V22, P1003, DOI 10.1071/WF13019; Abbott BW, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034014; Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Armstrong R.L., 2005, NO HEMISPHERE EASE G; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; BERGERON Y, 1995, WATER AIR SOIL POLL, V82, P437, DOI 10.1007/BF01182853; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bowman DMJS, 2014, GLOBAL ECOL BIOGEOGR, V23, P821, DOI 10.1111/geb.12180; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Brown PM, 2006, ECOLOGY, V87, P2500, DOI 10.1890/0012-9658(2006)87[2500:CEOFRA]2.0.CO;2; Calkin DC, 2011, FOREST POLICY ECON, V13, P378, DOI 10.1016/j.forpol.2011.02.007; Collins BM, 2009, ECOSYSTEMS, V12, P114, DOI 10.1007/s10021-008-9211-7; Crimmins MA, 2006, INT J CLIMATOL, V26, P1001, DOI 10.1002/joc.1300; Crimmins MA, 2004, INT J WILDLAND FIRE, V13, P455, DOI 10.1071/WF03064; Duffy PA, 2005, ECOL APPL, V15, P1317, DOI 10.1890/04-0739; Falk DA., 2013, MERGING SCI MANAGEME, P357; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Fensholt R., 2012, REMOTE SENS ENVIRON, V121, P144, DOI DOI 10.1016/j.rse.2012.01.017; Flannigan M. D., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P847, DOI 10.1007/s11027-005-9020-7; Flannigan MD, 1998, J VEG SCI, V9, P469, DOI 10.2307/3237261; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Fox J., 2017, SEM STRUCTURAL EQUAT; Fule PZ, 2014, GLOBAL ECOL BIOGEOGR, V23, P825, DOI 10.1111/geb.12136; Gagnon AS, 2005, ARCTIC, V58, P370, DOI 10.14430/arctic451; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Girardin MP, 2009, GLOBAL CHANGE BIOL, V15, P2751, DOI 10.1111/j.1365-2486.2009.01869.x; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Grace J.B., 2006, STRUCT EQ MOD NAT; Hagmann RK, 2014, FOREST ECOL MANAG, V330, P158, DOI [10.1016/j.foreco.2014.0, 10.1016/j.foreco.2014.06.044]; Hart SJ, 2015, P NATL ACAD SCI USA, V112, P4375, DOI 10.1073/pnas.1424037112; Hartmann B, 2005, J CLIMATE, V18, P4824, DOI 10.1175/JCLI3532.1; Harvey BJ, 2013, ECOLOGY, V94, P2475, DOI 10.1890/13-0188.1; HOLDEN Z, 2007, FIRE ECOL, V3, P18, DOI DOI 10.4996/FIREECOLOGY.0302018; Holden ZA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030804; Hostetler SW, 2006, ATLAS CLIMATIC CONTR, V5139; Hurteau MD, 2014, ENVIRON SCI TECHNOL, V48, P2298, DOI 10.1021/es4050133; Hurteau MD, 2011, BIOSCIENCE, V61, P139, DOI 10.1525/bio.2011.61.2.9; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; JOHNSON EA, 1993, CAN J FOREST RES, V23, P1213, DOI 10.1139/x93-153; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Kasischke ES, 2002, INT J WILDLAND FIRE, V11, P131, DOI 10.1071/WF02023; Keane RE, 2015, ECOL MODEL, V309, P33, DOI 10.1016/j.ecolmodel.2015.04.009; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Loehman RA, 2011, FORESTS, V2, P832, DOI 10.3390/f2040832; Fauria MM, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000181; Marin-Spiotta E, 2016, FDN RESTORATION ECOL; MCCAMMON BP, 1976, FOREST SCI, V22, P323; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; McKenzie D, 2011, ECOLOGICAL STUDIES; Miller JD, 2012, ECOL APPL, V22, P184, DOI 10.1890/10-2108.1; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; O'Connor CD, 2011, GEOGR COMPASS, V5, P329, DOI 10.1111/j.1749-8198.2011.00428.x; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parisien MA, 2014, ECOL APPL, V24, P1341, DOI 10.1890/13-1477.1; Parisien MA, 2011, ECOL APPL, V21, P789, DOI 10.1890/10-0326.1; R Core Team, 2021, R LANGUAGE ENV STAT; Refsgaard JC, 2006, ADV WATER RESOUR, V29, P1586, DOI 10.1016/j.advwatres.2005.11.013; Romps DM, 2014, SCIENCE, V346, P851, DOI 10.1126/science.1259100; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stocks BJ, 1998, CLIMATIC CHANGE, V38, P1, DOI 10.1023/A:1005306001055; SWETNAM TW, 1990, SCIENCE, V249, P1017, DOI 10.1126/science.249.4972.1017; Terrier A, 2013, ECOL APPL, V23, P21, DOI 10.1890/12-0425.1; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van Mantgem PJ, 2013, ECOL LETT, V16, P1151, DOI 10.1111/ele.12151; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Wallenius TH, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00055.1; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, CLIMATIC CHANGE, V109, P445, DOI 10.1007/s10584-011-0329-9; Westerling AL, 2002, INT J WILDLAND FIRE, V11, P257, DOI 10.1071/WF02009; Westerling AL, 2003, B AM METEOROL SOC, V84, P595, DOI 10.1175/BAMS-84-5-595; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Westerling AL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0178; Wiedinmyer Christine, 2007, Carbon Balance Manag, V2, P10, DOI 10.1186/1750-0680-2-10; WILCOX R.R, 2005, INTRO ROBUST ESTIMAT, P423; Williams AP, 2014, J APPL METEOROL CLIM, V53, P2671, DOI 10.1175/JAMC-D-14-0053.1; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Yool SR, 2001, GEOCARTO INT, V16, P7, DOI DOI 10.1080/10106040108542177; Zhang Quan-Fa, 2007, Journal of Forestry Research (Harbin), V18, P55, DOI 10.1007/s11676-007-0010-3; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	85	95	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188486	10.1371/journal.pone.0188486	http://dx.doi.org/10.1371/journal.pone.0188486			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244839	Green Published, gold			2022-12-26	WOS:000418184700006
J	Zhang, WF; Yan, XP; Yang, JQ				Zhang, Wenfen; Yan, Xinping; Yang, Jiaqi			Optimized maritime emergency resource allocation under dynamic demand	PLOS ONE			English	Article							ROBUST OPTIMIZATION; RISK-ASSESSMENT; MODEL; LOCATION	Emergency resource is important for people evacuation and property rescue when accident occurs. The relief efforts could be promoted by a reasonable emergency resource allocation schedule in advance. As the marine environment is complicated and changeful, the place, type, severity of maritime accident is uncertain and stochastic, bringing about dynamic demand of emergency resource. Considering dynamic demand, how to make a reasonable emergency resource allocation schedule is challenging. The key problem is to determine the optimal stock of emergency resource for supplier centers to improve relief efforts. This paper studies the dynamic demand, and which is defined as a set. Then a maritime emergency resource allocation model with uncertain data is presented. Afterwards, a robust approach is developed and used to make sure that the resource allocation schedule performs well with dynamic demand. Finally, a case study shows that the proposed methodology is feasible in maritime emergency resource allocation. The findings could help emergency manager to schedule the emergency resource allocation more flexibly in terms of dynamic demand.	[Zhang, Wenfen; Yan, Xinping] Wuhan Univ Technol, Intelligent Transportat Syst Res Ctr ITSC, Wuhan, Hubei, Peoples R China; [Zhang, Wenfen; Yan, Xinping] MoST Wuhan, Natl Engn Res Ctr Water Transport Safety WTSC, Wuhan, Hubei, Peoples R China; [Yang, Jiaqi] Wuhan Univ Technol, Sch Transportat, Wuhan, Hubei, Peoples R China	Wuhan University of Technology; National Engineering Research Center for Water Transport Safety; Wuhan University of Technology	Yan, XP (corresponding author), Wuhan Univ Technol, Intelligent Transportat Syst Res Ctr ITSC, Wuhan, Hubei, Peoples R China.; Yan, XP (corresponding author), MoST Wuhan, Natl Engn Res Ctr Water Transport Safety WTSC, Wuhan, Hubei, Peoples R China.	xpyan@whut.edu.cn	Yan, Xinping/F-3627-2017	Yan, Xinping/0000-0002-2265-2689; Zhang, Wenfen/0000-0002-3740-1890	Key Project in the National Science & Technology Pillar Program [2015BAG20B05]; project of National Science Foundation of China [51609194]; special funds of Hubei Technical Innovation Project [2016AAA055]	Key Project in the National Science & Technology Pillar Program; project of National Science Foundation of China(National Natural Science Foundation of China (NSFC)); special funds of Hubei Technical Innovation Project	The authors would like to thank the Key Project in the National Science & Technology Pillar Program (Grant No.2015BAG20B05),the project of National Science Foundation of China (Grant No. 51609194), the special funds of Hubei Technical Innovation Project (Grant No. 2016AAA055), for their financial support in this research.	Ai YF, 2015, TRANSPORT RES E-LOG, V83, P170, DOI 10.1016/j.tre.2015.09.006; Ben-Tal A, 2000, MATH PROGRAM, V88, P411, DOI 10.1007/PL00011380; Ben-Tal A, 2004, MATH PROGRAM, V25, P1; Ben-Tal A, 2009, EUR J OPER RES, V199, P922, DOI 10.1016/j.ejor.2009.01.058; Bertsimas D, 2004, OPER RES, V52, P35, DOI 10.1287/opre.1030.0065; Bozorgi-Amiri A, 2013, OR SPECTRUM, V35, P905, DOI 10.1007/s00291-011-0268-x; Caunhye A.M., 2012, SOCIOECONOMIC PLANNI, V46, P4, DOI [10.1016/j.seps.2011.04.004, DOI 10.1016/J.SEPS.2011.04.004, https://doi.org/10.1016/j.seps.2011.04.004]; Caunhye AM, 2016, TRANSPORT RES E-LOG, V90, P161, DOI 10.1016/j.tre.2015.10.011; Fiedrich F, 2000, SAFETY SCI, V35, P41, DOI 10.1016/S0925-7535(00)00021-7; Fiorucci P., 2009, RISK ANAL, V29, p62 ; Leung SCH, 2007, EUR J OPER RES, V181, P224, DOI 10.1016/j.ejor.2006.06.011; Li X., 2012, SYSTEMS ENG PROCEDIA, V5, P248, DOI [DOI 10.1016/J.SEPR0.2012.04.039, 10.1016/j.sepro.2012.04.039, DOI 10.1016/J.SEPRO.2012.04.039]; Liu Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175840; MULVEY JM, 1995, OPER RES, V43, P264, DOI 10.1287/opre.43.2.264; Najafi M, 2013, TRANSPORT RES E-LOG, V49, P217, DOI 10.1016/j.tre.2012.09.001; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143052; Salmeron J, 2010, PROD OPER MANAG, V19, P561, DOI 10.1111/j.1937-5956.2009.01119.x; Sheu JB, 2010, TRANSPORT RES E-LOG, V46, P1, DOI 10.1016/j.tre.2009.07.005; Soares CG, 2001, RELIAB ENG SYST SAFE, V74, P299, DOI 10.1016/S0951-8320(01)00104-1; Sormunen OVE, 2015, P I MECH ENG M-J ENG, V229, P303, DOI 10.1177/1475090213515640; Tzeng GH, 2007, TRANSPORT RES E-LOG, V43, P673, DOI 10.1016/j.tre.2006.10.012; Vairaktarakis GL, 2000, INT J PROD ECON, V66, P213, DOI 10.1016/S0925-5273(99)00129-2; Vlachos D, 2007, COMPUT OPER RES, V34, P367, DOI 10.1016/j.cor.2005.03.005; Wang J., 2012, SYSTEMS ENG PROCEDIA, V5, P125, DOI DOI 10.1016/J.SEPRO.2012.04.020; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; Wang Y, 2015, EXPERT SYST APPL, V42, P5019, DOI 10.1016/j.eswa.2015.02.058; Wu B, 2016, SAFETY SCI, V88, P108, DOI 10.1016/j.ssci.2016.04.026; Yang HM, 2015, J TRANSPORT INFORM S, V33, P82; Yu CS, 2000, INT J PROD ECON, V64, P385, DOI 10.1016/S0925-5273(99)00074-2; Zhang D, 2016, SAFETY SCI, V82, P352, DOI 10.1016/j.ssci.2015.10.004	31	9	10	9	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189411	10.1371/journal.pone.0189411	http://dx.doi.org/10.1371/journal.pone.0189411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240792	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600032
J	Hayashi, H; Cherpokova, D; Martinod, K; Witsch, T; Wong, SL; Gallant, M; Cifuni, SM; Guarente, LP; Wagner, DD				Hayashi, Hideki; Cherpokova, Deya; Martinod, Kimberly; Witsch, Thilo; Wong, Siu Ling; Gallant, Maureen; Cifuni, Stephen M.; Guarente, Leonard P.; Wagner, Denisa D.			Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL OXIDATIVE STRESS; PEPTIDYLARGININE DEIMINASE 4; DEEP-VEIN THROMBOSIS; NADPH-OXIDASE; EXTRACELLULAR TRAPS; ACTIVATION; HOMOLOG; RELEASE; GENE	Inflammation is a common denominator in chronic diseases of aging. Yet, how inflammation fuels these diseases remains unknown. Neutrophils are the primary leukocytes involved in the early phase of innate immunity and inflammation. As part of their anti-microbial defense, neutrophils form extracellular traps (NETs) by releasing decondensed chromatin lined with cytotoxic proteins. NETs have been shown to induce tissue injury and thrombosis. Here, we demonstrated that Sirt3, a nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase, an enzyme linked to human longevity, was expressed in mouse neutrophils and platelets. Using Sirt3-/- mice as a model of accelerated aging, we investigated the effects of Sirt3 deficiency on NETosis and platelet function, aiming to detect enhancement of thrombosis. More mitochondrial reactive oxygen species (ROS) were generated in neutrophils and platelets of Sirt3-/- mice compared to WT, when stimulated with a low concentration of phorbol 12-myristate 13-acetate (PMA) and a high concentration of thrombin, respectively. There were no differences in in vitro NETosis, with or without stimulation. Platelet aggregation was mildly augmented in Sirt3-/- mice compared to WT mice, when stimulated with a low concentration of collagen. The effect of Sirt3 deficiency on platelet and neutrophil activation in vivo was examined by the venous thrombosis model of inferior vena cava stenosis. Elevation of plasma DNA concentration was observed after stenosis in both genotypes, but no difference was shown between the two genotypes. The systemic response to thrombosis was enhanced in Sirt3-/- mice with significantly elevated neutrophil count and reduced platelet count. However, no differences were observed in incidence of thrombus formation, thrombus weight and thrombin-antithrombin complex generation between WT and Sirt3-/- mice. We conclude that Sirt3 does not considerably impact NET formation, platelet function, or venous thrombosis in healthy young mice.	[Hayashi, Hideki; Cherpokova, Deya; Martinod, Kimberly; Witsch, Thilo; Wong, Siu Ling; Gallant, Maureen; Cifuni, Stephen M.; Wagner, Denisa D.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02215 USA; [Hayashi, Hideki; Cherpokova, Deya; Martinod, Kimberly; Witsch, Thilo; Wong, Siu Ling; Wagner, Denisa D.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Guarente, Leonard P.] MIT, Dept Biol, Paul F Glenn Ctr Sci Aging, Cambridge, MA USA; [Wagner, Denisa D.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital	Wagner, DD (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02215 USA.; Wagner, DD (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Wagner, DD (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02215 USA.	denisa.wagner@childrens.harvard.edu	Martinod, Kimberly/K-4742-2019; Wong, Siu Ling Christine/A-9895-2019	Martinod, Kimberly/0000-0002-1026-6107; 	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL102101, R01HL125501]; Deutsche Forschungsgemeinschaft [CH 1734/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135765, R01HL102101, R01HL125501] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health Grants R01HL102101 and R01HL125501 (to D.D.W.). D.C. was supported by a postdoctoral fellowship of the Deutsche Forschungsgemeinschaft (CH 1734/1-1).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852; Cakman I, 1996, MECH AGEING DEV, V87, P197, DOI 10.1016/0047-6374(96)01708-3; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Chlopicki S, 2004, ANTIOXID REDOX SIGN, V6, P691, DOI 10.1089/1523086041361640; Clark RA, 1999, J INFECT DIS, V179, pS309, DOI 10.1086/513849; DAHLGREN C, 1992, BIOCHIM BIOPHYS ACTA, V1137, P182, DOI 10.1016/0167-4889(92)90200-U; Dayal S, 2013, CIRCULATION, V127, P1308, DOI 10.1161/CIRCULATIONAHA.112.000966; Delaney MK, 2016, ARTERIOSCL THROM VAS, V36, P846, DOI 10.1161/ATVBAHA.116.307308; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; Favaloro EJ, 2014, SEMIN THROMB HEMOST, V40, P621, DOI 10.1055/s-0034-1384631; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; HANDIN RI, 1977, J CLIN INVEST, V59, P959, DOI 10.1172/JCI108718; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; KASJANOVOVA D, 1986, MECH AGEING DEV, V37, P175, DOI 10.1016/0047-6374(86)90074-6; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Koyama T, 2011, FREE RADICAL BIO MED, V51, P1258, DOI 10.1016/j.freeradbiomed.2011.05.028; Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953; Kumari S, 2015, J BIOL CHEM, V290, P12290, DOI 10.1074/jbc.M114.615948; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Martinod K, 2017, J EXP MED, V214, P439, DOI 10.1084/jem.20160530; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ogawa Kishiko, 2008, Immun Ageing, V5, P13, DOI 10.1186/1742-4933-5-13; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Puurunen MK, 2016, THROMB RES, V145, P27, DOI 10.1016/j.thromres.2016.06.033; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; SALVEMINI D, 1989, BRIT J PHARMACOL, V97, P1145, DOI 10.1111/j.1476-5381.1989.tb12572.x; Schroder AK, 2003, MECH AGEING DEV, V124, P419, DOI 10.1016/S0047-6374(03)00017-4; SHATOS MA, 1991, ARTERIOSCLER THROMB, V11, P594, DOI 10.1161/01.ATV.11.3.594; Sillesen M, 2016, J TRAUMA ACUTE CARE, V80, P26, DOI 10.1097/TA.0000000000000896; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang XQ, 2014, J CELL MOL MED, V18, P2298, DOI 10.1111/jcmm.12395; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; ZAHAVI J, 1980, THROMB RES, V17, P329, DOI 10.1016/0049-3848(80)90067-5; Zeng LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088019; Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4; Zhang PP, 2013, THROMB RES, V132, P696, DOI 10.1016/j.thromres.2013.09.034	60	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188341	10.1371/journal.pone.0188341	http://dx.doi.org/10.1371/journal.pone.0188341			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236713	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100015
J	Jaworska, K; Huc, T; Samborowska, E; Dobrowolski, L; Bielinska, K; Gawlak, M; Ufnal, M				Jaworska, Kinga; Huc, Tomasz; Samborowska, Emilia; Dobrowolski, Leszek; Bielinska, Klaudia; Gawlak, Maciej; Ufnal, Marcin			Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; INTESTINAL BARRIER; DISEASE; CHOLINE; CARNITINE; BETAINE	An increased blood trimethylamine N-oxide (TMAO) has emerged as a marker of cardiovascular mortality, however, the mechanisms of the increase are not clear. We evaluated if hypertension was associated with changes in the colon permeability to trimethylamine (TMA), a TMAO precursor. We did experiments on male, 24-26-week-old normotensive Wistar-Kyoto rats (WKY), spontaneously hypertensive rats (SHR) and SHR treated with enalapril, an antihypertensive drug (SHR-E). To check the colon permeability and liver TMA clearance, blood was collected from the portal vein and hepatic veins confluence, at baseline and after the intracolonic administration of TMA. Arterial blood pressure (BP) and intestinal blood flow (IBF) recordings and histological assessment of the colon were performed. SHR showed an increased gut-blood barrier permeability to TMA. Namely, at baseline SHR had a higher BP and portal blood TMA, but a lower IBF than WKY. After the intracolonic administration of TMA, SHR had a significantly higher portal blood TMA and higher TMA liver clearance than WKY. In SHR the arteriolar walls of the colon mucosa were significantly thicker than in WKY. Furthermore, SHR showed a significant decrease in the height of the mucosa. In contrast, SHR-E had lower portal blood TMA, lower BP and smaller thickness of arteriolar walls, but higher IBF than SHR, which indicates improved function of the gut-blood barrier in SHR-E. All groups had similar immunostaining of occludin and zonula occludens1, markers of tight junctions. In conclusion, hypertensive rats show an increased permeability of the colon to TMA, which is accompanied by morphological and hemodynamic alterations in the colon. Therefore, cardiovascular diseases may be characterized by an increased permeability of the gut-blood barrier to bacterial metabolites such as TMA.	[Jaworska, Kinga; Huc, Tomasz; Bielinska, Klaudia; Ufnal, Marcin] Med Univ Warsaw, Dept Expt Physiol & Pathophysiol, Lab Ctr Preclin Res, Warsaw, Poland; [Samborowska, Emilia] Polish Acad Sci, Inst Biochem & Biophys, Mass Spectrometry Lab, Warsaw, Poland; [Dobrowolski, Leszek] Polish Acad Sci, Dept Renal & Body Fluid Physiol, M Mossakowski Med Res Ctr, Warsaw, Poland; [Gawlak, Maciej] Med Univ Warsaw, Ctr Preclin Res, Lab Physiol & Pathophysiol, Warsaw, Poland	Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Medical University of Warsaw	Ufnal, M (corresponding author), Med Univ Warsaw, Dept Expt Physiol & Pathophysiol, Lab Ctr Preclin Res, Warsaw, Poland.	mufnal@wum.edu.pl	Ufnal, Marcin/I-6868-2019; Dobrowolski, Leszek/GPF-8063-2022; Jaworska, Kinga/AAP-9827-2020; Bielińska, Klaudia/W-7107-2018; Huć, Tomasz/W-6888-2018	Ufnal, Marcin/0000-0003-0088-8284; Jaworska, Kinga/0000-0002-0281-015X; Bielińska, Klaudia/0000-0003-0142-5943; Huć, Tomasz/0000-0001-6491-3800; Samborowska, Emilia/0000-0002-0646-0847	National Science Centre, Poland [2016/21/B/NZ5/02544]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by National Science Centre, Poland grant no. 2016/21/B/NZ5/02544.	Bain MA, 2005, CURR DRUG METAB, V6, P227, DOI 10.2174/1389200054021807; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; FINK MP, 1991, SURGERY, V110, P154; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kuhn T, 2017, CLIN CHEM LAB MED, V55, P261, DOI 10.1515/cclm-2016-0374; Li XS, 2017, EUROPEAN HEART J; Mansoor JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095331; Matheson PJ, 2000, J SURG RES, V93, P182, DOI 10.1006/jsre.2000.5862; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Mishra RC, 2010, AM J PHYSIOL-HEART C, V298, pH1789, DOI 10.1152/ajpheart.00810.2009; Nowinski A, 2018, NUTRITION, V46, P7, DOI 10.1016/j.nut.2017.08.001; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Santisteban MM, 2017, CIRC RES, V120, P312, DOI 10.1161/CIRCRESAHA.116.309006; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmieder RE, 2010, DTSCH ARZTEBL INT, V107, P866, DOI 10.3238/arztebl.2010.0866; Senthong V., 2016, J AM HEART ASS, V5; Thuijls G, 2009, SHOCK, V31, P164, DOI 10.1097/SHK.0b013e31817fc310; Tomasova L, 2016, MOLECULES, V21, DOI 10.3390/molecules21111558; Tomasova L, 2016, NITRIC OXIDE-BIOL CH, V60, P50, DOI 10.1016/j.niox.2016.09.007; Ufnal M, 2017, MED HYPOTHESES, V98, P35, DOI 10.1016/j.mehy.2016.11.012; Ufnal M, 2014, CAN J CARDIOL, V30, P1700, DOI 10.1016/j.cjca.2014.09.010; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Washington Christopher, 2012, Clin Colon Rectal Surg, V25, P228, DOI 10.1055/s-0032-1329534; Yancey PH, 2015, J EXP BIOL, V218, P1880, DOI 10.1242/jeb.114355; ZEISEL SH, 1983, J PHARMACOL EXP THER, V225, P320; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	30	73	76	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							0189310	10.1371/journal.pone.0189310	http://dx.doi.org/10.1371/journal.pone.0189310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236735	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100056
J	Paris, TM; Allan, SA; Udell, BJ; Stansly, PA				Paris, Thomson M.; Allan, Sandra A.; Udell, Bradley J.; Stansly, Philip A.			Evidence of behavior-based utilization by the Asian citrus psyllid of a combination of UV and green or yellow wavelengths	PLOS ONE			English	Article							BLOCKING PLASTIC FILMS; DIAPHORINA-CITRI; HEMIPTERA LIVIIDAE; ABDOMINAL COLOR; SPECTRAL SENSITIVITY; STICKY TRAPS; VISUAL CUES; ULTRAVIOLET; FLIGHT; VISION	The Asian citrus psyllid, Diaphorina citri, vectors huanglongbing (HLB), the most serious disease affecting citrus globally. D. citri and HLB have spread to the major citrus growing regions of North America causing billions of dollars of damage in Florida alone. The visual behavior of D. citri is not well characterized and more knowledge is needed to improve attractive traps for monitoring and control of the D. citri. Bioassays were conducted to evaluate attraction to light transmitted through different colored filters. The addition of ultra-violet light (< 400 nm) enhanced attraction of D. citri to transparent visual targets made of green or yellow filters. However, attraction to blue targets was unaffected by UV light. This is the first study to demonstrate a phytophagous insect responding to a hue that is a combination of long and short wavelengths. Further testing is needed to determine how D. citri uses such discriminatory powers in the field. Our results further imply that D. citri utilize color vision, as the less intense yellow and green hues were chosen over white light. In summary, this research provides an increased understanding of D. citri visual behavior and can be used for the development of a more attractive D. citri trap than those currently available.	[Paris, Thomson M.; Stansly, Philip A.] Southwest Citrus Res & Extens Ctr, Entomol & Nematol Dept, Immokalee, FL USA; [Paris, Thomson M.; Allan, Sandra A.; Udell, Bradley J.] ARS, USDA, Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Udell, Bradley J.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Allan, SA (corresponding author), ARS, USDA, Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	sandy.allan@ars.usda.gov			Florida Citrus Research and Development Foundation [701]	Florida Citrus Research and Development Foundation	All funds for this research were provided by the Florida Citrus Research and Development Foundation agreement no 701. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Heidi Burnside for assisting with assays. Kirsten Pelz-Stelinski and her lab for providing a HLB positive citrus plant. Nathen Lord for assisting in the measurements of HLB+ plants using his spectrophotometer at Georgia College and State University. This work was funded by the Florida Citrus Research and Development Foundation agreement no 701. Mention of a trademark or proprietary product is solely for the purpose of providing specific information and does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture and does not imply its approval to the exclusion of other products that may also be suitable. USDA is an equal opportunity provider and employer.	ADLERZ WC, 1968, J ECON ENTOMOL, V61, P1276, DOI 10.1093/jee/61.5.1276; Allan SA, 2015, GROW DAY INT RES C H; Antignus Y, 2001, ENVIRON ENTOMOL, V30, P394, DOI 10.1603/0046-225X-30.2.394; Bove JM, 2006, J PLANT PATHOL, V88, P7; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Caldwell MM., 1971, PHOTOPHYSIOLOGY, V6, P131, DOI [10.1016/b978-0-12-282606-1.50010-6, DOI 10.1016/B978-0-12-282606-1.50010-6, 10.1016/B978-0-12-282606-1.50010-6]; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; COOMBE PE, 1982, PHYSIOL ENTOMOL, V7, P243, DOI 10.1111/j.1365-3032.1982.tb00297.x; COOMBE PE, 1981, J COMP PHYSIOL, V144, P83, DOI 10.1007/BF00612801; Croxton SD, 2014, PEST MANAG SCI, V70, P318, DOI 10.1002/ps.3566; DAUMER K, 1956, Z VERGL PHYSIOL, V38, P413; Doring TF, 2007, ENTOMOL GEN, V30, P233; Doring TF, 2014, ANN APPL BIOL, V165, P3, DOI 10.1111/aab.12142; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; Doring TF, 2011, PHYSIOL ENTOMOL, V36, P392, DOI 10.1111/j.1365-3032.2011.00805.x; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Farnier K, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00067; Finkbeiner SD, 2017, J EXP BIOL, V220, P1267, DOI 10.1242/jeb.153593; GAUSMAN HW, 1975, AGRON J, V67, P720, DOI 10.2134/agronj1975.00021962006700050036x; Godfrey KE, 2013, FLA ENTOMOL, V96, P1406, DOI 10.1653/024.096.0420; GOLDSMITH TH, 1994, VISION RES, V34, P1479, DOI 10.1016/0042-6989(94)90150-3; Gottwald TR, 2007, CITRUS HUANGOLONGBIN; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2010, CROP PROT, V29, P1341, DOI 10.1016/j.cropro.2010.06.003; HARDIE J, 1989, J INSECT PHYSIOL, V35, P619, DOI 10.1016/0022-1910(89)90124-8; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hodges AW, 2012, FE903 EDIS IFAS; Holmes MG, 2002, PLANT CELL ENVIRON, V25, P85, DOI 10.1046/j.1365-3040.2002.00779.x; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2006, INVERTEBRATE VISION, P250; KENNEDY JS, 1959, ANNU REV ENTOMOL, V4, P139, DOI 10.1146/annurev.en.04.010159.001035; KENNEDY JS, 1951, NATURE, V168, P825, DOI 10.1038/168825a0; Kevan P. G., 1978, The pollination of flowers by insects, P51; Kirchner SM, 2005, J INSECT PHYSIOL, V51, P1255, DOI 10.1016/j.jinsphys.2005.07.002; Kohen E., 1995, PHOTOBIOLOGY; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; KRING JB, 1972, ANNU REV ENTOMOL, V17, P461, DOI 10.1146/annurev.en.17.010172.002333; Kumar P, 2006, ENVIRON ENTOMOL, V35, P1069, DOI 10.1603/0046-225X-35.4.1069; Legarrea S, 2010, PHOTOCHEM PHOTOBIOL, V86, P324, DOI 10.1111/j.1751-1097.2009.00657.x; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; MACDOWALL FD, 1972, CAN ENTOMOL, V104, P299, DOI 10.4039/Ent104299-3; Mann RS, 2011, B ENTOMOL RES, V101, P89, DOI 10.1017/S0007485310000222; Martini X, 2016, FLA ENTOMOL, V99, P178, DOI 10.1653/024.099.0204; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; Michaud JP, 1999, FLA ENTOMOL, V82, P424, DOI 10.2307/3496869; Miranda MP, 2015, J ECON ENTOMOL, V108, P245, DOI 10.1093/jee/tou036; Mishra AR, 2012, T ASABE, V55, P711; MOERICKE V, 1969, ENTOMOL EXP APPL, V12, P524, DOI 10.1007/BF00297083; Moericke V., 1955, ANGE ENTOMOL, V37, P29; MOERICKE V, 1950, Z TIERPSYCHOL, V7, P263; Moericke V, 1979, PUBLIKATIONEN WISSEN; Monzo C, 2015, ENVIRON ENTOMOL, V44, P780, DOI 10.1093/ee/nvv032; Moore W.D., 1965, P FLA STATE HORTIC S, V78, P187; NEUMEYER C, 1992, J COMP PHYSIOL A, V171, P639; Paris TM, 2017, ENVIRON ENTOMOL, V46, P143, DOI 10.1093/ee/nvw161; Paris TM, 2015, ENTOMOL EXP APPL, V155, P137, DOI 10.1111/eea.12294; Patt Joseph M., 2014, Insects, V5, P921, DOI 10.3390/insects5040921; Patti JM, 2010, ENVIRON ENTOMOL, V39, P618, DOI 10.1603/EN09216; Pourreza A, 2014, T ASABE, V57, P259; Pourreza A, 2013, ASABE ANN INT MET; Pourreza A, 2015, COMPUT ELECTRON AGR, V110, P221, DOI 10.1016/j.compag.2014.11.021; Prokopy RJ, 1983, ANNU REV ENTOMOL, V28, P217; Qureshi JA, 2014, J ECON ENTOMOL, V107, P125; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Sankaran S, 2013, SENSORS-BASEL, V13, P2117, DOI 10.3390/s130202117; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Setamou M, 2014, J INSECT BEHAV, V27, P540, DOI 10.1007/s10905-014-9448-2; Setamou M, 2012, J INSECT BEHAV, V25, P264, DOI 10.1007/s10905-011-9295-3; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Stelinski L, 2013, JOVE-J VIS EXP, DOI 10.3791/50229; Stockton DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149815; Tansey JA, 2017, PEST MANAG SCI, V73, P904, DOI 10.1002/ps.4362; Tiwari S, 2013, PEST MANAG SCI, V69, P535, DOI 10.1002/ps.3407; Wenninger EJ, 2008, ANN ENTOMOL SOC AM, V101, P585, DOI 10.1603/0013-8746(2008)101[585:DASPIA]2.0.CO;2; Wenninger EJ, 2009, ANN ENTOMOL SOC AM, V102, P476, DOI 10.1603/008.102.0318; Wenninger EJ, 2009, ENVIRON ENTOMOL, V38, P225, DOI 10.1603/022.038.0128; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; WOLFENBARGER DO, 1968, J ECON ENTOMOL, V61, P34, DOI 10.1093/jee/61.1.34	84	23	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189228	10.1371/journal.pone.0189228	http://dx.doi.org/10.1371/journal.pone.0189228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236740	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100051
J	Ochieng, J; Afari-Sefa, V; Lukumay, PJ; Dubois, T				Ochieng, Justus; Afari-Sefa, Victor; Lukumay, Philipo Joseph; Dubois, Thomas			Determinants of dietary diversity and the potential role of men in improving household nutrition in Tanzania	PLOS ONE			English	Article							MICRONUTRIENT ADEQUACY; RURAL TANZANIA; BURKINA-FASO; LOW-INCOME; FOOD; INDICATOR; WOMEN; SECURITY; CHILDREN; DISEASE	Good nutrition is a prerequisite for a healthy and active life, especially for agriculture-dependent households. However, diets in most households in Tanzania lack diversity because the intake of meat, poultry, fish, and vegetables and fruits is low. This study estimates factors influencing dietary diversity of the household, children under five years, and women using primary survey data. It qualitatively assesses male dietary patterns and men's potential role in improving the nutritional status of the entire household. The findings show that the most consumed foods within the household are cereals, vegetables, oils and fats, spices, condiments and beverages. Children (d = 0.4; p<0.05) and women (d = 0.5; p<0.01) in female-headed households have low dietary diversity compared to those in male-headed households. Women and children access less diverse diets since 46% and 26%, achieved minimum dietary diversity respectively. Production of vegetables (coef. 0.34; p<0.05) play an important role in improving the dietary diversity of women. Gender (coef. 0.05; p<0.10) and education of the household head (coef. 0.02; p<0.01), food preparation and nutrition training (coef. 0.10; p<0.05) are important factors influencing dietary diversity of the members of a household. Results suggest that there is a need to support community-based programs to provide information on food and the importance of vegetables, their preparation, consumption and utilization to address food and nutrition challenges. Men can contribute towards improving household nutrition security by reducing consumption of food away from the home, especially during periods of food shortages. We recommend the use of complementary quantitative research to determine the patterns and dynamics of men's dietary diversity and compare it with that of other household members.	[Ochieng, Justus; Dubois, Thomas] Eastern & Southern Africa, World Vegetable Ctr, Arusha, Tanzania; [Afari-Sefa, Victor] World Vegetable Ctr, West & Cent Africa Coastal & Humid Reg, IITA Benin Campus, Cotonou, Benin; [Lukumay, Philipo Joseph] Univ Delaware, Dept Appl Econ & Stat, Newark, DC USA	University of Delaware	Ochieng, J (corresponding author), Eastern & Southern Africa, World Vegetable Ctr, Arusha, Tanzania.	justus.ochieng@worldveg.org		Justus, Ochieng/0000-0002-6326-1377	German Federal Ministry for Economic Cooperation and Development (GIZ) Tanzania, Dar es Salaam [83219278]	German Federal Ministry for Economic Cooperation and Development (GIZ) Tanzania, Dar es Salaam	Funding for this research was provided by the German Federal Ministry for Economic Cooperation and Development (GIZ) Tanzania, Dar es Salaam, Grant Number 83219278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari-Sefa V, 2012, FOOD SECUR, V4, P115, DOI 10.1007/s12571-011-0158-8; Ampt F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0561-9; Anderson CL, 2017, WORLD DEV, V90, P169, DOI 10.1016/j.worlddev.2016.09.005; [Anonymous], [No title captured]; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Cochrane N aDS, EIB15 US DEP AGR EC; Ecker O, 2010, AFR J AGRIC RESOUR E, V4, P175; FAO, 1997, AGR FOOD NUTR AFRICA; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Fort MP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2361-6; Frees EW., 2010, REGRESSION MODELING; Gujarati D. N, 2003, BASIC ECONOMETRICS, V4th; Handa S, 1996, J DEV ECON, V50, P165, DOI 10.1016/0304-3878(96)00008-9; Herrador Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133435; HYTTEN FE, 1964, J OBSTET GYN BR COMM, V71, P255; IFPRI, 2014, ACCOUNTABILITY; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Keatinge JDH, 2011, FOOD SECUR, V3, P491, DOI 10.1007/s12571-011-0150-3; Keding GB, 2012, FOOD SECUR, V4, P129, DOI 10.1007/s12571-011-0163-y; Kennedy G., 2010, GUID MEAS HOUS IND D; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Leach V., 2009, 0931 REPOA; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mirmiran P, 2004, ASIA PAC J CLIN NUTR, V13, P56; Nyaruhucha CNM M J. M., 2007, TANZANIA HLTH RES B, V8, P162; Ochieng J., 2017, RENEWABLE AGR FOOD S, P1; Ota E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub2; Otieno P, 2016, INVOLVING MEN NUTR; Pillai A, 2016, AGR FOOD SECURITY, V5, P22; Quisumbing A. R., 1995, Women: the key to food security.; Quisumbing AR, 2013, 01294 IFPRI; Rajendran S., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-017-0127-3; Ransom E, 2003, NUTR WOMEN ADOLESCEN; Savy M, 2007, PUBLIC HEALTH NUTR, V10, P71, DOI 10.1017/S1368980007219627; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Steyn NP, 2014, NUTRITION, V30, P55, DOI 10.1016/j.nut.2013.06.002; [The United Republic of Tanzania Ministry of Labour Employment and Youth Development National Policy of Youth Development Policy URT], 2007, NAT POL YOUTH DEV PO; TNNS. Tanzania National Nutrition Survey, 2014, TANZ NAT NUTR SURV 2; URT, 2001, RUR DEV STRAT REP UN; van't Riet H, 2002, PUBLIC HEALTH NUTR, V5, P515, DOI 10.1079/PHN2001324; WHO, 2015, MICR DEF; Yimer F T F, 2015, 80 ESSP IFPRI EDRI	45	65	65	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189022	10.1371/journal.pone.0189022	http://dx.doi.org/10.1371/journal.pone.0189022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232413	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200019
J	Misterska, E; Glowacki, J; Okret, A; Laurentowska, M; Glowacki, M				Misterska, Ewa; Glowacki, Jakub; Okret, Adam; Laurentowska, Maria; Glowacki, Maciej			Back and neck pain and function in females with adolescent idiopathic scoliosis: A follow-up at least 23 years after conservative treatment with a Milwaukee brace	PLOS ONE			English	Article							QUALITY-OF-LIFE; ROLAND-MORRIS QUESTIONNAIRE; HEALTH SURVEY QUESTIONNAIRE; DISABILITY SCALE; CURVE PROGRESSION; RELIABILITY; VALIDITY; INDEX; SPINE; INSTRUMENTATION	We aimed to explore the long-term outcomes of back and neck pain and functionality in adult females with adolescent idiopathic scoliosis (AIS), who had been treated with a Milwaukee brace, in a follow-up study a minimum of 23 years after the completion of the treatment, using radiological, clinical and socio-demographical data. Thirty AIS patients (scoliosis group-SG), were included in the study based on an extensive search of Pediatric Orthopedics and Traumatology Clinic charts. All treatments were successfully completed between 1974 and 1990. In all cases, scoliosis had not been detected before the age of 10 and was not combined with any major spinal deformities at the time when the brace treatment was implemented. In those patients, the Risser sign 4 and minimum two years post-menarche was defined as a maturity, after that time the brace treatment was completed. Patients were excluded from the study if they, at the time of the follow-up examinations, suffered from any other disease leading to trunk deformity. Forty patients met the criteria for inclusion, but due to change some personal details, not all of them were contacted. Finally, 30 women returned for a follow-up evaluation. Patients' follow-up period was mean 27.77 yrs. +/- SD 3.30 (range 23-35). Curvature change from the end of the treatment until the present day was mean 9.1 degrees +/- SD 7.64 (range 0-27). A control group of 42 healthy females (healthy controls group-HG) matching the age profile of the patient group was randomly selected for comparative purposes. Both SG and HG completed the Polish versions of the Revised Oswestry Lower Back Pain Disability Index (RODI), the Rolland-Morris Questionnaire (RMQ), the Quebec Back Pain Disability Scale (QDS), the Neck Disability Index (NDI) and the Copenhagen Neck Functional Disability Scale (CNFDS). Descriptive statistics were calculated for demographics and baseline questionnaire scores. To determine if the investigated sample sizes are equivalent, the chi-square test was used. The chi-square test was used to compare qualitative features between persons with scoliosis and healthy controls. In addition, a Mann-Whitney test was utilized to compare differences between both groups in regard to quantitative characteristics. To establish relations between quantitative data such as e.g. age, duration of brace application, apical translation, Cobb angle, and questionnaire results, we used Spearman's rank correlation (marked as rS). To determine dependency between quantitative and qualitative characteristics, e.g. between questionnaire numerical data and marital status, place of residence or curve type, ANOVA Kruskal-Wallis test was used. A p<0.05 indicates statistical significance. Statistical calculations were performed by Statistica software. In regards to RODI, RMQ, QDS, NDI and CNFDS (both for total scores and particular sub-sections), statistically significant differences (p <0.001) between both samples were found, indicating higher levels of pain and neck and lower back pain-related disability among persons with scoliosis. Associations exist between RODI and RMQ (rS = 0.76) QDS (rS = 0.70), NDI (rS = 0.69) and CNFDS (rS = 0.60). RMQ was associated with QDS (rS = 0.71) and NDI (rS = 0.69), whereas QDS correlated with NDI (rS = 0.80) and CNFDS (rS = 0.60). NDI was also associated with CNFDS (rS = 0.81). Persons with scoliosis treated in adolescence with a Milwaukee brace display significant restrictions in everyday activities, due to lower back pain (LBP) and neck-related disabilities, compared to healthy controls. In addition, back pain is associated with curve progression in long-term follow-up after conservative treatment. Moreover, LBP-related disability coexists with restrictions experienced due to neck pain.	[Misterska, Ewa] Univ Secur, Dept Pedag & Psychol, Poznan, Poland; [Glowacki, Jakub; Okret, Adam] HCP Med Ctr, Poznan, Poland; [Laurentowska, Maria] Poznan Univ Phys Educ, Dept Physiol, Poznan, Poland; [Glowacki, Maciej] Poznan Univ Med Sci, Dept Pediat Orthopaed & Traumatol, Poznan, Poland	Poznan University of Medical Sciences	Misterska, E (corresponding author), Univ Secur, Dept Pedag & Psychol, Poznan, Poland.	emisterska1@wp.pl		Glowacki, Jakub/0000-0002-8200-742X; Laurentowska, Maria/0000-0002-9598-9944				Andersen MO, 2006, SPINE, V31, P350, DOI 10.1097/01.brs.0000197649.29712.de; ANDRIACCHI TP, 1976, J BONE JOINT SURG AM, V58, P806, DOI 10.2106/00004623-197658060-00011; Ariens GA, 2000, SCAND J WORK ENV HEA, V26, P7, DOI 10.5271/sjweh.504; Baker DJ, 1989, BACK PAIN NEW APPROA, P174; BALAGUE F, 1988, SCAND J REHABIL MED, V20, P175; Cagnie B, 2007, EUR SPINE J, V16, P679, DOI 10.1007/s00586-006-0269-7; CARR WA, 1980, J BONE JOINT SURG AM, V62, P599, DOI 10.2106/00004623-198062040-00015; CONNOLLY PJ, 1995, J BONE JOINT SURG AM, V77A, P1210, DOI 10.2106/00004623-199508000-00011; Danielsson Aina J, 2015, Spine Deform, V3, P440, DOI 10.1016/j.jspd.2015.05.005; Danielsson AJ, 2001, SPINE, V26, P516; Danielsson AJ, 2001, EUR SPINE J, V10, P278, DOI 10.1007/s005860100309; Danielsson AJ, 2003, SPINE, V28, P2078; Davidson M, 2002, PHYS THER, V82, P8, DOI 10.1093/ptj/82.1.8; DICKSON JH, 1990, J BONE JOINT SURG AM, V72A, P678, DOI 10.2106/00004623-199072050-00006; DIRAIMONDO CV, 1988, J PEDIATR ORTHOPED, V8, P143; EDGAR MA, 1988, J BONE JOINT SURG BR, V70, P712, DOI 10.1302/0301-620X.70B5.3192566; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; FOWLES JV, 1978, CLIN ORTHOP RELAT R, P212; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Gabos PG, 2004, J BONE JOINT SURG AM, V86A, P1891, DOI 10.2106/00004623-200409000-00006; GALANTE J, 1970, J BONE JOINT SURG AM, VA 52, P498, DOI 10.2106/00004623-197052030-00007; GOLDSTEIN JM, 1991, SPINE, V16, P1150, DOI 10.1097/00007632-199110000-00004; GORTMAKER SL, 1993, J RES ADOLESCENCE, V0003; Grevitt M, 1997, J BONE JOINT SURG BR, V79B, P48, DOI 10.1302/0301-620X.79B1.1269; Haefeli M, 2006, SPINE, V31, P355, DOI 10.1097/01.brs.0000197664.02098.09; HILIBRAND AS, 1995, J PEDIATR ORTHOPED, V15, P627, DOI 10.1097/01241398-199509000-00015; Jordan A, 1998, J MANIP PHYSIOL THER, V21, P520; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Lange JE, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-17; LONSTEIN JE, 1994, J BONE JOINT SURG AM, V76A, P1207, DOI 10.2106/00004623-199408000-00011; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; MIERAU D, 1989, SPINE, V14, P526, DOI 10.1097/00007632-198905000-00010; Misterska E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-84; Misterska E, 2011, SPINE, V36, pE1722, DOI 10.1097/BRS.0b013e318216ad48; MOSKOWITZ A, 1980, J BONE JOINT SURG AM, V62, P364, DOI 10.2106/00004623-198062030-00006; NACHEMSON A, 1968, ACTA ORTHOP SCAND, V39, P466, DOI 10.3109/17453676808989664; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; NILSONNE U, 1968, ACTA ORTHOP SCAND, V39, P456, DOI 10.3109/17453676808989663; Opara J, 2006, SPINE, V31, P2744, DOI 10.1097/01.brs.0000244632.76447.62; Ramirez N, 1999, J PEDIATR ORTHOPED, V19, P198; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Ryan CG, 2011, ERGONOMICS, V54, P531, DOI 10.1080/00140139.2011.570458; Skov T, 1996, OCCUP ENVIRON MED, V53, P351, DOI 10.1136/oem.53.5.351; Stratford PW, 1996, PHYS THER, V76, P359, DOI 10.1093/ptj/76.4.359; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Topalis C, 2017, SCOLIOSIS SPINAL DIS, V12, DOI 10.1186/s13013-017-0125-z; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vianin M, 2008, J CHIROPR MED, V7, P161, DOI 10.1016/j.jcm.2008.07.001; Walsh TL, 2003, SPINE, V28, P607, DOI 10.1097/00007632-200303150-00017; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; Wiggins CG, 2003, NEUROSURG FOCUS, V14, pE3; Yue PY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-789	53	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189358	10.1371/journal.pone.0189358	http://dx.doi.org/10.1371/journal.pone.0189358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228056	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600047
J	McLachlan, SMS; Kaiser, GW; Longrich, NR				McLachlan, Sandy M. S.; Kaiser, Gary W.; Longrich, Nicholas R.			Maaqwi cascadensis: A large, marine diving bird (Avialae: Ornithurae) from the Upper Cretaceous of British Columbia, Canada	PLOS ONE			English	Article							NANAIMO GROUP; VANCOUVER-ISLAND; GULF ISLANDS; MAESTRICHTIAN FORAMINIFERA; SEDIMENTARY-ROCKS; WASHINGTON-STATE; SPRAY FORMATIONS; FOSSIL EVIDENCE; NORTH-AMERICA; UPPER LAMBERT	Mesozoic bird fossils from the Pacific Coast of North America are rare, but small numbers are known from the Late Cretaceous aged sediments of Hornby Island, British Columbia. Most are unassociated fragments that offer little information, but additional preparation of a large coracoid has revealed more details of its structure, as well as three associated wing bones. Phylogenetic analysis suggests that Maaqwi cascadensis, gen. et sp. nov. represents a derived crown or near-crown member of Ornithurae, and specifically suggests affinities with Vegaviidae. M. cascadensis is characterized by large size, and regressions based on dimensions of the coracoid suggest a large bird, with an estimated body mass of approximately 1.5 kilograms. The bones are robust, with thick walls, suggesting that M. cascadensis was a bird adapted for diving, similar to modern loons and grebes. The wings are short, while the coracoid is unusually short and broad, similar to modern loons. Along with the Ichthyornithes and Hesperornithes, M. cascadensis and Vegaviidae appear to represent a third clade of bird that evolved to exploit marine habitats in the Late Cretaceous, one specialized for foot-propelled diving and rapid cruising flight over water.	[McLachlan, Sandy M. S.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [McLachlan, Sandy M. S.; Kaiser, Gary W.] Royal BC Museum, Dept Nat Hist, Victoria, BC, Canada; [Longrich, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Longrich, Nicholas R.] Univ Bath, Milner Ctr Evolut, Bath, Avon, England	University of Victoria; University of Bath; University of Bath	McLachlan, SMS (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada.; McLachlan, SMS (corresponding author), Royal BC Museum, Dept Nat Hist, Victoria, BC, Canada.	sandymcl@uvic.ca	McLachlan, Sandy/ABD-2408-2021	McLachlan, Sandy/0000-0003-3902-7190; Longrich, Nicholas/0000-0002-9586-8907				Hospitaleche CA, 2015, ANN PALEONTOL, V101, P315, DOI 10.1016/j.annpal.2015.10.002; Angnolin FL, 2017, SCI NATURE, V104; Aotsuka K, 2016, CRETACEOUS RES, V63, P154, DOI 10.1016/j.cretres.2016.03.003; Bain HA, 2016, SEDIMENT GEOL, V337, P113, DOI 10.1016/j.sedgeo.2016.03.010; Bell A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141690; Brodkorb P., 1963, P 13 INT ORN C AM OR, VVol. 1, P55; Bullard T, 1999, BRITISH COLUMBIA PAL, V22, P11; Burnham D, 2005, J VERTEBR PALEONTOL, V25, p41A; Cameron BEB, 1988, UNPUB, P1; Carter E. S., 2006, GEOLOGICAL ASS CANAD, P109; Cerda IA, 2015, HIST BIOL, V27, P549, DOI 10.1080/08912963.2014.896907; CHIAPPE LM, 1991, ALCHERINGA, V15, P333, DOI 10.1080/03115519108619028; Chiappe Luis M., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P203; Chiappe Luis M., 2002, P240; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clarke JA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)387<0001:TMAPPO>2.0.CO;2; Clarke JA, 2016, NATURE, V538, P502, DOI 10.1038/nature19852; Davis Leo Carson, 1997, Journal of the Arkansas Academy of Science, V51, P197; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Dyke G, 2011, CAN J EARTH SCI, V48, P1489, DOI 10.1139/E11-050; Elzanowski A, 2000, J VERTEBR PALEONTOL, V20, P712, DOI 10.1671/0272-4634(2000)020[0712:AAQFTL]2.0.CO;2; Elzanowski A, 2012, PALAEONTOLOGY, V55, P1199, DOI 10.1111/j.1475-4983.2012.01187.x; Enkin RJ, 2001, CAN J EARTH SCI, V38, P1403, DOI 10.1139/e01-031; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Haggart J., 1991, FIELD GUIDE PALEONTO, P223; HAGGART J W, 1989, Geological Survey of Canada Bulletin, P181; Haggart JW, 2005, CAN J EARTH SCI, V42, P2001, DOI 10.1139/E05-066; Haggart JW, 2000, ABSTRACTS PROGRAM, V32, pA; Haggart JW, 2017, CRETACEOUS RES; Hasegawa T, 2015, GEOLOGICAL SOC AM AB, V45, P517; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Hope S., 2002, MESOZOIC BIRDS HEADS, P239; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; HOWARD H, 1969, CONDOR, V71, P68, DOI 10.2307/1366050; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Katnick DC, 2003, CAN J EARTH SCI, V40, P375, DOI 10.1139/E03-005; Kim BY, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002696; Klein N, 2015, CONTRIB ZOOL, V84, P59, DOI 10.1163/18759866-08401005; Kodama KP, 2001, GEOL SOC AM BULL, V113, P1171, DOI 10.1130/0016-7606(2001)113<1171:CCPPFL>2.0.CO;2; Krijgsman W, 2006, EARTH PLANET SC LETT, V242, P205, DOI 10.1016/j.epsl.2005.11.052; LAMBRECHT K., 1929, PALAEONTOLOGISCHE ZEITSCHR, V11, P121; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Longrich N, 2009, CRETACEOUS RES, V30, P161, DOI 10.1016/j.cretres.2008.06.007; Ludvigsen R, 1995, 1 BRIT COL PAL S COU, P1; Ludvigsen R., 1998, W COAST FOSSILS GUID; Ludvigsen Rolf, 1996, P156; Mahoney JB, 1999, GEOLOGY, V27, P195; Marsh O.C., 1880, ODONTORNITHES MONOGR, DOI [10.5962/bhl.title.61298, DOI 10.5962/BHL.TITLE.61298]; Marshall JL, 2017, HDB IMMUNOSENESCENCE, P1; Martin Larry D., 2012, Palaeoworld, V21, P59, DOI 10.1016/j.palwor.2012.02.005; Martin Larry D., 2002, P165; Martin-Silverstone E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160333; Matthews WA, 2017, TECTONICS, V36, P854, DOI 10.1002/2017TC004531; Mayr G, 2005, J ZOOL SYST EVOL RES, V43, P61, DOI 10.1111/j.1439-0469.2004.00291.x; MCGUGAN A, 1982, MICROPALEONTOLOGY, V28, P399, DOI 10.2307/1485452; MCGUGAN A, 1979, CAN J EARTH SCI, V16, P2263, DOI 10.1139/e79-211; McGugan A., 1962, J ALBERTA SOC PETROL, V10, P585; McLachlan SMS, 2017, J SYSTEMATIC PALAEON; Miller IM, 2006, EARTH PLANET SC LETT, V245, P95, DOI 10.1016/j.epsl.2006.02.022; Morrison K, 2005, CAN J EARTH SCI, V42, P2097, DOI 10.1139/E05-081; Muller J.E., 1970, GEOLOGICAL SURVEY CA, V69-25, P1, DOI DOI 10.4095/102353; Mustard P., 2003, GEOLOGICAL FIELD TRI, P103; Mustard P.S., 1994, GEOLOGY GEOLOGIC HAZ, V481, P27, DOI [DOI 10.4095/203246, 10.4095/203246]; Mustard PS, 2000, GEOL SOC AM CORD SEC, V32, pA; NICHOLLS EL, 1992, CAN J EARTH SCI, V29, P377, DOI 10.1139/e92-033; Nicholls EL, 2002, CAN J EARTH SCI, V39, P1591, DOI 10.1139/E02-075; Nicholls EL, 2001, PALEOBIOS S, V21, P97; Norberg U., 1990, VERTEBRATE FLIGHT ME; Nudds RL, 2004, P ROY SOC B-BIOL SCI, V271, pS324, DOI 10.1098/rsbl.2004.0167; Ogg JG, 2016, CONCISE GEOLOGIC TIME SCALE 2016, P167, DOI 10.1016/B978-0-444-59467-9.00013-3; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1992, Journal of Vertebrate Paleontology, V12, P122; Peecook BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127792; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Raub T.D., 1998, EOS T AM GEOPHYS UN, V79, P223; Simons EM, 2009, THESIS; SLITER W V, 1973, Journal of Foraminiferal Research, V3, P167; Smith NA, 2014, ANAT REC, V297, P188, DOI 10.1002/ar.22841; Usher JL, 1952, GEOLOGICAL SURVEY CA, V21, P1; Vullo R, 2012, J VERTEBR PALEONTOL, V32, P1198, DOI 10.1080/02724634.2012.681078; WARD PD, 1978, CAN J EARTH SCI, V15, P405, DOI 10.1139/e78-045; Ward PD, 1997, SCIENCE, V277, P1642, DOI 10.1126/science.277.5332.1642; Ward PD, 2012, GEOL SOC AM BULL, V124, P957, DOI 10.1130/B30077.1; Wilson LE, 2016, CAN J EARTH SCI, V53, P1476, DOI 10.1139/cjes-2016-0053; Zakharov YD, 2013, SEDIMENT GEOL, V295, P77, DOI 10.1016/j.sedgeo.2013.08.004; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; [No title captured]	91	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189473	10.1371/journal.pone.0189473	http://dx.doi.org/10.1371/journal.pone.0189473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220405	gold, Green Published			2022-12-26	WOS:000417469900061
J	Zhang, M; Shen, ZW; Meng, GQ; Lu, Y; Wang, YL				Zhang, Ming; Shen, Zhiwei; Meng, Guoqing; Lu, Yu; Wang, Yilei			Genome-wide analysis of the Brachypodium distachyon (L.) P. Beauv. Hsp90 gene family reveals molecular evolution and expression profiling under drought and salt stresses	PLOS ONE			English	Article							ARABIDOPSIS TRANSCRIPTION FACTOR; ABSCISIC-ACID; HEAT-STRESS; PROTEIN; CHAPERONE; HEAT-SHOCK-PROTEIN-90; DUPLICATION; MECHANISMS; INFERENCE; SEQUENCE	The structure, evolution, and function of heat shock proteins 90 (Hsp90s) have been investigated in great detail in fungi and animals. However, studies on the Hsp90 genes in plants are generally limited. Brachypodium distachyon (L.) P. Beauv., as a model plant for cereal crops, has become a potential biofuel grass. During its long evolution, the Hsp90 gene family in Brachypodium has developed some strategies to cope with adverse environments. How the Hsp90 gene family in Brachypodium evolved in different plant lineages and what its role is in plant responses to drought and salt stresses remains to be elucidated. We used a set of different bioinformatics tools to identify 94 Hsp90 genes from 10 species representing four plant lineages and classified into three subgroups. Eight BdHsp90 genes were detected from B. distachyon. The number of exon-intron structures differed in each subgroup, and the motif analysis revealed that these genes were relatively conservative in each group. The fragments duplication and tandem duplication, which are the prime powers for functional diversity, generally occurred during the duplication of the whole plant genome. Transcriptional analysis of the BdHsp90 genes under salt and drought stress conditions indicated that the expression of these genes was delayed or increased at different stress time points; The expression was more affected in that of Bradi3g39630, Bradi4g06370, and Bradi1g30130. Our findings suggest the involvement of BdHsp90s in plant abiotic stress response, and further consolidate our views on the stress response mechanism of Hsp90 in general.	[Zhang, Ming; Shen, Zhiwei; Meng, Guoqing; Lu, Yu; Wang, Yilei] Heze Univ, Coll Life Sci, Heze, Shandong, Peoples R China	Heze University	Wang, YL (corresponding author), Heze Univ, Coll Life Sci, Heze, Shandong, Peoples R China.	wangyilei001@163.com			Heze university scientific funds of Doctor research funds [XY16BS11]	Heze university scientific funds of Doctor research funds	This work was supported by Heze university scientific funds of Doctor research funds (XY16BS11) to MZ; Its roles lie in soft analysis and paper publish fees.	Agarwal G, 2016, PLANT BIOTECHNOL J, V14, P1563, DOI 10.1111/pbi.12520; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hao PC, 2015, PROTEOMICS, V15, P1544, DOI 10.1002/pmic.201400179; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackson SE, 2004, NAT STRUCT MOL BIOL, V11, P1152, DOI 10.1038/nsmb1204-1152; Jacob P, 2017, PLANT BIOTECHNOL J, V15, P405, DOI 10.1111/pbi.12659; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Klein EM, 2006, PLANT J, V48, P657, DOI 10.1111/j.1365-313X.2006.02904.x; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Liu Yunfei, 2014, Yichuan, V36, P1043, DOI 10.3724/SP.J.1005.2014.1043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv DW, 2014, MOL CELL PROTEOMICS, V13, P632, DOI 10.1074/mcp.M113.030171; Maksymiec W, 2011, BIOL PLANTARUM, V55, P112, DOI 10.1007/s10535-011-0015-9; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shinozaki F, 2006, J BIOL CHEM, V281, P16361, DOI 10.1074/jbc.M600891200; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Song WL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-124; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Xu ZS, 2012, INT J MOL SCI, V13, P15706, DOI 10.3390/ijms131215706; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang H, 2016, BIOTECHNOLOGY BIOTEC, V30, P545; Zhang J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-532; Zhang L, 2012, J APPL PHYCOL, V24, P1601, DOI 10.1007/s10811-012-9821-5; Zhang M, 2014, J PROTEOME RES, V13, P4281, DOI 10.1021/pr500400t; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	67	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189187	10.1371/journal.pone.0189187	http://dx.doi.org/10.1371/journal.pone.0189187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216330	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800091
J	Strug, MR; Su, RW; Kim, TH; Mauriello, A; Ticconi, C; Lessey, BA; Young, SL; Lim, JM; Jeong, JW; Fazleabas, AT				Strug, Michael R.; Su, Ren-Wei; Kim, Tae Hoon; Mauriello, Alessandro; Ticconi, Carlo; Lessey, Bruce A.; Young, Steven L.; Lim, Jeong Mook; Jeong, Jae-Wook; Fazleabas, Asgerally T.			RBPJ mediates uterine repair in the mouse and is reduced in women with recurrent pregnancy loss	FASEB JOURNAL			English	Article						Notch; decidualization; embryo implantation; IFN-gamma	ENDOMETRIAL STROMAL CELLS; PROGESTERONE-RECEPTOR; INTERFERON-GAMMA; IFN-GAMMA; T-CELLS; DECIDUALIZATION; PATHWAY; EXPRESSION; UTERUS; NOTCH1	Unexplained recurrent pregnancy loss (uRPL) is associated with repeated embryo loss and endometrial repair with elevated endometrial expression of inflammatory cytokines, including IFN-gamma. Notch signaling through its transcription factor recombination signal binding protein J kappa (RBPJ) regulates mechanisms including the immune response and repair after tissue injury. Initially, null mutation of RBPJ in the mouse uterus (Pgr(cre/+)Rbpj(f/f); Rbpj c-KO) results in subfertility, but we have found that these mice become infertile after pregnancy as a result of dysfunctional postpartum uterine repair, including delayed endometrial epithelial and myometrial regeneration. RNA sequencing of postpartum uterine repair sites revealed global up-regulation of inflammatory pathways, including IFN signaling. Consistent with elevated IFN-gamma, macrophages were recruited and polarized toward an M1-cytotoxic phenotype, which is associated with preventing repair and promoting further tissue injury. Through embryo transfer experiments, we show that dysfunctional postpartum repair directly impairs future embryo implantation in Rbpj c-KO mice. Last, we clinically correlated our findings from the Rbpj c-KO mouse in women diagnosed with uRPL. Reduced RBPJ in women with uRPL was associated with increased levels of IFN-gamma. The data, taken together, indicate that RBPJ regulates inflammation during endometrial repair, which is essential for future pregnancy potential, and its dysregulation may serve as an unidentified contributor to uRPL in women.	[Strug, Michael R.; Su, Ren-Wei; Kim, Tae Hoon; Jeong, Jae-Wook; Fazleabas, Asgerally T.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, 333 Bostwick Ave NE,Suite 4027 VAI, Grand Rapids, MI 49503 USA; [Su, Ren-Wei] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Mauriello, Alessandro; Ticconi, Carlo] Tor Vergata Univ, Dept Biomed & Prevent, Sect Gynecol & Obstet, Rome, Italy; [Lessey, Bruce A.] Greenville Hlth Syst, Dept Obstet & Gynecol, Greenville, SC USA; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Lim, Jeong Mook] Seoul Natl Univ, Dept Agr Biotechnol, World Class Univ WCU Biomodulat, Seoul, South Korea	Michigan State University; South China Agricultural University; University of Rome Tor Vergata; Greenville Health System; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU)	Fazleabas, AT (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, 333 Bostwick Ave NE,Suite 4027 VAI, Grand Rapids, MI 49503 USA.	asgi@hc.msu.edu	Ticconi, Carlo/AAU-9766-2021; Young, Steven L/G-2304-2014; MAURIELLO, ALESSANDRO/K-4705-2016; Ticconi, Carlo/AAZ-1010-2021	Young, Steven L/0000-0002-5205-4495; MAURIELLO, ALESSANDRO/0000-0002-7351-5676; Ticconi, Carlo/0000-0003-1923-2744	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD042280, F30 HD082951]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F30HD082951, R01HD067721, R01HD042280] Funding Source: NIH RePORTER	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank F. DeMayo [U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences), N. Carlesso (Beckman Research Institute of the City of Hope, Durate, CA, USA), and T. Honjo (Kyoto University, Kyoto, Japan) for kindly providing the Pgr<SUP>pre/+</SUP> and Rbpj<SUP>flox/flox</SUP> mice. The authors also thank S. Bond, S. Poncil, A. Ochoa, and M. Olson (all from Michigan State University, Grand Rapids, MI, USA) for their excellent technical assistance. The authors thank R. Ergasti for her contribution to collecting and organizing of human tissues. The authors thank the Michigan State University Research Technology Support Facility Genomics Core for their assistance with library preparation and RNA-Seq. The authors also thank M. Winn (Van Andel Research Institute Bioinformatics and Biostatistics Core, Grand Rapids, MI, USA), for performing data analysis of the RNA-Seq results. Funding for this study was provided by the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grants R01 HD042280 to A.T.F. and F30 HD082951 to M.R.S.). The authors declare no conflicts of interest.	Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P63, DOI 10.1016/j.fertnstert.2012.09.023; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; BRANDON JM, 1994, ANAT RECORD, V240, P233, DOI 10.1002/ar.1092400210; BRANDON JM, 1990, J REPROD FERTIL, V88, P151; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Chen CP, 2015, REPROD SCI, V22, P1461, DOI 10.1177/1933719115585148; Chen P, 2016, J OBSTET GYNAECOL RE, V42, P669, DOI 10.1111/jog.12957; Chiang CM, 1997, GYNECOL OBSTET INVES, V43, P245, DOI 10.1159/000291866; Christiansen OB, 2005, FERTIL STERIL, V83, P821, DOI 10.1016/j.fertnstert.2004.12.018; Christiansen OB, 2008, GYNECOL OBSTET INVES, V66, P257, DOI 10.1159/000149575; Comba C, 2015, FERTIL STERIL, V104, P1467, DOI 10.1016/j.fertnstert.2015.08.011; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; FINN CA, 1971, ADV REPROD PHYSIOL, V5, P1; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Goddard LM, 2014, CELL, V156, P549, DOI 10.1016/j.cell.2013.12.025; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Huang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044285; Ishida Y, 2004, J IMMUNOL, V172, P1848, DOI 10.4049/jimmunol.172.3.1848; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jaiswal MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15221; Jaslow CR, 2010, FERTIL STERIL, V93, P1234, DOI 10.1016/j.fertnstert.2009.01.166; JAYATILAK PG, 1984, BIOL REPROD, V31, P556, DOI 10.1095/biolreprod31.3.556; Kaitu'u-Lino TJ, 2010, ENDOCRINOLOGY, V151, P3386, DOI 10.1210/en.2009-1334; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kosova G, 2015, HUM REPROD, V30, P519, DOI 10.1093/humrep/deu355; Krieg SA, 2012, MOL HUM REPROD, V18, P442, DOI 10.1093/molehr/gas017; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Liang PY, 2015, REPROD BIOMED ONLINE, V31, P823, DOI 10.1016/j.rbmo.2015.08.009; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; LUDWIG H, 1991, ANN NY ACAD SCI, V622, P28, DOI 10.1111/j.1749-6632.1991.tb37848.x; Luster AD, 1998, P ASSOC AM PHYSICIAN, V110, P183; Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; OKA C, 1995, DEVELOPMENT, V121, P3291; Orent W, 2016, HUM MOL GENET, V25, P404, DOI 10.1093/hmg/ddv474; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rudolph M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032922; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Shynlova O, 2013, J CELL MOL MED, V17, P311, DOI 10.1111/jcmm.12012; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Su RW, 2015, J CLIN ENDOCR METAB, V100, pE433, DOI 10.1210/jc.2014-3720; Ticconi C, 2011, AM J REPROD IMMUNOL, V66, P452, DOI 10.1111/j.1600-0897.2011.01021.x; Weimar CHE, 2013, HUM REPROD UPDATE, V19, P542, DOI 10.1093/humupd/dmt025; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Winter WE, 2014, LABMEDICINE, V45, P92, DOI 10.1309/LMF28S2GIMXNWHMM; Yoshii A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.117929; Zhang S, 2014, CELL RES, V24, P925, DOI 10.1038/cr.2014.82	74	18	20	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2452	2466		10.1096/fj.201701032R	http://dx.doi.org/10.1096/fj.201701032R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29242273	Green Published			2022-12-26	WOS:000432528000012
J	Guo, PY; Wang, Y; Dai, CX; Tao, CL; Wu, F; Xie, XZ; Yu, HT; Zhu, QD; Li, JJ; Ye, LY; Yu, FX; Shan, YF; Yu, ZP; Dhanasekaran, R; Zheng, RY; Chen, G				Guo, Pengyi; Wang, Yi; Dai, Chunxiu; Tao, Chonglin; Wu, Fang; Xie, Xiaozai; Yu, Haitao; Zhu, Qiandong; Li, Junjian; Ye, Longyun; Yu, Fuxiang; Shan, Yunfeng; Yu, Zhengping; Dhanasekaran, Renumathy; Zheng, Rongyuan; Chen, Gang			Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/beta-catenin-induced FGF18 expression in hepatocellular carcinoma	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; VIRUS-X PROTEIN; DOWN-REGULATION; CELL-PROLIFERATION; COLORECTAL-CANCER; IN-VITRO; GENES; TRANSFORMATION; MUTATIONS; LEUKEMIA	Ribosomal protein s15a (RPS15A) plays a promotive role in the mRNA/ribosome interactions during early translation. Our previous study has found that inhibiting RPS15A expression can decrease proliferation and induce cell cycle arrest in hepatocellular carcinoma (HCC) cell lines. However, the mechanism underlying the involvement of RPS15A in HCC pathogenesis and the clinical significance of RPS15A expression remain unclear. In this study, an evaluation of RPS15A expression in 110 surgically resected HCCs and matched tumor-adjacent normal tissues revealed an overexpression of RPS15A in HCC, which was correlated with worse survival. In addition, tumor tissue with higher RPS15A expression demonstrated a higher microvascular density (MVD). Subsequently, two HCC cell lines, Huh7 (low-level constitutive RPS15A expression) and HepG2 (high RPS15A expression) were used to further evaluate the role of RPS15A in angiogenesis. The co-culture experiment of HCC cells with endothelial cells revealed that the induced overexpression of RPS15A in Huh7 cells increased the angiogenic potential of HUVEC in a paracrine fashion; conversely, knockdown of RPS15A in HepG2 cells showed an opposite effect. Further analysis indicated that RPS15A modulated FGF signaling by enhancing Wnt/beta-catenin-mediated FGF18 expression in HCC cells. FGF18, in turn, through binding to its FGFR3 receptor on endothelial cells, can activate the AKT and ERK pathway and promotes angiogenesis in a tumor microenvironment. Our in vivo experiment further confirmed that inhibition of RPS15A expression in HCC xenografts dramatically hindered tumor growth and inhibited tumor angiogenesis. Together, our findings suggest that RPS15A promotes angiogenesis in HCCs by enhancing Wnt/beta-catenin induced FGF18 expression. The RPS15A/FGF18 pathway may be a rational target for anti-angiogenic therapy of HCC.	[Guo, Pengyi; Tao, Chonglin; Xie, Xiaozai; Yu, Haitao; Zhu, Qiandong; Li, Junjian; Ye, Longyun; Yu, Fuxiang; Shan, Yunfeng; Yu, Zhengping; Chen, Gang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wenzhou 2, Zhejiang, Peoples R China; [Wang, Yi] Wenzhou Med Univ, Res Ctr Evidence Based Med & Clin Epidemiol, Sch Publ Hlth & Management, Wenzhou, Zhejiang, Peoples R China; [Dai, Chunxiu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Tradit Chinese Med, Wenzhou, Zhejiang, Peoples R China; [Wu, Fang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Dhanasekaran, Renumathy] Stanford Univ, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Zheng, Rongyuan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Stanford University; Wenzhou Medical University	Chen, G (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wenzhou 2, Zhejiang, Peoples R China.; Zheng, RY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China.	zhengry@aliyun.com; cg_2188@hotmail.com	dhanasekaran, renumathy/B-3300-2014	dhanasekaran, renumathy/0000-0001-8819-7511	Natural Science Foundation of Zhejiang Province [LY17H160047]; National Natural Science Foundation of China [81201953]; Research Found for the Doctoral Fund of Ministry of Education of China [20113321120003]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Found for the Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by the grants from the Natural Science Foundation of Zhejiang Province (LY17H160047), the National Natural Science Foundation of China (81201953), the Research Found for the Doctoral Fund of Ministry of Education of China (20113321120003).	Akiyama N, 2000, MOL CELL BIOL, V20, P3266, DOI 10.1128/MCB.20.9.3266-3273.2000; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Antoine M, 2006, BIOCHEM BIOPH RES CO, V346, P224, DOI 10.1016/j.bbrc.2006.05.105; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; Bertram J, 1998, EUR J CANCER, V34, P731, DOI 10.1016/S0959-8049(97)10081-8; Carli A, 2012, EUR CELLS MATER, V24, P107, DOI 10.22203/eCM.v024a08; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen JW, 2016, INT J ONCOL, V48, P1628, DOI 10.3892/ijo.2016.3366; Cinque L, 2015, NATURE, V528, P272, DOI 10.1038/nature16063; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Fancello L, 2017, ONCOTARGET, V8, P14462, DOI 10.18632/oncotarget.14895; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hofman IJF, 2017, LEUKEMIA, V31, P1706, DOI 10.1038/leu.2016.370; Hsieh A, 2011, CANCER LETT, V300, P162, DOI 10.1016/j.canlet.2010.09.018; Jones DT, 2013, DIS MODEL MECH, V6, P115, DOI 10.1242/dmm.009183; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kumar P, 2016, GENE DEV, V30, P1573, DOI 10.1101/gad.282418.116; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; LAVOIE C, 1994, J BIOL CHEM, V269, P14625; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lian ZR, 2004, MOL CARCINOGEN, V40, P34, DOI 10.1002/mc.20012; Lim KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022258; Lim S, 2013, P NATL ACAD SCI USA, V110, pE2298, DOI 10.1073/pnas.1301838110; Liu J, 2006, ONCOGENE, V25, P1008, DOI 10.1038/sj.onc.1209138; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Ljungstrom V, 2016, BLOOD, V127, P1007, DOI 10.1182/blood-2015-10-674572; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Perdu J, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<74::AID-HUMU14>3.0.CO;2-F; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Ronca R, 2015, EXPERT OPIN THER TAR, V19, P1361, DOI 10.1517/14728222.2015.1062475; Ruptier C, 2011, ONCOGENE, V30, P4656, DOI 10.1038/onc.2011.171; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shimokawa T, 2003, CANCER RES, V63, P6116; Shukla SK, 2012, FEBS J, V279, P3859, DOI 10.1111/j.1742-4658.2012.08745.x; SLOVAK ML, 1995, CANCER RES, V55, P4214; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; Wang CM, 2015, HEPATOLOGY, V61, P200, DOI 10.1002/hep.27396; Wang F, 2011, CANCER SCI, V102, P2007, DOI 10.1111/j.1349-7006.2011.02065.x; Xu MY, 2014, GENE, V536, P84, DOI 10.1016/j.gene.2013.11.075; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Zhang C, 2014, CANCER BIOTHER RADIO, V29, P451, DOI 10.1089/cbr.2014.1698; Zhao XM, 2015, TUMOR BIOL, V36, P6733, DOI 10.1007/s13277-015-3371-9	48	31	33	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1220	1236		10.1038/s41388-017-0017-y	http://dx.doi.org/10.1038/s41388-017-0017-y			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29242604				2022-12-26	WOS:000426505400007
J	Serrano-Munoz, D; Gomez-Soriano, J; Bravo-Esteban, E; Vazquez-Farinas, M; Taylor, J; Avendano-Coy, J				Serrano-Munoz, Diego; Gomez-Soriano, Julio; Bravo-Esteban, Elisabeth; Vazquez-Farinas, Maria; Taylor, Julian; Avendano-Coy, Juan			Intensity matters: Therapist-dependent dose of spinal transcutaneous electrical nerve stimulation	PLOS ONE			English	Article							HEALTHY-HUMAN SUBJECTS; EXPERIMENTAL PAIN; H-REFLEX; PARAMETER MANIPULATION; HEMIPARETIC SUBJECTS; CORD-INJURY; TENS; SPASTICITY; THRESHOLDS; HUMANS	The intensity used during transcutaneous electrical nerve stimulation (TENS) in both, clinical practice and research studies, is often based on subjective commands such as strong but comfortable sensation. There is no consensus regarding the effectiveness dose of TENS. The objective was to determine the difference in the effect of spinal TENS on soleus H-reflex modulation when applied by two therapists instructed to apply the stimulation at a strong but comfortable intensity. Twenty healthy volunteers divided into two groups: Therapist 1 (n = 10) and Therapist 2 (n = 10). Both therapist applied spinal TENS and sham stimulation at the T1012 spinal level for 40min in random order to each subject, at an intensity designed to produce a strong but comfortable sensation. To avoid habituation, the intensity was adjusted every 2min. Soleus H-reflex was recorded before, during, and 10min after TENS by an observer blinded to the stimulus applied. Despite the instruction to apply TENS at a strong comfortable level, a significant difference in current density was identified: Therapist 1 (0.67mA/cm(2), SD 0.54) applied more than Therapist 2 (0.53mA/cm(2), SD 0.57; p<0.001) at the onset of the intervention. Maximal peak-to-peak H-reflex amplitude was inhibited significantly more 10min following TENS applied by Therapist 1 (-0.15mV, SD 0.16) compared with Therapist 2 (0.04mV, SD 0.16; p = 0.03). Furthermore, current density significantly correlated with the inhibitory effect on peak-to-peak Soleus H-reflex amplitude 10 min after stimulation (Rho = -0.38; p = 0.04). TENS intensity dosage by the therapist based on the subjective perception of the participants alone is unreliable and requires objective standardization. In addition, higher current density TENS produced greater inhibition of the Soleus H-reflex	[Serrano-Munoz, Diego; Taylor, Julian] Hosp Nacl Paraplej, Sensorimotor Funct Grp, Toledo, Spain; [Gomez-Soriano, Julio; Bravo-Esteban, Elisabeth; Avendano-Coy, Juan] Castilla Mancha Univ, Nursing & Physiotherapy Sch, Toledo Physiotherapy Res Grp GIFTO, Toledo, Spain; [Vazquez-Farinas, Maria] Hosp Nacl Paraplej, SESCAM, Toledo, Spain; [Taylor, Julian] NHS, Buckinghamshire Healthcare Trust, Natl Spinal Injuries Ctr, Stoke Mandeville Spinal Res, Aylesbury, Bucks, England; [Taylor, Julian] Univ Oxford, Harris Manchester Coll, Oxford, England	Hospital Nacional de Paraplejicos; Hospital Nacional de Paraplejicos; University of Oxford	Gomez-Soriano, J (corresponding author), Castilla Mancha Univ, Nursing & Physiotherapy Sch, Toledo Physiotherapy Res Grp GIFTO, Toledo, Spain.	julio.soriano@uclm.es	Gómez-Soriano, Julio/AAE-2990-2019; Serrano-Muñoz, Diego/AAD-2803-2019; Taylor, Julian/AAC-2802-2021; Avendaño Coy, Juan/Q-3631-2019	Gómez-Soriano, Julio/0000-0002-5542-4105; Serrano-Muñoz, Diego/0000-0002-7521-5087; Taylor, Julian/0000-0003-2553-2348; Avendaño Coy, Juan/0000-0002-8760-3490	Foundation Mutua Madrilena-Adeslas	Foundation Mutua Madrilena-Adeslas	Diego Serrano-Munoz was supported by Foundation Mutua Madrilena-Adeslas (2015).	Aarskog R, 2007, PHYSIOTHER RES INT, V12, P251, DOI 10.1002/pri.384; Avendano-Coy J, 2017, ARCH PHYS MED REHAB, V98, P888, DOI 10.1016/j.apmr.2016.11.020; Aydin G, 2005, AM J PHYS MED REHAB, V84, P584, DOI 10.1097/01.phm.0000171173.86312.69; Bjordal JM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-51; Buonocore M, 2007, Eura Medicophys, V43, P155; Chen CC, 2010, J PAIN, V11, P53, DOI 10.1016/j.jpain.2009.05.008; Chesterton LS, 2003, PAIN, V106, P73, DOI 10.1016/S0304-3959(03)00292-6; Chesterton LS, 2002, PAIN, V99, P253, DOI 10.1016/S0304-3959(02)00118-5; Claydon LS, 2008, EUR J PAIN, V12, P696, DOI 10.1016/j.ejpain.2007.10.014; Claydon LS, 2013, CLIN J PAIN, V29, P533, DOI 10.1097/AJP.0b013e318262330f; Claydon LS, 2011, CLIN J PAIN, V27, P635, DOI 10.1097/AJP.0b013e31821962b4; Cramp FL, 2000, ARCH PHYS MED REHAB, V81, P324, DOI 10.1016/S0003-9993(00)90079-0; CRONE C, 1990, EXP BRAIN RES, V81, P35; Dean J, 2006, CLIN PHYSIOL FUNCT I, V26, P314, DOI 10.1111/j.1475-097X.2006.00689.x; DEYO RA, 1990, AM J PHYS MED REHAB, V69, P6, DOI 10.1097/00002060-199002000-00003; Ellrich J, 2005, NEUROMODULATION, V8, P225, DOI 10.1111/j.1525-1403.2005.00029.x; Fernandez-Tenorio E, 2016, NEUROLOGIA; Gomez-Soriano J, 2012, REV NEUROLOGIA, V55, P217, DOI 10.33588/rn.5504.2012229; GOULET C, 1994, ARCH PHYS MED REHAB, V75, P1132, DOI 10.1016/0003-9993(94)90090-6; Hardy SG, 2002, PHYS THER, V82, P354, DOI 10.1093/ptj/82.4.354; Hofstoetter US, 2014, J SPINAL CORD MED, V37, P202, DOI 10.1179/2045772313Y.0000000149; HUICHAN CWY, 1993, CAN J NEUROL SCI, V20, P97, DOI 10.1017/S0317167100047636; Joodaki M R, 2001, Electromyogr Clin Neurophysiol, V41, P23; Kim EJ, 2003, CLIN NEUROPHYSIOL, V114, P1189, DOI 10.1016/S1388-2457(03)00106-8; Lazarou L, 2009, CLIN J PAIN, V25, P773, DOI 10.1097/AJP.0b013e3181a7ece3; LEVIN MF, 1992, ELECTROEN CLIN NEURO, V85, P131, DOI 10.1016/0168-5597(92)90079-Q; LITTLE JW, 1985, ARCH PHYS MED REHAB, V66, P19; Martins FL, 2012, BRAZ J PHYS THER, V16, P337, DOI 10.1590/S1413-35552012005000032; Moran F, 2011, J PAIN, V12, P929, DOI 10.1016/j.jpain.2011.02.352; Ng SSM, 2007, STROKE, V38, P2953, DOI 10.1161/STROKEAHA.107.490318; Pantaleao MA, 2011, J PAIN, V12, P581, DOI 10.1016/j.jpain.2010.11.001; PETRIE J, 1985, CLIN EXP RHEUMATOL, V3, P151; Pinheiro GT, 2008, FISIOTER PESQUI, V15, P118; Ristic D, 2008, EUR J PAIN, V12, P480, DOI 10.1016/j.ejpain.2007.07.013; Rutjes AWS, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002823.pub2, 10.1002/14651858.CD007321.pub2]; Schunke M, 2011, PROMETHEUS TEXTO ATL, V1, P66; Simorgh L, 2008, Electromyogr Clin Neurophysiol, V48, P301; Turi Z, 2014, BRAIN STIMUL, V7, P460, DOI 10.1016/j.brs.2014.01.059; Vassal F, 2013, CLIN NEUROPHYSIOL, V124, P1861, DOI 10.1016/j.clinph.2013.04.001; Walsh DM, 2000, CLIN PHYSIOL, V20, P191; Watson T, 2020, ELECTROPHYSICAL AGEN	41	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189734	10.1371/journal.pone.0189734	http://dx.doi.org/10.1371/journal.pone.0189734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244850	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700056
J	Zaltsman, N; Ionescu, AC; Weiss, EI; Brambilla, E; Beyth, S; Beyth, N				Zaltsman, Nathan; Ionescu, Andrei C.; Weiss, Ervin I.; Brambilla, Eugenio; Beyth, Shaul; Beyth, Nurit			Surface-modified nanoparticles as anti-biofilm filler for dental polymers	PLOS ONE			English	Article							AMMONIUM POLYETHYLENEIMINE NANOPARTICLES; RESIN-BASED COMPOSITES; STREPTOCOCCUS-MUTANS; ANTIMICROBIAL ACTIVITY; TRANS-CINNAMALDEHYDE; ANTIBACTERIAL ACTIVITY; CARVACROL; BIOCOMPATIBILITY; RELEASE; EUGENOL	The objective of the study was to synthesis silica nanoparticles modified with (i)a tertiary amine bearing two t-cinnamaldehyde substituents or (ii) dimethyl-octyl ammonium, alongside the well-studied quaternary ammonium polyethyleneimine nanoparticles. These were to be evaluated for their chemical and mechanical properties, as well for antibacterial and antibiofilm activity. Samples were incorporated in commercial dental resin material and the degree of monomer conversion, mechanical strength, and water contact angle were tested to characterize the effect of the nanoparticles on resin material. Antibacterial activity was evaluated with the direct contact test and the biofilm inhibition test against Streptococcus mutans. Addition of cinnamaldehyde-modified particles preserved the degree of conversion and compressive strength of the base material and increased surface hydrophobicity. Quaternary ammonium functional groups led to a decrease in the degree of conversion and to low compressive strength, without altering the hydrophilic nature of the base material. In the direct contact test and the anti-biofilm test, the polyethyleneimine particles exhibited the strongest antibacterial effect. The cinnamaldehyde-modified particles displayed antibiofilm activity, silica particles with quaternary ammonium were ineffective. Immobilization of t-cinnamaldehyde onto a solid surface via amine linkers provided a better alternative to the wellknown quaternary ammonium bactericides.	[Zaltsman, Nathan; Beyth, Nurit] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Dept Prosthodont, Jerusalem, Israel; [Ionescu, Andrei C.; Brambilla, Eugenio] Univ Milan, IRCCS Galeazzi Inst, Dept Biomed Surg & Dent Sci, Milan, Italy; [Weiss, Ervin I.] Tel Aviv Univ, Goldschleger Sch Dent Med, Tel Aviv, Israel; [Beyth, Shaul] Hadassah Univ Hosp, Orthoped Surg Complex, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Milan; Tel Aviv University; Hebrew University of Jerusalem	Beyth, N (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il		IONESCU, Andrei/0000-0001-9051-4109	Isidor Cabakoff fund	Isidor Cabakoff fund	This work was supported by the Isidor Cabakoff fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz I, 2013, QUINTESSENCE INT, V44, P209, DOI 10.3290/j.qi.a29056; Amalaradjou MAR, 2011, FOODBORNE PATHOG DIS, V8, P1095, DOI 10.1089/fpd.2011.0841; Antonucci JM, 2012, DENT MATER, V28, P219, DOI 10.1016/j.dental.2011.10.004; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Beyth N, 2008, BIOMATERIALS, V29, P4157, DOI 10.1016/j.biomaterials.2008.07.003; Beyth N, 2007, J DENT, V35, P201, DOI 10.1016/j.jdent.2006.07.009; Beyth S, 2014, J ANTIMICROB CHEMOTH, V69, P854, DOI 10.1093/jac/dkt441; DIDRY N, 1993, PHARMAZIE, V48, P301; ENDO Y, 1987, APPL ENVIRON MICROB, V53, P2050, DOI 10.1128/AEM.53.9.2050-2055.1987; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Goto A, 2015, ACS SYM SER, V1187, P171; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Hahnel S, 2014, J ADHES DENT, V16, P313, DOI 10.3290/j.jad.a31800; Ionescu A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5372-4; Ionescu A, 2012, EUR J ORAL SCI, V120, P458, DOI 10.1111/j.1600-0722.2012.00983.x; Junior J.A.A., 2014, NEW J GLASS CERAMICS, V4, P29, DOI DOI 10.4236/njgc.2014.42004; Kawahara T, 2009, POLYM J, V41, P744, DOI 10.1295/polymj.PJ2009026; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Liberman A, 2014, SURF SCI REP, V69, P132, DOI 10.1016/j.surfrep.2014.07.001; Makwana S, 2014, LWT-FOOD SCI TECHNOL, V57, P470, DOI 10.1016/j.lwt.2014.01.043; MATSUDA M, 1963, MAKROMOLEKUL CHEM, V65, P224; Nostro A, 2012, APPL MICROBIOL BIOT, V96, P1029, DOI 10.1007/s00253-012-4091-3; Sato K, 2006, BIOL PHARM BULL, V29, P2292, DOI 10.1248/bpb.29.2292; Shvero DK, 2013, INT ENDOD J, V46, P747, DOI 10.1111/iej.12054; Shvero DK, 2010, J BIOMED MATER RES B, V94B, P367, DOI 10.1002/jbm.b.31662; Soteropulos CE, 2012, JOVE-J VIS EXP, DOI 10.3791/3866; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Wei QY, 2011, INT J FOOD MICROBIOL, V150, P164, DOI 10.1016/j.ijfoodmicro.2011.07.034; Yudovin-Farber I, 2008, BIOMACROMOLECULES, V9, P3044, DOI 10.1021/bm8004897; Yudovin-Farber I, 2010, J NANOMATER, V2010, DOI 10.1155/2010/826343; Zaltsman N, 2016, J APPL BIOMATER FUNC, V14, pE205, DOI 10.5301/jabfm.5000269; Zhou H, 2014, INT J ORAL SCI, V6, P77, DOI 10.1038/ijos.2014.18; Zhu YJ, 2009, J AGR FOOD CHEM, V57, P5518, DOI 10.1021/jf9007554	33	21	23	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e189397	10.1371/journal.pone.0189397	http://dx.doi.org/10.1371/journal.pone.0189397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244848	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700031
J	Boguta, P; Sokolowska, Z; Skic, K				Boguta, Patrycja; Sokolowska, Zofia; Skic, Kamil			Use of thermal analysis coupled with differential scanning calorimetry, quadrupole mass spectrometry and infrared spectroscopy (TG-DSC-QMS-FTIR) to monitor chemical properties and thermal stability of fulvic and humic acids	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; MINERAL MATRIX; SUBSTANCES; PYROLYSIS; COMBUSTION; SEDIMENTS; BEHAVIOR; CARBON; SHALE	Thermogravimetry-coupled with differential scanning calorimetry, quadrupole mass spectrometry, and Fourier-transform infrared spectroscopy (TG-DSC-QMS-FTIR)-was applied to monitor the thermal stability (in an N-2 pyrolytic atmosphere) and chemical properties of natural polymers, fulvic (FA) and humic acids (HA), isolated from chemically different soils. Three temperature ranges, R1, 40-220 degrees C; R2, 220-430 degrees C; and R3, 430-650 degrees C, were distinguished from the DSC data, related to the main thermal processes of different structures (including transformations without weight loss). Weight loss (Delta M) estimated from TG curves at the above temperature intervals revealed distinct differences within the samples in the content of physically adsorbed water (at R1), volatile and labile functional groups (at R2) as well as recalcitrant and refractory structures (at R3). QMS and FTIR modules enabled the chemical identification (by masses and by functional groups, respectively) of gaseous species evolved during thermal decomposition at R1, R2 and R3. Variability in shape, area and temperature of TG, DSC, QMS and FTIR peaks revealed differences in thermal stability and chemical structure of the samples between the FAs and HAs fractions of different origin. The statistical analysis showed that the parameters calculated from QMS (areas of m/z = 16, 17, 18, 44), DSC (MaxDSC) and TG (Delta M) at R1, R2 and R3 correlated with selected chemical properties of the samples, such as N, O and COOH content as well as E2/E6 and E2/E4 indexes. This indicated a high potential for the coupled method to monitor the chemical changes of humic substances. A new humification parameter, HTD, based on simple calculations of weight loss at specific temperature intervals proved to be a good alternative to indexes obtained from other methods. The above findings showed that the TG-DSC-QMS-FTIR coupled technique can represent a useful tool for the comprehensive assessment of FAs and HAs properties related to their various origin.	[Boguta, Patrycja; Sokolowska, Zofia; Skic, Kamil] Polish Acad Sci, Inst Agrophys, Dept Phys Chem Porous Mat, Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Boguta, P (corresponding author), Polish Acad Sci, Inst Agrophys, Dept Phys Chem Porous Mat, Lublin, Poland.	p.boguta@ipan.lublin.pl	Boguta, Patrycja/AAL-9890-2020	Boguta, Patrycja/0000-0003-4996-8795; Sokolowska, Zofia/0000-0003-2309-0785; Skic, Kamil/0000-0001-6921-1015	National Science Centre, Poland [DEC-2013/11/D/NZ9/02545]	National Science Centre, Poland(National Science Centre, Poland)	The studies were partly carried out within the framework of a research project. The project was financed from funds of National Science Centre, Poland, on the basis of decision number: DEC-2013/11/D/NZ9/02545 (granted to PB) (www: https://www.ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade R, 2010, GL SCI TECHNOL, V03, P13; Arenillas A, 1999, J ANAL APPL PYROL, V50, P31, DOI 10.1016/S0165-2370(99)00024-8; Boguta P, 2016, J GEOCHEM EXPLOR, V168, P119, DOI 10.1016/j.gexplo.2016.06.004; Boguta P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153626; Chen KY, 2012, ENVIRON POLLUT, V162, P151, DOI 10.1016/j.envpol.2011.10.036; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Cihlar Z., 2010, PET COAL, V52, P254; De la Rosa JM, 2008, CATENA, V74, P296, DOI 10.1016/j.catena.2008.03.004; de Moraes GM, 2011, REV BRAS CIENC SOLO, V35, P1597, DOI 10.1590/S0100-06832011000500014; de Oliveira LC, 2009, J BRAZIL CHEM SOC, V20, P1135, DOI 10.1590/S0103-50532009000600020; Dell'Abate MT, 2003, J SEP SCI, V26, P433, DOI 10.1002/jssc.200390057; Esteves VI, 1999, MAR CHEM, V63, P225, DOI 10.1016/S0304-4203(98)00064-4; Fan C, 2015, FUEL, V139, P502, DOI 10.1016/j.fuel.2014.09.021; Fernandez JM, 2008, CHEMOSPHERE, V73, P1838, DOI 10.1016/j.chemosphere.2008.08.001; Gao NB, 2014, J ANAL APPL PYROL, V105, P43, DOI 10.1016/j.jaap.2013.10.002; Giovanela M, 2004, GEOCHEM J, V38, P255, DOI 10.2343/geochemj.38.255; Giovanela M, 2010, J MOL STRUCT, V981, P111, DOI 10.1016/j.molstruc.2010.07.038; Guo F, 2016, SCI REP, V6; Hoffmann K, 2013, ECOL CHEM ENG A, V20, P261, DOI 10.2428/ecea.2013.20(02)026; Johnson K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8628; Kaljuvee T, 2013, J THERM ANAL CALORIM, V113, P1063, DOI 10.1007/s10973-013-2957-y; Klavins M., 2010, MIRES PEAT, P207; Kononova M.M., 1969, SOIL ORGANIC MATTER, DOI DOI 10.1016/B978-0-08-011470-5.50007-1; Kopczynski M, 2015, CHEM PROCESS ENG-INZ, V36, P209, DOI 10.1515/cpe-2015-0014; Liu H, 2012, J NANOPART RES, V14, P468; Liu HM, 2013, APPL CLAY SCI, V80-81, P398, DOI 10.1016/j.clay.2013.07.005; Lopez-Capel E, 2006, J ANAL APPL PYROL, V75, P82, DOI 10.1016/j.jaap.2005.04.004; Manning DAC, 2005, MINERAL MAG, V69, P425, DOI 10.1180/0026461056940260; Mastrolonardo G, 2014, J GEOCHEM EXPLOR, V143, P174, DOI 10.1016/j.gexplo.2014.04.010; Neris J, 2014, GEODERMA, V235, P240, DOI 10.1016/j.geoderma.2014.07.018; Oudghiri F, 2016, INFRARED PHYS TECHN, V78, P268, DOI 10.1016/j.infrared.2016.08.015; Plante AF, 2009, GEODERMA, V153, P1, DOI 10.1016/j.geoderma.2009.08.016; PURMALIS O, 2011, APPL CHEM, V24, P89; Rodriguez-Pastor I, 2015, CARBON, V84, P299, DOI 10.1016/j.carbon.2014.12.027; Salgado J, 2004, THERMOCHIM ACTA, V410, P141, DOI 10.1016/S0040-6031(03)00400-3; SIRBU C., 2010, PHYS AUC CRAIOVA, V20, P120; Swift R.S., 1996, SOIL SCI SOC AM J, V3, P1018, DOI DOI 10.2136/sssabookser5.3.c35; Szombathova A N, 2004, ACTA SCI POL AGR, V3, P37; Tan K.H., 2003, HUMIC MATTER SOIL EN; Trompowsky PM, 2005, ORG GEOCHEM, V36, P1480, DOI 10.1016/j.orggeochem.2005.08.001; Tudorachi N, 2011, POLYM TEST, V30, P397, DOI 10.1016/j.polymertesting.2011.02.007; Yan JW, 2013, FUEL, V104, P307, DOI 10.1016/j.fuel.2012.10.024; Zhang YL, 2011, ESTUAR COAST SHELF S, V93, P220, DOI [10.1016/j.ecss.2011.03.005, 10.1016/j.ecss.2010.12.025]	43	24	25	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189653	10.1371/journal.pone.0189653	http://dx.doi.org/10.1371/journal.pone.0189653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240819	gold, Green Submitted, Green Published			2022-12-26	WOS:000417905600060
J	Chornyy, S; Parnis, A; Shmoish, M; Cassel, D				Chornyy, Sergiy; Parnis, Anna; Shmoish, Michael; Cassel, Dan			High abundance of ArfGAP1 found in the mossy fibers in hilus of the dentate gyrus region of the mouse brain	PLOS ONE			English	Article							LOCALIZATION; HIPPOCAMPAL; ZINC	The Arf GTPase-activating protein ArfGAP1 and its brain-specific isoform ArfGAP1 B play an important role in neurotransmission. Here we analyzed the distribution of ArfGAP1 in the mouse brain. We found high levels of ArfGAP1 in the mouse dentate gyrus where it displayed especially elevated level in the polymorph layer (hilus). Importantly, the ArfGAP1 signal follows the pathway of the granular cell axons so-called mossy fibers which extend from the dentate gyrus to CA3 via stratum lucidum and partially stratum oriens. Additionally, we identified differential expression of ArfGAP1 in the isocortex. Thus, staining with anti-ArfGAP1 antibodies allows distinction between cortical cell layers 1, 2, 3 and 5 from 4 and 6. Taken together, our data suggest that ArfGAP1 can be used as a specific marker of the dentate mossy fibers and as for visualization of cortical layers in immunohistochemical studies.	[Chornyy, Sergiy; Parnis, Anna; Cassel, Dan] Technion Israel Inst Technol, Dept Biol, Haifa, Israel; [Shmoish, Michael] Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, Haifa, Israel; [Chornyy, Sergiy] Univ Haifa, Dept Psychol, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Haifa	Chornyy, S (corresponding author), Technion Israel Inst Technol, Dept Biol, Haifa, Israel.; Chornyy, S (corresponding author), Univ Haifa, Dept Psychol, Haifa, Israel.	sch_1982@yahoo.com	Chornyy, Sergiy/CAF-1485-2022	Chornyy, Sergiy/0000-0003-3169-495X	Israel Science Foundation [2020030]	Israel Science Foundation(Israel Science Foundation)	Grant to D.C. number 2020030 awarded by the Israel Science Foundation www.isf.org.il.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Buchwalow I, 2011, SCI REP-UK, V1, DOI 10.1038/srep00028; Candiello E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29950; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Delvendahl I, 2013, J PHYSIOL-LONDON, V591, P3179, DOI 10.1113/jphysiol.2012.248294; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Munster-Wandowski A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00210; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Parnis A, 2006, J BIOL CHEM, V281, P3785, DOI 10.1074/jbc.M508959200; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Sluyter F, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-5; Swenson RS, 2006, REV CLIN FUNCTIONAL; Wiera G, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00427	14	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189659	10.1371/journal.pone.0189659	http://dx.doi.org/10.1371/journal.pone.0189659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240824	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600061
J	Tomlinson, MS; Bommarito, PA; Martin, EM; Smeester, L; Fichorova, RN; Onderdonk, AB; Kuban, KCK; O'Shea, TM; Fry, RC				Tomlinson, Martha Scott; Bommarito, Paige A.; Martin, Elizabeth M.; Smeester, Lisa; Fichorova, Raina N.; Onderdonk, Andrew B.; Kuban, Karl C. K.; O'Shea, T. Michael; Fry, Rebecca C.			Microorganisms in the human placenta are associated with altered CpG methylation of immune and inflammation-related genes	PLOS ONE			English	Article							NF-KAPPA-B; HELICOBACTER-PYLORI; EMBRYONIC-DEVELOPMENT; DOWN-REGULATION; INFECTION; PREGNANCY; MECHANISMS; CYTOKINES; PATHWAYS; SYSTEM	Microorganisms in the placenta have been linked to adverse pregnancy outcomes as well as neonatal illness. Inflammation in the placenta has been identified as a contributing factor in this association, but the underlying biological mechanisms are not yet fully understood. The placental epigenome may serve as an intermediate between placental microbes and inflammation, contributing to adverse outcomes in the offspring. In the present study, genome-wide DNA methylation (n = 486,428 CpG sites) of 84 placentas was analyzed in relation to 16 species of placental microorganisms using samples collected from the Extremely Low Gestation Age Newborns (ELGAN) cohort. A total of n = 1,789 CpG sites, corresponding to n = 1,079 genes, displayed differential methylation (q<0.1) in relation to microorganisms. The altered genes encode for proteins that are involved in immune/inflammatory responses, specifically the NF-kappa B signaling pathway. These data support bacteria-dependent epigenetic patterning in the placenta and provide potential insight into mechanisms that associate the presence of microorganisms in the placenta to pregnancy and neonatal outcomes. This study lays the foundation for investigations of the placental micro-biome and its role in placental function.	[Tomlinson, Martha Scott; Bommarito, Paige A.; Martin, Elizabeth M.; Smeester, Lisa; Fry, Rebecca C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Fichorova, Raina N.] Harvard Med Sch, Lab Genital Tract Biol, Dept Obstet & Gynecol, Boston, MA USA; [Fichorova, Raina N.; Onderdonk, Andrew B.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Onderdonk, Andrew B.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Kuban, Karl C. K.] Boston Med Ctr, Dept Pediat, Div Pediat Neurol, Boston, MA USA; [O'Shea, T. Michael] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fry, RC (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.	rfry@unc.edu		Fry, Rebecca/0000-0003-0899-9018; Onderdonk, Andrew/0000-0001-8998-8972; Smeester, Lisa/0000-0001-5283-0485	National Institutes of Health [R01 ES019315, P42ES005948, T32ES007018, 1UG30D023348-01, 5U01NS040069-05, 2R01NS040069 - 06A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, T32ES007018] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (http://www.nih.gov): R01 ES019315, P42ES005948, T32ES007018, 1UG30D023348-01, 5U01NS040069-05 and 2R01NS040069 - 06A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Arntzen KJ, 1998, J PERINAT MED, V26, P17, DOI 10.1515/jpme.1998.26.1.17; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bobetsis YA, 2007, J DENT RES, V86, P169, DOI 10.1177/154405910708600212; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cookson VJ, 2010, HISTOL HISTOPATHOL, V25, P945, DOI 10.14670/HH-25.945; Daca-Roszak P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2202-0; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; Ding SZ, 2010, FUTURE ONCOL, V6, P851, DOI [10.2217/fon.10.37, 10.2217/FON.10.37]; Espin-Palazon R, 2016, EXP HEMATOL, V44, P519, DOI 10.1016/j.exphem.2016.03.010; Eude-Le Parco Isabelle, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS11, DOI 10.1186/1471-2393-7-S1-S11; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00280-10; Gheorghe CP, 2010, INT J DEV BIOL, V54, P507, DOI 10.1387/ijdb.082770cg; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Griesinger G, 2001, J SOC GYNECOL INVEST, V8, P334, DOI 10.1016/S1071-5576(01)00135-6; Hadfield KA, 2011, J REPROD IMMUNOL, V89, P1, DOI 10.1016/j.jri.2010.11.008; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Leviton A, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00058; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Lovicu FJ, 2011, PHILOS T R SOC B, V366, P1204, DOI 10.1098/rstb.2010.0339; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Martin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141294; Martin EM, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvv011; McCracken SA, 2004, J IMMUNOL, V172, P4583, DOI 10.4049/jimmunol.172.7.4583; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Minarovits J, 2009, ACTA MICROBIOL IMM H, V56, P1, DOI 10.1556/AMicr.56.2009.1.1; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Stacey KJ, 1996, J IMMUNOL, V157, P2116; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yin L, 2011, MUCOSAL IMMUNOL, V4, P409, DOI 10.1038/mi.2010.83	47	17	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188664	10.1371/journal.pone.0188664	http://dx.doi.org/10.1371/journal.pone.0188664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240761	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600009
J	Apelgren, P; Amoroso, M; Lindahl, A; Brantsing, C; Rotter, N; Gatenholm, P; Kolby, L				Apelgren, Peter; Amoroso, Matteo; Lindahl, Anders; Brantsing, Camilla; Rotter, Nicole; Gatenholm, Paul; Kolby, Lars			Chondrocytes and stem cells in 3D-bioprinted structures create human cartilage in vivo	PLOS ONE			English	Article							CHONDROGENIC DIFFERENTIATION; TISSUE; BONE; COCULTURE; HYDROGELS; RECONSTRUCTION; FABRICATION; DEFECTS; SKIN	Cartilage repair and replacement is a major challenge in plastic reconstructive surgery. The development of a process capable of creating a patient-specific cartilage framework would be a major breakthrough. Here, we described methods for creating human cartilage in vivo and quantitatively assessing the proliferative capacity and cartilage-formation ability in mono-and co-cultures of human chondrocytes and human mesenchymal stem cells in a three-dimensional (3D)-bioprinted hydrogel scaffold. The 3D-bioprinted constructs (5 x 5 x 1.2 mm) were produced using nanofibrillated cellulose and alginate in combination with human chondrocytes and human mesenchymal stem cells using a 3D-extrusion bioprinter. Immediately following bioprinting, the constructs were implanted subcutaneously on the back of 48 nude mice and explanted after 30 and 60 days, respectively, for morphological and immunohistochemical examination. During explantation, the constructs were easy to handle, and the majority had retained their macroscopic grid appearance. Constructs consisting of human nasal chondrocytes showed good proliferation ability, with 17.2% of the surface areas covered with proliferating chondrocytes after 60 days. In constructs comprising a mixture of chondrocytes and stem cells, an additional proliferative effect was observed involving chondrocyte production of glycosaminoglycans and type 2 collagen. This clinically highly relevant study revealed 3D bioprinting as a promising technology for the creation of human cartilage.	[Apelgren, Peter; Amoroso, Matteo; Kolby, Lars] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Plast Surg, Gothenburg, Sweden; [Lindahl, Anders; Brantsing, Camilla] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Rotter, Nicole] Univ Med Ctr Ulm, Dept Otorhinolaryngol, Ulm, Germany; [Gatenholm, Paul] Chalmers Univ Technol, Dept Chem & Chem Engn, Bioprinting Ctr 3D, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Ulm University; Chalmers University of Technology	Apelgren, P (corresponding author), Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Plast Surg, Gothenburg, Sweden.	peter.apelgren@vgregion.se	Apelgren, Peter/AAH-1148-2020; Kolby, Lars/ABC-8602-2020; Lindahl, Anders/H-9550-2014	Kolby, Lars/0000-0001-9808-5935; Lindahl, Anders/0000-0003-2871-5166; Rotter, Nicole/0000-0003-1537-8340	Sahlgrenska Academy at the University of Gothenburg; Sahlgrenska University Hospital	Sahlgrenska Academy at the University of Gothenburg; Sahlgrenska University Hospital	Funding by Sahlgrenska Academy at the University of Gothenburg and the Sahlgrenska University Hospital.	Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556; Antoine EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122500; Aung A, 2011, ARTHRITIS RHEUM-US, V63, P148, DOI 10.1002/art.30086; Avila H. M., 2016, BIOPRINTING, V1, P22, DOI DOI 10.1016/J.BPRINT.2016.08.003; Bahney CS, 2014, J BONE MINER RES, V29, P1269, DOI 10.1002/jbmr.2148; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h; Barth I, 2008, HUM GENE THER, V19, P441, DOI 10.1089/hum.2008.0409; Bigdeli N, 2009, STEM CELLS, V27, P1812, DOI 10.1002/stem.114; Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Chung JHY, 2013, BIOMATER SCI-UK, V1, P763, DOI 10.1039/c3bm00012e; Dai Z, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416648810; de Windt TS, 2014, STEM CELL TRANSL MED, V3, P723, DOI 10.5966/sctm.2013-0207; Estes BT, 2006, ARTHRITIS RHEUM-US, V54, P1222, DOI 10.1002/art.21779; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Firmin F, 2010, ADV OTO-RHINO-LARYNG, V68, P25, DOI 10.1159/000314561; Firmin Francoise, 2011, Semin Plast Surg, V25, P257, DOI 10.1055/s-0031-1288917; Fox NJ, 1997, SOC SCI MED, V45, P649, DOI 10.1016/S0277-9536(96)00381-4; Gao GF, 2015, BIOTECHNOL LETT, V37, P2349, DOI 10.1007/s10529-015-1921-2; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008; Holzl K, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/3/032002; Hwang NS, 2007, FEBS LETT, V581, P4172, DOI 10.1016/j.febslet.2007.07.049; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413; Kang HW, 2015, METHODS MOL BIOL, V1340, P161, DOI 10.1007/978-1-4939-2938-2_11; Ko CY, 2016, J TISSUE ENG REGEN M, V10, pE485, DOI 10.1002/term.1846; Langer R, 2016, J PEDIATR SURG, V51, P8, DOI 10.1016/j.jpedsurg.2015.10.022; Lee V, 2014, TISSUE ENG PART C-ME, V20, P473, DOI [10.1089/ten.tec.2013.0335, 10.1089/ten.TEC.2013.0335]; Lettry V, 2010, JPN J VET RES, V58, P5; Lindahl A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0369; Liu X, 2010, BIOMATERIALS, V31, P9406, DOI 10.1016/j.biomaterials.2010.08.052; Markstedt K, 2015, BIOMACROMOLECULES, V16, P1489, DOI 10.1021/acs.biomac.5b00188; Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240; Moller T, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001227; Osorno G, 1999, PLAST RECONSTR SURG, V104, P1951, DOI 10.1097/00006534-199912000-00001; Ozbolat IT, 2016, BIOMATERIALS, V76, P321, DOI 10.1016/j.biomaterials.2015.10.076; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polak J, 2008, ADV TISSUE ENG, Vxxxviii; Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028; Stojkovska J, 2010, J MATER SCI-MATER M, V21, P2869, DOI 10.1007/s10856-010-4135-0; Wu L., 2011, TISSUE ENG PART A, V17, P9; Wu L, 2013, STEM CELLS DEV, V22, P2356, DOI 10.1089/scd.2013.0118; Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001; Zhao YM, 2015, J TISSUE ENG REGEN M, V9, P826, DOI 10.1002/term.1643; Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209; Zopf DA, 2013, JAMA FACIAL PLAST SU, V15, P131, DOI 10.1001/2013.jamafacial.25	51	70	74	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189428	10.1371/journal.pone.0189428	http://dx.doi.org/10.1371/journal.pone.0189428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236765	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100068
J	Lania, BG; Morari, J; de Souza, AL; da Silva, MN; de Almeida, AR; Veira-Damiani, G; Alegre, SM; Cesar, CL; Velloso, LA; Cintra, ML; Mala, NB; Velho, PENF				Lania, Bruno Grosselli; Morari, Joseane; de Souza, Aglecio Luis; da Silva, Marilene Neves; de Almeida, Amanda Roberta; Veira-Damiani, Gislaine; Alegre, Sarah Monte; Cesar, Carlos Lenz; Velloso, Licio Augusto; Cintra, Maria Leticia; Mala, Nilson Borlina; Neves Ferreira Velho, Paulo Eduardo			Topical use and systemic action of green and roasted coffee oils and ground oils in a cutaneous incision model in rats (Rattus norvegicus albinus)	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; SKIN REGENERATION; CHRONIC WOUNDS; INTERLEUKIN-12; ADIPONECTIN; KERATINOCYTES; MICROSCOPY; DISEASE	Introduction Wounds are a common health problem. Coffee is widely consumed and its oil contains essential fatty acids. We evaluated the local (skin) and systemic effects associated with the topical use of coffee oils in rats. Methods Punch skin wounds (6 mm) incisions were generated on the backs of 75 rats. Saline (SS), mineral oil (MO), green coffee oil (GCO), roasted coffee oil (RCO), green coffee ground oil (GCGO) or roasted coffee ground oil (RCGO) were topically applied to the wounds. Healing was evaluated by visual and histological/morphometric optical microscopy examination; second harmonics generation (SHG) microscopy, wound tissue q-PCR (values in fold-change) and blood serum (ELISA, values in pg/mL). Results RCO treated animals presented faster wound healing (0.986 vs. 0.422), higher mRNA expression of IGF-1 (2.78 vs. 1.00, p = 0.01), IL-6 (10.72 vs. 1.00, p = 0.001) and IL-23 (4.10 vs. 1.2, p = 0.05) in early stages of wound healing; higher IL-12 (3.32 vs. 1.00, p = 0.05) in the later stages; and lower serum levels of IFN-gamma (11.97 vs. 196.45, p = 0.01). GCO treatment led to higher mRNA expression of IL-6 (day 2: 7.94 vs. 1.00, p = 0.001 and day 4: 6.90 vs. 1.00, p = 0.01) and IL-23 (7.93 vs. 1.20, p = 0.001) in the early stages. The RCO treatment also produced higher serum IFN-alpha levels throughout the experiment (day 2: 52.53 vs. 21.20; day 4: 46.98 vs. 21.56; day 10: 83.61 vs. 25.69, p = 0.05) and lower levels of IL-4 (day 4: 0.9 vs. 13.36, p = 0.01), adiponectin (day 10: 8,367.47 vs. 16,526.38, p = 0.001) and IFN-gamma (day 4: 43.03 vs. 196.45, p = 0.05). The SHG analysis showed a higher collagen density in the RCO and GCO treatments (p = 0.05). Conclusion Topical treatment with coffee oils led to systemic actions and faster wound healing in rats. Further studies should be performed are necessary to assess the safety of topical vegetal oil use for skin lesions.	[Lania, Bruno Grosselli; da Silva, Marilene Neves; de Almeida, Amanda Roberta; Veira-Damiani, Gislaine; Neves Ferreira Velho, Paulo Eduardo] Univ Estadual Campinas, Lab Appl Res Dermatol & Bartonella Infect, Sch Med Sci, Campinas, SP, Brazil; [Morari, Joseane; Velloso, Licio Augusto] Univ Estadual Campinas, Cell Signaling Lab, Campinas, SP, Brazil; [Morari, Joseane; Velloso, Licio Augusto] Univ Estadual Campinas, Obes & Comorbid Res Ctr, Sch Med Sci, Campinas, SP, Brazil; [de Souza, Aglecio Luis; Alegre, Sarah Monte] Univ Estadual Campinas, Metab Lab, Internal Med, Sch Med Sci, Campinas, SP, Brazil; [Alegre, Sarah Monte; Velloso, Licio Augusto; Neves Ferreira Velho, Paulo Eduardo] Univ Estadual Campinas, Clin Med Dept, Sch Med Sci, Campinas, SP, Brazil; [Cesar, Carlos Lenz] Univ Estadual Campinas, Natl Inst Photon Appl Cell Biol INFABIC, Gleb Wataghin Inst Phys, Campinas, SP, Brazil; [Cintra, Maria Leticia] Univ Estadual Campinas, Pathol Anat Dept, Sch Med Sci, Campinas, SP, Brazil; [Mala, Nilson Borlina] Agron Inst Campinas, Aromat Plants Div, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC)	Lania, BG (corresponding author), Univ Estadual Campinas, Lab Appl Res Dermatol & Bartonella Infect, Sch Med Sci, Campinas, SP, Brazil.	bruglania@gmail.com	DE SOUZA, AGLECIO/Q-4056-2016; Morari Ricciardi de Aguiar, Joseane/AHE-2586-2022; Lenz Cesar, Carlos/F-2442-2018; Cintra, Maria Leticia/CAE-8585-2022; Velloso, Licio/AAJ-3778-2020; Grosselli Lania, Bruno/J-7496-2012	Lenz Cesar, Carlos/0000-0001-5573-9636; Maia, Nilson/0000-0001-9084-7157; Morari, Joseane/0000-0002-0728-4283; Silva, Marilene/0000-0002-0885-1083; Grosselli Lania, Bruno/0000-0003-4949-7444	Sao Paulo Research Foundation - Fapesp [07/59319-5]; Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp [015/2014, 043/2016]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes [01P-04520-2013]	Sao Paulo Research Foundation - Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grant # 07/59319-5 Sao Paulo Research Foundation - Fapesp - http://www.fapesp.br/en/ - NBM; grant # 015/2014 - Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp - http://www.sbd-sp.org.br/funadersp.php - PENFV; grant # 043/2016 - Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp - http://www.sbd-sp.org.br/funadersp.php - PENFV; grant # 01P-04520-2013 - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes - http://www.capes.gov.br/ - BGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam SY, 2012, BIOCHEM BIOPH RES CO, V421, P197, DOI 10.1016/j.bbrc.2012.03.134; Amiri FT, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16323; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; BLOOM H, 1945, LANCET, V249, P559; Bollag WB, 2013, J INVEST DERMATOL, V133, P2505, DOI 10.1038/jid.2013.271; Bryan D, 2005, CYTOKINE, V31, P429, DOI 10.1016/j.cyto.2005.06.015; Butzelaar L, 2016, EXP DERMATOL, V25, P797, DOI 10.1111/exd.13100; Cicchi R, 2010, J BIOPHOTONICS, V3, P34, DOI 10.1002/jbio.200910062; Das LM, 2015, J INVEST DERMATOL, V135, P389, DOI 10.1038/jid.2014.375; Dawid-Pac R, 2013, POSTEP DERM ALERGOL, V30, P170, DOI 10.5114/pdia.2013.35620; de Moura RF, 2015, INT J OBES LOND; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x; Gerber SA, 2015, RADIAT RES, V183, P72, DOI 10.1667/RR13802.1; Gomes FP, 1981, CAPITULO 14 EXPT COM; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Gupta A, 2008, WOUND REPAIR REGEN, V16, P784, DOI 10.1111/j.1524-475X.2008.00431.x; Hantao LW, 2013, TALANTA, V116, P1079, DOI 10.1016/j.talanta.2013.08.033; Jarbrink K, SYST REV; Kawai K, 2008, BIOCHEM BIOPH RES CO, V374, P269, DOI 10.1016/j.bbrc.2008.07.045; Li J, 2015, BIOMED OPT EXPRESS, V6, P4277, DOI 10.1364/BOE.6.004277; MacLeod AS, 2016, ADV WOUND CARE, V5, P65, DOI 10.1089/wound.2014.0608; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Meglio PD, 2010, F1000 BIOL REP, V2; Mikita N, 2011, J DERMATOL, V38, P839, DOI 10.1111/j.1346-8138.2011.01237.x; Nascimento AP, 2006, BRIT J NUTR, V96, P1069, DOI 10.1017/BJN20061955; Oliveira LS, 2008, BIORESOURCE TECHNOL, V99, P3244, DOI 10.1016/j.biortech.2007.05.074; Pirila E, 2002, WOUND REPAIR REGEN, V10, P38, DOI 10.1046/j.1524-475X.2002.10605.x; Poole CF, 2013, J CHROMATOGR A, V1296, P2, DOI 10.1016/j.chroma.2013.01.097; Ribeiro H, 2017, EUROPEAN J LIPID SCI, V115, P330; Salathia NS, 2013, J INVEST DERMATOL, V133, P812, DOI 10.1038/jid.2012.374; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Society A. O. C., 1994, OFFICIAL METHODS REC; Tanno H, 2015, AM J PATHOL, V185, P3248, DOI 10.1016/j.ajpath.2015.08.012; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wagemaker TAL, 2015, INT J COSMETIC SCI, V37, P506, DOI 10.1111/ics.12225; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yuwono HS., 2014, SCAND J SURG, V2, P25	39	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188779	10.1371/journal.pone.0188779	http://dx.doi.org/10.1371/journal.pone.0188779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236720	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100030
J	Liu, C; Zhou, MS; Li, Y; Wang, AM; Chadipiralla, K; Tian, RX; Raij, L				Liu, Chang; Zhou, Ming-Sheng; Li, Yao; Wang, Aimei; Chadipiralla, Kiranmai; Tian, Runxia; Raij, Leopoldo			Oral nicotine aggravates endothelial dysfunction and vascular inflammation in diet-induced obese rats: Role of macrophage TNF alpha	PLOS ONE			English	Article							SALT-SENSITIVE HYPERTENSION; LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; INCREASED OXIDATIVE STRESS; TYPE-2 DIABETIC MICE; ACETYLCHOLINE-RECEPTOR; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME	Obesity and cigarette smoke are major cardiovascular (CV) risk factors and, when coexisting in the same individuals, have additive/synergistic effects upon CVD. We studied the mechanisms involved in nicotine enhancement of CVD in Sprague Dawley rats with diet-induced obesity. The rats were fed either a high fat (HFD) or normal rat chow diet with or without nicotine (100 mg/L in drinking water) for 20 weeks. HFD rats developed central obesity, increased systolic blood pressure (SBP), aortic superoxide (O-2(-)) production, and impaired endothelial nitric oxide synthase (eNOS) and endothelium-dependent relaxation to acetylcholine (EDR). Nicotine further increased SBP, O-2(-) and impaired eNOS and EDR in obese rats. In the peritoneal macrophages from obese rats, tumor necrosis factor (TNF)alpha, interleukin 1 beta and CD36 were increased, and were further increased in nicotine-treated obese rats. Using PCR array we found that 3 of 84 target proinflammatory genes were increased by 2-4 fold in the aorta of obese rats, 11 of the target genes were further increased in nicotine-treated obese rats. HUVECs, incubated with conditioned medium from the peritoneal macrophages of nicotine treated-obese rats, exhibited reduced eNOS and increased NADPH oxidase subunits gp91phox and p22phox expression. Those effects were partially prevented by adding anti-TNF alpha antibody to the conditioned medium. Our results suggest that nicotine aggravates the CV effects of diet-induced obesity including the oxidative stress, vascular inflammation and endothelial dysfunction. The underlying mechanisms may involve in targeting endothelium by enhancement of macrophage-derived TNF alpha.	[Liu, Chang] Jinzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol, Jinzhou, Peoples R China; [Zhou, Ming-Sheng] Shenyang Med Univ, Dept Physiol, Shenyang, Liaoning, Peoples R China; [Zhou, Ming-Sheng; Li, Yao; Wang, Aimei] Jinzhou Med Univ, Dept Physiol, Jinzhou, Peoples R China; [Chadipiralla, Kiranmai; Tian, Runxia; Raij, Leopoldo] Univ Miami, Miller Sch Med, Miami VAMC, Nephrol Hypertens Sect, Miami, FL 33136 USA	Jinzhou Medical University; Shenyang Medical College; Jinzhou Medical University; University of Miami	Zhou, MS (corresponding author), Shenyang Med Univ, Dept Physiol, Shenyang, Liaoning, Peoples R China.; Zhou, MS (corresponding author), Jinzhou Med Univ, Dept Physiol, Jinzhou, Peoples R China.	zhoums1963@163.com			National Natural Science Foundation of China [81470532, 81670384, 31471138]; Liaoning Province; Florida Biomedical Research Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Province(Natural Science Foundation of Liaoning Province); Florida Biomedical Research Grant	This work was supported by the grants from the National Natural Science Foundation of China (No. 81470532, 81670384), an award for distinguished professor in Liaoning Province and a Florida Biomedical Research Grant to Ming-Sheng Zhou, by grant from the National Natural Science Foundation of China (31471138) to Chang Liu.	Adamopoulos D, 2008, CLIN EXP PHARMACOL P, V35, P458, DOI 10.1111/j.1440-1681.2008.04896.x; Akbartabartoori M, 2006, EUR J CARDIOV PREV R, V13, P938, DOI 10.1097/01.hjr.0000214613.29608.f5; Babakr AT, 2014, DIABETES METAB SYNDR, V7, P513, DOI 10.2147/DMSO.S70904; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Baltar VT, 2011, CANCER EPIDEM BIOMAR, V20, P869, DOI 10.1158/1055-9965.EPI-10-1235; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Chen WY, 2012, CIRC RES, V111, P824, DOI 10.1161/CIRCRESAHA.112.278002; Chen Z, 2015, CIRCULATION, V131, P805, DOI 10.1161/CIRCULATIONAHA.114.013675; Codoner-Franch P, 2010, INT J PEDIATR OBES, V5, P56, DOI 10.3109/17477160903055945; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Dschietzig T, 2012, CARDIOVASC RES, V95, P97, DOI 10.1093/cvr/cvs149; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hanna ST, 2006, J CARDIOVASC PHARM, V47, P348; Harwani SC, 2016, CIRC RES, V119, P1101, DOI 10.1161/CIRCRESAHA.116.309402; Harwani SC, 2012, CIRC RES, V111, P1190, DOI 10.1161/CIRCRESAHA.112.277475; Higashi Y, 2002, NEW ENGL J MED, V346, P1954, DOI 10.1056/NEJMoa013591; Hjellvik V, 2013, EUR J EPIDEMIOL, V28, P35, DOI 10.1007/s10654-012-9758-7; Jaimes EA, 2004, ARTERIOSCL THROM VAS, V24, P1031, DOI 10.1161/01.ATV.0000127083.88549.58; Karatzi K, 2007, INT J CARDIOL, V120, P404, DOI 10.1016/j.ijcard.2006.07.200; KELLERSTANISLAWSKI B, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1160; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Mariappan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046568; Marsot A, 2016, Int J Toxicol, V35, P179, DOI 10.1177/1091581815618935; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Miyata S, 2015, ACTA CARDIOL, V70, P282, DOI 10.1080/AC.70.3.3080632; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pan A, 2015, CIRCULATION, V132, P1795, DOI 10.1161/CIRCULATIONAHA.115.017926; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Sinha-Hikim I, 2016, CELL TISSUE RES; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Thorgeirsson TE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.81; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang C, 2017, ARTERIOSCL THROM VAS, V37, P53, DOI 10.1161/ATVBAHA.116.307264; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang YJ, 2004, INT IMMUNOPHARMACOL, V4, P1675, DOI 10.1016/j.intimp.2004.07.028; Woolf KJ, 2012, AM J CARDIOL, V110, P968, DOI 10.1016/j.amjcard.2012.05.028; Xu TY, 2015, ACTA PHARMACOL SIN, V36, P429, DOI 10.1038/aps.2015.5; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963; Zhang HR, 2010, ARTERIOSCL THROM VAS, V30, P2156, DOI 10.1161/ATVBAHA.110.214700; Zheng YS, 2015, PANCREAS, V44, P500, DOI 10.1097/MPA.0000000000000294; Zhou MS, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0211-6; Zhou MS, 2014, AM J HYPERTENS, V27, P873, DOI 10.1093/ajh/hpt272; Zhou MS, 2013, AM J PHYSIOL-HEART C, V305, pH563, DOI 10.1152/ajpheart.00042.2013; Zhou MS, 2010, J HYPERTENS, V28, P527, DOI 10.1097/HJH.0b013e3283340da8	56	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188439	10.1371/journal.pone.0188439	http://dx.doi.org/10.1371/journal.pone.0188439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236702	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100017
J	Barreira, DMPG; Fumian, TM; Tonini, MAL; Volpini, LPB; Santos, RP; Ribeiro, ALC; Leite, JPG; Souza, MTBDE; Brasil, P; da Cunha, DC; Miagostovich, MP; Spano, LC				Pires Goncalves Barreira, Debora Maria; Fumian, Tulio Machado; Loureiro Tonini, Marco Andre; Bondi Volpini, Lays Paula; Santos, Rodrigo Pratte; Chaves Ribeiro, Anezia Lima; Gagliardi Leite, Jose Paulo; de Moraes e Souza, Marcia Terezinha Baroni; Brasil, Patricia; da Cunha, Denise Cotrim; Miagostovich, Marize Pereira; Spano, Liliana Cruz			Detection and molecular characterization of the novel recombinant norovirus GII.P16-GII.4 Sydney in southeastern Brazil in 2016	PLOS ONE			English	Article							EMERGENCE; OUTBREAKS; STRAIN; GASTROENTERITIS; EVOLUTION; INCREASE; GII.2; CHINA	Noroviruses are the leading cause of acute gastroenteritis (AGE) in all age groups worldwide. Despite the high genetic diversity of noroviruses, most AGE outbreaks are caused by a single norovirus genotype: GII.4. Since 1995, several different variants of norovirus GII.4 have been associated with pandemics, with each variant circulating for 3 to 8 years. The Sydney_2012 variant was first reported in Australia and then in other countries. A new variant, GII.P16-GII.4, was recently described in Japan and South Korea and then in the USA, France, Germany and England. In our study, 190 faecal specimens were collected from children admitted to a paediatric hospital and a public health facility during a surveillance study of sporadic cases of AGE conducted between January 2015 and July 2016. The norovirus was detected by RT-qPCR in 51 samples (26.8%), and in 37 of them (72.5%), the ORF1-2 junction was successfully sequenced. The new recombinant GII.P16-GII.4 Sydney was revealed for the first time in Brazil in 2016 and predominated among other strains (9 GII.Pe-GII.4, 3 GII.P17-GII.17, 1 GII.Pg-GII.1, 1 GII.P16-GII.3 and 1 GII.PNA-GII.4). The epidemiological significance of this new recombinant is still unknown, but continuous surveillance studies may evaluate its impact on the population, its potential to replace the first recombinant GII.Pe-GII.4 Sydney 2012 variant, and the emergence of new recombinant forms of GII.P16.	[Pires Goncalves Barreira, Debora Maria; Loureiro Tonini, Marco Andre; Bondi Volpini, Lays Paula; Santos, Rodrigo Pratte; Spano, Liliana Cruz] Univ Fed Espirito Santo, Hlth Sci Ctr, Pathol Dept, Lab Virol & Infect Gastroenteritis, Av Marechal Campos 1468, Vitoria, ES, Brazil; [Fumian, Tulio Machado; Gagliardi Leite, Jose Paulo; de Moraes e Souza, Marcia Terezinha Baroni; Miagostovich, Marize Pereira] Oswaldo Cruz Inst, Lab Comparat & Environm Virol, BR-4365 Rio De Janeiro, RJ, Brazil; [Chaves Ribeiro, Anezia Lima] Cent Lab Publ Hlth, Av Marechal Mascarenhas Moraes 2025, Vitoria, ES, Brazil; [Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Av Brasil 4365, Rio De Janeiro, RJ, Brazil; [da Cunha, Denise Cotrim] Sergio Arouca Publ Hlth Natl Sch, Av Brasil 4365, Rio De Janeiro, RJ, Brazil	Universidade Federal do Espirito Santo; Fundacao Oswaldo Cruz	Barreira, DMPG (corresponding author), Univ Fed Espirito Santo, Hlth Sci Ctr, Pathol Dept, Lab Virol & Infect Gastroenteritis, Av Marechal Campos 1468, Vitoria, ES, Brazil.	deborambarreira@yahoo.com.br	Fumian, Tulio/AAC-4724-2021; LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Brasil, Patricia/P-3536-2014	Brasil, Patricia/0000-0001-9555-7976	Espirito Santo Research Foundation (FAPES)/National Council for Scientific and Technological Development (CNPq)/Department of Science and Technology (Decit)-Science Technology and Strategic Inputs (SCTIE) Health Ministry (MS)/Health (SESA) [10/2013-PPSUS]; PROEP/CNPQ [402135/2011-3]; Espirito Santo Research Foundation (FAPES)	Espirito Santo Research Foundation (FAPES)/National Council for Scientific and Technological Development (CNPq)/Department of Science and Technology (Decit)-Science Technology and Strategic Inputs (SCTIE) Health Ministry (MS)/Health (SESA); PROEP/CNPQ; Espirito Santo Research Foundation (FAPES)	We would like to thank the Health Surveillance Management and the Monitoring Service in Diarrheal Diseases of Espirito Santo state, the Technical School of Health of the municipality of Vitoria, and Dr. Alba Lilia Rosetti de Almeida (Epidemiological Surveillance Service of the Hospital Estadual Infantil Nossa Senhora da Gloria), Oswaldo Cruz Institute/Fiocruz, and Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (Faperj). This study was supported by Esporito Santo Research Foundation (FAPES)/National Council for Scientific and Technological Development (CNPq)/Department of Science and Technology (Decit)-Secretary of Science Technology and Strategic Inputs (SCTIE)-Health Ministry (MS)/Health's Secretary (SESA) (no. 10/2013-PPSUS), and PROEP/CNPQ (no. 402135/2011-3).; This study was supported by Espirito Santo Research Foundation (FAPES)/National Council for Scientific and Technological Development (CNPq)/Department of Science and Technology (Decit)-Secretary of Science Technology and Strategic Inputs (SCTIE) Health Ministry (MS)/Health's Secretary (SESA) (no.10/2013-PPSUS), and PROEP/CNPQ (no. 402135/2011-3). The first author had a scholarship from Espirito Santo Research Foundation (FAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade JSR, 2017, INFECT GENET EVOL, V51, P28, DOI 10.1016/j.meegid.2017.03.011; Ao YY, 2017, EMERG INFECT DIS, V23, P1172, DOI 10.3201/eid2307.170034; Arana A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098875; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Bidalot M, 2017, EURO SURVEILL, V22; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Cannon JL, 2017, J CLIN MICROBIOL, V55, P2208, DOI 10.1128/JCM.00455-17; Chan MCW, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00343-17, 10.1128/genomea.00343-17]; Chan MCW, 2014, EMERG INFECT DIS, V20, P658, DOI [10.3201/eid2004.131457, 10.3201/eid2004.13457]; Choi YW, 2016, J ETHNOPHARMACOL, V178, P17, DOI 10.1016/j.jep.2015.12.010; da Silva LD, 2017, INFECT GENET EVOL, V48, P1, DOI 10.1016/j.meegid.2016.11.027; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Fumian TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145391; Green K., 2013, FIELDS VIROLOGY, V1, P583; Hernandez JD, 2016, INFECT GENET EVOL, V39, P365, DOI 10.1016/j.meegid.2016.02.007; Iritani N, 2012, J MED VIROL, V84, P517, DOI 10.1002/jmv.23211; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Liu LTC, 2017, EMERG INFECT DIS, V23, P1180, DOI 10.3201/eid2307.170212; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu J, 2017, EMERG INFECT DIS, V23, P1188, DOI 10.3201/eid2307.170333; Mans J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-168; Martin D.P., 2015, VIRUS EVOL, V26; Matsushima Y, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.26.21173; Matsushima Y, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01099-16; Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005; Mizukoshi F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00705; Siqueira JA, 2016, INFECT GENET EVOL, V44, P361, DOI 10.1016/j.meegid.2016.07.037; Mori K, 2017, J MED VIROL, V89, P363, DOI 10.1002/jmv.24624; Nahar S, 2013, INFECT GENET EVOL, V20, P325, DOI 10.1016/j.meegid.2013.09.021; Niendorf S, 2017, EURO SURVEILL, V26; Parra GI, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006136; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Ruis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179572; Silva Luciana Damascena da, 2013, Mem Inst Oswaldo Cruz, V108, P1068, DOI 10.1590/0074-0276130293; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thanh H Dang, 2016, PLOS ONE, V5; Hoa-Tran TN, 2015, INFECT GENET EVOL, V30, P27, DOI 10.1016/j.meegid.2014.12.003; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Tohma K, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00187-17; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Wang YH, 2012, ARCH VIROL, V157, P2417, DOI 10.1007/s00705-012-1437-1; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746	53	20	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189504	10.1371/journal.pone.0189504	http://dx.doi.org/10.1371/journal.pone.0189504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236779	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100075
J	Sandahl, TD; Stoy, SH; Laursen, TL; Rodgaard-Hansen, S; Moller, HJ; Moller, S; Vilstrup, H; Gronbaek, H				Sandahl, Thomas Damgaard; Stoy, Sidsel Hyldgaard; Laursen, Tea Lund; Rodgaard-Hansen, Sidsel; Moller, Holger Jon; Moller, Soren; Vilstrup, Hendrik; Gronbaek, Henning			The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients	PLOS ONE			English	Article							HEPATIC MACROPHAGE ACTIVATION; PLASMA ENDOTOXIN; DENDRITIC CELLS; SURVIVAL; INJURY; CD163; DECOMPENSATION; PROGNOSIS; FIBROSIS; MARKERS	Background and aims Hepatic macrophages (Kupffer cells) are involved in the immunopathology of alcoholic liver disease (ALD). The mannose receptor (MR, CD206), expressed primarily by macrophages, mediates endocytosis, antigen presentation and T-cell activation. A soluble form, sMR, has recently been identified in humans. We aimed to study plasma sMR levels and its correlation with disease severity and survival in ALD patients. Methods We included 50 patients with alcoholic hepatitis (AH), 68 alcoholic cirrhosis (AC) patients (Child-Pugh A (23), B (24), C (21)), and 21 healthy controls (HC). Liver status was described by the Glasgow Alcoholic Hepatitis Score (GAHS), Child-Pugh (CP) and MELD-scores, and in AC patients the hepatic venous pressure gradient (HVPG) was measured by liver vein catheterisation. We used Kaplan-Meier statistics for short-term survival (84-days) in AH patients and long-term (4 years) in AC patients. We measured plasma sMR by ELISA. Results Median sMR concentrations were significantly elevated in AH 1.32(IQR: 0.69) and AC 0.46 (0.5) compared to HC 0.2(0.06) mg/L; p<0.001 and increased in a stepwise manner with the CP-score (p<0.001). In AC sMR predicted portal hypertension (HVPG >= 10 mmHg) with an area under the Receiver Operator Characteristics curve of 0.86 and a high sMR cut-off (>0.43 mg/l) was associated with increased mortality (p=0.005). Conclusion The soluble mannose receptor is elevated in alcoholic liver disease, especially in patients with AH. Its blood level predicts portal hypertension and long-term mortality in AC patients.	[Sandahl, Thomas Damgaard; Stoy, Sidsel Hyldgaard; Laursen, Tea Lund; Vilstrup, Hendrik; Gronbaek, Henning] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark; [Rodgaard-Hansen, Sidsel; Moller, Holger Jon] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark; [Moller, Soren] Univ Copenhagen, Hvidovre Hosp, Fac Hlth Sci, Dept Clin Physiol & Nucl Med,Ctr Funct & Diagnost, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Sandahl, TD (corresponding author), Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark.	TDS@clin.au.dk	Gronbaek, Henning/AAJ-3202-2020	Gronbaek, Henning/0000-0001-8998-7910; Sandahl, Thomas Damgaard/0000-0001-9807-6852; Moller, Holger Jon/0000-0001-7687-5995	NOVO Nordisk foundation; Danish Council for Strategic Research [TRAIN 10-092797]; Novo Nordisk Fonden [NNF13OC0006329, NNF11OC1014467, NNF14OC0012141] Funding Source: researchfish	NOVO Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by an unrestricted grant from The NOVO Nordisk foundation (http://novonordiskfonden.dk/en) and The Danish Council for Strategic Research (http://ufm.dk/en/research-and-innovation/councils-and-commissions/former-councils-and-commissions/the-danish-council-for-strategic-research) (TRAIN 10-092797).	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Andersen ES, 2014, EUR J CLIN MICROBIOL, V33, P117, DOI 10.1007/s10096-013-1936-3; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Bosma BM, 2006, LIVER TRANSPLANT, V12, P384, DOI 10.1002/lt.20659; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; FUKUI H, 1991, J HEPATOL, V12, P162, DOI 10.1016/0168-8278(91)90933-3; Granfeldt A, 2013, CRIT CARE MED, V41, pE309, DOI 10.1097/CCM.0b013e31828a45ef; Graversen JH, 2012, MOL THER, V20, P1550, DOI 10.1038/mt.2012.103; Gronbaek H, 2012, ALIMENT PHARM THER, V36, P173, DOI 10.1111/j.1365-2036.2012.05134.x; Gronbaek H, 2016, J HEPATOL, V64, P813, DOI 10.1016/j.jhep.2015.11.021; Groszmann Roberto, 2006, Clin Liver Dis, V10, P499, DOI 10.1016/j.cld.2006.08.005; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Holland-Fischer P, 2011, GUT, V60, P1389, DOI 10.1136/gut.2010.234542; Jalan R, 2015, J HEPATOL, V62, P831, DOI 10.1016/j.jhep.2014.11.012; Jordens R, 1999, INT IMMUNOL, V11, P1775, DOI 10.1093/intimm/11.11.1775; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kjaergaard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092331; Lanthier N, 2015, J HEPATOL, V63, P609, DOI 10.1016/j.jhep.2015.04.003; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Linehan SA, 2003, LAB INVEST, V83, P1223, DOI 10.1097/01.LAB.0000081392.93701.6F; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Martinez-Pomares L, 2003, J LEUKOCYTE BIOL, V73, P604, DOI 10.1189/jlb.0902450; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rasmussen TK, 2010, J RHEUMATOL, V37, P2014, DOI 10.3899/jrheum.100259; Rode A, 2013, GUT, V62, P1231, DOI 10.1136/gutjnl-2012-304135; Rodgaard-Hansen S, 2013, CLIN CHEM LAB MED, P1; Rodgaard-Hansen S, 2015, INFECT DIS-NOR, V47, P203, DOI 10.3109/00365548.2014.984321; Sandahl TD, 2016, ALIMENT PHARM THER, V43, P1222, DOI 10.1111/apt.13618; Sandahl TD, 2014, AM J GASTROENTEROL, V109, P1749, DOI 10.1038/ajg.2014.262; Steib CJ, 2011, GUT, V60, P1307, DOI 10.1136/gut.2011.242560; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; TYGSTRUP N, 1964, ACTA MED SCAND, V175, P291; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Waidmann O, 2013, J HEPATOL, V58, P956, DOI 10.1016/j.jhep.2013.01.005; Yin M, 2001, J IMMUNOL, V166, P4737, DOI 10.4049/jimmunol.166.7.4737; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200	41	28	28	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e189345	10.1371/journal.pone.0189345	http://dx.doi.org/10.1371/journal.pone.0189345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236785	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100058
J	Keller, JI; Ballif, BA; Clair, RMS; Vincent, JJ; Monroy, MC; Stevens, L				Keller, Judith I.; Ballif, Bryan A.; Clair, Riley M. St.; Vincent, James J.; Monroy, M. Carlota; Stevens, Lori			Chagas disease vector blood meal sources identified by protein mass spectrometry	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; FEEDING PATTERNS; HEMIPTERA REDUVIIDAE; HETERODUPLEX-ASSAY; TRIATOMA-VITTICEPS; TRANSMISSION; STATE; DOGS; HUMANS; EVOLUTIONARY	Chagas disease is a complex vector borne parasitic disease involving blood feeding Triatominae (Hemiptera: Reduviidae) insects, also known as kissing bugs, and the vertebrates they feed on. This disease has tremendous impacts on millions of people and is a global health problem. The etiological agent of Chagas disease, Trypanosoma cruzi (Kinetoplas-tea: Trypanosomatida: Trypanosomatidae), is deposited on the mammalian host in the insect's feces during a blood meal, and enters the host's blood stream through mucous membranes or a break in the skin. Identifying the blood meal sources of triatomine vectors is critical in understanding Chagas disease transmission dynamics, can lead to identification of other vertebrates important in the transmission cycle, and aids management decisions. The latter is particularly important as there is little in the way of effective therapeutics for Chagas disease. Several techniques, mostly DNA-based, are available for blood meal identification. However, further methods are needed, particularly when sample conditions lead to low-quality DNA or to assess the risk of human cross-contamination. We demonstrate a proteomics-based approach, using liquid chromatography tandem mass spectrometry (LCMS/MS) to identify host-specific hemoglobin peptides for blood meal identification in mouse blood control samples and apply LC-MS/MS for the first time to Triatoma dimidiata insect vectors, tracing blood sources to species. In contrast to most proteins, hemoglobin, stabilized by iron, is incredibly stable even being preserved through geologic time. We compared blood stored with and without an anticoagulant and examined field-collected insect specimens stored in suboptimal conditions such as at room temperature for long periods of time. To our knowledge, this is the first study using LC-MS/MS on field-collected arthropod disease vectors to identify blood meal composition, and where blood meal identification was confirmed with more traditional DNA-based methods. We also demonstrate the potential of synthetic peptide standards to estimate relative amounts of hemoglobin acquired when insects feed on multiple blood sources. These LC-MS/MS methods can contribute to developing Ecohealth control strategies for Chagas disease transmission and can be applied to other arthropod disease vectors.	[Keller, Judith I.; Ballif, Bryan A.; Clair, Riley M. St.; Vincent, James J.; Monroy, M. Carlota; Stevens, Lori] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Monroy, M. Carlota] Univ San Carlos, Lab Entomol Aplicada & Parasitol, Escuela Biol, Fac Ciencias Quim & Farm, Ciudad De Guatemala, Guatemala	University of Vermont; Universidad de San Carlos de Guatemala	Ballif, BA; Stevens, L (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	bballif@uvm.edu; lori.stevens@uvm.edu		Stevens, Lori/0000-0003-3847-5979; St. Clair, Riley/0000-0001-6123-7288	National Institute of Allergy and Infectious Diseases (NIAID) [R03AI26268/1-2]; National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program [BCS-1216193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI126268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER; Direct For Biological Sciences [1216193] Funding Source: National Science Foundation	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of Health (http://www.nih.gov/) grant 8P20GM103449 (BAB) from the INBRE program of the NIGMS, National Institutes of Health (NIH) (http://www.nih.gov/) grant R03AI26268/1-2 (LS) from the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) and National Science Foundation (http://nsf.gov/) grant BCS-1216193 (LS, CM) as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Institutes of Health or the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Boischio A, 2009, CAD SAUDE PUBLICA, V25, pS149, DOI 10.1590/S0102-311X2009001300014; Bosseno MF, 2006, AM J TROP MED HYG, V74, P303, DOI 10.4269/ajtmh.2006.74.303; Breniere SF, 2004, J MED ENTOMOL, V41, P1015, DOI 10.1603/0022-2585-41.6.1015; Buitrago R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1499-0; Buitrago R, 2012, INFECT GENET EVOL, V12, P21, DOI 10.1016/j.meegid.2011.09.005; Calzada JE, 2010, AM J TROP MED HYG, V82, P580, DOI 10.4269/ajtmh.2010.09-0397; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Canals M, 2001, J MED ENTOMOL, V38, P303, DOI 10.1603/0022-2585-38.2.303; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; Ramirez JD, 2013, VET PARASITOL, V196, P216, DOI 10.1016/j.vetpar.2012.12.054; Vasquez Ana Maria de, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P217, DOI 10.1590/S0036-46652004000400008; Dumonteil E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005422; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Freitas SPC, 2005, REV SAUDE PUBL, V39, P27, DOI 10.1590/S0034-89102005000100004; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goloborodko AA, 2013, J AM SOC MASS SPECTR, V24, P301, DOI 10.1007/s13361-012-0516-6; Goncalves TCM, 2000, REV SAUDE PUBL, V34, P348, DOI 10.1590/S0034-89102000000400006; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; Gottdenker NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001884; Greenwalt DE, 2013, P NATL ACAD SCI USA, V110, P18496, DOI 10.1073/pnas.1310885110; Gurtler RE, 2015, ACTA TROP, V151, P32, DOI 10.1016/j.actatropica.2015.05.029; Gurtler RE, 2007, PARASITOLOGY, V134, P69, DOI 10.1017/S0031182006001259; Gurtler RE, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.1.TM0550010024; GURTLER RE, 1991, T ROY SOC TROP MED H, V85, P741, DOI 10.1016/0035-9203(91)90440-A; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002300, 10.1371/journal.pntd.0002570]; Humair PF, 2007, J MED ENTOMOL, V44, P869, DOI 10.1603/0022-2585(2007)44[869:MIOBSI]2.0.CO;2; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; Justi SA, 2017, TRENDS PARASITOL, V33, P42, DOI 10.1016/j.pt.2016.11.002; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Kjos SA, 2013, J MED ENTOMOL, V50, P1126, DOI 10.1603/ME12242; Klotz SA, 2014, AM J MED, V127, P421, DOI 10.1016/j.amjmed.2013.12.017; Laskay UA, 2012, DEV HOST BLOOD MEAL; Laskay UA, 2013, J MED ENTOMOL, V50, P1282, DOI 10.1603/ME12125; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lucero DE, 2013, AM J TROP MED HYG, V88, P630, DOI 10.4269/ajtmh.12-0448; Lucero DE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003365; Melton T, 2007, J FORENSIC SCI, V52, P1305, DOI 10.1111/j.1556-4029.2007.00553.x; Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1; de Souza RDM, 2011, MEM I OSWALDO CRUZ, V106, P16, DOI 10.1590/S0074-02762011000100003; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Natarajan C, 2015, MOL BIOL EVOL, V32, P978, DOI 10.1093/molbev/msu403; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Niare S., 2016, Malaria Journal, V15; Onder O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2730; Pellecer MJ, 2013, AM J TROP MED HYG, V88, P638, DOI 10.4269/ajtmh.12-0458; Pena VH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001530; Pineda V, 2011, VET PARASITOL, V178, P360, DOI 10.1016/j.vetpar.2010.12.043; Pinto J, 2012, REV INST MED TROP SP, V54, P83, DOI 10.1590/S0036-46652012000200005; Pizarro Juan Carlos, 2007, Kinetoplastid Biol Dis, V6, P1, DOI 10.1186/1475-9292-6-1; Pizarro JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003585; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Buitrago NLR, 2013, INFECT GENET EVOL, V19, P141, DOI 10.1016/j.meegid.2013.07.002; Sanchez-Valdez FJ, 2015, EXPERT REV VACCINES, V14, P681, DOI 10.1586/14760584.2015.989989; Sasaki Hitoshi, 2003, Medical Entomology and Zoology, V54, P283; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Song Y, 2015, J AM SOC MASS SPECTR, V26, P1875, DOI 10.1007/s13361-015-1185-z; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Stevens L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003047; Stevens L, 2012, EMERG INFECT DIS, V18, P646, DOI 10.3201/eid1804.111396; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Waleckx E, 2014, EMERG INFECT DIS, V20, P2141, DOI 10.3201/eid2012.131576; Wickramasekara Samanthi, 2008, Emerg Infect Dis, V14, P1273, DOI 10.3201/eid1408.080227; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; ZELEDON R, 1981, ANNU REV ENTOMOL, V26, P101, DOI 10.1146/annurev.en.26.010181.000533	73	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189647	10.1371/journal.pone.0189647	http://dx.doi.org/10.1371/journal.pone.0189647			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232402	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200064
J	Michalska-Hejduk, D; Wolski, GJ; Harnisch, M; Otte, A; Bomanowska, A; Donath, TW				Michalska-Hejduk, Dorota; Wolski, Grzegorz J.; Harnisch, Matthias; Otte, Annette; Bomanowska, Anna; Donath, Tobias W.			Restoration of floodplain meadows: Effects on the re-establishment of mosses	PLOS ONE			English	Article							NORTHERN UPPER RHINE; PLANT-MATERIAL; FEN-MEADOW; ALLUVIAL GRASSLANDS; MOLINION MEADOWS; VASCULAR PLANTS; ARABLE FIELDS; SPHAGNUM; VEGETATION; IMPACT	species diversity and vegetation cover. Although bryophytes contribute considerably to the species diversity of meadows, they are rarely addressed in restoration projects. This project is a first step toward making recommendations for including mosses in alluvial floodplain restoration projects. The opportunity to assess the diversity and ecological requirements of mosses on floodplain meadows presented itself within the framework of a vegetation monitoring that took place in 2014 on meadows located along the northern Upper Rhine. In this area, large-scale meadow restoration projects have taken place since 1997 in both the functional and fossil floodplains. Other studies have shown that bryophytes are generally present in green hay used in restoration, providing inadvertent bryophyte introduction. We compared bryophyte communities in donor and restored communities and correlated these communities with environmental variables-taking into account that the mosses on the restoration sites possibly developed from green hay. This analysis provided insights as to which species of bryophytes should be included in future restoration projects, what diaspores should be used, and how they should be transferred. Data on bryophyte occurrence were gathered from old meadows, and from restoration sites. We found distinct differences in bryophyte composition (based on frequency) in restored communities in functional flood plains compared to donor communities. Generally, restoration sites are still characterized by a lower species-richness, with a significantly lower occurrence of rare and red listed species and a lower species-heterogeneity. In conclusion, our research establishes what mosses predominate in donor and restored alluvial meadows along the northern Upper River, and what microsite conditions favour particular species. This points the way to deliberate introduction of moss diaspores for more complete alluvial meadow restoration.	[Michalska-Hejduk, Dorota; Wolski, Grzegorz J.; Bomanowska, Anna] Univ Lodz, Fac Biol & Environm Protect, Dept Geobot & Plant Ecol, Lodz, Poland; [Harnisch, Matthias] Dept Ecol & Environm, City Of Riedstadt, Riedstadt, Germany; [Otte, Annette] Justus Liebig Univ Giessen, Dept Landscape Ecol & Landscape Planning, Giessen, Germany; [Donath, Tobias W.] Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany	University of Lodz; Justus Liebig University Giessen; University of Kiel	Otte, A (corresponding author), Justus Liebig Univ Giessen, Dept Landscape Ecol & Landscape Planning, Giessen, Germany.	annetteotte@compuserve.com	Donath, Tobias W./B-2856-2012; Wolski, Grzegorz J./O-8568-2019; Wolski, Grzegorz/K-8817-2018	Donath, Tobias W./0000-0003-1874-1096; Wolski, Grzegorz J./0000-0003-1480-8003; Wolski, Grzegorz/0000-0003-1480-8003; Bomanowska, Anna/0000-0001-5648-2852; Michalska-Hejduk, Dorota/0000-0003-3135-4445	Frankfurt Airport Company (Fraport AG)	Frankfurt Airport Company (Fraport AG)	This study was financially supported by the Frankfurt Airport Company (Fraport AG). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Authors thank Dr. hab. Ewa Fudali from the University of Environmental and Life Sciences in Wroclaw for revising critical bryophyte species. This study was financially supported by the Frankfurt Airport Company (Fraport AG). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, BRYOPHYTE BIOL; [Anonymous], 2015, STAT SOFTW SYST DAT; [Anonymous], KLIMADATEN BUNDESREP; [Anonymous], 2015, PC ORD MULTIVARIATE; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Bissels S, 2005, PHYTOCOENOLOGIA, V35, P469, DOI 10.1127/0340-269X/2005/0035-0469; Bissels S, 2004, BIOL CONSERV, V118, P641, DOI 10.1016/j.biocon.2003.10.013; Boger K., GRUNLANDVEGETATION H; Bourgeois B, 2012, AQUAT BOT, V100, P76, DOI 10.1016/j.aquabot.2012.03.010; Buchwald R., 2007, Fitosociologia (Pavia), V44, P313; Bugnon JL, 1997, WETLANDS, V17, P513, DOI 10.1007/BF03161517; Burkart M, 2001, GLOBAL ECOL BIOGEOGR, V10, P449, DOI 10.1046/j.1466-822x.2001.00270.x; Burmeier S, 2010, PLANT SOIL, V333, P351, DOI 10.1007/s11104-010-0350-1; Cobbaert D, 2004, APPL VEG SCI, V7, P209, DOI 10.1111/j.1654-109X.2004.tb00612.x; Cooper DJ, 2000, RESTOR ECOL, V8, P103, DOI 10.1046/j.1526-100x.2000.80016.x; Decleer K, 2013, J NAT CONSERV, V21, P65, DOI 10.1016/j.jnc.2012.10.004; Dieren K, 2001, BRYOPHYT BIBL, V56, P1, DOI DOI 10.1639/0007-2745(2002)105[; Donath TW, 2007, BIOL CONSERV, V138, P224, DOI 10.1016/j.biocon.2007.04.020; Donath TW, 2015, AGR ECOSYST ENVIRON, V200, P102, DOI 10.1016/j.agee.2014.11.004; Donath TW, 2003, APPL VEG SCI, V6, P13, DOI 10.1111/j.1654-109X.2003.tb00560.x; Drehwald U, 2013, ROTE LISTE MOOSE HES; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; DURING HJ, 1990, BOT J LINN SOC, V104, P79, DOI 10.1111/j.1095-8339.1990.tb02212.x; Eichberg C, 2010, APPL VEG SCI, V13, P425, DOI 10.1111/j.1654-109X.2010.01082.x; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Ferland C, 1997, CAN J BOT, V75, P1110, DOI 10.1139/b97-122; Gosselink J.G., 2000, WETLANDS; Graf MD, 2008, APPL VEG SCI, V11, P521, DOI 10.3170/2008-7-18565; Graf MD, 2010, RESTOR ECOL, V18, P121, DOI 10.1111/j.1526-100X.2008.00437.x; Groeneveld EVG, 2007, RESTOR ECOL, V15, P709, DOI 10.1111/j.1526-100X.2007.00283.x; Grootjans AP, 2002, HYDROBIOLOGIA, V478, P149, DOI 10.1023/A:1021030731292; Habel JC, 2013, BIODIVERS CONSERV, V22, P2131, DOI 10.1007/s10531-013-0537-x; Harnisch M, 2014, VERWENDUNG MAHDGUT R; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Holzel N, 2006, RENATURIERUNG STROMT; Ingerpuu N, 2005, PLANT ECOL, V180, P69, DOI 10.1007/s11258-005-2508-0; Jeschke M, 2006, TUEXENIA, V26, P223; Jeschke M, 2008, 6 EUR C EC REST SUST, P1; Jeschke M, 2008, FLORA, V203, P557, DOI 10.1016/j.flora.2007.09.006; Jeschke M, 2012, TUEXENIA, P269; Joyce C.B., 1998, EUROPEAN WET GRASSLA; Joyce CB, 2014, ECOL ENG, V66, P91, DOI 10.1016/j.ecoleng.2013.05.008; Kacki Z, 2010, POL J ENVIRON STUD, V19, P351; Kiehl K, 2006, RESTOR ECOL, V14, P148, DOI 10.1111/j.1526-100X.2006.00115.x; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Kirmer A, 2001, APPL VEG SCI, V4, P19, DOI 10.1111/j.1654-109X.2001.tb00230.x; Klimkowska A, 2015, APPL VEG SCI, V18, P110, DOI 10.1111/avsc.12127; Klimkowska A, 2010, RESTOR ECOL, V18, P924, DOI 10.1111/j.1526-100X.2009.00554.x; Knapp R, 1954, ANGEW PFLANZENSOZIOL, V2, P1145; Kotowski W, 2001, PLANT ECOL, V155, P147, DOI 10.1023/A:1013214716842; Laberge V, 2015, LAND DEGRAD DEV, V26, P813, DOI 10.1002/ldr.2243; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Liira J, 2008, J VEG SCI, V19, P3, DOI 10.3170/2007-8-18308; Longton RE, 1984, J HATTORI BOT LAB, V55, P147; LUBW, 2005, ROT LIST ART MOOS BA; Ludwig G., 1996, SCHRIFTENREIHE VEGET, V28, P189; Malson K, 2007, BIOL CONSERV, V135, P435, DOI 10.1016/j.biocon.2006.10.017; McCune B, 2002, ANAL ECOLOGICAL COMM; Michalska-Hejduk D, 2012, POL J ENVIRON STUD, V21, P1731; MURRAY KJ, 1993, OECOLOGIA, V96, P200, DOI 10.1007/BF00317733; Pfadenhauer J, 2000, SICHERUNG ENTWICKLUN, P37; Poptcheva K, 2009, AGR ECOSYST ENVIRON, V134, P108, DOI 10.1016/j.agee.2009.06.004; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Quinty F, 2000, SUSTAINING OUR PEATL, VII; Reznickova M, 2007, BIOLOGIA, V62, P675, DOI 10.2478/s11756-007-0130-4; RINCON E, 1988, J BRYOL, V15, P209, DOI 10.1179/jbr.1988.15.1.209; Rochefort L, 2000, BRYOLOGIST, V103, P503, DOI 10.1639/0007-2745(2000)103[0503:SAKGIH]2.0.CO;2; Rochefort L, 2003, WETL ECOL MANAG, V11, P3, DOI 10.1023/A:1022011027946; Schmalholz M, 2009, CAN J FOREST RES, V39, P1871, DOI 10.1139/X09-113; Schmiede R, 2012, APPL VEG SCI, V15, P290, DOI 10.1111/j.1654-109X.2011.01168.x; Seffer J., 1999, MORAVA RIVER FLOODPL; Sundberg S, 2012, RESTOR ECOL, V20, P331, DOI 10.1111/j.1526-100X.2011.00782.x; Tallowin JRB, 2001, RESTOR ECOL, V9, P167, DOI 10.1046/j.1526-100x.2001.009002167.x; Torok P, 2011, BIODIVERS CONSERV, V20, P2311, DOI 10.1007/s10531-011-9992-4; Udd D, 2016, J VEG SCI, V27, P165, DOI 10.1111/jvs.12322; van der Hoek D, 2006, APPL VEG SCI, V9, P185, DOI 10.1658/1402-2001(2006)9[185:FSIRTS]2.0.CO;2; VANDERMAAREL E, 1979, VEGETATIO, V39, P97, DOI 10.1007/BF00052021; Vecrin MP, 2002, APPL VEG SCI, V5, P263, DOI 10.1111/j.1654-109X.2002.tb00556.x; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Wierzcholska S, 2008, SCIRPA FAC RERUM NAT, V186, P194; Zelnik I, 2008, BIOLOGIA, V63, P187, DOI 10.2478/s11756-008-0042-y	81	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0187944	10.1371/journal.pone.0187944	http://dx.doi.org/10.1371/journal.pone.0187944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29227995	Green Submitted, Green Published, gold			2022-12-26	WOS:000417648600003
J	Shu, H; Chi, JW; Li, J; Zhang, W; Lv, WS; Wang, J; Deng, YJ; Hou, X; Wang, YG				Shu, Hongyan; Chi, Jingwei; Li, Jing; Zhang, Wei; Lv, Wenshan; Wang, Jie; Deng, Yujie; Hou, Xu; Wang, Yangang			A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; APOE P.LEU167DEL MUTATION; GENE; PROTEIN; UPDATE; CHOLESTEROL; DATABASE; LIGAND; DOMAIN; PCSK9	Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevation of serum cholesterol bound to low-density lipoprotein. Mutations in LDLR are the major factors responsible for FH. In this study, we recruited a four-generation Chinese family with FH and identified the clinical features of hypercholesterolemia. All affected individuals shared a novel indel mutation (c.1885_1889delinsGATCATCAACC) in exon 13 of LDLR. The mutation segregated with the hypercholesterolemia phenotype in the family. To analyze the function of the indel, we established stable clones of mutant and wild-type LDLR in Hep G2 cells. The mutant LDLR was retained in the endoplasmic reticulum (ER) and failed to glycosylate via the Golgi. Moreover, the membrane LDLR was reduced and lost the ability to take up LDL. Our data also expand the spectrum of known LDLR mutations.	[Shu, Hongyan; Chi, Jingwei; Lv, Wenshan; Wang, Jie; Deng, Yujie; Hou, Xu; Wang, Yangang] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao, Peoples R China; [Shu, Hongyan] Linzi Dist Peoples Hosp, Dept Endocrinol, Zibo, Peoples R China; [Li, Jing] Linzi Dist Peoples Hosp, Dept Gerontol, Zibo, Peoples R China; [Zhang, Wei] Linzi Dist Peoples Hosp, Dept Thorac Surg, Zibo, Peoples R China	Qingdao University	Hou, X; Wang, YG (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao, Peoples R China.	jacob72hou@yahoo.com; wangyangang0532@outlook.com			National Natural Science Foundation of China [8157060759, 31201055]; Natural Science Foundation of Shandong Province [2015GSF118007, ZR2016CB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The study was supported by the National Natural Science Foundation of China (8157060759, 31201055) and the Natural Science Foundation of Shandong Province (2015GSF118007, ZR2016CB06).	Awan Z, 2013, ATHEROSCLEROSIS, V231, P218, DOI 10.1016/j.atherosclerosis.2013.09.007; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; FRANCKE U, 1984, P NATL ACAD SCI-BIOL, V81, P2826, DOI 10.1073/pnas.81.9.2826; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Garcia-Garcia A B, 2001, Hum Mutat, V18, P458, DOI 10.1002/humu.1218; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Heath KE, 2001, ATHEROSCLEROSIS, V154, P243, DOI 10.1016/S0021-9150(00)00647-X; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Huijgen R, 2012, EUR HEART J, V33, P2325, DOI 10.1093/eurheartj/ehs038; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Leren TP, 2014, ATHEROSCLEROSIS, V237, P76, DOI 10.1016/j.atherosclerosis.2014.08.038; Marduel M, 2013, HUM MUTAT, V34, P83, DOI 10.1002/humu.22215; Mollaki V, 2014, ATHEROSCLEROSIS, V237, P798, DOI 10.1016/j.atherosclerosis.2014.09.031; PULLINGER CR, 1995, J CLIN INVEST, V95, P1225, DOI 10.1172/JCI117772; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Strom TB, 2014, FEBS OPEN BIO, V4, P321, DOI 10.1016/j.fob.2014.03.007; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Vallejo-Vaz AJ, 2015, ATHEROSCLEROSIS, V243, P257, DOI 10.1016/j.atherosclerosis.2015.09.021; Wang H, 2014, CHIN CONT DECIS CONF, P1371, DOI 10.1109/CCDC.2014.6852380	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189316	10.1371/journal.pone.0189316	http://dx.doi.org/10.1371/journal.pone.0189316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228028	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600043
J	Alazawi, W; Bernabe, E; Tai, D; Janicki, T; Kemos, P; Samsuddin, S; Syn, WK; Gillam, D; Turner, W				Alazawi, William; Bernabe, Eduardo; Tai, David; Janicki, Tomasz; Kemos, Polychronis; Samsuddin, Salma; Syn, Wing-Kin; Gillam, David; Turner, Wendy			Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; UNITED-STATES; HEALTH; PREVALENCE	Background and aims Non-alcoholic fatty liver disease (NAFLD) has a bidirectional association with metabolic syndrome. It affects up to 30% of the general population, 70% of individuals with diabetes and 90% with obesity. The main histological hallmark of progressive NAFLD is fibrosis. There is a bidirectional epidemiological link between periodontitis and metabolic syndrome. NAFLD, periodontitis and diabetes share common risk factors, are characterised by inflammation and associated with changes in commensal bacteria. Therefore we tested the hypothesis that periodontitis is associated with NAFLD and with significant fibrosis in two study groups. Methods We analyzed data from a population-based survey and a patient-based study. NHANES III participants with abdominal ultrasound and sociodemographic, clinical, and oral examination data were extracted and appropriate weighting applied. In a separate patient-based study, consenting patients with biopsy-proved NAFLD (or with liver indices too mild to justify biopsy) underwent dental examination. Basic Periodontal Examination score was recorded. Results In NHANES, periodontitis was significantly associated with steatosis in 8172 adults even after adjusting for sociodemographic factors. However, associations were fully explained after accounting for features of metabolic syndrome. In the patient-based study, periodontitis was significantly more common in patients with biopsy-proven NASH and any fibrosis (F0-F4) than without NASH (p = 0.009). Periodontitis was more common in patients with NASH and significant fibrosis (F2-4) than mild or no fibrosis (F0-1, p = 0.04). Conclusions Complementary evidence from an epidemiological survey and a clinical study show that NAFLD is associated with periodontitis and that the association is stronger with significant liver fibrosis.	[Alazawi, William; Tai, David; Kemos, Polychronis; Samsuddin, Salma; Syn, Wing-Kin] Queen Mary Univ London, Blizard Inst, London, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London, England; [Janicki, Tomasz; Gillam, David; Turner, Wendy] Queen Mary Univ London, Dent Inst, London, England; [Syn, Wing-Kin] Ralph H Johnson Vet Affairs Med Ctr, Sect Gastroenterol, Charleston, SC USA; [Syn, Wing-Kin] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC USA	University of London; Queen Mary University London; University of London; King's College London; University of London; Queen Mary University London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Alazawi, W (corresponding author), Queen Mary Univ London, Blizard Inst, London, England.	w.alazawi@qmul.ac.uk	Bernabe, Eduardo/R-3441-2017; Syn, Wing-Kin/AAB-8406-2020	Bernabe, Eduardo/0000-0002-1858-3713; Turner, Wendy/0000-0002-4280-8345; Gillam, David/0000-0002-8669-6138; Alazawi, William/0000-0002-3891-5914	Diabetes Research and Wellness Fund; MRC New Investigator Award; MRC [MR/N00308X/1] Funding Source: UKRI; Medical Research Council [MR/N00308X/1] Funding Source: researchfish; National Institute for Health Research [ACF-2016-19-012] Funding Source: researchfish	Diabetes Research and Wellness Fund; MRC New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Diabetes Research and Wellness Fund. WA is in receipt of an MRC New Investigator Award. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Bambha K, 2012, HEPATOLOGY, V55, P769, DOI 10.1002/hep.24726; Batchelor P, 2014, BRIT DENT J, V217, P405, DOI 10.1038/sj.bdj.2014.912; Demmer RT, 2012, DIABETES CARE, V35, P2036, DOI 10.2337/dc11-2453; Dumitrescu A. L., 2015, FRONT PUBLIC HEALTH, V3, P278, DOI [DOI 10.3389/fpubh.2015.00278, 10.3389/fpubh.2015.00278]; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; EMRICH LJ, 1991, J PERIODONTOL, V62, P123, DOI 10.1902/jop.1991.62.2.123; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Fitzpatrick E, 2014, WORLD J GASTROENTERO, V20, P10851, DOI 10.3748/wjg.v20.i31.10851; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Guggenheimer J, 2007, LIVER TRANSPLANT, V13, P280, DOI 10.1002/lt.21038; Hayashi J, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0369-2; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Jimenez M, 2012, OBESITY, V20, P1718, DOI 10.1038/oby.2011.291; Kinane D.F., 2017, PERIODONTAL DIS NAT, V3, P17038, DOI [10.1038/nrdp.2017.38, DOI 10.1038/NRDP.2017.38]; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Ma JT, 2017, J HEPATOL, V66, P390, DOI 10.1016/j.jhep.2016.09.022; Mantovani A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020217; Merchant AT, 2007, J CLIN PERIODONTOL, V34, P1007, DOI 10.1111/j.1600-051X.2007.01148.x; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Periodontology BSo, 2011, BAS PER EX BPE 2011; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Schenkein HA, 2013, J CLIN PERIODONTOL, V40, pS51, DOI [10.1111/jcpe.12060, 10.1902/jop.2013.134006]; SHLOSSMAN M, 1990, J AM DENT ASSOC, V121, P532, DOI 10.14219/jada.archive.1990.0211; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3; Socransky SS, 2000, PERIODONTOLOGY, V28, P12, DOI DOI 10.1034/J.1600-0757.2002.280102.X; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Tai FWD, 2015, DIABETIC MED, V32, P1121, DOI 10.1111/dme.12725; Taylor G W, 1998, Ann Periodontol, V3, P30, DOI 10.1902/annals.1998.3.1.30; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; White DA, 2012, BRIT DENT J, V213, P567, DOI 10.1038/sj.bdj.2012.1088; Yoneda M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-16	42	37	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0185902	10.1371/journal.pone.0185902	http://dx.doi.org/10.1371/journal.pone.0185902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220367	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900002
J	Okamoto, C; Hayakawa, Y; Aoyama, T; Komaki, H; Minatoguchi, S; Iwasa, M; Yamada, Y; Kanamori, H; Kawasaki, M; Nishigaki, K; Mikami, A; Minatoguchi, S				Okamoto, Chihiro; Hayakawa, Yuka; Aoyama, Takuma; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kanamori, Hiromitsu; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya			Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats	PLOS ONE			English	Article							BLOOD-PRESSURE; URINARY SODIUM; EXCRETION; RISK	Objective A high salt intake causes hypertension and leads to cardiovascular disease. Therefore, a low salt diet is now recommended to prevent hypertension and cardiovascular disease. However, it is still unknown whether an excessively low salt diet is beneficial or harmful for the heart. Methods Wistar Kyoto rats (WKYs) and spontaneously hypertensive rats (SHRs) received normal salt chow (0.9% salt diet) and excessively low salt chow (0.01% salt diet referred to as saltless diet) for 8 weeks from 8 to 16 weeks of age. The effects of the excessively low salt diet on the cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems were investigated. Results The excessively low salt diet did not affect the systolic blood pressure but significantly increased the heart rate both in WKYs and SHRs. The excessively low salt diet significantly elevated plasma renin activity, plasma angiotensin I, II and aldosterone concentrations, and plasma noradrenaline and adrenaline concentrations both in WKYs and SHRs. Cardiac expressions of renin, prorenin, (P)RR, angiotensinogen, and angiotensin II AT1 receptor and phosphorylated (p)-ERK1/2, p-HSP27, p-38MAPK, and TGF-beta 1 were significantly enhanced by the excessively low salt diet in both WKYs and SHRs. The excessively low salt diet accelerated cardiac interstitial and perivascular fibrosis and increased the cardiomyocyte size and interventricular septum thickness in WKYs and SHRs but the extent was greater in SHRs. Conclusion An excessively low salt diet damages the heart through activation of plasma renin-angiotensin-aldosterone and sympatho-adrenal systems and activation of cardiac (P) RR and angiotensin II AT1 receptor and their downstream signals both in WKYs and SHRs.	[Okamoto, Chihiro; Hayakawa, Yuka; Aoyama, Takuma; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kanamori, Hiromitsu; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan	Gifu University	Minatoguchi, S (corresponding author), Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan.	minatos@gifu-u.ac.jp			Gifu University Graduate School of Medicine; Salt Science Research Foundation; Suzuken Memorial Foundation	Gifu University Graduate School of Medicine; Salt Science Research Foundation; Suzuken Memorial Foundation	This work was supported by a grant from the Gifu University Graduate School of Medicine (to Shinya. Minatoguchi) and from Salt Science Research Foundation (to Shinya. Minatoguchi) and from Suzuken Memorial Foundation (to Y Yamada, C Okamoto and Shinya Minatoguchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Carillo BA, 2007, REGUL PEPTIDES, V140, P5, DOI 10.1016/j.regpep.2006.11.007; COHN JN, 1995, CLIN CARDIOL, V18, P4; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; ELLIOTT P, 1988, BRIT MED J, V297, P319; Freel EM, 2004, J AM SOC NEPHROL, V15, P1993, DOI 10.1097/01.ASN.0000132473.50966.14; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Hayakawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120453; Hodge G, 2002, ACTA PHYSIOL SCAND, V174, P209, DOI 10.1046/j.1365-201x.2002.00937.x; Huang Y, 2007, KIDNEY INT, V72, P45052; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; LEENEN FHH, 1989, J HYPERTENS, V7, P57, DOI 10.1097/00004872-198901000-00009; Manger WM., 1982, ADV CARDIOL, V30, P17; Muhlestein JB, 2010, AM J CARDIOL, V106, P764, DOI 10.1016/j.amjcard.2010.04.040; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; REID JL, 1986, AM J CARDIOL, V57, pE6, DOI 10.1016/0002-9149(86)90716-2; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schroten NF, 2012, HEART FAIL REV, V17, P191, DOI 10.1007/s10741-011-9262-2; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; WARREN S E, 1980, Clinical Cardiology, V3, P348	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189099	10.1371/journal.pone.0189099	http://dx.doi.org/10.1371/journal.pone.0189099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220406	Green Submitted, gold, Green Published			2022-12-26	WOS:000417469900033
J	Shionoya, Y; Sunada, K; Shigeno, K; Nakada, A; Honda, M; Nakamura, T				Shionoya, Yoshiki; Sunada, Katsuhisa; Shigeno, Keiji; Nakada, Akira; Honda, Michitaka; Nakamura, Tatsuo			Can nerve regeneration on an artificial nerve conduit be enhanced by ethanol-induced cervical sympathetic ganglion block?	PLOS ONE			English	Article							RAT SCIATIC-NERVE; GROWTH-FACTOR; BLOOD-FLOW; POLYGLYCOLIC ACID; SCHWANN-CELLS; COLLAGEN TUBE; SURGICAL-TREATMENT; PERIPHERAL-NERVES; MOLECULAR-BASIS; GUIDE TUBE	This study aimed to determine whether nerve regeneration by means of an artificial nerve conduit is promoted by ethanol-induced cervical sympathetic ganglion block (CSGB) in a canine model. This study involved two experiments-in part I, the authors examined the effect of CSGB by ethanol injection on long-term blood flow to theorofacial region; part II involved evaluation of the effect of CSGB by ethanol injection on inferior alveolar nerve (IAN) repair using polyglycolic acid-collagen tubes. In part I, seven Beagles were administered left CSGB by injection of 99.5% ethanol under direct visualization by means of thoracotomy, and changes in oral mucosal blood flow in the mental region and nasal skin temperature were evaluated. The increase in blood flow on the left side lasted for 7 weeks, while the increase in average skin temperature lasted 10 weeks on the left side and 3 weeks on the right. In part II, fourteen Beagles were each implanted with a polyglycolic acid-collagen tube across a 10-mm gap in the left IAN. A week after surgery, seven of these dogs were administered CSGB by injection of ethanol. Electrophysiological findings at 3 months after surgery revealed significantly higher sensory nerve conduction velocity and recovery index (ratio of left and right IAN peak amplitudes) after nerve regeneration in the reconstruction+CSGB group than in the reconstruction-only group. Myelinated axons in the reconstruction+CSGB group were greater in diameter than those in the reconstruction-only group. Administration of CSGB with ethanol resulted in improved nerve regeneration in some IAN defects. However, CSGB has several physiological effects, one of which could possibly be the long-term increase in adjacent blood flow.	[Shionoya, Yoshiki] Nippon Dent Univ Hosp Tokyo, Dept Dent Anesthesia, Tokyo, Japan; [Sunada, Katsuhisa] Nippon Dent Univ Tokyo, Dept Dent Anesthesiol, Sch Life Dent Tokyo, Tokyo, Tokyo, Japan; [Shigeno, Keiji; Nakada, Akira; Honda, Michitaka; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan	Nippon Dental University; Nippon Dental University; Kyoto University	Shionoya, Y (corresponding author), Nippon Dent Univ Hosp Tokyo, Dept Dent Anesthesia, Tokyo, Japan.	ysk.shionoya@gmail.com	Honda, Michitaka/GRX-6955-2022; sunada, katsuhisa/ABA-4418-2020	sunada, katsuhisa/0000-0003-1904-0160; Shionoya, Yoshiki/0000-0001-5012-4907				ALBORCH E, 1977, CIRC RES, V41, P278, DOI 10.1161/01.RES.41.3.278; De Luigi A, 1998, NEUROSCIENCE, V83, P1245, DOI 10.1016/S0306-4522(97)00381-3; DELATORRE JC, 1988, NEUROSCI LETT, V94, P269, DOI 10.1016/0304-3940(88)90029-8; DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Ghai A, 2016, ACTA ANAESTH BELG, V67, P6; Haapaniemi T, 1998, EXP NEUROL, V149, P433, DOI 10.1006/exnr.1997.6745; HEUMANN R, 1987, J EXP BIOL, V132, P133; Higa K, 2006, ANESTHESIOLOGY, V105, P1238, DOI 10.1097/00000542-200612000-00024; Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508; Ide C, 1998, EXP NEUROL, V154, P99, DOI 10.1006/exnr.1998.6921; IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0; Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033; Inada Yuji, 2007, Neurosurgery, V61, pE1105; Kakuyama M, 2000, REGION ANESTH PAIN M, V25, P389, DOI 10.1053/rapm.2000.6450; Kim Y, 2009, J PERIODONTAL RES, V44, P695, DOI 10.1111/j.1600-0765.2008.01177.x; Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x; Liao CD, 2017, PAIN MED, V18, P488, DOI 10.1093/pm/pnw145; Liao CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167476; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LUNDBORG G, 1982, J NEUROPATH EXP NEUR, V41, P412, DOI 10.1097/00005072-198207000-00004; Maquet V, 2000, J BIOMED MATER RES, V52, P639, DOI 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.3.CO;2-7; MARTINI R, 1994, J NEUROSCI, V14, P7180; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; Millesi H., 1987, MICRORECONSTRUCTION, P223; Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040; Narouze S, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0424-5; Ohno K, 1997, ANESTH ANALG, V85, P1312, DOI 10.1097/00000539-199712000-00024; Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; SANDERS FK, 1946, J PHYSIOL-LONDON, V105, P152, DOI 10.1113/jphysiol.1946.sp004160; Seo K, 2016, PAIN MED, V17, P2360, DOI 10.1093/pm/pnw088; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Terakawa Y, 2009, REGION ANESTH PAIN M, V34, P553, DOI 10.1097/AAP.0b013e3181b4c505; THOENEN H, 1988, CELL MOL NEUROBIOL, V8, P35, DOI 10.1007/BF00712909; Wang YC, 2001, NEUROSURGERY, V49, P628, DOI 10.1097/00006123-200109000-00017; WULF H, 1992, ANAESTHESIST, V41, P146; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092258; Yoshitani M, 2007, J THORAC CARDIOV SUR, V133, P726, DOI 10.1016/j.jtcvs.2006.08.089; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189297	10.1371/journal.pone.0189297	http://dx.doi.org/10.1371/journal.pone.0189297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220373	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900045
J	Panmanee, W; Charoenlap, N; Atichartpongkul, S; Mahavihakanont, A; Whiteside, MD; Winsor, G; Brinkman, FSL; Mongkolsuk, S; Hassett, DJ				Panmanee, Warunya; Charoenlap, Nisanart; Atichartpongkul, Sopapan; Mahavihakanont, Aekkapol; Whiteside, Matthew D.; Winsor, Geoff; Brinkman, Fiona S. L.; Mongkolsuk, Skorn; Hassett, Daniel J.			The OxyR-regulated phnW gene encoding 2-aminoethylphosphonate: pyruvate aminotransferase helps protect Pseudomonas aeruginosa from tert-butyl hydroperoxide	PLOS ONE			English	Article							OXIDATIVE STRESS; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; GENOME DATABASE; EXPRESSION; CONSTRUCTION; PATHOGENESIS; DEGRADATION; SELECTION; VECTORS	The LysR member of bacterial transactivators, OxyR, governs transcription of genes involved in the response to H2O2 and organic (alkyl) hydroperoxides (AHP) in the Gram-negative pathogen, Pseudomonas aeruginosa. We have previously shown that organisms lacking OxyR are rapidly killed by < 2 or 500 mM H2O2 in planktonic and biofilm bacteria, respectively. In this study, we first employed a bioinformatic approach to elucidate the potential regulatory breadth of OxyR by scanning the entire P. aeruginosa PAO1 genome for canonical OxyR promoter recognition sequences (ATAG-N-7-CTAT-N-7-ATAG-N-7-CTAT). Of > 100 potential OxyR-controlled genes, 40 were strategically selected that were not predicted to be involved in the direct response to oxidative stress (e.g., catalase, peroxidase, etc.) and screened such genes by RT-PCR analysis for potentially positive or negative control by OxyR. Differences were found in 7 of 40 genes when comparing an oxyR mutant vs. PAO1 expression that was confirmed by beta-galactosidase reporter assays. Among these, phnW, encoding 2-aminoethylphosphonate: pyruvate aminotransferase, exhibited reduced expression in the oxyR mutant compared to wild-type bacteria. Electrophoretic mobility shift assays indicated binding of OxyR to the phnW promoter and DNase I footprinting analysis also revealed the sequences to which OxyR bound. Interestingly, a phnW mutant was more susceptible to t-butyl-hydroperoxide (t-BOOH) treatment than wild-type bacteria. Although we were unable to define the direct mechanism underlying this phenomenon, we believe that this may be due to a reduced efficiency for this strain to degrade t-BOOH relative to wild-type organisms because of modulation of AHP gene transcription in the phnW mutant.	[Panmanee, Warunya; Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Charoenlap, Nisanart; Atichartpongkul, Sopapan; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Mahavihakanont, Aekkapol; Mongkolsuk, Skorn] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Whiteside, Matthew D.; Winsor, Geoff; Brinkman, Fiona S. L.] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand	University System of Ohio; University of Cincinnati; Chulabhorn Research Institute; Simon Fraser University; Mahidol University	Hassett, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Daniel.Hassett@UC.Edu	Brinkman, Fiona/N-3195-2013	Brinkman, Fiona/0000-0002-0584-4099; Winsor, Geoffrey/0000-0001-6848-1638	National Institutes of Health [R01 GM-69845-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 GM-69845-01.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Borisova SA, 2011, J BIOL CHEM, V286, P22283, DOI 10.1074/jbc.M111.237735; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DUMORA C, 1983, EUR J BIOCHEM, V133, P119, DOI 10.1111/j.1432-1033.1983.tb07436.x; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grosser N, 2004, BIOCHEM BIOPH RES CO, V314, P351, DOI 10.1016/j.bbrc.2003.12.089; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Hassett DJ, 2014, J MICROBIOL, V52, P211, DOI 10.1007/s12275-014-4068-2; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Kim AD, 2002, J BACTERIOL, V184, P4134, DOI 10.1128/JB.184.15.4134-4140.2002; Kruczek C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149229; Miller JH., 1992, SHORT COURSE BACTERI, P72; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Vattanaviboon P, 2002, BIOCHEM BIOPH RES CO, V299, P177, DOI 10.1016/S0006-291X(02)02602-5; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; World Health Organization, WORLD HLTH STAT; Zheng M, 2001, J BACTERIOL, V183, P4571, DOI 10.1128/JB.183.15.4571-4579.2001	31	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189066	10.1371/journal.pone.0189066	http://dx.doi.org/10.1371/journal.pone.0189066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216242	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800064
J	Kim, JH; Lee, E; Friedline, RH; Suk, S; Jung, DY; Dagdeviren, S; Hu, XD; Inashima, K; Noh, HL; Kwon, JY; Nambu, A; Huh, JR; Han, MS; Davis, RJ; Lee, AS; Lee, KW; Kim, JK				Kim, Jong Hun; Lee, Eunjung; Friedline, Randall H.; Suk, Sujin; Jung, Dae Young; Dagdeviren, Sezin; Hu, Xiaodi; Inashima, Kunikazu; Noh, Hye Lim; Kwon, Jung Yeon; Nambu, Aya; Huh, Jun R.; Han, Myoung Sook; Davis, Roger J.; Lee, Amy S.; Lee, Ki Won; Kim, Jason K.			Endoplasmic reticulum chaperone GRP78 regulates macrophage function and insulin resistance in diet-induced obesity	FASEB JOURNAL			English	Article						glucose metabolism; inflammation; unfolded protein response	TRANSCRIPTION FACTOR; ADIPOSE-TISSUE; ALTERNATIVE ACTIVATION; ER STRESS; IKK-BETA; INFLAMMATION; SENSITIVITY; PROTEINS; ATF6; MICE	Obesity-mediated inflammation is a major cause of insulin resistance, and macrophages play an important role in this process. The 78-kDa glucose-regulated protein (GRP78) is a major endoplasmic reticulum chaperone that modulates unfolded protein response (UPR), and mice with GRP78 heterozygosity were resistant to diet-induced obesity. Here, we show that mice with macrophage-selective ablation of GRP78 (Lyz-GRP78(-/-)) are protected from skeletal muscle insulin resistance without changes in obesity compared with wild-type mice after 9 wk of high-fat diet. GRP78-deficient macrophages demonstrated adapted UPR with up-regulation of activating transcription factor (ATF)-4 and M2-polarization markers. Diet-induced adipose tissue inflammation was reduced, and bone marrow-derived macrophages from Lyz-GRP78(-/-) mice demonstrated a selective increase in IL-6 expression. Serum IL-13 levels were elevated by >4-fold in Lyz-GRP78(-/-) mice, and IL-6 stimulated the myocyte expression of IL-13 and IL-13 receptor. Lastly, recombinant IL-13 acutely increased glucose metabolism in Lyz-GRP78(-/-) mice. Taken together, our data indicate that GRP78 deficiency activates UPR by increasing ATF-4, and promotes M2-polarization of macrophages with a selective increase in IL-6 secretion. Macrophage-derived IL-6 stimulates the myocyte expression of IL-13 and regulates muscle glucose metabolism in a paracrine manner. Thus, our findings identify a novel crosstalk between macrophages and skeletal muscle in the modulation of obesity-mediated insulin resistance.	[Kim, Jong Hun; Lee, Eunjung; Friedline, Randall H.; Suk, Sujin; Jung, Dae Young; Dagdeviren, Sezin; Hu, Xiaodi; Inashima, Kunikazu; Noh, Hye Lim; Kwon, Jung Yeon; Han, Myoung Sook; Davis, Roger J.; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Program Mol Med, Worcester, MA USA; [Nambu, Aya; Huh, Jun R.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA USA; [Kim, Jong Hun; Lee, Eunjung; Suk, Sujin; Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Ki Won] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Amy S.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Wellness Emergence Ctr, Suwon, South Korea; [Lee, Eunjung] Korea Food Res Inst, Seongnam, South Korea; [Kwon, Jung Yeon] Oregon State Univ, Astoria, OR USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); Seoul National University (SNU); University of Southern California; Seoul National University (SNU); Korea Food Research Institute (KFRI); Oregon State University	Lee, KW (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Albert Sherman Ctr, Program Mol Med, 368 Plantat St,AS9-1041, Worcester, MA 01605 USA.	kiwon@snu.ac.kr; jason.kim@umassmed.edu	Dagdeviren, Sezin/CAI-5833-2022; Dagdeviren, Sezin/I-9277-2019; Lee, Ki Won/M-4114-2018	Han, Myoung Sook/0000-0002-7226-2590; Davis, Roger/0000-0002-0130-1652; Nambu, Aya/0000-0002-2797-6420; Lee, Amy/0000-0002-0378-5443; Kim, Jason/0000-0002-7185-042X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, 5U2C-DK093000, R01-DK079999, R24-DK090963]; Mid-Career Researcher Program of the National Research Foundation [2015R1A2A1A10053567]; Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079999, R01DK080756, U2CDK093000, R24DK090963] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mid-Career Researcher Program of the National Research Foundation; Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Payal Patel, Duy Tran, Kevin Hsu, Marilia Loubato, and Sung-Yong Hwang (all from University of Massachusetts Medical School) for technical support. This study was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants R01-DK080756 and 5U2C-DK093000 to J.K.K.; R01-DK079999 to A.S.L. and J.K.K.; and R24-DK090963 to R.J.D. and J.K.K.), and the Mid-Career Researcher Program (Grant 2015R1A2A1A10053567 to K.W.L.) of the National Research Foundation, funded by the Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning. R.J.D. is an investigator of the Howard Hughes Medical Institute. The authors declare no conflicts of interest.	Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Dagdeviren S, 2016, MOL CELL BIOL, V36, P2956, DOI 10.1128/MCB.00181-16; Darkhal P, 2015, INT J OBESITY, V39, P1292, DOI 10.1038/ijo.2015.52; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Iwasaki Y, 2014, DIABETES, V63, P152, DOI 10.2337/db13-0757; Jiang LQ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1359, DOI 10.1152/ajpendo.00236.2013; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kewalramani G, 2010, CURR OPIN CLIN NUTR, V13, P382, DOI 10.1097/MCO.0b013e32833aabd9; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shi Y, 2009, TOXICOL SCI, V109, P247, DOI 10.1093/toxsci/kfp060; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Wang Y, 2000, J BIOL CHEM, V275, P27013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	41	21	24	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2292	2304		10.1096/fj.201701017R	http://dx.doi.org/10.1096/fj.201701017R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242277	Green Published			2022-12-26	WOS:000429051400046
J	Rapp, AE; Hachemi, Y; Kemmler, J; Koenen, M; Tuckermann, J; Ignatius, A				Rapp, Anna E.; Hachemi, Yasmine; Kemmler, Julia; Koenen, Mascha; Tuckermann, Jan; Ignatius, Anita			Induced global deletion of glucocorticoid receptor impairs fracture healing	FASEB JOURNAL			English	Article						inflammation; knockout mice; steroids; bone repair; endochondral ossification	OSTEOBLAST-TARGETED DISRUPTION; T-CELLS; BONE; MICE; DIFFERENTIATION; THERAPY; INFLAMMATION; DIMERIZATION; MACROPHAGES; SUPPRESSION	Although endogenous glucocorticoids (GCs) are important regulators of bone integrity and the immune system, their role in bone repair after fracture-a process highly dependent on inflammation and bone formationis unclear. Because most effects of GCs are mediated by the glucocorticoid receptor (GR), we used an inducible global GR knockout (GR(gtROSACreERT2)) mouse model to eliminate endogenous GC action in all cells contributing to bone repair. The healing process was analyzed by cytokine/chemokine multiplex analysis, flow cytometry, histology, gene-expression analysis, microcomputed tomography, and biomechanical analysis. We observed increased early systemic and local inflammatory responses, as well as a significantly higher number of T cells infiltrating the fracture callus. Later in the healing process, we found impaired endochondral ossification in the absence of the GR, leading to persistent cartilage in the calli of the GR(gtROSACreERT2) mice, decreased bending stiffness, and a significantly lower proportion of healed bones. Collectively, our data show that the absence of the GR significantly impairs fracture healing associated with a defective cartilage-to-bone transition, underscoring an important role of GCs during fracture healing.	[Rapp, Anna E.; Kemmler, Julia; Ignatius, Anita] Ulm Univ, Med Ctr, Ctr Trauma Res Ulm, Inst Orthopaed Res & Biomech, Helmholtzstr 14, D-89081 Ulm, Germany; [Hachemi, Yasmine; Koenen, Mascha; Tuckermann, Jan] Ulm Univ, Inst Comparat Mol Endocrinol, Helmholtzstrasse 8-1,Room 3-34, D-89081 Ulm, Germany	Ulm University; Ulm University	Ignatius, A (corresponding author), Ulm Univ, Med Ctr, Ctr Trauma Res Ulm, Inst Orthopaed Res & Biomech, Helmholtzstr 14, D-89081 Ulm, Germany.; Tuckermann, J (corresponding author), Ulm Univ, Inst Comparat Mol Endocrinol, Helmholtzstrasse 8-1,Room 3-34, D-89081 Ulm, Germany.	jan.tuckermann@uni-ulm.de; anita.ignatius@uni-ulm.de	Ignatius, Anita/M-6012-2013; Koenen, Mascha/GWZ-9700-2022; Rapp, Anna Elise/L-8807-2016	Ignatius, Anita/0000-0002-4782-1979; Koenen, Mascha/0000-0002-1024-4506; Rapp, Anna Elise/0000-0001-5122-765X	German Research Foundation in the Collaborative Research Centre 1149 Study, Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma [CRC 1149, C02/INST 40/492-1]	German Research Foundation in the Collaborative Research Centre 1149 Study, Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma	The authors thank G. Strauss (Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center) for the use of the fluorescence-activated cell sorting facility and her support. The authors acknowledge the excellent technical assistance of N. Mobius (Institute of Comparative Molecular Endocrinology, Ulm University), I. Baum, S. Schroth, U. Maile, and M. Tomo (Institute of Orthopaedic Research and Biomechanics, Ulm University Medical Centre). This work was financed by the German Research Foundation in the context of the Collaborative Research Centre 1149 Study, Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma (CRC 1149, C02/INST 40/492-1). The authors declare no conflicts of interest.	Aslan M, 2005, DENT TRAUMATOL, V21, P222, DOI 10.1111/j.1600-9657.2005.00300.x; Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Carcamo-Orive I, 2010, J BONE MINER RES, V25, P2115, DOI 10.1002/jbmr.120; Conaway HH, 2016, BONE, V93, P43, DOI 10.1016/j.bone.2016.08.024; Coutinho AE, 2012, ENDOCRINOLOGY, V153, P234, DOI 10.1210/en.2011-1398; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Frenkel B, 2015, ADV EXP MED BIOL, V872, P179, DOI 10.1007/978-1-4939-2895-8_8; Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.2015; Hubner Sabine, 2012, Biomol Concepts, V3, P241, DOI 10.1515/bmc-2011-0033; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Jia D, 2006, ENDOCRINOLOGY, V147, P5592, DOI 10.1210/en.2006-0459; Kalak R, 2009, BONE, V45, P61, DOI 10.1016/j.bone.2009.03.673; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Koetz KR, 2012, J CLIN ENDOCR METAB, V97, P85, DOI 10.1210/jc.2011-2036; Li J, 2012, INJURY, V43, P1284, DOI 10.1016/j.injury.2012.04.014; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Maes C, 2013, CALCIFIED TISSUE INT, V92, P307, DOI 10.1007/s00223-012-9689-z; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Piemontese M, 2016, AM J PHYSIOL-ENDOC M, V311, pE587, DOI 10.1152/ajpendo.00219.2016; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Tu JW, 2014, BONE, V69, P12, DOI 10.1016/j.bone.2014.08.016; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Waters RV, 2000, ACTA ORTHOP SCAND, V71, P316, DOI 10.1080/000164700317411951; Weber AJ, 2010, STEROIDS, V75, P282, DOI 10.1016/j.steroids.2010.01.005; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200; Zhou H, 2009, DEVELOPMENT, V136, P427, DOI 10.1242/dev.027706	36	18	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2235	2245		10.1096/fj.201700459RR	http://dx.doi.org/10.1096/fj.201700459RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217668	Green Published, hybrid			2022-12-26	WOS:000429051400041
J	Zhang, W; Chen, EM; Chen, M; Ye, CY; Qi, YY; Ding, QH; Li, H; Xue, DT; Gao, X; Pan, ZJ				Zhang, Wei; Chen, Erman; Chen, Mo; Ye, Chenyi; Qi, Yiying; Ding, Qianhai; Li, Hang; Xue, Deting; Gao, Xiang; Pan, Zhijun			IGFBP7 regulates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells via Wnt/beta-catenin signaling pathway	FASEB JOURNAL			English	Article						IGFBP7; BMSCs; osteogenesis	PROTEIN-RELATED PROTEIN-1; FACTOR-BINDING PROTEIN-7; PERIODONTAL-LIGAMENT; IN-VITRO; CULTURED OSTEOBLASTS; STROMAL CELLS; ACTIVIN-A; EXPRESSION; INDUCTION; MARKER	Insulin-like growth factor-binding protein 7 (IGFBP7), a low-affinity IGF binder, may play an important role in bone metabolism. However, its function in osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (BMSCs) remains unclear. Therefore, we investigated its effects on osteogenic differentiation. Overexpression of IGFBP7 enhanced the expression of osteo-specific genes and proteins, and IGFBP7 knockdown decreased osteogenesis-specific markers. More mineral deposits and higher alkaline phosphatase activity were observed after the up-regulation of IGFBP7. Moreover, beta-catenin levels were up-regulated by the overexpression of IGFBP7 or the addition of extracellular IGFBP7 protein and were reduced by the depletion of IGFBP7. The increase in osteogenic differentiation due to the overexpression of IGFBP7 was partially decreased by specific Wnt/beta-catenin signaling inhibitors. Using a rat tibial osteotomy model, a sheet of IGFBP7-overexpressing BMSCs improved bone healing, as demonstrated by imaging, biomechanical, and histologic analyses. Taken together, these findings indicate that IGFBP7 regulates the osteogenic differentiation of BMSCs partly via the Wnt/-catenin signaling pathway.	[Zhang, Wei; Chen, Erman; Ye, Chenyi; Qi, Yiying; Ding, Qianhai; Li, Hang; Xue, Deting; Gao, Xiang; Pan, Zhijun] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhejiang, Peoples R China; [Chen, Mo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Rheumatol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Wei; Chen, Erman; Ye, Chenyi; Qi, Yiying; Ding, Qianhai; Li, Hang; Xue, Deting; Gao, Xiang; Pan, Zhijun] Zhejiang Univ, Res Inst Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Chen, Mo] Hangzhou Hosp Tradit Chinese Med, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Xue, DT; Gao, X (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhejiang, Peoples R China.	blueskine@zju.edu.cn; gaoxiang162@zju.edu.cn		Xue, deting/0000-0001-6388-2862	Zhejiang Medical and Health Science and Technology Plan Project [2014KYA92, 2015KYB182]; Zhejiang Provincial Natural Science Foundation of China [LY16H060003, LY15H060002, LY15H060001, LY13H060002, LY18H060003, LY17H060002]; National Natural Science Foundation of China [81672147, 81501906, 81572124]; Department of Eduction of Zhejiang province [Y201328201]	Zhejiang Medical and Health Science and Technology Plan Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Eduction of Zhejiang province	This research was supported by Zhejiang Provincial Natural Science Foundation of China (LY18H060003; LY15H060002; LY15H060001; LY17H060002; LY16H060003; and LY13H060002), National Natural Science Foundation of China (81672147, 81501906 and 81572124), Department of Eduction of Zhejiang province (Y201328201), and Zhejiang Medical and Health Science and Technology Plan Project (2015KYB182, 2014KYA92). The authors declare no conflicts of interest.	Ahmadzadeh A, 2016, CELL TISSUE RES, V363, P321, DOI 10.1007/s00441-015-2300-y; Aisha MD, 2014, EXP CELL RES, V326, P46, DOI 10.1016/j.yexcr.2014.06.003; Akiel M, 2014, J HEPATOCELL CARCINO, V1, P9, DOI 10.2147/JHC.S44460; Al-Kharobi H, 2014, CELL MOL LIFE SCI, V71, P1469, DOI 10.1007/s00018-013-1508-9; Alves RDAM, 2013, MOL CELL PROTEOMICS, V12, P2890, DOI 10.1074/mcp.M112.024927; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bolomsky A, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0105-1; Bosemark P, 2014, J ORTHOP RES, V32, P721, DOI 10.1002/jor.22599; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen EM, 2015, FEBS LETT, V589, P4088, DOI 10.1016/j.febslet.2015.11.021; Chen FM, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0288-1; Chen HC, 2010, ARTHRITIS RHEUM-US, V62, P781, DOI 10.1002/art.27288; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Court-Brown CM, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.00793; Dudek H, 2014, MOL THER, V22, P92, DOI 10.1038/mt.2013.233; El-Hoss J, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00862; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Hooper AT, 2009, CIRC RES, V105, P201, DOI 10.1161/CIRCRESAHA.109.196790; James MJ, 2004, GENE EXPR PATTERNS, V4, P595, DOI 10.1016/j.modgep.2004.01.013; Jeffries MA, 2016, ARTHRITIS RHEUMATOL, V68, P1403, DOI 10.1002/art.39555; Kang YQ, 2014, ACS APPL MATER INTER, V6, P9622, DOI 10.1021/am502056q; Kutsukake M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-54; LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306; Liao Y, 2016, MOL THER, V24, P1860, DOI 10.1038/mt.2016.140; Liu WJ, 2014, BBA-GEN SUBJECTS, V1840, P1125, DOI 10.1016/j.bbagen.2013.11.003; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10227; Ma DD, 2009, J ENDODONT, V35, P1546, DOI 10.1016/j.joen.2009.07.016; MacDonald BT, 2012, COLD SPRING HARB PER, V4; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Park JS, 2010, BIOMATERIALS, V31, P6239, DOI 10.1016/j.biomaterials.2010.05.002; Pereira RC, 1999, ENDOCRINOLOGY, V140, P228, DOI 10.1210/en.140.1.228; Pereira RC, 1999, ENDOCRINOLOGY, V140, P1998, DOI 10.1210/en.140.5.1998; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi YY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0256-1; Qi YY, 2014, KNEE SURG SPORT TR A, V22, P1424, DOI 10.1007/s00167-012-2256-3; Qi YY, 2013, CYTOTHERAPY, V15, P44, DOI 10.1016/j.jcyt.2012.10.006; Qi YY, 2012, CELL TRANSPLANT, V21, P693, DOI 10.3727/096368911X623844; Rao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085340; Regard J. B., 2012, COLD SPRING HARB PER, V4; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Sugii H, 2014, BONE, V66, P62, DOI 10.1016/j.bone.2014.05.021; Sun HL, 2014, STEM CELLS, V32, P1943, DOI 10.1002/stem.1671; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Takahata M, 2012, J BONE MINER RES, V27, P26, DOI 10.1002/jbmr.518; Tan WX, 2015, BIOCHEM BIOPH RES CO, V460, P639, DOI 10.1016/j.bbrc.2015.03.082; Tao K, 2016, TOXICOL LETT, V240, P68, DOI 10.1016/j.toxlet.2015.10.007; Tsai SC, 2012, INT J ONCOL, V41, P2065, DOI 10.3892/ijo.2012.1640; Tsai YH, 2015, FEBS LETT, V589, P2058, DOI 10.1016/j.febslet.2015.06.023; Usui T, 2002, INT IMMUNOL, V14, P1273, DOI 10.1093/intimm/dxf102; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2010, CELL, V141, P746, DOI 10.1016/j.cell.2010.05.014; Wang ZF, 2015, J BIOMED MATER RES B, V103, P1204, DOI 10.1002/jbm.b.33288; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Xu LL, 2015, FASEB J, V29, P1143, DOI 10.1096/fj.14-254169; Xue DT, 2017, ONCOTARGET, V8, P42098, DOI 10.18632/oncotarget.16887; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yoon H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6176; Zhang W, 2015, GROWTH FACTORS, V33, P356, DOI 10.3109/08977194.2015.1108313; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhou XP, 2015, GROWTH FACTORS, V33, P23, DOI 10.3109/08977194.2014.969420	62	41	43	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2280	2291		10.1096/fj.201700998RR	http://dx.doi.org/10.1096/fj.201700998RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242275				2022-12-26	WOS:000429051400045
J	Aghdassi, AA; John, DS; Sendler, M; Weiss, FU; Reinheckel, T; Mayerle, J; Lerch, MM				Aghdassi, Ali A.; John, Daniel S.; Sendler, Matthias; Weiss, F. Ulrich; Reinheckel, Thomas; Mayerle, Julia; Lerch, Markus M.			Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC TRYPSINOGEN GENE; ACINAR-CELLS; HEREDITARY PANCREATITIS; PROTEASE ACTIVATION; ASPARTIC PROTEASE; PROCATHEPSIN-B; MICE; APOPTOSIS; DEGRADATION; CANCER	Acute pancreatitis is a complex disorder involving both premature intracellular protease activation and inflammatory cell invasion. An initiating event is the intracellular activation of trypsinogen by cathepsin B (CTSB), which can be induced directly via G protein-coupled receptors on acinar cells or through inflammatory cells. Here, we studied CTSB regulation by another lysosomal hydrolase, cathepsin D (CTSD), using mice with a complete (CTSD-/-) or pancreas-specific conditional CTSD knockout (KO) (CTSD(f/f/)p48(Cre/+)). We induced acute pancreatitis by repeated caerulein injections and isolated acinar and bone marrow cells for ex vivo studies. Supramaximal caerulein stimulation induced subcellular redistribution of CTSD from the lysosomal to the zymogen-containing subcellular compartment of acinar cells and activation of CTSD, CTSB, and trypsinogen. Of note, the CTSD KO greatly reduced CTSB and trypsinogen activation in acinar cells, and CTSD directly activated CTSB but not trypsinogen in vitro. During pancreatitis in pancreas-specific CTSD(f/f/)p48(Cre/+) animals, markers of severity were reduced only at 1 h, whereas in the complete KO, this effect also included the late disease phase (8 h), indicating an important effect of extra-acinar CTSD on course of the disease. CTSD-/- leukocytes exhibited reduced cytokine release after lipopolysaccharide (LPS) stimulation, and CTSD KO also reduced caspase-3 activation and apoptosis in acinar cells stimulated with the intestinal hormone cholecystokinin. In summary, CTSD is expressed in pancreatic acinar and inflammatory cells, undergoes subcellular redistribution and activation during experimental pancreatitis, and regulates disease severity by potently activating CTSB. Its impact is only minimal and transient in the early, acinar cell-dependent phase of pancreatitis and much greater in the later, inflammatory cell-dependent phase of the disease.	[Aghdassi, Ali A.; John, Daniel S.; Sendler, Matthias; Weiss, F. Ulrich; Mayerle, Julia; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, D-17475 Greifswald, Germany; [Reinheckel, Thomas] Albert Ludwigs Univ Freiburg, Med Fac, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Mayerle, Julia] Ludwigs Maximilians Univ Munich, Dept Med 2, D-80539 Munich, Germany	Greifswald Medical School; University of Freiburg; University of Munich	Aghdassi, AA (corresponding author), Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.	aghdassi@uni-greifswald.de	Mayerle, Julia/W-7907-2019; Aghdassi, Ali/X-5836-2019; Sendler, Matthias/V-9341-2017; Reinheckel, Thomas/AAL-9761-2021; Lerch, Markus M./E-2206-2016	Reinheckel, Thomas/0000-0001-9866-9105; Lerch, Markus M./0000-0002-9643-8263; Mayerle, Julia/0000-0002-3666-6459; Weiss, Frank Ulrich/0000-0003-3369-6369; Aghdassi, Ali/0000-0002-0569-7316; Sendler, Matthias/0000-0003-3554-9426; Sendler, Matthias/0000-0001-6494-4105	Deutsche Forschungsgemeinschaft [DFG AG 203/2-1]; DFG [GRK1947]; PePPP Project - European Union [ESF/14-BM-A55-0045/16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); PePPP Project - European Union	This work was supported by Deutsche Forschungsgemeinschaft Grant DFG AG 203/2-1 (to A. A. A.) with additional support from DFG GRK1947(A3) and the PePPP Project Grant ESF/14-BM-A55-0045/16 funded by the European Union. The authors declare that they have no conflicts of interest with the contents of this article.	Aghdassi AA, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-26; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Conner G. E, 2002, HDB PROTEOLYTIC ENZY, P746; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Essin K, 2007, AM J PHYSIOL-CELL PH, V293, pC45, DOI 10.1152/ajpcell.00450.2006; Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; Haendeler J, 2005, J BIOL CHEM, V280, P42945, DOI 10.1074/jbc.M506985200; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; KAWABATA T, 1993, J BIOCHEM-TOKYO, V113, P389, DOI 10.1093/oxfordjournals.jbchem.a124056; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keim V, 2001, AM J MED, V111, P622, DOI 10.1016/S0002-9343(01)00958-5; Kern U, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0313-5; Ketscher A, 2016, BIOCHIMIE, V122, P219, DOI 10.1016/j.biochi.2015.07.020; Ketterer S, 2017, FEBS J, V284, P1437, DOI 10.1111/febs.13980; Kirschke H, 1985, Prog Clin Biol Res, V180, P61; KOIKE H, 1982, AM J PHYSIOL, V242, pG297, DOI 10.1152/ajpgi.1982.242.4.G297; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; LERCH MM, 1993, GASTROENTEROLOGY, V104, P1768, DOI 10.1016/0016-5085(93)90658-Y; LERCH MM, 1995, J CLIN INVEST, V95, P2222, DOI 10.1172/JCI117912; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Mehanna S, 2016, BIOCHEM BIOPH RES CO, V469, P405, DOI 10.1016/j.bbrc.2015.12.002; Meister T, 2010, J PHYSIOL PHARMACOL, V61, P565; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Mooren FC, 2001, FASEB J, V15, P659, DOI 10.1096/fj.00-0172com; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Polajnar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102500; Quraishi O, 2001, J BIOL CHEM, V276, P8118, DOI 10.1074/jbc.M005851200; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Schaschke N, 2000, FEBS LETT, V482, P91, DOI 10.1016/S0014-5793(00)02047-0; SCHMIDT J, 1992, GASTROENTEROLOGY, V103, P1009, DOI 10.1016/0016-5085(92)90036-X; Schwaiger T, 2014, GUT, V63, P494, DOI 10.1136/gutjnl-2012-303635; Sendler M, 2016, J BIOL CHEM, V291, P14717, DOI 10.1074/jbc.M116.718999; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Talukdar R, 2016, GASTROENTEROLOGY, V151, P747, DOI 10.1053/j.gastro.2016.06.042; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; vanderStappen JWJ, 1996, INT J CANCER, V67, P547, DOI 10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zheng X, 2008, BBA-MOL CELL RES, V1783, P2294, DOI 10.1016/j.bbamcr.2008.07.027; Zhou W, 2006, NEUROSCIENCE, V143, P689, DOI 10.1016/j.neuroscience.2006.08.019	61	31	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1018	1029		10.1074/jbc.M117.814772	http://dx.doi.org/10.1074/jbc.M117.814772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29229780	Green Published, hybrid			2022-12-26	WOS:000422864500022
J	Glatz, W; Steinwender, G; Tarmann, L; Malle, EM; Schorkhuber, M; Wackernagel, W; Petrovski, G; Wedrich, A; Ivastinovic, D				Glatz, Wilfried; Steinwender, Gernot; Tarmann, Lisa; Malle, Eva Maria; Schoerkhuber, Marlene; Wackernagel, Werner; Petrovski, Goran; Wedrich, Andreas; Ivastinovic, Domagoj			Vitreous hyper-reflective dots in pseudophakic cystoid macular edema assessed with optical coherence tomography	PLOS ONE			English	Article							CATARACT-SURGERY; LENS FRAGMENTS; PHACOEMULSIFICATION; INTERFACE	Purpose This study compares the presence of vitreous hyper-reflective dots (VHDs) detected with optical coherence tomography (OCT) between eyes with pseudophakic cystoid macular edema (CME) and those with no CME after cataract surgery. In addition, we evaluated the impact of VHDs on the responsiveness of pseudophakic CME to cortisone treatment. Setting Department of Ophthalmology, Medical University of Graz, Austria. Design Retrospective, monocenter case-controlled study. Methods Inclusion criteria for the study group and the control group were CME and no CME within 12 weeks following uneventful phacoemulsification in otherwise healthy eyes, respectively. VHDs (number and size) and the macular thickness were assessed with OCT. Furthermore, the number of peribulbar or intravitreal steroid injections was assessed. Results A total of 284 eyes from 267 patients were analyzed, among which 119 met the inclusion criteria for the study (n = 63) and the control group (n = 56). VHDs were observed in 54 (85.7%) study eyes and 21 (37.5%, p = 0.013) control eyes. The number of VHDs was 3.9 +/- 3.4 in the study group and 0.7 +/- 1 in the control group (p<0.001). The size of the VHDs was 33.5 +/- 9.1 mu m and 36.6 +/- 17.9 mu m in the study and control groups, respectively (p = 0.978). Overall, the number of VHDs correlated with central subfield thickness (r = 0.584, p<0.001), cube volume (r = 0.525, p<0.001), and postoperative best-corrected visual acuity (BCVA) (r = -0.563, p<0.001). The number of VHDs did not correlate with the frequency of peribulbar or intravitreal steroid injections. Conclusion VHDs occurred more often in eyes with CME than in eyes without CME following cataract surgery. In addition, the number of VHDs had an impact on the extent of macular thickening and subsequently postoperative BCVA. No correlation was found between the number of VHDs and the frequency of required peribulbar or intravitreal steroid injections.	[Glatz, Wilfried; Steinwender, Gernot; Tarmann, Lisa; Malle, Eva Maria; Schoerkhuber, Marlene; Wackernagel, Werner; Wedrich, Andreas; Ivastinovic, Domagoj] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Petrovski, Goran] Univ Oslo, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Petrovski, Goran] Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo Univ Hosp, Oslo, Norway	Medical University of Graz; University of Oslo; University of Oslo	Glatz, W (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	wilfried.glatz@medunigraz.at	Wedrich, Andreas/AAE-9171-2020	Petrovski, Goran/0000-0003-2905-9252				Ang A, 2004, J CATARACT REFR SURG, V30, P849, DOI 10.1016/j.jcrs.2003.08.026; Biro Z, 2008, EYE, V22, P8, DOI 10.1038/sj.eye.6702460; Cagini C, 2009, CURR EYE RES, V34, P1036, DOI 10.3109/02713680903288937; Henderson BA, 2007, J CATARACT REFR SURG, V33, P1550, DOI 10.1016/j.jcrs.2007.05.013; Ivastinovic D, 2017, ACTA OPHTHALMOL, V95, pE347, DOI 10.1111/aos.13104; Ivastinovic D, 2012, AM J OPHTHALMOL, V153, P705, DOI 10.1016/j.ajo.2011.09.009; Kim JE, 1996, OPHTHALMOLOGY, V103, P575, DOI 10.1016/S0161-6420(96)30651-9; Kim SJ, 2009, CURR OPIN OPHTHALMOL, V20, P46, DOI 10.1097/ICU.0b013e3283199162; Krebs I, 2011, BRIT J OPHTHALMOL, V95, P1415, DOI 10.1136/bjo.2010.192385; Loewenstein A, 2010, DEV OPHTHALMOL, V47, P148, DOI 10.1159/000320078; Miyake K, 2002, SURV OPHTHALMOL, V47, pS203, DOI 10.1016/S0039-6257(02)00294-1; Oh JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095066; RAVIOLA G, 1971, INVEST OPHTH VISUAL, V10, P851; Ray Subhransu, 2002, Semin Ophthalmol, V17, P167, DOI 10.1076/soph.17.3.167.14747; Saito M, 2013, RETINA-J RET VIT DIS, V33, P559, DOI 10.1097/IAE.0b013e31826710ea; Sebag J, 2009, Trans Am Ophthalmol Soc, V107, P35; Seidel G, 2016, JAMA OPHTHALMOL, V134, P1104, DOI 10.1001/jamaophthalmol.2016.2507; Seidel G, 2015, AM J OPHTHALMOL, V159, P365, DOI 10.1016/j.ajo.2014.11.002; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Ursell PG, 1999, J CATARACT REFR SURG, V25, P1492, DOI 10.1016/S0886-3350(99)00196-0; Xu HP, 2011, INVEST OPHTH VIS SCI, V52, P249, DOI 10.1167/iovs.10-6001; Yaqoob Zahid, 2005, Biotechniques, V39, pS6, DOI 10.2144/000112090; Yonekawa Y, 2012, CURR OPIN OPHTHALMOL, V23, P26, DOI 10.1097/ICU.0b013e32834cd5f8; YOSHIMOTO H, 1984, GRAEF ARCH CLIN EXP, V221, P276, DOI 10.1007/BF02134123	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189194	10.1371/journal.pone.0189194	http://dx.doi.org/10.1371/journal.pone.0189194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244855	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700020
J	Zeinomar, N; Thai, A; Cloud, AJ; McDonald, JA; Liao, Y; Terry, MB				Zeinomar, Nur; Thai, Ashley; Cloud, Ann J.; McDonald, Jasmine A.; Liao, Yuyan; Terry, Mary Beth			Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry	PLOS ONE			English	Article							RISK-FACTORS; SURVIVAL; COHORT; HEALTH; EPIDEMIOLOGY; LIFE; PATTERNS; HISTORY; DISEASE	Purpose Alcohol consumption is an established and important risk factor for breast cancer incidence in the general population. However, the relationship between alcohol and mortality among women with breast cancer is less clear. This study examines the effect of alcohol consumption on mortality in women affected with breast cancer at baseline from a high-risk family breast and ovarian cancer registry. Methods We studied 1116 women affected with breast cancer at baseline from the Metropolitan New York Registry. The examined reported alcohol consumption (total of beer, wine, liquor) was defined as the average number of drinks per week reported from age 12 to age at baseline. We assessed vital status of each participant using participant or family reported data and we used the National Death Index to supplement deaths reported through family updates. We used Cox proportional hazards models to estimate the association between alcohol intake and overall mortality (HRO), breast cancer-specific mortality (HR BC), and non-breast cancer mortality (HRNBC), adjusted for confounders. Results After a mean follow-up of 9.1 years, we observed 211 total deaths and 58 breast cancer deaths. Compared to non-drinkers, we found that both low and moderate to heavy levels of alcohol intake were not associated with greater overall mortality (<= 3 drinks/week: HRO : 0.66, 95% CI: 0.38-1.14); > 3 drinks/week: HRO : 1.16, 95% CI: 0.85-1.58), breast cancer-specific mortality (<= 3 drinks/week: HRBC : 0.62, 95% CI: 0.19-2.03; > 3 drinks/week: HRBC: 0.96, 95% CI: 0.49-1.89), or non-breast cancer-specific mortality (<= 3 drinks/week: HRNBC : 0.73, 95% CI: 0.32-1.6; >3 drinks/week: HRNBC : 1.18, 95% CI: 0.75-1.86). Conclusions Alcohol intake reported from age 12 to age at baseline was not associated with overall or breast cancer-specific mortality in this cohort of affected women with a family history of breast cancer.	[Zeinomar, Nur; Thai, Ashley; Cloud, Ann J.; McDonald, Jasmine A.; Liao, Yuyan; Terry, Mary Beth] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Terry, Mary Beth] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA	Columbia University; Columbia University	Terry, MB (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.; Terry, MB (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	mt146@cumc.columbia.edu	McDonald, Jasmine/L-4249-2019	McDonald, Jasmine/0000-0002-8270-8074; Terry, Mary Beth/0000-0002-4106-5033	National Cancer Institute [UM1 CA164920, 4R25CA094061-15]; NATIONAL CANCER INSTITUTE [T32CA094061, UM1CA164920, R25CA094061, K01CA186943] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant UM1 CA164920 and 4R25CA094061-15 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the BCFR.	Ali AMG, 2014, CANC EPIDEMIOLOGY BI, V23; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bernstein JL, 2013, EUR J CANCER, V49, P2979, DOI 10.1016/j.ejca.2013.04.028; Bidstrup PE, 2013, ACTA ONCOL, V52, P327, DOI 10.3109/0284186X.2012.746466; Bilgrad R., 2009, NATL DEATH INDEX USE; Breslow RA, 2011, AM J EPIDEMIOL, V174, P1044, DOI 10.1093/aje/kwr210; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Colditz GA, 2012, BREAST CANCER RES TR, V133, P1097, DOI 10.1007/s10549-012-1985-9; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fan SJ, 2000, CANCER RES, V60, P5635; Feigelson HS, 2001, CANCER CAUSE CONTROL, V12, P895, DOI 10.1023/A:1013737616987; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Harris HR, 2012, BRIT J CANCER, V106, P592, DOI 10.1038/bjc.2011.561; Hellmann SS, 2010, EUR J CANCER PREV, V19, P366, DOI 10.1097/CEJ.0b013e32833b4828; Holm M, 2013, INT J CANCER, V132, P686, DOI 10.1002/ijc.27652; Horn-Ross PL, 2004, CANCER EPIDEM BIOMAR, V13, P405; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Jain MG, 2000, BREAST CANCER RES TR, V64, P201, DOI 10.1023/A:1006402323445; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Kwan ML, 2013, CANCER EPIDEM BIOMAR, V22, P32, DOI 10.1158/1055-9965.EPI-12-1022; Kwan ML, 2010, J CLIN ONCOL, V28, P4410, DOI 10.1200/JCO.2010.29.2730; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lowry SJ, 2016, CANCER EPIDEM BIOMAR, V25, P1268, DOI 10.1158/1055-9965.EPI-16-0151; Ochoa EM, 2010, BEHAV MED, V36, P123, DOI 10.1080/08964289.2010.516783; Newcomb PA, 2013, J CLIN ONCOL, V31, P1939, DOI 10.1200/JCO.2012.46.5765; Reding KW, 2008, CANCER EPIDEM BIOMAR, V17, P1988, DOI 10.1158/1055-9965.EPI-07-2897; Scoccianti C, 2013, FUTURE ONCOL, V9, P1315, DOI 10.2217/fon.13.94; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Skeie G, 2009, CANCER CAUSE CONTROL, V20, P1955, DOI 10.1007/s10552-009-9390-3; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Sprague BL, 2010, BREAST CANCER RES TR, V124, P487, DOI 10.1007/s10549-010-0869-0; Terry MB, 2006, ANN EPIDEMIOL, V16, P230, DOI 10.1016/j.annepidem.2005.06.048; Vrieling A, 2012, BREAST CANCER RES TR, V136, P195, DOI 10.1007/s10549-012-2230-2	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189118	10.1371/journal.pone.0189118	http://dx.doi.org/10.1371/journal.pone.0189118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244822	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700017
J	Knotel, D; Seidel, R; Prohaska, S; Deane, MN; Baum, D				Knoetel, David; Seidel, Ronald; Prohaska, Steffen; Deane, Mason N.; Baum, Daniel			Automated segmentation of complex patterns in biological tissues: Lessons from stingray tessellated cartilage	PLOS ONE			English	Article							MINERALIZATION; ALGORITHMS; SKELETON; GROWTH; SHARKS	Introduction Many biological structures show recurring tiling patterns on one structural level or the other. Current image acquisition techniques are able to resolve those tiling patterns to allow quantitative analyses. The resulting image data, however, may contain an enormous number of elements. This renders manual image analysis infeasible, in particular when statistical analysis is to be conducted, requiring a larger number of image data to be analyzed. As a consequence, the analysis process needs to be automated to a large degree. In this paper, we describe a multi-step image segmentation pipeline for the automated segmentation of the calcified cartilage into individual tesserae from computed tomography images of skeletal elements of stingrays. Methods Besides applying state-of-the-art algorithms like anisotropic diffusion smoothing, local thresholding for foreground segmentation, distance map calculation, and hierarchical watershed, we exploit a graph-based representation for fast correction of the segmentation. In addition, we propose a new distance map that is computed only in the plane that locally best approximates the calcified cartilage. This distance map drastically improves the separation of individual tesserae. We apply our segmentation pipeline to hyomandibulae from three individuals of the round stingray (Urobatis halleri), varying both in age and size. Results Each of the hyomandibula datasets contains approximately 3000 tesserae. To evaluate the quality of the automated segmentation, four expert users manually generated ground truth segmentations of small parts of one hyomandibula. These ground truth segmentations allowed us to compare the segmentation quality w.r.t. individual tesserae. Additionally, to investigate the segmentation quality of whole skeletal elements, landmarks were manually placed on all tesserae and their positions were then compared to the segmented tesserae. With the proposed segmentation pipeline, we sped up the processing of a single skeletal element from days or weeks to a few hours.	[Knoetel, David; Prohaska, Steffen; Baum, Daniel] Zuse Inst Berlin, Dept Visual Data Anal, Berlin, Germany; [Seidel, Ronald; Deane, Mason N.] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany	Zuse Institute Berlin; Max Planck Society	Knotel, D (corresponding author), Zuse Inst Berlin, Dept Visual Data Anal, Berlin, Germany.	knoetel@zib.de	Dean, Mason N/C-8758-2014	Dean, Mason N/0000-0002-5026-6216; Baum, Daniel/0000-0003-1550-7245; Knotel, David/0000-0002-1955-309X	HFSP Young Investigators Grant [RGY0067-2013]; Gottfried Wilhelm Leibniz-Preis [DFG-FR 2190/4-1]	HFSP Young Investigators Grant; Gottfried Wilhelm Leibniz-Preis	The research of MND, DK and RS was funded by an HFSP Young Investigators Grant (RGY0067-2013, http//www.hfsp.org/ to MND. MND was supported by DFG-FR 2190/4-1 Gottfried Wilhelm Leibniz-Preis 2010. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Raoush R, 2006, PHYSICA A, V361, P441, DOI 10.1016/j.physa.2005.05.043; Baum D, 2016, EUROVIS 2016 SHORT P; Bernard D, 2011, ACTA MATER, V59, P6228, DOI 10.1016/j.actamat.2011.06.022; Beucher S, 1994, COMP IMAG VIS, V2, P69; Beucher S, 1979, INT WORKSH IM PROC P; Beucher S., 1992, MATH MORPHOLOGY IMAG, V34, P433; BRESENHAM JE, 1965, IBM SYST J, V4, P25, DOI 10.1147/sj.41.0025; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; CLEMENT JG, 1992, AUST J MAR FRESH RES, V43, P157; Dale S, 2014, POWDER TECHNOL, V264, P550, DOI 10.1016/j.powtec.2014.06.009; Dean MN, 2010, J APPL ICHTHYOL, V26, P263, DOI 10.1111/j.1439-0426.2010.01417.x; Dean MN, 2015, SEMIN CELL DEV BIOL, V46, P51, DOI 10.1016/j.semcdb.2015.10.022; Dean MN, 2009, J ANAT, V215, P227, DOI 10.1111/j.1469-7580.2009.01116.x; Dunlop JWC, 2011, MATER TODAY, V14, P70, DOI 10.1016/S1369-7021(11)70056-6; Flajolet P., 2013, INTRO ANAL ALGORITHM, Vsecond; Ghalib AM, 1999, J COMPUT CIVIL ENG, V13, P80, DOI 10.1061/(ASCE)0887-3801(1999)13:2(80); Godehardt M., 2006, 9 EUR C NDT DGZFP BE; Jones MW, 2006, IEEE T VIS COMPUT GR, V12, P581, DOI 10.1109/TVCG.2006.56; Kaestner A, 2005, Fifth International Conference on 3-D Digital Imaging and Modeling, Proceedings, P410, DOI 10.1109/3DIM.2005.54; Kim H, 2003, COMPUT-AIDED CIV INF, V18, P254, DOI 10.1111/1467-8667.00315; Lyons K, 2014, ENVIRON TOXICOL CHEM, V33, P1380, DOI 10.1002/etc.2564; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Meyer F., 1990, Journal of Visual Communication and Image Representation, V1, P21, DOI 10.1016/1047-3203(90)90014-M; NAJMAN L, 1994, SIGNAL PROCESS, V38, P99, DOI 10.1016/0165-1684(94)90059-0; Najman L, 1996, IEEE T PATTERN ANAL, V18, P1163, DOI 10.1109/34.546254; Oberlaender M, 2009, J NEUROSCI METH, V180, P147, DOI 10.1016/j.jneumeth.2009.03.008; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; ROSENFEL.A, 1966, J ACM, V13, P471; Saadatfar M., 2010, ADV XRAY TOMOGRAPHY, P269; Seidel R, 2016, J ANAT, V229, P681, DOI 10.1111/joa.12508; Stalling D., 2005, VISUAL HDB, V38, P749, DOI DOI 10.1016/B978-012387582-2/50040-X; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vincent L., 1994, DIGITAL IMAGE PROCES, P43; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wirjadi O, 2007, SURVEY 3D IMAGE SEGM, V35; Zanoguera F, IM PROC 1999 ICIP 99, V1	38	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188018	10.1371/journal.pone.0188018	http://dx.doi.org/10.1371/journal.pone.0188018			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236705	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100009
J	Li, B; Pei, YJ; Wu, H; Huang, DJ				Li, Bo; Pei, Yijian; Wu, Hao; Huang, Dijiang			MADM-based smart parking guidance algorithm	PLOS ONE			English	Article								In smart parking environments, how to choose suitable parking facilities with various attributes to satisfy certain criteria is an important decision issue. Based on the multiple attributes decision making (MADM) theory, this study proposed a smart parking guidance algorithm by considering three representative decision factors (i.e., walk duration, parking fee, and the number of vacant parking spaces) and various preferences of drivers. In this paper, the expected number of vacant parking spaces is regarded as an important attribute to reflect the difficulty degree of finding available parking spaces, and a queueing theory-based theoretical method was proposed to estimate this expected number for candidate parking facilities with different capacities, arrival rates, and service rates. The effectiveness of the MADM-based parking guidance algorithm was investigated and compared with a blind search-based approach in comprehensive scenarios with various distributions of parking facilities, traffic intensities, and user preferences. Experimental results show that the proposed MADM-based algorithm is effective to choose suitable parking resources to satisfy users' preferences. Furthermore, it has also been observed that this newly proposed Markov Chain-based availability attribute is more effective to represent the availability of parking spaces than the arrival rate-based availability attribute proposed in existing research.	[Li, Bo; Pei, Yijian; Wu, Hao] Yunnan Univ, Sch Informat Sci & Engn, Kunming, Yunnan, Peoples R China; [Huang, Dijiang] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA	Yunnan University; Arizona State University; Arizona State University-Tempe	Li, B (corresponding author), Yunnan Univ, Sch Informat Sci & Engn, Kunming, Yunnan, Peoples R China.	libo@ynu.edu.cn	Wu, Hao/T-5893-2019	Wu, Hao/0000-0002-3696-9281; Huang, Dijiang/0000-0003-3257-6349	National Natural Science Foundation of China [61562092, 61562090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National Natural Science Foundation of China (61562092 (B.L.), 61562090 (H.W.)), URL:www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bonsall P, 2004, TRANSPORT RES C-EMER, V12, P321, DOI 10.1016/j.trc.2004.07.013; Cai WY, 2015, 2015 IEEE 16TH INTERNATIONAL CONFERENCE ON COMMUNICATION TECHNOLOGY (ICCT), P419, DOI 10.1109/ICCT.2015.7399872; Caliskan M, 2007, IEEE VTS VEH TECHNOL, P277, DOI 10.1109/VETECS.2007.69; Geng YF, 2013, IEEE T INTELL TRANSP, V14, P1129, DOI 10.1109/TITS.2013.2252428; Gross D, 2008, FUNDAMENTALS QUEUEIN; He F, 2015, TRANSPORT RES B-METH, V73, P1, DOI 10.1016/j.trb.2014.12.003; Idris M., 2009, INF TECHNOL J, V8, P138; Idris M. Y. I., 2009, Information Technology Journal, V8, P101, DOI 10.3923/itj.2009.101.113; Ji YJ, 2015, IET INTELL TRANSP SY, V9, P202, DOI 10.1049/iet-its.2013.0184; Jonkers E, 2011, IEEE INT C INTELL TR, P858, DOI 10.1109/ITSC.2011.6082804; Klappenecker A, 2014, AD HOC NETW, V12, P243, DOI 10.1016/j.adhoc.2012.03.002; Lu RX, 2009, IEEE INFOCOM SER, P1413, DOI 10.1109/INFCOM.2009.5062057; Mamandi A., 2015, PROC INT S COMP SC S; Masmoudi I, 2015, IEEE SYS MAN CYBERN, P2974, DOI 10.1109/SMC.2015.517; Mei ZY, 2011, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2011-104; Polycarpou E., 2013, P 2013 IEEE 14 INT S, P1, DOI DOI 10.1109/WOWMOM.2013.6583499; Rajabioun T, 2015, IEEE T INTELL TRANSP, V16, P2913, DOI 10.1109/TITS.2015.2428705; Shin JH, 2014, TRANSPORT RES C-EMER, V44, P299, DOI 10.1016/j.trc.2014.04.010; Tesoriere G., 2013, IET INTELLIGENT TRAN, V8, P445; Pham TN, 2015, IEEE ACCESS, V3, P1581, DOI 10.1109/ACCESS.2015.2477299; Thompson RG, 2001, TRANSPORT RES C-EMER, V9, P69, DOI 10.1016/S0968-090X(00)00031-0; Yang SJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016107; Yongjie Lin, 2015, CICTP 2015. Efficient, Safe and Green Multimodal Transportation. 15th COTA International Conference of Transportation Professionals. Proceedings, P281, DOI 10.1061/9780784479292.026; Yu FQ, 2015, 3RD INTERNATIONAL CONFERENCE ON TRANSPORTATION INFORMATION AND SAFETY (ICTIS 2015), P370, DOI 10.1109/ICTIS.2015.7232145	25	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188283	10.1371/journal.pone.0188283	http://dx.doi.org/10.1371/journal.pone.0188283			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236698	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100014
J	Esteve-Gasent, MD; Snell, CB; Adetunji, SA; Piccione, J				Esteve-Gasent, Maria D.; Snell, Chloe B.; Adetunji, Shakirat A.; Piccione, Julie			Serological detection of Tick-Borne Relapsing Fever in Texan domestic dogs	PLOS ONE			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE GLPQ; BORRELIA-TURICATAE; UNITED-STATES; LYME BORRELIOSIS; SENTINELS; INFECTION; OUTBREAK; PERSICA; ANTIGEN; CAMP	Tick-Borne Relapsing Fever (TBRF) is caused by spirochetes in the genus Borrelia. Very limited information exists on the incidence of this disease in humans and domestic dogs in the United States. The main objective of this study is to evaluate exposure of dogs to Borrelia turicatae, a causative agent of TBRF, in Texas. To this end, 878 canine serum samples were submitted to Texas A&M Veterinary Medical Diagnostic Laboratory from October 2011 to September 2012 for suspected tick-borne illnesses. The recombinant Borrelial antigen glycerophosphodiester phosphodiesterase (GlpQ) was expressed, purified, and used as a diagnostic antigen in both ELISA assays and Immunoblot analysis. Unfortunately, due to significant background reaction, the use of GlpQ as a diagnostic marker in the ELISA assay was not effective in discriminating dogs exposed to B. turicatae. Nevertheless, immunoblot assays showed that 17 out of 853 samples tested were considered to be seropositive, which constitutes 1.99% of all Texas samples tested in this study. The majority of positive samples were from central and southern Texas. Exposure to TBRF spirochetes may be seasonal, with 70.59% (12 out of 17) of the cases detected between June and December. In addition, 2 out of the 17 sero-reactive cases (11.76%) showed reactivity to both B. burgdorferi (causative agent of Lyme disease) and B. turicatae (a causative agent of TBRF). This is the first report of TBRF sero-prevalence in companion animals in an endemic area. Our findings further indicate that B. turicatae is maintained in domestic canids in Texas in regions where human disease also occurs, suggesting that domestic dogs could serve as sentinels for this disease.	[Esteve-Gasent, Maria D.; Snell, Chloe B.; Adetunji, Shakirat A.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Piccione, Julie] Texas A&M Vet Med Diagnost Lab, College Stn, TX USA; [Snell, Chloe B.] Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Esteve-Gasent, MD (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	MEsteve-Gassent@cvm.tamu.edu	Esteve-Gassent, Maria/AAF-2597-2020; Adetunji, Shakirat/AAP-3480-2021	Esteve-Gassent, Maria/0000-0001-5921-2794; Adetunji, Shakirat/0000-0002-5352-3695	Texas AgriLife; TVMDLs; Department of Veterinary Pathobiology, Texas A&M University, AgriLife grant [TEXV 6579, I-9524]	Texas AgriLife; TVMDLs; Department of Veterinary Pathobiology, Texas A&M University, AgriLife grant	This research was supported by grants from Texas AgriLife and TVMDLs seed grant to the project Improving diagnostic methods for Lyme disease, and epidemiology of human and animal infections in TX, and the Department of Veterinary Pathobiology, Texas A&M University, AgriLife grant TEXV 6579 (Project I-9524). The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Anderson JF, 2002, MED CLIN N AM, V86, P205, DOI 10.1016/S0025-7125(03)00083-X; Baneth G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1530-5; Boyle WK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002767; BREITSCHWERDT EB, 1994, J CLIN MICROBIOL, V32, P352, DOI 10.1128/JCM.32.2.352-357.1994; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Cutler SJ, 2015, CLIN LAB MED, V35, P847, DOI 10.1016/j.cll.2015.07.001; Davis H, 2002, PEDIATR INFECT DIS J, V21, P703, DOI 10.1097/00006454-200207000-00020; Donaldson TG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004383; Dworkin MS, 2008, INFECT DIS CLIN N AM, V22, P449, DOI 10.1016/j.idc.2008.03.006; Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273; Dworkin MS, 2002, AM J TROP MED HYG, V66, P753, DOI 10.4269/ajtmh.2002.66.753; Dworkin MS, 2002, MED CLIN N AM, V86, P417, DOI 10.1016/S0025-7125(03)00095-6; Forrester JD, 2015, MMWR-MORBID MORTAL W, V64, P58; Fotso AF, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00254; Fuchs I, 2015, VECTOR-BORNE ZOONOT, V15, P446, DOI 10.1089/vbz.2014.1764; Gaither M, 2016, J ENVIRON HEALTH, V78, P8; Halperin T, 2006, ACTA TROP, V98, P189, DOI 10.1016/j.actatropica.2006.04.004; Jones JM, 2015, MMWR-MORBID MORTAL W, V64, P651; Kelly AL, 2014, TICKS TICK-BORNE DIS, V5, P95, DOI 10.1016/j.ttbdis.2013.08.005; Krishnavajhala A, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02503-16; Lopez JE, 2014, J INFECT DIS, V210, P1639, DOI 10.1093/infdis/jiu306; Lopez JE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002454; Lopez JE, 2010, CLIN VACCINE IMMUNOL, V17, P564, DOI 10.1128/CVI.00518-09; Lopez-Alonso M., 2011, ENCY ENV HLTH, P454, DOI [10.1016/B978-0-444-52272-6.00593-6, DOI 10.1016/B978-0-444-52272-6.00593-6]; McGregor E, 2016, J VET SCI RES, V2; Piccione J, 2016, J VET INTERN MED, V30, P1222, DOI 10.1111/jvim.14363; Porcella SF, 2000, J CLIN MICROBIOL, V38, P3561, DOI 10.1128/JCM.38.10.3561-3571.2000; Prevention CfDCa, 1995, JAMA-J AM MED ASSOC, V274, P937; Schurer JM, 2014, AM J TROP MED HYG, V90, P1184, DOI 10.4269/ajtmh.13-0749; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Shang ES, 1997, J BACTERIOL, V179, P2238, DOI 10.1128/jb.179.7.2238-2246.1997; Shirani D, 2016, TICKS TICK-BORNE DIS, V7, P424, DOI 10.1016/j.ttbdis.2015.12.020; Smith FD, 2012, COMP IMMUNOL MICROB, V35, P163, DOI 10.1016/j.cimid.2011.12.009; Wagner B, 2012, PREV VET MED, V107, P275, DOI 10.1016/j.prevetmed.2012.07.002; Whitney MS, 2007, VET CLIN PATH, V36, P212, DOI 10.1111/j.1939-165X.2007.tb00213.x; Wilder HK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003617; Wodecka B, 2016, TICKS TICK-BORNE DIS, V7, P1010, DOI 10.1016/j.ttbdis.2016.05.008	37	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189786	10.1371/journal.pone.0189786	http://dx.doi.org/10.1371/journal.pone.0189786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232415	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200066
J	Liu, RX; Meng, QC; Zheng, F; Kong, LJ; Yuan, JH; Lubberstedt, T				Liu, Ruixiang; Meng, Qingchang; Zheng, Fei; Kong, Lingjie; Yuan, Jianhua; Lubberstedt, Thomas			Genetic mapping of QTL for maize leaf width combining RIL and IF2 populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ZEA-MAYS L.; ARCHITECTURE; LEAVES; PHOTOSYNTHESIS; METAANALYSIS; DISSECTION; TASSEL; YIELD; ANGLE	Leaf width is an important component of plant architecture that affects light capture during photosynthesis and wind circulation under dense planting conditions. To improve understanding of the genetic mechanisms involved in leaf width at different positions, a comprehensive evaluation using the RIL (Recombinant Inbred Line) and IF2 (Immortalized F-2) populations and a subsequent meta-analysis were performed. Forty-seven QTL associated with leaf width at different positions below the tassel were detected. The individual effects of QTL explained 3.5% to 17.0% of the observed phenotypic variation, and ten QTL explained over 10%. The initial QTL were integrated into eight mQTL (meta-QTL) through a meta-analysis. Our results suggested that leaf widths at different positions may be affected by several of the same mQTL and may also be regulated by many different mQTL. These results provide useful information for breeding high density tolerant inbred lines and hybrid cultivars, as well as for using marker-assisted selection for important mQTL.	[Liu, Ruixiang; Meng, Qingchang; Zheng, Fei; Kong, Lingjie; Yuan, Jianhua] Jiangsu Acad Agr Sci, Inst Food Crops, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China; [Lubberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA USA	Jiangsu Academy of Agricultural Sciences; Iowa State University	Yuan, JH (corresponding author), Jiangsu Acad Agr Sci, Inst Food Crops, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China.	yuanjh@jaas.ac.cn		Lubberstedt, Thomas/0000-0002-0526-0798	National Natural Science Foundation of China [3171444]; Jiangsu Academy of Agricultural Science and Technology Innovation Fund [CX(13)5003]; National Key Research and Development Program of China [2016YFD0101205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Academy of Agricultural Science and Technology Innovation Fund; National Key Research and Development Program of China	This work was financed by the National Natural Science Foundation of China (No.3171444), Jiangsu Academy of Agricultural Science and Technology Innovation Fund (CX(13)5003), and National Key Research and Development Program of China (2016YFD0101205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alam M F, 2004, J Zhejiang Univ Sci, V5, P406, DOI 10.1631/jzus.2004.0406; ARCADE A, 2005, BIOMERCATOR VERSION; Bauer P, 2004, PLANTA, V219, P359, DOI 10.1007/s00425-004-1233-6; Byrne ME, 2005, CURR OPIN PLANT BIOL, V8, P59, DOI 10.1016/j.pbi.2004.11.009; Cai HG, 2012, MOL BREEDING, V30, P251, DOI 10.1007/s11032-011-9615-5; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Goffinet B, 2000, GENETICS, V155, P463; Guo SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119095; Henderson DC, 2005, DEV BIOL, V282, P455, DOI 10.1016/j.ydbio.2005.03.027; Hou XB, 2015, EUPHYTICA, V205, P421, DOI 10.1007/s10681-015-1401-8; Hua JP, 2002, GENETICS, V162, P1885; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Ku LX, 2010, THEOR APPL GENET, V121, P951, DOI 10.1007/s00122-010-1364-z; Ku LX, 2012, PLANT BREEDING, V131, P591, DOI 10.1111/j.1439-0523.2012.01993.x; Li C, 2015, INT CONF INFO SCI, P10, DOI 10.1109/ICIST.2015.7288911; Li Y, 2011, CROP SCI, V51, P2391, DOI 10.2135/cropsci2011.03.0148; Ma DL, 2014, EUR J AGRON, V58, P1, DOI 10.1016/j.eja.2014.04.001; Meng L, 2015, CROP J; MOCK JJ, 1975, EUPHYTICA, V24, P613, DOI 10.1007/BF00132898; Moon J, 2011, CURR OPIN PLANT BIOL, V14, P24, DOI 10.1016/j.pbi.2010.08.012; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Pelleschi S, 2006, MOL BREEDING, V17, P21, DOI 10.1007/s11032-005-1031-2; Scanlon MJ, 2000, CURR OPIN PLANT BIOL, V3, P31, DOI 10.1016/S1369-5266(99)00040-0; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Timmermans MCP, 1998, DEVELOPMENT, V125, P2813; Tingting G, 2014, THEOR APPL GENET, V127; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Wang J., 2013, PLANT AN GEN 21 C PL; Wassom JJ, 2013, MAYDICA, V58, P318; Wei XM, 2016, PLANT BREEDING, V135, P671, DOI 10.1111/pbr.12422; Yang C, 2016, THEOR APPL GENET, V129, P2191, DOI 10.1007/s00122-016-2767-2; Yang N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004573	38	6	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189441	10.1371/journal.pone.0189441	http://dx.doi.org/10.1371/journal.pone.0189441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232707	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200044
J	McGowan, JE; Kratch, J; Chattopadhyay, S; Joe, B; Conti, HR; Chakravarti, R				McGowan, Jenna E.; Kratch, Jacqueline; Chattopadhyay, Saurabh; Joe, Bina; Conti, Heather R.; Chakravarti, Ritu			Bioinformatic analysis reveals new determinants of antigenic 14-3-3 proteins and a novel antifungal strategy	PLOS ONE			English	Article							CANDIDA; 14-3-3-PROTEINS; 14-3-3-EPSILON; EVOLUTION; ISOFORMS; MARKER; MODEL	The ubiquitously expressed 14-3-3 family of proteins is evolutionarily conserved from yeast to mammals. Their involvement in humoral and cellular immune responses is emerging through studies in drosophila and humans. In humans, a select group of 14-3-3 isoforms are antigenic; however the determinants of their antigenicity are not known. Here, we show that although mammalian 14-3-3 proteins are mostly conserved, subtle differences between their isoforms may give rise to their antigenicity. We observed syntenic relations among all the isoforms of 14-3-3 for mammals, but not with that of birds or amphibians. However, the parasitic 14-3-3 isoforms, which have known antigenic properties, show unique sequence, structure and evolution compared to the human 14-3-3. Moreover we report, for the first time the existence of a bacterial 14-3-3 protein. Contrary to the parasitic isoforms, both bacterial and yeast 14-3-3 exhibited significant homology with mammalian 14-3-3 in protein sequence as well as structure. Furthermore, a human 14-3-3 inhibitor caused significant killing of Candida albicans, which could be due to the inhibition of the structurally similar yeast homologue of 14-3-3, BMH, which is essential for its life cycle. Overall, our bioinformatic analysis combined with the demonstration of a novel antifungal role of a peptide inhibitor of human 14-3-3 indicates that the sequences and structural similarities between the mammalian, bacterial and fungal proteins are likely determinants of the antigenic nature of these proteins. Further, we propose that molecular mimicry triggered by microbial infections with either yeast or bacteria may contribute to the antigenic role of human 14-3-3.	[McGowan, Jenna E.; Chakravarti, Ritu] Univ Toledo, Dept Surg, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Kratch, Jacqueline; Conti, Heather R.] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Chattopadhyay, Saurabh] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Joe, Bina] Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Chakravarti, R (corresponding author), Univ Toledo, Dept Surg, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	ritu.chakravarti@utoledo.edu	Chakravarti, Ritu/K-8928-2019; Chattopadhyay, Saurabh/I-4091-2019	Chakravarti, Ritu/0000-0003-4680-8374; Chattopadhyay, Saurabh/0000-0002-2930-1523	Scientist Development Grant-American Heart Association [15SDG2308025]; Start Up Funds University of Toledo	Scientist Development Grant-American Heart Association; Start Up Funds University of Toledo	This work was supported by the Scientist Development Grant (15SDG2308025)-American Heart Association and the Start Up Funds University of Toledo. The funders had no role in study design, design, data collection and analysis, decision to publish or preparation of the manuscript.	Assossou O, 2004, FEMS MICROBIOL LETT, V234, P19, DOI 10.1111/j.1574-6968.2004.tb09508.x; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chakravarti R, 2015, ARTHRITIS RHEUMATOL, V67, P1913, DOI 10.1002/art.39130; Cognetti D, 2002, YEAST, V19, P55, DOI 10.1002/yea.804; Colucci M, 2004, MULT SCLER J, V10, P477, DOI 10.1191/1352458504MS1089OA; Conti HR, 2011, MUCOSAL IMMUNOL, V4, P448, DOI 10.1038/mi.2011.5; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duarte J, 2012, J INFECT DIS, V206, P1781, DOI 10.1093/infdis/jis595; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Foote Molly, 2012, Int J Biochem Mol Biol, V3, P152; Gilden D, 2016, J NEUROL SCI, V364, P141, DOI 10.1016/j.jns.2016.03.020; Grignetti M, 1995, Minerva Med, V86, P551; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hatzipetros I, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-79; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelly MN, 2009, MICROBIOL-SGM, V155, P1536, DOI 10.1099/mic.0.027532-0; Kilani RT, 2007, J RHEUMATOL, V34, P1650; Kistner A, 2017, RHEUMATOLOGY OXFORD; Kumamoto CA, 2011, CURR OPIN MICROBIOL, V14, P386, DOI 10.1016/j.mib.2011.07.015; Kumar R, 2017, EUR J CELL BIOL, V96, P206, DOI 10.1016/j.ejcb.2017.02.006; Lalle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078090; Lidar M, 2009, INFECT SEROLOGIES AU, V2200, P649; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Liu M, 2014, TUMOR BIOL, V35, P4247, DOI 10.1007/s13277-013-1555-8; Lottersberger F, 2003, GENETICS, V165, P1717; Lozano-Duran R, 2015, MOL PLANT MICROBE IN, V28, P511, DOI 10.1094/MPMI-10-14-0322-CR; LU G, 1993, J IMMUNOL, V150, P2823; Maksymowych WP, 2014, CLIN EXP RHEUMATOL, V32, pS35; Maksymowych WP, 2015, J RHEUMATOL, V42, P1587, DOI 10.3899/jrheum.141385; Mancini M, 2011, J PHARMACOL EXP THER, V336, P596, DOI 10.1124/jpet.110.172536; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Mohd Bakri M, 2010, J ORAL MICROBIOL, V2, DOI [10.3402/jom.v2i0.5780., DOI 10.3402/JOM.V2I0.5780]; Morassutti AL, 2012, VECTOR-BORNE ZOONOT, V12, P961, DOI 10.1089/vbz.2011.0957; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Parua PK, 2010, MOL CELL BIOL, V30, P5273, DOI 10.1128/MCB.00715-10; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Sammel AM, 2016, ANN RHEUM DIS, V75, P567, DOI 10.1136/annrheumdis-2016-eular.1318; Shandala T, 2011, J CELL SCI, V124, P2165, DOI 10.1242/jcs.080598; Siles-Lucas M, 2008, EXP PARASITOL, V119, P516, DOI 10.1016/j.exppara.2008.01.009; Slubowski CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113528; Tsai Hung-Chin, 2014, BMC Res Notes, V7, P97, DOI 10.1186/1756-0500-7-97; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Ulvila J, 2011, J LEUKOCYTE BIOL, V89, P649, DOI 10.1189/jlb.0410195; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Wang WF, 1996, J MOL EVOL, V43, P384; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189503	10.1371/journal.pone.0189503	http://dx.doi.org/10.1371/journal.pone.0189503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232712	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200053
J	Selakovic, D; Joksimovic, J; Zaletel, I; Puskas, N; Matovic, M; Rosic, G				Selakovic, Dragica; Joksimovic, Jovana; Zaletel, Ivan; Puskas, Nela; Matovic, Milovan; Rosic, Gvozden			The opposite effects of nandrolone decanoate and exercise on anxiety levels in rats may involve alterations in hippocampal parvalbumin-positive interneurons	PLOS ONE			English	Article							ANABOLIC-ANDROGENIC STEROIDS; ELEVATED PLUS-MAZE; SWIMMING EXERCISE; PHYSICAL-EXERCISE; OPEN-FIELD; TESTOSTERONE UNDECANOATE; PREFRONTAL CORTEX; ADOLESCENT USE; MESSENGER-RNA; DOPING AGENTS	The aim of this study was to evaluate the behavioral effects of chronic (six weeks) nandrolone decanoate (ND, 20 mg/kg, s.c., weekly in single dose) administration (in order to mimic heavy human abuse), and exercise (swimming protocol of 60 minutes a day, five days in a row/two days break), applied alone and simultaneously with ND, in male rats (n = 40). Also, we evaluated the effects of those protocols on hippocampal parvalbumin (PV) content and the possible connection between the alterations in certain parts of hippocampal GABAergic system and behavioral patterns. Both ND and exercise protocols induced increase in testosterone, dihydrotestosterone and estradiol blood levels. Our results confirmed anxiogenic effects of ND observed in open field (OF) test (decrease in the locomotor activity, as well as in frequency and cumulative duration in the centre zone) and in elevated plus maze (EPM) test (decrease in frequency and cumulative duration in open arms, and total exploratory activity), that were accompanied with a mild decrease in the number of PV interneurons in hippocampus. Chronic exercise protocol induced significant increase in hippocampal PV neurons (dentate gyrus and CA1 region), followed by anxiolytic-like behavioral changes, observed in both OF and EPM (increase in all estimated parameters), and in evoked beam walking test (increase in time to cross the beam), compared to ND treated animals. The applied dose of ND was sufficient to attenuate beneficial effects of exercise in rats by means of decreased exercise -induced anxiolytic effect, as well as to reverse exercise -induced augmentation in number of PV immunoreactive neurons in hippocampus. Our results implicate the possibility that alterations in hippocampal PV interneurons (i.e. GABAergic system) may be involved in modulation of anxiety level induced by ND abuse and/or extended exercise protocols.	[Selakovic, Dragica; Joksimovic, Jovana; Rosic, Gvozden] Univ Kragujevac, Dept Physiol, Fac Med Sci, Kragujevac, Serbia; [Zaletel, Ivan; Puskas, Nela] Univ Belgrade, Inst Histol & Embryol Aleksander D Kostic, Sch Med, Belgrade, Serbia; [Matovic, Milovan] Univ Kragujevac, Deparment Nucl Med, Fac Med Sci, Clin Ctr Kragujevac, Kragujevac, Serbia	University of Kragujevac; University of Belgrade; University of Kragujevac	Rosic, G (corresponding author), Univ Kragujevac, Dept Physiol, Fac Med Sci, Kragujevac, Serbia.	grosic@medf.kg.ac.rs	Zaletel, Ivan/O-4681-2016	Zaletel, Ivan/0000-0002-4841-788X; Rosic, Gvozden/0000-0003-2003-4358; Selakovic, Dragica/0000-0001-8264-2477	Faculty of Medical Sciences, University of Kragujevac, Serbia [JP 01/13]; Ministry of Education, Science, and Technological Development of Serbia [175061]	Faculty of Medical Sciences, University of Kragujevac, Serbia; Ministry of Education, Science, and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by Faculty of Medical Sciences, University of Kragujevac, Serbia (JP 01/13) and Ministry of Education, Science, and Technological Development of Serbia(Grant No 175061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAE, 2015, TOXICOL APPL PHARM, V282, P285, DOI 10.1016/j.taap.2014.12.007; Aksu I, 2012, NEUROSCI LETT, V531, P176, DOI 10.1016/j.neulet.2012.10.045; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; Bahrke MS, 1998, CHILD ADOL PSYCH CL, V7, P821, DOI 10.1016/S1056-4993(18)30214-1; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Bartholomew JB, 1998, J BEHAV MED, V21, P205, DOI 10.1023/A:1018732025340; Bento-Silva MT, 2010, BRAZ J PHARM SCI, V46, P79, DOI 10.1590/S1984-82502010000100009; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cunningham RL, 2007, NEUROSCIENCE, V150, P609, DOI 10.1016/j.neuroscience.2007.09.038; da Cruz Julia Niehues, 2012, Revista de Ciencias Farmaceuticas Basica e Aplicada, V33, P115; da Silva SG, 2010, BRAIN DEV-JPN, V32, P137, DOI 10.1016/j.braindev.2008.12.012; Dishman RK, 1996, PHYSIOL BEHAV, V60, P699; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dunn A L, 1991, Exerc Sport Sci Rev, V19, P41; Eilam R, 1999, HIPPOCAMPUS, V9, P534, DOI 10.1002/(SICI)1098-1063(1999)9:5<534::AID-HIPO7>3.0.CO;2-R; Fox KR, 1999, PUBLIC HEALTH NUTR, V2, P411, DOI 10.1017/S1368980099000567; Frankenfeld SP, 2014, J ENDOCRINOL, V220, P143, DOI 10.1530/JOE-13-0259; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Ghanbari-Niaki A, 2010, INT J ENDOCRINOL MET, V8, P147; Harley CW, 2000, HIPPOCAMPUS, V10, P693; Hassan AF, 2013, INT J HEALTH SCI-IJH, V7, P47, DOI 10.12816/0006020; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Heiderstadt KM, 2000, LAB ANIM, V34, P20, DOI 10.1258/002367700780578028; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Jannatifar R, 2015, INT J REPROD BIOMED, V13, P779; Joksimovic, 2014, SER J CLIN RES, V15, P129, DOI DOI 10.2478/SJECR-2014-0017; Joksimovic J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178922; Kalueff AV, 2004, ACTA NEUROBIOL EXP, V64, P439; Kindlundh AMS, 1999, ADDICTION, V94, P543, DOI 10.1046/j.1360-0443.1999.9445439.x; Kindlundh AMS, 2001, EUR J PUBLIC HEALTH, V11, P322, DOI 10.1093/eurpub/11.3.322; Kouvelas D, 2008, INT J NEUROPSYCHOPH, V11, P925, DOI 10.1017/S1461145708008754; Kurling S, 2005, BRAIN RES, V1044, P67, DOI 10.1016/j.brainres.2005.02.071; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Liu FF, 2016, MOL NEUROBIOL, V53, P6680, DOI 10.1007/s12035-015-9571-x; Liu X, 2010, NEUROSCI LETT, V476, P99, DOI 10.1016/j.neulet.2010.04.011; Long SF, 1996, PROG NEURO-PSYCHOPH, V20, P839, DOI 10.1016/0278-5846(96)00063-2; Lumia AR, 2010, PHYSIOL BEHAV, V100, P199, DOI 10.1016/j.physbeh.2010.01.007; Manna I, 2004, CAN J APPL PHYSIOL, V29, P172, DOI 10.1139/h04-013; Minerly AE, 2010, PHARMACOL BIOCHEM BE, V94, P404, DOI 10.1016/j.pbb.2009.10.001; MINKIN DM, 1993, PHARMACOL BIOCHEM BE, V44, P959, DOI 10.1016/0091-3057(93)90031-N; Nguyen JCD, 2013, BEHAV BRAIN RES, V256, P598, DOI 10.1016/j.bbr.2013.09.004; NILSSON S, 1995, EUR J CLIN PHARMACOL, V48, P9; Okamoto M, 2012, P NATL ACAD SCI USA, V109, P13100, DOI 10.1073/pnas.1210023109; Olivares EL, 2014, PHYSIOL BEHAV, V126, P15, DOI 10.1016/j.physbeh.2013.12.006; Pagonis TA, 2006, EUR PSYCHIAT, V21, P551, DOI 10.1016/j.eurpsy.2005.09.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pomara C, 2016, J CELL PHYSIOL, V231, P1385, DOI 10.1002/jcp.25272; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Purkayastha S., 2012, WORLD J LIFE SCI MED, V2, P123; Rainer Q, 2014, NEUROPHARMACOLOGY, V83, P79, DOI 10.1016/j.neuropharm.2014.03.015; Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006; Rosic G, 2014, NEUROENDOCRINOL LETT, V35, P703; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Shahraki M.R., 2015, INT J HIGH RISK BEHA, V4; Sjoqvist F, 2008, LANCET, V371, P1872, DOI 10.1016/S0140-6736(08)60801-6; Sugizaki MM, 2006, INT J CARDIOL, V112, P191, DOI 10.1016/j.ijcard.2005.08.039; Takahashi M, 2004, ENDOCR J, V51, P425, DOI 10.1507/endocrj.51.425; Trenton AJ, 2005, CNS DRUGS, V19, P571, DOI 10.2165/00023210-200519070-00002; Troakes C, 2009, STRESS, V12, P362, DOI 10.1080/10253890802506391; Woerdeman J, 2011, EXPERT OPIN INV DRUG, V20, P87, DOI 10.1517/13543784.2011.544651; Yau S. Y, 2013, NEUROSCI BEHAV HLTH, V5, P5; Zaletel I, 2016, REV NEUROSCIENCE, V27, P397, DOI 10.1515/revneuro-2015-0042; Zhang XW, 2016, ASIAN J ANDROL, V18, P791, DOI 10.4103/1008-682X.160886	70	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189595	10.1371/journal.pone.0189595	http://dx.doi.org/10.1371/journal.pone.0189595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232412	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200060
J	Choi, JW; Ku, Y; Yoo, BW; Kim, JA; Lee, DS; Chai, YJ; Kong, HJ; Kim, HC				Choi, Jin Woo; Ku, Yunseo; Yoo, Byeong Wook; Kim, Jung-Ah; Lee, Dong Soon; Chai, Young Jun; Kong, Hyoun-Joong; Kim, Hee Chan			White blood cell differential count of maturation stages in bone marrow smear using dual-stage convolutional neural networks	PLOS ONE			English	Article							PERFORMANCE EVALUATION; DM96 SYSTEM; CLASSIFICATION; DIAGNOSIS; CANCER	The white blood cell differential count of the bone marrow provides information concerning the distribution of immature and mature cells within maturation stages. The results of such examinations are important for the diagnosis of various diseases and for follow-up care after chemotherapy. However, manual, labor-intensive methods to determine the differential count lead to inter-and intra-variations among the results obtained by hematologists. Therefore, an automated system to conduct the white blood cell differential count is highly desirable, but several difficulties hinder progress. There are variations in the white blood cells of each maturation stage, small inter-class differences within each stage, and variations in images because of the different acquisition and staining processes. Moreover, a large number of classes need to be classified for bone marrow smear analysis, and the high density of touching cells in bone marrow smears renders difficult the segmentation of single cells, which is crucial to traditional image processing and machine learning. Few studies have attempted to discriminate bone marrow cells, and even these have either discriminated only a few classes or yielded insufficient performance. In this study, we propose an automated white blood cell differential counting system from bone marrow smear images using a dual-stage convolutional neural network (CNN). A total of 2,174 patch images were collected for training and testing. The dual-stage CNN classified images into 10 classes of the myeloid and erythroid maturation series, and achieved an accuracy of 97.06%, a precision of 97.13%, a recall of 97.06%, and an F-1 score of 97.1%. The proposed method not only showed high classification performance, but also successfully classified raw images without single cell segmentation and manual feature extraction by implementing CNN. Moreover, it demonstrated rotation and location invariance. These results highlight the promise of the proposed method as an automated white blood cell differential count system.	[Choi, Jin Woo; Ku, Yunseo; Yoo, Byeong Wook] Seoul Natl Univ, Grad Sch, Interdisciplinary Program Bioeng, Seoul, South Korea; [Kim, Jung-Ah; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Lab Med, Seoul, South Korea; [Chai, Young Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Surg, Seoul, South Korea; [Kong, Hyoun-Joong] Chungnam Natl Univ, Coll Med, Dept Biomed Engn, Daejeon, South Korea; [Kim, Hee Chan] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Kim, Hee Chan] Seoul Natl Univ Hosp, Dept Biomed Engn, Seoul, South Korea; [Kim, Hee Chan] Seoul Natl Univ, Inst Med & Biol Engn, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chungnam National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, HC (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.; Kim, HC (corresponding author), Seoul Natl Univ Hosp, Dept Biomed Engn, Seoul, South Korea.; Kim, HC (corresponding author), Seoul Natl Univ, Inst Med & Biol Engn, Med Res Ctr, Seoul, South Korea.	hckim@snu.ac.kr	Chai, Young/AAW-6684-2021	Kim, Hee Chan/0000-0002-2112-426X; Ku, Yunseo/0000-0003-2737-4427; Lee, Darrall/0000-0002-6990-4441; Kong, Hyoun-Joong/0000-0001-5456-4862	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT & Future Planning) [NRF-2016R1E1A1A01942072]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT & Future Planning)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT & Future Planning, NRF-2016R1E1A1A01942072, http://www.nrf.re.kr/index). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Albarqouni S, 2016, IEEE T MED IMAGING, V35, P1313, DOI 10.1109/TMI.2016.2528120; Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442; Beksac M, 1997, CYTOMETRY, V30, P145, DOI 10.1002/(SICI)1097-0320(19970615)30:3<145::AID-CYTO5>3.0.CO;2-K; Bene M-C, 2012, DIFFERENTIAL LEUKOCY, P33; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Boser B., 1992, P 5 ANN WORKSH COMP; Briggs C, 2009, INT J LAB HEMATOL, V31, P48, DOI 10.1111/j.1751-553X.2007.01002.x; Cheng JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24454; Codella N., 2016, ARXIV161004662; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; Cornet E, 2008, INT J LAB HEMATOL, V30, P536, DOI 10.1111/j.1751-553X.2007.00996.x; DEVET HCW, 1995, J CLIN EPIDEMIOL, V48, P869, DOI 10.1016/0895-4356(94)00225-F; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; He K., 2016, IEEE C COMPUTER VISI; Hengen H, MED IM 2002 INT SOC; Huang C., 2016, P IEEE C COMP VIS PA; Escalante HJ, 2012, ARTIF INTELL MED, V55, P163, DOI 10.1016/j.artmed.2012.03.005; Kainz P, 2016, NEURAL COMPUT APPL, P1; Kaur M, 2014, J CLIN DIAGN RES, V8, pFC13, DOI 10.7860/JCDR/2014/9823.4760; Kim J, 2017, HEALTHC INFORM RES, V23, P169, DOI 10.4258/hir.2017.23.3.169; Kim KG, 2016, HEALTHC INFORM RES, V22, P351, DOI 10.4258/hir.2016.22.4.351; Kratz A, 2005, AM J CLIN PATHOL, V124, P770, DOI 10.1309/XMB9K0J41LHLATAY; Krizhevsky A., 2012, NEURIPS, P1106; Lee Lik Hang, 2013, J Pathol Inform, V4, P14, DOI 10.4103/2153-3539.114205; Mikolov T., 2010, P 11 ANN C INT SPEEC; Mohammed Emad A, 2014, J Pathol Inform, V5, P9, DOI 10.4103/2153-3539.129442; Osowski S, 2007, KERNEL METHODS IN BIOENGINEERING, SIGNAL AND IMAGE PROCESSING, P93; Osowski S, 2009, IEEE T INSTRUM MEAS, V58, P2159, DOI 10.1109/TIM.2008.2006726; Pan C, 2012, EXPERT SYST APPL, V39, P7479, DOI 10.1016/j.eswa.2012.01.114; Rao P, 2016, CONT COMP INF IC3I 2; Reta C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130805; Sermanet P., 2013, P IEEE C COMP VIS PA; SIMONYAN K, 2015, COMPUTER SCI; Simonyan K, 2014, ARXIV14062199CS; Siroic R, 2007, INSTR MEAS TECHN C P; Sjostrom PJ, 1999, ARTIFICIAL NEURAL NE, P18; Song SH, 2017, HEALTHC INFORM RES, V23, P285, DOI 10.4258/hir.2017.23.4.285; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Staroszczyk T, 2012, INT WORKSH MACH LEAR; Theera-Umpon N, 2005, INT C FUZZ SYST KNOW; Theera-Umpon N, 2000, PATT REC 2000 P 15 I; Theera-Umpon N, 2007, IEEE T INF TECHNOL B, V11, P353, DOI 10.1109/TITB.2007.892694; Wang HB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034003; Wei Y., 2014, ARXIV PREPRINT ARXIV; Zheng X, 2011, IM SIGN PROC CISP 20; Zheng X, 2011, BIOM ENG INF BMEI 20	49	39	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189259	10.1371/journal.pone.0189259	http://dx.doi.org/10.1371/journal.pone.0189259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228051	Green Published, gold			2022-12-26	WOS:000417648600040
J	Hanemoto, T; Hikichi, Y; Kikuchi, N; Kozawa, T				Hanemoto, Tsukasa; Hikichi, Yusuke; Kikuchi, Norimasa; Kozawa, Tadahiko			The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting	PLOS ONE			English	Article							INTRAVITREAL AFLIBERCEPT INJECTION; DISEASE BURDEN; RANIBIZUMAB; PREVALENCE; OUTCOMES	Objective To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. Methods Single-center, cross-sectional survey of caregivers of patients with wAMD performed in a hospital in Mito-City, a rural area in Japan. Caregiver burden was evaluated using the Burden Index of Caregivers (BIC-11), and depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale. Retrospective medical chart review was conducted to monitor resource use and visual acuity outcomes in patients. The productivity loss of caregivers accompanying patients on hospital visits was estimated using the human capital method. Results Seventy-one patient-caregiver pairs were included. Most caregivers were female (74.6%), spouse/partner (54.9%), employed (46.5%), and the primary caregiver (85.9%). Patients received anti-VEGF treatment as follows: treat-and-extend (T & E; n = 42), switch (from as-needed [PRN] to T & E; n = 18), PRN (n = 10), and other (n = 1). Caregiver-related burden (total BIC-11 scores) were 4.29 (T&E) 4.60 (PRN), and 5.33 (switch) (p = NS). The mean number of hospital visits was lower with T&E than PRN (7.88 vs. 14.0 [p = 0.00674] in year 1 and 5.68 vs. 9.0 in year 2). For patients who switched from PRN to T&E, the mean number of hospital visits decreased from 13.21 to 7.43 (p<0.0001) in the first year after switch. The productivity loss associated with accompanying patients to the hospital was lower for caregivers of patients receiving T&E than PRN (mean differences: 74,456.04 JPY [p = 0.00284] in year 1 and 40843.14 JPY in year 2), and was also reduced for caregivers of patients who switched from PRN to T&E. Conclusion wAMD treatment with anti-VEGF agents via T&E reduced hospital visits compared with PRN, where associated monitoring visits are necessary to provide good patient outcomes. T&E was associated with a reduction trend in caregiver burden, including time and costs.	[Hanemoto, Tsukasa; Kozawa, Tadahiko] Kozawa Eye Hosp, Dept Ophthalmol, Ibaraki, Japan; [Hikichi, Yusuke] Bayer Yakuhin Ltd, Market Access Hlth Econ & Outcomes Res, Tokyo, Japan; [Kikuchi, Norimasa] Clinical Study Support Inc, CR Div, Nagoya, Aichi, Japan	Bayer AG	Hanemoto, T (corresponding author), Kozawa Eye Hosp, Dept Ophthalmol, Ibaraki, Japan.	hanemoto@tb3.so-net.ne.jp		Hikichi, Yusuke/0000-0002-1699-6821; Hanemoto, Tsukasa/0000-0002-2444-4234	Bayer Yakuhin, Ltd.; Clinical Study Support, Inc.; Bayer Pharmaceuticals	Bayer Yakuhin, Ltd.; Clinical Study Support, Inc.; Bayer Pharmaceuticals(Bayer AG)	This study was funded by Bayer Yakuhin, Ltd. The funder provided support in the form of salary for YH, and was involved in the study design, data collection, data analysis, decision to publish, and preparation of the manuscript. Clinical Study Support, Inc., was contracted by Bayer Yakuhin, Ltd, and provided support in the form of salary for NK, and was involved in data collection and data analysis.; Medical writing assistance was provided by PAREXEL and was funded by Bayer Pharmaceuticals.	Berg K, 2015, OPHTHALMOLOGY, V122, P146, DOI 10.1016/j.ophtha.2014.07.041; Braich PS, 2012, OPHTHALMOLOGY, V119, P221, DOI 10.1016/j.ophtha.2011.07.038; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chin-Yee D, 2016, BRIT J OPHTHALMOL, V100, P914, DOI 10.1136/bjophthalmol-2015-306987; Dilokthornsakul P, 2014, INT J OPHTHALMOL-CHI, V7, P145, DOI 10.3980/j.issn.2222-3959.2014.01.27; Forbes A, 2007, CLIN REHABIL, V21, P563, DOI 10.1177/0269215507075035; Giannakaki-Zimmermann H, 2016, OPHTHALMOLOGICA, V236, P201, DOI 10.1159/000452929; Gohil R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129361; Gopinath B, 2015, AGING MENT HEALTH, V19, P239, DOI 10.1080/13607863.2014.924477; Hanemoto T., 2013, 67 ANN C JAP CLIN OP; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Ministry of Health Labour and Welfare and Ministry of Education Culture Sports Science and Technology, 2015, CULT SPORTS SCI TECH; Miyashita M, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-52; Ogura Y, 2015, BRIT J OPHTHALMOL, V99, P92, DOI 10.1136/bjophthalmol-2014-305076; Ohnaka M, 2016, GRAEFES ARCH CLIN EX; Prenner JL, 2015, AM J OPHTHALMOL, V160, P725, DOI 10.1016/j.ajo.2015.06.023; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Varano M, 2016, CLIN OPHTHALMOL, V10, P257, DOI 10.2147/OPTH.S92616; Varano M, 2015, CLIN OPHTHALMOL, V9, P2243, DOI 10.2147/OPTH.S92548; Vukicevic M, 2016, EYE, V30, P413, DOI 10.1038/eye.2015.235; Weyer-Wendl H, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0116-4; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; World Health Organization, ICD 10 VERS 2016 VIS; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017	29	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189035	10.1371/journal.pone.0189035	http://dx.doi.org/10.1371/journal.pone.0189035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220371	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900028
J	Wei, L; Chen, G; Yang, ZF; Yu, T; Quan, WL; Li, YQ				Wei, Liang; Chen, Gang; Yang, Zhengfei; Yu, Tao; Quan, Weilun; Li, Yongqin			Detection of spontaneous pulse using the acceleration signals acquired from CPR feedback sensor in a porcine model of cardiac arrest	PLOS ONE			English	Article							CHEST COMPRESSION; CARDIOPULMONARY-RESUSCITATION; CAROTID PULSE; DIAGNOSTIC-ACCURACY; LIFE-SUPPORT; SWINE MODEL; QUALITY; DEFIBRILLATION; IMPEDANCE; CHECK	Background Reliable detection of return of spontaneous circulation with minimal interruptions of chest compressions is part of high-quality cardiopulmonary resuscitation (CPR) and routinely done by checking pulsation of carotid arteries. However, manual palpation was time-consuming and unreliable even if performed by expert clinicians. Therefore, automated accurate pulse detection with minimal interruptions of chest compression is highly desirable during cardiac arrest especially in out-of-hospital settings. Objective To investigate whether the acceleration (ACC) signals acquired from accelerometer-based CPR feedback sensor can be used to distinguish perfusing rhythm (PR) from pulseless electrical activity (PEA) in a porcine model of cardiac arrest. Methods Cardiac arrest was induced in 49 male adult pigs. ECG, arterial blood pressure (ABP) and ACC waveforms were simultaneously recorded during CPR. 3-second segments containing compression-free signals during chest compression pauses were extracted and only those segments with organized rhythm were used for analysis. PR was defined as systolic arterial pressure > 60 mmHg and pulse pressure > 10 mmHg, while PEA was defined as an organized rhythm that does not meet the above criteria for PR. Peak correlation coefficient (CCp) of the cross-correlation function between pre-processed ECG and ACC, was used to discriminate PR and PEA. Results 63 PR and 153 PEA were identified from the total of 1025 extracted segments. CCp was significantly higher for PR as compared to PEA (0.440 +/- 0.176 vs. 0.067 +/- 0.042, p<0.01) and highly correlated with ABP (r = 0.848, p<0.001). The area under the receiver operating characteristic curve, sensitivity, specificity and accuracy were 0.965, 93.6%, 97.5% and 96.7% for the ACC-based automatic spontaneous pulse detection. Conclusions In this animal model, the ACC signals acquired from an accelerometer-based CPR feedback sensor can be used to detect the presence of spontaneous pulse with high accuracy.	[Wei, Liang; Chen, Gang; Li, Yongqin] Third Mil Med Univ, Sch Biomed Engn, Chongqing, Peoples R China; [Yang, Zhengfei; Yu, Tao] Sun Yat Sen Univ, Emergency Dept, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Quan, Weilun] ZOLL Med Corp, Chelmsford, MA USA	Army Medical University; Sun Yat Sen University	Li, YQ (corresponding author), Third Mil Med Univ, Sch Biomed Engn, Chongqing, Peoples R China.; Yu, T (corresponding author), Sun Yat Sen Univ, Emergency Dept, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China.	dryutao@yeah.net; leeoken@gmail.com		yu, tao/0000-0001-5012-9353	Natural Science Foundation Project of Chongqing [cstc2017jcyjBX0053]; ZOLL Medical Corporation	Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); ZOLL Medical Corporation	This work was supported by Natural Science Foundation Project of Chongqing (cstc2017jcyjBX0053), http.//xmgl.cstc.gov.cn. The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ZOLL Medical Corporation provided support in the form of a salary for author WQ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aase SO, 2002, IEEE T BIO-MED ENG, V49, P263, DOI 10.1109/10.983461; Alonso E, 2016, RESUSCITATION, V99, P56, DOI 10.1016/j.resuscitation.2015.11.014; Ayala U, 2014, RESUSCITATION, V85, P957, DOI 10.1016/j.resuscitation.2014.04.007; Babbs CF, 2008, RESUSCITATION, V77, P306, DOI 10.1016/j.resuscitation.2007.12.018; Boussen S, 2016, MED ENG PHYS, V38, P1028, DOI 10.1016/j.medengphy.2016.05.001; Brouwer TF, 2015, CIRCULATION, V132, P1030, DOI 10.1161/CIRCULATIONAHA.115.014016; Cecchin F, 2001, CIRCULATION, V103, P2483; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Eberle B, 1996, RESUSCITATION, V33, P107, DOI 10.1016/S0300-9572(96)01016-7; Graham CA, 2002, RESUSCITATION, V53, P37, DOI 10.1016/S0300-9572(01)00487-7; Heradstveit BE, 2012, RESUSCITATION, V83, P813, DOI 10.1016/j.resuscitation.2012.02.021; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Larabee TM, 2008, RESUSCITATION, V78, P196, DOI 10.1016/j.resuscitation.2008.03.011; Larabee TM, 2011, AM J EMERG MED, V29, P1141, DOI 10.1016/j.ajem.2010.05.013; Lundin M, 1999, WORLD J SURG, V23, P252, DOI 10.1007/PL00013177; Moule P, 2000, RESUSCITATION, V44, P195, DOI 10.1016/S0300-9572(00)00139-8; Ochoa FJ, 1998, RESUSCITATION, V37, P173, DOI 10.1016/S0300-9572(98)00055-0; Oh J, 2012, RESUSCITATION, V83, P500, DOI 10.1016/j.resuscitation.2011.09.028; PARADIS NA, 1992, CHEST, V101, P123, DOI 10.1378/chest.101.1.123; Paradis NA, 2012, RESUSCITATION, V83, P1287, DOI 10.1016/j.resuscitation.2012.02.016; Pokorna M, 2010, J EMERG MED, V38, P614, DOI 10.1016/j.jemermed.2009.04.064; Poon KM, 2016, RESUSCITATION, V102, P80, DOI 10.1016/j.resuscitation.2016.02.021; Rad AB, 2016, RESUSCITATION, V102, P44, DOI 10.1016/j.resuscitation.2016.01.015; Reynolds JC, 2013, RESUSCITATION, V84, P843, DOI 10.1016/j.resuscitation.2012.11.031; RIVERS EP, 1993, CRIT CARE MED, V21, P878, DOI 10.1097/00003246-199306000-00016; de Gauna SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150139; Ruiz J, 2013, RESUSCITATION, V84, P1345, DOI 10.1016/j.resuscitation.2013.05.020; Ruiz J, 2013, RESUSCITATION, V84, P1223, DOI 10.1016/j.resuscitation.2013.01.034; SEDGWICK ML, 1992, RESUSCITATION, V24, P73, DOI 10.1016/0300-9572(92)90175-C; Soar J, 2015, RESUSCITATION, V95, pE71, DOI 10.1016/j.resuscitation.2015.07.042; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Tibballs J, 2009, RESUSCITATION, V80, P61, DOI 10.1016/j.resuscitation.2008.10.002; Valenzuela TD, 2005, CIRCULATION, V112, P1259, DOI 10.1161/CIRCULATIONAHA.105.537282; Wijshoff RWCGR, 2013, RESUSCITATION, V84, P1625, DOI 10.1016/j.resuscitation.2013.07.019; Yu T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/279192; Yu T, 2010, CRIT CARE MED, V38, P916, DOI 10.1097/CCM.0b013e3181cd1291; Zhang HH, 2012, RESUSCITATION, V83, P1281, DOI 10.1016/j.resuscitation.2012.07.016	37	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189217	10.1371/journal.pone.0189217	http://dx.doi.org/10.1371/journal.pone.0189217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220414	Green Submitted, Green Published, gold			2022-12-26	WOS:000417469900041
J	Brittin, J; Frerichs, L; Sirard, JR; Wells, NM; Myers, BM; Garcia, J; Sorensen, D; Trowbridge, MJ; Huang, T				Brittin, Jeri; Frerichs, Leah; Sirard, John R.; Wells, Nancy M.; Myers, Beth M.; Garcia, Jeanette; Sorensen, Dina; Trowbridge, Matthew J.; Huang, Terry			Impacts of active school design on school-time sedentary behavior and physical activity: A pilot natural experiment	PLOS ONE			English	Article							CHILDREN; MODERATE; HEALTH; ADOLESCENTS; INDICATORS; OBESITY; GENDER; RECESS; AGE	Background Children spend a significant portion of their days in sedentary behavior (SB) and on average fail to engage in adequate physical activity (PA). The school built environment may influence SB and PA, but research is limited. This natural experiment evaluated whether an elementary school designed to promote movement impacted students' school-time SB and PA. Methods Accelerometers measured SB and PA at pre and post time-points in an intervention group who moved to the new school (n = 21) and in a comparison group experiencing no school environmental change (n = 20). Difference-in-difference (DD) analysis examined SB and PA outcomes in these groups. Measures were also collected post-intervention from an independent, grade-matched group of students in the new school (n = 21). Results As expected, maturational increases in SB were observed. However, DD analysis estimated that the intervention attenuated increase in SB by 81.2 +/- 11.4 minutes/day (p<0.001), controlling for time in moderate to vigorous physical activity (MVPA). The intervention was also estimated to increase daily number of breaks from SB by 23.4 +/- 2.6 (p<.001) and to increase light physical activity (LPA) by 67.7 +/- 10.7 minutes/day (p<0.001). However, the intervention decreased MVPA by 10.3 +/- 2.3 minutes/day (p<0.001). Results of gradematched independent samples analysis were similar, with students in the new vs. old school spending 90.5 +/- 16.1 fewer minutes/day in SB, taking 21.1 +/- 2.7 more breaks from SB (p<0.001), and spending 64.5 +/- 14.8 more minutes in LPA (p<0.001), controlling for time in MVPA. Students in the new school spent 13.1 +/- 2.7 fewer minutes in MVPA (p<0.001) than their counterparts in the old school. Conclusions This pilot study found that active school design had beneficial effects on SB and LPA, but not on MVPA. Mixed results point to a need for active classroom design strategies to mitigate SB, and quick access from classrooms to areas permissive of high-intensity activities to promote MVPA. Integrating active design with programs/policies to promote PA may yield greatest impact on PA of all intensities.	[Brittin, Jeri] HDR, Dept Built Environm Res, Omaha, NE 68114 USA; [Brittin, Jeri] Univ Nebraska, Coll Architecture, Dept Interior Design, Lincoln, NE 68588 USA; [Frerichs, Leah] Univ North Carolina Chapel Hill, Sch Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Sirard, John R.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Kinesiol, Amherst, MA 01003 USA; [Wells, Nancy M.; Myers, Beth M.] Cornell Univ, Coll Human Ecol, Dept Design & Environm Anal, Ithaca, NY USA; [Garcia, Jeanette] Univ Cent Florida, Coll Educ & Human Sci, Dept Educ & Human Serv, Orlando, FL 32816 USA; [Sorensen, Dina] VMDO Architects, Charlottesville, VA USA; [Trowbridge, Matthew J.] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA; [Huang, Terry] CUNY, Grad Ctr, Sch Publ Hlth, New York, NY USA	University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Massachusetts System; University of Massachusetts Amherst; Cornell University; State University System of Florida; University of Central Florida; University of Virginia; City University of New York (CUNY) System	Brittin, J (corresponding author), HDR, Dept Built Environm Res, Omaha, NE 68114 USA.; Brittin, J (corresponding author), Univ Nebraska, Coll Architecture, Dept Interior Design, Lincoln, NE 68588 USA.	jeri.brittin@hdrinc.com	Brittin, Jeri/P-3780-2019	Brittin, Jeri/0000-0002-1316-6451; Huang, Terry/0000-0001-5544-5187	Youth-Nex, Center to Promote Effective Youth Development at the University of Virginia; Robert Wood Johnson Foundation [69550]; U.S. Department of Agriculture (USDA) through the Food & Nutrition Service (FNS) People's Garden pilot program [CN-CGP-11-0047]; Cornell University Agricultural Experiment Station [NYC-327-465]; Cornell Cooperative Extension (Smith Lever funds) through the National Institutes for Food and Agriculture (NIFA) USDA; Cornell University's Atkinson Center for a Sustainable Future (ACSF); College of Human Ecology, Cornell University; Bronfenbrenner Center for Translational Research (BCTR), Cornell University; Cornell Cooperative Extension Summer Intern Program; HDR; VMDO	Youth-Nex, Center to Promote Effective Youth Development at the University of Virginia; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); U.S. Department of Agriculture (USDA) through the Food & Nutrition Service (FNS) People's Garden pilot program; Cornell University Agricultural Experiment Station; Cornell Cooperative Extension (Smith Lever funds) through the National Institutes for Food and Agriculture (NIFA) USDA; Cornell University's Atkinson Center for a Sustainable Future (ACSF); College of Human Ecology, Cornell University; Bronfenbrenner Center for Translational Research (BCTR), Cornell University; Cornell Cooperative Extension Summer Intern Program; HDR; VMDO	The work in Virginia was partially supported by funding from Youth-Nex, the Center to Promote Effective Youth Development at the University of Virginia (co-Pls: Huang and Trowbridge). The New York data collection (PI: Wells) was funded in part by the Robert Wood Johnson Foundation through its Active Living Research Program (#69550). Federal funding was provided by the U.S. Department of Agriculture (USDA) through the Food & Nutrition Service (FNS) People's Garden pilot program (Project #CN-CGP-11-0047) and by the Cornell University Agricultural Experiment Station (Hatch funds) (#NYC-327-465) and Cornell Cooperative Extension (Smith Lever funds) through the National Institutes for Food and Agriculture (NIFA) USDA. Additional funding for the New York data came from: Cornell University's Atkinson Center for a Sustainable Future (ACSF); The College of Human Ecology, Cornell University; The Bronfenbrenner Center for Translational Research (BCTR), Cornell University; and the Cornell Cooperative Extension Summer Intern Program. Funding organizations played no role in the design, implementation, or publication of this study. HDR and VMDO provided support in the form of salaries for JB and DS, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121238; Allison KR, 2007, CAN J PUBLIC HEALTH, V98, P97, DOI 10.1007/BF03404317; Anderson PM, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0001; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Brittin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132597; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Carlson JA, 2015, PREV MED, V81, P67, DOI 10.1016/j.ypmed.2015.08.006; Cliff DP, 2016, OBES REV, V17, P330, DOI 10.1111/obr.12371; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; Cradock AL, 2007, AM J PREV MED, V33, P106, DOI 10.1016/j.amepre.2007.04.009; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Francis SL, 2013, MED SCI SPORT EXER, V45, P1508, DOI 10.1249/MSS.0b013e31828b2f3a; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4483-5; Hinckson E, 2016, SPORTS MED, V46, P977, DOI 10.1007/s40279-015-0436-2; Huang TTK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120084; KLESGES RC, 1990, HEALTH PSYCHOL, V9, P435, DOI 10.1037/0278-6133.9.4.435; Kohl HW., 2013, ED STUD BOD TAK PHYS; Kwon S, 2013, J PEDIATR-US, V162, P1169, DOI 10.1016/j.jpeds.2012.11.071; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, pA1, DOI DOI 10.1111/J.1753-4887.2008.00136.X; Pindus DM, 2014, INT J BEHAV MED, V21, P757, DOI 10.1007/s12529-013-9344-8; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Skala KA, 2012, J PHYS ACT HEALTH, V9, P481, DOI 10.1123/jpah.9.4.481; Stratton G, 2005, PREV MED, V41, P828, DOI 10.1016/j.ypmed.2005.07.009; Suchert V, 2015, PREV MED, V76, P48, DOI 10.1016/j.ypmed.2015.03.026; Toftager M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099369; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Ekris E, 2016, OBES REV, V17, P833, DOI 10.1111/obr.12426; Wells NM, 2014, PREV MED, V69, pS27, DOI 10.1016/j.ypmed.2014.10.012	40	14	15	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189236	10.1371/journal.pone.0189236	http://dx.doi.org/10.1371/journal.pone.0189236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216300	Green Published, gold			2022-12-26	WOS:000417337800104
J	Sikora, AE; Wierzbicki, IH; Zielke, RA; Ryner, RF; Korotkov, KV; Buchanan, SK; Noinaj, N				Sikora, Aleksandra E.; Wierzbicki, Igor H.; Zielke, Ryszard A.; Ryner, Rachael F.; Korotkov, Konstantin V.; Buchanan, Susan K.; Noinaj, Nicholas			Structural and functional insights into the role of BamD and BamE within the beta-barrel assembly machinery in Neisseria gonorrhoeae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BAM complex; BamD; BamE; cell envelope; Neisseria gonorrhoeae	OUTER-MEMBRANE LIPOPROTEIN; CRYSTAL-STRUCTURE; CELL-ENVELOPE; ESSENTIAL COMPONENT; YAET COMPLEX; PROTEIN; BIOGENESIS; SYSTEM; DOMAIN; SMPA	The -barrel assembly machinery (BAM) is a conserved multicomponent protein complex responsible for the biogenesis of -barrel outer membrane proteins (OMPs) in Gram-negative bacteria. Given its role in the production of OMPs for survival and pathogenesis, BAM represents an attractive target for the development of therapeutic interventions, including drugs and vaccines against multidrug-resistant bacteria such as Neisseria gonorrhoeae. The first structure of BamA, the central component of BAM, was from N. gonorrhoeae, the etiological agent of the sexually transmitted disease gonorrhea. To aid in pharmaceutical targeting of BAM, we expanded our studies to BamD and BamE within BAM of this clinically relevant human pathogen. We found that the presence of BamD, but not BamE, is essential for gonococcal viability. However, BamE, but not BamD, was cell-surface-displayed under native conditions; however, in the absence of BamE, BamD indeed becomes surface-exposed. Loss of BamE altered cell envelope composition, leading to slower growth and an increase in both antibiotic susceptibility and formation of membrane vesicles containing greater amounts of vaccine antigens. Both BamD and BamE are expressed in diverse gonococcal isolates, under host-relevant conditions, and throughout different phases of growth. The solved structures of Neisseria BamD and BamE share overall folds with Escherichia coli proteins but contain differences that may be important for function. Together, these studies highlight that, although BAM is conserved across Gram-negative bacteria, structural and functional differences do exist across species, which may be leveraged in the development of species-specific therapeutics in the effort to combat multidrug resistance.	[Sikora, Aleksandra E.; Wierzbicki, Igor H.; Zielke, Ryszard A.; Ryner, Rachael F.] Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97330 USA; [Korotkov, Konstantin V.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Buchanan, Susan K.] NIDDK, NIH, Bethesda, MD 20892 USA; [Noinaj, Nicholas] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Noinaj, Nicholas] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Oregon State University; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sikora, AE (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97330 USA.; Noinaj, N (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.; Noinaj, N (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	aleksandra.sikora@oregonstate.edu; nnoinaj@purdue.edu	Sikora, Aleksandra E/HGD-6641-2022	Korotkov, Konstantin/0000-0002-2182-6843	NIAID, National Institutes of Health [R01-AI117235]; Intramural Research Program of the NIDDK, National Institutes of Health; Department of Biological Sciences at Purdue University; Showalter Trust Award; NIAID, National Institutes of Health Grant [1K22AI113078-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI113078, R01AI117235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the NIDDK, National Institutes of Health; Department of Biological Sciences at Purdue University; Showalter Trust Award; NIAID, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIAID, National Institutes of Health Grant R01-AI117235. To whom correspondence may be addressed. E-mail: aleksandra.sikora@oregonstate.edu.; Supported by the Intramural Research Program of the NIDDK, National Institutes of Health.; Supported by the Department of Biological Sciences at Purdue University, a Showalter Trust Award, and NIAID, National Institutes of Health Grant 1K22AI113078-01. To whom correspondence may be addressed. E-mail: nnoinaj@purdue.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Baarda BI, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00037-17; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bergal HT, 2016, STRUCTURE, V24, P243, DOI 10.1016/j.str.2015.10.030; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONNELL TD, 1988, MOL MICROBIOL, V2, P227, DOI 10.1111/j.1365-2958.1988.tb00024.x; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Jansen KB, 2015, J BIOL CHEM, V290, P2126, DOI 10.1074/jbc.M114.584524; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jongerius I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003528; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lewis C, 2008, MICROBIOL-SGM, V154, P979, DOI 10.1099/mic.0.2007/011999-0; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mehr IJ, 2000, GENETICS, V154, P523; MENARD R, 1993, J BACTERIOL, V175, P5899; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; O'Neil PK, 2015, BIOCHEMISTRY-US, V54, P6303, DOI 10.1021/acs.biochem.5b00852; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BR, 2015, J BACTERIOL, V197, P1051, DOI 10.1128/JB.02329-14; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2012, J BACTERIOL, V194, P1002, DOI 10.1128/JB.06426-11; Roier S, 2016, MICROB CELL, V3, P257, DOI 10.15698/mic2016.06.508; Rollauer SE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0023; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ryan KR, 2010, MICROBIOL-SGM, V156, P742, DOI 10.1099/mic.0.035055-0; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Spence J. M., 2008, CURR PROTOC MICROBIO, DOI [10. 1002/9780471729259. mc04a01s8 18770539, DOI 10.1002/9780471729259.MC04A01S818770539]; Unemo M, 2015, SEX TRANSM INFECT, V91, pA111, DOI 10.1136/sextrans-2015-052270.295; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007; Webb CT, 2012, J MOL BIOL, V422, P545, DOI 10.1016/j.jmb.2012.05.035; Wierzbicki IH, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.432; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zielke R. A., 2014, CURR PROTOC MICROBIO, V34, DOI [10. 1002/9780471729259. mc04a03s34 25082007, DOI 10.1002/9780471729259.MC04A03S3425082007]; Zielke RA, 2016, MOL CELL PROTEOMICS, V15, P2338, DOI 10.1074/mcp.M116.058800; Zielke RA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0453-1; Zielke RA, 2014, MOL CELL PROTEOMICS, V13, P1299, DOI 10.1074/mcp.M113.029538	77	23	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1106	1119		10.1074/jbc.RA117.000437	http://dx.doi.org/10.1074/jbc.RA117.000437			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29229778	Green Published, hybrid			2022-12-26	WOS:000423515000001
J	Welty, S; Teng, YQ; Liang, ZB; Zhao, WX; Sanders, LH; Greenamyre, JT; Rubio, ME; Thathiah, A; Kodali, R; Wetzel, R; Levine, AS; Lan, L				Welty, Starr; Teng, Yaqun; Liang, Zhuobin; Zhao, Weixing; Sanders, Laurie H.; Greenamyre, J. Timothy; Rubio, Maria Eulalia; Thathiah, Amantha; Kodali, Ravindra; Wetzel, Ronald; Levine, Arthur S.; Lan, Li			RAD52 is required for RNA-templated recombination repair in post-mitotic neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; amyloid (A); neuron; recombination; RNA; oxidative damage	DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA-DAMAGE; ATM GENE; NEUROGENESIS; ANTIOXIDANTS; PROTEIN; CANCER; RISK	It has been long assumed that post-mitotic neurons only utilize the error-prone non-homologous end-joining pathway to repair double-strand breaks (DSBs) associated with oxidative damage to DNA, given the inability of non-replicating neuronal DNA to utilize a sister chromatid template in the less error-prone homologous recombination (HR) repair pathway. However, we and others have found recently that active transcription triggers a replication-independent recombinational repair mechanism in G(0)/G(1) phase of the cell cycle. Here we observed that the HR repair protein RAD52 is recruited to sites of DNA DSBs in terminally differentiated, post-mitotic neurons. This recruitment is dependent on the presence of a nascent mRNA generated during active transcription, providing evidence that an RNA-templated HR repair mechanism exists in non-dividing, terminally differentiated neurons. This recruitment of RAD52 in neurons is decreased by transcription inhibition. Importantly, we found that high concentrations of amyloid , a toxic protein associated with Alzheimer's disease, inhibits the expression and DNA damage response of RAD52, potentially leading to a defect in the error-free, RNA-templated HR repair mechanism. This study shows a novel RNA-dependent repair mechanism of DSBs in post-mitotic neurons and demonstrates that defects in this pathway may contribute to neuronal genomic instability and consequent neurodegenerative phenotypes such as those seen in Alzheimer's disease.	[Welty, Starr; Teng, Yaqun; Levine, Arthur S.; Lan, Li] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA; [Welty, Starr; Teng, Yaqun; Levine, Arthur S.; Lan, Li] UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Teng, Yaqun] Tsinghua Univ, Sch Med, 1 Tsinghua Yuan, Beijing 100084, Peoples R China; [Liang, Zhuobin; Zhao, Weixing] Yale Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sanders, Laurie H.] Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27710 USA; [Greenamyre, J. Timothy; Thathiah, Amantha] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15213 USA; [Rubio, Maria Eulalia] Univ Pittsburgh, Sch Med, Dept Neurobiol & Otolaryngol, Pittsburgh, PA 15261 USA; [Kodali, Ravindra] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Yale University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University	Lan, L (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	lil64@pitt.edu	Liang, Zhuobin/ABC-1209-2020; Wetzel, Ronald/G-7453-2011	Greenamyre, J. Timothy/0000-0003-3468-7878	National Institutes of Health [GM118833, DC013048]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health Grants GM118833 (to L. L.) and DC013048 (to M. E. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Heidenreich E, 2003, EMBO J, V22, P2274, DOI 10.1093/emboj/cdg203; Helfricht A, 2013, CELL CYCLE, V12, P3070, DOI 10.4161/cc.26033; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Lawson ARJ, 2011, GENOME RES, V21, P505, DOI 10.1101/gr.115782.110; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ma CJ, 2017, J BIOL CHEM, V292, P11702, DOI 10.1074/jbc.M117.794545; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; Nakanishi K, 2011, METHODS MOL BIOL, V745, P283, DOI 10.1007/978-1-61779-129-1_16; Ristic D, 2003, NUCLEIC ACIDS RES, V31, P5229, DOI 10.1093/nar/gkg729; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897; Wei LZ, 2015, P NATL ACAD SCI USA, V112, pE3495, DOI 10.1073/pnas.1507105112; Wei LZ, 2013, J CELL SCI, V126, P4414, DOI 10.1242/jcs.128272; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	36	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1353	1362		10.1074/jbc.M117.808402	http://dx.doi.org/10.1074/jbc.M117.808402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29217771	Green Published, hybrid			2022-12-26	WOS:000423515000021
J	Carretta, M; Brouwers-Vos, AZ; Bosman, M; Horton, SJ; Martens, JHA; Vellenga, E; Schuringa, JJ				Carretta, Marco; Brouwers-Vos, Annet Z.; Bosman, Matthieu; Horton, Sarah J.; Martens, Joost H. A.; Vellenga, Edo; Schuringa, Jan Jacob			BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9(+) leukemic cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; HEMATOPOIETIC STEM-CELL; LONG-TERM EXPANSION; EX-VIVO ASSAYS; SELF-RENEWAL; TRANSCRIPTIONAL ELONGATION; THERAPEUTIC TARGET; BET BROMODOMAINS; BRD4	In the present work we aimed to identify targetable signaling networks in human MLL-AF9 leukemias. We show that MLL-AF9 cells critically depend on FLT3-ligand induced pathways as well as on BRD3/4 for their survival. We evaluated the in vitro and in vivo efficacy of the BRD3/4 inhibitor I-BET151 in various human MLL-AF9 (primary) models and patient samples and analyzed the transcriptome changes following treatment. To further understand the mode of action of BRD3/4 inhibition, we performed ChIP-seq experiments on the MLL-AF9 complex in THP1 cells and compared it to RNA-seq data of I-BET151 treated cells. While we could confirm a consistent and specific downregulation of key-oncogenic drivers such as MYC and BCL2, we found that the majority of I-BET151-responsive genes were not direct MLL-AF9 targets. In fact, MLL-AF9 specific targets such as the HOXA cluster, MEIS1 and other cell cycle regulators such as CDK6 were not affected by I-BET151 treatment. Furthermore, we also highlight how MLL-AF9 transformed cells are dependent on the function of non-mutated hematopoietic transcription factors and tyrosine kinases such as the FLT3TAK1/ NF-kB pathway, again impacting on BCL2 but not on the HOXA cluster. We conclude that BRD3/4 and the FLT3-TAK1/NF-kB pathways collectively control a set of targets that are critically important for the survival of human MLL-AF9 cells.	[Carretta, Marco; Brouwers-Vos, Annet Z.; Bosman, Matthieu; Horton, Sarah J.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, CRCG, Dept Expt Hematol, Groningen, Netherlands; [Martens, Joost H. A.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci & Med, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Horton, Sarah J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England	University of Groningen; Radboud University Nijmegen; University of Cambridge	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, CRCG, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl	Martens, Joost/D-4966-2012	Martens, Joost/0000-0003-2008-6537; CARRETTA, MARCO/0000-0002-8135-7188	EU [FP7-PEOPLE-2010-ITN-264361]	EU(European Commission)	This work was supported by the EU (FP7-PEOPLE-2010-ITN-264361 EuroCancer StemCell Training network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Prof. dr. J. J. Erich and Dr. A. van Loon and colleagues (Departments of Obstetrics, University Medical Center Groningen and Martini Hospital Groningen) for collecting cord blood; Henk Moes and Geert Mesander from the Flow Cytometrics Facility for technical assistance with cell sorting; Jenny Jaques, and Mariana Pliego for technical assistance with the experiments and Vincent van den Boom for help with ChIP experiments. This work was supported by the EU (FP7-PEOPLE-2010-ITN-264361 EuroCancer StemCell Training network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. I-BET151 was kindly provided by Nicholas Smithers (GSK R&D, UK).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Birkenkamp KU, 2004, LEUKEMIA, V18, P103, DOI 10.1038/sj.leu.2403145; Bosman MCJ, 2014, BLOOD, V124, P3130, DOI 10.1182/blood-2014-04-569780; Chiarella E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114795; Dafflon C, 2017, LEUKEMIA; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dawson MA, 2011, NATURE; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; Griessinger E, 2007, LEUKEMIA, V21, P877, DOI 10.1038/sj.leu.2404614; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Grosjean-Raillard J, 2008, APOPTOSIS, V13, P1148, DOI 10.1007/s10495-008-0243-4; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Kamezaki K, 2014, EXP HEMATOL, V42, P192, DOI 10.1016/j.exphem.2013.11.008; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuo HP, 2013, CANCER CELL, V24, P423, DOI 10.1016/j.ccr.2013.08.019; Lavallee VP, 2015, NAT GENET, V47, P1030, DOI 10.1038/ng.3371; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Mair B, 2014, TRENDS PHARMACOL SCI, V35, P136, DOI 10.1016/j.tips.2014.01.001; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mizukawa B, 2011, BLOOD, V118, P5235, DOI 10.1182/blood-2011-04-351817; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Prange KH, 2017, ONCOGENE; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Sontakke P, 2016, LEUKEMIA, V30, P2064, DOI 10.1038/leu.2016.108; Sontakke P, 2014, METHODS MOL BIOL, V1185, P195, DOI 10.1007/978-1-4939-1133-2_13; Stein EM, 2015, CURR OPIN HEMATOL, V22, P92, DOI 10.1097/MOH.0000000000000123; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Wajapeyee N, 2013, GENE DEV, V27, P2221, DOI 10.1101/gad.227413.113; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zuber J, 2011, NATURE; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189102	10.1371/journal.pone.0189102	http://dx.doi.org/10.1371/journal.pone.0189102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240787	gold, Green Submitted, Green Published			2022-12-26	WOS:000417905600018
J	Jeong, JE; Rhee, JK; Kim, TM; Kwak, SM; Bang, SH; Cho, H; Cheon, YH; Min, JA; Yoo, GS; Kim, K; Choi, JS; Choi, SW; Kim, DJ				Jeong, Jo-Eun; Rhee, Je-Keun; Kim, Tae-Min; Kwak, Su-Min; Bang, Sol-hee; Cho, Hyun; Cheon, Young-Hoon; Min, Jung Ah; Yoo, Gil Sang; Kim, Kyudong; Choi, Jung-Seok; Choi, Sam-Wook; Kim, Dai-Jin			The association between the nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults	PLOS ONE			English	Article							VIDEO GAME ADDICTION; ALCOHOL DEPENDENCE; GENDER-DIFFERENCES; PATHOLOGICAL GAMBLERS; CHINESE ADOLESCENTS; RISK-FACTORS; POLYMORPHISM; IMPULSIVITY; POPULATION; COMPUTER	The primary aim of this study was to investigate the genetic predisposition of Internet gaming disorder (IGD), and the secondary aim was to compare the results to those of alcohol dependence (AD). Two independent case-control studies were conducted. A total of 30 male participants with IGD, diagnosed according to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, and 30 sex-matched controls participated in study 1. We designed targeted exome sequencing (TES) to test for 72 candidate genes that have been implicated in the pathogenesis of addiction. The genes included seven neurotransmitter (dopamine, serotonin, glutamate, r-aminobutyric acid (GABA), norepinephrine, acetylcholine, and opioid) system genes. A total of 31 male in-patients with AD and 29 normal male controls (NC) were enrolled in study 2. The same 72 genes included in study 1 and ten additional genes related to alcohol-metabolic enzyme were selected as the target genes, and we identified the genetic variants using the same method (TES). The IGD group had a lower frequency of the T allele of rs1044396 in the nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4), and this variant represents a protective allele against IGD. However, we did not find a significant difference in the polymorphisms of the 72 genes that encode neurotransmitter systems between the AD and NC groups. This study demonstrated that rs1044396 of CHRNA4 was significantly associated with IGD.	[Jeong, Jo-Eun; Kwak, Su-Min; Bang, Sol-hee; Cho, Hyun; Kim, Dai-Jin] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Rhee, Je-Keun; Kim, Tae-Min] Catholic Univ Korea, Coll Med, Catholic Canc Res Inst, Seoul, South Korea; [Kim, Tae-Min] Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea; [Cheon, Young-Hoon] Incheon Chamsarang Hosp, Dept Psychiat, Incheon, South Korea; [Min, Jung Ah] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Yoo, Gil Sang; Kim, Kyudong] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Jung-Seok] SMU SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Choi, Jung-Seok] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Sam-Wook] True Mind Mental Hlth Clin, Dept Psychiat, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, DJ (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea.	kdj922@chollian.net		Jeong, Jo-Eun/0000-0002-4200-278X; Rhee, Je-Keun/0000-0003-4811-8895	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI12C-0113]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI12C-0113) to DJK, http://www.mohw.go.kr/eng/index.jsp.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Alvarez-Moya EM, 2007, COMPR PSYCHIAT, V48, P452, DOI 10.1016/j.comppsych.2007.03.008; Ball D, 2008, ADDICTION, V103, P360, DOI 10.1111/j.1360-0443.2007.02061.x; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Breitling LP, 2009, PHARMACOGENOMICS J, V9, P219, DOI 10.1038/tpj.2009.6; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cao FL, 2007, EUR PSYCHIAT, V22, P466, DOI 10.1016/j.eurpsy.2007.05.004; Chiu SI, 2004, CYBERPSYCHOL BEHAV, V7, P571, DOI 10.1089/1094931042403127; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; de Kloet SF, 2015, BIOCHEM PHARMACOL, V97, P425, DOI 10.1016/j.bcp.2015.07.014; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Dick DM, 2003, ALCOHOL CLIN EXP RES, V27, P868, DOI 10.1097/01.ALC.0000065436.24221.63; Enoch MA, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0412-1; Faraci P, 2013, J MED INTERNET RES, V15, P220, DOI 10.2196/jmir.2935; Fattore L, 2014, FRONT NEUROENDOCRIN, V35, P272, DOI 10.1016/j.yfrne.2014.04.003; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; FORCIER MW, 1988, J OCCUP ENVIRON MED, V30, P246; Fuentes D, 2006, J INT NEUROPSYCH SOC, V12, P907, DOI 10.1017/S1355617706061091; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Griffiths M, 2000, CYBERPSYCHOL BEHAV, V3, P211, DOI 10.1089/109493100316067; Griffiths MD, 2004, J ADOLESCENCE, V27, P87, DOI 10.1016/j.adolescence.2003.10.007; Grucza RA, 2006, ALCOHOL RES HEALTH, V29, P172; Han DH, 2007, J ADDICT MED, V1, P133, DOI 10.1097/ADM.0b013e31811f465f; Hartmann T, 2006, J COMPUT-MEDIAT COMM, V11, P910, DOI 10.1111/j.1083-6101.2006.00301.x; HELZER JE, 1988, J STUD ALCOHOL, V49, P219, DOI 10.15288/jsa.1988.49.219; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Internet-World-Stats, 2016, WORLD INT US 2016; Kertzman S, 2008, PSYCHIAT RES, V161, P1, DOI 10.1016/j.psychres.2007.06.026; Kim JY, 2016, J BEHAV ADDICT, V5, P631, DOI 10.1556/2006.5.2016.077; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2005, J NERV MENT DIS, V193, P273, DOI 10.1097/01.nmd.0000158373.85150.57; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lee HC, 2001, J KOREAN MED SCI, V16, P745, DOI 10.3346/jkms.2001.16.6.745; Lee YS, 2008, J AFFECT DISORDERS, V109, P165, DOI 10.1016/j.jad.2007.10.020; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MJ, 2014, TWIN RES HUM GENET, V17, P279, DOI 10.1017/thg.2014.32; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Liang LC, 2016, COMPUT HUM BEHAV, V63, P463, DOI 10.1016/j.chb.2016.04.043; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; MALETZKY BM, 1974, AM J PSYCHIAT, V131, P445; Ogletree SM, 2007, SEX ROLES, V56, P537, DOI 10.1007/s11199-007-9193-5; Montag C, 2012, J ADDICT MED, V6, P191, DOI 10.1097/ADM.0b013e31825ba7e7; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nordin C, 2007, J GAMBL STUD, V23, P113, DOI 10.1007/s10899-006-9049-x; Park BL, 2013, HUM GENET, V132, P657, DOI 10.1007/s00439-013-1281-8; Pawlikowski M, 2014, ADDICT RES THEORY, V22, P166, DOI 10.3109/16066359.2013.793313; Pinto E, 2008, ALCOHOL ALCOHOLISM, V43, P398, DOI 10.1093/alcalc/agn015; Portugal GS, 2008, BEHAV BRAIN RES, V193, P1, DOI 10.1016/j.bbr.2008.05.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Santos JR, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00046; Sargent JD, 2010, ADDICTION, V105, P506, DOI 10.1111/j.1360-0443.2009.02782.x; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Starcevic V, 2017, CNS SPECTRUMS, V22, P7, DOI 10.1017/S1092852915000863; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; The American Psychiatric Association, 2012, INT US DIS; Tomkins DM, 2001, CAN MED ASSOC J, V164, P817; Vink JM, 2016, ADDICT BIOL, V21, P460, DOI 10.1111/adb.12218; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; World Health Organization, 2016, ICD 11 BET IN PRESS; Yau Yvonne H C, 2012, Minerva Psichiatr, V53, P153; Yee N, 2006, CYBERPSYCHOL BEHAV, V9, P772, DOI 10.1089/cpb.2006.9.772; Yen JY, 2009, PSYCHIAT CLIN NEUROS, V63, P218, DOI 10.1111/j.1440-1819.2009.01943.x; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	75	14	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188358	10.1371/journal.pone.0188358	http://dx.doi.org/10.1371/journal.pone.0188358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240768	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600007
J	Rotwein, P				Rotwein, Peter			Diversification of the insulin-like growth factor 1 gene in mammals	PLOS ONE			English	Article							FACTOR-I GENE; BINDING-PROTEIN-DELTA; IGF-I; FUNCTIONAL-ANALYSIS; SEXUAL-DIMORPHISM; POSTNATAL-GROWTH; HORMONE RECEPTOR; MESSENGER-RNAS; EXPRESSION; TRANSCRIPTION	Insulin-like growth factor 1 (IGF1), a small, secreted peptide growth factor, is involved in a variety of physiological and patho-physiological processes, including somatic growth, tissue repair, and metabolism of carbohydrates, proteins, and lipids. IGF1 gene expression appears to be controlled by several different signaling cascades in the few species in which it has been evaluated, with growth hormone playing a major role by activating a pathway involving the Stat5b transcription factor. Here, genes encoding IGF1 have been evaluated in 25 different mammalian species representing 15 different orders and ranging over similar to 180 million years of evolutionary diversification. Parts of the IGF1 gene have been fairly well conserved. Like rat Igf1 and human IGF1, 21 of 23 other genes are composed of 6 exons and 5 introns, and all 23 also contain recognizable tandem promoters, each with a unique leader exon. Exon and intron lengths are similar in most species, and DNA sequence conservation is moderately high in orthologous exons and proximal promoter regions. In contrast, putative growth hormone-activated Stat5b-binding enhancers found in analogous locations in rodent Igf1 and in human IGF1 loci, have undergone substantial variation in other mammals, and a processed retro-transposed IGF1 pseudogene is found in the sloth locus, but not in other mammalian genomes. Taken together, the fairly high level of organizational and nucleotide sequence similarity in the IGF1 gene among these 25 species supports the contention that some common regulatory pathways had existed prior to the beginning of mammalian speciation.	[Rotwein, Peter] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Rotwein, P (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	Diabetes, Digestive and Kidney Diseases, United States National Institutes of Health [R01 DK063703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	Diabetes, Digestive and Kidney Diseases, United States National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Diabetes, Digestive and Kidney Diseases, United States National Institutes of Health, R01 DK063703. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677; Adamo ML., 1995, DIABETES REV, V3, P2; Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Alzhanov D, 2015, PHYSIOL GENOMICS, V47, P559, DOI 10.1152/physiolgenomics.00062.2015; AN MR, 1995, MOL CELL ENDOCRINOL, V114, P77, DOI 10.1016/0303-7207(95)03644-M; Annibalini G, 2016, BBA-GENE REGUL MECH, V1859, P757, DOI 10.1016/j.bbagrm.2016.03.014; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; BICHELL DP, 1992, MOL ENDOCRINOL, V6, P1899, DOI 10.1210/me.6.11.1899; Billiard J, 2001, J BIOL CHEM, V276, P31238, DOI 10.1074/jbc.M103634200; BLUNDELL TL, 1980, NATURE, V287, P781, DOI 10.1038/287781a0; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; Chia DJ, 2010, J BIOL CHEM, V285, P17636, DOI 10.1074/jbc.M110.117697; Das R, 2015, BIOCHEM SOC T, V43, P1057, DOI 10.1042/BST20150078; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Feigerlova E, 2013, ENDOCR DEV, V24, P118, DOI 10.1159/000342586; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; HALL LJ, 1992, DNA CELL BIOL, V11, P301, DOI 10.1089/dna.1992.11.301; HOYT EC, 1988, MOL ENDOCRINOL, V2, P1077, DOI 10.1210/mend-2-11-1077; JANSEN E, 1992, BIOCHEM BIOPH RES CO, V187, P1219, DOI 10.1016/0006-291X(92)90433-L; KIM SW, 1991, MOL ENDOCRINOL, V5, P1964, DOI 10.1210/mend-5-12-1964; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Laz EV, 2009, MOL ENDOCRINOL, V23, P1242, DOI 10.1210/me.2008-0449; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LOWE WL, 1987, P NATL ACAD SCI USA, V84, P8946, DOI 10.1073/pnas.84.24.8946; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; Mittanck DW, 1997, MOL CELL ENDOCRINOL, V126, P153, DOI 10.1016/S0303-7207(96)03979-2; Mukherjee A, 2016, AM J PHYSIOL-ENDOC M, V311, pE519, DOI 10.1152/ajpendo.00212.2016; NOLTEN LA, 1995, MOL ENDOCRINOL, V9, P1488, DOI 10.1210/me.9.11.1488; Nolten LA, 1996, J BIOL CHEM, V271, P31846, DOI 10.1074/jbc.271.50.31846; NOLTEN LA, 1994, MOL ENDOCRINOL, V8, P1636, DOI 10.1210/me.8.12.1636; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434; ROTWEIN P, 1986, P NATL ACAD SCI USA, V83, P77, DOI 10.1073/pnas.83.1.77; Rotwein P, 2017, ENDOCRINOLOGY, V158, P804, DOI 10.1210/en.2016-1920; Rotwein P, 2012, TRENDS ENDOCRIN MET, V23, P186, DOI 10.1016/j.tem.2012.01.001; Scalco RC, 2015, EUR J ENDOCRINOL, V173, P291, DOI 10.1530/EJE-15-0398; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Schwartz TS, 2016, INTEGR COMP BIOL, V56, P171, DOI 10.1093/icb/icw046; SHIMATSU A, 1987, J BIOL CHEM, V262, P7894; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; STEENBERGH PH, 1993, MOL REPROD DEV, V35, P365, DOI 10.1002/mrd.1080350408; SUSSENBACH JS, 1991, ADV EXP MED BIOL, V293, P1; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Telgmann R, 2009, FASEB J, V23, P1303, DOI 10.1096/fj.08-116863; TOBIN G, 1990, MOL ENDOCRINOL, V4, P1914, DOI 10.1210/mend-4-12-1914; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Umayahara Y, 1999, J BIOL CHEM, V274, P10609, DOI 10.1074/jbc.274.15.10609; Varco-Merth B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050278; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Venditti C, 2010, TRENDS ECOL EVOL, V25, P14, DOI 10.1016/j.tree.2009.06.010; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; Waters MJ, 2016, GROWTH HORM IGF RES, V28, P6, DOI 10.1016/j.ghir.2015.06.001; Waters MJ, 2015, BIOCHEM J, V466, P1, DOI 10.1042/BJ20141293; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007	69	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189642	10.1371/journal.pone.0189642	http://dx.doi.org/10.1371/journal.pone.0189642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240807	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600058
J	Singh, B; Saqib, M; Gupta, A; Kumar, P; Bhaskar, S				Singh, Bindu; Saqib, Mohd; Gupta, Ananya; Kumar, Pawan; Bhaskar, Sangeeta			Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages	PLOS ONE			English	Article							PHAGOSOME MATURATION ARREST; PROTECTIVE EFFICACY; ADAPTIVE IMMUNITY; DEFENSE; INNATE; INFECTION; SURVIVAL; EVASION; ROLES; CELLS	Mycobacterium indicus pranii (MIP) is a potent vaccine candidate against tuberculosis (TB) as it has demonstrated significant protection in animal models of tuberculosis as well as in clinical trials. Higher protective efficacy of MIP against TB as compared to BCG provoked the efforts to gain insight into the molecular mechanisms underlying MIP mediated protection against Mycobacterium tuberculosis (M.tb). Autophagy, initially described as a cell survival mechanism during starvation, also plays a key role in host resistance to M.tb. Virulent mycobacteria like M.tb, suppresses host autophagy response to increase its survival in macrophages. Since mycobacterial species have been shown to vary widely in their autophagy-inducing properties, in the present study, we examined the autophagy inducing efficacy of MIP and its role in MIP-mediated protection against M.tb. MIP was found to be potent inducer of autophagy in macrophages. Induced autophagy was responsible for reversal of the phagosome maturation block and phagolysosome fusion inhibition in M.tb infected macrophages, which ultimately lead to significantly enhanced clearance of M.tb from the macrophages. This is an important study which further delineated the underlying mechanisms for significant immunotherapeutic activity observed in TB patients / animal models of tuberculosis, given MIP therapy along with chemotherapy.	[Singh, Bindu; Saqib, Mohd; Gupta, Ananya; Bhaskar, Sangeeta] Natl Inst Immunol, Prod Dev Cell, Delhi, India; [Kumar, Pawan] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi	Bhaskar, S (corresponding author), Natl Inst Immunol, Prod Dev Cell, Delhi, India.	sangeeta@nii.ac.in	Gupta, Ananya/AAW-6021-2021; Singh, Bindu/GXG-7548-2022; SAQIB, MOHD/AAH-9193-2021; KUMAR, PAWAN/E-5522-2012; Kumar, Pawan/GXF-7072-2022; Gupta, Ananya/ABG-6201-2021	Gupta, Ananya/0000-0001-7917-7877; Singh, Bindu/0000-0003-2974-1737; SAQIB, MOHD/0000-0002-3800-0490; KUMAR, PAWAN/0000-0003-0712-8763; Bhaskar, Sangeeta/0000-0001-7902-5267	National Institute of Immunology	National Institute of Immunology	This work was supported by the Core research grant of National Institute of Immunology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Goletti D, 2013, CYTOKINE GROWTH F R, V24, P335, DOI 10.1016/j.cytogfr.2013.01.002; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039215; Gupta A, 2012, VACCINE, V30, P6198, DOI 10.1016/j.vaccine.2012.07.061; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; Sharma SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03514-1; Songane M, 2012, TUBERCULOSIS, V92, P388, DOI 10.1016/j.tube.2012.05.004; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Xu Yi, 2010, Proc Am Thorac Soc, V7, P22, DOI 10.1513/pats.200909-103JS; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	36	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189606	10.1371/journal.pone.0189606	http://dx.doi.org/10.1371/journal.pone.0189606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236768	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100085
J	Zieger, SL; Ammerschubert, S; Polle, A; Scheu, S				Zieger, Sarah L.; Ammerschubert, Silke; Polle, Andrea; Scheu, Stefan			Root-derived carbon and nitrogen from beech and ash trees differentially fuel soil animal food webs of deciduous forests	PLOS ONE			English	Article							STABLE-ISOTOPE; PHOTOSYNTHATE CARBON; FERTILIZER ADDITION; UPLAND GRASSLAND; FAGUS-SYLVATICA; PLANT CARBON; COLLEMBOLA; MITES; FLUX; ACARI	Evidence is increasing that soil animal food webs are fueled by root-derived carbon (C) and also by root-derived nitrogen (N). Functioning as link between the above-and belowground system, trees and their species identity are important drivers structuring soil animal communities. A pulse labeling experiment using N-15 and C-13 was conducted by exposing beech (Fagus sylvatica) and ash (Fraxinus excelsior) seedlings to (CO2)-C-13 enriched atmosphere and tree leaves to 15 N ammonium chloride solution in a plant growth chamber under controlled conditions for 72 h. C and N fluxes into the soil animal food web of beech, associated with ectomycorrhizal fungi (EMF), and ash, associated with arbuscular mycorrhizal fungi (AMF), were investigated at two sampling dates (5 and 20 days after labeling). All of the soil animal taxa studied incorporated root-derived C, while root-derived N was only incorporated into certain taxa. Tree species identity strongly affected C and N incorporation with the incorporation in the beech rhizosphere generally exceeding that in the ash rhizosphere. Incorporation differed little between 5 and 20 days after labeling indicating that both C and N are incorporated quickly into soil animals and are used for tissue formation. Our results suggest that energy and nutrient fluxes in soil food webs depend on the identity of tree species with the differences being associated with different types of mycorrhiza. Further research is needed to prove the generality of these findings and to quantify the flux of plant C and N into soil food webs of forests and other terrestrial ecosystems.	[Zieger, Sarah L.; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Anim Ecol, Gottingen, Germany; [Ammerschubert, Silke; Polle, Andrea] Univ Gottingen, Busgen Inst, Forest Bot & Tree Physiol, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Zieger, SL (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Anim Ecol, Gottingen, Germany.	szieger@gwdg.de	Scheu, Stefan/H-7049-2015	Polle, Andrea/0000-0001-8697-6394; Bluhm, Sarah L./0000-0001-7314-7415	German Research Foundation [GRK1086/2]	German Research Foundation(German Research Foundation (DFG))	This project was funded by the German Research Foundation [GRK1086/2, project A04].	Albers D, 2006, ECOLOGY, V87, P235, DOI 10.1890/04-1728; Anderson J.M., 1975, P51; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BEHANPELLETIER VM, 1983, REV ECOL BIOL SOL, V20, P221; Brose U, 2014, OIKOS, V123, P1153, DOI 10.1111/oik.01768; BRUMME R, 1992, PLANT SOIL, V142, P273, DOI 10.1007/BF00010972; Brzostek ER, 2013, BIOGEOCHEMISTRY, V115, P65, DOI 10.1007/s10533-012-9818-9; BURYN R, 1992, EXP APPL ACAROL, V14, P67, DOI 10.1007/BF01205353; Cesarz S, 2013, SOIL BIOL BIOCHEM, V61, P23, DOI 10.1016/j.soilbio.2013.02.003; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Constantinescu IC, 2007, ANALELE STIINTIFICE, P83; David JF, 1997, BIOL FERT SOILS, V24, P66, DOI 10.1007/BF01420222; Digel C, 2014, OIKOS, V123, P1157, DOI 10.1111/oik.00865; Ehnes RB, 2014, ECOLOGY, V95, P527, DOI 10.1890/13-0620.1; Eissfeller V, 2013, SOIL BIOL BIOCHEM, V62, P76, DOI 10.1016/j.soilbio.2013.03.002; Endlweber K, 2009, SOIL BIOL BIOCHEM, V41, P1151, DOI 10.1016/j.soilbio.2009.02.022; Filser J, 2002, PEDOBIOLOGIA, V46, P234, DOI 10.1078/0031-4056-00130; Fujii S, 2016, PEDOBIOLOGIA, V59, P225, DOI 10.1016/j.pedobi.2016.05.001; Gilbert KJ, 2014, SOIL BIOL BIOCHEM, V76, P45, DOI 10.1016/j.soilbio.2014.05.005; Glanville H, 2012, SOIL BIOL BIOCHEM, V48, P88, DOI 10.1016/j.soilbio.2012.01.015; GUNN A, 1993, PEDOBIOLOGIA, V37, P303; Heidemann K, 2014, OIKOS, V123, P1199, DOI 10.1111/j.1600-0706.2013.00872.x; Heidemann K, 2014, EXP APPL ACAROL, V64, P49, DOI 10.1007/s10493-014-9807-x; Hertenberger G, 2004, RAPID COMMUN MASS SP, V18, P2415, DOI 10.1002/rcm.1615; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; HURLBUTT HW, 1968, SYST ZOOL, V17, P261, DOI 10.2307/2412005; Johnson D, 2002, NEW PHYTOL, V153, P327, DOI 10.1046/j.0028-646X.2001.00316.x; Johnson D, 2002, SOIL BIOL BIOCHEM, V34, P1521, DOI 10.1016/S0038-0717(02)00126-8; Kempson D., 1963, Pedobiologia, V3, P1; Klarner B, 2013, SOIL BIOL BIOCHEM, V57, P327, DOI 10.1016/j.soilbio.2012.08.013; Koehler HH, 1999, AGR ECOSYST ENVIRON, V74, P395, DOI 10.1016/S0167-8809(99)00045-6; Kubisch P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00064; Kudrin AA, 2015, SOIL BIOL BIOCHEM, V86, P193, DOI 10.1016/j.soilbio.2015.03.017; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Langel R, 2014, RAPID COMMUN MASS SP, V28, P1019, DOI 10.1002/rcm.6878; Larsen T, 2007, PLANT SOIL, V295, P253, DOI 10.1007/s11104-007-9280-y; Leake Jr, 2002, ECOL STU AN, V157, P345; Lemanski K, 2014, OECOLOGIA, V176, P487, DOI 10.1007/s00442-014-3037-0; Lemanski K, 2014, SOIL BIOL BIOCHEM, V69, P38, DOI 10.1016/j.soilbio.2013.10.034; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; Merbach W, 1999, J PLANT NUTR SOIL SC, V162, P373, DOI 10.1002/(SICI)1522-2624(199908)162:4<373::AID-JPLN373>3.0.CO;2-#; MURAOKA M, 1976, Applied Entomology and Zoology, V11, P1; Ostle N, 2007, SOIL BIOL BIOCHEM, V39, P768, DOI 10.1016/j.soilbio.2006.09.025; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; Phillips RP, 2005, GLOBAL CHANGE BIOL, V11, P983, DOI 10.1111/j.1365-2486.2005.00959.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Pollierer MM, 2012, FUNCT ECOL, V26, P978, DOI 10.1111/j.1365-2435.2012.02005.x; Pollierer MM, 2009, SOIL BIOL BIOCHEM, V41, P1221, DOI 10.1016/j.soilbio.2009.03.002; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Potapov AM, 2016, PEDOBIOLOGIA, V59, P189, DOI 10.1016/j.pedobi.2016.07.002; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Riha G., 1951, Zoologische Jahrbuecher (Systematik), V80, P407; RIHANI M, 1995, EUR J SOIL BIOL, V31, P67; Ruf A, 2006, SOIL BIOL BIOCHEM, V38, P2390, DOI 10.1016/j.soilbio.2006.03.008; SCHAEFER M, 1990, OECOLOGIA, V82, P128, DOI 10.1007/BF00318544; Scheu S, 2004, OECOLOGIA, V139, P347, DOI 10.1007/s00442-004-1513-7; Scheu S, 2000, OECOLOGIA, V123, P285, DOI 10.1007/s004420051015; Scheunemann N., 2016, FOOD WEBS, V9, P39, DOI [10.1016/j.fooweb, DOI 10.1016/J.FOOWEB.2016.02.006, DOI 10.1016/J.FOOWEB]; Scheunemann N, 2015, OECOLOGIA, V179, P1135, DOI 10.1007/s00442-015-3415-2; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Semenina EE, 2011, PEDOBIOLOGIA, V54, P101, DOI 10.1016/j.pedobi.2010.10.004; Semenyuk II, 2011, BIOL BULL+, V38, P283, DOI 10.1134/S1062359011030137; SHAW PJA, 1988, PEDOBIOLOGIA, V31, P179; Tedersoo L, 2016, ISME J, V10, P346, DOI 10.1038/ismej.2015.116; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Valtanen K, 2014, MYCORRHIZA, V24, P645, DOI 10.1007/s00572-014-0581-8; van Hees PAW, 2005, SOIL BIOL BIOCHEM, V37, P1, DOI 10.1016/j.soilbio.2004.06.010; Walter D.E., 2013, MITES ECOLOGY EVOLUT, DOI DOI 10.1007/978-94-007-7164-2; Wichern F, 2008, SOIL BIOL BIOCHEM, V40, P30, DOI 10.1016/j.soilbio.2007.08.010; WOLTERS V, 1985, OECOLOGIA, V65, P229, DOI 10.1007/BF00379222; Zieger SL, 2017, BASIC APPL ECOL, V22, P28, DOI 10.1016/j.baae.2017.06.006	75	11	11	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189502	10.1371/journal.pone.0189502	http://dx.doi.org/10.1371/journal.pone.0189502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236746	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100074
J	Cao, RH; Cao, P; Lin, H; Fan, X				Cao, Rihong; Cao, Ping; Lin, Hang; Fan, Xiang			Experimental and numerical study of the failure process and energy mechanisms of rock-like materials containing cross unpersistent joints under uniaxial compression	PLOS ONE			English	Article							DISCONTINUOUS DEFORMATION ANALYSIS; FRACTURE COALESCENCE BEHAVIOR; FINITE-ELEMENT-METHOD; 2 UNPARALLEL FISSURES; CRACK-PROPAGATION; PARTICLE MODEL; RED SANDSTONE; MASS MODELS; FLAWS; SIMULATION	Joints and fissures in natural rocks have a significant influence on the stability of the rock mass, and it is often necessary to evaluate strength failure and crack evolution behavior. In this paper, based on experimental tests and numerical simulation (PFC2D), the macromechanical behavior and energy mechanism of jointed rock-like specimens with cross nonpersistent joints under uniaxial loading were investigated. The focus was to study the effect of joint dip angle a and intersection angle. on the characteristic stress, the coalescence modes and the energy release of jointed rock-like specimens. For specimens with Upsilon= 30 degrees and 45 degrees, the UCS (uniaxial compression strength), CIS (crack initiation stress) and CDiS (critical dilatancy stress) increase as a increases from 0 degrees to 75 degrees. When. = 60 degrees and 75 degrees, the UCS, CIS and CDiS increase as a increases from 0 degrees to 60 degrees and decrease when a is over 60 degrees. Both the inclination angle a and intersection angle. have great influence on the failure pattern of pre-cracked specimens. With different a and., specimens exhibit 4 kinds of failure patterns. Both the experimental and numerical results show that the energy of a specimen has similar trends with characteristic stress as a increases.	[Cao, Rihong; Cao, Ping; Lin, Hang] Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China; [Cao, Rihong] Univ Western Australia, Sch Civil Environm & Min Engn, Perth, WA, Australia; [Fan, Xiang] Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China	Central South University; University of Western Australia; Chang'an University	Lin, H (corresponding author), Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China.	hanglin@csu.edu.cn	Lin, Hang/E-3318-2013	Lin, Hang/0000-0002-5924-5163	National Natural Science Foundation of China [11772358, 51404179, 51774322, 51474249]; Innovation Driven Plan of Central South University [2016CX019]; Graduate Student Innovation Project of Central South University [2015zzts074]; Fundamental Research Funds for the Central Universities [310821161008]; Opening Fund of the State Key Laboratory of Geo-hazard Prevention and Geo-environment Protection [SKLGP2016K009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Driven Plan of Central South University; Graduate Student Innovation Project of Central South University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Opening Fund of the State Key Laboratory of Geo-hazard Prevention and Geo-environment Protection	This study was funded by National Natural Science Foundation of China, grant numbers 11772358, 51404179, to Ping Cao (http://faculty.csu.edu.cn/caoping/zh_CN/yjgk/27500/list/index.htm); National Natural Science Foundation of China, grant numbers 51774322, 51474249, to Hang Lin (http://srse.csu.edu.cn/channels/1058.html); Innovation Driven Plan of Central South University, grant numbers 2016CX019, to Hang Lin (http://srse.csu.edu.cn/channels/1058.html); Graduate Student Innovation Project of Central South University, grant numbers 2015zzts074, to Dr Ri-hong Cao; Fundamental Research Funds for the Central Universities, grant numbers 310821161008, to Hang Lin (http://srse.csu.edu.cn/channels/1058.html); Opening Fund of the State Key Laboratory of Geo-hazard Prevention and Geo-environment Protection, grant numbers SKLGP2016K009, to Hang Lin (http://srse.csu.edu.cn/channels/1058.html).	Areias P, 2013, INT J NUMER METH ENG, V94, P1099, DOI 10.1002/nme.4477; Areias P, 2009, COMPUT MECH, V45, P61, DOI 10.1007/s00466-009-0418-z; Bahaaddini M, 2013, COMPUT GEOTECH, V49, P206, DOI 10.1016/j.compgeo.2012.10.012; Bittencourt TN, 1996, ENG FRACT MECH, V55, P321, DOI 10.1016/0013-7944(95)00247-2; Bobet A, 1998, INT J FRACTURE, V92, P221, DOI 10.1023/A:1007460316400; Bobet A, 1998, INT J ROCK MECH MIN, V35, P863, DOI 10.1016/S0148-9062(98)00005-9; Cao P, 2015, ENG GEOL, V187, P113, DOI 10.1016/j.enggeo.2014.12.010; Cao RH, 2018, ARCH CIV MECH ENG, V18, P198, DOI 10.1016/j.acme.2017.06.010; Cao RH, 2016, ROCK MECH ROCK ENG, V49, P4319, DOI 10.1007/s00603-016-1029-6; Cao RH, 2016, ROCK MECH ROCK ENG, V49, P763, DOI 10.1007/s00603-015-0779-x; Cho N, 2007, INT J ROCK MECH MIN, V44, P997, DOI 10.1016/j.ijrmms.2007.02.002; Colombo D, 2006, ENG FRACT MECH, V73, P490, DOI 10.1016/j.engfracmech.2005.08.007; Dyskin AV, 2003, ENG FRACT MECH, V70, P2115, DOI 10.1016/S0013-7944(02)00240-0; Fan X, 2015, ENG GEOL, V190, P17, DOI 10.1016/j.enggeo.2015.02.008; Gu J, 2009, INT J NUMER ANAL MET, V33, P1449, DOI 10.1002/nag.772; HOEK E, 1965, INT J FRACT MECH, V1, P137; Itasca, 2015, PART FLOW COD 3 DIM; Lee H, 2011, INT J SOLIDS STRUCT, V48, P979, DOI 10.1016/j.ijsolstr.2010.12.001; Li HQ, 2014, ROCK MECH ROCK ENG, V47, P2087, DOI 10.1007/s00603-013-0504-6; Li HQ, 2012, INT J SOLIDS STRUCT, V49, P2482, DOI 10.1016/j.ijsolstr.2012.05.012; Li YP, 2005, INT J SOLIDS STRUCT, V42, P2505, DOI 10.1016/j.ijsolstr.2004.09.033; [梁昌玉 Liang Changyu], 2012, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V31, P1830; Lin H, 2016, GEOTECH TEST J, V39, P137, DOI 10.1520/GTJ20140268; Lin H, 2013, INT J ROCK MECH MIN, V60, P12, DOI 10.1016/j.ijrmms.2012.12.027; Ma GW, 2009, INT J FRACTURE, V156, P21, DOI 10.1007/s10704-009-9342-7; Manouchehrian A, 2012, ACTA MECH SINICA-PRC, V28, P1389, DOI 10.1007/s10409-012-0145-0; Camones LAM, 2013, ENG GEOL, V153, P80, DOI 10.1016/j.enggeo.2012.11.013; Moes N, 1999, INT J NUMER METH ENG, V46, P131, DOI 10.1002/(SICI)1097-0207(19990910)46:1<131::AID-NME726>3.0.CO;2-J; Moes N, 2002, ENG FRACT MECH, V69, P813, DOI 10.1016/S0013-7944(01)00128-X; Ning YJ, 2011, INT J ROCK MECH MIN, V48, P964, DOI 10.1016/j.ijrmms.2011.06.011; Ning YJ, 2011, COMPUT GEOTECH, V38, P40, DOI 10.1016/j.compgeo.2010.09.003; Park CH, 2010, ENG FRACT MECH, V77, P2727, DOI 10.1016/j.engfracmech.2010.06.027; Park CH, 2009, INT J ROCK MECH MIN, V46, P819, DOI 10.1016/j.ijrmms.2009.02.006; Potyondy DO, 2007, INT J ROCK MECH MIN, V44, P677, DOI 10.1016/j.ijrmms.2006.10.002; Prudencio M, 2007, INT J ROCK MECH MIN, V44, P890, DOI 10.1016/j.ijrmms.2007.01.005; Sagong M, 2002, INT J ROCK MECH MIN, V39, P229, DOI 10.1016/S1365-1609(02)00027-8; SHEN B, 1995, ENG FRACT MECH, V51, P73, DOI 10.1016/0013-7944(94)00201-R; Shi G. H., 1992, T 9 ARM C APPL MATH, P57; SHI GH, 1989, INT J NUMER ANAL MET, V13, P359, DOI 10.1002/nag.1610130403; Tang CA, 1998, ENG FRACT MECH, V61, P311, DOI 10.1016/S0013-7944(98)00067-8; Tang CA, 2001, INT J ROCK MECH MIN, V38, P925, DOI 10.1016/S1365-1609(01)00065-X; Wong LNY, 2009, ROCK MECH ROCK ENG, V42, P475, DOI 10.1007/s00603-008-0002-4; Wong L.N.Y., 2008, CRACK COALESCENCE MO; Wong LNY, 2014, ROCK MECH ROCK ENG, V47, P1921, DOI 10.1007/s00603-013-0424-5; Wong LNY, 2013, INT J SOLIDS STRUCT, V50, P3685, DOI 10.1016/j.ijsolstr.2013.07.010; Wong RHC, 1998, INT J ROCK MECH MIN, V35, P147, DOI 10.1016/S0148-9062(97)00303-3; Wong RHC, 2001, ROCK MECHANICS IN THE NATIONAL INTEREST, VOLS 1 AND 2, P843; [谢和平 xie Heping], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P3003; Chen X, 2012, INT J MIN SCI TECHNO, V22, P213, DOI 10.1016/j.ijmst.2011.08.012; Yang SQ, 2012, ROCK MECH ROCK ENG, V45, P563, DOI 10.1007/s00603-011-0206-x; Yang SQ, 2009, ENG FRACT MECH, V76, P1833, DOI 10.1016/j.engfracmech.2009.04.005; Yang SQ, 2014, ENG GEOL, V178, P28, DOI 10.1016/j.enggeo.2014.06.005; Yang SQ, 2013, INT J ROCK MECH MIN, V63, P82, DOI 10.1016/j.ijrmms.2013.06.008; Yang SQ, 2011, INT J FRACTURE, V168, P227, DOI 10.1007/s10704-010-9576-4; Yang XX, 2017, INT J ROCK MECH MIN, V92, P40, DOI 10.1016/j.ijrmms.2016.12.010; Zhang HH, 2010, ENG ANAL BOUND ELEM, V34, P41, DOI 10.1016/j.enganabound.2009.07.006	56	20	20	7	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188646	10.1371/journal.pone.0188646	http://dx.doi.org/10.1371/journal.pone.0188646			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232392	Green Submitted, Green Published, gold			2022-12-26	WOS:000417698200008
J	Guillory, AN; Clayton, RP; Prasal, A; El Ayadi, A; Herndon, DN; Finnerty, CC				Guillory, Ashley N.; Clayton, Robert P.; Prasal, Anesh; El Ayadi, Amina; Herndon, David N.; Finnerty, Celeste C.			Biventricular differences in beta-adrenergic receptor signaling following burn injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FAILING HUMAN HEARTS; GENE-EXPRESSION; PULMONARY-HYPERTENSION; G-PROTEINS; FACTOR-I; FAILURE; KINASE; NOREPINEPHRINE; CATECHOLAMINES	Burn injury detrimentally affects the myocardium, primarily due to over-activation of P-adrenergic receptors (beta-AR). Autopsy reports from our institution reveal that patients often suffer from right ventricle (RV) failure. Since burn injury affects beta-AR signaling in the left ventricle (LV), we proposed that beta-AR signaling may also be altered in the RV. A rodent model with a scald burn of 60% of the total body surface area was used to test this hypothesis. Ventricles were isolated 7 days post-burn. We examined the expression of p-ARs via Western blotting and the mRNA expression of downstream signaling proteins via qRT-PCR. Cyclic adenosine monophosphate (cAMP) production and protein kinase A (PKA) activity were measured in membrane and cytosolic fractions, respectively, using enzyme immunoassay kits. beta(1)-AR protein expression was significantly increased in the RV following burn injury compared to non-burned RV but not in the LV (p = 0.0022). In contrast, beta(2)-AR expression was unaltered among the groups while G(ai) expression was significantly higher in the LV post-burn (p = 0.023). B-arrestin-1 and G-protein coupled receptor kinase-2 mRNA expression were significantly increased in the left ventricle post-burn (p = 0.001, p<0.0001, respectively). cAMP production and PKA activity were significantly lower in the LV post-burn (p = 0.0063, 0.0042, respectively). These data indicate that burn injury affects the beta-AR signaling pathway in the RV independently of the LV. Additionally, non-canonical beta-AR signaling may be activated in the RV as cAMP production and PKA activity were unchanged despite changes in beta(1)-AR protein expression.	[Guillory, Ashley N.; Prasal, Anesh; El Ayadi, Amina; Herndon, David N.; Finnerty, Celeste C.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Guillory, Ashley N.; Prasal, Anesh; El Ayadi, Amina; Herndon, David N.; Finnerty, Celeste C.] Shriners Hosp Children Galveston, Galveston, TX 77550 USA; [Guillory, Ashley N.; Clayton, Robert P.; El Ayadi, Amina; Herndon, David N.; Finnerty, Celeste C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Guillory, Ashley N.] Univ Texas Med Branch, Dept Phys Assistant Studies, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Finnerty, CC (corresponding author), Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA.; Finnerty, CC (corresponding author), Shriners Hosp Children Galveston, Galveston, TX 77550 USA.; Finnerty, CC (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.	ccfinner@utmb.edu	Herndon, David/AAC-3354-2020	El Ayadi, Amina/0000-0002-3657-0633	National Institutes of Health [P50-GM60338, R01GM056687, R01GM112936]; Shriners Hospitals for Children [80100, 84291, 80500, 84202, 71001]; Institute for Translational Sciences at the University of Texas Medical Branch; National Center for Advancing Translational Sciences, National Institutes of Health [UL1RR029876]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; Institute for Translational Sciences at the University of Texas Medical Branch; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grants from the National Institutes of Health (P50-GM60338 [DNH], R01GM056687 [DNH], R01GM112936 [CCF]; https://www.nih.gov/) and Shriners Hospitals for Children (80100 [DNH], 84291 [CCF], 80500 [DNH], 84202 [CCF], 71001 [DNH]; https://www.shrinershospitalsforchildren.org/). This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1RR029876 [awarded to Allen Brasier, UTMB) from the National Center for Advancing Translational Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2006, J AM COLL CARDIOL, V48, P1387, DOI 10.1016/j.jacc.2006.06.048; Bartel S, 1996, MOL CELL BIOCHEM, V157, P171; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Brooks NC, 2012, MOL MED, V18, P707, DOI 10.2119/molmed.2011.00277; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Debette S, 2011, CIRC RES, V109, P554, DOI 10.1161/CIRCRESAHA.111.243790; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; FELDMAN AM, 1989, J MOL CELL CARDIOL, V21, P359, DOI 10.1016/0022-2828(89)90646-9; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Fischer V, 2008, ANN NY ACAD SCI, V1148, P400, DOI 10.1196/annals.1410.013; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Fu Q, 2015, CELL SIGNAL, V27, P707, DOI 10.1016/j.cellsig.2014.11.018; Guillory AN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010053; Guillory AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074784; HERNDON DN, 1978, J SURG RES, V25, P394, DOI 10.1016/S0022-4804(78)80003-1; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Infanger M, 2004, BURNS, V30, P305, DOI 10.1016/j.burns.2003.12.006; Irlbeck M, 1996, CARDIOVASC RES, V31, P157, DOI 10.1016/0008-6363(95)00188-3; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Katz AM, 2000, CIRCULATION, V102, P69; Koshy US, 1997, J SURG RES, V68, P133, DOI 10.1006/jsre.1997.5032; Kulp GA, 2010, SHOCK, V33, P369, DOI 10.1097/SHK.0b013e3181b92340; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luttrell LM, 2002, J CELL SCI, V115, P455; Molina CE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000858; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; NEUMANN J, 1988, LANCET, V2, P936; Pereira CT, 2006, J AM COLL SURGEONS, V202, P536, DOI 10.1016/j.jamcollsurg.2005.11.002; Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Pucci A, 2009, J HEART LUNG TRANSPL, V28, P402, DOI 10.1016/j.healun.2008.12.022; RAAB W, 1960, AM J CARDIOL, V5, P571, DOI 10.1016/0002-9149(60)90121-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spasojevic N, 2011, PHYSIOL RES, V60, pS171, DOI 10.33549/physiolres.932173; Sun LS, 1997, PEDIATR RES, V42, P12, DOI 10.1203/00006450-199707000-00003; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; Wang C, 1996, CRIT CARE MED, V24, P118, DOI 10.1097/00003246-199601000-00020; Williams FN, 2011, J BURN CARE RES, V32, P269, DOI 10.1097/BCR.0b013e31820aafcf; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189527	10.1371/journal.pone.0189527	http://dx.doi.org/10.1371/journal.pone.0189527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232706	Green Published, gold			2022-12-26	WOS:000417698200056
J	Struelens, Q; Pomar, KG; Herrera, SL; Huanca, GN; Dangles, O; Rebaudo, F				Struelens, Quentin; Gonzales Pomar, Karina; Loza Herrera, Susi; Nina Huanca, Gaby; Dangles, Olivier; Rebaudo, Francois			Market access and community size influence pastoral management of native and exotic livestock species: A case study in communities of the Cordillera Real in Bolivia's high Andean wetlands	PLOS ONE			English	Article							GRAZING BEHAVIOR; POPULATION; BIODIVERSITY; LAND; INSTITUTIONS; ALTIPLANO; RESOURCES; DYNAMICS; DENSITY; SYSTEMS	Grazing areas management is of utmost importance in the Andean region. In the valleys of the Bolivian Cordillera Real near La Paz, pastoralism constitutes the traditional way for people to insure food security and economical sustainability. In these harsh mountains, unique and productive wetlands sustained by glacial water streams are of utmost importance for feeding cattle herds during the dry season. After the colonization by the Spanish, a shift in livestock species has been observed, with the introduction of exotic species such as cows and sheep, resulting in a different impact on pastures compared to native camelid species-llamas and alpacas. Here we explored some of the social-economical and environmental drivers that motivate Bolivian pastoralists to prefer exotic over native livestock species, based on 36 household surveys in the Cordillera Real. We constructed a Partial Least Squares Structural Equation Model in order to assess the relationships between these drivers. Our results suggest that the access to market influenced pastoralists to reshape their herd composition, by increasing the number of sheep. They also suggest that community size increased daily grazing time in pastures, therefore intensifying the grazing pressure. At a broader scale, this study highlights the effects of some social-economical and environmental drivers on mountain herding systems.	[Struelens, Quentin; Dangles, Olivier; Rebaudo, Francois] UnivParisSud, CNRS, IRD, ParisSaclay,UMR EGCE, Gif Sur Yvette, France; [Struelens, Quentin; Rebaudo, Francois] Univ Mayor San Marcos, Inst Ecol, Ctr Anal Espacial, La Paz, Bolivia; [Gonzales Pomar, Karina; Loza Herrera, Susi; Nina Huanca, Gaby] Univ Mayor San Marcos, Inst Ecol, Ctr Postgrad Ecol & Conservac, La Paz, Bolivia; [Loza Herrera, Susi] Herbario Nacl Bolivia, Convenio IE MNHN, La Paz, Bolivia; [Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Universidad Nacional Mayor de San Marcos; Universidad Nacional Mayor de San Marcos; Pontificia Universidad Catolica del Ecuador	Struelens, Q; Rebaudo, F (corresponding author), UnivParisSud, CNRS, IRD, ParisSaclay,UMR EGCE, Gif Sur Yvette, France.; Struelens, Q; Rebaudo, F (corresponding author), Univ Mayor San Marcos, Inst Ecol, Ctr Anal Espacial, La Paz, Bolivia.	quentin.struelens@ird.fr; francois.rebaudo@ird.fr	Rebaudo, Francois/AAA-7176-2020; Struelens, Quentin/AAE-2658-2019; Rebaudo, Francois/F-9115-2011	Rebaudo, Francois/0000-0002-3672-0101; Rebaudo, Francois/0000-0002-3672-0101; Struelens, Quentin Francois/0000-0002-8747-2988	Fond Francais pour l'Environnement Mondial; Fondation pour la Recherche sur la Biodiversite	Fond Francais pour l'Environnement Mondial; Fondation pour la Recherche sur la Biodiversite	This work was funded by the Fond Francais pour lEnvironnement Mondial (http://www.ffem.fr/fr) and the Fondation pour la Recherche sur la Biodiversite (http://www.fondationbiodiversite.fr/fr/) (Modeling biodiversity and land use interactions under changing glacial water availability in tropical high Andean wetlands - BIOTHAW, AAP-SCEN-2011-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 1997, DEV CHANGE, V28, P435, DOI 10.1111/1467-7660.00050; Ambelu A, 2017, WEATHER CLIM EXTREME, V17, P7, DOI 10.1016/j.wace.2017.06.001; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; Westreicher CA, 2007, NOMAD PEOPLES, V11, P87, DOI 10.3167/np.2007.110205; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Ansaloni F, 2013, BIO-BASED APPL ECON, V2, P173; Anthelme F, 2014, ARCT ANTARCT ALP RES, V46, P811, DOI 10.1657/1938-4246-46.4.811; Bah A, 2006, MATH COMPUT MODEL, V44, P513, DOI 10.1016/j.mcm.2005.02.014; BAIED CA, 1993, MT RES DEV, V13, P145, DOI 10.2307/3673632; Bebbington A, 1999, WORLD DEV, V27, P2021, DOI 10.1016/S0305-750X(99)00104-7; Blench R., 2001, YOU CANT GO HOME AGA; Bonacic C., 1991, AV EN CIENC VET, V6; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; BROWMAN DL, 1974, CURR ANTHROPOL, V15, P188, DOI 10.1086/201455; Buttolph LP, 2004, J APPL ECOL, V41, P664, DOI 10.1111/j.0021-8901.2004.00921.x; Campero J, 2004, SITUACION RECURSOS Z; Castellaro G. G., 2004, Agricultura Tecnica, V64, P353; Chin W.W., 1999, STAT STRATEG SMALL S, V1, P307, DOI DOI 10.1093/deafed/enz026; Dangles O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175814; del Monte-Luna P, 2004, GLOBAL ECOL BIOGEOGR, V13, P485, DOI 10.1111/j.1466-822X.2004.00131.x; Dong SK, 2011, ECOL SOC, V16; DUMONT B, 1995, SMALL RUMINANT RES, V16, P27, DOI 10.1016/0921-4488(94)00036-7; ENSMINGER J, 1991, AM ETHNOL, V18, P683, DOI 10.1525/ae.1991.18.4.02a00030; Forester DJ, 1996, CONSERV BIOL, V10, P1253, DOI 10.1046/j.1523-1739.1996.10041253.x; Franklin W., 1982, MAMMALIAN BIOL S AM, V6, P57; GALVIN KA, 1992, AM J HUM BIOL, V4, P209, DOI 10.1002/ajhb.1310040206; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; GENIN D, 1994, J RANGE MANAGE, V47, P245, DOI 10.2307/4003025; Gideon L., 2012, HDB SURVEY METHODOLO, P108, DOI DOI 10.1007/978-1-4614-3876-2; Goodale MRG, 2001, J RURAL STUD, V17, P183, DOI 10.1016/S0743-0167(00)00041-3; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Henrich J, 1997, HUM ECOL, V25, P319, DOI 10.1023/A:1021982324396; HOYLE RH, 1994, J CONSULT CLIN PSYCH, V62, P429, DOI 10.1037/0022-006X.62.3.429; Huayhua M., 2013, REV CAD CEOM, V26, P33; Kadwell M, 2001, P ROY SOC B-BIOL SCI, V268, P2575, DOI 10.1098/rspb.2001.1774; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Latan H, 2013, RESULTS PARTIAL LEAS; Lopez-i-Gelats F, 2015, HUM ECOL, V43, P267, DOI 10.1007/s10745-015-9731-7; Loza Herrera Susi, 2015, Ecología en Bolivia, V50, P39; McKinney LA, 2010, ORGAN ENVIRON, V23, P3, DOI 10.1177/1086026609358965; Molinillo M, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P137; Nina Huanca G, 2015, SER HUMANO ACTOR DIN; Ostrom E., 1994, RULES GAMES COMMON P; PFISTER JA, 1989, APPL ANIM BEHAV SCI, V23, P237, DOI 10.1016/0168-1591(89)90114-7; Poteete AR, 2004, DEV CHANGE, V35, P435, DOI 10.1111/j.1467-7660.2004.00360.x; Preston D, 2003, MT RES DEV, V23, P141, DOI 10.1659/0276-4741(2003)023[0141:GAECOT]2.0.CO;2; Quenta E, 2016, GLOBAL CHANGE BIOL, V22, P3196, DOI 10.1111/gcb.13310; R Core Team, 2021, R LANGUAGE ENV STAT; Rundel PW, 2000, MT RES DEV, V20, P262, DOI 10.1659/0276-4741(2000)020[0262:PTUPEO]2.0.CO;2; San Martin F, 1989, INVESTIG PASTOS FORR, V6; Sanchez G., 2013, PLS PATH MODELING R; Schumacker R.E., 2004, BEGINNERS GUIDE STRU, V2nd ed.; Shaw AK, 2012, J MAMMAL, V93, P658, DOI 10.1644/11-MAMM-A-257.1; Squeo FA, 2006, BOFEDALES HIGH ALTIT; Swepston L., 1990, OKLAHOMA CITY U L RE, V15, P677; Upton M., 2011, GUIDELINES PREPARATI; Verzijl A, 2013, MT RES DEV, V33, P280, DOI 10.1659/MRD-JOURNAL-D-12-00123.1; Vinzi V. E., 2010, HDB PARTIAL LEAST SQ, DOI [DOI 10.1007/978-3-540-32827-8_29, DOI 10.1007/978-3-540-32827-8]; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Winkel T, 2016, GLOBAL ENVIRON CHANG, V39, P195, DOI 10.1016/j.gloenvcha.2016.05.007; Wood EC, 2004, J ARID ENVIRON, V59, P565, DOI 10.1016/j.jaridenv.2004.03.022; Wurzinger M, 2008, J ANIM BREED GENET, V125, P311, DOI 10.1111/j.1439-0388.2007.00713.x; Yager K., 2008, PIRINEOS, V163, P97, DOI DOI 10.3989/PIRINE0S.2008.V163.25	63	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189409	10.1371/journal.pone.0189409	http://dx.doi.org/10.1371/journal.pone.0189409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP5GS	29228062	gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600053
J	Sulykos, I; Gaal, ZA; Czigler, I				Sulykos, Istvan; Gaal, Zsofia Anna; Czigler, Istvan			Visual mismatch negativity to vanishing parts of objects in younger and older adults	PLOS ONE			English	Article							DICHOPTIC BACKWARD-MASKING; AGE-RELATED-CHANGES; EVOKED-POTENTIALS; PATTERN-REVERSAL; ATTENTION	We investigated visual mismatch negativity (vMMN) to vanishing parts of continuously present objects by comparing the event-related potentials (ERPs) to infrequently (deviant) and frequently (standard) disappearing parts of the objects. This paradigm both excludes low-level stimulus-specific adaptation differences between the responses to deviants and standards, and increases the ecological validity of the stimuli. In comparison to frequently disappearing parts of the stimulus objects, infrequently vanishing parts elicited posterior negative event-related brain activity (vMMN). However, no vMMN emerged to the reappearance of the same parts of the objects. We compared the ERPs of an older and a younger sample of participants. In the 120-180 ms time period vMMN was similar in the two age groups, but in the 180-220 ms time period vMMN emerged only in the younger participants. We consider this difference as an index of more elaborate automatic processing of infrequent stimulus changes in younger adults.	[Sulykos, Istvan; Gaal, Zsofia Anna; Czigler, Istvan] HAS, Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Sulykos, Istvan] Eotvos Lorand Univ, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University	Sulykos, I (corresponding author), HAS, Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.; Sulykos, I (corresponding author), Eotvos Lorand Univ, Budapest, Hungary.	sulykos.istvan@ttk.mta.hu		Czigler, Istvan/0000-0003-1661-3808	National Research Found of Hungary [OTKA 104462, 115457]; Hungarian Academy of Sciences	National Research Found of Hungary; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the National Research Found of Hungary (OTKA 104462 and 115457), http://www.otka.hu/en and the Janos Bolyal Research Scholarship of the Hungarian Academy of Sciences, http://mta.hu/.; The study was supported the by the National Research Found of Hungary (OTKA 104462 and 115457) and by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. We thank Dr. Szonya Durant and Dr. Dagmar Muller for the helpful comments. We thank for the technical assistance by Zsuzsa d'Albini and Zsuzsa Kovacs.	Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Bendixen A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00060; Berti S, 2011, NEUROREPORT, V20, P702; Besle J, 2005, EXP BRAIN RES, V166, P337, DOI 10.1007/s00221-005-2375-x; Bradley NJ, 2015, J VIS, V15, P1; Cheng CH, 2013, INT J PSYCHOPHYSIOL, V90, P165, DOI 10.1016/j.ijpsycho.2013.06.026; Clery H, 2012, NEUROPSYCHOLOGIA, V50, P979, DOI 10.1016/j.neuropsychologia.2012.01.035; CRAMER G, 1982, EXP AGING RES, V8, P103, DOI 10.1080/03610738208258405; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; Czigler I, 2007, PSYCHOPHYSIOLOGY, V44, P610, DOI 10.1111/j.1469-8986.2007.00530.x; Czigler I, 2014, COGN AFFECT BEHAV NE, V14, P278, DOI 10.3758/s13415-013-0193-3; Czigler I, 2014, BRAIN TOPOGR, V27, P590, DOI 10.1007/s10548-013-0316-8; DILOLLO V, 1982, J EXP PSYCHOL HUMAN, V8, P225, DOI 10.1037/0096-1523.8.2.225; Gaal ZA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00015; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Hahn S, 1995, PSYCHOL AGING, V10, P597, DOI 10.1037/0882-7974.10.4.597; Harris JA, 2011, J VISION, V11, DOI 10.1167/11.7.3; Hoshiyama M, 2001, BRAIN TOPOGR, V13, P293, DOI 10.1023/A:1011132830123; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jeffreys D. A., 1977, SPATIAL CONTRAST, P80; Kecskes-Kovacs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00532; Kecskes-Kovacs K, 2013, EUR J NEUROSCI, V37, P662, DOI 10.1111/ejn.12061; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Kimura M, 2010, NEUROSCI LETT, V485, P198, DOI 10.1016/j.neulet.2010.09.011; Kimura M, 2009, PSYCHOPHYSIOLOGY, V46, P402, DOI 10.1111/j.1469-8986.2008.00767.x; KLINE D W, 1976, Experimental Aging Research, V2, P333, DOI 10.1080/03610737608257990; KLINE DW, 1978, J GERONTOL, V33, P76, DOI 10.1093/geronj/33.1.76; Koivisto M, 2007, NEUROREPORT, V18, P753, DOI 10.1097/WNR.0b013e3280c143c8; Kovacs I, 1996, BEHAV BRAIN RES, V82, P1, DOI 10.1016/S0166-4328(97)81103-5; Kramer AF, 1995, PSYCHOL SCI, V6, P381, DOI 10.1111/j.1467-9280.1995.tb00530.x; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Kremlacek J, 2006, VISION RES, V46, P485, DOI 10.1016/j.visres.2005.10.001; Kremlacek J, 2016, CORTEX, V80, P76, DOI 10.1016/j.cortex.2016.03.017; Lorenzo-Lopez L, 2004, NEUROREPORT, V15, P2633, DOI 10.1097/00001756-200412030-00015; Mezer E, 2004, DOC OPHTHALMOL, V109, P229, DOI 10.1007/s10633-004-8055-5; Mounts JRW, 2005, ACTA PSYCHOL, V118, P261, DOI 10.1016/j.actpsy.2004.09.001; Mueller D, 2013, FRONT HUMAN NEUROSCI, V7; Muller D, 2012, BRAIN RES, V1472, P89, DOI 10.1016/j.brainres.2012.07.016; Muller D, 2010, J COGNITIVE NEUROSCI, V22, P1179, DOI 10.1162/jocn.2009.21271; Muller D., 2013, FRONT HUM NEUROSCI, V7, P1; O'Shea RP, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00038; Ortells JJ, 2016, COGNITION, V146, P143, DOI 10.1016/j.cognition.2015.09.012; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Roinishvili M, 2011, VISION RES, V51, P417, DOI 10.1016/j.visres.2010.12.011; Rousselet GA, 2004, TRENDS COGN SCI, V8, P363, DOI 10.1016/j.tics.2004.06.003; Salthouse TA, 1982, THEORY COGNITIVE AGI; Samuel AG, 2001, J EXP PSYCHOL HUMAN, V27, P1433, DOI 10.1037/0096-1523.27.6.1433; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Shawkat FS, 1997, DOC OPHTHALMOL, V94, P307, DOI 10.1007/BF02580856; Stefanics G, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01074; Stefanics G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00666; Stothart G, 2013, NEUROBIOL AGING, V34, P1302, DOI 10.1016/j.neurobiolaging.2012.08.012; Susac A, 2014, BRAIN TOPOGR, V27, P648, DOI 10.1007/s10548-013-0340-8; Takeshima Y, 2016, EXP BRAIN RES, V234, P549, DOI 10.1007/s00221-015-4486-3; Tales A, 2002, NEUROREPORT, V13, P969, DOI 10.1097/00001756-200205240-00014; Urakawa T, 2010, NEUROIMAGE, V52, P302, DOI 10.1016/j.neuroimage.2010.03.071; Urban A, 2011, SCHIZOPH RES, V102, P320; WALSH DA, 1976, J GERONTOL, V31, P178, DOI 10.1093/geronj/31.2.178; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winkler I, 2005, J COGNITIVE NEUROSCI, V17, P320, DOI 10.1162/0898929053124866; Zhang DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049517	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188929	10.1371/journal.pone.0188929	http://dx.doi.org/10.1371/journal.pone.0188929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP5GS	29228033	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600018
J	Truong, VT; Li, CY; Brown, RL; Moore, RA; Garcia, VF; Crotty, EJ; Taylor, MD; Ngo, TMN; Mazur, W				Truong, Vien T.; Li, Candice Y.; Brown, Rebeccah L.; Moore, Ryan A.; Garcia, Victor F.; Crotty, Eric J.; Taylor, Michael D.; Ngo, Tam M. N.; Mazur, Wojciech			Occult RV systolic dysfunction detected by CMR derived RV circumferential strain in patients with pectus excavatum	PLOS ONE			English	Article							RIGHT-VENTRICULAR FUNCTION; MAGNETIC-RESONANCE; TISSUE TRACKING; REPAIR; CHILDREN; SURGERY; PATTERN; INDEX	Aims To investigate the right ventricular (RV) strain in pectus excavatum (PE) patients using cardiac magnetic resonance tissue tracking (CMR TT). Materials and methods Fifty consecutive pectus excavatum patients, 10 to 32 years of age (mean age 15 +/- 4 years), underwent routine cardiac magnetic resonance imaging (CMR) including standard measures of chest geometry and cardiac size and function. The control group consisted of 20 healthy patients with a mean age of 17 +/- 5 years. RV longitudinal and circumferential strain magnitude was assessed by a dedicated RV tissue tracking software. Results Fifty patients with images of sufficient quality were included in the analysis. The mean right and left ventricular ejection fractions were 55 +/- 5% and 59 +/- 4%. The RV global longitudinal strain was -21.88 +/- 4.63%. The RV circumferential strain at base, mid-cavity and apex were -13.66 +/- 3.09%, -11.31 +/- 2.79%, -20.73 +/- 3.45%, respectively. There was no statistically significant decrease in right ventricular or left ventricular ejection fraction between patients and controls (p > 0.05 for each). There was no significant difference in RV global longitudinal strain between two groups (-21.88 +/- 4.63 versus -21.99 +/- 3.58; p = 0.93). However, there was significant decrease in mid-cavity circumferential strain magnitude in pectus patients compared with controls (-11.31 +/- 2.79 versus -16.19 +/- 2.86; p < 0.001). PE patients had a significantly higher basal circumferential strain (-13.66 +/- 3.09% versus -9.76 +/- 1.79; p < 0.001) as well as apical circumferential strain (-20.73 +/- 3.45% versus -12.07 +/- 3.38) than control group. Conclusion Mid-cavity circumferential strain but not longitudinal strain is reduced in pectus excavatum patients. Basal circumferential strain as well as apical circumferential strain were increased as compensatory mechanism for reduced mid-cavity circumferential strain. Further studies are needed to establish clinical significance of this finding.	[Truong, Vien T.; Mazur, Wojciech] Christ Hosp, Dept Cardiol, Cincinnati, OH 45219 USA; [Truong, Vien T.; Ngo, Tam M. N.] Pham Ngoc Thach Univ Med, Dept Cardiol, Ho Chi Minh City, Vietnam; [Li, Candice Y.; Moore, Ryan A.; Taylor, Michael D.] Cincinnati Childrens Hosp Med Ctr, Dept Cardiol, Cincinnati, OH 45229 USA; [Brown, Rebeccah L.; Garcia, Victor F.] Cincinnati Childrens Hosp Med Ctr, Dept Surg, Cincinnati, OH 45229 USA; [Crotty, Eric J.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA	Christ Hospital - Ohio; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Mazur, W (corresponding author), Christ Hosp, Dept Cardiol, Cincinnati, OH 45219 USA.	mazurw@ohioheart.org						Bistoquet A, 2008, MED IMAGE ANAL, V12, P69, DOI 10.1016/j.media.2007.10.009; Fagelman KM, 2015, J PEDIATR SURG, V50, P1130, DOI 10.1016/j.jpedsurg.2014.11.043; Feng JX, 2001, J PEDIATR SURG, V36, P1770, DOI 10.1053/jpsu.2001.28820; Fokin AA, 2009, SEMIN THORAC CARDIOV, V21, P44, DOI 10.1053/j.semtcvs.2009.03.001; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; HALLER JA, 1987, J PEDIATR SURG, V22, P904, DOI 10.1016/S0022-3468(87)80585-7; Harrild DM, 2012, INT J CARDIOVAS IMAG, V28, P2009, DOI 10.1007/s10554-012-0035-3; Hor KN, 2010, JACC-CARDIOVASC IMAG, V3, P144, DOI 10.1016/j.jcmg.2009.11.006; Jaroszewski D, 2010, J AM BOARD FAM MED, V23, P230, DOI 10.3122/jabfm.2010.02.090234; Jaroszewski DE, 2007, ANN THORAC SURG, V84, P429, DOI 10.1016/j.athoracsur.2007.03.077; Kind T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-35; Kowalewski J, 1999, J THORAC CARDIOV SUR, V118, P87, DOI 10.1016/S0022-5223(99)70145-5; Levy PT, 2014, J AM SOC ECHOCARDIOG, V27, P549, DOI 10.1016/j.echo.2014.01.015; de Siqueira MEM, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0258-x; Oezcan S, 2012, EUR HEART J-CARD IMG, V13, P673, DOI 10.1093/ehjci/jer284; Pettersen E, 2007, J AM COLL CARDIOL, V49, P2450, DOI 10.1016/j.jacc.2007.02.062; Raina A, 2013, J HEART LUNG TRANSPL, V32, P777, DOI 10.1016/j.healun.2013.05.004; Saleh RS, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-73; Sigalet DL, 2003, J PEDIATR SURG, V38, P380, DOI 10.1053/jpsu.2003.50112; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; St Peter SD, 2011, J PEDIATR SURG, V46, P2270, DOI 10.1016/j.jpedsurg.2011.09.009; Tandon A, 2014, J CARDIOVASC MAGN R, V16, pP250, DOI [10.1186/1532-429X-16-S1-P250, DOI 10.1186/1532-429X-16-S1-P250]; Topper A, 2016, INTERACT CARDIOV TH, V22, P38, DOI 10.1093/icvts/ivv286; Truong VT, 2017, MAGN RESON IMAGING, V38, P189, DOI 10.1016/j.mri.2017.01.007	24	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189128	10.1371/journal.pone.0189128	http://dx.doi.org/10.1371/journal.pone.0189128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228013	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600035
J	Suzuki, C; Aoki-Yoshida, A; Aoki, R; Sasaki, K; Takayama, Y; Mizumachi, K				Suzuki, Chise; Aoki-Yoshida, Ayako; Aoki, Reiji; Sasaki, Keisuke; Takayama, Yoshiharu; Mizumachi, Koko			The distinct effects of orally administered Lactobacillus rhamnosus GG and Lactococcus lactis subsp lactis C59 on gene expression in the murine small intestine	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; STRAIN GG; PROBIOTICS; OLIGODEOXYNUCLEOTIDE; EXOPOLYSACCHARIDE; BIOSYNTHESIS; MODULATION; PREVENTION; COMMENSAL; ADHESION	The molecular mechanisms of strain-specific probiotic effects and the impact of the oral administration of probiotic strains on the host's gene expression are not yet well understood. The aim of this study was to investigate the strain-specific effects of probiotic strain intake on gene expression in the murine small intestine. Two distinct strains of lactic acid bacteria, Lactobacillus rhamnosus GG (GG) and Lactococcus lactis subsp. lactis C59 (C59), were orally administered to BALB/c mice, daily for 2 weeks. The total RNA was isolated from the upper (including the duodenum) and lower (the terminal ileum) small intestine, and gene expression was assessed by microarray analysis. The data revealed (1) oral administration of C59 and GG markedly down-regulated the expression of genes encoding fibrinogen subunits and plasminogen in the upper small intestine; (2) administration of more than 1 x 10(7) CFU/day of GG changed the gene expression of the host ileum. (3) strain-and dose-related effects on various GO biological processes; and (4) enrichment for B cell-related Gene Ontology terms among up-regulated genes in the terminal ileum of mice administered the 1 x 10(9) CFU/day of GG. The distinct effects of GG and C59 on gene expression in the intact small intestine provide clues to understand how the health beneficial effects of specific strains of probiotic bacteria are mediated by interactions with intestinal cells.	[Suzuki, Chise; Aoki-Yoshida, Ayako; Aoki, Reiji; Sasaki, Keisuke; Takayama, Yoshiharu; Mizumachi, Koko] Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Aoki-Yoshida, Ayako] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Mizumachi, Koko] NARO, Western Reg Agr Res Ctr, Fukuyama, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan; University of Tokyo; National Agriculture & Food Research Organization - Japan	Suzuki, C (corresponding author), Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan.	csuzuki@affrc.go.jp	Takayama, Yoshiharu/M-8826-2019; SUZUKI, Chise/AAR-1986-2020; Takayama, Yoshiharu/E-3662-2010; Sasaki, Keisuke/AAK-3516-2020; Aoki, Ayako/GXV-4979-2022	Takayama, Yoshiharu/0000-0003-4532-7114; SUZUKI, Chise/0000-0001-7148-8101; Takayama, Yoshiharu/0000-0003-4532-7114; Aoki, Ayako/0000-0003-4535-8586	Ministry of Agriculture, Forestry, and Fisheries (MAFF); Council for Science, Technology, and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next generation agriculture, forestry, and fisheries (Japanese)" (NARO) [14532924]	Ministry of Agriculture, Forestry, and Fisheries (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); Council for Science, Technology, and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next generation agriculture, forestry, and fisheries (Japanese)" (NARO)	This study was supported in part by a grant "Development of evaluation and management methods for supply of safe, reliable, and functional food and farm produce (2006-2010)" from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) to CS; and by the Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next generation agriculture, forestry, and fisheries (grant no. 14532924, URL http://www.naro.affrc.go.jp/brain/sip/introduction/index.html (Japanese)" (NARO) to YT, CS, MY, and RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Yoshida A, 2016, BENEF MICROBES, V7, P421, DOI 10.3920/BM2015.0169; Aoki-Yoshida A, 2016, J PROTEOME RES, V15, P3126, DOI 10.1021/acs.jproteome.6b00262; Ballouz S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw957; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Canani RB, 2017, J ALLERGY CLIN IMMUN, V139, P1906, DOI 10.1016/j.jaci.2016.10.050; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Carasi P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/361604; Collado MC, 2015, PEDIATR RES, V77, P182, DOI 10.1038/pr.2014.173; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Claes IJJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-161; Di Caro S, 2005, DIGEST LIVER DIS, V37, P320, DOI 10.1016/j.dld.2004.12.008; Espino E, 2015, J PROTEOME RES, V14, P1010, DOI 10.1021/pr501041a; FAO/WHO, 2002, GUIDL EV PROB FOODS; Finamore A, 2012, J NUTR, V142, P375, DOI 10.3945/jn.111.148924; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; GORBACH SL, 1987, LANCET, V2, P1519; Harata G, 2016, EUR J NUTR; Haro C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-28; He F, 2005, MICROBIOL IMMUNOL, V49, P995; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Iliev ID, 2008, SCAND J IMMUNOL, V67, P370, DOI 10.1111/j.1365-3083.2008.02080.x; Iliev ID, 2005, CELL MICROBIOL, V7, P403, DOI 10.1111/j.1462-5822.2004.00470.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isolauri E, 2003, GUT, V52, P436, DOI 10.1136/gut.52.3.436; KAILA M, 1995, ARCH DIS CHILD, V72, P51, DOI 10.1136/adc.72.1.51; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kikuchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086416; Kitazawa H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00201; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; McDonald KG, 2007, BIOTECHNIQUES, V43, P50, DOI 10.2144/000112514; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; McDonald KG, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-1; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyazawa K, 2015, MICROBIOL IMMUNOL, V59, P99, DOI 10.1111/1348-0421.12226; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Nomura M, 2012, BIOSCI BIOTECH BIOCH, V76, P1459, DOI 10.1271/bbb.120121; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Suzuki C, 2008, INT J FOOD MICROBIOL, V123, P159, DOI 10.1016/j.ijfoodmicro.2007.12.022; Suzuki C, 2013, BIOSCI BIOTECH BIOCH, V77, P2013, DOI 10.1271/bbb.130322; Szajewska H, 2013, ALIMENT PHARM THER, V38, P467, DOI 10.1111/apt.12403; Tuomola EM, 1998, INT J FOOD MICROBIOL, V41, P45, DOI 10.1016/S0168-1605(98)00033-6; Uematsu Satoshi, 2008, V183, P1; Vajro P, 2011, J PEDIATR GASTR NUTR, V52, P740, DOI 10.1097/MPG.0b013e31821f9b85; Vandenplas Y, 2015, J PEDIAT-BRAZIL, V91, P6, DOI 10.1016/j.jped.2014.08.005; Velez MP, 2007, APPL ENVIRON MICROB, V73, P3595, DOI 10.1128/AEM.02083-06; Yan F, 2017, MUCOSAL IMMUNOL, V10, P117, DOI 10.1038/mi.2016.43; Yoshida A, 2011, FEMS IMMUNOL MED MIC, V61, P315, DOI 10.1111/j.1574-695X.2010.00777.x	58	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188985	10.1371/journal.pone.0188985	http://dx.doi.org/10.1371/journal.pone.0188985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220366	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900023
J	Gong, J; Bai, T; Zhang, L; Qian, W; Song, J; Hou, XH				Gong, Jing; Bai, Tao; Zhang, Lei; Qian, Wei; Song, Jun; Hou, Xiaohua			Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; GUT MICROBIOTA; GASTROINTESTINAL MOTILITY; INTESTINAL MICROBIOTA; PROBIOTIC BACTERIA; RHAMNOSUS GG; METAANALYSIS; DISEASE; TRANSIT; PREVENTION	Objective To investigate the effects of four strains, generally used in clinic, including Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis, and their related products on human colonic smooth muscle in vitro. Methods Human colonic circular muscle strips obtained from disease-free margins of resected segments from 25 patients with colorectal cancer were isometrically examined in a constant-temperature organ bath and exposed to different concentrations of living bacteria, sonicated cell fractions and cell-free supernatant (CFS). The area under the curve (AUC) representing the contractility of smooth muscle strips was calculated. Results (1) The four living probiotics inhibited the contractility of human colonic muscle strips only at high concentration (10 10 CFUs/mL, all P<0.05). (2) The sonicated cell fractions from the four probiotics obviously inhibited human colonic smooth muscle strips in a dose-dependent manner (P<0.01). (3) The CFS from the four probiotics also inhibited colonic smooth muscle strips in a dose-dependent manner (all P<0.05). (4) The inhibition effect of CFS from Streptococcus thermophilus and Enterococcus faecalis decreased obviously when pretreated with NG-nitro-L-arginine (L-NNA, 10(-5) mol/L) (P<0.05), but not the Bifidobacterium longum and Lactobacillus acidophilus (P>0.05). Conclusion Four common probiotics related products, including the sonicated cell fractions and the CFS, obviously inhibited human colonic smooth muscles strips contraction in a dose-dependent manner. Only high concentration living probiotics (10(10) CFUs/mL) can inhibit the colonic smooth muscles strips contraction. The NO pathway may be partly involved in the inhibitory effect of CFS from Streptococcus thermophilus and Enterococcus faecalis.	[Gong, Jing; Bai, Tao; Zhang, Lei; Qian, Wei; Song, Jun; Hou, Xiaohua] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Song, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan, Hubei, Peoples R China.	song111jun@126.com	Song, Jun/T-7177-2019; Bai, Tao/ABD-7952-2020	Song, Jun/0000-0002-0255-4547; 	 [81330014];  [81670488]	; 	This work was supported by 81330014, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, Xiaohua Hou, 2014.01 to 2018.12; 81670488, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prisearch-list, Jun Song, 2017.01 to 2020.12.	Ammoscato F, 2013, NEUROGASTROENT MOTIL, V25, P984, DOI 10.1111/nmo.12232; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; Bermudez-Brito M, 2014, BRIT J NUTR, V111, P1727, DOI 10.1017/S0007114513004303; Dore J, 2013, UNITED EUR GASTROENT, V1, P311, DOI 10.1177/2050640613502477; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Gorbach SL, 2002, DIGEST LIVER DIS, V34, pS2, DOI 10.1016/S1590-8658(02)80155-4; Grasa L, 2015, MICROB ECOL, V70, P835, DOI 10.1007/s00248-015-0613-8; Guarino MPL, 2008, J CLIN GASTROENTEROL, V42, pS185, DOI 10.1097/MCG.0b013e31817e1cac; Kale-Pradhan PB, 2010, PHARMACOTHERAPY, V30, P119, DOI 10.1592/phco.30.2.119; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Korhonen R, 2001, INFLAMMATION, V25, P223, DOI 10.1023/A:1010971703271; Marchesi J, 2007, CURR OPIN INFECT DIS, V20, P508, DOI 10.1097/QCO.0b013e3282a56a99; Massi M, 2006, WORLD J GASTROENTERO, V12, P5987, DOI 10.3748/wjg.v12.i37.5987; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; Miller LE, 2013, WORLD J GASTROENTERO, V19, P4718, DOI 10.3748/wjg.v19.i29.4718; Molina MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127262; Orel R, 2014, WORLD J GASTROENTERO, V20, P11505, DOI 10.3748/wjg.v20.i33.11505; Ortiz-Lucas M, 2013, REV ESP ENFERM DIG, V105, P19, DOI 10.4321/s1130-01082013000100005; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sanders ME, 2013, GUT, V62, P787, DOI 10.1136/gutjnl-2012-302504; Sobko T, 2006, FREE RADICAL BIO MED, V41, P985, DOI 10.1016/j.freeradbiomed.2006.06.020; Valentin N, 2015, EXPERT OPIN INV DRUG, V24, P769, DOI 10.1517/13543784.2015.1025132; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012	28	9	9	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189257	10.1371/journal.pone.0189257	http://dx.doi.org/10.1371/journal.pone.0189257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216305	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800109
J	Grygorowicz, M; Michalowska, M; Walczak, T; Owen, A; Grabski, JK; Pyda, A; Piontek, T; Kotwicki, T				Grygorowicz, Monika; Michalowska, Martyna; Walczak, Tomasz; Owen, Adam; Grabski, Jakub Krzysztof; Pyda, Andrzej; Piontek, Tomasz; Kotwicki, Tomasz			Discussion about different cut-off values of conventional hamstring-to-quadriceps ratio used in hamstring injury prediction among professional male football players	PLOS ONE			English	Article							SOCCER PLAYERS; RISK-FACTORS; ISOKINETIC STRENGTH; MUSCLE STRENGTH; SPECIFICITY; POSITION; TORQUE; TESTS; LEG	Objective To measure the sensitivity and specificity of differences cut-off values for isokinetic H-con/Q(con) ratio in order to improve the capacity to evaluate (retrospectively) the injury of hamstring muscles in professional soccer screened with knee isokinetic tests. Design Retrospective study. Methods Medical and biomechanical data of professional football players playing for the same team for at least one season between 2010 and 2016 were analysed. Hamstring strain injury cases and the reports generated via isokinetic testing were investigated. Isokinetic concentric( con) hamstring(H) and quadriceps(Q) absolute strength in addition with H-con/Q(con) ratio were examined for the injured versus uninjured limbs among injured players, and for the injured and non-injured players. 2 x 2 contingency table was used for comparing variables: predicted injured or predicted uninjured with actual injured or actual uninjured. Sensitivity, specificity, accuracy, positive and negative predictive values, and positive and negative likelihood ratio were calculated for three different cut-off values (0.47 vs. 0.6 vs. 0.658) to compare the discriminative power of an isokinetic test, whilst examining the key value of H-con/Q(con) ratio which may indicate the highest level of ability to predispose a player to injury. McNemar's chi(2) test with Yates's correction was used to determine agreement between the tests. PQStat software was used for all statistical analysis, and an alpha level of p <0.05 was used for all statistical comparisons. Results 340 isokinetic test reports on both limbs of 66 professional soccer players were analysed. Eleven players suffered hamstring injuries during the analysed period. None of these players sustained recurrence of hamstring injury. One player sustained hamstring strain injury on both legs, thus the total number of injuries was 12. Application of different cut-off values for H-con/Q(con) significantly affected the sensitivity and specificity of isokinetic test used as a tool for muscle injury detection. The use of 0.47 of H-con/Q(con) as a discriminate value resulted in significantly lower sensitivity when compared to 0.658 threshold (sensitivity of 16.7% vs. 91.7%, respectively; t = 6.125, p = 0.0133). Calculated values of specificity (when three different cut-off were applied) were also significantly different. Threshold of 0.6 of H-con/Q(con) resulted with significantly lower specificity compared to 0.47 value (specificity of 46.9% vs. 94.5%, respectively; t = 153.0, p<0.0001), and significantly higher specificity when compared to 0.658 (specificity of 46.9% vs. 24.1%, respectively; t = 229.0, p<0.0001). Conclusion The use of different cut-off values for H-con/Q(con) significantly affected the sensitivity and specificity of isokinetic testing. The interpretation of usefulness of isokinetic test as a screening tool in a group of male professional football players to predict hamstring injury occurrence within the next 12 months might be therefore significantly biased due to the different threshold values of H-con/Q(con). Using one "normative" value as a cut-off (e.g. 0.47 or 0.60, or 0.658) to quantify soccer players (or not) to the group with a higher risk of knee injury might result in biased outcomes due to the natural strength asymmetry that is observed within the group of soccer players.	[Grygorowicz, Monika] Poznan Univ Med Sci, Dept Spondyloortopaed & Biomech Spine, Poznan, Poland; [Grygorowicz, Monika; Michalowska, Martyna; Owen, Adam; Pyda, Andrzej; Piontek, Tomasz] FIFA Med Ctr Excellence, Rehasport Clin, Poznan, Poland; [Michalowska, Martyna; Walczak, Tomasz; Grabski, Jakub Krzysztof] Poznan Univ Tech, Inst Appl Mech, Poznan, Poland; [Piontek, Tomasz; Kotwicki, Tomasz] Poznan Univ Med Sci, Spine Disorders & Paediat Orthopaed Dept, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Technology; Poznan University of Medical Sciences	Grygorowicz, M (corresponding author), Poznan Univ Med Sci, Dept Spondyloortopaed & Biomech Spine, Poznan, Poland.; Grygorowicz, M (corresponding author), FIFA Med Ctr Excellence, Rehasport Clin, Poznan, Poland.	monika.grygorowicz@rehasport.pl	Białecka, Martyna/V-6895-2017; Walczak, Tomasz/H-4149-2014; Grabski, Jakub Krzysztof/F-7509-2014; Grygorowicz, Monika Małgorzata/A-1357-2012; Grygorowicz, Monika/GWU-5803-2022	Białecka, Martyna/0000-0002-0409-3123; Walczak, Tomasz/0000-0001-9211-6235; Grabski, Jakub Krzysztof/0000-0002-0553-1084; Grygorowicz, Monika Małgorzata/0000-0002-9575-2074; Grygorowicz, Monika/0000-0002-9575-2074				Ardern CL, 2015, J STRENGTH COND RES, V29, P997, DOI 10.1519/JSC.0000000000000747; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; BALOGUN J A, 1987, Journal of Orthopaedic and Sports Physical Therapy, V8, P525; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Bennell K, 1998, BRIT J SPORT MED, V32, P309, DOI 10.1136/bjsm.32.4.309; Carvalho Alberto, 2016, J Hum Kinet, V51, P19, DOI 10.1515/hukin-2015-0166; Cohen DD, 2015, INT J SPORT PHYSIOL, V10, P325, DOI 10.1123/ijspp.2014-0088; Cotte T, 2011, BIOL SPORT, V28, P89, DOI 10.5604/942736; Croisier J. L., 1999, Annales de Readaptation et de Medecine Physique, V42, P497, DOI 10.1016/S0168-6054(00)87704-1; Croisier J. L., 1999, Annales de Readaptation et de Medecine Physique, V42, P538, DOI 10.1016/S0168-6054(00)88381-6; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; Croisier JL, 2002, AM J SPORT MED, V30, P199, DOI 10.1177/03635465020300020901; Dauty M., 2003, Annales de Readaptation et de Medecine Physique, V46, P601, DOI 10.1016/j.annrmp.2003.04.001; Dauty M, 2003, ISOKINET EXERC SCI, V11, P139; Dauty M, 2016, MLTJ-MUSCLE LIGAMENT, V6, P116, DOI 10.11138/mltj/2016.6.1.116; Dibrezzo R, 1985, J Orthop Sports Phys Ther, V7, P65; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Fonseca S.T., 2007, REV BRAS MED ESPORTE, V13, p125e; Fousekis K, 2011, BRIT J SPORT MED, V45, P709, DOI 10.1136/bjsm.2010.077560; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Fritz JM, 2001, PHYS THER, V81, P1546, DOI 10.1093/ptj/81.9.1546; Gayardo A, 2012, REV BRAS MED ESPORTE, V18, P186, DOI 10.1590/S1517-86922012000300010; HEISER TM, 1984, AM J SPORT MED, V12, P368, DOI 10.1177/036354658401200506; Henderson G, 2010, J SCI MED SPORT, V13, P397, DOI 10.1016/j.jsams.2009.08.003; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Houweling TAW, 2009, ISOKINET EXERC SCI, V17, P213, DOI 10.3233/IES-2009-0356; Huber J, 2013, ARCH ORTHOP TRAUM SU, V133, P541, DOI 10.1007/s00402-013-1681-1; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lehance C, 2009, SCAND J MED SCI SPOR, V19, P243, DOI 10.1111/j.1600-0838.2008.00780.x; Little T, 2005, J STRENGTH COND RES, V19, P76; MANGINE R E, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P147; McCall A, 2015, BRIT J SPORT MED, V49, P583, DOI 10.1136/bjsports-2014-094104; Orchard J, 1997, AM J SPORT MED, V25, P81, DOI 10.1177/036354659702500116; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; PATON RW, 1989, J BIOMED ENG, V11, P229, DOI 10.1016/0141-5425(89)90147-7; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Reid N, 2010, WIRES COMPUT STAT, V2, P517, DOI 10.1002/wics.110; Ruas CV, 2015, J STRENGTH COND RES, V29, P1220, DOI 10.1519/JSC.0000000000000766; Sliwowski R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144021; Tourny-Chollet C, 2000, ISOKINET EXERC SCI, V8, P187, DOI 10.3233/IES-2000-0050; van Dyk N, 2016, AM J SPORT MED, V44, P1789, DOI 10.1177/0363546516632526; WYSE JP, 1994, BRIT J SPORT MED, V28, P167, DOI 10.1136/bjsm.28.3.167; Zabka FF, 2011, REV BRAS MED ESPORTE, V17, P189, DOI 10.1590/S1517-86922011000300008; Zakas A, 1995, J SPORT MED PHYS FIT, V35, P199; Zvijac JE, 2013, AM J SPORT MED, V41, P1511, DOI 10.1177/0363546513487983	48	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188974	10.1371/journal.pone.0188974	http://dx.doi.org/10.1371/journal.pone.0188974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216241	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800053
J	Kim, YG; Baltabekova, AZ; Zhiyenbay, EE; Aksambayeva, AS; Shagyrova, ZS; Khannanov, R; Ramanculov, EM; Shustov, AV				Kim, Yuriy G.; Baltabekova, Aliya Zh.; Zhiyenbay, Erzhan E.; Aksambayeva, Altynai S.; Shagyrova, Zhadyra S.; Khannanov, Rinat; Ramanculov, Erlan M.; Shustov, Alexandr V.			Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; NONCYTOPATHIC REPLICATION; ANTIVIRAL RESPONSES; MEMBRANE-PROTEINS; I IFN; CELLS; ALPHA; INDUCTION; INFECTION; DETERMINANT	B18R protein of Vaccinia virus binds to type I interferons and inhibits activation of interferon-mediated signal transduction. Cells which have unimpaired interferon signaling such as primary cell cultures or some industrially important cell lines are capable of development of an antiviral state. An establishment of the antiviral state limits replication of RNA-viruses and can suppress replication of RNA vectors. The interferon inhibitor B18R effectively prevents the establishment of the antiviral state. For this reason, B18R has become a ubiquitous component of protocols for epigenetic reprogramming which use transfections of RNA replicons or mRNA. Despite wide practical applicability, commercially available B18R is predominantly produced in cell cultures and little information has been published on a production and use of bacterially expressed B18R. Objectives of this study were to produce B18R in an E.coli expression system and to confirm the product's biological activity by using it to maintain RNA-vectors in cell cultures capable of the antiviral state. The described method allows the expression and efficient refolding to obtain 10-100 mg of B18R from a small-scale culture and the production process is economically attractive compared to a use of an eukaryotic expression. To check for a presence of the biological activity of bacterially-expressed B18R the protein was used to support persistence of an autonomously replicating RNA-vector in a cell culture which is capable of the antiviral state. A RNA-containing virus, Venezuelan equine encephalitis virus (VEE) can serve as an efficient vector for heterologous expression in cell cultures, although its replication is sensitive to the effects of type I interferons which limit a range of cell lines for a use with this vector. The VEE replicon was utilized to direct an expression of recombinant human granulocyte colony stimulating factor (G-CSF). The producing replicon could persist in HEK293 cells for sufficiently long time only in presence of B18R, whereas addition of B18R not only allowed persistence of the replicon but also increased production from the replicon. A model product granulocyte colony stimulating factor accumulated to 35.5 mu g/ml during a 7 day experiment. This work describes efficacious expression and refolding of the viral cytokine inhibitor and demonstrates a utility of bacterially-expressed B18R.	[Kim, Yuriy G.; Zhiyenbay, Erzhan E.; Ramanculov, Erlan M.] Nazarbayev Univ, Natl Lab Astana, Astana, Kazakhstan; [Baltabekova, Aliya Zh.; Aksambayeva, Altynai S.; Shagyrova, Zhadyra S.; Khannanov, Rinat; Shustov, Alexandr V.] Natl Ctr Biotechnol, Astana, Kazakhstan	Nazarbayev University; National Center for Biotechnology (NCB)	Shustov, AV (corresponding author), Natl Ctr Biotechnol, Astana, Kazakhstan.	shustov@biocenter.kz	Ramankulov, Yerlan/AAG-7450-2019; Shustov, Alexander V/K-1148-2013; Khannanov, Rinat/ABG-6012-2021	Ramankulov, Yerlan/0000-0001-6786-3028; Shustov, Alexander V/0000-0001-9880-9382; Ramanculov, Erlan/0000-0001-6791-4497; Khannanov, Rinat/0000-0001-5085-7596	Ministry of Education and Science of the Republic of Kazakhstan [0115RK01788, 0214RK02428]	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by a funding from Ministry of Education and Science of the Republic of Kazakhstan by grants with numbers 0115RK01788 and 0214RK02428.	Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Aranda Alejandro, 2011, Recent Pat Biotechnol, V5, P212; Casales E, 2008, VIROLOGY, V376, P242, DOI 10.1016/j.virol.2008.03.016; Casales E, 2010, NEW BIOTECHNOL, V27, P138, DOI 10.1016/j.nbt.2010.02.005; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Cruz CC, 2010, VIROLOGY, V399, P1, DOI 10.1016/j.virol.2009.12.031; Farazmandfar T, 2012, CELL J, V14, P76; Fritz-French C, 2014, J INTERF CYTOK RES, V34, P510, DOI 10.1089/jir.2013.0072; Frolov I, 1999, J VIROL, V73, P3854, DOI 10.1128/JVI.73.5.3854-3865.1999; Frolov I, 2012, J VIROL, V86, P5055, DOI 10.1128/JVI.07223-11; Gardner CL, 2009, VIROLOGY, V390, P338, DOI 10.1016/j.virol.2009.05.030; Gehrke R, 2005, J GEN VIROL, V86, P1045, DOI 10.1099/vir.0.80677-0; Gomez AM, 2015, J IMMUNOL, V194, P2300, DOI 10.4049/jimmunol.1402147; Grieder FB, 1999, VIROLOGY, V257, P106, DOI 10.1006/viro.1999.9662; Ho TH, 2016, J VIROL, V90, P1557, DOI 10.1128/JVI.02161-15; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Kawaguchi S, 2009, IMMUNOL LETT, V123, P9, DOI 10.1016/j.imlet.2009.01.008; Konopka JL, 2009, J VIROL, V83, P12432, DOI 10.1128/JVI.00564-09; Kremer Melanie, 2012, Methods Mol Biol, V890, P59, DOI 10.1007/978-1-61779-876-4_4; Kummerer BM, 2012, J GEN VIROL, V93, P1991, DOI 10.1099/vir.0.043752-0; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Lackner A, 2012, METHODS MOL BIOL, V801, P75, DOI 10.1007/978-1-61779-352-3_6; Liptakova H, 1997, VIROLOGY, V232, P86, DOI 10.1006/viro.1997.8527; Lundstrom K, 2003, BBA-BIOMEMBRANES, V1610, P90, DOI 10.1016/S0005-2736(02)00721-6; Lundstrom K, 2010, METHODS MOL BIOL, V601, P149, DOI 10.1007/978-1-60761-344-2_10; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Meyers JA, 2006, CYTOKINE, V35, P235, DOI 10.1016/j.cyto.2006.09.001; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nivitchanyong T, 2009, VIRUS RES, V141, P1, DOI 10.1016/j.virusres.2008.12.019; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Philp A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077200; Quabius ES, 2015, NEW BIOTECHNOL, V32, P229, DOI 10.1016/j.nbt.2014.04.008; Quetglas JI, 2012, GENE THER, V19, P271, DOI 10.1038/gt.2011.99; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Schott JW, 2015, CURR OPIN PHARMACOL, V24, P135, DOI 10.1016/j.coph.2015.09.004; Spotts DR, 1998, J VIROL, V72, P10286, DOI 10.1128/JVI.72.12.10286-10291.1998; Vancova I, 1998, J GEN VIROL, V79, P1647, DOI 10.1099/0022-1317-79-7-1647; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yoshioka N, 2013, CELL STEM CELL, V13, P246, DOI 10.1016/j.stem.2013.06.001; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	43	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189308	10.1371/journal.pone.0189308	http://dx.doi.org/10.1371/journal.pone.0189308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216299	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800115
J	Tang, JY; Bullen, NP; Ahmad, S; Whitney, JC				Tang, Jenny Y.; Bullen, Nathan P.; Ahmad, Shehryar; Whitney, John C.			Diverse NADase effector families mediate interbacterial antagonism via the type VI secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbiology; bacteria; protein secretion; protein structure; protein-protein interaction; type VI secretion; interbacterial antagonism; Pseudomonas protegens; NADase effectors	COMPLETE GENOME SEQUENCE; STRUCTURE REFINEMENT; RHS PROTEINS; TOXIN; VGRG; PAAR; COLONIZATION; COMPETITION; PATHOGENS; PATHWAYS	The bacterial type VI secretion system (T6SS) mediates antagonistic cell-cell interactions between competing Gram-negative bacteria. In plant-beneficial bacteria, this pathway has been shown to suppress the growth of bacterial pathogens; however, the identification and mode of action of T6SS effector proteins that mediate this protective effect remain poorly defined. Here, we identify two previously uncharacterized effectors required for interbacterial antagonism by the plant commensal bacterium Pseudomonas protegens. Consistent with the established effector-immunity paradigm for antibacterial T6SS substrates, the toxic activities of these effectors are neutralized by adjacently encoded cognate immunity determinants. Although one of these effectors, RhsA, belongs to the family of DNase enzymes, the activity of the other was not apparent from its sequence. To determine the mechanism of toxicity of this latter effector, we determined its 1.3 crystal structure in complex with its immunity protein and found that it resembles NAD(P)(+)-degrading enzymes. In line with this structural similarity, biochemical characterization of this effector, termed Tne2 (Type VI secretion NADase effector family 2), demonstrates that it possesses potent NAD(P)(+) hydrolase activity. Tne2 is the founding member of a widespread family of interbacterial NADases predicted to transit not only the Gram-negative T6SS but also the Gram-positive type VII secretion system, a pathway recently implicated in interbacterial competition among Firmicutes. Together, this work identifies new T6SS effectors employed by a plant commensal bacterium to antagonize its competitors and broadly implicates NAD(P)(+)-hydrolyzing enzymes as substrates of interbacterial conflict pathways found in diverse bacterial phyla.	[Tang, Jenny Y.; Bullen, Nathan P.; Ahmad, Shehryar; Whitney, John C.] McMaster Univ, Michael DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Tang, Jenny Y.; Bullen, Nathan P.; Ahmad, Shehryar; Whitney, John C.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Whitney, JC (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	jwhitney@mcmaster.ca		Ahmad, Shehryar/0000-0002-2747-5212	McMaster University; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05350]	McMaster University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by start-up funds from McMaster University and Discovery Grant RGPIN-2017-05350 from the Natural Sciences and Engineering Research Council of Canada (to J.C.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anderson MC, 2017, CELL HOST MICROBE, V21, P769, DOI 10.1016/j.chom.2017.05.004; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernal P, 2017, ISME J, V11, P972, DOI 10.1038/ismej.2016.169; Bondage DD, 2016, P NATL ACAD SCI USA, V113, pE3931, DOI 10.1073/pnas.1600428113; Bosch J, 2007, ACTA CRYSTALLOGR D, V63, P179, DOI 10.1107/S0907444906045471; Cao Zhenping, 2016, Nat Microbiol, V2, P16183, DOI 10.1038/nmicrobiol.2016.183; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cianfanelli FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005735; Decoin V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089411; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hachani A, 2014, J BIOL CHEM, V289, P17872, DOI 10.1074/jbc.M114.563429; Hecht AL, 2016, EMBO REP, V17, P1281, DOI 10.15252/embr.201642282; Ho BT, 2017, P NATL ACAD SCI USA, V114, P9427, DOI 10.1073/pnas.1711219114; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; JOHNSON SL, 1970, J BIOL CHEM, V245, P4519; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ma JL, 2017, ENVIRON MICROBIOL, V19, P345, DOI 10.1111/1462-2920.13621; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2016, P NATL ACAD SCI USA, V113, pE5044, DOI 10.1073/pnas.1608858113; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Sun J, 2015, NAT STRUCT MOL BIOL, V22, P672, DOI 10.1038/nsmb.3064; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vettiger A, 2016, CELL, V167, P99, DOI 10.1016/j.cell.2016.08.023; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Whitney JC, 2014, MOL MICROBIOL, V92, P529, DOI 10.1111/mmi.12571; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	50	57	58	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1504	1514		10.1074/jbc.RA117.000178	http://dx.doi.org/10.1074/jbc.RA117.000178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29237732	Green Published, hybrid			2022-12-26	WOS:000424201700002
J	Xu, X; Jia, HZ; Lei, Y; Jia, CH; Liu, G; Chai, JY; Peng, YT; Xie, JL				Xu, Xun; Jia, Hongzhi; Lei, Yu; Jia, Chunhua; Liu, Gang; Chai, Junyu; Peng, Yanting; Xie, Jilong			Theoretical proposal of a low-loss wide-bandwidth silicon photonic crystal fiber for supporting 30 orbital angular momentum modes	PLOS ONE			English	Article							DESIGN	We propose a novel four-ring hollow-core silicon photonic crystal fiber (PCF), and we systematically and theoretically investigate the properties of their vector modes. Our PCF can stably support 30 OAM states from the wavelength of 1.5 mu m to 2.4 mu m, with a large effective refractive index separation of above 1x10(-4). The confinement loss is less than 1x10(-9) dB/m at the wavelength of 1.55 mu m, and the average confinement loss is less than 1x10(-8) dB/m from the wavelength of 1.2 mu m to 2.4 mu m. Moreover, the curve of the dispersion tends to flatten as the wavelength increases. In addition, we comparably investigate PCFs with different hole spacing. This kind of fiber structure will be a potential candidate for high-capacity optical fiber communications and OAM sensing applications using fibers.	[Xu, Xun; Jia, Hongzhi; Lei, Yu; Jia, Chunhua; Liu, Gang; Chai, Junyu; Peng, Yanting; Xie, Jilong] Univ Shanghai Sci & Technol, Sch Opt Elect & Comp Engn, Shanghai Key Lab Modern Opt Syst, Engn Res Ctr Opt Instruments & Syst,Minist Educ, Shanghai, Peoples R China	University of Shanghai for Science & Technology	Jia, HZ (corresponding author), Univ Shanghai Sci & Technol, Sch Opt Elect & Comp Engn, Shanghai Key Lab Modern Opt Syst, Engn Res Ctr Opt Instruments & Syst,Minist Educ, Shanghai, Peoples R China.	hzjia@usst.edu.cn	Chai, Junyu/AAF-7394-2020	Chai, Junyu/0000-0002-3544-5312				ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Amezcua-Correa R, 2007, OPT EXPRESS, V15, P17577, DOI 10.1364/OE.15.017577; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Brunet C, 2015, OPT EXPRESS, V23, P10553, DOI 10.1364/OE.23.010553; Brunet C, 2014, OPT EXPRESS, V22, P26117, DOI 10.1364/OE.22.026117; Franke-Arnold S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033823; Furhapter S, 2005, OPT LETT, V30, P1953, DOI 10.1364/OL.30.001953; Furhapter S, 2005, OPT EXPRESS, V13, P689, DOI 10.1364/OPEX.13.000689; Gregg P, 2015, OPTICA, V2, P267, DOI 10.1364/OPTICA.2.000267; Gregg P, 2013, C LAS EL OSA; Huang H, 2014, OPT LETT, V39, P197, DOI 10.1364/OL.39.000197; ICENOGLE HW, 1976, APPL OPTICS, V15, P2348, DOI 10.1364/AO.15.002348; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Knight JC, 1996, OPT LETT, V21, P1547, DOI 10.1364/OL.21.001547; Li H, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/aa612c; Li HS, 2017, OPT LETT, V42, P179, DOI 10.1364/OL.42.000179; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Maji P.S., 2013, ISRN OPT, V2013, P9; Medjouri A, 2015, OPTIK, V126, P5718, DOI 10.1016/j.ijleo.2015.09.035; Mortensen NA, 2003, OPT LETT, V28, P393, DOI 10.1364/OL.28.000393; Ramachandran S, 2013, NANOPHOTONICS-BERLIN, V2, P455, DOI 10.1515/nanoph-2013-0047; Wang ZX, 2011, OPT EXPRESS, V19, P482, DOI 10.1364/OE.19.000482; Yaman F, 2009, OSA TECHNICAL DIGEST; Yan Y, 2012, OPT LETT, V37, P3645, DOI 10.1364/OL.37.003645; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161; Yue Y, 2012, C LAS EL OSA	26	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189660	10.1371/journal.pone.0189660	http://dx.doi.org/10.1371/journal.pone.0189660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236786	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100090
J	Lee, H; Park, KH; Ryu, JH; Choi, AR; Yu, JH; Lim, J; Han, K; Kim, SI; Yang, CW; Chung, BH; Oh, EJ				Lee, Hyeyoung; Park, Ki Hyun; Ryu, Ji Hyeong; Choi, Ae-Ran; Yu, Ji Hyun; Lim, Jihyang; Han, Kyungja; Kim, Sang Il; Yang, Chul Woo; Chung, Byung Ha; Oh, Eun-Jee			Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients	PLOS ONE			English	Article							T-CELL RESPONSES; SOLID-ORGAN TRANSPLANTATION; LINKED IMMUNOSORBENT SPOT; IMMEDIATE-EARLY PROTEIN; RENAL-TRANSPLANTATION; CONSENSUS GUIDELINES; MEDIATED-IMMUNITY; LYMPHOCYTE CTL; HIGH-RISK; INFECTION	Although cytomegalovirus (CMV) specific cell-mediated immunity (CMI) has been suggested as a predictive marker for CMV infection, proper CMI monitoring strategy in CMV-seropositive recipients and optimal method are not defined. The aim of this study was to evaluate two interferon gamma release assays during early post-transplant period as a predictor of the development of CMV infection in CMV-seropositive patients. A total of 124 CMV-seropositive recipients who received kidney transplantation from CMV-seropositive donor were prospectively examined. At pre-transplant and post-transplant 1 and 3 months, CMV-CMIs were tested using QuantiFERON-CMV assay (QF-CMV) and CMV specific T cell ELISPOT against CMV pp65 and IE-1 antigens (pp65-ELISPOT, IE-1-ELISPOT). CMV DNAemia occurred in 16 (12.9%) patients within 3 months after transplant. Post-transplant pp65 or IE-1 ELISPOT response, but not QF-CMV, was significantly associated with CMV DNAemia. The pp65 ELISPOT (cut-off; 30 spots/200,000 cells) and IE-1 ELISPOT (10 spots/200,000 cells) at post-transplant 1 month predicted the risk of post-transplant CMV DNAemia (P = 0.019). Negative predictive values (NPV) for protection from CMV DNAemia in case of positive ELISPOT results were 94.5% (95% CI: 86.9-97.8%) and 97.6% (95% CI: 86.3-99.6%) in pp65-ELISPOT and IE-1-ELISPOT assays, respectively. These results suggest that the variability may exist between CMV ELISPOT assays and QF-CMV, and CMV ELISPOT at post-transplant 1 month can identify the risk of CMV DNAemia in seropositive kidney transplant recipients.	[Lee, Hyeyoung; Ryu, Ji Hyeong; Choi, Ae-Ran; Lim, Jihyang; Han, Kyungja; Oh, Eun-Jee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Hyeyoung] SamKwang Med Labs, Seoul, South Korea; [Park, Ki Hyun] Catholic Univ Korea, Grad Sch, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Yu, Ji Hyun; Yang, Chul Woo; Chung, Byung Ha; Oh, Eun-Jee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea; [Yu, Ji Hyun; Yang, Chul Woo; Chung, Byung Ha] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Sang Il] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Infect, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Oh, EJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Lab Med, Seoul, South Korea.; Chung, BH; Oh, EJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea.; Chung, BH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea.	chungbh@catholic.a.c.kr; ejoh@catholic.ac.kr		Oh, Eun-Jee/0000-0001-5870-915X	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C3417]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [NRF-2017R1A2B4011181]; SamKwang Medical Laboratories	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea; SamKwang Medical Laboratories	This work was supported by a grant (HI14C3417) of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea to C.W.Y. It was also supported by a grant (NRF-2017R1A2B4011181) of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea to E-J.O. SamKwang Medical Laboratories provided support in the form of salaries for H.Y.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate D, 2013, J CLIN MICROBIOL, V51, P2501, DOI 10.1128/JCM.00563-13; Abate D, 2012, J CLIN MICROBIOL, V50, P1974, DOI 10.1128/JCM.06406-11; Abate D, 2010, J INFECT DIS, V202, P585, DOI 10.1086/654931; Bestard O, 2013, AM J TRANSPLANT, V13, P1793, DOI 10.1111/ajt.12256; Boppana SB, 1996, VIROLOGY, V222, P293, DOI 10.1006/viro.1996.0424; BORYSIEWICZ LK, 1988, J EXP MED, V168, P919, DOI 10.1084/jem.168.3.919; Brennan DC, 1999, TRANSPLANTATION, V67, P1011, DOI 10.1097/00007890-199904150-00013; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Cantisan S, 2013, AM J TRANSPLANT, V13, P738, DOI 10.1111/ajt.12049; Chung BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042011; Costa C, 2014, J CLIN VIROL, V61, P523, DOI 10.1016/j.jcv.2014.09.015; Dmitrienko S, 2007, KIDNEY INT, V72, P1014, DOI 10.1038/sj.ki.5002464; Gibson L, 2004, J IMMUNOL, V172, P2256, DOI 10.4049/jimmunol.172.4.2256; Gyulai Z, 2000, J INFECT DIS, V181, P1537, DOI 10.1086/315445; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Khan N, 2002, J INFECT DIS, V185, P1025, DOI 10.1086/339963; Kim SH, 2015, INFECT CHEMOTHER, V47, P105, DOI 10.3947/ic.2015.47.2.105; Kim Y, 2012, TRANSL RES, V160, P230, DOI 10.1016/j.trsl.2012.02.009; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Leone F, 2016, TRANSPL INFECT DIS, V18, P191, DOI 10.1111/tid.12509; Lisboa LF, 2012, TRANSPLANTATION, V93, P195, DOI 10.1097/TP.0b013e31823c1cd4; Lochmanova A, 2010, TRANSPL P, V42, P3574, DOI 10.1016/j.transproceed.2010.07.101; Lucia M, 2014, CLIN INFECT DIS, V59, P1537, DOI 10.1093/cid/ciu589; Lucia M, 2014, TRANSPL INT, V27, P643, DOI 10.1111/tri.12318; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Manuel O, 2013, CLIN INFECT DIS, V56, P817, DOI 10.1093/cid/cis993; MCLAUGHLINTAYLOR E, 1994, J MED VIROL, V43, P103, DOI 10.1002/jmv.1890430119; Lopez-Oliva MO, 2014, TRANSPLANTATION, V97, P839, DOI 10.1097/01.TP.0000438025.96334.eb; Park KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210726; Pelte C, 2004, J IMMUNOL, V172, P6783, DOI 10.4049/jimmunol.172.11.6783; Razonable RR, 2013, AM J TRANSPLANT, V13, P93, DOI 10.1111/ajt.12103; Ritta M, 2015, NEW MICROBIOL, V38, P329; Saldan A, 2016, J CLIN MICROBIOL, V54, P1352, DOI 10.1128/JCM.03128-15; STINSKI MF, 1978, J VIROL, V26, P686, DOI 10.1128/JVI.26.3.686-701.1978; Waldman WJ, 1996, AM J PATHOL, V148, P105; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	36	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189488	10.1371/journal.pone.0189488	http://dx.doi.org/10.1371/journal.pone.0189488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232714	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200049
J	Jovic, K; Sterken, MG; Grilli, J; Bevers, RPJ; Rodriguez, M; Riksen, JAG; Allesina, S; Kammenga, JE; Snoek, LB				Jovic, Katharina; Sterken, Mark G.; Grilli, Jacopo; Bevers, Roel P. J.; Rodriguez, Miriam; Riksen, Joost A. G.; Allesina, Stefano; Kammenga, Jan E.; Snoek, L. Basten			Temporal dynamics of gene expression in heat-stressed Caenorhabditis elegans	PLOS ONE			English	Article							SHOCK TRANSCRIPTIONAL RESPONSE; C. ELEGANS; LIFE-SPAN; MOLECULAR CHAPERONES; HUMAN-DISEASE; LONGEVITY; MOBILITY; EVENT; CELLS; LISTS	There is considerable insight into pathways and genes associated with heat-stress conditions. Most genes involved in stress response have been identified using mutant screens or gene knockdowns. Yet, there is limited understanding of the temporal dynamics of global gene expression in stressful environments. Here, we studied global gene expression profiles during 12 hours of heat stress in the nematode C. elegans. Using a high-resolution time series of increasing stress exposures, we found a distinct shift in gene expression patterns between 3-4 hours into the stress response, separating an initially highly dynamic phase from a later relatively stagnant phase. This turning point in expression dynamics coincided with a phenotypic turning point, as shown by a strong decrease in movement, survival and, progeny count in the days following the stress. Both detectable at transcriptional and phenotypic level, this study pin-points a relatively small time frame during heat stress at which enough damage is accumulated, making it impossible to recover the next few days.	[Jovic, Katharina; Sterken, Mark G.; Bevers, Roel P. J.; Rodriguez, Miriam; Riksen, Joost A. G.; Kammenga, Jan E.; Snoek, L. Basten] Wageningen Univ, Lab Nematol, Wageningen, Netherlands; [Grilli, Jacopo; Allesina, Stefano] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA	Wageningen University & Research; University of Chicago	Kammenga, JE (corresponding author), Wageningen Univ, Lab Nematol, Wageningen, Netherlands.	Jan.Kammenga@wur.nl	Allesina, Stefano/A-2255-2009; Snoek, Basten L/E-4713-2014	Snoek, Basten L/0000-0001-5321-2996; Allesina, Stefano/0000-0003-0313-8374; Jovic, Katharina/0000-0002-9145-5953	ERASysbio-plus ZonMW project GRAPPLE - Iterative modelling of gene regulatory interactions underlying stress, disease and ageing in C. elegans [90201066]; Netherlands Organization for Scientific Research [823.01.001]; Human Frontiers Science Program Organisation (HFSPO) [RGP0028-2014]; Direct For Biological Sciences [1148867] Funding Source: National Science Foundation	ERASysbio-plus ZonMW project GRAPPLE - Iterative modelling of gene regulatory interactions underlying stress, disease and ageing in C. elegans; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Human Frontiers Science Program Organisation (HFSPO); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	LBS was funded by ERASysbio-plus ZonMW project GRAPPLE - Iterative modelling of gene regulatory interactions underlying stress, disease and ageing in C. elegans (project 90201066) and The Netherlands Organization for Scientific Research (project no. 823.01.001). KJ, JG and JAGR were funded by the Human Frontiers Science Program Organisation (HFSPO), grant RGP0028-2014.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Aprison EZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105513; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BRENNER S, 1974, GENETICS, V77, P71; Brunquell J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2837-5; Cypser JR, 2013, MECH AGEING DEV, V134, P291, DOI 10.1016/j.mad.2013.02.003; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HOSONO R, 1980, EXP GERONTOL, V15, P285, DOI 10.1016/0531-5565(80)90032-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Shin Heesun, 2011, BMC Res Notes, V4, P34, DOI 10.1186/1756-0500-4-34; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snoek BL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3899-8; Snoek L. B., 2013, NUCLEIC ACIDS RES, V41, P1; Snoek LB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03912; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Truttmann MC, 2017, P NATL ACAD SCI USA, V114, pE152, DOI 10.1073/pnas.1619234114; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van der Velde KJ, 2014, NUCLEIC ACIDS RES, V42, pD794, DOI 10.1093/nar/gkt1044; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zevian SC, 2014, METHODS, V68, P450, DOI 10.1016/j.ymeth.2014.04.015; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	41	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189445	10.1371/journal.pone.0189445	http://dx.doi.org/10.1371/journal.pone.0189445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228038	gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600056
J	McGee, JA; Ergas, C; Greiner, PT; Clement, MT				McGee, Julius Alexander; Ergas, Christina; Greiner, Patrick Trent; Clement, Matthew Thomas			How do slums change the relationship between urbanization and the carbon intensity of well-being?	PLOS ONE			English	Article							LESS-DEVELOPED-COUNTRIES; ENERGY-CONSUMPTION; CHILD-MORTALITY; CO2 EMISSIONS; IMPACT; POPULATION; STIRPAT; WATER	This study examines how the relationship between urbanization (measured as the percentage of total population living in urban areas) and the carbon intensity of well-being (CIWB) (measured as a ratio of carbon dioxide emissions and life expectancy) in most nations from 1960-2013 varies based on the economic context and whereabouts of a substantial portion of a nation's urban population. To accomplish this, we use the United Nations' (UN) definition of slum households to identify developing countries that have substantial slum populations, and estimate a Prais-Winsten regression model with panel-corrected standard errors (PCSE), allowing for disturbances that are heteroskedastic and contemporaneously correlated across panels. Our findings indicate that the rate of increase in CIWB for countries without substantial slum populations begins to slow down at higher levels of urbanization, however, the association between urbanization and CIWB is much smaller in countries with substantial slum populations. Overall, while urbanization is associated with increases in CIWB, the relationship between urban development and CIWB is vastly different in developed nations without slums than in under-developed nations with slums.	[McGee, Julius Alexander] Portland State Univ, Dept Sociol, Portland, OR 97207 USA; [Ergas, Christina] Univ Tennessee, Dept Sociol, Knoxville, TN USA; [Greiner, Patrick Trent] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA; [Clement, Matthew Thomas] Texas State Univ, Dept Sociol, San Marcos, TX USA	Portland State University; University of Tennessee System; University of Tennessee Knoxville; University of Oregon; Texas State University System; Texas State University San Marcos	McGee, JA (corresponding author), Portland State Univ, Dept Sociol, Portland, OR 97207 USA.	cjulius@pdx.edu						Al-mulali U, 2013, RENEW SUST ENERG REV, V23, P107, DOI 10.1016/j.rser.2013.02.041; Andrew K Jorgenson, 2015, PLOS ONE, V10; Andrew K. Jorgenson, 2015, PLOS ONE, V10; [Anonymous], 2002, BANGLADESH DEV STUDI, V28; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Becker D.R., 2003, ENVIRON IMPACT ASSES, V23, P367, DOI 10.1016/S0195-9255(02)00098-7; Brady D., 2007, STUD COMP INT DEV, V42, P1; Brant Liddle, 2013, CONSUMPTION DRIVEN E; Brundtland G., 1987, OUR COMMON FUTURE, V383; Chun-yan R. E. N., 2006, INFLUENCE URBANIZATI, V25, P233; Creutzig F, 2015, P NATL ACAD SCI USA, V112, P6283, DOI 10.1073/pnas.1315545112; Davis M, 2017, PLANET SLUMS; Dietz T, 2012, APPL GEOGR, V32, P21, DOI 10.1016/j.apgeog.2010.10.011; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Fan Y, 2006, ENVIRON IMPACT ASSES, V26, P377, DOI 10.1016/j.eiar.2005.11.007; Farmer P., 1999, INFECT INEQUALITIES; Givens J. E, 2016, HUMAN ECOLOGY REV, V22, P107; Jorgenson A., 2012, URBAN STUD, V49, P3495; Jorgenson A. K., 2010, ORG ENV, V23, P189; Jorgenson A. K., 2012, SOC SCI RES, V41, P242, DOI DOI 10.1016/J.SSRESEARCH; JORGENSON AK, 2005, AM J SOCIOL, V118, P1, DOI DOI 10.1086/665990; Jorgenson AK., 2015, J ENV STUDIES SCI, V5, P277, DOI [10.1007/s13412-015-0234-z, DOI 10.1007/S13412-015-0234-Z]; Jorgenson AK, 2007, ORGAN ENVIRON, V20, P137, DOI 10.1177/1086026607302153; Jorgenson AK, 2016, SUSTAIN DEV, V24, P53, DOI 10.1002/sd.1606; Jorgenson AK, 2014, NAT CLIM CHANGE, V4, P186, DOI 10.1038/NCLIMATE2110; Jorgenson AK, 2010, J POVERTY, V14, P382, DOI 10.1080/10875549.2010.517073; Liddle B, 2004, POPUL ENVIRON, V26, P23, DOI 10.1023/B:POEN.0000039951.37276.f3; Liddle B., 1989, J TRANSP GEOGR, V28, P22; Liddle B, 2014, POPUL ENVIRON, V35, P286, DOI 10.1007/s11111-013-0198-4; Martinez-Zarzoso I, 2011, ECOL ECON, V70, P1344, DOI 10.1016/j.ecolecon.2011.02.009; Menz T, 2011, POPUL ENVIRON, V33, P55, DOI 10.1007/s11111-011-0132-6; Mishra V, 2009, RESOUR ENERGY ECON, V31, P210, DOI 10.1016/j.reseneeco.2009.04.002; Poumanyvong P, 2012, ENERG POLICY, V46, P268, DOI 10.1016/j.enpol.2012.03.059; ROGERS RG, 1989, J BIOSOC SCI, V21, P245, DOI 10.1017/S0021932000017934; Scanlan SJ, 2010, INT J COMP SOCIOL, V51, P211, DOI 10.1177/0020715210363458; Shandra CL, 2011, ORGAN ENVIRON, V24, P107, DOI 10.1177/1086026611413931; Suneeta D Fernandes, 2007, GLOBAL BIOGEOCHEMICA, V21; UN-HABITAT, 2006, STAT WORLDS CIT; United Nations Environment Program, 2012, GUID GREEN EC DIV SU; United Nations Environment Programme, 2011, GREEN EC; World Bank, 2015, WORLD DEV INDICATORS; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2007, SOC SCI RES, V36, P855, DOI 10.1016/j.ssresearch.2006.06.007; Zhu HM, 2012, ECON LETT, V117, P848, DOI 10.1016/j.econlet.2012.09.001	44	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189024	10.1371/journal.pone.0189024	http://dx.doi.org/10.1371/journal.pone.0189024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220352	Green Published, Green Submitted, gold			2022-12-26	WOS:000417469900026
J	Yeh, SJ; Tang, SC; Tsai, LK; Lee, CW; Chen, YF; Liu, HM; Yang, SH; Kuo, MF; Jeng, JS				Yeh, Shin-Joe; Tang, Sung-Chun; Tsai, Li-Kai; Lee, Chung-Wei; Chen, Ya-Fang; Liu, Hon-Man; Yang, Shih-Hung; Kuo, Meng-Fai; Jeng, Jiann-Shing			Color Doppler ultrasonography as an alternative tool for postoperative evaluation of collaterals after indirect revascularization surgery in Moyamoya disease	PLOS ONE			English	Article							DURO-ARTERIO-SYNANGIOSIS; CHILDHOOD MOYAMOYA; SUBARACHNOID HEMORRHAGE; ADULT PATIENTS; SONOGRAPHY; ANGIOGRAPHY; NATIONWIDE	The cerebral hypoperfusion caused by chronic progressive stenosis or occlusion of intracranial arteries in moyamoya disease can be treated by direct bypass or indirect revascularization procedures. The extent of collaterals from the external carotid artery (ECA) after indirect revascularization surgery is the key point of angiographic follow-up, and the invasiveness of angiography impelled us to investigate the role of ultrasonography in the evaluation of collaterals. We hypothesized that the collaterals shown on angiography might produce corresponding hemodynamic changes in color Doppler ultrasonography. We prospectively recruited moyamoya patients who underwent indirect revascularization surgery and received both preoperative and postoperative angiography and color Doppler ultrasound studies. The collaterals on angiography were graded according to Matsushima method. A total of 21 patients (age, 17 +/- 10.2 years) with 24 operated hemispheres were enrolled. Patients who showed better collateral establishment by angiography had higher end-diastolic velocity (EDV), lower resistance index (RI), and larger flow volume in the superficial temporal artery (STA) and ECA (all p < 0.05). In STA, increase of EDV greater than 13.5 cm/sec or reduction of RI greater than 0.19 after operation corresponded to 94% of Matsushima grade A+B. In ECA, post-operative EDV greater than 22 cm/sec or increase of EDV greater than 6.4 cm/sec also corresponded to 94% of Matsushima grade A+B. Our findings revealed potential roles of color Doppler ultrasonography in identifying patients with poor collaterals after indirect revascularization procedures.	[Yeh, Shin-Joe; Tang, Sung-Chun; Tsai, Li-Kai; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Yeh, Shin-Joe; Tang, Sung-Chun; Tsai, Li-Kai; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chung-Wei; Chen, Ya-Fang; Liu, Hon-Man] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Shih-Hung; Kuo, Meng-Fai] Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Kuo, MF (corresponding author), Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan.	mfkenator@gmail.com	yeh, shin-joe/HGV-0244-2022	LEE, CHUNG-WEI/0000-0002-3573-2506; CHEN, YA-FANG/0000-0003-2995-9189; Tsai, Li-Kai/0000-0001-8420-6951; LIU, HON-MAN/0000-0001-6715-6366; Yeh, Shin-Joe/0000-0003-1511-6295; JENG, JIANN-SHING/0000-0002-1456-3686; KUO, MENG-FAI/0000-0002-1803-2719; Tang, Sung-Chun/0000-0003-3731-5973; YANG, SHIH-HUNG/0000-0002-8572-4977	National Science Council of the Republic of China, Taiwan [NSC 101-2321-B-002-085, NSC 102-2321-B-002-064, MOST 103-2321-B-002-033, MOST 103-2321-B-002-032]; National Taiwan University Hospital [104-N2871, MOST 104-2314-B-002-131]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by grants from the National Science Council of the Republic of China, Taiwan (NSC 101-2321-B-002-085, NSC 102-2321-B-002-064 and MOST 103-2321-B-002-033; all of these grants were for Dr. Meng-Fai Kuo. MOST 103-2321-B-002-032, for Ya-Fang Chen) for maintaining the multi-year project of "Platform establishment, validation, and biomarkers study in cerebrovascular diseases: using pediatric moyamoya disease as a pilot", as well as National Taiwan University Hospital grants (104-N2871 and MOST 104-2314-B-002-131, for Dr. Shin-Joe Yeh) in paying for English editing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IM, 2014, STROKE, V45, P1090, DOI 10.1161/STROKEAHA.113.004273; Blauwblomme T, 2016, AM J NEURORADIOL, V37, P706, DOI 10.3174/ajnr.A4592; Chen PC, 2014, STROKE, V45, P1258, DOI 10.1161/STROKEAHA.113.004160; Cho HH, 2016, AM J NEURORADIOL, V37, P932, DOI 10.3174/ajnr.A4614; Fushimi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148925; Huang APH, 2009, CEREBROVASC DIS, V28, P247, DOI 10.1159/000228254; Kim T, 2016, J STROKE, V18, P21, DOI 10.5853/jos.2015.01739; Kleinloog R, 2012, J NEUROL NEUROSUR PS, V83, P531, DOI 10.1136/jnnp-2011-301387; Kohno K, 1998, NEUROSURGERY, V42, P752, DOI 10.1097/00006123-199804000-00043; Lee YS, 2004, J NEUROIMAGING, V14, P319, DOI 10.1177/1051228404264958; MATSUSHIMA T, 1990, ACTA NEUROCHIR, V104, P96, DOI 10.1007/BF01842826; Mizoi K, 1996, SURG NEUROL, V45, P541, DOI 10.1016/0090-3019(95)00475-0; Patel NN, 2010, NEUROSURG CLIN N AM, V21, P553, DOI 10.1016/j.nec.2010.03.008; Perren F, 2005, J NEUROSURG, V103, P869, DOI 10.3171/jns.2005.103.5.0869; Perren F, 2005, NEUROLOGY, V64, P558, DOI 10.1212/01.WNL.0000150546.70817.87; Ruan LT, 2006, J CLIN ULTRASOUND, V34, P60, DOI 10.1002/jcu.20201; Sakamoto S, 2006, ACTA NEUROCHIR, V148, P77, DOI 10.1007/s00701-005-0634-z; STEINMEIER R, 1993, NEUROSURGERY, V33, P10; Toscano M, 2014, EUR NEUROL, V72, P330, DOI 10.1159/000364862; YAMADA I, 1992, NEURORADIOLOGY, V34, P318, DOI 10.1007/BF00588191; Yeh SJ, 2016, ULTRASOUND MED BIOL, V42, P2844, DOI 10.1016/j.ultrasmedbio.2016.07.016	21	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188948	10.1371/journal.pone.0188948	http://dx.doi.org/10.1371/journal.pone.0188948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220356	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900022
J	Lavania, S; Anthwal, D; Bhalla, M; Singh, N; Haldar, S; Tyagi, JS				Lavania, Surabhi; Anthwal, Divya; Bhalla, Manpreet; Singh, Nagendra; Haldar, Sagarika; Tyagi, Jaya Sivaswami			Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PULMONARY TUBERCULOSIS; MICROSCOPY METHOD; INCOME COUNTRIES; NORTHERN INDIA; GENE-MUTATIONS; RPOB GENE; DNA; DIAGNOSIS; PCR	Direct smear microscopy of sputum forms the mainstay of TB diagnosis in resource-limited settings. Stained sputum smear slides can serve as a ready-made resource to transport sputum for molecular drug susceptibility testing. However, bio-safety is a major concern during transport of sputum/stained slides and for laboratory workers engaged in processing Mycobacterium tuberculosis infected sputum specimens. In this study, a bio-safe USP (Universal Sample Processing) concentration-based sputum processing method (Bio-safe method) was assessed on 87 M. tuberculosis culture positive sputum samples. Samples were processed for Ziehl-Neelsen (ZN) smear, liquid culture and DNA isolation. DNA isolated directly from sputum was subjected to an IS6110 PCR assay. Both sputum DNA and DNA extracted from bio-safe ZN concentrated smear slides were subjected to rpoB PCR and simultaneously assessed by DNA sequencing for determining rifampin (RIF) resistance. All sputum samples were rendered sterile by Bio-safe method. Bio-safe smears exhibited a 5% increment in positivity over direct smear with a 14% increment in smear grade status. All samples were positive for IS6110 and rpoB PCR. Thirty four percent samples were RIF resistant by rpoB PCR product sequencing. A 100% concordance (kappa value = 1) was obtained between sequencing results derived from bio-safe smear slides and bio-safe sputum. This study demonstrates that Bio-safe method can address safety issues associated with sputum processing, provide an efficient alternative to sample transport in the form of bio-safe stained concentrated smear slides and can also provide information on drug (RIF) resistance by direct DNA sequencing.	[Lavania, Surabhi; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi, India; [Lavania, Surabhi; Singh, Nagendra] Gautam Buddha Univ, Sch Biotechnol, Yamuna Express Way, Greater Noida, Uttar Pradesh, India; [Anthwal, Divya; Haldar, Sagarika; Tyagi, Jaya Sivaswami] NCR Biotech Sci Cluster, Ctr Biodesign & Diagnost, Translat Hlth Sci & Technol Inst, 3rd Milestone,Faridabad Gurgaon Express Way, Faridabad, India; [Bhalla, Manpreet] Natl Inst TB & Resp Dis, Dept Microbiol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Gautam Buddha University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Tyagi, JS (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi, India.; Haldar, S; Tyagi, JS (corresponding author), NCR Biotech Sci Cluster, Ctr Biodesign & Diagnost, Translat Hlth Sci & Technol Inst, 3rd Milestone,Faridabad Gurgaon Express Way, Faridabad, India.	sagarikahaldar@thsti.res.in; jayatyagi.aiims@gmail.com	Anthwal, Divya/AAV-1472-2021	Singh, Nagendra/0000-0003-0419-0684	SBIRI grant by BIRAC, Government of India, JST [BT/SBIRI/SP-0001/13]	SBIRI grant by BIRAC, Government of India, JST	This work was supported by SBIRI grant by BIRAC, Government of India (BT/SBIRI/SP-0001/13), JST.	Anthwal D, 2017, J CLIN MICROBIOL; Arora J, 2013, INT J MYCOBACT, V2, P109, DOI 10.1016/j.ijmyco.2013.03.001; Bhutia R, 2013, INT J TUBERC LUNG D, V17, P258, DOI 10.5588/ijtld.12.0452; Cauwelaert ND, 2011, J CLIN MICROBIOL, V49, P3600, DOI 10.1128/JCM.00745-11; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P2697, DOI 10.1128/JCM.43.6.2697-2702.2005; Chedore P, 2002, J CLIN MICROBIOL, V40, P4077, DOI 10.1128/JCM.40.11.4077-4080.2002; de Almeida IN, 2015, REV ARGENT MICROBIOL, V47, P47, DOI 10.1016/j.ram.2014.12.002; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Ereqat S, 2011, TROP MED INT HEALTH, V16, P360, DOI 10.1111/j.1365-3156.2010.02697.x; Gupta A, 2013, J CLIN LAB ANAL, V27, P31, DOI 10.1002/jcla.21558; Jain A, 2008, INDIAN J MED RES, V128, P300; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kumar M, 2011, J MED MICROBIOL, V60, P1410, DOI 10.1099/jmm.0.031633-0; Kumar P, 2014, TUBERCULOSIS, V94, P73, DOI 10.1016/j.tube.2013.10.001; Kwiecien R, 2011, DTSCH ARZTEBL INT, V108, P515, DOI 10.3238/arztebl.2011.0515; Lingala M. A. L., 2010, Journal of Microbiology and Antimicrobials, V2, P13; Makadia JS, 2012, INDIAN J CLIN BIOCHE, V27, P370, DOI 10.1007/s12291-012-0228-5; Maurya AK, 2013, INDIAN J MED MICROBI, V31, P40, DOI 10.4103/0255-0857.108720; Nathavitharana RR, 2016, J CLIN MICROBIOL, V54, P1624, DOI 10.1128/JCM.00251-16; Rakotosamimanana N, 2017, INT J INFECT DIS, V56, P248, DOI 10.1016/j.ijid.2016.12.005; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Revised national tuberculosis control programme (RNTCP), 2005, MOD LAB TECHN; Selvakumar N, 2002, J CLIN MICROBIOL, V40, P3017, DOI 10.1128/JCM.40.8.3017-3020.2002; Shenai S, 2009, INT J INFECT DIS, V13, P46, DOI 10.1016/j.ijid.2008.03.025; Singhal R, 2013, INT J MYCOBACT, V2, P84, DOI 10.1016/j.ijmyco.2013.03.003; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Suresh N, 2007, J MICROBIOL METH, V68, P291, DOI 10.1016/j.mimet.2006.09.001; Swaminathan S, 2016, TUBERCULOSIS, V101, P31, DOI 10.1016/j.tube.2016.08.002; Thirumurugan R, 2015, J INFECT PUBLIC HEAL, V8, P619, DOI 10.1016/j.jiph.2015.05.003; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; UNITAID, 2015, UNITAID TUB DIAGN TE, Vfourth.; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; WHO, 2016, GLOB TUB REP; WHO, 2016, US LOOP MED IS AMPL; World Health Organization, 2016, US MOL LIN PROB ASS; World Health Organization, 2017, WHO M REP TECHN EXP; World Health Organization (WHO), MULT RES TUB MDR TB	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189149	10.1371/journal.pone.0189149	http://dx.doi.org/10.1371/journal.pone.0189149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216262	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800081
J	Lu, G; Huang, J; Yang, QL; Xu, HB; Wu, PX; Fu, C; Li, SJ				Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun			Identification and genetic characterization of hepacivirus and pegivirus in commercial equine serum products in China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GB-VIRUS; NONPRIMATE HEPACIVIRUS; HORSES; TRANSMISSION; PURIFICATION; GONADOTROPIN; INFECTION	Equine hepacivirus (EqHV), equine pegivirus (EPgV) and Theiler's disease-associated virus (TDAV) are three novel equine viruses in the family Flaviviridae. EqHV and EPgV have been identified to circulate in the equine population worldwide, whereas TDAV has not been detected in equines since the first reported case. To date, no studies have focused on investigating EqHV, EPgV and TDAV in commercial equine sera or equine blood products in China. Considering the potential threat of EqHV, EPgV and TDAV to biosecurity and considering their possible influences on research results, equine sera for cell culture propagation and pregnant mare serum gonadotropin (PMSG) were purchased from different companies in China and investigated for EqHV, EPgV and TDAV in this study. By performing nested PCR or two rounds of PCR targeting the viral NS3 gene, four serum samples were confirmed to be EqHV-, EPgV-, or TDAV-RNA positive; all of the PMSG samples were negative for these three viruses. Subsequent sequencing results indicated that the serum samples contained multiple viral variants of EqHV, EPgV or TDAV, and a genetic analysis based on the partial NS3 gene of the three equine viruses was performed. Our study is the first to confirm the presence of EqHV, EPgV and TDAV in equine sera for cell culture propagation that is commercially available in China and provides the first demonstration of the presence of TDAV in China.	[Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun] Guangdong Technol Engn Res Ctr Pet Guangzhou, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Technol Engn Res Ctr Pet Guangzhou, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn			National Natural Science Foundation of China [31372448, 31672563, 31402259]; Special Fund for Agro-scientific Research in the Public Interest [201303042]; National Key Research and Development Program of China [2016YFD0501004, 2016YFD0501010]; Promote Scientific and Technological Development Program [2013B040200032]; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Research and Development Program of China; Promote Scientific and Technological Development Program; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases	This work was supported by the National Natural Science Foundation of China (31372448, 31672563), The Special Fund for Agro-scientific Research in the Public Interest (201303042), The National Key Research and Development Program of China (2016YFD0501004, 2016YFD0501010), The National Natural Science Foundation of China (31402259), The Promote Scientific and Technological Development Program (2013B040200032), and The Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; CHRISTAKOS S, 1979, J BIOL CHEM, V254, P4253; Elia G, 2017, TRANSBOUND EMERG DIS, V64, P1354, DOI 10.1111/tbed.12679; Feucht HH, 1997, LANCET, V349, P435, DOI 10.1016/S0140-6736(97)80062-1; Gemaque BS, 2014, EMERG INFECT DIS, V20, P2180, DOI 10.3201/eid2012.140603; GOSPODAROWICZ D, 1972, ENDOCRINOLOGY, V91, P101, DOI 10.1210/endo-91-1-101; Kapoor A, 2015, MBIO, V6, DOI 10.1128/mBio.01466-15; Kapoor A, 2013, J VIROL, V87, P7185, DOI 10.1128/JVI.00324-13; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kapoor A, 2013, ANTIMICROB AGENTS CH, V57, P2761, DOI 10.1128/AAC.00029-13; Leary TP, 1996, J VIROL, V70, P9028, DOI 10.1128/JVI.70.12.9028-9030.1996; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Lefrere JJ, 1999, TRANSFUSION, V39, P83, DOI 10.1046/j.1537-2995.1999.39199116899.x; Lu G, 2017, ARCH VIROLOGY; Lu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155662; Lyons S, 2014, J GEN VIROL, V95, P1701, DOI 10.1099/vir.0.065094-0; Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498; Postel A, 2016, VET MICROBIOL, V182, P8, DOI 10.1016/j.vetmic.2015.10.032; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Ramsay JD, 2015, HEPATOLOGY, V61, P1533, DOI 10.1002/hep.27689; Reuter G, 2014, ACTA VET HUNG, V62, P422, DOI 10.1556/AVet.2014.011; Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; de Souza AJS, 2015, ACTA TROP, V152, P56, DOI 10.1016/j.actatropica.2015.08.014; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189208	10.1371/journal.pone.0189208	http://dx.doi.org/10.1371/journal.pone.0189208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216266	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800095
J	Takeuchi, H; Abe, M; Takumi, Y; Hashimoto, T; Kobayashi, R; Osoegawa, A; Miyawaki, M; Okamoto, T; Sugio, K				Takeuchi, Hideya; Abe, Miyuki; Takumi, Yohei; Hashimoto, Takafumi; Kobayashi, Ryoji; Osoegawa, Atsushi; Miyawaki, Michiyo; Okamoto, Tatsuro; Sugio, Kenji			The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-GROWTH; EXPRESSION; VOLUME; ACTIVATION; DISEASE; OSTEOSARCOMA; INFLAMMATION; COAGULATION; THROMBOSIS	Activated platelets promote tumor cell growth, angiogenesis, and invasion. Platelet activity can be inferred by platelet volume indices (PVIs), which include platelet distribution width (PDW), mean platelet volume (MPV), platelet distribution width-to-platelet count ratio (PDW/P), and mean platelet volume-to-platelet count ratio. Platelets and platelet-related markers, such as the platelet-to-lymphocyte ratio, have been found to be significant prognostic factors in patients with breast cancer. However, the role of PVIs for predicting survival in breast cancer remains unknown; hence, we performed this retrospective analysis of 275 patients with breast cancer. PVIs were compared with clinicopathological variables, and were assessed to identify independent indicators associated with disease-free survival (DFS) using the Cox proportional hazards model. An elevated PDW/P significantly correlated with age and HER2 status. Univariate analysis revealed that elevated PDW, MPV, and PDW/P as well as tumor size, nuclear grade, and lymph node involvement were significantly associated with inferior DFS rates (tumor size: p<0.01; nuclear grade, lymph node involvement, PDW, MPV, and PDW/P: p<0.05). On multivariate analysis, a large tumor size and elevated PDW/P were significant prognostic factors for DFS, with hazard ratios of 3.24 (95% confidence interval [CI]: 1.24-8.47) and 2.99 (95% CI: 1.18-7.57), respectively (p<0.05). Our study is the first to reveal that an elevated PDW/P significantly reduces DFS in patients with breast carcinoma. Measuring the PDW/P is simple, relatively inexpensive, and almost universally available using routine blood counts; this makes it an attractive biomarker for improved risk assessment.	[Takeuchi, Hideya; Abe, Miyuki; Takumi, Yohei; Hashimoto, Takafumi; Kobayashi, Ryoji; Osoegawa, Atsushi; Miyawaki, Michiyo; Okamoto, Tatsuro; Sugio, Kenji] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Oita, Japan	Oita University	Takeuchi, H (corresponding author), Oita Univ, Fac Med, Dept Thorac & Breast Surg, Oita, Japan.	takeuchi@oita-u.ac.jp		Osoegawa, Atsushi/0000-0002-8327-3631				Cho SY, 2013, PLATELETS, V24, P375, DOI 10.3109/09537104.2012.701028; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gu ML, 2016, BREAST CANCER-TOKYO, V23, P752, DOI 10.1007/s12282-015-0635-6; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Inagaki N, 2014, LUNG CANCER, V83, P97, DOI 10.1016/j.lungcan.2013.08.020; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; Kaito K, 2005, BRIT J HAEMATOL, V128, P698, DOI 10.1111/j.1365-2141.2004.05357.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang DW, 2010, CANCER LETT, V294, P125, DOI 10.1016/j.canlet.2010.01.031; Kapoor JR, 2008, NEW ENGL J MED, V358, P1638, DOI 10.1056/NEJMc080056; Kaushansky K, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345.Con1_345_344; Kayacan O, 2006, AM J CLIN ONCOL-CANC, V29, P328, DOI 10.1097/01.coc.0000221300.72657.e0; Kraeima J, 2013, BRIT J CANCER, V109, P866, DOI 10.1038/bjc.2013.401; Kumagai S, 2015, MOL CLIN ONCOL, V3, P197, DOI 10.3892/mco.2014.436; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; MATSUO K, 1993, J CLIN ENDOCR METAB, V77, P996, DOI 10.1210/jc.77.4.996; MIYAZONO K, 1990, ANN NY ACAD SCI, V593, P51, DOI 10.1111/j.1749-6632.1990.tb16099.x; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Shen J, 2009, THROMB RES, V123, P604, DOI 10.1016/j.thromres.2008.04.004; Stegner D, 2014, THROMB RES, V133, pS149, DOI 10.1016/S0049-3848(14)50025-4; Sulzbacher I, 2003, MODERN PATHOL, V16, P66, DOI 10.1097/01.MP.0000043522.76788.0A; Takagi S, 2014, CANCER SCI, V105, P983, DOI 10.1111/cas.12464; Takeuchi H, 2016, ADV BREAST CANC RES, V5, P49; Takeuchi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177137; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Zhang F, 2016, TUMOR BIOL, V37, P9323, DOI 10.1007/s13277-015-4774-3	32	39	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189166	10.1371/journal.pone.0189166	http://dx.doi.org/10.1371/journal.pone.0189166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216259	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800085
J	Boulet, A; Vest, KE; Maynard, MK; Gammon, MG; Russell, AC; Mathews, AT; Cole, SE; Zhu, XY; Phillips, CB; Kwong, JQ; Dodani, SC; Leary, SC; Cobine, PA				Boulet, Aren; Vest, Katherine E.; Maynard, Margaret K.; Gammon, Micah G.; Russell, Antoinette C.; Mathews, Alexander T.; Cole, Shelbie E.; Zhu, Xinyu; Phillips, Casey B.; Kwong, Jennifer Q.; Dodani, Sheel C.; Leary, Scot C.; Cobine, Paul A.			The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; cytochrome c oxidase (complex IV); mitochondria; copper transport; membrane transport	SACCHAROMYCES-CEREVISIAE; HYPERTROPHIC CARDIOMYOPATHY; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; TISSUE DISTRIBUTION; BINDING PROTEIN; HUMAN MYOBLASTS; ATP SYNTHASOME; P-I; SCO2	Copper is required for the activity of cytochrome c oxidase (COX), the terminal electron-accepting complex of the mitochondrial respiratory chain. The likely source of copper used for COX biogenesis is a labile pool found in the mitochondrial matrix. In mammals, the proteins that transport copper across the inner mitochondrial membrane remain unknown. We previously reported that the mitochondrial carrier family protein Pic2 in budding yeast is a copper importer. The closest Pic2 ortholog in mammalian cells is the mitochondrial phosphate carrier SLC25A3. Here, to investigate whether SLC25A3 also transports copper, we manipulated its expression in several murine and human cell lines. SLC25A3 knockdown or deletion consistently resulted in an isolated COX deficiency in these cells, and copper addition to the culture medium suppressed these biochemical defects. Consistent with a conserved role for SLC25A3 in copper transport, its heterologous expression in yeast complemented copper-specific defects observed upon deletion of PIC2. Additionally, assays in Lactococcus lactis and in reconstituted liposomes directly demonstrated that SLC25A3 functions as a copper transporter. Taken together, these data indicate that SLC25A3 can transport copper both in vitro and in vivo.	[Boulet, Aren; Leary, Scot C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK 7N 5E5, Canada; [Vest, Katherine E.; Maynard, Margaret K.; Gammon, Micah G.; Russell, Antoinette C.; Mathews, Alexander T.; Cole, Shelbie E.; Zhu, Xinyu; Phillips, Casey B.; Cobine, Paul A.] Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA; [Kwong, Jennifer Q.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Dodani, Sheel C.] Univ Texas Dallas, Dept Chem & Biochem, Dallas, TX 75080 USA	University of Saskatchewan; Auburn University System; Auburn University; Emory University; University of Texas System; University of Texas Dallas	Cobine, PA (corresponding author), Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA.	paul.cobine@auburn.edu	Cobine, Paul/AAH-6619-2020; Kwong, Jennifer/L-4348-2019; Cobine, Paul A/G-3107-2011	Cobine, Paul/0000-0001-6012-0985; Cobine, Paul A/0000-0001-6012-0985; Vest, Katherine/0000-0002-3391-8649; Russell, Antoinette/0000-0003-4725-1758	National Science Foundation [MCB1158497]; National Institutes of Health [R01GM120211, R01GM079465]; Canadian Institutes of Health Research; Summer Scholar Cellular and Molecular Bioscience Program, Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, R01GM120211] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1158497] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Summer Scholar Cellular and Molecular Bioscience Program, Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB1158497 (to P. A. C.), National Institutes of Health Grants R01GM120211 (to P. A. C. and S. C. L.) and R01GM079465 (to Christopher J. Chang (University of California-Berkeley) for work performed by S. C. D.), and Canadian Institutes of Health Research (to S. C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Summer Scholar Cellular and Molecular Bioscience Program, Auburn University.	Allen KJ, 2006, BIOMETALS, V19, P555, DOI 10.1007/s10534-005-5918-5; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Baker ZN, 2017, HUM MOL GENET, V26, P4617, DOI 10.1093/hmg/ddx344; Baker ZN, 2017, METALLOMICS, V9, P1501, DOI 10.1039/c7mt00221a; Bode M, 2015, MOL BIOL CELL, V26, P2385, DOI 10.1091/mbc.E14-11-1526; Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Cavero S, 2003, MOL MICROBIOL, V50, P1257, DOI 10.1046/j.1365-2958.2003.03742.x; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Hlynialuk C. J., 2015, CELL REP, V2015, pS2211; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Horvath R, 2005, J INHERIT METAB DIS, V28, P479, DOI 10.1007/s10545-005-0479-x; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025; Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440; Jett KA, 2018, J BIOL CHEM, V293, P4644, DOI 10.1074/jbc.R117.816132; Joost K, 2010, PEDIATR NEUROL, V42, P227, DOI 10.1016/j.pediatrneurol.2009.10.004; Kaplan JH, 2016, BIOPHYS J, V110, P7, DOI 10.1016/j.bpj.2015.11.025; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; Leary SC, 2007, CELL METAB, V5, P403, DOI 10.1016/j.cmet.2007.04.002; Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385; Leary SC, 2013, MOL BIOL CELL, V24, P683, DOI 10.1091/mbc.E12-09-0705; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Lu YW, 2017, MOL BIOL CELL, V28, P1489, DOI 10.1091/mbc.E17-03-0195; Marobbio CMT, 2015, MOL GENET METAB, V115, P27, DOI 10.1016/j.ymgme.2015.03.003; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Morgada MN, 2015, P NATL ACAD SCI USA, V112, P11771, DOI 10.1073/pnas.1505056112; Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pyatskowit JW, 2008, COMP BIOCHEM PHYS C, V147, P316, DOI 10.1016/j.cbpc.2007.11.008; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Seifert EL, 2016, J BIOL CHEM, V291, P26126, DOI 10.1074/jbc.M116.744714; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; West EC, 2004, EXP BIOL MED, V229, P756, DOI 10.1177/153537020422900807; Williams JR, 2016, NEUROBIOL DIS, V89, P1, DOI 10.1016/j.nbd.2016.01.020; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	64	56	56	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1887	1896		10.1074/jbc.RA117.000265	http://dx.doi.org/10.1074/jbc.RA117.000265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29237729	hybrid, Green Published			2022-12-26	WOS:000424948000003
J	Ma, ZX; Strickland, KT; Cherne, MD; Sehanobish, E; Rohde, KH; Self, WT; Davidson, VL				Ma, Zhongxin; Strickland, Kyle T.; Cherne, Michelle D.; Sehanobish, Esha; Rohde, Kyle H.; Self, William T.; Davidson, Victor L.			The Rv2633c protein of Mycobacterium tuberculosis is a non-heme di-iron catalase with a possible role in defenses against oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catalase; metalloenzyme; Mycobacterium tuberculosis; reactive oxygen species (ROS); enzyme kinetics; hemerythrin; non-heme iron	METHYLOCOCCUS-CAPSULATUS BATH; HEMERYTHRIN; DIVERSITY; TUNNEL; ENZYME; PH	The Rv2633c gene in Mycobacterium tuberculosis is rapidly up-regulated after macrophage infection, suggesting that Rv2633c is involved in M. tuberculosis pathogenesis. However, the activity and role of the Rv2633c protein in host colonization is unknown. Here, we analyzed the Rv2633c protein sequence, which revealed the presence of an HHE cation-binding domain common in hemerythrin-like proteins. Phylogenetic analysis indicated that Rv2633c is a member of a distinct subset of hemerythrin-like proteins exclusive to mycobacteria. The Rv2633c sequence was significantly similar to protein sequences from other pathogenic strains within that subset, suggesting that these proteins are involved in mycobacteria virulence. We expressed and purified the Rv2633c protein in Escherichia coli and found that it contains two iron atoms, but does not behave like a hemerythrin. It migrated as a dimeric protein during size-exclusion chromatography. It was not possible to reduce the protein or observe any evidence for its interaction with O-2. However, Rv2633c did exhibit catalase activity with a k(cat) of 1475 s(-1) and K-m of 10.1 +/- 1.7 mm. Cyanide and azide inhibited the catalase activity with K-i values of 3.8 m and 37.7 m, respectively. Rv2633c's activity was consistent with a role in defenses against oxidative stress generated during host immune responses after M. tuberculosis infection of macrophages. We note that Rv2633c is the first example of a non-heme di-iron catalase, and conclude that it is a member of a subset of hemerythrin-like proteins exclusive to mycobacteria, with likely roles in protection against host defenses.	[Ma, Zhongxin; Strickland, Kyle T.; Cherne, Michelle D.; Sehanobish, Esha; Rohde, Kyle H.; Self, William T.; Davidson, Victor L.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Davidson, VL (corresponding author), 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	victor.davidson@ucf.edu	Self, William/A-6704-2008; Self, William/Q-4113-2019		Burnett School of Biomedical Sciences	Burnett School of Biomedical Sciences	This research was supported by Startup Funds from the Burnett School of Biomedical Sciences (to K. H. R. and V. L. D). The authors declare that they have no conflicts of interest with the contents of this article.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; BAERT JL, 1992, EUR J BIOCHEM, V209, P563, DOI 10.1111/j.1432-1033.1992.tb17321.x; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen KHC, 2015, J INORG BIOCHEM, V150, P81, DOI 10.1016/j.jinorgbio.2015.04.001; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karlsen OA, 2005, FEBS J, V272, P2428, DOI 10.1111/j.1742-4658.2005.04663.x; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li XB, 2015, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00777, 10.3389/fmicb.2014.00573, 10.3389/fmicb.2014.00800]; Makris TM, 2010, P NATL ACAD SCI USA, V107, P15391, DOI 10.1073/pnas.1007953107; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Njuma OJ, 2017, J BIOL CHEM, V292, P18408, DOI 10.1074/jbc.M117.791202; Que L, 1996, ACCOUNTS CHEM RES, V29, P190, DOI 10.1021/ar950146g; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; TAKAGI T, 1991, FEBS LETT, V285, P25, DOI 10.1016/0014-5793(91)80716-G; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	30	10	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1590	1595		10.1074/jbc.RA117.000421	http://dx.doi.org/10.1074/jbc.RA117.000421			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29242190	hybrid, Green Published			2022-12-26	WOS:000424201700012
J	Wales, JA; Chen, CY; Breci, L; Weichsel, A; Bernier, SG; Sheppeck, JE; Solinga, R; Nakai, T; Renhowe, PA; Jung, J; Montfort, WR				Wales, Jessica A.; Chen, Cheng-Yu; Breci, Linda; Weichsel, Andrzej; Bernier, Sylvie G.; Sheppeck, James E., II; Solinga, Robert; Nakai, Takashi; Renhowe, Paul A.; Jung, Joon; Montfort, William R.			Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); nitric oxide; protein-drug interaction; photoaffinity labeling; mass spectrometry (MS); nuclear magnetic resonance (NMR)	NO-INDEPENDENT STIMULATORS; IRON-HISTIDINE BOND; NITRIC-OXIDE; H-NOX; NMR-SPECTROSCOPY; CLOSTRIDIUM-BOTULINUM; SITE IDENTIFICATION; YC-1 BINDING; PROTEINS; ACTIVATION	Soluble guanylyl cyclase (sGC) is the receptor for nitric oxide and a highly sought-after therapeutic target for the management of cardiovascular diseases. New compounds that stimulate sGC show clinical promise, but where these stimulator compounds bind and how they function remains unknown. Here, using a photolyzable diazirine derivative of a novel stimulator compound, IWP-051, and MS analysis, we localized drug binding to the 1 heme domain of sGC proteins from the hawkmoth Manduca sexta and from human. Covalent attachments to the stimulator were also identified in bacterial homologs of the sGC heme domain, referred to as H-NOX domains, including those from Nostoc sp. PCC 7120, Shewanella oneidensis, Shewanella woodyi, and Clostridium botulinum, indicating that the binding site is highly conserved. The identification of photoaffinity-labeled peptides was aided by a signature MS fragmentation pattern of general applicability for unequivocal identification of covalently attached compounds. Using NMR, we also examined stimulator binding to sGC from M. sexta and bacterial H-NOX homologs. These data indicated that stimulators bind to a conserved cleft between two subdomains in the sGC heme domain. L12W/T48W substitutions within the binding pocket resulted in a 9-fold decrease in drug response, suggesting that the bulkier tryptophan residues directly block stimulator binding. The localization of stimulator binding to the sGC heme domain reported here resolves the longstanding question of where stimulators bind and provides a path forward for drug discovery.	[Wales, Jessica A.; Chen, Cheng-Yu; Breci, Linda; Weichsel, Andrzej; Montfort, William R.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Bernier, Sylvie G.; Sheppeck, James E., II; Solinga, Robert; Nakai, Takashi; Renhowe, Paul A.; Jung, Joon] Ironwood Pharmaceut, Cambridge, MA 02142 USA	University of Arizona; Ironwood Pharmaceuticals, Inc.	Montfort, WR (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	montfort@email.arizona.edu			National Institutes of Health from NIEHS [ES06694]; National Institutes of Health from NCI [CA023074]; BIO5 Institute of the University of Arizona; National Institutes of Health from the National Center for Research Resources (NCRR) [1S10 RR028868-01]; National Institutes of Health from NIGMS [P41GM103399, P41RR002301]; University of Wisconsin-Madison; National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; U.S. Department of Agriculture; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, S10RR028868, S10RR008438, S10RR025062, S10RR023438, S10RR029220, P41RR002301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, T32GM008804, R01GM117357] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; National Institutes of Health from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin-Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by National Institutes of Health Grant ES06694 from NIEHS to the Southwest Environmental Health Sciences Center (SWEHSC), National Institutes of Health Grant CA023074 from NCI to the University of Arizona Cancer Center, and the BIO5 Institute of the University of Arizona. The Thermo Fisher LTQ Orbitrap Velos mass spectrometer was provided by National Institutes of Health Grant 1S10 RR028868-01 from the National Center for Research Resources (NCRR). This study made use of the National Magnetic Resonance Facility at Madison (NMRFAM), which is supported by National Institutes of Health Grant P41GM103399 from NIGMS (old number: P41RR002301). Equipment was purchased with funds from the University of Wisconsin-Madison, the National Institutes of Health (Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220), the National Science Foundation (Grants DMB-8415048, OIA-9977486, and BIR-9214394), and the U.S. Department of Agriculture. We are particularly grateful to Dr. Marco Tonelli of NMRFAM for help with acquiring and interpreting NMR data.	Aguirre C., 2015, CURR PROTOC PROTEIN, V81, DOI [10. 1002/0471140864. ps1718s81 26237672, DOI 10.1002/0471140864.PS1718S8126237672]; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Daiber A, 2015, ANTIOXID REDOX SIGN, V23, P899, DOI 10.1089/ars.2015.6376; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dubinsky L, 2012, BIOORGAN MED CHEM, V20, P554, DOI 10.1016/j.bmc.2011.06.066; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Galle J, 1999, BRIT J PHARMACOL, V127, P195, DOI 10.1038/sj.bjp.0702495; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Herzik MA, 2014, P NATL ACAD SCI USA, V111, pE4156, DOI 10.1073/pnas.1416936111; Hespen CW, 2016, ACS CHEM BIOL, V11, P2337, DOI 10.1021/acschembio.6b00431; Hu XH, 2008, J BIOL CHEM, V283, P20968, DOI 10.1074/jbc.M801501200; Hu XH, 2008, J AM CHEM SOC, V130, P15748, DOI 10.1021/ja804103y; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Lahiri T, 2014, BIOCHEMISTRY-US, V53, P2126, DOI 10.1021/bi401597m; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Mota F, 2014, BIOORG MED CHEM LETT, V24, P1075, DOI 10.1016/j.bmcl.2014.01.015; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakai T, 2016, ACS MED CHEM LETT, V7, P465, DOI 10.1021/acsmedchemlett.5b00479; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Plate L, 2013, TRENDS BIOCHEM SCI, V38, P566, DOI 10.1016/j.tibs.2013.08.008; Purohit R, 2014, BIOCHEMISTRY-US, V53, P101, DOI 10.1021/bi4015133; Ramanathan S, 2011, BIOCHEMISTRY-US, V50, P7787, DOI 10.1021/bi201060c; Smith E, 2015, FUTURE MED CHEM, V7, P159, DOI [10.4155/FMC.14.152, 10.4155/fmc.14.152]; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stone JR, 1998, CHEM BIOL, V5, P255, DOI 10.1016/S1074-5521(98)90618-4; Straub A, 2001, BIOORG MED CHEM LETT, V11, P781, DOI 10.1016/S0960-894X(01)00073-7; Verhoest PR, 2012, J MED CHEM, V55, P9045, DOI 10.1021/jm3007799; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Ying JF, 2017, J BIOMOL NMR, V68, P101, DOI 10.1007/s10858-016-0072-7; Yoo BK, 2012, ACS CHEM BIOL, V7, P2046, DOI 10.1021/cb3003539; Yoo BK, 2012, J BIOL CHEM, V287, P6851, DOI 10.1074/jbc.M111.299297; Zhang HM, 2014, CHEM COMMUN, V50, P4891, DOI 10.1039/c4cc01528b; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	51	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1850	1864		10.1074/jbc.RA117.000457	http://dx.doi.org/10.1074/jbc.RA117.000457			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222330	hybrid, Green Published			2022-12-26	WOS:000424201700033
J	Fahrner, M; Pandey, SK; Muik, M; Traxler, L; Butorac, C; Stadlbauer, M; Zayats, V; Krizova, A; Plenk, P; Frischauf, I; Schindl, R; Gruber, HJ; Hinterdorfer, P; Ettrich, R; Romanin, C; Derler, I				Fahrner, Marc; Pandey, Saurabh K.; Muik, Martin; Traxler, Lukas; Butorac, Carmen; Stadlbauer, Michael; Zayats, Vasilina; Krizova, Adela; Plenk, Peter; Frischauf, Irene; Schindl, Rainer; Gruber, Hermann J.; Hinterdorfer, Peter; Ettrich, Rudiger; Romanin, Christoph; Derler, Isabella			Communication between N terminus and loop2 tunes Orai activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); calcium release-activated calcium channel protein 1 (ORAI1); electrophysiology; signal transduction; stromal interaction molecule 1 (STIM1)	FAST CA2+-DEPENDENT INACTIVATION; MOLECULAR-DYNAMICS SIMULATIONS; CRAC CHANNELS; TRANSMEMBRANE SEGMENT; STIM1; PORE; PROTEIN; DOMAIN; DETERMINANTS; PERMEATION	Ca2+ release-activated Ca2+ (CRAC) channels constitute the major Ca2+ entry pathway into the cell. They are fully reconstituted via intermembrane coupling of the Ca2+-selective Orai channel and the Ca2+-sensing protein STIM1. In addition to the Orai C terminus, the main coupling site for STIM1, the Orai N terminus is indispensable for Orai channel gating. Although the extended transmembrane Orai N-terminal region (Orai1 amino acids 73-91; Orai3 amino acids 48-65) is fully conserved in the Orai1 and Orai3 isoforms, Orai3 tolerates larger N-terminal truncations than Orai1 in retaining store-operated activation. In an attempt to uncover the reason for these isoform-specific structural requirements, we analyzed a series of Orai mutants and chimeras. We discovered that it was not the N termini, but the loop2 regions connecting TM2 and TM3 of Orai1 and Orai3 that featured distinct properties, which explained the different, isoform-specific behavior of Orai N-truncation mutants. Atomic force microscopy studies and MD simulations suggested that the remaining N-terminal portion in the non-functional Orai1 N-truncation mutants formed new, inhibitory interactions with the Orai1-loop2 regions, but not with Orai3-loop2. Such a loop2 swap restored activation of the N-truncation Orai1 mutants. To mimic interactions between the N terminus and loop2 in full-length Orai1 channels, we induced close proximity of the N terminus and loop2 via cysteine cross-linking, which actually caused significant inhibition of STIM1-mediated Orai currents. In aggregate, maintenance of Orai activation required not only the conserved N-terminal region but also permissive communication of the Orai N terminus and loop2 in an isoform-specific manner.	[Fahrner, Marc; Muik, Martin; Traxler, Lukas; Butorac, Carmen; Stadlbauer, Michael; Krizova, Adela; Plenk, Peter; Frischauf, Irene; Schindl, Rainer; Gruber, Hermann J.; Hinterdorfer, Peter; Romanin, Christoph; Derler, Isabella] Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria; [Pandey, Saurabh K.; Zayats, Vasilina; Ettrich, Rudiger] Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Nove Hrady 37333, Czech Republic; [Schindl, Rainer] Med Univ Graz, Inst Biophys, Neue Stiftingtalstr 6-4, A-8010 Graz, Austria	Johannes Kepler University Linz; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Graz	Romanin, C; Derler, I (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	christoph.romanin@jku.at; Isabella.derler@jku.at	Schindl, Rainer/V-4205-2019; Fahrner, Marc/AAI-7927-2021; Pandey, Saurabh Kumar/H-8148-2014; Frischauf, Irene/AAG-2007-2019; Romanin, Christoph/D-5399-2009; Hoeglinger, Carmen/AAF-9364-2021; Derler, Isabella/B-7871-2019; Ettrich, Rudi H/C-1463-2011; Schindl, Rainer/E-3959-2013	Pandey, Saurabh Kumar/0000-0002-5923-5045; Frischauf, Irene/0000-0003-0661-2932; Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Ettrich, Rudi H/0000-0001-8624-7706; Fahrner, Marc/0000-0002-2689-0158; Tiffner, Adela/0000-0002-7529-4504; Hinterdorfer, Peter/0000-0003-2583-1305; Hoglinger, Carmen/0000-0002-2754-592X; Schindl, Rainer/0000-0003-0896-8887; Zayats, Vasilina/0000-0002-9355-8171	Austrian Science Fund (FWF) [P25210, P27641, P28123, P28498, P28701, P26067, P27263, W1250]; program Inter-COST [LTC17069]; European Cooperation in Science and Technology (COST) action [BM1406]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); program Inter-COST; European Cooperation in Science and Technology (COST) action(European Cooperation in Science and Technology (COST))	This work was supported in part by the Austrian Science Fund (FWF) projects P25210 and P27641 (to I. D.), P28123 (to M. F.), P28498 (to M. M.), P28701 (to R. S.), P26067 (to R. S. and C. R.), and P27263 as well as W1250 (to C. R.) and by the program Inter-COST (project LTC17069) (to R. E.). This work was also supported in part by a European Cooperation in Science and Technology (COST) action (BM1406) (to R. S., R. H. E., and C. R). The authors declare that they have no conflicts of interest with the contents of this article.	Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bergsmann J, 2011, J BIOL CHEM, V286, P31565, DOI 10.1074/jbc.M111.227546; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2018, J BIOL CHEM, V293, P1259, DOI 10.1074/jbc.M117.812206; Derler I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad7808; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fahrner M, 2014, J BIOL CHEM, V289, P33231, DOI 10.1074/jbc.M114.610022; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Frischauf I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1901; Frischauf I, 2011, J BIOL CHEM, V286, P8577, DOI 10.1074/jbc.M110.187179; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTTER JL, 1993, REV SCI INSTRUM, V64, P3342, DOI 10.1063/1.1144449; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Srikanth S, 2011, J BIOL CHEM, V286, P35318, DOI 10.1074/jbc.M111.265884; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wildling L, 2011, BIOCONJUGATE CHEM, V22, P1239, DOI 10.1021/bc200099t; Yamashita M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14512; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13725; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	70	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1271	1285		10.1074/jbc.M117.812693	http://dx.doi.org/10.1074/jbc.M117.812693			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29237733	Green Published, hybrid			2022-12-26	WOS:000423515000014
J	Merten, V; Christiansen, B; Javidpour, J; Piatkowski, U; Puebla, O; Gasca, R; Hoving, HJT				Merten, Veronique; Christiansen, Bernd; Javidpour, Jamileh; Piatkowski, Uwe; Puebla, Oscar; Gasca, Rebeca; Hoving, Henk-Jan T.			Diet and stable isotope analyses reveal the feeding ecology of the orangeback squid Sthenoteuthis pteropus (Steenstrup 1855) (Mollusca, Ommastrephidae) in the eastern tropical Atlantic	PLOS ONE			English	Article							DOSIDICUS-GIGAS; JUMBO SQUID; RANGE EXPANSION; SOUTHERN-OCEAN; GELATINOUS-ZOOPLANKTON; TROPHIC INTERACTIONS; GENUS STHENOTEUTHIS; MYCTOPHID FISHES; HUMBOLDT SQUID; YELLOWFIN TUNA	In the eastern tropical Atlantic, the orangeback flying squid Sthenoteuthis pteropus (Steenstrup 1855) (Cephalopoda, Ommastrephidae) is a dominant species of the epipelagic nekton community. This carnivore squid has a short lifespan and is one of the fastest-growing squids. In this study, we characterise the role of S. pteropus in the pelagic food web of the eastern tropical Atlantic by investigating its diet and the dynamics of its feeding habits throughout its ontogeny and migration. During three expeditions in the eastern tropical Atlantic in 2015, 129 specimens were caught by hand jigging. Stomach content analyses (via visual identification and DNA barcoding) were combined with stable isotope data (partial derivative N-15 and partial derivative C-13) of muscle tissue to describe diet, feeding habits and trophic ecology of S. pteropus. Additionally, stable isotope analyses of incremental samples along the squid's gladius D the chitinous spiniform structure supporting the muscles and organs D were carried out to explore possible diet shifts through ontogeny and migration. Our results show that S. pteropus preys mainly on myctophid fishes (e.g. Myctophum asperum, Myctophum nitidulum, Vinciguerria spp.), but also on other teleost species, cephalopods (e.g. Enoploteuthidae, Bolitinidae, Ommastrephidae), crustaceans and possibly on gelatinous zooplankton as well. The squid shows a highly opportunistic feeding behaviour that includes cannibalism. Our study indicates that the trophic position of S. pteropus may increase by approximately one trophic level from a mantle length of 15 cm to 47 cm. The reconstructed isotope-based feeding chronologies of the gladii revealed high intra- and inter-individual variability in the squid's trophic position and foraging area. These findings are not revealed by diet or muscle tissue stable isotope analysis. This suggests a variable and complex life history involving individual variation and migration. The role of S. pteropus in transferring energy and nutrients from lower to higher trophic levels may be underestimated and important for understanding how a changing ocean impacts food webs in the eastern Atlantic.	[Merten, Veronique; Javidpour, Jamileh; Piatkowski, Uwe; Puebla, Oscar; Hoving, Henk-Jan T.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Christiansen, Bernd] Univ Hamburg, Inst Hydrobiol & Fishery Sci, Hamburg, Germany; [Puebla, Oscar] Christian Albrechts Univ Kiel, Kiel, Germany; [Gasca, Rebeca] El Colegio Frontera Sur, Chetmal, Mexico	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Hamburg; University of Kiel; El Colegio de la Frontera Sur (ECOSUR)	Merten, V (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	vmerten@geomar.de	Gasca, Rebeca/Q-7720-2016; Piatkowski, Uwe/G-4161-2011; Hoving, Henk-Jan T./A-9267-2018; Javidpour, Jamileh/M-3733-2015	Gasca, Rebeca/0000-0002-9716-1964; Piatkowski, Uwe/0000-0003-1558-5817; Hoving, Henk-Jan T./0000-0002-4330-6507; Puebla, Oscar/0000-0001-9700-5841; Javidpour, Jamileh/0000-0003-0492-8706	DFG [CP1218, MSM49]	DFG(German Research Foundation (DFG))	Henk-Jan T. Hoving and Uwe Piatkowski obtained the funding for this study from the DFG-supported Cluster of Excellence 80 "The Future Ocean" (grant CP1218), http://www.futureocean.org/en/index.php. Shiptime and associated financial support were provided by the DFG (grant MSM49 to Bernd Christiansen).	[Anonymous], 2017, MARINE SPECIES IDENT; [Anonymous], 2007, TREE LIFE WEB PROJEC; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; ARKHIPKIN A, 1992, J EXP MAR BIOL ECOL, V163, P261, DOI 10.1016/0022-0981(92)90054-E; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BIGGS DC, 1976, B MAR SCI, V26, P14; Bizikov VA, 1991, SQUID AGE DETERMINAT, P39; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Breiby A., 1985, Northwest Atlantic Fisheries Organization Scientific Council Studies, P125; BRODEUR RD, 1992, MAR ECOL PROG SER, V84, P101, DOI 10.3354/meps084101; Brodeur RD, 1987, 57 NOAA NMFS; Bulman CM, 2002, MAR FRESHWATER RES, V53, P59, DOI 10.1071/MF01057; Burridge AK, 2016, PROG OCEANOGR; Caddy JF, 1998, REV FISH BIOL FISHER, V8, P431, DOI 10.1023/A:1008807129366; Cailliet GM, 1977, P 1 PAC NW TECHN WOR, P1; Campana SE, 2004, PHOTOGRAPHIC ATLAS F; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Cherel Y, 2009, MAR BIOL, V156, P699, DOI 10.1007/s00227-008-1121-x; Choy CA, 2016, MAR ECOL PROG SER, V549, P9, DOI 10.3354/meps11680; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P979, DOI 10.1098/rstb.1996.0088; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Doubleday ZA, 2016, CURR BIOL, V26, pR406, DOI 10.1016/j.cub.2016.04.002; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Gasca R, 2004, HYDROBIOLOGIA, V530, P529, DOI 10.1007/s10750-004-2657-5; Gasca R, 2017, MAR BIODIVERS; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; HARBISON GR, 1977, DEEP-SEA RES, V24, P465, DOI 10.1016/0146-6291(77)90484-2; HEEGER T, 1992, MAR ECOL PROG SER, V88, P293, DOI 10.3354/meps088293; HOPKINS TL, 1992, MAR BIOL, V114, P185, DOI 10.1007/BF00349518; Hoving HJT, 2016, DEEP-SEA RES PT I, V116, P94, DOI 10.1016/j.dsr.2016.08.001; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Hoving HJT, 2017, NAT SCI REPORTS, V7; Hunsicker ME, 2010, MAR ECOL PROG SER, V415, P91, DOI 10.3354/meps08750; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jackson GD, 2007, REV FISH BIOL FISHER, V17, P79, DOI 10.1007/s11160-007-9055-9; KEAR AJ, 1992, J EXP MAR BIOL ECOL, V156, P161, DOI 10.1016/0022-0981(92)90243-4; KINZER J, 1985, MAR BIOL, V85, P313, DOI 10.1007/BF00393252; Kruse S, 2015, MAR ECOL PROG SER, V529, P63, DOI 10.3354/meps11288; Laval P., 1980, Oceanography and Marine Biology an Annual Review, V18, P11; Lavaniegos B. E., 1999, CRUSTACEANS BIODIVER, VI, P489; Li YK, 2017, FISH RES, V187, P22, DOI 10.1016/j.fishres.2016.11.005; LIPINSKI MR, 1995, S AFR J MARINE SCI, V15, P207; Lordan C, 1998, S AFR J MARINE SCI, V20, P153; Lorrain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022194; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Madin LP, 1977, DEEP RES, V24; Magurran AE, 1986, INDIVIDUAL DIFFERENC, P338; Markaida U, 2003, J MAR BIOL ASSOC UK, V83, P290; Markaida U, 2006, FISH RES, V79, P16, DOI 10.1016/j.fishres.2006.02.016; Menard F, 2007, MAR BIOL, V153, P141, DOI 10.1007/s00227-007-0789-7; Menard M., 1980, NATURE, V283; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Parry M, 2008, MAR BIOL, V153, P249, DOI 10.1007/s00227-007-0800-3; Partridge L., 1985, P207; Perez JAA, 1996, CAN J FISH AQUAT SCI, V53, P2837, DOI 10.1139/cjfas-53-12-2837; Piatkowski U, 2001, FISH RES, V52, P5, DOI 10.1016/S0165-7836(01)00226-0; Piatkowski U, 1998, S AFR J MARINE SCI, V20, P375; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Piontkovski S, 2003, J PLANKTON RES, V25, P1021, DOI 10.1093/plankt/25.9.1021; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Roper CFE, 2010, FAO SPECIES CATALOGU, V2; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; Ruiz-Cooley RI, 2006, J MAR BIOL ASSOC UK, V86, P437, DOI 10.1017/S0025315406013324; Ruiz-Cooley RI, 2013, PLOS ONE, V8; Sassa C, 2004, MAR ECOL PROG SER, V278, P279, DOI 10.3354/meps278279; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P41; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P83; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P7; Shreeve RS, 2009, MAR ECOL PROG SER, V386, P221, DOI 10.3354/meps08064; Shulman GE, 2002, B MAR SCI, V71, P815; Sigman DM, 1999, GLOBAL BIOGEOCHEM CY, V13, P1149, DOI 10.1029/1999GB900038; Smale MJ, 1996, PHILOS T ROY SOC B, V351, P1067, DOI 10.1098/rstb.1996.0094; Stewart JS, 2014, GLOBAL CHANGE BIOL, V20, P1832, DOI 10.1111/gcb.12502; Trull TW, 2008, DEEP-SEA RES PT II, V55, P820, DOI 10.1016/j.dsr2.2007.12.035; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199; VENABLES WN, 2002, MODERN APPL STAT S F; Vinogradov M. E., 1996, HYPERIID AMPHIPODS A; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Watanabe H, 2002, MAR ECOL PROG SER, V236, P263, DOI 10.3354/meps236263; Wells MJ, 1996, PHILOS T R SOC B, V351, P1083, DOI 10.1098/rstb.1996.0095; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104; Zuev G.V., 1993, P653; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuyev G, 2002, B MAR SCI, V71, P1019	97	18	20	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189691	10.1371/journal.pone.0189691	http://dx.doi.org/10.1371/journal.pone.0189691			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244845	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000418184700051
J	Lu, WY; Hwang, JK; Zeng, FF; Leal, WS				Lu, WeiYu; Hwang, Justin K.; Zeng, Fangfang; Leal, Walter S.			DEET as a feeding deterrent	PLOS ONE			English	Article							LABRAL APICAL CHEMORECEPTORS; MALE MOSQUITOS; AEDES-AEGYPTI; REPELLENTS; BLOOD; CULICIDAE; RESPONSES	The insect repellent N, N-diethyl-3-methylbenzamide (DEET), is a multimodal compound that acts as a spatial repellent as well as an irritant (contact repellent), thus being perceived by the insect's olfactory and gustatory systems as an odorant and a tastant, respectively. Soon after DEET was developed, almost 6 decades ago, it was reported that it reduced mosquito feeding on blood mixed with this repellent. It is now known that the mosquito proboscis senses contact repellents with the tips (labella) of the labium, which remain in direct contact with the outer layers of the skin, while the stylets, including the feeding deterrent sensor (labrum), penetrate the skin. We designed a behavioral assay that allowed us to measure feeding deterrence without complications from contact or spatial repellency. Using the southern house mosquito, Culex quinquefasciatus, we demonstrate here that when DEET was mixed with blood and covered by Parafilm (R) layers, the mean number of landings and duration of contacts with surfaces covering blood mixed with DEET or blood plus solvent (dimethyl sulfoxide) did not differ significantly thus implying that DEET did not leak to the outer surface. The feeding times, however, were significantly different. When blood was mixed either with 0.1 or 1% DEET, female southern house mosquitoes spent significantly (P<0.0001) less time feeding than the time spent feeding on blood mixed only with the solvent. By contrast, significant differences in the mean times of feeding on blood containing 1% picaridin and blood plus solvent were significant at 5%, but not at 1% level. Like DEET, the contact repellent and insecticide, permethrin, caused a significant (P<0.0001) reduction in feeding time. We, therefore, concluded, that in this context, DEET, permethrin, and, to a lesser extent, picaridin, act as feeding deterrents.	[Lu, WeiYu; Hwang, Justin K.; Zeng, Fangfang; Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Lu, WeiYu/0000-0002-7788-3425; Leal Filho, Walter/0000-0002-1241-5225	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01A1095514, R21A1128931]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI128931, R01AI095514] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under awards R01A1095514 and R21A1128931. FZ was supported in part by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	BARZEEV M, 1959, J ECON ENTOMOL, V52, P263, DOI 10.1093/jee/52.2.263; Choo YM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00306; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208; Kessler S, 2014, PHYSIOL ENTOMOL, V39, P172, DOI 10.1111/phen.12061; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; Kong XQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011910; Leal WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42826; LISCIA A, 1993, J INSECT PHYSIOL, V39, P261, DOI 10.1016/0022-1910(93)90097-B; Miller JR, 2009, J ECON ENTOMOL, V102, P2056, DOI 10.1603/029.102.0606; Nikbakhtzadeh MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00004; Obermayr U, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P91; Wahid I, 2003, J MED ENTOMOL, V40, P150, DOI 10.1603/0022-2585-40.2.150; Werner-Reiss U, 1999, J INSECT PHYSIOL, V45, P629, DOI 10.1016/S0022-1910(98)00152-8; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	17	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189243	10.1371/journal.pone.0189243	http://dx.doi.org/10.1371/journal.pone.0189243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240785	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600022
J	Marshall, RS; Asllani, I; Pavol, MA; Cheung, YK; Lazar, RM				Marshall, Randolph S.; Asllani, Iris; Pavol, Marykay A.; Cheung, Ying-Kuen; Lazar, Ronald M.			Altered cerebral hemodyamics and cortical thinning in asymptomatic carotid artery stenosis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER-HYPERINTENSITIES; TYPE-2 DIABETES-MELLITUS; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; OLDER-ADULTS; SUBCORTICAL TYPE; BLOOD-PRESSURE; THICKNESS; DEMENTIA	Cortical thinning is a potentially important biomarker, but the pathophysiology in cerebrovascular disease is unknown. We investigated the association between regional cortical blood flow and regional cortical thickness in patients with asymptomatic unilateral high-grade internal carotid artery disease without stroke. Twenty-nine patients underwent high resolution anatomical and single-delay, pseudocontinuous arterial spin labeling magnetic resonance imaging with partial volume correction to assess gray matter baseline flow. Cortical thickness was estimated using Freesurfer software, followed by co-registration onto each patient's cerebral blood flow image space. Paired t-tests assessed regional cerebral blood flow in motor cortex (supplied by the carotid artery) and visual cortex (indirectly supplied by the carotid) on the occluded and unoccluded side. Pearson correlations were calculated between cortical thickness and regional cerebral blood flow, along with age, hypertension, diabetes and white matter hyperintensity volume. Multiple regression and generalized estimating equation were used to predict cortical thickness bilaterally and in each hemisphere separately. Cortical blood flow correlated with thickness in motor cortex bilaterally (p = 0.0002), and in the occluded and unoccluded sides individually; age (p = 0.002) was also a predictor of cortical thickness in the motor cortex. None of the variables predicted cortical thickness in visual cortex. Blood flow was significantly lower on the occluded versus unoccluded side in the motor cortex (p<0.0001) and in the visual cortex (p = 0.018). On average, cortex was thinner on the side of occlusion in motor but not in visual cortex. The association between cortical blood flow and cortical thickness in carotid arterial territory with greater thinning on the side of the carotid occlusion suggests that altered cerebral hemodynamics is a factor in cortical thinning.	[Marshall, Randolph S.; Pavol, Marykay A.; Cheung, Ying-Kuen; Lazar, Ronald M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA; [Asllani, Iris] Rochester Inst Technol, Coll Engn, Dept Biomed Engn, Rochester, NY 14623 USA	Columbia University; Rochester Institute of Technology	Marshall, RS (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.	rsm2@columbia.edu			National Institute for Neurological Disorders and Stroke [R01NS076277]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076277] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institute for Neurological Disorders and Stroke, https://www.ninds.nih.gov/, R01NS076277 (Co-Pls: RSM, RML).	Alosco ML, 2014, J AM SOC HYPERTENS, V8, P561, DOI 10.1016/j.jash.2014.04.002; Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Arbique D, 2014, J AM MED DIR ASSOC, V15, P234, DOI 10.1016/j.jamda.2013.10.014; Asllani I, 2008, MAGNETIC RE IN PRESS; Asllani I, 2009, P ISMRM; Asllani I, 2016, NEUROIMAGE-CLIN, V12, P640, DOI 10.1016/j.nicl.2016.09.013; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; Balestrini S, 2013, NEUROLOGY, V80, P2145, DOI 10.1212/WNL.0b013e318295d71a; Boesen ME, 2015, ATHEROSCLEROSIS, V243, P211, DOI 10.1016/j.atherosclerosis.2015.09.008; BOGOUSSLAVSKY J, 1986, NEUROLOGY, V36, P373, DOI 10.1212/WNL.36.3.373; Castro M, 2009, ACAD RADIOL, V16, P1201, DOI 10.1016/j.acra.2009.03.022; Claassen DO, 2016, AGING DIS, V7, P220, DOI 10.14336/AD.2015.1110; Dai WY, 2012, MAGN RESON MED, V67, P1252, DOI 10.1002/mrm.23103; DELATORRE JC, 1993, BRAIN RES, V623, P6, DOI 10.1016/0006-8993(93)90003-6; Duering M, 2015, NEUROLOGY, V84, P1685, DOI 10.1212/WNL.0000000000001502; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Flores G, 2016, SYNAPSE, V70, P198, DOI 10.1002/syn.21887; Giannopoulos S, 2010, EUR J NEUROL, V17, P1457, DOI 10.1111/j.1468-1331.2010.03087.x; Gonzalez CE, 2015, J HYPERTENS, V33, P1242, DOI 10.1097/HJH.0000000000000531; Gottesman RF, 2009, BEHAV NEUROL, V22, P63, DOI 10.3233/BEN-2009-0261; Gutierrez J, 2017, CEREBROVASC DIS, V43, P124, DOI 10.1159/000454867; Ithapu V, 2014, HUM BRAIN MAPP, V35, P4219, DOI 10.1002/hbm.22472; Jones PW, 2016, RESTOR NEUROL NEUROS, V34, P733, DOI 10.3233/RNN-150623; Kim HJ, 2014, EUR J NEUROL, V21, P744, DOI 10.1111/ene.12376; Krumm S, 2016, NEUROBIOL AGING, V38, P188, DOI 10.1016/j.neurobiolaging.2015.11.001; Kumar R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126595; Lambert C, 2015, NEUROIMAGE-CLIN, V9, P194, DOI 10.1016/j.nicl.2015.07.002; MacIntosh BJ, 2015, AM J NEURORADIOL, V36, P295, DOI 10.3174/ajnr.A4094; Marshall RS, 2012, NEUROLOGY, V78, P250, DOI 10.1212/WNL.0b013e31824365d3; Marshall RS, 2016, J NEUROL SCI, V367, P143, DOI 10.1016/j.jns.2016.05.011; Meyer ML, 2017, J ALZHEIMERS DIS, V57, P195, DOI 10.3233/JAD-161041; Moller C, 2016, NEUROBIOL AGING, V38, P21, DOI 10.1016/j.neurobiolaging.2015.10.020; Moran C, 2015, NEUROLOGY, V85, P1123, DOI 10.1212/WNL.0000000000001982; Pacheco J, 2015, NEUROBIOL AGING, V36, P903, DOI 10.1016/j.neurobiolaging.2014.08.031; Peng B, 2015, NEUROSCI LETT, V606, P100, DOI 10.1016/j.neulet.2015.08.030; Pettigrew C, 2016, NEUROIMAGE-CLIN, V12, P116, DOI 10.1016/j.nicl.2016.06.010; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; RADU EW, 1978, NEURORADIOLOGY, V17, P7, DOI 10.1007/BF00345262; Rundek T, 2017, NEUROLOGY, V88, P2036, DOI 10.1212/WNL.0000000000003951; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salles GF, 2016, HYPERTENSION, V67, P693, DOI 10.1161/HYPERTENSIONAHA.115.06981; Seo SW, 2012, ALZ DIS ASSOC DIS, V26, P106, DOI 10.1097/WAD.0b013e31822e0831; Seo SW, 2010, J NEUROIMAGING, V20, P37, DOI 10.1111/j.1552-6569.2008.00293.x; Shaw ME, 2016, NEUROBIOL AGING, V39, P202, DOI 10.1016/j.neurobiolaging.2015.12.009; Tchistiakova E, 2016, NEUROBIOL AGING, V45, P98, DOI 10.1016/j.neurobiolaging.2016.05.011; Tchistiakova E, 2014, NEUROIMAGE-CLIN, V5, P36, DOI 10.1016/j.nicl.2014.05.020; Tosun D, 2010, NEUROIMAGE, V52, P186, DOI 10.1016/j.neuroimage.2010.04.033; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; van Sloten TT, 2014, J AM COLL CARDIOL, V63, P1739, DOI 10.1016/j.jacc.2013.12.041; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wennberg AMV, 2016, J NEUROL SCI, V365, P89, DOI 10.1016/j.jns.2016.04.017; Werner R, 2005, MAGNET RESON MED, V53, P1096, DOI 10.1002/mrm.20443; Weston PSJ, 2016, NEUROLOGY, V87, P2050, DOI 10.1212/WNL.0000000000003322; Yamauchi H, 2007, ANN NEUROL, V61, P454, DOI 10.1002/ana.21104	58	23	23	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189727	10.1371/journal.pone.0189727	http://dx.doi.org/10.1371/journal.pone.0189727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240808	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600070
J	Okonafua, F; Imosemi, D; Igboin, B; Adeyemi, A; Chibuko, C; Idowu, A; Imongan, W				Okonafua, Friday; Imosemi, Donald; Igboin, Brian; Adeyemi, Adegboyega; Chibuko, Chioma; Idowu, Adewale; Imongan, Wilson			Maternal death review and outcomes: An assessment in Lagos State, Nigeria	PLOS ONE			English	Review							NORTHERN NIGERIA; MORTALITY; CARE; BARRIERS	The objective of the study was to investigate the results of Maternal and Perinatal Death Surveillance and Response (MPDSR) conducted in three referral hospitals in Lagos State, Nigeria over a two-year period and to report the outcomes and the lessons learned. MPDRS panels were constituted in the three hospitals, and beginning from January 2015, we conducted monthly MPDSR in the three hospitals using a nationally approved protocol. Data on births and deaths and causes of deaths as identified by the MPDSR panels were collated in the hospitals. The results show that over a 21-month period (January 1, 2015-September 30, 2016), maternal mortality ratio (MMR) remained high in the hospitals. Although there was a trend towards an increase in MMR in Lagos Island Maternity Hospital and Gbagada General Hospital, and a trend towards a decline in Ajeromi Hospital, none of these trends were statistically significant. Eclampsia, primary post-partum haemorrhage, obstructed labour and puerperal sepsis were the leading obstetric causes of death. By contrast, delay in arrival in hospital, the lack of antenatal care and patients' refusal to receive recommended treatment were the patients' associated causes of death, while delay in treatment, poor use of treatment protocols, lack of equipment and lack of skills by providers to use available equipment were the identified facility-related causes of death. Failure to address the patients and facility-related causes of maternal mortality possibly accounted for the persistently high maternal mortality ratio in the hospitals. We conclude that interventions aimed at redressing all causes of maternal deaths identified in the reviews will likely reduce the maternal mortality ratios in the hospitals.	[Okonafua, Friday; Igboin, Brian; Chibuko, Chioma; Imongan, Wilson] WHARC, Program & Res Unit, Benin, Edo State, Nigeria; [Okonafua, Friday] Univ Med Sci UNIMED, Ondo, Ondo State, Nigeria; [Okonafua, Friday] Univ Benin, CERHI, Benin, Edo State, Nigeria; [Imosemi, Donald] LIMN, Dept Obstet & Gynecol, Lagos, Lagos State, Nigeria; [Adeyemi, Adegboyega] GGH, Dept Obstet & Gynecol, Lagos, Lagos State, Nigeria; [Idowu, Adewale] AGH, Dept Obstet & Gynecol, Lagos, Lagos State, Nigeria; [Okonafua, Friday] Univ Med Sci, Laje Rd, Ondo City, Ondo State, Nigeria; [Imongan, Wilson] Womens Hlth & Act Res Ctr, Lagos Benin Expressway, Igue Iheya, Edo State, Nigeria	University of Benin	Okonafua, F (corresponding author), WHARC, Program & Res Unit, Benin, Edo State, Nigeria.; Okonafua, F (corresponding author), Univ Med Sci UNIMED, Ondo, Ondo State, Nigeria.; Okonafua, F (corresponding author), Univ Benin, CERHI, Benin, Edo State, Nigeria.; Okonafua, F (corresponding author), Univ Med Sci, Laje Rd, Ondo City, Ondo State, Nigeria.	feokonofua@yahoo.co.uk	Dangal, Ganesh/O-1989-2017; Okonofua, Friday/AAB-9703-2021	Dangal, Ganesh/0000-0002-5834-5525; Okonofua, Friday/0000-0002-8777-2606	Macarthur Foundation [13-103979-000-INP]	Macarthur Foundation	This work was supported by Macarthur Foundation under grant number 13-103979-000-INP.	Achem FF, 2014, BJOG-INT J OBSTET GY, V121, P75, DOI 10.1111/1471-0528.12817; Aisien OA, 2010, J CLIN MED RES, V2, P55; Ande Adedapo, 2012, Niger Postgrad Med J, V19, P83; de Kok Bregje, 2017, HLTH POLICY PLANNING, P1; Doctor HV, 2012, INT J POPUL RES, V2012; Fabamwo A. O., 2010, African Journal of Reproductive Health, V14, P55; Fagbamigbe AF, 2017, HEALTH CARE WOMEN IN, V38, P17, DOI 10.1080/07399332.2016.1225743; Fagbamigbe AF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0527-y; Federal Ministry of Health Abuja, NAT MDR GUID 2013; Federal Ministry of Health Abuja, 2015, NAT GUID MAT PER DEA; Hofman JJ, 2014, INT J GYNECOL OBSTET, V126, P111, DOI [10.1016/j.ijgo.2014.02.014, 10.1016/]; Hussein J, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0158-4; Hussein Julia, 2012, Afr J Reprod Health, V16, P9; Kullima AA, 2009, ANN AFR MED, V8, P81, DOI 10.4103/1596-3519.56233; Lagos State Ministry of Health, MAT CHILD MORT RED P; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; Njuguna J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2376-z; Ogu RN, 2017, MIDWIFERY, V55, P1, DOI 10.1016/j.midw.2017.08.008; Okonofua F, 2017, BMC REPROD HLTH, P14; Okonofua FE, 2016, REV OBSTET COMPLICAT; Okonofua F, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0305-6; Okonofua F, 2011, HEALTH POLICY, V99, P131, DOI 10.1016/j.healthpol.2010.07.013; Onah H E, 2005, J Obstet Gynaecol, V25, P569, DOI 10.1080/01443610500231484; Oye-Adeniran BA, 2011, J OBSTET GYNAECOL, V31, P315, DOI 10.3109/01443615.2011.561381; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; WHO, 2013, MAT DEATH SURV RESP; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188392	10.1371/journal.pone.0188392	http://dx.doi.org/10.1371/journal.pone.0188392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240754	gold, Green Submitted, Green Published			2022-12-26	WOS:000417905600008
J	Perri, V; Gianchecchi, E; Cifaldi, L; Pellegrino, M; Giorda, E; Andreani, M; Cappa, M; Fierabracci, A				Perri, Valentina; Gianchecchi, Elena; Cifaldi, Loredana; Pellegrino, Marsha; Giorda, Ezio; Andreani, Marco; Cappa, Marco; Fierabracci, Alessandra			Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INFLUENZA-VIRUS INFECTION; CYTOMEGALOVIRUS-INFECTION; T-CELLS; DENDRITIC CELLS; RECEPTORS; LYMPHOCYTES; EFFECTOR; MICE; AUTOANTIBODIES	Type 1 diabetes is an autoimmune disease, in which pancreatic ss cells are destroyed by autoreactive T cells in genetically predisposed individuals. Serum beta cell autoantibody specificities have represented the mainstay for classifying diabetes as autoimmune-mediated and for stratifying risk in first-degree relatives. In recent years, approaches were attempted to solve the difficult issue of detecting rare antigen-specific autoreactive T cells and their significance to etiopathogenesis such as the use of the MHC multimer technology. This tool allowed the specific detection of increased percentages of GAD65 autoreactive T cells by means of HLA A*02:01 GAD65 AA 114-122 pentamers in newly diagnosed diabetics. Here we provide evidence that GAD65 AA 114-122 pentamers can depict a GAD65 AA114-122 peptide expandable population of functionally and phenotypically skewed, preliminary characterized CD3(-)CD8(dull)CD56(+) 'memory-like' NK cells in PBMC of newly diagnosed diabetics. Our data suggest that the NK cell subset could bind the HLA class I GAD65 AA 114-122 pentamer through ILT2 inhibitory receptor. CD107a expression revealed increased degranulation of CD3(-)CD8(dull)CD56(+) NK cells in GAD65 AA 114-122 and FLU peptide expanded peripheral blood mononuclear cells of diabetics following GAD65 AA 114-122 peptide HLA A*02:01 presentation in respect to the unpulsed condition. CD107a expression was enriched in ILT2 positive NK cells. As opposite to basal conditions where similar percentages of CD3(-)CD56(+)ILT2(+) cells were detected in diabetics and controls, CD3(-)CD56(+)CD107a(+) and CD3(-)CD56(+)ILT2(+)CD107a(+) cells were significantly increased in T1D PBMC either GAD65 AA 114-122 or FLU peptides stimulated after co-culture with GAD65 AA 114-122 pulsed APCs. As control, healthy donor NK cells showed similar degranulation against both GAD65 AA 114-122 pulsed and unpulsed APCs. The pathogenetic significance of the CD3(-)CD8(dull)CD56(+) 'memory-like NK cell subset' with increased response upon secondary challenge in diabetics remains to be elucidated.	[Perri, Valentina; Gianchecchi, Elena; Pellegrino, Marsha; Fierabracci, Alessandra] IRCCS, Bambino Gesu Childrens Hosp, Infectivol & Clin Trials Res Dept, Type Diabet Ctr 1, Rome, Italy; [Cifaldi, Loredana] IRCCS, Bambino Gesu Childrens Hosp, Pediat Hematol & Oncol Dept, Rome, Italy; [Giorda, Ezio] IRCCS, Bambino Gesu Childrens Hosp, Res Labs, Rome, Italy; [Andreani, Marco] Polyclin Tor Vergata, IME Fdn, Lab Immunogenet & Transplant Biol, Rome, Italy; [Cappa, Marco] Bambino Gesu Pediat Hosp, Endocrinol Dept, Rome, Italy; [Gianchecchi, Elena] Vismederi Srl, Siena, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Rome Tor Vergata; IRCCS Bambino Gesu	Fierabracci, A (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Infectivol & Clin Trials Res Dept, Type Diabet Ctr 1, Rome, Italy.	alessandra.fierabracci@opbg.net	Pellegrino, Marsha/K-4500-2016; Cifaldi, Loredana/AAI-1972-2019; Andreani, Marco/AAA-5208-2020; Fierabracci, Alessandra/K-5930-2016; Giorda, Ezio/AAH-9950-2019	Pellegrino, Marsha/0000-0002-9002-3622; Andreani, Marco/0000-0003-3451-3624; Fierabracci, Alessandra/0000-0003-3078-9754; Giorda, Ezio/0000-0002-5875-832X; Cifaldi, Loredana/0000-0001-5014-430X	Italian Ministry of Health Ricerca Corrente [RC 201602P003714]	Italian Ministry of Health Ricerca Corrente(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health Ricerca Corrente RC 201602P003714 (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Allan DSJ, 1999, J EXP MED, V189, P1149, DOI 10.1084/jem.189.7.1149; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; Blery M, 2000, HUM IMMUNOL, V61, P51, DOI 10.1016/S0198-8859(99)00157-3; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cifaldi L, 2015, CANCER RES, V75, P824, DOI 10.1158/0008-5472.CAN-14-1643; De Maria A, 2008, CURR HIV RES, V6, P433, DOI 10.2174/157016208785861221; Della Chiesa M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00351; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fierabracci A, 2002, SPRINGER SEMIN IMMUN, V24, P243, DOI 10.1007/s00281-002-0114-y; Fierabracci A., European Patent, Patent No. 1748296; Fierabracci A, 2011, DIABETES-METAB RES, V27, P216, DOI 10.1002/dmrr.1165; Gabrielli S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1376595; GARCIASUAREZ J, 1995, BRIT J HAEMATOL, V89, P653, DOI 10.1111/j.1365-2141.1995.tb08382.x; Geary CD, 2017, SEMIN IMMUNOL, V31, P11, DOI 10.1016/j.smim.2017.08.012; Gianchecchi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110755; Giuliani L, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/576219; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Horwitz DA, 1997, IMMUNOL TODAY, V18, P538, DOI 10.1016/S0167-5699(97)01149-3; HUSSAIN MJ, 1987, DIABETOLOGIA, V30, P907, DOI 10.1007/BF00295872; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kos FJ, 1998, IMMUNOL RES, V17, P303, DOI 10.1007/BF02786453; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lee J.H., 2015, BIOMED RES INT, V2015, P10, DOI DOI 10.1155/2015/137020; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Li TT, 2017, J IMMUNOL, V198, P1242, DOI 10.4049/jimmunol.1502186; Lopez-Sejas N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00476; Mallone R, 2013, CLIN IMMUNOL, V149, P286, DOI 10.1016/j.clim.2013.02.009; Marcenaro E, 2012, ADV EXP MED BIOL, V946, P295, DOI 10.1007/978-1-4614-0106-3_17; Marcenaro E, 2011, IMMUNOTHERAPY-UK, V3, P1075, DOI [10.2217/IMT.11.99, 10.2217/imt.11.99]; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Morel E, 2008, J IMMUNOL, V181, P2368, DOI 10.4049/jimmunol.181.4.2368; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nabekura T, 2016, J EXP MED, V213, P2745, DOI 10.1084/jem.20160726; NEGISHI K, 1986, DIABETOLOGIA, V29, P352, DOI 10.1007/BF00903343; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; PANINABORDIGNON P, 1995, J EXP MED, V181, P1923, DOI 10.1084/jem.181.5.1923; Peng H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01143; Poggi A, 2007, AUTOIMMUN REV, V6, P295, DOI 10.1016/j.autrev.2006.07.003; Popko K, 2015, CENT EUR J IMMUNOL, V40, P470, DOI 10.5114/ceji.2015.56971; Rodacki M, 2007, DIABETES, V56, P177, DOI 10.2337/db06-0493; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Shabrish S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3769590; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Velluzzi F, 2016, ACTA DIABETOL, V53, P73, DOI 10.1007/s00592-015-0751-y; Venkatasubramanian S, 2016, MUCOSAL IMMUNOL; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Vosshenrich CAJ, 2005, CURR OPIN IMMUNOL, V17, P151, DOI 10.1016/j.coi.2005.01.005; WILSON RG, 1986, BRIT MED J, V293, P244, DOI 10.1136/bmj.293.6541.244; Young NT, 2001, J IMMUNOL, V166, P3933, DOI 10.4049/jimmunol.166.6.3933; Zhou G, 2013, EUR J IMMUNOL, V43, P929, DOI 10.1002/eji.201242620	62	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189615	10.1371/journal.pone.0189615	http://dx.doi.org/10.1371/journal.pone.0189615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236750	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100086
J	Vanetti, C; Bifari, F; Vicentini, LM; Cattaneo, MG				Vanetti, Claudia; Bifari, Francesco; Vicentini, Lucia M.; Cattaneo, Maria Grazia			Fatty acids rather than hormones restore in vitro angiogenesis in human male and female endothelial cells cultured in charcoal-stripped serum	PLOS ONE			English	Article							THYROID-HORMONE; GROWTH-FACTOR; ESTROGEN; PROLIFERATION; SEX; CANCER; METABOLISM; ANDROGENS; MIGRATION; MEMBRANE	Charcoal-stripped serum (CSS) is a well-accepted method to model effects of sex hormones in cell cultures. We have recently shown that human endothelial cells (ECs) fail to growth and to undergo in vitro angiogenesis when cultured in CSS. However, the mechanism(s) underlying the CSS-induced impairment of in vitro EC properties are still unknown. In addition, whether there is any sexual dimorphism in the CSS-induced EC phenotype remains to be determined. Here, by independently studying human male and female ECs, we found that CSS inhibited both male and female EC growth and in vitro angiogenesis, with a more pronounced effect on male EC sprouting. Reconstitution of CSS with 17-beta estradiol, dihydrotestosterone, or the lipophilic thyroid hormone did not restore EC functions in both sexes. On the contrary, supplementation with palmitic acid or the acetyl-CoA precursor acetate significantly rescued the CSS-induced inhibition of growth and sprouting in both male and female ECs. We can conclude that the loss of metabolic precursors (e.g., fatty acids) rather than of hormones is involved in the impairment of in vitro proliferative and angiogenic properties of male and female ECs cultured with CSS.	[Vanetti, Claudia; Vicentini, Lucia M.; Cattaneo, Maria Grazia] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Bifari, Francesco] Univ Milan, Lab Cell Metab & Regenerat Med, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Milan; University of Milan	Cattaneo, MG (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.	mgrazia.cattaneo@unimi.it	Vanetti, Claudia/AAU-3012-2021; Vanetti, Claudia/ABF-3075-2021; Cattaneo, Maria Grazia/H-3067-2017; Bifari, Francesco/M-3430-2014	Vanetti, Claudia/0000-0003-4490-6675; Cattaneo, Maria Grazia/0000-0002-1582-9933; Bifari, Francesco/0000-0003-2028-3012	Dept of Medical Biotechnology and Translational Medicine, University of Milano [15-6-3003005-323, 15-6-3003005-5, 15-6-3003005-14, 15-6-3003005-10]; MSD-SIF fellowship	Dept of Medical Biotechnology and Translational Medicine, University of Milano; MSD-SIF fellowship	This work was supported by the Dept of Medical Biotechnology and Translational Medicine, University of Milano (Piano Sviluppo Linea B, grant numbers 15-6-3003005-323 and 15-6-3003005-5 to LMV, and 15-6-3003005-14 and 15-6-3003005-10 to MGC). CV is a recipient of a MSD-SIF fellowship. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116195; Addis R, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0018-2; Cai JJ, 2011, AM J PHYSIOL-HEART C, V300, pH1210, DOI 10.1152/ajpheart.01210.2010; Cao ZM, 2009, ENDOCR RES, V34, P101, DOI 10.3109/07435800903204082; Cappellini E, 2015, LIFE SCI, V131, P30, DOI 10.1016/j.lfs.2015.03.018; Cattaneo MG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10139-x; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chambliss KL, 2002, STEROIDS, V67, P413, DOI 10.1016/S0039-128X(01)00177-5; Concina P, 2000, J VASC RES, V37, P202, DOI 10.1159/000025732; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Della Torre S, 2014, NAT REV ENDOCRINOL, V10, P13, DOI 10.1038/nrendo.2013.203; Fisher DA, 1996, CLIN CHEM, V42, P135; Goglia L, 2010, MOL HUM REPROD, V16, P761, DOI 10.1093/molehr/gaq049; Gopal S, 2012, MOL HUM REPROD, V18, P410, DOI 10.1093/molehr/gas011; Harvey K, 2002, J LAB CLIN MED, V140, P188, DOI 10.1067/mlc.2002.126827; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Helies-Toussaint C, 2006, BBA-MOL CELL BIOL L, V1761, P765, DOI 10.1016/j.bbalip.2006.05.013; Ishikawa T, 2013, J CLIN INVEST, V123, P3488, DOI 10.1172/JCI66533; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Leake R. E., 1987, STEROID HORMONES PRA, P213; Leening MJG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5992; Lorenz M, 2015, ATHEROSCLEROSIS, V240, P61, DOI 10.1016/j.atherosclerosis.2015.02.018; Menazza S, 2016, CIRC RES, V118, P994, DOI 10.1161/CIRCRESAHA.115.305376; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mousa SA, 2014, ANGIOGENESIS, V17, P463, DOI 10.1007/s10456-014-9418-5; Oviedo PJ, 2007, FERTIL STERIL, V88, P326, DOI 10.1016/j.fertnstert.2006.11.185; Oviedo PJ, 2011, MOL CELL ENDOCRINOL, V335, P96, DOI 10.1016/j.mce.2010.06.020; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Regitz-Zagrosek V, 2017, PHYSIOL REV, V97, P1, DOI 10.1152/physrev.00021.2015; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Sikora MJ, 2016, ENDOCRINOLOGY, V157, P3760, DOI 10.1210/en.2016-1297; Somjen D, 2004, J ENDOCRINOL, V180, P97, DOI 10.1677/joe.0.1800097; Strober W, 2015, CURR PROTOC IMMUNOL, V111; Swerdloff RS, 2017, ENDOCR REV, V38, P220, DOI 10.1210/er.2016-1067; Torres-Estay V, 2017, ANGIOGENESIS, V20, P25, DOI 10.1007/s10456-016-9525-6; Trenti A, 2017, J PHARMACOL EXP THER, V361, P398, DOI 10.1124/jpet.116.238212; Vanetti C, 2016, ENDOCR RES, V41, P325, DOI 10.3109/07435800.2016.1155599; Ventura-Clapier R, 2017, CARDIOVASC RES, V113, P711, DOI 10.1093/cvr/cvx066; VISCARDI RM, 1991, LAB INVEST, V65, P250; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117	42	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189528	10.1371/journal.pone.0189528	http://dx.doi.org/10.1371/journal.pone.0189528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232396	Green Submitted, Green Published, gold			2022-12-26	WOS:000417698200057
J	Heckel, M; Geissdorfer, W; Herbst, FA; Stiel, S; Ostgathe, C; Bogdan, C				Heckel, Maria; Geissdoerfer, Walter; Herbst, Franziska A.; Stiel, Stephanie; Ostgathe, Christoph; Bogdan, Christian			Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) at a palliative care unit: A prospective single service analysis	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; INFECTION; PREVALENCE; EPIDEMIOLOGY; SURVEILLANCE; GERMANY; IMPACT	Background The emergence of multidrug-resistant bacterial microorganisms is a particular challenge for the health care systems. Little is known about the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Gram-negative bacteria (MDRGNB) in patients of palliative care units (PCU). Aim The primary aim of this study was to determine the carriage of MRSA among patients of a PCU at a German University Hospital and to assess whether the positive cases would have been detected by a risk-factor-based screening-approach. Design Between February 2014 and January 2015 patients from our PCU were tested for MRSA carriage within 48 hours following admission irrespective of pre-existing risk factors. In addition, risk factors for MRSA colonization were assessed. Samples from the nostrils and, if applicable, from pre-existing wounds were analysed by standardized culture-based laboratory techniques for the presence of MRSA and of other bacteria and fungi. Results from swabs taken prior to admission were also recorded if available. Results 297 out of 317 patients (93.7%) fulfilled one or more MRSA screening criteria. Swabs from 299 patients were tested. The detection rate was 2.1% for MRSA. All MRSA cases would have been detected by a risk-factor-based screening-approach. Considering the detected cases and the results from swabs taken prior to admission, 4.1% of the patients (n = 13) were diagnosed with MRSA and 4.1% with MDRGNB (n = 13), including two patients with MRSA and MDRGNB (0.6%). The rate of MRSA carriage in PCU patients (4.1%) was elevated compared to the rate seen in the general cohort of patients admitted to our University Hospital (2.7%). Conclusions PCU patients have an increased risk to carry MRSA compared to other hospitalized patients. Although a risk factor-based screening is likely to detect all MRSA carriers amongst PCU patients, we rather recommend a universal screening to avoid the extra effort to identify the few risk factor-negative patients (< 7%). As we did not perform a systematic MDRGNB screening, further studies are needed to determine the true prevalence of MDRGNB amongst PCU patients.	[Heckel, Maria; Ostgathe, Christoph] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Palliat Med, Comprehens Canc Ctr CCC Erlangen EMN, Univ Klinikum Erlangen, Erlangen, Germany; [Geissdoerfer, Walter; Bogdan, Christian] Univ Klinikum Erlangen, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, Erlangen, Germany; [Geissdoerfer, Walter; Bogdan, Christian] Friedrich Alexander Univ FAU Erlangen Nurnberg, Erlangen, Germany; [Herbst, Franziska A.; Stiel, Stephanie] Hannover Med Sch, Inst Gen Practice, Hannover, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Hannover Medical School	Heckel, M (corresponding author), Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Palliat Med, Comprehens Canc Ctr CCC Erlangen EMN, Univ Klinikum Erlangen, Erlangen, Germany.; Geissdorfer, W (corresponding author), Univ Klinikum Erlangen, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, Erlangen, Germany.; Geissdorfer, W (corresponding author), Friedrich Alexander Univ FAU Erlangen Nurnberg, Erlangen, Germany.	maria.heckel@uk-erlangen.de; walter.geissdoerfer@uk-erlangen.de	Herbst, Franziska A./AAP-5067-2021; Ostgathe, Christoph/I-4385-2019	Herbst, Franziska A./0000-0003-2602-9277; Ostgathe, Christoph/0000-0003-4449-5036; Heckel, Maria/0000-0001-6212-2562; Stiel, Stephanie/0000-0002-5963-2526	German Federal Ministry of Education and Research (BMBF) [01GY1314]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)	The presented study was part of the project M-EndoL-MRSA in end-of-life care which was financed by the German Federal Ministry of Education and Research (BMBF) (https://www.bmbf.de/en/index.html) and administratively monitored by the project management agency-part of the German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt) (http://www.dlr.de/dlr/en/desktopdefault.aspx/tabid-10002/) Grant Number: 01GY1314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Ali S, 2005, PALLIATIVE MED, V19, P188, DOI 10.1191/0269216305pm1011oa; [Anonymous], 2014, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V57, P696; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; [Anonymous], 2008, EPID B, V42, P363; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bukki J, 2011, PALLIATIVE MED, V27, P84; Dand P, 2005, PALLIATIVE MED, V19, P185, DOI 10.1191/0269216305pm997oa; Davies H, 2000, Nurs Stand, V14, P35; Diederen B, 2005, J CLIN MICROBIOL, V43, P1925, DOI 10.1128/JCM.43.4.1925-1927.2005; Diekema DJ, 2007, CLIN INFECT DIS, V44, P1101, DOI 10.1086/512820; ECDC, 2014, ANT RES INT DAT EARS; European Centre for Disease Prevention and Control (ECDC), 2015, ANN REPORT EUROPEAN; Gammon J, 1998, Int J Nurs Pract, V4, P84; Ghanem HM, 2013, AM J HOSP PALLIAT ME, V30, P377, DOI 10.1177/1049909112452335; Gleeson A, 2016, PALLIATIVE MED, V30, P374, DOI 10.1177/0269216315595158; Gurieva T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002874; Heckel Maria, 2017, J Palliat Med, V20, P273, DOI 10.1089/jpm.2016.0301; Herrmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073876; Hospiz- und Palliativ-Erfassung (HOPE), 2015, CLARA KLIN FORSCH CL; Hubner C, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0093-0; Jazmati N, 2017, EUR J CLIN MICROBIOL, V36, P1847, DOI 10.1007/s10096-017-3000-1; Jorgensen JH, 2015, MANUAL CLIN MICROBIO; Kaye KS, 2015, PHARMACOTHERAPY, V35, P949, DOI 10.1002/phar.1636; Kock R, 2013, EPIDEMIOL B, V5, P41; Loulergue J, 2006, EUR J CLIN MICROBIOL, V25, P407, DOI 10.1007/s10096-006-0144-9; McAllister SK, 2011, J CLIN MICROBIOL, V49, P4126, DOI 10.1128/JCM.05323-11; Meyer E, 2014, DTSCH ARZTEBL INT, V111, P331, DOI 10.3238/arztebl.2014.0331; Mitteilung der Kommission fur Krankenhaushygiene und Infektionspravention am RKI, 1999, BUNDESGESUNDHEITSBLA, V42, P954; Newton JT, 2001, J HOSP INFECT, V48, P275, DOI 10.1053/jhin.2001.1019; O'Riordan MT, 2015, INFECT CONT HOSP EP, V36, P856, DOI 10.1017/ice.2015.111; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Otter JA, 2015, CLIN MICROBIOL INFEC, V21, P1057, DOI 10.1016/j.cmi.2015.09.021; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pogue JM, 2015, CLIN MICROBIOL INFEC, V21, P302, DOI 10.1016/j.cmi.2014.12.025; Prentice W, 1998, PALLIATIVE MED, V12, P443, DOI 10.1191/026921698673226380; Rees J, 2000, Nurs Stand, V14, P32; Robotham JV, 2016, LANCET INFECT DIS, V16, P348, DOI 10.1016/S1473-3099(15)00417-X; Schmalz O, 2016, PALLIATIVE MED, V30, P703, DOI 10.1177/0269216316637772; Schroder C, 2015, INT J MED MICROBIOL, V305, P799, DOI 10.1016/j.ijmm.2015.08.034; Sipahi OR, 2008, EXPERT REV ANTI-INFE, V6, P523, DOI 10.1586/14787210.6.4.523; Skyman E, 2010, SCAND J CARING SCI, V24, P101, DOI 10.1111/j.1471-6712.2009.00692.x; Stiel S, 2015, BMC PALLIAT CARE; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Tubbicke A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-438; Verhoeven P, 2010, J CLIN MICROBIOL, V48, P4242, DOI 10.1128/JCM.01425-10; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P1704, DOI 10.1111/j.1469-0691.2011.03502.x	47	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188940	10.1371/journal.pone.0188940	http://dx.doi.org/10.1371/journal.pone.0188940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228010	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600020
J	Lim, J; Kim, K; Choi, S; Park, SM				Lim, Juwon; Kim, Kyuwoong; Choi, Seulggie; Park, Sang Min			The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; UNITED-STATES; VIRUS SEROPREVALENCE; INFECTION; CHILDREN; DISEASE; ADULTS; SEROEPIDEMIOLOGY; IMMUNIZATION; IMMUNITY	Background Vaccination for hepatitis A virus (HAV) has been implemented as one of the national vaccination programs despite the epidemiological transition of HAV in the Republic of Korea. While the national HAV vaccination program is largely associated with the shift of socioeconomic trend in the country, concerns have been raised on the effectiveness of the HAV immunization. The objective of this study was to examine the epidemiological trend of HAV and assess the effectiveness of the nationwide HAV vaccination policy based on a nationally representative sample of the Korean population collected in 2015. Methods We analyzed anti-HAV of 5,856 respondents aged >= 10 years collected from Korean National Health and Nutrition Examination Survey (KNHANES) data in 2015. We estimated age-adjusted anti-HAV prevalence by sociodemographic and other characteristics. We evaluated the factors associated with anti-HAV positivity among each age group (10-19, 20-29, 30-45 and over 45 years old). Results The prevalence of anti-HAV among adults aged >= 10 years was 72.5% (95% confidence interval, CI, 73.7-71.4) in 2015. The lowest age-specific prevalence was among adults aged 20-29 years with 11.9% (95% CI 9.3-15.1%). The prevalence of anti-HAV among those aged 10-14 and 15-19 years was 59.7% (95% CI 52.7-66.4) and 24.0% (95% CI 19.5-29.3), respectively. The prevalence of anti-HAV among adults aged between 30 and 44 years rapidly increased from below 20% to above 90%. The prevalence of anti-HAV among adults aged >= 45 years was 97.8% (95% CI 96.0-97.6). Factors significantly associated with anti-HAV positivity among those aged 10-19 years old were young age, higher house income and high influenza vaccination rate. Compared to the respondents aged 10-19 years (those who were subject to the national childhood vaccine recommendation), those aged 20-29 years (those who were not subject to the recommendation) had low adjusted odds ratio (OR, 0.52 95% CI 0.34-.81 P-value = 0.004) for anti-HAV positivity. Conclusions The age-adjusted anti-HAV prevalence showed a U-shaped association, implying the high dependence of anti-HAV prevalence on age and the epidemiological shift. The inclusion of the hepatitis A vaccine into the national immunization recommendation was effective shown by the increase of immunity in the general population. However, the vaccination rate was low in the low-income group. Young adults aged 20-39 years may benefit from inclusion in the HAV vaccination program due to the significantly low vaccination rate.	[Lim, Juwon] Seoul Natl Univ, Dept Med, Seoul, South Korea; [Lim, Juwon] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Int Healthcare Ctr, Seoul, South Korea; [Kim, Kyuwoong; Choi, Seulggie; Park, Sang Min] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, SM (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019	Park, Sang Min/0000-0002-7498-4829				Barkai G, 2009, PEDIATR INFECT DIS J, V28, P391, DOI 10.1097/INF.0b013e318190655c; Bassal R, 2017, PEDIATR INFECT DIS J, V36, pE248, DOI 10.1097/INF.0000000000001640; Brundage SC, 2006, AM FAM PHYSICIAN, V73, P2162; Cho SE, 2013, J EPIDEMIOL, V23, P270, DOI 10.2188/jea.JE20120188; Ciocca M, 2000, VACCINE, V18, pS71, DOI 10.1016/S0264-410X(99)00470-3; Dhankhar P, 2015, VALUE HEALTH, V18, P358, DOI 10.1016/j.jval.2015.02.004; Gallone MF, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005884; Hankin-Wei A, 2016, VACCINE, V34, P4243, DOI 10.1016/j.vaccine.2016.06.040; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Heo JY, 2013, AM J INFECT CONTROL, V41, pE97, DOI 10.1016/j.ajic.2013.03.300; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Jenson HB, 2004, CURR OPIN PEDIATR, V16, P89, DOI 10.1097/00008480-200402000-00017; Jeong Sook-Hyang, 2008, Korean J Gastroenterol, V51, P331; Kim KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170432; Kim YJ, 2010, INTERVIROLOGY, V53, P10, DOI 10.1159/000252778; Klevens RM, 2015, VACCINE, V33, P6192, DOI 10.1016/j.vaccine.2015.10.009; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee A, 2009, KOREAN J LAB MED, V29, P563, DOI 10.3343/kjlm.2009.29.6.563; Lee D, 2008, INTERVIROLOGY, V51, P70, DOI 10.1159/000127428; Lee H, 2011, J KOREAN MED SCI, V26, P791, DOI 10.3346/jkms.2011.26.6.791; Luyten J, 2009, PHARMACOECONOMICS, V27, P379, DOI 10.2165/00019053-200927050-00003; Ly KN, 2015, J INFECT DIS, V212, P176, DOI 10.1093/infdis/jiu834; Mellou K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116939; Moon S, 2016, J KOREAN MED SCI, V31, P67, DOI 10.3346/jkms.2016.31.1.67; Pan Xin-juan, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P862; Quezada A, 2008, REV PANAM SALUD PUBL, V23, P303, DOI 10.1590/S1020-49892008000500002; Rein DB, 2007, PEDIATRICS, V119, pE12, DOI 10.1542/peds.2006-1573; SIEGL G, 1981, J GEN VIROL, V57, P331, DOI 10.1099/0022-1317-57-2-331; Sohn YM, 2000, YONSEI MED J, V41, P34, DOI 10.3349/ymj.2000.41.1.34; Thompson C, 2017, VACCINE, V35, P170, DOI 10.1016/j.vaccine.2016.11.002; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Yun H, 2011, J MED VIROL, V83, P2073, DOI 10.1002/jmv.22229; Zhuang GH, 2008, VACCINE, V26, P4608, DOI 10.1016/j.vaccine.2008.05.086	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189210	10.1371/journal.pone.0189210	http://dx.doi.org/10.1371/journal.pone.0189210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220416	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900039
J	Cho, IJ; Chang, HJ; Sung, JM; Yun, YM; Kim, HC; Chung, N				Cho, In-Jeong; Chang, Hyuk-Jae; Sung, Ji Min; Yun, Young Mi; Kim, Hyeon Chang; Chung, Namsik			Associations of changes in body mass index with all-cause and cardiovascular mortality in healthy middle-aged adults	PLOS ONE			English	Article							WEIGHT CHANGE; OLD-AGE; HEART-FAILURE; RISK-FACTORS; LEAN MASS; OBESITY; VARIABILITY; DISEASE; MEN; EPIDEMIOLOGY	Background Conflicting data exist regarding the association of body mass index (BMI) changes with all-cause and cardiovascular (CV) mortality. The current study investigated the association between changes in BMI and all-cause, CV, and non-CV mortality in a large cohort of middle-aged adults. Methods A total of 379,535 adults over 40 years of age without pre-existing CV disease or cancer at baseline were enrolled to undergo a series of at least three health examinations of biennial intervals. Changes in BMI between baseline, midpoint follow-up, and final health examination during mean 9.3 years were defined according to the pattern of BMI change as follows: stable, sustained gain, sustained loss, and fluctuation. The relationship between BMI change category and mortality was assessed by multivariate Cox regression reporting hazard ratio (HR) with 95% confidence interval (95% CI). Results During a mean follow-up of 10.7 years for mortality, 12,378 deaths occurred from all causes, of which 2,114 were CV and 10,264 were non-CV deaths. Sustained BMI gain was associated with the lower risk of all-cause (HR 0.89, 95% CI: 0.83-0.95), CV (HR 0.84, 95% CI 0.72-0.98), and non-CV mortality (HR 0.90, 95% CI 0.84-0.96) compared with stable BMI. Conversely, sustained BMI loss (HR 1.25, 95% CI 1.19-1.32) and fluctuation (HR 1.13, 95% CI 1.08-1.19) displayed a higher risk of all-cause mortality compared with stable BMI, which was mainly attributable to the increase in non-CV mortality. Conclusion Sustained BMI gains were associated with reduced risk of all-cause, CV, and non-CV mortality in middle-aged healthy adults.	[Cho, In-Jeong; Chang, Hyuk-Jae; Sung, Ji Min; Kim, Hyeon Chang; Chung, Namsik] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Yun, Young Mi] Yonsei Univ, Coll Med, Hlth IT Accelerat Platform Technol Innovat Ctr, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	hjchang@yuhs.ac	; Kim, Hyeon Chang/F-8796-2019	Chang, Hyuk-Jae/0000-0002-6139-7545; Kim, Hyeon Chang/0000-0001-7867-1240	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2012027176]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (No. 2012027176) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715).	Andersen KK, 2013, INT J STROKE, V12, P12016; ANDRES R, 1993, ANN INTERN MED, V119, P737, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00022; Antonopoulos AS, 2016, OBES REV, V13, P12440; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Heiat Asefeh, 2003, Prev Cardiol, V6, P104, DOI 10.1111/j.1520-037X.2003.01046.x; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Kim NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139924; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Lee JS, 2001, INT J OBESITY, V25, P1063, DOI 10.1038/sj.ijo.0801633; Lee YM, 2017, OBES REV, V18, P129, DOI 10.1111/obr.12481; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; NHIS, NAT HLTH SCREEN STAT; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rzehak P, 2007, EUR J EPIDEMIOL, V22, P665, DOI 10.1007/s10654-007-9167-5; Stern D, 2014, INT J OBESITY, V38, P1503, DOI 10.1038/ijo.2014.74; Strandberg TE, 2003, INT J OBESITY, V27, P950, DOI 10.1038/sj.ijo.0802313; Tamakoshi K, 2003, INT J OBESITY, V27, P1059, DOI 10.1038/sj.ijo.0802386; WALLACE JI, 1995, J AM GERIATR SOC, V43, P329, DOI 10.1111/j.1532-5415.1995.tb05803.x; Wannamethee SG, 2002, ARCH INTERN MED, V162, P2575, DOI 10.1001/archinte.162.22.2575; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zhang JY, 1996, CIRCULATION, V94, P1089, DOI 10.1161/01.CIR.94.5.1089	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189180	10.1371/journal.pone.0189180	http://dx.doi.org/10.1371/journal.pone.0189180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216261	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800088
J	Lin, YC; Chen, HS				Lin, Yi-Chun; Chen, Harn-Shen			Longer time to peak glucose during the oral glucose tolerance test increases cardiovascular risk score and diabetes prevalence	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; HYPERGLYCEMIA; SENSITIVITY; ASSOCIATION; INTOLERANCE; PROGRESSION; SECRETION; MORTALITY	Introduction The pattern of glucose levels during an oral glucose tolerance test (OGTT) may be useful for predicting diabetes or cardiovascular disease (CVD). Our aim was to determine whether the time to peak glucose during the OGTT is associated with CVD risk scores and diabetes. Methods Individuals with impaired fasting glucose (IFG) were enrolled in this observational study. Participants were grouped by the measured time to peak glucose (30, 60, 90 and 120 min) during the 75g OGTT. The primary outcome was 10-year CVD risk scores (using the Framingham risk score calculator). Secondary outcomes evaluated effect of time to peak glucose on prevalence of diabetes and indicators of glucose homeostasis. Results A total of 125 patients with IFG underwent OGTTs. Framingham 10-year risk score for the 90-min group was 1.7 times higher than for the 60-min group (6.98 +/- 6.56% vs. 4.05 +/- 4.60%, P = 0.023). Based on multivariate linear regression, time to peak glucose at 90 min was associated with a higher Framingham risk score than 60-min group (beta coefficient: 2.043, 95% confidence interval: 0.067-6.008, P = 0.045). The percentages of patients with HbA(1c) >= 6.5%, isolated post-challenge hyperglycemia (IPH) and diabetes (combined IPH and HbA(1c) >= 6.5%) were significantly increased with longer times to peak glucose. Prevalence of diabetes was higher in the 90-min group than in the 60-min group (31.5% vs. 5.7%, P = 0.001). Conclusions In subjects with IFG, those with a longer time to peak glucose had a higher Framingham 10-year risk score and were associated with a greater likelihood of IPH and diabetes.	[Lin, Yi-Chun; Chen, Harn-Shen] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan; [Lin, Yi-Chun; Chen, Harn-Shen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, HS (corresponding author), Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan.; Chen, HS (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.	chenhs@vghtpe.gov.tw			Taipei Veterans General Hospital [V102C-043, V105C-161]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by Taipei Veterans General Hospital (V102C-043 and V105C-161)	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1613, DOI 10.2337/dc05-1711; BERGSTROM RW, 1990, J CLIN ENDOCR METAB, V71, P1447, DOI 10.1210/jcem-71-6-1447; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Borch-Johnsen K, 1999, LANCET, V354, P617; Crandall JP, 2009, J CLIN ENDOCR METAB, V94, P1595, DOI 10.1210/jc.2008-1829; Dinh W, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-63; EFENDIC S, 1984, ENDOCR REV, V5, P395, DOI 10.1210/edrv-5-3-395; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayashi T, 2013, DIABETES CARE, V36, P1229, DOI 10.2337/dc12-0246; Kim JY, 2012, DIABETES CARE, V35, P1925, DOI 10.2337/dc11-2476; KOSAKA K, 1977, DIABETES, V26, P944, DOI 10.2337/diab.26.10.944; Kramer CK, 2014, DIABETES RES CLIN PR, V105, P88, DOI 10.1016/j.diabres.2014.04.023; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ning F, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-76; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Qian L, 2008, CLIN ENDOCRINOL, V69, P575, DOI 10.1111/j.1365-2265.2008.03209.x; Qiao Q, 2002, EUR HEART J, V23, P1267, DOI 10.1053/euhj.2001.3113; REAVEN GM, 1976, AM J MED, V60, P80, DOI 10.1016/0002-9343(76)90536-2; Retnakaran R, 2010, CLIN ENDOCRINOL, V73, P476, DOI 10.1111/j.1365-2265.2010.03834.x; Selvarajah S, 2014, INT J CARDIOL, V176, P211, DOI 10.1016/j.ijcard.2014.07.066; Smith NL, 2002, ARCH INTERN MED, V162, P209, DOI 10.1001/archinte.162.2.209	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189047	10.1371/journal.pone.0189047	http://dx.doi.org/10.1371/journal.pone.0189047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216249	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800060
J	Delbart, F; Brams, M; Gruss, F; Noppen, S; Peigneur, S; Boland, S; Chaltin, P; Brandao-Neto, J; von Delft, F; Touw, WG; Joosten, RP; Liekens, S; Tytgat, J; Ulens, C				Delbart, Florian; Brams, Marijke; Gruss, Fabian; Noppen, Sam; Peigneur, Steve; Boland, Sandro; Chaltin, Patrick; Brandao-Neto, Jose; von Delft, Frank; Touw, Wouter G.; Joosten, Robbie P.; Liekens, Sandra; Tytgat, Jan; Ulens, Chris			An allosteric binding site of the alpha 7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; IN-VITRO; MODULATION; DOMAIN; VALIDATION; MECHANISM; IDENTIFICATION; POTENTIATION; COGNITION; INSIGHTS	Nicotinic acetylcholine receptors (nAChRs) belong to the family of pentameric ligand-gated ion channels and mediate fast excitatory transmission in the central and peripheral nervous systems. Among the different existing receptor subtypes, the homomeric alpha 7 nAChR has attracted considerable attention because of its possible implication in several neurological and psychiatric disorders, including cognitive decline associated with Alzheimer's disease or schizophrenia. Allosteric modulators of ligand-gated ion channels are of particular interest as therapeutic agents, as they modulate receptor activity without affecting normal fluctuations of synaptic neurotransmitter release. Here, we used X-ray crystallography and surface plasmon resonance spectroscopy of alpha 7-acetylcholine-binding protein (AChBP), a humanized chimera of a snail AChBP, which has 71% sequence similarity with the extracellular ligand-binding domain of the human alpha 7 nAChR, to investigate the structural determinants of allosteric modulation. We extended previous observations that an allosteric site located in the vestibule of the receptor offers an attractive target for receptor modulation. We introduced seven additional humanizing mutations in the vestibule-located binding site of AChBP to improve its suitability as a model for studying allosteric binding. Using a fragment-based screening approach, we uncovered an allosteric binding site located near the beta 8-beta 9 loop, which critically contributes to coupling ligand binding to channel opening in human alpha 7 nAChR. This work expands our understanding of the topology of allosteric binding sites in AChBP and, by extrapolation, in the human alpha 7nAChRas determined by electrophysiology measurements. Our insights pave the way for drug design strategies targeting nAChRs involved in ion channel-mediated disorders.	[Delbart, Florian; Brams, Marijke; Gruss, Fabian; Ulens, Chris] Katholieke Univ Leuven, Fac Med, Lab Struct Neurobiol, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Noppen, Sam; Liekens, Sandra] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst Med Res, B-3000 Leuven, Belgium; [Peigneur, Steve; Tytgat, Jan] Katholieke Univ Leuven, Lab Toxicol & Pharmacol, Fac Pharmaceut Sci, B-3000 Leuven, Belgium; [Boland, Sandro; Chaltin, Patrick] Cistim Leuven Vzw, Ctr Innovat & Stimulat Drug Discovery Leuven, B-3001 Heverlee, Belgium; [Chaltin, Patrick] Katholieke Univ Leuven, Ctr Innovat & Stimulat Drug Discovery Leuven, B-3001 Heverlee, Belgium; [Chaltin, Patrick] Katholieke Univ Leuven, Ctr Drug Design & Discovery, B-3001 Heverlee, Belgium; [Brandao-Neto, Jose; von Delft, Frank] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX11 0QX, Oxon, England; [Touw, Wouter G.; Joosten, Robbie P.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; Diamond Light Source; Netherlands Cancer Institute	Ulens, C (corresponding author), Dept Cellular & Mol Med, Lab Struct Neurobiol, Herestr 49,PB601, B-3000 Leuven, Belgium.	chris.ulens@kuleuven.be	Joosten, Robbie P./I-9317-2012; Noppen, Sam/F-8681-2018	Joosten, Robbie P./0000-0002-2323-2686; Noppen, Sam/0000-0002-2831-5042; Brandao-Neto, Jose/0000-0001-6015-320X; Tytgat, Jan/0000-0003-1778-6022; von Delft, Frank/0000-0003-0378-0017; Peigneur, Steve/0000-0003-0504-5702	KU Leuven C3-project [C32/16/035]; Horizon program of the European Union; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant [665501]; research Foundation Flanders (FWO); Netherlands Organization for Scientific Research (NWO) [723.013.003]; iNEXT project [653706]	KU Leuven C3-project(KU Leuven); Horizon program of the European Union; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant; research Foundation Flanders (FWO)(FWO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); iNEXT project	This work was supported in part by KU Leuven C3-project C32/16/035 (to C.U., S.L., and J.T.) and iNEXT project 653706 supported by the Horizon 2020 program of the European Union (to F.D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie Grant 665501 with the research Foundation Flanders (FWO).; Supported by Vidi Grant 723.013.003 from the Netherlands Organization for Scientific Research (NWO).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bertrand D, 2015, PHARMACOL REV, V67, P1025, DOI 10.1124/pr.113.008581; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broad LM, 2006, J PHARMACOL EXP THER, V318, P1108, DOI 10.1124/jpet.106.104505; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; Gill-Thind JK, 2015, J BIOL CHEM, V290, P3552, DOI 10.1074/jbc.M114.619221; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hays JT, 2008, NEW ENGL J MED, V359, P2018, DOI 10.1056/NEJMct0800146; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hu HD, 2017, BIOPHYS J, V112, p321A, DOI 10.1016/j.bpj.2016.11.1739; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Joosten RP, 2017, CURR OPIN STRUC BIOL, V44, P9, DOI 10.1016/j.sbi.2016.10.010; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nys M, 2016, P NATL ACAD SCI USA, V113, pE6696, DOI 10.1073/pnas.1603101113; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Plested AJR, 2016, NAT STRUCT MOL BIOL, V23, P494, DOI 10.1038/nsmb.3214; Sauguet L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149795; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schiebel J, 2016, ACS CHEM BIOL, V11, P1693, DOI 10.1021/acschembio.5b01034; SCHRATTENHOLZ A, 1993, EUR J BIOCHEM, V216, P671, DOI 10.1111/j.1432-1033.1993.tb18187.x; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Touw WG, 2016, ACTA CRYSTALLOGR D, V72, P1110, DOI 10.1107/S2059798316013036; Touw WG, 2016, J MOL BIOL, V428, P1375, DOI 10.1016/j.jmb.2016.02.002; Touw WG, 2015, ACTA CRYSTALLOGR D, V71, P1604, DOI 10.1107/S1399004715008263; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; van Beusekom B, 2018, PROTEIN SCI, V27, P798, DOI 10.1002/pro.3353; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429	62	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2534	2545		10.1074/jbc.M117.815316	http://dx.doi.org/10.1074/jbc.M117.815316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29237730	Green Published, hybrid			2022-12-26	WOS:000425308300025
J	Forsberg, Z; Bissaro, B; Gullesen, J; Dalhus, B; Vaaje-Kolstad, G; Eijsink, VGH				Forsberg, Zarah; Bissaro, Bastien; Gullesen, Jonathan; Dalhus, Bjorn; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.			Structural determinants of bacterial lytic polysaccharide monooxygenase functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulose; chitin; hydrogen peroxide; protein evolution; site-directed mutagenesis; substrate specificity; LPMO; regioselectivity	OXIDATIVE CLEAVAGE; CELLOBIOSE DEHYDROGENASE; CELLULOSE DEGRADATION; CRYSTAL-STRUCTURE; BINDING; CHITIN; OLIGOSACCHARIDES; SPECIFICITY; ACTIVATION; DISCOVERY	Bacterial lytic polysaccharide monooxygenases (LPMO10s) use redox chemistry to cleave glycosidic bonds in the two foremost recalcitrant polysaccharides found in nature, namely cellulose and chitin. Analysis of correlated mutations revealed that the substrate-binding and copper-containing surface of LPMO10s composes a network of co-evolved residues and interactions, whose roles in LPMO functionality are unclear. Here, we mutated a subset of these correlated residues in a newly characterized C1/C4-oxidizing LPMO10 from Micromonospora aurantiaca (MaLPMO10B) to the corresponding residues in strictly C1-oxidizing LPMO10s. We found that surface properties near the catalytic copper, i.e. side chains likely to be involved in substrate positioning, are major determinants of the C1:C4 ratio. Several MaLPMO10B mutants almost completely lost C4-oxidizing activity while maintaining C1-oxidizing activity. These mutants also lost chitin-oxidizing activity, which is typically observed for C1/C4-oxidizing, but not for C1-oxidizing, cellulose-active LPMO10s. Selective loss in C1-oxidizing activity was not observed. Additional mutational experiments disclosed that neither truncation of the MaLPMO10B family 2 carbohydrate-binding module nor mutations altering access to the solvent-exposed axial copper coordination site significantly change the C1:C4 ratio. Importantly, several of the mutations that altered interactions with the substrate exhibited reduced stability. This effect could be explained by productive substrate binding that protects LPMOs from oxidative self-inactivation. We discuss these stability issues in view of recent findings on LPMO catalysis, such as the involvement of H2O2. Our results show that residues on the substrate-binding surface of LPMOs have co-evolved to optimize several of the interconnected properties: substrate binding and specificity, oxidative regioselectivity, catalytic efficiency, and stability.	[Forsberg, Zarah; Bissaro, Bastien; Gullesen, Jonathan; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.] Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, N-1432 As, Norway; [Bissaro, Bastien] INRA, UMR792, Ingn Syst Biol & Proc, F-31400 Toulouse, France; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, N-0318 Oslo, Norway; [Dalhus, Bjorn] Rigshosp, Oslo Univ Hosp, Clin Lab Med, Dept Microbiol, N-0424 Oslo, Norway	Norwegian University of Life Sciences; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of Oslo; University of Oslo; National Hospital Norway	Forsberg, Z (corresponding author), Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, N-1432 As, Norway.	zarah.forsberg@nmbu.no	Forsberg, Zarah/AAM-2395-2020; Bissaro, Bastien/AAI-6814-2020; Dalhus, Bjørn/AAK-2895-2020; BISSARO, Bastien/AAL-7130-2021	Bissaro, Bastien/0000-0001-8354-3892; Forsberg, Zarah/0000-0002-8236-7986	Research Council of Norway [214138, 214613, 226247]; Vista Programme of the Norwegian Academy of Science and Letters Grant [6510]; European Union [267196]; French Institut National de la Recherche Agronomique (INRA); South-Eastern Norway Regional Health Authority Grant [2015095]	Research Council of Norway(Research Council of Norway); Vista Programme of the Norwegian Academy of Science and Letters Grant; European Union(European Commission); French Institut National de la Recherche Agronomique (INRA); South-Eastern Norway Regional Health Authority Grant	This work was supported by Research Council of Norway Grants 214138, 214613, and 226247 (to G. V.-K. and V. G. H. E.), by Vista Programme of the Norwegian Academy of Science and Letters Grant 6510 (to Z. F.), by European Union in the framework of the Marie-Curie FP7 COFUND People Programme (through the award of an AgreenSkills Fellowship under Grant 267196), by the French Institut National de la Recherche Agronomique (INRA) (to B. B.), and by the South-Eastern Norway Regional Health Authority Grant 2015095 (Regional Core Facility for Structural Biology) (to B. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Danneels B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178446; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Span EA, 2017, ACS CHEM BIOL, V12, P1095, DOI 10.1021/acschembio.7b00016; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2016, J CHROMATOGR A, V1445, P46, DOI 10.1016/j.chroma.2016.03.064; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	60	64	64	0	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1397	1412		10.1074/jbc.M117.817130	http://dx.doi.org/10.1074/jbc.M117.817130			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29222333	Green Published, hybrid			2022-12-26	WOS:000423515000025
J	Davis, CJ; Lupker, SJ				Davis, Colin J.; Lupker, Stephen J.			A backwards glance at words: Using reversed-interior masked primes to test models of visual word identification	PLOS ONE			English	Article							POSITION PRIMING CONSTRAINT; DIFFERENT TASK EVIDENCE; SAME-DIFFERENT TASK; PRINTED WORD; READING ALOUD; PERCEPTION; RECOGNITION; ENGLISH; INFORMATION; INHIBITION	The experiments reported here used "feminine ordinal indicator" Reversed-Interior" (RI) primes (e.g., cetupmor-COMPUTER) in three different masked priming paradigms in order to test between different models of orthographic coding/visual word recognition. The results of Experiment 1, using a standard masked priming methodology, showed no evidence of priming from RI primes, in contrast to the predictions of the Bayesian Reader and LTRS models. By contrast, Experiment 2, using a sandwich priming methodology, showed significant priming from RI primes, in contrast to the predictions of open bigram models, which predict that there should be no orthographic similarity between these primes and their targets. Similar results were obtained in Experiment 3, using a masked prime same-different task. The results of all three experiments are most consistent with the predictions derived from simulations of the Spatial-coding model.	[Davis, Colin J.] Univ Bristol, Bristol, Avon, England; [Lupker, Stephen J.] Univ Western Ontario, London, ON, Canada	University of Bristol; Western University (University of Western Ontario)	Davis, CJ (corresponding author), Univ Bristol, Bristol, Avon, England.	pscjd@bristol.ac.uk		Davis, Colin/0000-0001-5814-5104	ESRC [RES-000-22-3354]; Natural Sciences and Engineering Research Council of Canada [A6333]; ESRC [ES/G031754/1] Funding Source: UKRI; Economic and Social Research Council [ES/G031754/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was partially supported by ESRC Grant RES-000-22-3354 to Colin J. Davis and Stephen J. Lupker and a Natural Sciences and Engineering Research Council of Canada Grant A6333 to Stephen J. Lupker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2011, PSYCHOL REV, V118, P570, DOI 10.1037/a0024811; Adelman JS, EASYNET COMPUTATIONA; Dunabeitia JA, 2011, LANG COGNITIVE PROC, V26, P509, DOI 10.1080/01690965.2010.499215; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bowers JS, 2012, PSYCHOL BULL, V138, P389, DOI 10.1037/a0026450; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Davis CJ, 2005, BEHAV RES METHODS, V37, P65, DOI 10.3758/BF03206399; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Davis CJ, 2006, FROM INKMARKS TO IDEAS: CURRENT ISSUES IN LEXICAL PROCESSING, P180; Davis CJ, 2006, J EXP PSYCHOL HUMAN, V32, P668, DOI 10.1037/0096-1523.32.3.668; Davis CJ, 2006, J EXP PSYCHOL HUMAN, V32, P535, DOI 10.1037/0096-1523.32.3.535; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Grainger J, MENTAL LEXICON, P1; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Grainger J, 2006, J EXP PSYCHOL HUMAN, V32, P865, DOI 10.1037/0096-1523.32.4.865; Guerrera C, 2008, LANG COGNITIVE PROC, V23, P117, DOI 10.1080/01690960701579722; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; Kinoshita S, 2012, Q J EXP PSYCHOL, V65, P1296, DOI 10.1080/17470218.2012.655749; Kinoshita S, 2010, Q J EXP PSYCHOL, V63, P194, DOI 10.1080/17470210902957174; Kinoshita S, 2009, J EXP PSYCHOL LEARN, V35, P1, DOI 10.1037/a0014277; Lupker SJ, 2015, J EXP PSYCHOL HUMAN, V41, P1281, DOI 10.1037/xhp0000087; Lupker SJ, 2015, LANG COGN NEUROSCI, V30, P781, DOI 10.1080/23273798.2015.1015430; Lupker SJ, 2015, J EXP PSYCHOL HUMAN, V41, P138, DOI 10.1037/a0038392; Lupker SJ, 2009, J EXP PSYCHOL LEARN, V35, P618, DOI 10.1037/a0015278; McClelland JL, EXPLORATIONS PARALLE; Norris D, 2008, J EXP PSYCHOL GEN, V137, P434, DOI 10.1037/a0012799; Norris D, 2012, PSYCHOL REV, V119, P517, DOI 10.1037/a0028450; PAAP KR, 1982, PSYCHOL REV, V89, P573, DOI 10.1037/0033-295X.89.5.573; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; Perea M., 2003, MASKED PRIMING STATE, P97, DOI DOI 10.4324/9780203502846; Perea M, 2011, Q J EXP PSYCHOL, V64, P2065, DOI 10.1080/17470218.2011.582131; POLLATSEK A, 1995, J EXP PSYCHOL LEARN, V21, P785, DOI 10.1037/0278-7393.21.3.785; RUMELHART DE, 1982, PSYCHOL REV, V89, P60, DOI 10.1037/0033-295X.89.1.60; Schoonbaert S, 2004, LANG COGNITIVE PROC, V19, P333, DOI 10.1080/01690960344000198; Stinchcombe EJ, 2012, LANG COGNITIVE PROC, V27, P475, DOI 10.1080/01690965.2010.550928; Van der Haegen L, 2009, BRAIN LANG, V108, P112, DOI 10.1016/j.bandl.2008.06.005; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Whitney C., 2013, LETT ORDER IS ENCODE; Whitney C, 2012, EXPT PSYCHOL; Whitney C, SERIOL2 MODEL ORTHOG; Whitney C., 2004, THESIS; Zorzi M, 1998, J EXP PSYCHOL HUMAN, V24, P1131, DOI 10.1037/0096-1523.24.4.1131	47	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189056	10.1371/journal.pone.0189056	http://dx.doi.org/10.1371/journal.pone.0189056			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244824	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700016
J	Hammond, SL; Leek, AN; Richman, EH; Tjalkens, RB				Hammond, Sean L.; Leek, Ashley N.; Richman, Evan H.; Tjalkens, Ronald B.			Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; PARKINSONS-DISEASE; NIGROSTRIATAL SYSTEM; HUNTINGTONS-DISEASE; NONHUMAN-PRIMATES; TRANSDUCTION; EXPRESSION; BRAIN; THERAPY; MICE	The non-pathogenic parvovirus, adeno-associated virus (AAV), is an efficient vector for transgene expression in vivo and shows promise for treatment of brain disorders in clinical trials. Currently, there are more than 100 AAV serotypes identified that differ in the binding capacity of capsid proteins to specific cell surface receptors that can transduce different cell types and brain regions in the CNS. In the current study, multiple AAV serotypes expressing a GFP reporter (AAV1, AAV2/1, AAVDJ, AAV8, AAVDJ8, AAV9, AAVDJ9) were screened for their infectivity in both primary murine astrocyte and neuronal cell cultures. AAV2/1, AAVDJ8 and AAV9 were selected for further investigation of their tropism throughout different brain regions and cell types. Each AAV was administered to P0-neonatal mice via intracerebroventricular injections (ICV). Brains were then systematically analyzed for GFP expression at 3 or 6 weeks post-infection in various regions, including the olfactory bulb, striatum, cortex, hippocampus, substantia nigra (SN) and cerebellum. Cell counting data revealed that AAV2/1 infections were more prevalent in the cortical layers but penetrated to the midbrain less than AAVDJ8 and AAV9. Additionally, there were differences in the persistence of viral transgene expression amongst the three serotypes examined in vivo at 3 and 6 weeks post-infection. Because AAV-mediated transgene expression is of interest in neurodegenerative diseases such as Parkinson's Disease, we examined the SN with microscopy techniques, such as CLARITY tissue transmutation, to identify AAV serotypes that resulted in optimal transgene expression in either astrocytes or dopaminergic neurons. AAVDJ8 displayed more tropism in astrocytes compared to AAV9 in the SN region. We conclude that ICV injection results in lasting expression of virally encoded transgene when using AAV vectors and that specific AAV serotypes are required to selectively deliver transgenes of interest to different brain regions in both astrocytes and neurons.	[Hammond, Sean L.; Richman, Evan H.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Leek, Ashley N.; Tjalkens, Ronald B.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Tjalkens, RB (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	ron.tjalkens@colostate.edu		Richman, Evan/0000-0002-6313-7616	National Institutes of Health [NS096841, ES021656]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (nih.gov), NS096841 (SLH) and ES021656 (RBT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Bartus RT, 2013, NEUROLOGY, V80, P1698, DOI 10.1212/WNL.0b013e3182904faa; Burger C, 2004, AM SOC GENE THERAPY, V10, P302; Chakrabarty P, 2013, PLOS ONE, V8; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Connor B, 2016, GENE THER, V23, P283, DOI 10.1038/gt.2015.113; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; De Miranda BR, 2014, TOXICOL SCI; De Miranda BR, 2015, MOL PHARMACOL, V87, P1021, DOI 10.1124/mol.114.095398; Dodiya HB, 2010, MOL THER, V18, P579, DOI 10.1038/mt.2009.216; Drinkut A, 2012, MOL THER, V20, P534, DOI 10.1038/mt.2011.249; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Hemphill DD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05861; Holehonnur R, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-28; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Ikezu T., 2015, COGNITIVE ENHANCEMEN, P111; Kim JY, 2014, JOVE-J VIS EXP, DOI 10.3791/51863; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kiyota T, 2012, GENE THER, V19, P724, DOI 10.1038/gt.2011.126; Kiyota T, 2009, MOL THER, V17, P803, DOI 10.1038/mt.2009.44; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Li K, 2014, J NEUROSCI, V34, P7622, DOI 10.1523/JNEUROSCI.4690-13.2014; Li WC, 2015, AM J PHYSIOL-REG I, V309, pR138, DOI 10.1152/ajpregu.00319.2014; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; McFarland NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086048; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Meng X, 2015, SPECIFIC GENE EXPRES, P1; Merienne N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00106; Miller JG, 2011, SEARCH AND DESTROY, 2ND EDITION: AFRICAN-AMERICAN MALES IN THE CRIMINAL JUSTICE SYSTEM, P1; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Vagner T, 2016, MOL CELL NEUROSCI, V77, P76, DOI 10.1016/j.mcn.2016.10.007; von Jonquieres G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065646	47	72	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188830	10.1371/journal.pone.0188830	http://dx.doi.org/10.1371/journal.pone.0188830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244806	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700010
J	Volkova, S; Ayton, E; Porterfield, K; Corley, CD				Volkova, Svitlana; Ayton, Ellyn; Porterfield, Katherine; Corley, Courtney D.			Forecasting influenza-like illness dynamics for military populations using neural networks and social media	PLOS ONE			English	Article							HEALTH; SURVEILLANCE	This work is the first to take advantage of recurrent neural networks to predict influenza-like illness (ILI) dynamics from various linguistic signals extracted from social media data. Unlike other approaches that rely on timeseries analysis of historical ILI data and the state-of-the-art machine learning models, we build and evaluate the predictive power of neural network architectures based on Long Short Term Memory (LSTMs) units capable of nowcasting (predicting in "feminine ordinal indicator" real-time") and forecasting (predicting the future) ILI dynamics in the 2011 - 2014 influenza seasons. To build our models we integrate information people post in social media e.g., topics, embeddings, word ngrams, stylistic patterns, and communication behavior using hashtags and mentions. We then quantitatively evaluate the predictive power of different social media signals and contrast the performance of the-state-of-the-art regression models with neural networks using a diverse set of evaluation metrics. Finally, we combine ILI and social media signals to build a joint neural network model for ILI dynamics prediction. Unlike the majority of the existing work, we specifically focus on developing models for local rather than national ILI surveillance, specifically for military rather than general populations in 26 U.S. and six international locations., and analyze how model performance depends on the amount of social media data available per location. Our approach demonstrates several advantages: (a) Neural network architectures that rely on LSTM units trained on social media data yield the best performance compared to previously used regression models. (b) Previously under-explored language and communication behavior features are more predictive of ILI dynamics than stylistic and topic signals expressed in social media. (c) Neural network models learned exclusively from social media signals yield comparable or better performance to the models learned from ILI historical data, thus, signals from social media can be potentially used to accurately forecast ILI dynamics for the regions where ILI historical data is not available. (d) Neural network models learned from combined ILI and social media signals significantly outperform models that rely solely on ILI historical data, which adds to a great potential of alternative public sources for ILI dynamics prediction. (e) Location-specific models outperform previously used location-independent models e.g., U.S. only. (f) Prediction results significantly vary across geolocations depending on the amount of social media data available and ILI activity patterns. (g) Model performance improves with more tweets available per geo-location e.g., the error gets lower and the Pearson score gets higher for locations with more tweets.	[Volkova, Svitlana; Ayton, Ellyn; Porterfield, Katherine; Corley, Courtney D.] Pacific Northwest Natl Lab, Data Sci & Analyt Grp, Comp & Analyt Div, Natl Secur Directorate, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Volkova, S (corresponding author), Pacific Northwest Natl Lab, Data Sci & Analyt Grp, Comp & Analyt Div, Natl Secur Directorate, Richland, WA 99352 USA.	svitlana.volkova@pnnl.gov	, 叶叶叶/ABE-1619-2020	Corley, Courtney/0000-0003-3741-9705	Defense Threat Reduction Agency [CB10082]; Deep Learning for Scientific Discovery Initiative at the Pacific Northwest National Laboratory	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Deep Learning for Scientific Discovery Initiative at the Pacific Northwest National Laboratory	This research was supported by a contract from the Defense Threat Reduction Agency to the Pacific Northwest National Laboratory under contract CB10082, and supported in part by the Deep Learning for Scientific Discovery Initiative at the Pacific Northwest National Laboratory.	Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein John S, 2006, AMIA Annu Symp Proc, P866; Charron L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125154; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Coppersmith G, 2014, P ICWSM; Corley CD, 2010, INT J ENV RES PUB HE, V7, P596, DOI 10.3390/ijerph7020596; Das Debjani, 2005, MMWR Suppl, V54, P41; Diaz-Aviles E, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P82; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Lamb A, 2013, P NAACL HLT, P789; Manning CD., 2012, INTRO INFORM RETRIEV, DOI [10.1017/cbo9780511809071.007, DOI 10.1017/CBO9780511809071.007]; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Nsoesie EO, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2998; Odlum M., 2015, 2015 APHA ANN M EXP; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Paul MJ, 2016, BIOCOMPUT-PAC SYM, P468; Paul MJ, 2014, PLOS ONE, V9, DOI [10.1371/currents.outbreaks.90b9ed0f59bae4ccaa683a39865d9117, 10.1371/journal.pone.0103408]; Rehurek R., 2010, P LREC 2010 WORKSH N; Riley P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003064; Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513; Smith MC, 2015, REAL TIME MEASUREMEN; Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038; Volkova S, 2016, P NAACL WORKSH COMP; Volkova S, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0102-z; Yu, 2014, FOND T SIGN PROC, V7, P197, DOI [10.1561/2000000039, DOI 10.1561/2000000039]	32	45	46	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188941	10.1371/journal.pone.0188941	http://dx.doi.org/10.1371/journal.pone.0188941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244814	gold, Green Submitted, Green Published			2022-12-26	WOS:000418184700013
J	Haynert, K; Kiggen, M; Klarner, B; Merman, M; Scheu, S				Haynert, Kristin; Kiggen, Mirijam; Klarner, Bernhard; Merman, Mark; Scheu, Stefan			The structure of salt marsh soil mesofauna food webs - The prevalence of disturbance	PLOS ONE			English	Article							MITES ACARI ORIBATIDA; BODY-MASS CONSTRAINTS; STABLE-ISOTOPES; TROPHIC INTERACTIONS; ALLOCHTHONOUS INPUT; VEGETATION ZONATION; SPATIAL-PATTERNS; INTERTIDAL MITES; ORGANIC-MATTER; CARBON	Mesofauna taxa fill key trophic positions in soil food webs, even in terrestrial-marine boundary habitats characterized by frequent natural disturbances. Salt marshes represent such boundary habitats, characterized by frequent inundations increasing from the terrestrial upper to the marine pioneer zone. Despite the high abundance of soil mesofauna in salt marshes and their important function by facilitating energy and carbon flows, the structure, trophic ecology and habitat-related diet shifts of mesofauna species in natural salt marsh habitats is virtually unknown. Therefore, we investigated the effects of natural disturbance (inundation frequency) on community structure, food web complexity and resource use of soil mesofauna using stable isotope analysis (N-15, C-13) in three salt marsh zones. In this intertidal habitat, the pioneer zone is exposed to inundations twice a day, but lower and upper salt marshes are less frequently inundated based on shore height. The mesofauna comprised 86 species / taxa dominated by Collembola, Oribatida and Mesostigmata. Shifts in environmental disturbances influenced the structure of food webs, diversity and density declined strongly from the land to the sea pointing to the importance of increasing levels of inundation frequency. Accordingly, the reduced diversity and density was associated by a simplification of the food web in the pioneer zone as compared to the less inundated lower and upper salt marsh with a higher number of trophic levels. Strong variations in delta N-15 signatures demonstrated that mesofauna species are feeding at multiple trophic levels. Primary decomposers were low and most mesofauna species functioned as secondary decomposers or predators including second order predators or scavengers. The results document that major decomposer taxa, such as Collembola and Oribatida, are more diverse than previously assumed and predominantly dwell on autochthonous resources of the respective salt marsh zone. The results further suggest that Mesostigmata mostly adopt an intraguild predation lifestyle. The high trophic position of a large number of predators suggests that intraguild predation is of significant importance in salt marsh food webs. Presumably, intraguild predation contributes to stabilizing the salt marsh food web against disturbances.	[Haynert, Kristin; Kiggen, Mirijam; Klarner, Bernhard; Merman, Mark; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany; [Haynert, Kristin] Senckenberg Meer, Dept Marine Res, Wilhelmshaven, Germany	University of Gottingen; University of Gottingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Haynert, K (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany.; Haynert, K (corresponding author), Senckenberg Meer, Dept Marine Res, Wilhelmshaven, Germany.	kristin.haynert@biologie.uni-goettingen.de	Scheu, Stefan/H-7049-2015	Klarner, Bernhard/0000-0003-1867-4911	Volkswagen Foundation [ZN2930]	Volkswagen Foundation(Volkswagen)	This study was funded by the Volkswagen Foundation within the funding initiative of the Ministry for Science and Culture of Lower Saxony, Germany under project number ZN2930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARP WJ, 1993, VEGETATIO, V104, P133, DOI 10.1007/BF00048149; Balke T, 2017, ESTUAR COAST SHELF S, V198, P288, DOI 10.1016/j.ecss.2017.09.021; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BELL SS, 1980, ECOL MONOGR, V50, P487, DOI 10.2307/1942654; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bockelmann AC, 2002, AQUAT BOT, V73, P211, DOI 10.1016/S0304-3770(02)00022-0; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Carlier A, 2009, AQUAT BIOL, V5, P167, DOI 10.3354/ab00147; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Colombini I, 2003, OCEANOGR MAR BIOL, V41, P115; Connolly J., 1979, Proceedings of the Society of Photo-Optical Instrumentation Engineers, vol.181. Contemporary Optical Systems & Components Specifications, P141; Connolly RM, 2005, OECOLOGIA, V144, P684, DOI 10.1007/s00442-005-0167-4; CRAFT CB, 1988, ESTUAR COAST SHELF S, V26, P633, DOI 10.1016/0272-7714(88)90039-X; Creach V, 1997, ESTUAR COAST SHELF S, V44, P599, DOI 10.1006/ecss.1996.0147; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Digel C, 2014, OIKOS, V123, P1157, DOI 10.1111/oik.00865; Doi H, 2009, POPUL ECOL, V51, P57, DOI 10.1007/s10144-008-0127-z; Dubois S, 2014, J SEA RES, V88, P87, DOI 10.1016/j.seares.2014.01.004; ELEUTERIUS LN, 1979, B MAR SCI, V29, P394; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Evin LA, 2002, CONCEPTS CONTROVER 8, P661; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fernandes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087436; Galvan K, 2008, MAR ECOL PROG SER, V359, P37, DOI 10.3354/meps07321; Heidemann K, 2014, OIKOS, V123, P1199, DOI 10.1111/j.1600-0706.2013.00872.x; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hild A, 1999, WADDEN SEA ECOSYSTEM, P299; Ho CK, 2008, ECOLOGY, V89, P1714, DOI 10.1890/07-1069.1; Illig J, 2005, J TROP ECOL, V21, P589, DOI 10.1017/S0266467405002646; Klarner B, 2013, SOIL BIOL BIOCHEM, V57, P327, DOI 10.1016/j.soilbio.2012.08.013; KNEIB RT, 1984, ESTUARIES, V7, P392, DOI 10.2307/1351621; Koehler HH, 1999, AGR ECOSYST ENVIRON, V74, P395, DOI 10.1016/S0167-8809(99)00045-6; Krab EJ, 2012, METHODS ECOL EVOL, V3, P138, DOI 10.1111/j.2041-210X.2011.00126.x; Kratina P, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00121.1; Kreeger DA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P187; Kwak TJ, 1997, OECOLOGIA, V110, P262, DOI 10.1007/s004420050159; Lange G, 2018, J SEA RES, V131, P12, DOI 10.1016/j.seares.2017.10.002; LUXTON M, 1990, J ROY SOC NEW ZEAL, V20, P419, DOI 10.1080/03036758.1990.10426720; LUXTON M, 1967, J ANIM ECOL, V36, P257, DOI 10.2307/2911; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Marx MT, 2009, PESQUI AGROPECU BRAS, V44, P1002, DOI 10.1590/S0100-204X2009000800032; Mertens J, 2007, BELG J ZOOL, V137, P177; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MURAOKA M, 1976, Applied Entomology and Zoology, V11, P1; Olff H, 1997, J ECOL, V85, P799, DOI 10.2307/2960603; PERLMUTTER DG, 1991, ECOLOGY, V72, P2170, DOI 10.2307/1941568; PERSSON L, 1992, AM NAT, V140, P59, DOI 10.1086/285403; Petersen J, 2014, WADDEN SEA ECOSYSTEM, P32; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson BJ, 1999, ACTA OECOL, V20, P479, DOI 10.1016/S1146-609X(99)00120-4; Pfingstl T, 2014, ZOOMORPHOLOGY, V133, P359, DOI 10.1007/s00435-014-0228-5; Pfingstl T, 2013, ACAROLOGIA, V53, P369, DOI 10.1051/acarologia/20132101; Pfingstl T, 2013, EXP APPL ACAROL, V61, P87, DOI 10.1007/s10493-013-9681-y; Polderman PJG, 1974, ORIBATIDA ACARI SALI, V8, P49; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Pollierer MM, 2009, SOIL BIOL BIOCHEM, V41, P1221, DOI 10.1016/j.soilbio.2009.03.002; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; REINEKING A, 1993, ISOTOPENPRAXIS, V29, P169, DOI 10.1080/10256019308046151; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Riera P, 1999, MAR ECOL PROG SER, V187, P301, DOI 10.3354/meps187301; ROCKETT C L, 1980, International Journal of Acarology, V6, P219; Romanuk TN, 2003, ENVIRON ENTOMOL, V32, P1343, DOI 10.1603/0046-225X-32.6.1343; Roper T., 2012, J HYDROL, P454; Salgado JP, 2007, HYDROBIOLOGIA, V587, P225, DOI 10.1007/s10750-007-0685-7; Sanchez JM, 1996, J VEG SCI, V7, P695, DOI 10.2307/3236381; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Scheu S, 2000, OECOLOGIA, V123, P285, DOI 10.1007/s004420051015; Scheunemann N, 2015, SOIL BIOL BIOCHEM, V81, P81, DOI 10.1016/j.soilbio.2014.11.006; Schmid-Araya JM, 2000, FRESHWATER BIOL, V44, P149, DOI 10.1046/j.1365-2427.2000.00594.x; Schmid-Araya JM, 2002, ECOLOGY, V83, P1271, DOI 10.2307/3071942; Schneider FD, 2012, ECOL LETT, V15, P436, DOI 10.1111/j.1461-0248.2012.01750.x; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; SCHULTE G, 1973, Netherlands Journal of Sea Research, V7, P68, DOI 10.1016/0077-7579(73)90033-1; Schulte G., 1976, J SOIL ECOLOGY, V16, P332; Schutz M., 2014, PROC IEEE INT C INF, P1, DOI DOI 10.1109/EPE.2014.6910898; Silvestri S, 2005, ESTUAR COAST SHELF S, V62, P119, DOI 10.1016/j.ecss.2004.08.010; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Sterzynska M, 2000, PEDOBIOLOGIA, V44, P402, DOI 10.1078/S0031-4056(04)70058-X; Tanner BR, 2007, ORG GEOCHEM, V38, P474, DOI 10.1016/j.orggeochem.2006.06.009; Tiunov AV, 2007, BIOL BULL+, V34, P395, DOI 10.1134/S1062359007040127; Tornroos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078910; van der Lee EM, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007072; Voege Sandra, 2008, Senckenbergiana Maritima, V38, P93; WEIGMANN G, 1973, Z WISS ZOOL ABT A, V186, P295; Weigmann Gerd, 2009, Soil Organisms, V81, P85; Williams RJ, 2004, AM NAT, V163, P458, DOI 10.1086/381964; WITTE JI, 1984, MAR ECOL PROG SER, V14, P129, DOI 10.3354/meps014129; WITTEVEEN J, 1988, HOLARCTIC ECOL, V11, P1; WITTEVEEN J, 1987, J INSECT PHYSIOL, V33, P59, DOI 10.1016/0022-1910(87)90105-3; Zajac RN, 2003, LIMNOL OCEANOGR, V48, P829, DOI 10.4319/lo.2003.48.2.0829	95	18	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189645	10.1371/journal.pone.0189645	http://dx.doi.org/10.1371/journal.pone.0189645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240806	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600059
J	Kim, HI; Schultz, CR; Buras, AL; Friedman, E; Fedorko, A; Seamon, L; Chandramouli, GVR; Maxwell, GL; Bachmann, AS; Risinger, JI				Kim, Hong Im; Schultz, Chad R.; Buras, Andrea L.; Friedman, Elizabeth; Fedorko, Alyssa; Seamon, Leigh; Chandramouli, Gadisetti V. R.; Maxwell, G. Larry; Bachmann, Andre S.; Risinger, John I.			Ornithine decarboxylase as a therapeutic target for endometrial cancer	PLOS ONE			English	Article							POLYAMINE METABOLISM; DIFLUOROMETHYLORNITHINE DFMO; ONCOGENE ALTERATIONS; DOUBLE-BLIND; C-MYC; CELLS; CHEMOPREVENTION; EXPRESSION; GROWTH; AMPLIFICATION	Ornithine Decarboxylase (ODC) a key enzyme in polyamine biosynthesis is often overexpressed in cancers and contributes to polyamine-induced cell proliferation. We noted ubiquitous expression of ODC1 in our published endometrial cancer gene array data and confirmed this in the cancer genome atlas (TCGA) with highest expression in non-endometrioid, high grade, and copy number high cancers, which have the worst clinical outcomes. ODC1 expression was associated with worse overall survival and increased recurrence in three endometrial cancer gene expression datasets. Importantly, we confirmed these findings using quantitative real-time polymerase chain reaction (qRT-PCR) in a validation cohort of 60 endometrial cancers and found that endometrial cancers with elevated ODC1 had significantly shorter recurrence-free intervals (KM log-rank p = 0.0312, Wald test p = 5.59e-05). Difluoromethylornithine (DFMO) a specific inhibitor of ODC significantly reduced cell proliferation, cell viability, and colony formation in cell line models derived from undifferentiated, endometrioid, serous, carcinosarcoma (mixed mesodermal tumor; MMT) and clear cell endometrial cancers. DFMO also significantly reduced human endometrial cancer ACI-98 tumor burden in mice compared to controls (p = 0.0023). ODC-regulated polyamines (putrescine [Put] and/or spermidine [Spd]) known activators of cell proliferation were strongly decreased in response to DFMO, in both tumor tissue ([Put] (p = 0.0006), [Spd] (p < 0.0001)) and blood plasma ([Put] (p < 0.0001), [Spd] (p = 0.0049)) of treated mice. Our study indicates that some endometrial cancers appear particularly sensitive to DFMO and that the polyamine pathway in endometrial cancers in general and specifically those most likely to suffer adverse clinical outcomes could be targeted for effective treatment, chemoprevention or chemoprevention of recurrence.	[Kim, Hong Im; Buras, Andrea L.; Fedorko, Alyssa; Risinger, John I.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA; [Schultz, Chad R.; Bachmann, Andre S.] Michigan State Univ, Dept Pediat & Human Dev, Grand Rapids, MI 49503 USA; [Buras, Andrea L.; Friedman, Elizabeth; Fedorko, Alyssa; Seamon, Leigh; Risinger, John I.] Spectrum Hlth, Grand Rapids, MI 49503 USA; [Chandramouli, Gadisetti V. R.] Genepria Consulting, Columbia, MD USA; [Maxwell, G. Larry] Inova Fairfax Womens Hosp, Dept Obsteter & Gynecol, Falls Church, VA USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University College of Human Medicine; Inova Fairfax Hospital	Risinger, JI (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA.; Bachmann, AS (corresponding author), Michigan State Univ, Dept Pediat & Human Dev, Grand Rapids, MI 49503 USA.; Risinger, JI (corresponding author), Spectrum Hlth, Grand Rapids, MI 49503 USA.	andre.bachmann@hc.msu.edu; john.risinger@hc.msu.edu		Buras, Andrea L/0000-0001-9735-2798; Fedorko, Alyssa/0000-0003-1256-7795	Michigan State University-internal funds; GenEpria Consulting Inc.	Michigan State University-internal funds; GenEpria Consulting Inc.	This study received funding in the form of Michigan State University-internal funds to J. I. Risinger and A. S. Bachmann. GenEpria Consulting Inc. provided support in the form of salaries for the author GVRC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Alexiou GA, 2017, FUTURE ONCOL, V13, P809, DOI 10.2217/fon-2016-0266; Auvinen M, 2003, INT J BIOCHEM CELL B, V35, P496, DOI 10.1016/S1357-2725(02)00305-9; Bachmann Andre S, 2004, Hawaii Med J, V63, P371; Bachmann AS, 2012, POLYAMINE DRUG DISCO, P257; Barakat RR, 2009, PRINCIPLES PRACTICE, Vxv; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; Berek JS, 2015, BEREK HACKERS GYNECO, Vxvi; Blaustein A, 2011, BLAUSTEINS PATHOLOGY, Vxv; BORST MP, 1990, GYNECOL ONCOL, V38, P364, DOI 10.1016/0090-8258(90)90074-U; BOYD J, 1991, MOL CARCINOGEN, V4, P189, DOI 10.1002/mc.2940040305; Brasky TM, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw251; Burke CA, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0494-4; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Day RS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-213; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; HOLINKA CF, 1989, CANCER RES, V49, P3297; HOLINKA CF, 1985, IN VITRO CELL DEV B, V21, P697, DOI 10.1007/BF02620925; Howlader N., 2016, SEER CANC STAT REV; Karlsson A, 2001, GENE CHROMOSOME CANC, V31, P345, DOI 10.1002/gcc.1153; Kavlashvili T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148912; Koomoa DLT, 2008, CANCER RES, V68, P9825, DOI 10.1158/0008-5472.CAN-08-1865; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; LANZA A, 1990, European Journal of Gynaecological Oncology, V11, P269; LANZA A, 1991, ANN NY ACAD SCI, V622, P485; Levin VA, 2000, CLIN CANCER RES, V6, P3878; Lynch PM, 2016, GUT, V65, P286, DOI 10.1136/gutjnl-2014-307235; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; Maxwell GL, 2013, GYNECOL ONCOL, V130, P169, DOI 10.1016/j.ygyno.2013.04.017; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Meyskens Frank L Jr, 2014, Recent Results Cancer Res, V202, P115, DOI 10.1007/978-3-642-45195-9_14; MINOCHA SC, 1990, J CHROMATOGR, V511, P177, DOI 10.1016/S0021-9673(01)93283-2; MONK BJ, 1994, AM J OBSTET GYNECOL, V171, P1193, DOI 10.1016/0002-9378(94)90131-7; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; MOSHIER JA, 1993, CANCER RES, V53, P2618; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Nagendra DC, 2012, MOL CARCINOGEN, V51, P826, DOI 10.1002/mc.20850; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Raj KP, 2013, BRIT J CANCER, V108, P512, DOI 10.1038/bjc.2013.15; Rial NS, 2009, ESSAYS BIOCHEM, V46, P111, DOI [10.1042/BSE0460008, 10.1042/bse0460008]; Risinger JI, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00139; Rodriguez-Sallaberry C, 2001, BIOL REPROD, V65, P587, DOI 10.1095/biolreprod65.2.587; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; SATO S, 1991, TOHOKU J EXP MED, V165, P137, DOI 10.1620/tjem.165.137; Seiler N, 1998, INT J ONCOL, V13, P993; Sholler GLS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127246; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808	58	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189044	10.1371/journal.pone.0189044	http://dx.doi.org/10.1371/journal.pone.0189044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240775	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600015
J	Reimer, M; Denby, E; Zustiak, SP; Schober, JM				Reimer, Michael; Denby, Elisabeth; Zustiak, Silviya P.; Schober, Joseph M.			Ras GAP-related and C-terminal domain-dependent localization and tumorigenic activities of IQGAP1 in melanoma cells	PLOS ONE			English	Article							LAMELLIPODIA FORMATION; MECHANICAL-PROPERTIES; ACTIN DYNAMICS; HUMAN-SKIN; F-ACTIN; PROTEIN; MIGRATION; BINDING; PHOSPHORYLATION; MOTILITY	IQGAP1 interacts with a number of binding partners through a calponin homology domain (CHD), aWWmotif, IQ repeats, a Ras GAP-related domain (GRD), and a conserved C-terminal (CT) domain. Among various biological and cellular functions, IQGAP1 is known to play a role in actin cytoskeleton dynamics during membrane ruffling and lamellipodium protrusion. In addition, phosphorylation near the CT domain is thought to control IQGAP1 activity through regulation of intramolecular interaction. In a previous study, we discovered that IQGAP1 preferentially localizes to retracting areas in B16F10 mouse melanoma cells, not areas of membrane ruffling and lamellipodium protrusion. Nothing is known of the domains needed for retraction localization and very little is known of IQGAP1 function in the actin cytoskeleton of melanoma cells. Thus, we examined localization of IQGAP1 mutants to retracting areas, and characterized knock down phenotypes on tissue culture plastic and physiologic-stiffness hydrogels. Localization of IQGAP1 mutants (S1441E/S1443D, S1441A/S1443A, Delta CHD, Delta GRD or Delta CT) to retracting and protruding cell edges were measured. In retracting areas there was a decrease in S1441A/S1443A, Delta GRD and Delta CT localization, a minor decrease in Delta CHD localization, and normal localization of the S1441E/S1443D mutant. In areas of cell protrusion just behind the lamellipodium leading edge, we surprisingly observed both Delta GRD and Delta CT localization, and increased number of microtubules. IQGAP1 knock down caused loss of cell polarity on laminin-coated glass, decreased proliferation on tissue culture polystyrene, and abnormal spheroid growth on laminin-coated hydrogels. We propose that the GRD and CT domains regulate IQGAP1 localization to retracting actin networks to promote a tumorigenic role in melanoma cells.	[Reimer, Michael; Denby, Elisabeth; Schober, Joseph M.] Southern Illinois Univ Edwardsville, Dept Pharmaceut Sci, Edwardsville, IL 62025 USA; [Zustiak, Silviya P.] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA; [Reimer, Michael] Millipore Sigma, St Louis, MO USA; [Denby, Elisabeth] UES Inc, Dayton, OH USA	Southern Illinois University System; Southern Illinois University Edwardsville; Saint Louis University; Washington University (WUSTL); Merck KGaA; MilliporeSigma; UES, Inc.	Schober, JM (corresponding author), Southern Illinois Univ Edwardsville, Dept Pharmaceut Sci, Edwardsville, IL 62025 USA.	joschob@siue.edu			Southern Illinois University Edwardsville School of Pharmacy; Saint Louis University; Research Grants for Graduate Students program at Southern Illinois University Edwardsville	Southern Illinois University Edwardsville School of Pharmacy; Saint Louis University; Research Grants for Graduate Students program at Southern Illinois University Edwardsville	This work was funded in part by a Research Grant from the Southern Illinois University Edwardsville School of Pharmacy awarded to J.M.S. and by start-up funds awarded to S.P.Z. by Saint Louis University. M.R. was funded by the Research Grants for Graduate Students program at Southern Illinois University Edwardsville.	AGACHE PG, 1980, ARCH DERMATOL RES, V269, P221, DOI 10.1007/BF00406415; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Choi Suyong, 2015, Advances in Biological Regulation, V60, P29, DOI 10.1016/j.jbior.2015.10.004; Choi S, 2013, EMBO J, V32, P2617, DOI 10.1038/emboj.2013.191; Foroutannejad S, 2014, BIOCHEM BIOPH RES CO, V448, P39, DOI 10.1016/j.bbrc.2014.04.038; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ishikawa T, 2014, MATRIX BIOL, V38, P69, DOI 10.1016/j.matbio.2014.06.002; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jausoro I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056574; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lee BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176370; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Liu J, 2016, BIOCHEMISTRY-US, V55, P6433, DOI 10.1021/acs.biochem.6b00745; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Meacci G, 2016, MOL BIOL CELL, V27, P3471, DOI 10.1091/mbc.E16-02-0107; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Mizuno Hiroaki, 2012, Biophysics (Nagoya-shi), V8, P95, DOI 10.2142/biophysics.8.95; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Ramalingam N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9496; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ruiz-Saenz A, 2011, J CELL SCI, V124, P2529, DOI 10.1242/jcs.083634; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Schober JM, 2012, BIOCHEM BIOPH RES CO, V417, P67, DOI 10.1016/j.bbrc.2011.11.056; Schwartz MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081689; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takahashi K, 2008, EXP CELL RES, V314, P2313, DOI 10.1016/j.yexcr.2008.04.009; Tanos BE, 2015, J CELL SCI, V128, P853, DOI 10.1242/jcs.118703; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Wang H, 2016, NAT METHODS, V13, P755, DOI [10.1038/NMETH.3926, 10.1038/nmeth.3926]; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60	53	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189589	10.1371/journal.pone.0189589	http://dx.doi.org/10.1371/journal.pone.0189589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240845	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600051
J	Shapira, A; Sterkin, A; Fried, M; Yehezkel, O; Zalevsky, Z; Polat, U				Shapira, Alon; Sterkin, Anna; Fried, Moshe; Yehezkel, Oren; Zalevsky, Zeev; Polat, Uri			Increased gamma band activity for lateral interactions in humans	PLOS ONE			English	Article							VISUAL-CORTEX; COLLINEAR FACILITATION; GABA CONCENTRATION; RECEPTIVE-FIELDS; BRAIN ACTIVITY; OSCILLATIONS; FREQUENCY; RESPONSES; SYNCHRONIZATION; SUPPRESSION	Collinear facilitation of contrast sensitivity supported by lateral interactions within primary visual cortex is implicated in contour and object perception, with neural correlates in several frequency bands. Although higher component of the ERP power spectrum, the gamma-band, is postulated to reflect object representation, attention and memory, its neuronal source has been questioned, suggesting it is an artifact reflecting saccadic eye movements. Here we explored the gamma-band activity during collinear facilitation with no saccade-related confounds. We used single-trial spectral analysis of ERP in occipital channels in a time-window of nearly complete saccadic suppression and discarded sporadic trials containing saccades, in order to avoid saccadic artifacts. Although converging evidence suggests that gamma-band oscillations emerge from local excitatory-inhibitory balance involving GABAergic inhibition, here we show activity amplification during facilitatory collinear interactions, presumably dominated by excitations, in the gamma-band 150-350 milliseconds following onset of low near-threshold contrast stimulus. This result highlights the potential role of gamma-band oscillations in neuronal encoding of basic processes in visual perception. Thus, our findings suggest that gamma-band ERP spectrum analysis may serve as a useful and reliable tool for exploring basic perception, both in normal adults and in special populations.	[Shapira, Alon; Zalevsky, Zeev] Bar Ilan Univ, Fac Engn, Inst Nanotechnol & Adv Mat, Nano Photon Ctr, Ramat Gan, Israel; [Sterkin, Anna; Fried, Moshe; Yehezkel, Oren] Tel Aviv Univ, Sackler Fac Med, Goldschleger Eye Res Inst, Tel Hashomer, Israel; [Polat, Uri] Bar Ilan Univ, Sch Optometry & Vis Sci, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University	Polat, U (corresponding author), Bar Ilan Univ, Sch Optometry & Vis Sci, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	uri.polat@biu.ac.il	Zalevsky, Zeev/H-4571-2016					Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; Adjamian P, 2008, J VISION, V8, DOI 10.1167/8.7.4; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bauer M, 2014, J NEUROSCI, V34, P16117, DOI 10.1523/JNEUROSCI.3474-13.2014; Bauer M, 2012, J VISION, V12, DOI 10.1167/12.4.5; BECK J, 1987, COMPUT VISION GRAPH, V37, P299, DOI 10.1016/S0734-189X(87)80006-3; Bonneh Y, 1999, VISION RES, V39, P271, DOI 10.1016/S0042-6989(98)00112-6; Bonneh YS, 2010, J VISION, V10, DOI 10.1167/10.14.22; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; CAELLI T, 1985, VISION RES, V25, P671, DOI 10.1016/0042-6989(85)90173-7; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carl C, 2012, NEUROIMAGE, V59, P1657, DOI 10.1016/j.neuroimage.2011.09.020; Cass J, 2006, J VISION, V6, P915, DOI 10.1167/6.9.5; Cass JR, 2005, VISION RES, V45, P2728, DOI 10.1016/j.visres.2005.03.010; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Chen CC, 2001, NEUROREPORT, V12, P655, DOI 10.1097/00001756-200103260-00008; Crook JM, 2002, EXP BRAIN RES, V143, P295, DOI 10.1007/s00221-002-1007-y; Daugman J. G., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V758, P19; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Ellenbogen T, 2006, SPATIAL VISION, V19, P547, DOI 10.1163/156856806779194062; Fried M, 2014, VISION RES, V101, P62, DOI 10.1016/j.visres.2014.05.004; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Friston KJ, 2015, CURR OPIN NEUROBIOL, V31, P1, DOI 10.1016/j.conb.2014.05.004; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Gerard-Mercier F, 2016, J NEUROSCI, V36, P3925, DOI 10.1523/JNEUROSCI.4492-15.2016; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2004, NEUROREPORT, V15, P1837, DOI 10.1097/01.wnr.0000137077.26010.12; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Herzog MH, 2002, NATURE, V415, P433, DOI 10.1038/415433a; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hoogenboom N, 2010, NEUROIMAGE, V51, P1162, DOI 10.1016/j.neuroimage.2010.03.041; Jacobs J., 2010, J NEUROSCI; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kasamatsu T, 2010, EXP BRAIN RES, V201, P453, DOI 10.1007/s00221-009-2057-1; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lev M, 2015, J VISION, V15, DOI 10.1167/15.13.10; Lev M, 2011, VISION RES, V51, P2488, DOI 10.1016/j.visres.2011.10.008; LUTZENBERGER W, 1995, NEUROSCI LETT, V183, P39, DOI 10.1016/0304-3940(94)11109-V; Meirovithz E, 2010, CEREB CORTEX, V20, P1293, DOI 10.1093/cercor/bhp191; Michalareas G., 2016, NEURON; Mizobe K, 2001, VISUAL NEUROSCI, V18, P377, DOI 10.1017/S0952523801183045; Muthukumaraswamy SD, 2013, FRONTIERS HUMAN NEUR, V7; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nunez PL, 2010, BRAIN STRUCT FUNCT, V215, P67, DOI 10.1007/s00429-010-0277-6; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Ozaktas HM, 2001, THE FRACTIONAL FOURI; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Pantev Christo, 1995, Brain Topography, V7, P321, DOI 10.1007/BF01195258; Polat U, 2006, VISION RES, V46, P953, DOI 10.1016/j.visres.2005.09.031; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Polat U, 1996, VISION RES, V36, P2099, DOI 10.1016/0042-6989(95)00281-2; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Polat U, 2000, SPATIAL VISION, V13, P393, DOI 10.1163/156856800741270; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polat U, 2007, VISION RES, V47, P2473, DOI 10.1016/j.visres.2007.06.007; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; RIEMSLAG FCC, 1988, ELECTROEN CLIN NEURO, V70, P281, DOI 10.1016/0013-4694(88)90046-6; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sedley W, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00595; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Shani R, 2006, SPATIAL VISION, V19, P413, DOI 10.1163/156856806778457386; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Solomon JA, 2000, VISION RES, V40, P279, DOI 10.1016/S0275-5408(99)00059-9; Sterkin A, 2009, J VISION, V9, P754; Sterkin A, 2008, VISION RES, V48, P1641, DOI 10.1016/j.visres.2008.04.018; Sterkin A, 2012, VISION RES, V61, P115, DOI 10.1016/j.visres.2011.09.015; Sterkin A, 2008, J VISION, V8, DOI 10.1167/8.7.17; Swettenham JB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00076; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanaka Y, 1998, VISION RES, V38, P2591, DOI 10.1016/S0042-6989(97)00465-3; THICKBROOM GW, 1985, BRAIN RES, V339, P271, DOI 10.1016/0006-8993(85)90092-7; TURNER MR, 1986, BIOL CYBERN, V55, P71; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Woods RL, 2002, VISION RES, V42, P733, DOI 10.1016/S0042-6989(01)00313-3; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100; Zomet A, 2008, BIOL PSYCHIAT, V64, P667, DOI 10.1016/j.biopsych.2008.05.030	99	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0187520	10.1371/journal.pone.0187520	http://dx.doi.org/10.1371/journal.pone.0187520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240758	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600004
J	Zhang, XL; Sun, CW; Zhang, Z; Dai, ZJ; Chen, Y; Yuan, X; Yuan, ZM; Tang, WB; Li, LZ; Hu, ZL				Zhang, Xueli; Sun, Congwei; Zhang, Zheng; Dai, Zhijun; Chen, Yuan; Yuan, Xiong; Yuan, Zheming; Tang, Wenbang; Li, Lanzhi; Hu, Zhongli			Genetic dissection of main and epistatic effects of QTL based on augmented triple test cross design	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ELITE RICE HYBRID; INBRED LINES; INBREEDING DEPRESSION; ARABIDOPSIS-THALIANA; MOLECULAR MARKERS; TESTCROSS DESIGN; DRAFT SEQUENCE; GRAIN-YIELD; HETEROSIS	The use of heterosis has considerably increased the productivity of many crops; however, the biological mechanism underpinning the technique remains elusive. The North Carolina design III (NCIII) and the triple test cross (TTC) are powerful and popular genetic mating design that can be used to decipher the genetic basis of heterosis. However, when using the NCIII design with the present quantitative trait locus (QTL) mapping method, if epistasis exists, the estimated additive or dominant effects are confounded with epistatic effects. Here, we propose a two-step approach to dissect all genetic effects of QTL and digenic interactions on a whole genome without sacrificing statistical power based on an augmented TTC (aTTC) design. Because the aTTC design has more transformation combinations than do the NCIII and TTC designs, it greatly enriches the QTL mapping for studying heterosis. When the basic population comprises recombinant inbred lines (RIL), we can use the same materials in the NCIII design for aTTC-design QTL mapping with transformation combination Z(1), Z(2), and Z(4) to obtain genetic effect of QTL and digenic interactions. Compared with RIL-based TTC design, RIL-based aTTC design saves time, money, and labor for basic population crossed with F1. Several Monte Carlo simulation studies were carried out to confirm the proposed approach; the present genetic parameters could be identified with high statistical power, precision, and calculation speed, even at small sample size or low heritability. Additionally, two elite rice hybrid datasets for nine agronomic traits were estimated for real data analysis. We dissected the genetic effects and calculated the dominance degree of each QTL and digenic interaction. Real mapping results suggested that the dominance degree in Z(2) that mainly characterize heterosis showed overdominance and dominance for QTL and digenic interactions. Dominance and overdominance were the major genetic foundations of heterosis in rice.	[Zhang, Xueli; Sun, Congwei; Zhang, Zheng; Dai, Zhijun; Chen, Yuan; Yuan, Xiong; Yuan, Zheming; Tang, Wenbang; Li, Lanzhi] Hunan Agr Univ, Hunan Engn & Technol Res Ctr Agr Big Data Anal &, Changsha, Hunan, Peoples R China; [Zhang, Xueli; Sun, Congwei; Zhang, Zheng; Dai, Zhijun; Chen, Yuan; Yuan, Xiong; Yuan, Zheming; Li, Lanzhi] Hunan Agr Univ, Hunan Prov Collaborat Innovat Ctr Key Agr Pest Co, Changsha, Hunan, Peoples R China; [Tang, Wenbang] Hunan Agr Univ, Rice Res Inst, Changsha, Hunan, Peoples R China; [Hu, Zhongli] Wuhan Univ, State Key Lab Hybrid Rice, Hubei Lotus Engn Ctr, Coll Life Sci, Wuhan, Hubei, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan Agricultural University; Wuhan University	Li, LZ (corresponding author), Hunan Agr Univ, Hunan Engn & Technol Res Ctr Agr Big Data Anal &, Changsha, Hunan, Peoples R China.; Li, LZ (corresponding author), Hunan Agr Univ, Hunan Prov Collaborat Innovat Ctr Key Agr Pest Co, Changsha, Hunan, Peoples R China.	lancy0829@163.com			China Postdoctoral Science Foundation [2012M511722, 2014T70769]; Natural Science Foundation of Hunan Province [2016JJ3070]; Scientific Research Fund of Hunan Provincial Education Department [2015118]; State key laboratory of crop germplasm innovation and resource utilization Breeding Base [16KFXM03]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); State key laboratory of crop germplasm innovation and resource utilization Breeding Base	This work was supported by China Postdoctoral Science Foundation (2012M511722), China Postdoctoral Science Foundation funded project (2014T70769), Natural Science Foundation of Hunan Province (2016JJ3070), Scientific Research Fund of Hunan Provincial Education Department (2015118), and State key laboratory of crop germplasm innovation and resource utilization Breeding Base (16KFXM03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cockerham CC, 1996, GENETICS, V143, P1437; Comstock R. E., 1952, Heterosis., P494; CROW JF, 1948, GENETICS, V33, P477; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Harushima Y, 1998, GENETICS, V148, P479; He XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024575; He XH, 2012, CHINESE SCI BULL, V57, P2655, DOI 10.1007/s11434-012-5127-x; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hola D, 2017, PLOS ONE, V12; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; HULL FH, 1945, J AM SOC AGRON, V37, P134; Jones DF, 1917, P NATL ACAD SCI USA, V3, P310, DOI 10.1073/pnas.3.4.310; Kao CH, 2002, GENETICS, V160, P1243; KEARSEY MJ, 1968, HEREDITY, V23, P403, DOI 10.1038/hdy.1968.52; Kearsey MJ, 2003, HEREDITY, V91, P456, DOI 10.1038/sj.hdy.6800306; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; Lariepe A, 2012, GENETICS, V190, P795, DOI 10.1534/genetics.111.133447; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Li ZK, 2001, GENETICS, V158, P1737; Liang QZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143548; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Liu DF, 1988, J HUAZHONG AGR U, V7, P311; Luo LJ, 2001, GENETICS, V158, P1755; Melchinger AE, 2008, GENETICS, V178, P2265, DOI 10.1534/genetics.107.084871; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Schon CC, 2010, THEOR APPL GENET, V120, P321, DOI 10.1007/s00122-009-1209-9; SHULL G.H., 1908, J HERED, V4, P296; STUBER CW, 1992, GENETICS, V132, P823; Syed NH, 2005, HEREDITY, V94, P295, DOI 10.1038/sj.hdy.6800558; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18376; XIAO JH, 1995, GENETICS, V140, P745; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Yuan L. P., 1998, ADV HYBRID RICE TECH, P27; ZENG ZB, 1994, GENETICS, V136, P1457; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189054	10.1371/journal.pone.0189054	http://dx.doi.org/10.1371/journal.pone.0189054			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240818	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600016
J	Desmond, C; Casale, D				Desmond, Chris; Casale, Daniela			Catch-up growth in stunted children: Definitions and predictors	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SOUTH-AFRICAN BIRTH; COGNITIVE-DEVELOPMENT; CHILDHOOD GROWTH; 20 COHORT; AGE; RECOVERY; POPULATION; ETHIOPIA; DEFICITS	This paper examines the incidence and correlates of linear growth catch up in early childhood among stunted children, using a range of definitions of catch up. Catch-up growth between two and five years of age is defined in both absolute terms (i.e. the centimetre height deficit from the healthy reference population mean is reduced) and relative terms (the height-for-age z-score improved or passed the -2SD or -1SD cut-off points). Data from a cohort study from urban South Africa are used to estimate the percentage of children who caught up and the predictors of catch-up growth according to these varying definitions. The results show that our sample of stunted children exhibits catch-up growth regardless of the definition used, however prevalence of catch up is highly sensitive to the way catch up is classified, ranging from 19%-93%. Of the biological, early growth, socioeconomic status and maternal reproductive variables included in the multivariate probit regressions, only a few were found to be consistent predictors of the incidence of catch-up growth. Mother's height was positively correlated with the incidence of catch-up growth and early stunting at one year was associated with a lower likelihood of subsequent catch up.	[Desmond, Chris] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Casale, Daniela] Univ Witwatersrand, Sch Econ & Business Sci, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Desmond, C (corresponding author), Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	ChrisDesmond@libstudies.com		Casale, Daniela/0000-0003-1337-1196				Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; Addo OY, 2015, AM J HUM BIOL, V27, P99, DOI 10.1002/ajhb.22614; Cameron N, 2005, AM J HUM BIOL, V17, P412, DOI 10.1002/ajhb.20408; Casale D, 2016, J DEV ORIG HLTH DIS, V7, P163, DOI 10.1017/S2040174415007175; Casale D, 2014, CHILD CARE HLTH DEV, V40, P900, DOI 10.1111/cch.12143; Crookston BT, 2010, J NUTR, V140, P1996, DOI 10.3945/jn.109.118927; Daelmans B, 2017, LANCET, V389, P9, DOI 10.1016/S0140-6736(16)31659-2; Fink G, 2014, AM J CLIN NUTR, V100, P182, DOI 10.3945/ajcn.113.080960; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Georgiadis A, 2017, SOC SCI MED, V179, P81, DOI 10.1016/j.socscimed.2017.02.031; Huang C, 2013, INT J EPIDEMIOL, V42, P160, DOI 10.1093/ije/dys207; Leroy JL, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0458-9; Lundeen EA, 2014, AM J CLIN NUTR, V100, P821, DOI 10.3945/ajcn.114.084368; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Martorell R, 2010, J NUTR, V140; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Norris SA, 2007, J INT DEV, V19, P1143, DOI DOI 10.1002/JID.1390; Outes I, 2013, ECON HUM BIOL, V11, P148, DOI 10.1016/j.ehb.2012.03.001; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; RICHTER LM, 1995, PAEDIATR PERINAT EP, V9, P109, DOI 10.1111/j.1365-3016.1995.tb00124.x; Schott WB, 2013, SOC SCI MED, V97, P278, DOI 10.1016/j.socscimed.2013.05.016; Shisana O, 2013, S AFRICAN NATL HLTH; Sokolovic N, 2014, EUR J CLIN NUTR, V68, P14, DOI 10.1038/ejcn.2013.208; Stein AD, 2010, AM J HUM BIOL, V22; Teivaanmaki T, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12326; Thurow R, 2016, BREASTFEED MED, V11, P416, DOI 10.1089/bfm.2016.0114; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang Y, 2012, USE PERCENTILES Z SC	29	35	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189135	10.1371/journal.pone.0189135	http://dx.doi.org/10.1371/journal.pone.0189135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236728	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100044
J	Ongaro, F; Scheggi, S; Ghosh, A; Denasi, A; Gracias, DH; Misra, S				Ongaro, Federico; Scheggi, Stefano; Ghosh, Arijit; Denasi, Alper; Gracias, David H.; Misra, Sarthak			Design, characterization and control of thermally-responsive and magnetically-actuated micro-grippers at the air-water interface	PLOS ONE			English	Article							MICROGRIPPERS; BIOPSY	The design and control of untethered microrobotic agents has drawn a lot of attention in recent years. This technology truly possesses the potential to revolutionize the field of minimally invasive surgery and microassembly. However, miniaturization and reliable actuation of micro-fabricated grippers are still challenging at sub-millimeter scale. In this study, we design, manufacture, characterize, and control four similarly-structured semi-rigid thermoresponsive micro-grippers. Furthermore, we develop a closed loop-control algorithm to demonstrate and compare the performance of the said grippers when moving in hard-to-reach and unpredictable environments. Finally, we analyze the grasping characteristics of three of the presented designs. Overall, not only does the study demonstrate motion control in unstructured dynamic environments-at velocities up to 3.4, 2.9, 3.3, and 1 body-lengths/s with 980, 750, 250, and 100 mu m-sized grippers, respectively-but it also aims to provide quantitative data and considerations to help a targeted design of magnetically-controlled thin micro-grippers.	[Ongaro, Federico; Scheggi, Stefano; Denasi, Alper; Misra, Sarthak] Univ Twente, Dept Biomech Engn, Surg Robot Lab, NL-7522 NB Enschede, Netherlands; [Gracias, David H.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Ghosh, Arijit; Gracias, David H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Misra, Sarthak] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 GZ Groningen, Netherlands; [Misra, Sarthak] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands	University of Twente; Johns Hopkins University; Johns Hopkins University; University of Groningen; University of Groningen	Ongaro, F (corresponding author), Univ Twente, Dept Biomech Engn, Surg Robot Lab, NL-7522 NB Enschede, Netherlands.	f.ongaro@utwente.nl	Gracias, David/A-1942-2010; Ghosh, Arijit/K-1919-2019; Ghosh, Arijit/AAK-5289-2020	Gracias, David/0000-0003-2735-4725; Ghosh, Arijit/0000-0003-3449-2317; 	European Research Council (ERC) under the European Union's Horizon Research and Innovation programme [638428]; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) [R01EB017742]	European Research Council (ERC) under the European Union's Horizon Research and Innovation programme(European Research Council (ERC)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH)	This project (ROBOTAR) has received funding from the European Research Council (ERC, https://erc.europa.eu/) under the European Union's Horizon 2020 Research and Innovation programme (Grant Agreement #638428). The research was also supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH, https://www.nih.gov/) under Award Number R01EB017742. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to acknowledge Dr. Danru Qu and Dr. Qinli Ma for help with the hysteresis loop measurements. This project (ROBOTAR) has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation programme (Grant Agreement #638428). The research reported in this publication was also supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) under Award Number R01EB017742. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abbott JJ, 2007, IEEE T ROBOT, V23, P1247, DOI 10.1109/TRO.2007.910775; Bechlioulis CP, 2014, AUTOMATICA, V50, P1217, DOI 10.1016/j.automatica.2014.02.020; Chatzipirpiridis G, 2015, ADV HEALTHC MATER, V4, P209, DOI 10.1002/adhm.201400256; Cullity BD., 2011, INTRO MAGNETIC MAT G; Denasi A, 2016, P ANN INT C MAN AUT, P1; Diller E., 2014, P ROB SCI SYST; Diller E, 2014, ADV FUNCT MATER, V24, P4397, DOI 10.1002/adfm.201400275; Fusco S, 2014, ADV MATER, V26, P952, DOI 10.1002/adma.201304098; Ghosh Arijit, 2017, Front Mech Eng, V3, DOI 10.3389/fmech.2017.00007; Gultepe E, 2013, ADV MATER, V25, P514, DOI 10.1002/adma.201203348; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Hosney A, 2016, P IEEE RAS-EMBS INT, P272, DOI 10.1109/BIOROB.2016.7523637; Khalil ISM, 2012, IEEE INT C INT ROBOT, P950, DOI 10.1109/IROS.2012.6386184; Kuo JC, 2014, SENSOR ACTUAT A-PHYS, V211, P121, DOI 10.1016/j.sna.2014.02.028; Leong TG, 2009, P NATL ACAD SCI USA, V106, P703, DOI 10.1073/pnas.0807698106; Love KR, 2013, TRENDS BIOTECHNOL, V31, P16, DOI 10.1016/j.tibtech.2013.03.001; Marieb E, 2004, HUMAN ANATOMY PHYSL, P703; Miyashita S, 2015, P IEEE INT C ROB AUT, P1490; Ongaro F, 2016, J MICROBIO ROB, P1; Ongaro F, 2016, P IEEE RAS-EMBS INT, P900, DOI 10.1109/BIOROB.2016.7523742; Ongaro F, 2016, P IEEE RAS-EMBS INT, P299, DOI 10.1109/BIOROB.2016.7523642; Pacchierotti C, 2017, IEEE T AUTOMATION SC; Pacchierotti C, 2016, FRONT ROBOT AI, V3, DOI 10.3389/frobt.2016.00053; Pandey S, 2013, JOVE-J VIS EXP, DOI 10.3791/50022; Scheggi S, 2017, P IEEE INT IN PRESS; Scheggi S., 2016, P PCIM EUR 2016 INT, P1; Sitti M, 2015, P IEEE, V103, P205, DOI 10.1109/JPROC.2014.2385105; Tortora G.J., 2012, PRINCIPLES ANATOMY P, V13th ed., P610; Yim S, 2014, IEEE T BIO-MED ENG, V61, P513, DOI 10.1109/TBME.2013.2283369; Yoo B, 2016, J INTEL MAT SYST STR, V27, P1075, DOI 10.1177/1045389X15585895; Zhang JC, 2017, IEEE ROBOT AUTOM LET, V2, P835, DOI 10.1109/LRA.2017.2657879; Zhang Z, 2016, IEEE ROBOTICS AUTOMA	33	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0187441	10.1371/journal.pone.0187441	http://dx.doi.org/10.1371/journal.pone.0187441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236716	Green Published, gold, Green Submitted			2022-12-26	WOS:000417884100003
J	Takahashi, K; Inukai, T; Imamura, T; Yano, M; Tomoyasu, C; Lucas, DM; Nemoto, A; Sato, H; Huang, MX; Abe, M; Kagami, K; Shinohara, T; Watanabe, A; Somazu, S; Oshiro, H; Akahane, K; Goi, K; Kikuchi, J; Furukawa, Y; Goto, H; Minegishi, M; Iwamoto, S; Sugita, K				Takahashi, Kazuya; Inukai, Takeshi; Imamura, Toshihiko; Yano, Mio; Tomoyasu, Chihiro; Lucas, David M.; Nemoto, Atsushi; Sato, Hiroki; Huang, Meixian; Abe, Masako; Kagami, Keiko; Shinohara, Tamao; Watanabe, Atsushi; Somazu, Shinpei; Oshiro, Hiroko; Akahane, Koshi; Goi, Kumiko; Kikuchi, Jiro; Furukawa, Yusuke; Goto, Hiroaki; Minegishi, Masayoshi; Iwamoto, Shotaro; Sugita, Kanji			Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEASOME INHIBITOR BORTEZOMIB; REFRACTORY MULTIPLE-MYELOMA; SINGLE-AGENT CARFILZOMIB; P-GLYCOPROTEIN; THERAPEUTIC ADVANCES; CHILDHOOD LEUKEMIA; INDUCED APOPTOSIS; T-CELL; EXPRESSION	Prognosis of childhood acute lymphoblastic leukemia (ALL) has been dramatically improved. However, prognosis of the cases refractory to primary therapy is still poor. Recent phase 2 study on the efficacy of combination chemotherapy with bortezomib (BTZ), a proteasome inhibitor, for refractory childhood ALL demonstrated favorable clinical outcomes. However, septic death was observed in over 10% of patients, indicating the necessity of biomarkers that could predict BTZ sensitivity. We investigated in vitro BTZ sensitivity in a large panel of ALL cell lines that acted as a model system for refractory ALL, and found that Philadelphia chromosome-positive (Ph+) ALL, IKZF1 deletion, and biallelic loss of CDKN2A were associated with favorable response. Even in Ph-negative ALL cell lines, IKZF1 deletion and bilallelic loss of CDKN2A were independently associated with higher BTZ sensitivity. BTZ showed only marginal cross-resistance to four representative chemotherapeutic agents (vincristine, dexamethasone, l-asparaginase, and daunorubicin) in B-cell precursor-ALL cell lines. To improve the efficacy and safety of proteasome inhibitor combination chemotherapy, we also analyzed the anti-leukemic activity of carfilzomib (CFZ), a second-generation proteasome inhibitor, as a substitute for BTZ. CFZ showed significantly higher activity than BTZ in the majority of ALL cell lines except for the P-glycoprotein-positive t(17; 19) ALL cell lines, and IKZF1 deletion was also associated with a favorable response to CFZ treatment. P-glycoprotein inhibitors effectively restored the sensitivity to CFZ, but not BTZ, in P-glycoprotein-positive t(17; 19) ALL cell lines. P-glycoprotein overexpressing ALL cell line showed a CFZ-specific resistance, while knockout of P-glycoprotein by genome editing with a CRISPR/Cas9 system sensitized P-glycoprotein-positive t(17; 19) ALL cell line to CFZ. These observations suggested that IKZF1 deletion could be a useful biomarker to predict good sensitivity to CFZ and BTZ, and that CFZ combination chemotherapy may be a new therapeutic option with higher anti-leukemic activity for refractory ALL that contain P-glycoprotein-negative leukemia cells.	[Takahashi, Kazuya; Inukai, Takeshi; Nemoto, Atsushi; Sato, Hiroki; Huang, Meixian; Abe, Masako; Kagami, Keiko; Shinohara, Tamao; Watanabe, Atsushi; Somazu, Shinpei; Oshiro, Hiroko; Akahane, Koshi; Goi, Kumiko; Sugita, Kanji] Univ Yamanashi, Dept Pediat, Sch Med, Chuo Ku, Kofu, Yamanashi, Japan; [Imamura, Toshihiko; Yano, Mio; Tomoyasu, Chihiro] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto, Japan; [Lucas, David M.] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [Kikuchi, Jiro; Furukawa, Yusuke] Jichi Med Sch, Stem Cell Regulat, Ctr Mol Med, Shimotsuke, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Hematol Oncol & Regenerat Med, Yokohama, Kanagawa, Japan; [Minegishi, Masayoshi] Japanese Red Cross Soc, Tohoku Block Ctr, Sendai, Miyagi, Japan; [Iwamoto, Shotaro] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan	University of Yamanashi; Kyoto Prefectural University of Medicine; University System of Ohio; Ohio State University; Jichi Medical University; Mie University	Inukai, T (corresponding author), Univ Yamanashi, Dept Pediat, Sch Med, Chuo Ku, Kofu, Yamanashi, Japan.	tinukai@yamanashi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	JSPS [15K09645]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Takeshi lnukai was supported by JSPS KAKENHI Grant Number 15K09645.	An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Ao L, 2012, MOL PHARMACEUT, V9, P2197, DOI 10.1021/mp300044b; Ariyasu T, 1998, Hum Cell, V11, P43; Asai D, 2013, CANCER MED-US, V2, P412, DOI 10.1002/cam4.87; Baudis M, 2006, PEDIATR BLOOD CANCER, V47, P757, DOI 10.1002/pbc.20635; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Brown RE, 2004, ANN CLIN LAB SCI, V34, P203; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; De Moerloose B, 2003, PEDIATR HEMAT ONCOL, V20, P381, DOI 10.1080/08880010390204007; Dhooge C, 1999, BRIT J HAEMATOL, V105, P676, DOI 10.1046/j.1365-2141.1999.01378.x; Dimopoulos MA, 2016, LANCET ONCOL, V17, P27, DOI 10.1016/S1470-2045(15)00464-7; GOASGUEN JE, 1993, BLOOD, V81, P2394; Goto H, 2009, LEUKEMIA RES, V33, P1386, DOI 10.1016/j.leukres.2008.12.003; Gupta SV, 2011, AAPS J, V13, P357, DOI 10.1208/s12248-011-9276-7; Gutman D, 2009, LEUKEMIA, V23, P2181, DOI 10.1038/leu.2009.123; Hawley TS, 2013, AM J HEMATOL, V88, P265, DOI 10.1002/ajh.23387; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Hijiya N, 2016, LEUKEMIA LYMPHOMA, V57, P748, DOI 10.3109/10428194.2015.1101098; Hirase C, 2009, LEUKEMIA RES, V33, P450, DOI 10.1016/j.leukres.2008.07.023; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; HIROSE M, 1982, GANN, V73, P600; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Horton TM, 2006, CANCER CHEMOTH PHARM, V58, P13, DOI 10.1007/s00280-005-0135-z; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P37, DOI 10.1002/pbc.21214; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Jakubowiak AJ, 2013, LEUKEMIA, V27, P2351, DOI 10.1038/leu.2013.152; Kang J, 2003, BRIT J HAEMATOL, V123, P921, DOI 10.1046/j.1365-2141.2003.04699.x; KAWAMURA M, 1995, BLOOD, V85, P2546, DOI 10.1182/blood.V85.9.2546.bloodjournal8592546; Kees UR, 1997, BLOOD, V89, P4161, DOI 10.1182/blood.V89.11.4161; Kortuem KM, 2013, BLOOD, V121, P893, DOI 10.1182/blood-2012-10-459883; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Lonial S, 2015, BLOOD, V126, P1536, DOI 10.1182/blood-2015-06-653261; Messinger Y, 2010, PEDIATR BLOOD CANCER, V55, P254, DOI 10.1002/pbc.22456; Messinger YH, 2012, BLOOD, V120, P285, DOI 10.1182/blood-2012-04-418640; MINEGISHI M, 1987, TOHOKU J EXP MED, V151, P283, DOI 10.1620/tjem.151.283; Moqadam FA, 2014, LEUKEMIA, V28, P1008, DOI 10.1038/leu.2013.308; Moreau P, 2017, LEUKEMIA, V31, P115, DOI 10.1038/leu.2016.186; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; O'Connor OA, 2009, CLIN CANCER RES, V15, P7085, DOI 10.1158/1078-0432.CCR-09-0822; Okabe S, 2010, EXP HEMATOL, V38, P765, DOI 10.1016/j.exphem.2010.04.017; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Olsson L, 2015, BRIT J HAEMATOL, V169, P479, DOI 10.1111/bjh.13342; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; SAVIGNANO C, 1993, HAEMATOLOGICA, V78, P261; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Szczepanek J, 2010, ANTICANCER RES, V30, P2119; Uno K, 2003, BLOOD, V101, P3658, DOI 10.1182/blood-2002-06-1770; Vij R, 2012, BRIT J HAEMATOL, V158, P739, DOI 10.1111/j.1365-2141.2012.09232.x; Williams RT, 2008, COLD SH Q B, V73, P461, DOI 10.1101/sqb.2008.73.039; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yeo KK, 2016, J PEDIAT HEMATOL ONC, V38, P345, DOI 10.1097/MPH.0000000000000560; Zahid MF, 2016, FUTURE ONCOL, V12, P1861, DOI 10.2217/fon-2016-0126	57	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188680	10.1371/journal.pone.0188680	http://dx.doi.org/10.1371/journal.pone.0188680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236701	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100024
J	Wang, C; Zeng, NF; Liu, SY; Miao, Q; Zhou, L; Ge, XN; Han, J; Guo, X; Yang, HC				Wang, Cong; Zeng, Nanfang; Liu, Siyu; Miao, Qi; Zhou, Lei; Ge, Xinna; Han, Jun; Guo, Xin; Yang, Hanchun			Interaction of porcine reproductive and respiratory syndrome virus proteins with SUMO-conjugating enzyme reveals the SUMOylation of nucleocapsid protein	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; REPLICASE ORF1A PROTEIN; EQUINE ARTERITIS VIRUS; INFLUENZA-A VIRUS; VIRAL REPLICATION; IN-VIVO; NONSTRUCTURAL PROTEIN-2; NUCLEOLAR LOCALIZATION; TARGETING RANGAP1; LELYSTAD-VIRUS	SUMOylation is a reversible post-translational modification that regulates the function of target protein. In this study, we first predicted by software that the multiple proteins of porcine reproductive and respiratory syndrome virus (PRRSV) could be sumoylated. Next, we confirmed that Nsp1 beta, Nsp4, Nsp9, Nsp10 and nucleocapsid (N) protein of PRRSV could interact with the sole SUMO E2 conjugating enzyme Ubc9, and Ubc9 could be co-localized with Nsp1 beta, Nsp4, Nsp9 and Nsp10 in the cytoplasm, while with N protein in both the cytoplasm and nucleus. Finally, we demonstrated that N protein could be sumoylated by either SUMO1 or SUMO2/3. In addition, the overexpression of Ubc9 could inhibit viral genomic replication at early period of PRRSV infection and the knockdown of Ubc9 by siRNA could promote the virus replication. These findings reveal the SUMOylation property of PRRSV N protein and the involvement of Ubc9 in PRRSV replication through interaction with multiple proteins of PRRSV. To our knowledge, this is the first study indicating the interplay between SUMO modification system and PRRSV.	[Guo, Xin; Yang, Hanchun] China Agr Univ, Key Lab Anim Epidemiol, Minist Agr, Coll Vet Med, Beijing, Peoples R China; China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Guo, X; Yang, HC (corresponding author), China Agr Univ, Key Lab Anim Epidemiol, Minist Agr, Coll Vet Med, Beijing, Peoples R China.	guoxin@cau.edu.cn; yanghanchun1@cau.edu.cn	Liu, Siyu/GYV-4856-2022	Zhou, Lei/0000-0002-8837-3965	National Natural Science Funds from National Natural Science Foundation of China [31572549]; National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology [2014CB542700]; earmarked fund for China Agriculture Research System from the Chinese Ministry of Agriculture [CARS-35]	National Natural Science Funds from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology; earmarked fund for China Agriculture Research System from the Chinese Ministry of Agriculture	This study was supported by National Natural Science Funds from National Natural Science Foundation of China (31572549) (http://www.nsfc.gov.cn/), National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology (2014CB542700) (http://www.most.gov.cn/), and the earmarked fund for China Agriculture Research System from the Chinese Ministry of Agriculture (CARS-35) (http://119.253.58.231/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2005, BIOCHEM BIOPH RES CO, V336, P22, DOI 10.1016/j.bbrc.2005.08.036; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Barysch SV, 2014, NAT PROTOC, V9, P896, DOI 10.1038/nprot.2014.053; Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37258; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Bentz GL, 2011, J VIROL, V85, P10144, DOI 10.1128/JVI.05035-11; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064877; Chen SC, 2011, J BIOL CHEM, V286, P31373, DOI 10.1074/jbc.M111.254896; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; Du J, 2016, J VIROL, V90, P682, DOI 10.1128/JVI.02307-15; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Fan BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138772; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hagemeier SR, 2010, J VIROL, V84, P4383, DOI 10.1128/JVI.02369-09; Han QL, 2014, J VIROL, V88, P9379, DOI 10.1128/JVI.00509-14; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Jaber T, 2009, J VIROL, V83, P10448, DOI 10.1128/JVI.00237-09; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Kappes MA, 2015, VIROLOGY, V481, P51, DOI 10.1016/j.virol.2015.01.028; Kappes MA, 2013, J VIROL, V87, P13456, DOI 10.1128/JVI.02435-13; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; Lee C, 2006, VIROLOGY, V346, P238, DOI 10.1016/j.virol.2005.11.005; Lee C, 2006, ADV EXP MED BIOL, V581, P145; Li Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004216; Li YH, 2015, VIRUS RES, V202, P48, DOI 10.1016/j.virusres.2014.12.027; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu X, 2015, J GEN VIROL, V96, P1276, DOI 10.1099/vir.0.000061; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattoscio Domenico, 2013, World J Virol, V2, P79, DOI 10.5501/wjv.v2.i2.79; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pei Y, 2008, VIRUS RES, V135, P107, DOI 10.1016/j.virusres.2008.02.012; Pejsak Z, 1997, VET MICROBIOL, V55, P317, DOI 10.1016/S0378-1135(96)01326-0; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rowland RR, 1999, VIRUS RES, V64, P1, DOI 10.1016/S0168-1702(99)00048-9; Rowland RRR, 2003, VIROLOGY, V316, P135, DOI 10.1016/S0042-6822(03)00482-3; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; SNIJDER EJ, 1994, J VIROL, V68, P5755, DOI 10.1128/JVI.68.9.5755-5764.1994; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Uemura A, 2013, CELL STRUCT FUNCT, V38, P67, DOI 10.1247/csf.12026; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; vanDinten LC, 1996, J VIROL, V70, P6625, DOI 10.1128/JVI.70.10.6625-6633.1996; Varadaraj A, 2014, IUBMB LIFE, V66, P27, DOI 10.1002/iub.1240; Wang XY, 2012, ANTIVIR RES, V96, P315, DOI 10.1016/j.antiviral.2012.09.004; Wang X, 2015, VIRUS RES, V210, P34, DOI 10.1016/j.virusres.2015.07.004; Wassenaar ALM, 1997, J VIROL, V71, P9313, DOI 10.1128/JVI.71.12.9313-9322.1997; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wilson VG, 2012, BIOMOLECULES, V2, P203, DOI 10.3390/biom2020203; Wimmer P, 2013, ONCOGENE, V32, P1626, DOI 10.1038/onc.2012.187; Wimmer P, 2010, ONCOGENE, V29, P5511, DOI 10.1038/onc.2010.284; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wongyanin P, 2012, J GEN VIROL, V93, P1236, DOI 10.1099/vir.0.040287-0; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhao S, 2015, VIRUS RES, V195, P217, DOI 10.1016/j.virusres.2014.10.021; Zhou L, 2015, EMERG INFECT DIS, V21, P2256, DOI 10.3201/eid2112.150360; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459; Zhu SS, 2006, EXP CELL RES, V312, P1042, DOI 10.1016/j.yexcr.2005.12.031	86	9	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189191	10.1371/journal.pone.0189191	http://dx.doi.org/10.1371/journal.pone.0189191			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236778	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100048
J	Sun, CN; Han, CY; Jiang, YJ; Han, N; Zhang, M; Li, G; Qiao, Q				Sun, Chaonan; Han, Chuyang; Jiang, Yuanjun; Han, Ning; Zhang, Miao; Li, Guang; Qiao, Qiao			Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR MONOCLONAL-ANTIBODIES; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; IONIZING-RADIATION; NECK-CANCER; GENE-EXPRESSION; IN-VITRO; HEAD; RADIOTHERAPY	The EGFR-specific mAb cetuximab is one of the most effective treatments for oropharyngeal carcinoma, while patient responses to EGFR inhibitors given alone are modest. Combination treatment with radiation can improve the efficacy of treatment through increasing radiosensitivity, while resistance to radiation after administration of cetuximab limits its efficiency. Radiation and drugs can damage the endoplasmic reticulum (ER) homeostatic state and result in ER stress (ERS), subsequently causing resistance to radiation and drugs. Whether the ERS pathway is involved in radioresistance after administration of cetuximab has not been reported. Herein, we show that cetuximab could increase the radiosensitivity of FaDu cells but not Detroit562 cells. In addition, cetuximab inhibited the radiation-induced activation of the ERS signalling pathway IRE1 alpha/ATF6-GRP78 in FaDu cells, while this effect was absent in Detroit562 cells. Silencing GRP78 increased the radiosensitivity of oropharyngeal carcinoma cells and inhibited radiation-induced DNA double-strand-break (DSB) repair and autophagy. More interestingly, silencing GRP78 abrogated resistance to cetuximab and radiation in Detroit562 cells and had a synergistic effect with cetuximab in increasing the radiosensitivity of FaDu cells. Immunohistochemistry showed that overexpression of both GRP78 and EGFR was associated with a poor prognosis in oropharyngeal carcinoma patients (P<0.05). Overall, the results of this study show that radioresistance after EGFR inhibition by cetuximab is mediated by the ERS signalling pathway IRE1 alpha/ATF6-GRP78. This suppression was consequently unable to inhibit radiation-induced DSB repair and autophagy in oropharyngeal carcinoma cells, which conferred resistance to radiotherapy and cetuximab. These results suggest that the cooperative effects of radiotherapy and cetuximab could be further improved by inhibiting GRP78 in non-responsive oropharyngeal carcinoma patients.	[Sun, Chaonan; Han, Chuyang; Han, Ning; Zhang, Miao; Li, Guang; Qiao, Qiao] China Med Univ, Hosp 1, Dept Radiotherapy, Shenyang, Liaoning, Peoples R China; [Jiang, Yuanjun] China Med Univ, Hosp 1, Dept Urol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Qiao, Q (corresponding author), China Med Univ, Hosp 1, Dept Radiotherapy, Shenyang, Liaoning, Peoples R China.	braveheart8063@outlook.com	jiang, anyi/GPT-0379-2022		National Natural Science Foundation of China [81402521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81402521).(www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2014, J CLIN ONCOL, V32, P2940, DOI 10.1200/JCO.2013.53.5633; Bonner JA, 2000, J CLIN ONCOL, V18, p47S; Bonner JA, 2016, EUR J CANCER, V64, P1, DOI 10.1016/j.ejca.2016.05.008; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Chiu CC, 2008, MOL CANCER THER, V7, P2788, DOI 10.1158/1535-7163.MCT-08-0172; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Gonzalez JE, 2012, CANCER BIOL THER, V13, P71, DOI 10.4161/cbt.13.2.18439; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Gurtner K, 2011, RADIOTHER ONCOL, V99, P323, DOI 10.1016/j.radonc.2011.05.035; Hara A, 2004, ACTA NEUROPATHOL, V108, P43, DOI 10.1007/s00401-004-0860-0; Jiang YJ, 2016, TUMOR BIOL, V37, P8131, DOI 10.1007/s13277-015-4590-9; Kasten-Pisula U, 2011, INT J RADIAT ONCOL, V80, P1181, DOI 10.1016/j.ijrobp.2011.02.043; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Kocher S, 2012, NUCLEIC ACIDS RES, V40, P8336, DOI 10.1093/nar/gks604; Lei Y, 2016, ONCOGENE, V35, P4698, DOI 10.1038/onc.2016.11; Lin CY, 2010, HEAD NECK-J SCI SPEC, V32, P1028, DOI 10.1002/hed.21287; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nickson CM, 2017, ONCOTARGET, V8, P29963, DOI 10.18632/oncotarget.16265; Pang XL, 2013, WORLD J GASTROENTERO, V19, P1736, DOI 10.3748/wjg.v19.i11.1736; Pivot X, 2005, ORAL ONCOL, V41, P320, DOI 10.1016/j.oraloncology.2004.09.011; Pozzi C, 2016, NAT MED, V22, P624, DOI 10.1038/nm.4078; Prabhu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052265; Qiao Q, 2017, CANC SCI; Qiao Q, 2013, ONCOL REP, V29, P380, DOI 10.3892/or.2012.2091; Qiao Q, 2012, ANTI-CANCER DRUG, V23, P597, DOI 10.1097/CAD.0b013e3283503fbc; Qiao QA, 2010, EXP HEMATOL, V38, P1199, DOI 10.1016/j.exphem.2010.08.007; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stegeman H, 2013, RADIOTHER ONCOL, V106, P383, DOI 10.1016/j.radonc.2013.02.001; Huynh TT, 2015, J NUTR BIOCHEM, V26, P466, DOI 10.1016/j.jnutbio.2014.11.015; Tuttle SW, 2012, CANCER BIOL THER, V13, P575, DOI 10.4161/cbt.19772; Uramoto H, 2005, LUNG CANCER, V49, P55, DOI 10.1016/j.lungcan.2004.12.011; van Emburgh BO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13665; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang M, 2014, CANCER RES, V74, P2825, DOI 10.1158/0008-5472.CAN-13-3157; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang ZL, 2016, INT J ONCOL, V48, P2558, DOI 10.3892/ijo.2016.3468; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yu LQ, 2016, MOL CELL ENDOCRINOL, V422, P31, DOI 10.1016/j.mce.2015.11.005	41	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188932	10.1371/journal.pone.0188932	http://dx.doi.org/10.1371/journal.pone.0188932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232380	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200015
J	Thomas, RG; Reyes, BMR; Gaston, BM; Acosta, NBR; Bederman, IR; Smith, LA; Sutton, MT; Wang, BL; Hunt, JF; Bonfield, TL				Thomas, Ryan G.; Reyes, Brenda M. Rivera; Gaston, Benjamin M.; Acosta, Nelki B. Rivera; Bederman, Ilya R.; Smith, Laura A.; Sutton, Morgan T.; Wang, Benlian; Hunt, John F.; Bonfield, Tracey L.			Conjugation of nitrated acetaminophen to Der p1 amplifies peripheral blood monocyte response to Der p1	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; CYSTIC-FIBROSIS; NITRIC-OXIDE; INCREASED NITROTYROSINE; GLUTATHIONE LEVELS; ASTHMA; LUNG; PARACETAMOL; CHILDHOOD; RISK	Background An association of acetaminophen use and asthma was observed in the International Study of Asthma and Allergies in Childhood study. However there are no clear mechanisms to explain an association between acetaminophen use and immunologic pathology. In acidic conditions like those in the stomach and inflamed airway, tyrosine residues are nitrated by nitrous and peroxynitrous acids. The resulting nitrotyrosine is structurally similar to 2,4-dinitrophenol and 2,4-dinitrochlorobenzene, known haptens that enhance immune responses by covalently binding proteins. Nitrated acetaminophen shares similar molecular structure. Objective We hypothesized the acetaminophen phenol ring undergoes nitration under acidic conditions, producing 3-nitro-acetaminophen which augments allergic responses by acting as a hapten for environmental allergens. Methods 3-nitro-acetaminophen was formed from acetaminophen in the presence of acidified nitrite, purified by high performance liquid chromatography, and assayed by gas-chromatography mass spectrometry. Purified 3-nitro-acetaminophen was reacted with Dermatophagoides pteronyssinus (Der p1) and analyzed by mass spectrometry to identify the modification site. Human peripheral blood mononuclear cells proliferation response was measured in response to 3-nitro-acetaminophen and to 3-nitro-acetaminophen-modified Der p1. Results Acetaminophen was modified by nitrous acid forming 3-nitro-acetaminophen over a range of different acidic conditions consistent with airway inflammation and stomach acidity. The Der p1 protein-hapten adduct creation was confirmed by liquid chromatography-mass spectrometry proteomics modifying cysteine 132. Peripheral blood mononuclear cells exposed to 3-nitro-acetaminophen-modified Der p1 had increased proliferation and cytokine production compared to acetaminophen and Der p1 alone (n = 7; p < 0.05). Conclusion These data suggests 3-nitro-acetaminophen formation and reaction with Der p1 provides a mechanism by which stomach acid or infection-induced low airway pH in patients could enhance the allergic response to proteins such as Der p1.	[Thomas, Ryan G.; Reyes, Brenda M. Rivera; Gaston, Benjamin M.; Acosta, Nelki B. Rivera] Univ Hosp Cleveland, Med Ctr, Rainbow Babies & Childrens Hosp, Dept Pediat,Div Pulmonol, Cleveland, OH 44106 USA; [Thomas, Ryan G.; Reyes, Brenda M. Rivera; Gaston, Benjamin M.; Bederman, Ilya R.; Smith, Laura A.; Sutton, Morgan T.; Bonfield, Tracey L.] Case Western Reserve Univ, Div Pulmonol, Dept Pediat, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Hunt, John F.] Airbase Therapeut, Charlottesville, VA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University	Bonfield, TL (corresponding author), Case Western Reserve Univ, Div Pulmonol, Dept Pediat, Cleveland, OH 44106 USA.	Tracey.Bonfield@case.edu		Bonfield, Tracey/0000-0001-9698-9113	National Heart Lung and Blood Institute [1P01HL101871, 1U10HL109250]; Children's Lung Foundation; Rainbow Babies & Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109250, P01HL101871] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Lung Foundation; Rainbow Babies & Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BG received funding from the National Heart Lung and Blood Institute grant numbers 1P01HL101871 and 1U10HL109250 (https://www.nhlbi.nih.gov/) as well as the Childrens Lung Foundation. RT received funding from the Fellowship Research Award Program Grant, Rainbow Babies & Childrens Foundation (http://www.uhhospitals.org/rainbow/about/rainbow-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093869; [Anonymous], ATLAS OF IMMUNOLOGY; Antczak A, 2001, AM J RESP CRIT CARE, V163, p725A; BAILEY DN, 1982, CLIN CHEM, V28, P187; Balint B, 2001, EUR RESPIR J, V17, P1201, DOI 10.1183/09031936.01.00072501; Balint B, 2001, THORAX, V56, P456, DOI 10.1136/thorax.56.6.456; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Beasley RW, 2011, AM J RESP CRIT CARE, V183, P171, DOI 10.1164/rccm.201005-0757OC; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229, DOI DOI 10.1016/S0076-6879(94)33026-3; Bischoff R, 2012, J PROTEOMICS, V75, P2275, DOI 10.1016/j.jprot.2012.01.041; Bonfield TL, 2006, J AUTOIMMUN, V26, P37, DOI 10.1016/j.jaut.2005.10.004; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; CEUPPENS JL, 1988, J IMMUNOL, V141, P3868; Cheong JC, 2010, J SEP SCI, V33, P1767, DOI 10.1002/jssc.201000087; Chipinda I., 2011, J ALLERGY, V2011, DOI DOI 10.1155/2011/839682; COOKE JP, 1990, AM J PHYSIOL, V259, pH804, DOI 10.1152/ajpheart.1990.259.3.H804; CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5; Dimova S, 2005, INT J BIOCHEM CELL B, V37, P1727, DOI 10.1016/j.biocel.2005.03.005; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Fan F, 2004, PROMEGA NOTES, V88, P2; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; FORREST JAH, 1982, CLIN PHARMACOKINET, V7, P93, DOI 10.2165/00003088-198207020-00001; Gessner C, 2003, RESP MED, V97, P1188, DOI 10.1016/S0954-6111(03)00225-7; Gorris HH, 2011, BIOCONJUGATE CHEM, V22, P1619, DOI 10.1021/bc2001787; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hanazawa T, 2000, AM J RESP CRIT CARE, V162, P1273, DOI 10.1164/ajrccm.162.4.9912064; Hanazawa T, 2000, J ALLERGY CLIN IMMUN, V105, P58, DOI 10.1016/S0091-6749(00)90178-7; HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Ichinose M, 2000, AM J RESP CRIT CARE, V162, P701, DOI 10.1164/ajrccm.162.2.9908132; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Kaminsky DA, 1999, J ALLERGY CLIN IMMUN, V104, P747, DOI 10.1016/S0091-6749(99)70283-6; Karle AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031483; Kelly FK, 1999, LANCET, V354, P482, DOI 10.1016/S0140-6736(99)01812-7; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; Kreiner-Moller E, 2012, J ALLERGY CLIN IMMUN, V130, P1434, DOI 10.1016/j.jaci.2012.09.017; Lakshmi VM, 2000, CHEM RES TOXICOL, V13, P891, DOI 10.1021/tx000115g; LEPERDRIEL F, 1968, ANN PHARM FR, V26, P227; MICHELI L, 1994, ENVIRON HEALTH PERSP, V102, P63, DOI 10.1289/ehp.94102s963; Mikkelesen SR, 2016, BIOANALYTICAL CHEM; Mudway IS, 2001, FREE RADICAL BIO MED, V31, P962, DOI 10.1016/S0891-5849(01)00671-2; Ricciardolo FLM, 2004, J ALLERGY CLIN IMMUN, V113, P610, DOI 10.1016/j.jaci.2003.12.034; Schulz O, 1999, CLIN EXP ALLERGY, V29, P439, DOI 10.1046/j.1365-2222.1999.00464.x; Sheehan WJ, 2016, NEW ENGL J MED, V375, P619, DOI 10.1056/NEJMoa1515990; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065; Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188614	10.1371/journal.pone.0188614	http://dx.doi.org/10.1371/journal.pone.0188614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228007	Green Submitted, gold, Green Published			2022-12-26	WOS:000417648600011
J	Diaz, G				Diaz, Giacomo			Contour recognition of complex leaf shapes	PLOS ONE			English	Article							ELLIPTIC FOURIER-ANALYSIS; FEATURES	The leaf shape is an important taxonomic character. Compared to the classic morphological leaf features such as veins, margin indentations, sinuses, etc., the shape is simpler to obtain by using the 'magic wand' or other contouring tools that are available in most of imaging applications. The only exception is when leaves develop large lobes that get in touch or overlap each other, as the presence of hidden or closed portions of the leaf border precludes the application of automatic methods and forces the leaf contour to be traced manually. This is a time consuming and relatively accurate operation that, nevertheless, can not be avoided, as overlapping lobes are characteristic features of the leaves of several plant species and varieties. The method described in the paper overcomes this problem as it allows the leaf contour to be achieved even in the presence of touching or overlapping lobes. The method involves three steps: (1) the acquisition of leaf images using a transilluminator, (2) a two-level image segmentation that allows all leaf components (blade, overlapping lobes and closed sinuses) to be represented in a single binary image, and (3) the contouring and concatenation of all binary outlines in a single, self-intersecting closed contour that reproduces accurately the leaf shape. The method can be extended to acquire the shape of leaves of herbarium specimens, that are often overlapped but can not be easily handled and repositioned because of their extreme fragility and relevant taxonomic value.	[Diaz, Giacomo] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy	University of Cagliari	Diaz, G (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	gdiaz@unica.it		DIAZ, GIACOMO/0000-0003-1214-2383				Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Chitwood DH, 2016, NEW PHYTOL, V210, P343, DOI 10.1111/nph.13754; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; DIAZ G, 1989, COMPUT BIOMED RES, V22, P405, DOI 10.1016/0010-4809(89)90034-7; DIAZ G, 1991, Journal International des Sciences de la Vigne et du Vin, V25, P37; Du JX, 2013, NEUROCOMPUTING, V116, P150, DOI 10.1016/j.neucom.2012.03.028; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Mancuso S, 1999, VITIS, V38, P73; Mokhtarian F, 2004, IEEE T IMAGE PROCESS, V13, P653, DOI 10.1109/TIP.2004.826126	12	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189427	10.1371/journal.pone.0189427	http://dx.doi.org/10.1371/journal.pone.0189427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220401	Green Submitted, Green Published, gold			2022-12-26	WOS:000417469900057
J	Irons, JL; Jeon, M; Leber, AB				Irons, Jessica L.; Jeon, Minjeong; Leber, Andrew B.			Pre-stimulus pupil dilation and the preparatory control of attention	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LOCUS-COERULEUS; VISUAL-SEARCH; COGNITIVE CONTROL; NEURONAL-ACTIVITY; ADAPTIVE GAIN; NEURAL BASIS; TASK; CONFLICT; SIZE	Task preparation involves multiple component processes, including a general evaluative process that signals the need for adjustments in control, and the engagement of task-specific control settings. Here we examined the dynamics of these different mechanisms in preparing the attentional control system for visual search. We explored preparatory activity using pupil dilation, a well-established measure of task demands and effortful processing. In an initial exploratory experiment, participants were cued at the start of each trial to search for either a salient color singleton target (an easy search task) or a low-salience shape singleton target (a difficult search task). Pupil dilation was measured during the preparation period from cue onset to search display onset. Mean dilation was larger in preparation for the difficult shape target than the easy color target. In two additional experiments, we sought to vary effects of evaluative processing and task-specific preparation separately. Experiment 2 showed that when the color and shape search tasks were matched for difficulty, the shape target no longer evoked larger dilations, and the pattern of results was in fact reversed. In Experiment 3, we manipulated difficulty within a single feature dimension, and found that the difficult search task evoked larger dilations. These results suggest that pupil dilation reflects expectations of difficulty in preparation for a search task, consistent with the activity of an evaluative mechanism. We did not find consistent evidence for relationship between pupil dilation and search performance (accuracy and response timing), suggesting that pupil dilation during search preparation may not be strongly linked to ongoing task-specific preparation.	[Irons, Jessica L.; Leber, Andrew B.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Jeon, Minjeong] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA USA	University System of Ohio; Ohio State University; University of California System; University of California Los Angeles	Irons, JL; Leber, AB (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	irons.39@osu.edu; leber.30@osu.edu	Leber, Andrew B/F-1887-2010	Leber, Andrew B/0000-0002-3537-1093; Irons, Jessica/0000-0002-0671-5168	National Science Foundation Perception, Action & Cognition grant [BCS-1632296]; NSF [BCS-1632296]	National Science Foundation Perception, Action & Cognition grant; NSF(National Science Foundation (NSF))	This work was supported by a National Science Foundation (https.//www.nst.gov/) Perception, Action & Cognition grant (BCS-1632296) awarded to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support was provided by NSF BCS-1632296 to A.B.L. We thank Lisa Heisterberg for help with data collection. We also thank Antonino Vallesi and two anonymous reviewers for their valuable comments on the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Aston-Jones G., 2002, SOC NEUR ABSTR, V2002, P86; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Chiew KS, 2016, J EXP PSYCHOL HUMAN, V42, P52, DOI 10.1037/xhp0000129; Chiew KS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00015; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Ebitz RB, 2015, NEURON, V85, P628, DOI 10.1016/j.neuron.2014.12.053; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Giesbrecht B, 2006, BRAIN RES, V1080, P63, DOI 10.1016/j.brainres.2005.09.068; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Goldinger SD, 2012, CURR DIR PSYCHOL SCI, V21, P90, DOI 10.1177/0963721412436811; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Ives HE, 1912, PHILOS MAG, V24, P149, DOI 10.1080/14786440708637317; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D., 1973, ATTENTION EFFORT; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mathot S, 2015, J EXP PSYCHOL GEN, V144, P513, DOI 10.1037/a0039168; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Peelena MV, 2011, P NATL ACAD SCI USA, V108, P12125, DOI 10.1073/pnas.1101042108; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Porter G, 2010, CORTEX, V46, P621, DOI 10.1016/j.cortex.2009.04.013; Porter G, 2010, CORTEX, V46, P637, DOI 10.1016/j.cortex.2009.04.014; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Rajkowski J., 2000, SOC NEUR ABSTR, V26, P838; RICHER F, 1985, PSYCHOPHYSIOLOGY, V22, P204, DOI 10.1111/j.1469-8986.1985.tb01587.x; RICHER F, 1983, J EXP PSYCHOL HUMAN, V9, P360, DOI 10.1037/0096-1523.9.3.360; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Vallesi A, 2014, BRAIN RES, V1579, P65, DOI 10.1016/j.brainres.2014.07.018; van Steenbergen H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00215; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; Walton ME, 2003, J NEUROSCI, V23, P6475; Wang CA, 2015, EUR J NEUROSCI, V41, P1102, DOI 10.1111/ejn.12883; Yantis S, 2008, CURR DIR PSYCHOL SCI, V17, P86, DOI 10.1111/j.1467-8721.2008.00554.x	58	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188787	10.1371/journal.pone.0188787	http://dx.doi.org/10.1371/journal.pone.0188787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220361	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900017
J	Papegaaij, S; Hortobagyi, T; Godde, B; Kaan, WA; Erhard, P; Voelcker-Rehage, C				Papegaaij, Selma; Hortobagyi, Tibor; Godde, Ben; Kaan, Wim A.; Erhard, Peter; Voelcker-Rehage, Claudia			Neural correlates of motor-cognitive dual-tasking in young and old adults	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; BRAIN ACTIVITY; FUNCTIONAL NEUROANATOMY; BALANCE PERFORMANCE; ATTENTIONAL DEMANDS; PHYSICAL-ACTIVITY; WORKING-MEMORY; WALKING SPEED; SINGLE-TASK; INTERFERENCE	When two tasks are performed simultaneously, performance often declines in one or both tasks. These so-called dual-task costs are more pronounced in old than in young adults. One proposed neurological mechanism of the dual-task costs is that old compared with young adults tend to execute single-tasks with higher brain activation. In the brain regions that are needed for both tasks, the reduced residual capacity may interfere with performance of the dual-task. This competition for shared brain regions has been called structural interference. The purpose of the study was to determine whether structural interference indeed plays a role in the age-related decrease in dual-task performance. Functional magnetic resonance imaging (fMRI) was used to investigate 23 young adults (20-29 years) and 32 old adults (66-89 years) performing a calculation (serial subtraction by seven) and balance-simulation (plantar flexion force control) task separately or simultaneously. Behavioral performance decreased during the dual-task compared with the single-tasks in both age groups, with greater dual-task costs in old compared with young adults. Brain activation was significantly higher in old than young adults during all conditions. Region of interest analyses were performed on brain regions that were active in both tasks. Structural interference was apparent in the right insula, as quantified by an age-related reduction in upregulation of brain activity from single-to dual-task. However, the magnitude of upregulation did not correlate with dual-task costs. Therefore, we conclude that the greater dual-task costs in old adults were probably not due to increased structural interference.	[Papegaaij, Selma; Hortobagyi, Tibor; Kaan, Wim A.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Godde, Ben; Voelcker-Rehage, Claudia] Jacobs Univ Bremen, Jacobs Ctr Lifelong Learning & Inst Dev, Bremen, Germany; [Erhard, Peter] Univ Bremen, Brain Res Inst, Bremen, Germany; [Voelcker-Rehage, Claudia] Tech Univ Chemnitz, Fac Behav & Social Sci, Inst Human Movement Sci & Hlth, Chemnitz, Germany	University of Groningen; Jacobs University; University of Bremen; Technische Universitat Chemnitz	Papegaaij, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.; Voelcker-Rehage, C (corresponding author), Jacobs Univ Bremen, Jacobs Ctr Lifelong Learning & Inst Dev, Bremen, Germany.; Voelcker-Rehage, C (corresponding author), Tech Univ Chemnitz, Fac Behav & Social Sci, Inst Human Movement Sci & Hlth, Chemnitz, Germany.	selmapapegaaij@gmail.com; claudia.voelcker-rehage@hsw.tu-chemnitz.de	Voelcker-Rehage, Claudia/ABA-2163-2020; Godde, Ben/F-5045-2013	Voelcker-Rehage, Claudia/0000-0001-5398-4099; Godde, Ben/0000-0001-9101-7286	Gratama Stichting [2014-08]; Graduate School of Medical Sciences [653013]	Gratama Stichting; Graduate School of Medical Sciences	This work was supported by the Gratama Stichting (2014-08, http://www.gratama.net/) and by a startup fund from the Graduate School of Medical Sciences (653013, http://www.rug.nl/research/gradschool-medical-sciences/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Boisgontier MP, 2013, NEUROSCI BIOBEHAV R, V37, P1824, DOI 10.1016/j.neubiorev.2013.07.014; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cherry B., 2005, AGING NEUROPSYCHOL; Cowell SF, 2000, NEUROIMAGE, V12, P565, DOI 10.1006/nimg.2000.0640; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Fera F, 2005, J NEUROSCI, V25, P11340, DOI 10.1523/JNEUROSCI.2736-05.2005; Gill DP, 2016, MED SCI SPORT EXER, V48, P297, DOI 10.1249/MSS.0000000000000758; Goble DJ, 2011, J NEUROSCI, V31, P16344, DOI 10.1523/JNEUROSCI.4159-11.2011; Godde B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00139; Granacher U, 2011, SPORTS MED, V41, P377, DOI 10.2165/11539920-000000000-00000; Hamacher D, 2015, NEUROSCI BIOBEHAV R, V57, P310, DOI 10.1016/j.neubiorev.2015.08.002; Hartley AA, 2001, PSYCHOL AGING, V16, P47, DOI 10.1037//0882-7974.16.1.47; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hoaglin D.C., 1987, J AM STAT ASS; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Johannsen L, 2013, NEUROPSYCHOLOGIA, V51, P2142, DOI 10.1016/j.neuropsychologia.2013.07.009; Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Karim HT, 2014, BRAIN RES, V1555, P20, DOI 10.1016/j.brainres.2014.01.033; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Klingberg T, 1997, COGNITIVE BRAIN RES, V6, P1, DOI 10.1016/S0926-6410(97)00010-4; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Kouzaki M, 2010, MUSCLE NERVE, V42, P78, DOI 10.1002/mus.21599; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53, DOI 10.1016/0957-4271(95)00014-3; Maquestiaux F, 2004, PSYCHOL AGING, V19, P649, DOI 10.1037/0882-7974.19.4.649; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; Mello EM, 2013, HUM MOVEMENT SCI, V32, P1310, DOI 10.1016/j.humov.2013.05.004; Menant JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109802; NAVON D, 1987, J EXP PSYCHOL HUMAN, V13, P435, DOI 10.1037/0096-1523.13.3.435; Ni YR, 2011, BRAIN RES BULL, V86, P395, DOI 10.1016/j.brainresbull.2011.08.016; Niemann C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9837321; Nijboer M, 2014, NEUROIMAGE, V100, P60, DOI 10.1016/j.neuroimage.2014.05.082; Nijboer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079583; O'Caoimh R, 2016, J ALZHEIMERS DIS, V51, P619, DOI 10.3233/JAD-150881; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Papegaaij S., 2014, FRONTIERS AGING NEUR, V6; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2013, PERSPECT PSYCHOL SCI, V8, P62, DOI 10.1177/1745691612469034; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Prosperini L, 2015, GAIT POSTURE, V41, P780, DOI 10.1016/j.gaitpost.2015.02.002; Reuter-Lorenz PA, 1999, PSYCHOL SCI, V10, P494, DOI 10.1111/1467-9280.00195; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Riley MA, 2005, J MOTOR BEHAV, V37, P311, DOI 10.3200/JMBR.37.4.311-324; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Salo E, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00102; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Sosnoff JJ, 2014, DISABIL REHABIL, V36, P205, DOI 10.3109/09638288.2013.782361; Stelzel C, 2011, PSYCHOL RES-PSYCH FO, V75, P476, DOI 10.1007/s00426-011-0368-x; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Talley KMC, 2014, J AGING HEALTH, V26, P616, DOI 10.1177/0898264314526619; Taube W, 2015, CORTEX, V64, P102, DOI 10.1016/j.cortex.2014.09.022; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; Tukey JW, 1977, EXPLORATORY DATA ANA; Van Impe A, 2013, AGE, V35, P2111, DOI 10.1007/s11357-012-9499-2; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; Vansteensel MJ, 2014, HUM BRAIN MAPP, V35, P5903, DOI 10.1002/hbm.22593; Voelcker-Rehage C, 2007, J GERONTOL B-PSYCHOL, V62, pP141, DOI 10.1093/geronb/62.3.P141; Voelcker-Rehage C, 2006, AGING NEUROPSYCHOL C, V13, P366, DOI 10.1080/138255890969339; Waldron-Perrine B., 2012, INT J; Walshe EA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00200; Wang XQ, 2015, AGE AGEING, V44, P205, DOI 10.1093/ageing/afu175; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wollesen B, 2015, AGING CLIN EXP RES, V27, P447, DOI 10.1007/s40520-014-0301-4; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	93	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189025	10.1371/journal.pone.0189025	http://dx.doi.org/10.1371/journal.pone.0189025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220349	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900027
J	Hight, RE; Beck, TW; Bemben, DA; Black, CD				Hight, Robert E.; Beck, Travis W.; Bemben, Debra A.; Black, Christopher D.			Adaptations in antagonist co-activation: Role in the repeated-bout effect	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ELBOW FLEXOR MUSCLES; EMG SIGNAL DECOMPOSITION; HUMAN MOTOR UNITS; ECCENTRIC EXERCISE; SURFACE EMG; RECRUITMENT THRESHOLD; BICEPS-BRACHII; FIRING RATE; VOLUNTARY CONTRACTIONS	Eccentric exercise results in an adaptation which attenuates muscle damage from subsequent exercise-termed the "repeated-bout effect (RBE)." Purpose: Study examined antagonist co-activation and motor-unit recruitment strategy, assessed via dEMG, concomitant to the RBE. Methods: Nine participants performed 5 sub-maximal isometric trapezoid (ramp-up, hold, ramp-down) contractions at force levels corresponding to 50% and 80% of maximal isometric strength (MVC). Surface EMG signals of the biceps brachii were decomposed into individual motor-unit action potential trains. The relationship between mean firing rate (MFR) of each motor-unit and its recruitment threshold (RT) was examined using linear regression. Eccentric exercise was then performed until biceps brachii MVC had decreased by similar to 40%. Surface EMG of the biceps and triceps were collected during eccentric exercise. MVC, range-of-motion (ROM), and delayed onset muscle soreness (DOMS) were measured 24-hours, 72-hours, and 1-week following eccentric exercise. Three weeks later all procedures were repeated. Results: Changes in MVC (-32 +/- 14% vs -25 +/- 10%; p = 0.034), ROM (-11% vs 6%; p = 0.01), and DOMS (31.0 +/- 19mm vs 19 +/- 12mm; p = 0.015) were attenuated following the second bout of exercise. Triceps EMG was reduced (16.8 +/- 9.5% vs. 12.6 +/- 7.2%; p = 0.03) during the second bout of eccentric exercise. The slope (-0.60 +/- 0.13 vs -0.70 +/- 0.18; p = 0.029) and y-intercept (46.5 +/- 8.3 vs 53.3 +/- 8.8; p = 0.020) of the MFR vs. RT relationship was altered during contractions at 80% of MVC prior to the second bout of eccentric exercise. No changes were observed at 50% of MVC. Conclusion: A reduction in antagonist co-activation during the second bout of eccentric exercise suggests less total force was required to move an identical external load. This finding is supported by the increased negative slope coefficient and an increased y-intercept of the linear relationship between RT and MFR.	[Hight, Robert E.; Beck, Travis W.; Bemben, Debra A.; Black, Christopher D.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Black, CD (corresponding author), Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.	cblack@ou.edu		Black, Christopher/0000-0003-2662-8341	University of Oklahoma Graduate College Robberson Grant; University of Oklahoma Graduate College Robberson Research and Creative Endeavors Grant	University of Oklahoma Graduate College Robberson Grant; University of Oklahoma Graduate College Robberson Research and Creative Endeavors Grant	Funded by University of Oklahoma Graduate College Robberson Grant. Role: No role was played by the funder in any aspect of the study.; The authors are thankful for the University of Oklahoma Graduate College Robberson Research and Creative Endeavors Grant for support of this project. Thanks are also due to Stephanie Rehm for her assistance with data collection and analysis.	Beck TW, 2012, MUSCLE NERVE, V46, P759, DOI 10.1002/mus.23386; Beck TW., 2011, CLIN KINESIOL, V65, P1; Black CD, 2008, MED SCI SPORT EXER, V40, P1605, DOI 10.1249/MSS.0b013e3181788dbe; Black CD, 2008, MED SCI SPORT EXER, V40, P1596, DOI 10.1249/MSS.0b013e3181757182; Black CD, 2008, J APPL PHYSIOL, V104, P639, DOI 10.1152/japplphysiol.00322.2007; Chang S-S, 2008, ENG MED BIOL SOC 200; Chen TC, 2003, EUR J APPL PHYSIOL, V89, P115, DOI 10.1007/s00421-002-0791-1; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Dartnall TJ, 2008, J NEUROPHYSIOL, V99, P1008, DOI 10.1152/jn.00686.2007; Dartnall TJ, 2011, J NEUROPHYSIOL, V105, P1225, DOI 10.1152/jn.00854.2010; Dartnall TJ, 2009, J NEUROPHYSIOL, V102, P413, DOI 10.1152/jn.91285.2008; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2015, J APPL PHYSIOL, V118, P1084, DOI 10.1152/japplphysiol.00061.2015; De Luca CJ, 2015, J NEUROPHYSIOL, V113, P1941, DOI 10.1152/jn.00555.2014; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2011, J NEUROPHYSIOL, V105, P983, DOI 10.1152/jn.01060.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113, DOI 10.1113/jphysiol.1982.sp014293; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Duclay J, 2008, MED SCI SPORT EXER, V40, P722, DOI 10.1249/MSS.0b013e31816184dc; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2015, J APPL PHYSIOL, V118, P1085, DOI 10.1152/japplphysiol.00107.2015; Farina D, 2011, J NEUROPHYSIOL, V105, P981, DOI 10.1152/jn.00855.2010; Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; GOLDEN CL, 1992, MED SCI SPORT EXER, V24, P926; Goodall S, 2017, ACTA PHYSIOL, V220, P486, DOI 10.1111/apha.12844; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; Herda TJ, 2015, MUSCLE NERVE, V52, P832, DOI 10.1002/mus.24597; Hortobagyi T, 1996, J APPL PHYSIOL, V80, P765, DOI 10.1152/jappl.1996.80.3.765; Howatson G, 2007, EUR J APPL PHYSIOL, V101, P207, DOI 10.1007/s00421-007-0489-5; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026007; Hu XG, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-99; Hu XG, 2013, MUSCLE NERVE, V48, P557, DOI 10.1002/mus.23819; Hu XG, 2013, J NEUROPHYSIOL, V110, P1205, DOI 10.1152/jn.00301.2012; Hubal MJ, 2007, MED SCI SPORT EXER, V39, P461, DOI 10.1249/01.mss.0000247007.19127.da; Kline JC, 2014, J NEUROPHYSIOL, V112, P2718, DOI 10.1152/jn.00724.2013; KOMI PV, 1972, ERGONOMICS, V15, P417, DOI 10.1080/00140137208924444; McHugh MP, 1999, SPORTS MED, V27, P157, DOI 10.2165/00007256-199927030-00002; Merletti R, 2008, J ELECTROMYOGR KINES, V18, P879, DOI 10.1016/j.jelekin.2008.09.002; NARDONE A, 1989, J PHYSIOL-LONDON, V409, P451, DOI 10.1113/jphysiol.1989.sp017507; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; Nosaka K, 2001, MED SCI SPORT EXER, V33, P1490, DOI 10.1097/00005768-200109000-00011; Nosaka K, 2001, EUR J APPL PHYSIOL, V85, P34, DOI 10.1007/s004210100430; Park I, 1999, MEAS PHYS ED EXERC S, V3, P249; Piitulainen H, 2012, SCAND J MED SCI SPOR, V22, P418, DOI 10.1111/j.1600-0838.2010.01228.x; Piitulainen H, 2011, EUR J APPL PHYSIOL, V111, P261, DOI 10.1007/s00421-010-1652-y; Piitulainen H, 2010, J ELECTROMYOGR KINES, V20, P879, DOI 10.1016/j.jelekin.2009.10.001; Starbuck C, 2012, EUR J APPL PHYSIOL, V112, P1005, DOI 10.1007/s00421-011-2053-6; Stock MS, 2012, MUSCLE NERVE, V45, P100, DOI 10.1002/mus.22266; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; Warren GL, 2000, MED SCI SPORT EXER, V32, P820, DOI 10.1097/00005768-200004000-00015; Weerakkody N, 2003, EXP BRAIN RES, V149, P141, DOI 10.1007/s00221-002-1341-0; Ye X, 2015, HUM MOVEMENT SCI, V40, P24, DOI 10.1016/j.humov.2014.11.011	57	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189323	10.1371/journal.pone.0189323	http://dx.doi.org/10.1371/journal.pone.0189323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216288	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800117
J	Klutsch, JG; Shamoun, SF; Erbilgin, N				Klutsch, Jennifer G.; Shamoun, Simon Francis; Erbilgin, Nadir			Drought stress leads to systemic induced susceptibility to a nectrotrophic fungus associated with mountain pine beetle in Pinus banksiana seedlings	PLOS ONE			English	Article							SPRUCE PICEA-ABIES; METHYL JASMONATE; INDUCED RESISTANCE; CLIMATE-CHANGE; NORWAY SPRUCE; BARK BEETLES; MEDIATED INTERACTIONS; DEFENSE RESPONSES; DENDROCTONUS-PONDEROSAE; CHEMICAL DEFENSES	Conifers have complex defense responses to initial attacks by insects and pathogens that can have cascading effects on success of subsequent colonizers. However, drought can affect a plant's ability to respond to biotic agents by potentially altering the resources needed for the energetically costly production of induced defense chemicals. We investigated the impact of reduced water on induced chemical defenses of jack pine (Pinus banksiana) seedlings from initial attack by biotic agents and resistance to subsequent challenge inoculation with a pathogenic fungal associate of mountain pine beetle (Dendroctonus ponderosae), Grosmannia clavigera. Applications of phytohormones (methyl salicylate and methyl jasmonate) and G. clavigera were used for initial induction of defenses. Monoterpene concentrations varied with initial induction from fungal and phytohormone application while watering treatment had no effect. Seedlings treated with G. clavigera and methyl jasmonate had the greatest monoterpene concentrations compared to the control and methyl salicylate-treated seedlings. However, the monoterpene response to the challenge inoculation varied with watering treatments, not with prior induction treatments, with lower monoterpene concentrations in fungal lesions on seedlings in the low to moderate watering treatments compared to normal watering treatment. Furthermore, prior induction from phytohormones resulted in systemic cross-induction of resistance to G. clavigera under normal watering treatment but susceptibility under low watering treatment. Seedlings stressed by low water conditions, which also had lower stomatal conductance than seedlings in the normal watering treatment, likely allocated resources to initial defense response but were left unable to acquire further resources for subsequent responses. Our results demonstrate that drought can affect interactions among tree-infesting organisms through systemic cross-induction of susceptibility.	[Klutsch, Jennifer G.; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Shamoun, Simon Francis] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	University of Alberta; Natural Resources Canada; Canadian Forest Service	Klutsch, JG (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	klutsch@ualberta.ca	Erbilgin, Nadir/F-3675-2014; Shamoun, Simon Francis/K-3003-2015	Erbilgin, Nadir/0000-0001-9912-8095; Shamoun, Simon Francis/0000-0002-5228-9884; Klutsch, Jennifer/0000-0001-8839-972X	Alberta Innovates New Faculty Award; Canada Research Chairs program; NSERC-Discovery; Vanier Canada Graduate Scholarship; Izzak Walton Killam Memorial Scholarship	Alberta Innovates New Faculty Award; Canada Research Chairs program(Canada Research Chairs); NSERC-Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship; Izzak Walton Killam Memorial Scholarship	This work was funded by an Alberta Innovates New Faculty Award, Canada Research Chairs program, and NSERC-Discovery to NE Alberta Innovates Technology Futures, the Vanier Canada Graduate Scholarship, and the Izzak Walton Killam Memorial Scholarship to JGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Arango-Velez A, 2016, PLANT CELL ENVIRON, V39, P726, DOI 10.1111/pce.12615; Arango-Velez A, 2014, TREE PHYSIOL, V34, P1220, DOI 10.1093/treephys/tpt101; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bleiker KP, 2009, MYCOL RES, V113, P3, DOI 10.1016/j.mycres.2008.06.004; Bonello P, 2006, PHYSIOL MOL PLANT P, V68, P95, DOI 10.1016/j.pmpp.2006.12.002; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Bostock RM, 2001, EUR J PLANT PATHOL, V107, P103, DOI 10.1023/A:1008703904253; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Colgan LJ, 2011, ECOL ENTOMOL, V36, P425, DOI 10.1111/j.1365-2311.2011.01283.x; Corcuera L, 2012, TREES-STRUCT FUNCT, V26, P799, DOI 10.1007/s00468-011-0651-x; Creeden EP, 2014, FOREST ECOL MANAG, V312, P239, DOI 10.1016/j.foreco.2013.09.051; CROISE L, 1993, ANN SCI FOREST, V50, P91, DOI 10.1051/forest:19930107; Croteau R., 1975, International Flavours and Food Additives, V6, P292; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Davis JM, 2002, MOL PLANT MICROBE IN, V15, P380, DOI 10.1094/MPMI.2002.15.4.380; Erb M, 2011, NEW PHYTOL, V189, P308, DOI 10.1111/j.1469-8137.2010.03450.x; Erbilgin N, 2006, OECOLOGIA, V148, P426, DOI 10.1007/s00442-006-0394-3; Erbilgin N, 2017, TREE PHYSIOL, V37, P338, DOI 10.1093/treephys/tpw105; Erbilgin N, 2014, PEERJ, V2, DOI 10.7717/peerj.491; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Erbilgin N, 2012, TREE PHYSIOL, V32, P946, DOI 10.1093/treephys/tps047; Eyles A, 2007, OECOLOGIA, V153, P365, DOI 10.1007/s00442-007-0741-z; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; Fischer EM, 2013, NAT CLIM CHANGE, V3, P1033, DOI [10.1038/NCLIMATE2051, 10.1038/nclimate2051]; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Goodsman DW, 2013, NEW PHYTOL, V197, P586, DOI 10.1111/nph.12019; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hudgins JW, 2004, PLANT PHYSIOL, V135, P2134, DOI 10.1104/pp.103.037929; Keefover-Ring K, 2016, J CHEM ECOL, V42, P1, DOI 10.1007/s10886-015-0659-6; Klutsch JG, 2016, OECOLOGIA, V182, P1, DOI 10.1007/s00442-016-3559-8; Klutsch JG, J CHEM ECOL IN PRESS; Kolb TE, 2016, FOREST ECOL MANAG, V380, P321, DOI 10.1016/j.foreco.2016.04.051; Kozlowski G, 1999, PHYSIOL MOL PLANT P, V55, P53, DOI 10.1006/pmpp.1999.0205; Krokene P, 2008, TREE PHYSIOL, V28, P29, DOI 10.1093/treephys/28.1.29; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Llusia J, 1998, CAN J BOT, V76, P1366, DOI 10.1139/cjb-76-8-1366; Lopez-Goldar X, 2016, ENVIRON EXP BOT, V130, P141, DOI 10.1016/j.envexpbot.2016.05.010; Lundborg L, 2016, PHYTOCHEMISTRY, V130, P99, DOI 10.1016/j.phytochem.2016.06.002; Lusebrink I, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00002; Lusebrink I, 2011, J CHEM ECOL, V37, P1013, DOI 10.1007/s10886-011-0008-3; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; Preisler HK, 2012, ECOLOGY, V93, P2421, DOI 10.1890/11-1412.1; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Robinson DA, 2003, VADOSE ZONE J, V2, P444, DOI 10.2113/2.4.444; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Sherwood P, 2016, PHYSIOL MOL PLANT P, V94, P118, DOI 10.1016/j.pmpp.2016.06.002; Sherwood P, 2015, TREE PHYSIOL, V35, P549, DOI 10.1093/treephys/tpv026; Six DL, 2004, SYMBIOSIS, V37, P207; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Tack AJM, 2012, ECOL LETT, V15, P177, DOI 10.1111/j.1461-0248.2011.01724.x; Teskey RO, 1987, TREE PHYSIOL, V3, P41, DOI 10.1093/treephys/3.1.41; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1	66	13	13	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189203	10.1371/journal.pone.0189203	http://dx.doi.org/10.1371/journal.pone.0189203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216258	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800093
J	Lin, CC; Wu, YT; Yang, WC; Tsai, MJ; Liu, JS; Yang, CY; Li, SY; Ou, SM; Tarng, DC; Hsu, CC				Lin, Chih-Ching; Wu, Yu-Te; Yang, Wu-Chang; Tsai, Min-Juei; Liu, Jia-Sin; Yang, Chi-Yu; Li, Szu-Yuan; Ou, Shuo-Ming; Tarng, Der-Cherng; Hsu, Chih-Cheng			Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; DIABETIC-NEPHROPATHY; COMBINATION THERAPY; RENAL-DISEASE; HEMODIALYSIS; ANTAGONIST; BENAZEPRIL; LOSARTAN; OUTCOMES; TRIAL	Dual renin angiotensin system (RAS) blockade using angiotensin-receptor blockers (ARBs) in combination with angiotensin converting enzyme inhibitors (ACEIs) is reported to improve proteinuria in both diabetic and non-diabetic patients. However, its renoprotective effect and safety remain uncertain in patients with advanced chronic kidney disease (CKD). From January 1, 2000 through June 30, 2009, we enrolled 14,117 pre-dialytic stage 5 CKD patients with serum creatinine >6mg/dL and hematocrit <28% under the treatment with erythropoiesis stimulating agents and RAS blockade. We used Cox proportional hazards regression models to estimate the hazard ratios (HRs) against the commencement of long-term dialysis and all-cause mortality for ACEI/ARB users. Over a median follow-up of 7 months, 9,867 patients (69.9%) required long-term dialysis and 2,805 (19.9%) died before progression to end-stage renal disease requiring dialysis. In comparison with the ARB-only users, dual blockade with ACEIs and ARBs was associated with a significantly higher risk of (1) death in all CKD patients (HR = 1.49, [95% CI, 1.30-1.71]; P = 0.02) and in diabetic subgroup (HR = 1.58, [95% CI, 1.34-1.86]; P = 0.02); (2) composite endpoint of long-term dialysis or death in diabetic subgroup (HR = 1.10, [95% CI, 1.01-1.20]; P = 0.04); (3) hyperkalemia-associated hospitalization in non-diabetic subgroup (HR, 2.74, [95% CI, 1.05-7.15]; P = 0.04). However, ACEIs users were associated with higher mortality than ARBs users in all CKD patients (HR = 1.17, [95% CI, 1.07-1.27]; P = 0.03) and in diabetic subgroup (HR = 1.32, [95% CI, 1.18-1.48]; P = 0.03). Monotherapy of RAS blockade, especially ARB, is more effective and safer than dual RAS blockade in pre-dialytic stage 5 CKD patients.	[Lin, Chih-Ching; Yang, Chi-Yu; Li, Szu-Yuan; Ou, Shuo-Ming; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Lin, Chih-Ching; Wu, Yu-Te; Yang, Wu-Chang; Tsai, Min-Juei; Yang, Chi-Yu; Li, Szu-Yuan; Ou, Shuo-Ming; Tarng, Der-Cherng] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wu, Yu-Te] Ho Ho Ho Hlth Manage Syst, Sungho Clin, Taoyuan, Taiwan; [Yang, Wu-Chang] Landseed Hosp, Dept Med, Div Nephrol, Taoyuan, Taiwan; [Tsai, Min-Juei] Chang Hua Hosp, Minist Hlth & Welf, Dept Med, Changhua, Taiwan; [Liu, Jia-Sin; Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; China Medical University Taiwan	Tarng, DC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.; Hsu, CC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Hsu, CC (corresponding author), Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan.	dctarng@vghtpe.gov.tw; cch@nhri.org.tw		Yang, Chih-Yu/0000-0001-9899-3159	Taipei Veterans General Hospital [V102E2-001]; National Science Council [NSC101-2314-6010-024-MY3]; Foundation for Poison Control; Ministry of Science and Technology in Taiwan [MOST 104-2314-B-010 -032 -MY3];  [V101C-188];  [V102C-060];  [V102C-129];  [V103C-043];  [V104C-026];  [V104C-050];  [V105C-075];  [V106C-036]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Foundation for Poison Control; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); ; ; ; ; ; ; ; 	This work was supported by intramural grants (V101C-188, V102C-060, V102C-129, V103C-043, V104C-026, V104C-050, V105C-075, V106C-036) and grants for the Integrated Genome Project (V102E2-001) from Taipei Veterans General Hospital, and the National Science Council (NSC101-2314-6010-024-MY3), Foundation for Poison Control, and the Ministry of Science and Technology (MOST 104-2314-B-010 -032 -MY3) in Taiwan.	An JN, 2012, CRIT CARE, V16, DOI 10.1186/cc11872; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chan KE, 2011, KIDNEY INT, V80, P978, DOI 10.1038/ki.2011.228; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gamboa JL, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0162-x; Gamboa JL, 2012, J AM SOC NEPHROL, V23, P334, DOI 10.1681/ASN.2011030287; Hou FF, 2007, J AM SOC NEPHROL, V18, P1889, DOI 10.1681/ASN.2006121372; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Kim MJ, 2003, YONSEI MED J, V44, P463, DOI 10.3349/ymj.2003.44.3.463; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li SY, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-89; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Ruilope LM, 2000, J HYPERTENS, V18, P89, DOI 10.1097/00004872-200018010-00013; Shikata K, 2013, J DIABETES INVEST, V4, P142, DOI 10.1111/jdi.12050; Song JH, 2003, CLIN NEPHROL, V60, P318; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; URIBARRI J, 1990, Journal of Diabetic Complications, V4, P3, DOI 10.1016/0891-6632(90)90057-C; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	22	10	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189126	10.1371/journal.pone.0189126	http://dx.doi.org/10.1371/journal.pone.0189126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216260	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800078
J	Liou, LS; Chang, CY; Chen, HJ; Tseng, CH; Chen, CY; Sung, FC				Liou, Li-Syue; Chang, Chih-Ya; Chen, Hsuan-Ju; Tseng, Chun-Hung; Chen, Cheng-Yu; Sung, Fung-Chang			Increased risk of peripheral arterial occlusive disease in patients with Bell's palsy using population data	PLOS ONE			English	Article							VIRUS VASCULOPATHY; HIGH PREVALENCE; FACIAL-NERVE; PROGRESSION; BURDEN; STROKE; DNA	Objective This population-based cohort study investigated the risk of developing peripheral arterial occlusive disease (PAOD) in patients with Bell's palsy. Methods We used longitudinal claims data of health insurance of Taiwan to identify 5,152 patients with Bell's palsy newly diagnosed in 2000-2010 and a control cohort of 20,608 patients without Bell's palsy matched by propensity score. Incidence and hazard ratio (HR) of PAOD were assessed by the end of 2013. Results The incidence of PAOD was approximately 1.5 times greater in the Bell's palsy group than in the non-Bell's palsy controls (7.75 vs. 4.99 per 1000 person-years). The Cox proportional hazards regression analysis measured adjusted HR was 1.54 (95% confidence interval (CI) = 1.35-1.76) for the Bell's palsy group compared to the non-Bell's palsy group, after adjusting for sex, age, occupation, income and comorbidities. Men were at higher risk of PAOD than women in the Bell's palsy group, but not in the controls. The incidence of PAOD increased with age in both groups, but the Bell's palsy group to control group HR of PAOD decreased as age increased. The systemic steroid treatment reduced 13% of PAOD hazard for Bell's palsy patients, compared to those without the treatment, but not significant. Conclusions Bell's palsy appears to be associated with an increased risk of developing PAOD. Further pathophysiologic, histopathology and immunologic research is required to explore the underlying biologic mechanism.	[Liou, Li-Syue] Hualien Tzu Chi Hosp, Dept Family Med, Buddhist Tzu Chi Med Fdn, Hualien, Hualien County, Taiwan; [Liou, Li-Syue; Chen, Cheng-Yu] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Family Med, New Taipei, Taiwan; [Liou, Li-Syue] TriServ Gen Hosp, Dept Family & Community Med, Taipei, Taiwan; [Liou, Li-Syue; Chang, Chih-Ya] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chang, Chih-Ya] TriServ Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Hsuan-Ju; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Sch Med, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	fcsung1008@yahoo.com	chihya, Chang/AAI-6537-2021		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Financial Disclosure This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.; The authors thank Dr. Jih-I Yeh, Dr. Shinn-Zong Lin, and Professor Jon-Son Kuo for their feedback regarding the manuscript drafts. This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	BENDITT EP, 1983, P NATL ACAD SCI-BIOL, V80, P6386, DOI 10.1073/pnas.80.20.6386; Brevetti G, 2008, J CARDIOVASC MED, V9, P382, DOI 10.2459/JCM.0b013e3282f03b90; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; Elkind Mitchell S. V., 2010, Infectious Disorders - Drug Targets, V10, P84; Espinola-Klein C, 2002, STROKE, V33, P2581, DOI 10.1161/01.STR.0000034789.82859.A4; Fabricant C, 1983, FEDERATION P; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; FURUTA Y, 1992, ACTA NEUROPATHOL, V84, P39, DOI 10.1007/BF00427213; Furuta Y, 2000, CLIN INFECT DIS, V30, P529, DOI 10.1086/313721; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Greco A, 2012, AUTOIMMUN REV, V12, P323, DOI 10.1016/j.autrev.2012.05.008; Hiramoto JS, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000651; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Holland J, 2008, CLIN EVIDENCE, V2008; Holland NJ, 2004, BMJ-BRIT MED J, V329, P553, DOI 10.1136/bmj.329.7465.553; Jackson CG, 1999, MED CLIN N AM, V83, P179, DOI 10.1016/S0025-7125(05)70096-1; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Lee CC, 2013, EUR J NEUROL, V20, P616, DOI 10.1111/j.1468-1331.2012.03765.x; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; Nagel MA, 2011, NEUROLOGY, V77, P364, DOI 10.1212/WNL.0b013e3182267bfa; Nagel M. A., 2010, Infectious Disorders - Drug Targets, V10, P105; Novo S, 2002, DIABETES OBES METAB, V4, pS1, DOI 10.1046/j.1463-1326.2002.0040s20s1.x; Peitersen E, 2002, ACTA OTO-LARYNGOL, V122, P4, DOI 10.1080/000164802320401694; Powers JF, 2005, AM J CLIN PATHOL, V123, P261, DOI 10.1309/2996TT2CTLTKN0KT; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shi Y, 2002, PATHOL INT, V52, P31, DOI 10.1046/j.1440-1827.2002.01312.x; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; Zandian A, 2014, MED SCI MONITOR, V20, P83, DOI 10.12659/MSM.889876; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188982	10.1371/journal.pone.0188982	http://dx.doi.org/10.1371/journal.pone.0188982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216223	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800054
J	Lucas, KN; Dabiri, JO; Lauder, GV				Lucas, Kelsey N.; Dabiri, John O.; Lauder, George V.			A pressure-based force and torque prediction technique for the study of fish-like swimming	PLOS ONE			English	Article							UNDULATORY LOCOMOTION; BODY STIFFNESS; WAKE; FIELDS; KINEMATICS; SPEED; HYDRODYNAMICS; PERFORMANCE; MORPHOLOGY; DYNAMICS	Many outstanding questions about the evolution and function of fish morphology are linked to swimming dynamics, and a detailed knowledge of time-varying forces and torques along the animal's body is a key component in answering many of these questions. Yet, quantifying these forces and torques experimentally represents a major challenge that to date prevents a full understanding of fish-like swimming. Here, we develop a method for obtaining these force and torque data non-invasively using standard 2D digital particle image velocimetry in conjunction with a pressure field algorithm. We use a mechanical flapping foil apparatus to model fish-like swimming and measure forces and torques directly with a load cell, and compare these measured values to those estimated simultaneously using our pressure-based approach. We demonstrate that, when out-of-plane flows are relatively small compared to the planar flow, and when pressure effects sufficiently dominate shear effects, this technique is able to accurately reproduce the shape, magnitude, and timing of locomotor forces and torques experienced by a fish-like swimmer. We conclude by exploring of the limits of this approach and its feasibility in the study of freely-swimming fishes.	[Lucas, Kelsey N.; Lauder, George V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Dabiri, John O.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Dabiri, John O.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Harvard University; Stanford University; Stanford University	Lucas, KN (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	kelsey.n.lucas@gmail.com			National Science Foundation [DGE-1144152]; Harvard University; Office of Naval Research Multi-University Research Initiative [N000141410533]	National Science Foundation(National Science Foundation (NSF)); Harvard University; Office of Naval Research Multi-University Research Initiative	This work was supported by a National Science Foundation Graduate Research Fellowship under grant DGE-1144152 and a Harvard University Chapman Fellowship to KNL and by the Office of Naval Research Multi-University Research Initiative Grant N000141410533 monitored by Dr. Bob Brizzolara to GVL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a National Science Foundation Graduate Research Fellowship under grant DGE-1144152 and a Harvard University Chapman Fellowship to KNL and by the Office of Naval Research Multi-University Research Initiative Grant N000141410533 monitored by Dr. Bob Brizzolara to GVL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thanks to Francis Carr, Ryan Feather, Patrick Thornycroft, Brad Gemmell, and Eric Tytell for technical assistance, and to Iman Borazjani, Kara Feilich, Elena Kramer, and Pete Girguis for helpful discussions. We also thank Eric Tytell, Sean Colin, and the anonymous reviewers for their feedback on earlier versions of this manuscript. The authors declare that no competing interests exist.	Akanyeti O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11044; Akanyeti O, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026001; Alben S, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4709477; Bale R., 2014, SCI REP-UK, V4, P1; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Dabiri JO, 2005, J EXP BIOL, V208, P3519, DOI 10.1242/jeb.01813; Dabiri JO, 2014, J EXP BIOL, V217, P331, DOI 10.1242/jeb.092767; de Kat R, 2012, EXP FLUIDS, V52, P1089, DOI 10.1007/s00348-011-1237-5; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Domenici P., 2009, FISH LOCOMOTION ECO; Donley JM, 2000, J EXP BIOL, V203, P3103; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2000, J EXP BIOL, V203, P2379; DUBOIS AB, 1974, J EXP BIOL, V60, P581; Feilich KL, 2016, EVOLUTION, V70, P2247, DOI 10.1111/evo.13021; Feilich KL, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/3/036002; Gemmell BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9790; Hefetz D., 1999, 3 INT WORKSH PART IM, P671; JAYNE BC, 1995, J EXP BIOL, V198, P585; Lamb H., 1945, HYDRODYNAMICS; Laskari A, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2129-5; Lauder GV, 2011, MAR TECHNOL SOC J, V45, P41, DOI 10.4031/MTSJ.45.4.8; Lauder GV, 2002, NEWS PHYSIOL SCI, V17, P235, DOI 10.1152/nips.01398.2002; LIGHTHILL MJ, 1969, ANNU REV FLUID MECH, V1, P413, DOI 10.1146/annurev.fl.01.010169.002213; Liu XF, 2006, EXP FLUIDS, V41, P227, DOI 10.1007/s00348-006-0152-7; Long JH, 1998, AM ZOOL, V38, P771; Lucas KN, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056019; Lucas KN, 2014, NAT COMMUN, P5; MCHENRY MJ, 1995, J EXP BIOL, V198, P2293; Muller UK, 1997, J EXP BIOL, V200, P2893; Muller UK, 2001, J EXP BIOL, V204, P2751; Noca F, 1997, J FLUID STRUCT, V11, P345, DOI 10.1006/jfls.1997.0081; Pritchard P.J., 2011, FOX MCDONALDS INTRO; Quinn DB, 2015, J FLUID MECH, V767, P430, DOI 10.1017/jfm.2015.35; Quinn DB, 2014, J FLUID MECH, V738, P250, DOI 10.1017/jfm.2013.597; Rosic MLN, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa5113; Schlueter-Kuck K, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.012501; Shelton RM, 2014, J EXP BIOL, V217, P2110, DOI 10.1242/jeb.098046; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283; Standen EM, 2007, J EXP BIOL, V210, P325, DOI 10.1242/jeb.02661; Tytell ED, 2004, J EXP BIOL, V207, P3265, DOI 10.1242/jeb.01139; Tytell ED, 2010, P NATL ACAD SCI USA, V107, P19832, DOI 10.1073/pnas.1011564107; Usherwood JR, 2005, J EXP BIOL, V208, P355, DOI 10.1242/jeb.01359; van Oudheusden BW, 2007, EXP FLUIDS, V43, P153, DOI 10.1007/s00348-007-0261-y; van Oudheusden BW, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/3/032001; Vogel S., 1994, LIFE MOVING FLUIDS P; Wang ZY, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2189-6; Webb PW, 2015, INTEGR COMP BIOL, V55, P753, DOI 10.1093/icb/icv053; WEBB PW, 1984, AM ZOOL, V24, P107; Weihs D., 1983, P339; White F., 2005, VISCOUS FLUID FLOW; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yates G.T., 1983, P177; Zar JH., 2010, BIOSTAT ANAL, V5th	56	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189225	10.1371/journal.pone.0189225	http://dx.doi.org/10.1371/journal.pone.0189225			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216264	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000417337800100
J	Bon, N; Couasnay, G; Bourgine, A; Sourice, S; Beck-Cormier, S; Guicheux, J; Beck, L				Bon, Nina; Couasnay, Greig; Bourgine, Annabelle; Sourice, Sophie; Beck-Cormier, Sarah; Guicheux, Jerome; Beck, Laurent			Phosphate (P-i)-regulated heterodimerization of the high-affinity sodium-dependent P-i transporters PiT1/Slc20a1 and PiT2/Slc20a2 underlies extracellular P-i sensing independently of P-i uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); bone; cartilage; extracellular-signal-regulated kinase (ERK); signaling; PiT1; PiT2; membrane transporters; phosphate sensing	APE LEUKEMIA-VIRUS; INORGANIC-PHOSPHATE; GENE-EXPRESSION; CELL-SURFACE; HYPERTROPHIC CHONDROCYTES; RETROVIRAL RECEPTOR; RAF/MEK/ERK PATHWAY; INDUCED APOPTOSIS; MESSENGER-RNA; OSTEOBLAST	Extracellular phosphate (P-i) can act as a signaling molecule that directly alters gene expression and cellular physiology. The ability of cells or organisms to detect changes in extracellular P-i levels implies the existence of a P-i-sensing mechanism that signals to the body or individual cell. However, unlike in prokaryotes, yeasts, and plants, the molecular players involved in P-i sensing in mammals remain unknown. In this study, we investigated the involvement of the high-affinity, sodium-dependent P-i transporters PiT1 and PiT2 in mediating P-i signaling in skeletal cells. We found that deletion of PiT1 or PiT2 blunted the P-i-dependent ERK1/2-mediated phosphorylation and subsequent gene up-regulation of the mineralization inhibitors matrix Gla protein and osteopontin. This result suggested that both PiTs are necessary for P-i signaling. Moreover, the ERK1/2 phosphorylation could be rescued by overexpressing P-i transport-deficient PiT mutants. Using cross-linking and bioluminescence resonance energy transfer approaches, we found that PiT1 and PiT2 form high-abundance homodimers and P-i-regulated low-abundance heterodimers. Interestingly, in the absence of sodium-dependent P-i transport activity, the PiT1-PiT2 heterodimerization was still regulated by extracellular P-i levels. Of note, when two putative P-i-binding residues, Ser-128 (in PiT1) and Ser-113 (in PiT2), were substituted with alanine, the PiT1-PiT2 heterodimerization was no longer regulated by extracellular P-i. These observations suggested that P-i binding rather than P-i uptake may be the key factor in mediating P-i signaling through the PiT proteins. Taken together, these results demonstrate that P-i-regulated PiT1-PiT2 heterodimerization mediates P-i sensing independently of P-i uptake.	[Bon, Nina; Couasnay, Greig; Bourgine, Annabelle; Sourice, Sophie; Beck-Cormier, Sarah; Guicheux, Jerome; Beck, Laurent] INSERM, RMeS Regenerat Med & Skeleton, STEP Team Skeletal Physiopathol & Joint Regenerat, U1229, F-44042 Nantes, France; [Bon, Nina; Couasnay, Greig; Bourgine, Annabelle; Sourice, Sophie; Beck-Cormier, Sarah; Guicheux, Jerome; Beck, Laurent] Univ Nantes, RMeS, UFR Odontol, UMR S 1229, F-44042 Nantes, France; [Guicheux, Jerome] CHU Nantes, PHU OTONN 4, F-44042 Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Nantes Universite; CHU de Nantes	Beck, L (corresponding author), INSERM, Fac Chirurg Dent, RMeS, U1229, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.	laurent.beck@inserm.fr	Couasnay, Greig/CAG-1588-2022; Beck-Cormier, Sarah/P-3091-2014; BECK, Laurent/P-2952-2014; guicheux, Jerome/F-7767-2013	Beck-Cormier, Sarah/0000-0001-5258-1933; BECK, Laurent/0000-0002-6730-2762; guicheux, Jerome/0000-0003-2754-3024; couasnay, greig/0000-0002-8190-7178	Region des Pays de la Loire (SENSEO); University of Nantes; Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique); Region des Pays de la Loire (BIOREGOS); INSERM; INSERM, Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique and SENSEO) [CIMATH 2]	Region des Pays de la Loire (SENSEO); University of Nantes; Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique); Region des Pays de la Loire (BIOREGOS); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM, Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique and SENSEO)	This work was supported by in part grants from INSERM, Region des Pays de la Loire (CIMATH 2, Nouvelle Equipe/Nouvelle Thematique and SENSEO). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from Region des Pays de la Loire (SENSEO) and University of Nantes.; Recipient of a fellowship from Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique) and University of Nantes.; Recipient of a fellowship from Region des Pays de la Loire (BIOREGOS) and INSERM.	Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; BERNER YN, 1988, ANNU REV NUTR, V8, P121, DOI 10.1146/annurev.nu.08.070188.001005; Bottger P, 2005, FEBS J, V272, P3060, DOI 10.1111/j.1742-4658.2005.04720.x; Bottger P, 2004, J VIROL, V78, P9564, DOI 10.1128/JVI.78.17.9564-9567.2004; Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Bottger P, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-21; Bourgine A, 2011, ARCH ORAL BIOL, V56, P977, DOI 10.1016/j.archoralbio.2011.03.001; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Chavkin NW, 2015, EXP CELL RES, V333, P39, DOI 10.1016/j.yexcr.2015.02.002; Chien ML, 1998, VIROLOGY, V240, P109, DOI 10.1006/viro.1997.8933; Chien ML, 1997, J VIROL, V71, P4564, DOI 10.1128/JVI.71.6.4564-4570.1997; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Farrell KB, 2009, J BIOL CHEM, V284, P29979, DOI 10.1074/jbc.M109.022566; Forand A, 2016, CELL REP, V16, P2736, DOI 10.1016/j.celrep.2016.08.012; Forand A, 2013, BLOOD, V121, P666, DOI 10.1182/blood-2012-05-427302; Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]; Kanatan M, 2003, J CELL PHYSIOL, V196, P180, DOI 10.1002/jcp.10270; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Klahr S, 1980, Adv Cyclic Nucleotide Res, V13, P133; KNOCHEL JP, 1977, ARCH INTERN MED, V137, P203, DOI 10.1001/archinte.137.2.203; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Kumar R, 2009, CURR OPIN NEPHROL HY, V18, P281, DOI 10.1097/MNH.0b013e32832b5094; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundquist Patrik, 2002, Swed Dent J Suppl, P1; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Marshall RW, 1976, CALCIUM PHOSPHATE MA, P162; Michigami T, 2013, CONTRIB NEPHROL, V180, P14, DOI 10.1159/000346776; Miedlich SU, 2010, J BIOL CHEM, V285, P18270, DOI 10.1074/jbc.M109.098616; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; Miyamoto K, 1999, NEPHROL DIAL TRANSPL, V14, P73, DOI 10.1093/ndt/14.suppl_1.73; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Naviglio S, 2006, J CELL BIOCHEM, V98, P1584, DOI 10.1002/jcb.20892; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Qi WJ, 2016, BIOCHEM SOC T, V44, P766, DOI 10.1042/BST20160026; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Salaun C, 2010, J BIOL CHEM, V285, P34408, DOI 10.1074/jbc.M110.130989; Salaun C, 2004, J MOL BIOL, V340, P39, DOI 10.1016/j.jmb.2004.04.050; Salaun C, 2002, J VIROL, V76, P4304, DOI 10.1128/JVI.76.9.4304-4311.2002; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5; Silver J, 2003, CURR OPIN NEPHROL HY, V12, P357, DOI 10.1097/00041552-200307000-00003; Takeyama S, 2001, BIOCHEM BIOPH RES CO, V282, P798, DOI 10.1006/bbrc.2001.4652; Teixeira CC, 2001, AM J PHYSIOL-CELL PH, V281, pC833, DOI 10.1152/ajpcell.2001.281.3.C833; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; WALSER M, 1961, J CLIN INVEST, V40, P723, DOI 10.1172/JCI104306; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zoidis E, 2004, J ENDOCRINOL, V181, P531, DOI 10.1677/joe.0.1810531	71	55	55	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2102	2114		10.1074/jbc.M117.807339	http://dx.doi.org/10.1074/jbc.M117.807339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29233890	Green Published, hybrid			2022-12-26	WOS:000424948000022
J	Magi, S; Iwamoto, K; Yumoto, N; Hiroshima, M; Nagashima, T; Ohki, R; Garcia-Munoz, A; Volinsky, N; Von Kriegsheim, A; Sako, Y; Takahashi, K; Kimura, S; Kholodenko, BN; Okada-Hatakeyama, M				Magi, Shigeyuki; Iwamoto, Kazunari; Yumoto, Noriko; Hiroshima, Michio; Nagashima, Takeshi; Ohki, Rieko; Garcia-Munoz, Amaya; Volinsky, Natalia; Von Kriegsheim, Alexander; Sako, Yasushi; Takahashi, Koichi; Kimura, Shuhei; Kholodenko, Boris N.; Okada-Hatakeyama, Mariko			Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; mathematical modeling; oligomerization; receptor tyrosine kinase; signal transduction	GROWTH-FACTOR RECEPTOR; BREAST-CANCER; NEGATIVE FEEDBACK; CELL-DIFFERENTIATION; EPITHELIAL-CELLS; DOWN-REGULATION; PROTEIN; KINASE; ACTIVATION; EXPRESSION	Feedback control is a key mechanism in signal transduction, intimately involved in regulating the outcome of the cellular response. Here, we report a novel mechanism by which PHLDA1, Pleckstrin homology-like domain, family A, member 1, negatively regulates ErbB receptor signaling by inhibition of receptor oligomerization. We have found that the ErbB3 ligand, heregulin, induces PHILDA1 expression in MCF-7 cells. Transcriptionally-induced PHLDA1 protein directly binds to ErbB3, whereas knockdown of PHLDA1 increases complex formation between ErbB3 and ErbB2. To provide insight into the mechanism for our time-course and single-cell experimental observations, we performed a systematic computational search of network topologies of the mathematical models based on receptor dimer-tetramer formation in the ErbB activation processes. Our results indicate that only a model in which PHLDA1 inhibits formation of both dimers and tetramer can explain the experimental data. Predictions made from this model were further validated by single-molecule imaging experiments. Our studies suggest a unique regulatory feature of PHLDA1 to inhibit the ErbB receptor oligomerization process and thereby control the activity of receptor signaling network.	[Magi, Shigeyuki; Iwamoto, Kazunari; Yumoto, Noriko; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Magi, Shigeyuki; Iwamoto, Kazunari; Okada-Hatakeyama, Mariko] Osaka Univ, Inst Prot Res, Lab Cell Syst, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Iwamoto, Kazunari; Takahashi, Koichi] RIKEN Quantitat Biol Ctr QBiC, Lab Biochem Simulat, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan; [Hiroshima, Michio] RIKEN Quantitat Biol Ctr QBiC, Lab Cell Signaling Dynam, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan; [Hiroshima, Michio; Sako, Yasushi] RIKEN Adv Sci Inst, Cellular Informat Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Nagashima, Takeshi] Tohoku Univ, Div Cell Proliferat, United Ctr Adv Res & Translat Med, Grad Sch Med,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Ohki, Rieko] Natl Canc Ctr, Res Inst, Div Rare Canc Res, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan; [Garcia-Munoz, Amaya; Volinsky, Natalia; Von Kriegsheim, Alexander; Kholodenko, Boris N.] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Kholodenko, Boris N.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Kholodenko, Boris N.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Kimura, Shuhei] Tottori Univ, Grad Sch Engn, 4-101 Koyama Minami, Tottori 6808552, Japan	RIKEN; Osaka University; RIKEN; RIKEN; RIKEN; Tohoku University; National Cancer Center - Japan; University College Dublin; University College Dublin; University College Dublin; Tottori University	Okada-Hatakeyama, M (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Okada-Hatakeyama, M (corresponding author), Osaka Univ, Inst Prot Res, Lab Cell Syst, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.	boris.kholodenko@ucd.ie; mokada@protein.osaka-u.ac.jp	Admin, SBI/HGB-2738-2022; von Kriegsheim, Alex/C-2371-2016	Iwamoto, Kazunari/0000-0001-9794-9420; von Kriegsheim, Alex/0000-0002-4952-8573	JSPS KAKENHI [15KT0084]; RIKEN Epigenome and Single Cell Project Grants; Cooperative Research Program of Institute for Protein Research, Osaka University [CRa-17-01]; Nagase Science Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT SPIRE Supercomputational Life Science; European Union FP7 SynSignal [613879]; European Union H2020 SmartNanoTox [686098]; Grants-in-Aid for Scientific Research [16K21624] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Epigenome and Single Cell Project Grants; Cooperative Research Program of Institute for Protein Research, Osaka University; Nagase Science Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT SPIRE Supercomputational Life Science; European Union FP7 SynSignal; European Union H2020 SmartNanoTox; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work supported in part by JSPS KAKENHI Grant 15KT0084, RIKEN Epigenome and Single Cell Project Grants, the Cooperative Research Program of Institute for Protein Research, Osaka University Grant CRa-17-01, Nagase Science Technology Foundation, and Astellas Foundation for Research on Metabolic Disorders (to M. O.-H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by MEXT SPIRE Supercomputational Life Science.; Supported by European Union FP7 SynSignal Grant 613879 and European Union H2020 SmartNanoTox Grant 686098. To whom correspondence may be addressed. E-mail: boris.kholodenko@ucd.ie.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Basseri S, 2013, DIABETES, V62, P158, DOI 10.2337/db12-0256; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dunn EF, 2011, J VIROL, V85, P422, DOI 10.1128/JVI.01671-10; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Furuuchi K, 2007, J IMMUNOL, V178, P1021, DOI 10.4049/jimmunol.178.2.1021; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hiroshima M, 2012, P NATL ACAD SCI USA, V109, P13984, DOI 10.1073/pnas.1200464109; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; Johnson EO, 2011, J CELL SCI, V124, P2711, DOI 10.1242/jcs.084970; Karamouzis MV, 2016, ONCOTARGET, V7, P5576, DOI 10.18632/oncotarget.6762; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kastrati I, 2015, ONCOGENE, V34, P2309, DOI 10.1038/onc.2014.180; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kimura S., 2011, SICE J CONTROL MEASU, V4, P105, DOI DOI 10.9746/JCMSI.4.105-4889; Li GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106349; Li JN, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.61; Mina M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11999; Moad AIH, 2013, CELL BIOCHEM BIOPHYS, V66, P567, DOI 10.1007/s12013-012-9504-5; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Nagai MA, 2007, BREAST CANCER RES TR, V106, P49, DOI 10.1007/s10549-006-9475-6; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nagashima T, 2015, FEBS J, V282, P613, DOI 10.1111/febs.13172; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Neef R, 2002, CANCER RES, V62, P5920; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Park ES, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.67; Pryor MM, 2015, MOL BIOL CELL, V26, P4109, DOI 10.1091/mbc.E14-06-1114; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033041; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Volinsky N, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140172; Wang Xiaoqi, 2018, Oncotarget, V9, P24914, DOI 10.18632/oncotarget.3674; Webb SED, 2008, BIOPHYS J, V94, P803, DOI 10.1529/biophysj.107.112623; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041613	52	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2206	2218		10.1074/jbc.M117.778399	http://dx.doi.org/10.1074/jbc.M117.778399			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29233889	Green Published, hybrid			2022-12-26	WOS:000424948000031
J	Attar, R; Johansen, MB; Valentin, JB; Aagaard, J; Jensen, SE				Attar, Rubina; Johansen, Martin Berg; Valentin, Jan Brink; Aagaard, Jorgen; Jensen, Svend Eggert			Treatment following myocardial infarction in patients with schizophrenia	PLOS ONE			English	Article							BIPOLAR AFFECTIVE-DISORDER; SEVERE MENTAL-ILLNESS; CARDIOVASCULAR RISK; MORTALITY-RATES; LIFE EXPECTANCY; BASE-LINE; CARE; REVASCULARIZATION; REGISTER; PEOPLE	Background A correlation between excess mortality from myocardial infarctions (MI) and schizophrenia has already been established. What remains unclear is whether the initial communication between the treating doctor and the corresponding patient contributes to this excess mortality. Aim The aim of this study is to investigate whether a patient with schizophrenia receives the same offers for examination and treatment following a MI compared to a psychiatric healthy control (PHC). Methods This cohort study includes patients diagnosed with schizophrenia at the time of their first MI (n = 47) in the years between 1995-2015 matched 1: 2 to psychiatric healthy MI patients on gender, age and year of first MI. All existing hospital files for the 141 patients were thoroughly reviewed and the number of offered and accepted examinations and treatments were extracted for comparisons between the two groups. Results In general patients with schizophrenia were less likely to be offered and accept examination and at the same time be offered and accept treatment as compared to PHCs (p< 0.01). In addition, there was a statistical trend towards patients with schizophrenia being more likely to decline examination (p = 0.10) and decline treatment (p = 0.09) compared to PHCs, while being offered examination and being offered treatment both contributed statistically insignificantly to the overall discrepancy between the two patient groups. Conclusions Being diagnosed with schizophrenia limits the treatment received following a first MI compared to PHCs. However, we are unable to pinpoint, whether Physician bias, patient's unwillingness to receive health care or both contribute to the excess mortality seen in these comorbid patients.	[Attar, Rubina; Johansen, Martin Berg; Jensen, Svend Eggert] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Attar, Rubina; Jensen, Svend Eggert] Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark; [Johansen, Martin Berg] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Valentin, Jan Brink; Aagaard, Jorgen] Aalborg Univ Hosp, Dept Psychiat, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Attar, R (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.; Attar, R (corresponding author), Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark.	r.attar@rn.dk	Valentin, Jan Brink/ABF-8892-2020; Johansen, Martin Nygård/L-6845-2014	Valentin, Jan Brink/0000-0002-8205-7179; Johansen, Martin Nygård/0000-0001-9790-0985; Attar, Rubina/0000-0003-1009-4189				Azad MC, 2016, ASIAN J PSYCHIATR, V19, P28, DOI 10.1016/j.ajp.2015.11.012; Boden R, 2015, J INTERN MED, V277, P727, DOI 10.1111/joim.12329; Bowie Christopher R, 2006, Neuropsychiatr Dis Treat, V2, P531, DOI 10.2147/nedt.2006.2.4.531; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buckley PF, 2007, CNS DRUGS, V21, P129, DOI 10.2165/00023210-200721020-00004; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; Correll CU, 2014, JAMA PSYCHIAT, V71, P1350, DOI 10.1001/jamapsychiatry.2014.1314; Corrigan PW, 2012, PSYCHIAT RES, V199, P65, DOI 10.1016/j.psychres.2012.04.009; Corrigan PW, 2004, SCHIZOPHRENIA BULL, V30, P481, DOI 10.1093/oxfordjournals.schbul.a007096; Curkendall SM, 2004, J CLIN PSYCHIAT, V65, P715; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P565, DOI 10.1001/archpsyc.58.6.565; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Laursen TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067133; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Laursen TM, 2011, J PSYCHIATR RES, V45, P29, DOI 10.1016/j.jpsychires.2010.04.027; Laursen TM, 2009, ARCH GEN PSYCHIAT, V66, P713, DOI 10.1001/archgenpsychiatry.2009.61; Lawford BR, 2016, CAN J PSYCHIAT; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P534, DOI 10.1192/bjp.183.6.534; Mitchell AJ, 2011, BRIT J PSYCHIAT, V198, P434, DOI 10.1192/bjp.bp.109.076950; Mitchell AJ, 2010, J PSYCHOPHARMACOL, V24, P69, DOI 10.1177/1359786810382056; Munk-Jorgensen P, 2000, ACTA PSYCHIAT SCAND, V102, P96, DOI 10.1034/j.1600-0447.2000.00019.x; Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026; Nielsen J, 2015, ACTA NEUROPSYCHIATR, V27, P106, DOI 10.1017/neu.2014.41; Nielsen RE, 2013, SCHIZOPHR RES, V146, P22, DOI DOI 10.1016/J.SCHRES.2013.02.025; Noblett JE, 2015, INT J PSYCHIAT MED, V50, P370, DOI 10.1177/0091217415612721; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perez-Pinar M, 2016, EUR PSYCHIAT, V35, P8, DOI 10.1016/j.eurpsy.2016.02.004; Petersen LA, 2003, HEALTH SERV RES, V38, P41, DOI 10.1111/1475-6773.00104; Sado J, 2016, ENV HLTH PREV MED, P1; Sarkar S, 2015, WORLD J PSYCHIATR, V5, P352, DOI 10.5498/wjp.v5.i4.352; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Wu SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134763; Wu SI, 2013, PSYCHOSOM MED, V75, P52, DOI 10.1097/PSY.0b013e31827612a6	38	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189289	10.1371/journal.pone.0189289	http://dx.doi.org/10.1371/journal.pone.0189289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236730	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100054
J	D'Almeida, M; Attik, N; Amalric, J; Brunon, C; Renaud, F; Abouelleil, H; Toury, B; Grosgogeat, B				D'Almeida, Melanie; Attik, Nina; Amalric, Julien; Brunon, Celine; Renaud, Francois; Abouelleil, Hazem; Toury, Berangere; Grosgogeat, Brigitte			Chitosan coating as an antibacterial surface for biomedical applications	PLOS ONE			English	Article							BACTERIAL ADHESION; PHYSICOCHEMICAL PROPERTIES; TITANIUM SURFACES; GRAFTED CHITOSAN; IMPLANT; CHITIN; TISSUE; RESISTANCE; SCAFFOLDS	Background and objectives A current public health issue is preventing post-surgical complications by designing antibacterial implants. To achieve this goal, in this study we evaluated the antibacterial activity of an animal-free chitosan grafted onto a titanium alloy. Methods Animal-free chitosan binding on the substrate was performed by covalent link via a two-step process using TriEthoxySilylPropyl Succinic Anhydride (TESPSA) as the coupling agent. All grafting steps were studied and validated by means of X-ray Photoelectron Spectroscopy (XPS), Time-of-Flight secondary ion mass spectrometry (ToF-SIMS) analyses and Dynamic-mode Secondary Ion Mass Spectrometry (DSIMS). The antibacterial activity against Escherichia coli and Staphylococcus aureus strains of the developed coating was assessed using the number of colony forming units (CFU). Results XPS showed a significant increase in the C and N atomic percentages assigned to the presence of chitosan. A thick layer of polymer deposit was detected by ToF-SIMS and the results obtained by DSIMS measurements are in agreement with ToF-SIMS and XPS analyses and confirms that the coating synthesis was a success. The developed coating was active against both gram negative and gram positive tested bacteria. Conclusion The success of the chitosan immobilization was proven using the surface characterization techniques applied in this study. The coating was found to be effective against Escherichia coli and Staphylococcus aureus strains.	[D'Almeida, Melanie; Attik, Nina; Abouelleil, Hazem; Toury, Berangere; Grosgogeat, Brigitte] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, Lab Multimat & Interfaces, Villeurbanne, France; [Attik, Nina; Abouelleil, Hazem; Grosgogeat, Brigitte] Univ Claude Bernard Lyon 1, Univ Lyon, UFR Odontol, Lyon, France; [Amalric, Julien; Brunon, Celine] Sci & Surface, Ecully, France; [Renaud, Francois] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, MATEIS,UMR 5510, Villeurbanne, France; [Grosgogeat, Brigitte] Hosp Civils Lyon, Serv Traitements & Consultat Dentaires, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Attik, N (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, Lab Multimat & Interfaces, Villeurbanne, France.; Attik, N (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, UFR Odontol, Lyon, France.	nina.attik@univ-lyon1.fr	GROSGOGEAT, Brigitte/AAE-2810-2019	GROSGOGEAT, Brigitte/0000-0003-2194-7300	Rhone-Alpes Region; DGCIS; FEDER; Global D; Fonds Unique Interministeriel program through the research project "Plastipolis"	Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); DGCIS; FEDER(European Commission); Global D; Fonds Unique Interministeriel program through the research project "Plastipolis"	This work was partially supported by the Rhone-Alpes Region, DGCIS, FEDER, Global D and the Fonds Unique Interministeriel program through the research project "Plastipolis".	Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008; [Anonymous], ISO221962007; Vazquez JA, 2013, MAR DRUGS, V11, P747, DOI 10.3390/md11030747; Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034; Behera SS, 2017, INT J BIOL MACROMOL, V98, P329, DOI 10.1016/j.ijbiomac.2017.02.017; Campos DM, 2015, ODONTOLOGY, V103, P210, DOI 10.1007/s10266-014-0162-5; Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897; Cordeiro JM, 2017, DENT MATER, V33, P1244, DOI 10.1016/j.dental.2017.07.013; D'Almeida M, 2015, APPL SURF SCI, V327, P296, DOI 10.1016/j.apsusc.2014.11.185; Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001; Deepthi S, 2016, INT J BIOL MACROMOL, V93, P1338, DOI 10.1016/j.ijbiomac.2016.03.041; Ferraris S, 2014, APPL SURF SCI, V311, P279, DOI 10.1016/j.apsusc.2014.05.056; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gilabert-Chirivella E, 2017, PROG ORG COAT, V111, P23, DOI 10.1016/j.porgcoat.2017.04.027; Godoy-Gallardo M, 2016, MAT SCI ENG C-MATER, V59, P524, DOI 10.1016/j.msec.2015.10.051; Grolik M, 2012, J MATER SCI-MATER M, V23, P1991, DOI 10.1007/s10856-012-4666-7; Gunda NSK, 2014, APPL SURF SCI, V305, P522, DOI 10.1016/j.apsusc.2014.03.130; Hequet A, 2011, COLLOID SURFACE B, V84, P301, DOI 10.1016/j.colsurfb.2011.01.012; Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009; Jiang T, 2014, NATURAL AND SYNTHETIC BIOMEDICAL POLYMERS, P91; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Kumirska J, 2011, POLYMERS-BASEL, V3, P1875, DOI 10.3390/polym3041875; Ma KN, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201600130; Marie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050326; Martin HJ, 2007, LANGMUIR, V23, P6645, DOI 10.1021/la063284v; McArthur S. L., 2014, SURFACE ANAL TECHNIQ, P9, DOI DOI 10.1007/978-3-319-01360-2_2; Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043; Mishnaevsky L, 2014, MAT SCI ENG R, V81, P1, DOI 10.1016/j.mser.2014.04.002; Perez-Anes A, 2015, ACS APPL MATER INTER, V7, P12882, DOI 10.1021/acsami.5b02402; Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x; Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367; Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648; Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441; Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q; Tejero R, 2014, PROG POLYM SCI, V39, P1406, DOI 10.1016/j.progpolymsci.2014.01.001; Tian YX, 2014, ACTA BIOMATER, V10, P4505, DOI 10.1016/j.actbio.2014.06.002; Toury B, 2013, Patent No. [WO2013110887 A1, 2013110887]; Wang ZL, 2014, CARBOHYD POLYM, V103, P38, DOI 10.1016/j.carbpol.2013.12.007; Xie YN, 2016, MATER LETT, V176, P74, DOI 10.1016/j.matlet.2016.04.076; Xu XF, 2011, APPL SURF SCI, V257, P10520, DOI 10.1016/j.apsusc.2011.07.033; Yeo IS, 2012, INT J ARTIF ORGANS, V35, P762, DOI 10.5301/ijao.5000154; Zemljic LF, 2013, APPL SURF SCI, V265, P697, DOI 10.1016/j.apsusc.2012.11.086; Zhang YF, 2007, J BIOMATER APPL, V21, P333, DOI 10.1177/0885328206063853; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhong X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146957	45	31	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189537	10.1371/journal.pone.0189537	http://dx.doi.org/10.1371/journal.pone.0189537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236781	Green Submitted, Green Published, gold			2022-12-26	WOS:000417884100080
J	Das, S; Tseng, LC; Wang, L; Hwang, JS				Das, Shagnika; Tseng, Li-Chun; Wang, Lan; Hwang, Jiang-Shiou			Burrow characteristics of the mud shrimp Austinogebia edulis, an ecological engineer causing sediment modification of a tidal flat	PLOS ONE			English	Article							CALLIANASSA-SUBTERRANEA DECAPODA; UPOGEBIA-MAJOR; BACTERIAL COMMUNITIES; FUNCTIONAL-MORPHOLOGY; ORGANIC-MATTER; TROPHIC MODES; WEST-COAST; NGOC-HO; THALASSINIDEA; CRUSTACEA	The mud shrimp Austinogebia edulis, being abundant in the intertidal zone of western Taiwan, constructs deep burrows (>1 m). This study highlights the potential of mud shrimps to modify sediment characteristics of the tidal flat by its burrowing behavior. We studied the structure of the burrow wall, compared the difference in the sediment composition of the burrow and the background sediment, and compared the organic content inside the burrow wall. This study was carried out from September 2015 to November 2016 in three areas of the western coast of Taiwan, namely Shengang, Hanbow, and Wangong. The present study found significant differences between burrow wall and the burrow lumen. The diameter of the burrow wall was double as wide as the inner burrow lumen at the opening and gradually increased to 10 times of the burrow lumen at 30 cm depth. The burrow wall of A. edulis showed low permeability and increased the sheer strength. Statistically, a significant difference was noticed in the comparison between the sediment composition of the burrow wall and the background (p < 0.05, Student's t-test). An accumulation of 3.63 for fine sand (t = -5.22, p < 0.001, fine sand) and 9 for clay (t = -25.01, p < 0.001, clay) was found in the upper burrow wall of A. edulis. This indicated that they somehow chose finer particles to build burrows. This will gradually change the sediment distribution-vertically and horizontally. The burrow wall consisted of a 24 times higher organic matter content than one individual of mud shrimp. The burrow may provide organic material as a potential food source. The mud shrimp thus transforms the sediment characteristics as an ecological engineer, which is expected to have a significant ecological impact on the ecosystem.	[Das, Shagnika; Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China	National Taiwan Ocean University; Shanxi University	Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.	jshwang@mail.ntou.edu.tw		Das, Shagnika/0000-0001-6157-6933; Tseng, Li-Chun/0000-0003-0251-565X	Ministry of Science and Technology (MOST) of Taiwan [MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019-001, MOST 106-2621-M-019-001];  [MOST 104-2811-M-019-005];  [MOST 105-2811-M-019-008];  [MOST 106-2811-M-019-004]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); ; ; 	We convey our gratitude to the Ministry of Science and Technology (MOST) of Taiwan for the financial support through the grant no. MOST 104-2611-M-019-004, MOST 105-2621-M-019-001 and MOST 105-2918-I-019-001 to J.-S. Hwang as well as the grant no. MOST 104-2811-M-019-005 and MOST 105-2811-M-019-008 to L.-C. Tseng. https://www.most.gov.tw/.; We are grateful to Professor Cheng I-Jiunn and his lab members for providing certain instruments to carry out this study. We convey our gratitude to the Ministry of Science and Technology (MOST) of Taiwan for the financial support through grant nos. MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019-001 and MOST 106-2621-M-019-001 to J.-S. Hwang as well as the grant nos. MOST 104-2811-M-019-005, MOST 105-2811-M-019-008 and MOST 106-2811-M-019-004 to L.-C. Tseng. We thank two anonymous referees for their editing and suggestions that substantially improved the quality of the manuscript. Finally, we thank Dr. Shao-Hung Peng and Mr. Chih-Ming Lin (members of J.-S. Hwang's laboratory) for their assistance during field sampling and Prof. Hans-Uwe Dahms for corrections of the English.	[Anonymous], 2013, COASTAL ECOSYSTEMS S; Atkinson RJA, 2005, OCEANOGR MAR BIOL, V43, P173; ATKINSON RJA, 1990, J NAT HIST, V24, P403; Atkinson RJA, 2015, NATURAL HIST CRUSTAC, V2, P100, DOI DOI 10.1111/Z0J.12326; Bearup D, 2017, ECOL COMPLEX; Berkenbusch K, 2000, MAR ECOL PROG SER, V192, P249, DOI 10.3354/meps192249; Bosley KM, 2017, ESTUAR COAST, V40, P1113, DOI 10.1007/s12237-016-0193-y; Botto F, 2000, ESTUAR COAST SHELF S, V51, P141, DOI 10.1006/ecss.2000.0642; Candisani LC, 2001, J MAR BIOL ASSOC UK, V81, P799, DOI 10.1017/S0025315401004611; Coelho VR, 2000, MAR ECOL PROG SER, V200, P229, DOI 10.3354/meps200229; COLIN PL, 1986, B MAR SCI, V38, P19; D'Andrea AF, 2009, LIMNOL OCEANOGR, V54, P1911, DOI 10.4319/lo.2009.54.6.1911; DAVIS WR, 1993, J EXP MAR BIOL ECOL, V171, P187, DOI 10.1016/0022-0981(93)90003-7; de Vaugelas JV, P 5 INT COR REEF C A, V6, P617; Dorgan KM, 2015, J EXP BIOL, V218, P176, DOI 10.1242/jeb.086983; DWORSCHAK P C, 1983, Marine Ecology, V4, P19, DOI 10.1111/j.1439-0485.1983.tb00286.x; DWORSCHAK P C, 1987, Investigacion Pesquera (Barcelona), V51, P421; DWORSCHAK PC, 2012, CRUSTACEA COMPLEMENT, V9, P109, DOI DOI 10.1163/9789047430179_004; Felder DL, 1994, DOMINANT INFAUNAL CO, P87; GRIFFIS RB, 1991, MAR ECOL PROG SER, V79, P171, DOI 10.3354/meps079171; Heuner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138086; Hong Jae-Sang, 2013, Ocean and Polar Research, V35, P323, DOI 10.4217/OPR.2013.35.4.323; Hughes S. W., 2005, Physics Education, V40, P468, DOI 10.1088/0031-9120/40/5/008; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Kinoshita K, 2008, MAR BIOL, V153, P277, DOI 10.1007/s00227-007-0802-1; Kinoshita K, 2005, J MAR BIOL ASSOC UK, V85, P943, DOI 10.1017/S0025315405011926; Kinoshita K, 2003, MAR ECOL PROG SER, V247, P159, DOI 10.3354/meps247159; Kinoshita KY, 2002, J CRUSTACEAN BIOL, V22, P474, DOI 10.1651/0278-0372(2002)022[0474:BSOTMS]2.0.CO;2; Kinoshita K, 2010, J MAR BIOL ASSOC UK, V90, P947, DOI 10.1017/S0025315410000214; KOIKE I, 1983, MAR ECOL PROG SER, V12, P185, DOI 10.3354/meps012185; KRISTENSEN E, 1991, J MAR RES, V49, P355, DOI 10.1357/002224091784995855; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; Lavesque Nicolas, 2016, Marine Biodiversity Records, V9, P14, DOI 10.1186/s41200-016-0001-1; Leiva FP, 2015, COMP BIOCHEM PHYS A, V189, P30, DOI 10.1016/j.cbpa.2015.07.008; Levinton J.S., 1989, Lecture Notes on Coastal and Estuarine Studies, V31, P1; Li HY, 2008, J ZOOL, V274, P301, DOI 10.1111/j.1469-7998.2007.00393.x; Lin FJ., 1994, THESIS; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MacGINITIE G. E., 1930, ANN & MAG NAT HIST, V6, P36; MEADOWS PS, 1989, MAR BIOL, V101, P75, DOI 10.1007/BF00393480; NASH RDM, 1984, J ZOOL, V202, P425, DOI 10.1111/j.1469-7998.1984.tb05093.x; Ngoc-Ho N, 2001, HYDROBIOLOGIA, V449, P47, DOI 10.1023/A:1017516331683; Ngoc-Ho N., 1992, Raffles Bulletin of Zoology, V40, P33; Nickell LA, 1995, MAR ECOL PROG SER, V128, P181, DOI 10.3354/meps128181; OTT J A, 1976, Senckenbergiana Maritima, V8, P61; Papaspyrou S, 2006, MAR BIOL, V148, P541, DOI 10.1007/s00227-005-0105-3; Papaspyrou S, 2005, AQUAT MICROB ECOL, V38, P181, DOI 10.3354/ame038181; PEMBERTON GS, 1976, SCIENCE, V192, P790, DOI 10.1126/science.192.4241.790; Peng SH, 2006, CRUSTACEANA, V79, P263, DOI 10.1163/156854006776759617; Powell RR., 1974, U CALIF PUBLS ZOOL, V104, P1; RHOADS DC, 1970, J MAR RES, V28, P150; Rossi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066650; ROWDEN AA, 1994, J MAR BIOL ASSOC UK, V74, P623, DOI 10.1017/S0025315400047706; Sassa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025041; Schaefer N., 1970, AFR ZOOL, V5, P309; SCOTT PJB, 1988, CAN J ZOOL, V66, P483, DOI 10.1139/z88-069; Seike K, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3096-y; Sepahvand Vahid, 2014, Nauplius, V22, P137; Shimoda K, 2004, MAR BIOL, V144, P723, DOI 10.1007/s00227-003-1237-y; SHINN E A, 1968, Journal of Paleontology, V42, P879; Stamhuis EJ, 1996, J EXP MAR BIOL ECOL, V204, P225, DOI 10.1016/0022-0981(96)02587-7; SUCHANEK TH, 1983, J MAR RES, V41, P281, DOI 10.1357/002224083788520216; TRASK PD, 1950, SCIENCE, V111, P666, DOI 10.1126/science.111.2894.666; TUDHOPE AW, 1984, J SEDIMENT PETROL, V54, P1091; Vaugelas JD, 1990, HYDROBIOLOGIA, V207, P269, DOI DOI 10.1007/BF00041465; Wada M., 2005, MICROBES ENVIRON, V20, P191, DOI DOI 10.1264/JSME2.20.191; Wada M, 2016, GENE, V576, P657, DOI 10.1016/j.gene.2015.10.017; WITBAARD R, 1989, SARSIA, V74, P209, DOI 10.1080/00364827.1989.10413430; Yong R.N., 1966, INTRO SOIL BEHAV; Ziebis W, 1996, NATURE, V382, P619, DOI 10.1038/382619a0	70	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0187647	10.1371/journal.pone.0187647	http://dx.doi.org/10.1371/journal.pone.0187647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236717	gold, Green Published, Green Submitted			2022-12-26	WOS:000417884100005
J	Shen, LZ; Jiang, H; He, MF; Liu, GQ				Shen, Lizhen; Jiang, Hua; He, Mingfang; Liu, Guoqing			Collaborative representation-based classification of microarray gene expression data	PLOS ONE			English	Article							SPECTRUM DISORDERS; PREDICTION; CANCER; SELECTION; MODEL	Microarray technology is important to simultaneously express multiple genes over a number of time points. Multiple classifier models, such as sparse representation (SR)-based method, have been developed to classify microarray gene expression data. These methods allocate the gene data points to different clusters. In this paper, we propose a novel collaborative representation (CR)-based classification with regularized least square to classify gene data. First, the CR codes a testing sample as a sparse linear combination of all training samples and then classifies the testing sample by evaluating which class leads to the minimum representation error. This CR-based classification approach is remarkably less complex than traditional classification methods but leads to very competitive classification results. In addition, compressive sensing approach is adopted to project the high-dimensional gene expression dataset to a lower-dimensional space which nearly contains the whole information. This compression without loss is beneficial to reduce the computational load. Experiments to detect subtypes of diseases, such as leukemia and autism spectrum disorders, are performed by analyzing the gene expression. The results show that the proposed CR-based algorithm exhibits significantly higher stability and accuracy than the traditional classifiers, such as support vector machine algorithm.	[Shen, Lizhen; He, Mingfang] Nanjing Tech Univ, Sch Biotechnol & Pharmaceut Engn, Nanjing 211800, Jiangsu, Peoples R China; [Jiang, Hua; Liu, Guoqing] Nanjing Tech Univ, Sch Phys & Math Sci, Nanjing 211800, Jiangsu, Peoples R China	Nanjing Tech University; Nanjing Tech University	Shen, LZ (corresponding author), Nanjing Tech Univ, Sch Biotechnol & Pharmaceut Engn, Nanjing 211800, Jiangsu, Peoples R China.	shenlz@njtech.edu.cn			Natural Science Foundation of the Jiangsu Higher Education Institutions of China [17KJB510024]	Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 17KJB510024).	Agostinelli F, 2016, BIOINFORMATICS, V32, P8, DOI 10.1093/bioinformatics/btw243; Agrawal S, 2015, PROCEDIA COMPUT SCI, V60, P769, DOI 10.1016/j.procs.2015.08.234; Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P118, DOI 10.1109/MSP.2007.4286571; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bhaskar H, 2006, COMPUT BIOL MED, V36, P1104, DOI 10.1016/j.compbiomed.2005.09.002; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Cheng XP, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0629-6; Cogill S, 2016, BIOINFORMATICS, V32, P3611, DOI 10.1093/bioinformatics/btw498; Dai W, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/162824; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fakhoury M, 2015, INT J DEV NEUROSCI, V43, P70, DOI 10.1016/j.ijdevneu.2015.04.003; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Huang HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149675; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Maulik U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-27; Qian JJ, 2013, IEEE COMPUT SOC CONF, P166, DOI 10.1109/CVPRW.2013.32; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Retico A, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-015-0067-3; Sha NJ, 2004, BIOMETRICS, V60, P812, DOI 10.1111/j.0006-341X.2004.00233.x; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Tang WL, 2011, J BIOINF COMPUT BIOL, V9, P631, DOI 10.1142/S0219720011005689; Walsh I, 2016, BRIEF BIOINFORM, V17, P831, DOI 10.1093/bib/bbv082; Yan K, 2017, ARTIF INTELL MED, V79, P1, DOI 10.1016/j.artmed.2017.03.006; Zhang KH, 2014, IEEE T PATTERN ANAL, V36, P2002, DOI 10.1109/TPAMI.2014.2315808; Zhang L, 2011, COMP VIS ICCV 2011 I, P4; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115; Zurcher NR, 2015, NEUROSCI BIOBEHAV R, V52, P56, DOI 10.1016/j.neubiorev.2015.02.002	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189533	10.1371/journal.pone.0189533	http://dx.doi.org/10.1371/journal.pone.0189533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236759	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100078
J	Milardi, M; Chapman, D; Lanzoni, M; Long, JM; Castaldelli, G				Milardi, Marco; Chapman, Duane; Lanzoni, Mattia; Long, James M.; Castaldelli, Giuseppe			First evidence of bighead carp wild recruitment in Western Europe, and its relation to hydrology and temperature	PLOS ONE			English	Article							HYPOPHTHALMICHTHYS-NOBILIS RICHARDSON; ASIAN CARP; SILVER CARP; ARISTICHTHYS-NOBILIS; RIVER; FISH; LAKES; SUITABILITY; TRANSPORT; MOLITRIX	Bighead carp (Hypophthalmichthys nobilis) have been introduced throughout Europe, mostly unintentionally, and little attention has been given to their potential for natural reproduction. We investigated the presence of young-of-the-year bighead carp in an irrigation canal network of Northern Italy and the environmental conditions associated with spawning in 2011-2015. The adult bighead carp population of the canal network was composed by large, likely mature, individuals with an average density of 45.2 kg/ha (over 10 fold more than in the main river). The 29 juvenile bighead carp found were 7.4-13.1 cm long (TL) and weighed 9.5-12.7 g. Using otolith-derived spawning dates we estimated that these juveniles were 94-100 days old, placing their fertilization and hatch dates in mid-to-end-June. Using this information in combination with thermal and hydraulic data, we examined the validity of existing models predicting the onset of spawning conditions and the viability of egg pathways to elucidate spawning location of the species. While evidence of reproduction was not found every year, we determined that potentially viable spawning conditions (annual degree-days and temperature thresholds) and pathways of egg drift suitable for hatching are present in short, slow-flowing canals.	[Chapman, Duane] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA; [Milardi, Marco; Lanzoni, Mattia; Castaldelli, Giuseppe] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy; [Long, James M.] Oklahoma State Univ, US Geol Survey, Oklahoma Cooperat Fish & Wildlife Res Unit, Stillwater, OK 74078 USA	United States Department of the Interior; United States Geological Survey; University of Ferrara; Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of the Interior; United States Geological Survey	Milardi, M (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy.	marco.milardi@gmail.com	Lanzoni, Mattia/AAL-5938-2021; Castaldelli, Giuseppe/Q-8301-2016	Lanzoni, Mattia/0000-0003-4976-5146; Castaldelli, Giuseppe/0000-0001-5954-1133; Chapman, Duane/0000-0002-1086-8853				Abdusamadov AS., 1987, J ICHTHYOL, V26, P41; Anderson KR, 2016, BIOINVASIONS REC, V5, P251, DOI 10.3391/bir.2016.5.4.10; Azevedo-Santos V, 2011, BACIA HIDROGRAFICA E; Boros G, 2014, J APPL ICHTHYOL, V30, P546, DOI 10.1111/jai.12325; Britton JR, 2013, ECOLOGY, V94, P2558, DOI 10.1890/13-0527.1; Castaldelli G, 2013, AQUAT CONSERV, V23, P405, DOI 10.1002/aqc.2345; Chapman DC, 2013, J GREAT LAKES RES, V39, P547, DOI 10.1016/j.jglr.2013.09.019; Charyev R, 1984, J ICHTHYOL, V24, P1; CHILTON EW, 1992, REV FISH BIOL FISHER, V2, P283, DOI 10.1007/BF00043520; Ciolac A., 2006, DUNAREA JOS GALATI, V21, P91; Conover G., 2007, MANAGEMENT CONTROL P; Cooke SL, 2016, BIOL INVASIONS, V18, P315, DOI 10.1007/s10530-015-1028-7; Coulter AA, 2013, FRESHWATER BIOL, V58, P1029, DOI 10.1111/fwb.12106; Deters JE, 2013, ENVIRON BIOL FISH, V96, P617, DOI 10.1007/s10641-012-0052-z; DONG SL, 1994, J FISH BIOL, V44, P621, DOI 10.1111/j.1095-8649.1994.tb01238.x; FAO, 2016, FISH AQ STAT YB; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Froese R, 2017, FISHBASE VERSION 03; Gandolfi G., 1991, PESCI ACQUE INTERNE; Garcia T, 2015, J GREAT LAKES RES, V41, P374, DOI 10.1016/j.jglr.2015.02.003; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; George A, 2017, COMP SIZE TERMINAL F; George AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119023; George AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073829; Gorbach E.I., 1981, Voprosy Ikhtiologii, V21, P835; Jankovic D, 1998, ITAL J ZOOL, V65, P227, DOI 10.1080/11250009809386819; Jongejans E, 2015, THEOR ECOL-NETH, V8, P207, DOI 10.1007/s12080-014-0245-5; Kocovsky PM, 2012, J GREAT LAKES RES, V38, P159, DOI 10.1016/j.jglr.2011.11.015; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Laird C.A, 2011, B ILL NAT HIST SURV, V35, P11, DOI DOI 10.5962/BHL.TITLE.50306; Lazareva L. P., 1977, Journal of Ichthyology, V17, P65; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Liu J. K., 1992, CULTIVATION CHINESE; Long JM, 2014, MANAG BIOL INVASION, V5, P363, DOI 10.3391/mbi.2014.5.4.07; Melotti P, 1987, CARPA ERBIVORA EMILI, P87; Milardi M, 2015, AQUATIC INVASIONS, V10; Murphy E.A., 2013, URBANA, V51, P61801; OPUSZYNSKI K, 1981, AQUACULTURE, V25, P223, DOI 10.1016/0044-8486(81)90184-8; Peters LM, 2006, T AM FISH SOC, V135, P1205, DOI 10.1577/T05-162.1; Solomon LE, 2016, BIOL INVASIONS, V18, P2883, DOI 10.1007/s10530-016-1180-8; USGS, 2016, NON AQ SPEC DAT; Verigin B. V., 1978, J ICHTHYOL+, V18, P143; Xie P, 2001, SCIENCE, V294, P999; Yi B, 1991, DISTRIBUTION NATURAL, P181; Zhao SY, 2016, HYDROBIOLOGIA, V765, P43, DOI 10.1007/s10750-015-2398-7	45	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189517	10.1371/journal.pone.0189517	http://dx.doi.org/10.1371/journal.pone.0189517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232384	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200054
J	Sacri, AS; Ferreira, D; Khoshnood, B; Gouya, L; Barros, H; Chalumeau, M				Sacri, Anne-Sylvia; Ferreira, Daniela; Khoshnood, Babak; Gouya, Laurent; Barros, Henrique; Chalumeau, Martin			Stability of serum ferritin measured by immunoturbidimetric assay after storage at-80 degrees C for several years	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IRON-DEFICIENCY ANEMIA; LONG-TERM STABILITY; BLOOD-SAMPLES; WHOLE-BLOOD; INFANTS; DETERMINANTS; PREVENTION; TRANSPORT; ANALYTES	Background Iron deficiency (ID) may impair long-term neurological development when it occurs in young infants. In cohort studies, it is sometimes necessary to evaluate ID with sera kept frozen for several years. To assess ID, learned societies recommend measuring serum ferritin (SF) level combined with C-reactive protein level. The long-term stability of C-reactive protein in frozen samples is well established but not ferritin. Methods We measured SF level (immunoturbidimetric assay; in micrograms per liter) immediately after collection from 53 young adults recruited and followed-up in Porto, Portugal, from 2011 to 2013 (SF1), and then, in 2016 in two aliquots kept frozen at-80 degrees C for 3 to 5 years: one without (SF2A) and one with (SF2B) intermediate thawing in 2014. We compared SF1 to SF2A then SF2B; statistical agreement was evaluated by the Bland and Altman method and the effect of intermediate thawing by regression modelling. Results Mean SF2A-SF1 and SF2B-SF1 differences were -2.1 (SD 7.0) and 48.9 (SD 66.9). Values for Bland and Altman 95% limits of agreement were higher for the comparison of SF2B and SF1 than SF2A and SF1: -82.2 to 179.9 and -15.8 to 11.8, respectively; the effect of thawing was highly significant (p < 0.001). Conclusions Agreement between SF values before and after 3 to 5 years of constant freezing at-80 degrees C was in a generally accepted range, which supports the hypothesis of ferritin's stability at this temperature for a long period. In long-term storage by freezing, intermediate thawing induced a major increase in values.	[Sacri, Anne-Sylvia; Khoshnood, Babak; Chalumeau, Martin] Univ Paris Descartes Paris, INSERM UMR1153, Ctr Rech Epidemiol & Stat,CRESS, Sorbonne Paris Cite,Euipe Epidemiol Perinatale Ob, Paris, France; [Sacri, Anne-Sylvia; Khoshnood, Babak; Chalumeau, Martin] Univ Paris Descartes Paris, Labex GR Ex, Paris, France; [Sacri, Anne-Sylvia; Chalumeau, Martin] Necker Enfants Malad Hosp, AP HP, Paris, France; [Sacri, Anne-Sylvia; Chalumeau, Martin] Univ Paris 05, Paris, France; [Sacri, Anne-Sylvia] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Ferreira, Daniela; Barros, Henrique] Univ Porto, Inst Sau Publ, EPIUnit, Oporto, Portugal; [Ferreira, Daniela; Barros, Henrique] Univ Paris Diderot, INSERM UMR 1149, Ctr Rech Inflammat, Paris, France; [Gouya, Laurent] ERL CNRS 8252, Fac Med Site Bichat, Labex GR Ex, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Sacri, AS (corresponding author), Univ Paris Descartes Paris, INSERM UMR1153, Ctr Rech Epidemiol & Stat,CRESS, Sorbonne Paris Cite,Euipe Epidemiol Perinatale Ob, Paris, France.; Sacri, AS (corresponding author), Univ Paris Descartes Paris, Labex GR Ex, Paris, France.; Sacri, AS (corresponding author), Necker Enfants Malad Hosp, AP HP, Paris, France.; Sacri, AS (corresponding author), Univ Paris 05, Paris, France.; Sacri, AS (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	anne-sylvia.sacri@inserm.fr	Barros, Henrique/Q-8609-2019; Khoshnood, Babak/N-9096-2017; Barros, Henrique/A-5488-2008	Barros, Henrique/0000-0003-4699-6571; Sacri, Anne-Sylvia/0000-0001-9719-3934	Secteur Francais des Aliments de l'Enfance; French Ministry of Health "DGOS PHRC regional" [AOR14053]; Paris Diderot University-Sorbonne Paris Cite	Secteur Francais des Aliments de l'Enfance; French Ministry of Health "DGOS PHRC regional"; Paris Diderot University-Sorbonne Paris Cite	This work was supported by the Secteur Francais des Aliments de l'Enfance https://www.secteurfrancaisdesalimentsdelenfance.com/ (ASS, MC); French Ministry of Health "DGOS PHRC regional 2014 no AOR14053" (http://solidarites-sante.gouv.fr/) to ASS, MC and the Paris Diderot University-Sorbonne Paris Cite (https://www.univ-paris-diderot.fr/) to ASS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTONI C, 2013, EUR FOOD SEC AUTH, V11, DOI DOI 10.2903/J.EFSA.2013.3408; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2005, ANN NAT QUAL CONTR M; Assessing the iron status of populations, 2007, JOINT WORLD HLTH ORG; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Bland JM, 1996, BRIT MED J, V312, P1079; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brinc D, 2012, CLIN BIOCHEM, V45, P816, DOI 10.1016/j.clinbiochem.2012.03.029; Chesher Douglas, 2008, Clin Biochem Rev, V29 Suppl 1, pS23; Domellof M, 2014, J PEDIATR GASTR NUTR, V58, P119, DOI 10.1097/MPG.0000000000000206; Doumatey AP, 2014, CLIN BIOCHEM, V47, P315, DOI 10.1016/j.clinbiochem.2013.12.014; Drammeh BS, 2008, CLIN CHEM, V54, P1883, DOI 10.1373/clinchem.2008.108761; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; Gonzalez-Gross M, 2008, INT J OBESITY, V32, pS66, DOI 10.1038/ijo.2008.185; Henriksen LO, 2014, SCAND J CLIN LAB INV, V74, P603, DOI 10.3109/00365513.2014.928940; Hercberg S, 2001, Public Health Nutr, V4, P537; Ishikawa S, 2007, J EPIDEMIOL, V17, P120, DOI 10.2188/jea.17.120; Jansen EHJM, 2013, BIOMARKERS, V18, P365, DOI 10.3109/1354750X.2013.781223; KUBASIK NP, 1982, CLIN CHEM, V28, P164; Lourenco S, 2015, RHEUMATOLOGY, V54, P1806, DOI 10.1093/rheumatology/kev110; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Mathew G, 2009, CLIN BIOCHEM, V42, P1732, DOI 10.1016/j.clinbiochem.2009.07.015; MOFFATT MEK, 1994, J PEDIATR-US, V125, P527, DOI 10.1016/S0022-3476(94)70003-6; Nilsson TK, 2005, THROMB RES, V116, P249, DOI 10.1016/j.thromres.2004.12.005; Ramos E, 2007, ACTA PAEDIATR, V96, P281, DOI 10.1111/j.1651-2227.2007.00107.x; Roncagliolo M, 1998, AM J CLIN NUTR, V68, P683, DOI 10.1093/ajcn/68.3.683; Sacri AS, 2017, MATERN CHILD NUTR; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tanner M, 2008, ANN CLIN BIOCHEM, V45, P375, DOI 10.1258/acb.2007.007183; van Eijsden M, 2005, CLIN CHEM, V51, P230; Wang B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001444.pub2; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188332	10.1371/journal.pone.0188332	http://dx.doi.org/10.1371/journal.pone.0188332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228047	Green Submitted, Green Published, gold			2022-12-26	WOS:000417648600009
J	Liu, JY; Summers, D				Liu, Junyan; Summers, David			Indole at low concentration helps exponentially growing Escherichia coli survive at high temperature	PLOS ONE			English	Article							TRYPTOPHANASE OPERON EXPRESSION; INHIBITION; SIGNAL; GENES; ACID; K-12; CONTRIBUTES; MAINTENANCE; RESISTANCE; INDUCTION	A culture of stationary phase Escherichia coli cells has been reported to produce copious indole when exposed to high temperature (50 degrees C), and this response has been proposed to aid survival. We reinvestigated this phenomenon and found that indole production under these conditions is probably not a direct response to heat stress. Rather, E. coli produces indole when growth is prevented, irrespective of whether this is due to heat stress, antibiotic treatment or the removal of nutrients. Moreover, 300 mu M indole produced at 50 degrees C does not improve the viability of heat stressed cells. Interestingly, a much lower concentration of indole (20 mu M) improves the survival of an indole-negative strain (Delta tnaA) when heat stressed during exponential growth. In addition we have shown that the distribution of tryptophanase, the enzyme responsible for indole synthesis, is highly heterogeneous among cells in a population, except during the transition between exponential and stationary phases. The observation that, despite the presence of the tryptophanase, very little indole is produced during early exponential phase suggests that there is post-translational regulation of the enzyme.	[Liu, Junyan; Summers, David] Univ Cambridge, Dept Genet, Cambridge, England	University of Cambridge	Summers, D (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.	d.summers@gen.cam.ac.uk	liu, junyan/HGV-1505-2022					Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Bordi C, 2003, MOL MICROBIOL, V48, P211, DOI 10.1046/j.1365-2958.2003.03428.x; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chimerel C, 2012, BBA-BIOMEMBRANES, V1818, P1590, DOI 10.1016/j.bbamem.2012.02.022; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; DEELEY MC, 1982, J BACTERIOL, V151, P942, DOI 10.1128/JB.151.2.942-951.1982; Field CM, 2012, PLASMID, V67, P88, DOI 10.1016/j.plasmid.2011.11.004; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Gaimster H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136691; Gaimster H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093168; Gayan E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01845; Gong F, 2002, J BIOL CHEM, V277, P17095, DOI 10.1074/jbc.M201213200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Govers SK, 2017, ENVIRON MICROBIOL, V19, P511, DOI 10.1111/1462-2920.13460; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2010, MICROB PATHOGENESIS, V49, P90, DOI 10.1016/j.micpath.2010.05.002; Hu Y, 2015, ENVIRON MICROBIOL, V17, P1275, DOI 10.1111/1462-2920.12567; Juneja VK, 1997, INT J FOOD MICROBIOL, V35, P231, DOI 10.1016/S0168-1605(96)01237-8; Kim J, 2015, J MICROBIOL, V53, P421, DOI 10.1007/s12275-015-5273-3; Kim J, 2013, MICROBIOL-SGM, V159, P2616, DOI 10.1099/mic.0.070615-0; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Kuczynska-Wisnik D, 2015, MICROBIOL-SGM, V161, P786, DOI 10.1099/mic.0.000012; Kwan BW, 2015, BIOTECHNOL BIOENG, V112, P588, DOI 10.1002/bit.25456; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Li G, 2014, MICROBIOL-SGM, V160, P2079, DOI 10.1099/mic.0.080705-0; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; PATIENT ME, 1993, MOL MICROBIOL, V9, P1089, DOI 10.1111/j.1365-2958.1993.tb01238.x; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; STEWART V, 1986, J BACTERIOL, V166, P217, DOI 10.1128/jb.166.1.217-223.1986; STEWART V, 1985, J BACTERIOL, V164, P731, DOI 10.1128/JB.164.2.731-740.1985; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Tomberlin JK, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600203; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; WOOD WA, 1947, J BIOL CHEM, V170, P313	42	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188853	10.1371/journal.pone.0188853	http://dx.doi.org/10.1371/journal.pone.0188853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216232	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800044
J	Van Nieuwenhuyse, E; Seemann, G; Panfilov, AV; Vandersickel, N				Van Nieuwenhuyse, Enid; Seemann, Gunnar; Panfilov, Alexander V.; Vandersickel, Nele			Effects of early afterdepolarizations on excitation patterns in an accurate model of the human ventricles	PLOS ONE			English	Article							LONG QT SYNDROME; CARDIAC-ARRHYTHMIAS; HUMAN HEART; REPOLARIZATION RESERVE; TRIGGERED ACTIVITY; DE-POINTES; TISSUE; REENTRY; WAVE; SIMULATION	Early Afterdepolarizations, EADs, are defined as the reversal of the action potential before completion of the repolarization phase, which can result in ectopic beats. However, the series of mechanisms of EADs leading to these ectopic beats and related cardiac arrhythmias are not well understood. Therefore, we aimed to investigate the influence of this single cell behavior on the whole heart level. For this study we used a modified version of the Ten Tusscher-Panfilov model of human ventricular cells (TP06) which we implemented in a 3D ventricle model including realistic fiber orientations. To increase the likelihood of EAD formation at the single cell level, we reduced the repolarization reserve (RR) by reducing the rapid delayed rectifier Potassium current and raising the L-type Calcium current. Varying these parameters defined a 2D parametric space where different excitation patterns could be classified. Depending on the initial conditions, by either exciting the ventricles with a spiral formation or burst pacing protocol, we found multiple different spatio-temporal excitation patterns. The spiral formation protocol resulted in the categorization of a stable spiral (S), a meandering spiral (MS), a spiral break-up regime (SB), spiral fibrillation type B (B), spiral fibrillation type A (A) and an oscillatory excitation type (O). The last three patterns are a 3D generalization of previously found patterns in 2D. First, the spiral fibrillation type B showed waves determined by a chaotic bi-excitable regime, i.e. mediated by both Sodium and Calcium waves at the same time and in same tissue settings. In the parameter region governed by the B pattern, single cells were able to repolarize completely and different (spiral) waves chaotically burst into each other without finishing a 360 degree rotation. Second, spiral fibrillation type A patterns consisted of multiple small rotating spirals. Single cells failed to repolarize to the resting membrane potential hence prohibiting the Sodium channel gates to recover. Accordingly, we found that Calcium waves mediated these patterns. Third, a further reduction of the RR resulted in a more exotic parameter regime whereby the individual cells behaved independently as oscillators. The patterns arose due to a phase-shift of different oscillators as disconnection of the cells resulted in continuation of the patterns. For all patterns, we computed realistic 9 lead ECGs by including a torso model. The B and A type pattern exposed the behavior of Ventricular Tachycardia (VT). We conclude that EADs at the single cell level can result in different types of cardiac fibrillation at the tissue and 3D ventricle level.	[Van Nieuwenhuyse, Enid; Panfilov, Alexander V.; Vandersickel, Nele] Univ Ghent, Dept Phys & Astron, Ghent, Belgium; [Seemann, Gunnar] Univ Heart Ctr Freiburg, Inst Expt Cardiovasc Med, Bad Krozingen, Germany; [Seemann, Gunnar] Univ Freiburg, Fac Med, Freiburg, Germany	Ghent University; Universitats Herzzentrum Freiburg; University of Freiburg	Van Nieuwenhuyse, E (corresponding author), Univ Ghent, Dept Phys & Astron, Ghent, Belgium.	enid.vannieuwenhuyse@ugent.be	Vandersickel, Nele/B-2984-2016; Seemann, Gunnar/D-3091-2011; Panfilov, Alexander/G-8459-2016	Seemann, Gunnar/0000-0001-7111-7992; Panfilov, Alexander/0000-0003-2643-642X	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	NV received funding from Research Foundation Flanders (FWO).; N. Vandersickel is funded by the Research Foundation Flanders (FWO).	Akar Fadi G, 2001, AM J PHYSL HEART CIR; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Boyden Penelope A., 2010, CARDIAC PURKINJE CEL; Bray MA, 2002, IEEE T BIO-MED ENG, V49, P1086, DOI 10.1109/TBME.2002.803516; Bray MA, 2001, AM PHYS SOC; Chang MG, 2013, HEART RHYTHM, V10, P575, DOI 10.1016/j.hrthm.2012.12.017; Chang MG, 2012, HEART RHYTHM, V9, P115, DOI 10.1016/j.hrthm.2011.08.014; Clayton R. H., 2010, PROGR BIOPHYSICS MOL; CRANEFIELD PF, 1977, CIRC RES, V41, P415, DOI 10.1161/01.RES.41.4.415; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fritz T, 2014, BIOMECH MODEL MECHAN, V13, P627, DOI 10.1007/s10237-013-0523-y; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Huffaker R, 2004, HEART RHYTHM, V1, P441, DOI 10.1016/j.hrthm.2004.06.005; Huffaker RB, 2007, AM J PHYSIOL-HEART C, V292, pH3089, DOI 10.1152/ajpheart.01309.2006; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Keener JP, 1996, BIOPHYS J, V71, P1335, DOI 10.1016/S0006-3495(96)79333-5; Keldermann RH, 2008, AM J PHYSIOL-HEART C, V294, pH764, DOI 10.1152/ajpheart.00906.2007; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Keller DUJ, 2012, IEEE T BIO-MED ENG, V59, P311, DOI 10.1109/TBME.2011.2168397; Keller DUJ, 2011, IEEE T BIO-MED ENG, V58, P2109, DOI 10.1109/TBME.2011.2147785; Keller DUJ, 2010, IEEE T BIO-MED ENG, V57, P1568, DOI 10.1109/TBME.2010.2046485; Kim TY, 2015, HEART RHYTHM, V12, P220, DOI 10.1016/j.hrthm.2014.10.003; Kogan BY, 2003, MODELING AND SIMULATION: THEORY AND PRACTICE, P177; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu GX, 2012, J PHYSIOL-LONDON, V590, P1171, DOI 10.1113/jphysiol.2011.218164; Mark-Anthony Bray, 2001, J CARDIOVASCULAR ELE; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Richards DF, 2013, COMPUT METHOD BIOMEC, V16, P802, DOI 10.1080/10255842.2013.795556; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Scarle S, 2009, MED BIOL ENG COMPUT, V47, P291, DOI 10.1007/s11517-008-0405-0; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; Ten Tusscher KHWJ, 2008, PROG BIOPHYS MOL BIO, V96, P152, DOI 10.1016/j.pbiomolbio.2007.07.026; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Umapathy Karthikeyan MSK, 2009, CIRCULATION ARRHYTHM; Vandersickel N, 2016, J PHYSIOL-LONDON, V594, P6865, DOI 10.1113/JP271728; Vandersickel N, 2015, HEART RHYTHM, V12, P1088, DOI 10.1016/j.hrthm.2015.01.033; Vandersickel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084595; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zimik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130632	54	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188867	10.1371/journal.pone.0188867	http://dx.doi.org/10.1371/journal.pone.0188867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216239	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800045
J	Geessink, N; Schoon, Y; van Goor, H; Rikkert, MO; Melis, R				Geessink, Noralie; Schoon, Yvonne; van Goor, Harry; Rikkert, Marcel Olde; Melis, Rene		TOPICS-MDS Consortium	Frailty and quality of life among older people with and without a cancer diagnosis: Findings from TOPICS-MDS	PLOS ONE			English	Article							COLORECTAL-CANCER; PERFORMANCE STATUS; FOLLOW-UP; POSTOPERATIVE OUTCOMES; GERIATRIC ASSESSMENT; TREATMENT DECISIONS; SURGERY; ASSOCIATION; PREDICTS; VALIDITY	Background The number of older cancer patients is rising. Especially in older people, treatment considerations should balance the impact of disease and treatment on quality of life (QOL) and survival. How a cancer diagnosis in older people interacts with concomitant frailty to impact on QOL is largely unknown. We aimed to determine the association between frailty and QOL among community-dwelling older people aged 65 years or above with and without a cancer diagnosis cross-sectionally and at 12 months follow-up. Methods Data were derived from the TOPICS-MDS database. Frailty was quantified by a frailty index (FI). QOL was measured with the subjective Cantril's Self Anchoring Ladder (CSAL, range: 0-10) and the health-related EuroQol-5D (EQ-5D, range:-0.33-1.00) at baseline and after 12 months. To determine associations, linear mixed models were used. Results 7493 older people (78.6 +/- 6.4 years, 58.4% female) were included. Dealing with a cancer diagnosis (n = 751) was associated with worse QOL both at baseline (CSAL:-0.25 (95%-CI:0.36;- 0.14), EQ-5D:-0.03 (95%-CI:-0.05;-0.02)) and at follow-up (CSAL:-0.13 (95%-CI:0.24;- 0.02), EQ-5D:-0.02 (95%-CI:-0.03;-0.00)). A ten percent increase in frailty was also associated with a decrease in QOL at baseline (CSAL:-0.35 (95%-CI:-0.38;-0.32), EQ-5D:0.12 (95%-CI:-0.12;-0.11)) and follow-up (CSAL:-0.27 (95%-CI:-0.30;-0.24), EQ-5D:-0.07 (95%-CI:-0.07;-0.06)). When mutually adjusting for frailty and a cancer diagnosis, associations between a cancer diagnosis and QOL only remained significant for CSAL at baseline (-0.14 (95%-CI:-0.25;-0.03)), whereas associations between frailty and QOL remained significant for all QOL outcomes at baseline and follow-up. No statistical interactions between cancer and frailty in their combined impact on QOL were found. Conclusions Cancer diagnosis and frailty were associated with worse health-related and self-perceived QOL both at baseline and at follow-up. Differences in QOL between older people with and without a cancer diagnosis were explained to a large extent by differences in frailty levels. This stresses the importance to take into account frailty in routine oncologic care.	[Geessink, Noralie; Schoon, Yvonne; Rikkert, Marcel Olde; Melis, Rene] Radboud Univ Nijmegen, Dept Geriatr Med, Med Ctr, Nijmegen, Netherlands; [Geessink, Noralie; Schoon, Yvonne; Melis, Rene] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands; [van Goor, Harry] Radboud Univ Nijmegen, Dept Surg, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Melis, R (corresponding author), Radboud Univ Nijmegen, Dept Geriatr Med, Med Ctr, Nijmegen, Netherlands.; Melis, R (corresponding author), Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands.	Rene.Melis@radboudumc.nl	Melis, René/J-5943-2012; Rikkert, M.G.M. Olde/H-8078-2014; Schoon, Y./L-4636-2015; van Goor, H./H-8035-2014	Melis, René/0000-0002-7863-4738; Rikkert, M.G.M. Olde/0000-0003-1397-1677; van Goor, H./0000-0003-0323-4876				Aapro MS, 2005, J CLIN ONCOL, V23, P2121, DOI 10.1200/JCO.2005.10.976; Abt NB, 2014, JAMA SURG, V149, P1068, DOI 10.1001/jamasurg.2014.1076; Aletti GD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.10.495; Baier P, 2016, EJSO-EUR J SURG ONC, V42, P1890, DOI 10.1016/j.ejso.2016.07.013; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; Chang SF, 2016, J CLIN NURS, V25, P2305, DOI 10.1111/jocn.13248; Choe YR, 2017, J GERIATR ONCOL, V8, P185, DOI 10.1016/j.jgo.2017.02.002; Choi D, 2015, NEUROSURGERY, V77, P698, DOI 10.1227/NEU.0000000000000907; Cooper Z, 2016, ANN SURG, V263, P1, DOI 10.1097/SLA.0000000000001491; CROOKS V, 1991, J GERONTOL, V46, pM139, DOI 10.1093/geronj/46.4.M139; Evers PD, 2014, WORLD J UROL, V32, P385, DOI 10.1007/s00345-013-1110-7; Fagard K, 2016, J GERIATR ONCOL, V7, P479, DOI 10.1016/j.jgo.2016.06.001; Faller H, 2015, PSYCHO-ONCOLOGY, V24, P1456, DOI 10.1002/pon.3811; Ferrucci L, 2003, CRIT REV ONCOL HEMAT, V46, P127, DOI 10.1016/S1040-8428(02)00177-4; Gani F, 2017, J GASTROINTEST SURG, V21, P822, DOI 10.1007/s11605-017-3373-6; Ghignone F, 2016, EJSO-EUR J SURG ONC, V42, P297, DOI 10.1016/j.ejso.2015.12.004; Gobbens RJJ, 2012, GERONTOLOGIST, V52, P619, DOI 10.1093/geront/gnr135; Guerard EJ, 2015, J CLIN ONCOL, V33; Hamaker ME, 2014, ACTA ONCOL, V53, P289, DOI 10.3109/0284186X.2013.840741; Huisman MG, 2017, EJSO-EUR J SURG ONC, V43, P1, DOI 10.1016/j.ejso.2016.06.003; Kelly CM, 2016, J ONCOL, V2016, DOI 10.1155/2016/6186543; Kojima G, 2016, J EPIDEMIOL COMMUN H, V70, P716, DOI 10.1136/jech-2015-206717; Kojima G, 2016, QUAL LIFE RES, V25, P1743, DOI 10.1007/s11136-015-1213-2; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lam K, 2013, SUPPORT CARE CANCER, V21, P3021, DOI 10.1007/s00520-013-1876-6; Loh V, 2014, AUST NZ J PUBL HEAL, V38, P35, DOI 10.1111/1753-6405.12164; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Lutomski JE, 2013, J AM GERIATR SOC, V61, P1625, DOI 10.1111/jgs.12430; Mazzola M, 2017, EJSO-EUR J SURG ONC, V43, P1566, DOI 10.1016/j.ejso.2017.06.006; Momeni M, 2014, INDIAN J CANCER, V51, P550, DOI 10.4103/0019-509X.175331; Naeim A, 2007, J CLIN EPIDEMIOL, V60, P79, DOI 10.1016/j.jclinepi.2005.11.026; Pal SK, 2010, CA-CANCER J CLIN, V60, P120, DOI 10.3322/caac.20059; Pergolotti M, 2017, J GERIATR ONCOL; Quinten C, 2015, EUR J CANCER, V51, P2808, DOI 10.1016/j.ejca.2015.08.027; Repetto L, 2002, J CLIN ONCOL, V20, P494, DOI 10.1200/JCO.20.2.494; Repetto L, 2001, CRIT REV ONCOL HEMAT, V37, P147, DOI 10.1016/S1040-8428(00)00104-9; Ronning B, 2016, J GERIATR ONCOL, V7, P195, DOI 10.1016/j.jgo.2016.03.002; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Schulkes KJG, 2017, LUNG, V195, P225, DOI 10.1007/s00408-017-9983-7; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Swaminathan V, 2012, ECANCERMEDICALSCIENC, V6, DOI 10.3332/ecancer.2012.243; Szende A, 2007, EQ 5D VALUE SETS INV; Thome B, 2004, QUAL LIFE RES, V13, P1067, DOI 10.1023/B:QURE.0000031342.11869.2f; Ugolini G, 2014, WORLD J GASTROENTERO, V20, P3762, DOI 10.3748/wjg.v20.i14.3762; Verhage F., 1964, INTELLIGENTIE LEEFTI; Vermillion SA, 2017, J SURG ONCOL, V115, P997, DOI 10.1002/jso.24617; Verweij NM, 2016, ANN SURG ONCOL, V23, P1875, DOI 10.1245/s10434-015-5085-z; YATES JW, 1980, CANCER, V45, P2220, DOI 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q; Ziegelstein RC, 2015, JAMA INTERN MED, V175, P888, DOI 10.1001/jamainternmed.2015.0861	49	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189648	10.1371/journal.pone.0189648	http://dx.doi.org/10.1371/journal.pone.0189648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244837	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700044
J	Henderson, HJ; Karanam, B; Samant, R; Vig, K; Singh, SR; Yates, C; Bedi, D				Henderson, Henry J.; Karanam, Balasubramanyam; Samant, Rajeev; Vig, Komal; Singh, Shree R.; Yates, Clayton; Bedi, Deepa			Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; GENE-EXPRESSION; BINDING; ABNORMALITIES; PROGRESSION; INVASION; DISEASE	The molecular mechanisms involved in breast cancer progression and metastasis still remain unclear to date. It is a heterogeneous disease featuring several different phenotypes with consistently different biological characteristics. Neuroligins are neural cell adhesion molecules that have been implicated in heterotopic cell adhesion. In humans, alterations in neuroligin genes are implicated in autism and other cognitive diseases. Until recently, neuroligins have been shown to be abundantly expressed in blood vessels and also play a role implicated in the growth of glioma cells. Here we report increased expression of neuroligin 4X (NLGN4X) in breast cancer. We found NLGN4X was abundantly expressed in breast cancer tissues. NLGN4X expression data for all breast cancer cell lines in the Cancer Cell Line Encyclopedia (CCLE) was analyzed. Correlation between NLGN4X levels and clinicopathologic parameters were analyzed within Oncomine datasets. Evaluation of these bioinfomatic datasets results revealed that NLGN4X expression was higher in triple negative breast cancer cells, particularly the basal subtype and tissues versus non-triple-negative sets. Its level was also observed to be higher in metastatic tissues. RT-PCR, flow cytometry and immunofluorescence study of MDA-MB-231 and MCF-7 breast cancer cells validated that NLGN4X was increased in MDA-MB-231. Knockdown of NLGN4X expression by siRNA decreased cell proliferation and migration significantly in MDA-MB-231 breast cancer cells. NLGN4X knockdown in MDA-MB-231 cells resulted in induction of apoptosis as determined by annexin staining, elevated caspase 3/7 and cleaved PARP by flow cytometry. High NLGN4X expression highly correlated with decrease in relapse free-survival in TNBC. NLGN4X might represent novel biomarkers and therapeutic targets for breast cancer. Inhibition of NLGN4X may be a new target for the prevention and treatment of breast cancer.	[Henderson, Henry J.; Bedi, Deepa] Tuskegee Univ, Dept Biomed Sci, Coll Vet Med, Tuskegee, AL 36088 USA; [Karanam, Balasubramanyam; Yates, Clayton] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Karanam, Balasubramanyam; Yates, Clayton] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA; [Samant, Rajeev] Univ Alabama Birmingham, Dept Pathobiol, Birmingham, AL USA; [Vig, Komal; Singh, Shree R.] Alabama State Univ, Ctr Nanobiotechnol Res, Montgomery, AL 36101 USA	Tuskegee University; Tuskegee University; Tuskegee University; University of Alabama System; University of Alabama Birmingham	Bedi, D (corresponding author), Tuskegee Univ, Dept Biomed Sci, Coll Vet Med, Tuskegee, AL 36088 USA.	dbedi@tuskegee.edu		Henderson, Henry/0000-0003-4218-623X; Singh, Shree R./0000-0002-3571-2222	NSF-CREST [HRD-1241701]; NIH/RCMI [G12 RR03059-21A1]; NIH/NIGMS SC2 [5SC2CA21102802-Deepa Bedi]; NATIONAL CANCER INSTITUTE [U54CA118638, SC2CA211028] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003374] Funding Source: NIH RePORTER	NSF-CREST(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); NIH/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS SC2; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NSF-CREST (HRD-1241701), G12 RR0305921A1 (NIH/RCMI), National Cancer Institute, 5SC2CA21102802, Dr. Deepa Bedi.; This work was supported by NSF-CREST (HRD-1241701), G12 RR03059-21A1(NIH/RCMI), and the NIH/NIGMS SC2 (5SC2CA21102802-Deepa Bedi) grant. Special thanks is given to Jason White, Benjamin Adu-Addai for assistance with data analysis and Kelvin Jones for laboratory assistance.	Bedi D, 2014, PROTEIN ENG DES SEL, V27, P235, DOI 10.1093/protein/gzu020; Chen W, 2009, J ORAL PATHOL MED, V38, P198, DOI 10.1111/j.1600-0714.2008.00706.x; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Ginsburg OM, 2011, BREAST J, V17, P289, DOI 10.1111/j.1524-4741.2011.01067.x; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHNSON JP, 1991, CANCER METAST REV, V10, P11, DOI 10.1007/BF00046840; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; Mohamed MM, CCS, V10, P3; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Samarelli AV, 2014, J BIOL CHEM, V289, P19466, DOI 10.1074/jbc.M113.530972; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Trojan L, 2005, ANTICANCER RES, V25, P183; Usami Y, 2013, INT J CANCER, V133, P568, DOI 10.1002/ijc.28066; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Wai Wong C, 2012, INT J CELL BIOL, DOI DOI 10.1155/2012/3402962012; Xin M, 2015, BIOMED PHARMACOTHER, V69, P179, DOI 10.1016/j.biopha.2014.11.024; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189662	10.1371/journal.pone.0189662	http://dx.doi.org/10.1371/journal.pone.0189662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244827	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700045
J	Rajaram, S; Wiecek, W; Lawson, R; Blak, BT; Zhao, YL; Hackett, J; Brody, R; Patel, V; Amzal, B				Rajaram, Sankarasubramanian; Wiecek, Witold; Lawson, Richard; Blak, Betina T.; Zhao, Yanli; Hackett, Judith; Brody, Robert; Patel, Vishal; Amzal, Billy			Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach	PLOS ONE			English	Article							SEASONAL INFLUENZA; UNITED-KINGDOM; INFECTION; TRANSMISSION; EPIDEMIC; ADULTS	Introduction During the 2013 -2014 influenza season, Public Health England extended routine influenza vaccination to all 2-and 3-year-old children in England. To estimate the impact of this change in policy on influenza-related morbidity and mortality, we developed a disease transmission and surveillance model informed by real-world data. Methods We combined real-world and literature data sources to construct a model of influenza transmission and surveillance in England. Data were obtained for four influenza seasons, starting with the 2010-2011 season. Bayesian inference was used to estimate model parameters on a season-by-season basis to assess the impact of targeting 2-and 3-year-old children for influenza vaccination. This provided the basis for the construction of counterfactual scenarios comparing vaccination rates of similar to 2% and similar to 35% in the 2-and 3-year-old population to estimate reductions in general practitioner (GP) influenza-like-illness (ILI) consultations, respiratory hospitalizations and deaths in the overall population. Results Our model was able to replicate the main patterns of influenza across the four seasons as observed through laboratory surveillance data. Targeting 2-and 3-year-old children for influenza vaccination resulted in reductions in the general population of between 6.2-9.9% in influenza-attributable GP ILI consultations, 6.1-10.7% in influenza-attributable respiratory hospitalizations, and 5.7-9.4% in influenza-attributable deaths. The decrease in influenzaattributable ILI consultations represents a reduction of between 4.5% and 7.3% across all ILI consultations. The reduction in influenza-attributable respiratory hospitalizations represents a reduction of between 1.2% and 2.3% across all respiratory hospitalizations. Reductions in influenza-attributable respiratory deaths represent a reduction of between 0.9% and 2.4% in overall respiratory deaths. Conclusion This study has provided evidence that extending routine influenza vaccination to all healthy children aged 2 and 3 years old leads to benefits in terms of reduced utilization of healthcare resources and fewer respiratory health outcomes and deaths.	[Rajaram, Sankarasubramanian; Blak, Betina T.] AstraZeneca, Luton, Beds, England; [Wiecek, Witold; Patel, Vishal; Amzal, Billy] LASER Analyt, London, England; [Lawson, Richard; Hackett, Judith; Brody, Robert] AstraZeneca, Gaithersburg, MD USA; [Zhao, Yanli] MedImmune, Gaithersburg, MD USA	AstraZeneca; AstraZeneca; AstraZeneca; Medimmune		rajram75@yahoo.com	Rajaram, Sankara/AAK-3204-2021; zhao, yan/GWC-9174-2022	Rajaram, Sankarasubramanian/0000-0002-8988-7511	AstraZeneca; Laser Analytica	AstraZeneca(AstraZeneca); Laser Analytica	This study was supported by AstraZeneca. Sankarasubramanian Rajaram is a former employee of AstraZeneca; Richard Lawson, Betina Blak, Judith Hackett, and Robert Brody are employees of AstraZeneca; Yanli Zhao is an employee of MedImmune, the biologics arm of AstraZeneca. Witold Wiecek and Billy Amzal are employees of LASER Analytica who have received funding for the current study from AstraZeneca. Vishal Patel is a former employee of LASER Analytica. The funder provided support in the form of salaries for authors Betina Blak, Robert Brody, Judith Hackett, Richard Lawson, Yanli Zhao, and Sankarasubramanian Rajaram (during the time of the study when Sankarasubramanian Rajaram was employed by AstraZeneca) and funding to Laser Analytica to conduct the study. Members of AstraZeneca were permitted to review the manuscript and offer comments, but the authors decided whether or not to address these comments. Editorial support was provided by Sinead Stewart and Talya Underwood, MPhil (Cantab) of Prime Global, Knutsford, UK, funded by AstraZeneca, in accordance with Good Publication Practice guidelines (Link). AstraZeneca did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D, 1980, BIOMETRIKA, V67, P191; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Department of Health, 2016, FLU IMM PROGR 2013 1; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Esposito S, 2006, VACCINE, V24, P629, DOI 10.1016/j.vaccine.2005.08.054; Fleming DM, 2016, EPIDEMIOL INFECT, V144, P537, DOI 10.1017/S0950268815001119; Fleming DM, 2010, J EPIDEMIOL COMMUN H, V64, P1062, DOI 10.1136/jech.2009.093450; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Fleming DM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1218-z; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Hardelid P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138659; Health Protection Agency, 2016, SURV INFL OTH RESP P; Health Protection Agency, 2016, SURV INFL OTH RESP V; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Jefferson Tom, 2010, COCHRANE DB SYST REV, V2010, P7; Jit M, 2013, HUM VACC IMMUNOTHER, V9, P834, DOI 10.4161/hv.23637; Loeb M, 2016, ANN INTERN MED, V165, P617, DOI 10.7326/M16-0513; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Matias G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3128-4; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; PEBODY R, 2014, EURO SURVEILL, V19; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Public Health England, 2016, PHE WEEKL INFL REP 2; Public Health England, 2016, SURV INFL OTH RESP V; Public Health England, 2016, SURV INFL OTH RESP V; Rajaram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010625; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; The Joint Committee on Vaccination and Immunisation, 2016, JCV STAT ANN INFL VA; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; WHO, 2014, INFL SEAS 2014; Wiccek W, 2015, VALUE HEALTH, V18, pA579, DOI 10.1016/j.jval.2015.09.1931; Zhao H, 2014, EURO SURVEILL, V19	41	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0186739	10.1371/journal.pone.0186739	http://dx.doi.org/10.1371/journal.pone.0186739			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244811	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700001
J	Miao, ZQ; Zhang, GX; Zhang, JZ; Li, JH; Yang, Y				Miao, Zhiqiang; Zhang, Guixian; Zhang, Junzhen; Li, Jianhui; Yang, Yu			Effect of early dietary energy restriction and phosphorus level on subsequent growth performance, intestinal phosphate transport, and AMPK activity in young broilers	PLOS ONE			English	Article							EARLY FEED RESTRICTION; MESSENGER-RNA EXPRESSION; NUTRIENT DENSITY; NAPI-IIB; FOOD-INTAKE; PROTEIN; AGE; COTRANSPORTER; METABOLISM; CALCIUM	We aimed to determine the effect of low dietary energy on intestinal phosphate transport and the possible underlying mechanism to explain the long-term effects of early dietary energy restriction and non-phytate phosphorus (NPP). A 2 x 3 factorial experiment, consisting of 2 energy levels and 3 NPP levels, was conducted. Broiler growth performance, intestinal morphology in 0-21 days and 22-35 days, type IIb sodium-phosphate co-transporter (NaPi-IIb) mRNA expression, adenylate purine concentrations in the duodenum, and phosphorylated adenosine monophosphate-activated protein kinase (AMPK-alpha) activity in 0-21 days were determined. The following results were obtained. (1) Low dietary energy (LE) induced a high feed conversion ratio (FCR) and significantly decreased body weight gain in young broilers, but LE induced significantly higher compensatory growth in low NPP (LP) groups than in the high or medium NPP groups (HP and MP). (2) LE decreased the villus height (VH) in the intestine, and LE-HP resulted in the lowest crypt depth (CD) and the highest VH:CD ratio in the initial phase. However, in the later period, the LE-LP group showed an increased VH:CD ratio and decreased CD in the intestine. (3) LE increased ATP synthesis and decreased AMP:ATP ratio in the duodenal mucosa of chickens in 0-21 days, and LP diet increased ATP synthesis and adenylate energy charges but decreased AMP production and AMP:ATP ratio. (4) LE led to weaker AMPK phosphorylation, higher mTOR phosphorylation, and higher NaPi-IIb mRNA expression. Thus, LE and LP in the early growth phase had significant compensatory and interactive effect on later growth and intestinal development in broilers. The effect might be relevant to energy status that LE leads to weaker AMPK phosphorylation, causing a lower inhibitory action toward mTOR phosphorylation. This series of events stimulates NaPi-IIb mRNA expression. Our findings provide a theoretical basis and a new perspective on intestinal phosphate transport regulation, with potential applications in broiler production.	[Miao, Zhiqiang; Zhang, Guixian; Zhang, Junzhen; Li, Jianhui; Yang, Yu] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong, Shanxi, Peoples R China	Shanxi Agricultural University	Li, JH; Yang, Y (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong, Shanxi, Peoples R China.	jianhui19840717@163.com; sxauywd@126.com			National Youth Science Fund Project [31301992]; Shanxi Agricultural University Youth Innovation Talent Support Fund Project [BJRC201603]; Shanxi Youth Science Fund Project [201601D202065]; National Science Fund Project [31472115]	National Youth Science Fund Project; Shanxi Agricultural University Youth Innovation Talent Support Fund Project; Shanxi Youth Science Fund Project; National Science Fund Project	This study was financially supported by the National Youth Science Fund Project (31301992), Shanxi Agricultural University Youth Innovation Talent Support Fund Project (BJRC201603), Shanxi Youth Science Fund Project (201601D202065), and National Science Fund Project (31472115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by the National Youth Science Fund Project (31301992), Shanxi Agricultural University Youth Innovation Talent Support Fund Project (BJRC201603), Shanxi Youth Science Fund Project (201601D202065), and National Science Fund Project (31472115).	ARMBRECHT HJ, 1990, MINER ELECTROL METAB, V16, P159; BAR A, 1981, J NUTR, V111, P399, DOI 10.1093/jn/111.3.399; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Brickett KE, 2007, POULTRY SCI, V86, P2117, DOI 10.1093/ps/86.10.2117; Camacho MA, 2004, POULTRY SCI, V83, P526, DOI 10.1093/ps/83.4.526; Casirola DM, 2006, FASEB J, V20, pA1274; Catache M, 2003, ACTA PAEDIATR, V92, P76, DOI 10.1111/j.1651-2227.2003.tb00473.x; Chen W, 2012, J POULT SCI, V49, P12, DOI 10.2141/jpsa.011001; Chin EH, 2013, J COMP PHYSIOL B, V183, P821, DOI 10.1007/s00360-013-0751-6; Dokladny K, 2016, J APPL PHYSIOL, V120, P692, DOI 10.1152/japplphysiol.00536.2015; Dudas PL, 2002, AM J PHYSIOL-REG I, V282, pR139, DOI 10.1152/ajpregu.00427.2001; Ferraris RP, 2001, J NUTR, V131, P779, DOI 10.1093/jn/131.3.779; Frederich M, 2009, J EXP BIOL, V212, P722, DOI 10.1242/jeb.021998; GARDINER EE, 1971, BRIT POULTRY SCI, V12, P31, DOI 10.1080/00071667108415851; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Hou YQ, 2011, BRIT J NUTR, V106, P357, DOI 10.1017/S0007114511000249; Katai K, 1999, BIOCHEM J, V343, P705, DOI 10.1042/0264-6021:3430705; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kirchner S, 2008, AM J CLIN NUTR, V87, P1028, DOI 10.1093/ajcn/87.4.1028; Kuhne H, 2016, NUTR RES, V36, P184, DOI 10.1016/j.nutres.2015.10.005; LEE M, 1961, J NUTR, V74, P249, DOI 10.1093/jn/74.3.249; Li JH, 2009, CHINA FEED, V17, P12; Li JH, 2017, ASIAN AUSTRAL J ANIM, V30, P221, DOI 10.5713/ajas.16.0540; Li JH, 2012, ASIAN AUSTRAL J ANIM, V25, P552, DOI 10.5713/ajas.2011.11266; Lippens M, 2000, BRIT POULTRY SCI, V41, P343, DOI 10.1080/713654926; Liu LL, 2016, CHINESE J ANIMAL NUT, V1, P92; Marks J, 2010, AM J PHYSIOL-RENAL, V299, pF285, DOI 10.1152/ajprenal.00508.2009; Meijer AJ, 2003, J NUTR, V133, p2057S, DOI 10.1093/jn/133.6.2057S; Ojano-Dirain CP, 2004, POULTRY SCI, V83, P1394, DOI 10.1093/ps/83.8.1394; Pan JQ, 2005, BRIT POULTRY SCI, V46, P374, DOI 10.1080/00071660500098152; Pi DA, 2014, J NUTR BIOCHEM, V25, P456, DOI 10.1016/j.jnutbio.2013.12.006; PLAVNIK I, 1989, POULTRY SCI, V68, P1118, DOI 10.3382/ps.0681118; Radanovic T, 2005, AM J PHYSIOL-GASTR L, V288, P51; Ren H, 2006, THESIS; Saddoris KL, 2010, J NUTR, V140, P731, DOI 10.3945/jn.109.110080; Shen YB, 2014, J ANIM SCI, V92, P5530, DOI 10.2527/jas.2014-7830; Shojaiefard M, 2006, BIOCHEM BIOPH RES CO, V345, P1611, DOI 10.1016/j.bbrc.2006.05.067; SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412; Tohno Y, 2014, BIOL TRACE ELEM RES, V161, P78, DOI 10.1007/s12011-014-0074-9; Tsiouris V, 2014, AVIAN PATHOL, V43, P139, DOI 10.1080/03079457.2014.889278; Tulipano G, 2012, ENDOCRINE, V42, P292, DOI 10.1007/s12020-012-9732-x; WALDROUP PW, 1975, POULTRY SCI, V54, P436, DOI 10.3382/ps.0540436; Wang X, 2014, POULTRY SCI, V93, P1463, DOI 10.3382/ps.2013-03838; Wang XY, 2015, BRIT J NUTR, V114, P553, DOI 10.1017/S0007114515001877; Williams KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1917, DOI 10.1152/ajpendo.00654.2006; Wu YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154410; Xu H, 2003, AM J PHYSIOL-CELL PH, V284, pC1262, DOI 10.1152/ajpcell.00456.2002; Xu H, 2002, AM J PHYSIOL-CELL PH, V282, pC487, DOI 10.1152/ajpcell.00412.2001; Xu H, 2001, AM J PHYSIOL-CELL PH, V280, pC628, DOI 10.1152/ajpcell.2001.280.3.C628; Xu S.Y., 2012, THESIS; Yang Y, 2007, J APPL POULTRY RES, V16, P280, DOI 10.1093/japr/16.2.280; Yi D, 2014, BRIT J NUTR, V111, P46, DOI 10.1017/S0007114513002171; Zhan XA, 2007, POULTRY SCI, V86, P654, DOI 10.1093/ps/86.4.654; Zhang S., 2009, THESIS; ZUBAIR AK, 1994, POULTRY SCI, V73, P529, DOI 10.3382/ps.0730529	56	6	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0186828	10.1371/journal.pone.0186828	http://dx.doi.org/10.1371/journal.pone.0186828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240752	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600001
J	Na, K; Oh, SH; Kim, SK				Na, Kiyong; Oh, Sang Ho; Kim, Sang Kyum			Acne keloidalis nuchae in Asian: A single institutional experience	PLOS ONE			English	Article							FOLLICULITIS; PREVALENCE; MANAGEMENT; SCALP	Acne keloidalis nuchae, a type of folliculitis involving the back of the neck, is common in black men, although rare cases have been reported in patients of other ethnicities. We analyzed the clinicopathological features of acne keloidalis nuchae in 17 Asians. Patients' age at the time of presentation ranged from 20 to 69 years. Most patients experienced the disease over 2 years (range, 3 months-20 years); follow-up data were available for 11 (65%) patients (range, 2-95 months). Nine (53%) patients had comorbidities, but none had a history of other skin disease or a family history of acne keloidalis nuchae. Macroscopically, seven (41%) patients had multiple erythematous pustulopapular lesions, and 10 (59%) had a single large plaque. Histopathologically, deep scarring folliculitis containing naked hair shafts was identified. In all cases, inflammation was most severe in the upper two-thirds of the dermis, and the differences in pustulopapular and plaque lesions were more prominent in the peri-inflammation area. Of the seven patients with plaque lesions treated with steroids alone or steroids and cryotherapy, three experienced plaque reduction. Acne keloidalis nuchae occurring in Asian patients frequently present with typical clinicopathological features, and therefore in spite of very low incidence the diagnosis of this disease entity should be considered in idiopathic scarring folliculitis of the posterior neck.	[Na, Kiyong; Kim, Sang Kyum] Yonsei Univ, Coll Med, Severance Hosp, Dept Pathol, Seoul, South Korea; [Oh, Sang Ho] Yonsei Univ, Coll Med, Severance Hosp, Dept Dermatol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Pathol, Seoul, South Korea.	nicekyumi@yuhs.ac	Na, Kiyong/V-1795-2018	Na, Kiyong/0000-0003-4220-6755; Oh, Sang Ho/0000-0002-4477-1400; Kim, Sang Kyum/0000-0003-0768-9923	National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931581]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: 2016R1D1A1B03931581). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: 2016R1D1A1B03931581).	Adegbidi H, 2005, INT J DERMATOL, V44, P49, DOI 10.1111/j.1365-4632.2005.02815.x; Bellavista S, 2012, GIORN ITAL DERMAT V, V147, P223; DINEHART SM, 1989, J DERMATOL SURG ONC, V15, P642, DOI 10.1111/j.1524-4725.1989.tb03603.x; Gloster HM, 2000, ARCH DERMATOL, V136, P1376, DOI 10.1001/archderm.136.11.1376; GRUNWALD MH, 1990, INT J DERMATOL, V29, P559, DOI 10.1111/j.1365-4362.1990.tb03468.x; HERZBERG AJ, 1990, AM J DERMATOPATH, V12, P109, DOI 10.1097/00000372-199004000-00001; Knable AL, 1997, J AM ACAD DERMATOL, V37, P570, DOI 10.1016/S0190-9622(97)70173-7; Loayza E, 2015, INT J DERMATOL, V54, pE183, DOI 10.1111/ijd.12092; Ogunbiyi A, 2005, J NATL MED ASSOC, V97, P736; Ogunbiyi A, 2015, BRIT J DERMATOL, V173, P22, DOI 10.1111/bjd.13422; Ogunbiyi A, 2016, CLIN COSMET INVESTI, V9, P483, DOI 10.2147/CCID.S99225; Piaserico S, 2009, ACTA DERM-VENEREOL, V89, P312, DOI 10.2340/00015555-0611; Pirmez R, 2016, AUSTRALAS J DERMATOL, V57, P156, DOI 10.1111/ajd.12271; Shapero J, 2011, J CUTAN MED SURG, V15, P238, DOI 10.2310/7750.2011.10057; Verma SB, 2010, AM J CLIN DERMATOL, V11, P433, DOI 10.2165/11537000-000000000-00000	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189790	10.1371/journal.pone.0189790	http://dx.doi.org/10.1371/journal.pone.0189790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240822	Green Submitted, gold, Green Published			2022-12-26	WOS:000417905600072
J	Roberts, PR; Zachariah, D; Morgan, JM; Yue, AM; Greenwood, EF; Phillips, PC; Kalra, PA; Green, D; Lewis, RJ; Kalra, PR				Roberts, Paul R.; Zachariah, Donah; Morgan, John M.; Yue, Arthur M.; Greenwood, Elizabeth F.; Phillips, Patrick C.; Kalra, Philip A.; Green, Darren; Lewis, Robert J.; Kalra, Paul R.			Monitoring of arrhythmia and sudden death in a hemodialysis population: The CRASH-ILR Study	PLOS ONE			English	Article							T-WAVE MORPHOLOGY; ATRIAL-FIBRILLATION; CARDIAC DEATH; DIALYSIS; DISEASE; EVENTS; EPIDEMIOLOGY; PERFORMANCE; PREVENTION; PROGNOSIS	Introduction It has been suggested that sudden cardiac death (SCD) contributes around 50% of cardiovascular and 27% of all-cause mortality in hemodialysis patients. The true burden of arrhythmias and arrhythmic deaths in this population, however, remains poorly characterised. Cardio Renal Arrhythmia Study in Hemodialysis (CRASH-ILR) is a prospective, implantable loop recorder single centre study of 30 established hemodialysis patients and one of the first to provide long-term ambulatory ECG monitoring. Methods 30 patients (60% male) aged 68 +/- 12 years receiving hemodialysis for 45 +/- 40 months with varied etiology (diabetes 37%, hypertension 23%) and left ventricular ejection fraction (LVEF) 55 +/- 8% received a Reveal XT implantable loop recorder (Medtronic, USA) between August 2011 and October 2014. ECG data from loop recorders were transmitted at each hemodialysis session using a remote monitoring system. Primary outcome was SCD or implantation of a (tachy or bradyarrhythmia controlling) device and secondary outcome, the development of arrhythmia necessitating medical intervention. Results During 379,512 hours of continuous ECG monitoring (mean 12,648 +/- 9,024 hours/patient), there were 8 deaths-2 SCD and 6 due to generalised deterioration/sepsis. 5 (20%) patients had a primary outcome event (2 SCD, 3 pacemaker implantations for bradyarrhythmia). 10 (33%) patients reached an arrhythmic primary or secondary end point. Median event free survival for any arrhythmia was 2.6 years (95% confidence intervals 1.6-3.6 years). Conclusions The findings confirm the high mortality rate seen in hemodialysis populations and contrary to initial expectations, bradyarrhythmias emerged as a common and potentially significant arrhythmic event.	[Roberts, Paul R.; Morgan, John M.; Yue, Arthur M.; Greenwood, Elizabeth F.; Phillips, Patrick C.] Southampton Univ Hosp, Southampton, Hants, England; [Zachariah, Donah; Lewis, Robert J.; Kalra, Paul R.] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England; [Kalra, Philip A.; Green, Darren] Salford Royal Hosp, Salford, Lancs, England	University of Southampton; Portsmouth Hospitals NHS Trust; Salford Royal NHS Foundation Trust; Salford Royal Hospital	Zachariah, D (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	donah.zachariah@nhs.net		Zachariah, Donah/0000-0002-2717-5594; Green, Darren/0000-0002-9370-8176	Portsmouth Hospitals NHS Trust, UK; Medtronic Ltd, UK	Portsmouth Hospitals NHS Trust, UK; Medtronic Ltd, UK(Medtronic)	CRASH ILR is sponsored by Portsmouth Hospitals NHS Trust, UK and partly funded by an unrestricted grant from Medtronic Ltd, UK. The funders however had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CRASH ILR is sponsored by Portsmouth Hospitals NHS Trust, UK and partly funded by an unrestricted grant from Medtronic Ltd, UK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, US REN DAT SYST USRD; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Bradshaw Pamela J, 2014, OPEN HEART, V1; Brown DW, 2005, AM J CARDIOL, V95, P409, DOI 10.1016/j.amjcard.2004.09.046; Charytan DM, 2016, CLIN J AM SOC NEPHRO, V11, P721, DOI 10.2215/CJN.09350915; Covic AC, 2013, ANN NONINVAS ELECTRO, V18, P188, DOI 10.1111/anec.12007; EDHAG O, 1976, ACTA MED SCAND, V200, P457; Genovesi S, 2013, EUROPACE, V15, P1025, DOI 10.1093/europace/eus412; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; Hickson LJ, 2014, AM J KIDNEY DIS, V64, P104, DOI 10.1053/j.ajkd.2013.11.018; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Lang Roberto M., RECOMMENDATIONS CARD; Lin CY, 2007, NEPHROL DIAL TRANSPL, V22, P2645, DOI 10.1093/ndt/gfm238; Mittal S, 2015, PACE, V38, P1464, DOI 10.1111/pace.12752; Oikawa K, 2009, INT J CARDIOL, V131, P370, DOI 10.1016/j.ijcard.2007.10.033; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Poulikakos D, 2014, J ELECTROCARDIOL, V47, P240, DOI 10.1016/j.jelectrocard.2013.11.010; Pun PH, 2015, NEPHROL DIAL TRANSPL, V30, P829, DOI 10.1093/ndt/gfu274; RANGANAT.N, 1972, CIRCULATION, V45, P282, DOI 10.1161/01.CIR.45.2.282; Rojo-Martinez E, 2013, REV NEUROLOGIA, V57, P251, DOI 10.33588/rn.5706.2013187; Sanders P, 2016, HEART RHYTHM, V13, P1425, DOI 10.1016/j.hrthm.2016.03.005; Saravanan P, 2010, INT J CARDIOL, V144, P431, DOI 10.1016/j.ijcard.2009.03.048; SHAW DB, 1985, BRIT HEART J, V53, P587; Silva RT, 2015, ARQ BRAS CARDIOL, V105, P493, DOI 10.5935/abc.20150106; Suzuki M, 2012, CLIN J AM SOC NEPHRO, V7, P1454, DOI 10.2215/CJN.09430911; Wong MCG, 2015, HEART RHYTHM, V12, P2047, DOI 10.1016/j.hrthm.2015.06.033; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108	27	28	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188713	10.1371/journal.pone.0188713	http://dx.doi.org/10.1371/journal.pone.0188713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240772	gold, Green Published, Green Submitted			2022-12-26	WOS:000417905600010
J	Zheng, AH; Jiang, B; Li, Y; Zhang, XH; Ding, C				Zheng, Aihua; Jiang, Bo; Li, Yan; Zhang, Xuehan; Ding, Chris			Elastic K-means using posterior probability	PLOS ONE			English	Article							FUZZY C-MEANS; ALGORITHM; CUT	The widely used K-means clustering is a hard clustering algorithm. Here we propose a Elastic K-means clustering model (EKM) using posterior probability with soft capability where each data point can belong to multiple clusters fractionally and show the benefit of proposed Elastic K-means. Furthermore, in many applications, besides vector attributes information, pairwise relations (graph information) are also available. Thus we integrate EKM with Normalized Cut graph clustering into a single clustering formulation. Finally, we provide several useful matrix inequalities which are useful for matrix formulations of learning models. Based on these results, we prove the correctness and the convergence of EKM algorithms. Experimental results on six benchmark datasets demonstrate the effectiveness of proposed EKM and its integrated model.	[Zheng, Aihua; Jiang, Bo; Zhang, Xuehan; Ding, Chris] Anhui Univ, Hefei, Anhui, Peoples R China; [Li, Yan] Anhui Broadcasting Movie & Televis Coll, Hefei, Anhui, Peoples R China	Anhui University	Zheng, AH (corresponding author), Anhui Univ, Hefei, Anhui, Peoples R China.	ahzheng214@ahu.edu.cn			Natural Science Foundation of Anhui Province [1508085QF127]; Natural Science Foundation of Anhui Higher Education Institutions of China [KJ2016A114]	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Natural Science Foundation of Anhui Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of Anhui Province (1508085QF127) and the Natural Science Foundation of Anhui Higher Education Institutions of China (KJ2016A114).	Bai CG, 2016, EUR J OPER RES, V248, P507, DOI 10.1016/j.ejor.2015.07.059; Bai X, 2008, ENTROPY BASED SOFT K; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; BEZDEK JC, 1980, IEEE T PATTERN ANAL, V2, P1, DOI 10.1109/TPAMI.1980.4766964; Biswas AK, 2014, IEEE INT C BIOINF BI, P97, DOI 10.1109/BIBE.2014.54; Bowen G. J., 2012, ISOMAP ISOSCAPES MOD; Deng T, 2014, COMM COM INF SC, V472, P88; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; HAGEN L, 1992, IEEE T COMPUT AID D, V11, P1074, DOI 10.1109/43.159993; Hu Z., 2014, ARXIV14036290; Huang J, 2014, ACM T KNOWL DISCOV D, V8, DOI 10.1145/2601434; Ji ZX, 2014, PATTERN RECOGN, V47, P2454, DOI 10.1016/j.patcog.2014.01.017; Jordan M, 2008, NEURAL COMPUT, V8, P129; Kim J, 2007, INT CONF ACOUST SPEE, P429; Lakizadeh A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159923; Lechner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105015; Li MJ, 2008, IEEE T KNOWL DATA EN, V20, P1519, DOI 10.1109/TKDE.2008.88; Li T, 2014, CH CRC DATA MIN KNOW, P149; Liu HF, 2012, IEEE T PATTERN ANAL, V34, P1299, DOI 10.1109/TPAMI.2011.217; Mejia-Roa E, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0485-4; Melin P, 2014, APPL SOFT COMPUT, V21, P568, DOI 10.1016/j.asoc.2014.04.017; Neumayer S, 2015, COMPUT NETW, V77, P117, DOI 10.1016/j.comnet.2014.10.026; Nie F, JOINT EUR C MACH LEA; Nie FP, 2011, IEEE T NEURAL NETWOR, V22, P1796, DOI 10.1109/TNN.2011.2162000; Polanski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134256; Qiao HL, 2015, PATTERN RECOGN LETT, V63, P71, DOI 10.1016/j.patrec.2015.05.019; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Tang JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142830; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tiantian Yang, 2014, Journal of Software, V9, P2120, DOI 10.4304/jsw.9.8.2120-2124; Wang Jianzhong, 2011, GEOMETRIC STRUCTURE, P221; Wu S, 2014, NEUROCOMPUTING, V135, P229, DOI 10.1016/j.neucom.2013.12.027; Xiang SM, 2011, IEEE T SYST MAN CY B, V41, P1250, DOI 10.1109/TSMCB.2011.2123886; Xu J., 2016, PROC INT J C ARTIF I, P2224; Yan X, 2012, P CIKM 2012 MIAM HI, P2259, DOI [10.1145/2396761.2398615, DOI 10.1145/2396761.2398615]; Yang HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164880; Yang  Yi, 2011, AAAI, P2; Yin XS, 2013, NEUROCOMPUTING, V103, P29, DOI 10.1016/j.neucom.2012.08.021; Yu YC, 2011, J SOFTWARE ENG; Zhang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122811; Zhang Z. Y., 2004, J SHANGHAI U ENGLISH, V8, P406, DOI DOI 10.1007/S11741-004-0051-1; Zhao ZH, 2013, CONSTR BUILD MATER, V43, P191, DOI 10.1016/j.conbuildmat.2013.01.032	44	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0188252	10.1371/journal.pone.0188252	http://dx.doi.org/10.1371/journal.pone.0188252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240756	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600006
J	Houser, J; Kozmon, S; Mishra, D; Mishra, SK; Romano, PR; Wimmerova, M; Koca, J				Houser, Josef; Kozmon, Stanislav; Mishra, Deepti; Mishra, Sushi K.; Romano, Patrick R.; Wimmerova, Michaels; Koca, Jaroslav			Influence of Trp flipping on carbohydrate binding in lectins. An example on Aleuria aurantia lectin AAL	PLOS ONE			English	Article							FUCOSE-SPECIFIC LECTIN; DISPERSION INTERACTIONS; CRYSTAL-STRUCTURE; PI INTERACTION; CORE FUCOSE; PROTEIN; APPROXIMATION; ENERGY; RECOGNITION; SPECIFICITY	Protein-carbohydrate interactions are very often mediated by the stacking CH-pi interactions involving the side chains of aromatic amino acids such as tryptophan (Trp), tyrosine (Tyr) or phenylalanine (Phe). Especially suitable for stacking is the Trp residue. Analysis of the PDB database shows Trp stacking for 265 carbohydrate or carbohydrate like ligands in 5 208 Trp containing motives. An appropriate model system to study such an interaction is the AAL lectin family where the stacking interactions play a crucial role and are thought to be a driving force for carbohydrate binding. In this study we present data showing a novel finding in the stacking interaction of the AAL Trp side chain with the carbohydrate. High resolution X-ray structure of the AAL lectin from Aleuria aurantia with alpha-methyl-L-fucoside ligand shows two possible Trp side chain conformations with the same occupation in electron density. The in silico data shows that the conformation of the Trp side chain does not influence the interaction energy despite the fact that each conformation creates interactions with different carbohydrate CH groups. Moreover, the PDB data search shows that the conformations are almost equally distributed across all Trp-carbohydrate complexes, which would suggest no substantial preference for one conformation over another.	[Houser, Josef; Kozmon, Stanislav; Mishra, Deepti; Mishra, Sushi K.; Wimmerova, Michaels; Koca, Jaroslav] Masaryk Univ, CEITEC MU Cent European Inst Technol, Brno, Czech Republic; [Houser, Josef; Wimmerova, Michaels; Koca, Jaroslav] Masaryk Univ, Natl Ctr Biomol Res, Fac Sci, Brno, Czech Republic; [Kozmon, Stanislav] Slovak Acad Sci, Inst Chem, Bratislava, Slovakia; [Mishra, Sushi K.] RIKEN, Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, Wako, Saitama, Japan; [Romano, Patrick R.] Baruch S Blumberg Inst, Doylestown, PA USA	Masaryk University Brno; Masaryk University Brno; Slovak Academy of Sciences; RIKEN	Wimmerova, M; Koca, J (corresponding author), Masaryk Univ, CEITEC MU Cent European Inst Technol, Brno, Czech Republic.; Wimmerova, M; Koca, J (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Fac Sci, Brno, Czech Republic.	michaw@chemi.muni.cz; jkoca@chemi.muni.cz	Mishra, Deepti/W-1605-2018; Mishra, Sushil K./AAV-9553-2021; Kozmon, Stanislav/AAQ-6945-2020; Koca, Jaroslav/E-4460-2012; Wimmerova, Michaela/A-4114-2010; Mishra, Sushil K./O-4779-2014; Houser, Josef/D-7319-2012	Mishra, Sushil K./0000-0002-3080-9754; Kozmon, Stanislav/0000-0002-0946-3453; Koca, Jaroslav/0000-0002-2780-4901; Wimmerova, Michaela/0000-0002-7108-4198; Mishra, Sushil K./0000-0002-3080-9754; Houser, Josef/0000-0003-4504-3891	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 [LQ1601]; Czech Science Foundation [13-25401S]; CESNET [LM2015042]; CERIT Scientific Cloud [LM2015085]; program SASPRO (ArIDARuM) [0005/01/02]; People Programme (Marie Curie Actions 7FP, grant REA) [609427]; Slovak Academy of Sciences	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020; Czech Science Foundation(Grant Agency of the Czech Republic); CESNET; CERIT Scientific Cloud; program SASPRO (ArIDARuM); People Programme (Marie Curie Actions 7FP, grant REA); Slovak Academy of Sciences(Slovak Academy of Sciences)	This work has been financially supported by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) and Czech Science Foundation (13-25401S). Additional computational resources were provided by the CESNET LM2015042 and the CERIT Scientific Cloud LM2015085, provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures". The research has been financed by the program SASPRO (ArIDARuM, 0005/01/02 - SK) and was co-funded by the People Programme (Marie Curie Actions 7FP, grant agreement REA no. 609427 - SK) and co-financed by the Slovak Academy of Sciences. SKM is an international fellow of the Japan Society for Proportion of Science.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Ahlrichs R, 2015, TURBOMOLE V7 0; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bekale L, 2015, COLLOID SURFACE B, V125, P309, DOI 10.1016/j.colsurfb.2014.11.037; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Case DA, 2014, AMBER 14; Chen WT, 2013, J AM CHEM SOC, V135, P9877, DOI 10.1021/ja4040472; Dingjan T, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00393; Eichkorn K, 1997, THEOR CHEM ACC, V97, P119, DOI 10.1007/s002140050244; EICHKORN K, 1995, CHEM PHYS LETT, V242, P652, DOI 10.1016/0009-2614(95)00838-U; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujihashi M, 2003, ACTA CRYSTALLOGR D, V59, P378, DOI 10.1107/S0907444902022175; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grossfield A., 2016, WHAM WEIGHTED HISTOG; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Houser J, 2015, ACTA CRYSTALLOGR D, V71, P442, DOI 10.1107/S1399004714026595; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Kozmon S, 2011, PHYS CHEM CHEM PHYS, V13, P14215, DOI 10.1039/c1cp21071h; Kozmon S, 2011, CHEM-EUR J, V17, P5680, DOI 10.1002/chem.201002876; Kulhanek P, 2013, PMFILIB TOOLKIT FREE; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Norton P, 2016, PROTEOMICS, V16, P3126, DOI 10.1002/pmic.201600064; Olausson J, 2008, GLYCOCONJUGATE J, V25, P753, DOI 10.1007/s10719-008-9135-7; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Romano PR, 2011, BIOCHEM BIOPH RES CO, V414, P84, DOI 10.1016/j.bbrc.2011.09.027; Sehnal D, 2015, NUCLEIC ACIDS RES, V43, pW383, DOI 10.1093/nar/gkv561; Sharma R, 2008, PHYS CHEM CHEM PHYS, V10, P2767, DOI 10.1039/b719764k; Sierka M, 2003, J CHEM PHYS, V118, P9136, DOI 10.1063/1.1567253; Spiwok V, 2017, MOLECULES, V22, DOI 10.3390/molecules22071038; Topin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071149; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Wimmerova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046032; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao Y, 2015, INTERDISCIP SCI, V7, P211, DOI 10.1007/s12539-015-0263-z	41	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189375	10.1371/journal.pone.0189375	http://dx.doi.org/10.1371/journal.pone.0189375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232414	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200036
J	Mohammadi, E; Pishevar, L; Boroujeni, PM				Mohammadi, Ehsan; Pishevar, Leila; Boroujeni, Parvin Mirzakouchaki			Effect of food simulating liquids on the flexural strength of a methacrylate and silorane-based composite	PLOS ONE			English	Article							PROVISIONAL RESTORATIVE MATERIALS; RESIN COMPOSITES; MECHANICAL-PROPERTIES; DENTAL COMPOSITES; SURFACE-ROUGHNESS; CHEMICAL DEGRADATION; SOLVENTS; WATER; HARDNESS; SORPTION	Objective The purpose of this study was to assess the effect of food-simulating liquids on the flexural strength of a methacrylate-based and a silorane-based resin composite. Materials and methods In this in vitro study, sixty specimens of Filtek P90 and Filtek Z350 composite were prepared in a customized mold (2 x 2 x 25 mm). The specimens of each composite were divided into five subgroups as follows: one as a control group and the other four groups included distilled water, heptane, 2% citric acid, and 50% aqueous ethanol. The specimens were stored in the solutions for one week at 37 degrees C, and the control group was stored at room temperature for the same period of time. Then, flexural strength values were measured. The statistical analysis was performed by One-Way ANOVA, Paired T test and post hoc LSD at a significance level of 0.05. Results In the control group, the mean flexural strength of Filtek P90 and Filtek Z350 were 155.1 MPa and 147.3 MPa, respectively, and there was no significant difference (P-value> 0.05). The mean flexural strength of Filtek P90 and Filtek Z350 significantly decreased in ethanol (P-value <0.05). Immersion in 0.02 N citric acid and heptane had no significant effect on the flexural strength of Filtek P90 and Filtek Z350. The maximum flexural strength of Filtek P90 was in the heptane group (192.6 MPa) and minimum flexural strength was in ethanol group (92.7 MPa) the maximum flexural strength of Filtek Z350 was in the heptane group (163.2 MPa) and minimum flexural strength was in the ethanol group (104.7 MPa). Conclusion The flexural strength of tested resin composites significantly affected by ethanol solution. The flexural strength of resin composites was not affected by other food simulating liquids.	[Mohammadi, Ehsan; Pishevar, Leila; Boroujeni, Parvin Mirzakouchaki] Islamic Azad Univ, Fac Dent, Dept Operat Dent, Isfahan Khorasgan Branch, Esfahan, Iran	Islamic Azad University	Pishevar, L (corresponding author), Islamic Azad Univ, Fac Dent, Dept Operat Dent, Isfahan Khorasgan Branch, Esfahan, Iran.	drleilapishevar@gmail.com		, leila/0000-0003-2575-0409				Akova T, 2006, DENT MATER, V22, P1130, DOI 10.1016/j.dental.2005.09.009; Anusavice K.J., 2003, PHILLIPS SCI DENT MA; ASMUSSEN E, 1984, SCAND J DENT RES, V92, P257; Badra VV, 2005, OPER DENT, V30, P213; CALAIS JG, 1988, J DENT RES, V67, P836, DOI 10.1177/00220345880670050801; Calheiros FC, 2013, DENT MATER J, V32, P228, DOI 10.4012/dmj.2012-271; Eick JD, 2006, J DENT, V34, P405, DOI 10.1016/j.jdent.2005.09.004; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Fong H, 2005, DENT MATER, V21, P520, DOI 10.1016/j.dental.2004.08.003; Arrais CAG, 2013, BRAZ ORAL RES, V27, P97, DOI 10.1590/S1806-83242013005000001; Hahnel S, 2010, OPER DENT, V35, P412, DOI 10.2341/09-337-L; Heintze SD, 2005, OPER DENT, V30, P617; KAO EC, 1989, DENT MATER, V5, P201, DOI 10.1016/0109-5641(89)90014-6; Lien W, 2010, DENT MATER, V26, P337, DOI 10.1016/j.dental.2009.12.004; MCKINNEY JE, 1985, J DENT RES, V64, P1326, DOI 10.1177/00220345850640111601; Oshida Y, 1999, BIO-MED MATER ENG, V9, P125; Sevimay M, 2008, J COMPOS MATER, V42, P69, DOI 10.1177/0021998307086205; Sideridou ID, 2011, DENT MATER, V27, P1003, DOI 10.1016/j.dental.2011.06.007; SODERHOLM KJ, 1982, ACTA ODONTOL SCAND, V40, P145, DOI 10.3109/00016358209012723; SODERHOLM KJM, 1983, J DENT RES, V62, P126, DOI 10.1177/00220345830620020801; Voltarelli FR, 2010, J APPL ORAL SCI, V18, P585, DOI 10.1590/S1678-77572010000600009; Vouvoudi EC, 2012, J MECH BEHAV BIOMED, V10, P87, DOI 10.1016/j.jmbbm.2012.02.007; Weinmann W, 2005, DENT MATER, V21, P68, DOI 10.1016/j.dental.2004.10.007; Yap AUJ, 2005, OPER DENT, V30, P129; Yap AUJ, 2000, OPER DENT, V25, P202; Yap AUJ, 2000, OPER DENT, V25, P170; Yap AUJ, 2004, DENT MATER, V20, P370, DOI 10.1016/j.dental.2003.06.001; Yap AUJ, 2001, J ORAL REHABIL, V28, P1015, DOI 10.1046/j.1365-2842.2001.00760.x; Yesilyurt C, 2009, DENT MATER J, V28, P362, DOI 10.4012/dmj.28.362	29	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188829	10.1371/journal.pone.0188829	http://dx.doi.org/10.1371/journal.pone.0188829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232691	Green Submitted, gold, Green Published			2022-12-26	WOS:000417698200011
J	Scheuer, S; Haase, D; Volk, M				Scheuer, Sebastian; Haase, Dagmar; Volk, Martin			Integrative assessment of climate change for fast-growing urban areas: Measurement and recommendations for future research	PLOS ONE			English	Article							GLOBAL LAND-USE; VULNERABILITY ASSESSMENT; SPATIALLY EXPLICIT; CHANGE ADAPTATION; ENVIRONMENTAL-CHANGE; METROPOLITAN REGION; CALIFORNIA DROUGHT; WATER-CONSUMPTION; ONGOING DROUGHT; AIR-TEMPERATURE	Over the 20th century, urbanization has substantially shaped the surface of Earth. With population rapidly shifting from rural locations towards the cities, urban areas have dramatically expanded on a global scale and represent crystallization points of social, cultural and economic assets and activities. This trend is estimated to persist for the next decades, and particularly the developing countries are expected to face rapid urban growth. The management of this growth will require good governance strategies and planning. By threatening the livelihoods, assets and health as foundations of human activities, another major global change contributor, climate change, became an equally important concern of stakeholders. Based on the climate trends observed over the 20th century, and a spatially explicit model of urbanization, this paper investigates the impacts of climate change in relation to different stages of development of urban areas, thus evolving a more integrated perspective on both processes. As a result, an integrative measure of climate change trends and impacts is proposed and estimated for urban areas worldwide. We show that those areas facing major urban growth are to a large extent also hotspots of climate change. Since most of these hotspots are located in the Global South, we emphasize the need for stakeholders to co-manage both drivers of global change. The presented integrative perspective is seen as a starting point to foster such co-management, and furthermore as a means to facilitate communication and knowledge exchange on climate change impacts.	[Scheuer, Sebastian; Haase, Dagmar] Humboldt Univ, Geog Dept, Landscape Ecol Lab, Berlin, Germany; [Haase, Dagmar; Volk, Martin] Helmholtz Ctr Environm Res Leipzig UFZ, Dept Computat Landscape Ecol, Leipzig, Germany	Humboldt University of Berlin; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Scheuer, S (corresponding author), Humboldt Univ, Geog Dept, Landscape Ecol Lab, Berlin, Germany.	sebastian.scheuer@geo.hu-berlin.de	Volk, Martin/F-1172-2010	Volk, Martin/0000-0003-0064-8133; Scheuer, Sebastian/0000-0002-5431-350X; Haase, Dagmar/0000-0003-4065-5194	AXA foundation; BiodivERsA project ENABLE [01LC1615A]; GREEN SURGE EU FP7 collaborative project GREENSURGE [FP7-ENV.2013.6.2-5-603567]	AXA foundation; BiodivERsA project ENABLE; GREEN SURGE EU FP7 collaborative project GREENSURGE	We thank the AXA foundation, the BiodivERsA project ENABLE (01LC1615A), and the GREEN SURGE EU FP7 collaborative project (FP7-ENV.2013.6.2-5-603567) GREENSURGE for financial support of this work.	Adenle AA, 2017, ECOL ECON, V141, P190, DOI 10.1016/j.ecolecon.2017.06.004; ANA (Agencia Nacional de Aguas), 2009, ATL REG METR AB URB; [Anonymous], 2016, LEARN LIV CHANG CLIM; Araos M, 2016, ENVIRON SCI POLICY, V66, P375, DOI 10.1016/j.envsci.2016.06.009; Barrett B, 2015, PREV MED, V70, P69, DOI 10.1016/j.ypmed.2014.11.013; Baumann M, 2016, J LAND USE SCI, V11, P672, DOI 10.1080/1747423X.2016.1241317; Becker A, 2013, EARTH SYST SCI DATA, V5, P71, DOI 10.5194/essd-5-71-2013; Binita KC, 2015, APPL GEOGR, V62, P62, DOI 10.1016/j.apgeog.2015.04.007; Boeckmann M, 2016, GEOFORUM, V73, P1, DOI 10.1016/j.geoforum.2016.04.006; Borsa AA, 2014, SCIENCE, V345, P1587, DOI 10.1126/science.1260279; Bronaugh D., 2019, ZYP ZHANG YUE PILON; Broto VC, 2017, WORLD DEV, V93, P1, DOI 10.1016/j.worlddev.2016.12.031; Chen C, 2016, ENVIRON SCI POLICY, V66, P403, DOI 10.1016/j.envsci.2016.05.007; Cheval S, 2014, GLOBAL PLANET CHANGE, V118, P85, DOI 10.1016/j.gloplacha.2014.04.005; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Compo GP, 2006, B AM METEOROL SOC, V87, P175, DOI 10.1175/BAMS-87-2-175; Croitoru AE, 2016, QUATERN INT, V415, P325, DOI 10.1016/j.quaint.2015.07.028; Doherty M, 2016, ENVIRON SCI POLICY, V66, P310, DOI 10.1016/j.envsci.2016.09.001; Domene E, 2006, URBAN STUD, V43, P1605, DOI 10.1080/00420980600749969; Easterling DR, 2000, J GEOPHYS RES-ATMOS, V105, P20101, DOI 10.1029/2000JD900166; EEA, 2007, CLIM CHANG WAT AD IS; Elagib NA, 2011, J HYDROL, V409, P612, DOI 10.1016/j.jhydrol.2011.08.047; Felizola ER, 2001, AN 10 S BRAS SENS RE; Fortes PTFO, 2007, AN 13 S BRAS SENS RE; Fragkias M., 2013, URBANIZATION BIODIVE, P409, DOI [10.1007/978-94-007-7088-1_21, DOI 10.1007/978-94-007-7088-1_21]; Gallo K, 2014, URBAN CLIM, V8, P1, DOI 10.1016/j.uclim.2014.04.005; Gocic M, 2013, GLOBAL PLANET CHANGE, V100, P172, DOI 10.1016/j.gloplacha.2012.10.014; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Guha-Sapir D., 2004, 30 YEARS NATURAL DIS; [GYA German Young Academy BAS Brazilian Academy of Sciences GNASL German National Academy of Sciences Leopoldina], 2014, WAT URB REG BUILD FU; Haase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066531; Hagen JO, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P801; Hardin E, 2017, SUSTAIN CITIES SOC, V28, P450, DOI 10.1016/j.scs.2016.09.004; Hatvani-Kovacs G, 2016, SUSTAIN CITIES SOC, V26, P278, DOI 10.1016/j.scs.2016.06.019; Hawtree D, 2015, HYDROL EARTH SYST SC, V19, P3033, DOI 10.5194/hess-19-3033-2015; Hofmann ME, 2011, GLOBAL ENVIRON CHANG, V21, P1106, DOI 10.1016/j.gloenvcha.2011.03.011; Kenny M. L., 2002, ETHICS PLACE ENV, V5, P123, DOI [10.1080/1366879022000020194, DOI 10.1080/1366879022000020194]; Kovats RS, 2005, RISK ANAL, V25, P1409, DOI 10.1111/j.1539-6924.2005.00688.x; Kumar P, 2016, LAND USE POLICY, V58, P514, DOI 10.1016/j.landusepol.2016.08.018; LEGATES DR, 1990, THEOR APPL CLIMATOL, V41, P11, DOI 10.1007/BF00866198; LETTENMAIER DP, 1994, J CLIMATE, V7, P586, DOI 10.1175/1520-0442(1994)007&lt;0586:HCTITC&gt;2.0.CO;2; Liu TT, 2016, ENVIRON SCI POLICY, V58, P41, DOI 10.1016/j.envsci.2016.01.002; Lorz C, 2012, ENVIRON EARTH SCI, V65, P1575, DOI 10.1007/s12665-011-1219-1; MacDonald GM, 2007, QUATERN INT, V173, P87, DOI 10.1016/j.quaint.2007.03.012; March H, 2010, PROF GEOGR, V62, P32, DOI 10.1080/00330120903375860; Marengo JA, 2015, CLIMATIC CHANGE, V129, P103, DOI 10.1007/s10584-014-1310-1; Matsuura K., 2015, TERRESTRIAL AIR TEMP; Matthews T, 2015, LANDSCAPE URBAN PLAN, V138, P155, DOI 10.1016/j.landurbplan.2015.02.010; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; McPhearson T, 2016, NATURE, V538, P165, DOI 10.1038/538165a; Metzger MJ, 2006, REG ENVIRON CHANGE, V6, P201, DOI 10.1007/s10113-006-0020-2; Modarres R, 2007, J ARID ENVIRON, V70, P344, DOI 10.1016/j.jaridenv.2006.12.024; Montgomery M., 2008, NEW GLOBAL FRONTIER, P17; [Office of Employment and Population Statistics Arizona Department of Administration], 2015, AR STAT COUNT POP PR; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Richman MB, 2015, PROCEDIA COMPUT SCI, V61, P428, DOI 10.1016/j.procs.2015.09.181; Romero-Lankao P, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1439; Russo S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124003; Satterthwaite D., 2007, ADAPTING CLIMATE CHA; SCCT (Surat Climate Change Trust), 2011, SUR CIT RES STRAT; Scheuer S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160471; Schneider U., 2011, GPCC DATA REP; Seto K. C, 2013, URBANIZATION BIODIVE, P1, DOI [10.1007/978-94-007-7088-1, DOI 10.1007/978-94-007-7088-1, DOI 10.1007/978-94-007-7088-1_1]; Seto KC, 2014, STRUNGMANN FORUM REP, P1; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Simon D, 2014, URBAN CLIM, V7, P1, DOI 10.1016/j.uclim.2014.02.005; Smith C, 2008, ENERG POLICY, V36, P4558, DOI 10.1016/j.enpol.2008.09.011; Solecki William, 2013, P485; Strauch M, 2013, J ENVIRON MANAGE, V127, pS24, DOI 10.1016/j.jenvman.2013.01.014; Tapia C, 2017, ECOL INDIC, V78, P142, DOI 10.1016/j.ecolind.2017.02.040; Taylor J, 2015, URBAN CLIM, V14, P517, DOI 10.1016/j.uclim.2015.08.001; Thomas F, 2014, ENVIRON SCI POLICY, V44, P271, DOI 10.1016/j.envsci.2014.08.011; Toni F, 2008, GLOBAL ENVIRON CHANG, V18, P575, DOI 10.1016/j.gloenvcha.2008.08.004; UN DESA (United Nations Department of Economics and Social Affairs), 2012, CLIM CHANG VULN ID L; UNEP, 2010, AFRICA WATER ATLAS; Wang XLL, 2001, J CLIMATE, V14, P2204, DOI 10.1175/1520-0442(2001)014<2204:COEWHI>2.0.CO;2; Whitaker JS, 2004, MON WEATHER REV, V132, P1190, DOI 10.1175/1520-0493(2004)132<1190:RWRUED>2.0.CO;2; WILLMOTT CJ, 1995, INT J CLIMATOL, V15, P221, DOI 10.1002/joc.3370150207; Yue S, 2003, THEOR APPL CLIMATOL, V75, P15, DOI 10.1007/s00704-002-0717-1; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654; Zuo W, 2017, INT J DISAST RISK RE, V24, P135, DOI 10.1016/j.ijdrr.2017.05.022	82	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189451	10.1371/journal.pone.0189451	http://dx.doi.org/10.1371/journal.pone.0189451			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP5YF	29232695	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200046
J	Thayer, KM; Galganov, JC; Stein, AJ				Thayer, Kelly M.; Galganov, Jesse C.; Stein, Avram J.			Dependence of prevalence of contiguous pathways in proteins on structural complexity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC MODULATORS; CONFORMATIONAL-CHANGE; MOLECULAR-BASIS; DYNAMICS; BINDING; MECHANISM; TRANSMISSION; TRANSITIONS; HYDROLYSIS	Allostery is a regulatory mechanism in proteins where an effector molecule binds distal from an active site to modulate its activity. Allosteric signaling may occur via a continuous path of residues linking the active and allosteric sites, which has been suggested by large conformational changes evident in crystal structures. An alternate possibility is that the signal occurs in the realm of ensemble dynamics via an energy landscape change. While the latter was first proposed on theoretical grounds, increasing evidence suggests that such a control mechanism is plausible. A major difficulty for testing the two methods is the ability to definitively determine that a residue is directly involved in allosteric signal transduction. Statistical Coupling Analysis (SCA) is a method that has been successful at predicting pathways, and experimental tests involving mutagenesis or domain substitution provide the best available evidence of signaling pathways. However, ascertaining energetic pathways which need not be contiguous is far more difficult. To date, simple estimates of the statistical significance of a pathway in a protein remain to be established. The focus of this work is to estimate such benchmarks for the statistical significance of contiguous pathways for the null model of selecting residues at random. We found that when 20% of residues in proteins are randomly selected, contiguous pathways at the 6 angstrom cutoff level were found with success rates of 51% in PDZ, 30% in p53, and 3% in MutS. The results suggest that the significance of pathways may have system specific factors involved. Furthermore, the possible existence of false positives for contiguous pathways implies that signaling could be occurring via alternate routes including those consistent with the energetic landscape model.	[Thayer, Kelly M.; Galganov, Jesse C.] Wesleyan Univ, Dept Math & Comp Sci, Middletown, CT 06459 USA; [Thayer, Kelly M.] Wesleyan Univ, Program Mol Biophys, Middletown, CT 06459 USA; [Thayer, Kelly M.] Wesleyan Univ, Dept Chem, Middletown, CT 06457 USA; [Galganov, Jesse C.] Wesleyan Univ, Program Bioinformat, Middletown, CT USA; [Stein, Avram J.] Wesleyan Univ, Dept Astron, Middletown, CT USA; [Stein, Avram J.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA	Wesleyan University; Wesleyan University; Wesleyan University; Wesleyan University; Wesleyan University; Wesleyan University	Thayer, KM (corresponding author), Wesleyan Univ, Dept Math & Comp Sci, Middletown, CT 06459 USA.; Thayer, KM (corresponding author), Wesleyan Univ, Program Mol Biophys, Middletown, CT 06459 USA.; Thayer, KM (corresponding author), Wesleyan Univ, Dept Chem, Middletown, CT 06457 USA.	kthayer@wesleyan.edu		Thayer, Kelly/0000-0001-7437-9517	National Science Foundation [CNS-0619508, CNS-0959856]	National Science Foundation(National Science Foundation (NSF))	The authors are grateful to the National Science Foundation for grants CNS-0619508 and CNS-0959856 to Wesleyan University for computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank David L. Beveridge for insightful discussion, and Henk Meij for technical support with high performance computing. JCG thanks Sean Segal for insight on algorithm optimization. Thanks to the National Science Foundation for grants CNS-0619508 and CNS-0959856 to Wesleyan University for computational resources.	Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Anderson KW, 2016, J BIOL CHEM, P9; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Barabasi AL, 2016, NETWORK SCIENCE, P1; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bhabha G, 2015, ACCOUNTS CHEM RES, V48, P423, DOI 10.1021/ar5003158; Bhattacharyya M, 2013, PROTEIN SCI, V22, P1399, DOI 10.1002/pro.2333; Case D.A, 2014, AMBER 14; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Feng ZW, 2015, AAPS J, V17, P1080, DOI 10.1208/s12248-015-9776-y; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Guo MY, 2015, J BACTERIOL, V197, P3317, DOI 10.1128/JB.00291-15; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hsin J, 2008, CURRENT PROTOCOLS BI, P33; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isogai S, 2016, NATURE, V530, P237, DOI 10.1038/nature16577; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Johnson CK, 2006, BIOCHEMISTRY-US, V45, P14233, DOI 10.1021/bi061058e; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; KORF RE, 1985, ARTIF INTELL, V27, P97, DOI 10.1016/0004-3702(85)90084-0; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krieger J, 2015, BIOPHYS J, V109, P1136, DOI 10.1016/j.bpj.2015.06.061; Lakhani B, 2017, J PHYS CHEM B; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Li HC, 2016, NUCLEIC ACIDS RES, V44, pD415, DOI 10.1093/nar/gkv1236; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Makarov GI, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1047, DOI 10.1134/S0006297915080106; Makhlynets OV, 2015, BIOCHEMISTRY-US, V54, P1444, DOI 10.1021/bi5015248; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; McLeish TCB, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056004; McLeish TCB, 2015, BIOPHYS J, V109, P1240, DOI 10.1016/j.bpj.2015.08.009; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Nosrati M., 2012, WORLD APPL PROGRAMMI, V2, P251; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Park HY, 2008, P NATL ACAD SCI USA, V105, P542, DOI 10.1073/pnas.0710810105; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Pieniazek SN, 2011, BIOPHYS J, V101, P1730, DOI 10.1016/j.bpj.2011.08.039; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; Ranganathan R, 2011, ORDER J THEORY ORDER, P1; REIF JH, 1985, INFORM PROCESS LETT, V20, P229, DOI 10.1016/0020-0190(85)90024-9; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Shang J, 2016, CHEM BIOL DRUG DES; SHARMA MB, 1989, INFORM PROCESS LETT, V32, P183, DOI 10.1016/0020-0190(89)90041-0; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Stolzenberg S, 2016, BIOCH BIOPHYS ACTA B, P1; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Tarjan R, 1971, SIAM J COMPUT, V1, P146; Thomas H., 2001, INTRO ALGORITHMS, V2nd; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Yang LW, 2006, NUCLEIC ACIDS RES, V34, pW24, DOI 10.1093/nar/gkl084; Zeng W, 2009, INT J GEOGR INF SCI, V23, P531, DOI 10.1080/13658810801949850; Zhou R, 2006, ARTIF INTELL, V170, P385, DOI 10.1016/j.artint.2005.12.002	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0188616	10.1371/journal.pone.0188616	http://dx.doi.org/10.1371/journal.pone.0188616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232711	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200007
J	Gao, X; Lampraki, EM; Al-Khalidi, S; Qureshi, MA; Desai, R; Wilson, JB				Gao, Xiao; Lampraki, Eirini-Maria; Al-Khalidi, Sarwah; Qureshi, Muhammad Asif; Desai, Rhea; Wilson, Joanna Beatrice			N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; NASOPHARYNGEAL CARCINOMA; DOUBLE-BLIND; ACTIVATION; CANCER; ALPHA; MODEL; MICE; INFECTION; INSIGHTS	Chronic inflammation results when the immune system responds to trauma, injury or infection and the response is not resolved. It can lead to tissue damage and dysfunction and in some cases predispose to cancer. Some viruses (including Epstein-Barr virus (EBV)) can induce inflammation, which may persist even after the infection has been controlled or cleared. The damage caused by inflammation, can itself act to perpetuate the inflammatory response. The latent membrane protein 1 (LMP1) of EBV is a pro-inflammatory factor and in the skin of transgenic mice causes a phenotype of hyperplasia with chronic inflammation of increasing severity, which can progress to pre-malignant and malignant lesions. LMP1 signalling leads to persistent deregulated expression of multiple proteins throughout the mouse life span, including TGF alpha S100A9 and chitinase-like proteins. Additionally, as the inflammation increases, numerous chemokines and cytokines are produced which promulgate the inflammation. Deposition of IgM, IgG, IgA and IgE and complement activation form part of this process and through genetic deletion of CD40, we show that this contributes to the more tissue-destructive aspects of the phenotype. Treatment of the mice with N-acetylcysteine (NAC), an antioxidant which feeds into the body's natural redox regulatory system through glutathione synthesis, resulted in a significantly reduced leukocyte infiltrate in the inflamed tissue, amelioration of the pathological features and delay in the inflammatory signature measured by in vivo imaging. Reducing the degree of inflammation achieved through NAC treatment, had the knock on effect of reducing leukocyte recruitment to the inflamed site, thereby slowing the progression of the pathology. These data support the idea that NAC could be considered as a treatment to alleviate chronic inflammatory pathologies, including post-viral disease. Additionally, the model described can be used to effectively monitor and accurately measure therapies for chronic inflammation.	[Gao, Xiao; Lampraki, Eirini-Maria; Al-Khalidi, Sarwah; Qureshi, Muhammad Asif; Desai, Rhea; Wilson, Joanna Beatrice] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Al-Khalidi, Sarwah] CRUK Cambridge Inst, Cambridge, England; [Qureshi, Muhammad Asif] DOW Univ, Karachi, Pakistan; [Desai, Rhea] Univ Auckland, Auckland, New Zealand	University of Glasgow; CRUK Cambridge Institute; Dow University of Health Sciences; University of Auckland	Wilson, JB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Joanna.wilson@glasgow.ac.uk	Desai, Rhea H/AAV-7005-2021; Lampraki, Eirini-Maria/U-5914-2019	Lampraki, Eirini-Maria/0000-0002-5688-8542; Al-Khalidi, Sarwah/0000-0002-6865-5498; Wilson, Joanna/0000-0003-4715-2530; Desai, Rhea/0000-0003-3311-3565; Qureshi, Prof. Dr. Muhammad Asif/0000-0002-8370-1069	China-University of Glasgow scholarship; Higher Education Commission of Pakistan/Dow University scholarship; Scottish Funding Council	China-University of Glasgow scholarship; Higher Education Commission of Pakistan/Dow University scholarship; Scottish Funding Council	XG was supported by a China-University of Glasgow scholarship. MAQ was a recipient of a Higher Education Commission of Pakistan/Dow University scholarship. EI and SA were supported by a studentship award from the Scottish Funding Council. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Baker WL, 2009, EUR J CARDIO-THORAC, V35, P521, DOI 10.1016/j.ejcts.2008.11.027; Baniyash M, 2006, SEMIN CANCER BIOL, V16, P80, DOI 10.1016/j.semcancer.2005.12.002; Berk M, 2013, TRENDS PHARMACOL SCI, V34, P167, DOI 10.1016/j.tips.2013.01.001; Blaschke S, 2000, J RHEUMATOL, V27, P866; Charalambous CT, 2007, CARCINOGENESIS, V28, P1839, DOI 10.1093/carcin/bgm055; Chen MJ, 2013, SCAND J GASTROENTERO, V48, P241, DOI 10.3109/00365521.2012.749509; Conrad C, 2014, J CYSTIC FIBROSIS OF; Dai W, 2016, P NATL ACAD SCI USA, V113, P3317, DOI 10.1073/pnas.1523436113; DOMINEY AM, 1993, CELL GROWTH DIFFER, V4, P1071; Forman HJ, 2001, MOL ASPECTS MED, V22, P1989; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Halliwell B, 2006, TRENDS BIOCHEM SCI, V31, P509, DOI 10.1016/j.tibs.2006.07.005; Hannigan A, 2007, J PROTEOME RES, V6, P3422, DOI 10.1021/pr0606878; Hannigan A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-11; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Leick M, 2014, CELL TISSUE RES, V355, P647, DOI 10.1007/s00441-014-1809-9; Liu B, 2009, MOL BIOL REP, V36, P761, DOI 10.1007/s11033-008-9241-4; Liu DD, 2008, CRIT CARE MED, V36, P565, DOI 10.1097/01.CCM.0000299737.24338.5C; Liu Y, 2007, EUR J PHARMACOL, V575, P142, DOI 10.1016/j.ejphar.2007.07.026; Loebel M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179124; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Lopez-Olivo MA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007356.pub2; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Oka S, 2000, FEBS LETT, V472, P196, DOI 10.1016/S0014-5793(00)01464-2; Ozdulger A, 2003, SHOCK, V19, P366, DOI 10.1097/00024382-200304000-00012; Paterson RL, 2003, CRIT CARE MED, V31, P2574, DOI 10.1097/01.CCM.0000089945.69588.18; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Qureshi Asif M, 2011, Genes Cancer, V2, P74, DOI 10.1177/1947601911402681; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Saeed M, 2014, JCPSP-J COLL PHYSICI, V24, pS216, DOI 11.2014/JCPSP.S216S218; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sansone Randy A, 2011, Innov Clin Neurosci, V8, P10; Stevenson D, 2005, CANCER RES, V65, P8826, DOI 10.1158/0008-5472.CAN-05-0591; SUTER PM, 1994, CHEST, V105, P190, DOI 10.1378/chest.105.1.190; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Wang HW, 2013, J CLIN IMMUNOL, V33, P649, DOI 10.1007/s10875-012-9852-3; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; You Y, 2009, DIGEST DIS SCI, V54, P1643, DOI 10.1007/s10620-008-0563-9; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zheng H, 2016, P NATL ACAD SCI USA, V113, P11283, DOI 10.1073/pnas.1607606113; ZONG YS, 1991, ONCOLOGY-BASEL, V48, P290	45	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189167	10.1371/journal.pone.0189167	http://dx.doi.org/10.1371/journal.pone.0189167			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228057	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000417648600038
J	Wang, LM; Cai, B; Zhou, SW; Zhu, HJ; Qu, L; Wang, XL; Chen, YL				Wang, Lamei; Cai, Bei; Zhou, Shiwei; Zhu, Haijing; Qu, Lei; Wang, Xiaolong; Chen, Yulin			RNA-seq reveals transcriptome changes in goats following myostatin gene knockout	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; SKELETAL-MUSCLE ATROPHY; ADIPOCYTE DIFFERENTIATION; TRANSGENIC EXPRESSION; MYOBLAST CELLS; GROWTH-FACTOR; CROSS-TALK; MICE; MUTATIONS; PROMOTES	Myostatin (MSTN) is a powerful negative regulator of skeletal muscle mass in mammalian species that is primarily expressed in skeletal muscles, and mutations of its encoding gene can result in the double-muscling trait. In this study, the CRISPR/Cas9 technique was used to edit MSTN in Shaanbei Cashmere goats and generate knockout animals. RNA sequencing was used to determine and compare the transcriptome profiles of the muscles from three wild-type (WT) goats, three fibroblast growth factor 5 (FGF5) knockout goats (FGF5(+/-)group) and three goats with disrupted expression of both the FGF5 and MSTN genes (FM(+/-)group). The sequence reads were obtained using the Illumina HiSeq 2000 system and mapped to the Capra hircus reference genome using TopHat (v2.0.9). In total, 68.93, 62.04 and 66.26 million clean sequencing reads were obtained from the WT, FM+/- and FGF5(+/-)groups, respectively. There were 201 differentially expressed genes (DEGs) between the WT and FGF5(+/-)groups, with 86 down-and 115 up-regulated genes in the FGF5(+/-)group. Between the WT and FM(+/-)groups, 121 DEGs were identified, including 81 down- and 40 up-regulated genes in the FM(+/-)group. A total of 198 DEGs were detected between the FGF5(+/-)group and FM(+/-)group, with 128 down- and 70 up-regulated genes in the FM(+/-)group. At the transcriptome level, we found substantial changes in genes involved in fatty acid metabolism and the biosynthesis of unsaturated fatty acids, such as stearoyl-CoA dehydrogenase, 3-hydroxyacyl-CoA dehydratase 2, ELOVL fatty acid elongase 6 and fatty acid synthase, suggesting that the expression levels of these genes may be directly regulated by MSTN and that these genes are likely downstream targets of MSTN with potential roles in lipid metabolism in goats. Moreover, five randomly selected DEGs were further validated with qRT-PCR, and the results were consistent with the transcriptome analysis. The present study provides insight into the unique transcriptome profile of the MSTN knockout goat, which is a valuable resource for studying goat genomics.	[Wang, Lamei; Cai, Bei; Zhou, Shiwei; Wang, Xiaolong; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Zhu, Haijing; Qu, Lei] Shaanxi Prov Engn & Technol Res Ctr Cashmere Goat, Yulin, Peoples R China; [Zhu, Haijing; Qu, Lei] Yulin Univ, Life Sci Res Ctr, Yulin, Peoples R China	Northwest A&F University - China; Yulin University	Chen, YL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	chenyulin@nwafu.edu.cn			National Natural Science Foundation of China [31372279, 31171377, 31572369, 31402038]; China Agriculture Research System [CARS-39-12]; Major Projects for New Varieties of Genetically Modified Organisms of China [2014ZX08008-002]; key Research Program of Shaanxi Province [2017NY-072]; Special Fund for Agro-scientific Research in the Public Interest [201303059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Major Projects for New Varieties of Genetically Modified Organisms of China; key Research Program of Shaanxi Province; Special Fund for Agro-scientific Research in the Public Interest	This work is supported by National Natural Science Foundation of China (31372279, 31171377, 31572369) to YC, and China Agriculture Research System (CARS-39-12) to YC, as well as the Major Projects for New Varieties of Genetically Modified Organisms of China (2014ZX08008-002) to YC, National Natural Science Foundation of China (31402038) and the key Research Program of Shaanxi Province (2017NY-072) to XW, and the Special Fund for Agro-scientific Research in the Public Interest (201303059) to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Belov AA, 2013, COLD SPRING HARBOR P, V5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Braun Susanne, 2002, European Journal of Cell Biology, V81, P375, DOI 10.1078/0171-9335-00258; Breitbart A, 2011, AM J PHYSIOL-HEART C, V300, pH1973, DOI 10.1152/ajpheart.00200.2011; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Cassar-Malek I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-63; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen QL, 2016, FISH PHYSIOL BIOCHEM, V42, P979, DOI 10.1007/s10695-015-0190-2; Chiu CY, 1999, GENOMICS, V61, P66, DOI 10.1006/geno.1999.5936; Choi KS, 2016, CELL SIGNAL, V28, P1642, DOI 10.1016/j.cellsig.2016.07.015; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Dominique JE, 2006, EXP CELL RES, V312, P2401, DOI 10.1016/j.yexcr.2006.04.012; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Elliott B, 2012, ACTA PHYSIOL, V205, P324, DOI 10.1111/j.1748-1716.2012.02423.x; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gerwins P, 2000, CRIT REV ONCOL HEMAT, V34, P185, DOI 10.1016/S1040-8428(00)00062-7; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Glenn TC, GDF11 INCREASES AGE; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; James NA, 1997, J ANIM SCI, V75, P571; Kainulainen H, 2015, MOL CELL ENDOCRINOL, V399, P131, DOI 10.1016/j.mce.2014.10.001; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; Kirk S, 2000, J CELL PHYSIOL, V184, P356, DOI 10.1002/1097-4652(200009)184:3<356::AID-JCP10>3.0.CO;2-R; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Kwon DY, 2013, MOL BIOL CELL, V24, P1863, DOI 10.1091/mbc.E13-01-0042; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lin J, 2010, NEUROSCIENCE, V165, P168, DOI 10.1016/j.neuroscience.2009.10.032; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Ma SSQ, 2016, VIRCHOWS ARCH, P1; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marsh A, 2016, PLOS ONE, V11; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakamura S, 2016, CURR BIOL, V26, P775, DOI 10.1016/j.cub.2016.01.024; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Ohsaki H, 2007, COMP BIOCHEM PHYS A, V148, P629, DOI 10.1016/j.cbpa.2007.08.004; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Patel UA, 2015, BIOTECHNOL PROGR, V31, P452, DOI 10.1002/btpr.2022; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Rossi AC, 2010, J PHYSIOL-LONDON, V588, P353, DOI 10.1113/jphysiol.2009.181008; Sadkowski T, 2008, J APPL GENET, V49, P237, DOI 10.1007/BF03195620; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripathi AK, 2013, APPL BIOCHEM BIOTECH, V169, P688, DOI 10.1007/s12010-012-0021-1; Uemura K, 2017, FEBS OPEN BIO, V7, P522, DOI 10.1002/2211-5463.12200; Uzman A., 2001, BIOCH MOL BIOL ED, V29, P126; Wang LW, 2010, PHARMACOGENET GENOM, V20, P401, DOI 10.1097/FPC.0b013e3283352860; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang XL, 2017, CRISPR CAS9 MEDIATED; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	98	16	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0187966	10.1371/journal.pone.0187966	http://dx.doi.org/10.1371/journal.pone.0187966			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228005	gold, Green Submitted, Green Published			2022-12-26	WOS:000417648600006
J	Bognar, Z; Fekete, K; Antus, C; Hocsak, E; Bognar, R; Tapodi, A; Boronkai, A; Farkas, N; Gallyas, F; Sumegi, B; Szanto, A				Bognar, Zita; Fekete, Katalin; Antus, Csenge; Hocsak, Eniko; Bognar, Rita; Tapodi, Antal; Boronkai, Arpad; Farkas, Nelli; Gallyas, Ferenc, Jr.; Sumegi, Balazs; Szanto, Arpad			Desethylamiodarone - A metabolite of amiodarone - Induces apoptosis on T24 human bladder cancer cells via multiple pathways	PLOS ONE			English	Article							N-DESETHYLAMIODARONE; P53; CARCINOMA; THERAPY; CYCLE; KINASE; ERK; IDENTIFICATION; ACCUMULATION; PRESERVATION	Bladder cancer (BC) is a common malignancy of the urinary tract that has a higher frequency in men than in women. Cytostatic resistance and metastasis formation are significant risk factors in BC therapy; therefore, there is great interest in overcoming drug resistance and in initiating research for novel chemotherapeutic approaches. Here, we suggest that desethylamiodarone (DEA) - a metabolite of amiodarone D may have cytostatic potential. DEA activates the collapse of mitochondrial membrane potential (detected by JC1 fluorescence), and induces cell death in T24 human transitional-cell bladder carcinoma cell line at physiologically achievable concentrations. DEA induces cell cycle arrest in the G0/G1 phase, which may contribute to the inhibition of cell proliferation, and shifts the Bax/ Bcl-2 ratio to initiate apoptosis, induce AIF nuclear translocation, and activate PARP-1 cleavage and caspase-3 activation. The major cytoprotective kinases D ERK and Akt D are inhibited by DEA, which may contribute to its cell death-inducing effects. DEA also inhibits the expression of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) and reduces colony formation of T24 bladder carcinoma cells, indicating its possible inhibitory effect on metastatic potential. These data show that DEA is a novel anti-cancer candidate of multiple cell death-inducing effects and metastatic potential. Our findings recommend further evaluation of its effects in clinical studies.	[Bognar, Zita; Fekete, Katalin; Antus, Csenge; Hocsak, Eniko; Bognar, Rita; Tapodi, Antal; Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Boronkai, Arpad] Univ Pecs, Dept Oncotherapy, Pecs, Hungary; [Farkas, Nelli] Univ Pecs, Inst Bioanal, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] MTA PTE Nucl Mitochondrial Res Grp, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Szanto, Arpad] Univ Pecs, Dept Urol, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Bognar, Z (corresponding author), Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary.	zita.bognar@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Gallyas, Ferenc/C-2272-2012	Farkas, Nelli/0000-0002-5349-6527	 [GINOP-2.3.2-15-2016-00049];  [GINOP-2.3.3-15-2016-00025];  [EFOP-3.6.1-16-2016-00004]	; ; 	This work was supported by GINOP-2.3.2-15-2016-00049 (Balazs Sumegi), https://www.palyazat.gov.hu; GINOP-2.3.3-15-2016-00025 (Balazs Sumegi), https://www.palyazat.gov.hu; and EFOP-3.6.1-16-2016-00004 (Balazs Sumegi), https://www.palyazat.gov.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PC, 1985, CIRCULATION, V72, P1064, DOI 10.1161/01.CIR.72.5.1064; Bhattacharya R, 2015, GENES DIS, V2, P225, DOI 10.1016/j.gendis.2015.04.001; BOS JL, 1989, CANCER RES, V49, P4682; Bosetti C, 2011, EUR UROL, V60, P1, DOI 10.1016/j.eururo.2011.03.047; BRIEN JF, 1987, CAN J PHYSIOL PHARM, V65, P360, DOI 10.1139/y87-062; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; COOPER MJ, 1994, ONCOL RES, V6, P569; CordonCardo C, 1997, CANCER RES, V57, P1217; DANIELS JM, 1989, TOXICOL APPL PHARM, V100, P350, DOI 10.1016/0041-008X(89)90321-9; Deng P, 2011, DRUG METAB DISPOS, V39, P1058, DOI 10.1124/dmd.110.037671; Dobashi Y, 2003, CURR MED CHEM, V10, P2549, DOI 10.2174/0929867033456495; Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GOEBL MG, 1991, CELL, V66, P623, DOI 10.1016/0092-8674(91)90106-9; Grossman HB, 1998, CLIN CANCER RES, V4, P829; Grossmann M, 2000, CLIN PHARMACOL THER, V67, P22, DOI 10.1067/mcp.2000.103822; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Himmel HM, 2000, N-S ARCH PHARMACOL, V362, P489, DOI 10.1007/s002100000301; HOLT DW, 1983, AM HEART J, V106, P840, DOI 10.1016/0002-8703(83)90006-6; Itahana Koji, 2010, Epigenomics, V2, P610; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Joshi Ashish, 2011, Perspect Health Inf Manag, V8, p1e; KANNAN R, 1989, FUND APPL TOXICOL, V13, P793, DOI 10.1016/0272-0590(89)90334-5; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li C, 2005, BRIT J CANCER, V92, P80, DOI 10.1038/sj.bjc.6602272; Malats W, 2005, LANCET ONCOL, V6, P678; Monni L, 2017, NEUROSCI LETT, V655, P95, DOI 10.1016/j.neulet.2017.06.040; PALLANDI RT, 1987, BRIT J PHARMACOL, V92, P97, DOI 10.1111/j.1476-5381.1987.tb11300.x; Park HS, 2013, MAR DRUGS, V11, P2347, DOI 10.3390/md11072347; Park HS, 2011, J FOOD SCI, V76, pT77, DOI 10.1111/j.1750-3841.2011.02099.x; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Qin ZK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-61; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Robert G, 2012, ONCOTARGET, V3, P1688; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Soyama A, 2002, PHARMACOL TOXICOL, V91, P174, DOI 10.1034/j.1600-0773.2002.910404.x; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Sternberg CN, 2007, UROLOGY, V69, P62, DOI 10.1016/j.urology.2006.10.041; Varbiro G, 2003, J PHARMACOL EXP THER, V307, P615, DOI 10.1124/jpet.103.053553; Varro A, 1996, BRIT J PHARMACOL, V117, P1181, DOI 10.1111/j.1476-5381.1996.tb16713.x; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Wu X, 2004, BJU INT, V93, P143, DOI 10.1111/j.1464-410X.2004.04574.x; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yao WL, 2015, CANCER LETT, V364, P70, DOI 10.1016/j.canlet.2015.04.028; Ye Q, 2014, ONCOGENE, V33, P1828, DOI 10.1038/onc.2013.122	54	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189470	10.1371/journal.pone.0189470	http://dx.doi.org/10.1371/journal.pone.0189470			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220397	Green Submitted, Green Published, gold			2022-12-26	WOS:000417469900060
J	Yonekura, S; Kuniyoshi, Y				Yonekura, Shogo; Kuniyoshi, Yasuo			Bodily motion fluctuation improves reaching success rate in a neurophysical agent via geometric-stochastic resonance	PLOS ONE			English	Article							NOISE; SYSTEMS	Organisms generate a variety of noise types, including neural noise, sensory noise, and noise resulting from fluctuations associated with movement. Sensory and neural noises are known to induce stochastic resonance (SR), which improves information transfer to the subjects control systems, including the brain. As a consequence, sensory and neural noise provide behavioral benefits, such as stabilization of posture and enhancement of feeding efficiency. In contrast, the benefits of fluctuations in the movements of a biological system remain largely unclear. Here, we describe a novel type of noise-induced order (NIO) that is realized by actively exploiting the motion fluctuations of an embodied system. In particular, we describe the theoretical analysis of a feedback-controlled embodied agent system that has a geometric end-effector. Furthermore, through several numerical simulations we demonstrate that the ratio of successful reaches to goal positions and capture of moving targets are improved by the exploitation of motion fluctuations. We report that reaching success rate improvement (RSRI) is based on the interaction of the geometric size of an end-effector, the agents motion fluctuations, and the desired motion frequency. Therefore, RSRI is a geometrically induced SR-like phenomenon. We also report an interesting result obtained through numerical simulations indicating that the agents neural and motion noise must be optimized to match the prey's motion noise in order to maximize the capture rate. Our study provides a new understanding of body motion fluctuations, as they were found to be the active noise sources for a behavioral NIO.	[Yonekura, Shogo; Kuniyoshi, Yasuo] Univ Tokyo, Tokyo, Japan	University of Tokyo	Yonekura, S; Kuniyoshi, Y (corresponding author), Univ Tokyo, Tokyo, Japan.	yonekura@isi.imi.i.u-tokyo.ac.jp; kuniyosh@isi.imi.i.u-tokyo.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO, http://www.nedogodp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Bulsara AR, 1996, PHYS TODAY, V49, P39, DOI 10.1063/1.881491; Burada PS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.130602; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Freund JA, 2002, J THEOR BIOL, V214, P71, DOI 10.1006/jtbi.2001.2445; Freund JA, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031910; Gammaitoni L, 1989, PHYS REV A, V40, P2114, DOI 10.1103/PhysRevA.40.2114; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Ghosh PK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.020601; HANGGI P, 1993, J STAT PHYS, V70, P25, DOI 10.1007/BF01053952; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hennig MH, 2002, NEUROCOMPUTING, V44, P115, DOI 10.1016/S0925-2312(02)00371-5; HU G, 1990, PHYS REV A, V42, P2030, DOI 10.1103/PhysRevA.42.2030; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Lindner B., 2002, COHERENCE STOCHASTIC; McDonnel MD, 2005, PLOS COMPUTATIONAL B, V5; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Rolls ET, 2014, EMOTION DECISION MAK; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Ward LM, 2002, BIOL CYBERN, V87, P91, DOI 10.1007/s00422-002-0328-z; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Yonekura S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011922; Zheng CM, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/60004	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188298	10.1371/journal.pone.0188298	http://dx.doi.org/10.1371/journal.pone.0188298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220402	gold, Green Published, Green Submitted			2022-12-26	WOS:000417469900009
J	Brinkhof, S; Groen, HJM; Siesling, SS; IJzerman, MJ				Brinkhof, Sander; Groen, Harry J. M.; Siesling, Sabine S.; IJzerman, Maarten J.			Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences	PLOS ONE			English	Article							PLASMA DNA; FRANCE	Objectives The main objective of this study is to determine the current use of lung cancer diagnostic procedures in two large hospitals in the Netherlands, to explore deviations in guideline adherence between the hospitals, and to estimate the budget impact of the diagnostic workup as well as the over- and underutilization. Materials & methods A state transition model for the diagnostic pathway for lung cancer patients was developed using existing clinical practice guidelines (CPG) combined with a systematic literature. In addition to the CPGs depicting current practice, diagnostic utilization was gathered in two large hospitals representing an academic tertiary care hospital and a large regional teaching hospital for patients, who were selected from the Netherlands cancer registry. Results The total population consisted of 376 patients with lung cancer. Not in all cases the guideline was followed, for instance in the usage of MR brain with stage III lung cancer patients (n = 70). The state-transition model predicts an average budget impact for the diagnostic pathway per patient estimated of (sic) 2496 in the academic tertiary care hospital and (sic) 2191 in the large regional teaching hospital. Conclusion The adherence to the CPG's differed between hospitals, which questions the adherence to CPG's in general. Adherence to CPG's could lead to less costs in the diagnostic pathway for lung cancer patients.	[Brinkhof, Sander; Siesling, Sabine S.; IJzerman, Maarten J.] Univ Twente, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Siesling, Sabine S.] Comprehens Canc Org, Utrecht, Netherlands; [IJzerman, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Med Sch, Dept Radiol, Groningen, Netherlands	University of Twente; University of Groningen; University of Groningen	IJzerman, MJ (corresponding author), Univ Twente, Dept Hlth Technol & Serv Res, Enschede, Netherlands.; IJzerman, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Med Sch, Dept Radiol, Groningen, Netherlands.	m.j.ijzerman@utwente.nl	Groen, Harry/AAP-2242-2021; IJzerman, Maarten/AAB-6894-2020	IJzerman, Maarten/0000-0001-5788-5805; Brinkhof, Sander/0000-0002-2377-6317; Groen, Harry J.M./0000-0002-2978-5265				Bommel ACMVAN, 2016, CLIN AUDITING INSTRU, P1; Chouaid C, 2004, BRIT J CANCER, V90, P397, DOI 10.1038/sj.bjc.6601547; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Flanagan MR, 2015, ANN THORAC SURG, V100, P2006, DOI 10.1016/j.athoracsur.2015.08.010; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Integraal Kankercentrum Nederland, 2013, RAPP LONGK; Integraal Kankercentrum Nederland, 2012, DUTCH CANC REG; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kumar P, 2009, CLIN MED; McGuire A, 2015, J MED ECON, V18, P525, DOI 10.3111/13696998.2015.1032974; Ostrow KL, 2010, CLIN CANCER RES, V16, P3463, DOI 10.1158/1078-0432.CCR-09-3304; Peled N, 2015, J CLIN ONCOL, V33; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Suicide, 2012, HLTH GLANC EUR 2012, P28; Taenzer A, 2012, J THORAC DIS, V4, P448, DOI 10.3978/j.issn.2072-1439.2012.08.17; Yoon KA, 2009, J MOL DIAGN, V11, P182, DOI 10.2353/jmoldx.2009.080098; Yoshida Yukihiro, 2013, Asian Cardiovasc Thorac Ann, V21, P693, DOI 10.1177/0218492312470670	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189251	10.1371/journal.pone.0189251	http://dx.doi.org/10.1371/journal.pone.0189251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216302	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800108
J	Kuboyama, K; Tanga, N; Suzuki, R; Fujikawa, A; Noda, M				Kuboyama, Kazuya; Tanga, Naomi; Suzuki, Ryoko; Fujikawa, Akihiro; Noda, Masaharu			Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation	PLOS ONE			English	Article							RECEPTOR-TYPE-Z; PROMOTES FUNCTIONAL RECOVERY; ZETA/RPTP-BETA; DEMYELINATED LESIONS; EXTRACELLULAR-MATRIX; MULTIPLE-SCLEROSIS; REMYELINATION; PLEIOTROPHIN; ACTIVATION; ASTROCYTES	Chondroitin sulfate proteoglycans (CSPGs), which are enriched in demyelinating plaques in neurodegenerative diseases, such as multiple sclerosis (MS), impair remyelination by inhibiting the migration and differentiation of oligodendrocyte precursor cells (OPCs) in the central nervous system (CNS). We herein show that protamine (PRM, also known as a heparin antagonist) effectively neutralizes the inhibitory activities of CSPGs, thereby enhancing OPC differentiation and (re) myelination in mice. Cell-based assays using mouse OPC-like OL1 cells revealed that the PRM treatment exerted masking effects on extracellular CSPGs and improved oligodendrocyte differentiation on inhibitory CSPG-coated substrates. PRM also bound to the extracellular region of protein tyrosine phosphatase receptor type Z (PTPRZ), a membrane-spanning CSPG predominantly expressed in OPCs, and functioned as a ligand mimetic of PTPRZ, thereby suppressing its negative regulatory activity on oligodendrocyte differentiation. In primary cultures, the differentiation of OPCs from wild-type and Ptprz-deficient mice was equally enhanced by PRM. Moreover, the intranasal administration of PRM accelerated myelination in the developing mouse brain, and its intracerebro-ventricular administration stimulated remyelination after cuprizone-induced demyelination. These results indicate that PRM has CSPG-neutralizing activity which promotes oligodendrocyte differentiation under developmental and morbid conditions.	[Kuboyama, Kazuya; Tanga, Naomi; Suzuki, Ryoko; Fujikawa, Akihiro; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi, Japan; [Tanga, Naomi; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Okazaki, Aichi, Japan; [Kuboyama, Kazuya] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neuropharmacol, Sanuki, Kagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokushima Bunri University	Fujikawa, A; Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi, Japan.; Noda, M (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Okazaki, Aichi, Japan.	fujikawa@nibb.ac.jp; madon@nibb.ac.jp	; Noda, Masaharu/D-7146-2016	Kuboyama, Kazuya/0000-0002-9878-1209; Noda, Masaharu/0000-0002-3796-524X	JSPS KAKENHI [26830050, 17K07355, 21700416, 24500390, 26110722, 16209008]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers: 26830050 (https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26830050/) and 17K07355 (https://kaken.nii.ac.jp/en/search/?kw=17K07355) for KK, 21700416 (https://kaken.nii.ac.jp/en/search/?kw=21700416), 24500390 (https://kaken.nii.ac.jp/en/search/?kw=24500390), and 26110722 (https://kaken.nii.ac.jp/en/search/?kw=26110722) for AF, and 16209008 (https://kaken.nii.ac.jp/en/search/?kw=16209008) for MN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiraman K, 2015, J NEUROSCI, V35, P3676, DOI 10.1523/JNEUROSCI.3510-14.2015; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bothwell M, 2017, ANNU REV MED, V68, P431, DOI 10.1146/annurev-med-050715-104400; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chandran P, 2012, NEUROSCIENCE, V202, P446, DOI 10.1016/j.neuroscience.2011.10.051; Chang AS, 2012, ANN NEUROL, V72, P918, DOI 10.1002/ana.23693; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Cua RC, 2013, GLIA, V61, P972, DOI 10.1002/glia.22489; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Dror DK, 2008, NUTR REV, V66, P250, DOI 10.1111/j.1753-4887.2008.00031.x; Du CS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11120; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fujikawa A, 2016, NEURAL REGEN RES, V11, P549, DOI 10.4103/1673-5374.180761; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Gonzalez GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31599; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; HORROW JC, 1985, ANESTH ANALG, V64, P348; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Karus M, 2016, GLIA, V64, P270, DOI 10.1002/glia.22928; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Kuboyama K, 2016, J BIOL CHEM, V291, P18117, DOI 10.1074/jbc.M116.742536; Kuboyama K, 2015, J NEUROSCI, V35, P12162, DOI 10.1523/JNEUROSCI.2127-15.2015; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lin TT, 2016, ACTA PHARM SIN B, V6, P352, DOI 10.1016/j.apsb.2016.04.001; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Medina-Rodriguez EM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43545; Matthews RT, 2002, J NEUROSCI, V22, P7536; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Muramoto A, 2013, NEUROSCI LETT, V550, P150, DOI 10.1016/j.neulet.2013.06.025; Murasugi A, 2003, BIOSCI BIOTECH BIOCH, V67, P2288, DOI 10.1271/bbb.67.2288; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Nap RJ, 2008, BIOPHYS J, V95, P4570, DOI 10.1529/biophysj.108.133801; Park YJ, 2005, FASEB J, V19, P1555, DOI 10.1096/fj.04-2322fje; Paveliev M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33916; Pendleton JC, 2013, EXP NEUROL, V247, P113, DOI 10.1016/j.expneurol.2013.04.003; Plemel JR, 2017, NATURE REV DRUG DISC; Pujol J, 2004, NEUROIMAGE, V22, P897, DOI 10.1016/j.neuroimage.2004.01.029; Sakuda K, 2017, BIOCHEM BIOPH RES CO, V487, P450, DOI 10.1016/j.bbrc.2017.04.085; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sokolowska E, 2016, EXPERT OPIN DRUG MET, V12, P897, DOI 10.1080/17425255.2016.1194395; Syed YA, 2013, EMBO MOL MED, V5, P1918, DOI 10.1002/emmm.201303123; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	64	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189164	10.1371/journal.pone.0189164	http://dx.doi.org/10.1371/journal.pone.0189164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216327	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800084
J	Lillo, MA; Gaete, PS; Puebla, M; Ardiles, NM; Poblete, I; Becerra, A; Simon, F; Figueroa, XF				Lillo, Mauricio A.; Gaete, Pablo S.; Puebla, Mariela; Ardiles, Nicolas M.; Poblete, Ines; Becerra, Alvaro; Simon, Felipe; Figueroa, Xavier F.			Critical contribution of Na+-Ca2+ exchanger to the Ca2+-mediated vasodilation activated in endothelial cells of resistance arteries	FASEB JOURNAL			English	Article						NO production; endothelium-dependent vasodilation; endothelium-derived hyperpolarization; Ca2+ signaling; endothelial NO synthase	MYOENDOTHELIAL GAP-JUNCTIONS; SODIUM-CALCIUM EXCHANGER; NA+/CA2+ EXCHANGE; NITRIC-OXIDE; CA2+ ENTRY; MOLECULAR DETERMINANTS; INTRACELLULAR CA2+; ION CHANNELS; NA+ ENTRY; RAT	Na+-Ca2+ exchanger (NCX) contributes to control the intracellular free Ca2+ concentration ([Ca2+](i)), but the functional activation of NCX reverse mode (NCXrm) in endothelial cells is controversial. We evaluated the participation of NCXrm-mediated Ca2+ uptake in the endothelium-dependent vasodilation of rat isolated mesenteric arterial beds. In phenylephrine-contracted mesenteries, the acetylcholine (ACh)-induced vasodilation was abolished by treatment with the NCXrm blockers SEA0400, KB-R7943, or SN-6. Consistent with that, the ACh-induced hyperpolarization observed in primary cultures of mesenteric endothelial cells and in smooth muscle of isolated mesenteric resistance arteries was attenuated by KB-R7943 and SEA0400, respectively. In addition, both blockers abolished the NO production activated by ACh in intact mesenteric arteries. In contrast, the inhibition of NCXrm did not affect the vasodilator responses induced by the Ca2+ ionophore, ionomycin, and the NO donor, S-nitroso-N-acetylpenicillamine. Furthermore, SEA0400, KB-R7943, and a small interference RNA directed against NCX1 blunted the increase in [Ca2+](i) induced by ACh or ATP in cultured endothelial cells. The analysis by proximity ligation assay showed that the NO-synthesizing enzyme, eNOS, and NCX1 were associated in endothelial cell caveolae of intact mesenteric resistance arteries. These results indicate that the activation of NCXrm has a central role in Ca2+-mediated vasodilation initiated by ACh in endothelial cells of resistance arteries.	[Lillo, Mauricio A.; Gaete, Pablo S.; Puebla, Mariela; Ardiles, Nicolas M.; Poblete, Ines; Figueroa, Xavier F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ave B OHiggins 340, Santiago 8331010, Chile; [Becerra, Alvaro; Simon, Felipe] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Becerra, Alvaro; Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile; [Becerra, Alvaro; Simon, Felipe] Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Becerra, Alvaro] Univ Bernardo OHiggins, Fac Salud Deporte & Recreac, Dept Ciencias Quim & Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad Andres Bello; Universidad Andres Bello; Universidad  Bernardo O'Higgins	Figueroa, XF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ave B OHiggins 340, Santiago 8331010, Chile.	xfigueroa@bio.puc.cl		Simon, Felipe/0000-0002-2653-9798; Lillo, Mauricio/0000-0002-2823-6619; Figueroa, Xavier/0000-0001-9656-9100	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100850, 1150530, 3160348, 1161288]; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; UNAB [DI-741-15/N]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21120178, 21120399]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy; UNAB; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Grants 1100850, 1150530, 3160348, and 1161288 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Millennium Institute on Immunology and Immunotherapy P09-016-F, and UNAB DI-741-15/N. In addition, doctoral and thesis support Scholarships 21120178 and 21120399 from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) also contributed to support this study. The authors declare no conflicts of interest.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Andrikopoulos P, 2017, CELL SIGNAL, V37, P12, DOI 10.1016/j.cellsig.2017.05.013; Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Bakker ENTP, 1997, AM J PHYSIOL-HEART C, V273, pH1848, DOI 10.1152/ajpheart.1997.273.4.H1848; Birinyi P, 2005, N-S ARCH PHARMACOL, V372, P63, DOI 10.1007/s00210-005-1079-x; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bondarenko A, 2004, BRIT J PHARMACOL, V143, P9, DOI 10.1038/sj.bjp.0705866; Bondarenko AI, 2017, VASC PHARMACOL, V89, P39, DOI 10.1016/j.vph.2017.01.002; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Daniel EE, 2006, J CELL MOL MED, V10, P529, DOI 10.1111/j.1582-4934.2006.tb00418.x; Domotor E, 1999, J PHYSIOL-LONDON, V515, P147, DOI 10.1111/j.1469-7793.1999.147ad.x; Dora KA, 2003, AM J PHYSIOL-HEART C, V285, pH119, DOI 10.1152/ajpheart.00643.2002; Figueroa XF, 2007, AM J PHYSIOL-HEART C, V293, pH1371, DOI 10.1152/ajpheart.01368.2006; Figueroa XF, 2013, NEUROPHARMACOLOGY, V75, P471, DOI 10.1016/j.neuropharm.2013.02.022; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fujimoto S, 1997, EUR J PHARMACOL, V330, P177, DOI 10.1016/S0014-2999(97)00180-5; Gaete PS, 2012, FREE RADICAL BIO MED, V52, P860, DOI 10.1016/j.freeradbiomed.2011.11.036; Girardin NC, 2010, PFLUG ARCH EUR J PHY, V460, P109, DOI 10.1007/s00424-010-0825-1; Goedicke-Fritz S, 2015, EUR J CELL BIOL, V94, P391, DOI 10.1016/j.ejcb.2015.06.002; Gosling M, 1998, J BIOL CHEM, V273, P21084, DOI 10.1074/jbc.273.33.21084; Goto Y, 1996, EUR J PHARMACOL, V314, P185, DOI 10.1016/S0014-2999(96)00532-8; Graier WF, 1998, J PHYSIOL-LONDON, V506, P109, DOI 10.1111/j.1469-7793.1998.109bx.x; Harnett KM, 2003, AM J MED, V115, p24S, DOI 10.1016/S0002-9343(03)00232-8; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Iwamoto T, 2004, J BIOL CHEM, V279, P7544, DOI 10.1074/jbc.M310491200; Kraft R, 2007, BIOCHEM BIOPH RES CO, V361, P230, DOI 10.1016/j.bbrc.2007.07.019; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Moccia F, 2002, BIOCHEM J, V364, P235, DOI 10.1042/bj3640235; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Niu CF, 2007, EUR J PHARMACOL, V573, P161, DOI 10.1016/j.ejphar.2007.06.033; Palygin OA, 2008, AM J PHYSIOL-HEART C, V294, pH1693, DOI 10.1152/ajpheart.01337.2007; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Schneider JC, 2002, AM J PHYSIOL-HEART C, V283, pH837, DOI 10.1152/ajpheart.00789.2001; Sedova M, 1999, CELL CALCIUM, V25, P333, DOI 10.1054/ceca.1999.0036; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Sharma V, 2014, GENESIS, V52, P93, DOI 10.1002/dvg.22735; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025432; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Traub O, 1999, J BIOL CHEM, V274, P20144, DOI 10.1074/jbc.274.29.20144; Tsoukias NM, 2011, WIRES SYST BIOL MED, V3, P93, DOI 10.1002/wsbm.97; Tykocki NR, 2012, PHARMACOL RES, V66, P544, DOI 10.1016/j.phrs.2012.08.004; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Wier WG, 2004, REV PHYSIOL BIOCH P, V150, P91, DOI 10.1007/s10254-003-0019-8; Wilson C, 2016, J PHYSIOL-LONDON, V594, P7267, DOI 10.1113/JP272927; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Zuccolo E, 2017, CELL CALCIUM, V66, P33, DOI 10.1016/j.ceca.2017.06.003	62	15	15	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2137	2147		10.1096/fj.201700365RR	http://dx.doi.org/10.1096/fj.201700365RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217667				2022-12-26	WOS:000429051400033
J	Blomme, A; Van Simaeys, G; Doumont, G; Costanza, B; Bellier, J; Otaka, Y; Sherer, F; Lovinfosse, P; Boutry, S; Palacios, AP; De Pauw, E; Hirano, T; Yokobori, T; Hustinx, R; Bellahcene, A; Delvenne, P; Detry, O; Goldman, S; Nishiyama, M; Castronovo, V; Turtoi, A				Blomme, Arnaud; Van Simaeys, Gaetan; Doumont, Gilles; Costanza, Brunella; Bellier, Justine; Otaka, Yukihiro; Sherer, Felicie; Lovinfosse, Pierre; Boutry, Sebastien; Palacios, Ana Perez; De Pauw, Edwin; Hirano, Touko; Yokobori, Takehiko; Hustinx, Roland; Bellahcene, Akeila; Delvenne, Philippe; Detry, Olivier; Goldman, Serge; Nishiyama, Masahiko; Castronovo, Vincent; Turtoi, Andrei			Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases	ONCOGENE			English	Article							BREAST-CANCER; TUMOR XENOGRAFTS; MOUSE MODELS; F-18-FDG PET; THERAPY; MICE; DISEASE	Cancer research is increasingly dependent of patient-derived xenograft model (PDX). However, a major point of concern regarding the PDX model remains the replacement of the human stroma with murine counterpart. In the present work we aimed at clarifying the significance of the human-to-murine stromal replacement for the fidelity of colorectal cancer (CRC) and liver metastasis (CRC-LM) PDX model. We have conducted a comparative metabolic analysis between 6 patient tumors and corresponding PDX across 4 generations. Metabolic signatures of cancer cells and stroma were measured separately by MALDI-imaging, while metabolite changes in entire tumors were quantified using mass spectrometry approach. Measurement of glucose metabolism was also conducted in vivo using [F-18]-fluorodeoxyglucose (FDG) and positron emission tomography (PET). In CRC/CRC-LM PDX model, human stroma was entirely replaced at the second generation. Despite this change, MALDI-imaging demonstrated that the metabolic profiles of both stromal and cancer cells remained stable for at least four generations in comparison to the original patient material. On the tumor level, profiles of 86 water-soluble metabolites as well as 93 lipid mediators underlined the functional stability of the PDX model. In vivo PET measurement of glucose uptake (reflecting tumor glucose metabolism) supported the ex vivo observations. Our data show for the first time that CRC/CRC-LM PDX model maintains the functional stability at the metabolic level despite the early replacement of the human stroma by murine cells. The findings demonstrate that human cancer cells actively educate murine stromal cells during PDX development to adopt the human-like phenotype.	[Blomme, Arnaud; Costanza, Brunella; Bellier, Justine; Palacios, Ana Perez; Bellahcene, Akeila; Castronovo, Vincent; Turtoi, Andrei] GIGA Canc Univ Liege, Metastasis Res Lab, Liege, Belgium; [Van Simaeys, Gaetan; Sherer, Felicie; Goldman, Serge] Univ Libre Bruxelles, Hop Erasme, Brussels, Belgium; [Van Simaeys, Gaetan; Doumont, Gilles; Sherer, Felicie; Goldman, Serge] Univ Libre Bruxelles, Ctr Microscopy & Mol Imaging, Brussels, Belgium; [Otaka, Yukihiro; Yokobori, Takehiko; Nishiyama, Masahiko] Gunma Univ, Dept Mol Pharmacol & Oncol, Grad Sch Med, Gunma, Japan; [Lovinfosse, Pierre; Hustinx, Roland] Liege Univ Hosp, Med Phys Dept, Nucl Med & Oncol Imaging Div, Liege, Belgium; [Boutry, Sebastien] Univ Mons, Dept Gen Organ & Biomed Chem, NMR & Mol Imaging Lab, Mons, Belgium; [Boutry, Sebastien] Univ Mons UMONS, Ctr Microscopy & Mol Imaging, Charleroi, Gosselies, Belgium; [De Pauw, Edwin] Univ Liege, Mass Spectrometry Lab, Liege, Belgium; [Hirano, Touko] Gunma Univ, Lab Analyt Instruments, Grad Sch Med, Gunma, Japan; [Delvenne, Philippe] Univ Liege, Univ Hosp, Dept Pathol, Liege, Belgium; [Detry, Olivier] Univ Liege, Univ Hosp, Dept Abdominal Surg, Liege, Belgium; [Turtoi, Andrei] Inst Rech Cancerol Montpellier, Tumor Microenvironm & Resistance Treatment Lab, Montpellier, France; [Turtoi, Andrei] Inst Canc Montpellier, Montpellier, France; [Turtoi, Andrei] INSERM, U1194, Montpellier, France; [Turtoi, Andrei] Univ Montpellier, Montpellier, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Gunma University; University of Liege; University of Mons; University of Liege; Gunma University; University of Liege; University of Liege; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Turtoi, A (corresponding author), GIGA Canc Univ Liege, Metastasis Res Lab, Liege, Belgium.; Turtoi, A (corresponding author), Inst Rech Cancerol Montpellier, Tumor Microenvironm & Resistance Treatment Lab, Montpellier, France.; Turtoi, A (corresponding author), Inst Canc Montpellier, Montpellier, France.; Turtoi, A (corresponding author), INSERM, U1194, Montpellier, France.; Turtoi, A (corresponding author), Univ Montpellier, Montpellier, France.	andrei.turtoi@inserm.fr	Bonnemaison, Marc/AAD-9243-2021; Turtoi, Andrei/ABD-1271-2021; Blomme, Arnaud/AGO-7915-2022; Costanza, Brunella/AAB-6354-2022; Detry, Olivier/I-9333-2019; Van Simaeys, Gaetan/AAR-8082-2020; Blomme, Arnaud/AAM-1440-2020	Turtoi, Andrei/0000-0003-3813-6635; Blomme, Arnaud/0000-0003-4183-8726; Detry, Olivier/0000-0002-9436-6673; Van Simaeys, Gaetan/0000-0002-2678-542X; Otaka, Yukihiro/0000-0002-9162-7188; Costanza, Brunella/0000-0001-8279-805X	University of Fiege; National Fund for Scientific Research (FNRS); Gunma University (GIAR Research Program for Omics-Based Medical Science); European Regional Development Fund (ERDF); Walloon Region; Fondation ULB; Fonds Erasme; "Association Vingotte Nuclear" (AVN); ERDF; FabEx Mablmprove Starting Grant	University of Fiege; National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Gunma University (GIAR Research Program for Omics-Based Medical Science); European Regional Development Fund (ERDF)(European Commission); Walloon Region; Fondation ULB; Fonds Erasme; "Association Vingotte Nuclear" (AVN); ERDF(European Commission); FabEx Mablmprove Starting Grant	The authors acknowledge the experimental support of Dr. Chantal Humblet, Mrs. Alice Marquet (GIGA-histology platform, ULg), Mr. Vincent Hennequiere, Mrs. Naima Maloujahmoum (Metastasis Research Laboratory), Mrs. Yezza Ben Salah (Tumor Microenvironment and Resistance to Treatment Lab, IRCM), Mr. Nicolas Passon (CMMI) and Mrs. Mari-Aline Laute (CMMI). The authors are thankful to Dr. Stephanie Gofflot (Biobank, University Hospital Liege) for providing patient material as well as the Cyclotron Unit of Erasme Hospital (Brussels, Belgium) for providing [18F]-FDG. Prof. Robert N. Muller (CMMI, Director of international partnerships) is thanked for his scientific input and support. Mr. Mathieu Roch (CMMI) is thanked for tumor volume measurements on MR images.This work was supported with grants from the University of Fiege, National Fund for Scientific Research (FNRS) and Gunma University (GIAR Research Program for Omics-Based Medical Science). The CMMI is supported by the European Regional Development Fund (ERDF), the Walloon Region, the Fondation ULB, the Fonds Erasme and the "Association Vingotte Nuclear" (AVN). GD is supported by the ERDF and the Walloon Region. Akeila Bellahcene is a Research Director at the FNRS. AT is a senior research fellow of the French National Institute of Health and Medical Research (INSERM) and is supported by FabEx Mablmprove Starting Grant. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Amos-Landgraf JM, 2014, P NATL ACAD SCI USA, V111, P16514, DOI 10.1073/pnas.1323064111; Blomme A, 2017, ONCOGENE, V36, P2116, DOI 10.1038/onc.2016.369; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Cassidy JW, 2015, CANCER RES, V75, P2963, DOI 10.1158/0008-5472.CAN-15-0727; Chiavarina B, 2017, CURR MED CHEM, V24, P2846, DOI 10.2174/0929867324666170428104311; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Fueger BJ, 2006, J NUCL MED, V47, P999; GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920; HOUGHTON JA, 1981, CANCER RES, V41, P144; Hylander BL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-110; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Lin D, 2017, ONCOTARGET, V8, P25928, DOI 10.18632/oncotarget.15237; Lou S, 2017, BBA-PROTEINS PROTEOM, V1865, P957, DOI 10.1016/j.bbapap.2016.09.020; McDonnell LA, 2014, J PROTEOME RES, V13, P1138, DOI 10.1021/pr400620y; Sanz L, 2009, LAB INVEST, V89, P91, DOI 10.1038/labinvest.2008.108; Sha W, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-51; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Valtorta S, 2017, J NUCL MED, V58, P42, DOI 10.2967/jnumed.116.176404; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Werner-Klein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097860; Xu LA, 1999, HUM GENE THER, V10, P2941, DOI 10.1089/10430349950016357; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	29	33	37	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	9					1237	1250		10.1038/s41388-017-0018-x	http://dx.doi.org/10.1038/s41388-017-0018-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FY0MK	29242606				2022-12-26	WOS:000426505400008
J	Butterfield, RJ; Dunn, DM; Hu, Y; Johnson, K; Bonnemann, CG; Weiss, RB				Butterfield, Russell J.; Dunn, Diane M.; Hu, Ying; Johnson, Kory; Bonnemann, Carsten G.; Weiss, Robert B.			Transcriptome profiling identifies regulators of pathogenesis in collagen VI related muscular dystrophy	PLOS ONE			English	Article							RNA-SEQ; SKELETAL-MUSCLE; SUPPORT OVERLAP; FIBROBLASTS; ULLRICH; REGENERATION; EXPRESSION; MATRIX; SKIN; GENE	Objectives The collagen VI related muscular dystrophies (COL6-RD), Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) are among the most common congenital muscular dystrophies and are characterized by distal joint laxity and a combination of distal and proximal joint contractures. Inheritance can be dominant negative (DN) or recessive depending on the type and location of the mutation. DN mutations allow incorporation of abnormal chains into secreted tetramers and are the most commonly identified mutation type in COL6-RD. Null alleles (nonsense, frameshift, and large deletions) do not allow incorporation of abnormal chains and act recessively. To better define the pathways disrupted by mutations in collagen VI, we have used a transcriptional profiling approach with RNA-Seq to identify differentially expressed genes in COL6-RD individuals from controls. Methods RNA-Seq allows precise detection of all expressed transcripts in a sample and provides a tool for quantification of expression data on a genomic scale. We have used RNA-Seq to identify differentially expressed genes in cultured dermal fibroblasts from 13 COL6-RD individuals (8 dominant negative and 5 null) and 6 controls. To better assess the transcriptional changes induced by abnormal collagen VI in the extracellular matrix (ECM); we compared transcriptional profiles from subjects with DN mutations and subjects with null mutations to transcriptional profiles from controls. Results Differentially expressed transcripts between COL6-RD and control fibroblasts include upregulation of ECM components and downregulation of factors controlling matrix remodeling and repair. DN and null samples are differentiated by downregulation of genes involved with DNA replication and repair in null samples. Conclusions Differentially expressed genes identified here may help identify new targets for development of therapies and biomarkers to assess the efficacy of treatments.	[Butterfield, Russell J.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Butterfield, Russell J.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Dunn, Diane M.; Weiss, Robert B.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Hu, Ying; Bonnemann, Carsten G.] NINDS, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Johnson, Kory] NINDS, Bioinformat Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Butterfield, RJ (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.; Butterfield, RJ (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	russell.butterfield@hsc.utah.edu	Hu, Ying/GQZ-8100-2022	Butterfield, Russell/0000-0002-8452-7189	Cure CMD; NIH [1K08NS097631-01]; Intramural Research Program of the NIH, NINDS; NIH/NINDS [1K08NS097631-01]; intramural funds of NINDS; CureCMD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS097631, ZIANS003129] Funding Source: NIH RePORTER	Cure CMD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); intramural funds of NINDS; CureCMD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CureCMD and NIH 1K08NS097631-01 to RJB; Intramural Research Program of the NIH, NINDS to CGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the patients and families for their participation in the study. The research was supported by funds from Cure CMD to RJB, NIH/NINDS 1K08NS097631-01 to RJB, and by intramural funds of NINDS to CGB.	Abe S, 2009, ZOOL SCI, V26, P315, DOI 10.2108/zsj.26.315; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Brandt K, 2015, GROWTH HORM IGF RES, V25, P34, DOI 10.1016/j.ghir.2014.11.001; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Demirdas S, 2017, CLIN GENET, V91, P411, DOI 10.1111/cge.12853; Foley AR, 2011, ANN NEUROL, V69, P206, DOI 10.1002/ana.22283; Frolova EG, 2014, MATRIX BIOL, V37, P35, DOI 10.1016/j.matbio.2014.02.003; Jimenez-Mallebrera C, 2006, NEUROMUSCULAR DISORD, V16, P571, DOI 10.1016/j.nmd.2006.07.015; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Paco S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145107; Paco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077430; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Park J, 2013, EXPERT REV ANTICANC, V13, P111, DOI [10.1586/ERA.12.164, 10.1586/era.12.164]; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Penisson-Besnier I, 2013, NEUROMUSCULAR DISORD, V23, P664, DOI 10.1016/j.nmd.2013.04.009; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P343, DOI 10.1590/S0004-282X2009000200035; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; SASSE J, 1981, DEV BIOL, V83, P79, DOI 10.1016/S0012-1606(81)80010-3; Schulz JN, 2016, J CELL SCI, V129, P706, DOI 10.1242/jcs.180216; Sharples AP, 2013, GROWTH HORM IGF RES, V23, P53, DOI 10.1016/j.ghir.2013.03.004; Sun K, 2017, DIABETOLOGIA, V60, P24, DOI 10.1007/s00125-016-4130-1; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Unlu G, 2014, INT J BIOCHEM CELL B, V47, P57, DOI 10.1016/j.biocel.2013.11.005; Voermans NC, 2007, AM J MED GENET A, V143A, P2215, DOI 10.1002/ajmg.a.31899; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7	41	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189664	10.1371/journal.pone.0189664	http://dx.doi.org/10.1371/journal.pone.0189664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244830	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700046
J	Flynn, AG; Anguzu, G; Mubiru, F; Kiragga, AN; Kamya, M; Meya, DB; Boulware, DR; Kambugu, A; Castelnuovo, BC				Flynn, Andrew G.; Anguzu, Godwin; Mubiru, Frank; Kiragga, Agnes N.; Kamya, Moses; Meya, David B.; Boulware, David R.; Kambugu, Andrew; Castelnuovo, Barbara C.			Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FUNDAMENTAL CAUSES; VIRAL SUPPRESSION; SOUTH-AFRICA; MORTALITY; PROGRAM; CARE; POPULATION; INFECTION; DETERMINANTS	Lifelong ART is essential to reducing HIV mortality and ending the epidemic, however the interplay between socioeconomic position and long-term outcomes of HIV-infected persons receiving antiretroviral therapy (ART) in sub-Saharan Africa is unknown. Furthering the understanding of factors related to long-term ART outcomes in this important region will aid the successful scale-up of ART programs. We enrolled 559 HIV-infected Ugandan adults starting ART in 2004-2005 at the Infectious Diseases Institute in Kampala, Uganda and followed them for 10 years. We documented baseline employment status, regular household income, education level, housing description, physical ability, and CD4 count. Viral load was measured every six months. Proportional hazard regression tested for associations between baseline characteristics and 1) mortality, 2) virologic failure, and 3) mortality or virologic failure as a composite outcome. Over ten years 23% (n = 127) of participants died, 6% (n = 31) were lost-to-follow-up and 23% (107/472) experienced virologic treatment failure. In Kaplan-Meier analysis we observed an association between employment and mortality, with the highest cumulative probability of death occurring in unemployed individuals. In univariate analysis unemployment and disease severity were associated with mortality, but in multivariable analysis the only association with mortality was disease severity. We observed an association between higher household income and an increased incidence of both virologic failure and the combined outcome, and an association between self-employment and lower incidence of virologic failure and the combined outcome when compared to unemployment. Formal education level and housing status were unrelated to outcomes. It is feasible to achieve good ten-year survival, retention-in-care, and viral suppression in a socioeconomically diverse population in a resource-limited setting. Unemployment appears to be related to adverse 10-year ART outcomes. A low level of formal education does not appear to be a barrier to successful long-term ART.	[Flynn, Andrew G.; Anguzu, Godwin; Mubiru, Frank; Kiragga, Agnes N.; Meya, David B.; Kambugu, Andrew; Castelnuovo, Barbara C.] Infect Dis Inst, Kampala, Uganda; [Kamya, Moses] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Meya, David B.; Boulware, David R.; Kambugu, Andrew] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA	Makerere University; University of Minnesota System; University of Minnesota Twin Cities	Flynn, AG (corresponding author), Infect Dis Inst, Kampala, Uganda.	apgflynn@gmail.com	Boulware, David R/GRS-0999-2022; Meya, David/AAO-2796-2020; Boulware, David R/AAF-7124-2021	Boulware, David R/0000-0002-4715-0060; , David/0000-0002-8854-0321	National Institute of Neurologic Diseases and Stroke [R01NS086312]; Doris Duke Charitable Foundation through the Doris Duke International Clinical Research Fellows Program at the University of Minnesota [DDICRF2012089]	National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Doris Duke Charitable Foundation through the Doris Duke International Clinical Research Fellows Program at the University of Minnesota	This work was supported in part by the National Institute of Neurologic Diseases and Stroke (R01NS086312, ninds.nih.gov), which supported DBM and DRB. This work was also supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at the University of Minnesota (DDICRF2012089, ddcf.org). Andrew Flynn was a Doris Duke International Clinical Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the International Academic Alliance, the Accordia Global Health Foundation, the HIV Medicine Association and the Doris Duke Charitable Foundation through the Doris Duke International Clinical Research Fellows Program at the University of Minnesota (DDICRF2012089). Andrew Flynn was a Doris Duke International Clinical Research Fellow.	Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Bassett I, 2009, J ACQUIR IMMUNE DEFI, V51; Birbeck GL, 2011, AM J TROP MED HYG, V85, P782, DOI 10.4269/ajtmh.2011.11-0187; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Castel AD, 2016, AIDS CARE, V28, P1355, DOI 10.1080/09540121.2016.1189496; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Cunningham WE, 2005, J HEALTH CARE POOR U, V16, P655; Fordyce EJ, 2002, J ACQ IMMUN DEF SYND, V30, P111, DOI 10.1097/00042560-200205010-00015; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox A., 2012, J BIOSOC SCI, V44; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; HOGG RS, 1994, LANCET, V344, P1120, DOI 10.1016/S0140-6736(94)90631-9; Honge BL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003499; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Karnofsky D, 1948, CANCER, V1; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; McFarland W, 2003, JAIDS-J ACQ IMM DEF, V33, P96, DOI 10.1097/00126334-200305010-00014; McMahon J, 2011, AIDS BEHAV, V15, P1503, DOI 10.1007/s10461-010-9759-z; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Muthulingam D, 2013, JAIDS-J ACQ IMM DEF, V63, P112, DOI 10.1097/QAI.0b013e3182894555; Namusobya J, 2013, CLIN INFECT DIS, V57, P1343, DOI 10.1093/cid/cit490; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Pavlova-McCalla E, 2012, J AIDS CLIN RES, V3; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Rapiti E, 2000, EPIDEMIOLOGY, V11, P496, DOI 10.1097/00001648-200009000-00003; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Richter LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086225; Shacham E, 2010, AIDS PATIENT CARE ST, V24, P229, DOI 10.1089/apc.2009.0275; Talisuna-Alamo S, 2012, JAIDS-J ACQ IMM DEF, V59, pE52, DOI 10.1097/QAI.0b013e318246e2aa; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2014, GAP REP GEN UNAIDS; WHO, 2010, ANT THER HIV INF AD; World Health Organisation, 2015, CAUS SPEC MORT EST 2	40	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189055	10.1371/journal.pone.0189055	http://dx.doi.org/10.1371/journal.pone.0189055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244807	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700015
J	Gschwantler-Kaulich, D; Weingartshofer, S; Rappaport-Furhauser, C; Zeilinger, R; Pils, D; Muhr, D; Braicu, EI; Kastner, MT; Tan, YY; Semmler, L; Sehouli, J; Singer, CF				Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Rappaport-Fuerhauser, Christine; Zeilinger, Robert; Pils, Dietmar; Muhr, Daniela; Braicu, Elena I.; Kastner, Marie-Therese; Tan, Yen Y.; Semmler, Lorenz; Sehouli, Jalid; Singer, Christian F.			Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers	PLOS ONE			English	Article							EPIDIDYMIS PROTEIN 4; REDUCING SALPINGO-OOPHORECTOMY; DIFFERENTIAL-DIAGNOSIS; MALIGNANCY ALGORITHM; PREOPERATIVE HE-4; RISK; BIOMARKERS; BREAST; CARCINOMA; CA125	Background Screening for ovarian cancer (OC) in women at high risk consists of a combination of carbohydrate antigen 125 (CA125) and transvaginal ultrasound, despite their low sensitivity and specificity. This could be improved by the combination of several biomarkers, which has been shown in average risk patients but has not been investigated until now in female BRCA mutation carriers. Methods Using a multiplex, bead-based, immunoassay system, we analyzed the concentrations of leptin, prolactin, osteopontin, insulin-like growth factor II, macrophage inhibitory factor, CA125 and human epididymis antigen 4 in 26 healthy wild type women, 26 healthy BRCA1 mutation carriers, 28 wildtype OC patients and 26 OC patients with BRCA1 mutation. Results Using the ROC analysis, we found a high overall sensitivity of 94.3% in differentiating healthy controls from OC patients with comparable results in the wildtype subgroup (sensitivity 92.8%, AUC = 0.988; p = 5.2e-14) as well as in BRCA1 mutation carriers (sensitivity 95.2%, AUC = 0.978; p = 1.7e-15) at an overall specificity of 92.3%. The used algorithm also allowed to identify healthy BRCA1 mutation carriers when compared to healthy wildtype women (sensitivity 88.4%, specificity 80.7%, AUC = 0.895; p = 6e-08), while this was less pronounced in patients with OC (sensitivity 66.7%, specificity 67.8%, AUC = 0.724; p = 0.00065). Conclusion We have developed an algorithm, which can differentiate between healthy women and OC patients and have for the first time shown, that such an algorithm can also be used in BRCA mutation carriers. To clarify a suggested benefit to the existing early detection program, large prospective trials with mainly early stage OC cases are warranted.	[Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Rappaport-Fuerhauser, Christine; Zeilinger, Robert; Muhr, Daniela; Kastner, Marie-Therese; Tan, Yen Y.; Semmler, Lorenz; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Comprehens Canc Ctr, Vienna, Austria; [Pils, Dietmar] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat Intelligent Syst CeMSIIS, Vienna, Austria; [Pils, Dietmar] Med Univ Vienna, Dept Surg, Vienna, Austria; [Braicu, Elena I.; Sehouli, Jalid] Univ Med Berlin, European Competence Ctr Ovarian Canc, Dept Gynecol, Ctr Oncol Surg, Charite Campus Virchow Klinikum, Berlin, Germany; [Tan, Yen Y.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; QIMR Berghofer Medical Research Institute	Gschwantler-Kaulich, D (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Comprehens Canc Ctr, Vienna, Austria.	daphne.gschwantler@kaulich.at	Tan, Yen/AAW-2357-2021	Tan, Yen/0000-0003-1063-5352; Semmler, Lorenz/0000-0003-4732-5227; Braicu, Ioana/0000-0001-5357-6001	Austrian Society of Endocrinological Oncology (OEGEO)	Austrian Society of Endocrinological Oncology (OEGEO)	The authors received a study grant from the Austrian Society of Endocrinological Oncology (OEGEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angioli R, 2013, GYNECOL ONCOL, V128, P579, DOI 10.1016/j.ygyno.2012.11.040; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Capriglione S, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-1026-y; Chudecka-Glaz A., 2017, DIS MARKERS, V2017; Clendenen TV, 2013, CANCER CAUSE CONTROL, V24, P741, DOI 10.1007/s10552-013-0156-6; Coleman RL, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.003; Dayyani F, 2016, INT J GYNECOL CANCER, V26, P1586, DOI 10.1097/IGC.0000000000000804; DePriest PD, 2003, J CLIN ONCOL S, V21, P194; Domchek SM, 2006, LANCET ONCOL, V7, P223, DOI 10.1016/S1470-2045(06)70585-X; Domchek SM, 2010, BREAST CANCER RES TR, V124, P195, DOI 10.1007/s10549-010-0799-x; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; El Bairi K, 2017, CELL ONCOL, V40, P105, DOI 10.1007/s13402-016-0309-1; El-Tanani MK, 2006, J BIOL CHEM, V281, P26587, DOI 10.1074/jbc.M604403200; Ferraro S, 2013, J CLIN PATHOL, V66, P273, DOI 10.1136/jclinpath-2012-201031; Fortner RT, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0315-6; Granato T, 2015, CLIN CHIM ACTA, V446, P147, DOI 10.1016/j.cca.2015.03.047; Patrono MG, 2015, GYNECOL ONCOL, V139, P568, DOI 10.1016/j.ygyno.2015.09.018; He G, 2012, J OBSTET GYNAECOL CA, V34, P567, DOI 10.1016/S1701-2163(16)35273-2; Horala A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010123; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Jin Jing Hui, 2016, Obstet Gynecol Sci, V59, P279, DOI 10.5468/ogs.2016.59.4.279; Karlan BY, 2014, CANCER EPIDEM BIOMAR, V23, P1383, DOI 10.1158/1055-9965.EPI-13-1361; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Macedo ACL, 2014, INT J GYNECOL CANCER, V24, P1222, DOI 10.1097/IGC.0000000000000192; Leung F, 2016, CANCER EPIDEM BIOMAR, V25, P1333, DOI 10.1158/1055-9965.EPI-15-1299; Lin JY, 2012, ASIAN PAC J CANCER P, V13, P5427, DOI 10.7314/APJCP.2012.13.11.5427; Lopez-Raton M, 2014, J STAT SOFTW, V61, P1; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Mannis GN, 2013, JAMA INTERN MED, V173, P96, DOI 10.1001/2013.jamainternmed.962; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Moore RG, 2011, OBSTET GYNECOL, V118, P280, DOI 10.1097/AOG.0b013e318224fce2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Pils D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-178; Plotti F, 2012, TUMOR BIOL, V33, P2117, DOI 10.1007/s13277-012-0471-7; R Core Team, 2018, R LANG ENV STAT COMP; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Riedl CC, 2015, J CLIN ONCOL, V33, P1128, DOI 10.1200/JCO.2014.56.8626; Scaletta G, 2017, EXPERT REV ANTICANC, V17, P827, DOI 10.1080/14737140.2017.1360138; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singer CF, 2015, WIEN KLIN WOCHENSCHR, V127, P981, DOI 10.1007/s00508-015-0880-x; Skates SJ, 2017, CLIN CANC RES; Skates SJ, 2016, CLIN CANCER RES, V22, P4542, DOI 10.1158/1078-0432.CCR-16-1391; Smith RA, 2017, CA-CANCER J CLIN, V67, P100, DOI 10.3322/caac.21392; Soletormos G, 2016, INT J GYNECOL CANCER, V26, P43, DOI 10.1097/IGC.0000000000000586; Terlikowska KM, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0254-7; Terry KL, 2016, CLIN CANCER RES, V22, P4664, DOI 10.1158/1078-0432.CCR-16-0316; Ueland FR, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7010014; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wilder JL, 2003, GYNECOL ONCOL, V89, P233, DOI 10.1016/S0090-8258(03)00051-9; Wu L, 2012, INT J GYNECOL CANCER, V22, P1106, DOI 10.1097/IGC.0b013e318263efa2	51	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189641	10.1371/journal.pone.0189641	http://dx.doi.org/10.1371/journal.pone.0189641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244844	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700043
J	Lee, JY; Kim, N; Nam, RH; Sohn, SH; Lee, SM; Choi, D; Yoon, H; Kim, YS; Lee, HS; Lee, DH				Lee, Ju Yup; Kim, Nayoung; Nam, Ryoung Hee; Sohn, Sung Hwa; Lee, Sun Min; Choi, Daeun; Yoon, Hyuk; Kim, Yong Sung; Lee, Hye Seung; Lee, Dong Ho			Probiotics reduce repeated water avoidance stress-induced colonic microinflammation in Wistar rats in a sex-specific manner	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; LACTOBACILLUS-FARCIMINIS TREATMENT; MAST-CELL; IMMUNE ACTIVATION; GUT MICROBIOTA; GENDER; INFLAMMATION; ASSOCIATION; RESPONSES; BARRIER	The colonic response to stress is greater in female rats than in male rats. The aim of this study was to evaluate the effect of probiotics in the repeated water avoidance stress (rWAS)-induced colonic microinflammation model of Wistar rats in a sex-specific manner. The three groups (no-stress, WAS, and WAS with probiotics) were exposed to r-WAS for 1 h daily for 10 days, and Lactobacillus farciminis was administered by oral gavage for 10 days to animals in the probiotics group. The visceromotor response (VMR) to colorectal distension (CRD) was assessed using a barostat and noninvasive manometry before and after WAS exposure. Immunohistochemistry for mast cells and real-time polymerase chain reaction (RT-PCR) for detection of mucosal cytokines were performed using distal colon tissue after the animals were sacrificed. Significant reduction of VMR to CRD (visceral analgesia) was observed at 60 mmHg in the female WAS group (P = 0.045), but not in males. In addition, the female WAS with probiotics group showed a significantly lower colonic mucosal mast cell count in comparison to the female WAS group (P = 0.013), but this phenomenon was not observed in the male group. The colonic mucosal mRNA levels of interferon-gamma (IFNR), tumor necrosis factor-alpha (TNFA), interleukin (IL) 6, and IL17 were higher in the female WAS group than in the male WAS group. The mRNA levels of IFNR, TNFA, and IL6 were significantly decreased in WAS females who received probiotics (all P < 0.050). In conclusion, rWAS is induced in a sex-specific manner. A 10-day-long treatment with L. farciminis is an effective therapy for rWAS-induced colonic microinflammation in female rates, but not in male rats.	[Lee, Ju Yup; Kim, Nayoung; Nam, Ryoung Hee; Sohn, Sung Hwa; Lee, Sun Min; Choi, Daeun; Yoon, Hyuk; Lee, Dong Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seoungnam, South Korea; [Lee, Ju Yup] Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sch Med, Dept Gastroenterol, Iksan, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sch Med, Digest Dis Res Inst, Iksan, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seoungnam, South Korea	Seoul National University (SNU); Keimyung University; Wonkwang University; Wonkwang University; Seoul National University (SNU)	Kim, N (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seoungnam, South Korea.	nayoungkim49@empas.com	Kim, Yong Sung/GMW-8652-2022; Yoon, Hyuk/AAT-4978-2020; Lee, Hye Seung/G-6419-2011	Kim, Yong Sung/0000-0001-8836-4818; Yoon, Hyuk/0000-0002-2657-0349; Lee, Hye Seung/0000-0002-1667-7986; Kim, Nayoung/0000-0002-9397-0406; Lee, Ju Yup/0000-0003-0021-5354; Lee, Darrall/0000-0002-6990-4441	Support Program for Women in Science, Engineering and Technology through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2016H1C3A1903202]	Support Program for Women in Science, Engineering and Technology through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning	This work was supported by Support Program for Women in Science, Engineering and Technology through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning, no. 2016H1C3A1903202. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2006, GUT, V55, P1090, DOI 10.1136/gut.2005.084194; Ait-Belgnaoui A, 2009, NEUROGASTROENT MOTIL, V21, P585, DOI 10.1111/j.1365-2982.2009.01280.x; Altemus M, 2006, HORM BEHAV, V50, P534, DOI 10.1016/j.yhbeh.2006.06.031; Barbara G, 2011, J NEUROGASTROENTEROL, V17, P349, DOI 10.5056/jnm.2011.17.4.349; Bashashati M, 2014, NEUROGASTROENT MOTIL, V26, P1036, DOI 10.1111/nmo.12358; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Choi YJ, 2017, J GASTROEN HEPATOL, V32, P1553, DOI 10.1111/jgh.13756; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Da Silva S, 2014, AM J PHYSIOL-GASTR L, V307, pG420, DOI 10.1152/ajpgi.00290.2013; Dai C, 2013, WORLD J GASTROENTERO, V19, P5973, DOI 10.3748/wjg.v19.i36.5973; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Dinan TG, 2008, AM J GASTROENTEROL, V103, P2570, DOI 10.1111/j.1572-0241.2008.01871.x; Distrutti E, 2016, WORLD J GASTROENTERO, V22, P2219, DOI 10.3748/wjg.v22.i7.2219; Gwee KA, 2010, J GASTROEN HEPATOL, V25, P1189, DOI 10.1111/j.1440-1746.2010.06353.x; Kim DB, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/5832051; Kim YS, 2014, J NEUROGASTROENTEROL, V20, P54, DOI 10.5056/jnm.2014.20.1.54; Lamine F, 2004, SCAND J GASTROENTERO, V39, P1250, DOI 10.1080/00365520410007953; Larauche M, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01980.x; Larauche M, 2012, WORLD J GASTROENTERO, V18, P225, DOI 10.3748/wjg.v18.i3.225; Lee BJ, 2011, J NEUROGASTROENTEROL, V17, P252, DOI 10.5056/jnm.2011.17.3.252; Lee JY, 2016, J NEUROGASTROENTEROL, V22, P694, DOI 10.5056/jnm16007; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Mackey E, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0113-7; Mazurak N, 2015, J NEUROGASTROENTEROL, V21, P471, DOI 10.5056/jnm15071; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Miao JJ, 2016, BIOSCI MICROB FOOD H, V35, P89, DOI 10.12938/bmfh.2015-013; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Munoz-Cruz S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/351829; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Rolland-Fourcade C, 2017, GUT, V66, P1767, DOI 10.1136/gutjnl-2016-312094; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Simren M, 2001, SCAND J GASTROENTERO, V36, P545, DOI 10.1080/003655201750153476; Talley NJ, 1998, GUT, V42, P690, DOI 10.1136/gut.42.5.690; Vanuytsel T, 2014, GUT, V63, P1293, DOI 10.1136/gutjnl-2013-305690; Watanabe Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150559; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	45	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188992	10.1371/journal.pone.0188992	http://dx.doi.org/10.1371/journal.pone.0188992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244820	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700014
J	Pena-Longobardo, LM; Rodriguez-Sanchez, B; Mata-Cases, M; Rodriguez-Manas, L; Capel, M; Oliva-Moreno, J				Pena-Longobardo, L. M.; Rodriguez-Sanchez, B.; Mata-Cases, M.; Rodriguez-Manas, L.; Capel, M.; Oliva-Moreno, J.			Is quality of life different between diabetic and non-diabetic people? The importance of cardiovascular risks	PLOS ONE			English	Article							BODY-MASS INDEX; HEALTH; OLDER; EXPECTANCY; SINGLE; COSTS	Background To analyse and compare the impact of cardiovascular risk factors and disease on health-related quality of life (HRQoL) in people with and without diabetes living in the community. Methods We used data of 1,905 people with diabetes and 19,031 people without diabetes from the last Spanish National Health Survey (years 2011 +/- 2012). The HRQoL instrument used was the EuroQol 5D-5L, based on time trade-off scores. Matching methods were used to assess any differences in the HRQoL in people with and without diabetes with the same characteristics (age, gender, education level, and healthy lifestyle), according to cardiovascular risk factors and diseases. Disparities were also analysed for every dimension of HRQoL: mobility, daily activities, personal care, pain/discomfort, and anxiety/depression. Results There were no significant differences in time trade-off scores between people with and without diabetes when cardiovascular risk factors or established cardiovascular disease were not present. However, when cardiovascular risk factors were present, the HRQoL score was significantly lower in people with diabetes than in those without. This difference was indeed greater when cardiovascular diseases were present. More precisely, people with diabetes and any of the cardiovascular risk factors, who have not yet developed any cardiovascular disease, report lower HRQoL, 0.046 TTO score points over 1 (7.93 over 100 in the VAS score) compared to those without diabetes, and 0.14 TTO score points of difference (14.61 over 100 in the VAS score) if cardiovascular diseases were present. In fact, when the three risk factors were present in people with diabetes, HRQoL was significantly lower (0.10 TTO score points over 1 and 10.86 points over 100 in VAS score), obesity being the most influential risk factor. Conclusions The presence of established cardiovascular disease and/or cardiovascular risk factors, specially obesity, account for impaired quality of life in people with diabetes.	[Pena-Longobardo, L. M.; Oliva-Moreno, J.] Univ Castilla La Mancha, Dept Econ Anal & Finance, Toledo, Spain; [Rodriguez-Sanchez, B.] Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands; [Mata-Cases, M.] Inst Catala Salut, Primary Hlth Care Ctr La Mina, Gerencia Ambit Atencio Primaria Barcelona Ciutat, Barcelona, Spain; [Mata-Cases, M.] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, DAP Cat Grp, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain; [Mata-Cases, M.] ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain; [Rodriguez-Manas, L.] Getafe Univ Hosp, Geriatr Serv, Madrid, Spain; [Capel, M.] Hlth Econ & Outcomes Res, Astrazeneca, Madrid, Spain	Universidad de Castilla-La Mancha; University of Groningen; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Hospital Universitario de Getafe	Pena-Longobardo, LM (corresponding author), Univ Castilla La Mancha, Dept Econ Anal & Finance, Toledo, Spain.	luzmaria.pena@uclm.es	mata-cases, manel/W-9485-2019; Oliva, Juan/A-1299-2011; Pena Longobardo, Luz Maria/K-6413-2017	mata-cases, manel/0000-0003-3693-3622; Oliva, Juan/0000-0002-8997-0307; RODRIGUEZ SANCHEZ, BEATRIZ/0000-0002-6146-068X; Pena Longobardo, Luz Maria/0000-0001-7224-2189; Rodriguez-Manas, Leocadio/0000-0002-6551-1333	AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca. The funder provided support in the form of salaries for authors MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva M, 2014, HEALTH ECON, V23, P487, DOI 10.1002/hec.2930; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anderson JM, 2012, J ACAD NUTR DIET, V112, P1747, DOI 10.1016/j.jand.2012.08.033; Banegas JR, 2007, EUR J CARDIOV PREV R, V14, P456, DOI 10.1097/HJR.0b013e3280803f29; Barrot-de la Puente J, 2015, INT J CLIN PRACT, V69, P1486, DOI 10.1111/ijcp.12741; Bergmann N, 2014, ENDOCR CONNECT, V3, DOI 10.1530/EC-14-0083; Castro-Rodriguez M, 2016, J AM MED DIR ASSOC, V17, P949, DOI 10.1016/j.jamda.2016.07.013; Clarke PM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000236; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Fu AZ, 2011, QUAL LIFE RES, V20, P825, DOI 10.1007/s11136-010-9819-x; GBD 2015 DALYs and HALE collaborators, 2017, LANCET, V16; Gil J, 2011, ECON HUM BIOL, V9, P78, DOI 10.1016/j.ehb.2010.05.016; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Hunger M, 2012, J DIABETES COMPLICAT, V26, P413, DOI 10.1016/j.jdiacomp.2012.05.008; Jagger C, 2003, J PUBLIC HEALTH MED, V25, P42, DOI 10.1093/pubmed/fdg009; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kiadaliri AA, 2016, HEALTH QUAL LIFE OUT, V26; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Kontodimopoulos N, 2012, EUR J HEALTH ECON, V13, P111, DOI 10.1007/s10198-010-0290-y; Ljungvall A, 2015, EUR J HEALTH ECON, V16, P5, DOI 10.1007/s10198-013-0545-5; Lopez-Bastida J, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-17; Lung TWC, 2011, QUAL LIFE RES, V20, P1669, DOI 10.1007/s11136-011-9902-y; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Mata Cases M, 2003, Aten Primaria, V31, P493; Mata-Cases M, 2016, EUR J HEALTH ECON, V17, P1001, DOI 10.1007/s10198-015-0742-5; Morgan CL, 2006, DIABETIC MED, V23, P1100, DOI 10.1111/j.1464-5491.2006.01936.x; Nolan CM, 2016, THORAX, V71, P493, DOI 10.1136/thoraxjnl-2015-207782; O'Reilly DJ, 2011, QUAL LIFE RES, V20, P939, DOI 10.1007/s11136-010-9828-9; Oliva J, 2004, DIABETES CARE, V27, P2616, DOI 10.2337/diacare.27.11.2616; Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rodriguez-Sanchez B, 2017, J AM MED DIR ASSOC, V18, P74, DOI 10.1016/j.jamda.2016.09.011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1973, BIOMETRICS, V29, P185, DOI 10.2307/2529685; Sinclair A, 2015, LANCET DIABETES ENDO, V3, P275, DOI 10.1016/S2213-8587(14)70176-7; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; Vaidya V, 2015, EXPERT REV PHARM OUT, V15, P487, DOI 10.1586/14737167.2015.1024661; Wacker ME, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0401-0	40	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189505	10.1371/journal.pone.0189505	http://dx.doi.org/10.1371/journal.pone.0189505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240836	Green Published, Green Submitted, gold			2022-12-26	WOS:000417905600039
J	Wang, DM; Hou, ZD; Gong, Y; Chen, SBA; Lin, L; Xiao, ZY				Wang, Danmin; Hou, Zhiduo; Gong, Yao; Chen, Subiao; Lin, Ling; Xiao, Zhengyu			Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis	PLOS ONE			English	Article							SPONDYLOARTHRITIS RESEARCH CONSORTIUM; INFLAMMATORY BACK-PAIN; RISK-FACTORS; AXIAL SPONDYLOARTHRITIS; SYNDESMOPHYTES; OSTEOPOROSIS; PREVALENCE; LESIONS; INDEX; ONSET	Objective This study aimed to assess the relationship between bone marrow edema (BME) on magnetic resonance imaging (MRI) and bone mineral density (BMD) in patients with ankylosing spondylitis (AS). Methods The study included 333 patients with AS who underwent BMD measurements and axial MRI. Additionally, 106 normal controls were included. The modified New York criteria were used as the classification criteria of AS. Clinical, laboratory, and imaging data were collected and analyzed. Lumbar spine and proximal femur BMD were assessed using dual-energy X-ray absorptiometry. Low BMD was defined by a Z-score <=-2. The Spondyloarthritis Research Consortium of Canada (SPARCC) MRI index was used to assess inflammation at the sacroiliac joint (SIJ) and spine. Results Among the 333 patients, the male: female ratio was 4.6: 1, mean patient age was 28.5 +/- 10.6 years, and mean disease duration was 7.3 +/- 6.8 years. The prevalences of low BMD, osteopenia, and osteoporosis were significantly higher among AS patients than among controls (19.8%, 62.8%, and 5.7% vs. 4.7%, 33.0%, and 0%, respectively, P = 0.000). The BMD values were significantly lower and prevalences of low BMD at both the spine and femur were significantly higher among patients with BME on MRI than among those without BME. Multivariate logistic regression analysis showed that male sex (OR 3.87, 95% CI 1.21 - 7.36, P = 0.023), high ASDAS-CRP score (OR 2.83, 95% CI 1.36-4.76, P = 0.015), the presence of BME on sacroiliac MRI (OR 2.83, 95% CI 1.77-6.23, P = 0.000) and spinal MRI (OR 4.06, 95% CI 1.96-8.46, P = 0.000), and high grade of sacroiliitis (OR 2.93, 95% CI 1.82-4.45, P = 0.002) were risk factors for low BMD (any site). The SPARCC scores of the SIJ were negatively correlated with femoral BMD (r = -0.22, 95% CI -0.33 to -0.10, P = 0.000).Additionally, the SPARCC scores of the spine were negatively correlated with BMD values (r = -0.23, 95% CI -0.36 to -0.09, P = 0.003) and Z- scores (r = -0.24, 95% CI -0.36 to -0.12, P = 0.001) at the spine. Conclusion Low BMD is common in AS patients. BME on MRI is highly associated with low BMD at both the spine and femur.	[Wang, Danmin; Hou, Zhiduo; Lin, Ling; Xiao, Zhengyu] Shantou Univ, Med Coll, Affiliated Hosp 1, Dept Rheumatol, Shantou, Guangdong, Peoples R China; [Gong, Yao; Chen, Subiao] Shantou Univ, Med Coll, Dept Rheumatol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Xiao, ZY (corresponding author), Shantou Univ, Med Coll, Affiliated Hosp 1, Dept Rheumatol, Shantou, Guangdong, Peoples R China.	deanyu@163.com	Hou, Zhiduo/AAA-8076-2022	Hou, Zhi-duo/0000-0001-7734-001X	Natural Science Foundation of China [81672640]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015045]; Sail plan training high-level personnel project of Guangdong Province [174019]; Guangdong Natural Science Foundation [2014A030313484]; Science and Technology Planning Project of Guangdong Province [2013B021800174, 2013B021800175]; Educational Commission of Guangdong Province [2013kjcx0077]; Shantou University Medical College Clinical Research Enhancement Initiative [2014110109]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases; Sail plan training high-level personnel project of Guangdong Province; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Educational Commission of Guangdong Province; Shantou University Medical College Clinical Research Enhancement Initiative	This study was supported by grants from Natural Science Foundation of China (81672640) to LL, the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases (2015045) to LL, Sail plan training high-level personnel project of Guangdong Province (174019) to LL, the Guangdong Natural Science Foundation (2014A030313484) to LL, Science and Technology Planning Project of Guangdong Province (20136021800174 and 20136021800175) to LL, the Educational Commission of Guangdong Province (2013kjcx0077) to LL, and Shantou University Medical College Clinical Research Enhancement Initiative (2014110109) to ZX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Natural Science Foundation of China (81672640), the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases (2015045), Sail plan training high-level personnel project of Guangdong Province (174019), the Guangdong Natural Science Foundation (2014A030313484), Science and Technology Planning Project of Guangdong Province (2013B021800174, and 2013B021800175), the Educational Commission of Guangdong Province (2013kjcx0077), and Shantou University Medical College Clinical Research Enhancement Initiative (2014110109).	Akgol G, 2014, RHEUMATOLOGY, V53, P497, DOI 10.1093/rheumatology/ket385; Appel H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2035; Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002; Bao J, 2014, CALCIFIED TISSUE INT, V95, P108, DOI 10.1007/s00223-014-9867-2; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Bellow M, 2000, ANN RHEUM DIS, V59, P135, DOI 10.1136/ard.59.2.135; Briot K, 2013, ANN RHEUM DIS, V72, P1914, DOI 10.1136/annrheumdis-2012-201845; DONNELLY S, 1994, ANN RHEUM DIS, V53, P117, DOI 10.1136/ard.53.2.117; Ferencz V, 2015, MED LITH, V51, P272; Gilgil E, 2005, J RHEUMATOL, V32, P292; Gratacos J, 1999, ARTHRITIS RHEUM, V42, P2319, DOI 10.1002/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G; Grazio S, 2012, RHEUMATOL INT, V32, P2801, DOI 10.1007/s00296-011-2066-9; Haugeberg G, 2010, ANN RHEUM DIS, V69, P1364, DOI 10.1136/ard.2009.124982; Hermann KGA, 2012, ANN RHEUM DIS, V71, P1278, DOI 10.1136/ard.2011.150680; Jevtic V, 2000, SKELETAL RADIOL, V29, P27, DOI 10.1007/s002560050005; Jimenez-Boj E, 2007, ARTHRITIS RHEUM-US, V56, P1118, DOI 10.1002/art.22496; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Karberg K, 2005, J RHEUMATOL, V32, P1290; Klingberg E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3833; Lange U, 2005, RHEUMATOL INT, V26, P115, DOI 10.1007/s00296-004-0515-4; Magrey MN, 2016, SEMIN ARTHRITIS RHEU, V46, P88, DOI 10.1016/j.semarthrit.2016.03.003; Maillefert JF, 2001, OSTEOPOROSIS INT, V12, P605, DOI 10.1007/s001980170084; Maksymowych WP, 2005, ARTHRIT RHEUM-ARTHR, V53, P703, DOI 10.1002/art.21445; Maksymowych WP, 2005, ARTHRIT RHEUM-ARTHR, V53, P502, DOI 10.1002/art.21337; Nazir L, 2015, J PAK MED ASSOC, V65, P973; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P1520, DOI 10.1136/ard.2009.110767; Ulu MA, 2014, CHINESE MED J-PEKING, V127, P2740, DOI 10.3760/cma.j.issn.0366-6999.20140367; Ulu MA, 2013, RHEUMATOL INT, V33, P1705, DOI 10.1007/s00296-012-2632-9; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Weijden MAC, 2012, CLIN RHEUMATOL, V31, P1529, DOI 10.1007/s10067-012-2018-0; van der Weijden MAC, 2011, CLIN RHEUMATOL, V30, P497, DOI 10.1007/s10067-010-1538-8; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wang D, 2015, CLIN EXP RHEUMATOL, V33, P465	33	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189569	10.1371/journal.pone.0189569	http://dx.doi.org/10.1371/journal.pone.0189569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8OT	29240803	Green Published, gold, Green Submitted			2022-12-26	WOS:000417905600046
J	Keer, S; Glass, B; McLean, D; Harding, E; Babbage, D; Leathem, J; Brinkman, Y; Prezant, B; Pearce, N; Douwes, J				Keer, Samuel; Glass, Bill; McLean, Dave; Harding, Elizabeth; Babbage, Duncan; Leathem, Janet; Brinkman, Yanis; Prezant, Bradley; Pearce, Neil; Douwes, Jeroen			Neuropsychological performance in solvent-exposed vehicle collision repair workers in New Zealand	PLOS ONE			English	Article							MIXED ORGANIC-SOLVENTS; OCCUPATIONAL-EXPOSURE; SPRAY PAINTERS; NEUROBEHAVIORAL PERFORMANCE; COGNITIVE IMPAIRMENT; CAR PAINTERS; MIXTURES; NEUROTOXICITY; TOXICITY; IMPACT	Objectives To assess whether contemporary solvent exposures in the vehicle collision repair industry are associated with objectively measured neuropsychological performance in collision repair workers. Methods The RBANS battery and additional tests were administered to 47 vehicle collision repair and 51 comparison workers randomly selected from a previous questionnaire study. Results Collision repair workers performed lower on tests of attention (digit span backwards: -1.5, 95% CI -2.4, -0.5; digit span total: -1.7, CI -3.3, -0.0; coding: -6.1, CI -9.9, -2.8; total attention scale: -9.3, CI -15.9, -2.8) and the RBANS total scale (-5.1, CI -9.1, -1.2). Additional tests also showed deficits in visual attention and reaction time (Trails B: -11.5, CI -22.4, -0.5) and motor speed/dexterity (coin rotation dominant hand & non-dominant: -2.9, CI -5.3, -0.4 and -3.1, CI -5.6, -0.7 respectively). The strongest associations were observed in panel beaters. Applying dichotomised RBANS outcomes based on the lowest percentile scores of a normative comparison group showed strongly increased risks for attention (5th percentile: OR 20.1, 95% CI 1.5, 263.3; 10th percentile: 8.8, CI 1.7, 46.2; and 20th percentile: 5.1, CI 1.5, 17.6, respectively). Those employed in the industry for <= 17 years (the median work duration) generally had lower scores in the attention domain scale and RBANS total scale compared to those employed >17 years suggesting a healthy worker survivor bias, but trends were inconsistent for other domains. Conclusions This study has found significant deficits in cognitive performance in collision repair workers despite low current airborne exposures in New Zealand.	[Keer, Samuel; Glass, Bill; McLean, Dave; Harding, Elizabeth; Brinkman, Yanis; Prezant, Bradley; Pearce, Neil; Douwes, Jeroen] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Babbage, Duncan] Auckland Univ Technol, Ctr eHlth, Auckland, New Zealand; [Babbage, Duncan] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Leathem, Janet; Brinkman, Yanis] Massey Univ, Sch Psychol, Wellington, New Zealand; [Pearce, Neil] London Sch Hyg & Trop Med, Dept Med Stat, London, England	Massey University; Auckland University of Technology; Auckland University of Technology; Massey University; University of London; London School of Hygiene & Tropical Medicine	Keer, S (corresponding author), Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand.	s.keer@massey.ac.nz	McLean, David J/F-3686-2015	McLean, David J/0000-0001-7147-2003; Pearce, Neil/0000-0002-9938-7852	Health Research Council (HRC) of New Zealand [RM 14828]	Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand)	The study was funded by a grant from the Health Research Council (HRC) of New Zealand (Grant number RM 14828 to JD/NP), URL http://www.hrc.govt.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinger DC, 2004, ENVIRON RES, V95, P394, DOI 10.1016/j.envres.2003.07.013; Bleecker ML, 2007, NEUROLOGY, V69, P470, DOI 10.1212/01.wnl.0000266628.43760.8c; Bockelmann I, 2004, DISABIL REHABIL, V26, P798, DOI 10.1080/09638280410001696719; Bockelmann I, 2002, DISABIL REHABIL, V24, P455, DOI 10.1080/09638280110102126; Brooke I, 1998, ANN OCCUP HYG, V42, P531, DOI 10.1093/annhyg/42.8.531; Caldwell DJ, 2000, AIHAJ, V61, P881, DOI 10.1202/0002-8894(2000)061<0881:HSEDCA>2.0.CO;2; Checkoway H., 2004, Research methods in occupational epidemiology, V2nd; COLVIN M, 1993, ENVIRON RES, V63, P122, DOI 10.1006/enrs.1993.1134; DANIELL W, 1993, BRIT J IND MED, V50, P368; Dick FD, 2006, OCCUP ENVIRON MED, V63, P221, DOI 10.1136/oem.2005.022400; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P429, DOI 10.1093/arclin/acq045; ESCALONA E, 1995, AM J IND MED, V27, P15, DOI 10.1002/ajim.4700270103; Foo S. C., 1994, Annals Academy of Medicine Singapore, V23, P650; Gidlow DA, 2015, OCCUP MED-OXFORD, V65, P348, DOI 10.1093/occmed/kqv018; Gobba F, 1995, SCAND J WORK ENV HEA, V21, P517, DOI 10.5271/sjweh.69; Golden C. J., 2002, STROOP COLOR WORD TE; GOLDMAN MS, 1983, AM PSYCHOL, V38, P1045, DOI 10.1037/0003-066X.38.10.1045; HANNINEN H, 1976, Scandinavian Journal of Work Environment and Health, V2, P240; HOOISMA J, 1993, NEUROTOXICOL TERATOL, V15, P397, DOI 10.1016/0892-0362(93)90057-U; Jang JY, 1999, INT ARCH OCC ENV HEA, V72, P107, DOI 10.1007/s004200050345; JAYJOCK MA, 1984, ANN OCCUP HYG, V28, P19, DOI 10.1093/annhyg/28.1.19; Kaukiainen A, 2009, NEUROTOXICOLOGY, V30, P1187, DOI 10.1016/j.neuro.2009.03.010; Kauppinen T, 2013, ANN OCCUP HYG, V57, P593, DOI 10.1093/annhyg/mes090; Keer S, 2016, NEUROTOXICOLOGY, V57, P223, DOI 10.1016/j.neuro.2016.10.005; KISHI R, 1993, ENVIRON RES, V62, P303, DOI 10.1006/enrs.1993.1115; Lee CR, 2005, IND HEALTH, V43, P320, DOI 10.2486/indhealth.43.320; Lovibond PF, 1998, J ABNORM PSYCHOL, V107, P520, DOI 10.1037/0021-843X.107.3.520; MAIZLISH NA, 1985, BRIT J IND MED, V42, P579; Mendoza J, 1995, J INT NEUROPSYCHOL S, V1, P355; Meyer-Baron M, 2008, NEUROTOXICOLOGY, V29, P349, DOI 10.1016/j.neuro.2008.02.005; Moen BE, 2000, ANN OCCUP HYG, V44, P185, DOI 10.1093/annhyg/44.3.185; Nelson H., 1991, NATL ADULT READING T; Randolph, 2012, RBANS UPDATE REPEATA; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rey A., 1958, LEXAMEN CLINIQUE PSY; Schweizer TA, 2006, NEUROPSYCHOPHARMACOL, V31, P1301, DOI 10.1038/sj.npp.1300941; Semple S, 2001, ANN OCCUP HYG, V45, P25, DOI 10.1016/S0003-4878(00)00007-7; SEPPALAINEN AM, 1985, SCAND J WORK ENV HEA, V11, P61; SEPPALAINEN AM, 1983, SCAND J WORK ENV HEA, V9, P15, DOI 10.5271/sjweh.2447; SEPPALAINEN AM, 1978, SCAND J WORK ENV HEA, V4, P304, DOI 10.5271/sjweh.2695; Smith A, 1982, SYMBOL DIGITS MODALI; SPURGEON A, 1994, OCCUP ENVIRON MED, V51, P626, DOI 10.1136/oem.51.9.626; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TRIEBIG G, 1992, INT ARCH OCC ENV HEA, V64, P361, DOI 10.1007/BF00379547; TRIEBIG G, 1992, INT ARCH OCC ENV HEA, V64, P353, DOI 10.1007/BF00379546; van der Hoek FJA, INT ARCH OCCUPATIONA, V73, P362; Wechsler D., 2012, WAIS 4 KASIKIRJA	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189108	10.1371/journal.pone.0189108	http://dx.doi.org/10.1371/journal.pone.0189108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8HS	29236771	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000417884100041
J	Sveen, LR; Grammes, FT; Ytteborg, E; Takle, H; Jorgensen, SM				Sveen, Lene Rydal; Grammes, Fabian Thomas; Ytteborg, Elisabeth; Takle, Harald; Jorgensen, Sven Martin			Genome-wide analysis of Atlantic salmon (Salmo salar) mucin genes and their role as biomarkers	PLOS ONE			English	Article							SKIN; STRESS; FISH; MUCUS; RESPONSES; HEALTH; WATER; L.	The aim of this study was to identify potential mucin genes in the Atlantic salmon genome and evaluate tissue-specific distribution and transcriptional regulation in response to aquaculture-relevant stress conditions in post-smolts. Seven secreted gel-forming mucin genes were identified based on several layers of evidence; annotation, transcription, phylogeny and domain structure. Two genes were annotated as muc2 and five genes as muc5. The muc2 genes were predominantly transcribed in the intestinal region while the different genes in the muc5 family were mainly transcribed in either skin, gill or pyloric caeca. In order to investigate transcriptional regulation of mucins during stress conditions, two controlled experiments were conducted. In the first experiment, handling stress induced mucin transcription in the gill, while transcription decreased in the skin and intestine. In the second experiment, long term intensive rearing conditions (fish biomass similar to 125 kg/m(3)) interrupted by additional confinement led to increased transcription of mucin genes in the skin at one, seven and fourteen days post-confinement.	[Sveen, Lene Rydal] Univ Bergen UiB, Sect Marine Dev Biol, Dept Biol, Bergen, Norway; [Sveen, Lene Rydal; Ytteborg, Elisabeth; Takle, Harald; Jorgensen, Sven Martin] Norwegian Inst Food Fisheries & Aquaculture Res N, Sect Fish Hlth, Div Aquaculture, As, Norway; [Grammes, Fabian Thomas] Norwegian Univ Life Sci NMBU, Fac Life Sci BIOVIT, Dept Anim & Aquaculture Sci IHA, Ctr Integrat Genet CIGENE, As, Norway	University of Bergen; Nofima; Norwegian University of Life Sciences	Sveen, LR (corresponding author), Univ Bergen UiB, Sect Marine Dev Biol, Dept Biol, Bergen, Norway.; Sveen, LR (corresponding author), Norwegian Inst Food Fisheries & Aquaculture Res N, Sect Fish Hlth, Div Aquaculture, As, Norway.	lene.sveen@nofima.no	; Ytteborg, Elisabeth/J-1032-2017	Sveen, Lene/0000-0003-3394-3462; Ytteborg, Elisabeth/0000-0002-3131-020X; Grammes, Fabian/0000-0002-9551-9280	Research Council of Norway [233870/E40, 237856/030]; CtrIAQUA SFI; Centre for Closed-Containment Aquaculture; CtrIAQUA partners	Research Council of Norway(Research Council of Norway); CtrIAQUA SFI; Centre for Closed-Containment Aquaculture; CtrIAQUA partners	The research was supported by the Research Council of Norway (grant 233870/E40) and was part of the CtrIAQUA SFI, Centre for Closed-Containment Aquaculture, funded by the Research Council of Norway (grant 237856/030) and the CtrIAQUA partners. The funders provided support in the form of salaries for authors (LS, EY, HT, SM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; ALLEN A, 1984, CIBA F SYMP, V109, P137, DOI 10.1002/9780470720905.ch10; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; BARTON BA, 1987, T AM FISH SOC, V116, P257, DOI 10.1577/1548-8659(1987)116&lt;257:MCOAPS&gt;2.0.CO;2; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bols NC, 2001, DEV COMP IMMUNOL, V25, P853, DOI 10.1016/S0145-305X(01)00040-4; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Esteban Angeles M, 2012, ISRN IMMUNOL, V2012, P853470, DOI [10.5402/2012/853470, DOI 10.5402/2012/853470]; Gismervik K, 2017, VETERINAERINSTITUTTE, V6, P2017; Hoole D., 2001, DIS CARP OTHER CYPRI; Iwama GK, 1998, ANN NY ACAD SCI, V851, P304, DOI 10.1111/j.1749-6632.1998.tb09005.x; Jevtov I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06653; Jin CS, 2015, J PROTEOME RES, V14, P3239, DOI 10.1021/acs.jproteome.5b00232; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lang T, 2016, SEARCHING EVOLUTIONA; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Ledy K, 2003, DIS AQUAT ORGAN, V56, P235, DOI 10.3354/dao056235; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Madetoja J, 2000, DIS AQUAT ORGAN, V43, P27, DOI 10.3354/dao043027; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Padra JT, 2014, INFECT IMMUN, V82, P5235, DOI 10.1128/IAI.01931-14; Perez-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065457; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Pittman K, 2011, J FISH DIS, V34, P931, DOI 10.1111/j.1365-2761.2011.01308.x; Radull J, 2002, MAR FRESHWATER RES, V53, P465, DOI 10.1071/MF01144; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Segner H, 2012, FISH PHYSIOL BIOCHEM, V38, P85, DOI 10.1007/s10695-011-9517-9; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Sundh H, 2010, BMC PHYSL, V10, P1; Sveen LR, 2016, AQUACULTURE, V464, P629, DOI 10.1016/j.aquaculture.2016.08.012; Svendsen YS, 1997, FISH SHELLFISH IMMUN, V7, P317, DOI 10.1006/fsim.1997.0087; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Marel M, 2010, J FISH DIS, V33, P431, DOI 10.1111/j.1365-2761.2010.01140.x; van der Marel M, 2012, FISH SHELLFISH IMMUN, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Vatsos IN, 2010, EUR J HISTOCHEM, V54, P107, DOI 10.4081/ejh.2010.e22; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; ZUCHELKOWSKI EM, 1981, ANAT RECORD, V200, P33, DOI 10.1002/ar.1092000104; ZUCHELKOWSKI EM, 1985, ANAT REC, V212, P327, DOI 10.1002/ar.1092120402	47	23	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189103	10.1371/journal.pone.0189103	http://dx.doi.org/10.1371/journal.pone.0189103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236729	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100040
J	Singh, BN; Tahara, N; Kawakami, Y; Das, S; Koyano-Nakagawa, N; Gong, WM; Garry, MG; Garry, DJ				Singh, Bhairab N.; Tahara, Naoyuki; Kawakami, Yasuhiko; Das, Satyabrata; Koyano-Nakagawa, Naoko; Gong, Wuming; Garry, Mary G.; Garry, Daniel J.			Etv2-miR-130a-Jarid2 cascade regulates vascular patterning during embryogenesis	PLOS ONE			English	Article							ETV2 GENE-EXPRESSION; SIGNALING PATHWAYS; MOUSE DEVELOPMENT; FATE DECISIONS; IN-VIVO; ANGIOGENESIS; ETS; DIFFERENTIATION; PROGENITORS; LINEAGES	Remodeling of the primitive vasculature is necessary for the formation of a complex branched vascular architecture. However, the factors that modulate these processes are incompletely defined. Previously, we defined the role of microRNAs ( miRNAs) in endothelial specification. In the present study, we further examined the Etv2-Cre mediated ablation of Dicer(L/L) and characterized the perturbed vascular patterning in the embryo proper and yolksac. We mechanistically defined an important role for miR-130a, an Etv2 downstream target, in the mediation of vascular patterning and angiogenesis in vitro and in vivo. Inducible overexpression of miR-130a resulted in robust induction of vascular sprouts and angiogenesis with increased uptake of acetylated-LDL. Mechanistically, miR-130a directly regulated Jarid2 expression by binding to its 3'-UTR region. Over-expression of Jarid2 in HUVEC cells led to defective tube formation indicating its inhibitory role in angiogenesis. The knockout of miR-130a showed increased levels of Jarid2 in the ES/EB system. In addition, the levels of Jarid2 transcripts were increased in the Etv2-null embryos at E8.5. In the in vivo settings, injection of miR-130a specific morpholinos in zebrafish embryos resulted in perturbed vascular patterning with reduced levels of endothelial transcripts in the miR-130a morphants. Further, co-injection of miR-130a mimics in the miR-130a morphants rescued the vascular defects during embryogenesis. qPCR and in situ hybridization techniques demonstrated increased expression of jarid2a in the miR-130a morphants in vivo. These findings demonstrate a critical role for Etv2-miR-130a-Jarid2 in vascular patterning both in vitro and in vivo.	[Singh, Bhairab N.; Das, Satyabrata; Koyano-Nakagawa, Naoko; Gong, Wuming; Garry, Mary G.; Garry, Daniel J.] Univ Minnesota, Lillehei Heart Inst Regenerat Med, Minneapolis, MN 55455 USA; [Singh, Bhairab N.; Das, Satyabrata; Koyano-Nakagawa, Naoko; Gong, Wuming; Garry, Mary G.; Garry, Daniel J.] Univ Minnesota, Sci Program, Minneapolis, MN 55455 USA; [Tahara, Naoyuki; Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Garry, Daniel J.] Univ Minnesota, Paul & Sheila Wellstone Muscular Dystrophy Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Garry, MG; Garry, DJ (corresponding author), Univ Minnesota, Lillehei Heart Inst Regenerat Med, Minneapolis, MN 55455 USA.; Garry, MG; Garry, DJ (corresponding author), Univ Minnesota, Sci Program, Minneapolis, MN 55455 USA.; Garry, DJ (corresponding author), Univ Minnesota, Paul & Sheila Wellstone Muscular Dystrophy Ctr, Minneapolis, MN 55455 USA.	garry002@umn.edu; garry@umn.edu	Das, Satyabrata/J-2629-2019; Gong, Wuming/GQH-9157-2022; Gong, Wuming/GQH-1435-2022	Gong, Wuming/0000-0002-3147-4028; Kawakami, Yasuhiko/0000-0002-0043-9705; Singh, Bhairab/0000-0002-9356-052X	National Institutes of Health [R01HL122576, U01HL100407, R01 AR064195]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support was obtained from the National Institutes of Health (R01HL122576 and U01HL100407 to DJG and R01 AR064195 to YK).	Akiyama R, 2014, DEVELOPMENT, V141, P1104, DOI 10.1242/dev.098905; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Colorado PC, 2000, CANCER RES, V60, P2520; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gong WM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14362; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Koyano-Nakagawa N, 2015, J BIOL CHEM, V290, P28107, DOI 10.1074/jbc.M115.662197; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Oh SY, 2015, MOL CELLS, V38, P1029, DOI 10.14348/molcells.2015.0331; Rasmussen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050103; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Salanga MC, 2010, DEV DYNAM, V239, P1178, DOI 10.1002/dvdy.22277; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi XZ, 2015, J BIOL CHEM, V290, P9614, DOI 10.1074/jbc.M114.614628; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Shi XZ, 2012, J CELL SCI, V125, P5329, DOI 10.1242/jcs.105239; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Singh BN, 2015, CELL REP, V13, P915, DOI 10.1016/j.celrep.2015.09.060; Singh BN, 2015, GENES-BASEL, V6, P417, DOI 10.3390/genes6020417; Singh BN, 2012, DEV BIOL, V371, P23, DOI 10.1016/j.ydbio.2012.07.033; Singh BN, 2010, BBA-MOL CELL RES, V1803, P288, DOI 10.1016/j.bbamcr.2009.11.009; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Sole Anna, 2013, BMC Res Notes, V6, P454, DOI 10.1186/1756-0500-6-454; Subramanian M, 2015, METHODS MOL BIOL, V1206, P29, DOI 10.1007/978-1-4939-1369-5_3; Sumanas S, 2016, CURR TOP DEV BIOL, V118, P77, DOI 10.1016/bs.ctdb.2016.01.005; Tallquist MD, 1999, ONCOGENE, V18, P7917, DOI 10.1038/sj.onc.1203216; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	47	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189010	10.1371/journal.pone.0189010	http://dx.doi.org/10.1371/journal.pone.0189010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232705	Green Published, gold, Green Submitted			2022-12-26	WOS:000417698200017
J	Eckstrand, KL; Mummareddy, N; Kang, H; Cowan, R; Zhou, MC; Zald, D; Silver, HJ; Niswender, KD; Avison, MJ				Eckstrand, Kristen L.; Mummareddy, Nishit; Kang, Hakmook; Cowan, Ronald; Zhou, Minchun; Zald, David; Silver, Heidi J.; Niswender, Kevin D.; Avison, Malcolm J.			An insulin resistance associated neural correlate of impulsivity in type 2 diabetes mellitus	PLOS ONE			English	Article							DOPAMINE TRANSPORTER FUNCTION; STOP-SIGNAL TASK; RESPONSE-INHIBITION; FUNCTIONAL CONNECTIVITY; COGNITIVE FUNCTION; BRAIN; FOOD; OBESITY; ACTIVATION; OVERWEIGHT	Central insulin resistance (IR) influences striatal dopamine (DA) tone, an important determinant of behavioral self-regulation. We hypothesized that an association exists between the degree of peripheral IR and impulse control, mediated by the impact of IR on brain circuits controlling the speed of executing "go" and/or "stop" responses. We measured brain activation and associated performance on a stop signal task (SST) in obese adults with type 2 diabetes (age, 48.1 +/- 6.9 yrs (mean +/- SD); BMI, 36.5 +/- 4.0 kg/m(2); HOMA-IR, 7.2 +/- 4.1; 12 male, 18 female). Increasing IR, but not BMI, was a predictor of shorter critical stop signal delay (cSSD), a measure of the time window during which a go response can be successfully countermanded (R-2 = 0.12). This decline was explained by an IR-associated increase in go speed (R-2 = 0.13) with little impact of IR or BMI on stop speed. Greater striatal fMRI activation contrast in stop error (SE) compared with stop success (SS) trials (CONSE>SS) was a significant predictor of faster go speeds (R-2 = 0.33, p = 0.002), and was itself predicted by greater IR (CONSE>SS vs HOMA-IR: R-2 = 0.10, p = 0.04). Furthermore, this impact of IR on striatal activation was a significant mediator of the faster go speeds and greater impulsivity observed with greater IR. These findings suggest a neural mechanism by which IR may increase impulsivity and degrade behavioral self-regulation.	[Eckstrand, Kristen L.; Mummareddy, Nishit; Avison, Malcolm J.] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA; [Kang, Hakmook; Zhou, Minchun] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Cowan, Ronald] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA; [Zald, David] Vanderbilt Univ, Dept Psychol, Med Ctr, Nashville, TN 37240 USA; [Silver, Heidi J.; Niswender, Kevin D.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Avison, MJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA.	calum.avison@vanderbilt.edu	Eckstrand, Kristen/AAV-4858-2020	Eckstrand, Kristen/0000-0002-6506-3649	Novo-Nordisk Investigator-Initiated Research Award, Vanderbilt MSTP [NIH T32 GM007347]; Ruth Kirschstein Fellowship NIH [F30 DK095543]; Vanderbilt CTSA NIH [UL1 TR000445]; Vanderbilt DRTC NIH [DK20593]; TN Valley Heathcare system	Novo-Nordisk Investigator-Initiated Research Award, Vanderbilt MSTP; Ruth Kirschstein Fellowship NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt CTSA NIH; Vanderbilt DRTC NIH; TN Valley Heathcare system	This work was funded by Novo-Nordisk Investigator-Initiated Research Award, Vanderbilt MSTP Program NIH T32 GM007347, Ruth Kirschstein Fellowship NIH F30 DK095543, Vanderbilt CTSA NIH UL1 TR000445, Vanderbilt DRTC NIH DK20593, TN Valley Heathcare system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DS, 2014, SYNAPSE, V68, P266, DOI 10.1002/syn.21736; Allom V, 2014, APPETITE, V80, P123, DOI 10.1016/j.appet.2014.05.007; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Babbs RK, 2013, PHYSIOL BEHAV, V121, P103, DOI 10.1016/j.physbeh.2013.03.025; Bari A, 2013, PSYCHOPHARMACOLOGY, V230, P89, DOI 10.1007/s00213-013-3141-6; Bartholdy S, 2016, NEUROSCI BIOBEHAV R, V64, P35, DOI 10.1016/j.neubiorev.2016.02.010; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Benedict L, 2006, NEUROENDOCRINOLOGY, V83, P20, DOI 10.1159/000093338; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Boghossian S, 2009, AM J PHYSIOL-REG I, V297, pR1302, DOI 10.1152/ajpregu.00252.2009; Braet C, 2007, EUR CHILD ADOLES PSY, V16, P473, DOI 10.1007/s00787-007-0623-2; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Bruce AS, 2010, INT J OBESITY, V34, P1494, DOI 10.1038/ijo.2010.84; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Chamberlain SR, 2015, CNS SPECTRUMS, V20, P500, DOI 10.1017/S1092852914000625; Chen YJ, 2014, DIABETES CARE, V37, P3157, DOI 10.2337/dc14-1683; Chen YC, 2014, DIABETES CARE; Congdon E, 2014, PSYCHIAT RES-NEUROIM, V222, P17, DOI 10.1016/j.pscychresns.2014.02.002; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; DIETRICH A, 2014, FRONT PSYCHOL, V5, DOI DOI 10.3389/FPSYG.2014.01073; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Eagle DM, 2007, PSYCHOPHARMACOLOGY, V192, P193, DOI 10.1007/s00213-007-0701-7; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Eisenstein SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133621; Fields SA, 2013, APPETITE, V70, P60, DOI 10.1016/j.appet.2013.06.089; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Filbey FM, 2016, OBESITY SILVER SPRIN; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Galioto R, 2015, J CLIN EXP NEUROPSYC, V37, P402, DOI 10.1080/13803395.2015.1023264; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Grant JE, 2015, ACTA PSYCHIAT SCAND, V131, P379, DOI 10.1111/acps.12353; Guthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019482; Guthoff M, 2010, J CLIN ENDOCR METAB, V95, P748, DOI 10.1210/jc.2009-1677; Hallschmid M, 2010, DIABETES, V59, P1101, DOI 10.2337/db09-1493; Haring HU., 2016, DIABETOLOGIA; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hawkins MAW, 2016, HEALTH PSYCHOL, V35, P199, DOI 10.1037/hea0000248; Hendrick OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013155; Hendrick OM, 2011, OBESITY SILVER SPRIN; Heni M, 2012, DIABETOLOGIA, V55, P1773, DOI 10.1007/s00125-012-2528-y; Heni M, 2015, NAT REV ENDOCRINOL, V11, P701, DOI 10.1038/nrendo.2015.173; Heni M, 2014, DIABETES, V63, P4083, DOI 10.2337/db14-0477; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Houben K, 2014, OBESITY, V22, pE6, DOI 10.1002/oby.20670; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Jastreboff AM, 2010, NEUROPSYCHOPHARMACOL; Jastreboff AM, 2012, DIABETES CARE; Ketterer C, 2011, DIABETES RES CLIN PR, V93, pS47, DOI 10.1016/S0168-8227(11)70013-4; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2011, CELL METAB, V13, P720, DOI 10.1016/j.cmet.2011.03.021; Kroemer NB, 2012, HUM BRAIN MAPP; Kulendran M, 2013, INT J OBES LOND; KULLMANN S, 2012, NEUROENDOCRINOLOGY, P13934; Kullmann S, 2015, DIABETES CARE; Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015; Kullmann S, 2012, HUM BRAIN MAPP, V33, P1052, DOI 10.1002/hbm.21268; Lasselin J, 2012, PSYCHONEUROENDOCRINO, V37, P1468, DOI 10.1016/j.psyneuen.2012.01.016; Lawyer SR, 2015, APPETITE, V95, P375, DOI 10.1016/j.appet.2015.07.031; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Liang J, 2013, INT J OBES LOND; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan GD, 2014, PSYCHOL REV, V121, P66, DOI 10.1037/a0035230; Maimaiti S, 2015, J GERONTOL A; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mole TB, 2015, PSYCHOL MED, V45, P771, DOI 10.1017/S0033291714001834; Muggleton NG, 2010, J COGNITIVE NEUROSCI, V22, P2804, DOI 10.1162/jocn.2010.21416; Musen G, 2012, DIABETES, V61, P2375, DOI 10.2337/db11-1669; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Nederkoorn C, 2014, OBESITY, V22, pE2, DOI 10.1002/oby.20621; Ng J, 2011, APPETITE, V57, P65, DOI 10.1016/j.appet.2011.03.017; Nummenmaa L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031089; Ott V, 2012, DIABETES OBES METAB, V14, P214, DOI 10.1111/j.1463-1326.2011.01490.x; Owens WA, 2012, J NEUROSCI, V32, P2637, DOI 10.1523/JNEUROSCI.3759-11.2012; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Schiff S, 2016, BRAIN COGNITION, V110, P112, DOI 10.1016/j.bandc.2015.10.001; Schilling TM, 2014, HUM BRAIN MAPP, V35, P1944, DOI 10.1002/hbm.22304; Schoffelmeer ANM, 2011, J NEUROSCI, V31, P1284, DOI 10.1523/JNEUROSCI.3779-10.2011; Sevak RJ, 2008, EUR J PHARMACOL, V581, P105, DOI 10.1016/j.ejphar.2007.11.047; Sevak RJ, 2007, J NEUROCHEM, V101, P151, DOI 10.1111/j.1471-4159.2006.04358.x; Sevak RJ, 2007, J PHARMACOL EXP THER, V320, P1216, DOI 10.1124/jpet.106.115600; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Stingl KT, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00157; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Stouffer MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9543; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yokum S, 2011, OBESITY, V19, P1775, DOI 10.1038/oby.2011.168; Zandbelt BB, 2013, J COGNITIVE NEUROSCI, V25, P157, DOI 10.1162/jocn_a_00309; Zhang H, 2014, DIABETES	103	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189113	10.1371/journal.pone.0189113	http://dx.doi.org/10.1371/journal.pone.0189113			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP5GS	29228027	Green Published, gold			2022-12-26	WOS:000417648600033
J	Wicha, P; Tocharus, J; Janyou, A; Jittiwat, J; Changtam, C; Suksamrarn, A; Tocharus, C				Wicha, Piyawadee; Tocharus, Jiraporn; Janyou, Adchara; Jittiwat, Jinatta; Changtam, Chatchawan; Suksamrarn, Apichart; Tocharus, Chainarong			Hexahydrocurcumin protects against cerebral ischemia/reperfusion injury, attenuates inflammation, and improves antioxidant defenses in a rat stroke model	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIC-STROKE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; ARTERY OCCLUSION; COLON-CANCER; CURCUMIN; ACTIVATION; MICE; MECHANISMS	The purpose of the present experiment was to investigate whether hexahydrocurcumin (HHC) attenuates brain damage and improves functional outcome via the activation of anti-oxidative activities, anti-inflammation, and anti-apoptosis following cerebral ischemia/reperfusion (I/R). In this study, rats with cerebral I/R injury were induced by a transient middle cerebral artery occlusion (MCAO) for 2 h, followed by reperfusion. The male Wistar rats were randomly divided into five groups, including the sham-operated, vehicle-treated, 10 mg/kg HHC-treated, 20 mg/kg HHC-treated, and 40 mg/kg HHC-treated I/R groups. The animals were immediately injected with HHC by an intraperitoneal administration at the onset of cerebral reperfusion. After 24 h of reperfusion, the rats were tested for neurological deficits, and the pathology of the brain was studied by 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin and eosin (H&E) staining, and terminal deoxynucleotidyltransferase UTP nick end labeling (TUNEL) staining. In addition, the brain tissues were prepared for protein extraction for Western blot analysis, a malondialdehyde (MDA) assay, a nitric oxide (NO) assay, a superoxide dismutase (SOD) assay, a glutathione (GSH) assay, and a glutathione peroxidase (GSH-Px) assay. The data revealed that the neurological deficit scores and the infarct volume were significantly reduced in the HHC-treated rats at all doses compared to the vehicle group. Treatment with HHC significantly attenuated oxidative stress and inflammation, with a decreased level of MDA and NO and a decreased expression of NF-kappa B (p65) and cyclooxygenase-2 (COX-2) in the I/R rats. HHC also evidently increased Nrf2 (nucleus) protein expression, heme oxygenase-1 (HO-1) protein expression, the antioxidative enzymes, and the superoxide dismutase (SOD) activity. Moreover, the HHC treatment also significantly decreased apoptosis, with a decrease in Bax and cleaved caspase-3 and an increase in Bcl-XL, which was in accordance with a decrease in the apoptotic neuronal cells. Therefore, the HHC treatment protects the brain from cerebral I/R injury by diminishing oxidative stress, inflammation, and apoptosis. The antioxidant properties of HHC may play an important role in improving functional outcomes and may offer significant neuroprotection against I/R damage.	[Wicha, Piyawadee; Janyou, Adchara; Tocharus, Chainarong] Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand; [Tocharus, Jiraporn] Chiang Mai Univ, Fac Med, Dept Physiol, Chiang Mai, Thailand; [Jittiwat, Jinatta] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand; [Changtam, Chatchawan] Huachiew Chalermprakiet Univ, Fac Sci & Technol, Div Phys Sci, Samut Prakan, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok, Thailand; [Tocharus, Chainarong] Chiang Mai Univ, Ctr Res & Dev Nat Prod Hlth, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Mahasarakham University; Ramkhamhaeng University; Ramkhamhaeng University; Chiang Mai University	Tocharus, C (corresponding author), Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand.; Tocharus, C (corresponding author), Chiang Mai Univ, Ctr Res & Dev Nat Prod Hlth, Chiang Mai, Thailand.	chainarongt@hotmail.com	Tocharus, Jiraporn/AFL-8828-2022; Suksamrarn, Apichart/R-8782-2019; Tocharus, Jiraporn/AAG-9267-2022		Thailand Research Fund [DBG5980003]; Royal Golden Jubilee (RGJ) PhD program [PHD/0008/2558]; Chiang Mai University research grant	Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee (RGJ) PhD program; Chiang Mai University research grant	This work was supported by: 1. Thailand Research Fund (DBG5980003) to AS; 2. Royal Golden Jubilee (RGJ) PhD program (Grant No. PHD/0008/2558) to PW; 3. Chiang Mai University research grant to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2002, J NEUROSCI RES, V68, P745, DOI 10.1002/jnr.10261; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Ansari S, 2011, JOVE-J VIS EXP, DOI 10.3791/2879; Arumugam TV, 2008, EXPERT OPIN THER TAR, V12, P19, DOI 10.1517/14728222.12.1.19; Ashwal S, 1999, PEDIATR RES, V46, P400; Bi XY, 2009, NEUROL RES, V31, P159, DOI 10.1179/174313209X393573; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cechetto D F, 2001, Prog Brain Res, V132, P391; Changtam C, 2010, EUR J MED CHEM, V45, P941, DOI 10.1016/j.ejmech.2009.11.035; Chen LY, 2012, BRAIN RES, V1475, P80, DOI 10.1016/j.brainres.2012.07.052; Dempe JS, 2013, MOL NUTR FOOD RES, V57, P1543, DOI 10.1002/mnfr.201200113; Deters M, 2008, PHARM RES-DORDR, V25, P1822, DOI 10.1007/s11095-008-9579-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dong HJ, 2014, NEUROL SCI, V35, P1387, DOI 10.1007/s10072-014-1718-4; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Ekshyyan O, 2004, FRONT BIOSCI-LANDMRK, V9, P1567, DOI 10.2741/1357; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Han J, 2014, NEUROCHEM RES, V39, P1292, DOI 10.1007/s11064-014-1311-5; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hicks A, 2009, ACTA NEUROBIOL EXP, V69, P1; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu ZJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/470975; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Orlando RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031869; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Permpoonputtana K, 2013, NEUROTOX RES, V23, P189, DOI 10.1007/s12640-012-9350-7; Rahme R, 2012, STROKE, V43, P550, DOI 10.1161/STROKEAHA.111.635185; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shukla PK, 2008, NEUROCHEM RES, V33, P1036, DOI 10.1007/s11064-007-9547-y; Somparn P, 2007, BIOL PHARM BULL, V30, P74, DOI 10.1248/bpb.30.74; Srimuangwong K, 2012, WORLD J GASTROENTERO, V18, P6951, DOI 10.3748/wjg.v18.i47.6951; Srimuangwong K, 2012, WORLD J GASTROENTERO, V18, P2383, DOI 10.3748/wjg.v18.i19.2383; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P697, DOI 10.1038/jcbfm.1994.88; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; Tuorkey M, 2009, BIOMED ENVIRON SCI, V22, P488, DOI 10.1016/S0895-3988(10)60006-2; Wang L, 2010, BRAIN RES, V1321, P143, DOI 10.1016/j.brainres.2009.12.046; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Young AR, 2007, J NEUROCHEM, V103, P1302, DOI 10.1111/j.1471-4159.2007.04866.x; Zhang HS, 2011, J CELL PHYSIOL, V226, P3385, DOI 10.1002/jcp.22691; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y	55	64	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189211	10.1371/journal.pone.0189211	http://dx.doi.org/10.1371/journal.pone.0189211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220411	Green Published, gold, Green Submitted			2022-12-26	WOS:000417469900040
J	Janssen, RH; Lakemond, CMM; Fogliano, V; Renzone, G; Scaloni, A; Vincken, JP				Janssen, Renske H.; Lakemond, Catriona M. M.; Fogliano, Vincenzo; Renzone, Giovanni; Scaloni, Andrea; Vincken, Jean-Paul			Involvement of phenoloxidase in browning during grinding of Tenebrio molitor larvae	PLOS ONE			English	Article							COLEOPTERAN INSECT; PROTEIN; MELANIN; BIOCHEMISTRY; TYROSINASE; ACID	Insects are investigated as alternative protein source to meet the increasing demand for proteins in the future. Enzymatic browning occurring during grinding of insect and subsequent extraction of proteins can influence the proteins' properties, but it is unclear which enzymes are responsible for this phenomenon. This study was performed on larvae of three commonly used insect species, namely Tenebrio molitor, Alphitobius diaperinus and Hermetia illucens. Oxygen consumption measurements on protein extracts showed activity on L-tyrosine, L-3,4-di-hydroxy-phenylalanine (L-DOPA) and L-dopamine, indicating phenoloxidase as a key player in browning. Furthermore, no reaction on 2,2'-azino-bis( 3-ethylbenzothiazoline-6-sulphonic acid) was observed, ruling out an important contribution of laccase to browning. The browning reaction was most prominent at pH 6 for T. molitor and A. diaperinus, and 7 for H. illucens. As the enzyme activity of H. illucens was the lowest with the darkest color formation, this was likely caused by another factor. The activity of phenoloxidase was confirmed for T. molitor and A. diaperinus by activity measurements after fractionation by anion-exchange chromatography. Color measurements showed the presence of activity on both L-DOPA and L-tyrosine in the same fractions. Both substrates were converted into dopachrome after incubation with enzyme-enriched fractions. No DOPA-decarboxylase, tyrosine hydroxylase and peroxidase activities were observed. By using native PAGE with L-DOPA as staining-solution, active T. molitor protein bands were resolved and characterized, identifying a tyrosinase/phenoloxidase as the active enzyme species. All together, these data confirmed that tyrosinase is an important enzyme in causing enzymatic browning in T. molitor and likely in A. diaperinus.	[Janssen, Renske H.; Lakemond, Catriona M. M.; Fogliano, Vincenzo] Wageningen Univ, Food Qual & Design, Wageningen, Netherlands; [Janssen, Renske H.; Vincken, Jean-Paul] Wageningen Univ, Lab Food Chem, Wageningen, Netherlands; [Renzone, Giovanni; Scaloni, Andrea] CNR, Prote & Mass Spectrometry Lab, ISPAAM, Naples, Italy	Wageningen University & Research; Wageningen University & Research; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Vincken, JP (corresponding author), Wageningen Univ, Lab Food Chem, Wageningen, Netherlands.	jean-paul.vincken@wur.nl	fogliano, vincenzo/A-1419-2009; Fogliano, Vincenzo/M-8166-2019; fogliano, vincenzo/W-6885-2019; RENZONE, GIOVANNI/B-5650-2015	fogliano, vincenzo/0000-0001-8786-9355; fogliano, vincenzo/0000-0001-8786-9355; Scaloni, Andrea/0000-0001-9362-8515; RENZONE, GIOVANNI/0000-0003-3621-6391; Vincken, Jean-Paul/0000-0001-8540-4327	Protein innovation program STW; Dutch ministry of Economic affairs [In2Food STW 12638]	Protein innovation program STW; Dutch ministry of Economic affairs(Ministry of Economic Affairs, Netherlands)	This research was funded by Protein innovation program STW together with the Dutch ministry of Economic affairs within the project In2Food STW 12638. As from January 2017 STW continues its activities as NWO Applied and Engineering Sciences, NWO domain TTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S. O, 2012, INSECT MOL BIOL BIOC; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Bukkens SGF, 1997, ECOL FOOD NUTR, V36, P287, DOI 10.1080/03670244.1997.9991521; Cho MY, 1999, FEBS LETT, V451, P303, DOI 10.1016/S0014-5793(99)00608-0; Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kim MH, 2000, EUR J BIOCHEM, V267, P2599, DOI 10.1046/j.1432-1327.2000.01271.x; KRAMER KJ, 1987, ARCH INSECT BIOCHEM, V6, P279, DOI 10.1002/arch.940060406; Kroll NG, 2003, FOOD SCI TECHNOL RES, V9, P205, DOI 10.3136/fstr.9.205; Kuijpers TFM, 2013, FEBS J, V280, P6184, DOI 10.1111/febs.12539; Le Bourvellec C, 2012, CRIT REV FOOD SCI, V52, P213, DOI 10.1080/10408398.2010.499808; LEE CY, 1995, ENZYMATIC BROWNING I; Lee KM, 2000, EUR J BIOCHEM, V267, P3695, DOI 10.1046/j.1432-1327.2000.01402.x; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; MCEVILY AJ, 1992, CRIT REV FOOD SCI, V32, P253, DOI 10.1080/10408399209527599; Melorose J, 2015, UN, V1, P587, DOI DOI 10.1017/CB09781107415324.004; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Palazzotto E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163422; Prigent SVE, 2007, J SCI FOOD AGR, V87, P2502, DOI 10.1002/jsfa.3011; Rohn S, 2006, MOL NUTR FOOD RES, V50, P696, DOI 10.1002/mnfr.200600043; Schosler H, 2012, APPETITE, V58, P39, DOI 10.1016/j.appet.2011.09.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Vie A, 1999, J BIOL CHEM, V274, P16788, DOI 10.1074/jbc.274.24.16788; Yang XH, 2009, J ADHESION, V85, P576, DOI 10.1080/00218460902996788; Yi LY, 2013, FOOD CHEM, V141, P3341, DOI 10.1016/j.foodchem.2013.05.115; Yoruk R, 2003, J FOOD BIOCHEM, V27, P361, DOI 10.1111/j.1745-4514.2003.tb00289.x	30	20	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189685	10.1371/journal.pone.0189685	http://dx.doi.org/10.1371/journal.pone.0189685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244828	Green Submitted, Green Published, gold			2022-12-26	WOS:000418184700050
J	Tae, BS; Jeong, CW; Kwak, C; Kim, HH; Moon, KC; Ku, JH				Tae, Bum Sik; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Moon, Kyung Chul; Ku, Ja Hyeon			Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer	PLOS ONE			English	Article							LYMPHOVASCULAR INVASION; UROTHELIAL CARCINOMA; 2ND RESECTION; CYSTECTOMY	The prognostic value of repeat transurethral resection of bladder tumor (TURBT) in patients with diagnosed high-risk, non-muscle-invasive bladder cancer (NMIBC) was investigated. We retrospectively reviewed the medical records of patients treated from October 2004 to December 2013 at Seoul National University who underwent repeated TURBT within 2 +/- 6 weeks after an initial resection. The study enrolled patients who had been diagnosed with NMIBC at both the initial and repeat TURBT; patients with muscle-invasive tumors on repeat TURBT were excluded. We used stepwise multivariate Cox regression models stratified by study to assess the independent effects of the predictive factors and estimated hazard ratios (HRs) from the Cox models. We investigated a total of 198 patients who were diagnosed with high-risk NMIBC. In logistic regression analyses, number of bladder tumors (2 +/- 7: OR, 2.319; 8 <= : OR, 3.353; p< 0.05), initially high tumor grade (OR, 2.435; p = 0.040), and presence of carcinoma in situ lesion (OR, 3.639; p = 0.017) correlated with residual tumor in the repeated-TURBT specimen. T1 stage in repeated-TURBT significantly correlated with recurrence (HR, 1.837; p = 0.010) and progression (HR, 2.806; p = 0.029) in multivariate analysis. The high grades of tumors in repeated-TURBT also significantly correlated with progression but not recurrence in the multivariate analysis (HR 2.152; p = 0.008). In this study, the pathologic findings in repeated-TURBT correlated with recurrence and progression in high-risk NMIBC. Repeated-TURBT is valuable because it can predict the recurrence and progression of high-risk NMIBC in addition to obtaining accurate pathologic findings.	[Tae, Bum Sik] Korea Univ, Coll Med, Ansan Hosp, Dept Urol, Ansan, South Korea; [Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea; [Moon, Kyung Chul] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Ku, JH (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	kuuro70@snu.ac.kr		Tae, Bum Sik/0000-0003-2963-7366	National Research Foundation of Korea [2016R1A2B4011623]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea, 2016R1A2B4011623, Dr. Ja Hyeon Ku.	Ali MH, 2010, J ENDOUROL, V24, P2047, DOI 10.1089/end.2010.0319; Babjuk M, 2016, EUROPEAN UROLOGY; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Babjuk M, 2010, EUR UROL, V58, P191, DOI 10.1016/j.eururo.2010.04.019; Bishr Mohamed, 2014, Can Urol Assoc J, V8, pE306, DOI 10.5489/cuaj.1514; Brauers A, 2001, J UROLOGY, V165, P808, DOI 10.1016/S0022-5347(05)66532-9; Divrik RT, 2006, J UROLOGY, V175, P1641, DOI 10.1016/S0022-5347(05)01002-5; Fritsche HM, 2010, EUR UROL, V57, P300, DOI 10.1016/j.eururo.2009.09.024; Grimm MO, 2003, J UROLOGY, V170, P433, DOI 10.1097/01.ju.0000070437.14275.e0; Guevara A, 2010, J UROLOGY, V183, P2161, DOI 10.1016/j.juro.2010.02.026; Han KS, 2008, J ENDOUROL, V22, P2699, DOI 10.1089/end.2008.0281; Herr HW, 2008, BJU INT, V102, P1242, DOI 10.1111/j.1464-410X.2008.07966.x; Herr HW, 2007, J UROLOGY, V177, P75, DOI 10.1016/j.juro.2006.08.070; Herr HW, 1999, J UROLOGY, V162, P74, DOI 10.1097/00005392-199907000-00018; Kim HS, 2014, UROL ONCOL-SEMIN ORI, V32, P1191, DOI 10.1016/j.urolonc.2014.05.008; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; Mathieu R, 2016, NAT REV UROL, V13, P471, DOI 10.1038/nrurol.2016.126; Orsola A, 2010, BJU INT, V105, P202, DOI 10.1111/j.1464-410X.2009.08694.x; Ramirez-Backhaus M, 2012, CURR UROL REP, V13, P109, DOI 10.1007/s11934-012-0234-4; Schips L, 2002, UROLOGY, V59, P220, DOI 10.1016/S0090-4295(01)01522-9; Shim JS, 2015, KOREAN J UROL, V56, P429, DOI 10.4111/kju.2015.56.6.429; Vasdev N, 2012, ECANCERMEDICALSCIENC, V6, DOI 10.3332/ecancer.2012.269	22	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189354	10.1371/journal.pone.0189354	http://dx.doi.org/10.1371/journal.pone.0189354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244843	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700028
J	Zingmond, DS; Arfer, KB; Gildner, JL; Leibowitz, AA				Zingmond, David S.; Arfer, Kodi B.; Gildner, Jennifer L.; Leibowitz, Arleen A.			The cost of comorbidities in treatment for HIV/AIDS in California	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; POPULATION-BASED COHORT; ANTIRETROVIRAL THERAPY; ADMINISTRATIVE DATA; GENERAL-POPULATION; UNITED-STATES; HEALTH-CARE; RISK; ERA; EXPENDITURES	Background Antiretroviral therapy has increased longevity for people living with HIV (PLWH). As a result, PLWH increasingly experience the common diseases of aging and the resources needed to manage these comorbidities are increasing. This paper characterizes the number and types of comorbidities diagnosed among PLWH covered by Medicare and examines how non-HIV comorbidities relate to outpatient, inpatient, and pharmaceutical expenditures. Methods The study examined Medicare expenditures for 9767 HIV-positive Californians enrolled in Medicare in 2010 (7208 persons dually covered by Medicare and Medicaid and 2559 with Medicare only). Costs included both out of pocket costs and those paid by Medicare and Medicaid. Comorbidities were determined by examining diagnosis codes. Findings Medicare expenditures for Californians with HIV averaged $47,036 in 2010, with drugs accounting for about 2/3 of the total and outpatient costs 19% of the total. Inpatient costs accounted for 18% of the total. About 64% of the sample had at least one comorbidity in addition to HIV. Cross-validation showed that adding information on comorbidities to the quantile regression improved the accuracy of predicted individual expenditures. Non-HIV comorbidities relating to health habits D diabetes, hypertension, liver disease (hepatitis C), renal insufficiency D are common among PLWH. Cancer was relatively rare, but added significantly to cost. Comorbidities had little effect on pharmaceutical costs, which were dominated by the cost of antiretroviral therapy, but had a major effect on hospital admission. Conclusions Comorbidities are prevalent among PLWH and add substantially to treatment costs for PLWH. Many of these comorbidities relate to health habits that could be addressed with additional prevention in ambulatory care, thereby improving health outcomes and ultimately reducing costs.	[Zingmond, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Zingmond, David S.] Vet Affairs Greater Los Angeles Healthcare Syst G, Dept Med, Los Angeles, CA USA; [Arfer, Kodi B.] Univ Calif Los Angeles, Global Ctr Children & Families, Los Angeles, CA USA; [Gildner, Jennifer L.; Leibowitz, Arleen A.] UCLA, Dept Publ Policy, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Leibowitz, AA (corresponding author), UCLA, Dept Publ Policy, Los Angeles, CA 90095 USA.	leibowia@luskin.ucla.edu		Leibowitz, Arleen/0000-0001-6970-0564	California HIV/AIDS Research Program (CHRP) of the University of California Grant [RP11-LA-020]; CLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) NIMH Grant [P30 MH058107-21]; UCLA Center for AIDS Research (CFAR) Grant [5P30A1028697]; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI [UL1TR000124];  [NIMH T32M H109205]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, T32MH109205] Funding Source: NIH RePORTER	California HIV/AIDS Research Program (CHRP) of the University of California Grant; CLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) NIMH Grant; UCLA Center for AIDS Research (CFAR) Grant; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the California HIV/AIDS Research Program (CHRP) of the University of California Grant # RP11-LA-020 (www.californiaaidssresearch.org) to AAL, JG, DZ; CLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) NIMH Grant #P30 MH058107-21 (www.chipts.ucla.edu) to ML, KA, JG; UCLA Center for AIDS Research (CFAR) Grant # 5P30A1028697 (aidsinstitute.ucla.edu) to ML; Postdoctoral award to Kodi Arfer, NIMH T32M H109205 to KA and a NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI # UL1TR000124 to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V27; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7; Cowell A, 2015, J HOSP MED, V10, P608, DOI 10.1002/jhm.2409; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; DHHS, GUIDELINES USE ANTIR; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Green TC, 2010, DRUG ALCOHOL DEPEN, V110, P208, DOI 10.1016/j.drugalcdep.2010.02.020; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hunt PW, 2014, CURR OPIN HIV AIDS, V9, P302, DOI 10.1097/COH.0000000000000072; Kaiser Family Foundation, 2014, MED MED FEE IND; Kates J., 2011, MEDICAID HIV NATL AN; Koenker R, 2016, QUANTREG QUANTILE RE; Koram N, 2013, COMORBIDITY PREVALEN; Krentz HB, 2015, HIV MED, V16, P38, DOI 10.1111/hiv.12176; Legarth RA, 2016, JAIDS-J ACQ IMM DEF, V71, P213, DOI 10.1097/QAI.0000000000000825; Leibowitz AA, 2015, AM J PUBLIC HEALTH, V105, P567, DOI 10.2105/AJPH.2014.302263; Meyer N, 2015, COMORBIDITIES PATIEN, P234; Nurutdinova D, 2012, AIDS, V26, P229, DOI 10.1097/QAD.0b013e32834e1404; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Yanik EL, 2016, AIDS, V30, P1663, DOI 10.1097/QAD.0000000000001077; Yehia BR, 2014, JAIDS-J ACQ IMM DEF, V67, P102, DOI 10.1097/QAI.0000000000000251	32	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2017	12	12							e0189392	10.1371/journal.pone.0189392	http://dx.doi.org/10.1371/journal.pone.0189392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8OT	29240798	Green Submitted, Green Published, gold			2022-12-26	WOS:000417905600030
J	DuSablon, A; Parks, J; Whitehurst, K; Estes, H; Chase, R; Vlahos, E; Sharma, U; Wert, D; Virag, J				DuSablon, Augustin; Parks, Justin; Whitehurst, K'Shylah; Estes, Heather; Chase, Robert; Vlahos, Eleftherios; Sharma, Uma; Wert, David; Virag, Jitka			EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice	PLOS ONE			English	Article							MALONYL-COA DECARBOXYLASE; IMPROVES CARDIAC-FUNCTION; COENZYME-A DECARBOXYLASE; FATTY-ACID OXIDATION; ISCHEMIC-HEART; EPH RECEPTORS; INFLAMMATORY RESPONSE; SUBSTRATE METABOLISM; GLUCOSE-OXIDATION; MTOR-INHIBITION	EphrinA1, a membrane-bound receptor tyrosine kinase ligand expressed in healthy cardiomyocytes, is lost in injured cells following myocardial infarction. Previously, we have reported that a single intramyocardial injection of chimeric ephrinA1-Fc at the time of ischemia reduced injury in the nonreperfused myocardium by 50% at 4 days post-MI by reducing apoptosis and inflammatory cell infiltration. In a clinically relevant model of acute ischemia (30min)/reperfusion (24hr or 4 days) injury, we now demonstrate that ephrinA1-Fc reduces infarct size by 46% and completely preserves cardiac function (ejection fraction, fractional shortening, and chamber dimensions) in the short-term (24hrs post-MI) as well as long-term (4 days). At 24 hours post-MI, diminished serum inflammatory cell chemoattractants in ephrinA1-Fc-treated mice reduces recruitment of neutrophils and leukocytes into the myocardium. Differences in relative expression levels of EphA-Rs are described in the context of their putative role in mediating cardioprotection. Validation by Western blotting of selected targets from mass spectrometry analyses of pooled samples of left ventricular tissue homogenates from mice that underwent 30min ischemia and 24hr of reperfusion (I/R) indicates that ephrinA1-Fc administration alters several regulators of signaling pathways that attenuate apoptosis, promote autophagy, and shift from FA metabolism in favor of increased glycolysis to optimize anaerobic ATP production. Taken together, reduced injury is due a combination of adaptive metabolic reprogramming, improved cell survival, and decreased inflammatory cell recruitment, suggesting that ephrinA1-Fc enhances the capacity of the heart to withstand an ischemic insult.	[DuSablon, Augustin; Parks, Justin; Whitehurst, K'Shylah; Estes, Heather; Chase, Robert; Vlahos, Eleftherios; Sharma, Uma; Wert, David; Virag, Jitka] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Virag, J (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA.	viragj@ecu.edu	Virag, Jitka Amira Ismail/AAW-7427-2020; Virag, Jitka/AAW-6690-2020	Virag, Jitka Amira Ismail/0000-0003-3321-9861; 	 [NHLBI-1R15HL124483];  [NCBC-2016-IDG-1008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL124483] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI-1R15HL124483 and NCBC-2016-IDG-1008.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Alrob OA, 2014, BIOCHEM SOC T, V42, P1043, DOI 10.1042/BST20140094; Angin Y, 2012, BIOCHEM J, V448, P43, DOI 10.1042/BJ20120060; Beadle RM, 2010, HEART, V96, P824, DOI 10.1136/hrt.2009.190256; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Blenck CL, 2016, CIRC RES, V118, P1294, DOI 10.1161/CIRCRESAHA.116.307509; Bohl S, 2009, AM J PHYSIOL-HEART C, V297, pH2054, DOI 10.1152/ajpheart.00836.2009; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; Buss SJ, 2010, AUTOPHAGY, V6, P304, DOI 10.4161/auto.6.2.11135; Chagas ACP, 2008, CURR PHARM DESIGN, V14, P2563, DOI 10.2174/138161208786071236; Chen-Scarabelli C, 2014, J GERIATR CARDIOL, V11, P338, DOI 10.11909/j.issn.1671-5411.2014.01.009; Cheng JF, 2006, J MED CHEM, V49, P4055, DOI 10.1021/jm0605029; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; D'Souza K, 2016, BIOCH BIOPHYS ACTA; Das A, 2014, J BIOL CHEM, V289, P4145, DOI 10.1074/jbc.M113.521062; DIMAURO S, 1981, SCIENCE, V212, P1277, DOI 10.1126/science.6262916; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Dries JL, 2011, J PHYSIOL-LONDON, V589, P1725, DOI 10.1113/jphysiol.2010.202366; DuSablon A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0114-y; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Dyck JRB, 2002, J MOL CELL CARDIOL, V34, P1099, DOI 10.1006/jmcc.2002.2060; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Edwards HV, 2012, BIOCHEM SOC T, V40, P210, DOI 10.1042/BST20110673; Fan GC, 2005, TRENDS CARDIOVAS MED, V15, P138, DOI 10.1016/j.tcm.2005.05.004; Fernandez-Caggiano M, 2016, MOL CELL PROTEOMICS, V15, P246, DOI 10.1074/mcp.M115.051862; Fillmore N, 2014, IUBMB LIFE, V66, P139, DOI 10.1002/iub.1253; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; French CJ, 2010, HISTOCHEM CELL BIOL, V134, P519, DOI 10.1007/s00418-010-0748-0; Glatz JFC, 2013, PROSTAG LEUKOTR ESS, V88, P71, DOI 10.1016/j.plefa.2012.04.009; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Heather LC, 2013, CIRC-HEART FAIL, V6, P1058, DOI 10.1161/CIRCHEARTFAILURE.112.000342; Husebye T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112359; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; Jellinghaus S, 2013, BBA-MOL CELL RES, V1833, P2201, DOI 10.1016/j.bbamcr.2013.05.017; Jones SP, 2015, CIRC RES, V116, P572, DOI 10.1161/CIRCRESAHA.116.305462; Jugdutt BI, 2012, HEART FAIL CLIN, V8, P43, DOI 10.1016/j.hfc.2011.08.006; Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Le TYL, 2014, ENDOCRINOLOGY, V155, P568, DOI 10.1210/en.2013-1755; Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]; Liepinsh E, 2016, BIOCHEM J, V473, P1191, DOI 10.1042/BCJ20160164; Lopaschuk GD, 2006, CARDIOVASC DRUG THER, V20, P433, DOI 10.1007/s10557-006-0634-0; Lopaschuk GD, 2001, CORONARY ARTERY DIS, V12, pS8; Lopez EF, 2015, AM J PHYSIOL-HEART C, V308, pH269, DOI 10.1152/ajpheart.00604.2014; Lu M, 2003, CANCER RES, V63, P3425; Luo Q, 2011, FREE RADICAL RES, V45, P1355, DOI 10.3109/10715762.2011.627330; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; Masoud WGT, 2014, CARDIOVASC RES, V101, P30, DOI 10.1093/cvr/cvt216; Mehta HM, 2014, ADV EXP MED BIOL, V844, P99, DOI 10.1007/978-1-4939-2095-2_6; Mentzer RM, 2011, J CARDIOVASC PHARM T, V16, P290, DOI 10.1177/1074248411410318; Michael LH, 1999, AM J PHYSIOL-HEART C, V277, pH660, DOI 10.1152/ajpheart.1999.277.2.H660; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nagendran J, 2013, J MOL CELL CARDIOL, V63, P180, DOI 10.1016/j.yjmcc.2013.07.020; Nakatani K, 2015, METABOLISM, V64, P1165, DOI 10.1016/j.metabol.2015.05.017; O'Neal WT, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00132; O'Neal WT, 2013, MED HYPOTHESES, V80, P738, DOI 10.1016/j.mehy.2013.02.024; Ojha N, 2008, AM J PHYSIOL-HEART C, V294, pH2435, DOI 10.1152/ajpheart.01190.2007; Okuda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072173; Opie LH, 1999, ARCH MAL COEUR VAISS, V92, P1755; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Perry CN, 2009, METHOD ENZYMOL, V453, P325, DOI 10.1016/S0076-6879(08)04016-0; Przyklenk K, 2011, AUTOPHAGY, V7, P432, DOI 10.4161/auto.7.4.14395; Qian J, 2009, CIRC RES, V105, P1223, DOI 10.1161/CIRCRESAHA.109.200378; Ravingerova T, 2013, PHYSIOL RES, V62, pS151, DOI 10.33549/physiolres.932597; Redel A, 2008, EXP BIOL MED, V233, P84, DOI 10.3181/0612-RM-308; REIMER KA, 1979, LAB INVEST, V40, P633; Ren SY, 2015, BBA-MOL BASIS DIS, V1852, P225, DOI 10.1016/j.bbadis.2014.04.029; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rosano GMC, 2008, CURR PHARM DESIGN, V14, P2551, DOI 10.2174/138161208786071317; Shaw J, 2008, AUTOPHAGY, V4, P427, DOI 10.4161/auto.5901; Sugano M, 2004, FASEB J, V18, P911, DOI 10.1096/fj.03-1148fje; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Taegtmeyer H, 1998, AM J CARDIOL, V82, p54K, DOI 10.1016/S0002-9149(98)00538-4; Tiyyagura SR, 2006, MT SINAI J MED, V73, P840; Trescher K, 2006, CARDIOVASC RES, V69, P746, DOI 10.1016/j.cardiores.2005.11.027; Ussher JR, 2008, CARDIOVASC RES, V79, P259, DOI 10.1093/cvr/cvn130; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Vandervelde S, 2006, CARDIOVASC PATHOL, V15, P83, DOI 10.1016/j.carpath.2005.10.006; Virag JAI, 2011, JOVE-J VIS EXP, DOI 10.3791/2581; Wang LQ, 2015, J HUAZHONG U SCI-MED, V35, P10, DOI 10.1007/s11596-015-1381-x; Wang XH, 2009, J MOL CELL CARDIOL, V47, P382, DOI 10.1016/j.yjmcc.2009.05.016; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455; Xu YP, 2014, CANCER RES, V74, P3630, DOI 10.1158/0008-5472.CAN-13-3615; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Yau TM, 2004, J THORAC CARDIOV SUR, V127, P1180, DOI 10.1016/j.jtcvs.2003.09.052; Young ME, 2001, AM J PHYSIOL-ENDOC M, V280, pE471, DOI 10.1152/ajpendo.2001.280.3.E471; Zarrouk-Mahjoub S, 2016, INT J CARDIOL, V221, P632, DOI 10.1016/j.ijcard.2016.07.073; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	102	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0189307	10.1371/journal.pone.0189307	http://dx.doi.org/10.1371/journal.pone.0189307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236774	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100055
J	Mininni, CJ; Caiafa, CF; Zanutto, BS; Tseng, KY; Lew, SE				Mininni, Camilo J.; Caiafa, Cesar F.; Silvano Zanutto, B.; Tseng, Kuei Y.; Lew, Sergio E.			Efficient enhancement of information in the prefrontal cortex during the presence of reward predicting stimuli	PLOS ONE			English	Article							D-1 DOPAMINE-RECEPTORS; WORKING-MEMORY; PYRAMIDAL NEURONS; VARIABILITY; COMPUTATION; POPULATION; MONKEYS; STATES; MODEL; COST	The prefrontal cortex (PFC) is a key brain structure for decision making, behavioural flexibility and working memory. Neurons in PFC encode relevant stimuli through changes in their firing rate, although the metabolic cost of spiking activity puts strong constrains to neural codes based on firing rate modulation. Thus, how PFC neural populations code relevant information in an efficient way is not clearly understood. To address this issue we made single unit recordings in the PFC of rats performing a GO/NOGO discrimination task and analysed how entropy between pairs of neurons changes during cue presentation. We found that entropy rises only during reward-predicting cues. Moreover, this change in entropy occurred along an increase in the efficiency of the whole process. We studied possible mechanisms behind the efficient gain in entropy by means of a two neuron leaky integrateand- fire model, and found that a precise relationship between synaptic efficacy and firing rate is required to explain the experimentally observed results.	[Mininni, Camilo J.; Silvano Zanutto, B.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Caiafa, Cesar F.] Consejo Nacl Invest Cient & Tecn, Inst Argentino Radioastron IAR CCT La Plata, La Plata, Argentina; [Silvano Zanutto, B.; Lew, Sergio E.] Univ Buenos Aires, Fac Ingn, Inst Ingn Biomed, Buenos Aires, DF, Argentina; [Tseng, Kuei Y.] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lew, SE (corresponding author), Univ Buenos Aires, Fac Ingn, Inst Ingn Biomed, Buenos Aires, DF, Argentina.	slew@fi.ubaar	Caiafa, Cesar/A-6045-2010; Lew, Sergio/AAE-7122-2022	Caiafa, Cesar/0000-0001-5437-6095; Lew, Sergio/0000-0001-7700-6687	Universidad de Buenos Aires; UBACYT [20020130100130BA, 20020100100902]; National Institutes of Health [R01-MH086507]; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas); PIP [114-201101-00021];  [PICT-2012-1519]	Universidad de Buenos Aires(University of Buenos Aires); UBACYT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); PIP; 	The work was supported by Universidad de Buenos Aires (CFC, BSZ, SEL), UBACYT 20020130100130BA (CFC, SEL), PICT-2012-1519 (CJM, CFC, BSZ, SEL), the National Institutes of Health Grant R01-MH086507 (KYT), and UBACYT 20020100100902 (SEL), CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), PIP 114-201101-00021 (CFC).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Birrell JM, 2000, J NEUROSCI, V20, P4320; Braitenberg V, 1991, ANATOMY CORTEX STAT; Carr DB, 1999, J NEUROSCI, V19, P11049, DOI 10.1523/JNEUROSCI.19-24-11049.1999; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Joshua M, 2007, J NEUROSCI METH, V163, P267, DOI 10.1016/j.jneumeth.2007.03.012; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; KOJIMA S, 1982, BRAIN RES, V248, P51, DOI 10.1016/0006-8993(82)91146-5; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 2002, J NEUROSCI, V22, P4746, DOI 10.1523/JNEUROSCI.22-11-04746.2002; Lew SE, 2014, NEUROPSYCHOPHARMACOL, V39, P3067, DOI 10.1038/npp.2014.160; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Puig MV, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00093; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sengupta B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003263; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Tseng KY, 2006, SYNAPSE, V59, P412, DOI 10.1002/syn.20255; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Watson C, 2006, RAT BRAIN STEREOTAXI	36	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2017	12	12							e0188579	10.1371/journal.pone.0188579	http://dx.doi.org/10.1371/journal.pone.0188579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8HS	29236787	Green Published, Green Submitted, gold			2022-12-26	WOS:000417884100020
J	Wang, YY; Chang, JH; Li, X; Pathak, R; Sridharan, V; Jones, T; Mao, XW; Nelson, G; Boerma, M; Hauer-Jensen, M; Zhou, DH; Shao, LJ				Wang, Yingying; Chang, Jianhui; Li, Xin; Pathak, Rupak; Sridharan, Vijayalakshmi; Jones, Tamako; Mao, Xiao Wen; Nelson, Gregory; Boerma, Marjan; Hauer-Jensen, Martin; Zhou, Daohong; Shao, Lijian			Low doses of oxygen ion irradiation cause long-term damage to bone marrow hematopoietic progenitor and stem cells in mice	PLOS ONE			English	Article							BODY PROTON IRRADIATION; GAMMA-IRRADIATION; STEM/PROGENITOR CELLS; IONIZING-RADIATION; MURINE MODEL; ABERRATIONS; SENESCENCE; DELETION; INJURY; MARS	During deep space missions, astronauts will be exposed to low doses of charged particle irradiation. The long-term health effects of these exposures are largely unknown. We previously showed that low doses of oxygen ion (O-16) irradiation induced acute damage to the hematopoietic system, including hematopoietic progenitor and stem cells in a mouse model. However, the chronic effects of low dose O-16 irradiation remain undefined. In the current study, we investigated the long-term effects of low dose O-16 irradiation on the mouse hematopoietic system. Male C57BL/6J mice were exposed to 0.05 Gy, 0.1 Gy, 0.25 Gy and 1.0 Gy whole body O-16 (600 MeV/n) irradiation. The effects of O-16 irradiation on bone marrow (BM) hematopoietic progenitor cells (HPCs) and hematopoietic stem cells (HSCs) were examined three months after the exposure. The results showed that the frequencies and numbers of BM HPCs and HSCs were significantly reduced in 0.1 Gy, 0.25 Gy and 1.0 Gy irradiated mice compared to 0.05 Gy irradiated and non-irradiated mice. Exposure of mice to low dose O-16 irradiation also significantly reduced the clongenic function of BM HPCs determined by the colony-forming unit assay. The functional defect of irradiated HSCs was detected by cobblestone area-forming cell assay after exposure of mice to 0.1 Gy, 0.25 Gy and 1.0 Gy of O-16 irradiation, while it was not seen at three months after 0.5 Gy and 1.0 Gy of.-ray irradiation. These adverse effects of O-16 irradiation on HSCs coincided with an increased intracellular production of reactive oxygen species (ROS). However, there were comparable levels of cellular apoptosis and DNA damage between irradiated and non-irradiated HPCs and HSCs. These data suggest that exposure to low doses of O-16 irradiation induces long-term hematopoietic injury, primarily via increased ROS production in HSCs.	[Wang, Yingying; Chang, Jianhui; Li, Xin; Pathak, Rupak; Sridharan, Vijayalakshmi; Boerma, Marjan; Hauer-Jensen, Martin; Zhou, Daohong; Shao, Lijian] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Jones, Tamako; Mao, Xiao Wen; Nelson, Gregory] Loma Linda Univ, Sch Med, Div Radiat Res, Dept Basic Sci, Loma Linda, CA 92350 USA; [Shao, Lijian] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA	University of Arkansas System; University of Arkansas Medical Sciences; Loma Linda University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shao, LJ (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.	lshao@uic.edu	wang, yingying/GRS-3058-2022; Shao, Lijian/AAA-1074-2020; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022	mao, xiao/0000-0002-4508-8689	National Space Biomedical Research Institute [NCC 9-58]; Centers of Biomedical Research Excellence [P20, GM109005]; National Institutes of Health [R01CA122023]; NATIONAL CANCER INSTITUTE [R01CA122023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the National Space Biomedical Research Institute through NCC 9-58 (MB), Centers of Biomedical Research Excellence (P20, GM109005, MHJ), and National Institutes of Health (R01CA122023, DZ).	Ainsworth E J, 1989, Adv Space Res, V9, P299, DOI 10.1016/0273-1177(89)90453-5; Boerma M, 2016, MUTAT RES-REV MUTAT, V770, P319, DOI 10.1016/j.mrrev.2016.07.003; Chai X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10181; Chang JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158097; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chang JH, 2015, RADIAT RES, V183, P240, DOI 10.1667/RR13887.1; Cho J, 2014, J CLIN INVEST, V124, P3159, DOI 10.1172/JCI61636; Chua HL, 2012, HEALTH PHYS, V103, P356, DOI 10.1097/HP.0b013e3182666d6f; Cucinotta Francis A, 2003, Gravit Space Biol Bull, V16, P11; Datta K, 2012, INT J RADIAT BIOL, V88, P213, DOI 10.3109/09553002.2012.639434; Epperly MW, 2011, RADIAT RES, V175, P759, DOI 10.1667/RR2398.1; Farres J, 2013, BLOOD, V122, P44, DOI 10.1182/blood-2012-12-472845; Gao DY, 1998, CRYOBIOLOGY, V36, P40, DOI 10.1006/cryo.1997.2060; George KA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00226; Gridley DS, 2008, IN VIVO, V22, P159; Gridley DS, 2006, IN VIVO, V20, P781; Habermehl D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113591; Hagan M P, 1986, Adv Space Res, V6, P201, DOI 10.1016/0273-1177(86)90293-0; Hamilton SA, 2006, J APPL PHYSIOL, V101, P789, DOI 10.1152/japplphysiol.01078.2005; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; Li HL, 2011, FREE RADICAL BIO MED, V51, P30, DOI 10.1016/j.freeradbiomed.2011.04.016; Luo-Owen X, 2012, RADIAT RES, V177, P251, DOI 10.1667/RR2785.1; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; PHILLIPS TL, 1982, INT J RADIAT ONCOL, V8, P2121, DOI 10.1016/0360-3016(82)90555-7; Raber J, 2015, RADIAT RES, V183, P708, DOI 10.1667/RR13951.1; Raber J, 2014, RADIAT RES, V181, P362, DOI 10.1667/RR13347.1; Rithidech KN, 2015, MUTAT RES-FUND MOL M, V781, P22, DOI 10.1016/j.mrfmmm.2015.09.001; Rithidech KN, 2013, MUTAT RES-GEN TOX EN, V756, P127, DOI 10.1016/j.mrgentox.2013.06.001; Ritter S, 2010, MUTAT RES-GEN TOX EN, V701, P38, DOI 10.1016/j.mrgentox.2010.04.007; Sanzari JK, 2014, LIFE SCI SPACE RES, V2, P86, DOI 10.1016/j.lssr.2014.01.003; Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Suman S, 2012, RADIAT ENVIRON BIOPH, V51, P303, DOI 10.1007/s00411-012-0418-9; TESTA NG, 1985, ANTICANCER RES, V5, P101; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Ware JH, 2010, RADIAT RES, V174, P325, DOI 10.1667/RR1979.1; Xu GS, 2015, FREE RADICAL BIO MED, V87, P15, DOI 10.1016/j.freeradbiomed.2015.05.045; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189466	10.1371/journal.pone.0189466	http://dx.doi.org/10.1371/journal.pone.0189466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232383	Green Published, Green Submitted, gold			2022-12-26	WOS:000417698200048
J	Zheng, XY; Zhao, X; Yang, YF; Jiang, HJ; Li, W; Sun, Y; Pu, XP				Zheng, Xi-Yuan; Zhao, Xin; Yang, Ying-Fan; Jiang, Han-Jie; Li, Wan; Sun, Yi; Pu, Xiao-Ping			Antioxidant, antiapoptotic and amino acid balance regulating activities of 1,7-dihydroxy-3,4,8-trimethoxyxanthone against dimethylnitrosamine-induced liver fibrosis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; GENE-EXPRESSION; IN-VITRO; RAT; PROTEOME; DISEASE; SUPPLEMENTATION; DJ-1; VIVO	Liver fibrosis represents the consequences of a sustained wound healing response to chronic liver injury which could be caused by viral, autoimmune, drugs, and so on. Unfortunately, there was no effective therapy available for liver fibrosis in clinic. In this study, we identified the anti-fibrotic effects of 1,7-dihydroxy-3,4,8-trimethoxyxanthone (ZYC-1) on the dimethylnitrosamine (DMN)-induced rat model. ZYC-1 was isolated from Swertia punicea Hemsl and was administrated to DMN-induced rat model. ZYC decreased the hyaluronic acid (HA), type IV collagen (CIV) and hydroxyproline (Hyp) levels and inhibited the expression of a smooth muscle actin (alpha-SMA) and transforming growth factor beta 1 (TGF-1 beta). The anti-fibrotic effect of ZYC-1 was also confirmed by Sirius Red staining. Finally, we identified 42 differentially expressed proteins by using proteomics analysis after ZYC-1 treatment, of which 17 were up-regulated and 25 were down-regulated. These Most of the 42 proteins are involved in the oxidative stress pathway, the mitochondrial-mediated apoptotic pathway and the amino acid metabolism pathway. Our study presented the first elucidated mechanisms of xanthone on liver fibrosis in vivo. This study pointed out that ZYC-1 may be used as a lead compound for hepatofibrosis treatment.	[Zheng, Xi-Yuan; Zhao, Xin; Yang, Ying-Fan; Jiang, Han-Jie; Li, Wan; Sun, Yi; Pu, Xiao-Ping] Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Zheng, Xi-Yuan; Zhao, Xin; Yang, Ying-Fan; Jiang, Han-Jie; Li, Wan; Sun, Yi; Pu, Xiao-Ping] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing, Peoples R China	Peking University; Peking University	Pu, XP (corresponding author), Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing, Peoples R China.; Pu, XP (corresponding author), Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing, Peoples R China.	pxp123@bjmu.edu.cn	Jiang, Hanjie/AAT-8422-2021	Jiang, Hanjie/0000-0001-6090-4552	Grant from Significant new drugs creation "Five-Year Plan" special science and Technology Major [2012ZX09103201-042]; National Natural Science Funds of China [81202937]; Innovative Drug Research Fund of Founder Group & Peking University Health Science Center [Founder 201004]	Grant from Significant new drugs creation "Five-Year Plan" special science and Technology Major; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Innovative Drug Research Fund of Founder Group & Peking University Health Science Center	This work was supported by a Grant from Significant new drugs creation "Five-Year Plan" special science and Technology Major (No. 2012ZX09103201-042), National Natural Science Funds of China (Grant No. 81202937), and Innovative Drug Research Fund of Founder Group & Peking University Health Science Center (No. Founder 201004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAKOKKO L, 1987, BIOCHEM J, V244, P75, DOI 10.1042/bj2440075; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bi WR, 2012, HEPATO-GASTROENTEROL, V59, P1960, DOI 10.5754/hge11750; Chu X, 2016, J PHARMACOL SCI, V130, P15, DOI 10.1016/j.jphs.2015.12.002; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515; FISCHER JE, 1990, JPEN-PARENTER ENTER, V14, pS249, DOI 10.1177/014860719001400518; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Fukushima H, 2007, HEPATOL RES, V37, P765, DOI 10.1111/j.1872-034X.2007.00123.x; JEZEQUEL AM, 1987, J HEPATOL, V5, P174, DOI 10.1016/S0168-8278(87)80570-6; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kim Y, 2013, FOOD CHEM, V137, P136, DOI 10.1016/j.foodchem.2012.10.006; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Kuwahata M, 2012, NUTR RES, V32, P522, DOI 10.1016/j.nutres.2012.06.007; Li WT, 2014, INDIAN J PHARMACOL, V46, P216, DOI 10.4103/0253-7613.129323; Liao CC, 2015, NUTRIENTS, V7, P8752, DOI 10.3390/nu7105434; Liu SF, 2010, HEPATO-GASTROENTEROL, V57, P1247; Lu GM, 2004, LIFE SCI, V74, P897, DOI 10.1016/j.lfs.2003.08.004; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mastroianni CM, 2014, INT J MOL SCI, V15, P9184, DOI 10.3390/ijms15069184; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; OSTER JR, 1986, J HEPATOL, V2, P299, DOI 10.1016/S0168-8278(86)80089-7; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Rosenbloom J, 2013, BBA-MOL BASIS DIS, V1832, P1088, DOI 10.1016/j.bbadis.2012.12.007; Ueno T, 2006, MED MOL MORPHOL, V39, P16, DOI 10.1007/s00795-006-0311-1; Wang BCC, 2012, MED SCI MONITOR, V18, pBR394, DOI 10.12659/MSM.883479; Xu Y, 2012, METABOLOMICS, V8, P475, DOI 10.1007/s11306-011-0333-0; Zhang GB, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0066-5; Zheng XY, 2014, J ETHNOPHARMACOL, V153, P854, DOI 10.1016/j.jep.2014.03.058; Zhong G.Y., 2010, WST MODERN TRADIT CH, V12, P122; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	34	3	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2017	12	12							e0189344	10.1371/journal.pone.0189344	http://dx.doi.org/10.1371/journal.pone.0189344			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5YF	29232404	gold, Green Published, Green Submitted			2022-12-26	WOS:000417698200032
J	Bucci, C; Francoeur, M; McGreal, J; Smolowitz, R; Zazueta-Novoa, V; Wessel, GM; Gomez-Chiarri, M				Bucci, Caitlin; Francoeur, Madison; McGreal, Jillon; Smolowitz, Roxanna; Zazueta-Novoa, Vanesa; Wessel, Gary M.; Gomez-Chiarri, Marta			Sea Star Wasting Disease in Asterias forbesi along the Atlantic Coast of North America	PLOS ONE			English	Article							MASS MORTALITY; VIRUS	As keystone species, sea stars serve to maintain biodiversity and species distribution through trophic level interactions in marine ecosystems. Recently, Sea Star Wasting Disease (SSWD) has caused widespread mass mortality in several sea star species from the Pacific Coast of the United States of America (USA) and Asterias forbesi on the Atlantic Coast. A densovirus, named Sea Star associated Densovirus (SSaDV), has been associated with the wasting disease in Pacific Coast sea stars, and limited samples of A. forbesi. The goal of this research is to examine the pathogenesis of SSWD in A. forbesi on the Atlantic Coast of the USA and to determine if SSaDV is associated with the wasting disease in this species. Histological examination of A. forbesi tissues affected with SSWD showed cuticle loss, vacuolation and necrosis of epidermal cells, and oedema of the dermis, but no consistent evidence indicating the cause of the lesions. Challenge experiments by cohabitation and immersion in infected water suggest that the cause of SSWD is viral in nature, as filtration (0.22 mu m) of water from tanks with sea stars exhibiting SSWD did not prevent the transmission and progression of the disease. Death of challenged sea stars occurred 7-10 d after exposure to infected water or sea stars, and the infectivity crossed species (A. forbesi and Pateria miniata) with equal penetrance. Of the 48 stars tested by quantitative real time PCR, 29 (60%) were positive for the SSaDV VP1 gene. These stars represent field-collected sea stars from all geographical regions (South Carolina to Maine) in 2012-2015, as well as stars exposed to infected stars or water from affected tanks. However, a clear association between the presence of SSaDV and SSWD signs in experimental and field-collected A. forbesi was not found in this study.	[Bucci, Caitlin; Francoeur, Madison; McGreal, Jillon; Gomez-Chiarri, Marta] Univ Rhode Isl, Dept Fisheries Anim & Vet Sci, Kingston, RI 02881 USA; [Smolowitz, Roxanna] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA; [Zazueta-Novoa, Vanesa; Wessel, Gary M.] Brown Univ, Dept Mol & Cellular Biol, Providence, RI 02912 USA	University of Rhode Island; Brown University	Gomez-Chiarri, M (corresponding author), Univ Rhode Isl, Dept Fisheries Anim & Vet Sci, Kingston, RI 02881 USA.	gomezchi@uri.edu		Gomez-Chiarri, Marta/0000-0002-2576-9612	State of Rhode Island Science and Technology Advisory Council Research Alliance [GR525448]; National Institutes of Health [2R01HD028152/9RO1GM125071]; National Science Foundation EPSCoR [EPS-1004057]; Rhode Island Genomics and Sequencing Center; Center for Marine Life Sciences [EPS-1004057]; URI College of the Environment and Life Sciences; Office Of The Director [1004057] Funding Source: National Science Foundation	State of Rhode Island Science and Technology Advisory Council Research Alliance; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCoR(National Science Foundation (NSF)); Rhode Island Genomics and Sequencing Center; Center for Marine Life Sciences; URI College of the Environment and Life Sciences; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was performed with support from the State of Rhode Island Science and Technology Advisory Council Research Alliance Grant GR525448 to GMW, MGC, and RS and National Institutes of Health 2R01HD028152/9RO1GM125071 to GMW. National Science Foundation EPSCoR Cooperative Agreement #EPS-1004057 provided support for travel awards and undergraduate research fellowships (SURF) to MF and JM and a graduate fellowship to CB (nee DelSesto) as well as partial support for the Rhode Island Genomics and Sequencing Center and the Center for Marine Life Sciences [EPSCoR Cooperative Agreement #EPS-1004057], where part of this research was performed. The URI College of the Environment and Life Sciences provided student travel awards to CB and JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Becker PT, 2008, J INVERTEBR PATHOL, V98, P136, DOI 10.1016/j.jip.2007.12.002; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Eckert G.L., 2000, P 5 CAL ISL S US DEP, P390; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; EVANS AS, 1976, YALE J BIOL MED, V49, P175; Fahsbender E, 2015, ARCH VIROL, V160, P2349, DOI 10.1007/s00705-015-2503-2; Gauger E, 2002, FISH ANIM VET SCI FA; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hyman L. H., 1955, INVERTEBRATES; Kohl WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153670; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; MacKenzie J, 1999, MAR FISH REV, V61, P66; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Menge BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153994; Montecino-Latorre D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163190; Omran N, 2006, EGYPT J AQUAT BIOL F, V10, P21; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Quinn RA, 2012, J SHELLFISH RES, V31, P485, DOI 10.2983/035.031.0208; Stevens A., 1996, THEORY PRACTICE HIST; Thurber RV, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.176	23	20	20	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188523	10.1371/journal.pone.0188523	http://dx.doi.org/10.1371/journal.pone.0188523			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228006	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600010
J	Buj, I; Marcic, Z; Caleta, M; Sanda, R; Geiger, MF; Freyhof, J; Machordom, A; Vukic, J				Buj, Ivana; Marcic, Zoran; Caleta, Marko; Sanda, Radek; Geiger, Matthias F.; Freyhof, Joerg; Machordom, Annie; Vukic, Jasna			Ancient connections among the European rivers and watersheds revealed from the evolutionary history of the genus Telestes (Actinopterygii; Cypriniformes)	PLOS ONE			English	Article							GENETIC-VARIABILITY; MOLECULAR PHYLOGENY; STATISTICAL-METHOD; CYPRINIDAE; PHYLOGEOGRAPHY; MUTICELLUS; TELEOSTEI; HAPLOTYPE; SOUFFIA; DIFFERENTIATION	In order to better understand the complex geologic history of the Mediterranean area, we have analysed evolutionary history, phylogeographic structure and molecular diversity of freshwater fishes belonging to the genus Telestes. As primary freshwater fishes distributed largely in the Mediterranean basin, this genus represents a suitable model system for investigating the historical biogeography of freshwater drainage systems in southern Europe. In this investigation we have included samples representing all Telestes species and based our analyses on one mitochondrial and one nuclear gene. We have investigated phylogenetic structure inside the genus Telestes, estimated divergence times, reconstructed ancestral distribution ranges and described intraspecific molecular diversity. Diversification of Telestes started in the Early Miocene, when the ancestors of T. souffia, lineage comprising T. croaticus and T. fontinalis, and the one comprising T. pleurobipunctatus and T. beoticus got isolated. The remaining species are genetically more closely related and form a common cluster in the recovered phylogenetic trees. Complex geological history of southern Europe, including formation of continental bridges, fragmentation of landmass, closing of the sea corridor, local tectonic activities, led to complicated biogeographical pattern of this genus, caused by multiple colonization events and passovers between ancient rivers and water basins. Especially pronounced diversity of Telestes found in the Adriatic watershed in Croatia and Bosnia and Herzegovina is a consequence of a triple colonization of this area by different lineages, which led to an existence of genetically distinct species in neighboring areas. Significant intraspecific structuring is present in T. souffia, T. muticellus, T. croaticus and T. pleurobipunctatus. Besides in well-structured species, elevated levels of genetic polymorphism were found inside T. turskyi and T. ukliva, as a consequence of their old origin and unconstrained evolutionary history.	[Buj, Ivana; Marcic, Zoran] Univ Zagreb, Div Zool, Dept Biol, Fac Sci, Zagreb, Croatia; [Caleta, Marko] Univ Zagreb, Fac Teacher Educ, Zagreb, Croatia; [Sanda, Radek] National Museum, Prague, Czech Republic; [Geiger, Matthias F.] Leibnitz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Freyhof, Joerg] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Machordom, Annie] Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, Madrid, Spain; [Vukic, Jasna] Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic	University of Zagreb; University of Zagreb; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Charles University Prague	Marcic, Z (corresponding author), Univ Zagreb, Div Zool, Dept Biol, Fac Sci, Zagreb, Croatia.	zmarcic@biol.pmf.hr	Vukic, Jasna/D-2811-2015; Ćaleta, Marko/AGT-7655-2022; Machordom, Annie/K-1737-2014; Geiger, Matthias/S-3459-2017	Vukic, Jasna/0000-0003-2243-0303; Ćaleta, Marko/0000-0002-4675-556X; Machordom, Annie/0000-0003-0341-0809; Geiger, Matthias/0000-0003-2403-0805	Czech Science Foundation [GA15-19382S]; SYNTHESYS Programme at the National Museum Prague - European Community Research Infrastructure Action [CZ-TAF-4228]; SYNTHESYS Programme at the Museo Nacional de Ciencias Naturales, Madrid, - European Community Research Infrastructure Action [ES-TAF-1187]; FREDIE; Leibnitz Association Joint Initiative for Research and Innovation (SAW)	Czech Science Foundation(Grant Agency of the Czech Republic); SYNTHESYS Programme at the National Museum Prague - European Community Research Infrastructure Action; SYNTHESYS Programme at the Museo Nacional de Ciencias Naturales, Madrid, - European Community Research Infrastructure Action; FREDIE; Leibnitz Association Joint Initiative for Research and Innovation (SAW)	This work was supported by the Czech Science Foundation (project GA15-19382S). IB received support from the SYNTHESYS Programme project CZ-TAF-4228 at the National Museum Prague, financed by European Community Research Infrastructure Action under the FP7 "Capacities" Programme. RS also received support from the SYNTHESYS Programme project ES-TAF-1187 at the Museo Nacional de Ciencias Naturales, Madrid, financed by European Community Research Infrastructure Action under the FP6 "Structuring the European Research Area" Programme. This study was also supported by the FREDIE project, supported by the Leibnitz Association Joint Initiative for Research and Innovation (SAW).	Banarescu P., 1992, ZOOGEOGRAPHY FRESHWA, V2, P88; Brouckaert RR, 2014, PLOS COMPUTATIONAL B, V10; Buj I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131580; Castresana J, 2001, MOL BIOL EVOL, V18, P465, DOI 10.1093/oxfordjournals.molbev.a003825; Dubut V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034423; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; FU YX, 1993, GENETICS, V133, P693; Geiger MF, 2014, MOL ECOL RESOUR, V14, P1210, DOI 10.1111/1755-0998.12257; Gilles A, 1998, CAN J FISH AQUAT SCI, V55, P2341, DOI 10.1139/cjfas-55-10-2341; Gilles A, 2010, ZOOL SCR, V39, P225, DOI 10.1111/j.1463-6409.2010.00417.x; Goodall-Copestake WP, 2012, HEREDITY, V109, P50, DOI 10.1038/hdy.2012.12; Harzhauser M, 2012, HYDROBIOLOGIA, V682, P27, DOI 10.1007/s10750-011-0618-3; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jimenez-Moreno G, 2008, REV PALAEOBOT PALYNO, V152, P237, DOI 10.1016/j.revpalbo.2008.05.005; Ketmaier V, 2004, MOL PHYLOGENET EVOL, V32, P1061, DOI 10.1016/j.ympev.2004.04.008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Machordom A, 1999, CR ACAD SCI III-VIE, V322, P15, DOI 10.1016/S0764-4469(99)80013-4; Maddison WP, 2019, MESQUITE MODULAR SYS; Marchetto F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-111; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Roegl F., 1998, ANN NATURHIST MUS A, V99A, P279; Rogl F, 1999, GEOL CARPATH, V50, P339; Salzburger W, 2003, MOL ECOL, V12, P2371, DOI 10.1046/j.1365-294X.2003.01911.x; Stefani F, 2004, J ZOOL SYST EVOL RES, V42, P323, DOI 10.1111/j.1439-0469.2004.00272.x; Stephanidis A., 1939, THESIS; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsigenopoulos CS, 2000, MOL PHYLOGENET EVOL, V14, P165, DOI 10.1006/mpev.1999.0702; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zaccara S, 2007, ZOOL SCR, V36, P443, DOI 10.1111/j.1463-6409.2007.00294.x; Zardoya R, 1998, P ROY SOC B-BIOL SCI, V265, P1365, DOI 10.1098/rspb.1998.0443	38	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0187366	10.1371/journal.pone.0187366	http://dx.doi.org/10.1371/journal.pone.0187366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29227999	gold, Green Submitted, Green Published			2022-12-26	WOS:000417648600002
J	Chee, SMQ; Wongsantichon, J; Siau, J; Thean, D; Ferrer, F; Robinson, RC; Lane, DP; Brown, CJ; Ghadessy, FJ				Chee, Sharon Min Qi; Wongsantichon, Jantana; Siau, Jiawei; Thean, Dawn; Ferrer, Fernando; Robinson, Robert C.; Lane, David P.; Brown, Christopher J.; Ghadessy, Farid J.			Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids	PLOS ONE			English	Article							SUPPRESSOR TRANSACTIVATION DOMAIN; PROTEIN-PROTEIN INTERACTION; ALPHA-HELICAL PEPTIDES; P53 PROTEIN; IN-VIVO; MDM2; INHIBITORS; DISCOVERY; REFINEMENT; COMPLEX	As primary p53 antagonists, Mdm2 and the closely related Mdm4 are relevant cancer therapeutic targets. We have previously described a series of cell-permeable stapled peptides that bind to Mdm2 with high affinity, resulting in activation of the p53 tumour suppressor. Within this series, highest affinity was obtained by modification of an obligate tryptophan residue to the non-natural L-6-chlorotryptophan. To understand the structural basis for improved affinity we have solved the crystal structure of this stapled peptide (M011) bound to Mdm2 (residues 6-125) at 1.66 angstrom resolution. Surprisingly, near identity to the structure of a related peptide (M06) without the 6-chloro modification is observed. Further analysis of linear and stapled peptides comprising 6-Me-tryptophan provides mechanistic insight into dual Mdm2/Mdm4 antagonism and confirms L98 of Mdm4 as a mutable steric gate. The results also highlight a possible role of the flexible hinge region in determining Mdm2/Mdm4 plasticity.	[Chee, Sharon Min Qi; Siau, Jiawei; Thean, Dawn; Ferrer, Fernando; Lane, David P.; Brown, Christopher J.; Ghadessy, Farid J.] ASTAR, p53Lab, Singapore, Singapore; [Wongsantichon, Jantana; Robinson, Robert C.] ASTAR, Inst Mol & Cellular Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Brown, CJ; Ghadessy, FJ (corresponding author), ASTAR, p53Lab, Singapore, Singapore.	cjbrown@p53Lab.a-star.edu.sg; fghadessy@p53Lab.a-star.edu.sg		Wongsantichon, Jantana/0000-0002-4134-2248; Lane, David/0000-0003-0551-3545	Agency for Science, Technology and Research, Singapore; Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research, Singapore (https://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Agency for Science, Technology and Research (A*STAR), Singapore for support.	Bird GH, 2016, NAT CHEM BIOL, V12, P845, DOI [10.1038/nchembio.2153, 10.1038/NCHEMBIO.2153]; Brown CJ, 2013, ACS CHEM BIOL, V8, P506, DOI 10.1021/cb3005148; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Chee SMQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104914; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fasan R, 2006, CHEMBIOCHEM, V7, P515, DOI 10.1002/cbic.200500452; Frost JR, 2015, ACS CHEM BIOL, V10, P1805, DOI 10.1021/acschembio.5b00119; Garcia-Echeverria C, 2000, J MED CHEM, V43, P3205, DOI 10.1021/jm990966p; Golestanian S, 2016, LIFE SCI, V145, P240, DOI 10.1016/j.lfs.2015.12.047; Haney CM, 2011, CHEM COMMUN, V47, P10915, DOI 10.1039/c1cc12010g; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hilinski GJ, 2014, J AM CHEM SOC, V136, P12314, DOI 10.1021/ja505141j; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Humenik M, 2009, ORG BIOMOL CHEM, V7, P4218, DOI 10.1039/b909188b; Jackson JC, 2006, J AM CHEM SOC, V128, P11124, DOI 10.1021/ja061099y; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kapoerchan VV, 2010, MOL IMMUNOL, V47, P1091, DOI 10.1016/j.molimm.2009.10.036; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kawamoto SA, 2012, J MED CHEM, V55, P1137, DOI 10.1021/jm201125d; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuhn SM, 2011, J AM CHEM SOC, V133, P3708, DOI 10.1021/ja1099787; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lau YH, 2015, CHEM SOC REV, V44, P91, DOI 10.1039/c4cs00246f; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lewis JC, 2015, CURR OPIN CHEM BIOL, V25, P27, DOI 10.1016/j.cbpa.2014.12.016; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lu X, 1996, ONCOGENE, V13, P413; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Philippe G, 2016, BIOPOLYMERS, V106, P853, DOI 10.1002/bip.22893; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Sakurai K, 2006, J AM CHEM SOC, V128, P11000, DOI 10.1021/ja063102j; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Tan YS, 2016, J PHYS CHEM LETT, V7, P3452, DOI 10.1021/acs.jpclett.6b01525; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189379	10.1371/journal.pone.0189379	http://dx.doi.org/10.1371/journal.pone.0189379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228061	Green Published, gold, Green Submitted			2022-12-26	WOS:000417648600051
J	Neupane, M; Geary, TW; Kiser, JN; Burns, GW; Hansen, PJ; Spencer, TE; Neibergs, HL				Neupane, Mahesh; Geary, Thomas W.; Kiser, Jennifer N.; Burns, Gregory W.; Hansen, Peter J.; Spencer, Thomas E.; Neibergs, Holly L.			Loci and pathways associated with uterine capacity for pregnancy and fertility in beef cattle	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LEUKEMIA INHIBITORY FACTOR; P38 MAP KINASE; EMBRYONIC-DEVELOPMENT; BOVINE ENDOMETRIUM; GENE-EXPRESSION; ESTROUS-CYCLE; OVINE UTERUS; PROGESTERONE; CONCEPTUS	Infertility and subfertility negatively impact the economics and reproductive performance of cattle. Of note, significant pregnancy loss occurs in cattle during the first month of pregnancy, yet little is known about the genetic loci influencing pregnancy success and loss in cattle. To identify quantitative trait loci (QTL) with large effects associated with early pregnancy loss, Angus crossbred heifers were classified based on day 28 pregnancy outcomes to serial embryo transfer. A genome wide association analysis (GWAA) was conducted comparing 30 high fertility heifers with 100% success in establishing pregnancy to 55 subfertile heifers with 25% or less success. A gene set enrichment analysis SNP (GSEA-SNP) was performed to identify gene sets and leading edge genes influencing pregnancy loss. The GWAA identified 22 QTL (p < 1 x 10(-5)), and GSEA-SNP identified 9 gene sets (normalized enrichment score > 3.0) with 253 leading edge genes. Network analysis identified TNF (tumor necrosis factor), estrogen, and TP53 (tumor protein 53) as the top of 671 upstream regulators (p < 0.001), whereas the SOX2 (SRY [sex determining region Y]-box 2) and OCT4 (octamer-binding transcription factor 4) complex was the top master regulator out of 773 master regulators associated with fertility (p < 0.001). Identification of QTL and genes in pathways that improve early pregnancy success provides critical information for genomic selection to increase fertility in cattle. The identified genes and regulators also provide insight into the complex biological mechanisms underlying pregnancy establishment in cattle.	[Neupane, Mahesh; Kiser, Jennifer N.; Neibergs, Holly L.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Geary, Thomas W.] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA; [Burns, Gregory W.; Spencer, Thomas E.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Hansen, Peter J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	Washington State University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; State University System of Florida; University of Florida	Neibergs, HL (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	neibergs@wsu.edu	Hansen, Peter/AAI-4693-2021; Spencer, Thomas/AAD-6434-2020	Hansen, Peter/0000-0003-3061-9333; Kiser, Jennifer/0000-0002-9944-6883; Burns, Gregory/0000-0003-0021-4319	Eunice Kennedy Shriver National Institute of Child and Human Development [1 R01 HD072898]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072898] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by Grant 1 R01 HD072898 from the Eunice Kennedy Shriver National Institute of Child and Human Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T., 2015, J PHARMACOGENOMICS P, V6, P4; Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bagci H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.338; Bauersachs S, 2008, EXP CLIN ENDOCR DIAB, V116, P371, DOI 10.1055/s-2008-1076714; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; BETTERIDGE KJ, 1980, J REPROD FERTIL, V59, P205, DOI 10.1530/jrf.0.0590205; BETTERIDGE KJ, 1988, THERIOGENOLOGY, V29, P155, DOI 10.1016/0093-691X(88)90038-6; Biase FH, 2016, P NATL ACAD SCI USA, V113, P14492, DOI 10.1073/pnas.1520945114; Biase FH, 2013, MOL REPROD DEV, V80, P977, DOI 10.1002/mrd.22257; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRAEND M, 1971, Animal Blood Groups and Biochemical Genetics, V2, P15; Brainard AM, 2007, SEMIN CELL DEV BIOL, V18, P332, DOI 10.1016/j.semcdb.2007.05.008; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Cochran SD, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-49; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Denicol AC, 2014, FASEB J, V28, P3975, DOI 10.1096/fj.14-253112; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; DISKIN MG, 1980, J REPROD FERTIL, V59, P463, DOI 10.1530/jrf.0.0590463; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Fleming JAGW, 2009, MOL CELL ENDOCRINOL, V299, P252, DOI 10.1016/j.mce.2008.10.025; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Geary TW, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141390; Geisert RD, 2003, REPRODUCTION, V126, P621, DOI 10.1530/reprod/126.5.621; GUILLOMOT M, 1988, REPROD NUTR DEV, V28, P1629, DOI 10.1051/rnd:19881008; Hansen PJ, 2004, REPROD FERT DEVELOP, V16, P1, DOI 10.1071/RD03073; Haouzi D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/951937; Hasler JF, 2014, THERIOGENOLOGY, V81, P152, DOI 10.1016/j.theriogenology.2013.09.010; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hoglund JK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-790; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Jasper MJ, 2007, J REPROD IMMUNOL, V73, P74, DOI 10.1016/j.jri.2006.06.003; Kan R, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-19; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Leese HJ, 2015, CELL SIGNALING MAMMA; Lonergan P, 2007, Soc Reprod Fertil Suppl, V64, P315; Lonergan P, 2016, REPROD FERT DEVELOP, V28, P66, DOI 10.1071/RD15326; Looney CR, 2006, THERIOGENOLOGY, V65, P201, DOI 10.1016/j.theriogenology.2005.09.023; Lupicka M, 2015, REPRODUCTION, V149, P317, DOI 10.1530/REP-14-0348; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Man JH, 2014, CELL REP, V9, P1812, DOI 10.1016/j.celrep.2014.10.055; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; McMillan WH, 1998, THERIOGENOLOGY, V50, P1053, DOI 10.1016/S0093-691X(98)00207-6; McMillan WH, 1999, ANIM REPROD SCI, V57, P127, DOI 10.1016/S0378-4320(99)00063-9; Minten MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069444; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Nusse R, 2001, NATURE, V411, P254, DOI 10.1038/35077199; Ortega MS, 2017, J DAIRY SCI, V100, P3725, DOI 10.3168/jds.2016-12260; PASKULIN DD, 2012, CELL, V3, DOI DOI 10.1038/CDDIS.2012.116; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pershing RA, 2002, J DAIRY SCI, V85, P3260, DOI 10.3168/jds.S0022-0302(02)74414-7; Peterson AJ, 2003, THERIOGENOLOGY, V59, P687, DOI 10.1016/S0093-691X(02)01248-7; Powell JAC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-146; Radi ZA, 2009, J TOXICOL PATHOL, V22, P109, DOI 10.1293/tox.22.109; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; ROCHE JF, 1981, VET REC, V109, P401, DOI 10.1136/vr.109.18.401; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Salleh N, 2014, SCI WORLD J, DOI 10.1155/2014/201514; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Satterfield MC, 2006, BIOL REPROD, V75, P289, DOI 10.1095/biolreprod.106.052944; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Smith RC, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-41; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Spencer TE, 2017, REPROD FERT DEVELOP, V29, P84, DOI [10.1071/RD16359, 10.1071/rd16359]; Spencer TE, 2004, BIOL REPROD, V71, P2, DOI 10.1095/biolreprod.103.024133; Spencer TE, 2016, J DAIRY SCI, V99, P5941, DOI 10.3168/jds.2015-10070; TAKAHARA H, 1992, J BIOL CHEM, V267, P520; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tribulo P, 2017, BIOL REPROD; Tribulo P, 2017, REPRODUCTION, V153, P405, DOI 10.1530/REP-16-0610; Tu Z.F., 2016, FOREST RESOURCES MAN, V1, P1; Ulbrich SE, 2013, METHODS, V59, P108, DOI 10.1016/j.ymeth.2012.10.013; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Winterhager E, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111690; Woo CH, 2002, MOL CELLS, V13, P470; Yang WC, 2013, ANIM REPROD SCI, V143, P24, DOI 10.1016/j.anireprosci.2013.10.008; Zhang S, 2014, CELL RES, V24, P925, DOI 10.1038/cr.2014.82; Zhang XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19361	96	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0188997	10.1371/journal.pone.0188997	http://dx.doi.org/10.1371/journal.pone.0188997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228019	Green Published, Green Submitted, gold			2022-12-26	WOS:000417648600026
J	Pereira-Santana, A; Alvarado-Robledo, EJ; Zamora-Briseno, JA; Ayala-Sumuano, JT; Gonzalez-Mendoza, VM; Espadas-Gil, F; Alcaraz, LD; Castano, E; Keb-Llanes, MA; Sanchez-Teyer, F; Rodriguez-Zapata, LC				Pereira-Santana, Alejandro; Alvarado-Robledo, Edyciel J.; Zamora-Briseno, Jesus A.; Ayala-Sumuano, Jorge T.; Gonzalez-Mendoza, Victor M.; Espadas-Gil, Francisco; Alcaraz, Luis D.; Castano, Enrique; Keb-Llanes, Miguel A.; Sanchez-Teyer, Felipe; Carlos Rodriguez-Zapata, Luis			Transcriptional profiling of sugarcane leaves and roots under progressive osmotic stress reveals a regulated coordination of gene expression in a spatiotemporal manner	PLOS ONE			English	Article							LEAF PROTEOME; DROUGHT; ACCUMULATION; SALT; IDENTIFICATION; INTEGRATION; TOLERANCE; PLATFORM; DATABASE; PROLINE	Sugarcane is one of the most important crops worldwide and is a key plant for the global production of sucrose. Sugarcane cultivation is severely affected by drought stress and it is considered as the major limiting factor for their productivity. In recent years, this plant has been subjected to intensive research focused on improving its resilience against water scarcity; particularly the molecular mechanisms in response to drought stress have become an underlying issue for its improvement. To better understand water stress and the molecular mechanisms we performed a de novo transcriptomic assembly of sugarcane (var. Mex 69-290). A total of 16 libraries were sequenced in a 2x100 bp configuration on a HiSeq-Illumina platform. A total of 536 and 750 genes were differentially up-regulated along with the stress treatments for leave and root tissues respectively, while 1093 and 531 genes were differentially down-regulated in leaves and roots respectively. Gene Ontology functional analysis showed that genes related to response of water deprivation, heat, abscisic acid, and flavonoid biosynthesis were enriched during stress treatment in our study. The reliability of the observed expression patterns was confirmed by RT-qPCR. Additionally, several physiological parameters of sugarcane were significantly affected due to stress imposition. The results of this study may help identify useful target genes and provide tissue-specific data set of genes that are differentially expressed in response to osmotic stress, as well as a complete analysis of the main groups is significantly enriched under this condition. This study provides a useful benchmark for improving drought tolerance in sugarcane and other economically important grass species.	[Pereira-Santana, Alejandro; Alvarado-Robledo, Edyciel J.; Zamora-Briseno, Jesus A.; Espadas-Gil, Francisco; Keb-Llanes, Miguel A.; Sanchez-Teyer, Felipe; Carlos Rodriguez-Zapata, Luis] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico; [Zamora-Briseno, Jesus A.] Univ Nacl Autonoma Mexico, Dept Neurobiol Desarrollo & Neurofisiol, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico; [Gonzalez-Mendoza, Victor M.; Castano, Enrique] Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Merida, Yucatan, Mexico; [Alcaraz, Luis D.] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Nacl Ciencias Sostenibilidad LANCIS, Mexico City, DF, Mexico	Centro de Investigacion Cientifica de Yucatan; Universidad Nacional Autonoma de Mexico; Centro de Investigacion Cientifica de Yucatan; Universidad Nacional Autonoma de Mexico	Rodriguez-Zapata, LC (corresponding author), Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico.	lcrz@cicy.mx	González-Mendoza, Victor Manuel/AGO-5694-2022; zamora, alejandro/AAT-6641-2021; TEYER, LORENZO FELIPE SÁNCHEZ/AAC-2433-2020; Rodriguez-Zapata, Luis/AAG-7569-2019; Pereira-Santana, Alejandro/F-7440-2019; Alcaraz, Luis David/D-1352-2011; TEYER, LORENZO FELIPE F SANCHEZ/B-6375-2014	González-Mendoza, Victor Manuel/0000-0003-0082-9954; zamora, alejandro/0000-0003-2079-9676; TEYER, LORENZO FELIPE SÁNCHEZ/0000-0002-1714-0240; Rodriguez-Zapata, Luis/0000-0002-4872-8231; Pereira-Santana, Alejandro/0000-0001-7714-9485; Alcaraz, Luis David/0000-0003-3284-0605; Castano, Enrique/0000-0003-2645-9541	Secretaria de Educacion Publica-Consejo Nacional de Cienciay Tecnologia (SEP-CONACYT) [215098]; SEP-CONACYT [407566]; Centro de Investigacion Cientifica de Yucatan, Mexico	Secretaria de Educacion Publica-Consejo Nacional de Cienciay Tecnologia (SEP-CONACYT); SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Centro de Investigacion Cientifica de Yucatan, Mexico	This work was supported by Secretaria de Educacion Publica-Consejo Nacional de Cienciay Tecnologia (SEP-CONACYT) (number: 215098). EJAR received the financial support of a scholarship (#407566) from SEP-CONACYT to obtain his master degree. (http://www.conacyt.mx/).; We'd like to thank "Colegio de Posgraduados (Colpos)" Campus Campeche, Mexico, for providing the plant material. We thank M.S. Miguel Herrera Alamillo for preserving and providing the in vitro plant material for the experimental analysis. We'd like to thank Fernando Contreras-Martin for his technical help. The authors would also like to thank the Centro de Investigacion Cientifica de Yucatan, Mexico, for supporting this research. We thank the anonymous referees for their constructive comments and suggestions.	Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2015, INT J AGRON, DOI DOI 10.1155/2015/547386; [Anonymous], 2016, INT J GENOMICS, DOI DOI 10.1155/2016/7840759; [Anonymous], 2015, ELUCIDATION ABIOTIC; Arencibia AD, 1998, TRANSGENIC RES, V7, P213, DOI 10.1023/A:1008845114531; Arreguin Cortes F.I, 2016, INT J SAF SECUR ENG, V6, P161, DOI DOI 10.2495/SAFE-V6-N2-161-170; Augustine SM, 2015, MOL BIOTECHNOL, V57, P475, DOI 10.1007/s12033-015-9841-x; Barrs H. D., 1962, AUST J BIOL SCI, V24, P519, DOI DOI 10.1071/BI9620413; Begcy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044697; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borges JC, 2001, GENET MOL BIOL, V24, P85, DOI 10.1590/S1415-47572001000100013; Cardoso-Silva CB, 2014, PLOS ONE; Carillo P, 2008, FUNCTIONAL PLANT BIO, V35, P412; Cha-Um S, 2008, PAK J BOT, V40, P2541; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Errabii T, 2006, AFR J BIOTECHNOL, V5, P1488; Esperon-Rodriguez M, 2016, AMBIO, V45, P146, DOI 10.1007/s13280-015-0690-4; de Andrade JCF, 2015, GENET MOL BIOL, V38, P465, DOI 10.1590/S1415-475738420140288; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; HOLM S, 1979, SCAND J STAT, V6, P65; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Imadi SR, 2015, J GENET, V94, P525, DOI 10.1007/s12041-015-0545-6; Iskandar HM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-12; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Kabir AH, 2016, FRONT PLANT SCI, V7, P1, DOI DOI 10.3389/FPLS.2016.01117; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KAUFMANN MR, 1971, PLANT PHYSIOL, V47, P453, DOI 10.1104/pp.47.4.453; Kim JY, 2012, PLANT CELL TISS ORG, V108, P297, DOI 10.1007/s11240-011-0043-3; Kissoudis C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00207; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; Lam E, 2009, GCB BIOENERGY, V1, P251, DOI 10.1111/j.1757-1707.2009.01016.x; Langmead B, 2010, CURRENT PROTOCOLS BI, P12; Lembke CG, 2012, PLANT MOL BIOL, V79, P461, DOI 10.1007/s11103-012-9922-1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li C, 2016, ADV METEOROL, V2016, DOI 10.1155/2016/6583906; Li M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2552-2; Ling H, 2014, PLOS ONE; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mattiello L, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0694-z; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moyer M, 2010, SCI AM, V303, P74, DOI 10.1038/scientificamerican0910-74; Munir N, 2009, TURK J BOT, V33, P407, DOI 10.3906/bot-0806-6; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Patade VY, 2012, MOL BIOL REP, V39, P3311, DOI 10.1007/s11033-011-1100-z; Popova AV, 2015, BBA-PROTEINS PROTEOM, V1854, P1517, DOI 10.1016/j.bbapap.2015.05.002; R Core Team, 2020, R LANG ENV STAT COMP; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rodrigues FA, 2011, BIOL PLANTARUM, V55, P43, DOI 10.1007/s10535-011-0006-x; Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007; Schwarz N, 2015, PLANT CELL PHYSIOL, V56, P346, DOI 10.1093/pcp/pcu167; Shouren Z., 1999, CHIN B BOT, V16, P444, DOI [10.3969/j.issn.1674-3466.1999.04.021, DOI 10.3969/J.ISSN.1674-3466.1999.04.021]; Tammisola Jussi, 2010, GM Crops, V1, P181, DOI 10.4161/gmcr.1.4.13173; Urban MO, 2017, J PROTEOMICS, V152, P188, DOI 10.1016/j.jprot.2016.11.004; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wang X, 2016, ALGORITHMS, V9, DOI 10.3390/a9040068; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang HM, 2014, ACTA PHYSIOL PLANT, V36, P1385, DOI 10.1007/s11738-014-1517-9; Zhang M, 2014, J PROTEOMICS, V109, P290, DOI 10.1016/j.jprot.2014.07.010; Zhao FY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01471; Zhou G, 2012, PLANT MOL BIOL REP, V30, P349, DOI 10.1007/s11105-011-0343-0	70	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2017	12	12							e0189271	10.1371/journal.pone.0189271	http://dx.doi.org/10.1371/journal.pone.0189271			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP5GS	29228055	gold, Green Submitted, Green Published			2022-12-26	WOS:000417648600041
J	Rumney, RMH; Coffelt, SB; Neale, TA; Dhayade, S; Tozer, GM; Miller, G				Rumney, Robin M. H.; Coffelt, Seth B.; Neale, Terence A.; Dhayade, Sandeep; Tozer, Gillian M.; Miller, Gaynor			PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development	PLOS ONE			English	Article							MAMMARY-TUMORS; MOUSE MODEL; T-CELLS; ANTICANCER THERAPIES; MEDIATED DEPLETION; DENDRITIC CELLS; PARACRINE LOOP; CANCER MODEL; MACROPHAGES; METASTASIS	CD68(+) tumor-associated macrophages (TAMs) are pro-tumorigenic, pro-angiogenic and are associated with decreased survival rates in patients with cancer, including breast cancer. Non-specific models of macrophage ablation reduce the number of TAMs and limit the development of mammary tumors. However, the lack of specificity and side effects associated with these models compromise their reliability. We hypothesized that specific and controlled macrophage depletion would provide precise data on the effects of reducing TAM numbers on tumor development. In this study, the MacLow mouse model of doxycycline-inducible and selective CD68(+) macrophage depletion was crossed with the murine mammary tumor virus (MMTV)-Polyoma virus middle T antigen (PyMT) mouse model of spontaneous ductal breast adenocarcinoma to generate the PyMT-MacLow line. In doxycyclinetreated PyMT-MacLow mice, macrophage numbers were decreased in areas surrounding tumors by 43%. Reducing the number of macrophages by this level delayed tumor progression, generated less proliferative tumors, decreased the vascularization of carcinomas and down-regulated the expression of many pro-angiogenic genes. These results demonstrate that depleting CD68(+) macrophages in an inducible and selective manner delays the development of mammary tumors and that the PyMT-MacLow model is a useful and unique tool for studying the role of TAMs in breast cancer.	[Rumney, Robin M. H.; Neale, Terence A.; Tozer, Gillian M.; Miller, Gaynor] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Coffelt, Seth B.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Coffelt, Seth B.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Coffelt, Seth B.; Dhayade, Sandeep] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; Univ Portsmouth, Portsmouth, Hants, England	University of Sheffield; University of Sheffield; University of Glasgow; Beatson Institute; University of Portsmouth	Miller, G (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Coffelt, SB (corresponding author), Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England.; Coffelt, SB (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland.; Coffelt, SB (corresponding author), Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland.	Seth.Coffelt@glasgow.ac.uk; g.miller@sheffield.ac.uk	Rumney, Robin M H/H-6805-2019; Coffelt, Seth/O-9929-2019	Rumney, Robin M H/0000-0002-4266-5962; Coffelt, Seth/0000-0003-2257-2862; Dhayade, Sandeep/0000-0002-1681-8216; Miller, Gaynor/0000-0003-4527-3814	Yorkshire Cancer Research; YCR [SPP039]; Women Academic Returners' Programme (WARP), University of Sheffield; Cancer Research UK [22311] Funding Source: researchfish	Yorkshire Cancer Research; YCR; Women Academic Returners' Programme (WARP), University of Sheffield; Cancer Research UK(Cancer Research UK)	Funding was provided by Yorkshire Cancer Research, http://yorkshirecancerresearch.org.uk/. GM, GMT and RMHR were supported by pump priming funding from the YCR (SPP039). RMHR was also supported by The Women Academic Returners' Programme (WARP), University of Sheffield. These authors received no specific funding for this work: SBC, SD and TAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaei-Bouchareb L, 2004, J LEUKOCYTE BIOL, V76, P359, DOI 10.1189/jlb.1103591; Bluff JE, 2009, BRIT J CANCER, V101, P666, DOI 10.1038/sj.bjc.6605196; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Charlton RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083203; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Coffelt SB, 2015, TRENDS IMMUNOL, V36, P198, DOI 10.1016/j.it.2015.02.006; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Galmbacher K, 2010, PLOS ONE, V5, pA93, DOI 10.1371/journal.pone.0009572; Gheryani N, 2013, GENESIS, V51, P41, DOI 10.1002/dvg.22343; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Lewen S, 2008, CANCER IMMUNOL IMMUN, V57, P507, DOI 10.1007/s00262-007-0389-x; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lunt SJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-2; Mahmud SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016412; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Ottewell PD, 2012, BREAST CANCER RES TR, V133, P523, DOI 10.1007/s10549-011-1782-x; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Ricciardelli C, 2011, AM J PATHOL, V179, P3075, DOI 10.1016/j.ajpath.2011.08.021; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Wright E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047616; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021155; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188591	10.1371/journal.pone.0188591	http://dx.doi.org/10.1371/journal.pone.0188591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220404	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000417469900012
J	Latorre, I; Minguez, S; Carrascosa, JM; Naves, J; Villar-Hernandez, R; Muriel, B; Prat, C; Garcia-Garcia, E; Casas, I; Domenech, E; Ferrandiz, C; Mateo, L; Dominguez, J				Latorre, Irene; Minguez, Sonia; Carrascosa, Jose-Manuel; Naves, Juan; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Casas, Irma; Domenech, Eugeni; Ferrandiz, Carlos; Mateo, Lourdes; Dominguez, Jose			Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; QUANTIFERON-TB GOLD; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; IMMUNOSUPPRESSIVE THERAPY; BLOOD-TESTS; IMMUNODIAGNOSIS; REACTIVATION; PERFORMANCE; IP-10	Background Clinical accuracy of IGRAs remains unclear on patients with immune-mediated inflammatory diseases (IMIDs). Here, we assess the impact of immunosuppressants and IMIDs on QuantiFERON-TB Gold In-Tube (QFN-G-IT) and T-SPOT. TB accuracy. Methods Patients with IMIDs who required latent tuberculosis infection (LTBI) screening were enrolled and classified into: (i) 50 patients with inflammatory rheumatic diseases, (ii) 50 patients with psoriasis and (iii) 30 patients with Crohn's disease. A total of 44 healthy individuals without immunosuppression were also included as controls. Tuberculin skin test (TST), T-SPOT. TB and QFN-G-IT assays were performed. IGRAs were performed following manufacturer's instructions. Results Immunosuppressant's intake was more frequent on patients with Crohn's disease and psoriasis. Positive IGRAs and TST results were reduced in Crohn's disease patients, whereas rate of indeterminate T-SPOT. TB results was increased in this group with respect to the other IMIDs analysed and controls. When IFN-gamma response was studied, the levels of this cytokine after mitogen stimulation were significantly lower in Crohn's and inflammatory rheumatic diseases than in psoriasis. Interestingly, psoriatic patients were the only ones not receiving corticosteroids. Furthermore, a negative correlation was observed between the IFN-gamma secreted after mitogen stimulation and corticosteroids dose. Conclusions IMIDs seem to negatively affect the clinical accuracy of IGRAs, being Crohn's disease patients the most affected individuals due to their concomitant drug-profile and impaired immune response.	[Latorre, Irene; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Dominguez, Jose] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Microbiol, Badalona, Spain; [Latorre, Irene; Minguez, Sonia; Carrascosa, Jose-Manuel; Naves, Juan; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Casas, Irma; Domenech, Eugeni; Ferrandiz, Carlos; Mateo, Lourdes; Dominguez, Jose] Univ Autonoma Barcelona, Barcelona, Spain; [Latorre, Irene; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Dominguez, Jose] Inst Salud Carlos III, CIBER Enfermedades Resp, Badalona, Spain; [Minguez, Sonia; Mateo, Lourdes] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Reumatol, Badalona, Spain; [Carrascosa, Jose-Manuel; Ferrandiz, Carlos] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Dermatol, Badalona, Spain; [Naves, Juan; Domenech, Eugeni] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Digestiu, Badalona, Spain; [Casas, Irma] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Med Prevent, Badalona, Spain; [Domenech, Eugeni] Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest, Badalona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Dominguez, J (corresponding author), Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Microbiol, Badalona, Spain.; Dominguez, J (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.; Dominguez, J (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Badalona, Spain.	jadominguez@igtp.cat	Aymerich, Cristina Prat/R-3484-2016; Villar-Hernández, Raquel/AGD-6666-2022; Latorre, Irene/H-8814-2017; Villar Hernández, Raquel/AFN-3894-2022	Aymerich, Cristina Prat/0000-0001-6974-9165; Villar-Hernández, Raquel/0000-0002-2249-0579; Latorre, Irene/0000-0001-8159-2455; Villar Hernández, Raquel/0000-0002-2249-0579; Garcia, Esther/0000-0003-3997-493X; Dominguez, Jose/0000-0001-7888-0309; Casas, Irma/0000-0002-5902-5777	Institute de Salud Carlos III, integrated in the Plan Nacional de I+D+I [PI 13/01546, PI16/01912]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Reumatologia (SCR); CERCA Programme/Generalitat de Catalunya	Institute de Salud Carlos III, integrated in the Plan Nacional de I+D+I; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Reumatologia (SCR); CERCA Programme/Generalitat de Catalunya	The research was supported by grants from: (i) the Institute de Salud Carlos III (PI 13/01546 and PI16/01912), integrated in the Plan Nacional de I+D+I and cofunded by the ISCIII-Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER); (ii) Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); (iii) Societat Catalana de Reumatologia (SCR); and (iv) CERCA Programme/Generalitat de Catalunya. JD is a researcher from the Miguel Servet programme.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Bao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0103763; Barcellini L, 2016, EUR RESPIR J, V48, P1411, DOI 10.1183/13993003.00510-2016; Bassukas ID, 2011, ACTA DERM-VENEREOL, V91, P444, DOI 10.2340/00015555-1106; Belard E, 2011, INFLAMM BOWEL DIS, V17, P2340, DOI 10.1002/ibd.21605; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Calabrese C, 2015, ARTHRIT CARE RES, V67, P1063, DOI 10.1002/acr.22454; Cantini F, 2014, J RHEUMATOL, V41, P47, DOI 10.3899/jrheum.140102; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Casas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006686; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dominguez J, 2008, J CROHNS COLITIS, V2, P250, DOI 10.1016/j.crohns.2008.05.007; Edwards A, 2017, THORAX, V72, P946, DOI 10.1136/thoraxjnl-2016-209397; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Guo SJ, 2014, INT J CLIN EXP MED, V7, P93; Helwig U, 2012, J CROHNS COLITIS, V6, P419, DOI 10.1016/j.crohns.2011.09.011; Hoffmann H, 2016, CLIN MICROBIOL INFEC, V22, P701, DOI 10.1016/j.cmi.2016.05.006; Kim HC, 2014, SCAND J INFECT DIS, V46, P763, DOI 10.3109/00365548.2014.938691; Latorre I, 2014, J INFECTION, V69, P590, DOI 10.1016/j.jinf.2014.06.013; Latorre I, 2014, J INFECTION, V69, P600, DOI 10.1016/j.jinf.2014.07.026; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Minguez S, 2012, CLIN RHEUMATOL, V31, P785, DOI 10.1007/s10067-012-1938-z; Petruccioli E, 2016, J INFECTION, V73, P588, DOI 10.1016/j.jinf.2016.09.008; Ramos JM, 2013, CLIN EXP MED, V13, P177, DOI 10.1007/s10238-012-0192-7; Redelman-Sidi G, 2013, AM J RESP CRIT CARE, V188, P422, DOI 10.1164/rccm.201209-1621CI; Ruiz-Manzano J, 2008, ARCH BRONCONEUMOL, V44, P551, DOI 10.1016/S1579-2129(08)60102-0; Santin M, 2016, ENFERM INFEC MICR CL, V34, P304, DOI 10.1016/j.eimc.2015.11.021; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Villar-Hernandez R, 2017, J INFECTION, V75, P315, DOI 10.1016/j.jinf.2017.07.004; Wong SH, 2014, INFLAMM BOWEL DIS, V20, P2067, DOI 10.1097/MIB.0000000000000147; Yi LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep30617	34	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189202	10.1371/journal.pone.0189202	http://dx.doi.org/10.1371/journal.pone.0189202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216277	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800092
J	Morimoto, M; Amano, Y; Oka, M; Harada, A; Fujita, H; Hikichi, Y; Tozawa, R; Yamaoka, M; Hara, T				Morimoto, Megumi; Amano, Yuichiro; Oka, Masahiro; Harada, Ayako; Fujita, Hisashi; Hikichi, Yukiko; Tozawa, Ryuichi; Yamaoka, Masuo; Hara, Takahito			Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f	PLOS ONE			English	Article							TESTOSTERONE REPLACEMENT; SKELETAL-MUSCLE; FEMALE RATS; ESTROGEN-RECEPTOR; CANCER CACHEXIA; MICE; ENOBOSARM; MECHANISM; SURVIVAL; THERAPY	Sarcopenia and cachexia present characteristic features of a decrease in skeletal muscle mass and strength, anorexia, and lack of motivation. Treatments for these diseases have not yet been established, although selective androgen receptor modulators (SARMs) are considered as therapeutic targets. We previously reported that a novel SARM compound, SARM-2f, exhibits anabolic effect on muscles, with less stimulatory effect on prostate weight compared with testosterone, in rat Hershberger assays and cancer cachexia models. In this study, we studied the mechanism of action for SARM-2f selectivity and also assessed whether the muscle increase by this compound might lead to improvement of muscle function and physical activity. First, we examined the tissue distribution of SARM-2f. Tissue concentration was 1.2-, 1.6-, and 1.9-fold as high as the plasma concentration in the levator ani muscle, brain, and prostate, respectively. This result showed that the tissue-selective pharmacological effect did not depend on SARM-2f concentration in the tissues. The ability of SARM-2f to influence androgen receptor (AR)-mediated transcriptional activation was examined by reporter assays using human normal prostate epithelial cells (PrEC) and skeletal muscle cells (SKMC). SARM-2f exerted higher activity against AR in SKMC than in PrEC. Mammalian two hybrid assays showed different co-factor recruitment patterns between SARM-2f and dihydrotestosterone. Next, we studied the effect of SARM-2f on motivation and physical functions such as sexual behavior and motor activities in castrated rat or mouse models. SARM-2f restored the sexual behavior that was lost by castration in male rats. SARM-2f also increased voluntary running distance and locomotor activities. These results suggest that tissue-specific AR regulation by SARM-2f, but not tissue distribution, might account for its tissue specific androgenic effect, and that the muscle mass increase by SARM-2f leads to improvement of physical function. Together, these findings suggest that SARM-2f might represent an effective treatment for sarcopenia and cachexia.	[Morimoto, Megumi; Hikichi, Yukiko; Yamaoka, Masuo; Hara, Takahito] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Amano, Yuichiro; Oka, Masahiro; Harada, Ayako; Tozawa, Ryuichi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CVM Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Fujita, Hisashi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, DMPK Unit, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Hara, T (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	takahito.hara@takeda.com			Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	I declare that Takeda Pharmaceutical Company Limited, the funder, provided support in the form of salaries for authors [M.M., Y.A., M.O., A.H., H.F., Y.H., R.T., M.Y., and T.H.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aikawa K, 2017, BIOORGAN MED CHEM, V25, P3330, DOI 10.1016/j.bmc.2017.04.018; [Anonymous], 2016, MED LETT DRUGS THER, V58, P33; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Baas W, 2016, TRANSL ANDROL UROL, V5, P890, DOI 10.21037/tau.2016.08.11; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Crawford J, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0522-0; Del Fabbro E, 2013, SUPPORT CARE CANCER, V21, P2599, DOI 10.1007/s00520-013-1832-5; Dillon EL, 2012, J CACHEXIA SARCOPENI, V3, P253, DOI 10.1007/s13539-012-0066-6; Garber K, 2016, NAT BIOTECHNOL, V34, P458, DOI 10.1038/nbt.3557; Gill JF, 2017, AGING CELL; Hara T, 2003, CANCER RES, V63, P149; Hayashida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111810; Hikichi Y, 2015, EUR J PHARMACOL, V765, P322, DOI 10.1016/j.ejphar.2015.08.052; Ibebunjo C, 2011, AM J PHYSIOL-ENDOC M, V300, pE327, DOI 10.1152/ajpendo.00402.2010; Jones AB, 2016, BEHAV BRAIN RES, V311, P279, DOI 10.1016/j.bbr.2016.05.058; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Mondello P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-828; Morimoto M, 2017, ONCOL LETT, V14, P8066, DOI 10.3892/ol.2017.7200; Narayanan R, 2017, MOL CEL IN PRESS JUN; Ogawa S, 2003, ENDOCRINOLOGY, V144, P230, DOI 10.1210/en.2002-220519; Pettan-Brewer C, 2014, PATHOBIOL AGING AGE, V4, DOI 10.3402/pba.v4.24824; Ponnusamy S, 2017, J CELL BIOCHEM, V118, P640, DOI 10.1002/jcb.25751; Rudolf AM, 2017, EXP GERONTOL, V98, P70, DOI 10.1016/j.exger.2017.08.007; Sakuma K, 2017, PFLUG ARCH EUR J PHY, V469, P573, DOI 10.1007/s00424-016-1933-3; Sinha I, 2014, CELL TISSUE RES, V357, P815, DOI 10.1007/s00441-014-1900-2; Spiteri T, 2012, BEHAV BRAIN RES, V230, P11, DOI 10.1016/j.bbr.2012.01.048; Srinath R, 2014, FUTURE ONCOL, V10, P187, DOI [10.2217/FON.13.273, 10.2217/fon.13.273]; Thoresen L, 2013, CLIN NUTR, V32, P65, DOI 10.1016/j.clnu.2012.05.009; Urban RJ, 2011, HORM RES PAEDIAT, V76, P81, DOI 10.1159/000329184; Ustunel I, 2003, ANAT HISTOL EMBRYOL, V32, P70, DOI 10.1046/j.1439-0264.2003.00441.x; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; von Haehling S, 2014, J AM MED DIR ASSOC, V15, P866, DOI 10.1016/j.jamda.2014.09.007; Wasley D., 2017, PSYCHO-ONCOLOGY; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Yamada C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140094; Zuloaga DG, 2011, ENDOCRINOLOGY, V152, P1572, DOI 10.1210/en.2010-1016	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189480	10.1371/journal.pone.0189480	http://dx.doi.org/10.1371/journal.pone.0189480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216311	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800124
J	Reveles, KR; Lawson, KA; Mortensen, EM; Pugh, MJV; Koeller, JM; Argamany, JR; Frei, CR				Reveles, Kelly R.; Lawson, Kenneth A.; Mortensen, Eric M.; Pugh, Mary Jo V.; Koeller, Jim M.; Argamany, Jacqueline R.; Frei, Christopher R.			National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014	PLOS ONE			English	Article							CLINICAL-PREDICTION RULE; HIGH-RISK ANTIBIOTICS; ACUTE-CARE FACILITIES; UNITED-STATES; ANTIMICROBIAL STEWARDSHIP; HOSPITALIZED-PATIENTS; DIARRHEA; MORTALITY; DISEASE; IMPACT	Introduction Prior studies demonstrated marked increases in Clostridium difficile infection (CDI) in the United States (U.S.) in recent years. The objective of this study was to describe the epidemiology of initial and recurrent CDI in a national Veterans Health Administration (VHA) cohort over a 12-year period. Methods This was a retrospective cohort study of all adult VHA beneficiaries with CDI (ICD-9-CM code 008.45) plus a positive CDI stool test between October 1, 2002 and September 30, 2014. Data were obtained from the VA Informatics and Computing Infrastructure. Recurrence was defined as a second ICD-9-CM code plus a new course of CDI therapy following a minimum three-day gap after the initial therapy was completed. CDI incidence and outcomes were presented descriptively and longitudinally. Results Overall, 30,326 patients met study inclusion criteria. CDI incidence increased from FY 2003 (1.6 per 10,000) to FY 2013 (5.1 per 10,000). Thereafter, CDI incidence decreased through FY 2014 (4.6 per 10,000). A total of 5,011 patients (17%) experienced a first recurrence and, of those, 1,713 (34%) experienced a second recurrence. Recurrence incidence increased 10-fold over the study period, from (0.1 per 10,000) in FY 2003, to (1.0 per 10,000) in FY 2014. Overall, 30-day mortality and median hospital length of stay (LOS) decreased among initial episodes over the study period. Mortality was higher for initial episodes (21%) compared to first recurrences (11%) and second recurrences (7%). Median hospital LOS was longer for first episodes (13 days) compared to first (9 days) and second recurrences (8 days). Conclusions Initial and recurrent CDI episodes increased among veterans over a 12-year period. Outcomes, such as mortality and hospital LOS improved in recent years; both of these outcomes are worse for initial CDI episodes than recurrent episodes.	[Reveles, Kelly R.; Lawson, Kenneth A.; Koeller, Jim M.; Argamany, Jacqueline R.; Frei, Christopher R.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Reveles, Kelly R.; Koeller, Jim M.; Argamany, Jacqueline R.; Frei, Christopher R.] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA; [Reveles, Kelly R.; Pugh, Mary Jo V.; Frei, Christopher R.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Mortensen, Eric M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med & Clin Sci, Dallas, TX 75390 USA; [Mortensen, Eric M.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Pugh, Mary Jo V.] UT Hlth San Antonio, Dept Epidemiol & Biostat, San Antonio, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Health San Antonio	Reveles, KR (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Reveles, KR (corresponding author), UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.; Reveles, KR (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.	kdaniels46@utexas.edu	Pugh, Mary Jo/K-5336-2019; Frei, Christopher/AAI-1421-2020; Mortensen, Eric/AAF-2713-2020; Reveles, Kelly/AAI-1575-2021	Pugh, Mary Jo/0000-0003-4196-7763; Frei, Christopher/0000-0002-0692-4787; 	American College of Clinical Pharmacy Research Institute Futures Grant; National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center [1P30AG044271-01A1]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001120]	American College of Clinical Pharmacy Research Institute Futures Grant; National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported, in part, by an American College of Clinical Pharmacy Research Institute Futures Grant, awarded to K.R.R. This material is also the result of work supported with resources and the use of facilities at the Audie L. Murphy Memorial VA Hospital, San Antonio, TX. Furthermore, K.R.R. is supported by the National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center (1P30AG044271-01A1) Career Development (KL2) Program. Finally, C.R.F. is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001120.	Aitken SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102848; Aldeyab MA, 2012, J ANTIMICROB CHEMOTH, V67, P2988, DOI 10.1093/jac/dks330; [Anonymous], 2012, STAT B; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Bhangu S, 2010, COLORECTAL DIS, V12, P241, DOI 10.1111/j.1463-1318.2009.01832.x; Chou AF, 2016, INFECT CONT HOSP EP, V37, P647, DOI 10.1017/ice.2016.26; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubberke ER, 2006, EMERG INFECT DIS, V12, P1576, DOI 10.3201/eid1210.060016; Evans ME, 2016, INFECT CONT HOSP EP, V37, P720, DOI 10.1017/ice.2016.27; Evans ME, 2014, INFECT CONT HOSP EP, V35, P1037, DOI 10.1086/677151; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Freedberg DE, 2013, AM J GASTROENTEROL, V108, P1794, DOI 10.1038/ajg.2013.333; Gabriel L, 2014, J HOSP INFECT, V88, P12, DOI 10.1016/j.jhin.2014.04.011; Hensgens MPM, 2013, CLIN INFECT DIS, V56, P1108, DOI 10.1093/cid/cis1209; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Huang CC, 2013, AM J EMERG MED, V31, P830, DOI 10.1016/j.ajem.2013.02.010; JOHNSON S, 1989, J INFECT DIS, V159, P340, DOI 10.1093/infdis/159.2.340; Kenneally C, 2007, CHEST, V132, P418, DOI 10.1378/chest.07-0202; Kurtzhalts KE, 2016, CLIN THER, V38, P1750, DOI 10.1016/j.clinthera.2016.06.004; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Lagrotteria D, 2006, CLIN INFECT DIS, V43, P547, DOI 10.1086/506354; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; McNulty C, 1997, J ANTIMICROB CHEMOTH, V40, P707, DOI 10.1093/jac/40.5.707; Mermel LA, 2013, JT COMM J QUAL PATIE, V39, P298, DOI 10.1016/S1553-7250(13)39042-4; Moehring RW, 2013, INFECT CONT HOSP EP, V34, P1055, DOI 10.1086/673144; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Naggie S, 2010, INFECTION, V38, P297, DOI 10.1007/s15010-010-0025-0; Nair S, 1998, AM J GASTROENTEROL, V93, P1873; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; O'Connor KA, 2004, QJM-INT J MED, V97, P423, DOI 10.1093/qjmed/hch076; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Ricciardi R, 2007, ARCH SURG-CHICAGO, V142, P624, DOI 10.1001/archsurg.142.7.624; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Tabak YP, 2013, INFECT CONT HOSP EP, V34, P588, DOI 10.1086/670621; Talpaert MJ, 2011, J ANTIMICROB CHEMOTH, V66, P2168, DOI 10.1093/jac/dkr253; Thomas C, 2002, CLIN INFECT DIS, V35, P1457, DOI 10.1086/342691; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wenisch JM, 2012, INFECTION, V40, P479, DOI 10.1007/s15010-012-0258-1; Yam P, 2012, AM J HEALTH-SYST PH, V69, P1142, DOI 10.2146/ajhp110512; Young-Xu Y, 2015, INFECT CONT HOSP EP, V36, P1038, DOI 10.1017/ice.2015.138; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447; Zilberberg MD, 2014, J HOSP MED, V9, P418, DOI 10.1002/jhm.2189; Zilberberg MD, 2009, CRIT CARE MED, V37, P2583, DOI 10.1097/CCM.0b013e3181ab8388	58	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189227	10.1371/journal.pone.0189227	http://dx.doi.org/10.1371/journal.pone.0189227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216276	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800101
J	Yang, SM; Lix, LM; Yan, L; Hinds, AM; Leslie, WD				Yang, Shuman; Lix, Lisa M.; Yan, Lin; Hinds, Aynslie M.; Leslie, William D.			International Classification of Diseases (ICD)-coded obesity predicts risk of incident osteoporotic fracture	PLOS ONE			English	Article							BODY-MASS INDEX; BONE; ASSOCIATION; VALIDITY; VALIDATION; DIAGNOSIS; ICD-9-CM; UPDATE; FAT	International Classification of Diseases (ICD) codes have been used to ascertain individuals who are obese. There has been limited research about the predictive value of ICD-coded obesity for major chronic conditions at the population level. We tested the utility of ICDcoded obesity versus measured obesity for predicting incident major osteoporotic fracture (MOF), after adjusting for covariates (i.e., age and sex). In this historical cohort study (2001-2015), we selected 61,854 individuals aged 50 years and older from the Manitoba Bone Mineral Density Database, Canada. Body mass index (BMI) >= 30 kg/m(2) was used to define measured obesity. Hospital and physician ICD codes were used to ascertain ICDcoded obesity and incident MOF. Average cohort age was 66.3 years and 90.3% were female. The sensitivity, specificity and positive predictive value for ICD-coded obesity using measured obesity as the reference were 0.11 (95% confidence interval [CI]: 0.10, 0.11), 0.99 (95% CI: 0.99, 0.99) and 0.79 (95% CI: 0.77, 0.81), respectively. ICD-coded obesity (adjusted hazard ratio [HR] 0.83; 95% CI: 0.70, 0.99) and measured obesity (adjusted HR 0.83; 95% CI: 0.78, 0.88) were associated with decreased MOF risk. Although the area under the receiver operating characteristic curve (AUROC) estimates for incident MOF were not significantly different for ICD-coded obesity versus measured obesity (0.648 for ICD-coded obesity versus 0.650 for measured obesity; P = 0.056 for AUROC difference), the category-free net reclassification index for ICD-coded obesity versus measured obesity was -0.08 (95% CI: -0.11, -0.06) for predicting incident MOF. ICD-coded obesity predicted incident MOF, though it had low sensitivity and reclassified MOF risk slightly less well than measured obesity.	[Yang, Shuman] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China; [Yang, Shuman; Lix, Lisa M.; Yan, Lin; Hinds, Aynslie M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Yang, Shuman; Leslie, William D.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada	Jilin University; University of Manitoba; University of Manitoba	Yang, SM (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China.; Yang, SM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Yang, SM (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	shumanyang@jlu.edu.cn		Leslie, William/0000-0002-1056-1691; Yang, Shuman/0000-0002-9169-5850	Canadian Institutes of Health Research (CIHR) Foundation grant [334013]; Manitoba Research Chair; Research Manitoba Postdoctoral Fellowship Award; Manitoba Centre for Health Policy [2015/2016-52]	Canadian Institutes of Health Research (CIHR) Foundation grant(Canadian Institutes of Health Research (CIHR)); Manitoba Research Chair; Research Manitoba Postdoctoral Fellowship Award; Manitoba Centre for Health Policy	This research was supported by a Canadian Institutes of Health Research (CIHR) Foundation grant to LML (#334013). LML is supported by a Manitoba Research Chair. SY was funded by a Research Manitoba Postdoctoral Fellowship Award.; The authors acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository (HIPC#2015/2016-52). The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Healthy Living, and Seniors, or other data providers is intended or should be inferred. Data used in this study are from the Population Research Data Repository housed at the Manitoba Centre for Health Policy, University of Manitoba and were derived from data provided by Manitoba Health, Healthy Living, and Seniors.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Bhan S, 2014, J BIOMECH, V47, P2391, DOI 10.1016/j.jbiomech.2014.04.026; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chan MY, 2014, J BONE MINER RES, V29, P2327, DOI 10.1002/jbmr.2288; Chateau D, 2012, CAN J PUBLIC HEALTH, V103, pS23, DOI 10.1007/BF03403825; COX DR, 1972, J R STAT SOC B, V34, P187; Crowson CS, 2014, STAT METHODS MED RES, V25, P1692; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Etherington J, 1996, J BONE MINER RES, V11, P1333; Fransoo R., 2011, ADULT OBESITY MANITO; Goff SL, 2012, PAEDIATR PERINAT EP, V26, P421, DOI 10.1111/j.1365-3016.2012.01303.x; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Kuhle S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-173; Leslie WD, 2005, J CLIN DENSITOM, V8, P25, DOI 10.1385/JCD:8:1:025; Leslie WD, 2010, J BONE MINER RES, V25, P2350, DOI 10.1002/jbmr.123; Lix LM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-301; Lloyd JT, 2015, EVAL HEALTH PROF, V38, P508, DOI 10.1177/0163278714553661; Martin BJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-70; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; O'Donnell S, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0143-2; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Prieto-Alhambra D, 2012, J BONE MINER RES, V27, P294, DOI 10.1002/jbmr.1466; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Roos LL, 2003, HEALTH SERV RES, V38, P1339, DOI 10.1111/1475-6773.00180; Shen J, 2016, J CLIN ENDOCR METAB, V101, P476, DOI 10.1210/jc.2015-3123; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; WHO, 2016, FACT SHEETS OB OV WH; World Health Organization, 2004, BMI CLASSIFICATION	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189168	10.1371/journal.pone.0189168	http://dx.doi.org/10.1371/journal.pone.0189168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216254	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800086
